PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bard-Chapeau, EA; Szumska, D; Jacob, B; Chua, BQL; Chatterjee, GC; Zhang, Y; Ward, JM; Urun, F; Kinameri, E; Vincent, SD; Ahmed, S; Bhattacharya, S; Osato, M; Perkins, AS; Moore, AW; Jenkins, NA; Copeland, NG				Bard-Chapeau, Emilie A.; Szumska, Dorota; Jacob, Bindya; Chua, Belinda Q. L.; Chatterjee, Gouri C.; Zhang, Yi; Ward, Jerrold M.; Urun, Fatma; Kinameri, Emi; Vincent, Stephane D.; Ahmed, Sayadi; Bhattacharya, Shoumo; Osato, Motomi; Perkins, Archibald S.; Moore, Adrian W.; Jenkins, Nancy A.; Copeland, Neal G.			Mice Carrying a Hypomorphic Evi1 Allele Are Embryonic Viable but Exhibit Severe Congenital Heart Defects	PLOS ONE			English	Article							MYELOID-TRANSFORMING GENE; NEURAL CREST MIGRATION; INTEGRATION SITE; FUSION PROTEIN; OUTFLOW-TRACT; ZINC FINGERS; STEM-CELLS; EXPRESSION; RECEPTOR; PROTOONCOGENE	The ecotropic viral integration site 1 (Evi1) oncogenic transcription factor is one of a number of alternative transcripts encoded by the Mds1 and Evi1 complex locus (Mecom). Overexpression of Evi1 has been observed in a number of myeloid disorders and is associated with poor patient survival. It is also amplified and/or overexpressed in many epithelial cancers including nasopharyngeal carcinoma, ovarian carcinoma, ependymomas, and lung and colorectal cancers. Two murine knockout models have also demonstrated Evi1's critical role in the maintenance of hematopoietic stem cell renewal with its absence resulting in the death of mutant embryos due to hematopoietic failure. Here we characterize a novel mouse model (designated Evi1(fl3)) in which Evi1 exon 3, which carries the ATG start, is flanked by loxP sites. Unexpectedly, we found that germline deletion of exon3 produces a hypomorphic allele due to the use of an alternative ATG start site located in exon 4, resulting in a minor Evi1 N-terminal truncation and a block in expression of the Mds1-Evi1 fusion transcript. Evi1(delta ex3/delta ex3) mutant embryos showed only a mild non-lethal hematopoietic phenotype and bone marrow failure was only observed in adult Vav-iCre/+, Evi1(fl3/fl3) mice in which exon 3 was specifically deleted in the hematopoietic system. Evi1(delta ex3/delta ex3) knockout pups are born in normal numbers but die during the perinatal period from congenital heart defects. Database searches identified 143 genes with similar mutant heart phenotypes as those observed in Evi1(delta ex3/delta ex3) mutant pups. Interestingly, 42 of these congenital heart defect genes contain known Evi1-binding sites, and expression of 18 of these genes are also effected by Evi1 siRNA knockdown. These results show a potential functional involvement of Evi1 target genes in heart development and indicate that Evi1 is part of a transcriptional program that regulates cardiac development in addition to the development of blood.	[Bard-Chapeau, Emilie A.; Chua, Belinda Q. L.; Ward, Jerrold M.; Ahmed, Sayadi; Jenkins, Nancy A.; Copeland, Neal G.] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Szumska, Dorota; Bhattacharya, Shoumo] Welcome Trust Ctr Human Genet, Oxford, England; [Jacob, Bindya; Osato, Motomi] Canc Sci Inst, Singapore, Singapore; [Chatterjee, Gouri C.] Yale Univ, Sch Med, MYSM Sch Med, New Haven, CT USA; [Zhang, Yi; Perkins, Archibald S.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Urun, Fatma; Kinameri, Emi; Moore, Adrian W.] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Vincent, Stephane D.] Univ Strasbourg, Inserm U964, CNRS UMR 7104, Dept Dev & Stem Cells,Inst Genet & Biol Mol & Cel, Illkirch Graffenstaden, France	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of Oxford; Wellcome Centre for Human Genetics; Yale University; University of Rochester; RIKEN; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Copeland, NG (corresponding author), Methodist Hosp, Res Inst, 6535 Fannin, Houston, TX 77030 USA.	ncopeland@tmhs.org	Vincent, Stéphane D/M-2046-2013; Moore, Adrian W/A-3339-2013; Osato, Motomi/N-5056-2014; Moore, Adrian Walton/AAN-5656-2021; Bhattacharya, Shoumo/F-4127-2010	Vincent, Stéphane D/0000-0003-1638-9615; Moore, Adrian W/0000-0002-8242-301X; Osato, Motomi/0000-0003-3982-9054; Moore, Adrian Walton/0000-0002-8242-301X; Bhattacharya, Shoumo/0000-0002-5571-0478; Urun-Bryant, Fatma Rabia/0000-0002-5200-2003; Szumska, Dorota/0000-0001-7764-9551; Zhang, Yi/0000-0003-2785-1780	Biomedical Research Council (BMRC); Agency for Science, Technology and Research (A*STAR), Singapore; Japan Society for Promotion of Sciences (JSPS); RIKEN Brain Science Institute (BSI) core grant; Cancer Prevention Research Institute of Texas (CPRIT); British Heart Foundation [RG/10/17/28553, PG/07/045/22690] Funding Source: researchfish	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Japan Society for Promotion of Sciences (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN Brain Science Institute (BSI) core grant; Cancer Prevention Research Institute of Texas (CPRIT); British Heart Foundation(British Heart Foundation)	This work was supported by the Biomedical Research Council (BMRC), Agency for Science, Technology and Research (A*STAR), Singapore; a Japan Society for Promotion of Sciences (JSPS) Grants-in-Aid Young Scientists (B), and a RIKEN Brain Science Institute (BSI) core grant to A. W. M.; and the Cancer Prevention Research Institute of Texas (CPRIT) (N.G.C. and N.A.J.). N.G.C. and N.A.J. are both CPRIT Scholars in Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzuherri H, 2006, GENE, V384, P154, DOI 10.1016/j.gene.2006.07.027; Baek ST, 2012, DEVELOPMENT, V139, P2040, DOI 10.1242/dev.074054; Bard-Chapeau EA, 2005, NAT MED, V11, P567, DOI 10.1038/nm1227; Bard-Chapeau EA, 2013, P NATL ACAD SCI USA, V110, pE2885, DOI 10.1073/pnas.1309310110; Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; BARTHOLOMEW C, 1994, ONCOGENE, V9, P939; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Beppu H, 2009, DEV BIOL, V331, P167, DOI 10.1016/j.ydbio.2009.04.032; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; BORDEREAUX D, 1990, ONCOGENE, V5, P925; Boyd KE, 2006, BLOOD, V107, P733, DOI 10.1182/blood-2003-05-1626; Brewer AC, 2005, STEM CELLS DEV, V14, P425, DOI 10.1089/scd.2005.14.425; Brooks DJ, 1996, BRIT J CANCER, V74, P1518, DOI 10.1038/bjc.1996.583; Choi YW, 2007, LUNG CANCER, V55, P43, DOI 10.1016/j.lungcan.2006.09.018; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Danesh SM, 2009, GENE EXPR PATTERNS, V9, P255, DOI 10.1016/j.gep.2009.04.002; DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; DOLLE P, 1994, MECH DEVELOP, V45, P91, DOI 10.1016/0925-4773(94)90023-X; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Floro KL, 2011, HUM MOL GENET, V20, P1097, DOI 10.1093/hmg/ddq554; FUNABIKI T, 1994, ONCOGENE, V9, P1575; Gammill LS, 2007, DEV NEUROBIOL, V67, P47, DOI 10.1002/dneu.20326; Gammill LS, 2006, DEVELOPMENT, V133, P99, DOI 10.1242/dev.02187; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Goyama S, 2010, INT J HEMATOL, V91, P753, DOI 10.1007/s12185-010-0618-5; Goyama S, 2009, CANCER SCI, V100, P990, DOI 10.1111/j.1349-7006.2009.01152.x; Guris DL, 2001, NAT GENET, V27, P293, DOI 10.1038/85855; Harhay GP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-166; Hohenauer T, 2012, DEVELOPMENT, V139, P2267, DOI 10.1242/dev.070110; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; IRUELAARISPE ML, 1993, DEV DYNAM, V197, P40, DOI 10.1002/aja.1001970105; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Koonin EV, 2010, NAT REV GENET, V11, P487, DOI 10.1038/nrg2810; Koos B, 2011, CLIN CANC RES; KUROKAWA M, 1995, ONCOGENE, V11, P833; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Lepore JJ, 2006, J CLIN INVEST, V116, P929, DOI 10.1172/JCi27363; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Loomes KM, 1999, HUM MOL GENET, V8, P2443, DOI 10.1093/hmg/8.13.2443; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; MacDonald ST, 2008, CARDIOVASC RES, V79, P448, DOI 10.1093/cvr/cvn101; Mariano JM, 1998, INT J DEV BIOL, V42, P1125; Metais JY, 2008, MOL THER, V16, P439, DOI 10.1038/sj.mt.6300372; Mitani K, 2004, ONCOGENE, V23, P4263, DOI 10.1038/sj.onc.1207777; Modlich U, 2008, LEUKEMIA, V22, P1519, DOI 10.1038/leu.2008.118; Mollard R, 2000, MECH DEVELOP, V94, P223, DOI 10.1016/S0925-4773(00)00303-8; MORISHITA K, 1990, ONCOGENE, V5, P1419; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakajima M, 2004, DEV DYNAM, V230, P795, DOI 10.1002/dvdy.20098; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Nerlov C, 2010, BIOESSAYS, V32, P680, DOI 10.1002/bies.201000004; Norris RA, 2010, DEV DYNAM, V239, P2118, DOI 10.1002/dvdy.22346; Nucifora G, 2006, GENE, V368, P1, DOI 10.1016/j.gene.2005.09.020; Ogawa S, 1996, LEUKEMIA, V10, P788; Ogawa S, 1996, ONCOGENE, V13, P183; Ogilvy S, 1998, BLOOD, V91, P419, DOI 10.1182/blood.V91.2.419.419_419_430; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; ROELEN BAJ, 1994, DEV BIOL, V166, P716, DOI 10.1006/dbio.1994.1350; Sanlaville D, 2006, J MED GENET, V43, P211, DOI 10.1136/jmg.2005.036160; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider Juergen E., 2004, BMC Developmental Biology, V4, P1; Sood R, 1999, LEUKEMIA, V13, P348, DOI 10.1038/sj.leu.2401360; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; TANAKA T, 1994, J BIOL CHEM, V269, P24020; Tissir F, 2004, DEV BRAIN RES, V149, P63, DOI 10.1016/j.devbrainres.2004.01.002; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; WANG YQ, 1995, MECH DEVELOP, V52, P275, DOI 10.1016/0925-4773(95)00408-S; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Weninger WJ, 2005, DEVELOPMENT, V132, P1337, DOI 10.1242/dev.01696; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; Yamashita N, 2005, BRIT J HAEMATOL, V131, P495, DOI 10.1111/j.1365-2141.2005.05793.x; Yatsula B, 2005, J BIOL CHEM, V280, P30712, DOI 10.1074/jbc.M504293200; Yokoi S, 2003, CLIN CANCER RES, V9, P4705; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057032; Zhang Y, 2011, BLOOD, V118, P3853, DOI 10.1182/blood-2011-02-334680	87	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89397	10.1371/journal.pone.0089397	http://dx.doi.org/10.1371/journal.pone.0089397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586749	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800020
J	Chen, JW; Wilson, ES; Dahmer, MK; Quasney, MW; Waterer, GW; Feldman, C; Wunderink, RG				Chen, Jiwang; Wilson, Esther S.; Dahmer, Mary K.; Quasney, Michael W.; Waterer, Grant W.; Feldman, Charles; Wunderink, Richard G.			Lack of Association of the Caspase-12 Long Allele with Community-Acquired Pneumonia in People of African Descent	PLOS ONE			English	Article							RESPIRATORY-FAILURE; UNITED-STATES; SEVERE SEPSIS; EPIDEMIOLOGY; POLYMORPHISM; EXPRESSION; MORTALITY; LINKAGE; IMPACT; TNF	Community-acquired pneumonia (CAP) is a common cause of sepsis. Active full-length caspase-12 (CASP12L), confined to the people of African descent, has been associated with increased susceptibility to and mortality from severe sepsis. The objective of this study was to determine whether CASP12L was a marker for susceptibility and/or severity of CAP. We examined three CAP cohorts and two control populations: 241 adult Memphis African American CAP patients, 443 pediatric African American CAP patients, 90 adult South African CAP patients, 120 Memphis healthy adult African American controls and 405 adult Chicago African American controls. Clinical outcomes including mortality, acute respiratory distress syndrome (ARDS), septic shock or severe sepsis, need for mechanical ventilation, and S. pneumoniae bacteremia. Neither in the three individual CAP cohorts nor in the combined CAP cohorts, was mortality in CASP12L carriers significantly different from that in non-CASP12L carriers. No statistically significant association between genotype and any measures of CAP severity was found in any cohort. We conclude that the functional CASP12L allele is not a marker for susceptibility and/or severity of CAP.	[Chen, Jiwang; Waterer, Grant W.; Wunderink, Richard G.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Chen, Jiwang] Univ Illinois, Sect Pulm Crit Care Sleep & Allergy, Chicago, IL USA; [Wilson, Esther S.] Oakbrook Pediat, Summerville, SC USA; [Dahmer, Mary K.; Quasney, Michael W.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Waterer, Grant W.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Feldman, Charles] Charlotte Maxeke Johannesburg Acad Hosp, Dept Internal Med, Div Pulmonol, Johannesburg, South Africa; [Feldman, Charles] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa	Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Michigan System; University of Michigan; University of Western Australia; University of Witwatersrand; University of Witwatersrand	Wunderink, RG (corresponding author), Northwestern Univ, Dept Med, Chicago, IL 60611 USA.	r-wunderink@northwestern.edu	Waterer, Grant/AAG-2385-2021; Feldman, Charles/ABF-3315-2020	Feldman, Charles/0000-0002-6881-8314; Wunderink, Richard/0000-0002-8527-4195	Northwestern Memorial Faculty Foundation; National Research Foundation of South Africa	Northwestern Memorial Faculty Foundation; National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was supported by a grant from the Northwestern Memorial Faculty Foundation (to JC) and the National Research Foundation of South Africa (to CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Ferwerda B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006870; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; MUNDY LM, 1995, AM J RESP CRIT CARE, V152, P1309, DOI 10.1164/ajrccm.152.4.7551387; Nadiri A, 2006, J IMMUNOL, V177, P4239, DOI 10.4049/jimmunol.177.7.4239; Patwari PP, 2008, PEDIATR CRIT CARE ME, V9, P553, DOI 10.1097/PCC.0b013e31818d32f1; PURCELL S, 2003, BIOINFORMATICS, V19, P149, DOI [DOI 10.1093/BIOINFORMATICS/19.1.149, 10.1093/bioinformatics/19.1.149]; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quasney MW, 2004, CRIT CARE MED, V32, P1115, DOI 10.1097/01.CCM.0000124872.55243.5A; Restrepo MI, 2009, EUR RESPIR J, V33, P153, DOI 10.1183/09031936.00054108; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Song Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-616; Temple SEL, 2003, GENES IMMUN, V4, P283, DOI 10.1038/sj.gene.6363963; Temple SEL, 2008, CELL IMMUNOL, V251, P69, DOI 10.1016/j.cellimm.2008.04.013; Tracey KJ, 2004, NATURE, V429, P35, DOI 10.1038/429035a; Wunderink RG, 2011, AM J RESP CRIT CARE, V184, P186, DOI 10.1164/rccm.201103-0381UP; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Yeretssian G, 2009, P NATL ACAD SCI USA, V106, P9016, DOI 10.1073/pnas.0813362106	23	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89194	10.1371/journal.pone.0089194	http://dx.doi.org/10.1371/journal.pone.0089194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586588	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000032
J	Nie, S; Wang, XW; Zhang, HF; Li, QL; Wang, BH				Nie, Sen; Wang, Xuwen; Zhang, Haifeng; Li, Qilang; Wang, Binghong			Robustness of Controllability for Networks Based on Edge-Attack	PLOS ONE			English	Article							COMPLEX NETWORKS; DYNAMICS; CASCADE	We study the controllability of networks in the process of cascading failures under two different attacking strategies, random and intentional attack, respectively. For the highest-load edge attack, it is found that the controllability of Erdos-Renyi network, that with moderate average degree, is less robust, whereas the Scale-free network with moderate power-law exponent shows strong robustness of controllability under the same attack strategy. The vulnerability of controllability under random and intentional attacks behave differently with the increasing of removal fraction, especially, we find that the robustness of control has important role in cascades for large removal fraction. The simulation results show that for Scale-free networks with various power-law exponents, the network has larger scale of cascades do not mean that there will be more increments of driver nodes. Meanwhile, the number of driver nodes in cascading failures is also related to the edges amount in strongly connected components.	[Nie, Sen; Wang, Xuwen; Wang, Binghong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Zhang, Haifeng] Anhui Univ, Sch Math Sci, Hefei 230039, Peoples R China; [Li, Qilang] Anhui Jianzhu Univ, Dept Math & Phys, Hefei, Peoples R China; [Wang, Binghong] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou, Zhejiang, Peoples R China; [Wang, Binghong] Southwest Univ Sci & Technol, Sch Sci, Mianyang, Sichuan, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui University; Anhui Jianzhu University; Wenzhou University; Southwest University of Science & Technology - China	Wang, XW (corresponding author), Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China.	xww86@mail.ustc.edu.cn; bhwang@ustc.edu.cn	Zhang, Hai-Feng/AAG-6272-2020; Zhang, Haifeng/B-2499-2012; Li, Qi-Lang/AAC-8464-2022; Li, Qi-Lang/B-5289-2015	Zhang, Haifeng/0000-0002-7094-669X; Li, Qi-Lang/0000-0003-0946-551X; Li, Qi-Lang/0000-0003-0946-551X; Wang, Xu-Wen/0000-0001-7670-3544	NSFC [11275186, 91024026, 11302001]; Major Important Project Fund for Anhui University Nature Science [KJ2011ZD07]	NSFC(National Natural Science Foundation of China (NSFC)); Major Important Project Fund for Anhui University Nature Science	BW was supported by NSFC under Grant No. 11275186 and No. 91024026, and the Major Important Project Fund for Anhui University Nature Science under Grant No. KJ2011ZD07. QL was supported by NSFC under Grant No. 11302001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Cowan NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038398; Donetti L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.188701; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056109; Huang XQ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.065101; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Lai YC, 2005, PRAMANA-J PHYS, V64, P483, DOI 10.1007/BF02706197; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Liu YY, 2013, P NATL ACAD SCI USA, V110, P2460, DOI 10.1073/pnas.1215508110; Liu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044459; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Moreno Y, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066130; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Parshani R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.048701; Posfai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01067; Pu CL, 2012, PHYSICA A, V391, P4420, DOI 10.1016/j.physa.2012.04.019; Ruths, 2013, COMPLEX NETWORKS, P185, DOI DOI 10.1007/978-3-642-36844-8_18; Shao J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036116; Sole RV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026102; Sorrentino F, 2007, CHAOS, V17, DOI 10.1063/1.2743098; Wang BB, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/58003; Wang WX, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026101; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056113; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu JJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066111; Yan G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.218703; Yang R, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026112; Yuan ZZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3447; Zheng JF, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/58002	37	60	61	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89066	10.1371/journal.pone.0089066	http://dx.doi.org/10.1371/journal.pone.0089066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586507	gold, Green Published			2022-12-27	WOS:000332389000023
J	Poulsen, C; Panjikar, S; Holton, SJ; Wilmanns, M; Song, YH				Poulsen, Christian; Panjikar, Santosh; Holton, Simon J.; Wilmanns, Matthias; Song, Young-Hwa			WXG100 Protein Superfamily Consists of Three Subfamilies and Exhibits an alpha-Helical C-Terminal Conserved Residue Pattern	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR REPLACEMENT; COMPLEX-FORMATION; VII SECRETION; VIRULENCE; SYSTEM; ESAT-6; IDENTIFICATION; PATHOGENESIS; EXPRESSION	Members of the WXG100 protein superfamily form homo- or heterodimeric complexes. The most studied proteins among them are the secreted T-cell antigens CFP-10 (10 kDa culture filtrate protein, EsxB) and ESAT-6 (6 kDa early secreted antigen target, EsxA) from Mycobacterium tuberculosis. They are encoded on an operon within a gene cluster, named as ESX-1, that encodes for the Type VII secretion system (T7SS). WXG100 proteins are secreted in a full-length form and it is known that they adopt a four-helix bundle structure. In the current work we discuss the evolutionary relationship between the homo- and heterodimeric WXG100 proteins, the basis of the oligomeric state and the key structural features of the conserved sequence pattern of WXG100 proteins. We performed an iterative bioinformatics analysis of the WXG100 protein superfamily and correlated this with the atomic structures of the representative WXG100 proteins. We find, firstly, that the WXG100 protein superfamily consists of three subfamilies: CFP-10-, ESAT-6- and sagEsxA-like proteins (EsxA proteins similar to that of Streptococcus agalactiae). Secondly, that the heterodimeric complexes probably evolved from a homodimeric precursor. Thirdly, that the genes of heterodimeric WXG100 proteins are always encoded in bi-cistronic operons and finally, by combining the sequence alignments with the X-ray data we identify a conserved C-terminal sequence pattern. The side chains of these conserved residues decorate the same side of the C-terminal a-helix and therefore form a distinct surface. Our results lead to a putatively extended T7SS secretion signal which combines two reported T7SS recognition characteristics: Firstly that the T7SS secretion signal is localized at the C-terminus of T7SS substrates and secondly that the conserved residues YxxxD/E are essential for T7SS activity. Furthermore, we propose that the specific a-helical surface formed by the conserved sequence pattern including YxxxD/E motif is a key component of T7SS-substrate recognition.	[Poulsen, Christian; Panjikar, Santosh; Holton, Simon J.; Wilmanns, Matthias; Song, Young-Hwa] EMBL Hamburg, Hamburg, Germany; [Song, Young-Hwa] Univ Lubeck, Inst Phys, Lubeck, Germany; [Panjikar, Santosh] Australian Synchrotron, Clayton, Vic, Australia; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	European Molecular Biology Laboratory (EMBL); University of Lubeck; Monash University	Song, YH (corresponding author), EMBL Hamburg, Hamburg, Germany.	song@physik.uni-luebeck.de	Panjikar, Santosh/D-2709-2012; Poulsen, Christian/M-4638-2014	Panjikar, Santosh/0000-0001-7429-3879; Wilmanns, Matthias/0000-0002-4643-5435	EC [LSHP-CT-012127]; BMBF [0312992A, PTJ-BIO 0313801L]	EC(European CommissionEuropean Commission Joint Research Centre); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the EC Grant ScrIn-Silico (LSHP-CT-012127) to M.W., by the BMBF Grant "X-MTB" (0312992A) to M.W., and by a grant within the BMBF programme Pathogenomik Plus (PTJ-BIO 0313801L) to M.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2002, BIOINFORMATICS, V18, P908, DOI 10.1093/bioinformatics/18.7.908; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson M, 2013, MOL MICROBIOL, V90, P734, DOI 10.1111/mmi.12395; Bern M, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-34; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Brunger AT, 2002, ACCOUNTS CHEM RES, V35, P404, DOI 10.1021/ar010034r; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Daugelat S, 2003, MICROBES INFECT, V5, P1082, DOI 10.1016/S1286-4579(03)00205-3; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Garufi G, 2008, J BACTERIOL, V190, P7004, DOI 10.1128/JB.00458-08; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; Harrington ED, 2007, P NATL ACAD SCI USA, V104, P13913, DOI 10.1073/pnas.0702636104; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ize B, 2006, SCIENCE, V313, P1583, DOI 10.1126/science.1132537; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirschner A, 2008, GENE, V422, P22, DOI 10.1016/j.gene.2008.06.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lightbody KL, 2008, J BIOL CHEM, V283, P17681, DOI 10.1074/jbc.M800123200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Poulsen C, 2010, FEBS LETT, V584, P669, DOI 10.1016/j.febslet.2009.12.057; RAMACHANDRAN GN, 1963, SCIENCE, V141, P288, DOI 10.1126/science.141.3577.288; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Roback P, 2007, NUCLEIC ACIDS RES, V35, P5085, DOI 10.1093/nar/gkm518; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shukla A, 2010, ACTA CRYSTALLOGR F, V66, P1421, DOI 10.1107/S1744309110036286; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Sundaramoorthy R, 2008, J MOL BIOL, V383, P603, DOI 10.1016/j.jmb.2008.08.047; Sutcliffe IC, 2011, ANTON LEEUW INT J G, V99, P127, DOI 10.1007/s10482-010-9507-4; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Teutschbein J, 2009, MICROBIOL RES, V164, P253, DOI 10.1016/j.micres.2006.11.016; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	49	64	71	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89313	10.1371/journal.pone.0089313	http://dx.doi.org/10.1371/journal.pone.0089313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586681	gold, Green Submitted, Green Published			2022-12-27	WOS:000332389000038
J	Chen, S; Rasgon, JL				Chen, Song; Rasgon, Jason L.			Culex tarsalis Vitellogenin Gene Promoters Investigated In Silico and In Vivo Using Transgenic Drosphila melanogaster	PLOS ONE			English	Article							WEST-NILE-VIRUS; AMERICAN MOSQUITOS DIPTERA; DROSOPHILA-MELANOGASTER; ANOPHELES-STEPHENSI; AEDES-AEGYPTI; REGULATORY ELEMENTS; SALIVARY-GLANDS; EXPRESSION; POSITION; CULICIDAE	Introduction: Genetic modification, or transgenesis, is a powerful technique to investigate the molecular interactions between vector-borne pathogens and their arthropod hosts, as well as a potential novel approach for vector-borne disease control. Transgenesis requires the use of specific regulatory regions, or promoters, to drive expression of genes of interest in desired target tissues. In mosquitoes, the vast majority of described promoters are from Anopheles and Aedes mosquitoes. Results: Culex tarsalis is one of the most important vectors of arboviruses (including West Nile virus) in North America, yet it has not been the subject of molecular genetic study. In order to facilitate molecular genetic work in this important vector species, we isolated four fat body-specific promoter sequences located upstream of the Cx. tarsalis vitellogenin genes (Vg1a, Vg1b, Vg2a and Vg2b). Sequences were analyzed in silico to identify requisite cis-acting elements. The ability for promoter sequences to drive expression of green fluorescent protein (GFP) in vivo was investigated using transgenic Drosophila melanogaster. All four promoters were able to drive GFP expression but there was dramatic variation between promoters and between individual Drosophila lines, indicating significant position effects. The highest expression was observed in line Vg2bL3, which was >300-fold higher than the lowest line Vg1aL2. Conclusions: These new promoters will be useful for driving expression of genes of interest in transgenic Cx. tarsalis and perhaps other insects.	[Rasgon, Jason L.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Chen, Song] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Rasgon, JL (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	jlr54@psu.edu		Rasgon, Jason/0000-0002-4050-8429	NIH [R01AI067371]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067371] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIH grant R01AI067371 to JLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNETT HC, 1956, AM J TROP MED HYG, V5, P86, DOI 10.4269/ajtmh.1956.5.86; Castronuevo P, 2002, DNA CELL BIOL, V21, P535, DOI 10.1089/104454902320219095; Chen S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-142; Chen XG, 2007, AM J TROP MED HYG, V76, P1118, DOI 10.4269/ajtmh.2007.76.1118; CLARK SH, 1986, GENETICS, V114, P819; Coates CJ, 1999, GENE, V226, P317, DOI 10.1016/S0378-1119(98)00557-5; Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Ishida Yuko, 1999, Journal of Sericultural Science of Japan, V68, P417; Jinwal UK, 2006, INSECT MOL BIOL, V15, P301, DOI 10.1111/j.1365-2583.2006.00644.x; KIRKPATRICK RB, 1994, DEV GENET, V15, P188, DOI 10.1002/dvg.1020150209; Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197; Kokoza VA, 2001, GENE, V274, P47, DOI 10.1016/S0378-1119(01)00602-3; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardo F, 2000, J BIOL CHEM, V275, P23861, DOI 10.1074/jbc.M909547199; Lombardo F, 2005, INSECT MOL BIOL, V14, P207, DOI 10.1111/j.1365-2583.2004.00549.x; MITSIALIS SA, 1985, NATURE, V317, P453, DOI 10.1038/317453a0; Moreira LA, 2000, P NATL ACAD SCI USA, V97, P10895, DOI 10.1073/pnas.97.20.10895; Noden BH, 1995, J PARASITOL, V81, P912, DOI 10.2307/3284039; Provost-Javier KN, 2010, INSECT MOL BIOL, V19, P423, DOI 10.1111/j.1365-2583.2010.00999.x; Reisen W, 2004, EMERG INFECT DIS, V10, P1369, DOI 10.3201/eid1008.040077; REISEN WK, 1993, J MED ENTOMOL, V30, P151, DOI 10.1093/jmedent/30.1.151; REISEN WK, 1995, J MED ENTOMOL, V32, P316, DOI 10.1093/jmedent/32.3.316; Skavdis G, 1996, EMBO J, V15, P344, DOI 10.1002/j.1460-2075.1996.tb00364.x; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; Turell MJ, 2010, J MED ENTOMOL, V47, P884, DOI 10.1603/ME10007; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Venkatesan M, 2007, MOL BIOL EVOL, V24, P1208, DOI 10.1093/molbev/msm040; Venkatesan M, 2010, MOL ECOL, V19, P1573, DOI 10.1111/j.1365-294X.2010.04577.x; XIONG B, 1995, P NATL ACAD SCI USA, V92, P9313, DOI 10.1073/pnas.92.20.9313; Yoshida S, 2006, INSECT MOL BIOL, V15, P403, DOI 10.1111/j.1365-2583.2006.00645.x	32	1	1	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88994	10.1371/journal.pone.0088994	http://dx.doi.org/10.1371/journal.pone.0088994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586476	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900024
J	Cole, MP; Tangpong, J; Oberley, TD; Chaiswing, L; Kiningham, KK; Clair, DKS				Cole, Marsha P.; Tangpong, Jitbanjong; Oberley, Terry D.; Chaiswing, Luksana; Kiningham, Kinsley K.; Clair, Daret K. St.			Nuclear Interaction between ADR-Induced p65 and p53 Mediates Cardiac Injury in iNOS (-/-) Mice	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; FACTOR-KAPPA-B; NITRIC-OXIDE; DOXORUBICIN CARDIOTOXICITY; GENE-EXPRESSION; TRANSGENIC MICE; CELL-DEATH; ADRIAMYCIN; MITOCHONDRIAL; ACTIVATION	Adriamycin (ADR) treatment causes an imbalance in the levels of nitric oxide ((NO)-N-center dot) and superoxide (O-2(center dot-)) production leading to cardiac injury. Previously we demonstrated that mice lacking inducible nitric oxide synthase (iNOS) have increased oxidative stress and mitochondrial injury. The molecular events leading to increased mitochondrial injury in iNOS deficient mice is unknown. ADR in the absence of iNOS preferentially activates a proapoptotic pathway without a concurrent increase in prosurvival pathways. Treatment with ADR leads to an increase in DNA binding activity of nuclear factor kappa B (NF kappa B) and p53 in wildtype mice. Following ADR treatment, p53, but not NF kappa B DNA binding activity, as well as the level of Bax, a p53 target gene, was increased in iNOS (-/-) mice. This apoptotic signaling effect in iNOS (-/-) is alleviated by overexpression of manganese superoxide dismutase (MnSOD). Increases in NF kappa B and p53 in ADR-treated wildtype mice did not lead to increases in target genes such as MnSOD, bcl-xL, or Bax. Moreover, co-immunoprecipitation analysis revealed that p65, a prominent member of the NF kappa B family, interacts with p53 in the nucleus. These results suggest that NF kappa B and p53 may counter act one another's actions in ADR-treated wildtype (WT) mice. Further, these results identify a novel mechanism by which oxidative stress may regulate transcription of proapoptotic genes.	[Cole, Marsha P.] Univ Louisville, Louisville, KY 40292 USA; [Tangpong, Jitbanjong] Walailak Univ, Sch Allied Hlth Sci & Publ Hlth, Nakhon Si Thammarat, Thailand; [Oberley, Terry D.; Chaiswing, Luksana] Univ Wisconsin, Dept Pathol, VA Hosp, Madison, WI 53706 USA; [Kiningham, Kinsley K.] Belmont Coll Pharm, Nashville, TN USA; [Clair, Daret K. St.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Clair, Daret K. St.] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY USA	University of Louisville; Walailak University; University of Wisconsin System; University of Wisconsin Madison; University of Kentucky; University of Kentucky	Cole, MP (corresponding author), Univ Louisville, Louisville, KY 40292 USA.	marcie.cole@louisville.edu			NIH [T32DK07778, R01CA80152, R01CA94853]; NATIONAL CANCER INSTITUTE [R01CA094853, R01CA080152] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL095769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants T32DK07778, R01CA80152, R01CA94853, and resources and facilities from the William S. Middleton Veterans Administration Hospital, Madison, WI. The content herein is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benderdour M, 2003, J BIOL CHEM, V278, P45154, DOI 10.1074/jbc.M306285200; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Chaiswing L, 2005, MOL CANCER THER, V4, P1056, DOI 10.1158/1535-7163.MCT-04-0322; Chaiswing L, 2004, TOXICOL PATHOL, V32, P536, DOI 10.1080/01926230490502601; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cole MP, 2006, CARDIOVASC RES, V69, P186, DOI 10.1016/j.cardiores.2005.07.012; Daosukho C, 2007, FREE RADICAL BIO MED, V42, P1818, DOI 10.1016/j.freeradbiomed.2007.03.007; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Drane P, 2001, ONCOGENE, V20, P430, DOI 10.1038/sj.onc.1204101; El-Boghdady NA, 2013, INDIAN J BIOCHEM BIO, V50, P202; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603; Jung K, 2001, ADV DRUG DELIVER REV, V49, P87, DOI 10.1016/S0169-409X(01)00128-4; Kiningham KK, 2001, BIOCHEM J, V353, P147, DOI 10.1042/bj3530147; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nithipongvanitch R, 2007, ANTIOXID REDOX SIGN, V9, P1001, DOI 10.1089/ars.2007.1632; Nithipongvanitch R, 2007, J HISTOCHEM CYTOCHEM, V55, P629, DOI 10.1369/jhc.6A7146.2007; OBERLEY LW, 1987, ARCH BIOCHEM BIOPHYS, V254, P69, DOI 10.1016/0003-9861(87)90082-8; ODonnell VB, 1997, BIOCHEMISTRY-US, V36, P15216, DOI 10.1021/bi971891z; OLSON RD, 1990, FASEB J, V4, P3076, DOI 10.1096/fasebj.4.13.2210154; Pacher P, 2003, CIRCULATION, V107, P896, DOI 10.1161/01.CIR.0000048192.52098.DD; Punj V, 2003, CELL MICROBIOL, V5, P225, DOI 10.1046/j.1462-5822.2003.00269.x; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Rudolph V, 2009, J BIOL CHEM, V284, P1461, DOI 10.1074/jbc.M802298200; Saad SY, 2004, J BIOCHEM MOL TOXIC, V18, P78, DOI 10.1002/jbt.20012; Sevilla L, 2001, HISTOL HISTOPATHOL, V16, P595, DOI 10.14670/HH-16.595; Slee EA, 2004, ONCOGENE, V23, P2809, DOI 10.1038/sj.onc.1207516; Umlauf J, 2002, Exp Clin Cardiol, V7, P35; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weinstein DM, 2000, J PHARMACOL EXP THER, V294, P396; Xi L, 2012, NITRIC OXIDE-BIOL CH, V26, P274, DOI 10.1016/j.niox.2012.03.006; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Yen HC, 1999, ARCH BIOCHEM BIOPHYS, V362, P59, DOI 10.1006/abbi.1998.1011; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909; Zingarelli B, 2002, FASEB J, V16, DOI 10.1096/fj.01-0533com	41	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89251	10.1371/journal.pone.0089251	http://dx.doi.org/10.1371/journal.pone.0089251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586632	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900037
J	Ellis, CK; Stahl, RS; Nol, P; Waters, WR; Palmer, MV; Rhyan, JC; VerCauteren, KC; McCollum, M; Salman, MD				Ellis, Christine K.; Stahl, Randal S.; Nol, Pauline; Waters, W. Ray; Palmer, Mitchell V.; Rhyan, Jack C.; VerCauteren, Kurt C.; McCollum, Matthew; Salman, M. D.			A Pilot Study Exploring the Use of Breath Analysis to Differentiate Healthy Cattle from Cattle Experimentally Infected with Mycobacterium bovis	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; SOLID-PHASE MICROEXTRACTION; WHITE-TAILED DEER; ELECTRONIC-NOSE; DAIRY-COWS; TUBERCULOSIS; BIOMARKERS; DISEASE; GAS; DIAGNOSIS	Bovine tuberculosis, caused by Mycobacterium bovis, is a zoonotic disease of international public health importance. Antemortem surveillance is essential for control; however, current surveillance tests are hampered by limitations affecting ease of use or quality of results. There is an emerging interest in human and veterinary medicine in diagnosing disease via identification of volatile organic compounds produced by pathogens and host-pathogen interactions. The objective of this pilot study was to explore application of existing human breath collection and analysis methodologies to cattle as a means to identify M. bovis infection through detection of unique volatile organic compounds or changes in the volatile organic compound profiles present in breath. Breath samples from 23 male Holstein calves (7 non-infected and 16 M. bovis-infected) were collected onto commercially available sorbent cartridges using a mask system at 90 days post-inoculation with M. bovis. Samples were analyzed using gas chromatography-mass spectrometry, and chromatographic data were analyzed using standard analytical chemical and metabolomic analyses, principle components analysis, and a linear discriminant algorithm. The findings provide proof of concept that breath-derived volatile organic compound analysis can be used to differentiate between healthy and M. bovis-infected cattle.	[Ellis, Christine K.; Salman, M. D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Anim Populat Hlth Inst, Ft Collins, CO 80523 USA; [Ellis, Christine K.; Stahl, Randal S.; VerCauteren, Kurt C.] Anim Plant & Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Nol, Pauline; Rhyan, Jack C.; McCollum, Matthew] Anim Plant & Hlth Inspect Serv, USDA, Vet Serv, Wildlife Livestock Dis Invest Team, Ft Collins, CO USA; [Waters, W. Ray; Palmer, Mitchell V.] ARS, USDA, Natl Anim Dis Ctr, Ames, IA USA	Colorado State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Salman, MD (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Anim Populat Hlth Inst, Ft Collins, CO 80523 USA.	m.d.salman@colostate.edu	Stahl, Randal/AAC-6492-2021; Palmer, Mitchell/R-7091-2018	Palmer, Mitchell/0000-0002-5902-3333	USDA-APHIS (United States Department of Agriculture's Animal and Plant Health Inspection Service)	USDA-APHIS (United States Department of Agriculture's Animal and Plant Health Inspection Service)	USDA-APHIS (United States Department of Agriculture's Animal and Plant Health Inspection Service) funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar U. B., 2011, Veterinary Research (Pakistan), V4, P24; Ameni G., 2003, International Journal of Applied Research in Veterinary Medicine, V1, P17; [Anonymous], 2011, GLOB TUB CONTR 2011; Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; Bass KE, 2013, CLIN VACCINE IMMUNOL; Biet F, 2005, VET RES, V36, P411, DOI 10.1051/vetres:2005001; Bolton EE, 2008, ANN REP COMPUT CHEM, P217; Burciaga-Robles LO, 2009, AM J VET RES, V70, P1291, DOI 10.2460/ajvr.70.10.1291; Cai LS, 2006, ANAL BIOANAL CHEM, V386, P1791, DOI 10.1007/s00216-006-0799-1; CHEN S, 1970, J LAB CLIN MED, V75, P628; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; Corradi M, 2003, AM J RESP CRIT CARE, V167, P1380, DOI 10.1164/rccm.200210-1253OC; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Dobbelaar P, 1996, VET QUART, V18, P151, DOI 10.1080/01652176.1996.9694638; ElliottMartin RJ, 1997, J AGR ENG RES, V67, P267, DOI 10.1006/jaer.1997.0168; Fend R, 2005, J CLIN MICROBIOL, V43, P1745, DOI 10.1128/JCM.43.4.1745-1751.2005; Fend R, 2006, J CLIN MICROBIOL, V44, P2039, DOI 10.1128/JCM.01591-05; Filzmoser P., 2009, INTRO MULTIVARIATE S; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Gerstman, 2003, EPIDEMIOLOGY KEPT SI; Guaman AV, 2012, J CHROMATOGR B, V881-82, P76, DOI 10.1016/j.jchromb.2011.12.001; HAWTHORNE SB, 1986, J CHROMATOGR SCI, V24, P258, DOI 10.1093/chromsci/24.6.258; Jeanbourquin P, 2007, MED VET ENTOMOL, V21, P217, DOI 10.1111/j.1365-2915.2007.00686.x; KAJI H, 1978, J CHROMATOGR, V145, P464, DOI 10.1016/S0378-4347(00)81377-8; Kaneen JB, 2006, MYCOBACTERIUM BOVIS, P2602; KLEMM WR, 1987, CHEM SENSES, V12, P77, DOI 10.1093/chemse/12.1.77; Knobloch H, 2009, AIP CONF PROC, V1137, P195, DOI 10.1063/1.3156505; Kwiatkowska S, 2007, RESP MED, V101, P574, DOI 10.1016/j.rmed.2006.06.015; Larsen MH, 2005, CURRENT PROTOCOLS MI; LEOPOLD DA, 1990, ARCH OTOLARYNGOL, V116, P354; LEUENBERGER C, 1984, ANAL CHEM, V56, P2518, DOI 10.1021/ac00277a057; LIDDELL K, 1976, POSTGRAD MED J, V52, P136, DOI 10.1136/pgmj.52.605.136; Ma WD, 1995, J CHEM ECOL, V21, P1895, DOI 10.1007/BF02033850; MANOLIS A, 1983, CLIN CHEM, V29, P5; McNerney R, 2012, FEMS MICROBIOL LETT, V328, P150, DOI 10.1111/j.1574-6968.2011.02493.x; Middleditch B, 1989, J CHROMATOGR LIB, P44; Moorhead KT, 2011, COMPUT METH PROG BIO, V101, P173, DOI 10.1016/j.cmpb.2010.07.010; Mottram TT, 1999, LIVEST PROD SCI, V61, P7, DOI 10.1016/S0301-6226(99)00045-7; Nawrath T, 2012, BEILSTEIN J ORG CHEM, V8, P290, DOI 10.3762/bjoc.8.31; NUNEZ AJ, 1984, J CHROMATOGR, V300, P127, DOI 10.1016/S0021-9673(01)87583-X; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pavlou AK, 2004, BIOSENS BIOELECTRON, V20, P538, DOI 10.1016/j.bios.2004.03.002; Peled N, 2012, SENSOR ACTUAT B-CHEM, V171, P588, DOI 10.1016/j.snb.2012.05.038; Phillips M, 1999, LANCET, V353, P1930, DOI 10.1016/S0140-6736(98)07552-7; Phillips M, 1999, J CHROMATOGR B, V729, P75, DOI 10.1016/S0378-4347(99)00127-9; Phillips M, 2004, J HEART LUNG TRANSPL, V23, P701, DOI 10.1016/j.healun.2003.07.017; Phillips M, 2007, TUBERCULOSIS, V87, P44, DOI 10.1016/j.tube.2006.03.004; Phillips M, 2006, BREAST CANCER RES TR, V99, P19, DOI 10.1007/s10549-006-9176-1; Phillips M, 2010, TUBERCULOSIS, V90, P145, DOI 10.1016/j.tube.2010.01.003; Pollock JM, 2000, VET REC, V146, P659, DOI 10.1136/vr.146.23.659; Probert CSJ, 2009, J GASTROINTEST LIVER, V18, P337; Purkhart R, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/027103; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Schmitt SM, 1997, J WILDLIFE DIS, V33, P749, DOI 10.7589/0090-3558-33.4.749; Scott-Thomas A, TUBERCULOSIS; Shaw SL, 2007, ENVIRON SCI TECHNOL, V41, P1310, DOI 10.1021/es061475e; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; SOROOSHIAN A, 2008, ATMOS CHEM PHYS DISC, V8, P10415, DOI DOI 10.5194/ACPD-8-10415-2008; Spinhirne JP, 2004, J CHROMATOGR A, V1025, P63, DOI 10.1016/j.chroma.2003.08.062; Spinhirne JP, 2003, BIOSYST ENG, V84, P239, DOI 10.1016/S1537-5110(02)00240-4; Spooner AD, 2009, ANALYST, V134, P1922, DOI 10.1039/b905627k; Syhre M, 2008, TUBERCULOSIS, V88, P317, DOI 10.1016/j.tube.2008.01.002; Syhre M, 2009, TUBERCULOSIS, V89, P263, DOI 10.1016/j.tube.2009.04.003; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Team R, 2005, R FDN STAT COMP; Turner C, 2012, BIOSYST ENG, V112, P75, DOI 10.1016/j.biosystemseng.2012.03.001; Uhde E, 1999, APPL SOLID SORBENTS; *USDA, 2005, 9145011 USDA APHIS, P1; Waters WR, 2007, VACCINE, V25, P7832, DOI 10.1016/j.vaccine.2007.08.029; Waters WR, 2004, J WILDLIFE DIS, V40, P66, DOI 10.7589/0090-3558-40.1.66; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; Westhoff M, 2010, INT J ION MOBIL SPEC, V13, P131, DOI 10.1007/s12127-010-0049-2; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810	78	35	36	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89280	10.1371/journal.pone.0089280	http://dx.doi.org/10.1371/journal.pone.0089280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586655	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700027
J	Martinez-Gonzalez, NA; Tandjung, R; Djalali, S; Huber-Geismann, F; Markun, S; Rosemann, T				Martinez-Gonzalez, Nahara Anani; Tandjung, Ryan; Djalali, Sima; Huber-Geismann, Flore; Markun, Stefan; Rosemann, Thomas			Effects of Physician-Nurse Substitution on Clinical Parameters: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PRIMARY-CARE OUTCOMES; HEALTH; PRACTITIONERS; MANAGEMENT	Background: Physicians' shortage in many countries and demands of high-quality and affordable care make physician-nurse substitution an appealing workforce strategy. The objective of this study is to conduct a systematic review and meta-analysis of randomised controlled trials (RCTs) assessing the impact of physician-nurse substitution in primary care on clinical parameters. Methods: We systematically searched OVID Medline and Embase, The Cochrane Library and CINAHL, up to August 2012; selected peer-reviewed RCTs comparing physician-led care with nurse-led care on changes in clinical parameters. Study selection and data extraction were performed in duplicate by independent reviewers. We assessed the individual study risk of bias; calculated the study-specific and pooled relative risks (RR) or weighted mean differences (WMD); and performed fixed-effects meta- analyses. Results: 11 RCTs (N = 30,247) were included; most were from Europe, generally small with higher risk of bias. In all studies, nurses provided care for complex conditions including HIV, hypertension, heart failure, cerebrovascular diseases, diabetes, asthma, Parkinson's disease and incontinence. Meta-analyses showed greater reductions in systolic blood pressure (SBP) in favour of nurse-led care (WMD -4.27 mmHg, 95% CI -6.31 to -2.23) but no statistically significant differences between groups in the reduction of diastolic blood pressure (DBP) (WMD -1.48 mmHg, 95% CI -3.05 to -0.09), total cholesterol (TC) (WMD -0.08 mmol/l, 95% CI -0.22 to 0.07) or glycosylated haemoglobin (WMD 0.12% HbAc1, 95% CI -0.13 to 0.37). Of other 32 clinical parameters identified, less than a fifth favoured nurse-led care while 25 showed no significant differences between groups. Limitations: disease-specific interventions from a small selection of healthcare systems, insufficient quantity and quality of studies, many different parameters. Conclusions: trained nurses appeared to be better than physicians at lowering SBP but similar at lowering DBP, TC or HbA1c. There is insufficient evidence that nurse-led care leads to better outcomes of other clinical parameters than physician-led care.	[Martinez-Gonzalez, Nahara Anani; Tandjung, Ryan; Djalali, Sima; Huber-Geismann, Flore; Markun, Stefan; Rosemann, Thomas] Univ Zurich, Inst Primary Care, Zurich, Switzerland	University of Zurich	Rosemann, T (corresponding author), Univ Zurich, Inst Primary Care, Zurich, Switzerland.	Thomas.Rosemann@usz.ch		Markun, Stefan/0000-0003-3317-0957; Martinez-Gonzalez, Nahara Anani/0000-0002-8258-4155	Health Services Research Fund (Bangerter foundation) from the Swiss Academy of Medical Sciences (SAMW); Swiss Association of Family Physicians (Hausarzte Schweiz)	Health Services Research Fund (Bangerter foundation) from the Swiss Academy of Medical Sciences (SAMW); Swiss Association of Family Physicians (Hausarzte Schweiz)	This study was funded by the Health Services Research Fund (Bangerter foundation) from the Swiss Academy of Medical Sciences (SAMW) and by the Swiss Association of Family Physicians (Hausarzte Schweiz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andryukhin A, 2010, EUR J GEN PRACT, V16, P205, DOI 10.3109/13814788.2010.527938; [Anonymous], 2008, REV MAN REVMAN; Chopra M, 2008, LANCET, V371, P668, DOI 10.1016/S0140-6736(08)60305-0; Denver EA, 2003, DIABETES CARE, V26, P2256, DOI 10.2337/diacare.26.8.2256; Du Moulin MFMT, 2007, J WOUND OSTOMY CONT, V34, P631, DOI 10.1097/01.WON.0000299814.98230.13; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hiss RG, 2007, DIABETES EDUCATOR, V33, P493, DOI 10.1177/0145721707301349; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; Houweling ST, 2011, J CLIN NURS, V20, P1264, DOI 10.1111/j.1365-2702.2010.03562.x; Jarman B, 2002, BRIT MED J, V324, P1072, DOI 10.1136/bmj.324.7345.1072; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kuethe M, 2011, PRIM CARE RESP J, V20, P84, DOI 10.4104/pcrj.2011.00003; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lenz ER, 2004, MED CARE RES REV, V61, P332, DOI 10.1177/1077558704266821; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Marcellus Lenora, 2004, Can J Nurs Res, V36, P82; Mundinger MO, 2000, JAMA-J AM MED ASSOC, V283, P59, DOI 10.1001/jama.283.1.59; Salsberg E, 2006, ACAD MED, V81, P782, DOI 10.1097/00001888-200609000-00003; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Sibbald B, 1998, BRIT MED J, V316, P201; SIBBALD B, 2004, J HLTH SERVICES R S1, V9, pS28; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Voogdt-Pruis HR, 2010, BRIT J GEN PRACT, V60, P40, DOI 10.3399/bjgp10X482095; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization, 2006, WORLD HLTH REP WORK; World Health Organization, 2008, TASK SHIFT RAT RED T	30	43	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89181	10.1371/journal.pone.0089181	http://dx.doi.org/10.1371/journal.pone.0089181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586577	Green Published, Green Accepted, gold			2022-12-27	WOS:000331880700022
J	Paiva, TD; de Albuquerque, AFC; Borges, BD; Harada, ML				Paiva, Thiago da Silva; Cavalcante de Albuquerque, Amanda Ferreira; Borges, Barbara do Nascimento; Harada, Maria Lucia			Description and Phylogeny of Tetrakeronopsis silvanetoi gen. nov., sp nov (Hypotricha, Pseudokeronopsidae), a New Benthic Marine Ciliate from Brazil	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; CILIOPHORA; SPIROTRICHEA; PROTOZOA; IDENTIFICATION; DISCREPANCIES; MORPHOLOGY; EVOLUTION; PROTISTA; MODEL	Pseudokeronopsidae Borror & Wicklow, 1983 are biotechnologically important ciliate protists which produce toxic defense substances; however, their diversity is still little known in Brazil. In the present study, Tetrakeronopsis silvanetoi, a new genus and species of marine pseudokeronopsid hypotrichs is described from samples of water with bottom sediment collected from the coast of Sao Paulo state. Its phylogenetic affinities to the "core urostyloids" are hypothesized based on analyses of the 18S-rDNA marker, and a new subfamily, the Nothoholostichinae subfam. nov., is erected to name the monophylum composed of pseudokeronopsids in which the anterior corona is usually formed by four frontal cirri. In addition, the new combination Monocoronella longissima comb. nov. is proposed for Nothoholosticha longissima (Dragesco & DragescoKerneis, 1986) Li et al., 2009.	[Paiva, Thiago da Silva] Univ Fed Rio de Janeiro, Inst Biol, Dept Zool, Lab Protistol, Rio De Janeiro, RJ, Brazil; [Paiva, Thiago da Silva; Harada, Maria Lucia] Fed Univ Para, Lab Biol Mol Francisco Mauro Salzano, Inst Ciencias Biol, BR-66059 Belem, PA, Brazil; [Cavalcante de Albuquerque, Amanda Ferreira] Univ Grande Rio, Duque De Caxias, RJ, Brazil; [Borges, Barbara do Nascimento] Univ Fed Rural Amazonia, Ctr Tecnol Agr, Inst Socioambiental & Recursos Hidr, Belem, PA, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Para; Universidade do Grande Rio; Universidade Federal Rural da Amazonia (UFRA)	Paiva, TD (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Zool, Lab Protistol, Rio De Janeiro, RJ, Brazil.	tpaiva@biologia.ufrj.br	Borges, Barbara N/G-1355-2012; da Silva Paiva, Thiago/E-9336-2015	Borges, Barbara N/0000-0002-5989-8287; 	CAPES; CNPq; FAPESP	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	CAPES, CNPq and FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anonymous, 2008, V88, P1; Berger H, 2003, EUR J PROTISTOL, V39, P373, DOI 10.1078/0932-4739-00006; Berger H., 2006, MONOGR BIOL, V85, P1, DOI DOI 10.1007/1-4020-5273-1_1; Berger H., 1999, MONOGRAPHIAE BIOL, V78, P1, DOI DOI 10.1007/978-94-011-4637-1; Berger Helmut, 2006, Monographiae Biologicae, V85, pi; Berger Helmut, 2008, Monographiae Biologicae, V88, pi; Berger Helmut, 1999, Monographiae Biologicae, V78, pi; BORROR AC, 1983, ACTA PROTOZOOL, V22, P97; Bos DH, 2005, DEV COMP IMMUNOL, V29, P211, DOI 10.1016/j.dci.2004.07.007; Carey P.G, 1992, MARINE INTERSTITIAL; Chen XM, 2011, J EUKARYOT MICROBIOL, V58, P497, DOI 10.1111/j.1550-7408.2011.00581.x; Chen XM, 2011, ZOOL SCR, V40, P659, DOI 10.1111/j.1463-6409.2011.00492.x; Couto Erminda C.G., 2003, Gayana, V67, P327; da Silva-Neto ID, 2012, EUR J PROTISTOL, V48, P48, DOI 10.1016/j.ejop.2011.07.004; Dembitsky VM, 2002, RUSS J BIOORG CHEM+, V28, P170, DOI 10.1023/A:1015748018820; Dieckmann J, 1995, EUR J PROTISTOL, V31, P372, DOI 10.1016/S0932-4739(11)80449-9; Dragesco J., 1986, Faune Tropicale, V26, P1; Fan YB, 2014, EUR J PROTISTOL, V50, P78, DOI 10.1016/j.ejop.2013.06.003; FENCHEL T, 1969, Ophelia, V6, P1; FENCHEL T, 1987, ECOLOGY PROTOZOA BIO; Foissner Wilhelm, 2002, Denisia, V5, P1; Gao F, 2010, ACTA OCEANOL SIN, V29, P90, DOI 10.1007/s13131-010-0067-2; Guella G, 2010, EUR J ORG CHEM, V2010, P427, DOI 10.1002/ejoc.200900905; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HOFLE G, 1994, ANGEW CHEM INT EDIT, V33, P1495, DOI 10.1002/anie.199414951; Huang J, 2014, MOL PHYLOGENET EVOL, V70, P337, DOI 10.1016/j.ympev.2013.10.005; Kattar M.R., 1970, B ZOOLOGIAE BIOLOGIA, V27, P123, DOI DOI 10.11606/ISSN.2526-3374.BFFCLUSPNSZOOBM.1970.121196; Li LQ, 2009, EUR J PROTISTOL, V45, P237, DOI 10.1016/j.ejop.2009.01.004; LUEKEN W, 1989, J PROTOZOOL, V36, P350, DOI 10.1111/j.1550-7408.1989.tb05525.x; Lynn DH, 2008, CILIATED PROTOZOA CH, V3; Miao M, 2011, SCI CHINA LIFE SCI, V54, P634, DOI 10.1007/s11427-011-4192-8; Miller M.A., 2010, P GAT COMP ENV WORKS; Motulsky H., 1999, ANAL DATA GRAPHPAD P; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; Paiva TS, 2009, GENET MOL RES, V8, P223, DOI 10.4238/vol8-1gmr529; Paiva TD, 2012, INT J SYST EVOL MICR, V62, P229, DOI 10.1099/ijs.0.031237-0; Pan Y, 2013, EUR J PROTISTOL, V49, P298, DOI 10.1016/j.ejop.2012.08.008; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Schmidt SL, 2007, J EUKARYOT MICROBIOL, V54, P201, DOI 10.1111/j.1550-7408.2007.00250.x; Shao C, 2008, INT J SYST EVOL MICR, V58, P2962, DOI 10.1099/ijs.0.65781-0; Song WB, 2011, J EUKARYOT MICROBIOL, V58, P11, DOI 10.1111/j.1550-7408.2010.00518.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wanick RC, 2004, ZOOTAXA, P1; WICKLOW BJ, 1982, PROTISTOLOGICA, V18, P299; YI Z, 2011, PLOS ONE, V6, P1; Yi ZZ, 2008, EUR J PROTISTOL, V44, P45, DOI 10.1016/j.ejop.2007.08.002; Yi ZZ, 2008, EUR J PROTISTOL, V44, P254, DOI 10.1016/j.ejop.2007.12.002	50	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e88954	10.1371/journal.pone.0088954	http://dx.doi.org/10.1371/journal.pone.0088954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586456	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700014
J	Balan, S; Bharathan, SP; Vellichiramal, NN; Sathyan, S; Joseph, V; Radhakrishnan, K; Banerjee, M				Balan, Shabeesh; Bharathan, Sumitha Prameela; Vellichiramal, Neetha Nanoth; Sathyan, Sanish; Joseph, Vijai; Radhakrishnan, Kurupath; Banerjee, Moinak			Genetic Association Analysis of ATP Binding Cassette Protein Family Reveals a Novel Association of ABCB1 Genetic Variants with Epilepsy Risk, but Not with Drug-Resistance	PLOS ONE			English	Article							JUVENILE MYOCLONIC EPILEPSY; MEDICALLY INTRACTABLE EPILEPSY; TEMPORAL-LOBE EPILEPSY; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; HIPPOCAMPAL SCLEROSIS; REFRACTORY EPILEPSY; TREATMENT RESPONSE; INDIAN POPULATION; FEBRILE SEIZURES	Epilepsy constitutes a heterogeneous group of disorders that is characterized by recurrent unprovoked seizures due to widely different etiologies. Multidrug resistance remains a major issue in clinical epileptology, where one third of patients with epilepsy continue to have seizures. Role of efflux transporters in multidrug resistant epilepsy has been attributed to drug-resistant epilepsy although, with discrepant observation in genetic studies. These discrepancies could be attributed to variety of factors such as variable definition of the anti-epileptic drug (AED)-resistance, variable epilepsy phenotypes and ethnicities among the studies. In the present study we inquired the role of multidrug transporters ABCB1 and ABCG2 variants in determining AED-resistance and susceptibility to epilepsy in three well-characterized cohorts comprising of mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) (prototype for AED-resistant epilepsy); juvenile myoclonic epilepsy (JME) (prototype for AED-responsive epilepsy); and healthy non-epileptic controls, in 738 subjects of Malayalam speaking south Indian ancestry. ABCB1 and ABCG2 variants were not found to be associated with drug resistance when AED-resistant and AED-responsive cohorts were compared. However, a significant association was observed between ABCB1 (C3435T) rs1045642 and risk of having epilepsy (MTLE-HS and JME pooled cohort; genotypic p-value = 0.0002; allelic p-value = 0.004). This association was seen persistent with MTLE-HS (genotypic p-value = 0.0008; allelic p-value = 0.004) and also with JME (genotypic p-value = 0.01; allelic p-value = 0.05) cohort individually. In-silico functional prediction indicated that ABCB1 rs1045642 has a deleterious impact on protein coding function and in splicing regulation. We conclude that the ABCB1 and ABCG2 variants do not confer to AED-resistance in the study population. However, ABCB1 rs1045642 increases vulnerability to epilepsy with greater tendency for MTLE-HS in south Indian ancestry from Kerala.	[Balan, Shabeesh; Bharathan, Sumitha Prameela; Vellichiramal, Neetha Nanoth; Sathyan, Sanish; Banerjee, Moinak] Rajiv Gandhi Ctr Biotechnol, Human Mol Genet Lab, Trivandrum, Kerala, India; [Balan, Shabeesh; Radhakrishnan, Kurupath] Sree Chitra Tirunal Inst Med Sci & Technol, R Madhavan Nayar Ctr Comprehens Epilepsy Care, Trivandrum, Kerala, India; [Joseph, Vijai] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Memorial Sloan Kettering Cancer Center	Banerjee, M (corresponding author), Rajiv Gandhi Ctr Biotechnol, Human Mol Genet Lab, Trivandrum, Kerala, India.	mbanerjee@rgcb.res.in	Banerjee, Moinak/X-4471-2018; SATHYAN, SANISH/CAF-8167-2022; Balan, Shabeesh/K-5753-2014; Joseph, Vijai/J-9158-2013	Balan, Shabeesh/0000-0002-1098-1290; Joseph, Vijai/0000-0002-7933-151X; Banerjee, Moinak/0000-0002-0842-0398; Prameela Bharathan, Sumitha/0000-0002-5830-8273	Board of Research in Nuclear Sciences (BRNS), Department of Atomic Energy, Government of India [2007/37/63/BRNS]; Kerala State Council for Science Technology and Environment (KSCSTE), Government of Kerala, India [082/FSHP/08/CSTE]	Board of Research in Nuclear Sciences (BRNS), Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); Kerala State Council for Science Technology and Environment (KSCSTE), Government of Kerala, India	Board of Research in Nuclear Sciences (BRNS), Department of Atomic Energy, Government of India: (No. 2007/37/63/BRNS) Kerala State Council for Science Technology and Environment (KSCSTE), Government of Kerala, India: (No. 082/FSHP/08/CSTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Aronica E, 2005, EPILEPSIA, V46, P849, DOI 10.1111/j.1528-1167.2005.66604.x; Auzmendi J, 2013, CURRENT PHARM DESIGN; Balan S, 2013, PHARMACOGENET GENOM, V23, P605, DOI 10.1097/FPC.0000000000000000; Balan S, 2013, GENE, V526, P449, DOI 10.1016/j.gene.2013.05.067; Balan S, 2012, EPILEPSY RES, V101, P288, DOI 10.1016/j.eplepsyres.2012.04.009; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bournissen FG, 2009, EPILEPSIA, V50, P898, DOI 10.1111/j.1528-1167.2008.01858.x; Brodie MJ, 2012, NEUROLOGY, V78, P1548, DOI 10.1212/WNL.0b013e3182563b19; Cavalleri GL, 2011, PHARMACOGENOMICS, V12, P1429, DOI [10.2217/PGS.11.85, 10.2217/pgs.11.85]; Decoster J, 2012, SCHIZOPHRENIA RES; Dong L, 2011, BRAIN RES; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fujii T, 2012, J PSYCHIATR RES, V46, P555, DOI 10.1016/j.jpsychires.2012.01.012; Grover S, 2010, BIOCHIMIE, V92, P1207, DOI 10.1016/j.biochi.2010.04.008; GRUNEWALD RA, 1993, ARCH NEUROL-CHICAGO, V50, P594, DOI 10.1001/archneur.1993.00540060034013; Haerian BS, 2010, SEIZURE-EUR J EPILEP, V19, P339, DOI 10.1016/j.seizure.2010.05.004; Haerian BS, 2011, PHARMACOGENOMICS, V12, P713, DOI [10.2217/pgs.10.212, 10.2217/PGS.10.212]; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hung CC, 2005, PHARMACOGENOMICS, V6, P411, DOI 10.1517/14622416.6.4.411; Hung CC, 2012, PHARMACOGENOMICS, V13, P159, DOI [10.2217/PGS.11.141, 10.2217/pgs.11.141]; Kasperaviciute D, 2009, PHARMACOGENOMICS, V10, P817, DOI 10.2217/PGS.09.34; Kim DW, 2006, SEIZURE-EUR J EPILEP, V15, P344, DOI 10.1016/j.seizure.2006.02.015; Kim DW, 2009, EPILEPSY RES, V84, P86, DOI 10.1016/j.eplepsyres.2008.12.001; Kim YO, 2006, SEIZURE-EUR J EPILEP, V15, P67, DOI 10.1016/j.seizure.2005.11.001; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kwan P, 2005, EPILEPSIA, V46, P224, DOI 10.1111/j.0013-9580.2005.31904.x; Kwan P, 2007, EPILEPSY BEHAV, V11, P112, DOI 10.1016/j.yebeh.2007.04.013; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Kwan P, 2011, PHARMACOGENOMICS, V12, P319, DOI [10.2217/pgs.10.183, 10.2217/PGS.10.183]; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lakhan R, 2009, EPILEPSY BEHAV, V14, P78, DOI 10.1016/j.yebeh.2008.08.019; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Liu JY, 2009, NEUROIMAGE, V46, P809, DOI 10.1016/j.neuroimage.2009.02.045; Loscher W, 2009, EPILEPSIA, V50, P1, DOI 10.1111/j.1528-1167.2008.01716.x; Marzolini C, 2004, CLIN PHARMACOL THER, V75, P13, DOI 10.1016/j.clpt.2003.09.012; Mathias RA, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-38; Ebid AHI, 2007, THER DRUG MONIT, V29, P305; Nurmohamed L, 2010, EPILEPSIA, V51, P1882, DOI 10.1111/j.1528-1167.2010.02588.x; PANAYIOTOPOULOS CP, 1994, EPILEPSIA, V35, P285, DOI 10.1111/j.1528-1157.1994.tb02432.x; Polli JW, 2009, DRUG METAB DISPOS, V37, P439, DOI 10.1124/dmd.108.024646; Radhakrishnan K, 2009, NAT REV NEUROL, V5, P323, DOI 10.1038/nrneurol.2009.53; Ramesha KN, 2011, EPILEPSIA, V52, P917, DOI 10.1111/j.1528-1167.2010.02891.x; Rathore C, 2011, NEUROLOGY, V76, P1925, DOI 10.1212/WNL.0b013e31821d74b3; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Seo T, 2006, PHARMACOGENOMICS, V7, P551, DOI 10.2217/14622416.7.4.551; Shaheen U, 2013, EPILEPSY RES; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Soranzo N, 2004, GENOME RES, V14, P1333, DOI 10.1101/gr.1965304; Tan NCK, 2004, NEUROLOGY, V63, P1090, DOI 10.1212/01.WNL.0000137051.33486.C7; Tang K, 2002, PHARMACOGENETICS, V12, P437, DOI 10.1097/00008571-200208000-00004; Thomas R, 2006, TISSUE ANTIGENS, V68, P225, DOI 10.1111/j.1399-0039.2006.00652.x; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; Vahab SA, 2009, DRUG METAB PHARMACOK, V24, P255, DOI 10.2133/dmpk.24.255; van Vliet EA, 2005, EPILEPSIA, V46, P1569, DOI 10.1111/j.1528-1167.2005.00250.x; Vijai J, 2003, SEIZURE-EUR J EPILEP, V12, P490, DOI 10.1016/S1059-1311(03)00049-9; Wieser HG, 2004, EPILEPSIA, V45, P32; Zhang CB, 2012, ADV DRUG DELIVER REV, V64, P930, DOI 10.1016/j.addr.2011.12.003	58	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89253	10.1371/journal.pone.0089253	http://dx.doi.org/10.1371/journal.pone.0089253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586633	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900071
J	Lai, RK; Chen, YW; Guan, XW; Nousome, D; Sharma, C; Canoll, P; Bruce, J; Sloan, AE; Cortes, E; Vonsattel, JP; Su, T; Delgado-Cruzata, L; Gurvich, I; Santella, RM; Ostrom, Q; Lee, A; Gregersen, P; Barnholtz-Sloan, J				Lai, Rose K.; Chen, Yanwen; Guan, Xiaowei; Nousome, Darryl; Sharma, Charu; Canoll, Peter; Bruce, Jeffrey; Sloan, Andrew E.; Cortes, Etty; Vonsattel, Jean-Paul; Su, Tao; Delgado-Cruzata, Lissette; Gurvich, Irina; Santella, Regina M.; Ostrom, Quinn; Lee, Annette; Gregersen, Peter; Barnholtz-Sloan, Jill			Genome-Wide Methylation Analyses in Glioblastoma Multiforme	PLOS ONE			English	Article							MGMT PROMOTER METHYLATION; DNA METHYLATION; CPG-ISLAND; HUMAN CANCERS; HUMAN BRAIN; CELLS; 5-HYDROXYMETHYLCYTOSINE; HYPERMETHYLATION; MUTATIONS; EPIGENOME	Few studies had investigated genome-wide methylation in glioblastoma multiforme (GBM). Our goals were to study differential methylation across the genome in gene promoters using an array-based method, as well as repetitive elements using surrogate global methylation markers. The discovery sample set for this study consisted of 54 GBM from Columbia University and Case Western Reserve University, and 24 brain controls from the New York Brain Bank. We assembled a validation dataset using methylation data of 162 TCGA GBM and 140 brain controls from dbGAP. HumanMethylation27 Analysis Bead-Chips (Illumina) were used to interrogate 26,486 informative CpG sites in both the discovery and validation datasets. Global methylation levels were assessed by analysis of L1 retrotransposon (LINE1), 5 methyl-deoxycytidine (5m-dC) and 5 hydroxylmethyl-deoxycytidine (5hm-dC) in the discovery dataset. We validated a total of 1548 CpG sites (1307 genes) that were differentially methylated in GBM compared to controls. There were more than twice as many hypomethylated genes as hypermethylated ones. Both the discovery and validation datasets found 5 tumor methylation classes. Pathway analyses showed that the top ten pathways in hypomethylated genes were all related to functions of innate and acquired immunities. Among hypermethylated pathways, transcriptional regulatory network in embryonic stem cells was the most significant. In the study of global methylation markers, 5m-dC level was the best discriminant among methylation classes, whereas in survival analyses, high level of LINE1 methylation was an independent, favorable prognostic factor in the discovery dataset. Based on a pathway approach, hypermethylation in genes that control stem cell differentiation were significant, poor prognostic factors of overall survival in both the discovery and validation datasets. Approaches that targeted these methylated genes may be a future therapeutic goal.	[Lai, Rose K.; Nousome, Darryl] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Lai, Rose K.; Nousome, Darryl] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90024 USA; [Lai, Rose K.; Nousome, Darryl] Univ Calif Los Angeles, Dept Prevent Med, Los Angeles, CA 90024 USA; [Chen, Yanwen; Guan, Xiaowei; Ostrom, Quinn; Barnholtz-Sloan, Jill] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Sharma, Charu] Columbia Univ, Dept Radiat Oncol, New York, NY USA; [Canoll, Peter; Vonsattel, Jean-Paul] Columbia Univ, Dept Pathol, New York, NY USA; [Bruce, Jeffrey] Columbia Univ, Dept Neurosurg, New York, NY USA; [Bruce, Jeffrey] Columbia Univ, Bartoli Brain Tumor Res Lab, New York, NY USA; [Sloan, Andrew E.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Neurol Surg, Cleveland, OH 44106 USA; [Cortes, Etty; Vonsattel, Jean-Paul] Columbia Univ, New York Brain Bank, New York, NY USA; [Su, Tao] Columbia Univ, Herbert Irving Canc Ctr, Pathol Core, New York, NY USA; [Delgado-Cruzata, Lissette; Gurvich, Irina; Santella, Regina M.] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA; [Delgado-Cruzata, Lissette; Gurvich, Irina; Santella, Regina M.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Biomarker Core, New York, NY USA; [Lee, Annette; Gregersen, Peter] N Shore Univ Hosp, Feinstein Inst Med Genet, Manhasset, NY USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Case Western Reserve University; Columbia University; Columbia University; Columbia University; Columbia University; Case Western Reserve University; Case Western Reserve University Hospital; Columbia University; Columbia University; Columbia University; Columbia University; Northwell Health; North Shore University Hospital	Lai, RK (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.	roselai@usc.edu	Bruce, Jeffrey N/AAC-5307-2022; Sloan, Andrew/AAE-9842-2020; Su, Tao/T-4411-2019; Barnholtz-Sloan, Jill/A-4817-2011; Ostrom, Quinn/F-1820-2018	Su, Tao/0000-0002-9148-6127; Barnholtz-Sloan, Jill/0000-0001-6190-9304; Ostrom, Quinn/0000-0003-3469-7558; Delgado-Cruzata, Lissette/0000-0002-2884-0234; Nousome, Darryl/0000-0002-5259-8599	National Cancer Institute [K07CA127468, R01CA139020-27064, P30CA014089, P30CA043703]; NATIONAL CANCER INSTITUTE [R01CA139020, P30CA043703, P30CA014089, K07CA127468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project described was supported by award number K07CA127468, R01CA139020-27064, P30CA014089 and P30CA043703, all from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JB, 2011, CANCER-AM CANCER SOC, V117, P1847, DOI 10.1002/cncr.25737; Bady P, 2012, ACTA NEUROPATHOL, V124, P547, DOI 10.1007/s00401-012-1016-2; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bert SA, 2013, CANCER CELL, V23, P9, DOI 10.1016/j.ccr.2012.11.006; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Christians A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033449; Cykowski MD, 2012, DIAGN MOL PATHOL, V21, P214, DOI 10.1097/PDM.0b013e31825d802b; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Easwaran H, 2012, GENOME RES, V22, P837, DOI 10.1101/gr.131169.111; Estecio MRH, 2012, MOL CANCER RES, V10, P1332, DOI 10.1158/1541-7786.MCR-12-0351; Estecio MRH, 2010, GENOME RES, V20, P1369, DOI 10.1101/gr.107318.110; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Havik AB, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-36; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Hughes LAE, 2012, BBA-REV CANCER, V1825, P77, DOI 10.1016/j.bbcan.2011.10.005; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Laffaire J, 2011, NEURO-ONCOLOGY, V13, P84, DOI 10.1093/neuonc/noq110; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023332; Orzan F, 2011, NEUROPATH APPL NEURO, V37, P381, DOI 10.1111/j.1365-2990.2010.01132.x; Quinlivan EP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn534; Rodic N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003402; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Shen J, 2012, HEPATOLOGY, V55, P1799, DOI 10.1002/hep.25569; Sher F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040399; Stricker I, 2012, ANTICANCER RES, V32, P3699; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Wang SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037928; Wang Y, 2013, CANCER RES, V73, P4801, DOI 10.1158/0008-5472.CAN-12-3273; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Wu HC, 2012, CARCINOGENESIS, V33, P1946, DOI 10.1093/carcin/bgs201; Wu HC, 2012, CARCINOGENESIS, V33, P1340, DOI 10.1093/carcin/bgs160; Wu XW, 2010, CANCER RES, V70, P2718, DOI 10.1158/0008-5472.CAN-09-3631; Xin YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011357; Zhang Y, 2012, NUCLEIC ACIDS RES, V40, P7257, DOI 10.1093/nar/gks429; Zhang YJ, 2012, WORLD J HEPATOL, V4, P169, DOI [10.4254/wjh.v4.i5.169., 10.4254/wjh.v4.i5.169]	46	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89376	10.1371/journal.pone.0089376	http://dx.doi.org/10.1371/journal.pone.0089376			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586730	Green Published, gold			2022-12-27	WOS:000331717900087
J	Lin, CSH; Chao, SY; Hammel, M; Nix, JC; Tseng, HL; Tsou, CC; Fei, CH; Chiou, HS; Jeng, US; Lin, YS; Chuang, WJ; Wu, JJ; Wang, SY				Lin, Chang Sheng-Huei; Chao, Shi-Yu; Hammel, Michal; Nix, Jay C.; Tseng, Hsiao-Ling; Tsou, Chih-Cheng; Fei, Chun-Hsien; Chiou, Huo-Sheng; Jeng, U-Ser; Lin, Yee-Shin; Chuang, Woei-Jer; Wu, Jiunn-Jong; Wang, Shuying			Distinct Structural Features of the Peroxide Response Regulator from Group A Streptococcus Drive DNA Binding	PLOS ONE			English	Article							ANGLE SCATTERING DATA; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; BACILLUS-SUBTILIS; IRON HOMEOSTASIS; PERR; FUR; VIRULENCE; PROTEIN; COMPUTATION	Group A streptococcus (GAS, Streptococcus pyogenes) is a strict human pathogen that causes severe, invasive diseases. GAS does not produce catalase, but has an ability to resist killing by reactive oxygen species (ROS) through novel mechanisms. The peroxide response regulator (PerR), a member of ferric uptake regulator (Fur) family, plays a key role for GAS to cope with oxidative stress by regulating the expression of multiple genes. Our previous studies have found that expression of an iron-binding protein, Dpr, is under the direct control of PerR. To elucidate the molecular interactions of PerR with its cognate promoter, we have carried out structural studies on PerR and PerR-DNA complex. By combining crystallography and small-angle X-ray scattering (SAXS), we confirmed that the determined PerR crystal structure reflects its conformation in solution. Through mutagenesis and biochemical analysis, we have identified DNA-binding residues suggesting that PerR binds to the dpr promoter at the per box through a winged-helix motif. Furthermore, we have performed SAXS analysis and resolved the molecular architecture of PerR-DNA complex, in which two 30 bp DNA fragments wrap around two PerR homodimers by interacting with the adjacent positively-charged winged-helix motifs. Overall, we provide structural insights into molecular recognition of DNA by PerR and define the hollow structural arrangement of PerR-30bpDNA complex, which displays a unique topology distinct from currently proposed DNA-binding models for Fur family regulators.	[Lin, Chang Sheng-Huei; Chao, Shi-Yu; Tseng, Hsiao-Ling; Tsou, Chih-Cheng; Fei, Chun-Hsien; Chiou, Huo-Sheng; Lin, Yee-Shin; Wang, Shuying] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Hammel, Michal] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Nix, Jay C.; Wu, Jiunn-Jong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Mol Biol Consortium, Berkeley, CA 94720 USA; [Tseng, Hsiao-Ling; Tsou, Chih-Cheng; Lin, Yee-Shin; Wang, Shuying] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Jeng, U-Ser] Natl Synchrotron Radiat Res Ctr, Hsinchu, Taiwan; [Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Wu, Jiunn-Jong] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan	National Cheng Kung University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Cheng Kung University; National Synchrotron Radiation Research Center; National Cheng Kung University; National Cheng Kung University	Wu, JJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Mol Biol Consortium, Berkeley, CA 94720 USA.	sswang23@mail.ncku.edu.tw; jjwu@mail.ncku.edu.tw	wang, shuying/HHZ-4516-2022; Wu, Jiunn-Jong/E-6075-2011	Hammel, Michal/0000-0002-5610-9289; Lin, Chang Sheng-Huei/0000-0002-6966-4417	NSC [1/2897-2311-B-006-006, 98-2311-B-006-004-MY3]; NIH MINOS [R01GM105404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	NSC(Ministry of Science and Technology, Taiwan); NIH MINOS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSC 1/2897-2311-B-006-006 and NSC 98-2311-B-006-004-MY3 to SW and NIH MINOS R01GM105404 to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; An YJ, 2009, NUCLEIC ACIDS RES, V37, P3442, DOI 10.1093/nar/gkp198; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; Brenot A, 2004, INFECT IMMUN, V72, P408, DOI 10.1128/IAI.72.1.408-413.2004; Brenot A, 2007, MOL MICROBIOL, V63, P1185, DOI 10.1111/j.1365-2958.2006.05577.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Diaz-Mireles E, 2004, MICROBIOL-SGM, V150, P1447, DOI 10.1099/mic.0.26961-0; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Duarte V, 2010, MOL BIOSYST, V6, P316, DOI 10.1039/b915042k; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaballa A, 2002, J BACTERIOL, V184, P6508, DOI 10.1128/JB.184.23.6508-6514.2002; Gibson CM, 2000, J BACTERIOL, V182, P448, DOI 10.1128/JB.182.2.448-455.2000; Giedroc DP, 2009, MOL MICROBIOL, V73, P1, DOI 10.1111/j.1365-2958.2009.06752.x; Grifantini Renata, 2011, J Bacteriol, V193, P6539, DOI 10.1128/JB.05924-11; Gryllos I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000145; Guinier A, 1955, SMALL ANGEL SCATTERI; Haikarainen T, 2010, J BIOL INORG CHEM, V15, P183, DOI 10.1007/s00775-009-0582-9; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Hantke K, 2001, BIOMETALS, V14, P239, DOI 10.1023/A:1012984713391; HENDRICKSON WA, 1989, BASIC LIFE SCI, V51, P317; Jacquamet L, 2009, MOL MICROBIOL, V73, P20, DOI 10.1111/j.1365-2958.2009.06753.x; Jacques DA, 2012, ACTA CRYSTALLOGR D, V68, P620, DOI 10.1107/S0907444912012073; Jeng US, 2010, J APPL CRYSTALLOGR, V43, P110, DOI 10.1107/S0021889809043271; Kim EJ, 1998, MOL MICROBIOL, V27, P187, DOI 10.1046/j.1365-2958.1998.00674.x; King KY, 2000, J BACTERIOL, V182, P5290, DOI 10.1128/JB.182.19.5290-5299.2000; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Loo CY, 2003, J BACTERIOL, V185, P2887, DOI 10.1128/JB.185.9.2887-2900.2003; Makthal N, 2013, J BIOL CHEM, V288, P18311, DOI 10.1074/jbc.M113.456590; Mongkolsuk S, 2002, MOL MICROBIOL, V45, P9, DOI 10.1046/j.1365-2958.2002.03015.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Ricci S, 2002, INFECT IMMUN, V70, P4968, DOI 10.1128/IAI.70.9.4968-4976.2002; Rink L, 2001, BIOMETALS, V14, P367, DOI 10.1023/A:1012986225203; Safo MK, 2005, J BACTERIOL, V187, P1833, DOI 10.1128/JB.187.5.1833-1844.2005; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shin JH, 2011, P NATL ACAD SCI USA, V108, P5045, DOI 10.1073/pnas.1017744108; Smith JL, 2004, CRIT REV MICROBIOL, V30, P173, DOI 10.1080/10408410490435151; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x; TROILLET N, 1994, SCHWEIZ MED WSCHR, V124, P1064; Tsou CC, 2008, INFECT IMMUN, V76, P4038, DOI 10.1128/IAI.00477-08; Tsou CC, 2010, INT J MED MICROBIOL, V300, P259, DOI 10.1016/j.ijmm.2009.09.002; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walker CF, 2004, ANNU REV NUTR, V24, P255, DOI 10.1146/annurev.nutr.23.011702.073054; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006	61	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89027	10.1371/journal.pone.0089027	http://dx.doi.org/10.1371/journal.pone.0089027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586487	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900044
J	Nishitani, K; Kobayashi, M; Kuroki, H; Mori, K; Shirai, T; Satake, T; Nakamura, S; Arai, R; Nakagawa, Y; Nakamura, T; Matsuda, S				Nishitani, Kohei; Kobayashi, Masahiko; Kuroki, Hiroshi; Mori, Koji; Shirai, Takaaki; Satake, Tsuyoshi; Nakamura, Shinnichiro; Arai, Ryuzo; Nakagawa, Yasuaki; Nakamura, Takashi; Matsuda, Shuichi			Ultrasound Can Detect Macroscopically Undetectable Changes in Osteoarthritis Reflecting the Superficial Histological and Biochemical Degeneration: Ex Vivo Study of Rabbit and Human Cartilage	PLOS ONE			English	Article							LIVING HUMAN CARTILAGE; ARTICULAR-CARTILAGE; QUANTITATIVE ULTRASOUND; ACOUSTIC STIFFNESS; KNEE; MODEL; BONE; INDENTATION; COLLAGEN; TIME	Recognizing subtle cartilage changes in the preclinical stage of osteoarthritis (OA) is essential for early diagnosis. To this end, the ability of the ultrasound signal intensity to detect macroscopically undetectable cartilage change was investigated. In this study, cartilage of rabbit OA model and human OA samples was examined by macroscopic evaluation, ultrasound signal intensity, histology with Mankin scores, and Fourier transform infrared imaging (FTIRI) analysis. Rabbit OA was induced by anterior cruciate ligament transection and evaluated at 1, 2, 4 and 12 weeks. Twenty human samples were harvested during total knee arthroplasty from OA patients who had macroscopically normal human cartilage (ICRS grade 0) on the lateral femoral condyle. In the animal study, there was no macroscopic OA change at 2 weeks, but histology detected degenerative changes at this time point. Ultrasound signal intensity also detected degeneration at 2 weeks. In human samples, all samples were obtained from macroscopically intact site, however nearly normal (0 <= Mankin score <2), early OA (2 <= Mankin score <6), and moderate OA (6 <= Mankin score <10) samples were actually intermixed. Ultrasound signal intensity was significantly different among these 3 stages and was well correlated with Mankin scores (R = -0.80) and FTIR parameters related to collagen and proteoglycan content in superficial zone. In conclusion, ultrasound can detect microscopic cartilage deterioration when such changes do not exist macroscopically, reflecting superficial histological and biochemical changes.	[Nishitani, Kohei; Kobayashi, Masahiko; Shirai, Takaaki; Satake, Tsuyoshi; Nakamura, Shinnichiro; Arai, Ryuzo; Nakagawa, Yasuaki; Nakamura, Takashi; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Kuroki, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Phys Therapy, Kyoto, Japan; [Mori, Koji] Yamaguchi Univ, Grad Sch Med, Dept Appl Med Engn Sci, Ube, Yamaguchi 755, Japan; [Nakagawa, Yasuaki; Nakamura, Takashi] Kyoto Med Ctr, Natl Hosp Org, Dept Orthopaed Surg, Kyoto, Japan	Kyoto University; Kyoto University; Yamaguchi University	Nishitani, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan.	nkohei@kuhp.kyoto-u.ac.jp	Nishitani, Kohei/ABB-1788-2021	Matsuda, Shuichi/0000-0003-0802-1255; Nishitani, Kohei/0000-0002-8327-3826	Grant of Japan Sports Medicine Foundation, Inc.;  [20240057]	Grant of Japan Sports Medicine Foundation, Inc.; 	This study was funded by Grant of Japan Sports Medicine Foundation, Inc. in 2007. This study was also supported by Grants-in-Aid for Scientific Research in Japan (No. 20240057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; Camacho NP, 2001, BIOPOLYMERS, V62, P1, DOI 10.1002/1097-0282(2001)62:1<1::AID-BIP10>3.0.CO;2-O; EHRLICH MG, 1978, ARTHRITIS RHEUM-US, V21, P761, DOI 10.1002/art.1780210704; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; Hattori K, 2005, ARTHRITIS RES THER, V7, pR38, DOI 10.1186/ar1463; Hattori K, 2006, J BONE JOINT SURG AM, V88A, P201, DOI 10.2106/JBJS.F.00589; Hattori K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2801; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kiviranta P, 2008, OSTEOARTHR CARTILAGE, V16, P796, DOI 10.1016/j.joca.2007.10.016; Kleemann RU, 2005, OSTEOARTHR CARTILAGE, V13, P958, DOI 10.1016/j.joca.2005.06.008; Kobrina Y, 2013, OSTEOARTHR CARTILAGE, V21, P462, DOI 10.1016/j.joca.2012.12.005; Kuroki H, 2006, OSTEOARTHR CARTILAGE, V14, P784, DOI 10.1016/j.joca.2006.02.001; Kuroki H, 2004, ARTHRITIS RES THER, V6, pR492, DOI 10.1186/ar1219; Kuroki H, 2009, KNEE SURG SPORT TR A, V17, P11, DOI 10.1007/s00167-008-0586-y; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Mori K, 2006, JSME INT J A-SOLID M, V49, P242, DOI 10.1299/jsmea.49.242; Mori K, 2002, INT CONGR SER, V1243, P133; Murata M, 2003, CLIN ORTHOP RELAT R, P285, DOI 10.1097/01.blo.0000059582.08469.ac; Nishitani K, 2011, J JAPANESE SOC CLIN, V19, P258; Nishitani K, 2009, AM J SPORT MED, V37, p139S, DOI 10.1177/0363546509350984; Nishitani K, 2008, AM J SPORT MED, V36, P2345, DOI 10.1177/0363546508322898; Saarakkala S, 2003, OSTEOARTHR CARTILAGE, V11, P697, DOI 10.1016/S1063-4584(03)00154-7; Saarakkala S, 2007, ARTHROSCOPY, V23, P1137, DOI 10.1016/j.arthro.2007.08.015; Van Dyck P, 2013, BONE JOINT J, V95, P738; Viren T, 2009, ULTRASOUND MED BIOL, V35, P1546, DOI 10.1016/j.ultrasmedbio.2009.04.004; Wang SX, 2007, ARTHRITIS RHEUM-US, V56, P1537, DOI 10.1002/art.22574; Zheng YP, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2566	28	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89484	10.1371/journal.pone.0089484	http://dx.doi.org/10.1371/journal.pone.0089484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586815	Green Published, gold			2022-12-27	WOS:000331717900104
J	Sandi, C; Sandi, M; Jassal, H; Ezzatizadeh, V; Anjomani-Virmouni, S; Al-Mahdawi, S; Pook, MA				Sandi, Chiranjeevi; Sandi, Madhavi; Jassal, Harvinder; Ezzatizadeh, Vahid; Anjomani-Virmouni, Sara; Al-Mahdawi, Sahar; Pook, Mark A.			Generation and Characterisation of Friedreich Ataxia YG8R Mouse Fibroblast and Neural Stem Cell Models	PLOS ONE			English	Article							GAA TRIPLET-REPEAT; FRATAXIN GENE; ANTISENSE TRANSCRIPT; EPIGENETIC CHANGES; DNA METHYLATION; POINT MUTATIONS; DENTATE NUCLEUS; MESSENGER-RNA; IRON; EXPRESSION	Background: Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disease caused by GAA repeat expansion in the first intron of the FXN gene, which encodes frataxin, an essential mitochondrial protein. To further characterise the molecular abnormalities associated with FRDA pathogenesis and to hasten drug screening, the development and use of animal and cellular models is considered essential. Studies of lower organisms have already contributed to understanding FRDA disease pathology, but mammalian cells are more related to FRDA patient cells in physiological terms. Methodology/Principal Findings: We have generated fibroblast cells and neural stem cells (NSCs) from control Y47R mice (9 GAA repeats) and GAA repeat expansion YG8R mice (190+120 GAA repeats). We then differentiated the NSCs in to neurons, oligodendrocytes and astrocytes as confirmed by immunocytochemical analysis of cell specific markers. The three YG8R mouse cell types (fibroblasts, NSCs and differentiated NSCs) exhibit GAA repeat stability, together with reduced expression of frataxin and reduced aconitase activity compared to control Y47R cells. Furthermore, YG8R cells also show increased sensitivity to oxidative stress and downregulation of Pgc-1 alpha and antioxidant gene expression levels, especially Sod2. We also analysed various DNA mismatch repair (MMR) gene expression levels and found that YG8R cells displayed significant reduction in expression of several MMR genes, which may contribute to the GAA repeat stability. Conclusions/Significance: We describe the first fibroblast and NSC models from YG8R FRDA mice and we confirm that the NSCs can be differentiated into neurons and glia. These novel FRDA mouse cell models, which exhibit a FRDA-like cellular and molecular phenotype, will be valuable resources to further study FRDA molecular pathogenesis. They will also provide very useful tools for preclinical testing of frataxin-increasing compounds for FRDA drug therapy, for gene therapy, and as a source of cells for cell therapy testing in FRDA mice.	[Sandi, Chiranjeevi; Sandi, Madhavi; Jassal, Harvinder; Ezzatizadeh, Vahid; Anjomani-Virmouni, Sara; Al-Mahdawi, Sahar; Pook, Mark A.] Brunel Univ, Sch Hlth Sci & Social Care, Ataxia Res Grp, Div Biosci, Uxbridge UB8 3PH, Middx, England	Brunel University	Pook, MA (corresponding author), Brunel Univ, Sch Hlth Sci & Social Care, Ataxia Res Grp, Div Biosci, Uxbridge UB8 3PH, Middx, England.	Mark.Pook@brunel.ac.uk			European Union [242193/EFACTS]; Wellcome Trust [089757]; GoFAR; Ataxia UK; FARA	European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); GoFAR; Ataxia UK; FARA	The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under grant agreement number 242193/EFACTS (CS, MS), the Wellcome Trust [089757] (SA), GoFAR, Ataxia UK and FARA (VE) to MAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Al-Mahdawi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074956; Anheim M, 2012, ARCH NEUROL-CHICAGO, V69, P912, DOI 10.1001/archneurol.2011.834; Bourn RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047085; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Calmels N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006379; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Chandok GS, 2012, NUCLEIC ACIDS RES, V40, P3964, DOI 10.1093/nar/gks021; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Chung DW, 2011, HUM MOL GENET, V20, P3467, DOI 10.1093/hmg/ddr263; Clark RM, 2007, HUM GENET, V120, P633, DOI 10.1007/s00439-006-0249-3; Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; De Blase I, 2007, ANN NEUROL, V61, P55, DOI 10.1002/ana.21052; Du JT, 2012, J BIOL CHEM, V287, P29861, DOI 10.1074/jbc.M112.391961; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Evans-Galea MV, 2011, NEUROGENETICS, V12, P307, DOI 10.1007/s10048-011-0296-3; Ezzatizadeh V, 2012, NEUROBIOL DIS, V46, P165, DOI 10.1016/j.nbd.2012.01.002; Filla A, 1996, AM J HUM GENET, V59, P554; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Gellera C, 2007, NEUROGENETICS, V8, P289, DOI 10.1007/s10048-007-0101-5; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Grant L, 2006, FEBS LETT, V580, P5399, DOI 10.1016/j.febslet.2006.09.006; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Halabi A, 2012, J BIOL CHEM, V287, P29958, DOI 10.1074/jbc.M112.356758; Heidari MM, 2009, CAN J NEUROL SCI, V36, P26, DOI 10.1017/S0317167100006260; Hick A, 2013, DIS MODEL MECH, V6, P608, DOI 10.1242/dmm.010900; Holemon H, 2007, BIOTECHNIQUES, V43, P683, DOI 10.2144/000112597; Khalil AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001486; Koeppen AH, 2007, ACTA NEUROPATHOL, V114, P163, DOI 10.1007/s00401-007-0220-y; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; Levison SW, 2003, DEV NEUROSCI-BASEL, V25, P184, DOI 10.1159/000072267; Liu J, 2011, STEM CELL REV REP, V7, P703, DOI 10.1007/s12015-010-9210-x; Lufino MMP, 2013, HUM MOL GENET, V22, P5173, DOI 10.1093/hmg/ddt370; Garcia-Gimenez JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020666; Marmolino D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010025; Marmolino D, 2009, CEREBELLUM, V8, P98, DOI 10.1007/s12311-008-0087-z; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Pandolfo M, 2008, ARCH NEUROL-CHICAGO, V65, P1296, DOI 10.1001/archneur.65.10.1296; Perdomini M, 2013, J NEUROCHEM, V126, P65, DOI 10.1111/jnc.12219; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Pook MA, 2001, NEUROGENETICS, V3, P185; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Puccio H, 2009, J NEUROL, V256, P18, DOI 10.1007/s00415-009-1004-1; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Sandi C, 2013, GENET RES INT, V2013, DOI 10.1155/2013/852080; Sarsero JP, 2003, J GENE MED, V5, P72, DOI 10.1002/jgm.320; Schols L, 1997, BRAIN, V120, P2131, DOI 10.1093/brain/120.12.2131; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Shan YX, 2013, ANTIOXID REDOX SIGN, V19, P1481, DOI 10.1089/ars.2012.4537; Sharma R, 2004, ANN NEUROL, V56, P898, DOI 10.1002/ana.20333; Sopher BL, 2011, NEURON, V70, P1071, DOI 10.1016/j.neuron.2011.05.027; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tan GL, 2003, HUM MOL GENET, V12, P1699, DOI 10.1093/hmg/ddg187; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Vaubel RA, 2013, MOL CELL NEUROSCI, V55, P50, DOI 10.1016/j.mcn.2012.08.003; Waldvogel D, 1999, ANN NEUROL, V46, P123, DOI 10.1002/1531-8249(199907)46:1<123::AID-ANA19>3.0.CO;2-H; Willis JH, 2008, MOL GENET METAB, V94, P491, DOI 10.1016/j.ymgme.2008.03.019; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Zuhlke CH, 2004, EUR J HUM GENET, V12, P979, DOI 10.1038/sj.ejhg.5201257	70	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89488	10.1371/journal.pone.0089488	http://dx.doi.org/10.1371/journal.pone.0089488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586819	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900105
J	Hsu, YC; Mildenstein, K; Hunter, K; Tkachenko, O; Mullen, CA				Hsu, Yu-Chiao; Mildenstein, Kurt; Hunter, Kordell; Tkachenko, Olena; Mullen, Craig A.			Acute Lymphoid Leukemia Cells with Greater Stem Cell Antigen-1 (Ly6a/Sca-1) Expression Exhibit Higher Levels of Metalloproteinase Activity and Are More Aggressive In Vivo	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; MONOCLONAL-ANTIBODY; POTENTIAL LIGANDS; MULTIGENE FAMILY; T-CELLS; LY-6; SCA-1; DIFFERENTIATION; ACTIVATION; ADHESION	Stem cell antigen-1 (Ly6a/Sca-1) is a gene that is expressed in activated lymphocytes, hematopoietic stem cells and stem cells of a variety of tissues in mice. Despite decades of study its functions remain poorly defined. These studies explored the impact of expression of this stem cell associated gene in acute lymphoid leukemia. Higher levels of Ly6a/Sca-1 expression led to more aggressive leukemia growth in vivo and earlier death of hosts. Leukemias expressing higher levels of Ly6a/Sca-1 exhibited higher levels of matrix metalloproteinases. The results suggest the hypothesis that the more aggressive behavior of Ly6a/Sca-1 expressing leukemias is due at least in part to greater capacity to degrade microenvironmental stroma and invade tissues.	[Hsu, Yu-Chiao; Mildenstein, Kurt; Hunter, Kordell; Tkachenko, Olena; Mullen, Craig A.] Univ Rochester, Dept Pediat, Rochester, NY 14627 USA	University of Rochester	Mullen, CA (corresponding author), Univ Rochester, Dept Pediat, Rochester, NY 14627 USA.	craig_mullen@urmc.rochester.edu			National Institutes of Health [R01 349 CA106289]; Alex's Lemonade Stand Foundation for Childhood Cancer [350]; Brockport Leukemia Dance Marathon; NATIONAL CANCER INSTITUTE [R01CA106289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation for Childhood Cancer; Brockport Leukemia Dance Marathon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (R01 349 CA106289, C.A.M.), Alex's Lemonade Stand Foundation for Childhood Cancer 350 (C.A.M.), and the Brockport Leukemia Dance Marathon (C.A.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAMEZAI A, 1995, P NATL ACAD SCI USA, V92, P4294, DOI 10.1073/pnas.92.10.4294; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; BRAKENHOFF RH, 1995, J CELL BIOL, V129, P1677, DOI 10.1083/jcb.129.6.1677; Dalen AGD, 2003, INT J CANCER, V103, P768, DOI 10.1002/ijc.10903; English A, 2000, J IMMUNOL, V165, P3763, DOI 10.4049/jimmunol.165.7.3763; Epting CL, 2004, J CELL SCI, V117, P6185, DOI 10.1242/jcs.01548; Epting CL, 2008, J CELL PHYSIOL, V217, P250, DOI 10.1002/jcp.21500; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; Franco GCN, 2011, EXP CELL RES, V317, P1454, DOI 10.1016/j.yexcr.2011.03.014; Grange C, 2008, NEOPLASIA, V10, P1433, DOI 10.1593/neo.08902; Hofmann UB, 2003, CANCER RES, V63, P8221; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Ishikawa N, 2007, CANCER RES, V67, P11601, DOI 10.1158/0008-5472.CAN-07-3243; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Kim RJ, 2010, CANCER LETT, V287, P172, DOI 10.1016/j.canlet.2009.06.010; KORNGOLD R, 1987, J EXP MED, V165, P1552, DOI 10.1084/jem.165.6.1552; Labelle JL, 2002, LEUKEMIA LYMPHOMA, V43, P1637, DOI 10.1080/1042819021000002974; LECLAIR KP, 1986, EMBO J, V5, P3227, DOI 10.1002/j.1460-2075.1986.tb04633.x; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; MALEK TR, 1986, J EXP MED, V164, P709, DOI 10.1084/jem.164.3.709; Mallya M, 2006, PROTEIN SCI, V15, P2244, DOI 10.1110/ps.062242606; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Mori S, 2003, BONE MARROW TRANSPL, V31, P865, DOI 10.1038/sj.bmt.1704021; Nieborowska-Skorska M, 2006, CANCER RES, V66, P4108, DOI 10.1158/0008-5472.CAN-05-1584; OKADA S, 1992, BLOOD, V80, P3044; ORTEGA G, 1986, J IMMUNOL, V137, P3240; Perez-Caro M, 2009, EMBO J, V28, P8, DOI 10.1038/emboj.2008.253; Pflugh DL, 2002, J IMMUNOL, V169, P5130, DOI 10.4049/jimmunol.169.9.5130; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; ROCK KL, 1989, IMMUNOL REV, V111, P195, DOI 10.1111/j.1600-065X.1989.tb00547.x; Seigel GM, 2005, MOL VIS, V11, P729; Shand JC, 2010, CANCER IMMUNOL IMMUN, V59, P1633, DOI 10.1007/s00262-010-0889-y; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stefanidakis M, 2009, BLOOD, V114, P3008, DOI 10.1182/blood-2008-04-148643; Treister A, 1998, INT J CANCER, V77, P306, DOI 10.1002/(SICI)1097-0215(19980717)77:2<306::AID-IJC22>3.0.CO;2-7; VANDERIJN M, 1989, P NATL ACAD SCI USA, V86, P4634; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Young FM, 2008, BIOL BLOOD MARROW TR, V14, P622, DOI 10.1016/j.bbmt.2008.02.015	40	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88966	10.1371/journal.pone.0088966	http://dx.doi.org/10.1371/journal.pone.0088966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586463	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700046
J	van Rooyen, JM; Murat, JB; Hammoudi, PM; Kieffer-Jaquinod, S; Coute, Y; Sharma, A; Pelloux, H; Belrhali, H; Hakimi, MA				van Rooyen, Jason M.; Murat, Jean-Benjamin; Hammoudi, Pierre-Mehdi; Kieffer-Jaquinod, Sylvie; Coute, Yohann; Sharma, Amit; Pelloux, Herve; Belrhali, Hassan; Hakimi, Mohamed-Ali			Assembly of the Novel Five-Component Apicomplexan Multi-Aminoacyl-tRNA Synthetase Complex Is Driven by the Hybrid Scaffold Protein Tg-p43	PLOS ONE			English	Article							COFACTOR ARC1P; P43 COMPONENT; YEAST ARC1P; NUCLEUS; SYSTEM; DOMAIN; DISSECTION; PRECURSOR; METRS	In Toxoplasma gondii, as in other eukaryotes, a subset of the amino-acyl-tRNA synthetases are arranged into an abundant cytoplasmic multi-aminoacyl-tRNA synthetase (MARS) complex. Through a series of genetic pull-down assays, we have identified the enzymes of this complex as: methionyl-, glutaminyl-, glutamyl-, and tyrosyl-tRNA synthetases, and we show that the N-terminal GST-like domain of a partially disordered hybrid scaffold protein, Tg-p43, is sufficient for assembly of the intact complex. Our gel filtration studies revealed significant heterogeneity in the size and composition of isolated MARS complexes. By targeting the tyrosyl-tRNA synthetases subunit, which was found exclusively in the complete 1 MDa complex, we were able to directly visualize MARS particles in the electron microscope. Image analyses of the negative stain data revealed the observed heterogeneity and instability of these complexes to be driven by the intrinsic flexibility of the domain arrangements within the MARS complex. These studies provide unique insights into the assembly of these ubiquitous but poorly understood eukaryotic complexes.	[van Rooyen, Jason M.; Belrhali, Hassan] European Mol Biol Lab, F-38042 Grenoble, France; [van Rooyen, Jason M.; Murat, Jean-Benjamin; Hammoudi, Pierre-Mehdi; Pelloux, Herve; Hakimi, Mohamed-Ali] CNRS, UMR5163, LAPM, Grenoble, France; [van Rooyen, Jason M.; Murat, Jean-Benjamin; Hammoudi, Pierre-Mehdi; Pelloux, Herve; Hakimi, Mohamed-Ali] Univ Grenoble 1, Grenoble, France; [Kieffer-Jaquinod, Sylvie; Coute, Yohann] CEA, IRTSV, Lab Biol Grande Echelle, Grenoble, France; [Sharma, Amit] ICGEB, Struct & Computat Biol Grp, New Delhi, India	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Belrhali, H (corresponding author), European Mol Biol Lab, F-38042 Grenoble, France.	belrhali@embl.fr; Mohamed-ali.hakimi@ujf-grenoble.fr	Hammoudi, Pierre-Mehdi/X-7801-2019; Pelloux, Hervé/M-7132-2014; HAKIMI, Mohamed-Ali/F-9806-2014; HAKIMI, Mohamed-ali/Q-6475-2019; HAKIMI, Mohamed-ali/GYJ-0879-2022; Couté, Yohann/G-2695-2015	Pelloux, Hervé/0000-0001-5727-5441; HAKIMI, Mohamed-Ali/0000-0002-2547-8233; HAKIMI, Mohamed-ali/0000-0002-2547-8233; Couté, Yohann/0000-0003-3896-6196; kieffer-jaquinod, Sylvie/0000-0003-1281-758X; van Rooyen, Jason/0000-0001-9485-8494; Hammoudi, Pierre-Mehdi/0000-0002-8511-356X	Agence Nationale Recherche, France	Agence Nationale Recherche, France(French National Research Agency (ANR))	This work was supported by the Agence Nationale Recherche, France [grant ANR Blanc 2012 TOXOHDAC -grant number ANR-12-BSV3-0009-01]; the Laboratoire d'Excellence ParaFrap, France [grant number ANR-11-LABX-0024]; the Fondation Innovations en Infectiologie Foundation, France (\FINOVI); and the Outstanding Scientist Research Programme of the Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bhatt TK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1522; Bougdour A, 2013, CELL HOST MICROBE, V13, P489, DOI 10.1016/j.chom.2013.03.002; Braun L, 2009, INT J PARASITOL, V39, P81, DOI 10.1016/j.ijpara.2008.07.009; Braun L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000920; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; CORNELISSEN AWCA, 1981, PARASITOLOGY, V83, P103, DOI 10.1017/S0031182000050071; Crepin T, 2002, BIOCHEMISTRY-US, V41, P13003, DOI 10.1021/bi026343m; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Galani K, 2005, FEBS LETT, V579, P969, DOI 10.1016/j.febslet.2004.11.112; Golinelli-Cohen MP, 2004, J MOL BIOL, V340, P15, DOI 10.1016/j.jmb.2004.04.040; Grosshans H, 2000, J STRUCT BIOL, V129, P288, DOI 10.1006/jsbi.2000.4226; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Havrylenko S, 2011, J BIOL CHEM, V286, P28476, DOI 10.1074/jbc.M111.254037; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ivakhno SS, 2004, EXP ONCOL, V26, P250; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Karanasios E, 2008, J MOL BIOL, V381, P763, DOI 10.1016/j.jmb.2008.06.044; Karanasios E, 2007, J MOL BIOL, V374, P1077, DOI 10.1016/j.jmb.2007.10.010; Karanasios E, 2010, FEBS LETT, V584, P3842, DOI 10.1016/j.febslet.2010.08.023; KELLERMANN O, 1982, J BIOL CHEM, V257, P1041; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Park SG, 2010, IUBMB LIFE, V62, P296, DOI 10.1002/iub.324; Park SG, 1999, J BIOL CHEM, V274, P16673, DOI 10.1074/jbc.274.24.16673; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Simader H, 2006, ACTA CRYSTALLOGR D, V62, P1510, DOI 10.1107/S0907444906039850; Simader H, 2006, NUCLEIC ACIDS RES, V34, P3968, DOI 10.1093/nar/gkl560; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Szymanski M, 2000, ACTA BIOCHIM POL, V47, P821; Wolfe CL, 2005, J BIOL CHEM, V280, P38870, DOI 10.1074/jbc.M502759200	41	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89487	10.1371/journal.pone.0089487	http://dx.doi.org/10.1371/journal.pone.0089487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586818	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700123
J	Mohamed-Ahmed, O; Nelson-Piercy, C; Bramham, K; Gao, HY; Kurinczuk, JJ; Brocklehurst, P; Knight, M				Mohamed-Ahmed, Olaa; Nelson-Piercy, Cathy; Bramham, Kate; Gao, Haiyan; Kurinczuk, Jennifer J.; Brocklehurst, Peter; Knight, Marian			Pregnancy Outcomes in Liver and Cardiothoracic Transplant Recipients: A UK National Cohort Study	PLOS ONE			English	Article							CARDIAC ALLOGRAFT VASCULOPATHY; MYCOPHENOLATE-MOFETIL; ORGAN-TRANSPLANTATION; LUNG TRANSPLANTATION; SENSITIZATION; METAANALYSIS; REGISTRY	Introduction: There are an increasing number of reports of pregnancy in transplant recipients but many questions remain regarding the effect of the transplant on pregnancy outcome, the pregnancy on the graft and the medication on the fetus. The majority of studies reporting outcomes in transplant recipients have focused on women with kidney transplants, and have included retrospective, voluntary registries or single centre studies. Methods: The UK Obstetric Surveillance System (UKOSS) was used to prospectively identify all pregnant women with a liver or cardiothoracic transplant in the United Kingdom, between January 2007 and January 2012. Data were collected on demographics, transplant characteristics, immunosuppression regimens, antenatal care, maternal, graft and neonatal outcomes. In an exploratory analysis, we tested for associations between "poor fetal outcome'' and medications used before or during pregnancy. Results and conclusions: We report 62 pregnancies in 56 liver transplant recipients and 14 pregnancies in 14 cardiothoracic transplant recipients (including 10 heart, three lung and one heart-lung recipient). Liver transplant recipients, in comparison to cardiothoracic, had similar livebirth rates (92% vs. 87%) but better fetal outcomes (median gestational age 38 weeks vs. 35 weeks; median birthweight 2698 g vs. 2365 g), fewer caesarean deliveries (47% vs. 62%), fewer maternal intensive care (ICU) admissions (19% vs. 29%) and fewer neonatal ICU admissions (25% vs. 54%). Nine women (12%) were taking mycophenolate mofetil at conception, which was associated with adverse fetal outcomes. Pregnancy in transplant recipients may have successful outcomes, but complication rates are high, emphasising the role of pre-conception counselling and further research into the long-term effect on maternal and graft survival rates.	[Mohamed-Ahmed, Olaa; Gao, Haiyan; Kurinczuk, Jennifer J.; Knight, Marian] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford OX1 2JD, England; [Nelson-Piercy, Cathy; Bramham, Kate] Kings Coll London, Womens Hlth Acad Ctr, Kings Hlth Partners, Div Womens Hlth, London WC2R 2LS, England; [Nelson-Piercy, Cathy] Guys & St Thomas NHS Fdn Trust, London, England; [Brocklehurst, Peter] UCL, Inst Womens Hlth, London WC1E 6BT, England	University of Oxford; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London	Mohamed-Ahmed, O (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford OX1 2JD, England.	olaa.mohamed-ahmed@npeu.ox.ac.uk	Knight, Marian/B-6225-2009	Knight, Marian/0000-0002-1984-4575; Bramham, Kate/0000-0002-6272-7921; Mohamed-Ahmed, Olaa/0000-0002-5284-469X	Policy Research Programme in the Department of Health; National Institute for Health Research [DRF-2009-02-18, NIHR-RP-011-032, ACF-2013-13-019] Funding Source: researchfish	Policy Research Programme in the Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper reports on an independent study that is funded by the Policy Research Programme in the Department of Health. The views expressed are not necessarily those of the Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang GS, 2008, AM J MED GENET A, V146A, P1963, DOI 10.1002/ajmg.a.32420; Armenti Vincent T, 2008, Transplant Rev (Orlando), V22, P223, DOI 10.1016/j.trre.2008.05.001; Baron O, 2002, J HEART LUNG TRANSPL, V21, P914, DOI 10.1016/S1053-2498(02)00388-1; Blume C, 2013, TRANSPLANTATION, V95, P222, DOI 10.1097/TP.0b013e318277e318; Bramham K, 2013, CLIN J AM SOC NEPHRO, V8, P563, DOI 10.2215/CJN.06400612; Bramham K, 2013, CLIN J AM SOC NEPHRO, V8, P290, DOI 10.2215/CJN.06170612; Christopher V, 2006, LIVER TRANSPLANT, V12, P1138, DOI 10.1002/lt.20810; Coffin CS, 2010, LIVER TRANSPLANT, V16, P56, DOI 10.1002/lt.21906; Cole TJ, 2011, ANN HUM BIOL, V38, P7, DOI 10.3109/03014460.2011.544139; Coscia Lisa A, 2010, Clin Transpl, P65; Cowan SW, 2012, CARDIOL CLIN, V30, P441, DOI 10.1016/j.ccl.2012.05.001; Deshpande NA, 2012, LIVER TRANSPLANT, V18, P621, DOI 10.1002/lt.23416; Estensen M, 2011, SCAND CARDIOVASC J, V45, P349, DOI 10.3109/14017431.2011.605168; Flack JM, 2010, CARDIOL CLIN, V28, P623, DOI 10.1016/j.ccl.2010.07.007; Ginwalla M, 2013, TRANSPL P, V45, P800, DOI 10.1016/j.transproceed.2012.10.038; Gyi KM, 2006, J CYST FIBROS, V5, P171, DOI 10.1016/j.jcf.2006.03.001; Hoeltzenbein M, 2012, AM J MED GENET A, V158A, P588, DOI 10.1002/ajmg.a.35223; Hou S, 2013, ADV CHRONIC KIDNEY D, V20, P253, DOI 10.1053/j.ackd.2013.01.011; Humphreys RA, 2012, J OBSTET GYNAECOL CA, V34, P416, DOI 10.1016/S1701-2163(16)35237-9; Kallen B, 2005, BJOG-INT J OBSTET GY, V112, P904, DOI 10.1111/j.1471-0528.2005.00607.x; Knight M, 2005, BJOG-INT J OBSTET GY, V112, P263, DOI 10.1111/j.1471-0528.2005.00609.x; McKay DB, 2006, NEW ENGL J MED, V354, P1281, DOI 10.1056/NEJMra050431; McKay DB, 2005, AM J TRANSPLANT, V5, P1592, DOI 10.1111/j.1600-6143.2005.00969.x; Miniero R, 2004, J HEART LUNG TRANSPL, V23, P898, DOI 10.1016/j.healun.2003.08.002; Nagy S, 2003, OBSTET GYNECOL, V102, P121, DOI 10.1016/S0029-7844(03)00369-7; National Transplantation Pregnancy Registry, 2012, NAT TRANSPL PREGN RE; O'Boyle PJ, 2010, AM J TRANSPLANT, V10, P180, DOI 10.1111/j.1600-6143.2009.02875.x; Pan H, 2012, LMSGROWTH MICROSOFT; RCOG, 2010, LABOUR WARD SOLUTION; RIZZONI G, 1992, NEPHROL DIAL TRANSPL, V7, P279, DOI 10.1093/oxfordjournals.ndt.a092129; Roberge S, 2013, ULTRASOUND OBST GYN, V41, P491, DOI 10.1002/uog.12421; Sau A, 2007, BJOG-INT J OBSTET GY, V114, P498, DOI 10.1111/j.1471-0528.2006.01232.x; Sibanda N, 2007, TRANSPLANTATION, V83, P1301, DOI 10.1097/01.tp.0000263357.44975.d0; Sifontis NM, 2006, TRANSPLANTATION, V82, P1698, DOI 10.1097/01.tp.0000252683.74584.29; Valantine H, 2004, J HEART LUNG TRANSPL, V23, pS187, DOI 10.1016/j.healun.2004.03.009; Weigt SS, 2013, SEMIN RESP CRIT CARE, V34, P336, DOI 10.1055/s-0033-1348467	36	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89151	10.1371/journal.pone.0089151	http://dx.doi.org/10.1371/journal.pone.0089151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586554	Green Published, gold			2022-12-27	WOS:000331711900096
J	Rees, MG; Davis, MI; Shen, M; Titus, S; Raimondo, A; Barrett, A; Gloyn, AL; Collins, FS; Simeonov, A				Rees, Matthew G.; Davis, Mindy I.; Shen, Min; Titus, Steve; Raimondo, Anne; Barrett, Amy; Gloyn, Anna L.; Collins, Francis S.; Simeonov, Anton			A Panel of Diverse Assays to Interrogate the Interaction between Glucokinase and Glucokinase Regulatory Protein, Two Vital Proteins in Human Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PLASMA-GLUCOSE; LIVER GLUCOKINASE; STRUCTURAL BASIS; P446L VARIANT; RAT-LIVER; TRANSLOCATION; ACTIVATOR; INSULIN; HEPATOCYTES	Recent genetic and clinical evidence has implicated glucokinase regulatory protein (GKRP) in the pathogenesis of type 2 diabetes and related traits. The primary role of GKRP is to bind and inhibit hepatic glucokinase (GCK), a critically important protein in human health and disease that exerts a significant degree of control over glucose metabolism. As activation of GCK has been associated with improved glucose tolerance, perturbation of the GCK-GKRP interaction represents a potential therapeutic target for pharmacological modulation. Recent structural and kinetic advances are beginning to provide insight into the interaction of these two proteins. However, tools to comprehensively assess the GCK-GKRP interaction, particularly in the context of small molecules, would be a valuable resource. We therefore developed three robust and miniaturized assays for assessing the interaction between recombinant human GCK and GKRP: an HTRF assay, a diaphorase-coupled assay, and a luciferase-coupled assay. The assays are complementary, featuring distinct mechanisms of detection (luminescence, fluorescence, FRET). Two assays rely on GCK enzyme activity modulation by GKRP while the FRET-based assay measures the GCK-GKRP protein-protein interaction independent of GCK enzymatic substrates and activity. All three assays are scalable to low volumes in 1536-well plate format, with robust Z' factors (> 0.7). Finally, as GKRP sequesters GCK in the hepatocyte nucleus at low glucose concentrations, we explored cellular models of GCK localization and translocation. Previous findings from freshly isolated rat hepatocytes were confirmed in cryopreserved rat hepatocytes, and we further extended this study to cryopreserved human hepatocytes. Consistent with previous reports, there were several key differences between the rat and human systems, with our results suggesting that human hepatocytes can be used to interrogate GCK translocation in response to small molecules. The assay panel developed here should help direct future investigation of the GCK-GKRP interaction in these or other physiologically relevant human systems.	[Rees, Matthew G.; Davis, Mindy I.; Shen, Min; Simeonov, Anton] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20852 USA; [Rees, Matthew G.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Rees, Matthew G.; Raimondo, Anne; Barrett, Amy; Gloyn, Anna L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX1 2JD, England; [Titus, Steve] GE Healthcare, Life Sci, Piscataway, NJ USA; [Gloyn, Anna L.] Churchill Hosp, OCDEM, ORH Trust, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LJ, England	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Oxford; General Electric; University of Oxford	Simeonov, A (corresponding author), NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20852 USA.	asimeono@mail.nih.gov		Gloyn, Anna/0000-0003-1205-1844	NIH; NHGRI [Z01- HG000024]; Wellcome Trust [095101/Z/10/Z]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004, ZIATR000125] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024, Z01HG000024] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded at NIH by the Molecular Libraries Common Fund Program of the NIH and NHGRI project number Z01- HG000024 (to FSC) and in Oxford by the Wellcome Trust (095101/Z/10/Z). ALG is a Wellcome Trust Senior Fellow in Basic Biomedical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden C, 2011, DIABETES, V60, P3110, DOI 10.2337/db11-0061; Basu A, 2000, DIABETES, V49, P272, DOI 10.2337/diabetes.49.2.272; Bebernitz GR, 2009, J MED CHEM, V52, P6142, DOI 10.1021/jm900839k; Beck T, 2013, BIOCHEMISTRY-US, V52, P6232, DOI 10.1021/bi400838t; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Bembenek ME, 2005, ASSAY DRUG DEV TECHN, V3, P533, DOI 10.1089/adt.2005.3.533; Bonadonna RC, 2010, J CLIN ENDOCR METAB, V95, P5028, DOI 10.1210/jc.2010-1041; Bourbonais FJ, 2012, BIOCHEM J, V441, P881, DOI 10.1042/BJ20110721; Bowler JM, 2013, ACS MED CHEM LETT, V4, P15, DOI 10.1021/ml400061x; Brocklehurst KJ, 2004, BIOCHEM J, V378, P693, DOI 10.1042/BJ20031414; Cain C, 2013, SCIBX, V6, DOI [10.1038/scibx.2013.1279, DOI 10.1038/SCIBX.2013.1279]; CARO JF, 1995, HORM METAB RES, V27, P19, DOI 10.1055/s-2007-979899; Choi JM, 2013, P NATL ACAD SCI USA, V110, P10171, DOI 10.1073/pnas.1300457110; Christesen HBT, 2002, DIABETES, V51, P1240, DOI 10.2337/diabetes.51.4.1240; Chu CA, 2004, AM J PHYSIOL-GASTR L, V286, pG627, DOI 10.1152/ajpgi.00218.2003; Cleveland PH, 2005, ASSAY DRUG DEV TECHN, V3, P213, DOI 10.1089/adt.2005.3.213; De Ceuninck F, 2013, BRIT J PHARMACOL, V168, P339, DOI 10.1111/j.1476-5381.2012.02184.x; Fujimoto Y, 2004, AM J PHYSIOL-ENDOC M, V287, pE414, DOI 10.1152/ajpendo.00575.2003; Futamura M, 2006, J BIOL CHEM, V281, P37668, DOI 10.1074/jbc.M605186200; GILES IG, 1976, BIOCHEM J, V157, P577, DOI 10.1042/bj1570577; Gloyn AL, 2003, DIABETES, V52, P2433, DOI 10.2337/diabetes.52.9.2433; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Kalgutkar AS, 2007, DRUG METAB DISPOS, V35, P2111, DOI 10.1124/dmd.107.016162; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kaminski MT, 2010, DIABETOLOGIA, V53; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Langer S, 2010, MOL ENDOCRINOL, V24, P1988, DOI 10.1210/me.2010-0115; LIANG Y, 1995, BIOCHEM J, V309, P167, DOI 10.1042/bj3090167; Lloyd DJ, 2013, NATURE, V504, P437, DOI 10.1038/nature12724; MATHIS G, 1993, CLIN CHEM, V39, P1953; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Meininger GE, 2011, DIABETES CARE, V34, P2560, DOI 10.2337/dc11-1200; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Niles WD, 2005, ASSAY DRUG DEV TECHN, V3, P189, DOI 10.1089/adt.2005.3.189; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Pautsch A, 2013, BIOCHEMISTRY-US, V52, P3523, DOI 10.1021/bi4000782; Pfefferkorn JA, 2012, J MED CHEM, V55, P1318, DOI 10.1021/jm2014887; Ralph EC, 2008, BIOCHEMISTRY-US, V47, P5028, DOI 10.1021/bi702516y; Rees MG, 2012, DIABETOLOGIA, V55, P114, DOI 10.1007/s00125-011-2348-5; Rees MG, 2012, J CLIN INVEST, V122, P205, DOI 10.1172/JCI46425; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; TOYODA Y, 1995, BIOCHEM BIOPH RES CO, V215, P467, DOI 10.1006/bbrc.1995.2488; VANDERCAMMEN A, 1992, BIOCHEM J, V286, P253, DOI 10.1042/bj2860253; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; VANSCHAFTINGEN E, 1995, BIOCHEM J, V308, P23, DOI 10.1042/bj3080023; Veiga-da-Cunha M, 2002, J BIOL CHEM, V277, P8466, DOI 10.1074/jbc.M105984200; Watanabe F, 2010, J BIOCHEM, V148, P713, DOI 10.1093/jb/mvq107; Wolff M, 2008, J BIOMOL SCREEN, V13, P837, DOI 10.1177/1087057108323910; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004	54	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89335	10.1371/journal.pone.0089335	http://dx.doi.org/10.1371/journal.pone.0089335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586696	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900126
J	Gonzalez-Zamora, A; Arroyo-Rodriguez, V; Escobar, F; Ros, M; Oyama, K; Ibarra-Manriquez, G; Stoner, KE; Chapman, CA				Gonzalez-Zamora, Arturo; Arroyo-Rodriguez, Victor; Escobar, Federico; Roes, Matthias; Oyama, Ken; Ibarra-Manriquez, Guillermo; Stoner, Kathryn E.; Chapman, Colin A.			Contagious Deposition of Seeds in Spider Monkeys' Sleeping Trees Limits Effective Seed Dispersal in Fragmented Landscapes	PLOS ONE			English	Article							ALOUATTA-PALLIATA; FOREST FRAGMENTS; RAIN-FOREST; DIVERSITY; AVAILABILITY; FRUIT; CONSEQUENCES; RECRUITMENT; QUANTITY; PATTERNS	The repeated use of sleeping sites by frugivorous vertebrates promotes the deposition and aggregation of copious amounts of seeds in these sites. This spatially contagious pattern of seed deposition has key implications for seed dispersal, particularly because such patterns can persist through recruitment. Assessing the seed rain patterns in sleeping sites thus represents a fundamental step in understanding the spatial structure and regeneration of plant assemblages. We evaluated the seed rain produced by spider monkeys (Ateles geoffroyi) in latrines located beneath 60 sleeping trees in two continuous forest sites (CFS) and three forest fragments (FF) in the Lacandona rainforest, Mexico. We tested for differences among latrines, among sites, and between forest conditions in the abundance, diversity (alpha-, beta- and, gamma-components) and evenness of seed assemblages. We recorded 45,919 seeds >= 5 mm (in length) from 68 species. The abundance of seeds was 1.7 times higher in FF than in CFS, particularly because of the dominance of a few plant species. As a consequence, community evenness tended to be lower within FF. beta-diversity of common and dominant species was two times greater among FF than between CFS. Although mean alpha-diversity per latrine did not differ among sites, the greater beta-diversity among latrines in CFS increased gamma-diversity in these sites, particularly when considering common and dominant species. Our results support the hypothesis that fruit scarcity in FF can 'force' spider monkeys to deplete the available fruit patches more intensively than in CFS. This feeding strategy can limit the effectiveness of spider monkeys as seed dispersers in FF, because (i) it can limit the number of seed dispersers visiting such fruit patches; (ii) it increases seed dispersal limitation; and (iii) it can contribute to the floristic homogenization (i. e., reduced beta-diversity among latrines) in fragmented landscapes.	[Gonzalez-Zamora, Arturo] Inst Ecol AC, Div Posgrad, Xalapa, Veracruz, Mexico; [Arroyo-Rodriguez, Victor; Oyama, Ken; Ibarra-Manriquez, Guillermo] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Escobar, Federico; Roes, Matthias] Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico; [Oyama, Ken] Univ Nacl Autonoma Mexico, Escuela Nacl Estudios Super, Morelia, Michoacan, Mexico; [Stoner, Kathryn E.] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Chapman, Colin A.] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Chapman, Colin A.] Wildlife Conservat Soc, Bronx, NY USA	Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico; Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico; New Mexico State University; McGill University; McGill University; Wildlife Conservation Society	Arroyo-Rodriguez, V (corresponding author), Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico.	victorarroyo_rodriguez@hotmail.com	Arroyo-Rodríguez, Víctor/C-9255-2009; Chapman, Colin/S-1911-2019; Escobar, Federico/C-1396-2011; Stoner, Kathryn E/E-1510-2015; Rös, Matthias/AAS-5755-2021	Arroyo-Rodríguez, Víctor/0000-0002-0858-0324; Chapman, Colin/0000-0002-8827-8140; Escobar, Federico/0000-0003-0179-7528; Stoner, Kathryn E/0000-0002-9964-1697; Rös, Matthias/0000-0002-5722-6321	Consejo Nacional de Ciencia y Tecnologia, CONACyT [CB-2005-51043, CB-2006-56799]; Direccion General de Asuntos del Personal Academico, DGAPA, Universidad Nacional Autonoma de Mexico, UNAM [IA-203111]; CONACyT	Consejo Nacional de Ciencia y Tecnologia, CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico, DGAPA, Universidad Nacional Autonoma de Mexico, UNAM(Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was funded by the Consejo Nacional de Ciencia y Tecnologia, CONACyT (grants CB-2005-51043 and CB-2006-56799) and the Direccion General de Asuntos del Personal Academico, DGAPA, Universidad Nacional Autonoma de Mexico, UNAM (project IA-203111). AGZ thanks the scholarship provided by CONACyT. KS thank UC MEXUS project. CAC thanks NSERC, CRC, and the Killam Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Arroyo-Rodriguez V, 2006, INT J PRIMATOL, V27, P1079, DOI 10.1007/s10764-006-9061-0; Arroyo-Rodriguez V, 2013, J ECOL, V101, P1449, DOI 10.1111/1365-2745.12153; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; CHAPMAN C, 1988, BEHAVIOUR, V105, P99, DOI 10.1163/156853988X00467; CHAPMAN CA, 1992, BIOTROPICA, V24, P527, DOI 10.2307/2389015; Chapman CA, 1998, AM J PRIMATOL, V45, P127; CHAPMAN CA, 1989, AM J PRIMATOL, V18, P53, DOI 10.1002/ajp.1350180106; CHAPMAN CA, 1989, OECOLOGIA, V79, P506, DOI 10.1007/BF00378668; Chaves OM, 2012, BIOTROPICA, V44, P105, DOI 10.1111/j.1744-7429.2011.00766.x; Chaves OM, 2011, INT J PRIMATOL, V32, P177, DOI 10.1007/s10764-010-9460-0; CONNELL J H, 1971, P298; Crawley M. J, 2002, STAT COMPUTING INTRO; Dew JL, 2008, CAM S BIO EVOL ANTHR, V55, P155; Dunn JC, 2009, AM J PRIMATOL, V71, P654, DOI 10.1002/ajp.20700; Feeley K, 2005, J TROP ECOL, V21, P99, DOI 10.1017/S0266467404001701; GARBER PA, 2006, NEW PERSPECTIVE STUD, P489; Gonzalez-Zamora A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046852; Grafen A., 2002, MODERN STAT LIFE SCI; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hubbell Stephen P., 2001, V32, pi; Ibarra-Manriquez G, 2010, ACTA BOT MEX, V90, P51; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jordano P., 1992, SEEDS ECOLOGY REGENE, P105; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Link A, 2006, J TROP ECOL, V22, P235, DOI 10.1017/S0266467405003081; Lobo D, 2011, DIVERS DISTRIB, V17, P287, DOI 10.1111/j.1472-4642.2010.00739.x; Marsh LK, 2003, INT J PRIMATOL, V24, P65, DOI 10.1023/A:1021446512364; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Neves N, 2010, AUS ECOL, V35, P545; Ochoa-Gaona S, 2000, BRENESIA, V54, P1; Bravo SP, 2012, ECOL RES, V27, P311, DOI 10.1007/s11284-011-0904-6; Ramos-Fernandez G, 2008, CAM S BIO EVOL ANTHR, V55, P351; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; Russo SE, 2004, ECOL LETT, V7, P1058, DOI 10.1111/j.1461-0248.2004.00668.x; Russo SE, 2011, PRIMATES PERSPECTIVE, V2, P523; Schupp E. W., 2007, Seed dispersal: theory and its application in a changing world, P445, DOI 10.1079/9781845931650.0445; Schupp E. W., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P19, DOI 10.1079/9780851995250.0019; SCHUPP EW, 1993, VEGETATIO, V108, P15; Schupp EW, 2010, SEED DISPERSAL EFFEC; Stevenson PR, 2000, AM J PRIMATOL, V50, P275, DOI 10.1002/(SICI)1098-2345(200004)50:4&lt;275::AID-AJP4&gt;3.0.CO;2-K; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Tabarelli M, 2012, BIOL CONSERV, V155, P136, DOI 10.1016/j.biocon.2012.06.020; Tombak KJ, 2012, PRIMATES, V53, P57, DOI 10.1007/s10329-011-0274-2; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7	48	20	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89346	10.1371/journal.pone.0089346	http://dx.doi.org/10.1371/journal.pone.0089346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586705	Green Published, gold			2022-12-27	WOS:000332390800017
J	Ikeda, M; Kan-no, H; Hayashi, M; Tsukada, H; Shida, M; Hirasawa, T; Muramatsu, T; Ogushi, Y; Mikami, M				Ikeda, Masae; Kan-no, Hidetoshi; Hayashi, Masaru; Tsukada, Hitomi; Shida, Masako; Hirasawa, Takeshi; Muramatsu, Toshinari; Ogushi, Yoichi; Mikami, Mikio			Predicting Perioperative Venous Thromboembolism in Japanese Gynecological Patients	PLOS ONE			English	Article							PULMONARY-EMBOLISM; D-DIMER; DIAGNOSIS; EXCLUSION; RISK; AGE	Objective: To develop a convenient screening method that can predict perioperative venous thromboembolism (VTE) and identify patients at risk of fatal perioperative pulmonary embolism (PE). Methods: Patients hospitalized for gynecological abdominal surgery (n = 183) underwent hematology tests and multidetector computed tomography (MDCT) to detect VTE. All statistical analyses were carried out using the SPSS software program (PASWV19.0J) Results: The following risk factors for VTE were identified by univariate analysis: plasmin-alpha2-plasmin inhibitor complex (PIC), thrombin-antithrombin III complex (TAT), and prolonged immobility (all p<0.001); age, neoadjuvant chemotherapy (NAC), malignancy, hypertension, past history of VTE, and hormone therapy (all p<0.01); and hemoglobin, transverse tumor diameter, ovarian disease, and menopause (all p<0.05). Multivariate analysis using these factors revealed that PIC, age, and transverse tumor diameter were significant independent determinants of the risk of VTE. We then calculated the incidence rate of perioperative VTE using PIC and transverse tumor diameter in patient groups stratified by age. In patients aged <= 40 years, PIC >= 1.3 mu g/mL and a transverse tumor diameter >= 10 cm identified the high-risk group for VTE with an accuracy of 93.6%. For patients in their 50 s, PIC >= 1.3 mg/mL identified a high risk of VTE with an accuracy of 78.2%. In patients aged >= 60 years, a transverse tumor diameter >= 15 cm (irrespective of PIC) or PIC >= 1.3 mu g/mL identified the high-risk group with an accuracy of 82.4%. Conclusions: We propose new screening criteria for VTE risk that are based on PIC, transverse tumor diameter, and age. Our findings suggest the usefulness of these criteria for predicting the risk of perioperative VTE and for identifying patients with a high risk of fatal perioperative PE.	[Ikeda, Masae; Kan-no, Hidetoshi; Hayashi, Masaru; Tsukada, Hitomi; Shida, Masako; Hirasawa, Takeshi; Muramatsu, Toshinari; Mikami, Mikio] Tokai Univ, Sch Med, Dept Obstet & Gynecol, Div Specialized Clin Sci, Isehara, Kanagawa 25911, Japan; [Ogushi, Yoichi] Tokai Univ, Sch Med, Dept Med Informat, Div Basic Med Sci & Mol Med, Isehara, Kanagawa 25911, Japan	Tokai University; Tokai University	Ikeda, M (corresponding author), Tokai Univ, Sch Med, Dept Obstet & Gynecol, Div Specialized Clin Sci, Isehara, Kanagawa 25911, Japan.	ikedam@tokai-u.jp		Mikami, Mikio/0000-0002-7496-3518				Asakura Hidesaku, 2011, Rinsho Byori, V59, P970; Caprini JA, 2004, CIRCULATION, V109, pI4, DOI 10.1161/01.CIR.0000122869.59485.36; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Di Nisio M, 2011, J GERONTOL A-BIOL, V66, P320, DOI 10.1093/gerona/glq207; Engelberger RP, 2011, THROMB RES, V127, P535, DOI 10.1016/j.thromres.2011.02.008; Fedullo PF, 2003, NEW ENGL J MED, V349, P1247, DOI 10.1056/NEJMcp035442; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Jinnin M, 2003, RHEUMATOLOGY, V42, P240, DOI 10.1093/rheumatology/keg071; Le Gal G, 2005, J THROMB HAEMOST, V3, P2457, DOI 10.1111/j.1538-7836.2005.01598.x; Mansencal N, 2003, ARCH MAL COEUR VAISS, V96, P1143; Merli G, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.06.008; Merli GJ, 2004, J THROMB THROMBOLYS, V18, P117, DOI 10.1007/s11239-004-0208-6; Righini M, 2008, J THROMB HAEMOST, V6, P1059, DOI 10.1111/j.1538-7836.2008.02981.x; Siccama RN, 2011, AGEING RES REV, V10, P304, DOI 10.1016/j.arr.2010.10.005; Stein PD, 2004, ARCH INTERN MED, V164, P2260, DOI 10.1001/archinte.164.20.2260; Vermeer HJ, 2005, THROMB RES, V115, P381, DOI 10.1016/j.thromres.2004.09.005; Wells PS, 2006, J THROMB THROMBOLYS, V21, P31, DOI 10.1007/s11239-006-5573-x; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66	20	7	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89206	10.1371/journal.pone.0089206	http://dx.doi.org/10.1371/journal.pone.0089206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586595	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000033
J	Zietkiewicz, E; Rutkiewicz, E; Pogorzelski, A; Klimek, B; Voelkel, K; Witt, M				Zietkiewicz, Ewa; Rutkiewicz, Ewa; Pogorzelski, Andrzej; Klimek, Barbara; Voelkel, Katarzyna; Witt, Michal			CFTR Mutations Spectrum and the Efficiency of Molecular Diagnostics in Polish Cystic Fibrosis Patients	PLOS ONE			English	Article							CONDUCTANCE REGULATOR GENE; HAPLOTYPES; CONSENSUS; ORIGIN; COMMON	Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane regulator gene (CFTR). In light of the strong allelic heterogeneity and regional specificity of the mutation spectrum, the strategy of molecular diagnostics and counseling in CF requires genetic tests to reflect the frequency profile characteristic for a given population. The goal of the study was to provide an updated comprehensive estimation of the distribution of CFTR mutations in Polish CF patients and to assess the effectiveness of INNOLiPA_CFTR tests in Polish population. The analyzed cohort consisted of 738 patients with the clinically confirmed CF diagnosis, prescreened for molecular defects using INNOLiPA_CFTR panels from Innogenetics. A combined efficiency of INNOLiPA CFTR_19 and CFTR_17_TnUpdate tests was 75.5%; both mutations were detected in 68.2%, and one mutation in 14.8% of the affected individuals. The group composed of all the patients with only one or with no mutation detected (109 and 126 individuals, respectively) was analyzed further using a mutation screening approach, i.e. SSCP/HD (single strand conformational polymorphism/heteroduplex) analysis of PCR products followed by sequencing of the coding sequence. As a result, 53 more mutations were found in 97 patients. The overall efficiency of the CF allele detection was 82.5% (7.0% increase compared to INNOLiPA tests alone). The distribution of the most frequent mutations in Poland was assessed. Most of the mutations repetitively found in Polish patients had been previously described in other European populations. The most frequent mutated allele, F508del, represented 54.5% of Polish CF chromosomes. Another eight mutations had frequencies over 1%, 24 had frequencies between 1 and 0.1%; c. 2052-2053insA and c.3468+2_3468+3insT were the most frequent non-INNOLiPA mutations. Mutation distribution described herein is also relevant to the Polish diaspora. Our study also demonstrates that the reported efficiency of mutation detection strongly depends on the diagnostic experience of referring health centers.	[Zietkiewicz, Ewa; Rutkiewicz, Ewa; Klimek, Barbara; Voelkel, Katarzyna; Witt, Michal] Polish Acad Sci, Inst Human Genet, Dept Mol & Clin Genet, PL-60479 Poznan, Poland; [Pogorzelski, Andrzej] Inst TB & Lung Dis, Dept Pneumol & Cyst Fibrosis, Rabka, Poland; [Witt, Michal] Int Inst Mol & Cell Biol, Warsaw, Poland	Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Zietkiewicz, E (corresponding author), Polish Acad Sci, Inst Human Genet, Dept Mol & Clin Genet, PL-60479 Poznan, Poland.	zietkiee@man.poznan.pl	Zietkiewicz, Ewa/ABP-3539-2022	Zietkiewicz, Ewa/0000-0003-2437-5088	Polish Scientific Committee [KBN-NN401-020-435]	Polish Scientific Committee	This work was supported by the grant from Polish Scientific Committee KBN-NN401-020-435 to EZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelicheva D, 1997, HUM GENET, V99, P513, DOI 10.1007/s004390050398; Aznarez I, 2000, Med Wieku Rozwoj, V4, P149; Bal J, 1995, Pediatr Pol, V70, P627; BAL J, 1991, HUM GENET, V86, P329; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Bozkowa K, 1971, Pediatr Pol, V46, P677; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Colombo C, 2011, J CYST FIBROS, V10, pS7, DOI 10.1016/S1569-1993(11)60003-9; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; Dequeker E, 2009, EUR J HUM GENET, V17, P51, DOI 10.1038/ejhg.2008.136; DORK T, 1994, HUM GENET, V94, P533; Dork T, 2000, HUM GENET, V106, P259, DOI 10.1007/s004390000246; Estivill X, 1997, HUM MUTAT, V10, P135, DOI 10.1002/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.3.CO;2-P; FAKHOURY K, 1992, ARCH DIS CHILD-FETAL, V67, P1204, DOI 10.1136/adc.67.10_Spec_No.1204; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; Frentescu L, 2008, J CYST FIBROS, V7, P423, DOI 10.1016/j.jcf.2008.03.004; Giannattasio S, 2006, GENET TEST, V10, P169, DOI 10.1089/gte.2006.10.169; Gorter RR, 2010, J PEDIATR GASTR NUTR, V50, P569, DOI 10.1097/MPG.0b013e3181bb3427; Grody Wayne W., 2001, Genetics in Medicine, V3, P149, DOI 10.1097/00125817-200103000-00010; Groman JD, 2004, AM J HUM GENET, V74, P176, DOI 10.1086/381001; Heaney DL, 2006, J MOL DIAGN, V8, P137, DOI 10.2353/jmoldx.2006.050065; Ivady G, 2011, J CYST FIBROS, V10, P217, DOI 10.1016/j.jcf.2010.12.009; Kanavakis E, 2003, CLIN GENET, V63, P400, DOI 10.1034/j.1399-0004.2003.00067.x; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM E, 1989, J PEDIATR-US, V114, P767, DOI 10.1016/S0022-3476(89)80134-9; Krenkova P, 2012, J CYST FIBROS S, VS, P1569; Makukh H, 2010, J CYST FIBROS, V9, P371, DOI 10.1016/j.jcf.2010.06.001; Radivojevic D, 2004, GENET TEST, V8, P276, DOI 10.1089/gte.2004.8.276; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Sluszniak Aleksandra, 2011, Przegl Lek, V68, P59; Southern KW, 2007, J CYST FIBROS, V6, P57, DOI 10.1016/j.jcf.2006.05.008; Traeger N, 2013, J CYST FIBROS S, VS1, P569; Witt M, 1999, Pneumonol Alergol Pol, V67, P137; World Health Organization (WHO), 2004, MOL GEN EP CYST FIBR; Zietkiewicz E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-174	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89094	10.1371/journal.pone.0089094	http://dx.doi.org/10.1371/journal.pone.0089094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586523	gold, Green Submitted, Green Published			2022-12-27	WOS:000332389000025
J	Oizumi, A; Nakayama, H; Okino, N; Iwahara, C; Kina, K; Matsumoto, R; Ogawa, H; Takamori, K; Ito, M; Suga, Y; Iwabuchi, K				Oizumi, Ami; Nakayama, Hitoshi; Okino, Nozomu; Iwahara, Chihiro; Kina, Katsunari; Matsumoto, Ryo; Ogawa, Hideoki; Takamori, Kenji; Ito, Makoto; Suga, Yasushi; Iwabuchi, Kazuhisa			Pseudomonas-Derived Ceramidase Induces Production of Inflammatory Mediators from Human Keratinocytes via Sphingosine-1-Phosphate	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; SIMULTANEOUS QUANTITATIVE-ANALYSIS; TREATED HACAT CELLS; ATOPIC-DERMATITIS; SPHINGOSINE 1-PHOSPHATE; STRATUM-CORNEUM; TNF-ALPHA; SKIN; HYDROLYSIS	Ceramide is important for water retention and permeability barrier functions in the stratum corneum, and plays a key role in the pathogenesis of atopic dermatitis (AD). A Pseudomonas aeruginosa-derived neutral ceramidase (PaCDase) isolated from a patient with AD was shown to effectively degrade ceramide in the presence of Staphylococcus aureus-derived lipids or neutral detergents. However, the effect of ceramide metabolites on the functions of differentiating keratinocytes is poorly understood. We found that the ceramide metabolite sphingosine-1-phosphate (S1P) stimulated the production of inflammatory mediators such as TNF-alpha and IL-8 from three-dimensionally cultured human primary keratinocytes (termed "3D keratinocytes''), which form a stratum corneum. PaCDase alone did not affect TNF-alpha gene expression in 3D keratinocytes. In the presence of the detergent Triton X-100, which damages stratum corneum structure, PaCDase, but not heat-inactivated PaCDase or PaCDase-inactive mutant, induced the production of TNF-alpha, endothelin-1, and IL-8, indicating that this production was dependent on ceramidase activity. Among various ceramide metabolites, sphingosine and S1P enhanced the gene expression of TNF-alpha, endothelin-1, and IL-8. The PaCDase-enhanced expression of these genes was inhibited by a sphingosine kinase inhibitor and by an S1P receptor antagonist VPC 23019. The TNF-alpha-binding antibody infliximab suppressed the PaCDase-induced upregulation of IL-8, but not TNF-alpha, mRNA. PaCDase induced NF-kappa B p65 phosphorylation. The NF-kappa B inhibitor curcumin significantly inhibited PaCDase-induced expression of IL-8 and endothelin-1. VPC 23019 and infliximab inhibited PaCDase-induced NF-kappa B p65 phosphorylation and reduction in the protein level of the NF-kappa B inhibitor I kappa B alpha. Collectively, these findings suggest that (i) 3D keratinocytes produce S1P from sphingosine, which is produced through the hydrolysis of ceramide by PaCDase, (ii) S1P induces the production of TNF-alpha via S1P receptors, and (iii) released TNF-alpha stimulates the production of inflammatory mediators such as IL-8.	[Oizumi, Ami; Nakayama, Hitoshi; Iwahara, Chihiro; Kina, Katsunari; Matsumoto, Ryo; Ogawa, Hideoki; Takamori, Kenji; Iwabuchi, Kazuhisa] Juntendo Univ, Sch Med, Inst Environm & Gender Specif Med, Urayasu, Japan; [Oizumi, Ami; Takamori, Kenji; Ito, Makoto] Juntendo Univ, Urayasu Hosp, Dept Dermatol, Urayasu, Japan; [Nakayama, Hitoshi; Iwabuchi, Kazuhisa] Juntendo Univ, Sch Hlth Care & Nursing, Biochem Lab, Urayasu, Japan; [Okino, Nozomu; Ito, Makoto] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan	Juntendo University; Juntendo University; Juntendo University; Kyushu University	Iwabuchi, K (corresponding author), Juntendo Univ, Sch Med, Inst Environm & Gender Specif Med, Urayasu, Japan.	iwabuchi@juntendo.ac.jp	Ito, Makoto/Q-6164-2019; Okino, Nozomu/AAY-2635-2021	ito, Makoto/0000-0003-3159-7818	Foundation of Strategic Research Projects in Private Universities [S1311011]; MEXT, Japan [24659293]; Grants-in-Aid for Scientific Research [23570142, 25461011] Funding Source: KAKEN	Foundation of Strategic Research Projects in Private Universities; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid (S1311011) from the Foundation of Strategic Research Projects in Private Universities and by a Grant-in-Aid for Exploratory Research (24659293) from the MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Gun Young, 1998, Journal of Dermatology (Tokyo), V25, P78; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Amarbayasgalan T, 2013, INT ARCH ALLERGY IMM, V160, P63, DOI 10.1159/000339666; BARKER JNWN, 1991, AM J PATHOL, V139, P869; Beck Lisa A., 2000, Journal of Allergy and Clinical Immunology, V106, pS258; Behne M, 2000, J INVEST DERMATOL, V114, P185, DOI 10.1046/j.1523-1747.2000.00846.x; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Chi HB, 2011, TRENDS PHARMACOL SCI, V32, P16, DOI 10.1016/j.tips.2010.11.002; Cho JW, 2007, INT J MOL MED, V19, P469; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; FERREIRA SH, 1989, J CARDIOVASC PHARM, V13, pS220, DOI 10.1097/00005344-198900135-00065; Fujita H, 2011, J ALLERGY CLIN IMMUN, V128, P574, DOI 10.1016/j.jaci.2011.05.016; Ghazvini Patty, 2010, J Pharm Pract, V23, P110, DOI 10.1177/0897190009360634; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; Hamanaka S, 2002, J INVEST DERMATOL, V119, P416, DOI 10.1046/j.1523-1747.2002.01836.x; Han YQ, 1999, J BIOL CHEM, V274, P787, DOI 10.1074/jbc.274.2.787; He XX, 2005, ANAL BIOCHEM, V340, P113, DOI 10.1016/j.ab.2005.01.058; Herzinger T, 2007, AM J CLIN DERMATOL, V8, P329, DOI 10.2165/00128071-200708060-00002; Houben E, 2006, J LIPID RES, V47, P1063, DOI 10.1194/jlr.M600001-JLR200; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; IMOKAWA G, 1991, J INVEST DERMATOL, V96, P523, DOI 10.1111/1523-1747.ep12470233; Inoue T, 2009, J BIOL CHEM, V284, P9566, DOI 10.1074/jbc.M808232200; Janjetovic Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005988; Japtok L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049427; Kalish H, 2012, METHODS, V56, P198, DOI 10.1016/j.ymeth.2011.12.003; Kato T, 2009, ALLERGY, V64, P1366, DOI 10.1111/j.1398-9995.2009.02023.x; Katoh M, 2009, J TOXICOL SCI, V34, P327, DOI 10.2131/jts.34.327; Kirschner N, 2009, AM J PATHOL, V175, P1095, DOI 10.2353/ajpath.2009.080973; Kita K, 2000, BBA-MOL CELL BIOL L, V1485, P111, DOI 10.1016/S1388-1981(00)00029-9; Kita K, 2002, BIOCHEM J, V362, P619, DOI 10.1042/0264-6021:3620619; KOCK A, 1990, J EXP MED, V172, P1609, DOI 10.1084/jem.172.6.1609; Kokolakis G, 2012, BRIT J DERMATOL, V166, P491, DOI 10.1111/j.1365-2133.2011.10689.x; LAMPE MA, 1983, J LIPID RES, V24, P131; Lee CS, 2009, INT IMMUNOPHARMACOL, V9, P1097, DOI 10.1016/j.intimp.2009.05.006; Leung DYM, 2003, CURR OPIN PEDIATR, V15, P399, DOI 10.1097/00008480-200308000-00008; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Li CM, 1998, GENOMICS, V50, P267, DOI 10.1006/geno.1998.5334; Lin YT, 2007, CLIN REV ALLERG IMMU, V33, P167, DOI 10.1007/s12016-007-0044-5; Lisby S, 2007, BIOCHEM PHARMACOL, V73, P526, DOI 10.1016/j.bcp.2006.11.006; Maniatis T, 1997, SCIENCE, V278, P818, DOI 10.1126/science.278.5339.818; Min JK, 2002, ANAL BIOCHEM, V303, P167, DOI 10.1006/abio.2002.5579; Nakayama H, 2008, J LEUKOCYTE BIOL, V83, P728, DOI 10.1189/jlb.0707478; Noborio R, 2010, PHOTODERMATOL PHOTO, V26, P159, DOI 10.1111/j.1600-0781.2010.00510.x; Ohnishi Y, 1999, CLIN DIAGN LAB IMMUN, V6, P101, DOI 10.1128/CDLI.6.1.101-104.1999; Okino N, 1998, J BIOL CHEM, V273, P14368, DOI 10.1074/jbc.273.23.14368; Park K, 2013, MOL CELL BIOL, V33, P752, DOI 10.1128/MCB.01103-12; Park T, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-33; Reines I, 2009, J INVEST DERMATOL, V129, P1954, DOI 10.1038/jid.2008.454; Ricci G, 2009, DRUGS, V69, P297, DOI 10.2165/00003495-200969030-00005; Rigopoulos D, 2008, EXPERT OPIN BIOL TH, V8, P123, DOI 10.1517/14712598.8.1.123; Sator PG, 2003, J AM ACAD DERMATOL, V48, P352, DOI 10.1067/mjd.2003.105; Sauer B, 2004, J BIOL CHEM, V279, P38471, DOI 10.1074/jbc.M313557200; Siehler S, 2001, J BIOL CHEM, V276, P48733, DOI 10.1074/jbc.M011072200; Spiekstra SW, 2009, TOXICOL IN VITRO, V23, P349, DOI 10.1016/j.tiv.2008.12.010; Spoler F, 2006, SKIN RES TECHNOL, V12, P261, DOI 10.1111/j.0909-752X.2006.00163.x; Sugita K, 2010, AM J PATHOL, V177, P1881, DOI 10.2353/ajpath.2010.100119; Sun J, 2012, INT IMMUNOPHARMACOL, V13, P170, DOI 10.1016/j.intimp.2012.03.025; Torii H, 2011, J DERMATOL, V38, P310, DOI 10.1111/j.1346-8138.2010.00971.x; Uchida Y, 2010, J INVEST DERMATOL, V130, P2472, DOI 10.1038/jid.2010.153; van Ruissen F, 1998, J INVEST DERMATOL, V110, P358, DOI 10.1046/j.1523-1747.1998.00155.x; Voegeli TS, 2009, INFLAMM RES, V58, P336, DOI 10.1007/s00011-009-8166-2; Walling HW, 2010, CLIN COSMET INVESTI, V3, P99; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xia P, 2011, CYTOKINE GROWTH F R, V22, P45, DOI 10.1016/j.cytogfr.2010.09.004	66	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89402	10.1371/journal.pone.0089402	http://dx.doi.org/10.1371/journal.pone.0089402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586752	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900039
J	Islami, F; Nasseri-Moghaddam, S; Pourshams, A; Poustchi, H; Semnani, S; Kamangar, F; Etemadi, A; Merat, S; Khoshnia, M; Dawsey, SM; Pharoah, PD; Brennan, P; Abnet, CC; Boffetta, P; Malekzadeh, R				Islami, Farhad; Nasseri-Moghaddam, Siavosh; Pourshams, Akram; Poustchi, Hossein; Semnani, Shahryar; Kamangar, Farin; Etemadi, Arash; Merat, Shahin; Khoshnia, Masoud; Dawsey, Sanford M.; Pharoah, Paul D.; Brennan, Paul; Abnet, Christian C.; Boffetta, Paolo; Malekzadeh, Reza			Determinants of Gastroesophageal Reflux Disease, Including Hookah Smoking and Opium Use- A Cross-Sectional Analysis of 50,000 Individuals	PLOS ONE			English	Article							LIFE-STYLE FACTORS; BODY-MASS INDEX; GENERAL-POPULATION; RISK-FACTORS; BARRETTS-ESOPHAGUS; WATERPIPE TOBACCO; GASTROINTESTINAL SYMPTOMS; SOCIOECONOMIC-STATUS; EROSIVE ESOPHAGITIS; CARCINOGEN EXPOSURE	Background:Gastroesophageal reflux disease (GERD) is a common cause of discomfort and morbidity worldwide. However, information on determinants of GERD from large-scale studies in low- to medium-income countries is limited. We investigated the factors associated with different measures of GERD symptoms, including frequency, patient-perceived severity, and onset time. Methods: We performed a cross-sectional analysis of the baseline data from a population-based cohort study of,50,000 individuals in in Golestan Province, Iran. GERD symptoms in this study included regurgitation and/or heartburn. Results: Approximately 20% of participants reported at least weekly symptoms. Daily symptoms were less commonly reported by men, those of Turkmen ethnicity, and nass chewers. On the other hand, age, body mass index, alcohol drinking, cigarette smoking, opium use, lower socioeconomic status, and lower physical activity were associated with daily symptoms. Most of these factors showed similar associations with severe symptoms. Women with higher BMI and waist to hip ratio were more likely to report frequent and severe GERD symptoms. Hookah smoking (OR 1.34, 95% CI 1.02-1.75) and opium use (OR 1.70, 95% CI 1.55-1.87) were associated with severe symptoms, whereas nass chewing had an inverse association (OR 0.87, 95% CI 0.76-0.99). After exclusion of cigarette smokers, hookah smoking was still positively associated and nass chewing was inversely associated with GERD symptoms (all frequencies combined). Conclusion: GERD is common in this population. The associations of hookah and opium use and inverse association of nass use with GERD symptoms are reported for the first time. Further studies are required to investigate the nature of these associations. Other determinants of GERD were mostly comparable to those reported elsewhere.	[Islami, Farhad; Nasseri-Moghaddam, Siavosh; Pourshams, Akram; Poustchi, Hossein; Kamangar, Farin; Etemadi, Arash; Merat, Shahin; Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Inst, Digest Oncol Res Ctr, Tehran, Iran; [Islami, Farhad; Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Islami, Farhad; Boffetta, Paolo] Mt Sinai Sch Med, Inst Transit Epidemiol, New York, NY USA; [Semnani, Shahryar; Khoshnia, Masoud] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran; [Kamangar, Farin] Morgan State Univ, Sch Community Hlth & Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA; [Etemadi, Arash; Dawsey, Sanford M.; Abnet, Christian C.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Pharoah, Paul D.] Univ Cambridge, Dept Oncol, Cambridge, England; [Pharoah, Paul D.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France	Tehran University of Medical Sciences; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Golestan University of Medical Sciences; Morgan State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC)	Islami, F (corresponding author), Univ Tehran Med Sci, Digest Dis Res Inst, Digest Oncol Res Ctr, Tehran, Iran.	farhad.islami@mssm.edu; sianasseri@yahoo.com	Pharoah, Paul/V-6658-2019; Semnani, Shahryar/N-2270-2016; Abnet, Christian C/C-4111-2015; Merat, Shahin/A-5478-2009; Khoshnia, Masoud/P-5665-2016; Etemadi, Arash/Y-7082-2018; Etemadi, Arash/C-1386-2016; Boffetta, Paolo/AAI-7767-2021; Malekzadeh, Reza/U-1382-2017	Pharoah, Paul/0000-0001-8494-732X; Semnani, Shahryar/0000-0002-8768-6142; Abnet, Christian C/0000-0002-3008-7843; Khoshnia, Masoud/0000-0001-7352-8058; Etemadi, Arash/0000-0002-3458-1072; Etemadi, Arash/0000-0002-3458-1072; Boffetta, Paolo/0000-0002-3811-2791; Malekzadeh, Reza/0000-0002-9820-6335; Pourshams, Akram/0000-0002-7950-3983; Malekzadeh, Reza/0000-0003-1043-3814; Islami, Farhad/0000-0002-7357-5994	Tehran University of Medical Sciences [81/15]; Cancer Research UK [C20/A5860]; Intramural Research Program of the US National Cancer Institute; International Agency for Research on Cancer; NATIONAL CANCER INSTITUTE [ZIACP000185] Funding Source: NIH RePORTER	Tehran University of Medical Sciences(Tehran University of Medical Sciences); Cancer Research UK(Cancer Research UK); Intramural Research Program of the US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); International Agency for Research on Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Golestan Cohort Study was supported by Tehran University of Medical Sciences (grant No: 81/15), Cancer Research UK (grant No: C20/A5860), the Intramural Research Program of the US National Cancer Institute, and various collaborative research agreements with the International Agency for Research on Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anggiansah R, 2013, ALIMENT PHARM THER, V37, P555, DOI 10.1111/apt.12208; Ayazi S, 2011, DIGEST DIS SCI, V56, P1718, DOI 10.1007/s10620-011-1694-y; BRUNNEMANN KD, 1985, J AGR FOOD CHEM, V33, P1178, DOI 10.1021/jf00066a039; Chen MH, 2005, SCAND J GASTROENTERO, V40, P759, DOI 10.1080/00365520510015610; Chen Z, 2011, ARCH SURG-CHICAGO, V146, P1164, DOI 10.1001/archsurg.2011.248; Cho JH, 2011, J GASTROEN HEPATOL, V26, P1034, DOI 10.1111/j.1440-1746.2011.06686.x; Cho YS, 2005, AM J GASTROENTEROL, V100, P747, DOI 10.1111/j.1572-0241.2005.41245.x; Collings KL, 2003, MED SCI SPORT EXER, V35, P730, DOI 10.1249/01.MSS.0000064937.99001.56; Cook MB, 2005, AM J EPIDEMIOL, V162, P1050, DOI 10.1093/aje/kwi325; Corley DA, 2007, GUT, V56, P756, DOI 10.1136/gut.2006.109413; Derakhshan MH, 2012, GUT, V61, P337, DOI 10.1136/gutjnl-2011-300633; Djarv T, 2012, WORLD J GASTROENTERO, V18, P3710, DOI 10.3748/wjg.v18.i28.3710; Eherer AJ, 2012, AM J GASTROENTEROL, V107, P372, DOI 10.1038/ajg.2011.420; Eissenberg T, 2009, AM J PREV MED, V37, P518, DOI 10.1016/j.amepre.2009.07.014; El Serag HB, 2013, GUT             0713, V2012, DOI [DOI 10.1136/GUTJNL-2012-304269, 10.1136/gutjnl-2012-304269]; El-Serag H, 2009, ALIMENT PHARM THER, V29, P470, DOI 10.1111/j.1365-2036.2008.03901.x; El-Serag H, 2008, DIGEST DIS SCI, V53, P2307, DOI 10.1007/s10620-008-0413-9; Eslick GD, 2012, OBES REV, V13, P469, DOI 10.1111/j.1467-789X.2011.00969.x; Fazel M, 2012, INT J PREVENTIVE MED, V3, pS10; Friedenberg FK, 2010, DIGEST DIS SCI, V55, P1911, DOI 10.1007/s10620-009-1004-0; FRIESEN M, 1985, MUTAT RES, V150, P177, DOI 10.1016/0027-5107(85)90114-9; Ganji A, 2009, MIDDLE E J DIG DIS, V1, P56, DOI DOI 10.15171/MIDDLE%20EAST%20J%20DI.V1I2.427; Gao L, 2010, ALIMENT PHARM THER, V32, P296, DOI 10.1111/j.1365-2036.2010.04334.x; Gunji T, 2011, J GASTROENTEROL, V46, P448, DOI 10.1007/s00535-010-0359-5; Irwin RS, 2000, NEW ENGL J MED, V343, P1715, DOI 10.1056/NEJM200012073432308; Islami F, 2009, INT J EPIDEMIOL, V38, P978, DOI 10.1093/ije/dyp195; Jacob P, 2013, CANCER EPIDEM BIOMAR, V22, P765, DOI 10.1158/1055-9965.EPI-12-1422; Jacob P, 2011, CANCER EPIDEM BIOMAR, V20, P2345, DOI 10.1158/1055-9965.EPI-11-0545; Jacobson BC, 2008, ARCH INTERN MED, V168, P1798, DOI 10.1001/archinte.168.16.1798; Jacobson BC, 2006, NEW ENGL J MED, V354, P2340, DOI 10.1056/NEJMoa054391; Jansson C, 2007, CLIN GASTROENTEROL H, V5, P1029, DOI 10.1016/j.cgh.2007.04.009; Jansson C, 2010, SCAND J GASTROENTERO, V45, P21, DOI 10.3109/00365520903401967; Johnson DA, 2004, GASTROENTEROLOGY, V126, P660, DOI 10.1053/j.gastro.2003.12.001; Khademi H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2502; Kikura-Hanajiri R, 2003, J CHROMATOGR B, V789, P139, DOI 10.1016/S1570-0232(03)00096-5; Kotzan J, 2001, PHARM RES-DORDR, V18, P1367, DOI 10.1023/A:1013010616496; Kumar S, 2011, INDIAN J GASTROENTER, V30, P135, DOI 10.1007/s12664-010-0066-4; Li YM, 2008, J GASTROEN HEPATOL, V23, P283, DOI 10.1111/j.1440-1746.2007.05045.x; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Locke GR, 1999, AM J MED, V106, P642, DOI 10.1016/S0002-9343(99)00121-7; Lofdahl HE, 2011, EUR J GASTROEN HEPAT, V23, P128, DOI 10.1097/MEG.0b013e3283424e25; MALAVEILLE C, 1982, CARCINOGENESIS, V3, P577, DOI 10.1093/carcin/3.5.577; Matsuki N, 2013, J GASTROENTEROL, V48, P340, DOI 10.1007/s00535-012-0649-1; Maziak W, 2011, ADDICT BEHAV, V36, P1, DOI 10.1016/j.addbeh.2010.08.030; Maziak W, 2009, NICOTINE TOB RES, V11, P806, DOI 10.1093/ntr/ntp066; MOAYYEDI P, 2006, LANCET, V367, P2086; Moazzez R, 2005, J DENT RES, V84, P1062, DOI 10.1177/154405910508401118; Moshkowitz M, 2011, WORLD J GASTROENTERO, V17, P1332, DOI 10.3748/wjg.v17.i10.1332; Murao T, 2011, DIGEST DIS SCI, V56, P2857, DOI 10.1007/s10620-011-1679-x; Nam SY, 2010, GASTROENTEROLOGY, V139, P1902, DOI 10.1053/j.gastro.2010.08.019; Nasseri-Moghaddam S, 2008, ALIMENT PHARM THER, V28, P144, DOI 10.1111/j.1365-2036.2008.03708.x; Ness-Jensen E, 2012, GUT, V61, P1390, DOI 10.1136/gutjnl-2011-300715; Nilsson M, 2003, JAMA-J AM MED ASSOC, V290, P66, DOI 10.1001/jama.290.1.66; Nilsson M, 2002, SCAND J GASTROENTERO, V37, P626, DOI 10.1080/00365520212502; Nocon M, 2006, ALIMENT PHARM THER, V23, P1601, DOI 10.1111/j.1365-2036.2006.02924.x; Nocon M, 2006, ALIMENT PHARM THER, V23, P169, DOI 10.1111/j.1365-2036.2006.02727.x; Nordenstedt H, 2008, GASTROENTEROLOGY, V134, P921, DOI 10.1053/j.gastro.2008.01.009; Nouraie M, 2007, ARCH IRAN MED, V10, P289; Nouraie M, 2007, AM J GASTROENTEROL, V102, P1353, DOI 10.1111/j.1572-0241.2007.01208.x; Nusrat S, 2012, EUR J GASTROEN HEPAT, V24, P233, DOI 10.1097/MEG.0b013e32834f6baa; Pandeya N, 2012, DIS ESOPHAGUS, V25, P573, DOI 10.1111/j.1442-2050.2011.01287.x; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Penagini R, 1997, GASTROENTEROLOGY, V113, P409, DOI 10.1053/gast.1997.v113.pm9247457; Pilotto A, 2006, J AM GERIATR SOC, V54, P1537, DOI 10.1111/j.1532-5415.2006.00899.x; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Radwan G, 2013, NICOTINE TOB RES, V15, P130, DOI 10.1093/ntr/nts099; Rey E, 2006, AM J GASTROENTEROL, V101, P229, DOI 10.1111/j.1572-0241.2006.00412.x; Richter P, 2008, NICOTINE TOB RES, V10, P1645, DOI 10.1080/14622200802412937; Robertson EV, 2013, GASTROENTEROLOGY, V145, P730, DOI 10.1053/j.gastro.2013.06.038; Ronkainen J, 2005, SCAND J GASTROENTERO, V40, P275, DOI 10.1080/00365520510011579; Sepanlou Sg, 2010, Middle East J Dig Dis, V2, P78; Shihadeh A, 2004, PHARMACOL BIOCHEM BE, V79, P75, DOI 10.1016/j.pbb.2004.06.005; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1399, DOI 10.1016/j.cgh.2013.05.009; Smoak BR, 2001, ANN OTO RHINOL LARYN, V110, P1117, DOI 10.1177/000348940111001206; Sobieraj DM, 2011, AM J MANAG CARE, V17, pE449; Somi MH, 2008, IRAN J PUBLIC HEALTH, V37, P85; Thomas GAO, 2005, NAT CLIN PRACT GASTR, V2, P536, DOI 10.1038/ncpgasthep0316; Trenerry VC, 1995, J CHROMATOGR A, V718, P217; Triadafilopoulos G, 1997, AM J GASTROENTEROL, V92, P2007; Trudgill NJ, 1998, SCAND J GASTROENTERO, V33, P568; van Soest EM, 2005, GUT, V54, P1062, DOI 10.1136/gut.2004.063685; Wang A, 2009, DIGEST DIS SCI, V54, P964, DOI 10.1007/s10620-009-0742-3; Wang JH, 2004, WORLD J GASTROENTERO, V10, P1647, DOI 10.3748/wjg.v10.i11.1647; Zagari RM, 2008, GUT, V57, P1354, DOI 10.1136/gut.2007.145177; ZARIDZE DG, 1986, CANCER DETECT PREV, V9, P435; Zheng ZL, 2008, GASTROENTEROLOGY, V135, P72, DOI 10.1053/j.gastro.2008.03.039	86	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89256	10.1371/journal.pone.0089256	http://dx.doi.org/10.1371/journal.pone.0089256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586635	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900072
J	Su, Y; Tang, WX; Gao, X; Yu, F; Dai, ZY; Zhao, JD; Lu, Y; Ji, F; Huang, SS; Yuan, YY; Han, MY; Song, YS; Zhu, YH; Kang, DY; Han, DY; Dai, P				Su, Yu; Tang, Wen-Xue; Gao, Xue; Yu, Fei; Dai, Zhi-Yao; Zhao, Jian-Dong; Lu, Yu; Ji, Fei; Huang, Sha-Sha; Yuan, Yong-Yi; Han, Ming-Yu; Song, Yue-Shuai; Zhu, Yu-Hua; Kang, Dong-Yang; Han, Dong-Yi; Dai, Pu			A Novel Mutation in the TECTA Gene in a Chinese Family with Autosomal Dominant Nonsyndromic Hearing Loss	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATION; DUTCH DFNA8/12 FAMILY; SENSORINEURAL DEAFNESS; TECTORIAL MEMBRANE; IMPAIRMENT; IDENTIFICATION; EXPRESSION; DFNB21; CONFIRMS; DELETION	TECTA-related deafness can be inherited as autosomal-dominant nonsyndromic deafness (designated DFNA) or as the autosomal-recessive version. The alpha-tectorin protein, which is encoded by the TECTA gene, is one of the major components of the tectorial membrane in the inner ear. Using targeted DNA capture and massively parallel sequencing (MPS), we screened 42 genes known to be responsible for human deafness in a Chinese family (Family 3187) in which common deafness mutations had been ruled out as the cause, and identified a novel mutation, c.257-262CCTTTC > GCT (p. Ser86Cys; p. Pro88del) in exon 3 of the TECTA gene in the proband and his extended family. All affected individuals in this family had moderate down-sloping hearing loss across all frequencies. To our knowledge, this is the second TECTA mutation identified in Chinese population. This study demonstrates that targeted genomic capture, MPS, and barcode technology might broaden the availability of genetic testing for individuals with undiagnosed DFNA.	[Su, Yu; Gao, Xue; Yu, Fei; Zhao, Jian-Dong; Lu, Yu; Ji, Fei; Huang, Sha-Sha; Yuan, Yong-Yi; Han, Ming-Yu; Song, Yue-Shuai; Zhu, Yu-Hua; Kang, Dong-Yang; Han, Dong-Yi; Dai, Pu] Peoples Liberat Army Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China; [Su, Yu; Han, Ming-Yu; Song, Yue-Shuai; Dai, Pu] Hainan Branch PLA Gen Hosp, Dept Otorhinolaryngol, Sanya, Peoples R China; [Tang, Wen-Xue] Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA USA; [Gao, Xue] Second Artillery Gen Hosp, Dept Otorhinolaryngol, Beijing, Peoples R China; [Dai, Zhi-Yao] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Otorhinolaryngol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Emory University; Chinese People's Liberation Army General Hospital	Han, DY (corresponding author), Peoples Liberat Army Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China.	hdy301@263.net; daipu301@vip.sina.com		Yuan, Yongyi/0000-0002-7936-4776; Song, Yueshuai/0000-0003-4580-4451; Tang, Wenxue/0000-0001-8087-0900	Chinese National Nature Science Foundation Research [81070792]; National Basic Research Program of China (973 Program) [2013CB945402]; National Natural Science Foundation of China [81230020]; State 863 High Technology R&D Key Project of China [2011AA02A112]; Natural Science Foundation of Beijing [7122172]; Minister of Science and Technology of China [2012BAI09B02]; Minister of Health of China [201202005];  [20120481482];  [201104779]	Chinese National Nature Science Foundation Research(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State 863 High Technology R&D Key Project of China(National High Technology Research and Development Program of China); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Minister of Science and Technology of China; Minister of Health of China; ; 	This work was supported by Chinese National Nature Science Foundation Research Grant (81070792), the National Basic Research Program of China (973 Program) (#2013CB945402) to HD. The Project of the National Natural Science Foundation of China (Grant No. 81230020), a grant from State 863 High Technology R&D Key Project of China (2011AA02A112), a grant from Natural Science Foundation of Beijing (Grant No 7122172), a grant from Minister of Science and Technology of China (2012BAI09B02) and a grant from Minister of Health of China (201202005) to PD, China postdoctoral granted financial support and speccial financial grant (No. 20120481482 & 201104779) to YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasti F, 2008, INT J PEDIATR OTORHI, V72, P249, DOI 10.1016/j.ijporl.2007.09.023; Alloisio N, 1999, EUR J HUM GENET, V7, P255, DOI 10.1038/sj.ejhg.5200273; Moreno-Pelayo MA, 2008, JARO-J ASSOC RES OTO, V9, P202, DOI 10.1007/s10162-008-0116-0; Balciuniene J, 1999, HUM GENET, V105, P211, DOI 10.1007/s004390051091; CHUNG AE, 1993, INT J DEV BIOL, V37, P141; Collin RWJ, 2008, EUR J HUM GENET, V16, P1430, DOI 10.1038/ejhg.2008.110; Cristobal R, 2008, ARCH DIS CHILD-FETAL, V93, P1462, DOI 10.1136/adc.2007.124214; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Dayhoff MO, 1978, PROT SEGM DICT 78 S1, pvii; de Heer AR, 2009, AUDIOL NEURO-OTOL, V14, P153, DOI 10.1159/000171477; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DZIADEK M, 1985, DEV BIOL, V111, P372, DOI 10.1016/0012-1606(85)90491-9; DZIADEK M, 1985, EMBO J, V4, P2513, DOI 10.1002/j.1460-2075.1985.tb03964.x; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Han Dong-yi, 2010, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V45, P265; Hildebrand MS, 2011, HUM MUTAT, V32, P825, DOI 10.1002/humu.21512; Hughes DC, 1998, GENOMICS, V48, P46, DOI 10.1006/geno.1997.5159; Iwasaki S, 2002, ARCH OTOLARYNGOL, V128, P913, DOI 10.1001/archotol.128.8.913; Kupka S, 2004, HNO, V52, P968, DOI 10.1007/s00106-003-0994-8; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; Lezirovitz K, 2012, GENE, V511, P280, DOI 10.1016/j.gene.2012.09.023; Li ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070134; Maeda Y, 2001, NEUROREPORT, V12, P3223, DOI 10.1097/00001756-200110290-00016; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer NC, 2007, CLIN GENET, V72, P130, DOI 10.1111/j.1399-0004.2007.00828.x; Meyer NC, 2007, AM J MED GENET A, V143A, P1623, DOI 10.1002/ajmg.a.31718; Moreno-Pelayo M A, 2001, J Med Genet, V38, pE13, DOI 10.1136/jmg.38.5.e13; Moteki H, 2012, J HUM GENET, V57, P587, DOI 10.1038/jhg.2012.73; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; Naz S, 2003, J MED GENET, V40, P360, DOI 10.1136/jmg.40.5.360; Pfister M, 2004, CELL PHYSIOL BIOCHEM, V14, P369, DOI 10.1159/000080347; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Plantinga RF, 2006, JARO-J ASSOC RES OTO, V7, P173, DOI 10.1007/s10162-006-0033-z; Rau A, 1999, J COMP NEUROL, V405, P271; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Sagong B, 2012, GENE, V492, P239, DOI 10.1016/j.gene.2011.10.022; Sagong B, 2010, ANN CLIN LAB SCI, V40, P380; Smith RJH, 2002, J COMMUN DISORD, V35, P367, DOI 10.1016/S0021-9924(02)00091-6; Steel KP, 1996, CURR OPIN NEUROBIOL, V6, P520, DOI 10.1016/S0959-4388(96)80059-6; Tang WX, 2012, GENET TEST MOL BIOMA, V16, P536, DOI 10.1089/gtmb.2011.0187; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Zhu Y, 2009, MITOCHONDRION, V9, P418, DOI 10.1016/j.mito.2009.07.006	46	5	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89240	10.1371/journal.pone.0089240	http://dx.doi.org/10.1371/journal.pone.0089240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586623	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900069
J	Qu, TT; Feng, Y; Jiang, Y; Zhu, PQ; Wei, ZQ; Chen, Y; Otto, M; Yu, YS				Qu, Tingting; Feng, Ye; Jiang, Yan; Zhu, Peiqiong; Wei, Zeqing; Chen, Yan; Otto, Michael; Yu, Yunsong			Whole Genome Analysis of a Community-Associated Methicillin-Resistant Staphylococcus aureus ST59 Isolate from a Case of Human Sepsis and Severe Pneumonia in China	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; VIRULENCE DETERMINANTS; MOLECULAR EPIDEMIOLOGY; SEQUENCE; TOXIN; INFECTIONS; EXPRESSION; ALIGNMENT; TAIWAN; GENES	We report a case of necrotizing pneumonia in a young patient caused by community acquired-methicillin resistant Staphylococcus aureus (CA-MRSA) in a teaching hospital in the People's Republic of China. The patient had a typical clinical presentation and was successfully treated with antibiotics and intravenous immunoglobulin. A CA-MRSA strain, named SA268, was isolated from the blood of the patient. The isolate was susceptible to most antimicrobial agents, except cephalosporins, penicillins, and b-lactamase inhibitor combinations. Multi-locus sequence typing (MLST) assigned SA268 to ST59, a clone widely spread in eastern Asia. The strain was positive for Panton Valentine Leukocidin (PVL)-encoding genes and SCCmec type V. We sequenced the complete genome of the SA268 isolate. The genome of SA268 was almost identical to that of the Taiwanese ST59 CA-MRSA strains M013 and SA957. However, we observed several differences in gene composition, which included differences in the SCCmec element and several lipoprotein genes that were present in the Taiwanese strains but absent from SA268.	[Qu, Tingting; Wei, Zeqing] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Feng, Ye; Jiang, Yan; Chen, Yan; Yu, Yunsong] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Zhu, Peiqiong] Zhejiang Med Coll, Dept Clin Med, Hangzhou, Zhejiang, Peoples R China; [Otto, Michael] NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA	Zhejiang University; Zhejiang University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Otto, M (corresponding author), NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	MOtto@niaid.nih.gov; yvys119@163.com	Chen, Yan/U-1480-2018	Chen, Yan/0000-0002-7679-1713; RAJENDRA PRASAD, JANAPATLA/0000-0003-4331-0925; Otto, Michael/0000-0002-2222-4115	National Science and Technology Major Project [2012ZX10004215]; Medicine and Health Research fund of Zhejiang Province [2009A009]; Ministry of Health of the People's Republic of China [201002021]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	National Science and Technology Major Project; Medicine and Health Research fund of Zhejiang Province; Ministry of Health of the People's Republic of China; Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research grants from the National Science and Technology Major Project (2012ZX10004215), the Medicine and Health Research fund of Zhejiang Province (No. 2009A009), the Ministry of Health of the People's Republic of China (no. 201002021), and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), U.S. National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P707; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Chen CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063210; Chuang YY, 2013, LANCET INFECT DIS, V13, P698, DOI 10.1016/S1473-3099(13)70136-1; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; David MZ, 2008, EMERG INFECT DIS, V14, P1693, DOI 10.3201/eid1411.080381; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Graves SF, 2010, J MOL MED, V88, P109, DOI 10.1007/s00109-009-0573-x; GUAY GG, 1993, ANTIMICROB AGENTS CH, V37, P191, DOI 10.1128/AAC.37.2.191; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huang TW, 2012, J BACTERIOL, V194, P1256, DOI 10.1128/JB.06666-11; Hung WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046987; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070602; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Schmitz FJ, 2001, J ANTIMICROB CHEMOTH, V47, P239, DOI 10.1093/jac/47.2.239; Szmigielski S, 1999, ZBL BAKT-INT J MED M, V289, P185; Thurlow LR, 2013, CELL HOST MICROBE, V13, P100, DOI 10.1016/j.chom.2012.11.012; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wu DJ, 2010, DIAGN MICR INFEC DIS, V67, P1, DOI 10.1016/j.diagmicrobio.2009.12.006; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407	40	10	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89235	10.1371/journal.pone.0089235	http://dx.doi.org/10.1371/journal.pone.0089235			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586619	Green Submitted, gold, Green Published			2022-12-27	WOS:000331714700079
J	Sanz-Moreno, A; Fuhrmann, D; Wolf, E; von Eyss, B; Eilers, M; Elsasser, HP				Sanz-Moreno, Adrian; Fuhrmann, David; Wolf, Elmar; von Eyss, Bjoern; Eilers, Martin; Elsaesser, Hans-Peter			Miz1 Deficiency in the Mammary Gland Causes a Lactation Defect by Attenuated Stat5 Expression and Phosphorylation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MIZ-1; CELL-PROLIFERATION; GENE-EXPRESSION; MYC; PROLACTIN; DIFFERENTIATION; GROWTH; SUPPRESSION; ACTIVATION; REVEALS	Miz1 is a zinc finger transcription factor with an N-terminal POZ domain. Complexes with Myc, Bcl-6 or Gfi-1 repress expression of genes like Cdkn2b (p15(Ink4)) or Cd-kn1a (p21(Cip1)). The role of Miz1 in normal mammary gland development has not been addressed so far. Conditional knockout of the Miz1 POZ domain in luminal cells during pregnancy caused a lactation defect with a transient reduction of glandular tissue, reduced proliferation and attenuated differentiation. This was recapitulated in vitro using mouse mammary gland derived HC11 cells. Further analysis revealed decreased Stat5 activity in Miz1 Delta POZ mammary glands and an attenuated expression of Stat5 targets. Gene expression of the Prolactin receptor (PrlR) and ErbB4, both critical for Stat5 phosphorylation (pStat5) or pStat5 nuclear translocation, was decreased in Miz1 Delta POZ females. Microarray, ChIP-Seq and gene set enrichment analysis revealed a down-regulation of Miz1 target genes being involved in vesicular transport processes. Our data suggest that deranged intracellular transport and localization of PrlR and ErbB4 disrupt the Stat5 signalling pathway in mutant glands and cause the observed lactation phenotype.	[Sanz-Moreno, Adrian; Fuhrmann, David; Elsaesser, Hans-Peter] Univ Marburg, Dept Cytobiol, Marburg, Germany; [Wolf, Elmar; von Eyss, Bjoern; Eilers, Martin] Univ Wurzburg, Theodor Boveri Inst, Bioctr, D-97070 Wurzburg, Germany	Philipps University Marburg; University of Wurzburg	Elsasser, HP (corresponding author), Univ Marburg, Dept Cytobiol, Marburg, Germany.	elsaesse@mailer.uni-marburg.de	von Eyss, Bjoern/P-1077-2019; Wolf, Elmar/AAY-8493-2021	von Eyss, Bjoern/0000-0002-4731-6841; Wolf, Elmar/0000-0002-5299-6335; Eilers, Martin/0000-0002-0376-6533; Fuhrmann, David/0000-0002-6208-9050; Sanz-Moreno, Adrian/0000-0001-9478-5432	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich Transregio 17]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich Transregio 17, Project B5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; BALL RK, 1988, MOL ENDOCRINOL, V2, P133, DOI 10.1210/mend-2-2-133; Blakely CM, 2005, DEVELOPMENT, V132, P1147, DOI 10.1242/dev.01655; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Do-Umehara HC, 2013, NAT IMMUNOL, V14, P461, DOI 10.1038/ni.2566; Dong J, 2010, DEV BIOL, V346, P196, DOI 10.1016/j.ydbio.2010.07.027; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Furth PA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2921; Gallego MI, 2001, DEV BIOL, V229, P163, DOI 10.1006/dbio.2000.9961; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Gebhardt A, 2007, J CELL SCI, V120, P2586, DOI 10.1242/jcs.007104; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gutzman JH, 2004, J STEROID BIOCHEM, V88, P69, DOI 10.1016/j.jsbmb.2003.10.008; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Herkert B, 2010, J CELL BIOL, V188, P905, DOI 10.1083/jcb.200908103; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Honnemann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034885; Hynes NE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2406; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; Ip M. M., 2000, METHODS MAMMARY GLAN; ITO S, 1968, J CELL BIOL, V39, pA168; Jahchan NS, 2012, DEVELOPMENT, V139, P3147, DOI 10.1242/dev.079616; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kime L, 2003, BIOCHEM J, V370, P291, DOI 10.1042/BJ20021679; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Le Guillou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045727; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liby K, 2003, BREAST CANCER RES TR, V79, P241, DOI 10.1023/A:1023956223037; Liu J, 2012, P NATL ACAD SCI USA, V109, P191, DOI 10.1073/pnas.1105176108; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; MARTE BM, 1995, MOL ENDOCRINOL, V9, P14, DOI 10.1210/me.9.1.14; Master SR, 2002, MOL ENDOCRINOL, V16, P1185, DOI 10.1210/me.16.6.1185; MERLO GR, 1994, ONCOGENE, V9, P443; Moroy T, 2011, SEMIN IMMUNOL, V23, P379, DOI 10.1016/j.smim.2011.09.001; Palmer CA, 2006, J MAMMARY GLAND BIOL, V11, P269, DOI 10.1007/s10911-006-9023-3; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Piazza TM, 2009, MOL ENDOCRINOL, V23, P202, DOI 10.1210/me.2008-0341; Saba I, 2011, BLOOD, V117, P3370, DOI 10.1182/blood-2010-09-310680; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stoelzle T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-63; Swaminathan G, 2008, J MAMMARY GLAND BIOL, V13, P81, DOI 10.1007/s10911-008-9068-6; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Wiese KE, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014290; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Wolf E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3535; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Yang YM, 2010, J TAIWAN INST CHEM E, V41, P1, DOI 10.1016/j.jtice.2009.11.002	66	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89187	10.1371/journal.pone.0089187	http://dx.doi.org/10.1371/journal.pone.0089187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586582	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900101
J	Unbehend, M; Hanniger, S; Vasquez, GM; Juarez, ML; Reisig, D; McNeil, JN; Meagher, RL; Jenkins, DA; Heckel, DG; Groot, AT				Unbehend, Melanie; Haenniger, Sabine; Vasquez, Gissella M.; Laura Juarez, Maria; Reisig, Dominic; McNeil, Jeremy N.; Meagher, Robert L.; Jenkins, David A.; Heckel, David G.; Groot, Astrid T.			Geographic Variation in Sexual Attraction of Spodoptera frugiperda Corn- and Rice-Strain Males to Pheromone Lures	PLOS ONE			English	Article							FALL ARMYWORM LEPIDOPTERA; CUTWORM MOTH LEPIDOPTERA; BORER OSTRINIA-NUBILALIS; HOST STRAINS; GENETIC-STRUCTURE; ENVIRONMENTAL-FACTORS; ADVERTISEMENT CALL; FIELD-EVALUATION; NOCTUIDAE CORN; TUNGARA FROG	The corn-and rice-strains of Spodoptera frugiperda exhibit several genetic and behavioral differences and appear to be undergoing ecological speciation in sympatry. Previous studies reported conflicting results when investigating male attraction to pheromone lures in different regions, but this could have been due to inter-strain and/or geographic differences. Therefore, we investigated whether corn- and rice-strain males differed in their response to different synthetic pheromone blends in different regions in North America, the Caribbean and South America. All trapped males were strain-typed by two strain-specific mitochondrial DNA markers. In the first experiment, we found a nearly similar response of corn- and rice-strain males to two different 4-component blends, resembling the corn-and rice-strain female blend we previously described from females in Florida. This response showed some geographic variation in fields in Canada, North Carolina, Florida, Puerto Rico, and South America (Peru, Argentina). In dose-response experiments with the critical secondary sex pheromone component (Z)-7-dodecenyl acetate (Z7-12:OAc), we found some strain-specific differences in male attraction. While the response to Z7-12: OAc varied geographically in the corn-strain, rice-strain males showed almost no variation. We also found that the minor compound (Z)-11-hexadecenyl acetate (Z11-16:OAc) did not increase attraction of both strains in Florida and of corn-strain males in Peru. In a fourth experiment, where we added the stereo-isomer of the critical sex pheromone component, (E)-7-dodecenyl acetate, to the major pheromone component (Z)-9-tetradecenyl acetate (Z9-14:OAc), we found that this compound was attractive to males in North Carolina, but not to males in Peru. Overall, our results suggest that both strains show rather geographic than strain-specific differences in their response to pheromone lures, and that regional sexual communication differences might cause geographic differentiation between populations.	[Unbehend, Melanie; Haenniger, Sabine; Heckel, David G.; Groot, Astrid T.] MPI Chem Ecol, MPICE, Dept Entomol, Jena, Germany; [Vasquez, Gissella M.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Laura Juarez, Maria] Secc Zool Agr, Estn Expt Agroind Obispo Colombres, San Miguel De Tucuman, Argentina; [Reisig, Dominic] N Carolina State Univ, Dept Entomol, Plymouth, NC USA; [McNeil, Jeremy N.] Univ Western Ontario, Dept Biol, London, ON, Canada; [Meagher, Robert L.] USDA, Insect Behav & Biocontrol Res Unit, Gainesville, FL USA; [Jenkins, David A.] USDA, Mayaguez, PR USA; [Groot, Astrid T.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Western University (University of Western Ontario); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Amsterdam	Unbehend, M (corresponding author), MPI Chem Ecol, MPICE, Dept Entomol, Jena, Germany.	munbehend@ice.mpg.de	Groot, Astrid/A-8954-2013; Hänniger, Sabine/AAA-8633-2019; Heckel, David G/K-2138-2013	Groot, Astrid/0000-0001-9595-0161; Hänniger, Sabine/0000-0001-8758-3568; Heckel, David G/0000-0001-8991-2150; Juarez, Maria Laura/0000-0002-4563-5080; Unbehend, Melanie/0000-0002-9237-3984; Reisig, Dominic/0000-0002-9979-5813	German Science Foundation [GR3627/2-1]; National Science Foundation [IOS-1052238, NSF-DEB-1025217]; Max Planck Gesellschaft	German Science Foundation(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Max Planck Gesellschaft(Max Planck Society)	This research was partly funded by the German Science Foundation (www.dfg.de; grant number GR3627/2-1), the National Science Foundation (www.nsf.gov; award IOS-1052238 and NSF-DEB-1025217), and the Max Planck Gesellschaft (www.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN JD, 1989, BIOTROPICA, V21, P340, DOI 10.2307/2388284; Andrade R, 2000, J BRAZIL CHEM SOC, V11, P609, DOI 10.1590/S0103-50532000000600009; Baker TC, 2002, P NATL ACAD SCI USA, V99, P13368, DOI 10.1073/pnas.222539799; BALABAN E, 1988, BEHAVIOUR, V105, P250, DOI 10.1163/156853988X00043; Batista-Pereira LG, 2006, J CHEM ECOL, V32, P1085, DOI 10.1007/s10886-006-9048-5; Belay DK, 2012, ANN ENTOMOL SOC AM, V105, P359, DOI 10.1603/AN11111; Bernal XE, 2005, HERPETOLOGICA, V61, P395, DOI 10.1655/04-87.1; CARDE RT, 1995, ANNU REV ENTOMOL, V40, P559, DOI 10.1146/annurev.en.40.010195.003015; Clark PL, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0501; DELISLE J, 1987, PHYSIOL ENTOMOL, V12, P157, DOI 10.1111/j.1365-3032.1987.tb00736.x; DELISLE J, 1994, J CHEM ECOL, V20, P45, DOI 10.1007/BF02065990; DESCOINS C, 1988, AGR ECOSYST ENVIRON, V21, P53, DOI 10.1016/0167-8809(88)90139-9; El-Sayed AM, 2009, J ECON ENTOMOL, V102, P815, DOI 10.1603/029.102.0301; Fleischer SJ, 2005, J ECON ENTOMOL, V98, P66, DOI 10.1603/0022-0493-98.1.66; Gemeno C, 2000, ANN ENTOMOL SOC AM, V93, P1322, DOI 10.1603/0013-8746(2000)093[1322:PBVACA]2.0.CO;2; Gemeno C, 2001, ENVIRON ENTOMOL, V30, P189, DOI 10.1603/0046-225X-30.2.189; Gonzalez-Zuarth CA, 2011, EVOL ECOL, V25, P831, DOI 10.1007/s10682-010-9449-3; Green JP, 2012, ETHOLOGY, V118, P766, DOI 10.1111/j.1439-0310.2012.02067.x; Groot AT, 2010, J EVOLUTION BIOL, V23, P2731, DOI 10.1111/j.1420-9101.2010.02124.x; Groot AT, 2007, J CHEM ECOL, V33, P353, DOI 10.1007/s10886-006-9233-6; Groot AT, 2010, SOUTHWEST ENTOMOL, V35, P367, DOI 10.3958/059.035.0317; Groot AT, 2010, ECOL ENTOMOL, V35, P105, DOI 10.1111/j.1365-2311.2009.01138.x; Groot AT, 2009, EVOLUTION, V63, P1987, DOI 10.1111/j.1558-5646.2009.00702.x; Groot AT, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-20; JONES RL, 1979, J CHEM ECOL, V5, P721, DOI 10.1007/BF00986556; Kaefer IL, 2012, ACTA ETHOL, V15, P187, DOI 10.1007/s10211-012-0126-0; Kawazu K, 2005, APPL ENTOMOL ZOOL, V40, P483, DOI 10.1303/aez.2005.483; KUMAR H, 1986, APPL ENTOMOL ZOOL, V21, P55, DOI 10.1303/aez.21.55; Lampert KP, 2003, MOL ECOL, V12, P3325, DOI 10.1046/j.1365-294X.2003.02016.x; Landolt PJ, 1997, ANNU REV ENTOMOL, V42, P371, DOI 10.1146/annurev.ento.42.1.371; Lassance JM, 2010, J CHEM ECOL, V36, P1155, DOI 10.1007/s10886-010-9856-5; Juarez ML, 2012, J ECON ENTOMOL, V105, P573, DOI 10.1603/EC11184; Leblois R, 2000, MOL ECOL, V9, P1905, DOI 10.1046/j.1365-294x.2000.01091.x; Lewter JA, 2006, FLA ENTOMOL, V89, P63, DOI 10.1653/0015-4040(2006)89[63:GVWABS]2.0.CO;2; Lima ER, 2009, CHEMOECOLOGY, V19, P29, DOI 10.1007/s00049-009-0005-y; Lu YJ, 1996, FLA ENTOMOL, V79, P48, DOI 10.2307/3495753; LUGINBILL PHILIP, 1928, U S DEPT AGRIC TECH BULL, V34, P1; MacDougall-Shackleton EA, 2001, EVOLUTION, V55, P2568, DOI 10.1111/j.0014-3820.2001.tb00769.x; Machado V, 2008, ANN ENTOMOL SOC AM, V101, P619, DOI 10.1603/0013-8746(2008)101[619:MCOHSO]2.0.CO;2; Malo EA, 2004, ANN ENTOMOL SOC AM, V97, P1273, DOI 10.1603/0013-8746(2004)097[1273:ASAERO]2.0.CO;2; Martinelli S, 2007, B ENTOMOL RES, V97, P225, DOI 10.1017/S0007485307004944; McElfresh JS, 1999, J CHEM ECOL, V25, P2505, DOI 10.1023/A:1020826208715; MCNEIL JN, 1991, ANNU REV ENTOMOL, V36, P407, DOI 10.1146/annurev.en.36.010191.002203; Meagher RL, 2003, FLA ENTOMOL, V86, P450, DOI 10.1653/0015-4040(2003)086[0450:IHSOFA]2.0.CO;2; Meagher RL, 2013, ENVIRON ENTOMOL, V42, P751, DOI 10.1603/EN13007; Miller DR, 1997, J CHEM ECOL, V23, P2013, DOI 10.1023/B:JOEC.0000006486.39056.48; MITCHELL ER, 1985, J ECON ENTOMOL, V78, P1364, DOI 10.1093/jee/78.6.1364; Nagoshi RN, 2006, J ECON ENTOMOL, V99, P671, DOI 10.1603/0022-0493-99.3.671; Nagoshi RN, 2006, ENVIRON ENTOMOL, V35, P561, DOI 10.1603/0046-225X-35.2.561; Nagoshi RN, 2003, INSECT MOL BIOL, V12, P453, DOI 10.1046/j.1365-2583.2003.00429.x; Nagoshi RN, 2007, ANN ENTOMOL SOC AM, V100, P394, DOI 10.1603/0013-8746(2007)100[394:IACOFA]2.0.CO;2; Nagoshi RN, 2008, J ECON ENTOMOL, V101, P742, DOI 10.1603/0022-0493(2008)101[742:UHTMTM]2.0.CO;2; Nagoshi RN, 2010, J ECON ENTOMOL, V103, P360, DOI 10.1603/EC09253; Nagoshi RN, 2010, ANN ENTOMOL SOC AM, V103, P283, DOI 10.1603/AN09046; Nagoshi RN, 2008, FLA ENTOMOL, V91, P546; Olvido AE, 2010, J INSECT SCI, V10, P1, DOI 10.1673/031.010.9001; Pashley D.P., 1989, Systematics Association Special Volume Series, P103; PASHLEY DP, 1988, FLA ENTOMOL, V71, P227, DOI 10.2307/3495425; PASHLEY DP, 1986, ANN ENTOMOL SOC AM, V79, P898, DOI 10.1093/aesa/79.6.898; PASHLEY DP, 1992, ANN ENTOMOL SOC AM, V85, P400, DOI 10.1093/aesa/85.4.400; Phelan P.L., 1992, P265; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Prohl H, 2006, EVOLUTION, V60, P1669; Prowell DP, 2004, ANN ENTOMOL SOC AM, V97, P1034, DOI 10.1603/0013-8746(2004)097[1034:MGAOHU]2.0.CO;2; R Development Core Team, 2007, R LANG ENV STAT COMP; Reddy GVP, 2004, TRENDS PLANT SCI, V9, P253, DOI 10.1016/j.tplants.2004.03.009; Roelofs WL, 1974, SEX PHEROMONES REPRO, P96; Roeser-Mueller K, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.7401; ROYER L, 1993, J CHEM ECOL, V19, P61, DOI 10.1007/BF00987471; ROYER L, 1991, ENTOMOL EXP APPL, V61, P131, DOI 10.1111/j.1570-7458.1991.tb02405.x; Ryan MJ, 1996, EVOLUTION, V50, P2435, DOI 10.1111/j.1558-5646.1996.tb03630.x; Schofl G, 2009, J EVOLUTION BIOL, V22, P1447, DOI 10.1111/j.1420-9101.2009.01759.x; Seppa P, 1999, HEREDITY, V82, P309, DOI 10.1038/sj.hdy.6884900; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; SPARKS AN, 1986, FLA ENTOMOL, V69, P603, DOI 10.2307/3495397; Tack EJ, 2005, EMU, V105, P27, DOI 10.1071/MU03053; TOTH M, 1992, J CHEM ECOL, V18, P1337, DOI 10.1007/BF00994360; TUMLINSON JH, 1986, J CHEM ECOL, V12, P1909, DOI 10.1007/BF01041855; Unbehend M, 2013, J CHEM ECOL, V39, P364, DOI 10.1007/s10886-013-0263-6; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Wu WQ, 1999, J CHEM ECOL, V25, P177, DOI 10.1023/A:1020849419193; Zhu Junwei, 2009, Journal of Asia-Pacific Entomology, V12, P247, DOI 10.1016/j.aspen.2009.04.005	84	47	64	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89255	10.1371/journal.pone.0089255	http://dx.doi.org/10.1371/journal.pone.0089255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586634	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900115
J	Knecht, H; Neulinger, SC; Heinsen, FA; Knecht, C; Schilhabel, A; Schmitz, RA; Zimmermann, A; dos Santos, VM; Ferrer, M; Rosenstiel, PC; Schreiber, S; Friedrichs, AK; Ott, SJ				Knecht, Henrik; Neulinger, Sven C.; Heinsen, Femke Anouska; Knecht, Carolin; Schilhabel, Anke; Schmitz, Ruth A.; Zimmermann, Alexandra; dos Santos, Vitor Martins; Ferrer, Manuel; Rosenstiel, Philip C.; Schreiber, Stefan; Friedrichs, Anette K.; Ott, Stephan J.			Effects of beta-Lactam Antibiotics and Fluoroquinolones on Human Gut Microbiota in Relation to Clostridium difficile Associated Diarrhea	PLOS ONE			English	Article							RIBOSOMAL-RNA; FECAL MICROBIOTA; RESISTANCE; DIVERSITY; DYNAMICS; DIFFERS; MODEL; ACIDS; RISK	Clostridium difficile infections are an emerging health problem in the modern hospital environment. Severe alterations of the gut microbiome with loss of resistance to colonization against C. difficile are thought to be the major trigger, but there is no clear concept of how C. difficile infection evolves and which microbiological factors are involved. We sequenced 16S rRNA amplicons generated from DNA and RNA/cDNA of fecal samples from three groups of individuals by FLX technology: (i) healthy controls (no antibiotic therapy); (ii) individuals receiving antibiotic therapy (Ampicillin/Sulbactam, cephalosporins, and fluoroquinolones with subsequent development of C. difficile infection or (iii) individuals receiving antibiotic therapy without C. difficile infection. We compared the effects of the three different antibiotic classes on the intestinal microbiome and the effects of alterations of the gut microbiome on C. difficile infection at the DNA (total microbiota) and rRNA (potentially active) levels. A comparison of antibiotic classes showed significant differences at DNA level, but not at RNA level. Among individuals that developed or did not develop a C. difficile infection under antibiotics we found no significant differences. We identified single species that were up-or down regulated in individuals receiving antibiotics who developed the infection compared to non-infected individuals. We found no significant differences in the global composition of the transcriptionally active gut microbiome associated with C. difficile infections. We suggest that up-and down regulation of specific bacterial species may be involved in colonization resistance against C. difficile providing a potential therapeutic approach through specific manipulation of the intestinal microbiome.	[Knecht, Henrik; Heinsen, Femke Anouska; Zimmermann, Alexandra; Rosenstiel, Philip C.; Schreiber, Stefan; Friedrichs, Anette K.; Ott, Stephan J.] Univ Kiel, Inst Clin Mol Biol IKMB, Kiel, Germany; [Neulinger, Sven C.; Schilhabel, Anke; Schmitz, Ruth A.] Univ Kiel, Inst Gen Microbiol IFAM, Kiel, Germany; [Knecht, Carolin] Univ Kiel, IMIS, Kiel, Germany; [dos Santos, Vitor Martins] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [dos Santos, Vitor Martins] LifeGlimmer GmbH, Berlin, Germany; [Ferrer, Manuel] CSIC, Lab Enzyme Discovery, Inst Catalysis, Madrid, Spain; [Schreiber, Stefan; Friedrichs, Anette K.; Ott, Stephan J.] Univ Hosp Schleswig Holstein UKSH, Dept Internal Med 1, Kiel, Germany	University of Kiel; University of Kiel; University of Kiel; Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); University of Kiel; Schleswig Holstein University Hospital	Ott, SJ (corresponding author), Univ Kiel, Inst Clin Mol Biol IKMB, Kiel, Germany.	s.ott@mucosa.de	Ott, Stephan J/G-1965-2010; Rosenstiel, Philip/A-5137-2009; Ferrer, Manuel/K-4535-2014	Rosenstiel, Philip/0000-0002-9692-8828; Ferrer, Manuel/0000-0003-4962-4714; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829	ERANET Project PathoGenoMics program [0315441A]	ERANET Project PathoGenoMics program	This work was supported by the ERANET Project PathoGenoMics program grant number 0315441A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Barc MC, 2004, ANTIMICROB AGENTS CH, V48, P1365, DOI 10.1128/AAC.48.4.1365-1368.2004; Bartlett JG, 2006, ANN INTERN MED, V145, P758, DOI 10.7326/0003-4819-145-10-200611210-00008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Blondeau JM, 2009, J ANTIMICROB CHEMOTH, V63, P238, DOI 10.1093/jac/dkn477; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Cloud J, 2007, CURR OPIN GASTROEN, V23, P4; Coates P, 2002, BRIT J DERMATOL, V146, P840, DOI 10.1046/j.1365-2133.2002.04690.x; Cotta M, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P1002, DOI 10.1007/0-387-30744-3_35; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; De La Cochetiere MF, 2005, J CLIN MICROBIOL, V43, P5588, DOI 10.1128/JCM.43.11.5588-5592.2005; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Duboc H, 2012, NEUROGASTROENT MOTIL, V24, P513, DOI 10.1111/j.1365-2982.2012.01893.x; Freeman HJ, 2008, WORLD J GASTROENTERO, V14, P2794, DOI 10.3748/wjg.14.2794; Fujimoto T, 2013, J GASTROEN HEPATOL, V28, P613, DOI 10.1111/jgh.12073; Gerding DN, 2004, CLIN INFECT DIS, V38, P646, DOI 10.1086/382084; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hove H, 1996, SCAND J GASTROENTERO, V31, P688, DOI 10.3109/00365529609009151; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Kohler W, 2001, MED MIKROBIOLOGIE, P200; Kyne L, 2002, CLIN INFECT DIS, V23, P653; Lau SKP, 2004, J MED MICROBIOL, V53, P1247, DOI 10.1099/jmm.0.45803-0; Lau SKP, 2004, DIAGN MICR INFEC DIS, V49, P255, DOI 10.1016/j.diagmicrobio.2004.04.012; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Manges AR, 2010, J INFECT DIS, V202, P1877, DOI 10.1086/657319; McDonald LC, 2007, CLIN INFECT DIS, V45, P1274, DOI 10.1086/522655; Mutschler E, 2008, ARZNEITMITTELWIRKUNG, P794; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Rajeshwair DS, 2011, IJBB, V5; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; ROLFE RD, 1984, INFECT IMMUN, V45, P185, DOI 10.1128/IAI.45.1.185-191.1984; Rousseau C, 2011, J MED MICROBIOL, V60, P1112, DOI 10.1099/jmm.0.029736-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stratil SB, 2013, MICROBIOLOGYOPEN, V2, P338, DOI 10.1002/mbo3.79; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Thomas Vincent, 2002, Microbial Ecology in Health and Disease, V14, P203, DOI 10.1080/08910600310002082; TVEDE M, 1989, LANCET, V1, P1156; Tzellos T, 2011, EXPERT OPIN PHARMACO, V12, P1233, DOI 10.1517/14656566.2011.553192; WILSON KH, 1993, CLIN INFECT DIS, V16, pS214, DOI 10.1093/clinids/16.Supplement_4.S214; Zhu M, 2006, COMPUT STAT DATA AN, V51, P918, DOI 10.1016/j.csda.2005.09.010	52	47	52	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89417	10.1371/journal.pone.0089417	http://dx.doi.org/10.1371/journal.pone.0089417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586762	Green Submitted, gold, Green Published			2022-12-27	WOS:000332396200052
J	Xeuatvongsa, A; Komada, K; Kitamura, T; Vongphrachanh, P; Pathammavong, C; Phounphenghak, K; Sisouk, T; Phonekeo, D; Sengkeopaseuth, B; Som-Oulay, V; Ishii, K; Wakita, T; Sugiyama, M; Hachiya, M				Xeuatvongsa, Anonh; Komada, Kenichi; Kitamura, Tomomi; Vongphrachanh, Phengta; Pathammavong, Chansay; Phounphenghak, Kongxay; Sisouk, Thongchanh; Phonekeo, Darouny; Sengkeopaseuth, Bounthanom; Som-Oulay, Vilasak; Ishii, Koji; Wakita, Takaji; Sugiyama, Masaya; Hachiya, Masahiko			Chronic Hepatitis B Prevalence among Children and Mothers: Results from a Nationwide, Population-Based Survey in Lao People's Democratic Republic	PLOS ONE			English	Article							C VIRUS-INFECTIONS; SURFACE-ANTIGEN; CAMBODIA; PROGRESS	Background: Hepatitis B is regarded as a serious public health issue in Lao People's Democratic Republic (Lao PDR), a Southeast Asian country. However, disease epidemiology among the general population is not well known, and thus a nationwide cross-sectional survey for hepatitis B surface antigen (HBsAg) prevalence in children and their mothers was conducted. Methods and findings: We applied three-stage cluster sampling using probability proportionate to size. After randomly selecting child (5 to 9 years old) and mother (15 to 45 years old) pairs from the selected villages, questionnaires and HBsAg rapid tests were conducted. Data from 965 child and mother pairs were analyzed. Multivariate logistic regression analyses were used to investigate the independent association of individual background characteristics for the odds of being HBsAg positive. In total, 17 children and 27 mothers were HBsAg positive. HBsAg prevalence was estimated to be 1.7% (95% confidence interval: 0.8%-2.6%) in children, and 2.9% (95% confidence interval: 1.7%-4.2%) in their mothers after taking sampling design and weight of each sample into account. Mother's infection status was positively associated with HBsAg positivity in children (p<0.001), whereas other potential risk factors, such as ethnicity, proximity to health centers, and history of surgery, were not. There were no significant associations between mother's HBsAg status and history of surgery, and other sociodemographic factors. Conclusions: Despite the slow implementation of the hepatitis B vaccination program, HBsAg prevalence among children and their mothers was not high in Lao PDR compared to reports from neighboring countries. The reasons for the differences in prevalence among these countries are unclear. We recommend that prevalence surveys be conducted in populations born before and after the implementation of a hepatitis B vaccination program to better understand the epidemiology of hepatitis B.	[Xeuatvongsa, Anonh; Pathammavong, Chansay; Phounphenghak, Kongxay] Minist Hlth, Natl Immunizat Program, Viangchan, Laos; [Komada, Kenichi; Kitamura, Tomomi; Hachiya, Masahiko] Natl Ctr Global Hlth & Med, Bur Int Cooperat, Shinjuku Ku, Tokyo, Japan; [Vongphrachanh, Phengta; Sisouk, Thongchanh; Phonekeo, Darouny; Sengkeopaseuth, Bounthanom; Som-Oulay, Vilasak] Minist Hlth, Natl Ctr Lab & Epidemiol, Viangchan, Laos; [Ishii, Koji; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Sugiyama, Masaya] Natl Ctr Global Hlth & Med, Hepatol Res Ctr, Ichikawa, Chiba, Japan	National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID); National Center for Global Health & Medicine - Japan	Hachiya, M (corresponding author), Natl Ctr Global Hlth & Med, Bur Int Cooperat, Shinjuku Ku, Tokyo, Japan.	m-hachiya@it.ncgm.go.jp	Hachiya, Masahiko/ABF-8472-2021	Hachiya, Masahiko/0000-0002-8720-5097; Kitamura, Tomomi/0000-0002-7956-4751	Grant for Nationa Center for Global Health and Medicine [25-8]; Grants-in-Aid for Scientific Research [25460580] Funding Source: KAKEN	Grant for Nationa Center for Global Health and Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by The Grant for Nationa Center for Global Health and Medicine (25-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P180; Ashraf H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-208; Clements CJ, 2006, VACCINE, V24, P1975, DOI 10.1016/j.vaccine.2005.11.035; DAMME PV, 2012, VACCINES, P205; Dunford L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039027; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hipgrave DB, 2003, AM J TROP MED HYG, V69, P288, DOI 10.4269/ajtmh.2003.69.288; IARC, 2012, AG CLASS IARC MON; Jutavijittum Prapan, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P674; Kane MA, 1996, LANCET, V348, P696, DOI 10.1016/S0140-6736(05)65598-5; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Leung N, 2009, HEPATOL INT, V3, pS24, DOI 10.1007/s12072-009-9142-1; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Lien TX, 2000, AM J TROP MED HYG, V62, P301, DOI 10.4269/ajtmh.2000.62.301; Lin YH, 2008, J CLIN MICROBIOL, V46, P3319, DOI 10.1128/JCM.00498-08; Merican I, 2000, J GASTROEN HEPATOL, V15, P1356, DOI 10.1046/j.1440-1746.2000.0150121356.x; Murakami H, 2008, VACCINE, V26, P1411, DOI 10.1016/j.vaccine.2008.01.002; Naing L, 2006, ARCH OROFAC SCI, V1, P9; Ol HS, 2009, SE ASIAN J TROP MED, V40, P963; Rani M, 2009, B WORLD HEALTH ORGAN, V87, P707, DOI 10.2471/BLT.08.059220; Rossi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044611; Sa-Nguanmoo P, 2010, J MED VIROL, V82, P1341, DOI 10.1002/jmv.21828; Soeung SC, 2009, AM J TROP MED HYG, V81, P252, DOI 10.4269/ajtmh.2009.81.252; Syhavong B, 2010, T ROY SOC TROP MED H, V104, P475, DOI 10.1016/j.trstmh.2010.03.002; Thai HD, 2009, ASIAN PAC J CANCER P, V10, P97; *UN POP FUND, 2005, LAO REPR HLTH SURV 2; *WHO, 2007, WPICPEPI52001E WHO; *WHO UNICEF, 2013, IMM COV EST; *WORLD BANK, 2012, POP DENS PER SQUAR K; World Health O, 2009, WKLY EPIDEMIOL REC, V84, P405, DOI DOI 10.1016/J.VACCINE.2009.10.110; World Health Organization, 2005, WPRRC56R8 WHO; World Health Organization (WHO), 2011, DOC IMP HEP B IMM BE	33	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88829	10.1371/journal.pone.0088829	http://dx.doi.org/10.1371/journal.pone.0088829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586408	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200029
J	Grinberg, F; Farrher, E; Ciobanu, L; Geffroy, F; Le Bihan, D; Shah, NJ				Grinberg, Farida; Farrher, Ezequiel; Ciobanu, Luisa; Geffroy, Francoise; Le Bihan, Denis; Shah, N. Jon			Non-Gaussian Diffusion Imaging for Enhanced Contrast of Brain Tissue Affected by Ischemic Stroke	PLOS ONE			English	Article							ATTENUATED MR SIGNAL; FIELD-GRADIENT NMR; HIGH B-VALUES; ANOMALOUS DIFFUSION; WATER DIFFUSION; WHITE-MATTER; CEREBRAL-ISCHEMIA; TENSOR ANALYSIS; AXON DIAMETER; WEIGHTED MRI	Recent diffusion MRI studies of stroke in humans and animals have shown that the quantitative parameters characterising the degree of non-Gaussianity of the diffusion process are much more sensitive to ischemic changes than the apparent diffusion coefficient (ADC) considered so far as the "gold standard''. The observed changes exceeded that of the ADC by a remarkable factor of 2 to 3. These studies were based on the novel non-Gaussian methods, such as diffusion kurtosis imaging (DKI) and log-normal distribution function imaging (LNDFI). As shown in our previous work investigating the animal stroke model, a combined analysis using two methods, DKI and LNDFI provides valuable complimentary information. In the present work, we report the application of three non-Gaussian diffusion models to quantify the deviations from the Gaussian behaviour in stroke induced by transient middle cerebral artery occlusion in rat brains: the gamma-distribution function (GDF), the stretched exponential model (SEM), and the biexponential model. The main goal was to compare the sensitivity of various non-Gaussian metrics to ischemic changes and to investigate if a combined application of several models will provide added value in the assessment of stroke. We have shown that two models, GDF and SEM, exhibit a better performance than the conventional method and allow for a significantly enhanced visualization of lesions. Furthermore, we showed that valuable information regarding spatial properties of stroke lesions can be obtained. In particular, we observed a stratified cortex structure in the lesions that were well visible in the maps of the GDF and SEM metrics, but poorly distinguishable in the ADC-maps. Our results provided evidence that cortical layers tend to be differently affected by ischemic processes.	[Grinberg, Farida; Farrher, Ezequiel; Shah, N. Jon] Forschungszentrum Juelich GmbH, Inst Neurosci & Med 4, Julich, Germany; [Ciobanu, Luisa; Geffroy, Francoise; Le Bihan, Denis] CEA Saclay, Commissariat Energie Atom & Energies Alternat, NeuroSpin, F-91191 Gif Sur Yvette, France; [Grinberg, Farida; Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Fac Med, JARA, Aachen, Germany	Helmholtz Association; Research Center Julich; CEA; RWTH Aachen University	Grinberg, F (corresponding author), Forschungszentrum Juelich GmbH, Inst Neurosci & Med 4, Julich, Germany.	f.grinberg@fz-juelich.de	Shah, N. Jon/H-5849-2013; Ciobanu, Luisa/E-7331-2014	Shah, N. Jon/0000-0002-8151-6169; Ciobanu, Luisa/0000-0001-6932-6859; Geffroy, Francoise/0000-0001-9281-0972; Farrher, Ezequiel/0000-0003-2902-8667				Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Barazany D, 2012, CEREB CORTEX, V22, P2016, DOI 10.1093/cercor/bhr277; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Bennett KM, 2004, MAGN RESON MED, V52, P994, DOI 10.1002/mrm.20286; Bennett KM, 2003, MAGNET RESON MED, V50, P727, DOI 10.1002/mrm.10581; Blockx I, 2012, NEUROIMAGE, V59, P957, DOI 10.1016/j.neuroimage.2011.08.062; Brugieres P, 2004, AM J NEURORADIOL, V25, P692; Buckley DL, 1999, MAGNET RESON MED, V41, P137, DOI 10.1002/(SICI)1522-2594(199901)41:1<137::AID-MRM19>3.0.CO;2-Y; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Callaghan P. T., 2011, TRANSLATIONAL DYNAMI; Capuani S, 2013, MAGN RESON IMAGING, V31, P359, DOI 10.1016/j.mri.2012.08.012; Chabert S, 2004, 12 ISMRM ANN M, P1938; Cheung JS, 2012, STROKE, V43, P2252, DOI 10.1161/STROKEAHA.112.661926; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Clark CA, 2000, MAGN RESON MED, V44, P852, DOI 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A; Dijkhuizen RM, 1999, J CEREBR BLOOD F MET, V19, P341, DOI 10.1097/00004647-199903000-00012; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Farrher E, 2012, MAGN RESON IMAGING, V30, P518, DOI 10.1016/j.mri.2011.12.012; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Gong NJ, 2013, MAGN RESON IMAGING, V31, P688, DOI 10.1016/j.mri.2012.10.027; Grinberg F, 2013, MICROPOR MESOPOR MAT, V178, P44, DOI 10.1016/j.micromeso.2013.02.046; Grinberg F, 2012, NMR BIOMED, V25, P1295, DOI 10.1002/nbm.2802; Grinberg F, 2011, NEUROIMAGE, V57, P1087, DOI 10.1016/j.neuroimage.2011.04.050; Grinberg F, 2011, AIP CONF PROC, V1330, P31, DOI [10.1063/1.3562226, 10.1063/1.3579171]; Hall MG, 2008, MAGN RESON MED, V59, P447, DOI 10.1002/mrm.21453; Hui ES, 2008, NEUROIMAGE, V42, P122, DOI 10.1016/j.neuroimage.2008.04.237; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Hui ES, 2012, BRAIN RES, V1451, P100, DOI 10.1016/j.brainres.2012.02.044; Jensen JH, 2011, NMR BIOMED, V24, P452, DOI 10.1002/nbm.1610; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Johnston DC, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.184430; Jones DK., 2011, DIFFUSION MRI THEORY; Kristoffersen A, 2013, J MAGN RESON IMAGING, V38, P1434, DOI 10.1002/jmri.24102; Kristoffersen A, 2012, J MAGN RESON IMAGING, V35, P181, DOI 10.1002/jmri.22826; Kristoffersen A, 2011, MAGN RESON MED, V66, P1639, DOI 10.1002/mrm.22960; Latt J, 2009, NMR BIOMED, V22, P619, DOI 10.1002/nbm.1376; Latt J, 2013, J MAGN RESON IMAGING, V37, P610, DOI 10.1002/jmri.23857; Le Bihan D, 2007, PHYS MED BIOL, V52, pR57, DOI 10.1088/0031-9155/52/7/R02; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Magin RL, 2011, COMMUN NONLINEAR SCI, V16, P4581, DOI 10.1016/j.cnsns.2011.04.002; Maier SE, 2004, MAGN RESON MED, V51, P321, DOI 10.1002/mrm.10685; Maier SE, 2010, NMR BIOMED, V23, P849, DOI 10.1002/nbm.1544; MCGIBNEY G, 1993, MED PHYS, V20, P1077, DOI 10.1118/1.597004; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; MILLER AJ, 1993, MAGN RESON IMAGING, V11, P1051, DOI 10.1016/0730-725X(93)90225-3; Minati L, 2007, CONCEPT MAGN RESON A, V30A, P278, DOI 10.1002/cmr.a.20094; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Mulkern RV, 2009, MAGN RESON IMAGING, V27, P1151, DOI 10.1016/j.mri.2009.05.003; Niendorf T, 1996, MAGN RESON MED, V36, P847, DOI 10.1002/mrm.1910360607; Nilsson M, 2013, MAGN RESON MATER PHY, V26, P345, DOI 10.1007/s10334-013-0371-x; Novikov DS, 2010, NMR BIOMED, V23, P682, DOI 10.1002/nbm.1584; Ozarslan E, 2006, J MAGN RESON, V183, P315, DOI 10.1016/j.jmr.2006.08.009; Palombo M, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3610367; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Rabinstein AA, 2009, PRACTICAL NEUROIMAGI; Roding M, 2012, J MAGN RESON, V222, P105, DOI 10.1016/j.jmr.2012.07.005; Sbarbati A, 2002, MAGN RESON IMAGING, V20, P479, DOI 10.1016/S0730-725X(02)00528-3; Schaefer Pamela W, 2006, Magn Reson Imaging Clin N Am, V14, P141, DOI 10.1016/j.mric.2006.06.005; Sen PN, 2005, MAGN RESON IMAGING, V23, P215, DOI 10.1016/j.mri.2004.11.014; Silva AC, 2008, J NEUROSCI METH, V167, P246, DOI 10.1016/j.jneumeth.2007.08.020; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sukstanskii AL, 2003, MAGNET RESON MED, V50, P735, DOI 10.1002/mrm.10586; Sukstanskii AL, 2002, J MAGN RESON, V157, P92, DOI 10.1006/jmre.2002.2582; Sun L, 2006, ACTA NEUROCHIR SUPPL, V96, P272; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; van Pul C, 2005, MAGNET RESON MED, V53, P348, DOI 10.1002/mrm.20353; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Yablonskiy DA, 2003, MAGNET RESON MED, V50, P664, DOI 10.1002/mrm.10578; Yablonskiy DA, 2010, NMR BIOMED, V23, P661, DOI 10.1002/nbm.1520; Zhao TJ, 2005, POLYMER, V46, P4839, DOI 10.1016/j.polymer.2005.03.081; Zhou XJ, 2010, MAGN RESON MED, V63, P562, DOI 10.1002/mrm.22285; Zille M, 2012, J CEREBR BLOOD F MET, V32, P213, DOI 10.1038/jcbfm.2011.150	81	50	52	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89225	10.1371/journal.pone.0089225	http://dx.doi.org/10.1371/journal.pone.0089225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586610	gold, Green Published			2022-12-27	WOS:000332390800011
J	Domingo, P; Gutierrez, MD; Gallego-Escuredo, JM; Torres, F; Mateo, GM; Villarroya, J; de los Santos, I; Domingo, JC; Villarroya, F; Del Rio, L; Estrada, V; Giralt, M				Domingo, Pere; del Mar Gutierrez, Maria; Miguel Gallego-Escuredo, Jose; Torres, Ferran; Maria Mateo, Gracia; Villarroya, Joan; de los Santos, Ignacio; Carles Domingo, Joan; Villarroya, Francesc; Del Rio, Luis; Estrada, Vicente; Giralt, Marta			Effects of Switching from Stavudine to Raltegravir on Subcutaneous Adipose Tissue in HIV-Infected Patients with HIV/HAART-Associated Lipodystrophy Syndrome (HALS). A Clinical and Molecular Study	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE INHIBITORS; MITOCHONDRIAL TOXICITY; BODY-COMPOSITION; TENOFOVIR DF; PROTEASE INHIBITORS; INSULIN-RESISTANCE; OXIDATIVE STRESS; REFERENCE VALUES; GENE-EXPRESSION	HIV-1/HAART-associated lipodystrophy syndrome (HALS) has been associated with exposure to stavudine (d4T) through mitochondrial dysfunction. We performed a 48-week study to assess the effects of switching from d4T to raltegravir (RAL) on metabolic and fat molecular parameters of patients with HALS. Forty-two patients with HALS and a median exposure to d4T. 7 years were switched to RAL and followed for 48 weeks. Fasting metabolic tests, HIV RNA, CD4 cell count, and fat measured by DEXA were obtained at baseline and week 48. mtDNA and gene transcripts for PPAR gamma, adiponectin, cytochrome b, Cox IV, TNF alpha, MCP-1 and CD68 were assessed in paired subcutaneous fat tissue biopsies. Lipid parameters, fasting glucose, insulin, and HOMA-IR did not change significantly. Whole body fat (P = 0.0027) and limb fat mass (P<0.0001) increased from baseline. Trunk/limb fat ratio (P = 0.0022), fat mass ratio (P = 0.0020), fat mass index (P = 0.0011) and percent leg fat normalized to BMI (P<0.0001) improved after 48 weeks. Relative abundance of mtDNA, expression of PPAR gamma, adiponectin, Cyt b, and MCP-1 genes increased, whereas Cox IV, TNF alpha, and CD68 did not change significantly from baseline. Switching from d4T to RAL in patients with HALS is associated with an increase in limb fat mass and an improvement in markers of adipocyte differentiation and mitochondrial function in SAT.	[Domingo, Pere; del Mar Gutierrez, Maria; Maria Mateo, Gracia] Univ Autonoma Barcelona, Hosp Santa Creu & San Pau, Infect Dis Unit, E-08193 Barcelona, Spain; [Miguel Gallego-Escuredo, Jose; Villarroya, Joan; Carles Domingo, Joan; Villarroya, Francesc; Giralt, Marta] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Miguel Gallego-Escuredo, Jose; Villarroya, Joan; Carles Domingo, Joan; Villarroya, Francesc; Giralt, Marta] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Torres, Ferran] Univ Autonoma Barcelona, Sch Med, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin,Biostat & Data Management Platform, E-08193 Barcelona, Spain; [Villarroya, Joan] Hosp Santa Creu & Sant Pau, Inst Recerca, Barcelona, Spain; [de los Santos, Ignacio] Hosp Princesa, Infect Dis Unit, Madrid, Spain; [Del Rio, Luis] CETIR, Barcelona, Spain; [Estrada, Vicente] Hosp Clin San Carlos, Infect Dis Unit, Madrid, Spain; [Miguel Gallego-Escuredo, Jose; Villarroya, Joan; Carles Domingo, Joan; Villarroya, Francesc; Giralt, Marta] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Miguel Gallego-Escuredo, Jose; Villarroya, Joan; Carles Domingo, Joan; Villarroya, Francesc; Giralt, Marta] CIBER, Santiago De Compostela, Spain	Autonomous University of Barcelona; University of Barcelona; University of Barcelona; Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau; Hospital de La Princesa; Hospital Clinico San Carlos; University of Barcelona	Domingo, P (corresponding author), Univ Autonoma Barcelona, Hosp Santa Creu & San Pau, Infect Dis Unit, E-08193 Barcelona, Spain.	pdomingo@santpau.cat	Estrada, Vicente/G-7518-2015; Pedrol, Joan Carles C Domingo/A-4856-2019; Giralt, Marta/A-4756-2013; Domingo, Pere/CAF-3577-2022; Villarroya, Joan/W-4066-2018; Domingo, Pere/AAP-7571-2021; Del Rio, Luis M/H-3037-2016; Torres, Ferran/D-1296-2011; Villarroya, Francesc/K-4357-2014	Pedrol, Joan Carles C Domingo/0000-0002-6356-0836; Giralt, Marta/0000-0001-7968-4190; Villarroya, Joan/0000-0002-7859-1109; Domingo, Pere/0000-0003-1138-5770; Del Rio, Luis M/0000-0003-0720-0673; Torres, Ferran/0000-0002-7355-7913; Estrada, Vicente/0000-0002-7795-5986; GALLEGO-ESCUREDO, JOSE MIGUEL/0000-0001-7899-8585; De Los Santos Gil, Ignacio/0000-0001-7073-5211; Villarroya, Francesc/0000-0003-1266-9142	Fondo de Investigaciones Sanitarias [FIS 08/00256, PI11/1512]; Fundacion para la Investigacion y Prevencion del SIDA en Espana [FIPSE 36610, 36572/06, 36697/07]; Red de Investigacion en SIDA [RIS RD12/0017/0014, RD06/0006/0005]; Merck, Sharp Dohme, Spain; Programa de Intensificacion de Investigadores, Instituto de Salud Carlos III [INT12/383, INT13/232]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion para la Investigacion y Prevencion del SIDA en Espana; Red de Investigacion en SIDA; Merck, Sharp Dohme, Spain(Merck & Company); Programa de Intensificacion de Investigadores, Instituto de Salud Carlos III(Instituto de Salud Carlos III)	This work has been partially funded by Fondo de Investigaciones Sanitarias (FIS 08/00256 and PI11/1512), Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE 36610, 36572/06, 36697/07), Red de Investigacion en SIDA (RIS RD12/0017/0014, RD06/0006/0005), and an unrestricted grant from Merck, Sharp & Dohme, Spain. Pere Domingo is supported by a grant from the Programa de Intensificacion de Investigadores, Instituto de Salud Carlos III (INT12/383 and INT13/232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet E, 2005, J CLIN DENSITOM, V8, P287, DOI 10.1385/JCD:8:3:287; Caron M, 2004, AIDS, V18, P2127, DOI 10.1097/00002030-200411050-00004; Caron M, 2008, ANTIVIR THER, V13, P27; Carr A, 2002, JAMA-J AM MED ASSOC, V288, P207, DOI 10.1001/jama.288.2.207; Carr A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001240; CDC, 1993, MMWR-MORBID MORTAL W, V41, P1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cote HCF, 2011, MITOCHONDRION, V11, P520, DOI 10.1016/j.mito.2011.01.011; Curran A, 2012, AIDS, V26, P475, DOI 10.1097/QAD.0b013e32834f3507; Domingo P, 2012, AIDS REV, V14, P112; Eron JJ, 2010, LANCET, V375, P396, DOI 10.1016/S0140-6736(09)62041-9; Feeney ER, 2010, CURR PHARM DESIGN, V16, P3339, DOI 10.2174/138161210793563482; Fontas E, 2004, J INFECT DIS, V189, P1056, DOI 10.1086/381783; Fontdevila J, 2005, ANTIVIR THER, V10, pL28; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gallego-Escuredo JM, 2010, CURR HIV RES, V8, P545, DOI 10.2174/157016210793499222; Giralt M, 2011, BEST PRACT RES CL EN, V25, P487, DOI 10.1016/j.beem.2010.12.001; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guri AJ, 2011, OBESITY, V19, P689, DOI 10.1038/oby.2010.230; Gutierrez MDM, 2007, EXPERT OPIN PHARMACO, V8, P1871, DOI 10.1517/14656566.8.12.1871; Jones SP, 2005, JAIDS-J ACQ IMM DEF, V40, P565, DOI 10.1097/01.qai.0000187443.30838.3e; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kim MJ, 2007, ANTIVIR THER, V12, P1273; Lagathu C, 2007, ANTIVIR THER, V12, P489; Lemieux S, 1996, AM J CLIN NUTR, V64, P685, DOI 10.1093/ajcn/64.5.685; Lichtenstein KA, 2001, AIDS, V15, P1389, DOI 10.1097/00002030-200107270-00008; Lo JC, 2005, CLIN INFECT DIS, V41, P1335, DOI 10.1086/496981; Mallon PWG, 2008, J INFECT DIS, V198, P1794, DOI 10.1086/593179; Martinez E, 2010, AIDS, V24, P1697, DOI 10.1097/QAD.0b013e32833a608a; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McComsey GA, 2013, J INFECT DIS, V207, P604, DOI 10.1093/infdis/jis720; MELLERT W, 1990, AIDS, V4, P527, DOI 10.1097/00002030-199006000-00006; Minami R, 2011, J INFECT CHEMOTHER, V17, P183, DOI 10.1007/s10156-010-0101-5; Moyle GJ, 2006, AIDS, V20, P2043, DOI 10.1097/01.aids.0000247574.33998.03; Mulligan K, 19 C RETR OPP INF SE; Nolan D, 2003, ANTIVIR THER, V8, P617; Perazella MA, 2010, KIDNEY INT, V78, P1060, DOI 10.1038/ki.2010.344; Perez-Matute P, 2011, CURR HIV RES, V9, P174, DOI 10.2174/157016211795945278; Podzamczer D, 2007, JAIDS-J ACQ IMM DEF, V44, P139, DOI 10.1097/QAI.0b013e31802bf122; Rockstroh JK, 2011, CLIN INFECT DIS, V53, P807, DOI 10.1093/cid/cir510; Stankov MV, 2007, ANTIVIR THER, V12, P205; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; Valantin MA, 2012, HIV MED, V13, P505, DOI 10.1111/j.1468-1293.2012.01004.x; Venhoff N, 2007, ANTIVIR THER, V12, P1075; Villarroya F, 2005, TRENDS PHARMACOL SCI, V26, P88, DOI 10.1016/j.tips.2004.12.005; Vrouenraets SME, 2012, HIV CLIN TRIALS, V13, P103, DOI 10.1310/hct1302-103	46	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89088	10.1371/journal.pone.0089088	http://dx.doi.org/10.1371/journal.pone.0089088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586518	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000024
J	Song, MR; Fellous, JM				Song, Minryung R.; Fellous, Jean-Marc			Value Learning and Arousal in the Extinction of Probabilistic Rewards: The Role of Dopamine in a Modified Temporal Difference Model	PLOS ONE			English	Article							PARTIAL-REINFORCEMENT; BASOLATERAL AMYGDALA; PREDICTION ERRORS; NEURAL SIGNALS; RELEASE; UNCERTAINTY; RESISTANCE; ATTENTION; NEURONS; MODULATION	Because most rewarding events are probabilistic and changing, the extinction of probabilistic rewards is important for survival. It has been proposed that the extinction of probabilistic rewards depends on arousal and the amount of learning of reward values. Midbrain dopamine neurons were suggested to play a role in both arousal and learning reward values. Despite extensive research on modeling dopaminergic activity in reward learning (e.g. temporal difference models), few studies have been done on modeling its role in arousal. Although temporal difference models capture key characteristics of dopaminergic activity during the extinction of deterministic rewards, they have been less successful at simulating the extinction of probabilistic rewards. By adding an arousal signal to a temporal difference model, we were able to simulate the extinction of probabilistic rewards and its dependence on the amount of learning. Our simulations propose that arousal allows the probability of reward to have lasting effects on the updating of reward value, which slows the extinction of low probability rewards. Using this model, we predicted that, by signaling the prediction error, dopamine determines the learned reward value that has to be extinguished during extinction and participates in regulating the size of the arousal signal that controls the learning rate. These predictions were supported by pharmacological experiments in rats.	[Song, Minryung R.] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Fellous, Jean-Marc] Univ Arizona, Grad Interdisciplinary Program Neurosci, Tucson, AZ 85721 USA; [Fellous, Jean-Marc] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Fellous, Jean-Marc] Univ Arizona, Dept Appl Math, Tucson, AZ USA	Korea Advanced Institute of Science & Technology (KAIST); University of Arizona; University of Arizona; University of Arizona	Fellous, JM (corresponding author), Univ Arizona, Grad Interdisciplinary Program Neurosci, Tucson, AZ 85721 USA.	fellous@email.arizona.edu	Fellous, Jean-Marc/AAP-3117-2021	Song, Minryung/0000-0002-9292-5988	Science Foundation Arizona; Samsung Scholarship; HHMI [52005889]	Science Foundation Arizona; Samsung Scholarship(Samsung); HHMI(Howard Hughes Medical Institute)	This study was funded by the Science Foundation Arizona (http://www.sfaz.org/), Samsung Scholarship (http://www.ssscholarship.com/), and HHMI Grant 52005889 (UBRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuthnott GW, 2007, TRENDS NEUROSCI, V30, P62, DOI 10.1016/j.tins.2006.12.003; BACON WE, 1962, J COMP PHYSIOL PSYCH, V55, P998, DOI 10.1037/h0048614; Beeler JA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00170; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Cheer JF, 2004, J NEUROSCI, V24, P4393, DOI 10.1523/JNEUROSCI.0529-04.2004; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2008, COGN AFFECT BEHAV NE, V8, P429, DOI 10.3758/CABN.8.4.429; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Dreyer JK, 2010, J NEUROSCI, V30, P14273, DOI 10.1523/JNEUROSCI.1894-10.2010; Esber GR, 2012, BIOL PSYCHIAT, V72, P1012, DOI 10.1016/j.biopsych.2012.05.023; Esber GR, 2011, P ROY SOC B-BIOL SCI, V278, P2553, DOI 10.1098/rspb.2011.0836; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Floresco SB, 2006, PSYCHOPHARMACOLOGY, V188, P567, DOI 10.1007/s00213-006-0404-5; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; French ED, 1997, NEUROREPORT, V8, P649, DOI 10.1097/00001756-199702100-00014; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Hall, 1982, QUANTITATIVE ANAL BE, V3, P241; Haselgrove M, 2004, J EXP PSYCHOL-ANIM B, V30, P240, DOI 10.1037/0097-7403.30.3.240; Horsley RR, 2012, BEHAV BRAIN RES, V229, P438, DOI 10.1016/j.bbr.2012.01.024; JENKINS HM, 1962, J EXP PSYCHOL, V64, P441, DOI 10.1037/h0048700; Le Pelley ME, 2004, Q J EXP PSYCHOL-B, V57, P193, DOI 10.1080/02724990344000141; LEWIS DJ, 1960, PSYCHOL BULL, V57, P1, DOI 10.1037/h0040963; Li J, 2011, NAT NEUROSCI, V14, P1250, DOI 10.1038/nn.2904; Li JA, 2011, P NATL ACAD SCI USA, V108, P55, DOI 10.1073/pnas.1014938108; Lupica CR, 2004, BRIT J PHARMACOL, V143, P227, DOI 10.1038/sj.bjp.0705931; McLaughlin RJ, 2007, NEUROSCIENCE, V146, P1484, DOI 10.1016/j.neuroscience.2007.03.025; Moquin KF, 2009, J NEUROCHEM, V110, P1491, DOI 10.1111/j.1471-4159.2009.06254.x; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Nassar MR, 2010, J NEUROSCI, V30, P12366, DOI 10.1523/JNEUROSCI.0822-10.2010; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Orban G, 2011, CURR OPIN NEUROBIOL, V21, P629, DOI 10.1016/j.conb.2011.05.026; Pan WX, 2008, J NEUROSCI, V28, P9619, DOI 10.1523/JNEUROSCI.0255-08.2008; Pan WX, 2013, NAT NEUROSCI, V16, P71, DOI 10.1038/nn.3283; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roesch MR, 2010, J NEUROPHYSIOL, V104, P587, DOI 10.1152/jn.00173.2010; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Sutton R.S., 1998, REINFORCEMENT LEARNI, VXVIII; THEIOS J, 1962, J EXP PSYCHOL, V64, P1, DOI 10.1037/h0046302; van der Meulen JAJ, 2007, CEREB CORTEX, V17, P1444, DOI 10.1093/cercor/bhl057; Weatherly JN, 2004, J PSYCHOL, V138, P495, DOI 10.3200/JRLP.138.6.495-504; WEINER I, 1985, PSYCHOPHARMACOLOGY, V86, P318, DOI 10.1007/BF00432221	53	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89494	10.1371/journal.pone.0089494	http://dx.doi.org/10.1371/journal.pone.0089494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586823	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000050
J	Chen, LS; Fann, JCY; Chiu, SYH; Yen, AMF; Wahlfors, T; Tammela, TL; Chen, HH; Auvinen, A; Schleutker, J				Chen, Li-Sheng; Fann, Jean Ching-Yuan; Chiu, Sherry Yueh-Hsia; Yen, Amy Ming-Fang; Wahlfors, Tiina; Tammela, Teuvo L.; Chen, Hsiu-Hsi; Auvinen, Anssi; Schleutker, Johanna			Assessing Interactions of Two Loci (rs4242382 and rs10486567) in Familial Prostate Cancer: Statistical Evaluation of Epistasis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; 5 GENETIC-VARIANTS; SUSCEPTIBILITY LOCI; CHROMOSOME 8Q24; RISK; POPULATIONS; MULTIPLE; HEREDITARY; BREAST	Understanding the impact of multiple genetic variants and their interactions on the disease penetrance of familial multiple prostate cancer is very relevant to the overall understanding of carcinogenesis. We assessed the joint effect of two loci on rs4242382 at 8q24 and rs10486567 at 7p15.2 to this end. We analyzed the data from a Finnish family-based genetic study, which was composed of 947 men including 228 cases in 75 families, to evaluate the respective effects of the two loci on the disease penetrance; in particular, the occurrence and number of prostate cancer cases within a family were utilized to evaluate the interactions between the two loci under the additive and multiplicative Poisson regression models. The risk alleles A at rs4242382 (OR = 1.14, 95% CI 1.08-1.19, P<0.0001) and a risk allele A at rs10486567 (OR = 1.06, 96% CI 1.01-1.11, P = 0.0208) were found to be associated with an increased risk of familial PrCa, especially with four or more cases within a family. A multiplicative model fitted the joint effect better than an additive model (likelihood ratio test X-2 = 13.89, P<0.0001). The influence of the risk allele A at rs10486567 was higher in the presence of the risk allele A at rs4242382 (OR = 1.09 (1.01-1.18) vs. 1.01 (0.95-1.07)). Similar findings were observed in non-aggressive PrCa, but not in aggressive PrCa. We demonstrated that two loci (rs4242382 and rs10486567) are highly associated with familial multiple PrCa, and the gene-gene interaction or statistical epistasis was consistent with the Fisher's multiplicative model. These loci's association and epistasis were observed for non-aggressive but not for aggressive tumors. The proposed statistical model can be further developed to accommodate multi-loci interactions to provide further insights into epistasis.	[Chen, Li-Sheng; Yen, Amy Ming-Fang] Taipei Med Univ, Sch Oral Hyg, Coll Oral Med, Taipei, Taiwan; [Fann, Jean Ching-Yuan] Kainan Univ, Sch Healthcare Management, Dept Hlth Ind Management, Tao Yuan, Taiwan; [Chiu, Sherry Yueh-Hsia] Chang Gung Univ, Coll Management, Dept & Grad Inst Hlth Care Management, Tao Yuan, Taiwan; [Wahlfors, Tiina; Schleutker, Johanna] Univ Tampere, Inst Biomed Technol, BioMediTech, FIN-33101 Tampere, Finland; [Tammela, Teuvo L.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Tammela, Teuvo L.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Chen, Hsiu-Hsi] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Auvinen, Anssi] Univ Tampere, Tampere Sch Publ Hlth, FIN-33101 Tampere, Finland; [Schleutker, Johanna] Univ Turku, Inst Biomed, Dept Med Biochem & Genet, Turku, Finland	Taipei Medical University; Nan Kai University Technology; Chang Gung University; Tampere University; Tampere University; Tampere University Hospital; Tampere University; National Taiwan University; Tampere University; University of Turku	Schleutker, J (corresponding author), Univ Tampere, Inst Biomed Technol, BioMediTech, FIN-33101 Tampere, Finland.	Johanna.Schleutker@utu.fi	Auvinen, Anssi/AAL-2111-2020; Auvinen, Anssi/AAD-9311-2020; Wahlfors, Tiina/U-7635-2018	Auvinen, Anssi/0000-0003-1125-4818; Chen, Hsiu-Hsi/0000-0002-5799-6705; Wahlfors, Tiina/0000-0002-3910-796X; Schleutker, Johanna/0000-0002-1863-0305	Sigrid Juselius Foundation; Academy of Finland [251074]; Finnish Cancer Organisations; Competitive Research Funding of the Pirkanmaa Hospital District [9N069]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Cancer Organisations; Competitive Research Funding of the Pirkanmaa Hospital District	This work was supported by the Sigrid Juselius Foundation, the Academy of Finland (251074), the Finnish Cancer Organisations, and the Competitive Research Funding of the Pirkanmaa Hospital District (9N069) grants to J.S. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Baker SG, 2005, BIOMETRICS, V61, P55, DOI 10.1111/j.0006-341X.2005.030924.x; Barnholtz-Sloan Jill S., 2011, Frontiers in Genetics, V2, P37, DOI 10.3389/fgene.2011.00037; Chang BL, 2011, CANCER EPIDEM BIOMAR, V20, P23, DOI 10.1158/1055-9965.EPI-10-0698; Edwards SM, 2004, AM J MED GENET C, V129C, P65, DOI 10.1002/ajmg.c.30027; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Lange EM, 2008, CANCER EPIDEM BIOMAR, V17, P2208, DOI 10.1158/1055-9965.EPI-08-0183; Machiela MJ, 2012, AM J EPIDEMIOL, V176, P1121, DOI 10.1093/aje/kws191; Pakkanen S, 2009, J NEGAT RESULTS BIOM, V15, P8; Penney KL, 2009, CLIN CANCER RES, V15, P3223, DOI 10.1158/1078-0432.CCR-08-2733; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Prokunina-Olsson L, 2010, CANCER EPIDEM BIOMAR, V19, P1349, DOI 10.1158/1055-9965.EPI-09-1181; Schleutker J, 2003, PROSTATE, V57, P280, DOI 10.1002/pros.10302; Sun J, 2010, PROSTATE, V71, P421, DOI [10.1002/pros.21256, DOI 10.1002/PR0S.21256]; Sun JL, 2008, PROSTATE, V68, P1257, DOI 10.1002/pros.20793; Sun JL, 2008, PROSTATE, V68, P489, DOI 10.1002/pros.20695; Suuriniemi M, 2007, CANCER EPIDEM BIOMAR, V16, P809, DOI 10.1158/1055-9965.EPI-06-1049; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Waters KM, 2009, CANCER EPIDEM BIOMAR, V18, P1285, DOI 10.1158/1055-9965.EPI-08-1142; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89508	10.1371/journal.pone.0089508	http://dx.doi.org/10.1371/journal.pone.0089508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586834	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900049
J	Kennedy, NA; Walker, AW; Berry, SH; Duncan, SH; Farquarson, FM; Louis, P; Thomson, JM; Satsangi, J; Flint, HJ; Parkhill, J; Lees, CW; Hold, GL				Kennedy, Nicholas A.; Walker, Alan W.; Berry, Susan H.; Duncan, Sylvia H.; Farquarson, Freda M.; Louis, Petra; Thomson, John M.; Satsangi, Jack; Flint, Harry J.; Parkhill, Julian; Lees, Charlie W.; Hold, Georgina L.		UK IBD Genetics Consortium	The Impact of Different DNA Extraction Kits and Laboratories upon the Assessment of Human Gut Microbiota Composition by 16S rRNA Gene Sequencing	PLOS ONE			English	Article							HUMAN FECAL SAMPLES; ULCERATIVE-COLITIS; BACTERIAL; DIVERSITY; COLLECTION; DISEASE; HEALTH; CROHNS; IBD	Introduction: Determining bacterial community structure in fecal samples through DNA sequencing is an important facet of intestinal health research. The impact of different commercially available DNA extraction kits upon bacterial community structures has received relatively little attention. The aim of this study was to analyze bacterial communities in volunteer and inflammatory bowel disease (IBD) patient fecal samples extracted using widely used DNA extraction kits in established gastrointestinal research laboratories. Methods: Fecal samples from two healthy volunteers (H3 and H4) and two relapsing IBD patients (I1 and I2) were investigated. DNA extraction was undertaken using MoBio Powersoil and MP Biomedicals FastDNA SPIN Kit for Soil DNA extraction kits. PCR amplification for pyrosequencing of bacterial 16S rRNA genes was performed in both laboratories on all samples. Hierarchical clustering of sequencing data was done using the Yue and Clayton similarity coefficient. Results: DNA extracted using the FastDNA kit and the MoBio kit gave median DNA concentrations of 475 (interquartile range 228-561) and 22 (IQR 9-36) ng/mu L respectively (p<0.0001). Hierarchical clustering of sequence data by Yue and Clayton coefficient revealed four clusters. Samples from individuals H3 and I2 clustered by patient; however, samples from patient I1 extracted with the MoBio kit clustered with samples from patient H4 rather than the other I1 samples. Linear modelling on relative abundance of common bacterial families revealed significant differences between kits; samples extracted with MoBio Powersoil showed significantly increased Bacteroidaceae, Ruminococcaceae and Porphyromonadaceae, and lower Enterobacteriaceae, Lachnospiraceae, Clostridiaceae, and Erysipelotrichaceae (p<0.05). Conclusion: This study demonstrates significant differences in DNA yield and bacterial DNA composition when comparing DNA extracted from the same fecal sample with different extraction kits. This highlights the importance of ensuring that samples in a study are prepared with the same method, and the need for caution when cross-comparing studies that use different methods.	[Kennedy, Nicholas A.; Satsangi, Jack; Lees, Charlie W.] Univ Edinburgh, Western Gen Hosp, Ctr Genom & Expt Med, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Walker, Alan W.; Parkhill, Julian] Wellcome Trust Sanger Inst, Pathogen Genom Grp, Hinxton, Cambs, England; [Berry, Susan H.; Hold, Georgina L.] Univ Aberdeen, Div Appl Med, Gastrointestinal Res Grp, Aberdeen, Scotland; [Duncan, Sylvia H.; Farquarson, Freda M.; Louis, Petra; Flint, Harry J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Thomson, John M.] Aberdeen Royal Infirm, Dept Digest Disorders, Aberdeen, Scotland	University of Edinburgh; Wellcome Trust Sanger Institute; University of Aberdeen; University of Aberdeen; University of Aberdeen	Hold, GL (corresponding author), Univ Aberdeen, Div Appl Med, Gastrointestinal Res Grp, Aberdeen, Scotland.	g.l.hold@abdn.ac.uk	Parkhill, Julian/G-4703-2011; Louis, Petra/Y-3779-2019; Walker, Alan W./AAE-8102-2019; Prescott, Natalie J/F-6490-2011; Kennedy, Nicholas Alexander/AET-5648-2022; Henderson, Paul/F-5106-2012; Hold, Georgina Louise/AAG-9923-2020	Parkhill, Julian/0000-0002-7069-5958; Louis, Petra/0000-0003-2115-2399; Walker, Alan W./0000-0001-5099-8495; Prescott, Natalie J/0000-0002-5901-7371; Kennedy, Nicholas Alexander/0000-0003-4368-1961; Henderson, Paul/0000-0003-3634-6428; Hold, Georgina Louise/0000-0001-7573-3397; Lees, Charlie/0000-0002-0732-8215; Simmons, Alison/0000-0003-3454-0710; Duncan, Sylvia/0000-0002-4903-0978; Parkes, Miles/0000-0002-6467-0631; Newman, William/0000-0002-6382-4678	CORE - The Digestive Disorders Foundation; Wellcome Trust [WT076964, WT097943MA]; Scottish Government Rural and Environment Science and Analytical Services; MRC [G0800675, MC_UU_12010/7, G0600329] Funding Source: UKRI; Medical Research Council [G0800675, G0600329] Funding Source: researchfish; Medical Research Foundation [C0482] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-026] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/75, ETM/137] Funding Source: researchfish	CORE - The Digestive Disorders Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Scottish Government Rural and Environment Science and Analytical Services; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	This project was funded by a grant from CORE - The Digestive Disorders Foundation. Funding for AWW, JP, and 454 pyrosequencing was provided by the Wellcome Trust (grant WT076964). NAK is funded by a Research Training Fellowship from the Wellcome Trust (grant number WT097943MA). SHD, FMF, PL, and HJF receive support from the Scottish Government Rural and Environment Science and Analytical Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Ariefdjohan MW, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-23; Claassen S, 2013, J MICROBIOL METH, V94, P103, DOI 10.1016/j.mimet.2013.05.008; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Hansen R, 2012, AM J GASTROENTEROL, V107, P1913, DOI 10.1038/ajg.2012.335; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Lawley B, 2012, GASTROENTEROL CLIN N, V41, P855, DOI 10.1016/j.gtc.2012.08.010; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Maukonen J, 2012, FEMS MICROBIOL ECOL, V79, P697, DOI 10.1111/j.1574-6941.2011.01257.x; McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; Persson S, 2011, DIAGN MICR INFEC DIS, V69, P240, DOI 10.1016/j.diagmicrobio.2010.09.023; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Simren M, 2013, GUT, V62, P159, DOI 10.1136/gutjnl-2012-302167; Smith Birgitte, 2011, Open Microbiol J, V5, P14, DOI 10.2174/1874285801105010014; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Yue JC, 2001, BIOMETRICS, V57, P743, DOI 10.1111/j.0006-341X.2001.00743.x; Zoetendal EG, 2004, J NUTR, V134, P465, DOI 10.1093/jn/134.2.465; Zoetendal EG, 2001, SYST APPL MICROBIOL, V24, P405, DOI 10.1078/0723-2020-00060	38	173	181	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e88982	10.1371/journal.pone.0088982	http://dx.doi.org/10.1371/journal.pone.0088982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586470	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700016
J	Lu, JL; Yan, ZZ				Lu, Jingli; Yan, Zaizai			A Class of Ratio Estimators of a Finite Population Mean Using Two Auxiliary Variables	PLOS ONE			English	Article							INFORMATION	In sample surveys, it is usual to increase the efficiency of the estimators by the use of the auxiliary information. We propose a class of ratio estimators of a finite population mean using two auxiliary variables and obtain mean square error (MSE) equations for the class of proposed estimators. We find theoretical conditions that make proposed family estimators more efficient than the traditional ratio estimator and the estimators proposed by Abu-Dayeh et al. using two auxiliary variables. In addition, we support these theoretical results with the aid of a numerical example.	[Lu, Jingli; Yan, Zaizai] Inner Mongolia Univ Technol, Coll Sci, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia University of Technology	Lu, JL (corresponding author), Inner Mongolia Univ Technol, Coll Sci, Hohhot, Inner Mongolia, Peoples R China.	lujingli2004@163.com			National Natural Science Foundation of China [11361036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China No. 11361036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Dayyeh WA, 2003, APPL MATH COMPUT, V139, P287, DOI 10.1016/S0096-3003(02)00180-7; Choudhury S, 2012, ASIAN J MATH STAT, V6; Feng S, 1996, SAMPLING SURVEY THEO; Kadilar C, 2004, APPL MATH COMPUT, V151, P893, DOI 10.1016/S0096-3003(03)00803-8; Kadilar C., 2006, HACET J MATH STAT, V35; RAJ D, 1965, J AM STAT ASSOC, V60, P270, DOI 10.2307/2283151; Singh D., 1986, THEORY ANAL SAMPLE S; Singh H.P., 2003, STAT TRANSITION, V6, P555; Singh HP, 2009, SORT-STAT OPER RES T, V33, P71; Singh R., 2012, J SCI RES, V56, P177; Singh R, 2012, J RELIAB STAT STUD, V5, P73; Sisodia B.V., 1981, J INDIAN SOC AGR STA, V33, P13; Upadhyaya LN, 1999, BIOMETRICAL J, V41, P627, DOI 10.1002/(SICI)1521-4036(199909)41:5<627::AID-BIMJ627>3.3.CO;2-N	13	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89538	10.1371/journal.pone.0089538	http://dx.doi.org/10.1371/journal.pone.0089538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586855	Green Submitted, gold, Green Published			2022-12-27	WOS:000331880700058
J	Suzuki, G; Tokuno, S; Nibuya, M; Ishida, T; Yamamoto, T; Mukai, Y; Mitani, K; Tsumatori, G; Scott, D; Shimizu, K				Suzuki, Go; Tokuno, Shinichi; Nibuya, Masashi; Ishida, Toru; Yamamoto, Tetsuo; Mukai, Yasuo; Mitani, Keiji; Tsumatori, Gentaro; Scott, Daniel; Shimizu, Kunio			Decreased Plasma Brain-Derived Neurotrophic Factor and Vascular Endothelial Growth Factor Concentrations during Military Training	PLOS ONE			English	Article							SLEEP-WAKE IDENTIFICATION; FACTOR BDNF LEVELS; MAJOR DEPRESSION; BEHAVIORAL ACTIONS; SERUM; STRESS; VEGF; EXERCISE; DEPRIVATION; EXPRESSION	Decreased concentrations of plasma brain-derived neurotrophic factor (BDNF) and serum BDNF have been proposed to be a state marker of depression and a biological indicator of loaded psychosocial stress. Stress evaluations of participants in military mission are critically important and appropriate objective biological parameters that evaluate stress are needed. In military circumstances, there are several problems to adopt plasma BDNF concentration as a stress biomarker. First, in addition to psychosocial stress, military missions inevitably involve physical exercise that increases plasma BDNF concentrations. Second, most participants in the mission do not have adequate quality or quantity of sleep, and sleep deprivation has also been reported to increase plasma BDNF concentration. We evaluated plasma BDNF concentrations in 52 participants on a 9-week military mission. The present study revealed that plasma BDNF concentration significantly decreased despite elevated serum enzymes that escaped from muscle and decreased quantity and quality of sleep, as detected by a wearable watch-type sensor. In addition, we observed a significant decrease in plasma vascular endothelial growth factor (VEGF) during the mission. VEGF is also neurotrophic and its expression in the brain has been reported to be up-regulated by antidepressive treatments and down-regulated by stress. This is the first report of decreased plasma VEGF concentrations by stress. We conclude that decreased plasma concentrations of neurotrophins can be candidates for mental stress indicators in actual stressful environments that include physical exercise and limited sleep.	[Suzuki, Go; Ishida, Toru; Yamamoto, Tetsuo; Mukai, Yasuo] Japan Ground Self Def Force, Test & Evaluat Command, Mil Med Res Unit, Setagaya Ku, Tokyo, Japan; [Suzuki, Go] Japan Self Def Force Cent Hosp, Dept Psychiat, Setagaya Ku, Tokyo, Japan; [Tokuno, Shinichi; Tsumatori, Gentaro] Natl Def Med Coll, Dept Def Med, Tokorozawa, Saitama 359, Japan; [Nibuya, Masashi] Natl Def Med Coll, Dept Psychiat, Tokorozawa, Saitama 359, Japan; [Mitani, Keiji] Japan Self Def Force Cent Hosp, Dept Internal Med, Setagaya Ku, Tokyo, Japan; [Scott, Daniel] Yale Univ, Sch Med, Dept Psychiat, Div Mol Psychiat, New Haven, CT USA; [Shimizu, Kunio] Natl Def Med Coll, Res Inst, Div Behav Sci, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan; Yale University; National Defense Medical College - Japan	Nibuya, M (corresponding author), Natl Def Med Coll, Dept Psychiat, Tokorozawa, Saitama 359, Japan.	nibrin@ndmc.ac.jp	Tokuno, Shinichi/L-1117-2019; Suzuki, Go/E-5081-2011	Tokuno, Shinichi/0000-0002-2691-6979; Suzuki, Go/0000-0003-3120-8683; Nibuya, Masashi/0000-0002-8292-2302	Japanese Ministry of Education and Science [24591650]; Japan Defense Force	Japanese Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Defense Force	The present study was performed with grants from the Japanese Ministry of Education and Science (24591650) for M.N. and from the Japan Defense Force for G.S., S.T., and M.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RCB, 1969, P ROY SOC MED, V62, P989, DOI 10.1177/003591576906201005; BAHARAV A, 1995, NEUROLOGY, V45, P1183, DOI 10.1212/WNL.45.6.1183; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Chen TC, 2001, MED SCI SPORT EXER, V33, P1732, DOI 10.1097/00005768-200110000-00018; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Dome P, 2012, J AFFECT DISORDERS, V136, P1159, DOI 10.1016/j.jad.2011.09.027; Elzinga BM, 2011, PSYCHOPHARMACOLOGY, V214, P319, DOI 10.1007/s00213-010-1961-1; Fornaro M, 2013, J AFFECT DI IN PRESS; Gorgulu Y, 2009, BRAIN RES BULL, V80, P158, DOI 10.1016/j.brainresbull.2009.06.016; Greene J, 2009, NEUROPSYCHOPHARMACOL, V34, P2459, DOI 10.1038/npp.2009.68; Halmai Z, 2013, J AFFECT DISORDERS, V144, P269, DOI 10.1016/j.jad.2012.09.006; Heine VM, 2005, EUR J NEUROSCI, V21, P1304, DOI 10.1111/j.1460-9568.2005.03951.x; Ibrahim L, 2011, BRAIN RES BULL, V86, P129, DOI 10.1016/j.brainresbull.2011.06.003; Kamata N, 2011, IND HEALTH, V49, P427, DOI 10.2486/indhealth.MS1257; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Kim YK, 2007, PROG NEURO-PSYCHOPH, V31, P78, DOI 10.1016/j.pnpbp.2006.06.024; Kotan Z, 2012, THER ADV PSYCHOPHARM, V2, P65, DOI 10.1177/2045125312436572; LANG H, 1982, CLIN CHEM, V28, P1439; Lee BH, 2007, J AFFECT DISORDERS, V101, P239, DOI 10.1016/j.jad.2006.11.005; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Marano CM, 2007, J CLIN PSYCHIAT, V68, P512, DOI 10.4088/JCP.v68n0404; Mitoma M, 2008, PROG NEURO-PSYCHOPH, V32, P679, DOI 10.1016/j.pnpbp.2007.11.011; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Newton SS, 2003, J NEUROSCI, V23, P10841; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Okuno K, 2011, PSYCHIAT RES, V186, P326, DOI 10.1016/j.psychres.2010.07.023; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Pillai A, 2010, INT J NEUROPSYCHOPH, V13, P535, DOI 10.1017/S1461145709991015; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; SCHIMKE RT, 1973, ADV ENZYMOL RAMB, V37, P135; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Sun FY, 2005, J NEUROSCI RES, V79, P180, DOI 10.1002/jnr.20321; Suzuki T, 2009, BIODEVICES 2009: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON BIOMEDICAL ELECTRONICS AND DEVICES, P326; Takebayashi M, 2010, J NEURAL TRANSM, V117, P1119, DOI 10.1007/s00702-010-0452-1; Tang SW, 2008, NEUROSCI LETT, V431, P62, DOI 10.1016/j.neulet.2007.11.019; Ventriglia M, 2009, PROG NEURO-PSYCHOPH, V33, P146, DOI 10.1016/j.pnpbp.2008.11.009; Warner-Schmidt JL, 2008, CURR OPIN PHARMACOL, V8, P14, DOI 10.1016/j.coph.2007.10.013; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; Zoladz JA, 2008, J PHYSIOL PHARMACOL, V59, P119	40	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89455	10.1371/journal.pone.0089455	http://dx.doi.org/10.1371/journal.pone.0089455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586790	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700046
J	Al-Rubeaan, K; Youssef, AM; Subhani, SN; Ahmad, NA; Al-Sharqawi, AH; Al-Mutlaq, HM; David, SK; AlNaqeb, D				Al-Rubeaan, Khalid; Youssef, Amira M.; Subhani, Shazia N.; Ahmad, Najlaa A.; Al-Sharqawi, Ahmad H.; Al-Mutlaq, Hind M.; David, Satish K.; AlNaqeb, Dhekra			Diabetic Nephropathy and Its Risk Factors in a Society with a Type 2 Diabetes Epidemic: A Saudi National Diabetes Registry-Based Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; GLYCEMIC CONTROL; PREVALENCE; MELLITUS; ARABIA; MICROALBUMINURIA; HYPERTENSION; PROGRESSION; FREQUENCY; SMOKING	Aim The prevalence of diabetic nephropathy and its risk factors have not been studied in a society known to have diabetes epidemic like Saudi Arabia. Using a large data base registry will provide a better understanding and accurate assessment of this chronic complication and its related risk factors. Methodology: A total of 54,670 patients with type 2 diabetes aged >= 25 years were selected from the Saudi National Diabetes Registry (SNDR) and analyzed for the presence of diabetic nephropathy. The American Diabetes Association (ADA) criterion was used to identify cases with microalbuminuria, macroalbuminuria and end stage renal disease (ESRD) for prevalence estimation and risk factor assessment. Results: The overall prevalence of diabetic nephropathy was 10.8%, divided into 1.2% microalbuminuria, 8.1% macroalbuninuria and 1.5% ESRD. Age and diabetes duration as important risk factors have a strong impact on the prevalence of diabetic nephropathy, ranging from 3.7% in patients aged 25-44 years and a duration of > 5 years, to 21.8% in patients >= 65 years with a diabetes duration of >= 15 years. Diabetes duration, retinopathy, neuropathy, hypertension, age >= 45 years, hyperlipidemia, male gender, smoking, and chronologically, poor glycemic control has a significantly high risk for diabetic nephropathy. Conclusion: The prevalence of diabetic nephropathy is underestimated as a result of a shortage of screening programs. Risk factors related to diabetic nephropathy in this society are similar to other societies. There is thus an urgent need for screening and prevention programs for diabetic nephropathy among the Saudi population.	[Al-Rubeaan, Khalid] King Saud Univ, Coll Med, Univ Diabet Ctr, Riyadh 11461, Saudi Arabia; [Youssef, Amira M.] King Saud Univ, Univ Diabet Ctr, Registry Dept, Riyadh 11461, Saudi Arabia; [Subhani, Shazia N.] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia; [Ahmad, Najlaa A.; Al-Sharqawi, Ahmad H.] King Saud Univ, Univ Diabet Ctr, Dept Biostat, Riyadh 11461, Saudi Arabia; [Al-Mutlaq, Hind M.] Qassim Univ, Dept Family & Community Med, Qasim, Saudi Arabia; [David, Satish K.] King Saud Univ, Strateg Ctr Diabet Res, Dept Informat Technol, Riyadh 11461, Saudi Arabia; [AlNaqeb, Dhekra] Univ Diabet Ctr, Res Dept, Univ Diabet Ctr, Riyadh 11461, Saudi Arabia	King Saud University; King Saud University; King Faisal Specialist Hospital & Research Center; King Saud University; Qassim University; King Saud University	Al-Rubeaan, K (corresponding author), King Saud Univ, Coll Med, Univ Diabet Ctr, Riyadh 11461, Saudi Arabia.	krubean@ksu.edu.sa	Youssef, Amira/AAZ-8030-2021; David, Satish Kumar/AAH-5373-2020	Youssef, Amira/0000-0002-8407-0924; 	King Abdulaziz City for Science and Technology (KACST)	King Abdulaziz City for Science and Technology (KACST)	This project was funded by King Abdulaziz City for Science and Technology (KACST). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Al-Nozha MM, 2004, SAUDI MED J, V25, P1603; Al-Nozha MM, 2005, SAUDI MED J, V26, P824; Alwakeel LS, 2008, ANN SAUDI MED, V28, P260; Alwakeel JS, 2011, ANN SAUDI MED, V31, P236, DOI 10.4103/0256-4947.81528; ALZAID AA, 1994, DIABETES RES CLIN PR, V26, P115, DOI 10.1016/0168-8227(94)90148-1; [Anonymous], 2011, MIDDLE E N AFRICA ME; Bash LD, 2008, ARCH INTERN MED, V168, P2440, DOI 10.1001/archinte.168.22.2440; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Ejerblad E, 2006, J AM SOC NEPHROL, V17, P1695, DOI 10.1681/ASN.2005060638; Fioretto P, 2006, J AM SOC NEPHROL, V17, pS86, DOI 10.1681/ASN.2005121343; Ford DJ, 2010, NEPHRON CLIN PRACT, V115, pC271, DOI 10.1159/000301236; Gall MA, 1997, BMJ-BRIT MED J, V314, P783, DOI 10.1136/bmj.314.7083.783; Gliklich R. E., 2010, REGISTRIES EVALUATIO; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Jarallah JS, 1999, TOB CONTROL, V8, P53, DOI 10.1136/tc.8.1.53; Keane WF, 2003, KIDNEY INT, V63, P1499, DOI 10.1046/j.1523-1755.2003.00885.x; KLEIN R, 1993, DIABETES CARE, V16, P1325, DOI 10.2337/diacare.16.10.1325; Magee GM, 2010, DIABETIC MED, V27, P1372, DOI 10.1111/j.1464-5491.2010.03105.x; Maric C, 2008, GENDER MED, V5, pS103, DOI 10.1016/j.genm.2008.03.010; Mehler PS, 1998, J GEN INTERN MED, V13, P842, DOI 10.1046/j.1525-1497.1998.00249.x; Mohan V, 2000, POSTGRAD MED J, V76, P569, DOI 10.1136/pmj.76.899.569; Ngarmukos Chardpraorn, 2006, J Med Assoc Thai, V89 Suppl 1, pS37; Raile K, 2007, DIABETES CARE, V30, P2523, DOI 10.2337/dc07-0282; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Shen FC, 2009, ACTANEPHROLOGICA, V23, P2; Unnikrishnan R, 2007, DIABETES CARE, V30, P2019, DOI 10.2337/dc06-2554; Viswanathan V, 2012, INDIAN J MED RES, V136, P46; Yang CW, 2011, NEPHROL DIAL TRANSPL, V26, P3249, DOI 10.1093/ndt/gfr011	31	78	80	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88956	10.1371/journal.pone.0088956	http://dx.doi.org/10.1371/journal.pone.0088956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586457	gold, Green Submitted, Green Published			2022-12-27	WOS:000331717900041
J	Vanoaica, L; Richman, L; Jaworski, M; Darshan, D; Luther, SA; Kuhn, LC				Vanoaica, Liviu; Richman, Larry; Jaworski, Maike; Darshan, Deepak; Luther, Sanjiv A.; Kuehn, Lukas C.			Conditional Deletion of Ferritin H in Mice Reduces B and T Lymphocyte Populations	PLOS ONE			English	Article							LABILE IRON POOL; MITOCHONDRIAL PERMEABILITY TRANSITION; NECROSIS-FACTOR FAMILY; MOLECULAR CONTROL; CELL DEVELOPMENT; MATURATION; HEMOCHROMATOSIS; INACTIVATION; TRANSFERRIN; INCREASES	The immune system and iron availability are intimately linked as appropriate iron supply is needed for cell proliferation, while excess iron, as observed in hemochromatosis, may reduce subsets of lymphocytes. We have tested the effects of a ferritin H gene deletion on lymphocytes. Mx-Cre mediated conditional deletion of ferritin H in bone marrow reduced the number of mature B cells and peripheral T cells in all lymphoid organs. FACS analysis showed an increase in the labile iron pool, enhanced reactive oxygen species formation and mitochondrial depolarization. The findings were confirmed by a B-cell specific deletion using Fth(lox/lox); CD19-Cre mice. Mature B cells were strongly under-represented in bone marrow and spleen of the deleted mice, whereas pre-B and immature B cells were not affected. Bone marrow B cells showed increased proliferation as judged by the number of cells in S and G2/M phase as well as BrdU incorporation. Upon in vitro culture with B-cell activating factor of the tumor necrosis factor family (BAFF), ferritin H-deleted spleen B cells showed lower survival rates than wild type cells. This was partially reversed with iron-chelator deferiprone. The loss of T cells was also confirmed by a T cell-specific deletion in Fth(lox/lox); CD4-Cre mice. Our data show that ferritin H is required for B and T cell survival by actively reducing the labile iron pool. They further suggest that natural B and T cell maturation is influenced by intracellular iron levels and possibly deregulated in iron excess or deprivation.	[Vanoaica, Liviu; Richman, Larry; Kuehn, Lukas C.] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland; [Jaworski, Maike; Luther, Sanjiv A.] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Darshan, Deepak] Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Lausanne; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Kuhn, LC (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland.	lukas.kuehn@epfl.ch	Luther, Sanjiv/AAP-6525-2020; Luther, Sanjiv A/B-4380-2016; Darshan, Deepak/B-8259-2013; , Sanjiv/B-4380-2016	Luther, Sanjiv/0000-0002-8758-957X; Luther, Sanjiv A/0000-0002-8758-957X; Darshan, Deepak/0000-0001-9719-5980; , Sanjiv/0000-0002-0614-561X	Swiss National Science Foundation [3100-065435, 31003A-130488]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx) grants 3100-065435 to LCK and 31003A-130488 to SAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosa FA, 1997, CLIN EXP IMMUNOL, V107, P548, DOI 10.1046/j.1365-2249.1997.d01-967.x; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Bubici C, 2006, HISTOL HISTOPATHOL, V21, P69, DOI 10.14670/HH-21.69; Cachero TG, 2006, BIOCHEMISTRY-US, V45, P2006, DOI 10.1021/bi051685o; Cruz E, 2006, BLOOD CELL MOL DIS, V37, P33, DOI 10.1016/j.bcmd.2006.04.004; Darshan D, 2009, HEPATOLOGY, V50, P852, DOI 10.1002/hep.23058; DESOUSA M, 1989, CLIN EXP IMMUNOL, V75, P1; DORNER MH, 1980, SCIENCE, V209, P1019, DOI 10.1126/science.6967622; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; Fink PJ, 2011, NAT REV IMMUNOL, V11, P544, DOI 10.1038/nri3028; GOLDING S, 1995, SCAND J IMMUNOL, V41, P229, DOI 10.1111/j.1365-3083.1995.tb03558.x; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; ISCOVE NN, 1978, J EXP MED, V147, P923, DOI 10.1084/jem.147.3.923; Johnson-Cadwell LI, 2007, J NEUROCHEM, V101, P1619, DOI 10.1111/j.1471-4159.2007.04516.x; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kakhlon O, 2001, BLOOD, V97, P2863, DOI 10.1182/blood.V97.9.2863; Krop I, 1996, J IMMUNOL, V157, P48; Kuhn LC, 2009, CELL METAB, V10, P439, DOI 10.1016/j.cmet.2009.11.005; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LEVI S, 1988, J BIOL CHEM, V263, P18086; Macedo MF, 2010, CLIN EXP IMMUNOL, V159, P363, DOI 10.1111/j.1365-2249.2009.04066.x; Ned RM, 2003, BLOOD, V102, P3711, DOI 10.1182/blood-2003-04-1086; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Pourzand C, 1999, P NATL ACAD SCI USA, V96, P6751, DOI 10.1073/pnas.96.12.6751; Prus E, 2008, CYTOM PART A, V73A, P22, DOI 10.1002/cyto.a.20491; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Rolink AG, 2004, IMMUNOL REV, V197, P41, DOI 10.1111/j.0105-2896.2004.0101.x; Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Von Boehmer H, 2004, ADV IMMUNOL, V84, P201, DOI 10.1016/S0065-2776(04)84006-9; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Xie CC, 2005, MOL CELL BIOL, V25, P6673, DOI 10.1128/MCB.25.15.6673-6681.2005	47	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89270	10.1371/journal.pone.0089270	http://dx.doi.org/10.1371/journal.pone.0089270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586648	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900077
J	Aflatoonian, MR; Sharifi, I; Parizi, MH; Fekri, AR; Aflatoonian, B; Sharifi, M; Khosravi, A; Khamesipour, A; Sharifi, H				Aflatoonian, Mohammad Reza; Sharifi, Iraj; Parizi, Maryam Hakimi; Fekri, Ali Reza; Aflatoonian, Behnaz; Sharifi, Maryam; Khosravi, Ahmad; Khamesipour, Ali; Sharifi, Hamid			A Prospective Cohort Study of Cutaneous Leishmaniasis Risk and Opium Addiction in South Eastern Iran	PLOS ONE			English	Article							MORPHINE; EPIDEMIOLOGY	Opium addiction and cutaneous leishmaniasis (CL) are endemic in different parts of Iran, particularly in Bam, where a massive earthquake occurred. This study was designed to compare the incidence rate and severity of CL cases among opium addicted and non-addicted individuals in south-eastern Iran. This study was carried out as a prospective cohort by active house-to-house visits of 1,481 habitants in Bam. CL cases were confirmed by smear and identification of Leishmania species was performed using nested-PCR. The data was analyzed by chi(2) and t-tests, using SPSS software and also Kaplan-Meier survival curve and long-rank test in Stata 11.2 and P < 0.05 was considered as significant. A total of 904 individuals consisting of 226 opium addicted and 678 non-addicted individuals were followed-up for a period of seven years. The two cohorts were similar in terms of age, sex and place of residency. A similar pattern of incidence was observed among the two cohort groups. In contrast, the severity of CL in terms of the number, duration and the size of the lesions in opium addicted individuals was significantly (P < 0.001) higher than non-opium addicted individuals. In conclusion, the present findings indicate that there is no relationship between the incidence of CL and opium addiction.	[Aflatoonian, Mohammad Reza] Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran; [Sharifi, Iraj; Parizi, Maryam Hakimi; Fekri, Ali Reza; Khosravi, Ahmad] Kerman Univ Med Sci, Leishmaniasis Res Ctr, Kerman, Iran; [Aflatoonian, Behnaz] Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran; [Sharifi, Maryam] Kerman Univ Med Sci, Kerman Oral & Dent Dis Res Ctr, Kerman, Iran; [Khamesipour, Ali] Univ Tehran Med Sci, Ctr Res & Training Skin Dis & Leprosy, Tehran, Iran; [Sharifi, Hamid] Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub, Kerman, Iran; [Sharifi, Hamid] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Sharifi, Hamid] Shahid Bahonar Univ Kerman, Dept Food Hyg & Publ Hlth, Fac Vet Med, Kerman, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences; Tehran University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Shahid Bahonar University of Kerman (SBUK)	Sharifi, I (corresponding author), Kerman Univ Med Sci, Leishmaniasis Res Ctr, Kerman, Iran.	iraj.sharifi@yahoo.com	Fekri, Alireza/ABH-1440-2020; Sharifi, Iraj/AAY-8267-2020; Reza, Aflatoonian Mohammad/Y-2246-2018; Sharifi, Hamid/B-5493-2019; Sharifi, Maryam/AAM-6960-2020; Khosravi, Ahmad/AAA-5264-2019	Fekri, Alireza/0000-0001-7009-2164; Reza, Aflatoonian Mohammad/0000-0002-2148-6690; Sharifi, Hamid/0000-0002-9008-7618; Aflatounian, Mohammadreza/0000-0003-4834-5086; Sharifi, Iraj/0000-0002-6894-6834; Hakimi Parizi, Maraym/0000-0002-9565-1513	Kerman University of Medical Sciences, Iran	Kerman University of Medical Sciences, Iran	This project was supported by Kerman University of Medical Sciences, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflatoonian MR, 2011, AM J ADDICTION, V20, P581, DOI 10.1111/j.1521-0391.2011.00170.x; Ahmadi J, 2007, AM J DRUG ALCOHOL AB, V33, P483, DOI 10.1080/00952990701301293; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; BUSSIERE JL, 1992, IMMUNOPHARM IMMUNOT, V14, P657, DOI 10.3109/08923979209005416; CHAO CC, 1990, J PHARMACOL EXP THER, V252, P605; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Farnia M, 2010, INT J DRUG POLICY, V21, P422, DOI 10.1016/j.drugpo.2010.03.008; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Gholampoor E., 2006, IRANIAN J PSYCHIAT, V1, P76; Gilvarry E, 2000, J CHILD PSYCHOL PSYC, V41, P55, DOI 10.1111/1469-7610.00549; Gouya M. M., 2010, NATL GUIDELINES CUTA, P1; Guernaoui S, 2006, PARASITOL RES, V98, P184, DOI 10.1007/s00436-005-0032-8; Lysle DT, 2000, IMMUNOPHARMACOLOGY, V46, P181, DOI 10.1016/S0162-3109(99)00172-1; McQuay H, 1999, LANCET, V353, P2229, DOI 10.1016/S0140-6736(99)03528-X; MOLITOR TW, 1992, J PHARMACOL EXP THER, V260, P581; Montazeri A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-4; Nadim A., 1995, Iranian Journal of Public Health, V24, P15; Noyes HA, 1998, J CLIN MICROBIOL, V36, P2877, DOI 10.1128/JCM.36.10.2877-2881.1998; PETERSON PK, 1987, J IMMUNOL, V138, P3907; Postigo JAR, 2010, INT J ANTIMICROB AG, V36, pS62, DOI 10.1016/j.ijantimicag.2010.06.023; Sacerdote P, 1997, BRIT J PHARMACOL, V121, P834, DOI 10.1038/sj.bjp.0701138; Seyedin Seyed Hesam, 2009, Am J Disaster Med, V4, P173; Sharifi I, 2011, IRAN J PUBLIC HEALTH, V40, P49; Singh PP, 2007, J NEUROIMMUNE PHARM, V2, P338, DOI 10.1007/s11481-007-9094-y; SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013; United Nations, 2003, GLOB ILL DRUG TRENDS, P101; VOUKASSOVITCH C, 1986, ANN MED-PSYCHOL, V144, P695; Wei G, 2003, BIOCHEM PHARMACOL, V65, P1761, DOI 10.1016/S0006-2952(03)00085-6; WHO, 2010, WHO TECH REP SER, V949, P1; YEAGER MP, 1995, ANESTHESIOLOGY, V83, P500, DOI 10.1097/00000542-199509000-00008; Ziaaddini H., 2005, J APPL SCI, V5, P380, DOI [10.3923/jas.2005.380.382, DOI 10.3923/JAS.2005.380.382]	33	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89043	10.1371/journal.pone.0089043	http://dx.doi.org/10.1371/journal.pone.0089043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586494	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700053
J	Gorea, A; Rider, D; Yang, Q				Gorea, Andrei; Rider, Delphine; Yang, Qing			A Unified Comparison of Stimulus-Driven, Endogenous Mandatory and 'Free Choice' Saccades	PLOS ONE			English	Article							REACTION-TIME DISTRIBUTIONS; VISUALLY GUIDED SACCADES; SUPERIOR COLLICULUS; EXPRESS-SACCADES; CORTICAL CONTROL; FIXATION OFFSET; EYE-MOVEMENTS; VOLUNTARY; MONKEY; MODEL	It has been claimed that saccades arising from the three saccade triggering modes-stimulus-driven, endogenous mandatory and 'free choice'-are driven by distinct mechanisms. We tested this claim by instructing observers to saccade from a white or black fixation disc to a same polarity (white or black) disc flashed for 100 or 200 ms presented either alone (Exo), or together with an opposite (Endo) or same (EndoFC) polarity disc (blocked and mixed sessions). Target(s) and distractor were presented at three inter-stimulus intervals (ISIs) relative to the fixation offset (ISI: -200, 0, +200 ms) and were displayed at random locations within a 4 degrees -to-6 degrees eccentricity range. The statistical analysis showed a global saccade triggering mode effect on saccade reaction times (SRTs) with Endo and EndoFC SRTs longer by about 27 ms than Exo-triggered ones but no effect for the Endo-EndoFC comparison. SRTs depended on both ISI (the "gap-effect''), and target duration. Bimodal best fits of the SRT-distributions were found in 65% of cases with their count not different across the three triggering modes. Percentages of saccades in the 'fast' and 'slow' ranges of bimodal fits did not depend on the triggering modes either. Bimodality tests failed to assert a significant difference between these modes. An analysis of the timing of a putative inhibition by the distractor (Endo) or by the duplicated target (EndoFC) yielded no significant difference between Endo and EndoFC saccades but showed a significant shortening with ISI similar to the SRT shortening suggesting that the distractor-target mutual inhibition is itself inhibited by 'fixation' neurons. While other experimental paradigms may well sustain claims of distinct mechanisms subtending the three saccade triggering modes, as here defined reflexive and voluntary saccades appear to differ primarily in the effectiveness with which inhibitory processes slow down the initial fast rise of the saccade triggering signal.	[Gorea, Andrei] Univ Paris 05, Lab Psychol Percept, Paris, France; CNRS, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Gorea, A (corresponding author), Univ Paris 05, Lab Psychol Percept, Paris, France.	Andrei.gorea@parisdescartes.fr			Agence Nationale Pour la Recherche [ANR-06-NEURO-042-01]	Agence Nationale Pour la Recherche(French National Research Agency (ANR))	Partly supported by the Agence Nationale Pour la Recherche (Grant ANR-06-NEURO-042-01 to A. Gorea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], J NEUROPHYSIOL, V78, P1108; BOCH R, 1984, EXP BRAIN RES, V55, P223; Bompas A, 2011, J NEUROSCI, V31, P12501, DOI 10.1523/JNEUROSCI.2234-11.2011; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown MRG, 2004, J NEUROPHYSIOL, V91, P873, DOI 10.1152/jn.00382.2003; Cardoso-Leite P, 2007, J VISION, V7, DOI 10.1167/7.6.11; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Cotti J, 2009, J PHYSIOL-LONDON, V587, P127, DOI 10.1113/jphysiol.2008.159459; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; DORRIS MC, 1995, J NEUROPHYSIOL, V73, P2558, DOI 10.1152/jn.1995.73.6.2558; Dorris MC, 1997, J NEUROSCI, V17, P8566; ELLISON AM, 1987, AM J BOT, V74, P1280, DOI 10.2307/2444163; FISCHER B, 1993, EXP BRAIN RES, V92, P528; FISCHER B, 1984, EXP BRAIN RES, V57, P191; FISCHER B, 1987, REV PHYSIOL BIOCH P, V106, P1, DOI 10.1007/BFb0027574; FISCHER B, 1995, BIOL CYBERN, V72, P185, DOI 10.1007/BF00201483; Forbes K, 1996, J COGNITIVE NEUROSCI, V8, P344, DOI 10.1162/jocn.1996.8.4.344; Gaymard B, 1999, EXP BRAIN RES, V129, P288, DOI 10.1007/s002210050899; Gezeck S, 1998, BIOL CYBERN, V78, P293, DOI 10.1007/s004220050434; Gezeck S, 1997, VISION RES, V37, P2119, DOI 10.1016/S0042-6989(97)00022-9; Hellwig B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-276; HENIK A, 1994, J COGNITIVE NEUROSCI, V6, P400, DOI 10.1162/jocn.1994.6.4.400; Kennard C, 2005, ANN NY ACAD SCI, V1039, P176, DOI 10.1196/annals.1325.017; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Klein RM, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P195; KOPECZ K, 1995, VISION RES, V35, P2911, DOI 10.1016/0042-6989(95)00066-9; Leach JCD, 2001, VISION RES, V41, P3437, DOI 10.1016/S0042-6989(01)00059-1; Marino RA, 2012, J COGNITIVE NEUROSCI, V24, P315, DOI 10.1162/jocn_a_00139; Matsumora T, 2008, J NEUROPHYSIOL, V100, P3361, DOI 10.1152/jn.90551.2008; Miller JO, 2001, J EXP PSYCHOL HUMAN, V27, P266, DOI 10.1037//0096-1523.27.2.266; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Muratov AL, 2010, ASTROPHYS J, V718, P1266, DOI 10.1088/0004-637X/718/2/1266; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nachev P, 2008, PROG BRAIN RES, V171, P391, DOI 10.1016/S0079-6123(08)00657-2; Otto TU, 2012, CURR BIOL, V22, P1391, DOI 10.1016/j.cub.2012.05.031; Pare M, 1996, J NEUROPHYSIOL, V76, P3666, DOI 10.1152/jn.1996.76.6.3666; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Pesaran B, 2010, CURR OPIN NEUROBIOL, V20, P166, DOI 10.1016/j.conb.2010.03.003; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; PIERROTDESEILLIGNY C, 1991, EXP BRAIN RES, V83, P607; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Reingold EM, 2004, J EXP PSYCHOL HUMAN, V30, P194, DOI 10.1037/0096-1523.30.1.194; Reingold EM, 2002, J COGNITIVE NEUROSCI, V14, P371, DOI 10.1162/089892902317361903; Rolfs M, 2007, J VISION, V7, DOI 10.1167/7.10.7; SASLOW MG, 1967, J OPT SOC AM, V57, P1024, DOI 10.1364/JOSA.57.001024; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schiller PH, 2000, VISION RES, V40, P1627, DOI 10.1016/S0042-6989(00)00058-4; Sheskin D., 2011, HDB PARAMETRIC NONPA, Vfifth, DOI [DOI 10.1201/9781420036268, 10.2307/2685909]; Sparks D L, 1989, Rev Oculomot Res, V3, P213; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; Sternberg S, 2001, ACTA PSYCHOL, V106, P147, DOI 10.1016/S0001-6918(00)00045-7; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; VINCENT SB, 1912, BEHAV MONOGR, V1; WALKER R, 1995, EXP BRAIN RES, V103, P294; Walker R, 2000, EXP BRAIN RES, V130, P540, DOI 10.1007/s002219900285; Walker R, 2006, VISION RES, V46, P2082, DOI 10.1016/j.visres.2005.12.009; Watanabe K, 2007, CEREB CORTEX, V17, pI88, DOI 10.1093/cercor/bhm102; WURTZ RH, 1972, J NEUROPHYSIOL, V35, P575, DOI 10.1152/jn.1972.35.4.575	65	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88990	10.1371/journal.pone.0088990	http://dx.doi.org/10.1371/journal.pone.0088990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586474	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700048
J	Kim, JH; Lee, HO; Cho, YJ; Kim, J; Chun, J; Choi, J; Lee, Y; Jung, WH				Kim, Jin Hyo; Lee, Han-Ok; Cho, Yong-Joon; Kim, Jeongmi; Chun, Jongsik; Choi, Jaehyuk; Lee, Younghoon; Jung, Won Hee			A Vanillin Derivative Causes Mitochondrial Dysfunction and Triggers Oxidative Stress in Cryptococcus neoformans	PLOS ONE			English	Article							CELL-WALL INTEGRITY; CANDIDA-ALBICANS; SUPEROXIDE-DISMUTASE; O-VANILLIN; RESISTANCE; SUSCEPTIBILITY; HOMEOSTASIS; PEROXIDASE; PHENOLICS; VIRULENCE	Vanillin is a well-known food and cosmetic additive and has antioxidant and antimutagenic properties. It has also been suggested to have antifungal activity against major human pathogenic fungi, although it is not very effective. In this study, the antifungal activities of vanillin and 33 vanillin derivatives against the human fungal pathogen Cryptococcus neoformans, the main pathogen of cryptococcal meningitis in immunocompromised patients, were investigated. We found a structural correlation between the vanillin derivatives and antifungal activity, showing that the hydroxyl or alkoxy group is more advantageous than the halogenated or nitrated group in benzaldehyde. Among the vanillin derivatives with a hydroxyl or alkoxy group, o-vanillin and o-ethyl vanillin showed the highest antifungal activity against C. neoformans. o-Vanillin was further studied to understand the mechanism of antifungal action. We compared the transcriptome of C. neoformans cells untreated or treated with o-vanillin by using RNA sequencing and found that the compound caused mitochondrial dysfunction and triggered oxidative stress. These antifungal mechanisms of o-vanillin were experimentally confirmed by the significantly reduced growth of the mutants lacking the genes involved in mitochondrial functions and oxidative stress response.	[Kim, Jin Hyo] Natl Acad Agr Sci, Rural Dev Adm, Chem Safety Div, Suwon, South Korea; [Lee, Han-Ok; Kim, Jeongmi; Jung, Won Hee] Chung Ang Univ, Dept Syst Biotechnol, Anseong, South Korea; [Cho, Yong-Joon; Chun, Jongsik] Seoul Natl Univ, ChunLab Inc, Seoul, South Korea; [Chun, Jongsik] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Choi, Jaehyuk] Korea Atom Energy Res Inst, Res Div Biotechnol, Jeongup, South Korea; [Lee, Younghoon] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea	Rural Development Administration (RDA); Chung Ang University; Seoul National University (SNU); Seoul National University (SNU); Korea Atomic Energy Research Institute (KAERI); Korea Advanced Institute of Science & Technology (KAIST)	Jung, WH (corresponding author), Chung Ang Univ, Dept Syst Biotechnol, Anseong, South Korea.	whjung@cau.ac.kr	Lee, Younghoon/C-1991-2011; Chun, Jongsik/R-8458-2017	Lee, Younghoon/0000-0002-3841-719X; Chun, Jongsik/0000-0003-3385-5171; Cho, Yong-Joon/0000-0003-3191-2670	National Academy of Agricultural Science, Rural Development of Administration [PJ008468]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT and Future Planning [NRF-2013R1A1A1A05007037]; Korean government (MSIP) [2010-0029167]	National Academy of Agricultural Science, Rural Development of Administration; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Korean government (MSIP)	This study was supported by the National Academy of Agricultural Science, Rural Development of Administration (J.H.K. PJ008468), the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning NRF-2013R1A1A1A05007037 (W.H.J.), and the NRF grant by the Korean government (MSIP) 2010-0029167 (W.H.J. and Y.L.). The URLs are [http://atis.rda.go.kr/rdais/main/main.vw] and [http://www.nrf.re.kr/nrf_eng_cms/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex D, 2012, ANTIMICROB AGENTS CH, V56, P4630, DOI 10.1128/AAC.00477-12; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bambach A, 2009, EUKARYOT CELL, V8, P1706, DOI 10.1128/EC.00066-09; Bang S, 2013, J SCI FOOD AGR; Bender T, 2010, PROTEOMICS, V10, P1426, DOI 10.1002/pmic.200800619; BOONCHIRD C, 1982, CAN J MICROBIOL, V28, P1235, DOI 10.1139/m82-184; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cerrutti P, 1996, INT J FOOD MICROBIOL, V29, P379, DOI 10.1016/0168-1605(95)00026-7; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Dagley MJ, 2011, MOL MICROBIOL, V79, P968, DOI 10.1111/j.1365-2958.2010.07503.x; Faria NCG, 2011, LETT APPL MICROBIOL, V52, P506, DOI 10.1111/j.1472-765X.2011.03032.x; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Giles SS, 2005, EUKARYOT CELL, V4, P46, DOI 10.1128/EC.4.1.46-54.2005; Giles SS, 2005, FUNGAL GENET BIOL, V42, P20, DOI 10.1016/j.fgb.2004.09.003; Jung WH, 2009, EUKARYOT CELL, V8, P1511, DOI 10.1128/EC.00166-09; Kim JH, 2006, J APPL MICROBIOL, V101, P181, DOI 10.1111/j.1365-2672.2006.02882.x; Kim J, 2012, FUNGAL GENET BIOL, V49, P955, DOI 10.1016/j.fgb.2012.08.006; LOPEZMALO A, 1995, FOOD MICROBIOL, V12, P213, DOI 10.1016/S0740-0020(95)80100-6; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; MATSUMURA H, 1993, MUTAT RES, V298, P163, DOI 10.1016/0165-1218(93)90037-E; Missall TA, 2004, MOL MICROBIOL, V51, P1447, DOI 10.1111/j.1365-2958.2004.03921.x; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Narasipura SD, 2005, MOL MICROBIOL, V55, P1782, DOI 10.1111/j.1365-2958.2005.04503.x; Oliver BG, 2008, MICROBIOL-SGM, V154, P960, DOI 10.1099/mic.0.2007/013805-0; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Qu Y, 2012, EUKARYOT CELL, V11, P532, DOI 10.1128/EC.05292-11; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sebolai OM, 2008, CAN J MICROBIOL, V54, P111, DOI 10.1139/w07-116; Shibata T, 2012, ANTIMICROB AGENTS CH, V56, P5892, DOI 10.1128/AAC.05954-11; Standards NCfCL, 2002, M27A2 STAND NCFCL; Steen BR, 2003, EUKARYOT CELL, V2, P1336, DOI 10.1128/EC.2.6.1336-1349.2003; Sun N, 2013, ANTIMICROB AGENTS CH, V57, P532, DOI 10.1128/AAC.01520-12; TAKAHASHI K, 1989, BIOCHEM BIOPH RES CO, V162, P1376, DOI 10.1016/0006-291X(89)90826-7; Tangen KL, 2007, MICROBIOL-SGM, V153, P29, DOI 10.1099/mic.0.2006/000927-0; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Walton NJ, 2003, PHYTOCHEMISTRY, V63, P505, DOI 10.1016/S0031-9422(03)00149-3; Xu T, 2012, ANTIMICROB AGENTS CH, V56, P2894, DOI 10.1128/AAC.05663-11; Xu T, 2011, ANTIMICROB AGENTS CH, V55, P1611, DOI 10.1128/AAC.01022-10	42	28	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89122	10.1371/journal.pone.0089122	http://dx.doi.org/10.1371/journal.pone.0089122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586538	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700063
J	Schofield, DJ; Cunich, M; Shrestha, RN; Callander, EJ; Passey, ME; Kelly, SJ; Tanton, R; Veerman, L				Schofield, Deborah J.; Cunich, Michelle; Shrestha, Rupendra N.; Callander, Emily J.; Passey, Megan E.; Kelly, Simon J.; Tanton, Robert; Veerman, Lennert			The Impact of Diabetes on the Labour Force Participation and Income Poverty of Workers Aged 45-64 Years in Australia	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; FINANCIAL BARRIERS; LIFE-STYLE; PRODUCTIVITY; PREVENTION; EMPLOYMENT; MELLITUS; POPULATION; STRATEGIES; DISABILITY	Objective: To quantify the poverty status and level of disadvantage experienced by Australians aged 45-64 years who have left the labour force due to diabetes in 2010. Research Design and Methods: A purpose-built microsimulation model, Health&Wealth MOD2030, was used to estimate the poverty status and level of disadvantage of those aged 45-64 years who prematurely retire from the workforce due to diabetes. A multiple regression model was used to identify significant differences in rates of income poverty and the degree of disadvantage between those out of the labour force due to diabetes and those employed full-or part-time with no diabetes. Results: 63.9% of people aged 45-64 years who were out of the labour force due to diabetes were in poverty in 2010. The odds of being in poverty for those with no diabetes and employed full-time (OR of being in poverty 0.02 95% CI: 0.01-0.04) or part-time (OR of being in poverty 0.10 95% CI: 0.05-0.23) are significantly lower than those for persons not in the labour force due to diabetes. Amongst those with diabetes, those who were able to stay in either full-or part-time employment were as much as 97% less likely to be in poverty than those who had to retire early because of the condition. Sensitivity analysis was used to assess impacts of different poverty line thresholds and key socioeconomic predictors of poverty. Conclusions: This study has shown that having diabetes and not being in the labour force because of this condition significantly increases the chances of living in poverty. Intervening to prevent or delay the onset of diabetes is likely to improve their living standards.	[Schofield, Deborah J.; Cunich, Michelle; Shrestha, Rupendra N.; Callander, Emily J.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Schofield, Deborah J.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Passey, Megan E.] Univ Sydney, Sch Publ Hlth, Univ Ctr Rural Hlth North Coast, Sydney, NSW 2006, Australia; [Kelly, Simon J.; Tanton, Robert] Univ Canberra, Natl Ctr Social & Econ Modelling, Canberra, ACT 2601, Australia; [Veerman, Lennert] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of Sydney; University of Sydney; University of Sydney; University of Canberra; University of Queensland	Cunich, M (corresponding author), Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia.	michelle.cunich@ctc.usyd.edu.au	Callander, Emily/M-5679-2017; Passey, Megan/AAC-7062-2019; Kelly, Simon/X-7282-2018; Veerman, Lennert/A-9973-2011	Callander, Emily/0000-0001-7233-6804; Passey, Megan/0000-0001-5766-0235; Kelly, Simon/0000-0002-8245-0181; Veerman, Lennert/0000-0002-3206-8232; Shrestha, Rupendra/0000-0001-5455-0735; Tanton, Robert/0000-0001-6825-7353; Cunich, Michelle/0000-0002-0163-3665; Schofield, Deborah/0000-0002-1658-494X	Australian Research Council [LP100100158]; Pfizer Australia	Australian Research Council(Australian Research Council); Pfizer Australia(PfizerPfizer Australia)	The development of the microsimulation model used in this research, Health&WealthMOD2030, is funded by the Australian Research Council (under grant LP100100158), and Pfizer Australia is a partner to the grant. All authors are independent from the funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GROWING COST OBESITY, DOI DOI 10.1097/SAP.0B013-31816FCAC418434822; [Anonymous], 2011, INF PAP DIS AG CAR A; Australian Bureau of Statistics, 2005, INF PAP BAS CONF UN; Bastida E, 2002, HEALTH ECON, V11, P403, DOI 10.1002/hec.676; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Bell P., 2000, GREGWT TABLE MACROS; Colagiuri S, 2008, HEALTH AFFAIR, V27, P256, DOI 10.1377/hlthaff.27.1.256; Costello P, 2007, INT REP 2007; DeVos K, 1997, REV INCOME WEALTH, P319; Diabetes Australia, 2013, NAT DIB SERV SCHEM N; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; European Commission EUROSTAT, 2013, GLOSS RISK POV RAT; Gillies CL, 2008, BMJ-BRIT MED J, V336, P1180, DOI 10.1136/bmj.39545.585289.25; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Greenwell H, 2001, INTRO POVERY MEASURE; Gulliford MC, 2004, DIABETIC MED, V21, P45, DOI 10.1046/j.1464-5491.2003.01061.x; HAGENAARS A, 1988, J HUM RESOUR, V23, P211, DOI 10.2307/145776; Hagenaars A., 1994, POVERTY STAT LATE 19; HUSE DM, 1989, JAMA-J AM MED ASSOC, V262, P2708, DOI 10.1001/jama.262.19.2708; International Diabetes Federation, DIAB PREV; JULIUS U, 1993, DIABETES METAB, V19, P202; Karter AJ, 2000, DIABETES CARE, V23, P477, DOI 10.2337/diacare.23.4.477; Keegan M., 2009, APPSIM DYNAMIC MICRO; Kraut A, 2001, DIABETES CARE, V24, P64, DOI 10.2337/diacare.24.1.64; Lavigne JE, 2003, PHARMACOECONOMICS, V21, P1123, DOI 10.2165/00019053-200321150-00006; Lazzarini PA, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-24; Lindstrom J, 2006, FINNISH DIABTES PREV, V368; Mayfield JA, 1999, DIABETES CARE, V22, P1105, DOI 10.2337/diacare.22.7.1105; Mejer L, 2000, INCOME POVERY EUROPE; Ng YC, 2001, DIABETES CARE, V24, P257, DOI 10.2337/diacare.24.2.257; Organisation for Economic Co-operation and Development, 2008, AG SOC; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Passey M, BMC PUBLIC HLTH REV, V12, P16; Rassler S, 2002, STAT MATCHING FREQUN; Ray NF, 1998, DIABETES CARE, V21, P296; Saunders P., 1996, POVERTY INCOME DISTR; Saunders P, 2007, POVERY AUSTR SENSITI; Saunders P, 2006, ECON REC, V82, P341, DOI 10.1111/j.1475-4932.2006.00344.x; Schofield D, 2012, IMPACT DIABETES LABO; Schofield D., 2011, INT J MICROSIMULATIO, V4, P32; Schofield D.J., 2010, BR J DIABETES VASC D, V10, P300, DOI [10.1177/1474651410385864, DOI 10.1177/1474651410385864]; Schofield Deborah J, 2011, BMC Public Health, V11, P418, DOI 10.1186/1471-2458-11-418; Schofield DJ, 2008, MED J AUSTRALIA, V189, P447, DOI 10.5694/j.1326-5377.2008.tb02119.x; Sorensen J, 2013, COST DIABETES RELATE; Trigger D, 2003, 59 NATSEM; Tunceli K, 2005, DIABETES CARE, V28, P2662, DOI 10.2337/diacare.28.11.2662; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Valdmanis V, 2001, AM J PUBLIC HEALTH, V91, P129, DOI 10.2105/AJPH.91.1.129; Vijan S, 2004, HEALTH SERV RES, V39, P1653, DOI 10.1111/j.1475-6773.2004.00311.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yassin AS, 2002, J OCCUP ENVIRON MED, V44, P136, DOI 10.1097/00043764-200202000-00008	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89360	10.1371/journal.pone.0089360	http://dx.doi.org/10.1371/journal.pone.0089360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586716	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000331714700110
J	Yakubov, B; Chen, L; Belkin, AM; Zhang, S; Chelladurai, B; Zhang, ZY; Matei, D				Yakubov, Bakhtiyor; Chen, Lan; Belkin, Alexey M.; Zhang, Sheng; Chelladurai, Bhadrani; Zhang, Zhong-Yin; Matei, Daniela			Small Molecule Inhibitors Target the Tissue Transglutaminase and Fibronectin Interaction	PLOS ONE			English	Article							OVARIAN-CANCER; TGF-BETA; EXPRESSION; ELEMENT; DOMAIN; CELLS	Tissue transglutaminase (TG2) mediates protein crosslinking through generation of epsilon-(gamma-glutamyl) lysine isopeptide bonds and promotes cell adhesion through interaction with fibronectin (FN) and integrins. Cell adhesion to the peritoneal matrix regulated by TG2 facilitates ovarian cancer dissemination. Therefore, disruption of the TG2-FN complex by small molecules may inhibit cell adhesion and metastasis. A novel high throughput screening (HTS) assay based on AlphaLISA (TM) technology was developed to measure the formation of a complex between His-TG2 and the biotinylated FN fragment that binds TG2 and to discover small molecules that inhibit this protein-protein interaction. Several hits were identified from 10,000 compounds screened. The top candidates selected based on >70% inhibition of the TG2/FN complex formation were confirmed by using ELISA and bioassays measuring cell adhesion, migration, invasion, and proliferation. In conclusion, the AlphaLISA bead format assay measuring the TG2-FN interaction is robust and suitable for HTS of small molecules. One compound identified from the screen (TG53) potently inhibited ovarian cancer cell adhesion to FN, cell migration, and invasion and could be further developed as a potential inhibitor for ovarian cancer dissemination.	[Yakubov, Bakhtiyor; Chelladurai, Bhadrani; Matei, Daniela] Indiana Univ Sch Med, Indiana Univ Dept Med, Indianapolis, IN 46202 USA; [Chen, Lan; Zhang, Sheng] Indiana Univ Sch Med, Chem Genom Core Facil, Indianapolis, IN 46202 USA; [Belkin, Alexey M.] Indiana Univ Sch Med, Univ Maryland Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Zhang, Zhong-Yin; Matei, Daniela] Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Indianapolis, IN 46202 USA; [Zhang, Zhong-Yin; Matei, Daniela] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Matei, Daniela] Indiana Univ Sch Med, VA Roudebush Hosp, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Yakubov, B (corresponding author), Indiana Univ Sch Med, Indiana Univ Dept Med, Indianapolis, IN 46202 USA.	byakubov@iu.edu; dmatei@iu.edu		Matei, Daniela/0000-0003-2169-5035	American Cancer Society [RSG-118022]; US Department of Veterans Affairs; Indiana University Simon Cancer Center; American Heart Association; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); US Department of Veterans Affairs(US Department of Veterans Affairs); Indiana University Simon Cancer Center; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Cancer Society RSG-118022, US Department of Veterans Affairs, and Indiana University Simon Cancer Center Pilot Funds to DM, and the American Heart Association grant to AMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Belkin AM, 2004, BIOCHEMISTRY-US, V43, P11760, DOI 10.1021/bi049266z; Belkin AM, 2005, BLOOD; BORSI L, 1986, ANAL BIOCHEM, V155, P335, DOI 10.1016/0003-2697(86)90443-4; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Condello S, 2013, FASEB J; Falasca L, 2005, J IMMUNOL, V174, P7330, DOI 10.4049/jimmunol.174.11.7330; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Fok JY, 2006, MOL CANCER THER, V5, P1493, DOI 10.1158/1535-7163.MCT-06-0083; FOLK JE, 1966, BIOCHIM BIOPHYS ACTA, V122, P244, DOI 10.1016/0926-6593(66)90066-X; Gertz M, 2010, DRUG METAB DISPOS, V38, P1147, DOI 10.1124/dmd.110.032649; Han BG, 2010, INT J BIOL MACROMOL, V47, P190, DOI 10.1016/j.ijbiomac.2010.04.023; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Khanna M, 2011, MOL CANCER THER, V10, P626, DOI 10.1158/1535-7163.MCT-10-0912; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Muegge I, 2001, J MED CHEM, V44, P1841, DOI 10.1021/jm015507e; Pfluger M, 2013, J BIOMOL SCREEN, V18, P67, DOI 10.1177/1087057112458316; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Verma A, 2008, CLIN CANCER RES, V14, P2476, DOI 10.1158/1078-0432.CCR-07-4529; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	31	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89285	10.1371/journal.pone.0089285	http://dx.doi.org/10.1371/journal.pone.0089285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586660	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700088
J	Evans, JS; Kiesecker, JM				Evans, Jeffrey S.; Kiesecker, Joseph M.			Shale Gas, Wind and Water: Assessing the Potential Cumulative Impacts of Energy Development on Ecosystem Services within the Marcellus Play	PLOS ONE			English	Article							NATURAL-GAS; MODELS	Global demand for energy has increased by more than 50 percent in the last half-century, and a similar increase is projected by 2030. This demand will increasingly be met with alternative and unconventional energy sources. Development of these resources causes disturbances that strongly impact terrestrial and freshwater ecosystems. The Marcellus Shale gas play covers more than 160,934 km 2 in an area that provides drinking water for over 22 million people in several of the largest metropolitan areas in the United States (e. g. New York City, Washington DC, Philadelphia & Pittsburgh). Here we created probability surfaces representing development potential of wind and shale gas for portions of six states in the Central Appalachians. We used these predictions and published projections to model future energy build-out scenarios to quantify future potential impacts on surface drinking water. Our analysis predicts up to 106,004 new wells and 10,798 new wind turbines resulting up to 535,023 ha of impervious surface (3% of the study area) and upwards of 447,134 ha of impacted forest (2% of the study area). In light of this new energy future, mitigating the impacts of energy development will be one of the major challenges in the coming decades.	[Evans, Jeffrey S.; Kiesecker, Joseph M.] Nature Conservancy, Ft Collins, CO 80524 USA; [Evans, Jeffrey S.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	Nature Conservancy; University of Wyoming	Evans, JS (corresponding author), Nature Conservancy, Ft Collins, CO 80524 USA.	jeffrey_evans@tnc.org		Evans, Jeffrey/0000-0002-5533-7044	Robertson Foundation	Robertson Foundation	Funding was provided by The Robertson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, GEOGRAPHICAL ENV MOD; [Anonymous], ANN EN OUTL 2013; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x; Barnes M, 2009, NAFR0108 USDA FOR SE; BIRNBAUM ZW, 1951, ANN MATH STAT, V22, P592, DOI 10.1214/aoms/1177729550; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown TC, 2008, J AM WATER RESOUR AS, V44, P1474, DOI 10.1111/j.1752-1688.2008.00252.x; Canter L., 2010, PROJ APPR, V28, P261, DOI [10.3152/146155110X12838715793200, DOI 10.3152/146155110X12838715793200]; Center for Watershed Protection, 2003, IMP IMP COV AQ SYST; Chow J, 2003, SCIENCE, V302, P1528, DOI 10.1126/science.1091939; Considine TJ, 2011, PENNSYLVANIA MARCELL; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Cressie N, 1991, STAT SPATIAL DATA; Cuffney TF, 2010, ECOL APPL, V20, P1384, DOI 10.1890/08-1311.1; Diggle P., 2003, STAT ANAL SPATIAL PO; Dudley N., 2003, RUNNING PURE IMPORTA; Duinker PN, 2007, ENVIRON IMPACT ASSES, V27, P206, DOI 10.1016/j.eiar.2006.11.001; Entrekin S, 2011, FRONT ECOL ENVIRON, V9, P503, DOI 10.1890/110053; Erturk M, 2011, RENEW SUST ENERG REV, V15, P2766, DOI 10.1016/j.rser.2011.03.028; Evans JS, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P139, DOI 10.1007/978-1-4419-7390-0_8; Evans JS, 2008, LANDSCAPE ECOLOGY, V5, P673; Evans JS, ARCGIS TOOLBOX UNPUB; Fargione J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041468; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; International Energy Agency, 2009, WORLD EN OUTL; Johnson N, 2010, 1 NAT CONS; Johnson N, 2011, 2 NAT CONS; Kaushal SS, 2005, P NATL ACAD SCI USA, V102, P13517, DOI 10.1073/pnas.0506414102; Kerr RA, 2010, SCIENCE, V328, P1624, DOI 10.1126/science.328.5986.1624; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; King RS, 2010, J N AM BENTHOL SOC, V29, P998, DOI 10.1899/09-144.1; McDaniel CN, 2002, BIOSCIENCE, V52, P929, DOI 10.1641/0006-3568(2002)052[0929:IHEUCB]2.0.CO;2; McDonald RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006802; Mooney C, 2011, SCI AM, V305, P80, DOI 10.1038/scientificamerican1111-80; Murphy MA, 2010, ECOLOGY, V91, P252, DOI 10.1890/08-0879.1; Naugle D, 2010, ENERGY DEV WILDLIFE; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Obermeyer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026698; Olmstead SM, 2013, P NATL ACAD SCI USA, V110, P4962, DOI 10.1073/pnas.1213871110; PHILLIPS JD, 1993, NATL GEOPHYS DATA GR; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pocewicz A, 2008, LANDSCAPE ECOL, V23, P195, DOI 10.1007/s10980-007-9159-6; Pontius GR, 2005, INT J GEOGR INF SCI, V19, P243, DOI 10.1080/13658810410001713434; Repetski JE, 2008, THERMAL MATURITY PAT; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Rozell DJ, 2012, RISK ANAL, V32, P1382, DOI 10.1111/j.1539-6924.2011.01757.x; Schueler T.R., 1994, IMPORTANCE IMPERVIOU, V1, P100; Schueler TR, 2009, J HYDROL ENG, V14, P309, DOI 10.1061/(ASCE)1084-0699(2009)14:4(309); Short W., 2008, DOEGO1020082567; U.S. Department of Energy, 2010, DOENETL402033110; U.S. Department of Energy, 2011, E WIND INT TRANSM ST; U.S. Environmental Protection Agency (EPA), 2009, SAF DRINK WAT INF SY; US Geological Survey, 2012, PROT AR DAT US PADUS; Ventyx Corporation, 2013, VEL SUIT EV EN MAP D; Vidic RD, 2013, SCIENCE, V340, DOI 10.1126/science.1235009; Warton DI, 2010, ANN APPL STAT, V4, P1383, DOI 10.1214/10-AOAS331; Wood R., 2011, Shale gas: a provisional assessment of climate change and environmental impacts; Yang LM, 2003, CAN J REMOTE SENS, V29, P230, DOI 10.5589/m02-098	62	54	55	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89210	10.1371/journal.pone.0089210	http://dx.doi.org/10.1371/journal.pone.0089210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586599	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900106
J	Gimbel, SI; Brewer, JB				Gimbel, Sarah I.; Brewer, James B.			Elaboration versus Suppression of Cued Memories: Influence of Memory Recall Instruction and Success on Parietal Lobe, Default Network, and Hippocampal Activity	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; RECOGNITION MEMORY; BRAIN-FUNCTION; CORTEX; RETRIEVAL; MODE; RECOLLECTION; FAMILIARITY; DISSOCIATION; COMPONENT	Functional imaging studies of episodic memory retrieval consistently report task-evoked and memory-related activity in the medial temporal lobe, default network and parietal lobe subregions. Associated components of memory retrieval, such as attention-shifts, search, retrieval success, and post-retrieval processing also influence regional activity, but these influences remain ill-defined. To better understand how top-down control affects the neural bases of memory retrieval, we examined how regional activity responses were modulated by task goals during recall success or failure. Specifically, activity was examined during memory suppression, recall, and elaborative recall of paired-associates. Parietal lobe was subdivided into dorsal (BA 7), posterior ventral (BA 39), and anterior ventral (BA 40) regions, which were investigated separately to examine hypothesized distinctions in sub-regional functional responses related to differential attention-to-memory and memory strength. Top-down suppression of recall abolished memory strength effects in BA 39, which showed a task-negative response, and BA 40, which showed a task-positive response. The task-negative response in default network showed greater negatively-deflected signal for forgotten pairs when task goals required recall. Hippocampal activity was task-positive and was influenced by memory strength only when task goals required recall. As in previous studies, we show a memory strength effect in parietal lobe and hippocampus, but we show that this effect is top-down controlled and sensitive to whether the subject is trying to suppress or retrieve a memory. These regions are all implicated in memory recall, but their individual activity patterns show distinct memory-strength-related responses when task goals are varied. In parietal lobe, default network, and hippocampus, top-down control can override the commonly identified effects of memory strength.	[Gimbel, Sarah I.; Brewer, James B.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Brewer, James B.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Brewer, JB (corresponding author), Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA.	jbrewer@ucsd.edu			NINDS [K02NS067427]; General Electric Medical Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS067427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); General Electric Medical Foundation(General Electric); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NINDS K02NS067427 and the General Electric Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ally BA, 2008, NEUROPSYCHOLOGIA, V46, P1800, DOI 10.1016/j.neuropsychologia.2008.02.026; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Brewer JB, 2002, TRENDS COGN SCI, V6, P217, DOI 10.1016/S1364-6613(02)01881-8; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Cabeza R, 2008, NEUROPSYCHOLOGIA, V46, P1813, DOI 10.1016/j.neuropsychologia.2008.03.019; Cabeza R, 2012, TRENDS COGN SCI, V16, P338, DOI 10.1016/j.tics.2012.04.008; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Ciaramelli E, 2008, NEUROPSYCHOLOGIA, V46, P1828, DOI 10.1016/j.neuropsychologia.2008.03.022; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Daselaar SM, 2006, CEREB CORTEX, V16, P1771, DOI 10.1093/cercor/bhj112; Daselaar SM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.013.2009; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Fleck MS, 2006, CEREB CORTEX, V16, P1623, DOI 10.1093/cercor/bhj097; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Gimbel SI, 2011, COGN NEUROSCI-UK, V2, P19, DOI 10.1080/17588928.2010.513770; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Henson RNA, 1999, J NEUROSCI, V19, P3962; Herron JE, 2004, NEUROIMAGE, V22, P1554, DOI 10.1016/j.neuroimage.2004.04.011; Huijbers W, 2013, J COGNITIVE NEUROSCI, V25, P1163, DOI 10.1162/jocn_a_00366; Hutchinson JB, 2014, CEREB CORTEX, V24, P49, DOI 10.1093/cercor/bhs278; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Israel SL, 2010, J COGNITIVE NEUROSCI, V22, P513, DOI 10.1162/jocn.2009.21198; Jaeger A, 2013, NEUROPSYCHOLOGIA, V51, P1061, DOI 10.1016/j.neuropsychologia.2013.02.018; Kim H, 2009, BRAIN RES, V1282, P103, DOI 10.1016/j.brainres.2009.05.080; Kirwan CB, 2007, HUM BRAIN MAPP, V28, P959, DOI 10.1002/hbm.20331; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Miller MI, 2005, P NATL ACAD SCI USA, V102, P9685, DOI 10.1073/pnas.0503892102; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; O'Connor AR, 2010, J NEUROSCI, V30, P2924, DOI 10.1523/JNEUROSCI.4225-09.2010; Okada K, 2012, HUM BRAIN MAPP, V33, P523, DOI 10.1002/hbm.21229; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reas ET, 2013, J COGNITIVE NEUROSCI, V25, P219, DOI 10.1162/jocn_a_00335; Reas ET, 2011, FRONT HUM NEUROSCI, V5, P1; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Seibert TM, 2011, NEUROIMAGE, V55, P788, DOI 10.1016/j.neuroimage.2010.11.078; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Squire LR, 2009, J NEUROSCI, V29, P12711, DOI 10.1523/JNEUROSCI.3575-09.2009; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Suzuki WA, 2003, J COMP NEUROL, V463, P67, DOI 10.1002/cne.10744; Talairach J., 1988, COPLANAR STEREOTAXIC; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Vilberg KL, 2009, NEUROREPORT, V20, P1295, DOI 10.1097/WNR.0b013e3283306798; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001	51	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89037	10.1371/journal.pone.0089037	http://dx.doi.org/10.1371/journal.pone.0089037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586492	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900076
J	Kumari, B; Kumar, R; Kumar, M				Kumari, Bandana; Kumar, Ravindra; Kumar, Manish			PalmPred: An SVM Based Palmitoylation Prediction Method Using Sequence Profile Information	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; PROTEIN SUBCELLULAR LOCATION; SUPPORT VECTOR MACHINE; STRUCTURAL CLASS; LIPID RAFTS; CSS-PALM; SITES; IDENTIFICATION; INSIGHTS	Protein palmitoylation is the covalent attachment of the 16-carbon fatty acid palmitate to a cysteine residue. It is the most common acylation of protein and occurs only in eukaryotes. Palmitoylation plays an important role in the regulation of protein subcellular localization, stability, translocation to lipid rafts and many other protein functions. Hence, the accurate prediction of palmitoylation site(s) can help in understanding the molecular mechanism of palmitoylation and also in designing various related experiments. Here we present a novel in silico predictor called 'PalmPred' to identify palmitoylation sites from protein sequence information using a support vector machine model. The best performance of PalmPred was obtained by incorporating sequence conservation features of peptide of window size 11 using a leave-one-out approach. It helped in achieving an accuracy of 91.98%, sensitivity of 79.23%, specificity of 94.30%, and Matthews Correlation Coefficient of 0.71. PalmPred outperformed existing palmitoylation site prediction methods - IFS-Palm and WAP-Palm on an independent dataset. Based on these measures it can be anticipated that PalmPred will be helpful in identifying candidate palmitoylation sites. All the source datasets, standalone and web-server are available at http://14.139.227.92/mkumar/palmpred/.	[Kumari, Bandana; Kumar, Ravindra; Kumar, Manish] Univ Delhi, Dept Biophys, New Delhi, India	University of Delhi	Kumar, M (corresponding author), Univ Delhi, Dept Biophys, South Campus, New Delhi, India.	manish@south.du.ac.in	Kumar, Manish/AGP-1250-2022; Kumar, Ravindra/F-2211-2017	Kumar, Manish/0000-0002-7936-9892; Kumar, Ravindra/0000-0002-0121-8402	University Grant Commission non-NET fellowship [Non-Net/139/2012]; University Grant Commission of India [20-12/2009(ii) EU-IV]	University Grant Commission non-NET fellowship; University Grant Commission of India	Bandana Kumari is supported by a University Grant Commission non-NET fellowship (Non-Net/139/2012) and Ravindra Kumar by a Senior Research fellowship (20-12/2009(ii) EU-IV) from the University Grant Commission of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANANT JS, 1992, J BIOL CHEM, V267, P687; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Cai YD, 2006, J THEOR BIOL, V238, P395, DOI 10.1016/j.jtbi.2005.05.035; Chou KC, 2004, BIOCHEM BIOPH RES CO, V321, P1007, DOI 10.1016/j.bbrc.2004.07.059; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Gao J, 2011, BIOCOMPUTING, V2012, P94; Gao Y, 2005, AMINO ACIDS, V28, P373, DOI 10.1007/s00726-005-0206-9; Hu LL, 2011, BIOCHIMIE, V93, P489, DOI 10.1016/j.biochi.2010.10.022; Hua SJ, 2001, J MOL BIOL, V308, P397, DOI 10.1006/jmbi.2001.4580; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jiang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065756; Joachims T., 1999, ADV KERNEL METHODS S; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Kumar M, 2006, J BIOL CHEM, V281, P5357, DOI 10.1074/jbc.M511061200; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Nishimura A, 2013, MOL CELL BIOL, V33, P1417, DOI 10.1128/MCB.01398-12; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oku S, 2013, J BIOL CHEM, V288, P19816, DOI 10.1074/jbc.M112.431676; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Shi SP, 2013, J MOL GRAPH MODEL, V40, P125, DOI 10.1016/j.jmgm.2012.12.006; Van Itallie CM, 2005, J CELL SCI, V118, P1427, DOI 10.1242/jcs.01735; Vapnik VN, 1995, NATURE STATICAL LEAR; Wang DA, 2005, J BIOL CHEM, V280, P19243, DOI 10.1074/jbc.M411472200; Wang XB, 2009, PROTEIN ENG DES SEL, V22, P707, DOI 10.1093/protein/gzp055; Witten I. H., 2005, DATA MINING PRACTICA; Wong W, 2004, J BIOL CHEM, V279, P444, DOI 10.1074/jbc.M304675200; Xie JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074506; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-458; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 2001, PROTEINS, V44, P57, DOI 10.1002/prot.1071	53	45	47	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89246	10.1371/journal.pone.0089246	http://dx.doi.org/10.1371/journal.pone.0089246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586628	Green Submitted, gold, Green Published			2022-12-27	WOS:000331711900114
J	Roan, E; Waters, CM; Teng, B; Ghosh, M; Schwingshackl, A				Roan, Esra; Waters, Christopher M.; Teng, Bin; Ghosh, Manik; Schwingshackl, Andreas			The 2-Pore Domain Potassium Channel TREK-1 Regulates Stretch-Induced Detachment of Alveolar Epithelial Cells	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; ATOMIC-FORCE MICROSCOPY; FOCAL ADHESION KINASE; MECHANISMS; SECRETION; HYPEROXIA; JUNCTIONS; PATHWAYS; OUTCOMES	Acute Respiratory Distress Syndrome remains challenging partially because the underlying mechanisms are poorly understood. While inflammation and loss of barrier function are associated with disease progression, our understanding of the biophysical mechanisms associated with ventilator-associated lung injury is incomplete. In this line of thinking, we recently showed that changes in the F-actin content and deformability of AECs lead to cell detachment with mechanical stretch. Elsewhere, we discovered that cytokine secretion and proliferation were regulated in part by the stretch-activated 2-pore domain K+ (K2P) channel TREK-1 in alveolar epithelial cells (AECs). As such, the aim of the current study was to determine whether TREK-1 regulated the mechanobiology of AECs through cytoskeletal remodeling and cell detachment. Using a TREK-1-deficient human AEC line (A549), we examined the cytoskeleton by confocal microscopy and quantified differences in the F-actin content. We used nano-indentation with an atomic force microscope to measure the deformability of cells and detachment assays to quantify the level of injury in our monolayers. We found a decrease in F-actin and an increase in deformability in TREK-1 deficient cells compared to control cells. Although total vinculin and focal adhesion kinase (FAK) levels remained unchanged, focal adhesions appeared to be less prominent and phosphorylation of FAK at the Tyr(925) residue was greater in TREK-1 deficient cells. TREK-1 deficient cells have less F-actin and are more deformable making them more resistant to stretch-induced injury.	[Roan, Esra] Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA; [Waters, Christopher M.; Teng, Bin; Ghosh, Manik; Schwingshackl, Andreas] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Schwingshackl, Andreas] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Waters, Christopher M.; Schwingshackl, Andreas] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA	University of Memphis; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Roan, E (corresponding author), Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA.	eroan@memphis.edu	Waters, Christopher/V-2759-2019		Le Bonheur Children's Foundation Research Center Grant [65-0308]; National Institutes of Health [HL094366]; PCCSDP [1K08HL118118-01A1]; American Lung Association [13-0323]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094366, K08HL118118] Funding Source: NIH RePORTER	Le Bonheur Children's Foundation Research Center Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PCCSDP; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the Le Bonheur Children's Foundation Research Center Grant 65-0308 (AS), the National Institutes of Health Grant HL094366 (CMW), the PCCSDP Grant 1K08HL118118-01A1 (AS), and the American Lung Association Grant 13-0323 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Cavalcante FSA, 2005, J APPL PHYSIOL, V98, P672, DOI 10.1152/japplphysiol.00619.2004; Cornejo RA, 2013, AM J RESP CRIT CARE, V188, P440, DOI 10.1164/rccm.201207-1279OC; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; Davidovich N, 2013, AM J RESP CELL MOL B; Davis KA, 2006, PFLUG ARCH EUR J PHY, V451, P631, DOI 10.1007/s00424-005-1505-4; Delong P, 2006, SEMIN DIALYSIS, V19, P517, DOI 10.1111/j.1525-139X.2006.00215.x; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; Dushianthan A, 2011, POSTGRAD MED J, V87, P612, DOI 10.1136/pgmj.2011.118398; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fredberg JJ, 2006, ANNU REV PHYSIOL, V68, P507, DOI 10.1146/annurev.physiol.68.072304.114110; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Goel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023070; Hraiech S, 2012, CURR OPIN CRIT CARE, V18, P495, DOI 10.1097/MCC.0b013e328357efe1; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Jacob AM, 2012, J APPL PHYSIOL, V113, P1377, DOI 10.1152/japplphysiol.01432.2011; Katz BZ, 2003, J BIOL CHEM, V278, P29115, DOI 10.1074/jbc.M212396200; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lin DC, 2007, J BIOMECH ENG-T ASME, V129, P430, DOI 10.1115/1.2720924; Luque T, 2013, ACTA BIOMATER, V9, P6852, DOI 10.1016/j.actbio.2013.02.044; Makena PS, 2010, AM J PHYSL LUNG CELL; Marinkovic A, 2013, AM J RESP CELL MOL, V48, P422, DOI 10.1165/rcmb.2012-0335OC; Matthay MA, 2002, AM J PHYSIOL-LUNG C, V283, pL678, DOI 10.1152/ajplung.00154.2002; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nagato AC, 2012, INT J EXP PATHOL, V93, P269, DOI 10.1111/j.1365-2613.2012.00823.x; Oeckler RA, 2007, CRIT CARE, V11, DOI 10.1186/cc6160; Radmacher M, 1997, IEEE ENG MED BIOL, V16, P47, DOI 10.1109/51.582176; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Roan E, 2011, AM J PHYSIOL-LUNG C, P301; Roan E, 2012, AM J PHYSIOL-LUNG C, V302, pL1235, DOI 10.1152/ajplung.00223.2011; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schwingshackl A., 2012, AM J PHYSL LUNG CELL; Schwingshackl A, 2013, AM J PHYSIOL-LUNG C, V304, pL276, DOI 10.1152/ajplung.00299.2012; Schwingshackl A, 2012, AM J PHYSIOL-LUNG C, V302, pL93, DOI 10.1152/ajplung.00078.2011; Wagh AA, 2008, AM J PHYSIOL-LUNG C, V295, pL54, DOI 10.1152/ajplung.00475.2007; Wilhelm KR, 2013, FEBS J; Yalcin HC, 2009, AM J PHYSIOL-LUNG C, V297, pL881, DOI 10.1152/ajplung.90562.2008; Zimmerman JJ, 2009, PEDIATRICS, V124, P87, DOI 10.1542/peds.2007-2462	41	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89429	10.1371/journal.pone.0089429	http://dx.doi.org/10.1371/journal.pone.0089429			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586773	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900142
J	Waman, VP; Kolekar, PS; Kale, MM; Kulkarni-Kale, U				Waman, Vaishali P.; Kolekar, Pandurang S.; Kale, Mohan M.; Kulkarni-Kale, Urmila			Population Structure and Evolution of Rhinoviruses	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; GENETIC-STRUCTURE; PHYLOGENETIC ANALYSIS; MOSAIC STRUCTURE; SPECIES C; RECOMBINATION; RECEPTOR; VIRUS; INFECTIONS; DIVERSITY	Rhinoviruses, formerly known as Human rhinoviruses, are the most common cause of air-borne upper respiratory tract infections in humans. Rhinoviruses belong to the family Picornaviridae and are divided into three species namely, Rhinovirus A, -B and -C, which are antigenically diverse. Genetic recombination is found to be one of the important causes for diversification of Rhinovirus species. Although emerging lineages within Rhinoviruses have been reported, their population structure has not been studied yet. The availability of complete genome sequences facilitates study of population structure, genetic diversity and underlying evolutionary forces, such as mutation, recombination and selection pressure. Analysis of complete genomes of Rhinoviruses using a model-based population genetics approach provided a strong evidence for existence of seven genetically distinct subpopulations. As a result of diversification, Rhinovirus A and -C populations are divided into four and two subpopulations, respectively. Genetically, the Rhinovirus B population was found to be homogeneous. Intra-species recombination was observed to be prominent in Rhinovirus A and -C species. Significant evidence of episodic positive selection was obtained for several sites within coding sequences of structural and nonstructural proteins. This corroborates well with known phenotypic properties such as antigenicity of structural proteins. Episodic positive selection appears to be responsible for emergence of new lineages especially in Rhinovirus A. In summary, the Rhinovirus population is an ensemble of seven distinct lineages. In case of Rhinovirus A, intra-species recombination and episodic positive selection contribute to its further diversification. In case of Rhinovirus C, intra- and inter-species recombinations are responsible for observed diversity. Population genetics approach was further useful to analyze phylogenetic tree topologies pertaining to recombinant strains, especially when trees are derived using complete genomes. Understanding of population structure serves as a foundation for designing new vaccines and drugs as well as to explain emergence of drug resistance amongst subpopulations.	[Waman, Vaishali P.; Kolekar, Pandurang S.; Kulkarni-Kale, Urmila] Univ Pune, Bioinformat Ctr, Pune, Maharashtra, India; [Kale, Mohan M.] Univ Pune, Dept Stat, Pune, Maharashtra, India	Savitribai Phule Pune University; Savitribai Phule Pune University	Kulkarni-Kale, U (corresponding author), Univ Pune, Bioinformat Ctr, Pune, Maharashtra, India.	urmila@bioinfo.net.in	Kulkarni-Kale, Urmila/G-6946-2011; Kolekar, Pandurang/ABF-7389-2020	Kolekar, Pandurang/0000-0003-0044-0076	Center of Excellence (CoE) grant from the Department of Information Technology (DeitY); Ministry of Communications & Information Technology (MCIT); Government of India, New Delhi; Department of Biotechnology (DBT), Government of India, New Delhi	Center of Excellence (CoE) grant from the Department of Information Technology (DeitY); Ministry of Communications & Information Technology (MCIT); Government of India, New Delhi; Department of Biotechnology (DBT), Government of India, New Delhi(Department of Biotechnology (DBT) India)	This work is supported by Center of Excellence (CoE) grant from the Department of Information Technology (DeitY), Ministry of Communications & Information Technology (MCIT), Government of India, New Delhi. UKK acknowledges DeitY, MCIT for financial assistance. VPW acknowledges the fellowship awarded by Department of Biotechnology (DBT), Government of India, New Delhi. PSK acknowledges the BioInformatics National Certification (BINC) fellowship awarded by DBT, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABZUG MJ, 1990, PEDIATR INFECT DIS J, V9, P881, DOI 10.1097/00006454-199012000-00005; [Anonymous], 1967, NATURE, V213, P761, DOI 10.1038/213761a0; APPLEYARD G, 1990, J GEN VIROL, V71, P1275, DOI 10.1099/0022-1317-71-6-1275; Baranowski E, 2001, SCIENCE, V292, P1102, DOI 10.1126/science.1058613; Basta HA, 2014, VIROLOGY, V448, P176, DOI 10.1016/j.virol.2013.10.006; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertino JS, 2002, AM J MED, V112, p42S; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Collinson J, 1996, THORAX, V51, P1115, DOI 10.1136/thx.51.11.1115; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Fischer W, 2012, J VIROL, V86, P13217, DOI 10.1128/JVI.01862-12; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I; HAMPARIAN VV, 1987, VIROLOGY, V159, P191; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hewat EA, 2000, EMBO J, V19, P6317, DOI 10.1093/emboj/19.23.6317; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; Khetsuriani N, 2008, EMERG INFECT DIS, V14, P1793, DOI 10.3201/eid1411.080386; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Laine P, 2005, J GEN VIROL, V86, P697, DOI 10.1099/vir.0.80445-0; Lauber C, 2012, J VIROL, V86, P3905, DOI 10.1128/JVI.07174-11; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lewis-Rogers N, 2009, MOL BIOL EVOL, V26, P969, DOI 10.1093/molbev/msp009; Li HF, 2009, J GENET, V88, P197, DOI 10.1007/s12041-009-0028-8; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Love RA, 2004, STRUCTURE, V12, P1533, DOI 10.1016/j.str.2004.05.024; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McIntyre CL, 2013, ARCH VIROL, V158, P1497, DOI 10.1007/s00705-013-1634-6; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; Miller EK, 2009, J CLIN VIROL, V46, P85, DOI 10.1016/j.jcv.2009.06.007; MORI J, 1994, J MED VIROL, V44, P323, DOI 10.1002/jmv.1890440403; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Petersen JFW, 1999, EMBO J, V18, P5463, DOI 10.1093/emboj/18.20.5463; PEVEAR DC, 1989, J VIROL, V63, P2002, DOI 10.1128/JVI.63.5.2002-2007.1989; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SLK, 2005, STAT BIOL HEALTH, P125, DOI 10.1007/0-387-27733-1_6; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Prasanna HC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-220; Pritchard JK, 2000, GENETICS, V155, P945; Privman E, 2012, MOL BIOL EVOL, V29, P1, DOI 10.1093/molbev/msr177; Rathe JA, 2010, ARCH VIROL, V155, P83, DOI 10.1007/s00705-009-0549-8; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Savolainen C, 2004, J GEN VIROL, V85, P2271, DOI 10.1099/vir.0.79897-0; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Schibler M, 2012, J GEN VIROL, V93, P93, DOI 10.1099/vir.0.035808-0; Seemungal TAR, 2000, EUR RESPIR J, V16, P677, DOI 10.1034/j.1399-3003.2000.16d19.x; SHERRY B, 1986, J VIROL, V57, P246, DOI 10.1128/JVI.57.1.246-257.1986; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0; SMITH JM, 1992, J MOL EVOL, V34, P126; STOTT EJ, 1968, J MED MICROBIOL, V1, P109, DOI 10.1099/00222615-1-1-109; Subramaniam S, 2013, INFECT GENET EVOL, V18, P1, DOI 10.1016/j.meegid.2013.04.027; Szmaragd C, 2007, MOL ECOL, V16, P4747, DOI 10.1111/j.1365-294X.2007.03564.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051439; Tapparel C, 2009, EMERG INFECT DIS, V15, P719, DOI 10.3201/eid1505.081286; UNCAPHER CR, 1991, VIROLOGY, V180, P814, DOI 10.1016/0042-6822(91)90098-V; Wisdom A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008518	81	24	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88981	10.1371/journal.pone.0088981	http://dx.doi.org/10.1371/journal.pone.0088981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586469	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900067
J	Yin, GY; Sheu, TJ; Menon, P; Pang, JJ; Ho, HC; Shi, SS; Xie, C; Smolock, E; Yan, C; Zuscik, MJ; Berk, BC				Yin, Guoyong; Sheu, Tzong-Jen; Menon, Prashanthi; Pang, Jinjiang; Ho, Hsin-Chiu; Shi, Shanshan; Xie, Chao; Smolock, Elaine; Yan, Chen; Zuscik, Michael J.; Berk, Bradford C.			Impaired Angiogenesis during Fracture Healing in GPCR Kinase 2 Interacting Protein-1 (GIT1) Knock Out Mice	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; QUALITY-OF-LIFE; ANGIOTENSIN-II; DISTRACTION OSTEOGENESIS; POSTMENOPAUSAL WOMEN; BONE-FORMATION; REPAIR; CELL; VEGF; OSTEOBLASTS	G protein coupled receptor kinase 2 (GRK2) interacting protein-1 (GIT1), is a scaffold protein that plays an important role in angiogenesis and osteoclast activity. We have previously demonstrated that GIT1 knockout (GIT1 KO) mice have impaired angiogenesis and dysregulated osteoclast podosome formation leading to a reduction in the bone resorbing ability of these cells. Since both angiogenesis and osteoclast-mediated bone remodeling are involved in the fracture healing process, we hypothesized that GIT1 participates in the normal progression of repair following bone injury. In the present study, comparison of fracture healing in wild type (WT) and GIT1 KO mice revealed altered healing in mice with loss of GIT1 function. Alcian blue staining of fracture callus indicated a persistence of cartilagenous matrix in day 21 callus samples from GIT1 KO mice which was temporally correlated with increased type 2 collagen immunostaining. GIT1 KO mice also showed a decrease in chondrocyte proliferation and apoptosis at days 7 and 14, as determined by PCNA and TUNEL staining. Vascular microcomputed tomography analysis of callus samples at days 7, 14 and 21 revealed decreased blood vessel volume, number, and connection density in GIT1 KO mice compared to WT controls. Correlating with this, VEGF-A, phospho-VEGFR2 and PECAM1 (CD31) were decreased in GIT1 KO mice, indicating reduced angiogenesis with loss of GIT1. Finally, calluses from GIT1 KO mice displayed a reduced number of tartrate resistant acid phosphatase-positive osteoclasts at days 14 and 21. Collectively, these results indicate that GIT1 is an important signaling participant in fracture healing, with gene ablation leading to reduced callus vascularity and reduced osteoclast number in the healing callus.	[Yin, Guoyong; Menon, Prashanthi; Pang, Jinjiang; Smolock, Elaine; Yan, Chen; Berk, Bradford C.] Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Yin, Guoyong; Menon, Prashanthi; Pang, Jinjiang; Smolock, Elaine; Yan, Chen; Berk, Bradford C.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Sheu, Tzong-Jen; Ho, Hsin-Chiu; Shi, Shanshan; Xie, Chao; Zuscik, Michael J.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Sheu, Tzong-Jen; Ho, Hsin-Chiu; Shi, Shanshan; Xie, Chao; Zuscik, Michael J.] Univ Rochester, Med Ctr, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA; [Yin, Guoyong] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthopaed, Nanjing, Jiangsu, Peoples R China	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Nanjing Medical University	Berk, BC (corresponding author), Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA.	brad_berk@urmc.rochester.edu		Berk, Bradford/0000-0002-2767-4115; Zuscik, Michael/0000-0003-0461-8708; Yan, Chen/0000-0002-1397-6358	NIH/NHLBI [R01 HL063462]; National Natural Science Foundation of China [81271988]; NIH/NIAMS [P50 AR054041-5471, P30 AR061307]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061307, P50AR054041] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH/NHLBI R01 HL063462 (to BCB), National Natural Science Foundation of China Grant #81271988 (to GY), NIH/NIAMS P50 AR054041-5471 (to MJZ) and NIH/NIAMS P30 AR061307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Alarcon T, 2011, OSTEOPOROSIS INT, V22, P1609, DOI 10.1007/s00198-010-1314-2; Arasapam G, 2006, J CELL BIOCHEM, V99, P450, DOI 10.1002/jcb.20905; Athanasopoulos AN, 2007, J BIOL CHEM, V282, P26746, DOI 10.1074/jbc.M705200200; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brenneman SK, 2006, J BONE MINER RES, V21, P809, DOI 10.1359/JBMR.060301; Dhillon RS, 2013, J BONE MINER RES, V28, P586, DOI 10.1002/jbmr.1765; Ding R, 2006, J PEDIATR ORTHOPED, V26, P157, DOI 10.1097/01.bpo.0000218521.98244.7e; Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003; Eckardt H, 2003, J ORTHOP RES, V21, P335, DOI 10.1016/S0736-0266(02)00159-6; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gerstenfeld LC, 2009, J BONE MINER RES, V24, P196, DOI 10.1359/JBMR.081113; Giannoudis PV, 2009, INJURY, V40, P213, DOI 10.1016/j.injury.2008.05.024; Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Konishi H, 2010, VASC MED, V15, P47, DOI 10.1177/1358863X09106326; Li G, 2002, J BONE MINER RES, V17, P791, DOI 10.1359/jbmr.2002.17.5.791; Lonnroos E, 2009, OSTEOPOROSIS INT, V20, P879, DOI 10.1007/s00198-008-0752-6; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Menon P, 2010, J CELL PHYSIOL, V225, P777, DOI 10.1002/jcp.22282; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Naik AA, 2009, J BONE MINER RES, V24, P251, DOI 10.1359/JBMR.081002; Natarajan K, 2004, MOL PHARMACOL, V65, P822, DOI 10.1124/mol.65.4.822; Olerud P, 2010, J SHOULDER ELB SURG, V19, P814, DOI 10.1016/j.jse.2009.11.046; Pang JJ, 2009, CIRCULATION, V119, P1524, DOI 10.1161/CIRCULATIONAHA.108.823997; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Pufe T, 2002, CELL TISSUE RES, V309, P387, DOI 10.1007/s00441-002-0605-0; Rui Z, 2012, INT J MOL MED, V30, P819, DOI 10.3892/ijmm.2012.1058; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Silverman SL, 2007, J RHEUMATOL, V34, P140; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Thompson Z, 2002, J ORTHOPAED RES, V20, P1091, DOI 10.1016/S0736-0266(02)00017-7; Wang J, 2009, ARTERIOSCL THROM VAS, V29, P202, DOI 10.1161/ATVBAHA.108.174391; Xie C, 2009, AM J PATHOL, V175, P772, DOI 10.2353/ajpath.2009.081099; Yin GY, 2004, MOL CELL BIOL, V24, P875, DOI 10.1128/MCB.24.2.875-885.2004; Zhang X., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P360; Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zuscik MJ, 2009, PRIMER METABOLIC BON, P61	47	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89127	10.1371/journal.pone.0089127	http://dx.doi.org/10.1371/journal.pone.0089127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586541	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900092
J	Messenger, AM; Barnes, AN; Gray, GC				Messenger, Ali M.; Barnes, Amber N.; Gray, Gregory C.			Reverse Zoonotic Disease Transmission (Zooanthroponosis): A Systematic Review of Seldom-Documented Human Biological Threats to Animals	PLOS ONE			English	Review							RESISTANT STAPHYLOCOCCUS-AUREUS; PANDEMIC H1N1 INFLUENZA; IMPENETRABLE NATIONAL-PARK; GORILLA-GORILLA-BERINGEI; CROSS-SPECIES INFECTION; MOLECULAR CHARACTERIZATION; GIARDIA-DUODENALIS; MOUNTAIN GORILLAS; GASTROINTESTINAL PARASITES; PHYLOGENETIC ANALYSIS	Background: Research regarding zoonotic diseases often focuses on infectious diseases animals have given to humans. However, an increasing number of reports indicate that humans are transmitting pathogens to animals. Recent examples include methicillin-resistant Staphylococcus aureus, influenza A virus, Cryptosporidium parvum, and Ascaris lumbricoides. The aim of this review was to provide an overview of published literature regarding reverse zoonoses and highlight the need for future work in this area. Methods: An initial broad literature review yielded 4763 titles, of which 4704 were excluded as not meeting inclusion criteria. After careful screening, 56 articles (from 56 countries over three decades) with documented human-to-animal disease transmission were included in this report. Findings: In these publications, 21 (38%) pathogens studied were bacterial, 16 (29%) were viral, 12 (21%) were parasitic, and 7 (13%) were fungal, other, or involved multiple pathogens. Effected animals included wildlife (n = 28, 50%), livestock (n = 24, 43%), companion animals (n = 13, 23%), and various other animals or animals not explicitly mentioned (n = 2, 4%). Published reports of reverse zoonoses transmission occurred in every continent except Antarctica therefore indicating a worldwide disease threat. Interpretation: As we see a global increase in industrial animal production, the rapid movement of humans and animals, and the habitats of humans and wild animals intertwining with great complexity, the future promises more opportunities for humans to cause reverse zoonoses. Scientific research must be conducted in this area to provide a richer understanding of emerging and reemerging disease threats. As a result, multidisciplinary approaches such as One Health will be needed to mitigate these problems.	[Messenger, Ali M.; Barnes, Amber N.; Gray, Gregory C.] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Messenger, Ali M.; Gray, Gregory C.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gray, GC (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.	gcgray@phhp.ufl.edu	Gray, Gregory C./ABF-1298-2020; Barnes, Amber/AAC-5251-2022	Gray, Gregory/0000-0002-4628-5908; Barnes, Amber/0000-0001-6284-3634	US Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance Operations; National Institute of Allergy and Infectious Diseases [R01 AI068803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068803] Funding Source: NIH RePORTER	US Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance Operations; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US Armed Forces Health Surveillance Center - Global Emerging Infections Surveillance Operations (multiple grants to GCG) and a supplement from the National Institute of Allergy and Infectious Diseases (R01 AI068803 to GCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2010, VET MICROBIOL, V146, P253, DOI 10.1016/j.vetmic.2010.05.019; Adejinmi O. J., 2008, Veterinary Research (Pakistan), V2, P38; Ash A, 2010, VET PARASITOL, V174, P206, DOI 10.1016/j.vetpar.2010.08.034; Behr M, 2000, LAB ANIMAL, V29, P23; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Berhane Y, 2010, AVIAN DIS, V54, P1275, DOI 10.1637/9422-061410-Reg.1; Brown C, 2004, REV SCI TECH OIE, V23, P435, DOI 10.20506/rst.23.2.1495; Chaber AL, 2010, CONSERV LETT, V3, P317, DOI 10.1111/j.1755-263X.2010.00121.x; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Coklin T, 2007, VET PARASITOL, V150, P297, DOI 10.1016/j.vetpar.2007.09.014; COSIVI O, 1995, REV SCI TECH OIE, V14, P733, DOI 10.20506/rst.14.3.875; Crossley B, 2012, EMERG INFECT DIS, V18, P315, DOI 10.3201/eid1802.111245; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DeHart RL, 2003, ANNU REV PUBL HEALTH, V24, P133, DOI 10.1146/annurev.publhealth.24.100901.140853; Dixon B, 2011, VET PARASITOL, V175, P20, DOI 10.1016/j.vetpar.2010.09.032; Epstein JH, 2009, MT SINAI J MED, V76, P448, DOI 10.1002/msj.20140; Erwin PC, 2004, EMERG INFECT DIS, V10, P2258, DOI 10.3201/eid1012.040094; Every AL, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-26; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Feagins AR, 2008, J MED VIROL, V80, P1379, DOI 10.1002/jmv.21223; Forgie SE, 2011, CLIN INFECT DIS, V52, P10, DOI 10.1093/cid/ciq030; Fournie G, 2013, VET J, V195, P8, DOI 10.1016/j.tvjl.2012.09.014; Graczyk TK, 2002, J PARASITOL, V88, P905, DOI 10.1645/0022-3395(2002)088[0905:AGDGAA]2.0.CO;2; Graczyk TK, 2002, PARASITOL RES, V88, P926, DOI 10.1007/s00436-002-0693-5; Graczyk TK, 2001, PARASITOL RES, V87, P368, DOI 10.1007/s004360000337; Guk Sang-Mee, 2004, Korean Journal of Parasitology, V42, P85, DOI 10.3347/kjp.2004.42.2.85; Hackendahl NC, 2004, JAVMA-J AM VET MED A, V225, P1573, DOI 10.2460/javma.2004.225.1573; Heller J, 2010, RISK ANAL, V30, P458, DOI 10.1111/j.1539-6924.2009.01342.x; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Holyoake PK, 2011, AUST VET J, V89, P427, DOI 10.1111/j.1751-0813.2011.00844.x; Hsieh JM, 2008, VET MICROBIOL, V126, P234, DOI 10.1016/j.vetmic.2007.07.013; Hubalek Z, 2003, EMERG INFECT DIS, V9, P403, DOI 10.3201/eid0903.020208; JACOBS PH, 1988, CUTIS, V42, P330; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Kaur T, 2008, AM J PRIMATOL, V70, P755, DOI 10.1002/ajp.20565; Kottler S, 2010, J VET INTERN MED, V24, P132, DOI 10.1111/j.1939-1676.2009.0424.x; Kwon NH, 2006, VET MICROBIOL, V117, P304, DOI 10.1016/j.vetmic.2006.05.006; Le Guyader F, 2000, APPL ENVIRON MICROB, V66, P3241, DOI 10.1128/AEM.66.8.3241-3248.2000; Leighton FA, 2004, CAN VET J, V45, P259; Lin Y, 2011, CLIN MED RES, V9, P7, DOI 10.3121/cmr.2010.944; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Michel AL, 2003, J ZOO WILDLIFE MED, V34, P364, DOI 10.1638/02-063; Morris DO, 2006, AM J VET RES, V67, P1421, DOI 10.2460/ajvr.67.8.1421; Muehlenbein MP, 2010, TRAVEL MED INFECT DI, V8, P169, DOI 10.1016/j.tmaid.2010.03.004; Nizeyi JB, 2001, J WILDLIFE DIS, V37, P239, DOI 10.7589/0090-3558-37.2.239; Noel C, 2005, J CLIN MICROBIOL, V43, P348, DOI 10.1128/JCM.43.1.348-355.2005; Pal M., 1997, Erkrankungen der Zootiere, V38, P355; Poon LLM, 2010, CLIN CHEM, V56, P1340, DOI 10.1373/clinchem.2010.149179; Prasad HK, 2005, TUBERCULOSIS, V85, P421, DOI 10.1016/j.tube.2005.08.005; Rubin JE, 2011, ZOONOSES PUBLIC HLTH, V58, P454, DOI 10.1111/j.1863-2378.2011.01392.x; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Scotch M, 2011, ECOHEALTH, V8, P376, DOI 10.1007/s10393-011-0706-x; Seguin JC, 1999, J CLIN MICROBIOL, V37, P1459, DOI 10.1128/JCM.37.5.1459-1463.1999; Sharma D. K., 2009, Haryana Veterinarian, V48, P108; Sleeman JM, 2000, J ZOO WILDLIFE MED, V31, P322, DOI 10.1638/1042-7260(2000)031[0322:GPOMGG]2.0.CO;2; Song MS, 2010, J CLIN MICROBIOL, V48, P3204, DOI 10.1128/JCM.00053-10; Swenson SL, 2010, J VET DIAGN INVEST, V22, P784, DOI 10.1177/104063871002200525; Teichroeb JA, 2009, AM J PHYS ANTHROPOL, V140, P498, DOI 10.1002/ajpa.21098; Tischer BK, 2010, VET MICROBIOL, V140, P266, DOI 10.1016/j.vetmic.2009.06.020; Trevennec K, 2011, INFLUENZA OTHER RESP; Weese JS, 2006, VET MICROBIOL, V115, P148, DOI 10.1016/j.vetmic.2006.01.004; Wevers D, 2011, J VIROL, V85, P10774, DOI 10.1128/JVI.00810-11; Willy ME, 1999, LAB ANIM SCI, V49, P42; Wilson ME, 2003, J APPL MICROBIOL, V94, p1S; World Association of Zoos and Aquariums, 2013, ZOOS AQ WORLD; World Health Organization, 2010, FAO OIE WHO COLL TRI; Worldbank, 2010, PEOPL PATH OUR PLAN, V1; Wrobel L, 2008, EUKARYOT CELL, V7, P1475, DOI 10.1128/EC.00162-08	68	119	120	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89055	10.1371/journal.pone.0089055	http://dx.doi.org/10.1371/journal.pone.0089055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586500	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200032
J	Lv, QW; Yin, YF; Li, X; Shan, GL; Wu, XN; Liang, D; Li, YZ; Zhang, X				Lv, Qianwen; Yin, Yufeng; Li, Xin; Shan, Guangliang; Wu, Xiangni; Liang, Di; Li, Yongzhe; Zhang, Xuan			The Status of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Are Not Associated with the Effect of Anti-TNF alpha Agent Treatment in Patients with Rheumatoid Arthritis: A Meta-Analysis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PROTEIN ANTIBODIES; CLINICAL-RESPONSE; THERAPY; PREDICTORS; INFLIXIMAB; CCP; ADALIMUMAB; REGISTER; EFFICACY	Objectives: This meta-analysis was conducted to investigate whether the status of rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibody are associated with the clinical response to anti-tumor necrosis factor (TNF) alpha treatment in rheumatoid arthritis (RA). Methods: A systemic literature review was performed using the MEDLINE, SCOPUS, Cochrane Library, ISI Web of Knowledge, and Clinical Trials Register databases, and Hayden's criteria of quality assessment for prognostic studies were used to evaluate all of the studies. The correlation between the RF and anti-CCP antibody status with the treatment effect of anti-TNF alpha agents was analyzed separately using the Mantel Haenszel method. A fixed-effects model was used when there was no significant heterogeneity; otherwise, a random-effects model was applied. Publication bias was assessed using Egger's linear regression and a funnel plot. Results: A total of 14 studies involving 5561 RA patients meeting the inclusion criteria were included. The overall analysis showed that the pooled relative risk for the predictive effects of the RF and anti-CCP antibody status on patient response to anti-TNF alpha agents was 0.98 (95% CI: 0.91-1.05, p = 0.54) and 0.88 (95% CI: 0.76-1.03, p = 0.11), respectively, with I-2 values of 43% (p = 0.05) and 67% (p<0.01), respectively. Subgroup analyses of different anti-TNFa alpha treatments (infliximab vs. etanercept vs. adalimumab vs. golimumab), response criteria (DAS28 vs. ACR20 vs. EULAR response), follow-up period (>= 6 vs. <6 months), and ethnic group did not reveal a significant association for the status of RF and anti-CCP. Conclusions: Neither the RF nor anti-CCP antibody status in RA patients is associated with a clinical response to anti-TNF alpha treatment.	[Lv, Qianwen; Yin, Yufeng; Li, Xin; Wu, Xiangni; Liang, Di; Li, Yongzhe; Zhang, Xuan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; [Lv, Qianwen; Yin, Yufeng; Li, Xin; Wu, Xiangni; Liang, Di; Li, Yongzhe; Zhang, Xuan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shan, Guangliang] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Stat, Beijing 100730, Peoples R China; [Shan, Guangliang] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, X (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China.	zxpumch2003@sina.com	zhang, xuan/GQO-8953-2022; zhang, xu/GRX-9733-2022; zhang, xuan/AAN-9914-2020	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699	National Natural Science Foundation of China [81325019, 81172859, 81273312]; Beijing Municipal Natural Science Foundation [7141008]; Research Special Fund for Public Welfare Industry of Health [20120217]; Capital Health Research and Development of Special [2011-4001-02]; National laboratory Special Fund [2060204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Research Special Fund for Public Welfare Industry of Health; Capital Health Research and Development of Special; National laboratory Special Fund	This work was supported by the grants from the National Natural Science Foundation of China (81325019, 81172859, and 81273312), Beijing Municipal Natural Science Foundation (7141008), the Research Special Fund for Public Welfare Industry of Health (20120217), the Capital Health Research and Development of Special (2011-4001-02), and the National laboratory Special Fund (2060204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandra, 2009, JOINT BONE SPINE REV, V76, P248; Avouac J, 2006, ANN RHEUM DIS, V65, P845, DOI 10.1136/ard.2006.051391; Bobbio-Pallavicini F, 2007, ANN RHEUM DIS, V66, P302, DOI 10.1136/ard.2006.060608; Bongi SM, 2004, AUTOIMMUNITY, V37, P495, DOI 10.1080/08916930400011965; Bos WH, 2008, J RHEUMATOL, V35, P1972; Braun-Moscovici Y, 2006, J RHEUMATOL, V33, P497; Canhao H, 2012, RHEUMATOLOGY, V51, P2020, DOI 10.1093/rheumatology/kes184; Cuchacovich M, 2008, CLIN EXP RHEUMATOL, V26, P1067; Forslind K, 2004, ANN RHEUM DIS, V63, P1090, DOI 10.1136/ard.2003.014233; Gibbons LJ, 2009, BIODRUGS, V23, P111, DOI 10.2165/00063030-200923020-00004; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Keystone EC, 2009, ANN RHEUM DIS, V68, P789, DOI 10.1136/ard.2008.099010; Klaasen R, 2011, RHEUMATOLOGY, V50, P1487, DOI 10.1093/rheumatology/ker010; Kristensen LE, 2008, RHEUMATOLOGY, V47, P495, DOI 10.1093/rheumatology/ken002; Lequerre T, 2007, RHEUMATOLOGY, V46, P446, DOI 10.1093/rheumatology/kel262; Mancarella L, 2007, J RHEUMATOL, V34, P1670; Potter C, 2009, ANN RHEUM DIS, V68, P69, DOI 10.1136/ard.2007.084715; Pruijn GJM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2903; Radovits BJ, 2009, ANN RHEUM DIS, V68, P1470, DOI 10.1136/ard.2008.094730; Soto L, 2011, CLIN RHEUMATOL, V30, P391, DOI 10.1007/s10067-011-1679-4; Tanaka Y, 2008, MOD RHEUMATOL, V18, P146, DOI 10.1007/s10165-008-0026-3; Vasilopoulos Y, 2011, CLIN EXP RHEUMATOL, V29, P701; Wijbrandts CA, 2008, ANN RHEUM DIS, V67, P1139, DOI 10.1136/ard.2007.080440	25	61	65	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89442	10.1371/journal.pone.0089442	http://dx.doi.org/10.1371/journal.pone.0089442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586782	Green Submitted, gold, Green Published			2022-12-27	WOS:000332390800022
J	Grotenhuis, AJ; Dudek, AM; Verhaegh, GW; Witjes, JA; Aben, KK; van der Marel, SL; Vermeulen, SH; Kiemeney, LA				Grotenhuis, Anne J.; Dudek, Aleksandra M.; Verhaegh, Gerald W.; Witjes, J. Alfred; Aben, Katja K.; van der Marel, Saskia L.; Vermeulen, Sita H.; Kiemeney, Lambertus A.			Prognostic Relevance of Urinary Bladder Cancer Susceptibility Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON GENETIC-VARIANTS; CONFERS SUSCEPTIBILITY; UROTHELIAL CARCINOMA; CLINICAL-OUTCOMES; SEQUENCE VARIANT; RISK; 8Q24; MARKERS; POLYMORPHISMS	In the last few years, susceptibility loci have been identified for urinary bladder cancer (UBC) through candidate-gene and genome-wide association studies. Prognostic relevance of most of these loci is yet unknown. In this study, we used data of the Nijmegen Bladder Cancer Study (NBCS) to perform a comprehensive evaluation of the prognostic relevance of all confirmed UBC susceptibility loci. Detailed clinical data concerning diagnosis, stage, treatment, and disease course of a population-based series of 1,602 UBC patients were collected retrospectively based on a medical file survey. Kaplan-Meier survival analyses and Cox proportional hazard regression were performed, and log-rank tests calculated, to evaluate the association between 12 confirmed UBC susceptibility variants and recurrence and progression in non-muscle invasive bladder cancer (NMIBC) patients. Among muscle-invasive or metastatic bladder cancer (MIBC) patients, association of these variants with overall survival was tested. Subgroup analyses by tumor aggressiveness and smoking status were performed in NMIBC patients. In the overall NMIBC group (n = 1,269), a statistically significant association between rs9642880 at 8q24 and risk of progression was observed (GT vs. TT: HR = 1.08 (95% CI: 0.76-1.54), GG vs. TT: HR = 1.81 (95% CI: 1.23-2.66), P for trend = 2.6x10(-3)). In subgroup analyses, several other variants showed suggestive, though non-significant, prognostic relevance for recurrence and progression in NMIBC and survival in MIBC. This study provides suggestive evidence that genetic loci involved in UBC etiology may influence disease prognosis. Elucidation of the causal variant(s) could further our understanding of the mechanism of disease, could point to new therapeutic targets, and might aid in improvement of prognostic tools.	[Grotenhuis, Anne J.; Aben, Katja K.; Vermeulen, Sita H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands; [Dudek, Aleksandra M.; Verhaegh, Gerald W.; Witjes, J. Alfred; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, Nijmegen, Netherlands; [Aben, Katja K.] Comprehens Canc Ctr Netherlands, Utrecht, Netherlands; [van der Marel, Saskia L.; Vermeulen, Sita H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Kiemeney, LA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands.	Bart.Kiemeney@radboudumc.nl	Aben, Katja KH/G-9686-2016; Grotenhuis, Anne/Q-1596-2015; Verhaegh, Gerald/L-4708-2015; Witjes, Fred/N-9665-2013; Vermeulen, Sita H./L-4716-2015; Kiemeney, Lambertus A./D-3357-2009	Aben, Katja KH/0000-0002-0214-2147; Verhaegh, Gerald/0000-0003-0227-2280; Vermeulen, Sita H./0000-0003-4913-8601; Kiemeney, Lambertus A./0000-0002-2368-1326	Radboud University Medical Centre	Radboud University Medical Centre	AG was supported by a research investment grant of the Radboud University Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, CLIN CANCER RES, V17, P1075, DOI 10.1158/1078-0432.CCR-10-0881; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Bertucci F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037943; Chang DW, 2012, UROL ONCOL-SEMIN ORI, V30, P524, DOI 10.1016/j.urolonc.2012.04.003; Chen M, 2010, CANCER PREV RES, V3, P1235, DOI 10.1158/1940-6207.CAPR-10-0035; Coate L, 2010, J CLIN ONCOL, V28, P4029, DOI 10.1200/JCO.2009.27.2336; Cortessis VK, 2010, CANCER EPIDEM BIOMAR, V19, P3150, DOI 10.1158/1055-9965.EPI-10-0763; Dai JY, 2012, CARCINOGENESIS, V33, P1327, DOI 10.1093/carcin/bgs147; Fasching PA, 2012, HUM MOL GENET, V21, P3926, DOI 10.1093/hmg/dds159; Figueroa JD, 2014, HUM MOL GENET, V23, P1387, DOI 10.1093/hmg/ddt519; Fu YP, 2012, P NATL ACAD SCI USA, V109, P4974, DOI 10.1073/pnas.1202189109; Gallagher DJ, 2010, CLIN CANCER RES, V16, P2819, DOI 10.1158/1078-0432.CCR-10-0028; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Garcia-Closas M, 2011, PHARMACOGENET GENOM, V21, P231, DOI 10.1097/FPC.0b013e32833e1b54; Golka K, 2009, PHARMACOGENET GENOM, V19, P903, DOI 10.1097/FPC.0b013e328331b554; Grisanzio Chiara, 2010, Genes Cancer, V1, P555, DOI 10.1177/1947601910381380; Grotenhuis AJ, 2010, FUTURE ONCOL, V6, P1433, DOI 10.2217/FON.10.109; Gu J, 2011, PERS MED, V8, P365, DOI 10.2217/PME.11.15; Hoskins JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041954; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Ke HL, 2013, CARCINOGENESIS, V34, P1006, DOI 10.1093/carcin/bgt006; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Ma Zhicheng, 2013, Mol Carcinog, V52, P916, DOI 10.1002/mc.21932; O'Donnell PH, 2012, MOL ONCOL, V6, P251, DOI 10.1016/j.molonc.2012.01.005; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rafnar T, 2011, HUM MOL GENET, V20, P4268, DOI 10.1093/hmg/ddr303; Rizzato C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027921; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Savas S, 2009, HUM MUTAT, V30, P1369, DOI 10.1002/humu.21078; Shan JX, 2012, BREAST CANCER RES TR, V135, P715, DOI 10.1007/s10549-012-2202-6; Spitz MR, 2005, J CLIN ONCOL, V23, P267, DOI 10.1200/JCO.2005.05.122; Suzuki M, 2011, CLIN GENITOURIN CANC, V9, P46, DOI 10.1016/j.clgc.2011.04.004; Sylvester RJ, 2011, EUR UROL, V60, P431, DOI 10.1016/j.eururo.2011.06.001; Takatsuno Y, 2013, ANN SURG ONCOL, V20, P1395, DOI 10.1245/s10434-012-2657-z; Tang W, 2012, HUM MOL GENET, V21, P1918, DOI 10.1093/hmg/ddr619; Tilki D, 2011, EUR UROL, V60, P484, DOI 10.1016/j.eururo.2011.05.053; van Rhijn BWG, 2012, UROL ONCOL-SEMIN ORI, V30, P518, DOI 10.1016/j.urolonc.2012.04.002; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Wang ML, 2009, CARCINOGENESIS, V30, P991, DOI 10.1093/carcin/bgp091; Wheeler HE, 2013, NAT REV GENET, V14, P23, DOI 10.1038/nrg3352; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Xing JL, 2011, EUR J CANCER, V47, P1699, DOI 10.1016/j.ejca.2011.02.004; Xun WW, 2011, MUTAGENESIS, V26, P657, DOI 10.1093/mutage/ger030; Yates DR, 2013, WORLD J UROL, V31, P53, DOI 10.1007/s00345-012-0954-6; Zhang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041930	48	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89164	10.1371/journal.pone.0089164	http://dx.doi.org/10.1371/journal.pone.0089164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586564	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900031
J	Lorgunpai, SJ; Grammas, M; Lee, DSH; McAvay, G; Charpentier, P; Tinetti, ME				Lorgunpai, Songprod Jonathan; Grammas, Marianthe; Lee, David S. H.; McAvay, Gail; Charpentier, Peter; Tinetti, Mary E.			Potential Therapeutic Competition in Community-Living Older Adults in the US: Use of Medications That May Adversely Affect a Coexisting Condition	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; CLINICAL-PRACTICE GUIDELINES; MULTIPLE CHRONIC CONDITIONS; ASSOCIATION TASK-FORCE; BONE-MINERAL DENSITY; HEART-FAILURE; MYOCARDIAL-INFARCTION; ELDERLY-PATIENTS; CHOLINESTERASE-INHIBITORS; FOCUSED UPDATE	Objective: The 75% of older adults with multiple chronic conditions are at risk of therapeutic competition (i.e. treatment for one condition may adversely affect a coexisting condition). The objective was to determine the prevalence of potential therapeutic competition in community-living older adults. Methods: Cross-sectional descriptive study of a representative sample of 5,815 community-living adults 65 and older in the U. S, enrolled 2007-2009. The 14 most common chronic conditions treated with at least one medication were ascertained from Medicare claims. Medication classes recommended in national disease guidelines for these conditions and used by >= 2% of participants were identified from in-person interviews conducted 2008-2010. Criteria for potential therapeutic competition included: 1), well-acknowledged adverse medication effect; 2) mention in disease guidelines; or 3) report in a systematic review or two studies published since 2000. Outcomes included prevalence of situations of potential therapeutic competition and frequency of use of the medication in individuals with and without the competing condition. Results: Of 27 medication classes, 15 (55.5%) recommended for one study condition may adversely affect other study conditions. Among 91 possible pairs of study chronic conditions, 25 (27.5%) have at least one potential therapeutic competition. Among participants, 1,313 (22.6%) received at least one medication that may worsen a coexisting condition; 753 (13%) had multiple pairs of such competing conditions. For example, among 846 participants with hypertension and COPD, 16.2% used a nonselective beta-blocker. In only 6 of 37 cases (16.2%) of potential therapeutic competition were those with the competing condition less likely to receive the medication than those without the competing condition. Conclusions: One fifth of older Americans receive medications that may adversely affect coexisting conditions. Determining clinical outcomes in these situations is a research and clinical priority. Effects on coexisting conditions should be considered when prescribing medications.	[Lorgunpai, Songprod Jonathan] Yale Univ, Sch Med, New Haven, CT USA; [Grammas, Marianthe; McAvay, Gail; Charpentier, Peter; Tinetti, Mary E.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Lee, David S. H.] Oregon Hlth & Sci Univ, Oregon State Univ, Coll Pharm, Portland, OR 97201 USA; [Tinetti, Mary E.] Sch Epidemiol & Publ Hlth, New Haven, CT USA	Yale University; Yale University; Oregon Health & Science University; Oregon State University	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.	mary.tinetti@yale.edu			Yale Pepper Center [P30AG021342];  [5R03AG035146]; NATIONAL INSTITUTE ON AGING [P30AG021342, R03AG035146] Funding Source: NIH RePORTER	Yale Pepper Center; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	5R03AG035146, Yale Pepper Center (P30AG021342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Rheumatology Subcommittee on Osteoarthritis Guidelines, 2011, REC MED MAN OST HIP; American Thoracic Society/European Respiratory Society Task Force, 2004, STAND DIAGN MAN PAT; American Urological Association, 2010, PHARM MAN PREM EJ; Anderson G, 2010, CHRONIC CARE MAKING; Au DH, 2002, CHEST, V121, P846, DOI 10.1378/chest.121.3.846; Au DH, 2000, AM J RESP CRIT CARE, V161, P827, DOI 10.1164/ajrccm.161.3.9904006; Aubert RE, 2010, DIABETES OBES METAB, V12, P716, DOI 10.1111/j.1463-1326.2010.01225.x; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bennett WL, 2012, ANN INTERN MED, V156, P27, DOI 10.7326/0003-4819-156-1-201201030-00005; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Brooks TWA, 2007, PHARMACOTHERAPY, V27, P684, DOI 10.1592/phco.27.5.684; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chrischilles E, 2001, CLIN THER, V23, P727, DOI 10.1016/S0149-2918(01)80022-9; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; Degner D, 2004, PHARMACOPSYCHIATRY, V37, pS39, DOI 10.1055/s-2004-815509; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; Dungen HD, 2011, EUR J HEART FAIL, V13, P670, DOI 10.1093/eurjhf/hfr020; Ettinger B., 1998, J MANAGE CARE PHARM, V4, P488, DOI [10.18553/jmcp.1998.4.5.488, DOI 10.18553/jmcp.1998.4.5.488]; Eurich DT, 2007, BMJ-BRIT MED J, V335, P497, DOI 10.1136/bmj.39314.620174.80; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fortin M, 2004, HEALTH QUAL LIFE OUT, V2, P51, DOI [10.1186/1477-7525-2-51, DOI 10.1186/1477-7525-2-51]; Galatius S, 2004, CARDIOLOGY, V102, P160, DOI 10.1159/000080485; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Gill SS, 2009, ARCH INTERN MED, V169, P867, DOI 10.1001/archinternmed.2009.43; GRADE Working Group, 2010, GRAD QUAL EV STRENGT; Graham DJ, 2006, JAMA-J AM MED ASSOC, V296, P1653, DOI 10.1001/jama.296.13.jed60058; Gray SL, 2010, ARCH INTERN MED, V170, P765, DOI 10.1001/archinternmed.2010.94; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; Hallas J, 2006, BMJ-BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Hawkins NM, 2011, J AM COLL CARDIOL, V57, P2127, DOI 10.1016/j.jacc.2011.02.020; Healthcare Cost and Utilization Project (HCUP), 2012, CLIN CLASS SYST; Hernandez RK, 2009, J AM GERIATR SOC, V57, P1997, DOI 10.1111/j.1532-5415.2009.02488.x; Hodgkinson JA, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X578034; Hsu PI, 2011, GASTROENTEROLOGY, V140, P791, DOI 10.1053/j.gastro.2010.11.056; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Ickowicz E, 2012, J AM GERIATR SOC, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Johnell K, 2012, DRUG AGING, V29, P751, DOI 10.1007/s40266-012-0002-7; Johnson EM, 2006, AM J GERIAT PSYCHIAT, V14, P796, DOI 10.1097/01.JGP.0000204328.50105.b3; Jyrkka J, 2006, EUR J CLIN PHARMACOL, V62, P151, DOI 10.1007/s00228-005-0079-6; Kenneth RD, 2005, AM J GASTROENTEROL, V100, P190, DOI DOI 10.1111/j.1572-0241.2005.41217.x; Kirby RS, 2003, UROLOGY, V61, P119, DOI 10.1016/S0090-4295(02)02114-3; Klabunde CN, 2006, MED CARE, V44, P921, DOI 10.1097/01.mlr.0000223480.52713.b9; Lau YT, 2012, PHARMACOTHERAPY, V32, P67, DOI 10.1002/PHAR.1007; Lentine KL, 2009, CLIN J AM SOC NEPHRO, V4, P1213, DOI 10.2215/CJN.00670109; Lo A, 2002, P SURV RES SECT AM S, P2139; Loke YK, 2009, DRUG SAFETY, V32, P219, DOI 10.2165/00002018-200932030-00004; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; National Osteoporosis Foundation, 2010, CLIN GUID PREV TREAT; National Quality Forum, 2014, MULT CHRON COND MCC; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Noyes K, 2011, PSYCHIAT SERV, V62, P1159, DOI 10.1176/ps.62.10.pss6210_1159; Padala KP, 2012, AM J GERIATR PHARMAC, V10, P296, DOI 10.1016/j.amjopharm.2012.08.002; Pantalone KM, 2012, DIABETES OBES METAB, V14, P803, DOI 10.1111/j.1463-1326.2012.01604.x; Park-Wyllie LY, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000157; Penning-van Beest FJA, 2006, CLIN THER, V28, P236, DOI 10.1016/j.clinthera.2006.01.002; Ray WA, 2009, CIRC-CARDIOVASC QUAL, V2, P155, DOI 10.1161/CIRCOUTCOMES.108.805689; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Solomon DH, 2004, HYPERTENSION, V44, P140, DOI 10.1161/01.HYP.0000136134.31846.83; Sowers JR, 2005, ARCH INTERN MED, V165, P161, DOI 10.1001/archinte.165.2.161; Tinetti ME, 2011, J AM GERIATR SOC, V59, P1686, DOI 10.1111/j.1532-5415.2011.03573.x; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Wang CH, 2003, CIRCULATION, V107, P1350, DOI 10.1161/01.CIR.0000054675.30348.9A; Wann LS, 2011, J AM COLL CARDIOL, V57, P223, DOI 10.1016/j.jacc.2010.10.001; Winkelmayer WC, 2008, ARCH INTERN MED, V168, P2368, DOI 10.1001/archinte.168.21.2368; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Work Group on Alzheimer's Disease and Other Dementias, 2011, PRACT GUID TREATM PA; Work Group on Major Depressive Disorder, 2011, PRACT GUID TREATM PA; World Health Organization, 2012, AN THER CHEM CLASS S; Yang JC, 2001, J GEN INTERN MED, V16, P112; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947	75	57	58	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89447	10.1371/journal.pone.0089447	http://dx.doi.org/10.1371/journal.pone.0089447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2ZX	24586786	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900046
J	Hong, JB; Chou, FJ; Ku, AT; Fan, HH; Lee, TL; Huang, YH; Yang, TL; Su, IC; Yu, IS; Lin, SW; Chien, CL; Ho, HN; Chen, YT				Hong, Jin-Bon; Chou, Fu-Ju; Ku, Amy T.; Fan, Hsiang-Hsuan; Lee, Tung-Lung; Huang, Yung-Hsin; Yang, Tsung-Lin; Su, I-Chang; Yu, I-Shing; Lin, Shu-Wha; Chien, Chung-Liang; Ho, Hong-Nerng; Chen, You-Tzung			A Nucleolus-Predominant piggyBac Transposase, NP-mPB, Mediates Elevated Transposition Efficiency in Mammalian Cells	PLOS ONE			English	Article							HIV-1 TAT; GERMLINE TRANSFORMATION; INSERTIONAL MUTAGENESIS; INTRACELLULAR DELIVERY; PROTEIN TRANSDUCTION; BAC TRANSGENESIS; SLEEPING-BEAUTY; GENE DISCOVERY; BASIC DOMAIN; STEM-CELLS	PiggyBac is a prevalent transposon system used to deliver transgenes and functionally explore the mammalian untouched genomic territory. The important features of piggyBac transposon are the relatively low insertion site preference and the ability of seamless removal from genome, which allow its potential uses in functional genomics and regenerative medicine. Efforts to increase its transposition efficiency in mammals were made through engineering the corresponding transposase (PBase) codon usage to enhance its expression level and through screening for mutant PBase variants with increased enzyme activity. To improve the safety for its potential use in regenerative medicine applications, site-specific transposition was achieved by using engineered zinc finger- and Gal4-fused PBases. An excision-prone PBase variant has also been successfully developed. Here we describe the construction of a nucleolus-predominant PBase, NP-mPB, by adding a nucleolus-predominant (NP) signal peptide from HIV-1 TAT protein to a mammalian codon-optimized PBase (mPB). Although there is a predominant fraction of the NP-mPB-tGFP fusion proteins concentrated in the nucleoli, an insertion site preference toward nucleolar organizer regions is not detected. Instead a 3-4 fold increase in piggyBac transposition efficiency is reproducibly observed in mouse and human cells.	[Hong, Jin-Bon; Chou, Fu-Ju; Ku, Amy T.; Fan, Hsiang-Hsuan; Chien, Chung-Liang; Ho, Hong-Nerng; Chen, You-Tzung] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan; [Hong, Jin-Bon; Lee, Tung-Lung; Huang, Yung-Hsin] Natl Taiwan Univ Hosp & Coll Med, Dept Dermatol, Taipei, Taiwan; [Yang, Tsung-Lin] Natl Taiwan Univ Hosp & Coll Med, Dept Otolaryngol, Taipei, Taiwan; [Yang, Tsung-Lin; Chien, Chung-Liang; Ho, Hong-Nerng; Chen, You-Tzung] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Su, I-Chang; Chen, You-Tzung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Yu, I-Shing] Natl Taiwan Univ, Coll Med, Transgen Mouse Model Core Facil, Natl Res Program Genom Med, Taipei 10764, Taiwan; [Yu, I-Shing] Natl Taiwan Univ, Coll Med, Lab Anim Ctr, Taipei 10764, Taiwan; [Lin, Shu-Wha] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Lin, Shu-Wha] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Chien, Chung-Liang; Ho, Hong-Nerng; Chen, You-Tzung] Natl Taiwan Univ, Ctr Genom Med, Stem Cell Core Lab, Taipei 10764, Taiwan; [Chien, Chung-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10764, Taiwan; [Ho, Hong-Nerng] Natl Taiwan Univ Hosp & Coll Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Taipei, Taiwan; [Chen, You-Tzung] Natl Taiwan Univ, Genome & Syst Biol Program, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chen, YT (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan.	youtzungchen@ntu.edu.tw	NTU, Ref07/AAX-7890-2021	LIN, SHU-WHA/0000-0001-6748-5581; CHEN, YOU-TZUNG/0000-0001-6510-3420; YANG, TSUNG-LIN/0000-0001-6521-8631; Ho, Hong-Nerng/0000-0002-7207-0089; Hong, Jin-Bon/0000-0001-9467-6463; Huang, Yung-Hsin/0000-0002-5180-934X; CHIEN, CHUNG-LIANG/0000-0001-9806-486X	National Taiwan University Hospital (NTUH) [NTUH. 102-N2298]; National Science Council (NSC) [NSC 101-2314-B-002-030-, NSC 98-2314-B-002-043-MY2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER	National Taiwan University Hospital (NTUH); National Science Council (NSC)(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was mainly supported by grants from the National Taiwan University Hospital (NTUH) to JBH (NTUH. 102-N2298) and the National Science Council (NSC) to JBH (NSC 101-2314-B-002-030-) and YTC (NSC 98-2314-B-002-043-MY2), and was partially supported by NTUH and NSC grants to TLY, SWL, and CLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albieri I, 2010, J BIOTECHNOL, V150, P11, DOI 10.1016/j.jbiotec.2010.07.027; Ammar I, 2012, NUCLEIC ACIDS RES, V40, P6693, DOI 10.1093/nar/gks317; Berry CC, 2007, IEEE T NANOBIOSCI, V6, P262, DOI 10.1109/TNB.2007.908973; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Caron NJ, 2004, BIOCHEM BIOPH RES CO, V319, P12, DOI 10.1016/j.bbrc.2004.04.180; Caron NJ, 2001, MOL THER, V3, P310, DOI 10.1006/mthe.2001.0279; Chen L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-93; Chen YT, 2010, STEM CELLS DEV, V19, P763, DOI 10.1089/scd.2009.0118; Chen YT, 2004, MOL CELL BIOL, V24, P9930, DOI 10.1128/MCB.24.22.9930-9941.2004; Crabb BS, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-21; Das C, 2004, VIROLOGY, V318, P306, DOI 10.1016/j.virol.2003.10.003; De Luca A, 2003, J CELL PHYSIOL, V194, P101, DOI 10.1002/jcp.10196; Di Matteo M, 2012, EXPERT OPIN BIOL TH, V12, P841, DOI 10.1517/14712598.2012.684875; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dubois Emeline, 2012, Int J Evol Biol, V2012, P436196, DOI 10.1155/2012/436196; Edenhofer F, 2008, CURR PHARM DESIGN, V14, P3628, DOI 10.2174/138161208786898833; Fraldi A, 2001, J CELL BIOCHEM, P247; Furushima K, 2012, GENETICS, V192, P1235, DOI 10.1534/genetics.112.140855; Galvan DL, 2009, J IMMUNOTHER, V32, P837, DOI 10.1097/CJI.0b013e3181b2914c; Gonzalez-Estevez C, 2003, P NATL ACAD SCI USA, V100, P14046, DOI 10.1073/pnas.2335980100; Guo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018189; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; HAUBER J, 1989, J VIROL, V63, P1181, DOI 10.1128/JVI.63.3.1181-1187.1989; Huang Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr908; Ikadai H, 2013, P NATL ACAD SCI USA, V110, pE1676, DOI 10.1073/pnas.1217712110; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kettlun C, 2011, MOL THER, V19, P1636, DOI 10.1038/mt.2011.129; Kim H, 2012, BIOCHEM BIOPH RES CO, V417, P335, DOI 10.1016/j.bbrc.2011.11.110; Kim SJ, 2011, J VET MED SCI, V73, P1453, DOI 10.1292/jvms.11-0054; Kong J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq658; Landrette SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026650; Lee CY, 2011, BIOMATERIALS, V32, P6264, DOI 10.1016/j.biomaterials.2011.05.012; Li J, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1358; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; Liu XJ, 2013, TRANSGENIC RES, V22, P417, DOI 10.1007/s11248-012-9642-y; Marcello A, 2004, GENE, V326, P1, DOI 10.1016/j.gene.2003.10.018; Martins S, 2012, INSECT MOL BIOL, V21, P414, DOI 10.1111/j.1365-2583.2012.01146.x; Mattis Aras N, 2012, Hepatology, V55, P2033, DOI 10.1002/hep.25715; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Meir YJJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-28; Meir Yaa-Jyuhn James, 2011, Chang Gung Med J, V34, P565; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; Morales ME, 2007, FASEB J, V21, P3479, DOI 10.1096/fj.07-8726com; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nagy K, 2011, STEM CELL REV REP, V7, P693, DOI 10.1007/s12015-011-9239-5; O'Brochta DA, 2011, P NATL ACAD SCI USA, V108, P16339, DOI 10.1073/pnas.1110628108; Owens JB, 2013, NUCLEIC ACIDS RES, V41, P9197, DOI 10.1093/nar/gkt677; Owens JB, 2012, NUCLEIC ACIDS RES, V40, P6978, DOI 10.1093/nar/gks309; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Pettitt SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061520; Ponti D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-32; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Rostovskaya M, 2013, GENESIS, V51, P135, DOI 10.1002/dvg.22362; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; RUBEN S, 1989, J VIROL, V63, P1; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schetelig MF, 2013, GENETICA, V141, P189, DOI 10.1007/s10709-013-9717-6; SIOMI H, 1990, J VIROL, V64, P1803, DOI 10.1128/JVI.64.4.1803-1807.1990; Su HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040075; Sun LV, 2008, NUCLEIC ACIDS RES, V36, pD729, DOI 10.1093/nar/gkm790; Trauner J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-73; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022993; Wang W, 2009, GENOME RES, V19, P667, DOI 10.1101/gr.085621.108; Warren IA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-86; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Wu S, 2007, NAT GENET, V39, P922, DOI 10.1038/ng2060; Yang RF, 2011, J INVEST DERMATOL, V131, P2458, DOI 10.1038/jid.2011.242; Yang YH, 2002, FEBS LETT, V532, P36, DOI 10.1016/S0014-5793(02)03624-4; You L, 2011, BIOCHEM BIOPH RES CO, V407, P1, DOI 10.1016/j.bbrc.2011.02.027; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhang X, 2012, GENE, V491, P272, DOI 10.1016/j.gene.2011.09.026	82	4	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89396	10.1371/journal.pone.0089396	http://dx.doi.org/10.1371/journal.pone.0089396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586748	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700037
J	Hsu, CY; Lee, YH; Liu, PH; Hsia, CY; Huang, YH; Lin, HC; Chiou, YY; Lee, FY; Huo, TI				Hsu, Chia-Yang; Lee, Yun-Hsuan; Liu, Po-Hong; Hsia, Cheng-Yuan; Huang, Yi-Hsiang; Lin, Han-Chieh; Chiou, Yi-You; Lee, Fa-Yauh; Huo, Teh-Ia			Decrypting Cryptogenic Hepatocellular Carcinoma: Clinical Manifestations, Prognostic Factors and Long-Term Survival by Propensity Score Model	PLOS ONE			English	Article							FATTY LIVER-DISEASE; TOTAL TUMOR VOLUME; PERFORMANCE STATUS; MILAN CRITERIA; SYSTEM; MANAGEMENT; CIRRHOSIS; FEATURES	Background and Aims: The clinical aspects of cryptogenic hepatocellular carcinoma (HCC), defined as HCC in patients without hepatitis B, C or alcoholism, are not clear. We investigated its clinical presentations, long-term survival and prognostic predictors. Methods: A total of 2645 HCC patients were studied. One-to-one matched pairs between viral/alcoholic and cryptogenic HCC patients were generated by using the propensity model. The survival analysis was performed with the Kaplan-Meier method and log-rank test, and hazard ratios were calculated with Cox proportional hazards model. Results: Among 366 (14%) patients with cryptogenic HCC, 34% of patients were presented with abdominal discomfort, and 31% of patients were identified incidentally. Compared to patients with viral/alcoholic HCC, cryptogenic HCC patients were significantly older (p<0.0001), with poorer performance status (p = 0.0031) and less often underwent curative treatment (p = 0.0041). They also had larger tumor burden (p<0.0001), poorer renal function (p<0.0001), lower a-fetoprotein level (p<0.0001), and more advanced Barcelona Clinic Liver Cancer stages (p<0.0001). With propensity score model, 366 pairs of similar HCC patients were selected and similar long-term survival between the two groups of patients was found (p = 0.1038). For cryptogenic HCC patients, alpha-fetoprotein >= 49 ng/mL (hazard ratio [HR]: 1.955, p = 0.0002), Child-TurcottePugh class B/C (HR: 2.798, p, 0.0001), performance status >= 1 (HR: 2.463, p, 0.0001) and vascular invasion (HR: 1.608, p = 0.0257) were independent predictors of poor prognosis. Conclusions: Patients with cryptogenic HCC are usually diagnosed with poor general condition at late stages. However, cryptogenic HCC patients have similar prognostic predictors and long-term survival compared with viral/alcoholic HCC patients. Diagnosis at an early stage may improve their clinical outcomes.	[Hsu, Chia-Yang; Lee, Yun-Hsuan; Liu, Po-Hong; Hsia, Cheng-Yuan; Lin, Han-Chieh; Chiou, Yi-You; Lee, Fa-Yauh] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Huang, Yi-Hsiang] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Huo, Teh-Ia] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan; [Hsu, Chia-Yang; Lee, Yun-Hsuan; Liu, Po-Hong; Huang, Yi-Hsiang; Lin, Han-Chieh; Lee, Fa-Yauh; Huo, Teh-Ia] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Hsia, Cheng-Yuan] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Chiou, Yi-You] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Hsu, Chia-Yang] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; University of California System; University of California Los Angeles	Huo, TI (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan.	tihuo@vghtpe.gov.tw	Liu, Po-Hong/HGB-9015-2022; Liu, Po-Hong/G-8459-2015	Liu, Po-Hong/0000-0001-6205-3704; Huang, Yi-Hsiang/0000-0001-5241-5425	Center of Excellence for Cancer Research at Taipei Veterans General Hospital, Taiwan [DOH102-TD-C-111-007]; Taipei Veterans General Hospital, Taipei, Taiwan [V102C-012]; Ministry of Education, Taiwan [101AC-D101]	Center of Excellence for Cancer Research at Taipei Veterans General Hospital, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This study was supported by grants from the Center of Excellence for Cancer Research at Taipei Veterans General Hospital (DOH102-TD-C-111-007), Taiwan, from Taipei Veterans General Hospital (V102C-012), Taipei, Taiwan, and from the Ministry of Education, Aim for the Top University Plan (101AC-D101), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2014, J MED VIROL, V86, P131, DOI 10.1002/jmv.23790; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2002, HEPATOLOGY, V35, P519, DOI 10.1053/jhep.2002.32089; Caldwell SH, 2004, J HEPATOL, V40, P578, DOI 10.1016/j.jhep.2004.02.013; Chang CH, 2013, MED CARE, V51, P908, DOI 10.1097/MLR.0b013e3182a502ba; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Gellert L, 2007, INTERN MED J, V37, P516, DOI 10.1111/j.1445-5994.2007.01392.x; Gopal P, 2014, CLIN GASTROENTEROL H, V12, P870, DOI 10.1016/j.cgh.2013.09.053; Hsu CY, 2013, ANN SURG ONCOL, V20, P2035, DOI 10.1245/s10434-012-2847-8; Hsu CY, 2013, HEPATOL INT, V7, P188, DOI 10.1007/s12072-011-9338-z; Hsu CY, 2013, HEPATOLOGY, V57, P112, DOI 10.1002/hep.25950; Hsu CY, 2010, J HEPATOL, V53, P108, DOI 10.1016/j.jhep.2010.01.038; Hsu CY, 2010, CANCER-AM CANCER SOC, V116, P3006, DOI 10.1002/cncr.25044; Kao WY, 2011, WORLD J SURG, V35, P858, DOI 10.1007/s00268-010-0928-z; Kubo S, 2013, LIVER CANCER, V2, P40, DOI 10.1159/000346214; Kudo M, 2011, ONCOLOGY-BASEL, V81, P50, DOI 10.1159/000333259; LEE CS, 1986, SURGERY, V99, P481; Lee SS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-335; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077240; Lee YH, 2012, ALIMENT PHARM THER, V36, P551, DOI 10.1111/j.1365-2036.2012.05226.x; Lee YH, 2013, HEPATOL INT, V7, P645, DOI 10.1007/s12072-012-9375-2; Lee YH, 2013, J GASTROINTEST SURG, V17, P730, DOI 10.1007/s11605-012-2081-5; Lee YH, 2012, J GASTROEN HEPATOL, V27, P1581, DOI 10.1111/j.1440-1746.2012.07151.x; Lin ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080276; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Pekow JR, 2007, CANCER-AM CANCER SOC, V109, P2490, DOI 10.1002/cncr.22701; Reddy SK, 2012, HEPATOLOGY, V55, P1809, DOI 10.1002/hep.25536; Tokushige K, 2011, J GASTROENTEROL, V46, P1230, DOI 10.1007/s00535-011-0431-9; Tokushige K, 2010, J GASTROENTEROL, V45, P960, DOI 10.1007/s00535-010-0237-1; Tsai YJ, 2011, HEPATOL INT, V5, P975, DOI 10.1007/s12072-011-9276-9; Yeh YP, 2013, HEPATOLOGY IN PRESS, DOI [10.1002/hep.26703, DOI 10.1002/HEP.26703]; Yokoi Y, 2005, J GASTROENTEROL, V40, P274, DOI 10.1007/s00535-004-1536-1	36	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89373	10.1371/journal.pone.0089373	http://dx.doi.org/10.1371/journal.pone.0089373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586728	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700033
J	Maeyama, J; Takatsuka, H; Suzuki, F; Kubota, A; Horiguchi, S; Komiya, T; Shimada, I; Murata, E; Osawa, Y; Kitagawa, H; Matsuki, T; Isaka, M; Yamamoto, S; Iho, S				Maeyama, Jun-ichi; Takatsuka, Hisakazu; Suzuki, Fumiko; Kubota, Ayumi; Horiguchi, Satomi; Komiya, Takako; Shimada, Ichiroh; Murata, Eri; Osawa, Youko; Kitagawa, Harukazu; Matsuki, Takasumi; Isaka, Masanori; Yamamoto, Saburo; Iho, Sumiko			A Palindromic CpG-Containing Phosphodiester Oligodeoxynucleotide as a Mucosal Adjuvant Stimulates Plasmacytoid Dendritic Cell-Mediated T(H)1 Immunity	PLOS ONE			English	Article							INDUCED IFN-ALPHA; CUTTING EDGE; P38 MAPK; DNA; OLIGONUCLEOTIDES; RESPONSES; TOXIN; INDUCTION; SEQUENCES; VACCINES	Background: CpG oligodeoxynucleotides (ODNs), resembling bacterial DNA, are currently tested in clinical trials as vaccine adjuvants. They have the nuclease-resistant phosphorothioate bond; the immune responses elicited differ according to the CpG ODN sequence and vaccination method. To develop a CpG ODN that can induce plasmacytoid dendritic cell (pDC)mediated T(H)1 immunity through the mucosa, we constructed phosphodiester G9.1 comprising one palindromic CpG motif with unique polyguanosine-runs that allows degradation similar to naturally occurring bacterial DNA. Methods: T(H)1 and T(H)2 immunity activation was evaluated by cytokine production pattern and T-bet/GATA-3 ratio in human peripheral blood mononuclear cells and mouse bone marrow cells. Adjuvanticity was evaluated in mice administered G9.1 with diphtheria toxoid (DT) through nasal vaccination. Results: G9.1 exhibited stronger IFN-alpha-inducing activity than A-class CpG ODN2216 and increased T-bet/GATA-3 ratio by enhancing T-bet expression. Nasally administered G9.1 plus DT induced DT-specific mucosal IgA and serum IgG, but not IgE, responses with antitoxin activity in C57BL/6 and BALB/c mice, possibly due to IFN/BAFF production. Induction of T(H)1, but not T(H)2, -type Abs depended completely on pDCs, the first in vivo demonstration by CpG ODNs. Conclusions: G9.1 is a promising mucosal adjuvant for induction of pDC-mediated T(H)1 immunity.	[Maeyama, Jun-ichi] Natl Inst Infect Dis, Dept Safety Res Blood & Biol Prod, Musashimurayama, Tokyo, Japan; [Takatsuka, Hisakazu] Niigata Univ, Grad Sch Med & Dent Sci, Div Legal Med, Niigata, Japan; [Suzuki, Fumiko] Univ Fukui, Dept Ophthalmol, Fac Med Sci, Fukui, Japan; [Kubota, Ayumi; Iho, Sumiko] Univ Fukui, Dept Anat & Neurosci, Fac Med Sci, Fukui, Japan; [Horiguchi, Satomi] Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect, Musashimurayama, Tokyo, Japan; [Shimada, Ichiroh; Murata, Eri; Osawa, Youko; Matsuki, Takasumi] Univ Fukui, Fac Med Sci, Fukui, Japan; [Shimada, Ichiroh; Matsuki, Takasumi; Iho, Sumiko] Univ Fukui, Res & Educ Program Life Sci & Translat Res Progra, Fukui 910, Japan; [Kitagawa, Harukazu] Emori & Co Ltd, Adm Control Off, Chem Subst Management, Fukui, Japan; [Isaka, Masanori] Nagoya City Univ, Sch Med, Dept Microbiol, Nagoya, Aichi 467, Japan; [Yamamoto, Saburo] Japan BCG Lab, Cent Lab, Kiyose, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Niigata University; University of Fukui; University of Fukui; National Institute of Infectious Diseases (NIID); University of Fukui; University of Fukui; Nagoya City University	Iho, S (corresponding author), Univ Fukui, Fac Med Sci, Host Def Lab, Fukui, Japan.	ihosumik@u-fukui.ac.jp			Japan Society for the Promotion of Science [22591105, 19591962]; Japan Science and Technology Agency [AS231Z03382G, AS2314067G, AS2121188G, 09-08, 06-057]; Japan Health Sciences Foundation [KHC1021, SH54411]; Smoking Research Foundation; Fukui University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Health Sciences Foundation; Smoking Research Foundation; Fukui University	This work was supported in part by a Grant-in-Aid for Scientific Research [22591105 to SI, JIM, 19591962 to SI] from the Japan Society for the Promotion of Science; A-STEP [AS231Z03382G to SI, AS2314067G and AS2121188G to SY, SI, 09-08 and 06-057 to SI] from the Japan Science and Technology Agency; a grant for Research on Publicly Essential Drugs and Medical Devices [KHC1021 to JIM, MI, SY, SI, SH54411 to SY, SI] from The Japan Health Sciences Foundation; and Smoking Research Foundation [to SI, JIM]; and Fukui University [SI]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal T, 2009, CLIN MICROBIOL INFEC, V15, P50, DOI 10.1111/j.1469-0691.2008.02113.x; Baban B, 2011, J IMMUNOL, V187, P2329, DOI 10.4049/jimmunol.1100276; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Cooper CL, 2004, VACCINE, V22, P3136, DOI 10.1016/j.vaccine.2004.01.058; de Vries IJM, 2011, MOL IMMUNOL, V48, P810, DOI 10.1016/j.molimm.2010.12.022; Faquim-Mauro EL, 1999, J IMMUNOL, V163, P3572; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Hartmann E, 2006, CLIN VACCINE IMMUNOL, V13, P1278, DOI 10.1128/CVI.00172-06; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Isaka M, 1999, VACCINE, V18, P743, DOI 10.1016/S0264-410X(99)00258-3; Kaetzel Charlotte S., 2007, P43, DOI 10.1007/978-0-387-72232-0_3; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Klinman DM, 2009, ADV DRUG DELIVER REV, V61, P248, DOI 10.1016/j.addr.2008.12.012; Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; KURAMOTO E, 1992, JPN J CANCER RES, V83, P1128, DOI 10.1111/j.1349-7006.1992.tb02734.x; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Maeyama J, 2009, VACCINE, V27, P1166, DOI 10.1016/j.vaccine.2008.12.025; McCluskie MJ, 1998, J IMMUNOL, V161, P4463; MCGHEE JR, 1992, VACCINE, V10, P75, DOI 10.1016/0264-410X(92)90021-B; Mellor AL, 2005, J IMMUNOL, V175, P5601, DOI 10.4049/jimmunol.175.9.5601; MIYAMURA K, 1974, J BIOL STAND, V2, P189, DOI 10.1016/0092-1157(74)90015-8; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Osawa Y, 2006, J IMMUNOL, V177, P4841, DOI 10.4049/jimmunol.177.7.4841; Pesce I, 2010, J INNATE IMMUN, V2, P144, DOI 10.1159/000254948; Sagara I, 2009, VACCINE, V27, P7292, DOI 10.1016/j.vaccine.2009.10.087; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Stavnezer J, 2009, J IMMUNOL, V182, P5, DOI 10.4049/jimmunol.182.1.5; Sugai T, 2005, VACCINE, V23, P5450, DOI 10.1016/j.vaccine.2004.09.041; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Takauji R, 2002, J LEUKOCYTE BIOL, V72, P1011; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Wingender G, 2006, EUR J IMMUNOL, V36, P12, DOI 10.1002/eji.200535602; Xin LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034062; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267; YAMAMOTO S, 1992, J IMMUNOL, V148, P4072; YAMAMOTO T, 1994, ANTISENSE RES DEV, V4, P119, DOI 10.1089/ard.1994.4.119	41	13	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e88846	10.1371/journal.pone.0088846	http://dx.doi.org/10.1371/journal.pone.0088846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586411	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700010
J	Zenner, ANRL; O'Callaghan, KM; Griffin, CT				Zenner, Annemie N. R. L.; O'Callaghan, Kathryn M.; Griffin, Christine T.			Lethal Fighting in Nematodes Is Dependent on Developmental Pathway: Male-Male Fighting in the Entomopathogenic Nematode Steinernema longicaudum	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; FIG WASPS; THELASTOMATID NEMATODE; PARASITOID WASP; ACTINIA-EQUINA; COMBAT; COMPETITION; AGGRESSION; CONFLICT; INVERTEBRATES	Aggressive encounters occur between competitors (particularly males) throughout the animal kingdom, and in some species can result in severe injury and death. Here we describe for the first time lethal interactions between male nematodes and provide evidence that the expression of this behaviour is developmentally controlled. Males of the entomopathogenic nematode Steinernema longicaudum coil around each other, resulting in injuries, paralysis and frequently death. The probability of death occurring between pairs of males was affected by the developmental pathway followed, being much greater among males that had passed through the infective juvenile (IJ, or dauer) stage than among males that had not. Post-IJ males are found only in newly colonised hosts, typically with few competing males present. Killing those few competitors may secure valuable resources (both females and a host cadaver for nourishment of offspring). Non-IJ males develop in subsequent generations within a host cadaver, where the presence of many closely related male competitors increases the risk: benefit ratio of fighting. Thus, passage through the IJ stage primes males for enhanced aggression in circumstances where this is more likely to result in increased reproductive success. Fighting occurred between males developing in mixed-sex social groups, indicating that it is an evolved trait and not an abnormal response to absence of females. This is supported by finding high mortality of males, but not of females, across a range of population densities in insect cadavers. We propose that these nematodes, with their relatively simple organization, may be a useful model for studies of aggression.	[Zenner, Annemie N. R. L.; O'Callaghan, Kathryn M.; Griffin, Christine T.] Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland	Maynooth University	Griffin, CT (corresponding author), Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland.	Christine.griffin@nuim.ie		Griffin, Christine/0000-0002-0399-8932	Science Foundation Ireland [05RFP/EEB0009];  [PRTLI 1]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); 	This study was funded by (1) PRTLI 1, administered by the Higher Education Authority of Ireland (www.hea.ie) and (2) Science Foundation Ireland Grant number 05RFP/EEB0009 ( www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2005, BEHAV ECOL SOCIOBIOL, V57, P366, DOI 10.1007/s00265-004-0861-y; ABELE LG, 1977, SCIENCE, V197, P81, DOI 10.1126/science.867055; ADAMSON ML, 1992, J PARASITOL, V78, P420, DOI 10.2307/3283638; Anderson C, 2003, BEHAV ECOL, V14, P54, DOI 10.1093/beheco/14.1.54; [Anonymous], 2005, WORMBOOK ONL REV C E; Bailey NW, 2009, TRENDS ECOL EVOL, V24, P439, DOI 10.1016/j.tree.2009.03.014; Baliadi Y, 2004, APPL ENTOMOL ZOOL, V39, P61, DOI 10.1303/aez.2004.61; Bean D, 2001, ANIM BEHAV, V62, P535, DOI 10.1006/anbe.2001.1779; Calahorro F, 2011, INVERTEBR NEUROSCI, V11, P73, DOI 10.1007/s10158-011-0126-1; Chasnov JR, 2011, EVOLUTION, V65, P2117, DOI 10.1111/j.1558-5646.2011.01272.x; Ciche TA, 2006, BIOL CONTROL, V38, P22, DOI 10.1016/j.biocontrol.2005.11.016; Cook JM, 2006, ANIM BEHAV, V71, P1095, DOI 10.1016/j.anbehav.2005.07.027; Cook JM, 1999, TRENDS ECOL EVOL, V14, P257, DOI 10.1016/S0169-5347(99)01661-4; COOMANS A, 1988, ZOOL SCR, V17, P15, DOI 10.1111/j.1463-6409.1988.tb00083.x; Curran KP, 2012, INVERTEBR NEUROSCI, V12, P81, DOI 10.1007/s10158-012-0140-y; DeCarvalho TN, 2004, ANIM BEHAV, V68, P473, DOI 10.1016/j.anbehav.2003.08.033; Del Giudice M, 2009, DEV REV, V29, P1, DOI 10.1016/j.dr.2008.09.001; Dillman AR, 2012, P NATL ACAD SCI USA, V109, pE2324, DOI 10.1073/pnas.1211436109; Emmons SW, 2012, SCIENCE, V338, P475, DOI 10.1126/science.1230251; Emmons SW, 2003, J NEUROBIOL, V54, P93, DOI 10.1002/neu.10163; ENQUIST M, 1990, ANIM BEHAV, V39, P1, DOI 10.1016/S0003-3472(05)80721-3; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Garcia LR, 2007, GENETICS, V175, P1761, DOI 10.1534/genetics.106.068304; Gaugler R., 2002, ENTOMOPATHOGENIC NEM; Gems D, 2000, GENETICS, V154, P1597; Giron D, 2004, NATURE, V430, P676, DOI 10.1038/nature02721; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Hall SE, 2013, RNA, V19, P306, DOI 10.1261/rna.036418.112; Hall SE, 2010, CURR BIOL, V20, P149, DOI 10.1016/j.cub.2009.11.035; HAMILTON WD, 1979, REPROD COMPETITION M, P167; Harari AR, 2000, P ROY SOC B-BIOL SCI, V267, P2071, DOI 10.1098/rspb.2000.1251; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Innocent TM, 2007, BEHAV ECOL, V18, P709, DOI 10.1093/beheco/arm034; Innocent TM, 2011, BEHAV ECOL, V22, P923, DOI 10.1093/beheco/arq209; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kaya Harry K., 1997, P281, DOI 10.1016/B978-012432555-5/50016-6; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Kureck IM, 2011, ANIM BEHAV, V82, P339, DOI 10.1016/j.anbehav.2011.05.008; LEIMAR O, 1991, EVOLUTION, V45, P862, DOI 10.1111/j.1558-5646.1991.tb04355.x; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Marco A, 2002, ETHOL ECOL EVOL, V14, P1; Moore JC, 2003, ANIM BEHAV, V66, P1101, DOI 10.1006/anbe.2003.2304; Murfin KE, 2012, BIOL BULL-US, V223, P85, DOI 10.1086/BBLv223n1p85; MURRAY MG, 1987, ANIM BEHAV, V35, P488, DOI 10.1016/S0003-3472(87)80274-9; MURRAY MG, 1989, ANIM BEHAV, V38, P186, DOI 10.1016/S0003-3472(89)80081-8; Poinar G.O. Jr, 1990, P23; POPIEL I, 1989, PARASITOLOGY, V99, P77, DOI 10.1017/S0031182000061047; Reinholdt K, 2003, P ROY SOC B-BIOL SCI, V270, P1171, DOI 10.1098/rspb.2003.2368; Rose JK, 2005, J NEUROSCI, V25, P7159, DOI 10.1523/JNEUROSCI.1833-05.2005; Rudin FS, 2012, P ROY SOC B-BIOL SCI, V279, P1904, DOI 10.1098/rspb.2011.2418; Rudin FS, 2011, BEHAV ECOL, V22, P1278, DOI 10.1093/beheco/arr125; Ryne C, 2009, ANIM BEHAV, V78, P1471, DOI 10.1016/j.anbehav.2009.09.033; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Tailliez P, 2006, INT J SYST EVOL MICR, V56, P2805, DOI 10.1099/ijs.0.64287-0; van Wilgenburg E, 2005, BEHAVIOUR, V142, P701, DOI 10.1163/1568539054729150; Yeh SR, 1996, SCIENCE, V271, P366, DOI 10.1126/science.271.5247.366; Zammit J, 2000, ANIM BEHAV, V60, P695, DOI 10.1006/anbe.2000.1522; ZERVOS S, 1988, PARASITOLOGY, V96, P353, DOI 10.1017/S0031182000058340; ZERVOS S, 1988, PARASITOLOGY, V96, P369, DOI 10.1017/S0031182000058352; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164; Zwarts L, 2012, FLY, V6, P35, DOI 10.4161/fly.19249	63	29	29	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89385	10.1371/journal.pone.0089385	http://dx.doi.org/10.1371/journal.pone.0089385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586738	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000331880700035
J	Deng, J; You, QH; Gao, Y; Yu, Q; Zhao, P; Zheng, YL; Fang, WJ; Xu, N; Teng, LS				Deng, Jing; You, Qihan; Gao, Yang; Yu, Qing; Zhao, Peng; Zheng, Yulong; Fang, Weijia; Xu, Nong; Teng, Lisong			Prognostic Value of Perineural Invasion in Gastric Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							EXPRESSION; RECURRENCE; SURVIVAL; ASSOCIATION; RESECTION	Background: The prognostic role of perineural invasion in gastric cancer is controversial. Here, we present a systemic review and meta-analysis of the association between perineural invasion and survival in resectable gastric cancer patients. Methods: A comprehensive literature search for relevant reports published up to April 2013 was performed using PubMed, Embase, Web of Science and Wanfang Data. Studies that investigated the role of perineural invasion with a sample size greater than 100 were included and analyzed. Results: A total of 30,590 gastric cancer patients who had undergone curative gastrectomy from twenty-four studies were included. The median rate of perineural invasion positive was 40.9% (6.8%-75.6%). Fourteen studies investigated overall survival unadjusted for other variables in 23,233 gastric cancer patients. The relative hazard estimates ranged from 0.568-7.901 with a combined random effects estimate of 2.261 (95% CI = 1.841-2.777, P = 0.000). The effect of perineural invasion on overall survival adjusted for other prognostic factors was reported in 17 studies incorporating 8,551 cases. The hazard estimates ranged from 0.420-8.110 with a pooled random effects estimates of 1.484 (95% CI = 1.237-1.781, P = 0.000). There was heterogeneity between the studies (Q = 49.22, I-squared = 67.5%, P = 0.000). Disease-free survival was investigated adjusted in four studies incorporating 9,083 cases and the pooled fixed hazard ratio estimate was 1.371(95% CI = 1.2301.527, P = 0.000). Conclusion: Perineural invasion is an independent prognostic factor affecting overall survival and disease-free survival of gastric cancer patients who had undergone the curative resection. This effect is independent of lymph node status, tumor size and the depth of invasion as well as a range of other biological variables on multivariate analysis. Large prospective studies are now needed to establish perineural invasion as an independent prognostic marker for gastric cancer.	[Deng, Jing; Zhao, Peng; Zheng, Yulong; Fang, Weijia; Xu, Nong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [You, Qihan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Gao, Yang; Yu, Qing] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Teng, Lisong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Xu, N (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	xunonghz@163.com	yu, qing/HGC-4611-2022; Zhao, Peng/HDO-7507-2022		Medical Science and Technology Program; Health Bureau of Zhejiang Province [2013KYB118]; Medicine Research Fund Projects; Administration of Traditional Chinese Medicine of Zhejiang Province [2011ZB071, 2013ZA073]	Medical Science and Technology Program; Health Bureau of Zhejiang Province; Medicine Research Fund Projects; Administration of Traditional Chinese Medicine of Zhejiang Province	This work was supported by Medical Science and Technology Program granted by Health Bureau of Zhejiang Province (No. 2013KYB118)(URL:http://www.zjwst.gov.cn/) and Medicine Research Fund Projects granted by Administration of Traditional Chinese Medicine of Zhejiang Province (No.2011ZB071; No.2013ZA073)(URL: http://www.zjtcm.gov.cn/public/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson P, 2004, COCHRANE LIB, P102; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bickenbach KA, 2013, ANN SURG ONCOL, V20, P2663, DOI 10.1245/s10434-013-2950-5; Bilici A, 2010, ANN SURG ONCOL, V17, P2037, DOI 10.1245/s10434-010-1027-y; Callagy GM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-153; Chiaravalli AM, 2001, VIRCHOWS ARCH, V439, P158, DOI 10.1007/s004280100441; Choi MG, 2009, EUR SURG RES, V42, P223, DOI 10.1159/000208521; Choi MG, 2012, CANCER-AM CANCER SOC, V118, P5227, DOI 10.1002/cncr.27541; Chou HH, 2013, AM J SURG, V205, P623, DOI 10.1016/j.amjsurg.2012.04.014; Costa WL, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-169; Deng J, 2012, ESMO 14 WORLD C GAST; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duraker N, 2003, SURG TODAY, V33, P95, DOI 10.1007/s005950300020; Fondevila C, 2004, BRIT J CANCER, V90, P206, DOI 10.1038/sj.bjc.6601455; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Honghu X, 2010, CHIN J GASTROINTEST, P413; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Kim DH, 2013, ANN SURG ONCOL, V20, P2317, DOI 10.1245/s10434-012-2700-0; Kim JW, 2013, CANCER CHEMOTH PHARM, V71, P1435, DOI 10.1007/s00280-013-2141-x; Kwon KJ, 2013, GASTRIC CANC; Li P, 2011, CHINESE CLIN ONCOLOG, V16, P97; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Luo TH, 2008, J GASTROINTEST SURG, V12, P1263, DOI 10.1007/s11605-008-0529-4; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Ryu WS, 2012, J SURG ONCOL, V106, P456, DOI 10.1002/jso.23097; Scartozzi M, 2006, BRIT J CANCER, V95, P445, DOI 10.1038/sj.bjc.6603286; Selcukbiricik F, 2012, ASIAN PAC J CANCER P, V13, P3149, DOI 10.7314/APJCP.2012.13.7.3149; Setala L, 2001, HISTOPATHOLOGY, V38, P13, DOI 10.1046/j.1365-2559.2001.01038.x; Setala LP, 1996, BRIT J CANCER, V74, P766, DOI 10.1038/bjc.1996.434; Smith GD, 1997, LANCET, V350, P1182, DOI 10.1016/S0140-6736(05)63833-0; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; TANAKA A, 1994, CANCER-AM CANCER SOC, V73, P550, DOI 10.1002/1097-0142(19940201)73:3<550::AID-CNCR2820730309>3.0.CO;2-0; Tural D, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-234; Ueno H, 2013, AM J SURG PATHOL, V37, P1542, DOI 10.1097/PAS.0b013e318297ef6e; Wang Chia-Siu, 2002, Chang Gung Med J, V25, P216; Wen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059154	37	73	84	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88907	10.1371/journal.pone.0088907	http://dx.doi.org/10.1371/journal.pone.0088907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586437	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900037
J	Fukami, K; Yamagishi, S; Iida, S; Matsuoka, H; Okuda, S				Fukami, Kei; Yamagishi, Sho-ichi; Iida, Shuji; Matsuoka, Hidehiro; Okuda, Seiya			Involvement of Iron-Evoked Oxidative Stress in Smoking-Related Endothelial Dysfunction in Healthy Young Men	PLOS ONE			English	Article							THERAPY; PRODUCTS; SMOKERS; SERUM; RISK	Background: Oxidative stress and smoking contribute to endothelial dysfunction. Iron might also play a role in oxidative stress generation and endothelial dysfunction. However, the involvement of iron in smoking-induced endothelial dysfunction in healthy smokers remains unclear. Therefore, we examined here whether (1) intravenous iron infusion impaired endothelial function evaluated by flow-mediated vasodilatation (FMD) in non-smokers, and (2) deferoxamine, a potent iron chelator, ameliorated endothelial dysfunction in healthy smokers. Methods: Eight healthy young male non-smokers (23 +/- 4 years old) received intravenous injection of saccharated ferric oxide (0.7 mg/kg body weight), while 10 age-matched healthy male smokers received deferoxamine mesylate (8.3 mg/kg body weight). At baseline, 5 and 20 minutes after treatment with iron or deferoxamine, biochemical variables were measured, including serum iron and marondialdehyde (MDA), a marker of lipid oxidation, and endothelial function was simultaneously evaluated by FMD. Results: Compared with non-smokers, FMD was significantly lower in smokers. Iron and MDA levels were significantly increased, whereas FMD was impaired by iron infusion in non-smokers. Conversely, deferoxamine treatment significantly decreased iron and MDA levels and restored the decreased FMD in smokers. Baseline serum iron and MDA levels in all 18 subjects (non-smokers and smokers) were correlated with each other. There was a significant inverse correlation between the changes in MDA values and FMD from baseline in 18 men. Endothelium-independent vasodilation by glyceryl trinitrate was unaltered by either treatment. Conclusions: Our present study suggests that iron-evoked oxidative stress might play a role in endothelial dysfunction in healthy smokers.	[Fukami, Kei; Iida, Shuji; Okuda, Seiya] Kurume Univ, Sch Med, Dept Med, Div Nephrol, Kurume, Fukuoka 830, Japan; [Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan; [Matsuoka, Hidehiro] Kurume Univ, Sch Med, Dept Med, Div Cardiovasc Med, Kurume, Fukuoka 830, Japan	Kurume University; Kurume University; Kurume University	Fukami, K (corresponding author), Kurume Univ, Sch Med, Dept Med, Div Nephrol, Kurume, Fukuoka 830, Japan.	fukami@med.kurume-u.ac.jp; shoichi@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22590904]; MEXT; Grants-in-Aid for Scientific Research [25461239] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Diabetic Nephropathy Research from the Ministry of Health, Labour and Welfare, for Scientific Research (C) (no. 22590904) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KF) and by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qaisi M, 2008, VASC HEALTH RISK MAN, V4, P647, DOI 10.2147/VHRM.S2769; Ando R, 2013, DIABETES VASC DIS RE, V10, P436, DOI 10.1177/1479164113486662; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Bo S, 2013, CURR MED CHEM, V20, P1323, DOI 10.2174/0929867311320100009; Bolanos Luis, 2008, Adv Perit Dial, V24, P90; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Drueke T, 2002, CIRCULATION, V106, P2212, DOI 10.1161/01.CIR.0000035250.66458.67; Duffy SJ, 2001, CIRCULATION, V103, P2799; FONTECAVE M, 1993, BIOCHIMIE, V75, P767, DOI 10.1016/0300-9084(93)90126-D; Fratta Pasini A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030291; Ganguli A, 2009, RENAL FAILURE, V31, P106, DOI 10.1080/08860220802599106; Ganz T, 2005, CELL METAB, V1, P155, DOI 10.1016/j.cmet.2005.02.005; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Juni RP, 2013, J AM COLL CARDIOL, V61, P1471, DOI 10.1016/j.jacc.2012.11.068; Ozkurt S, 2012, RENAL FAILURE, V34, P1, DOI 10.3109/0886022X.2011.623492; Poredos P, 2013, J ATHEROSCLER THROMB, V20, P1; Reis KA, 2005, INT HEART J, V46, P255, DOI 10.1536/ihj.46.255; Rooyakkers TM, 2002, EUR J CLIN INVEST, V32, P9, DOI 10.1046/j.1365-2362.2002.0320s1009.x; Schaller G, 2005, KIDNEY INT, V68, P2814, DOI 10.1111/j.1523-1755.2005.00754.x; Seet RCS, 2011, FREE RADICAL BIO MED, V50, P1787, DOI 10.1016/j.freeradbiomed.2011.03.019; Stirban A, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/968761; Swarnalatha G, 2010, SAUDI J KIDNEY DIS T, V21, P852; Tang YR, 2003, BIOL TRACE ELEM RES, V92, P97, DOI 10.1385/BTER:92:2:97; Tremblay AJ, 2004, CLIN BIOCHEM, V37, P785, DOI 10.1016/j.clinbiochem.2004.03.008; Yamagishi S, 2008, CURR PHARM DESIGN, V14, P2613, DOI 10.2174/138161208786071326	28	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89433	10.1371/journal.pone.0089433	http://dx.doi.org/10.1371/journal.pone.0089433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586777	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900096
J	Randau, TM; Friedrich, MJ; Wimmer, MD; Reichert, B; Kuberra, D; Stoffel-Wagner, B; Limmer, A; Wirtz, DC; Gravius, S				Randau, Thomas M.; Friedrich, Max J.; Wimmer, Matthias D.; Reichert, Ben; Kuberra, Dominik; Stoffel-Wagner, Birgit; Limmer, Andreas; Wirtz, Dieter C.; Gravius, Sascha			Interleukin-6 in Serum and in Synovial Fluid Enhances the Differentiation between Periprosthetic Joint Infection and Aseptic Loosening	PLOS ONE			English	Article							KNEE ARTHROPLASTY; TOTAL HIP; DIAGNOSIS; MARKERS; GUIDELINES; COUNT	The preoperative differentiation between septic and aseptic loosening after total hip or knee arthroplasty is essential for successful therapy and relies in part on biomarkers. The objective of this study was to assess synovial and serum levels of inflammatory proteins as diagnostic tool for periprosthetic joint infection and compare their accuracy with standard tests. 120 patients presenting with a painful knee or hip endoprosthesis for surgical revision were included in this prospective trial. Blood samples and samples of intraoperatively acquired joint fluid aspirate were collected. White blood cell count, Creactive protein, procalcitonin and interleukin-6 were determined. The joint aspirate was analyzed for total leukocyte count and IL-6. The definite diagnosis of PJI was determined on the basis of purulent synovial fluid, histopathology and microbiology. IL-6 in serum showed significantly higher values in the PJI group as compared to aseptic loosening and control, with specificity at 58.3% and a sensitivity of 79.5% at a cut-off value of 2.6 pg/ml. With a cut-off > 6.6 pg/ml, the specificity increased to 88.3%. IL-6 in joint aspirate had, at a cut-off of > 2100 pg/ml, a specificity of 85.7% and sensitivity of 59.4%. At levels > 9000 pg/ml, specificity was almost at 100% with sensitivity just below 50%, so PJI could be considered proven with IL-6 levels above this threshold. Our data supports the published results on IL-6 as a biomarker in PJI. In our large prospective cohort of revision arthroplasty patients, the use of IL-6 in synovial fluid appears to be a more accurate marker than either the white blood cell count or the C-reactive protein level in serum for the detection of periprosthetic joint infection. On the basis of the results we recommend the use of the synovial fluid biomarker IL-6 for the diagnosis of periprosthetic joint infection following total hip and knee arthroplasty.	[Randau, Thomas M.; Friedrich, Max J.; Wimmer, Matthias D.; Reichert, Ben; Kuberra, Dominik; Limmer, Andreas; Wirtz, Dieter C.; Gravius, Sascha] Univ Clin Bonn, Dept Orthoped & Trauma Surg, Bonn, Germany; [Stoffel-Wagner, Birgit] Univ Clin Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany	University of Bonn; University of Bonn	Gravius, S (corresponding author), Univ Clin Bonn, Dept Orthoped & Trauma Surg, Bonn, Germany.	sascha.gravius@ukb.uni-bonn.de	Randau, Thomas/AAY-8690-2021; Randau, Thomas Martin/AEP-9749-2022	Randau, Thomas Martin/0000-0002-5224-9639	Deutsch Arthrose-Hilfe e.V.	Deutsch Arthrose-Hilfe e.V.	This study was funded by a grant from the "Deutsch Arthrose-Hilfe e.V.'' (http://www.arthrose.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MS, 2008, J ARTHROPLASTY, V23, P65, DOI 10.1016/j.arth.2007.09.005; Bare J, 2006, CLIN ORTHOP RELAT R, P40, DOI 10.1097/01.blo.0000218727.14097.d5; Berbari E, 2010, J BONE JOINT SURG AM, V92A, P2102, DOI 10.2106/JBJS.I.01199; Bottner F, 2007, J BONE JOINT SURG BR, V89B, P94, DOI 10.1302/0301-620X.89B1.17485; Buttaro MA, 2010, CLIN ORTHOP RELAT R, V468, P3263, DOI 10.1007/s11999-010-1451-0; Deirmengian C, 2010, CLIN ORTHOP RELAT R, V468, P2017, DOI 10.1007/s11999-010-1298-4; Della Valle CJ, 2007, J ARTHROPLASTY, V22, P90, DOI 10.1016/j.arth.2007.04.013; Di Cesare PE, 2005, J BONE JOINT SURG AM, V87A, P1921, DOI 10.2106/JBJS.D.01803; Frommelt L, 2004, ORTHOPADE, V33, P822, DOI 10.1007/s00132-004-0677-5; Ghanem E, 2009, INT J INFECT DIS, V13, pE444, DOI 10.1016/j.ijid.2009.02.017; Glehr M, 2013, CLIN ORTHOP RELAT R, V471, P2621, DOI 10.1007/s11999-013-2998-3; Gollwitzer H, 2013, J BONE JOINT SURG AM, V95A, P644, DOI 10.2106/JBJS.L.00205; Jamsen E, 2009, J BONE JOINT SURG AM, V91A, P38, DOI 10.2106/JBJS.G.01686; Johnson AJ, 2011, INT ORTHOP, V35, P1621, DOI 10.1007/s00264-010-1175-5; Mihara M, CLIN SCI LOND, V122, P143; Morawietz L, 2006, J CLIN PATHOL, V59, P591, DOI 10.1136/jcp.2005.027458; Nilsdotter-Augustinsson A, 2007, ACTA ORTHOP, V78, P629, DOI 10.1080/17453670710014329; Nishimoto N, CLIN PHARM THER, V87, P483; Osmon DR, 2013, CLIN INFECT DIS, V56, DOI [10.1093/cid/cis803, 10.1093/cid/cis966]; Parvizi J, 2006, J BONE JOINT SURG AM, V88A, P138, DOI 10.2106/JBJS.F.00609; Parvizi J, 2011, CLIN ORTHOP RELAT R, V469, P3022, DOI 10.1007/s11999-011-1971-2; Peersman G, 2001, CLIN ORTHOP RELAT R, P15, DOI 10.1097/00003086-200111000-00003; Schinsky MF, 2008, J BONE JOINT SURG AM, V90A, P1869, DOI 10.2106/JBJS.G.01255; Segawa H, 1999, J BONE JOINT SURG AM, V81A, P1434, DOI 10.2106/00004623-199910000-00008; Toossi N, 2012, J ARTHROPLASTY, V27, P51, DOI 10.1016/j.arth.2012.03.021; Trampuz A, 2004, AM J MED, V117, P556, DOI 10.1016/j.amjmed.2004.06.022; Trampuz Andrej, 2005, Curr Opin Investig Drugs, V6, P185; Weiss S, 2006, ORTHOPADE, V35, P456, DOI 10.1007/s00132-005-0900-z; Wimmer MD, 2013, INT ORTHOP; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	30	85	93	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89045	10.1371/journal.pone.0089045	http://dx.doi.org/10.1371/journal.pone.0089045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586496	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900045
J	Slone, JS; Chunda-Liyoka, C; Perez, M; Mutalima, N; Newton, R; Chintu, C; Kankasa, C; Chipeta, J; Heimburger, DC; Vermund, SH; Friedman, DL				Slone, Jeremy S.; Chunda-Liyoka, Catherine; Perez, Marta; Mutalima, Nora; Newton, Robert; Chintu, Chifumbe; Kankasa, Chipepo; Chipeta, James; Heimburger, Douglas C.; Vermund, Sten H.; Friedman, Debra L.			Pediatric Malignancies, Treatment Outcomes and Abandonment of Pediatric Cancer Treatment in Zambia	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDHOOD CANCERS; SOCIOECONOMIC-STATUS; DEVELOPING-COUNTRIES; HIV CARE; CHILDREN; MALAWI; AFRICA; PREDICTORS; LYMPHOMA	Background: There exist significant challenges to the receipt of comprehensive oncologic treatment for children diagnosed with cancer in sub-Saharan Africa. To better define those challenges, we investigated treatment outcomes and risk factors for treatment abandonment in a cohort of children diagnosed with cancer at the University Teaching Hospital (UTH), the site of the only pediatric oncology ward in Zambia. Methods: Using an established database, a retrospective cohort study was conducted of children aged 0-15 years admitted to the pediatric oncology ward between July 2008 and June 2010 with suspected cancer. Diagnosis, mode of diagnosis, treatment outcome, and risk factors for abandonment of treatment were abstracted from this database and clinical medical records. Results: Among 162 children treated at the UTH during the study time period that met inclusion criteria, only 8.0% completed a treatment regimen with most of the patients dying during treatment or abandoning care. In multivariable analysis, shorter distance from home to the UTH was associated with a lower risk of treatment abandonment (Adjusted Odds Ratio [aOR] = 0.48 (95% confidence interval [CI] 0.23-0.97). Conversely maternal education less than secondary school was associated with increased risk for abandonment (aOR = 1.65; 95% CI 1.05-2.58). Conclusions: Despite availability of dedicated pediatric oncology treatment, treatment completion rates are poor, due in part to the logistical challenges faced by families, low educational status, and significant distance from the hospital. Alternative treatment delivery strategies are required to bring effective pediatric oncology care to the patients in need, as their ability to come to and remain at a central tertiary care facility for treatment is limited. We suggest that the extensive system now in place in most of sub-Saharan Africa that sustains life-long antiretroviral therapy for children with human immunodeficiency virus (HIV) infection be adapted for pediatric cancer treatment to improve outcome.	[Slone, Jeremy S.; Friedman, Debra L.] Vanderbilt Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, Nashville, TN 37212 USA; [Chunda-Liyoka, Catherine; Chintu, Chifumbe; Kankasa, Chipepo; Chipeta, James] Univ Teaching Hosp, Dept Pediat & Child Hlth, Lusaka, Zambia; [Chunda-Liyoka, Catherine; Chintu, Chifumbe; Kankasa, Chipepo; Chipeta, James] Univ Zambia, Sch Med, Lusaka, Zambia; [Perez, Marta] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Mutalima, Nora; Newton, Robert] Univ York, Epidemiol & Canc Stat Grp, York YO10 5DD, N Yorkshire, England; [Newton, Robert] Uganda Virus Res Inst Res Unit Acquired Immune De, Med Res Council, Entebbe, Uganda; [Heimburger, Douglas C.; Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Med, Div Gen Internal Med & Publ Hlth, Nashville, TN 37212 USA; [Heimburger, Douglas C.; Vermund, Sten H.] Vanderbilt Inst Global Hlth, Nashville, TN USA; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Div Pediat Infect Dis, Nashville, TN 37212 USA; [Friedman, Debra L.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Vanderbilt University; University of Zambia; University of Zambia; Vanderbilt University; University of York - UK; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Slone, JS (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, Nashville, TN 37212 USA.	jsslone@txch.org	Slone, Jeremy S./AAW-5762-2021; Chunda-Liyoka, Catherine/AAD-6343-2021; Vermund, Sten/AAD-3592-2020	Slone, Jeremy S./0000-0002-0700-7104; Vermund, Sten/0000-0001-7289-8698	National Institutes of Health [NIH 5 T32 HD 60554-3]; Cancer Research UK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research reported in this publication was supported by the National Institutes of Health under Award Number NIH 5 T32 HD 60554-3. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The original study which led to the creation of the University Teaching Hospital-University of York database was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjorlolo-Johnson G, 2013, JAIDS-J ACQ IMM DEF, V62, pE7, DOI 10.1097/QAI.0b013e3182706401; Arora RS, 2007, PEDIATR BLOOD CANCER, V49, P941, DOI 10.1002/pbc.21127; Badar F, 2009, ASIAN PAC J CANCER P, V10, P753; Bonilla M, 2010, EUR J CANCER, V46, P3280, DOI 10.1016/j.ejca.2010.07.001; Bonilla M, 2009, INT J CANCER, V125, P2144, DOI 10.1002/ijc.24534; Bowa K, 2009, TROP DOCT, V39, P5, DOI 10.1258/td.2008.070450; CHINTU C, 1995, ARCH DIS CHILD, V73, P100, DOI 10.1136/adc.73.2.100; De Boer J D, 2009, Afr J Paediatr Surg, V6, P3, DOI 10.4103/0189-6725.48566; Downing JR, 2002, CANCER CELL, V2, P437, DOI 10.1016/S1535-6108(02)00211-8; Duan YY, 2010, STEM CELLS, V28, P674, DOI 10.1002/stem.315; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Howard SC, 2004, JAMA-J AM MED ASSOC, V291, P2471, DOI 10.1001/jama.291.20.2471; Howard Scott C, 2007, Pediatr Blood Cancer, V48, P364, DOI 10.1002/pbc.21003; Israels T, 2008, PEDIATR BLOOD CANCER, V51, P639, DOI 10.1002/pbc.21703; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; Kellie SJ, 2008, EUR J CANCER, V44, P2388, DOI 10.1016/j.ejca.2008.07.022; Kumar A, 2013, PEDIATR BLOOD CANCER, V60, P771, DOI 10.1002/pbc.24454; Makata AM, 1996, AM J TROP MED HYG, V54, P343, DOI 10.4269/ajtmh.1996.54.343; Mattesini M, 2010, P NATL ACAD SCI USA, V107, P9507, DOI 10.1073/pnas.1004856107; Meremikwu MM, 2005, TROP MED INT HEALTH, V10, P92, DOI 10.1111/j.1365-3156.2004.01348.x; Metzger ML, 2003, LANCET, V362, P706, DOI 10.1016/S0140-6736(03)14228-6; Mgaya EM, 2000, E AFR MED J, V77, P435; Mostert S, 2010, ARCH DIS CHILD, V95, P20, DOI 10.1136/adc.2008.154138; Mostert S, 2006, PEDIATRICS, V118, pE1600, DOI 10.1542/peds.2005-3015; Mostert S, 2012, ASIAN PAC J CANCER P, V13, P6491, DOI 10.7314/APJCP.2012.13.12.6491; Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0; MUKIIBI JM, 1995, E AFR MED J, V72, P25; Mutalima Nora, 2010, Infect Agent Cancer, V5, P5, DOI 10.1186/1750-9378-5-5; Mutalima N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002505; Ndom P, 2008, CAN J UROL, V15, P3909; Pakhomov SV, 2004, ST HEAL T, V107, P411; Ribeiro RC, 2008, LANCET ONCOL, V9, P721, DOI 10.1016/S1470-2045(08)70194-3; Sachdeva A, 2005, PEDIAT BLOOD CANC, V45, P578; Samaila Modupeola Omotara, 2009, Afr J Paediatr Surg, V6, P19, DOI 10.4103/0189-6725.48570; Sinfield RL, 2007, PEDIATR BLOOD CANCER, V48, P515, DOI 10.1002/pbc.20917; Sitaresm MN, 2010, PSYCHO-ONCOLOGY, V19, P361, DOI 10.1002/pon.1578; Spinetta JJ, 2002, MED PEDIATR ONCOL, V38, P114, DOI 10.1002/mpo.1283; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Swaminathan I, 2008, INT J CANCER, V122, P2607, DOI 10.1002/ijc.23428; Sweet-Cordero A., 1999, MED PEDIATR ONCOL, V33, P151; Tanko Na'anlep M, 2009, Afr J Paediatr Surg, V6, P7, DOI 10.4103/0189-6725.48567; Torpey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042859; Tu SW, 2004, STUD HEALTH TECHNOL, V107, P174; Valsecchi MG, 2008, LANCET ONCOL, V9, P159, DOI 10.1016/S1470-2045(08)70028-7; Vermund SH, 2012, AIDS, V26, P1303, DOI 10.1097/QAD.0b013e3283552185	46	50	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89102	10.1371/journal.pone.0089102	http://dx.doi.org/10.1371/journal.pone.0089102			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586527	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900050
J	Sun, JR; Cheng, YH; Lai, PY; Lee, SY; Chou, YC; Fu, YC; Wu, CC; Chiueh, TS				Sun, Jun-Ren; Cheng, Yun-Hsiang; Lai, Pei-Yin; Lee, Shih-Yi; Chou, Yu-Ching; Fu, Yung-Chieh; Wu, Chen-Cheng; Chiueh, Tzong-Shi			Ultraviolet Light Enhances the Bovine Serum Albumin Fixation for Acid Fast Bacilli Stain	PLOS ONE			English	Article							GERMICIDAL IRRADIATION; UV-IRRADIATION; MYCOBACTERIA; CULTURE; DISINFECTION; INACTIVATION; TUBERCULOSIS; SYSTEM; SLIDES	The use of a liquid culture system such as MGIT broth has greatly improved the sensitivity of isolating mycobacteria in clinical laboratories. Microscopic visualization of acid fast bacilli (AFB) in the culture positive MGIT broth remains the first routine step for rapidly indicating the presence of mycobacteria. We modified an ultraviolet (UV) light fixation process to increase AFB cells adherence to the slide. The retained haze proportion of a 1-cm circle marked area on the smear slide was quantified after the staining procedure indicating the adherence degree of AFB cells. More AFB cells were preserved on the slide after exposure to UV light of either germicidal lamp or UV crosslinker in a time-dependent manner. We demonstrated both the bovine serum albumin (BSA) in MGIT media and UV light exposure were required for enhancing fixation of AFB cells. While applying to AFB stains for 302 AFB positive MGIT broths in clinics, more AFB cells were retained and observed on smear slides prepared by the modified fixation procedure rather than by the conventional method. The modified fixation procedure was thus recommended for improving the sensitivity of microscopic diagnosis of AFB cells in culture positive MGIT broth.	[Sun, Jun-Ren; Chiueh, Tzong-Shi] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Sun, Jun-Ren; Cheng, Yun-Hsiang; Lai, Pei-Yin; Chiueh, Tzong-Shi] Triserv Gen Hosp, Div Clin Pathol, Dept Pathol, Taipei, Taiwan; [Lee, Shih-Yi; Fu, Yung-Chieh; Wu, Chen-Cheng] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Div Clin Microbiol, Taipei, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Taipei Veterans General Hospital; National Defense Medical Center	Chiueh, TS (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	drche0523@gmail.com		Sun, jun-ren/0000-0002-8769-9170	Tri-Service General Hospital, Taiwan, Republic of China [TSGH-C102-127, TSGH-C102-175]	Tri-Service General Hospital, Taiwan, Republic of China	This study was supported by grant TSGH-C102-127 and TSGH-C102-175 from the Tri-Service General Hospital, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron EJ, 2010, J CLIN MICROBIOL, V48, P2014, DOI 10.1128/JCM.02503-09; BARTHOLOMEW JW, 1952, J BACTERIOL, V63, P779, DOI 10.1128/JB.63.6.779-783.1952; Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020175; Cejudo-Garcia MA, 2013, J CLIN MICROBIOL, V51, P3400, DOI 10.1128/JCM.00974-13; Cutler Timothy D., 2011, Animal Health Research Reviews, V12, P15, DOI 10.1017/S1466252311000016; DAVID HL, 1971, INFECT IMMUN, V4, P318, DOI 10.1128/IAI.4.3.318-319.1971; Eason Erica, 2003, Can J Infect Dis, V14, P322; Fathima NN, 2011, J PHOTOCH PHOTOBIO B, V105, P203, DOI 10.1016/j.jphotobiol.2011.09.003; Hadad DJ, 2012, J CLIN MICROBIOL, V50, P1440, DOI 10.1128/JCM.05835-11; Huang YM, 2008, LAB CHIP, V8, P1745, DOI 10.1039/b802762e; Kato K, 2003, BIOTECHNIQUES, V35, P1014, DOI 10.2144/03355rr01; Le Berre V, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng088; Li HJ, 2009, J CLIN MICROBIOL, V47, P3814, DOI 10.1128/JCM.01534-09; MANGELS JI, 1984, DIAGN MICR INFEC DIS, V2, P129, DOI 10.1016/0732-8893(84)90008-7; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; Memarzadeh F, 2010, AM J INFECT CONTROL, V38, pS13, DOI 10.1016/j.ajic.2010.04.208; MUROHASHI T, 1965, AM REV RESPIR DIS, V92, P817; MUROHASHI T, 1968, AM REV RESPIR DIS, V97, P306; Pai M, 2012, INT J TUBERC LUNG D, V16, P1281, DOI 10.5588/ijtld.12.0391; Perng CL, 2012, J MED MICROBIOL, V61, P944, DOI 10.1099/jmm.0.042424-0; Reed NG, 2010, PUBLIC HEALTH REP, V125, P15, DOI 10.1177/003335491012500105; Sun JR, 2009, J FORMOS MED ASSOC, V108, P119, DOI 10.1016/S0929-6646(09)60042-5; Williams-Bouyer N, 2000, J CLIN MICROBIOL, V38, P4167, DOI 10.1128/JCM.38.11.4167-4170.2000	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89370	10.1371/journal.pone.0089370	http://dx.doi.org/10.1371/journal.pone.0089370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586725	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900085
J	van der Straten, A; Stadler, J; Montgomery, E; Hartmann, M; Magazi, B; Mathebula, F; Schwartz, K; Laborde, N; Soto-Torres, L				van der Straten, Ariane; Stadler, Jonathan; Montgomery, Elizabeth; Hartmann, Miriam; Magazi, Busiswe; Mathebula, Florence; Schwartz, Katie; Laborde, Nicole; Soto-Torres, Lydia			Women's Experiences with Oral and Vaginal Pre-Exposure Prophylaxis: The VOICE-C Qualitative Study in Johannesburg, South Africa	PLOS ONE			English	Article							HIV PREVENTION; MICROBICIDE ACCEPTABILITY; TREATMENT ADHERENCE; GEL; MOTIVATION; SUPPORT; BARRIER; STIGMA; MODEL; TRIAL	Background: In VOICE, a multisite HIV pre-exposure prophylaxis (PrEP) trial, plasma drug levels pointed to widespread product nonuse, despite high adherence estimated by self-reports and clinic product counts. Using a socio-ecological framework (SEF), we explored socio-cultural and contextual factors that influenced participants' experience of daily vaginal gel and oral tablet regimens in VOICE. Methods: In Johannesburg, a qualitative ancillary study was concurrently conducted among randomly selected VOICE participants assigned to in-depth interviews (n = 41), serial ethnographic interviews (n = 21), or focus group discussions (n = 40). Audiotaped interviews were transcribed, translated, and coded thematically for analysis. Results: Of the 102 participants, the mean age was 27 years, and 96% had a primary sex partner with whom 43% cohabitated. Few women reported lasting nonuse, which they typically attributed to missed visits, lack of product replenishments, and family-related travel or work. Women acknowledged occasionally skipping or mistiming doses because they forgot, were busy, felt lazy or bored, feared or experienced side effects. However, nearly all knew or heard of other study participants who did not use products daily. Three overarching themes emerged from further analyses: ambivalence toward research, preserving a healthy status, and managing social relationships. These themes highlighted the profound and complex meanings associated with participating in a blinded HIV PrEP trial and taking antiretroviral-based products. The unknown efficacy of products, their connection with HIV infection, challenges with daily regimen given social risks, lack of support-from partners and significant others-and the relationship tradeoffs entailed by using the products appear to discourage adequate product use. Conclusions: Personal acknowledgment of product nonuse was challenging. This qualitative inquiry highlighted key influences at all SEF levels that shaped women's perceptions of trial participation and experiences with investigational products. Whether these impacted women's behaviors and may have contributed to ineffective trial results warrants further investigation.	[van der Straten, Ariane; Montgomery, Elizabeth; Hartmann, Miriam; Laborde, Nicole] RTI Int, Womens Global Hlth Imperat, San Francisco, CA 94104 USA; [van der Straten, Ariane] UCSF, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA; [Stadler, Jonathan; Magazi, Busiswe; Mathebula, Florence] Univ Witwatersrand, Sch Clin Med, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Soto-Torres, Lydia] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA	Research Triangle Institute; University of California System; University of California San Francisco; University of Witwatersrand; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	van der Straten, A (corresponding author), RTI Int, Womens Global Hlth Imperat, San Francisco, CA 94104 USA.	ariane@rti.org		Hartmann, Miriam/0000-0001-8109-9679; Montgomery, Elizabeth/0000-0002-5477-4445; van der Straten, Ariane/0000-0001-8536-648X; Stadler, Jonathan/0000-0002-2325-2660	Microbicide Trials Network (MTN) grant; National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Mental Health; U.S. National Institutes of Health (NIH) [5UM1AI068633]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069463, UM1AI068633] Funding Source: NIH RePORTER	Microbicide Trials Network (MTN) grant; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the Microbicide Trials Network (MTN) grant, an HIV/AIDS clinical trials network funded by the National Institute of Allergy and Infectious Diseases with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health (NIH) (5UM1AI068633). This cooperative agreement involved the active collaboration of the sponsor, NIH, with the grant recipients within the MTN. One NIH employee is co-author on this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdool Karim Quarraisha, 2010, Science, V329, P1168, DOI 10.1126/science.1193748; Abdulai MA, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-40; Ambia J., 2013, INT STD RES REV, V1, P12, DOI [10.9734/ISRR/2013/3531, DOI 10.9734/ISRR/2013/3531]; Amico KR, 2011, J HEALTH PSYCHOL, V16, P1071, DOI 10.1177/1359105311398727; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2013, JAIDS-J ACQ IMM DEF, V63, pS122, DOI 10.1097/QAI.0b013e3182986f69; Baeten JM, 2013, CURR HIV-AIDS REP, V10, P142, DOI 10.1007/s11904-013-0157-9; Busza J, 2012, COMMUNITY BASED APPR; Chakrapani V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051080; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cleary S, 2013, SOC SCI MED, V80, P37, DOI 10.1016/j.socscimed.2012.11.035; Corneli A, 2013, ASS RISK PERCEPTION; Crowcroft NS, 2013, LANCET INFECT DIS, V13, P564, DOI 10.1016/S1473-3099(13)70131-2; Dearing JW, 2013, AM J PREV MED, V44, pS70, DOI 10.1016/j.amepre.2012.09.038; Domanska CA, 2012, COLLEGIAN, V19, P23, DOI 10.1016/j.colegn.2011.09.006; Galarraga O, 2013, AIDS BEHAV, V17, P2283, DOI 10.1007/s10461-013-0415-2; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Haberer J, 2012, HIGH ADHERENCE ORAL; Hilber AM, 2012, SOC SCI MED, V74, P1311, DOI 10.1016/j.socscimed.2011.11.032; Karim SSA, 2011, NATURE, V474, P29, DOI 10.1038/474029a; Kincaid DL, 2000, SOC SCI MED, V50, P215, DOI 10.1016/S0277-9536(99)00276-2; Knowlton AR, 2011, AIDS BEHAV, V15, P1429, DOI 10.1007/s10461-010-9749-1; Larios SE, 2009, AIDS CARE, V21, P1335, DOI 10.1080/09540120902803190; Latkin CA, 2005, AIDS CARE, V17, pS102, DOI 10.1080/09540120500121185; Lewis J, 2007, SOC POLICY SOC, V6, P545, DOI 10.1017/S1474746407003880; Marrazzo J, 2013, PREEXPOSURE PROPHYLA; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Minnis AM, 2012, AIDS BEHAV; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Montgomery Catherine M, 2011, J Int AIDS Soc, V14 Suppl 2, pS4, DOI 10.1186/1758-2652-14-S2-S4; Montgomery CM, 2010, CULT HEALTH SEX, V12, P649, DOI 10.1080/13691051003736261; Montgomery E, 2013, MALE PARTNER ROLES I; Montgomery ET, 2012, AIDS BEHAV, V16, P1787, DOI 10.1007/s10461-012-0248-4; Montgomery ET, 2012, CULT HEALTH SEX, V14, P795, DOI 10.1080/13691058.2012.697191; Montgomery ET, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-30; Morrow K, 2003, J WOMENS HEALTH, V12, P655, DOI 10.1089/154099903322404302; Naar-King S, 2006, AIDS CARE, V18, P621, DOI 10.1080/09540120500471895; Namey E, 2005, QUALITATIVE RES METH; Nyblade L, 2011, VACCINE, V29, P8924, DOI 10.1016/j.vaccine.2011.09.067; O'Laughlin KN, 2012, AIDS BEHAV, V16, P1308, DOI 10.1007/s10461-011-0038-4; Parker Richard, 2001, AIDS BEHAV, V5, P105, DOI DOI 10.1023/A:1011399426632; Pool R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011600; Pool R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011632; Remien RH, 2013, AIDS BEHAV, V17, P1979, DOI 10.1007/s10461-013-0438-8; Saethre E, 2013, MED ANTHROPOL Q, V27, P103, DOI 10.1111/maq.12018; Saethre Eirik J, 2010, Anthropol Med, V17, P99, DOI 10.1080/13648470903569396; Sahin-Hodoglugil NN, 2011, AIDS CARE, V23, P1026, DOI 10.1080/09540121.2010.543879; Stadler J, 2010, AJAR-AFR J AIDS RES, V9, P345, DOI 10.2989/16085906.2010.545636; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2013, 8 INT C HIV TREATM P; van der Straten A, 2006, INTRAVAGINAL PRACTIC; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Vander Poorten E. B., 2012, ACTUATOR, P1; Ware NC, 2011, 6 INT C HIV TREATM P; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Woodsong C, 2011, AIDS BEHAV, P1; Woodsong C, 2008, AIDS EDUC PREV, V20, P171, DOI 10.1521/aeap.2008.20.2.171; Woodsong C, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18505, 10.7448/IAS.17.3.19158]	60	191	191	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89118	10.1371/journal.pone.0089118	http://dx.doi.org/10.1371/journal.pone.0089118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3VI	24586534	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900054
J	Yeon, JT; Kim, KJ; Choi, SW; Moon, SH; Park, YS; Ryu, BJ; Oh, J; Kim, MS; Erkhembaatar, M; Son, YJ; Kim, SH				Yeon, Jeong-Tae; Kim, Kwang-Jin; Choi, Sik-Won; Moon, Seong-Hee; Park, Young Sik; Ryu, Byung Jun; Oh, Jaemin; Kim, Min Seuk; Erkhembaatar, Munkhsoyol; Son, Young-Jin; Kim, Seong Hwan			Anti-Osteoclastogenic Activity of Praeruptorin A via Inhibition of p38/Akt-c-Fos-NFATc1 Signaling and PLC gamma-Independent Ca2+ Oscillation	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; CANCER-CELLS; BONE LOSS; C-FOS; DIFFERENTIATION; PATHWAY; RANKL; ACTIVATION; NFATC1; OSTEOIMMUNOLOGY	Background: A decrease of bone mass is a major risk factor for fracture. Several natural products have traditionally been used as herbal medicines to prevent and/or treat bone disorders including osteoporosis. Praeruptorin A is isolated from the dry root extract of Peucedanum praeruptorum Dunn and has several biological activities, but its anti-osteoporotic activity has not been studied yet. Materials and Methods: The effect of praeruptorin A on the differentiation of bone marrow-derived macrophages into osteoclasts was examined by phenotype assay and confirmed by real-time PCR and immunoblotting. The involvement of NFATc1 in the anti-osteoclastogenic action of praeruptorin A was evaluated by its lentiviral ectopic expression. Intracellular Ca2+ levels were also measured. Results: Praeruptorin A inhibited the RANKL-stimulated osteoclast differentiation accompanied by inhibition of p38 and Akt signaling, which could be the reason for praeruptorin A-downregulated expression levels of c-Fos and NFATc1, transcription factors that regulate osteoclast-specific genes, as well as osteoclast fusion-related molecules. The anti-osteoclastogenic effect of praeruptorin A was rescued by overexpression of NFATc1. Praeruptorin A strongly prevented the RANKL-induced Ca2+ oscillation without any changes in the phosphorylation of PLCc. Conclusion: Praeruptorin A could exhibit its anti-osteoclastogenic activity by inhibiting p38/Akt-c-Fos-NFATc1 signaling and PLCc-independent Ca2+ oscillation.	[Yeon, Jeong-Tae; Kim, Kwang-Jin; Son, Young-Jin] Sunchon Natl Univ, Res Inst Basic Sci, Sunchon, South Korea; [Choi, Sik-Won; Moon, Seong-Hee; Ryu, Byung Jun; Kim, Seong Hwan] Korea Res Inst Chem Technol, Div Drug Discovery Res, Pharmacol Res Ctr, Lab Translat Therapeut, Taejon 305606, South Korea; [Moon, Seong-Hee] Chungnam Natl Univ, Dept Biol, Taejon, South Korea; [Park, Young Sik] Natl Inst Food & Drug Safety Evaluat, Herbal Med Res Div, Cheongwon, South Korea; [Park, Young Sik; Kim, Seong Hwan] Chungnam Natl Univ, Grad Sch New Drug Discovery & Dev, Taejon, South Korea; [Oh, Jaemin] Wongkwang Univ, Sch Med, Dept Anat, Iksan, South Korea; [Oh, Jaemin] Wongkwang Univ, Sch Med, Inst Skeletal Dis, Iksan, South Korea; [Kim, Min Seuk; Erkhembaatar, Munkhsoyol] Wongkwang Univ, Sch Dent, Dept Oral Physiol, Iksan, South Korea	Sunchon National University; Korea Research Institute of Chemical Technology (KRICT); Chungnam National University; Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation; Chungnam National University; Wonkwang University; Wonkwang University; Wonkwang University	Son, YJ (corresponding author), Sunchon Natl Univ, Res Inst Basic Sci, Sunchon, South Korea.	sony@sunchon.ac.kr; hwan@krict.re.kr		Choi, Sik-Won/0000-0003-1726-2536	Korea Research Institute of Chemical Technology [SI-1304]; Korea Institute for Advancement of Technology [R0002019]; Korea Ministry of Knowledge Economy; Basic Science Research Program through the National Research Foundation of Korea [NRF-2012R1A1A1038381]; Ministry of Education, Science and Technology (MEST)	Korea Research Institute of Chemical Technology; Korea Institute for Advancement of Technology; Korea Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Korea Research Institute of Chemical Technology project's grant (SI-1304) and the Inter-ER Cooperation Projects (R0002019) of Korea Institute for Advancement of Technology, which were funded by the Korea Ministry of Knowledge Economy. MSK was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF-2012R1A1A1038381), funded by the Ministry of Education, Science and Technology (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel NZ, 2000, J BONE MINER RES, V15, P103, DOI 10.1359/jbmr.2000.15.1.103; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Choi SW, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/748687; Choi SW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/810563; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Del Fattore A, 2008, ARCH BIOCHEM BIOPHYS, V473, P147, DOI 10.1016/j.abb.2008.01.011; Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Fleisch H, 2003, EUR SPINE J, V12, pS142, DOI 10.1007/s00586-003-0622-z; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Ji Y, 1996, Zhongguo Zhong Xi Yi Jie He Za Zhi, V16, P676; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim MH, 2009, J CELL PHYSIOL, V221, P618, DOI 10.1002/jcp.21892; Koide M, 1999, ARCH ORAL BIOL, V44, P711, DOI 10.1016/S0003-9969(99)00067-9; Lee SH, 2008, J BIOL CHEM, V283, P11526, DOI 10.1074/jbc.M708935200; Lee SU, 2010, INT IMMUNOPHARMACOL, V10, P298, DOI 10.1016/j.intimp.2009.11.014; LI JM, 1994, ACTA PHARM SINIC, V15, P525; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Lippuner K, 1997, OSTEOPOROSIS INT, V7, P414, DOI 10.1007/PL00004149; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101; Miyazaki Tsuyoshi, 2006, Mod Rheumatol, V16, P68; Moon JB, 2012, J IMMUNOL, V188, P163, DOI 10.4049/jimmunol.1101254; Morabito N, 2002, J BONE MINER RES, V17, P1904, DOI 10.1359/jbmr.2002.17.10.1904; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Nemeth K, 2011, J IMMUNOL, V186, P13, DOI 10.4049/jimmunol.1002483; Papapetrou PD, 2009, HORM-INT J ENDOCRINO, V8, P96, DOI 10.14310/horm.2002.1226; Rozen S, 2000, Methods Mol Biol, V132, P365; Shen XL, 2006, BIOORGAN MED CHEM, V14, P7138, DOI 10.1016/j.bmc.2006.06.066; Song YL, 2012, XENOBIOTICA, V42, P221, DOI 10.3109/00498254.2011.609250; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2005, J PERIODONTAL RES, V40, P287, DOI 10.1111/j.1600-0765.2005.00814.x; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Wu JYC, 2003, EUR J PHARMACOL, V473, P9, DOI 10.1016/S0014-2999(03)01946-0; Yeon JT, 2012, BMB REP, V45, P171, DOI 10.5483/BMBRep.2012.45.3.171; Yu PJ, 2011, PHYTOTHER RES, V25, P550, DOI 10.1002/ptr.3295; Zhang Cun, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1356	45	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88974	10.1371/journal.pone.0088974	http://dx.doi.org/10.1371/journal.pone.0088974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586466	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900042
J	Mlacki, M; Darido, C; Jane, SM; Wilanowski, T				Mlacki, Michal; Darido, Charbel; Jane, Stephen M.; Wilanowski, Tomasz			Loss of Grainy Head-Like 1 Is Associated with Disruption of the Epidermal Barrier and Squamous Cell Carcinoma of the Skin	PLOS ONE			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTORS; STRIATE PALMOPLANTAR KERATODERMA; GROWTH-FACTOR RECEPTOR; HUMAN LUNG-CANCER; TUMOR-SUPPRESSOR; TRANSGENIC MICE; DIFFERENTIATION COMPLEX; OVARIAN-CANCER; RAS ONCOGENE; MAST-CELLS	The Grainyhead-like 1 (GRHL1) transcription factor regulates the expression of desmosomal cadherin desmoglein 1 (Dsg1) in suprabasal layers of the epidermis. As a consequence, the epidermis of Grhl1-null mice displays fewer desmosomes that are abnormal in structure. These mice also exhibit mild chronic skin barrier defects as evidenced by altered keratinocyte terminal differentiation, increased expression of inflammatory markers and infiltration of the skin by immune cells. Exposure of Grhl1(-/-) mice to a standard chemical skin carcinogenesis protocol results in development of fewer papillomas than in wild type control animals, but with a rate of conversion to squamous cell carcinoma (SCC) that is strikingly higher than in normal littermates. The underlying molecular mechanism differs from mice with conditional ablation of a closely related Grhl family member, Grhl3, in the skin, which develop SCC due to the loss of expression of phosphatase and tensin homolog (PTEN) and activation of the phosphatidylinositol 3-kinase (PI3K)/AKT/mechanistic target of rapamycin (mTOR) signaling pathway.	[Mlacki, Michal; Wilanowski, Tomasz] Nencki Inst Expt Biol, Lab Signal Transduct, Warsaw, Poland; [Darido, Charbel; Jane, Stephen M.] Monash Univ, Dept Med, Cent Clin Sch, Prahran, Vic, Australia; [Jane, Stephen M.] Alfred Hosp, Prahran, Vic 3181, Australia	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Monash University; Florey Institute of Neuroscience & Mental Health	Wilanowski, T (corresponding author), Nencki Inst Expt Biol, Lab Signal Transduct, Warsaw, Poland.	t.wilanowski@nencki.gov.pl	Wilanowski, Tomasz/R-4077-2016; Darido, Charbel/H-2800-2016; Mlacki, Michal/O-2955-2013	Darido, Charbel/0000-0002-6541-324X; Mlacki, Michal/0000-0002-5755-9839; Jane, Stephen Marsden/0000-0002-1045-0481; Wilanowski, Tomasz/0000-0003-4447-8164	European Molecular Biology Organization Installation [2131]; Marie Curie International Reintegration (EU) [256096]; National Science Centre of Poland [2011/03/N/NZ3/01957]; Mazovia Region (Poland and European Social Fund, EU); National Health and Medical Research Council of Australia [628365]; Association for International Cancer Research [11-0060]; Victorian Cancer Agency Clare Oliver Fellowship; Worldwide Cancer Research [11-0060] Funding Source: researchfish	European Molecular Biology Organization Installation; Marie Curie International Reintegration (EU)(European Commission); National Science Centre of Poland(National Science Centre, Poland); Mazovia Region (Poland and European Social Fund, EU); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Association for International Cancer Research; Victorian Cancer Agency Clare Oliver Fellowship; Worldwide Cancer Research	This work was supported by the European Molecular Biology Organization Installation Grant 2131 (http://www.embo.org/), the Marie Curie International Reintegration rant 256096 (FP7, EU)(http://ec.europa.eu/research/mariecurieactions/), the National Science Centre of Poland predoctoral grant 2011/03/N/NZ3/01957 (http://www.ncn.gov.pl/), supporting scholarship for PhD student in the Mazovia Region (Poland and European Social Fund, EU) (MM) (https://www.oeiizk.waw.pl/doktoranci/andhttp://ec.europa.eu/esf/), the National Health and Medical Research Council of Australia grant 628365 (http://www.nhmrc.gov.au/), the Association for International Cancer Research grant 11-0060 (http://www.aicr.org.uk/) and by the Victorian Cancer Agency Clare Oliver Fellowship (CD) (http://www.victoriancanceragency.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KM, 2008, J INVEST DERMATOL, V128, P917, DOI 10.1038/sj.jid.5701099; Aldhous MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006285; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Auden A, 2006, GENE EXPR PATTERNS, V6, P964, DOI 10.1016/j.modgep.2006.03.011; Augustin I, 2013, J EXP MED, V210, P1761, DOI 10.1084/jem.20121871; BAILLEUL B, 1990, CELL, V62, P697, DOI 10.1016/0092-8674(90)90115-U; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; Bangert C, 2011, CLIN DERMATOL, V29, P360, DOI 10.1016/j.clindermatol.2011.01.006; Beaudry VG, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001168; Blanpain C, 2013, NAT CELL BIOL, V15, P126, DOI 10.1038/ncb2657; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; Bolitho C, 2010, ENDOCR-RELAT CANCER, V17, P929, DOI 10.1677/ERC-10-0107; Booth DR, 1998, AMYLOID, V5, P262, DOI 10.3109/13506129809007299; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Breitenbach U, 2001, J INVEST DERMATOL, V117, P634, DOI 10.1046/j.0022-202x.2001.01437.x; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; Christophi GP, 2004, J NEUROCHEM, V91, P1439, DOI 10.1111/j.1471-4159.2004.02826.x; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Cui TT, 2012, CARCINOGENESIS, V33, P2326, DOI 10.1093/carcin/bgs273; Dang H, 2006, MOL CARCINOGEN, V45, P126, DOI 10.1002/mc.20154; Darash-Yahana M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006695; Darido C, 2011, CANCER CELL, V20, P635, DOI 10.1016/j.ccr.2011.10.014; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Deng L, 2010, BBA-REV CANCER, V1806, P42, DOI 10.1016/j.bbcan.2010.01.004; Devoogdt N, 2004, ANN NY ACAD SCI, V1028, P380, DOI 10.1196/annals.1322.044; Dusek RL, 2011, NAT REV CANCER, V11, P317, DOI 10.1038/nrc3051; Frame S, 2000, CURR OPIN GENET DEV, V10, P106, DOI 10.1016/S0959-437X(99)00052-0; Franzen CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042132; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Greenhalgh DA, 1996, CANCER RES, V56, P4413; Hainaut P, 2009, LANCET ONCOL, V10, P913, DOI 10.1016/S1470-2045(09)70198-6; Hardman MJ, 2005, AM J PATHOL, V167, P1561, DOI 10.1016/S0002-9440(10)61241-2; Hayes KR, 2005, MOL PHARMACOL, V67, P1360, DOI 10.1124/mol.104.009175; He DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032126; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hoffjan S, 2007, BRIT J DERMATOL, V157, P441, DOI 10.1111/j.1365-2133.2007.07999.x; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hunt DM, 2001, EUR J HUM GENET, V9, P197, DOI 10.1038/sj.ejhg.5200605; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; JARVINEN M, 1987, ACTA HISTOCHEM, V82, P5; KARASHIMA S, 1990, INT J CANCER, V45, P244, DOI 10.1002/ijc.2910450207; Kawanishi H, 2008, CLIN CANCER RES, V14, P2579, DOI 10.1158/1078-0432.CCR-07-1922; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; KITAMURA Y, 1978, BLOOD, V52, P447; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Kos J, 2000, CLIN CANCER RES, V6, P505; Kottke MD, 2006, J CELL SCI, V119, P797, DOI 10.1242/jcs.02888; KUSHNER I, 1988, METHOD ENZYMOL, V163, P373; Lukanidin E, 2012, SEMIN CANCER BIOL, V22, P216, DOI 10.1016/j.semcancer.2012.02.006; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Milan E, 2012, J PROTEOMICS, V76, P91, DOI 10.1016/j.jprot.2012.06.022; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Moshkovskii SA, 2007, PROTEOM CLIN APPL, V1, P107, DOI 10.1002/prca.200600229; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Oh ST, 2009, DERM-ENDOCRINOL, V1, P114, DOI 10.4161/derm.1.2.7750; Ohtani H, 2009, J PATHOL, V217, P21, DOI 10.1002/path.2448; Pappas P, 2003, CHEM-BIOL INTERACT, V143, P55, DOI 10.1016/S0009-2797(02)00172-2; Patel S, 2003, MAMM GENOME, V14, P140, DOI 10.1007/s00335-002-2205-4; Rickman L, 1999, HUM MOL GENET, V8, P971, DOI 10.1093/hmg/8.6.971; Rohrl J, 2012, J IMMUNOL, V188, P4931, DOI 10.4049/jimmunol.1102442; Sallenave J M, 2000, Respir Res, V1, P87, DOI 10.1186/rr18; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Sundberg JP, 1997, MOL CARCINOGEN, V20, P19, DOI 10.1002/(SICI)1098-2744(199709)20:1<19::AID-MC4>3.0.CO;2-D; Ting SB, 2003, BIOCHEM J, V370, P953, DOI 10.1042/BJ20021476; Walser TC, 2007, J IMMUNOTHER, V30, P490, DOI 10.1097/CJI.0b013e318031b551; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; Wilanowski T, 2008, EMBO J, V27, P886, DOI 10.1038/emboj.2008.24; Yang LL, 2012, CARCINOGENESIS, V33, P1863, DOI 10.1093/carcin/bgs226; Yasuda S, 2005, BLOOD, V105, P3893, DOI 10.1182/blood-2003-10-3501	70	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89247	10.1371/journal.pone.0089247	http://dx.doi.org/10.1371/journal.pone.0089247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586629	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700081
J	Ji, WT; Chen, HR; Lin, CH; Lee, JW; Lee, CC				Ji, Wen-Tsai; Chen, Hau-Ren; Lin, Chun-Hsuan; Lee, Jeng-Woei; Lee, Ching-Chih			Monocyte Chemotactic Protein 1 (MCP-1) Modulates Pro-Survival Signaling to Promote Progression of Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							CHEMOATTRACTANT PROTEIN-1; EXPRESSION; GROWTH; AKT; PHOSPHORYLATION; INTERLEUKIN-6; ANGIOGENESIS; RECEPTOR; PATHWAY; TRANSCRIPTION	Background: Monocyte chemotactic protein-1 (MCP-1) recruits monocytes and macrophages to inflammation sites, and inflammatory infiltration correlates with the progression of head and neck squamous cell carcinoma (HNSCC). This study aims to determine whether MCP-1 expression is related to HNSCC malignancy and patient survival. We also investigated the relationship between MCP-1 expression and the phosphorylation state of the pro-survival pathway factors Akt, ERK, and STAT3. Methods: Expression of MCP-1 and related proteins in HNSCC cell lines was investigated using western blotting. HNSCC patients (34) without distant metastasis at diagnosis were recruited for tissue specimen evaluation of MCP-1 expression and clinical outcomes. The relationship between MCP-1 expression and survival was evaluated using the Cox proportional hazard model with stepwise selection. Results: High-grade HNSCC cell lines were found to have higher levels of active Akt, ERK, and/or STAT3 than did lower grade cell lines under serum-free condition. OCSL, the most malignant cell line, had the highest level of endogenous MCP-1. Administration of exogenous recombinant MCP-1 increased phosphorylation of Akt, ERK, and STAT3 in a dose-and time-dependent manner and increased cellular resistance to serum starvation. Inhibition of Akt, ERK, or STAT3 reduced cell growth and caused cell death. Long-term survival of HNSCC patients was negatively associated with the histological intensity of MCP-1, implicating MCP-1 as a potential prognostic marker for HNSCC. Conclusions: These results suggest that overexpressed MCP-1 in cancer cells may promote HNSCC progression through upregulating pro-survival signaling pathways. High cellular MCP-1 expression is related to poor overall survival rate in HNSCC patients.	[Ji, Wen-Tsai; Chen, Hau-Ren] Natl Chung Cheng Univ, Coll Sci, Inst Mol Biol, Dept Life Sci, Min Hsiung, Chia Yi, Taiwan; [Ji, Wen-Tsai; Chen, Hau-Ren] Natl Chung Cheng Univ, Coll Sci, Inst Biomed Sci, Min Hsiung, Chia Yi, Taiwan; [Lin, Chun-Hsuan] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Lee, Jeng-Woei] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Lee, Jeng-Woei] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan	National Chung Cheng University; National Chung Cheng University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University	Lee, JW (corresponding author), Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan.	jwlee@mail.tcu.edu.tw; hematcd@hotamil.com			National Science Council [101-2314-B-303-011-MY2, 100-2314-B-303-002-]; Buddhist Dalin Tzu Chi General Hospital [DTCRD101(2)-E-06]	National Science Council(Ministry of Science and Technology, Taiwan); Buddhist Dalin Tzu Chi General Hospital	This study was supported partly by the National Science Council (101-2314-B-303-011-MY2 and 100-2314-B-303-002-) and Buddhist Dalin Tzu Chi General Hospital (DTCRD101(2)-E-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2012, ORAL ONCOL, V48, P1220, DOI 10.1016/j.oraloncology.2012.06.006; Albanell J, 2001, CANCER RES, V61, P6500; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Blankesteijn WM, 2008, TRENDS PHARMACOL SCI, V29, P175, DOI 10.1016/j.tips.2008.01.003; Boslooper K, 2008, PATHOLOGY, V40, P500, DOI 10.1080/00313020802198010; Caers J, 2008, B CANCER, V95, P301, DOI 10.1684/bdc.2008.0600; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Cripps C, 2010, CURR ONCOL, V17, P37; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hideshima T, 2001, BLOOD, V98, p639A; Huang TT, 2010, J FORMOS MED ASSOC, V109, P326, DOI 10.1016/S0929-6646(10)60060-5; Jain SK, 2010, MOL NUTR FOOD RES, V54, P1371, DOI 10.1002/mnfr.200900177; Koga M, 2008, BIOCHEM BIOPH RES CO, V365, P279, DOI 10.1016/j.bbrc.2007.10.182; Lee CC, 2010, CLIN CHIM ACTA, V411, P1116, DOI 10.1016/j.cca.2010.04.010; Lee TL, 2006, MOL CANCER THER, V5, P8, DOI 10.1158/1535-7163.MCT-05-0069; Liao YM, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-22; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; MacManus CF, 2007, MOL CANCER RES, V5, P737, DOI 10.1158/1541-7786.MCR-07-0032; Moral M, 2008, HISTOL HISTOPATHOL, V23, P1269, DOI 10.14670/HH-23.1269; Nakashima J, 2000, CLIN CANCER RES, V6, P2702; Pan YB, 2012, CANCER LETT, V326, P155, DOI 10.1016/j.canlet.2012.07.033; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ravishankaran P, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-18; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sen M, 2012, CLIN CANCER RES, V18, P4986, DOI 10.1158/1078-0432.CCR-12-0792; Shih JY, 2006, J CANC MOL, V2, P101; Tabuchi Keiji, 2011, Int J Otolaryngol, V2011, P638058, DOI 10.1155/2011/638058; Timofeeva OA, 2013, P NATL ACAD SCI USA, V110, P1267, DOI 10.1073/pnas.1211805110; Tse KP, 2007, CLIN CANCER RES, V13, P6320, DOI 10.1158/1078-0432.CCR-07-1029; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Wolff HA, 2011, RADIAT ENVIRON BIOPH, V50, P145, DOI 10.1007/s00411-010-0341-x; Yoshimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058791; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483	42	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88952	10.1371/journal.pone.0088952	http://dx.doi.org/10.1371/journal.pone.0088952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586454	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900065
J	Jujic, A; Nilsson, PM; Engstrom, G; Hedblad, B; Melander, O; Magnusson, M				Jujic, Amra; Nilsson, Peter M.; Engstrom, Gunnar; Hedblad, Bo; Melander, Olle; Magnusson, Martin			Atrial Natriuretic Peptide and Type 2 Diabetes Development - Biomarker and Genotype Association Study	PLOS ONE			English	Article							PROSPECTIVE MALMO DIET; METABOLIC SYNDROME; ANGIOTENSIN-II; GENETIC VARIANT; BLOOD-PRESSURE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; HYPERTENSIVE PATIENTS; INSULIN-RESISTANCE; RECEPTOR	Background: We have recently shown that low plasma levels of mid-regional atrial natriuretic peptide (MR-ANP) predict development of diabetes and glucose progression over time, independently of known risk factors for diabetes development. However, since MR-ANP levels might be influenced by unknown factors causing diabetes, we cannot rule out that such relationship might be confounded. Previous studies have shown an association of a single nucleotide polymorphism rs5068 on the natriuretic peptide precursor A (NPPA) locus gene with higher levels of circulating ANP. Since gene variants are inherited randomly and not subject to confounding, we aimed to investigate whether the variant rs5068 within the NPPA locus is associated with incident type 2 diabetes. Methods: We genotyped the variant rs5068 within the NPPA locus in 27,307 individuals without known diabetes from the Malmo "Diet Cancer Study. Incident diabetes was retrieved through national and regional registers (median follow-up time of 14 years, 2,823 incident diabetes cases). Results: In Cox regression analysis adjusted for age, sex and BMI, we found that the carriers of at least one copy of the G allele of rs5068 had lower likelihood of incident diabetes within 14 years (HR = 0.88, 95% CI 0.78-0.99, p = 0.037). Conclusion: Our results indicate a role of the ANP system in the etiology of type 2 diabetes and might help provide insight in the metabolic actions of natriuretic peptides and the pathophysiology of type 2 diabetes.	[Jujic, Amra; Magnusson, Martin] Skane Univ Hosp, Dept Heart Failure & Valvular Dis, Malmo, Sweden; [Jujic, Amra; Nilsson, Peter M.; Engstrom, Gunnar; Hedblad, Bo; Melander, Olle; Magnusson, Martin] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Nilsson, Peter M.; Melander, Olle] Skane Univ Hosp, Ctr Emergency Med, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital	Jujic, A (corresponding author), Skane Univ Hosp, Dept Heart Failure & Valvular Dis, Malmo, Sweden.	amra.jujic@med.lu.se	Magnusson, Martin/AAE-1185-2020	Magnusson, Martin/0000-0003-1710-5936; Engstrom, Gunnar/0000-0002-8618-9152; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Jujic, Amra/0000-0002-9506-0158; Melander, Olle/0000-0002-2581-484X	Swedish Medical Research Council; Swedish Heart and Lung Foundation; Medical Faculty of Lund University, Skane University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; Southwest Skanes Diabetes Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Knut and Alice Wallenberg Foundation; Marianne and Marcus Wallenberg Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University, Skane University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; Southwest Skanes Diabetes Foundation; King Gustaf V and Queen Victoria Foundation; Lennart Hanssons Memorial Fund; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Marianne and Marcus Wallenberg Foundation	Drs. Magnusson and Melander were supported by grants from the Swedish Medical Research Council (http://www.vr.se/inenglish. 4. 12fff4451215cbd83e4800015152.html), the Swedish Heart and Lung Foundation (http://www.hjart-lungfonden.se/Om-Hjart-lungfonden/About-HLF/), the Medical Faculty of Lund University, Skane University Hospital, the Albert Pahlsson Research Foundation (ams.orbelon.com), the Crafoord Foundation (www.crafoord.se), the Ernhold Lundstroms Research Foundation (https://www.mah.se/PageFiles/3463/Microsoft%20Word%20-%20Kung%C3%B6relse%202011.pdf), the Region Skane (http://www.skane.se/), the Hulda and Conrad Mossfelt Foundation, the Southwest Skanes Diabetes Foundation, the King Gustaf V and Queen Victoria Foundation, the Lennart Hanssons Memorial Fund (http://www.hypertoni.org/stadgar_lennart_hanssons_mem.htm), Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/), and the Marianne and Marcus Wallenberg Foundation. Drs. Nilsson and Hedblad were supported by grants from the Swedish Medical Research Council and the Swedish Heart and Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora P, 2013, J CLIN INVEST, V123, P3378, DOI 10.1172/JCI67383; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Cannone V, 2013, DIABETES CARE, V36, P2850, DOI 10.2337/dc12-2337; Cannone V, 2011, J AM COLL CARDIOL, V58, P629, DOI 10.1016/j.jacc.2011.05.011; Carlsson PO, 1998, DIABETOLOGIA, V41, P127, DOI 10.1007/s001250050880; Cederholm J, 2008, DIABETES CARE, V31, P2038, DOI 10.2337/dc08-0662; Ellis KL, 2011, J MOL CELL CARDIOL, V50, P695, DOI 10.1016/j.yjmcc.2011.01.010; Enhorning S, 2013, INT J OBESITY, V37, P598, DOI 10.1038/ijo.2012.88; Fliser D, 2004, CIRCULATION, V110, P1103, DOI 10.1161/01.CIR.0000140265.21608.8E; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Hammerer-Lercher A, 2004, CLIN CHEM, V50, P1174, DOI 10.1373/clinchem.2003.028316; Henriksen EJ, 2003, DIABETES OBES METAB, V5, P214, DOI 10.1046/j.1463-1326.2003.00265.x; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Jujic A, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-64; Levin ER, 1998, NEW ENGL J MED, V339, P321; Li CR, 2005, STROKE, V36, P725, DOI 10.1161/01.STR.0000158925.12740.87; Lindholm E, 2001, EUR J EPIDEMIOL, V17, P983, DOI 10.1023/A:1020036805655; LOPEZ MJ, 1995, NATURE, V378, P65, DOI 10.1038/378065a0; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Magnusson M, 2004, DIABETES CARE, V27, P1929, DOI 10.2337/diacare.27.8.1929; Magnusson M, 2012, J CLIN ENDOCR METAB, V97, P638, DOI 10.1210/jc.2011-2425; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; National Board of Health and Welfare, 2003, FING PULS MON PUBL H, P1992; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Olsen MH, 2005, HYPERTENSION, V46, P660, DOI 10.1161/01.HYP.0000179575.13739.72; Persson M, 2007, ARTERIOSCL THROM VAS, V27, P1411, DOI 10.1161/ATVBAHA.107.142679; Pfister R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001112; Prasad A, 2004, CIRCULATION, V110, P1507, DOI 10.1161/01.CIR.0000141736.76561.78; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rubattu S, 2007, J HYPERTENS, V25, P833, DOI 10.1097/HJH.0b013e32803cae3c; Salomaa V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010100; UEHLINGER DE, 1986, J CARDIOVASC PHARM, V8, P1122, DOI 10.1097/00005344-198611000-00005; Velloso LA, 2006, DIABETES-METAB RES, V22, P98, DOI 10.1002/dmrr.611; Verspohl EJ, 1996, PEPTIDES, V17, P1023; Wang TJ, 2007, CIRCULATION, V115, P1345, DOI 10.1161/CIRCULATIONAHA.106.655142; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; YANDLE TG, 1994, J INTERN MED, V235, P561, DOI 10.1111/j.1365-2796.1994.tb01263.x; Yvan-Charvet L, 2005, DIABETES, V54, P991, DOI 10.2337/diabetes.54.4.991	41	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89201	10.1371/journal.pone.0089201	http://dx.doi.org/10.1371/journal.pone.0089201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586593	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900103
J	Wang, Y; Gao, JX; Wang, JS; Qiu, J				Wang, Yan; Gao, Jixi; Wang, Jinsheng; Qiu, Jie			Value Assessment of Ecosystem Services in Nature Reserves in Ningxia, China: A Response to Ecological Restoration	PLOS ONE			English	Article							LAND-USE CHANGE; VALUATION; IMPACTS; CLIMATE; AREA	Changes in land use can cause significant changes in the ecosystem structure and process variation of ecosystem services. This study presents a detailed spatial, quantitative assessment of the variation in the value of ecosystem services based on land use change in national nature reserves of the Ningxia autonomous region in China. We used areas of land use types calculated from the remote sensing data and the adjusted value coefficients to assess the value of ecosystem services for the years 2000, 2005, and 2010, analyzing the fluctuations in the valuation of ecosystem services in response to land use change. With increases in the areas of forest land and water bodies, the value of ecosystem services increased from 182.3x10(7) to 223.8x10(7) US$ during 2000-2010. Grassland and forest land accounted for 90% of this increase. The values of all ecosystem services increased during this period, especially the value of ecosystem services for biodiversity protection and soil formation and protection. Ecological restoration in the reserves had a positive effect on the value of ecosystem services during 2000-2010.	[Wang, Yan; Gao, Jixi; Wang, Jinsheng] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Wang, Yan; Gao, Jixi; Qiu, Jie] Nanjing Inst Environm Sci, Minist Environm Protect, Nanjing, Jiangsu, Peoples R China	Beijing Normal University	Gao, JX (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	gaoeco@163.com			National Special Scientific Research of Environmental Protection Public Welfare [201209027]; National Science and Technology Support Project [2012BAC01B00]; National Ecological Environment Change Assessment by Remote Sensing Survey Project [2000-2010]	National Special Scientific Research of Environmental Protection Public Welfare; National Science and Technology Support Project; National Ecological Environment Change Assessment by Remote Sensing Survey Project	The National Special Scientific Research of Environmental Protection Public Welfare Project (No. 201209027), the National Science and Technology Support Project (No. 2012BAC01B00), and the National Ecological Environment Change Assessment by Remote Sensing Survey Project (2000-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Burkhard B, 2010, ECOL COMPLEX, V7, P257, DOI 10.1016/j.ecocom.2010.07.001; [陈雅敏 Chen Yamin], 2012, [复旦学报. 自然科学版, Journal of Fudan University. Natural Sciences], V51, P377; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R., 1997, NATURES SERVICES SOC, P49; Costanza R., 2015, INTRO ECOLOGICAL EC; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Fisher B, 2008, BIOL CONSERV, V141, P1167, DOI 10.1016/j.biocon.2008.02.019; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; [高艳妮 Gao Yanni], 2012, [地理科学进展, Progress in Geography], V31, P109; Heal G, 2000, ECOSYSTEMS, V3, P24, DOI 10.1007/s100210000006; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Kaplowitz M. D., 2000, Agriculture and Human Values, V17, P169, DOI 10.1023/A:1007669404425; Koschke L, 2012, ECOL INDIC, V21, P54, DOI 10.1016/j.ecolind.2011.12.010; Kreuter UP, 2001, ECOL ECON, V39, P333, DOI 10.1016/S0921-8009(01)00250-6; Kubiszewski I, 2013, ECOSYST SERV, V3, pE11, DOI 10.1016/j.ecoser.2012.11.004; Li HL, 2011, ENRGY PROCED, V5, P1109, DOI 10.1016/j.egypro.2011.03.195; Li JC, 2010, AGR ECOSYST ENVIRON, V139, P766, DOI 10.1016/j.agee.2010.10.019; Li RQ, 2007, ENVIRON MONIT ASSESS, V128, P503, DOI 10.1007/s10661-006-9344-0; Li TH, 2010, ECOL ECON, V69, P1427, DOI 10.1016/j.ecolecon.2008.05.018; Limburg KE, 2002, ECOL ECON, V41, P409, DOI 10.1016/S0921-8009(02)00090-3; Liu Y, 2012, ECOL MODEL, V225, P127, DOI 10.1016/j.ecolmodel.2011.11.017; Lorencova E, 2013, LAND USE POLICY, V33, P183, DOI 10.1016/j.landusepol.2012.12.012; Paula BM, 2012, AGR ECOSYST ENVIRON, V154, P34, DOI 10.1016/j.agee.2011.07.010; MEA, 2005, MILL EC ASS EC WELLB; MEA, 2003, MILL EC ASS EC WELLB; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; [彭建 Peng Jian], 2005, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V41, P594; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Sawut M, 2013, CAN J SOIL SCI, V93, P99, DOI [10.4141/CJSS2012-010, 10.4141/cjss2012-010]; Song GL, 2011, PROCEDIA ENVIRON SCI, V11, P1365, DOI 10.1016/j.proenv.2011.12.205; Su CH, 2012, ACTA OECOL, V44, P46, DOI 10.1016/j.actao.2011.11.006; Su CH, 2013, GLOBAL PLANET CHANGE, V101, P119, DOI 10.1016/j.gloplacha.2012.12.014; Summers JK, 2012, AMBIO, V41, P327, DOI 10.1007/s13280-012-0256-7; Troy A, 2006, ECOL ECON, V60, P435, DOI 10.1016/j.ecolecon.2006.04.007; Turner RK, 2003, ECOL ECON, V46, P493, DOI 10.1016/S0921-8009(03)00189-7; Wang X, 2010, ECOL ECON, V69, P2549, DOI 10.1016/j.ecolecon.2010.07.031; [王宗明 Wang Zongming], 2004, [自然资源学报, Journal of Natural Resources], V19, P55; Wang ZongMing, 2004, China Environmental Science, V24, P125; Wilson MA, 2002, ECOLOGICAL EC, V41, P441; Wu KY, 2013, CITIES, V31, P276, DOI 10.1016/j.cities.2012.08.003; [谢高地 XIE Gao-di], 2008, [自然资源学报, Journal of Natural Resources], V23, P911; [谢高地 Xie Gaodi], 2003, [自然资源学报, Journal of Natural Resources], V18, P189; Yang WR, 2011, ECOL COMPLEX, V8, P153, DOI 10.1016/j.ecocom.2011.01.004; Zhang Fang-min, 2012, Yingyong Shengtai Xuebao, V23, P307; [赵军 ZHAO Jun], 2010, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V24, P36; 高志强, 2008, [科学通报, Chinese Science Bulletin], V53, P317	47	37	42	11	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89174	10.1371/journal.pone.0089174	http://dx.doi.org/10.1371/journal.pone.0089174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586571	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900100
J	Ye, DW; Liu, C; Liu, TT; Tian, XB; Xiang, HB				Ye, Da-Wei; Liu, Cheng; Liu, Tao-Tao; Tian, Xue-Bi; Xiang, Hong-Bing			Motor Cortex-Periaqueductal Gray-Spinal Cord Neuronal Circuitry May Involve in Modulation of Nociception: A Virally Mediated Transsynaptic Tracing Study in Spinally Transected Transgenic Mouse Model	PLOS ONE			English	Article							MELANOCORTIN 4 RECEPTOR; TRANSCRANIAL MAGNETIC STIMULATION; ROSTRAL VENTROMEDIAL MEDULLA; ACUTE-RENAL-FAILURE; POSSIBLE MECHANISM; NEUROPATHIC PAIN; RAT MODEL; NUCLEUS; ACTIVATION; EXPRESSION	Several studies have shown that motor cortex stimulation provided pain relief by motor cortex plasticity and activating descending inhibitory pain control systems. Recent evidence indicated that the melanocortin-4 receptor (MC4R) in the periaqueductal gray played an important role in neuropathic pain. This study was designed to assess whether MC4R signaling existed in motor cortex-periaqueductal gray-spinal cord neuronal circuitry modulated the activity of sympathetic pathway by a virally mediated transsynaptic tracing study. Pseudorabies virus (PRV)-614 was injected into the left gastrocnemius muscle in adult male MC4R-green fluorescent protein (GFP) transgenic mice (n = 15). After a survival time of 4-6 days, the mice (n = 5) were randomly assigned to humanely sacrifice, and spinal cords and brains were removed and sectioned, and processed for PRV-614 visualization. Neurons involved in the efferent control of the left gastrocnemius muscle were identified following visualization of PRV-614 retrograde tracing. The neurochemical phenotype of MC4R-GFP-positive neurons was identified using fluorescence immunocytochemical labeling. PRV-614/MC4R-GFP dual labeled neurons were detected in spinal IML, periaqueductal gray and motor cortex. Our findings support the hypothesis that MC4R signaling in motor cortex-periaqueductal gray-spinal cord neural pathway may participate in the modulation of the melanocortin-sympathetic signaling and contribute to the descending modulation of nociceptive transmission, suggesting that MC4R signaling in motor cortex-periaqueductal gray-spinal cord neural pathway may modulate the activity of sympathetic outflow sensitive to nociceptive signals.	[Ye, Da-Wei] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Ctr Canc, Wuhan 430074, Hubei, Peoples R China; [Liu, Cheng; Liu, Tao-Tao; Tian, Xue-Bi; Xiang, Hong-Bing] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Anaesthesiol & Pain Med, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xiang, HB (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Anaesthesiol & Pain Med, Wuhan 430074, Hubei, Peoples R China.	xhbtj2004@163.com	Xiang, Hongbing/AAP-1588-2020		National Natural Science Foundation of P.R. China [81271766]; National Natural Science Foundation of Hubei Province [2013CFB121]; Fundamental Scientific Research Business Expense for Higher School of Central Government [2012 TS060]; Ministry of Health of P.R. China	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Hubei Province; Fundamental Scientific Research Business Expense for Higher School of Central Government; Ministry of Health of P.R. China	This work was supported by grants from National Natural Science Foundation of P.R. China (No. 81271766 to H. X.), National Natural Science Foundation of Hubei Province (No. 2013CFB121 to H. X.), Special Fund of Fundamental Scientific Research Business Expense for Higher School of Central Government (2012 TS060 to H. X.) and 2010 Clinical Key Disciplines Construction Grant from the Ministry of Health of P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chu HC, 2012, NEUROL RES, V34, P871, DOI 10.1179/1743132812Y.0000000085; Chu HC, 2012, CAN J NEUROL SCI, V39, P458, DOI 10.1017/S0317167100013962; Chu HC, 2012, INT J NEUROSCI, V122, P74, DOI 10.3109/00207454.2011.630542; Franklin K., 2007, MOUSE BRAIN STEREOTA; Kerman IA, 2006, J NEUROSCI, V26, P3423, DOI 10.1523/JNEUROSCI.5283-05.2006; Kerman IA, 2003, J NEUROSCI, V23, P4657; Lee TK, 2007, AM J PHYSIOL-REG I, V292, pR1532, DOI 10.1152/ajpregu.00633.2006; Lefaucheur JP, 2012, EUR J PAIN, V16, P1403, DOI 10.1002/j.1532-2149.2012.00150.x; Leong ML, 2011, J NEUROSCI, V31, P17028, DOI 10.1523/JNEUROSCI.1268-11.2011; Li P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080295; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Niu ZJ, 2012, NEUROSCI LETT, V529, P112, DOI 10.1016/j.neulet.2012.09.034; Onesti E, 2013, EUR J PAIN, V17, P1347, DOI 10.1002/j.1532-2149.2013.00320.x; Pagano RL, 2012, PAIN, V153, P2359, DOI 10.1016/j.pain.2012.08.002; Pagano RL, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.08.003; Pan XC, 2013, J HUAZHONG U SCI-MED, V33, P195, DOI 10.1007/s11596-013-1096-9; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Voss-Andreae A, 2007, ENDOCRINOLOGY, V148, P1550, DOI 10.1210/en.2006-1389; Wei F, 2010, J NEUROSCI, V30, P8624, DOI 10.1523/JNEUROSCI.5389-09.2010; Xiang HB, 2013, MOVEMENT DISORD, V28, P2037, DOI 10.1002/mds.25632; Xiang HB, 2013, BRAIN, V136, DOI 10.1093/brain/awt123; Xiang HB, 2013, ACTA NEUROCHIR, V155, P1667, DOI 10.1007/s00701-013-1743-8; Xiang HB, 2013, PAIN PHYSICIAN, V16, pE47; Ye DW, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.11.003; Ye DW, 2012, J HUAZHONG U SCI-MED, V32, P216, DOI 10.1007/s11596-012-0038-2	27	39	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89486	10.1371/journal.pone.0089486	http://dx.doi.org/10.1371/journal.pone.0089486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586817	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900149
J	Lykens, K; Moayad, N; Biswas, S; Reyes-Ortiz, C; Singh, KP				Lykens, Kristine; Moayad, Neda; Biswas, Swati; Reyes-Ortiz, Carlos; Singh, Karan P.			Impact of a Community Based Implementation of REACH II Program for Caregivers of Alzheimer's Patients	PLOS ONE			English	Article							DEMENTIA CAREGIVERS; HEALTH; RESOURCES; INTERVENTIONS; DEPRESSION; BURDEN; CARE	Background: In 2009 an estimated 5.3 million people in the United States were afflicted with Alzheimer's disease, a degenerative form of dementia. The impact of this disease is not limited to the patient but also has significant impact on the lives and health of their family caregivers. The Resources for Enhancing Alzheimer's Caregiver Health (REACH II) program was developed and tested in clinical studies. The REACH II program is now being delivered by community agencies in several locations. This study examines the impact of the REACH II program on caregiver lives and health in a city in north Texas. Study design: Family caregivers of Alzheimer's patients were assessed using an instrument covering the multi-item domains of Caregiver Burden, Depression, Self-Care, and Social Support upon enrollment in the program and at the completion of the 6 month intervention. The domain scores were analyzed using a multivariate paired t-test and Bonferroni confidence interval for the differences in pre- and post-service domain scores. Results: A total of 494 families were enrolled in the program during the period January 1, 2011 through June 30, 2012. Of these families 177 completed the 6 month program and have pre - and post service domain scores. The median age for the caregivers was 62 years. The domain scores for Depression and Caregiver Burden demonstrated statistically significant improvements upon program completion. Conclusion: The REACH II intervention was successfully implemented by a community agency with comparable impacts to those of the clinical trial warranting wider scale implementation.	[Lykens, Kristine] Univ N Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Hlth Management & Policy, Ft Worth, TX USA; [Moayad, Neda] Univ N Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Behav & Community Hlth, Ft Worth, TX USA; [Biswas, Swati] Univ Texas Dallas, Dept Math Sci, Richardson, TX 75083 USA; [Reyes-Ortiz, Carlos] Oakwood Hosp & Med Ctr, Dept Internal Med, Dearborn, MI USA; [Singh, Karan P.] Univ Alabama Birmingham, Ctr Comprehens Canc, Biostat & Bioinformat Shared Facil, Birmingham, AL USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of Texas System; University of Texas Dallas; Beaumont Health; University of Alabama System; University of Alabama Birmingham	Lykens, K (corresponding author), Univ N Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Hlth Management & Policy, Ft Worth, TX USA.	Kristine.Lykens@unthsc.edu		Reyes-Ortiz, Carlos Alfonso/0000-0001-7983-7791	United Way of Tarrant County, Texas	United Way of Tarrant County, Texas	The authors would like to acknowledge the funding provided for this evaluation project by the United Way of Tarrant County, Texas. The funders contracted with the authors to conduct an evaluation of the implementation. They were provided updates of design, data collection, and analysis. The decision to publish was made by the authors and the funder had no role in the preparation of the manuscript.	Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Czaja SJ, 2009, J AM GERIATR SOC, V57, P1064, DOI 10.1111/j.1532-5415.2009.02260.x; Elliott AF, 2010, J AM GERIATR SOC, V58, P30, DOI 10.1111/j.1532-5415.2009.02631.x; Etters L, 2008, J AM ACAD NURSE PRAC, V20, P423, DOI 10.1111/j.1745-7599.2008.00342.x; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; Karlin N J, 2001, Am J Alzheimers Dis Other Demen, V16, P177, DOI 10.1177/153331750101600306; Maslow K., 2012, TRANSLATING INNOVATI; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; Nichols LO, 2008, J AM GERIATR SOC, V56, P413, DOI 10.1111/j.1532-5415.2007.01569.x; Powers DV, 2002, J GERONTOL B-PSYCHOL, V57, pP205, DOI 10.1093/geronb/57.3.P205; Schubert CC, 2008, J GEN INTERN MED, V23, P1736, DOI 10.1007/s11606-008-0711-0; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Schulz R, 2003, PSYCHOL AGING, V18, P357, DOI 10.1037/0882-7974.18.3.357; Schulz R, 2002, GERONTOLOGIST, V42, P589, DOI 10.1093/geront/42.5.589; Taylor DH, 2008, J AM GERIATR SOC, V56, P322, DOI 10.1111/j.1532-5415.2007.01558.x; Teri L, 2012, GERONTOLOGIST, V52, P452, DOI 10.1093/geront/gnr132; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Wisniewski SR, 2003, PSYCHOL AGING, V18, P375, DOI 10.1037/0882-7974.18.3.375; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090	19	27	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89290	10.1371/journal.pone.0089290	http://dx.doi.org/10.1371/journal.pone.0089290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24586664	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800014
J	Fritz, G; Megerle, JA; Westermayer, SA; Brick, D; Heermann, R; Jung, K; Radler, JO; Gerland, U				Fritz, Georg; Megerle, Judith A.; Westermayer, Sonja A.; Brick, Delia; Heermann, Ralf; Jung, Kirsten; Raedler, Joachim O.; Gerland, Ulrich			Single Cell Kinetics of Phenotypic Switching in the Arabinose Utilization System of E. coli	PLOS ONE			English	Article							P-BAD PROMOTER; MAJOR FACILITATOR SUPERFAMILY; BETA-GALACTOSIDASE PRODUCTS; STOCHASTIC GENE-EXPRESSION; ESCHERICHIA-COLI; INDUCTION KINETICS; ARABAD PROMOTER; BACTERIAL; DYNAMICS; TRANSPORTER	Inducible switching between phenotypes is a common strategy of bacteria to adapt to fluctuating environments. Here, we analyze the switching kinetics of a paradigmatic inducible system, the arabinose utilization system in E. coli. Using time-lapse fluorescence microscopy of microcolonies in a microfluidic chamber, which permits sudden up-and down-shifts in the inducer arabinose, we characterize the single-cell gene expression dynamics of the araBAD operon responsible for arabinose degradation. While there is significant, inducer-dependent cell-to-cell variation in the timing of the on-switching, the off-switching triggered by sudden removal of arabinose is homogeneous and rapid. We find that rapid off-switching does not depend on internal arabinose degradation. Because the system is regulated via the internal arabinose level sensed by AraC, internal arabinose must be rapidly depleted by leakage or export from the cell, or by degradation via a non-canonical pathway. We explored whether the poorly characterized membrane protein AraJ, which is part of the arabinose regulon and has been annotated as a possible arabinose efflux protein, is responsible for rapid depletion. However, we find that AraJ is not essential for rapid switching to the off-state. We develop a mathematical model for the arabinose system, which quantitatively describes both the heterogeneous on-switching and the homogeneous off-switching. The model also predicts that mutations which disrupt the positive feedback of internal arabinose on the production of arabinose uptake proteins change the heterogeneous on-switching behavior into a homogeneous, graded response. We construct such a mutant and confirm the graded response experimentally. Taken together, our results indicate that the physiological switching behavior of this sugar utilization system is asymmetric, such that off-switching is always rapid and homogeneous, while on-switching is slow and heterogeneously timed at sub-saturating inducer levels.	[Fritz, Georg; Gerland, Ulrich] Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, Munich, Germany; [Fritz, Georg; Gerland, Ulrich] Univ Munich, CeNS, Munich, Germany; [Fritz, Georg; Heermann, Ralf; Jung, Kirsten] Univ Munich, Ctr Integrated Prot Sci CiPSM, Martinsried, Germany; [Fritz, Georg; Heermann, Ralf; Jung, Kirsten] Univ Munich, Dept Biol, Martinsried, Germany; [Megerle, Judith A.; Westermayer, Sonja A.; Brick, Delia] Univ Munich, Fac Phys, Munich, Germany; [Megerle, Judith A.; Westermayer, Sonja A.; Brick, Delia] Univ Munich, CeNS, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich; University of Munich	Gerland, U (corresponding author), Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, Munich, Germany.	gerland@lmu.de	Heermann, Ralf/E-1793-2013; Rädler, Joachim/AAD-8747-2019; Gerland, Ulrich/I-9902-2016; Fritz, Georg/F-3910-2010; Heermann, Ralf/CAF-8609-2022	Heermann, Ralf/0000-0003-0631-6156; Rädler, Joachim/0000-0002-5846-1489; Gerland, Ulrich/0000-0002-0859-6422; Fritz, Georg/0000-0002-1503-9165; 	Excellence Cluster "Nanosystems Initiative Munich", by the Deutsche Forschungsgemeinschaft [RA655/6-1, GE1098/4-1]; Excellence Cluster "Center for Protein Science Munich" [Exc114/2]; Deutsche Forschungsgemeinschaft [SPP1617]	Excellence Cluster "Nanosystems Initiative Munich", by the Deutsche Forschungsgemeinschaft; Excellence Cluster "Center for Protein Science Munich"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Excellence Cluster "Nanosystems Initiative Munich", by the Deutsche Forschungsgemeinschaft via grants RA655/6-1 and GE1098/4-1, and the Excellence Cluster "Center for Protein Science Munich" (Exc114/2). GF was supported through the priority program SPP1617 "Phenotypic heterogeneity and sociobiology of bacterial populations" of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anetzberger C, 2009, MOL MICROBIOL, V73, P267, DOI 10.1111/j.1365-2958.2009.06768.x; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Bost S, 1999, J BACTERIOL, V181, P2185, DOI 10.1128/JB.181.7.2185-2191.1999; Boulineau S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061686; Brachmann AO, 2013, NAT CHEM BIOL, V9, P573, DOI [10.1038/NCHEMBIO.1295, 10.1038/nchembio.1295]; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DARUWALLA KR, 1981, BIOCHEM J, V200, P611, DOI 10.1042/bj2000611; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Fritz G, 2009, J MOL BIOL, V393, P272, DOI 10.1016/j.jmb.2009.08.037; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HUBER RE, 1984, CAN J MICROBIOL, V30, P411, DOI 10.1139/m84-060; HUBER RE, 1980, J BACTERIOL, V141, P528, DOI 10.1128/JB.141.2.528-533.1980; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; JOHNSON CM, 1995, J BACTERIOL, V177, P3438, DOI 10.1128/jb.177.12.3438-3442.1995; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Khlebnikov A, 2000, J BACTERIOL, V182, P7029, DOI 10.1128/JB.182.24.7029-7034.2000; Koita K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043700; Liu JY, 1999, J BIOL CHEM, V274, P22977, DOI 10.1074/jbc.274.33.22977; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; M_uller-Hill B., 1996, LAC OPERON SHORT HIS; Makela J, 2013, NUCLEIC ACIDS RES, V41, P6544, DOI 10.1093/nar/gkt350; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Mettetal JT, 2006, P NATL ACAD SCI USA, V103, P7304, DOI 10.1073/pnas.0509874103; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; NOVOTNY CP, 1966, BIOCHIM BIOPHYS ACTA, V117, P217, DOI 10.1016/0304-4165(66)90169-3; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PATRICK JW, 1968, J BIOL CHEM, V243, P4312; Perkins TJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.83; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; REEDER T, 1991, J BACTERIOL, V173, P7765, DOI 10.1128/jb.173.24.7765-7771.1991; REIZER J, 1983, J BACTERIOL, V156, P354, DOI 10.1128/JB.156.1.354-361.1983; Rietkotter E, 2008, MOL MICROBIOL, V68, P768, DOI 10.1111/j.1365-2958.2008.06194.x; Robert L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.12; Sambrock J, 1989, MOL CLONING LAB MANU; Schleif R, 2000, TRENDS GENET, V16, P559, DOI 10.1016/S0168-9525(00)02153-3; SCHLEIF R, 1969, J MOL BIOL, V46, P185, DOI 10.1016/0022-2836(69)90065-5; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Youssef S, 2011, INTEGR BIOL-UK, V3, P1095, DOI 10.1039/c1ib00035g	46	32	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89532	10.1371/journal.pone.0089532	http://dx.doi.org/10.1371/journal.pone.0089532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586851	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000054
J	Murray, J; Bottle, A; Sharland, M; Modi, N; Aylin, P; Majeed, A; Saxena, S				Murray, Joanna; Bottle, Alex; Sharland, Mike; Modi, Neena; Aylin, Paul; Majeed, Azeem; Saxena, Sonia		Med Neonates Investigator Grp	Risk Factors for Hospital Admission with RSV Bronchiolitis in England: A Population-Based Birth Cohort Study	PLOS ONE			English	Article							SYNCYTIAL-VIRUS-INFECTION; YOUNG-CHILDREN; DISEASE; INFANTS; BURDEN	Objective: To examine the timing and duration of RSV bronchiolitis hospital admission among term and preterm infants in England and to identify risk factors for bronchiolitis admission. Design: A population-based birth cohort with follow-up to age 1 year, using the Hospital Episode Statistics database. Setting: 71 hospitals across England. Participants: We identified 296618 individual birth records from 2007/08 and linked to subsequent hospital admission records during the first year of life. Results: In our cohort there were 7189 hospital admissions with a diagnosis of bronchiolitis, 24.2 admissions per 1000 infants under 1 year (95% CI 23.7-24.8), of which 15% (1050/7189) were born preterm (47.3 bronchiolitis admissions per 1000 preterm infants (95% CI 44.4-50.2)). The peak age group for bronchiolitis admissions was infants aged 1 month and the median was age 120 days (IQR = 61-209 days). The median length of stay was 1 day (IQR = 0-3). The relative risk (RR) of a bronchiolitis admission was higher among infants with known risk factors for severe RSV infection, including those born preterm (RR = 1.9, 95% CI 1.8-2.0) compared with infants born at term. Other conditions also significantly increased risk of bronchiolitis admission, including Down's syndrome (RR = 2.5, 95% CI 1.7-3.7) and cerebral palsy (RR = 2.4, 95% CI 1.5-4.0). Conclusions: Most (85%) of the infants who are admitted to hospital with bronchiolitis in England are born at term, with no known predisposing risk factors for severe RSV infection, although risk of admission is higher in known risk groups. The early age of bronchiolitis admissions has important implications for the potential impact and timing of future active and passive immunisations. More research is needed to explain why babies born with Down's syndrome and cerebral palsy are also at higher risk of hospital admission with RSV bronchiolitis.	[Murray, Joanna; Bottle, Alex; Aylin, Paul; Majeed, Azeem; Saxena, Sonia] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Sharland, Mike] St Georges Hosp NHS Trust, Paediat Infect Dis Unit, London, England; [Modi, Neena] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Neonatal Med, London, England	Imperial College London; St Georges University London; Imperial College London	Murray, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	joanna.murray@imperial.ac.uk	Saxena, Sonia/ABD-7737-2021; Saxena, Sonia K/G-4821-2013; Petrou, Stavros/ABD-8323-2021	Saxena, Sonia/0000-0003-3787-2083; Saxena, Sonia K/0000-0003-3787-2083; sharland, mike/0000-0001-8626-8291; Majeed, Azeem/0000-0002-2357-9858; Bottle, Alex/0000-0001-9978-2011; Petrou, Stavros/0000-0003-3121-6050; Aylin, Paul/0000-0003-4589-1743	National Institute for Health Research (NIHR) Programme Grant for Applied Research [RP-PG-0707-10010]; Neonatal Data Analysis Unit from Abbott International; Danone UK; Dr Foster Unit at Imperial by Dr Foster Intelligence, an independent healthcare information company; NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) for North West London; NIHR Imperial Biomedical Research Centre; NIHR Imperial Centre for Patient Safety and Service Quality; National Institute for Health Research (NIHR) [RP-PG-0707-10010]; Information Centre of the NHS; NIHR; National Institute for Health Research [RP-PG-0707-10010, CDF-2011-04-048] Funding Source: researchfish	National Institute for Health Research (NIHR) Programme Grant for Applied Research(National Institute for Health Research (NIHR)); Neonatal Data Analysis Unit from Abbott International; Danone UK(Danone Nutricia); Dr Foster Unit at Imperial by Dr Foster Intelligence, an independent healthcare information company; NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) for North West London; NIHR Imperial Biomedical Research Centre; NIHR Imperial Centre for Patient Safety and Service Quality; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Information Centre of the NHS; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	JM was funded through a National Institute for Health Research (NIHR) Programme Grant for Applied Research (RP-PG-0707-10010) held by NM; JM and NM declare financial support from this award for the submitted work. Support for data analysis was received from the Neonatal Data Analysis Unit led by NM. Unrestricted support for the Neonatal Data Analysis Unit from Abbott International and Danone UK is acknowledged. The Dr Foster Unit at Imperial are principally funded via a research grant by Dr Foster Intelligence, an independent healthcare information company and joint venture with the Information Centre of the NHS. The Unit is affiliated with the NIHR Imperial Centre for Patient Safety and Service Quality at Imperial College Healthcare NHS Trust. The Department of Primary Care & Public Health at Imperial College is grateful for support from the NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) for North West London (a partnership between Chelsea and Westminster NHS Foundation Trust and Imperial College London), the NIHR Imperial Biomedical Research Centre (a partnership between Imperial College Healthcare NHS Trust and Imperial College London), and the NIHR Imperial Centre for Patient Safety and Service Quality. SS has an NIHR career development fellowship. This publication presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RP-PG-0707-10010). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in the study design, collection, analysis, and interpretation of data, in the writing of the report or in the decision to submit the paper for publication.	Agency for Healthcare Research and Quality (AHRQ), 2003, CLIN CLASS SOFTW ICD; Audit Commission, 2011, EV 3 YEARS PBR DAT A; Aylin Paul, 2004, BMJ, V329, P1207; Barben J, 2008, THORAX, V63, P1103, DOI 10.1136/thx.2007.094706; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bont L, 2011, PEDIATR INFECT DIS J, V30, P785, DOI 10.1097/INF.0b013e31821fef9e; Bottle A, 2009, QUAL SAF HEALTH CARE, V18, P303, DOI 10.1136/qshc.2007.026096; Bush A, 2007, BMJ-BRIT MED J, V335, P1037, DOI 10.1136/bmj.39374.600081.AD; Carbonell-Estrany XAVI, 2001, PEDIAT INFECT DIS J, V20; Deshpande SA, 2003, ARCH DIS CHILD, V88, P1065, DOI 10.1136/adc.88.12.1065; Figueras-Aloy J, 2004, PEDIAT INFECT DIS J, V23; Garcia CG, 2010, PEDIATRICS, V126, pE1453, DOI 10.1542/peds.2010-0507; Hall CB, 2010, LANCET, V375, P1500, DOI 10.1016/S0140-6736(10)60401-1; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Houben ML, 2011, PEDIATRICS, V127, P35, DOI 10.1542/peds.2010-0581; Joint Committee on Vaccination and Immunisation - Respiratory Syncitial Virus (RSV) Subgroup, 2010, RSV SUBGR 8 JUN 2010; Koehoorn M, 2008, PEDIATRICS, V122, P1196, DOI 10.1542/peds.2007-2231; Ladhani S, 2010, PEDIATR INFECT DIS J, V29, P310, DOI 10.1097/INF.0b013e3181d73322; Law BJ, 2002, RESP MED, V96, pS1, DOI 10.1053/rmed.2002.1294; Manktelow BN, 2001, ARCH DIS CHILD-FETAL, V85, pF33, DOI 10.1136/fn.85.1.F33; Muller-Pebody B, 2002, EPIDEMIOL INFECT, V129, P99, DOI 10.1017/S095026880200729X; Murray J, 2013, J PUBLIC HEALTH-UK, V35, P298, DOI 10.1093/pubmed/fds077; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; *OFF NAT STAT, 2008, BIRTH STAT BIRTHS PA; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Patel H, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004878; Saxena S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007484; Scottish Intercollegiate Guidelines Network (SIGN), 2006, 91 SIGN; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Spurling GKP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005189.pub2; Stensballe LG, 2008, CLIN INFECT DIS, V46, P1165, DOI 10.1086/529438; The NHS Information Centre for Health and Social Care, 2009, HES ONL DAT DICT IMP; The NHS Information Centre for Health and Social Care HESonline Hospital Episode Statistic, 2010, NHS MAT STAT; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Wang D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15050; Wang D, 2008, HEALTH TECHNOL ASSES, V12, piii, DOI DOI 10.3310/HTA12020; Wang D, 2008, HEALTH TECHNOL ASSES, V12, pix; Wren C, 2000, HEART, V83, P414, DOI 10.1136/heart.83.4.414	39	116	120	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89186	10.1371/journal.pone.0089186	http://dx.doi.org/10.1371/journal.pone.0089186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586581	Green Published, Green Accepted, gold			2022-12-27	WOS:000332389000030
J	Szell, M; Grauwin, S; Ratti, C				Szell, Michael; Grauwin, Sebastian; Ratti, Carlo			Contraction of Online Response to Major Events	PLOS ONE			English	Article							SENTENCE-LENGTH; AROUSAL	Quantifying regularities in behavioral dynamics is of crucial interest for understanding collective social events such as panics or political revolutions. With the widespread use of digital communication media it has become possible to study massive data streams of user-created content in which individuals express their sentiments, often towards a specific topic. Here we investigate messages from various online media created in response to major, collectively followed events such as sport tournaments, presidential elections, or a large snow storm. We relate content length and message rate, and find a systematic correlation during events which can be described by a power law relation-the higher the excitation, the shorter the messages. We show that on the one hand this effect can be observed in the behavior of most regular users, and on the other hand is accentuated by the engagement of additional user demographics who only post during phases of high collective activity. Further, we identify the distributions of content lengths as lognormals in line with statistical linguistics, and suggest a phenomenological law for the systematic dependence of the message rate to the lognormal mean parameter. Our measurements have practical implications for the design of micro-blogging and messaging services. In the case of the existing service Twitter, we show that the imposed limit of 140 characters per message currently leads to a substantial fraction of possibly dissatisfying to compose tweets that need to be truncated by their users.	[Szell, Michael; Grauwin, Sebastian; Ratti, Carlo] MIT, Senseable City Lab, Cambridge, MA 02139 USA; [Grauwin, Sebastian] Univ Lyon, Rhone Alpes Inst Complex Syst, Lyon, France; [Grauwin, Sebastian] Ecole Normale Super Lyon, INRIA, CNRS, Comp Sci Lab LIP,UMR 5668, F-69364 Lyon, France	Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Inria	Szell, M (corresponding author), MIT, Senseable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mszell@mit.edu		grauwin, sebastian/0000-0002-2674-6498; Szell, Michael/0000-0003-3022-2483	Ericsson's "Signature of Humanity" fellowship	Ericsson's "Signature of Humanity" fellowship	Sebastian Grauwin acknowledges financial support from Ericsson's "Signature of Humanity" fellowship. Further supporters of Senseable City Laboratory are: the National Science Foundation, the AT&T Foundation, the Rockefeller Foundation, the MIT SMART program, the MIT CCES program, Audi Volkswagen, BBVA, The Coca Cola Company, Ericsson, Expo 2015, Ferrovial, GE, and all the members of the MIT Senseable City Lab Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, P 5 INT AAAI C WEBL; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Boyd D., 2010, 43 HAW INT C SYST SC, V2010, P1, DOI DOI 10.1109/HICSS.2010.412; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Dickman SJ, 2002, HUM FACTORS, V44, P429, DOI 10.1518/0018720024497673; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Furuhashi S, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.034004; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gonzalez-Bailon S, 2012, ASSESSING BIAS COMMU; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Guo JQ, 2007, I C WIREL COMM NETW, P2988, DOI 10.1109/WICOM.2007.742; Head H, 1920, BRAIN, V43, P87, DOI 10.1093/brain/43.2.87; HOLMES DI, 1985, J ROY STAT SOC A STA, V148, P328, DOI 10.2307/2981893; Kleinberg J, 2003, DATA MIN KNOWL DISC, V7, P373, DOI 10.1023/A:1024940629314; Klimek P, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/6/063008; Klimek P, 2011, PHYSICA A, V390, P3870, DOI 10.1016/j.physa.2011.05.033; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lehmann J., 2012, P 21 INT C WORLD WID, P251, DOI [10.1145/2187836.2187871, DOI 10.1145/2187836.2187871]; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Milian M, 2009, LOS ANGELES TIMES; Paus T, 2000, PROG BRAIN RES, V126, P65; Sarno D., 2009, LOS ANGELES TIMES; Shamma D, 2010, TWEETGEIST CAN TWITT; Sobkowicz P, 2013, EPJ DATA SCI, V2, DOI 10.1140/epjds14; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Szell M, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500646; Szell M, 2010, SOC NETWORKS, V32, P313, DOI 10.1016/j.socnet.2010.06.001; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Tavares G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065774; Thurner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029796; WAKE WC, 1957, J R STAT SOC SER A-G, V120, P331, DOI 10.2307/2343104; Weber D, 1846, HANDWORTERBUCH PHYSL, V549, P1846; Williams CB, 1940, BIOMETRIKA, V31, P356, DOI 10.1093/biomet/31.3-4.356; Yang J., 2011, P 4 ACM INT C WEB SE, P177	36	15	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89052	10.1371/journal.pone.0089052	http://dx.doi.org/10.1371/journal.pone.0089052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24586499	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000022
J	Ying, LH; Wu, XC; Lin, CD; Jiang, L				Ying, Liuhua; Wu, Xinchun; Lin, Chongde; Jiang, Lina			Traumatic Severity and Trait Resilience as Predictors of Posttraumatic Stress Disorder and Depressive Symptoms among Adolescent Survivors of the Wenchuan Earthquake	PLOS ONE			English	Article							PSYCHOLOGICAL RESILIENCE; PSYCHOMETRIC EVALUATION; POSITIVE EMOTIONS; CHILDREN; SCALE; PTSD; PREVALENCE; INDIVIDUALS; CONSTRUCT; EXPOSURE	Purpose: To examine the associations between trauma severity, trait resilience, and posttraumatic stress disorder (PTSD) and depressive symptoms among adolescent survivors of the Wenchuan earthquake, China. Methods: 788 participants were randomly selected from secondary schools in the counties of Wenchuan and Maoxian, the two areas most severely affected by the earthquake. Participants completed four main questionnaires including the Child PTSD Symptom Scale, the Center for Epidemiologic Studies Depression Scale for Children, the Connor and Davidson's Resilience Scale, and the Severity of Exposure to Earthquake Scale. Results: After adjusting for the effect of age and gender, four aspects of trauma severity (i.e., direct exposure, indirect exposure, worry about others, and house damage) were positively associated with the severity of PTSD and depressive symptoms, whereas trait resilience was negatively associated with PTSD and depressive symptoms and moderated the relationship between subjective experience (i.e., worry about others) and PTSD and depressive symptoms. Conclusions: Several aspects (i.e., direct exposure, indirect exposure, worry about others, and house damage) of earthquake experiences may be important risk factors for the development and maintenance of PTSD and depression. Additionally, trait resilience exhibits the beneficial impact on PTSD and depressive symptoms and buffers the effect of subjective experience (i.e., worry about others) on PTSD and depressive symptoms.	[Ying, Liuhua] Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China; [Ying, Liuhua; Lin, Chongde] Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China; [Wu, Xinchun] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Jiang, Lina] Hangzhou Dianzi Univ, Coll Humanities & Law, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University; Beijing Normal University; Beijing Normal University; Hangzhou Dianzi University	Ying, LH (corresponding author), Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China.	ying2269@sina.com; linchongde@263.net			Philosophy and Social Sciences Research, Ministry of Education, China [08JZD0026]; Key Research Institutes of Humanities and Social Science of Ministry of Education, China [11JJD190006]; Science Foundation of Zhejiang Sci-Tech University [13062175-Y]	Philosophy and Social Sciences Research, Ministry of Education, China; Key Research Institutes of Humanities and Social Science of Ministry of Education, China; Science Foundation of Zhejiang Sci-Tech University	This study was supported by Key Projects of Philosophy and Social Sciences Research, Ministry of Education, China (Grant number: 08JZD0026), Projects of Key Research Institutes of Humanities and Social Science of Ministry of Education, China (Grant number: 11JJD190006) and Science Foundation of Zhejiang Sci-Tech University (Grant number: 13062175-Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; An YY, 2013, J LOSS TRAUMA, V18, P556, DOI 10.1080/15325024.2012.719351; Barkmann C, 2008, EUR CHILD ADOLES PSY, V17, P116, DOI 10.1007/s00787-008-1013-0; Basoglu M, 2004, J TRAUMA STRESS, V17, P133, DOI 10.1023/B:JOTS.0000022619.31615.e8; Bensimon M, 2012, PERS INDIV DIFFER, V52, P782, DOI 10.1016/j.paid.2012.01.011; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Block JH, 1980, DEV COGNITION AFFECT, P39; Bonanno GA, 2005, AM PSYCHOL, V60, P265, DOI 10.1037/0003-066X.60.3.265b; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Bulut S, 2005, SCHOOL PSYCHOL INT, V26, P55, DOI 10.1177/0143034305050893; Cao H, 2003, SOC PSYCH PSYCH EPID, V38, P204, DOI 10.1007/s00127-003-0619-2; Catalano D, 2011, REHABIL PSYCHOL, V56, P200, DOI 10.1037/a0024571; Chen SH, 2002, J CHIN INST ENG, V25, P597, DOI 10.1080/02533839.2002.9670734; Cohen J., 1983, APPL MULTIPLE REGRES; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Eksi A, 2009, EUR CHILD ADOLES PSY, V18, P384, DOI 10.1007/s00787-009-0745-9; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; FENDRICH M, 1990, AM J EPIDEMIOL, V131, P538, DOI 10.1093/oxfordjournals.aje.a115529; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Fu C, 2014, J AFFECT DISORDERS, V155, P149, DOI 10.1016/j.jad.2013.10.041; Furr JM, 2010, J CONSULT CLIN PSYCH, V78, P765, DOI 10.1037/a0021482; Galatzer-Levy IR, 2013, EMOTION, V13, P545, DOI 10.1037/a0031314; Galea S, 2008, J TRAUMA STRESS, V21, P357, DOI 10.1002/jts.20355; Giannopoulou I, 2006, EUR PSYCHIAT, V21, P160, DOI 10.1016/j.eurpsy.2005.09.005; Goenjian AK, 2011, J AFFECT DISORDERS, V133, P509, DOI 10.1016/j.jad.2011.04.053; Goenjian AK, 2009, J AFFECT DISORDERS, V112, P81, DOI 10.1016/j.jad.2008.04.006; Groome D, 2004, BRIT J PSYCHOL, V95, P387, DOI 10.1348/0007126041528149; Jacoby J., 2004, SISSY 1 11; Jorgensen Ivar Elvik, 2008, Int J Adolesc Med Health, V20, P23; Kent M, 2011, J TRAUMA STRESS, V24, P591, DOI 10.1002/jts.20685; Kolaitis G, 2003, EUR CHILD ADOLES PSY, V12, P273, DOI 10.1007/s00787-003-0339-x; Kutz I, 2006, PERS INDIV DIFFER, V40, P1579, DOI 10.1016/j.paid.2006.01.002; Lepore SJ., 2006, HDB POSTTRAUMATIC GR, P24; Li HCW, 2010, J ADV NURS, V66, P2582, DOI 10.1111/j.1365-2648.2010.05440.x; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; McDermott BM, 2005, CAN J PSYCHIAT, V50, P137, DOI 10.1177/070674370505000302; Ong AD, 2006, J PERS SOC PSYCHOL, V91, P730, DOI 10.1037/0022-3514.91.4.730; Ong AD, 2010, PSYCHOL AGING, V25, P516, DOI 10.1037/a0019384; Park CL, 2008, AM J ORTHOPSYCHIAT, V78, P300, DOI 10.1037/a0014054; Pinquart M, 2009, J APPL DEV PSYCHOL, V30, P53, DOI 10.1016/j.appdev.2008.10.005; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; Qu ZY, 2012, ARCH WOMEN MENT HLTH, V15, P49, DOI 10.1007/s00737-011-0255-x; Roussos A, 2005, AM J PSYCHIAT, V162, P530, DOI 10.1176/appi.ajp.162.3.530; Rutter M, 2006, JACOBS FOUND SER ADO, P26, DOI 10.1017/CBO9780511616259.003; Rutter M, 2012, DEV PSYCHOPATHOL, V24, P335, DOI 10.1017/S0954579412000028; Salcioglu E, 2008, WORLD J PEDIATR, V4, P165, DOI 10.1007/s12519-008-0032-8; Thienkrua W, 2006, JAMA-J AM MED ASSOC, V296, P549, DOI 10.1001/jama.296.5.549; Trickey D, 2012, CLIN PSYCHOL REV, V32, P122, DOI 10.1016/j.cpr.2011.12.001; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Vanderbilt-Adriance E, 2008, CLIN CHILD FAM PSYCH, V11, P30, DOI 10.1007/s10567-008-0031-2; Velleman R., 2007, ADV PSYCHIAT TREATME, V13, P79, DOI [10.1192/apt.bp.106.002386, DOI 10.1192/APT.BP.106.002386]; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041665; Wang X, 1993, RATING SCALES MENTAL; Waugh CE, 2011, EMOTION, V11, P1059, DOI 10.1037/a0021786; WEISSMAN MM, 1980, J NERV MENT DIS, V168, P736, DOI 10.1097/00005053-198012000-00005; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Windle G, 2011, REV CLIN GERONTOL, V21, P152, DOI 10.1017/S0959259810000420; Ying LH, 2013, EUR CHILD ADOLES PSY, V22, P567, DOI 10.1007/s00787-013-0400-3; Yu XN, 2007, SOC BEHAV PERSONAL, V35, P19, DOI 10.2224/sbp.2007.35.1.19; Zang W, 2009, CHINESE J S CHINA NO, V4, P59; Zhang C, 2009, CHINESE J SPECIAL ED, V9, P93; Zheng YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029404	67	73	75	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89401	10.1371/journal.pone.0089401	http://dx.doi.org/10.1371/journal.pone.0089401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24586751	gold, Green Published			2022-12-27	WOS:000332389000044
J	Roescher, AM; Timmer, A; Erwich, JJHM; Bos, AF				Roescher, Annemiek M.; Timmer, Albert; Erwich, Jan Jaap H. M.; Bos, Arend F.			Placental Pathology, Perinatal Death, Neonatal Outcome, and Neurological Development: A Systematic Review	PLOS ONE			English	Article							CEREBRAL-PALSY; FETAL-DEATH; GESTATIONAL-AGE; RISK-FACTORS; CHORIOAMNIONITIS; LESIONS; INFANTS; CLASSIFICATION; STILLBIRTHS; REPRODUCIBILITY	Background: The placenta plays a crucial role during pregnancy for growth and development of the fetus. Less than optimal placental performance may result in morbidity or even mortality of both mother and fetus. Awareness among pediatricians, however, of the benefit of placental findings for neonatal care, is limited. Objectives: To provide a systematic overview of the relation between placental lesions and neonatal outcome. Data sources: Pubmed database, reference lists of selected publications and important research groups in the field. Study appraisal and synthesis methods: We systematically searched the Pubmed database for literature on the relation between placental lesions and fetal and neonatal mortality, neonatal morbidity and neurological outcome. We conducted three separate searches starting with a search for placental pathology and fetal and neonatal mortality, followed by placental pathology and neonatal morbidity, and finally placental pathology and neurological development. We limited our search to full-text articles published in English from January 1995 to October 2013. We refined our search results by selecting the appropriate articles from the ones found during the initial searches. The first selection was based on the title, the second on the abstract, and the third on the full article. The quality of the selected articles was determined by using the Newcastle-Ottawa Quality Assessment Scale. Results: Placental lesions are one of the main causes of fetal death, where placental lesions consistent with maternal vascular underperfusion are most important. Several neonatal problems are also associated with placental lesions, whereby ascending intrauterine infection (with a fetal component) and fetal thrombotic vasculopathy constitute the greatest problem. Conclusions: The placenta plays a key role in fetal and neonatal mortality, morbidity, and outcome. Pediatricians should make an effort to obtain the results of placental examinations.	[Roescher, Annemiek M.; Bos, Arend F.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Neonatol, Groningen, Netherlands; [Timmer, Albert] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Erwich, Jan Jaap H. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Roescher, AM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Neonatol, Groningen, Netherlands.	a.m.roescher@umcg.nl			University of Groningen	University of Groningen	This study was part of the research program of the Postgraduate School for Behavioral and Cognitive Neurosciences (BCN), University of Groningen. Annemiek Roescher was financially supported by a Junior Scientific Master Class grant of the University of Groningen. The authors have no financial relationships relevant to this article to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Chapman Ira, 2002, J Perinatol, V22, P236, DOI 10.1038/sj.jp.7210685; [Anonymous], 1992, INT CLASS DIS; Ariel I, 2004, HUM PATHOL, V35, P729, DOI 10.1016/j.humpath.2004.02.010; Baergen RN, 2001, PEDIATR DEVEL PATHOL, V4, P144, DOI 10.1007/s100240010135; Baergen RN, 2002, MANUAL PATHOLOGY HUM; Beaudet L, 2007, J OBSTET GYNAECOL CA, V29, P315, DOI 10.1016/S1701-2163(16)32431-8; Beebe LA, 1996, OBSTET GYNECOL, V87, P771, DOI 10.1016/0029-7844(95)00483-1; Been JV, 2009, ARCH DIS CHILD-FETAL, V94, pF218, DOI 10.1136/adc.2008.150458; Benirschke K, 2006, PATHOLOGY HUMAN PLAC, V5th; BERNTON EW, 1987, SCIENCE, V238, P519, DOI 10.1126/science.2821620; Bersani I, 2012, J MATERN-FETAL NEO M, V25, P12, DOI 10.3109/14767058.2012.663161; Blair E, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.022; Bonetti LR, 2011, ARCH GYNECOL OBSTET, V283, P231, DOI 10.1007/s00404-009-1317-4; Bonnin A, 2011, NEUROSCIENCE, V197, P1, DOI 10.1016/j.neuroscience.2011.10.005; Bring HS, 2013, ACTA OBSTET GYNECOL; Bry K, 1997, J CLIN INVEST, V99, P2992, DOI 10.1172/JCI119494; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Burke CJ, 2007, PEDIATR DEVEL PATHOL, V10, P35, DOI 10.2350/06-02-0042.1; Chang KTE, 2011, PEDIATR DEVEL PATHOL, V14, P345, DOI 10.2350/10-07-0882-OA.1; Chau V, 2009, ANN NEUROL, V66, P155, DOI 10.1002/ana.21713; Chen ML, 2011, INVEST OPHTH VIS SCI, V52, P7052, DOI 10.1167/iovs.11-7380; Cross JC, 2001, THERIOGENOLOGY, V55, P193, DOI 10.1016/S0093-691X(00)00454-4; Dammann O, 2009, EARLY HUM DEV, V85, P325, DOI 10.1016/j.earlhumdev.2008.12.010; de Galan-Roosen AEM, 2002, EUR J OBSTET GYN R B, V103, P37, DOI 10.1016/S0301-2115(02)00024-6; de Laat MWM, 2006, OBSTET GYNECOL, V107, P1049, DOI 10.1097/01.AOG.0000209197.84185.15; Dix L, 2010, PATHOLOG RES INT, V2010; Elbers J, 2011, PEDIATRICS, V127, pE722, DOI 10.1542/peds.2010-1490; Evers IM, 2003, PLACENTA, V24, P819, DOI 10.1016/S0143-4004(03)00128-0; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Fox H, 2007, PATHOLOGY PLACENTA, V3rd; GROSS I, 1990, AM J PHYSIOL, V259, pL337, DOI 10.1152/ajplung.1990.259.6.L337; Hayes BC, 2013, ARCH DIS CHILD-FETAL, V98, pF233, DOI 10.1136/archdischild-2012-301992; Heazell AEP, 2009, J OBSTET GYNAECOL, V29, P225, DOI 10.1080/01443610802716042; Helgadottir LB, 2013, ACTA OBSTET GYN SCAN, V92, P325, DOI 10.1111/aogs.12044; Holcroft CJ, 2004, AM J OBSTET GYNECOL, V191, P2010, DOI 10.1016/j.ajog.2004.05.005; Horn LC, 2004, EUR J OBSTET GYN R B, V113, P134, DOI 10.1016/S0301-2115(03)00371-3; Incerpi MH, 1998, AM J OBSTET GYNECOL, V178, P1121, DOI 10.1016/S0002-9378(98)70311-4; Jobe Alan H, 2005, J Perinatol, V25 Suppl 2, pS31, DOI 10.1038/sj.jp.7211317; Khong TY, 2000, HUM PATHOL, V31, P292; Kidron D, 2009, PLACENTA, V30, P700, DOI 10.1016/j.placenta.2009.05.009; Korteweg FJ, 2008, PLACENTA, V29, P71, DOI 10.1016/j.placenta.2007.07.003; Korteweg FJ, 2006, BJOG-INT J OBSTET GY, V113, P393, DOI 10.1111/j.1471-0528.2006.00881.x; Korteweg FJ, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.10.026; Korteweg FJ, 2009, OBSTET GYNECOL, V114, P809, DOI 10.1097/AOG.0b013e3181b72ebe; Kramer BW, 2009, SEMIN FETAL NEONAT M, V14, P2, DOI 10.1016/j.siny.2008.08.011; Kraus FT., 2004, PLACENTAL PATHOLOGY; Larsen WJ, 2001, HUMAN EMBRYOLOGY, V3; Lee SA, 2012, EPIGENOMICS-UK, V4, P561, DOI [10.2217/EPI.12.49, 10.2217/epi.12.49]; Leviton A, 2010, PEDIATR RES, V67, P95, DOI 10.1203/PDR.0b013e3181bf5fab; Lewis SH., 1999, PATHOLOGY PLACENTA; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Locatelli A, 2005, EUR J OBSTET GYN R B, V123, P52, DOI 10.1016/j.ejogrb.2005.03.003; McDonald DGM, 2004, HUM PATHOL, V35, P875, DOI 10.1016/j.humpath.2004.02.014; Mehta Rajeev, 2006, Indian Journal of Pediatrics, V73, P25, DOI 10.1007/BF02758255; Moscuzza F, 2011, GYNECOL ENDOCRINOL, V27, P319, DOI 10.3109/09513590.2010.487619; Nelson KB, 2011, PLACENTA, V32, P623, DOI 10.1016/j.placenta.2011.06.021; Ogino S, 2000, HUM PATHOL, V31, P945, DOI 10.1053/hupa.2000.9036; Ogunyemi D, 1998, ACTA OBSTET GYN SCAN, V77, P722, DOI 10.1034/j.1600-0412.1998.770705.x; Ogunyemi D, 2003, J Matern Fetal Neonatal Med, V13, P102, DOI 10.1080/jmf.13.2.102.109; Pathak S, 2011, VIRCHOWS ARCH, V459, P565, DOI 10.1007/s00428-011-1157-z; Perrone S, 2012, J MATERN-FETAL NEO M, V25, P110, DOI 10.3109/14767058.2012.664344; Petersen OFaye, 2006, HDB PLACENTAL PATHOL; Polam S, 2005, ARCH PEDIAT ADOL MED, V159, P1032, DOI 10.1001/archpedi.159.11.1032; Redline RW, 2007, HUM PATHOL, V38, P1439, DOI 10.1016/j.humpath.2007.05.025; Redline RW, 2007, PEDIATR DEVEL PATHOL, V10, P282, DOI 10.2350/06-12-0203.1; Redline RW, 2005, AM J OBSTET GYNECOL, V192, P452, DOI 10.1016/j.ajog.2004.07.030; Redline RW, 2004, HUM PATHOL, V35, P1494, DOI 10.1016/j.humpath.2004.08.003; Redline RW, 2004, PEDIATR DEVEL PATHOL, V7, P443, DOI 10.1007/s10024-004-2020-x; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Redline RW, 2004, PEDIATR DEVEL PATHOL, V7, P237, DOI 10.1007/s10024-003-8083-2; Redline RW, 1998, ARCH PATHOL LAB MED, V122, P1091; Redline RW, 2002, PEDIATR RES, V52, P713, DOI 10.1203/00006450-200211000-00017; Redline RW, 2000, ARCH PATHOL LAB MED, V124, P1785; Reiman M, 2008, J PEDIATR-US, V152, P642, DOI 10.1016/j.jpeds.2007.09.051; Richardson BS, 2006, AM J OBSTET GYNECOL, V195, P1357, DOI 10.1016/j.ajog.2006.03.053; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Roescher AM, 2011, EARLY HUM DEV, V87, P315, DOI 10.1016/j.earlhumdev.2011.01.040; Rovira N, 2011, EARLY HUM DEV, V87, P253, DOI 10.1016/j.earlhumdev.2011.01.024; Saleemuddin A, 2010, PEDIATR DEVEL PATHOL, V13, P459, DOI 10.2350/10-01-0774-OA.1; SAPOLSKY R, 1987, SCIENCE, V238, P522, DOI 10.1126/science.2821621; Sato M, 2011, J OBSTET GYNAECOL RE, V37, P1313, DOI 10.1111/j.1447-0756.2010.01519.x; Speer CP, 2011, NEONATOLOGY, V99, P316, DOI 10.1159/000326619; Suppiej A, 2009, EARLY HUM DEV, V85, P187, DOI 10.1016/j.earlhumdev.2008.09.410; Tellefsen CH, 2011, PEDIATR DEVEL PATHOL, V14, P99, DOI 10.2350/10-07-0870-OA.1; van Vliet EOG, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.03.024; VanderWielen B, 2011, AM J MED GENET A, V155A, P1073, DOI 10.1002/ajmg.a.34016; Vergani P, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.098; Viscardi RM, 2001, EARLY HUM DEV, V62, P1, DOI 10.1016/S0378-3782(01)00114-1; Watterberg KL, 1996, PEDIATRICS, V97, P210; Willet KE, 2000, PEDIATR RES, V48, P782, DOI 10.1203/00006450-200012000-00014; Wintermark P, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.08.024; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Zanconato Giovanni, 2007, Archives of Gynecology and Obstetrics, V276, P619, DOI 10.1007/s00404-007-0391-8	93	97	102	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89419	10.1371/journal.pone.0089419	http://dx.doi.org/10.1371/journal.pone.0089419			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586764	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900042
J	Duncan, LE; Holmans, PA; Lee, PH; O'Dushlaine, CT; Kirby, AW; Smoller, JW; Ongur, D; Cohen, BM				Duncan, Laramie E.; Holmans, Peter A.; Lee, Phil H.; O'Dushlaine, Colm T.; Kirby, Andrew W.; Smoller, Jordan W.; Oenguer, Dost; Cohen, Bruce M.			Pathway Analyses Implicate Glial Cells in Schizophrenia	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; PSYCHIATRIC-DISORDERS; BIPOLAR DISORDER; PREFRONTAL CORTEX; ASSOCIATION; GENOMEWIDE; DENSITY	Background: The quest to understand the neurobiology of schizophrenia and bipolar disorder is ongoing with multiple lines of evidence indicating abnormalities of glia, mitochondria, and glutamate in both disorders. Despite high heritability estimates of 81% for schizophrenia and 75% for bipolar disorder, compelling links between findings from neurobiological studies, and findings from large-scale genetic analyses, are only beginning to emerge. Method: Ten publically available gene sets (pathways) related to glia, mitochondria, and glutamate were tested for association to schizophrenia and bipolar disorder using MAGENTA as the primary analysis method. To determine the robustness of associations, secondary analyses were performed with: ALIGATOR, INRICH, and Set Screen. Data from the Psychiatric Genomics Consortium (PGC) were used for all analyses. There were 1,068,286 SNP-level p-values for schizophrenia (9,394 cases/12,462 controls), and 2,088,878 SNP-level p-values for bipolar disorder (7,481 cases/9,250 controls). Results: The Glia-Oligodendrocyte pathway was associated with schizophrenia, after correction for multiple tests, according to primary analysis (MAGENTA p = 0.0005, 75% requirement for individual gene significance) and also achieved nominal levels of significance with INRICH (p = 0.0057) and ALIGATOR (p = 0.022). For bipolar disorder, Set Screen yielded nominally and method-wide significant associations to all three glial pathways, with strongest association to the Glia-Astrocyte pathway (p = 0.002). Conclusions: Consistent with findings of white matter abnormalities in schizophrenia by other methods of study, the Glia-Oligodendrocyte pathway was associated with schizophrenia in our genomic study. These findings suggest that the abnormalities of myelination observed in schizophrenia are at least in part due to inherited factors, contrasted with the alternative of purely environmental causes (e.g. medication effects or lifestyle). While not the primary purpose of our study, our results also highlight the consequential nature of alternative choices regarding pathway analysis, in that results varied somewhat across methods, despite application to identical datasets and pathways.	[Duncan, Laramie E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Duncan, Laramie E.; Lee, Phil H.; Smoller, Jordan W.] Massachusetts Gen Hosp, PNGU, Boston, MA 02114 USA; [Duncan, Laramie E.; Lee, Phil H.; Smoller, Jordan W.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Duncan, Laramie E.; Lee, Phil H.; O'Dushlaine, Colm T.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Duncan, Laramie E.; Lee, Phil H.; Oenguer, Dost; Cohen, Bruce M.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Holmans, Peter A.] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales; [Lee, Phil H.; Kirby, Andrew W.] Massachusetts Gen Hosp, ATGU, Boston, MA 02114 USA; [Oenguer, Dost] McLean Hosp, Schizophrenia & Bipolar Disorder Program, Belmont, MA 02178 USA; [Cohen, Bruce M.] McLean Hosp, Shervert Frazier Res Inst, Belmont, MA 02178 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Cardiff University; Harvard University; Massachusetts General Hospital; Harvard University; McLean Hospital; Harvard University; McLean Hospital	Duncan, LE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	laramied@gmail.com	Holmans, Peter/F-4518-2015; Cohen, Bruce M./AAZ-4986-2020; Duncan, Laramie/AAG-6605-2019; Duncan, Laramie/AAW-5306-2021	Holmans, Peter/0000-0003-0870-9412; Duncan, Laramie/0000-0003-1131-661X	LED - Jonathan Edwards Brooking Memorial Fund for Mental Health Research at McLean Hospital; National Institute of Mental Health (NIMH) [T32MH017119]; JWS - National Institute of Mental Health (NIMH) [K24MH094614]; DO - NIMH [R21MH096107-01A1]; BMC - Maltz Distinguished Investigator Award; National Alliance for Research on Schizophrenia and Depression (NARSAD); Medical Research Council [MR/L010305/1] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH101367, R21MH096107, K24MH094614, T32MH017119] Funding Source: NIH RePORTER	LED - Jonathan Edwards Brooking Memorial Fund for Mental Health Research at McLean Hospital; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); JWS - National Institute of Mental Health (NIMH); DO - NIMH; BMC - Maltz Distinguished Investigator Award; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding supporting for this work is as follows: LED - Jonathan Edwards Brooking Memorial Fund for Mental Health Research at McLean Hospital & National Institute of Mental Health (NIMH) grant T32MH017119; JWS - National Institute of Mental Health (NIMH) grant K24MH094614; DO - NIMH grant R21MH096107-01A1; BMC - Maltz Distinguished Investigator Award, National Alliance for Research on Schizophrenia and Depression (NARSAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Cataldo AM, 2010, AM J PATHOL, V177, P575, DOI 10.2353/ajpath.2010.081068; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Development Core Team, 2005, R LANG ENV STAT COMP; Goudriaan A, 2014, SCHIZOPHRENIA BULL, V40, P925, DOI 10.1093/schbul/sbt109; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hyman SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003142; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Kato T, 2000, BIPOLAR DISORD, V2, P180, DOI 10.1034/j.1399-5618.2000.020305.x; KETY SEYMOUR S., 1950, TRANS AND STUD COLL PHYS PHILADELPHIA, V18, P103; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Lips ES, 2012, MOL PSYCHIATR, V17, P996, DOI 10.1038/mp.2011.117; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Moskvina V, 2011, GENET EPIDEMIOL, V35, P861, DOI 10.1002/gepi.20636; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Ongur D, 2008, BIOL PSYCHIAT, V64, P718, DOI 10.1016/j.biopsych.2008.05.014; Ongur D, 2011, BIOL PSYCHIAT, V70, P169, DOI 10.1016/j.biopsych.2011.01.033; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Rajkowska G, 2001, BIOL PSYCHIAT, V49, P741, DOI 10.1016/S0006-3223(01)01080-0; Rezin GT, 2009, NEUROCHEM RES, V34, P1021, DOI 10.1007/s11064-008-9865-8; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi N, 2011, PROG NEUROBIOL, V93, P13, DOI 10.1016/j.pneurobio.2010.09.004; Uranova NA, 2004, SCHIZOPHR RES, V67, P269, DOI 10.1016/S0920-9964(03)00181-6; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e	39	41	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89441	10.1371/journal.pone.0089441	http://dx.doi.org/10.1371/journal.pone.0089441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586781	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700045
J	Goel, SA; Guo, LW; Wang, BW; Guo, S; Roenneburg, D; Ananiev, GE; Hoffmann, FM; Kent, KC				Goel, Shakti A.; Guo, Lian-Wang; Wang, Bowen; Guo, Song; Roenneburg, Drew; Ananiev, Gene E.; Hoffmann, F. Michael; Kent, K. Craig			High-Throughput Screening Identifies Idarubicin as a Preferential Inhibitor of Smooth Muscle versus Endothelial Cell Proliferation	PLOS ONE			English	Article							DRUG-ELUTING STENTS; RE-ENDOTHELIALIZATION; INTIMAL HYPERPLASIA; NEOINTIMA FORMATION; GENE-TRANSFER; TGF-BETA; RESTENOSIS; PACLITAXEL; SIROLIMUS; CORONARY	Intimal hyperplasia is the cause of the recurrent occlusive vascular disease (restenosis). Drugs currently used to treat restenosis effectively inhibit smooth muscle cell (SMC) proliferation, but also inhibit the growth of the protective luminal endothelial cell (EC) lining, leading to thrombosis. To identify compounds that selectively inhibit SMC versus EC proliferation, we have developed a high-throughput screening (HTS) format using human cells and have employed this to screen a multiple compound collection (NIH Clinical Collection). We developed an automated, accurate proliferation assay in 96-well plates using human aortic SMCs and ECs. Using this HTS format we screened a 447-drug NIH Clinical Library. We identified 11 compounds that inhibited SMC proliferation greater than 50%, among which idarubicin exhibited a unique feature of preferentially inhibiting SMC versus EC proliferation. Concentration-response analysis revealed this differential effect most evident over an similar to 10 nM-5 mM window. In vivo testing of idarubicin in a rat carotid injury model at 14 days revealed an 80% reduction of intimal hyperplasia and a 45% increase of lumen size with no significant effect on reendothelialization. Taken together, we have established a HTS assay of human vascular cell proliferation, and identified idarubicin as a selective inhibitor of SMC versus EC proliferation both in vitro and in vivo. Screening of larger and more diverse compound libraries may lead to the discovery of next-generation therapeutics that can inhibit intima hyperplasia without impairing re-endothelialization.	[Goel, Shakti A.; Guo, Lian-Wang; Wang, Bowen; Roenneburg, Drew; Kent, K. Craig] Univ Wisconsin, Dept Surg, Madison, WI 53706 USA; [Guo, Song; Ananiev, Gene E.; Hoffmann, F. Michael] UW Carbone Canc Ctr, Small Mol Screening & Synth Facil, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System	Guo, LW (corresponding author), Univ Wisconsin, Dept Surg, Madison, WI 53706 USA.	guo@surgery.wisc.edu	Goel, Shakti/AAE-8363-2020	Goel, Shakti/0000-0002-1249-0647; Hoffmann, F. Michael/0000-0002-2770-9656	National Heart, Lung, and Blood Institute [R01-HL-068673]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068673] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Public Health Service Grant (R01-HL-068673 to K. C. K.) from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antczak C, 2007, J BIOMOL SCREEN, V12, P521, DOI 10.1177/1087057107300463; Breen DM, 2012, ATHEROSCLEROSIS, V222, P375, DOI 10.1016/j.atherosclerosis.2012.03.021; Brown MA, 2010, ARTERIOSCL THROM VAS, V30, P2150, DOI 10.1161/ATVBAHA.110.207076; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; Ewald JA, 2009, J BIOMOL SCREEN, V14, P853, DOI 10.1177/1087057109340314; Forte A, 2013, INT J CARDIOL, V168, P3370, DOI 10.1016/j.ijcard.2013.04.153; Gertz ZM, 2011, CARDIOVASC THER, V29, pE54, DOI 10.1111/j.1755-5922.2010.00187.x; Giordano A, 2012, AM J PHYSIOL-HEART C, V302, pH135, DOI 10.1152/ajpheart.00490.2011; Hacker Timothy A, 2007, J Invasive Cardiol, V19, P269; Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kingston PA, 2003, CIRCULATION, V108, P2819, DOI 10.1161/01.CIR.0000097068.49080.A0; Kundi R, 2009, CARDIOVASC RES, V84, P326, DOI 10.1093/cvr/cvp220; Li FYL, 2012, CIRCULATION, V126, P1267, DOI 10.1161/CIRCULATIONAHA.112.108159; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; Mehilli J, 2010, J AM COLL CARDIOL, V55, P2710, DOI 10.1016/j.jacc.2010.02.009; Mills B, 2012, PERFUSION-UK, V27, P520, DOI 10.1177/0267659112452316; Mills B, 2012, INTIMAL HYPERPLASIA; Mukadam Sophie, 2012, Drug Metab Lett, V6, P43; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Nugent HM, 1999, CIRC RES, V84, P384, DOI 10.1161/01.RES.84.4.384; Sachsenmeier KF, 2012, J BIOMOL SCREEN, V17, P993, DOI 10.1177/1087057112443987; Song P, 2011, CIRC RES, V109, P1230, DOI 10.1161/CIRCRESAHA.111.250423; Sun L, 2012, MOLECULES, V17, P3333, DOI 10.3390/molecules17033333; Suwanabol PA, 2011, J SURG RES, V167, P287, DOI 10.1016/j.jss.2010.12.020; Tian W, 2006, J ENDOVASC THER, V13, P616, DOI 10.1583/05-1802MR.1; Togni M, 2005, J AM COLL CARDIOL, V46, P231, DOI 10.1016/j.jacc.2005.01.062; Tomasini-Johansson BR, 2012, MATRIX BIOL J INT SO; Torella D, 2009, AM J PHYSIOL-HEART C, V297, pH2015, DOI 10.1152/ajpheart.00738.2009; Vallieres K, 2009, VASC PHARMACOL, V51, P50, DOI 10.1016/j.vph.2009.02.003; Volkova M, 2011, CURR CARDIOL REV, V7, P214, DOI 10.2174/157340311799960645; Werk M, 2008, CIRCULATION, V118, P1358, DOI 10.1161/CIRCULATIONAHA.107.735985; Wessely R, 2006, J AM COLL CARDIOL, V47, P708, DOI 10.1016/j.jacc.2005.09.047; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; Yao EH, 2009, CARDIOVASC RES, V81, P797, DOI 10.1093/cvr/cvn355; Yoon JW, 2012, INT J CARDIOLOGY; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	39	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89349	10.1371/journal.pone.0089349	http://dx.doi.org/10.1371/journal.pone.0089349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586708	gold, Green Submitted, Green Published			2022-12-27	WOS:000331880700029
J	Collins, LM; Warnock, ND; Tosh, DG; McInnes, C; Everest, D; Montgomery, WI; Scantlebury, M; Marks, N; Dick, JTA; Reid, N				Collins, Lisa M.; Warnock, Neil D.; Tosh, David G.; McInnes, Colin; Everest, David; Montgomery, W. Ian; Scantlebury, Mike; Marks, Nikki; Dick, Jaimie T. A.; Reid, Neil			Squirrelpox Virus: Assessing Prevalence, Transmission and Environmental Degradation	PLOS ONE			English	Article							SCIURUS-VULGARIS; RED SQUIRRELS; GREY SQUIRRELS; DISEASE; POXVIRUS; COMPETITION; INFECTION; PARTICLES; DECLINE	Red squirrels (Sciurus vulgaris) declined in Great Britain and Ireland during the last century, due to habitat loss and the introduction of grey squirrels (Sciurus carolinensis), which competitively exclude the red squirrel and act as a reservoir for squirrelpox virus (SQPV). The disease is generally fatal to red squirrels and their ecological replacement by grey squirrels is up to 25 times faster where the virus is present. We aimed to determine: (1) the seropositivity and prevalence of SQPV DNA in the invasive and native species at a regional scale; (2) possible SQPV transmission routes; and, (3) virus degradation rates under differing environmental conditions. Grey (n = 208) and red (n = 40) squirrel blood and tissues were sampled. Enzyme-linked immunosorbent assay (ELISA) and quantitative real-time polymerase chain reaction (qPCR) techniques established seropositivity and viral DNA presence, respectively. Overall 8% of squirrels sampled (both species combined) had evidence of SQPV DNA in their tissues and 22% were in possession of antibodies. SQPV prevalence in sampled red squirrels was 2.5%. Viral loads were typically low in grey squirrels by comparison to red squirrels. There was a trend for a greater number of positive samples in spring and summer than in winter. Possible transmission routes were identified through the presence of viral DNA in faeces (red squirrels only), urine and ectoparasites (both species). Virus degradation analyses suggested that, after 30 days of exposure to six combinations of environments, there were more intact virus particles in scabs kept in warm (25 degrees C) and dry conditions than in cooler (5 and 15 degrees C) or wet conditions. We conclude that SQPV is present at low prevalence in invasive grey squirrel populations with a lower prevalence in native red squirrels. Virus transmission could occur through urine especially during warm dry summer conditions but, more notably, via ectoparasites, which are shared by both species.	[Collins, Lisa M.; Warnock, Neil D.; Tosh, David G.; Montgomery, W. Ian; Dick, Jaimie T. A.; Reid, Neil] Queens Univ Belfast, Sch Biol Sci, Quercus, Belfast, Antrim, North Ireland; [Collins, Lisa M.; Warnock, Neil D.; Montgomery, W. Ian; Scantlebury, Mike; Marks, Nikki; Dick, Jaimie T. A.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Collins, Lisa M.; Dick, Jaimie T. A.] Queens Univ Belfast, Inst Global Food Secur, Belfast, Antrim, North Ireland; [Collins, Lisa M.] Lincoln Univ, Sch Life Sci, Lincoln, Lincs, England; [McInnes, Colin] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Everest, David] Anim Hlth & Vet Labs Agcy, Addlestone, Surrey, England	Queens University Belfast; Queens University Belfast; Queens University Belfast; University of Lincoln; Moredun Research Institute; Veterinary Laboratories Agency	Reid, N (corresponding author), Queens Univ Belfast, Sch Biol Sci, Quercus, Belfast, Antrim, North Ireland.	neil.reid@qub.ac.uk	Reid, Neil/M-8517-2019; Reid, Neil/D-1896-2010; Collins, Lisa/C-9562-2014	Reid, Neil/0000-0001-8951-8292; Reid, Neil/0000-0001-8951-8292; McInnes, Colin/0000-0002-1465-9901; Collins, Lisa/0000-0002-8596-5498	Northern Ireland Environment Agency (NIEA); Quercus, Queen's University Belfast (QUB); People's Trust for Endangered Species (PTES); Moredun Research Institute; Animal Health and Veterinary Laboratories Agency (AHVLA)	Northern Ireland Environment Agency (NIEA); Quercus, Queen's University Belfast (QUB); People's Trust for Endangered Species (PTES); Moredun Research Institute; Animal Health and Veterinary Laboratories Agency (AHVLA)	This project was part-funded by the Natural Heritage Research Partnership (NHRP) between the Northern Ireland Environment Agency (NIEA) and Quercus, Queen's University Belfast (QUB) and part-funded by the People's Trust for Endangered Species (PTES) conducted in collaboration with the Moredun Research Institute and the Animal Health and Veterinary Laboratories Agency (AHVLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin JW, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-33; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bruemmer CM, 2010, EPIDEMIOL INFECT, V138, P941, DOI 10.1017/S0950268810000816; Carey M., 2007, IRISH SQUIRREL SURVE; Carroll B, 2009, EPIDEMIOL INFECT, V137, P257, DOI 10.1017/S0950268808000836; Duff JP, 1996, VET REC, V138, P527; Everest DJ, 2010, VET REC, V167, P1007, DOI 10.1136/vr.c4111; Everest DJ, 2012, VET REC, V170, P188, DOI 10.1136/vr.e1128; Gurnell J, 2004, J ANIM ECOL, V73, P26, DOI 10.1111/j.1365-2656.2004.00791.x; Gurnell J, 2009, 11 FOR COMM; Gurnell John, 1996, P67; Kallio ER, 2006, J GEN VIROL, V87, P2127, DOI 10.1099/vir.0.81643-0; LaRose JP, 2010, VET REC, V167, P297, DOI 10.1136/vr.c4196; Lees J, 2011, NO IR SQUIRR FOR STA; LIVINGTON C. W., 1960, JOUR AMER VET MED ASSOC, V137, P651; McInnes CJ, 2013, ANIM CONSERV, V16, P51, DOI 10.1111/j.1469-1795.2012.00570.x; McInnes CJ, 2006, J GEN VIROL, V87, P2115, DOI 10.1099/vir.0.81966-0; Middleton AD, 1930, P ZOOL SOC LOND, V2, P809; Rushton SP, 2006, EPIDEMIOL INFECT, V134, P521, DOI 10.1017/S0950268805005303; Sainsbury AW, 2008, ECOHEALTH, V5, P305, DOI 10.1007/s10393-008-0191-z; Sainsbury AW, 2000, ANIM CONSERV, V3, P229, DOI 10.1017/S1367943000000949; SCOTT AC, 1981, VET REC, V109, P202, DOI 10.1136/vr.109.10.202; Simpson VR, 2010, VET REC, V167, P59, DOI 10.1136/vr.b4887; Sweet D, 1997, J FORENSIC SCI, V42, P320; Tompkins DM, 2002, P ROY SOC B-BIOL SCI, V269, P529, DOI 10.1098/rspb.2001.1897; Wauters LA, 1999, ETHOLOGY, V105, P1053, DOI 10.1046/j.1439-0310.1999.10512488.x	26	31	33	6	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89521	10.1371/journal.pone.0089521	http://dx.doi.org/10.1371/journal.pone.0089521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586845	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000331717900114
J	Huang, L; Pike, D; Sleat, DE; Nanda, V; Lobel, P				Huang, Ling; Pike, Douglas; Sleat, David E.; Nanda, Vikas; Lobel, Peter			Potential Pitfalls and Solutions for Use of Fluorescent Fusion Proteins to Study the Lysosome	PLOS ONE			English	Article							TRIPEPTIDYL PEPTIDASE-I; IDENTIFICATION; DEFICIENT; BINDING; DEGRADATION; EXPRESSION; SYSTEM; FORMS; GENE; NPC2	Use of fusion protein tags to investigate lysosomal proteins can be complicated by the acidic, protease-rich environment of the lysosome. Potential artifacts include degradation or release of the tag and acid quenching of fluorescence. Tagging can also affect protein folding, glycosylation and/or trafficking. To specifically investigate the use of fluorescent tags to reveal lysosomal localization, we tested mCherry derivatives as C-terminal tags for Niemann-Pick disease type C protein 2 (NPC2), a luminal lysosomal protein. Full-length mCherry was released from the NPC2 chimera while deletion of the 11 N-terminal residues of mCherry generated a cleavage-resistant (cr) fluorescent variant. Insertion of proline linkers between NPC2 and crmCherry had little effect while Gly-Ser linkers promoted cleavage. The NPC2-crmCherry fusion was targeted to the lysosome and restored function in NPC2-deficient cells. Fusion of crmCherry to known and candidate lysosomal proteins revealed that the linkers had different effects on lysosomal localization. Direct fusion of crmCherry impaired mannose 6-phosphorylation and lysosomal targeting of the lysosomal protease tripeptidyl peptidase I (TPP1), while insertion of linkers corrected the defects. Molecular modeling suggested structural bases for the effects of different linkers on NPC2 and TPP1 fusion proteins. While mCherry fusion proteins can be useful tools for studying the lysosome and related organelles, our findings underscore the potential artifacts associated with such applications.	[Huang, Ling; Pike, Douglas; Sleat, David E.; Nanda, Vikas; Lobel, Peter] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Huang, Ling] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Pike, Douglas; Sleat, David E.; Nanda, Vikas; Lobel, Peter] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lobel, P (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	lobel@cabm.rutgers.edu		Pike, Douglas/0000-0001-8880-9485; Nanda, Vikas/0000-0003-2786-8347	National Institutes of Health [R01DK054317, R01 NS037918]; Ara Parseghian Medical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by grants from the National Institutes of Health (R01DK054317 and R01 NS037918) and the Ara Parseghian Medical Research Foundation http://www.parseghian.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dierks T, 2013, J BIOL CHEM; DOEBBER TW, 1978, ENDOCRINOLOGY, V103, P1794, DOI 10.1210/endo-103-5-1794; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Guhaniyogi J, 2009, J BIOL CHEM, V284, P3985, DOI 10.1074/jbc.M806943200; Hohenwarter O, 1997, J BIOTECHNOL, V54, P131, DOI 10.1016/S0168-1656(97)00044-8; Holtzman E, 1989, LYSOSOMES; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hundeshagen P, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-38; IOANNOU YA, 1992, J CELL BIOL, V119, P1137, DOI 10.1083/jcb.119.5.1137; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Kollmann K, 2005, PROTEOMICS, V5, P3966, DOI 10.1002/pmic.200401247; Krueger C, 2006, J GENE MED, V8, P1037, DOI 10.1002/jgm.932; Lee H, 2013, HUM GENE THER, V24, P655, DOI 10.1089/hum.2013.001; Lin L, 2001, BIOCHEM J, V357, P49, DOI 10.1042/0264-6021:3570049; Liou HL, 2006, J BIOL CHEM, V281, P36710, DOI 10.1074/jbc.M608743200; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Matsumoto A, 2011, BIOTECHNIQUES, V51, P55, DOI 10.2144/000113705; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; PAGE AE, 1993, ARCH BIOCHEM BIOPHYS, V306, P354, DOI 10.1006/abbi.1993.1523; Pal A, 2009, J BIOL CHEM, V284, P3976, DOI 10.1074/jbc.M806947200; REDDY VB, 1978, SCIENCE, V200, P494, DOI 10.1126/science.205947; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHUERMANN M, 1990, NUCLEIC ACIDS RES, V18, P4945, DOI 10.1093/nar/18.16.4945; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sleat DE, 2008, J PROTEOME RES, V7, P3010, DOI 10.1021/pr800135v; Sleat DE, 1996, J BIOL CHEM, V271, P19191, DOI 10.1074/jbc.271.32.19191; Sleat DE, 2013, MOL CELL PROTEOMICS, DOI DOI 10.1074/mcp.R112.027110; Sohar I, 2000, CLIN CHEM, V46, P1005; Summa C. M., 2002, THESIS U PENNSYLVANI; Sun PL, 2008, P NATL ACAD SCI USA, V105, P16590, DOI 10.1073/pnas.0807472105; Tillett D, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e26; VALENZANO KJ, 1995, J BIOL CHEM, V270, P16441, DOI 10.1074/jbc.270.27.16441; Wujek P, 2004, J BIOL CHEM, V279, P12827, DOI 10.1074/jbc.M313173200; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284	43	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88893	10.1371/journal.pone.0088893	http://dx.doi.org/10.1371/journal.pone.0088893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586430	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900035
J	Portis, E; Barchi, L; Toppino, L; Lanteri, S; Acciarri, N; Felicioni, N; Fusari, F; Barbierato, V; Cericola, F; Vale, G; Rotino, GL				Portis, Ezio; Barchi, Lorenzo; Toppino, Laura; Lanteri, Sergio; Acciarri, Nazzareno; Felicioni, Nazzareno; Fusari, Fabio; Barbierato, Valeria; Cericola, Fabio; Vale, Giampiero; Rotino, Giuseppe Leonardo			QTL Mapping in Eggplant Reveals Clusters of Yield-Related Loci and Orthology with the Tomato Genome	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SOLANUM-MELONGENA; FRUIT-SHAPE; DOMESTICATION TRAITS; WILT RESISTANCE; CAPSICUM-ANNUUM; HIGH-RESOLUTION; GENE-FUNCTION; LINKAGE MAP; PEPPER	In spite of its widespread cultivation and nutritional and economic importance, the eggplant (Solanum melongena L.) genome has not been extensively explored. A lack of knowledge of the patterns of inheritance of key agronomic traits has hindered the exploitation of marker technologies to accelerate its genetic improvement. An already established F2 intraspecific population of eggplant bred from the cross `305E40' x `67/3' was phenotyped for 20 agronomically relevant traits at two sites. Up to seven quantitative trait loci (QTL) per trait were identified and the percentage of the phenotypic variance (PV) explained per QTL ranged from 4 to 93%. Not all the QTL were detectable at both sites, but for each trait at least one major QTL (PV explained >= 10%) was identified. Although no detectable QTL x environment interaction was found, some QTL identified were location-specific. Many of the fruit-related QTL clustered within specific chromosomal regions, reflecting either linkage and/or pleiotropy. Evidence for putative tomato orthologous QTL/genes was obtained for several of the eggplant QTL. Information regarding the inheritance of key agronomic traits was obtained. Some of the QTL, along with their respective linked markers, may be useful in the context of marker-assisted breeding.	[Portis, Ezio; Barchi, Lorenzo; Lanteri, Sergio; Cericola, Fabio] Univ Turin, DISAFA Plant Genet & Breeding, Turin, Italy; [Toppino, Laura; Barbierato, Valeria; Rotino, Giuseppe Leonardo] Consiglio Ric & Sperimentaz Agr CRA ORL, Res Unit Vegetable Crops, Lodi, Italy; [Acciarri, Nazzareno; Felicioni, Nazzareno; Fusari, Fabio] Consiglio Ric & Sperimentaz Agr CRA ORA, Res Unit Vegetable Crops, Lodi, Italy; [Vale, Giampiero] Consiglio Ric & Sperimentaz Agr CRA GPG, Genom Res Ctr, Piacenza, Italy; [Vale, Giampiero] Consiglio Ric & Sperimentaz Agr CRA RIS, Rice Res Unit, Vercelli, Italy	University of Turin; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Rotino, GL (corresponding author), Consiglio Ric & Sperimentaz Agr CRA ORL, Res Unit Vegetable Crops, Lodi, Italy.	giuseppeleonardo.rotino@entecra.it	BARCHI, Lorenzo/ABC-4206-2020; Valè, Giampiero/ABF-1492-2020; Lanteri, Sergio/P-4902-2015	BARCHI, Lorenzo/0000-0001-6414-4239; Valè, Giampiero/0000-0003-2158-9726; Lanteri, Sergio/0000-0003-3012-8710; Toppino, Laura/0000-0002-8664-1233; Acciarri, Nazzareno/0000-0002-0892-5994; PORTIS, Ezio/0000-0002-1548-6096	Italian Ministry of Agricultural Alimentary and Forest Politics	Italian Ministry of Agricultural Alimentary and Forest Politics	This research was partially supported by the Italian Ministry of Agricultural Alimentary and Forest Politics in the framework of "PROM'' and "ESPLORA'' projects. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; Barchi L, 2007, GENOME, V50, P51, DOI 10.1139/G06-140; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Barchi L, 2010, GENOME, V53, P805, DOI [10.1139/g10-073, 10.1139/G10-073]; Ben Chaim A, 2001, THEOR APPL GENET, V102, P1016, DOI 10.1007/s001220000461; Bradshaw JE, 2008, THEOR APPL GENET, V116, P193, DOI 10.1007/s00122-007-0659-1; Cericola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073702; Chadha M. L., 1993, Advances in horticulture: vegetable crops - Volume 5., P105; Chaim AB, 2003, THEOR APPL GENET, V106, P889, DOI 10.1007/s00122-002-1132-9; CHURCHILL GA, 1994, GENETICS, V138, P963; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; Daunay Marie-Christine, 2008, P163; DEVICENTE MC, 1993, GENETICS, V134, P585; Doganlar S, 2002, GENETICS, V161, P1713; ECPGR, 2008, MIN DESCR EGGPL CAPS; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Frary A, 2003, THEOR APPL GENET, V107, P359, DOI 10.1007/s00122-003-1257-5; Fukuoka H, 2012, THEOR APPL GENET, V125, P47, DOI 10.1007/s00122-012-1815-9; Grandilio S, 1996, MOL BREEDING, V2, P251, DOI 10.1007/BF00564202; Grandillo S, 1999, THEOR APPL GENET, V99, P978, DOI 10.1007/s001220051405; Huang ZJ, 2011, THEOR APPL GENET, V123, P465, DOI 10.1007/s00122-011-1599-3; IBPGR, 1990, DESCR EGGPL; JANSEN RC, 1994, GENETICS, V138, P871; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1993, GENETICS, V135, P205; LANDER ES, 1989, GENETICS, V121, P185; Lebeau A, 2011, PHYTOPATHOLOGY, V101, P154, DOI 10.1094/PHYTO-02-10-0048; Li Z, 2001, THEOR APPL GENET, V103, P1167, DOI 10.1007/s001220100672; Lindhout P, 2002, EUPHYTICA, V124, P217, DOI 10.1023/A:1015686601404; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Meyer RS, 2012, MOL PHYLOGENET EVOL, V63, P685, DOI 10.1016/j.ympev.2012.02.006; Miyatake K, 2012, THEOR APPL GENET, V124, P1403, DOI 10.1007/s00122-012-1796-8; Munos S, 2011, PLANT PHYSIOL, V156, P2244, DOI 10.1104/pp.111.173997; Nunome T, 2001, BREEDING SCI, V51, P19, DOI 10.1270/jsbbs.51.19; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Pilet-Nayel ML, 2002, THEOR APPL GENET, V106, P28, DOI 10.1007/s00122-002-0985-2; Prohens J, 2012, EUPHYTICA, V186, P517, DOI 10.1007/s10681-012-0652-x; Rao GU, 2003, THEOR APPL GENET, V106, P1457, DOI 10.1007/s00122-003-1204-5; Rizza F, 2002, PLANT CELL REP, V20, P1022, DOI 10.1007/s00299-001-0429-5; Rodriguez-Burruezo A, 2008, EUR J HORTIC SCI, V73, P76; Swamy BPM, 2008, BIOTECHNOL ADV, V26, P106, DOI 10.1016/j.biotechadv.2007.09.005; Toppino L, 2008, MOL BREEDING, V22, P237, DOI 10.1007/s11032-008-9170-x; van der Knaap E, 2001, THEOR APPL GENET, V103, P353, DOI 10.1007/s001220100623; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wu FN, 2009, THEOR APPL GENET, V118, P927, DOI 10.1007/s00122-008-0950-9; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Zhang N, 2012, THEOR APPL GENET, V125, P273, DOI 10.1007/s00122-012-1832-8; Zygier S, 2005, THEOR APPL GENET, V111, P437, DOI 10.1007/s00122-005-2015-7	53	48	56	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89499	10.1371/journal.pone.0089499	http://dx.doi.org/10.1371/journal.pone.0089499			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586828	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900108
J	Yeo, J; Crawford, EL; Blomquist, TM; Stanoszek, LM; Dannemiller, RE; Zyrek, J; De Las Casas, LE; Khuder, SA; Willey, JC				Yeo, Jiyoun; Crawford, Erin L.; Blomquist, Thomas M.; Stanoszek, Lauren M.; Dannemiller, Rachel E.; Zyrek, Jill; De Las Casas, Luis E.; Khuder, Sadik A.; Willey, James C.			A Multiplex Two-Color Real-Time PCR Method for Quality-Controlled Molecular Diagnostic Testing of FFPE Samples	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; RNA EXPRESSION ANALYSIS; STANDARDIZED RT-PCR; MYC X E2F-1/P21; GENE-EXPRESSION; MESSENGER-RNA; QUANTITATION; OPTIMIZATION; PERFORMANCE; CANCER	Background: Reverse transcription quantitative real-time PCR (RT-qPCR) tests support personalized cancer treatment through more clinically meaningful diagnosis. However, samples obtained through standard clinical pathology procedures are formalin-fixed, paraffin-embedded (FFPE) and yield small samples with low integrity RNA containing PCR interfering substances. RT-qPCR tests able to assess FFPE samples with quality control and inter-laboratory reproducibility are needed. Methods: We developed an RT-qPCR method by which 1) each gene was measured relative to a known number of its respective competitive internal standard molecules to control for interfering substances, 2) two-color fluorometric hydrolysis probes enabled analysis on a real-time platform, 3) external standards controlled for variation in probe fluorescence intensity, and 4) pre-amplification maximized signal from FFPE RNA samples. Reagents were developed for four genes comprised by a previously reported lung cancer diagnostic test (LCDT) then subjected to analytical validation using synthetic native templates as test articles to assess linearity, signal-to-analyte response, lower detection threshold, imprecision and accuracy. Fitness of this method and these reagents for clinical testing was assessed in FFPE normal (N = 10) and malignant (N = 10) lung samples. Results: Reagents for each of four genes, MYC, E2F1, CDKN1A and ACTB comprised by the LCDT had acceptable linearity (R-2>0.99), signal-to-analyte response (slope 1.060.05), lower detection threshold (<10 molecules) and imprecision (CV<20%). Poisson analysis confirmed accuracy of internal standard concentrations. Internal standards controlled for experimentally introduced interference, prevented false-negatives and enabled pre-amplification to increase signal without altering measured values. In the fitness for purpose testing of this two-color fluorometric LCDT using surgical FFPE samples, the diagnostic accuracy was 93% which was similar to that previously reported for analysis of fresh samples. Conclusions: This quality-controlled two-color fluorometric RT-qPCR approach will facilitate the development of reliable, robust RT-qPCR-based molecular diagnostic tests in FFPE clinical samples.	[Yeo, Jiyoun; Crawford, Erin L.; Blomquist, Thomas M.; Stanoszek, Lauren M.; Dannemiller, Rachel E.; Khuder, Sadik A.; Willey, James C.] Univ Toledo, Dept Med, Div Pulmonary Crit Care & Sleep Med, Toledo, OH 43606 USA; [Zyrek, Jill; De Las Casas, Luis E.; Willey, James C.] Univ Toledo, Dept Pathol, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Willey, JC (corresponding author), Univ Toledo, Dept Med, Div Pulmonary Crit Care & Sleep Med, Hlth Sci Campus, Toledo, OH 43606 USA.	james.willey2@utoledo.edu			National Institutes of Health [CA132806, CA138397]; George Isaac Cancer Research Fund; NATIONAL CANCER INSTITUTE [R21CA138397, R21CA132806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Isaac Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health grants, CA132806 and CA138397, and the George Isaac Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, 22174 ISO BS EN; Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; APOSTOLAKOS MJ, 1993, ANAL BIOCHEM, V213, P277, DOI 10.1006/abio.1993.1421; Blomquist TM, 2013, PLOS ONE IN PRESS; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caliendo AM, 2011, J CLIN MICROBIOL, V49, P2854, DOI 10.1128/JCM.00471-11; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Chung JY, 2006, DIAGN MOL PATHOL, V15, P229, DOI 10.1097/01.pdm.0000213468.91139.2d; Coyle VM, 2010, NAT REV CLIN ONCOL, V7, P90, DOI 10.1038/nrclinonc.2009.214; Crawford EL, 2002, BIOCHEM BIOPH RES CO, V293, P509, DOI 10.1016/S0006-291X(02)00243-7; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; DeMuth JP, 1998, AM J RESP CELL MOL, V19, P18, DOI 10.1165/ajrcmb.19.1.3077; Ellison S.L.R., 2012, QUANTIFYING UNCERTAI, V3rd; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Gelderblom HC, 2006, ANTIVIR THER, V11, P95; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; Godfrey TE, 2000, J MOL DIAGN, V2, P84, DOI 10.1016/S1525-1578(10)60621-6; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Huggett Jim F, 2008, BMC Res Notes, V1, P70, DOI 10.1186/1756-0500-1-70; Khleif SN, 2010, CLIN CANCER RES, V16, P3299, DOI 10.1158/1078-0432.CCR-10-0880; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Overdevest JB, 2009, CLIN CHEM, V55, P684, DOI 10.1373/clinchem.2008.118554; Poste G, 2012, CLIN CANCER RES, V18, P1515, DOI 10.1158/1078-0432.CCR-11-2206; Schumacher W, 2007, J CLIN VIROL, V38, P304, DOI 10.1016/j.jcv.2006.12.022; Sen K, 2004, 815B04001 US EPA; Sen K, 2010, GUIDANCE IN IN PRESS; Sidor IF, 2013, J VET DIAGN INVEST, V25, P72, DOI 10.1177/1040638712470945; Stanoszek LM, 2013, J MOL DIAGN, V15, P391, DOI 10.1016/j.jmoldx.2013.02.004; Stenman J, 2001, NAT BIOTECHNOL, V19, P1011, DOI 10.1038/nbt1101-1011b; Swanson P, 2006, J VIROL METHODS, V134, P237, DOI 10.1016/j.jviromet.2006.01.012; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Tichopad A, 2009, CLIN CHEM, V55, P1816, DOI 10.1373/clinchem.2009.126201; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; Warner KA, 2003, J MOL DIAGN, V5, P176, DOI 10.1016/S1525-1578(10)60470-9; Willey James C., 2004, V258, P13; [No title captured]	37	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89395	10.1371/journal.pone.0089395	http://dx.doi.org/10.1371/journal.pone.0089395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586747	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900090
J	Aristegui, J; Duarte, CM; Reche, I; Gomez-Pinchetti, JL				Aristegui, Javier; Duarte, Carlos M.; Reche, Isabel; Gomez-Pinchetti, Juan L.			Krill Excretion Boosts Microbial Activity in the Southern Ocean	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; ANTARCTIC KRILL; EUPHAUSIA-SUPERBA; SCOTIA SEA; PHYTOPLANKTON; BACTERIA; GROWTH; ICE; TEMPERATURE; LIMITATION	Antarctic krill are known to release large amounts of inorganic and organic nutrients to the water column. Here we test the role of krill excretion of dissolved products in stimulating heterotrophic bacteria on the basis of three experiments where ammonium and organic excretory products released by krill were added to bacterial assemblages, free of grazers. Our results demonstrate that the addition of krill excretion products (but not of ammonium alone), at levels expected in krill swarms, greatly stimulates bacteria resulting in an order-of-magnitude increase in growth and production. Furthermore, they suggest that bacterial growth rate in the Southern Ocean is suppressed well below their potential by resource limitation. Enhanced bacterial activity in the presence of krill, which are major sources of DOC in the Southern Ocean, would further increase recycling processes associated with krill activity, resulting in highly efficient krill-bacterial recycling that should be conducive to stimulating periods of high primary productivity in the Southern Ocean.	[Aristegui, Javier; Gomez-Pinchetti, Juan L.] Univ Las Palmas Gran Canaria, Inst Oceanog & Cambio Global IOCAG, Las Palmas Gran Canaria, Spain; [Duarte, Carlos M.] CSIC UIB, Inst Mediterraneo Estudios Avanzados IMEDEA, Esporles, Illes Balears, Spain; [Duarte, Carlos M.] Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia; [Reche, Isabel] Univ Granada, Fac Ciencias, Dept Ecol, Granada, Spain; [Gomez-Pinchetti, Juan L.] Spanish Bank Algae BEA, Telde, Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; University of Western Australia; University of Granada	Aristegui, J (corresponding author), Univ Las Palmas Gran Canaria, Inst Oceanog & Cambio Global IOCAG, Las Palmas Gran Canaria, Spain.	javier.aristegui@ulpgc.es	Arístegui, Javier/D-5833-2013; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Pinchetti, Juan Luis Gómez/AAB-3479-2020; Reche, Isabel/K-7120-2014; Duarte, Carlos M/A-7670-2013	Arístegui, Javier/0000-0002-7526-7741; Reche, Isabel/0000-0003-2908-1724; Duarte, Carlos M/0000-0002-1213-1361; Gomez Pinchetti, Juan Luis/0000-0003-4668-0462	Spanish Ministry of Science and Innovation [REN2002-04165-CO3-O2, POL2006-00550/CTM]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research is a contribution to projects ICEPOS (REN2002-04165-CO3-O2) and ATOS (POL2006-00550/CTM), funded by the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti S, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000753; Atkinson A, 2012, DEEP-SEA RES PT II, V59, P147, DOI 10.1016/j.dsr2.2011.06.008; Atkinson A, 2009, DEEP-SEA RES PT I, V56, P727, DOI 10.1016/j.dsr.2008.12.007; Atkinson A, 1997, MAR ECOL PROG SER, V160, P63, DOI 10.3354/meps160063; Atkinson A, 2000, LIMNOL OCEANOGR, V45, P55, DOI 10.4319/lo.2000.45.1.0055; Church MJ, 2009, P NATL ACAD SCI USA, V106, P15519, DOI 10.1073/pnas.0908881106; Church MJ, 2000, APPL ENVIRON MICROB, V66, P455, DOI 10.1128/AEM.66.2.455-466.2000; Duarte CM, 2005, LIMNOL OCEANOGR, V50, P1844, DOI 10.4319/lo.2005.50.6.1844; Ducklow HW, 2012, J MARINE SYST, V98-99, P26, DOI 10.1016/j.jmarsys.2012.03.003; Ducklow HW, 2003, ANTARCT RES SER, V78, P143, DOI DOI 10.1029/078ARS09; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Gasol JM, APPL ENV MICROBIOL, V65, P4475; Gleiber MR, 2012, MAR ECOL PROG SER, V471, P23, DOI 10.3354/meps10021; GOEYENS L, 1991, MAR ECOL PROG SER, V78, P241, DOI 10.3354/meps078241; GRANELI E, 1993, POLAR BIOL, V13, P201, DOI 10.1007/BF00238930; Graneli W, 2004, DEEP-SEA RES PT II, V51, P2569, DOI 10.1016/j.dsr2.2001.01.003; JOHNSON MA, 1984, J CRUSTACEAN BIOL, V4, P174, DOI 10.1163/1937240X84X00570; Kerouel R, 1997, MAR CHEM, V57, P265, DOI 10.1016/S0304-4203(97)00040-6; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; KIRCHMAN DL, 1990, LIMNOL OCEANOGR, V35, P1258, DOI 10.4319/lo.1990.35.6.1258; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Lehette P, 2012, MAR ECOL PROG SER, V459, P29, DOI 10.3354/meps09746; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Nedwell DB, 1999, FEMS MICROBIOL ECOL, V30, P101; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; Ortega-Retuerta E, 2009, LIMNOL OCEANOGR, V54, P1941, DOI 10.4319/lo.2009.54.6.1941; Pomeroy LR, 2001, AQUAT MICROB ECOL, V23, P187, DOI 10.3354/ame023187; PRICE HJ, 1988, MAR BIOL, V97, P67, DOI 10.1007/BF00391246; Priddle J, 1997, J PLANKTON RES, V19, P1305, DOI 10.1093/plankt/19.9.1305; Ross WF, 1934, J BIOL CHEM, V104, P531; Ruiz-Halpern S, 2011, LIMNOL OCEANOGR, V56, P521, DOI 10.4319/lo.2011.56.2.0521; Schmidt K, 2006, LIMNOL OCEANOGR, V51, P2409, DOI 10.4319/lo.2006.51.5.2409; Schmidt K, 2014, LIMNOL OCEANOGR, V59, P17, DOI 10.4319/lo.2014.59.1.0017; Schmidt K, 2012, DEEP-SEA RES PT II, V59, P159, DOI 10.1016/j.dsr2.2011.05.002; SHARP JH, 1993, MAR CHEM, V41, P37, DOI 10.1016/0304-4203(93)90104-V; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Smetacek V., 2008, IMPACTS GLOBAL WARMI, P45; Smetacek V, 1989, BER POLARFORSCH, V65, P1; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Suzuki H, 2001, POLAR BIOL, V24, P697, DOI 10.1007/s003000100271; Tarling GA, 2009, DEEP-SEA RES PT I, V56, P1994, DOI 10.1016/j.dsr.2009.07.004; THOMAS C, 1995, MAR CHEM, V49, P155, DOI 10.1016/0304-4203(94)00061-H; Tovar-Sanchez A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029096; TREGUER P, 1992, POLAR BIOL, V12, P149; WEFER G, 1988, DEEP-SEA RES, V35, P891, DOI 10.1016/0198-0149(88)90066-0; Wickham SA, 2007, AQUAT MICROB ECOL, V46, P1, DOI 10.3354/ame046001; WIEBE WJ, 1993, MICROBIAL ECOL, V25, P151, DOI 10.1007/BF00177192; WILLIAMS PJL, 1982, LIMNOL OCEANOGR, V27, P576, DOI 10.4319/lo.1982.27.3.0576	51	22	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89391	10.1371/journal.pone.0089391	http://dx.doi.org/10.1371/journal.pone.0089391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586744	gold, Green Published			2022-12-27	WOS:000331711900138
J	Bengtsson, K; Nilsson, S; Robinson, ND				Bengtsson, Katarina; Nilsson, Sara; Robinson, Nathaniel D.			Conducting Polymer Electrodes for Gel Electrophoresis	PLOS ONE			English	Article							ELECTROCHEMICAL OVER-OXIDATION; TRANSISTORS; FILMS	In nearly all cases, electrophoresis in gels is driven via the electrolysis of water at the electrodes, where the process consumes water and produces electrochemical by-products. We have previously demonstrated that p-conjugated polymers such as poly(3,4-ethylenedioxythiophene) (PEDOT) can be placed between traditional metal electrodes and an electrolyte to mitigate electrolysis in liquid (capillary electroosmosis/electrophoresis) systems. In this report, we extend our previous result to gel electrophoresis, and show that electrodes containing PEDOT can be used with a commercial polyacrylamide gel electrophoresis system with minimal impact to the resulting gel image or the ionic transport measured during a separation.	[Bengtsson, Katarina; Nilsson, Sara; Robinson, Nathaniel D.] Linkoping Univ, Dept Phys Chem & Biol, Transport & Separat Grp, Linkoping, Sweden	Linkoping University	Robinson, ND (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Transport & Separat Grp, Linkoping, Sweden.	natro@ifm.liu.se	Robinson, Nathaniel D./A-5334-2008	Robinson, Nathaniel D./0000-0002-2773-5096	Swedish Science Council (Vetenskapsradet) [621-2007-3983, 325-2008-7537]	Swedish Science Council (Vetenskapsradet)(Swedish Research Council)	The authors thank the Swedish Science Council (Vetenskapsradet) for financial support through grants 621-2007-3983 and 325-2008-7537. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Erlandsson PG, 2011, ELECTROPHORESIS, V32, P784, DOI 10.1002/elps.201000617; Erlandsson PG, 2011, Patent No. [WO 2011102801, 2011102801]; Henderson RD, 2010, LAB CHIP, V10, P1869, DOI 10.1039/c003333b; Isaksson J, 2007, NAT MATER, V6, P673, DOI 10.1038/nmat1963; Minden JS, 2009, ELECTROPHORESIS, V30, pS156, DOI 10.1002/elps.200900098; Mortimer RJ, 2006, DISPLAYS, V27, P2, DOI 10.1016/j.displa.2005.03.003; Robinson L, 2006, LAB CHIP, V6, P1277, DOI 10.1039/b609893b; Robinson ND, 2006, J ELECTROCHEM SOC, V153, pH39, DOI 10.1149/1.2172534; Tehrani P, 2005, SMART MATER STRUCT, V14, pN21, DOI 10.1088/0964-1726/14/4/N03; Tehrani P, 2007, SOLID STATE IONICS, V177, P3521, DOI 10.1016/j.ssi.2006.10.008; THACKERAY JW, 1985, J PHYS CHEM-US, V89, P5133, DOI 10.1021/j100269a048	11	9	9	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89416	10.1371/journal.pone.0089416	http://dx.doi.org/10.1371/journal.pone.0089416			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586761	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900141
J	Sarlabous, L; Torres, A; Fiz, JA; Jane, R				Sarlabous, Leonardo; Torres, Abel; Fiz, Jose A.; Jane, Raimon			Evidence towards Improved Estimation of Respiratory Muscle Effort from Diaphragm Mechanomyographic Signals with Cardiac Vibration Interference Using Sample Entropy with Fixed Tolerance Values	PLOS ONE			English	Article							APPROXIMATE ENTROPY; SURFACE MECHANOMYOGRAM; FORCE; SEISMOCARDIOGRAPHY; STIMULATION; COMPLEXITY; HUMANS	The analysis of amplitude parameters of the diaphragm mechanomyographic (MMGdi) signal is a non-invasive technique to assess respiratory muscle effort and to detect and quantify the severity of respiratory muscle weakness. The amplitude of the MMGdi signal is usually evaluated using the average rectified value or the root mean square of the signal. However, these estimations are greatly affected by the presence of cardiac vibration or mechanocardiographic (MCG) noise. In this study, we present a method for improving the estimation of the respiratory muscle effort from MMGdi signals that is robust to the presence of MCG. This method is based on the calculation of the sample entropy using fixed tolerance values (fSampEn), that is, with tolerance values that are not normalized by the local standard deviation of the window analyzed. The behavior of the fSampEn parameter was tested in synthesized mechanomyographic signals, with different ratios between the amplitude of the MCG and clean mechanomyographic components. As an example of application of this technique, the use of fSampEn was explored also in recorded MMGdi signals, with different inspiratory loads. The results with both synthetic and recorded signals indicate that the entropy parameter is less affected by the MCG noise, especially at low signal-to-noise ratios. Therefore, we believe that the proposed fSampEn parameter could improve estimates of respiratory muscle effort from MMGdi signals with the presence of MCG interference.	[Sarlabous, Leonardo; Torres, Abel; Fiz, Jose A.; Jane, Raimon] Inst Bioengn Catalunya IBEC, Barcelona, Spain; [Sarlabous, Leonardo; Torres, Abel; Fiz, Jose A.; Jane, Raimon] CIBER BBN, Barcelona, Spain; [Sarlabous, Leonardo; Torres, Abel; Jane, Raimon] Univ Politecn Cataluna, Dept ESAII, Barcelona, Spain; [Fiz, Jose A.] Hosp Badalona Germans Trias & Pujol, CIBERES, Dept Pneumol, Badalona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Germans Trias i Pujol	Torres, A (corresponding author), Inst Bioengn Catalunya IBEC, Barcelona, Spain.	abel.torres@upc.edu	Sarlabous, Leonardo/L-2333-2014; Cebrian, Abel Torres/I-5730-2014; Sarlabous, Leonardo/AAZ-7951-2020	Sarlabous, Leonardo/0000-0002-0495-8422; Cebrian, Abel Torres/0000-0003-2678-1303; Sarlabous, Leonardo/0000-0002-0495-8422; Jane, Raimon/0000-0002-6541-8729	Spanish Ministry of Business and Competitiveness (MINECO) [TEC2010-21703-C03-01]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement of the Government of Catalonia [FI-DGR 2010]; European Social Fund	Spanish Ministry of Business and Competitiveness (MINECO); Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement of the Government of Catalonia; European Social Fund(European Social Fund (ESF))	This work was supported in part by the Spanish Ministry of Business and Competitiveness (MINECO) under grant TEC2010-21703-C03-01. The first author was supported by the grant FI-DGR 2010 from the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement of the Government of Catalonia and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Bellemare F, 2005, DIAPHRAGM RESPONSES, P755; Cashaback JGA, 2013, J ELECTROMYOGR KINES, V23, P78, DOI 10.1016/j.jelekin.2012.08.004; Castiglioni P, 2007, P ANN INT IEEE EMBS, P3954, DOI 10.1109/IEMBS.2007.4353199; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Cramer JT, 2000, MUSCLE NERVE, V23, P1826, DOI 10.1002/1097-4598(200012)23:12<1826::AID-MUS5>3.0.CO;2-7; Nguyen H, 2012, IEEE ENG MED BIO, P3553, DOI 10.1109/EMBC.2012.6346733; Kaczmarek P, 2005, J ELECTROMYOGR KINES, V15, P617, DOI 10.1016/j.jelekin.2005.03.005; Kaczmarek P, 2009, J ELECTROMYOGR KINES, V19, P553, DOI 10.1016/j.jelekin.2008.03.007; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; LAPORTA D, 1985, J APPL PHYSIOL, V58, P1469, DOI 10.1152/jappl.1985.58.5.1469; Madeleine P, 2002, EUR J APPL PHYSIOL, V87, P327, DOI 10.1007/s00421-002-0655-8; Madeleine P, 2006, J NEUROSCI METH, V158, P89, DOI 10.1016/j.jneumeth.2006.05.018; Molina-Pico A, 2011, ARTIF INTELL MED, V53, P97, DOI 10.1016/j.artmed.2011.06.007; ORIZIO C, 1993, CRIT REV BIOMED ENG, V21, P201; Orizio C, 1999, J ELECTROMYOGR KINES, V9, P131, DOI 10.1016/S1050-6411(98)00044-3; Orizio C, 2008, J NEUROSCI METH, V173, P59, DOI 10.1016/j.jneumeth.2008.05.012; PETITJEAN M, 1994, MUSCLE NERVE, V17, P1201, DOI 10.1002/mus.880171011; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Richman JS, 2004, METHOD ENZYMOL, V384, P172; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; SALERNO DM, 1990, J CARDIOVASC TECHNOL, V9, P111; Sarlabous L, 2013, IEEE ENG MED BIO, P3845, DOI 10.1109/EMBC.2013.6610383; Sarlabous L, 2013, J ELECTROMYOGR KINES, V23, P548, DOI 10.1016/j.jelekin.2012.12.007; Sarlabous L, 2012, IEEE ENG MED BIO, P3400, DOI 10.1109/EMBC.2012.6346695; Sarlabous L, 2010, IEEE ENG MED BIO, P5967, DOI 10.1109/IEMBS.2010.5627570; Sinderby C, 1985, J APPL PHYSIOL, V79, P1803; Tavakolian K, 2013, MED ENG PHYS, P1; Tobin M, 1998, J APPL PHYSIOL, V65, P309; Torres A, 2008, IEEE ENG MED BIO, P2112, DOI 10.1109/IEMBS.2008.4649610; Uchiyama T, 2013, MED BIOL ENG COMPUT, V51, P1349, DOI 10.1007/s11517-013-1107-9; Uchiyama T, 2011, MED BIOL ENG COMPUT, V49, P1035, DOI 10.1007/s11517-011-0752-0; ZANETTI JM, 1991, COMPUTER-BASED MEDICA SYSTEMS, P4, DOI 10.1109/CBMS.1991.128936; Zhang X, 2012, J ELECTROMYOGR KINES, V22, P901, DOI 10.1016/j.jelekin.2012.06.005	34	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88902	10.1371/journal.pone.0088902	http://dx.doi.org/10.1371/journal.pone.0088902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586436	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900060
J	Silveira, SD; de Melo-Minardi, RC; da Silveira, CH; Santoro, MM; Meira, W				Silveira, Sabrina de Azevedo; de Melo-Minardi, Raquel Cardoso; da Silveira, Carlos Henrique; Santoro, Marcelo Matos; Meira, Wagner, Jr.			ENZYMAP: Exploiting Protein Annotation for Modeling and Predicting EC Number Changes in UniProt/Swiss-Prot	PLOS ONE			English	Article							LINEAR ALGEBRA; ERRORS; TOOL; CLASSIFICATION; RESOURCE; DATABASE	The volume and diversity of biological data are increasing at very high rates. Vast amounts of protein sequences and structures, protein and genetic interactions and phenotype studies have been produced. The majority of data generated by high-throughput devices is automatically annotated because manually annotating them is not possible. Thus, efficient and precise automatic annotation methods are required to ensure the quality and reliability of both the biological data and associated annotations. We proposed ENZYMatic Annotation Predictor (ENZYMAP), a technique to characterize and predict EC number changes based on annotations from UniProt/Swiss-Prot using a supervised learning approach. We evaluated ENZYMAP experimentally, using test data sets from both UniProt/Swiss-Prot and UniProt/TrEMBL, and showed that predicting EC changes using selected types of annotation is possible. Finally, we compared ENZYMAP and DETECT with respect to their predictions and checked both against the UniProt/Swiss-Prot annotations. ENZYMAP was shown to be more accurate than DETECT, coming closer to the actual changes in UniProt/Swiss-Prot. Our proposal is intended to be an automatic complementary method (that can be used together with other techniques like the ones based on protein sequence and structure) that helps to improve the quality and reliability of enzyme annotations over time, suggesting possible corrections, anticipating annotation changes and propagating the implicit knowledge for the whole dataset.	[Silveira, Sabrina de Azevedo; de Melo-Minardi, Raquel Cardoso; Meira, Wagner, Jr.] Univ Fed Minas Gerais, Dept Comp Sci, Belo Horizonte, MG, Brazil; [Silveira, Sabrina de Azevedo; Santoro, Marcelo Matos] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [da Silveira, Carlos Henrique] Univ Fed Paraiba, Dept Biotechnol, BR-58059900 Joao Pessoa, Paraiba, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal da Paraiba	Silveira, SD (corresponding author), Univ Fed Minas Gerais, Dept Comp Sci, Belo Horizonte, MG, Brazil.	sabrinas@dcc.ufmg.br; meira@dcc.ufmg.br	de Melo-Minardi, Raquel C./AAG-6540-2021; Silveira, Sabrina/AID-6483-2022; Silveira, Carlos/V-5476-2019; de Azevedo Silveira, Sabrina/AAG-8549-2021; Meira, Wagner/AAT-9286-2020	Silveira, Sabrina/0000-0002-4723-2349; Silveira, Carlos/0000-0001-6979-8469; Meira, Wagner/0000-0002-2614-2723; C. de Melo-Minardi, Raquel/0000-0001-5190-100X	Coordenacao de Aperfeicomento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Pro-Reitoria de Pesquisa (PRPQ) da Universidade Federal de Minas Gerais (UFMG)	Coordenacao de Aperfeicomento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-Reitoria de Pesquisa (PRPQ) da Universidade Federal de Minas Gerais (UFMG)	This work was supported by Coordenacao de Aperfeicozmento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and Pro-Reitoria de Pesquisa (PRPQ) da Universidade Federal de Minas Gerais (UFMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; [Anonymous], 2007, UNIPROT NEWS; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becavin C, 2011, BIOINFORMATICS, V27, P1413, DOI 10.1093/bioinformatics/btr143; Benson DA, 2009, NUCLEIC ACIDS RES, V37, pD26, DOI 10.1093/nar/gkn723; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berry MW, 1995, SIAM REV, V37, P573, DOI 10.1137/1037127; Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Deerwester Scott C., 1989, US patent, Patent No. [US4839853A, 4839853]; del-Castillo-Negrete D, 2007, J COMPUT PHYS, V222, P265, DOI 10.1016/j.jcp.2006.07.022; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Egelhofer V, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000661; Elden L, 2006, ACT NUMERIC, V15, P327, DOI 10.1017/S0962492906240017; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fritz MHY, 2011, GENOME RES, V21, P734, DOI 10.1101/gr.114819.110; Furnham N, 2012, NUCLEIC ACIDS RES, V40, pD776, DOI 10.1093/nar/gkr852; Furnham N, 2009, NAT CHEM BIOL, V5, P521, DOI 10.1038/nchembio0809-521; Green ML, 2005, NUCLEIC ACIDS RES, V33, P4035, DOI 10.1093/nar/gki711; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Hung SS, 2010, BIOINFORMATICS, V26, P1690, DOI 10.1093/bioinformatics/btq266; John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Lawrence MC, 2004, J MOL BIOL, V335, P1343, DOI 10.1016/j.jmb.2003.11.032; LESK AM, 2005, DATABASE ANNOTATION; Lima T, 2009, NUCLEIC ACIDS RES, V37, pD471, DOI 10.1093/nar/gkn661; Mewes HW, 2011, NUCLEIC ACIDS RES, V39, pD220, DOI 10.1093/nar/gkq1157; Pang-Ning T, 2006, INTRO DATA MINING; Pires DEV, 2013, BIOINFORMATICS, V29, P855, DOI 10.1093/bioinformatics/btt058; Pires DEV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S4-S12; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Quester S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-376; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; R Core Team, 2012, R LANG ENV STAT COMP; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Silveira S. A., 2012, 2012 IEEE Symposium on Biological Data Visualization (BioVis 2012), P49, DOI 10.1109/BioVis.2012.6378592; Walter MC, 2009, NUCLEIC ACIDS RES, V37, pD408, DOI 10.1093/nar/gkn749; Webb E. C., 1992, Enzyme nomenclature 1992. Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes.; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869	43	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89162	10.1371/journal.pone.0089162	http://dx.doi.org/10.1371/journal.pone.0089162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586563	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900097
J	Storbeck, M; Hupperich, K; Gaspar, JA; Meganathan, K; Carrera, LM; Wirth, R; Sachinidis, A; Wirth, B				Storbeck, Markus; Hupperich, Kristina; Gaspar, John Antonydas; Meganathan, Kesavan; Carrera, Lilian Martinez; Wirth, Radu; Sachinidis, Agapios; Wirth, Brunhilde			Neuronal-Specific Deficiency of the Splicing Factor Tra2b Causes Apoptosis in Neurogenic Areas of the Developing Mouse Brain	PLOS ONE			English	Article							VALPROIC ACID; EXON 10; HISTONE CHAPERONE; SEX DETERMINATION; RNA-RECOGNITION; TAU GENE; PROTEIN; EXPRESSION; TRA2-BETA; CELLS	Alternative splicing (AS) increases the informational content of the genome and is more prevalent in the brain than in any other tissue. The splicing factor Tra2b (Sfrs10) can modulate splicing inclusion of exons by specifically detecting GAA-rich binding motifs and its absence causes early embryonic lethality in mice. TRA2B has been shown to be involved in splicing processes of Nasp (nuclear autoantigenic sperm protein), MAPT (microtubule associated protein tau) and SMN (survival motor neuron), and is therefore implicated in spermatogenesis and neurological diseases like Alzheimer's disease, dementia, Parkinson's disease and spinal muscular atrophy. Here we generated a neuronal-specific Tra2b knock-out mouse that lacks Tra2b expression in neuronal and glial precursor cells by using the Nestin-Cre. Neuronal-specific Tra2b knock-out mice die immediately after birth and show severe abnormalities in cortical development, which are caused by massive apoptotic events in the ventricular layers of the cortex, demonstrating a pivotal role of Tra2b for the developing central nervous system. Using whole brain RNA on exon arrays we identified differentially expressed alternative exons of Tubulind1 and Shugoshin-like2 as in vivo targets of Tra2b. Most interestingly, we found increased expression of the cyclin dependent kinase inhibitor 1a (p21) which we could functionally link to neuronal precursor cells in the affected brain regions. We provide further evidence that the absence of Tra2b causes p21 upregulation and ultimately cell death in NSC34 neuronal-like cells. These findings demonstrate that Tra2b regulates splicing events essential for maintaining neuronal viability during development. Apoptotic events triggered via p21 might not be restricted to the developing brain but could possibly be generalized to the whole organism and explain early embryonic lethality in Tra2b-depleted mice.	[Storbeck, Markus; Hupperich, Kristina; Carrera, Lilian Martinez; Wirth, Radu; Wirth, Brunhilde] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Storbeck, Markus; Hupperich, Kristina; Carrera, Lilian Martinez; Wirth, Brunhilde] Univ Cologne, Inst Genet, Cologne, Germany; [Storbeck, Markus; Hupperich, Kristina; Carrera, Lilian Martinez; Wirth, Brunhilde] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Gaspar, John Antonydas; Meganathan, Kesavan; Sachinidis, Agapios] Univ Cologne, Insitute Neurophysiol, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne	Wirth, B (corresponding author), Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany.	brunhilde.wirth@uk-koeln.de	Sachinidis, Agapios/AAD-4178-2020; Sachinidis, Agapios/AAM-7988-2020; Wirth, Brunhilde/H-3192-2019	Wirth, Brunhilde/0000-0003-4051-5191	Center for Molecular Medicine Cologne [D5]; EU [2012-305121]; Deutsche Forschungsgemeinschaft [Wi945-14/1]	Center for Molecular Medicine Cologne; EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The research leading to these results has received funding from the Center for Molecular Medicine Cologne (grant no. D5) (http://www.zmmk.unikoeln.de/), from the EU Program FP7 Program under grant agreement no. 2012-305121 (Project acronym NeurOmics) and the Deutsche Forschungsgemeinschaft Wi945-14/1 to BW (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Alekseev OM, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-50; Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Alekseev OM, 2003, J BIOL CHEM, V278, P8846, DOI 10.1074/jbc.M210352200; BELOTE JM, 1982, P NATL ACAD SCI-BIOL, V79, P1568, DOI 10.1073/pnas.79.5.1568; BELOTE JM, 1983, DEV BIOL, V95, P512, DOI 10.1016/0012-1606(83)90054-4; Best Andrew, 2013, Int J Cell Biol, V2013, P843781, DOI 10.1155/2013/843781; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brichta L, 2003, HUM MOL GENET, V12, P2481, DOI 10.1093/hmg/ddg256; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; BUTLER B, 1986, EMBO J, V5, P3607, DOI 10.1002/j.1460-2075.1986.tb04689.x; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cha HY, 2013, ANN SURG ONCOL; Cipriani A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003196.pub2; Clery A, 2011, NAT STRUCT MOL BIOL, V18, P443, DOI 10.1038/nsmb.2001; Clift D, 2011, CYTOGENET GENOME RES, V133, P234, DOI 10.1159/000323793; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; DAVIS R, 1994, DRUGS, V47, P332, DOI 10.2165/00003495-199447020-00008; Elliott DJ, 2012, BIOCHEM SOC T, V40, P784, DOI 10.1042/BST20120036; Erkelenz S, 2013, RNA, V19, P96, DOI 10.1261/rna.037044.112; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grellscheid S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002390; Grellscheid SN, 2011, NUCLEIC ACIDS RES, V39, P8092, DOI 10.1093/nar/gkr495; Han BR, 2013, ONCOL REP, V30, P2999, DOI 10.3892/or.2013.2747; HARPER JW, 1993, CELL, V75, P805; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Jiang ZH, 2003, J BIOL CHEM, V278, P18997, DOI 10.1074/jbc.M301800200; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kan Z, 2005, NUCLEIC ACIDS RES, V33, P5659, DOI 10.1093/nar/gki834; Kato A, 2004, DEV BIOL, V269, P196, DOI 10.1016/j.ydbio.2004.01.026; Kondo S, 2004, GENES CELLS, V9, P121, DOI 10.1111/j.1356-9597.2004.00709.x; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Linde M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010611; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Mende Y, 2010, HUM MOL GENET, V19, P2154, DOI 10.1093/hmg/ddq094; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Pechnick RN, 2008, P NATL ACAD SCI USA, V105, P1358, DOI 10.1073/pnas.0711030105; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Pihlajamaki J, 2011, CELL METAB, V14, P208, DOI 10.1016/j.cmet.2011.06.007; PLEY UM, 1995, J BIOL CHEM, V270, P2395, DOI 10.1074/jbc.270.5.2395; Qiu TZ, 2013, FUTURE ONCOL, V9, P255, DOI [10.2217/fon.12.173, 10.2217/FON.12.173]; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; Richardson RT, 2000, J BIOL CHEM, V275, P30378, DOI 10.1074/jbc.M003781200; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Roberts JM, 2013, J COMP NEUROL; Roth KA, 2001, MENT RETARD DEV D R, V7, P261, DOI 10.1002/mrdd.1036; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Shen ML, 2012, NUCLEIC ACIDS RES, V40, P428, DOI 10.1093/nar/gkr713; Shepard PJ, 2011, NUCLEIC ACIDS RES, V39, P8928, DOI 10.1093/nar/gkr481; Shi JH, 2008, J BIOL CHEM, V283, P28660, DOI 10.1074/jbc.M802645200; Shukla S, 2008, CIRC RES, V103, P485, DOI 10.1161/CIRCRESAHA.108.178384; Smrzka OW, 2000, CURR BIOL, V10, P413, DOI 10.1016/S0960-9822(00)00418-8; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stamm S, 1999, MOL BRAIN RES, V64, P108, DOI 10.1016/S0169-328X(98)00313-1; STAMM S, 1992, NUCLEIC ACIDS RES, V20, P5097, DOI 10.1093/nar/20.19.5097; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsuda K, 2011, NUCLEIC ACIDS RES, V39, P1538, DOI 10.1093/nar/gkq854; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wang YZ, 2005, J BIOL CHEM, V280, P14230, DOI 10.1074/jbc.M413846200; Wu XS, 2009, NAT NEUROSCI, V12, P1003, DOI 10.1038/nn.2355; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zheng S, 2013, TRENDS GENET; Zhou JH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S10	82	16	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89020	10.1371/journal.pone.0089020	http://dx.doi.org/10.1371/journal.pone.0089020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586484	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900070
J	Slater, MJ; Mgaya, YD; Stead, SM				Slater, Matthew J.; Mgaya, Yunus D.; Stead, Selina M.			Perceptions of Rule-Breaking Related to Marine Ecosystem Health	PLOS ONE			English	Article							COASTAL RESOURCE-MANAGEMENT; FISHERIES; PHILIPPINES; BEHAVIOR	Finding effective solutions to manage marine resources is high on political and conservation agendas worldwide. This is made more urgent by the rate of increase in the human population and concomitant resource pressures in coastal areas. This paper links empirical socio-economic data about perceptions of marine resource health to the breaking of marine management rules, using fisheries as a case study. The relationship between perceived rule-breaking (non-compliance with regulations controlling fishing) and perceived health of inshore marine environments was investigated through face-to-face interviews with 299 heads of households in three Tanzanian coastal communities in November and December 2011. Awareness of rules controlling fishing activity was high among all respondents. Fishers were able to describe more specific rules controlling fishing practices than non-fishers (t = 3.5, df = 297, p<0.01). Perceived breaking of fishing regulations was reported by nearly half of all respondents, saying "some'' (32% of responses) or " most'' (15% of responses) people break fishing rules. Ordinal regression modelling revealed a significant linkage (z = -3.44, p<0.001) in the relationship between respondents' perceptions of deteriorating marine health and their perception of increased rule-breaking. In this paper, inferences from an empirical study are used to identify and argue the potential for using perceptions of ecosystem health and level of rule-breaking as a means to guide management measures. When considering different management options (e. g. Marine Protected Areas), policy makers are advised to take account of and utilise likely egoistic or altruistic decision-making factors used by fishers to determine their marine activities.	[Slater, Matthew J.; Stead, Selina M.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mgaya, Yunus D.] Univ Dar Es Salaam, Dept Aquat Sci & Fisheries, Dar Es Salaam, Tanzania	Newcastle University - UK; University of Dar es Salaam	Slater, MJ (corresponding author), Inst Marine Resources GmbH, Dept Marine Aquaculture, Bremerhaven, Germany.	m.slater@ncl.ac.uk		Mgaya, Yunus/0000-0002-9592-4913; Slater, Matthew James/0000-0001-8588-544X	Leverhulme Trust, UK limited	Leverhulme Trust, UK limited	This work was funded by the Leverhulme Trust, UK limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Al-Hafedh YS, 2012, REV AQUACULT, V4, P21, DOI 10.1111/j.1753-5131.2012.01057.x; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cornish D., 1986, SITUATIONAL CRIME PR, P1; FAO (Food and Agriculture Organization of the United Nation), 2010, SOFIA STAT WORLD FIS, P218; Hansla A, 2008, J ENVIRON PSYCHOL, V28, P1, DOI 10.1016/j.jenvp.2007.08.004; Hauck M, 2008, MAR POLICY, V32, P635, DOI 10.1016/j.marpol.2007.11.004; Iaquinta DL, 2000, 10 WORLD C; Jagers SC, 2012, MAR POLICY, V36, P969, DOI 10.1016/j.marpol.2012.02.004; Jentoft S, 2004, MAR POLICY, V28, P127, DOI 10.1016/j.marpol.2003.05.001; Maliao RJ, 2009, MAR POLICY, V33, P818, DOI 10.1016/j.marpol.2009.03.003; Nielsen JR, 2003, MAR POLICY, V27, P409, DOI 10.1016/S0308-597X(03)00024-1; Nielsen SS, 2010, INT J PUBLIC HEALTH, V55, P357, DOI 10.1007/s00038-010-0145-4; Olsen SB, 2002, COAST MANAGE, V30, P325, DOI 10.1080/089207502900309; Pomeroy RS, 1997, OCEAN COAST MANAGE, V36, P97, DOI 10.1016/S0964-5691(97)00016-1; Reijneveld SA, 2012, INT J PUBLIC HEALTH, V57, P351, DOI 10.1007/s00038-012-0350-4; Sesabo J.K., 2005, FNU70; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001; Sutinen J.G., 1999, INT J SOC ECON, V26, P174, DOI [10.1108/03068299910229569, DOI 10.1108/03068299910229569]; SUTINEN JG, 1990, OCEAN DEV INT LAW, V21, P335, DOI 10.1080/00908329009545942; Warner TE, 2001, MAR POLICY, V36, P922; Williamson O.E., 1975, MARKETS HIERARCHIES	23	7	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89156	10.1371/journal.pone.0089156	http://dx.doi.org/10.1371/journal.pone.0089156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586558	Green Published, gold, Green Submitted			2022-12-27	WOS:000332390800008
J	Halsby, KD; Walsh, AL; Campbell, C; Hewitt, K; Morgan, D				Halsby, Kate D.; Walsh, Amanda L.; Campbell, Colin; Hewitt, Kirsty; Morgan, Dilys			Healthy Animals, Healthy People: Zoonosis Risk from Animal Contact in Pet Shops, a Systematic Review of the Literature	PLOS ONE			English	Review							TURTLE-ASSOCIATED SALMONELLOSIS; COWPOX VIRUS TRANSMISSION; RAT BITE FEVER; LYMPHOCYTIC-CHORIOMENINGITIS; UNITED-STATES; PARATYPHI-B; INFECTION; OUTBREAK; HUMANS; PSITTACOSIS	Background: Around 67 million pets are owned by households in the United Kingdom, and an increasing number of these are exotic animals. Approximately a third of pets are purchased through retail outlets or direct from breeders. A wide range of infections can be associated with companion animals. Objectives: This study uses a systematic literature review to describe the transmission of zoonotic disease in humans associated with a pet shop or other location selling pets (incidents of rabies tracebacks and zoonoses from pet food were excluded). Data sources: PubMed and EMBASE. Results: Fifty seven separate case reports or incidents were described in the 82 papers that were identified by the systematic review. Summary information on each incident is included in this manuscript. The infections include bacterial, viral and fungal diseases and range in severity from mild to life threatening. Infections associated with birds and rodents were the most commonly reported. Over half of the reports describe incidents in the Americas, and three of these were outbreaks involving more than 50 cases. Many of the incidents identified relate to infections in pet shop employees. Limitations: This review may have been subject to publication bias, where unusual and unexpected zoonotic infections may be over-represented in peer-reviewed publications. It was also restricted to English-language articles so that pathogens that are more common in non-Western countries, or in more exotic animals not common in Europe and the Americas, may have been under-represented. Conclusions/implications: A wide spectrum of zoonotic infections are acquired from pet shops. Salmonellosis and psittacosis were the most commonly documented diseases, however more unusual infections such as tularemia also appeared in the review. Given their potential to spread zoonotic infection, it is important that pet shops act to minimise the risk as far as possible.	[Halsby, Kate D.; Walsh, Amanda L.; Hewitt, Kirsty; Morgan, Dilys] Publ Hlth England, Gastrointestinal Emerging & Zoonot Infect Dept, London, England; [Campbell, Colin] Hosp Badalona Germans Trias & Pujol, Ctr Epidemiol Study Sexually Transmitted Infect &, ICO, Badalona, Spain; [Hewitt, Kirsty] London Deanery, London KSS Specialty Sch Publ Hlth, London, England	Public Health England; Hospital Germans Trias i Pujol	Halsby, KD (corresponding author), Publ Hlth England, Gastrointestinal Emerging & Zoonot Infect Dept, London, England.	kate.halsby@phe.gov.uk		Campbell, Colin/0000-0002-6239-3378				ALESTIG K, 1963, ACTA MED SCAND, V174, P441; Amman BR, 2007, EMERG INFECT DIS, V13, P719, DOI 10.3201/eid1305.061269; Anand C M, 1997, Can J Infect Dis, V8, P318; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 1975, Br Med J, V1, P283; [Anonymous], 2003, CONTROL SUBSTANCES H; [Anonymous], 1973, BMJ-BRIT MED J, V4, P58; [Anonymous], 2004, CONTROL SUBSTANCES H; [Anonymous], 2002, CONTROL SUBSTANCES H; Avashia SB, 2004, EMERG INFECT DIS, V10, P483, DOI 10.3201/eid1003.030695; Becker C, 2009, DTSCH ARZTEBL INT, V106, P329, DOI 10.3238/arztebl.2009.0329; Bilek J, 2005, Bratisl Lek Listy, V106, P383; BREITSCHWERDT EB, 1995, J AM VET MED ASSOC, V206, P1928; BROHOLM KA, 1977, SCAND J INFECT DIS, V9, P263, DOI 10.3109/inf.1977.9.issue-4.02; Budoia J, 2012, J AM ACAD DERMATOL, V66, pAB108; Bugg RJ, 1999, VET J, V157, P295, DOI 10.1053/tvjl.1998.0327; Campe H, 2009, EMERG INFECT DIS, V15, P777, DOI 10.3201/eid1505.090159; Ceianu C, 2008, CLIN VACCINE IMMUNOL, V15, P1749, DOI 10.1128/CVI.00275-08; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P484; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P462; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P628; CHOMEL BB, 1992, PEDIATR INFECT DIS J, V11, P479, DOI 10.1097/00006454-199206000-00011; Craig C, 1997, Can Commun Dis Rep, V23, P129; Day MJ, 2012, EMERG INFECT DIS, DOI DOI 10.3201/EID1812.120664.ACCESSED; Dovc A, 2005, VET RES COMMUN, V29, P23, DOI 10.1007/s11259-005-0834-2; Downing ND, 2001, ANN ROY COLL SURG, V83, P279; Elliott SP, 2007, CLIN MICROBIOL REV, V20, P13, DOI 10.1128/CMR.00016-06; Elsendoorn A, 2011, J INFECTION, V63, P391, DOI 10.1016/j.jinf.2011.06.004; Finsterer Josef, 2005, J Infect, V51, pE67, DOI 10.1016/j.jinf.2004.08.019; FRIEDMANN CT, 1973, CALIF MED, V118, P51; Gaudie CM, 2008, VET REC, V163, P599, DOI 10.1136/vr.163.20.599; Gaulin C, 2005, CAN J PUBLIC HEALTH, V96, P471, DOI 10.1007/BF03405194; Geffray L, 1999, REV MED INTERNE, V20, P888, DOI 10.1016/S0248-8663(00)80094-6; GREGG MB, 1975, B WORLD HEALTH ORGAN, V52, P549; Gregory D W, 1997, Semin Respir Infect, V12, P7; Harris JR, 2011, EMERG INFECT DIS, V17, P268, DOI 10.3201/eid1702.101046; Harris JR, 2009, PEDIATRICS, V124, P1388, DOI 10.1542/peds.2009-0272; HIRSCH MS, 1974, NEW ENGL J MED, V291, P610, DOI 10.1056/NEJM197409192911206; HPA, 2009, 3 HPA HPR; HPA, 2009, RED RISKS SALM INF R; Hughes C, 1997, INFECT CONT HOSP EP, V18, P165; Ipsos MORI, 2004, EX PETS; Itoh N, 2011, VET PARASITOL, V176, P74, DOI 10.1016/j.vetpar.2010.10.048; Jack DC, 1997, CAN VET J, V38, P653; JERNELIUS H, 1975, SCAND J INFECT DIS, V7, P91, DOI 10.3109/inf.1975.7.issue-2.03; Kanazawa Y, 1976, Jpn J Antibiot, V29, P601; KATOH T, 1991, Journal of Dermatology (Tokyo), V18, P356, DOI 10.1111/j.1346-8138.1991.tb03098.x; Kile JC, 2005, ARCH PEDIAT ADOL MED, V159, P1022, DOI 10.1001/archpedi.159.11.1022; LAMM SH, 1972, AM J EPIDEMIOL, V95, P511, DOI 10.1093/oxfordjournals.aje.a121418; Lynch M, 1999, J INFECTION, V38, P182, DOI 10.1016/S0163-4453(99)90248-7; Maegawa N, 2001, Nihon Kokyuki Gakkai Zasshi, V39, P753; Mermin J, 1997, PEDIATRICS, V99, P399, DOI 10.1542/peds.99.3.399; Messmer TO, 1997, J CLIN MICROBIOL, V35, P2043, DOI 10.1128/JCM.35.8.2043-2046.1997; Mochizuki T, 2005, INT J DERMATOL, V44, P765, DOI 10.1111/j.1365-4632.2004.02180.x; Mochizuki Takashi, 2002, Nihon Ishinkin Gakkai Zasshi, V43, P1, DOI 10.3314/jjmm.43.1; Moroney JF, 1998, CLIN INFECT DIS, V26, P1425, DOI 10.1086/516368; MORRISON WM, 1991, J INFECTION, V22, P71, DOI 10.1016/0163-4453(91)91038-Y; Nagano N, 2006, JPN J INFECT DIS, V59, P132; NAGEL P, 1982, GASTROENTEROLOGY, V82, P1436; Ninove L, 2009, EMERG INFECT DIS, V15, P781, DOI 10.3201/eid1505.090235; Noah DL, 1996, AM J PUBLIC HEALTH, V86, P1149, DOI 10.2105/AJPH.86.8_Pt_1.1149; Oxberry SL, 2003, VET MICROBIOL, V93, P167, DOI 10.1016/S0378-1135(03)00017-8; Palmer SR, 1998, ZOONOSES BIOL CLIN P; Pet Food Manufacturers association, 2014, PET STAT FAQS; Pet Food Manufacturers Association, 2012, PET POP 2008 2012; Plant M, 1996, ANNU REV PUBL HEALTH, V17, P221; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Rosen T, 2000, SOUTHERN MED J, V93, P936, DOI 10.1097/00007611-200093090-00023; Rotz LD, 1998, J AM VET MED ASSOC, V212, P1198; Saito T, 2005, J CLIN MICROBIOL, V43, P3011, DOI 10.1128/JCM.43.6.3011-3013.2005; Shiraki Y, 2006, J AM ACAD DERMATOL, V55, P153, DOI 10.1016/j.jaad.2005.05.048; Shvartsblat S, 2004, AM J IND MED, V45, P357, DOI 10.1002/ajim.10359; STEHRGREEN JK, 1987, AM J PUBLIC HEALTH, V77, P345, DOI 10.2105/AJPH.77.3.345; Swanson SJ, 2007, NEW ENGL J MED, V356, P21, DOI 10.1056/NEJMoa060465; TAUXE RV, 1985, JAMA-J AM MED ASSOC, V254, P237, DOI 10.1001/jama.254.2.237; Vanrompay D, 2007, EMERG INFECT DIS, V13, P1108, DOI 10.3201/eid1307.070074; VICIANA P, 1993, REV CLIN ESP, V192, P28; Weese JS, 2006, VET MICROBIOL, V115, P148, DOI 10.1016/j.vetmic.2006.01.004; Wright JG, 2005, EMERG INFECT DIS, V11, P1235, DOI 10.3201/eid1108.050111; Xiao LH, 2009, J CLIN MICROBIOL, V47, P3017, DOI 10.1128/JCM.00226-09	80	30	30	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89309	10.1371/journal.pone.0089309	http://dx.doi.org/10.1371/journal.pone.0089309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586679	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000037
J	Sheu, TT; Chiang, BL; Yen, JH; Lin, WC				Sheu, Ting-Ting; Chiang, Bor-Luen; Yen, Jui-Hung; Lin, Wen-Chi			Premature CD4(+) T Cell Aging and Its Contribution to Lymphopenia-Induced Proliferation of Memory Cells in Autoimmune-Prone Non-Obese Diabetic Mice	PLOS ONE			English	Article							AGE-RELATED-CHANGES; HOMEOSTATIC PROLIFERATION; RHEUMATOID-ARTHRITIS; CD28 EXPRESSION; CUTTING EDGE; NAIVE; LYMPHOCYTES; INDUCTION; IL-7; TCR	Lymphopenia-induced proliferation (LIP), a mechanism to maintain a constant number of T cells in circulation, occurs in both normal aging and autoimmune disease. The incidence of most autoimmune diseases increases with age, and premature CD4(+) T cell aging has been reported in several autoimmune diseases. In this study, we tested the hypothesis that premature CD4(+) T cell aging can cause autoimmune disease by examining whether premature CD4(+) T cell aging exists and causes LIP in our mouse model. Non-obese diabetic (NOD) mice were used because, in addition to Treg defects, the LIP of T cells has been shown to plays a causative role in the development of insulin-dependent diabetes mellitus (IDDM) in these mice. We found that with advancing age, NOD mice exhibited an accelerated decrease in the number of CD4(+) T cells due to the loss of naive cells. This was accompanied by an increase in the percentage of memory cells, leading to a reduced naive/memory ratio. In addition, both the percentage of CD28(+) cells in CD4(+) T cells and IL-2 production decreased, while the percentage of FAS(+) CD44(+) increased, suggesting that NOD mice exhibit premature CD4(+) T cell aging. This process preferentially contributed to LIP of memory cells. Therefore, our results suggest that premature CD4(+) T cell aging underlies the development of IDDM in NOD mice. Given that CD28 and IL-2 play important roles in Treg function, the relationships between premature CD4(+) T cell aging and lymphopenia as well as Treg defects in autoimmune-prone NOD mice are proposed.	[Sheu, Ting-Ting] Tzu Chi Univ, Dept Immunol, Hualien, Taiwan; [Sheu, Ting-Ting; Lin, Wen-Chi] Tzu Chi Univ, Inst Microbiol Immunol & Biochem, Hualien, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ, Grad Inst Immunol, Taipei 10764, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Yen, Jui-Hung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Tzu Chi University	Sheu, TT (corresponding author), Tzu Chi Univ, Dept Immunol, Hualien, Taiwan.	tsheu1@mail.tcu.edu.tw		CHIANG, BOR-LUEN/0000-0002-6705-0286; Sheu, Ting-Ting/0000-0001-5183-357X	National Science Council [94-2312-B-320-002]; Tzu Chi University, Taiwan, Republic of China [TCIRP 95005-04, TCMRC-P-100005]	National Science Council(Ministry of Science and Technology, Taiwan); Tzu Chi University, Taiwan, Republic of China	This work was supported by grant 94-2312-B-320-002 from the National Science Council as well as grants TCIRP 95005-04 and TCMRC-P-100005 from Tzu Chi University, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Arnold B, 2005, TRENDS IMMUNOL, V26, P406, DOI 10.1016/j.it.2005.06.002; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; AZUMA M, 1993, J IMMUNOL, V150, P1147; Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Bosco N, 2005, J IMMUNOL, V175, P162, DOI 10.4049/jimmunol.175.1.162; Boucher N, 1998, EXP GERONTOL, V33, P267, DOI 10.1016/S0531-5565(97)00132-0; Bourgeois C, 2005, J IMMUNOL, V174, P5316, DOI 10.4049/jimmunol.174.9.5316; Calzascia T, 2008, P NATL ACAD SCI USA, V105, P2999, DOI 10.1073/pnas.0712135105; Chang X, 2008, J IMMUNOL, V181, P2399, DOI 10.4049/jimmunol.181.4.2399; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; Datta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003118; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Dendrou CA, 2008, J CLIN IMMUNOL, V28, P685, DOI 10.1007/s10875-008-9237-9; Dujardin HC, 2004, P NATL ACAD SCI USA, V101, P14473, DOI 10.1073/pnas.0403303101; Dummer W, 2001, J IMMUNOL, V166, P2460, DOI 10.4049/jimmunol.166.4.2460; Effros RB, 1997, DEV COMP IMMUNOL, V21, P471, DOI 10.1016/S0145-305X(97)00027-X; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fasth AER, 2004, SCAND J IMMUNOL, V60, P199, DOI 10.1111/j.0300-9475.2004.01464.x; FORMBY B, 1988, DIABETES, V37, P1305, DOI 10.2337/diabetes.37.9.1305; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; Fulop T, 2003, ARTHRITIS RES THER, V5, P290, DOI 10.1186/ar1019; GERDES J, 1984, J IMMUNOL, V133, P1710; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Goronzy JJ, 2006, EXP GERONTOL, V41, P246, DOI 10.1016/j.exger.2005.12.002; Goronzy JJ, 2005, IMMUNOL REV, V204, P55, DOI 10.1111/j.0105-2896.2005.00245.x; Goronzy JJ, 2003, ARTHRITIS RES THER, V5, P225, DOI 10.1186/ar974; Goudy KS, 2011, EUR J IMMUNOL, V41, P1480, DOI 10.1002/eji.201040890; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Hamilton SE, 2006, NAT IMMUNOL, V7, P475, DOI 10.1038/ni1326; Jameson SC, 2005, SEMIN IMMUNOL, V17, P231, DOI 10.1016/j.smim.2005.02.003; Jang E, 2006, ARTHRITIS RHEUM-US, V54, P492, DOI 10.1002/art.21567; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Koetz K, 2000, P NATL ACAD SCI USA, V97, P9203, DOI 10.1073/pnas.97.16.9203; KOIZUMI T, 1986, IMMUNOLOGY, V59, P43; Kovaiou RD, 2006, IMMUNOL LETT, V107, P8, DOI 10.1016/j.imlet.2006.07.006; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Le Campion A, 2009, BLOOD, V114, P1784, DOI 10.1182/blood-2008-12-192120; Lee N, 2012, J GERONTOL A-BIOL, V67, P254, DOI 10.1093/gerona/glr237; LERNER A, 1989, EUR J IMMUNOL, V19, P977, DOI 10.1002/eji.1830190604; Lin MH, 2013, DIABETOLOGIA, V56, P136, DOI 10.1007/s00125-012-2722-y; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Maehr R, 2005, J CLIN INVEST, V115, P2934, DOI 10.1172/JCI25485; Marleau AM, 2005, J LEUKOCYTE BIOL, V78, P575, DOI 10.1189/jlb.0105050; Martin B, 2006, BLOOD, V108, P270, DOI 10.1182/blood-2006-01-0017; Maue AC, 2009, TRENDS IMMUNOL, V30, P301, DOI 10.1016/j.it.2009.04.007; McGuire HM, 2009, P NATL ACAD SCI USA, V106, P19438, DOI 10.1073/pnas.0903561106; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; Miller CN, 2013, INT IMMUNOL, V25, P471, DOI 10.1093/intimm/dxt012; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Monti P, 2008, J CLIN INVEST, V118, P1806, DOI 10.1172/JCI35197; Moralejo DH, 2011, LIFE SCI, V89, P748, DOI 10.1016/j.lfs.2011.08.016; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Nikolich-Zugich J, 2005, J EXP MED, V201, P837, DOI 10.1084/jem.20050341; Pawelec G, 1999, EXP GERONTOL, V34, P419, DOI 10.1016/S0531-5565(99)00002-9; Piccirillo CA, 2005, ANN NY ACAD SCI, V1051, P72, DOI 10.1196/annals.1361.048; Potestio M, 1999, EXP GERONTOL, V34, P659, DOI 10.1016/S0531-5565(99)00041-8; Prelog M, 2008, ARTHRITIS RHEUM-US, V58, P2153, DOI 10.1002/art.23599; Prelog M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-34; Rabinovitch A, 2007, CELL BIOCHEM BIOPHYS, V48, P159, DOI 10.1007/s12013-007-0029-2; ROCHA B, 1983, J IMMUNOL, V131, P2158; Rutledge EA, 2009, EXP DIABETES RES, DOI 10.1155/2009/835650; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; SANSONI P, 1993, BLOOD, V82, P2767; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schulze-Koops H, 2004, ARTHRITIS RES THER, V6, P178, DOI 10.1186/ar1208; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Selmi C, 2011, IMMUNOL CELL BIOL, V89, P70, DOI 10.1038/icb.2010.126; Serreze DV, 2001, J IMMUNOL, V166, P1352, DOI 10.4049/jimmunol.166.2.1352; Sgouroudis E, 2009, DIABETES-METAB RES, V25, P208, DOI 10.1002/dmrr.945; Snyder MR, 2002, J IMMUNOL, V168, P3839, DOI 10.4049/jimmunol.168.8.3839; Sprent J, 2003, IMMUNOL LETT, V85, P145, DOI 10.1016/S0165-2478(02)00221-3; Stoffel B, 1998, EUR J IMMUNOL, V28, P874, DOI 10.1002/(SICI)1521-4141(199803)28:03<874::AID-IMMU874>3.0.CO;2-T; Subra JF, 2001, CLIN EXP IMMUNOL, V126, P540, DOI 10.1046/j.1365-2249.2001.01696.x; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tajima M, 2008, J EXP MED, V205, P1019, DOI 10.1084/jem.20071133; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tanchot C, 1997, Semin Immunol, V9, P331, DOI 10.1006/smim.1997.0090; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Thewissen M, 2005, ANN NY ACAD SCI, V1051, P255, DOI 10.1196/annals.1361.066; UTSUYAMA M, 1992, MECH AGEING DEV, V63, P57, DOI 10.1016/0047-6374(92)90016-7; Vallejo AN, 1999, J IMMUNOL, V162, P6572; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; van der Werf N, 2007, DIABETES-METAB RES, V23, P169, DOI 10.1002/dmrr.695; Wakikawa A, 1997, MECH AGEING DEV, V94, P113, DOI 10.1016/S0047-6374(97)01880-0; Warrington KJ, 2001, ARTHRITIS RHEUM, V44, P13, DOI 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wetzel JD, 2006, J VIROL, V80, P3078, DOI 10.1128/JVI.80.6.3078-3082.2006; Wicker LS, 2005, J AUTOIMMUN, V25, P29, DOI 10.1016/j.jaut.2005.09.009; WICKER LS, 1994, J EXP MED, V180, P1705, DOI 10.1084/jem.180.5.1705; Winstead CJ, 2008, J IMMUNOL, V180, P7305, DOI 10.4049/jimmunol.180.11.7305; WONG S, 1995, DIABETES, V44, P326, DOI 10.2337/diabetes.44.3.326; Woods JA, 2003, BRAIN BEHAV IMMUN, V17, P384, DOI 10.1016/S0889-1591(03)00030-8; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159; Yu AX, 2000, J IMMUNOL, V165, P2556, DOI 10.4049/jimmunol.165.5.2556; ZHOU T, 1995, J EXP MED, V182, P129, DOI 10.1084/jem.182.1.129; ZIPRIS D, 1991, J IMMUNOL, V146, P3763; Zou JX, 2009, LEUKEMIA, V23, P1288, DOI 10.1038/leu.2009.14	108	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89379	10.1371/journal.pone.0089379	http://dx.doi.org/10.1371/journal.pone.0089379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586733	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000041
J	Mitchell, CJ; Churchward-Venne, TA; Parise, G; Bellamy, L; Baker, SK; Smith, K; Atherton, PJ; Phillips, SM				Mitchell, Cameron J.; Churchward-Venne, Tyler A.; Parise, Gianni; Bellamy, Leeann; Baker, Steven K.; Smith, Kenneth; Atherton, Philip J.; Phillips, Stuart M.			Acute Post-Exercise Myofibrillar Protein Synthesis Is Not Correlated with Resistance Training-Induced Muscle Hypertrophy in Young Men	PLOS ONE			English	Article							SIGNALING MOLECULE PHOSPHORYLATION; EXERCISE-INDUCED INCREASE; SINGLE-BIOPSY APPROACH; RATES IN-VIVO; SKELETAL-MUSCLE; MYOFIBER HYPERTROPHY; FED STATE; CLUSTER-ANALYSIS; HUMANS; SOY	Muscle hypertrophy following resistance training (RT) involves activation of myofibrillar protein synthesis (MPS) to expand the myofibrillar protein pool. The degree of hypertrophy following RT is, however, highly variable and thus we sought to determine the relationship between the acute activation of MPS and RT-induced hypertrophy. We measured MPS and signalling protein activation after the first session of resistance exercise (RE) in untrained men (n = 23) and then examined the relation between MPS with magnetic resonance image determined hypertrophy. To measure MPS, young men (24 +/- 1 yr; body mass index = 26.4 +/- 0.9 kg.m(2)) underwent a primed constant infusion of L-[ring-C-13(6)] phenylalanine to measure MPS at rest, and acutely following their first bout of RE prior to 16 wk of RT. Rates of MPS were increased 235638% (P<0.001) above rest 60-180 min post-exercise and 184 +/- 28% (P = 0.037) 180-360 min post exercise. Quadriceps volume increased 7.9 +/- 1.6% (-1.9-24.7%) (P<0.001) after training. There was no correlation between changes in quadriceps muscle volume and acute rates of MPS measured over 1-3 h (r = 0.02), 3-6 h (r = 0.16) or the aggregate 1-6 h post-exercise period (r = 0.10). Hypertrophy after chronic RT was correlated (r = 0.42, P = 0.05) with phosphorylation of 4E-BP1(Thr37/46) at 1 hour post RE. We conclude that acute measures of MPS following an initial exposure to RE in novices are not correlated with muscle hypertrophy following chronic RT.	[Mitchell, Cameron J.; Churchward-Venne, Tyler A.; Parise, Gianni; Bellamy, Leeann; Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, Exercise Metab Res Grp, Hamilton, ON, Canada; [Baker, Steven K.] McMaster Univ, Sch Med, Dept Neurol, Hamilton, ON L8S 4L8, Canada; [Smith, Kenneth; Atherton, Philip J.] Sch Grad Entry Med & Hlth, MRC ARUK Ctr Excellence Musculoskeletal Ageing Re, Metab & Mol Physiol Res Grp, Derby, England	McMaster University; McMaster University	Phillips, SM (corresponding author), McMaster Univ, Dept Kinesiol, Exercise Metab Res Grp, Hamilton, ON, Canada.	phillis@mcmaster.ca	Mitchell, Cameron/I-4423-2019; Phillips, Stuart/B-2343-2009	Mitchell, Cameron/0000-0003-3843-6806; Phillips, Stuart/0000-0002-1956-4098; Churchward-Venne, Tyler/0000-0001-6006-5461; Atherton, Philip/0000-0002-7286-046X; Smith, Ken/0000-0001-8971-6635	National Science and Engineering Research Council (NSERC) of Canada; NSERC; MRC [MR/K00414X/1] Funding Source: UKRI; Medical Research Council [MR/K00414X/1] Funding Source: researchfish	National Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the National Science and Engineering Research Council (NSERC) of Canada to SMP and GP. CJM and LB were supported by research fellowships from NSERC for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Burd NA, 2012, J APPL PHYSIOL, V113, P896, DOI 10.1152/japplphysiol.00513.2012; Burd NA, 2012, BRIT J NUTR, V108, P958, DOI 10.1017/S0007114511006271; Burd NA, 2012, METABOLISM, V61, P931, DOI 10.1016/j.metabol.2011.11.004; Burd NA, 2010, J PHYSIOL-LONDON, V588, P3119, DOI 10.1113/jphysiol.2010.192856; Burd NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012033; Cermak NM, 2012, AM J CLIN NUTR, V96, P1454, DOI 10.3945/ajcn.112.037556; Churchward-Venne TA, 2012, J PHYSIOL-LONDON, V590, P2751, DOI 10.1113/jphysiol.2012.228833; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; Glynn EL, 2010, AM J PHYSIOL-REG I, V299, pR533, DOI 10.1152/ajpregu.00077.2010; Hartman JW, 2007, AM J CLIN NUTR, V86, P373, DOI 10.1093/ajcn/86.2.373; Kim PL, 2005, J PHYSIOL-LONDON, V568, P283, DOI 10.1113/jphysiol.2005.093708; Mayhew DL, 2011, J PHYSIOL-LONDON, V589, P3023, DOI 10.1113/jphysiol.2010.202432; Mayhew DL, 2009, J APPL PHYSIOL, V107, P1655, DOI 10.1152/japplphysiol.91234.2008; Mitchell CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078636; Mitchell CJ, 2012, J APPL PHYSIOL, V113, P71, DOI 10.1152/japplphysiol.00307.2012; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Phillips SM, 2002, CAN J PHYSIOL PHARM, V80, P1045, DOI [10.1139/y02-134, 10.1139/Y02-134]; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Phillips SM, 1999, AM J PHYSIOL-ENDOC M, V276, pE118; Tang JE, 2008, AM J PHYSIOL-REG I, V294, pR172, DOI 10.1152/ajpregu.00636.2007; Tang JE, 2009, J APPL PHYSIOL, V107, P987, DOI 10.1152/japplphysiol.00076.2009; Terzis G, 2008, EUR J APPL PHYSIOL, V102, P145, DOI 10.1007/s00421-007-0564-y; Thalacker-Mercer AE, 2009, APPL PHYSIOL NUTR ME, V34, P632, DOI 10.1139/H09-038; West DWD, 2012, EUR J APPL PHYSIOL, V112, P2693, DOI 10.1007/s00421-011-2246-z; West DWD, 2009, J PHYSIOL-LONDON, V587, P5239, DOI 10.1113/jphysiol.2009.177220; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Wilkinson SB, 2007, AM J CLIN NUTR, V85, P1031, DOI 10.1093/ajcn/85.4.1031	29	143	143	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89431	10.1371/journal.pone.0089431	http://dx.doi.org/10.1371/journal.pone.0089431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586775	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700043
J	Orgel, JPRO; Persikov, AV; Antipova, O				Orgel, Joseph P. R. O.; Persikov, Anton V.; Antipova, Olga			Variation in the Helical Structure of Native Collagen	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; I COLLAGEN; MOLECULAR-STRUCTURE; TRIPLE-HELIX; CRYSTAL-STRUCTURE; DIFFRACTION PATTERN; UNIT-CELL; X-RAY; CONFORMATION; MODEL	The structure of collagen has been a matter of curiosity, investigation, and debate for the better part of a century. There has been a particularly productive period recently, during which much progress has been made in better describing all aspects of collagen structure. However, there remain some questions regarding its helical symmetry and its persistence within the triple-helix. Previous considerations of this symmetry have sometimes confused the picture by not fully recognizing that collagen structure is a highly complex and large hierarchical entity, and this affects and is effected by the super-coiled molecules that make it. Nevertheless, the symmetry question is not trite, but of some significance as it relates to extracellular matrix organization and cellular integration. The correlation between helical structure in the context of the molecular packing arrangement determines which parts of the amino acid sequence of the collagen fibril are buried or accessible to the extracellular matrix or the cell. In this study, we concentrate primarily on the triple-helical structure of fibrillar collagens I and II, the two most predominant types. By comparing X-ray diffraction data collected from type I and type II containing tissues, we point to evidence for a range of triple-helical symmetries being extant in the molecules native environment. The possible significance of helical instability, local helix dissociation and molecular packing of the triplehelices is discussed in the context of collagen's supramolecular organization, all of which must affect the symmetry of the collagen triple-helix.	[Orgel, Joseph P. R. O.] IIT, Dept Biol, Chicago, IL 60616 USA; [Orgel, Joseph P. R. O.] IIT, Dept Phys, Chicago, IL 60616 USA; [Orgel, Joseph P. R. O.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Orgel, Joseph P. R. O.; Antipova, Olga] IIT, Pritzker Inst Biomed Sci & Engn, Chicago, IL 60616 USA; [Orgel, Joseph P. R. O.; Antipova, Olga] Argonne Natl Lab, Adv Photon Source, BioCAT, Lemont, IL USA; [Persikov, Anton V.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Illinois Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology; United States Department of Energy (DOE); Argonne National Laboratory; Princeton University	Orgel, JPRO (corresponding author), IIT, Dept Biol, Chicago, IL 60616 USA.	orgel@iit.edu			U.S. Department of Energy, Basic Energy Sciences, Office of Science [W31-109-ENG-38]; National Institutes of Health-supported Research Center [RR-08630]; National Science Foundation [MCB0644015 CAREER]; U.S. Army Research Laboratory; U.S. Army Research Office [W911NF 09-1-0378]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER	U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health-supported Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract No. W31-109-ENG-38. BioCAT is a National Institutes of Health-supported Research Center (RR-08630). The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health. This work was also supported by the National Science Foundation (Grant #MCB0644015 CAREER) and this material is based upon work supported by, or in part by, the U.S. Army Research Laboratory and the U.S. Army Research Office under contract/grant number W911NF 09-1-0378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antipova O, 2010, J BIOL CHEM, V285, P7087, DOI 10.1074/jbc.M109.060400; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bella J, 2010, J STRUCT BIOL, V170, P377, DOI 10.1016/j.jsb.2010.02.003; Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; BRADSHAW JP, 1989, J MOL BIOL, V205, P685, DOI 10.1016/0022-2836(89)90314-8; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Brown EM, 2013, INT J BIOL MACROMOL, V53, P20, DOI 10.1016/j.ijbiomac.2012.10.029; COHEN C, 1953, J AM CHEM SOC, V75, P2783, DOI 10.1021/ja01107a523; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; FRASER RDB, 1981, INT J BIOL MACROMOL, V3, P193, DOI 10.1016/0141-8130(81)90063-5; FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2; Henderson R, 2004, Q REV BIOPHYS, V37, P3, DOI 10.1017/S0033583504003920; HULMES DJS, 1977, J MOL BIOL, V110, P643, DOI 10.1016/S0022-2836(77)80082-X; JESIOR JC, 1980, FEBS LETT, V113, P238, DOI 10.1016/0014-5793(80)80600-4; KLUG A, 1958, ACTA CRYSTALLOGR, V11, P199, DOI 10.1107/S0365110X58000517; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381; OKUYAMA K, 1981, J MOL BIOL, V152, P427, DOI 10.1016/0022-2836(81)90252-7; OKUYAMA K, 1977, POLYM J, V9, P341, DOI 10.1295/polymj.9.341; Okuyama K, 2006, BIOPOLYMERS, V84, P421, DOI 10.1002/bip.20499; Orgel JPRO, 2011, CONNECT TISSUE RES, V52, P2, DOI 10.3109/03008207.2010.511353; Orgel JPRO, 2011, CONNECT TISSUE RES, V52, P18, DOI 10.3109/03008207.2010.511354; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Orgel JP, 2000, STRUCT FOLD DES, V8, P137, DOI 10.1016/S0969-2126(00)00089-7; Orgel JPRO, 2001, STRUCTURE, V9, P1061, DOI 10.1016/S0969-2126(01)00669-4; Orgel JPRO, 2002, FIBRE DIFFRACTION RE, V10, P40; PAIN RH, 2000, MECH PROTEIN FOLDING; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Rainey JK, 2002, PROTEIN SCI, V11, P2748, DOI 10.1110/ps.0218502; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Sweeney SM, 2008, J BIOL CHEM; Uzel SGM, 2009, INTEGR BIOL, V1, P452, DOI 10.1039/b906864c; WESS TJ, 1995, J MOL BIOL, V248, P487, DOI 10.1006/jmbi.1995.0236	43	36	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89519	10.1371/journal.pone.0089519	http://dx.doi.org/10.1371/journal.pone.0089519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586843	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700057
J	Bhattacharya, S; Haertel, C; Maelicke, A; Montag, D				Bhattacharya, Soumee; Haertel, Christin; Maelicke, Alfred; Montag, Dirk			Galantamine Slows Down Plaque Formation and Behavioral Decline in the 5XFAD Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							PYROGLUTAMATE A-BETA; TRANSGENIC MICE; MEMORY DEFICITS; NICOTINIC RECEPTORS; AMYLOID PLAQUES; NEURON LOSS; THERAPY; ABNORMALITIES; STIMULATION; STRATEGIES	The plant alkaloid galantamine is an established symptomatic drug treatment for Alzheimer's disease (AD), providing temporary cognitive and global relief in human patients. In this study, the 5X Familial Alzheimer's Disease (5XFAD) mouse model was used to investigate the effect of chronic galantamine treatment on behavior and amyloid beta (A beta) plaque deposition in the mouse brain. Quantification of plaques in untreated 5XFAD mice showed a gender specific phenotype; the plaque density increased steadily reaching saturation in males after 10 months of age, whereas in females the density further increased until after 14 months of age. Moreover, females consistently displayed a higher plaque density in comparison to males of the same age. Chronic oral treatment with galantamine resulted in improved performance in behavioral tests, such as open field and light-dark avoidance, already at mildly affected stages compared to untreated controls. Treated animals of both sexes showed significantly lower plaque density in the brain, i. e., the entorhinal cortex and hippocampus, gliosis being always positively correlated to plaque load. A high dose treatment with a daily uptake of 26 mg/kg body weight was tolerated well and produced significantly larger positive effects than a lower dose treatment (14 mg/kg body weight) in terms of plaque density and behavior. These results strongly support that galantamine, in addition to improving cognitive and behavioral symptoms in AD, may have disease-modifying and neuroprotective properties, as is indicated by delayed Ab plaque formation and reduced gliosis.	[Bhattacharya, Soumee; Haertel, Christin; Montag, Dirk] Leibniz Inst Neurobiol, Neurogenet Special Lab, Magdeburg, Germany; [Maelicke, Alfred] Galantos Pharma GmbH, Nieder Olm, Germany	Leibniz Institut fur Neurobiologie (LIN)	Montag, D (corresponding author), Leibniz Inst Neurobiol, Neurogenet Special Lab, Magdeburg, Germany.	montag@LIN-magdeburg.de	Montag, Dirk/D-3925-2014	Montag, Dirk/0000-0002-4964-1330	German Ministry for Education and Research (BMBF) special network program KMU-Innovativ-2	German Ministry for Education and Research (BMBF) special network program KMU-Innovativ-2	This study was supported by the German Ministry for Education and Research (BMBF) special network program KMU-Innovativ-2(http://www.bmbf.de/en/986.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziata I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3734; Becker JA, 2011, ANN NEUROL, V69, P1032, DOI 10.1002/ana.22333; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Cancelli I, 2006, J CLIN NEUROPHYSIOL, V23, P421, DOI 10.1097/01.wnp.0000218991.99714.ee; Chetelat G, 2012, NEUROLOGY, V78, P477, DOI 10.1212/WNL.0b013e318246d67a; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; COURT JA, 1994, CNS DRUGS, V2, P216, DOI 10.2165/00023210-199402030-00006; DeMattos RB, 2012, NEURON, V76, P908, DOI 10.1016/j.neuron.2012.10.029; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Grimm A, 2012, MOL NEUROBIOL, V46, P151, DOI 10.1007/s12035-012-8281-x; GUNTERN R, 1992, EXPERIENTIA, V48, P8, DOI 10.1007/BF01923594; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Jessen F, 2001, AM J PSYCHIAT, V158, P1319, DOI 10.1176/appi.ajp.158.8.1319; Kalinin S, 2012, NEUROBIOL AGING, V33, P1651, DOI 10.1016/j.neurobiolaging.2011.04.012; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kavanagh S, 2011, ACTA NEUROL SCAND, V124, P302, DOI 10.1111/j.1600-0404.2011.01525.x; Keller C, 2011, J ALZHEIMERS DIS, V24, P109, DOI 10.3233/JAD-2010-101290; Kihara T, 1998, BRAIN RES, V792, P331, DOI 10.1016/S0006-8993(98)00138-3; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lalonde R, 2012, NEUROSCI BIOBEHAV R, V36, P1357, DOI 10.1016/j.neubiorev.2012.02.011; Lenzken SC, 2007, CHEM-BIOL INTERACT, V165, P138, DOI 10.1016/j.cbi.2006.11.008; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Maelicke A, 2001, BIOL PSYCHIAT, V49, P279, DOI 10.1016/S0006-3223(00)01109-4; Maelicke A, 2010, J MOL NEUROSCI, V40, P135, DOI 10.1007/s12031-009-9269-5; Matharu B, 2009, J NEUROL SCI, V280, P49, DOI 10.1016/j.jns.2009.01.024; Montag-Sallaz M, 2003, LEARN MEMORY, V10, P99, DOI 10.1101/lm.53403; Montag-Sallaz M, 2003, GENES BRAIN BEHAV, V2, P20, DOI 10.1034/j.1601-183X.2003.00003.x; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Patel L, 2011, DRUG AGING, V28, P539, DOI 10.2165/11591860-000000000-00000; Peng X, 1997, MOL PHARMACOL, V51, P776, DOI 10.1124/mol.51.5.776; Prvulovic D, 2010, EXPERT OPIN DRUG MET, V6, P345, DOI 10.1517/17425251003592137; Rao PPN, 2013, BIOORG MED CHEM LETT, V23, P239, DOI 10.1016/j.bmcl.2012.10.111; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Schafer S, 2007, J NEURAL TRANSM, V114, P387, DOI 10.1007/s00702-006-0580-9; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Seltzer B, 2010, CLIN INTERV AGING, V5, P1; Sergi G, 2013, P NUTR SOC, V72, P160, DOI 10.1017/S0029665112002753; Shukla V, 2013, FASEB J, V27, P174, DOI 10.1096/fj.12-217497; Singh M, 2013, EUR J MED CHEM, V70, P165, DOI 10.1016/j.ejmech.2013.09.050; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Sturchler-Pierrat C, 2000, ANN NY ACAD SCI, V920, P134; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; Takata K, 2010, J BIOL CHEM, V285, P40180, DOI 10.1074/jbc.M110.142356; Tong Y, 2010, NEUROGENETICS, V11, P41, DOI 10.1007/s10048-009-0201-5; Unger C, 2006, J PHARMACOL EXP THER, V317, P30, DOI 10.1124/jpet.105.098566; Vassar RJ, 2005, SOC NEUROSCI, V587, P2; Villarroya M, 2007, EXPERT OPIN INV DRUG, V16, P1987, DOI 10.1517/13543784.16.12.1987; Wallin AK, 2011, NEUROPSYCH DIS TREAT, V7, P565, DOI 10.2147/NDT.S24196; Wang HX, 2012, BEHAV BRAIN RES, V233, P237, DOI 10.1016/j.bbr.2012.05.007; Webster SJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt182; Wengenack TM, 2011, NEUROIMAGE, V54, P113, DOI 10.1016/j.neuroimage.2010.08.033; Whishaw IQ, 1999, MODERN TECHNIQUES NE, P1243, DOI 10.1007/978-3-642-58552-4_44; Wirths O, 2010, J BIOL CHEM, V285, P41517, DOI 10.1074/jbc.M110.178707	62	74	76	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89454	10.1371/journal.pone.0089454	http://dx.doi.org/10.1371/journal.pone.0089454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586789	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900099
J	Ratia, K; Light, SH; Antanasijevic, A; Anderson, WF; Caffrey, M; Lavie, A				Ratia, Kiira; Light, Samuel H.; Antanasijevic, Aleksandar; Anderson, Wayne F.; Caffrey, Michael; Lavie, Arnon			Discovery of Selective Inhibitors of the Clostridium difficile Dehydroquinate Dehydratase	PLOS ONE			English	Article							3-DEHYDROQUINASE; INTERMEDIATE; EPIDEMIOLOGY; INFECTION; MECHANISM	A vibrant and healthy gut flora is essential for preventing the proliferation of Clostridium difficile, a pathogenic bacterium that causes severe gastrointestinal symptoms. In fact, most C. difficile infections (CDIs) occur after broad-spectrum antibiotic treatment, which, by eradicating the commensal gut bacteria, allows its spores to proliferate. Hence, a C. difficile specific antibiotic that spares the gut flora would be highly beneficial in treating CDI. Towards this goal, we set out to discover small molecule inhibitors of the C. difficile enzyme dehydroquinate dehydratase (DHQD). DHQD is the 3 rd of seven enzymes that compose the shikimate pathway, a metabolic pathway absent in humans, and is present in bacteria as two phylogenetically and mechanistically distinct types. Using a high-throughput screen we identified three compounds that inhibited the type I C. difficile DHQD but not the type II DHQD from Bacteroides thetaiotaomicron, a highly represented commensal gut bacterial species. Kinetic analysis revealed that the compounds inhibit the C. difficile enzyme with Ki values ranging from 10 to 20 mu M. Unexpectedly, kinetic and biophysical studies demonstrate that inhibitors also exhibit selectivity between type I DHQDs, inhibiting the C. difficile but not the highly homologous Salmonella enterica DHQD. Therefore, the three identified compounds seem to be promising lead compounds for the development of C. difficile specific antibiotics.	[Ratia, Kiira] Univ Illinois, Res Resources Ctr, Chicago, IL USA; [Light, Samuel H.; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Light, Samuel H.; Anderson, Wayne F.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA; [Antanasijevic, Aleksandar; Caffrey, Michael; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lavie, A (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	Lavie@uic.edu		Lavie, Arnon/0000-0001-5591-8722; Light, Sam/0000-0002-8074-1348	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200700058C, HHSN272201200026C]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contracts No. HHSN272200700058C and HHSN272201200026C. The HTS portion of this work was funded by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antanasijevic A, 2013, PLOS ONE IN PRESS; BUTLER JR, 1974, J AM CHEM SOC, V96, P1617, DOI 10.1021/ja00812a069; CHAUDHURI S, 1986, BIOCHEM J, V239, P699, DOI 10.1042/bj2390699; Credito KL, 2004, ANTIMICROB AGENTS CH, V48, P4430, DOI 10.1128/AAC.48.11.4430-4434.2004; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gourley DG, 1999, NAT STRUCT BIOL, V6, P521; Harris JM, 1996, BIOCHEM J, V319, P333, DOI 10.1042/bj3190333; HERRMANN KM, 1995, PLANT PHYSIOL, V107, P7, DOI 10.1104/pp.107.1.7; KLEANTHOUS C, 1992, BIOCHEM J, V282, P687, DOI 10.1042/bj2820687; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; Light SH, 2011, BIOCHEMISTRY-US, V50, P2357, DOI 10.1021/bi102020s; Light SH, 2011, J BIOL CHEM, V286, P3531, DOI 10.1074/jbc.M110.192831; McCullough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033958; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; MITSUHASHI S, 1954, BIOCHIM BIOPHYS ACTA, V15, P54; Mullane KM, 2011, CLIN INFECT DIS, V53, P440, DOI 10.1093/cid/cir404; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Ramirez B, 2013, METH MOL BI IN PRESS; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	21	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89356	10.1371/journal.pone.0089356	http://dx.doi.org/10.1371/journal.pone.0089356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586713	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900082
J	Shukrun, M; Jabareen, A; Abou-Kandil, A; Chamias, R; Aboud, M; Huleihel, M				Shukrun, Meital; Jabareen, Azhar; Abou-Kandil, Ammar; Chamias, Rachel; Aboud, Mordechai; Huleihel, Mahmoud			HTLV-1 Tax Oncoprotein Inhibits the Estrogen-Induced-ER alpha-Mediated BRCA1 Expression by Interaction with CBP/p300 Cofactors	PLOS ONE			English	Article							T-CELL LEUKEMIA; LUMINAL EPITHELIAL-CELLS; ELEMENT-BINDING PROTEIN; VIRUS TYPE-1 TAX; NF-KAPPA-B; BREAST-CANCER; TRANSCRIPTIONAL ACTIVATION; I INFECTION; GENE; 12-O-TETRADECANOYLPHORBOL-13-ACETATE	BRCA1 is a multifunctional tumor suppressor, whose expression is activated by the estrogen (E2)-liganded ERa receptor and regulated by certain recruited transcriptional co-activators. Interference with BRCA1 expression and/or functions leads to high risk of breast or/and ovarian cancer. Another multifunctional protein, HTLV-1Tax oncoprotein, is widely regarded as crucial for developing adult T-cell leukemia and other clinical disorders. Tax profile reveals that it can antagonize BRCA1 expression and/or functionality. Therefore, we hypothesize that Tax expression in breast cells can sensitize them to malignant transformation by environmental carcinogens. Here we examined Tax effect on BRCA1 expression by testing its influence on E2-induced expression of BRCA1 promoter-driven luciferase reporter (BRCA1-Luc). We found that E2 strongly stimulated this reporter expression by liganding to ER alpha, which consequently associated with BRCA1 promoter, while ERa concomitantly recruited CBP/p300 to this complex for co-operative enhancement of BRCA1 expression. Introducing Tax into these cells strongly blocked this E2-ERa-mediated activation of BRCA1 expression. We noted, also, that Tax exerted this inhibition by binding to CBP/p300 without releasing them from their complex with ER alpha. Chip assay revealed that the binding of Tax to the CBP/p300-ER alpha complex, prevented its link to AP1 site. Interestingly, we noted that elevating the intracellular pool of CBP or p300 to excessive levels dramatically reduced the Tax-mediated inhibition of BRCA1 expression. Exploring the mechanism of this reduction revealed that the excessive co-factors were sufficient to bind separately the free Tax molecules, thus lowering their amount in the CBP/p300-ER alpha complex and relieving, thereby, the inhibition of BRCA1 expression.	[Shukrun, Meital; Jabareen, Azhar; Abou-Kandil, Ammar; Chamias, Rachel; Aboud, Mordechai; Huleihel, Mahmoud] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel	Ben Gurion University	Huleihel, M (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel.	mahmoudh@bgu.ac.il			Israel Cancer Assosiation (ICA) [20130213]	Israel Cancer Assosiation (ICA)	This work was supported by Israel Cancer Assosiation (ICA), No. 20130213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; Arisawa K, 2006, CANCER SCI, V97, P535, DOI 10.1111/j.1349-7006.2006.00212.x; Azran Inbal, 2004, Retrovirology, V1, P20; Azran-Shaish I, 2008, J MOL MED, V86, P799, DOI 10.1007/s00109-008-0335-1; BARTEK J, 1991, P NATL ACAD SCI USA, V88, P3520, DOI 10.1073/pnas.88.9.3520; Bartholin L, 2007, GENE, V393, P153, DOI 10.1016/j.gene.2007.02.007; Belrose G, 2011, BLOOD, V118, P2483, DOI 10.1182/blood-2010-11-321364; Corkery D, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-50; D'Agostino DM, 2012, ADV CANCER RES, V113, P45, DOI 10.1016/B978-0-12-394280-7.00002-6; Durnitrescu RG, 2005, ALCOHOL, V35, P213, DOI 10.1016/j.alcohol.2005.04.005; Galea GL, 2013, J BIOL CHEM, V288, P9035, DOI 10.1074/jbc.M112.405456; Garcia-Vallejo F, 2005, BRAZ J MED BIOL RES, V38, P241, DOI 10.1590/S0100-879X2005000200013; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; Giam CZ, 2007, FRONT BIOSCI, V12, P1496, DOI 10.2741/2163; Girault I, 2006, MATURITAS, V54, P342, DOI 10.1016/j.maturitas.2006.06.003; Harrod R, 2000, J BIOL CHEM, V275, P11852, DOI 10.1074/jbc.275.16.11852; Hayashibara T, 2003, BIOCHEM BIOPH RES CO, V300, P128, DOI 10.1016/S0006-291X(02)02793-6; Hockings JK, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1987; Hockings JK, 2006, CANCER RES, V66, P2224, DOI 10.1158/0008-5472.CAN-05-1619; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Iwanaga R, 2008, ONCOGENE, V27, P5635, DOI 10.1038/onc.2008.174; Jack N, 2000, INT J CANCER, V85, P298, DOI 10.1002/(SICI)1097-0215(20000115)85:2&lt;298::AID-; Jeffy BD, 2005, NEOPLASIA, V7, P873, DOI 10.1593/neo.05256; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Latona Melissa, 2011, Adv NPs PAs, V2, P23; LeVasseur RJ, 1998, J HUM VIROL, V1, P214; Liu BY, 2006, INVEST OPHTH VIS SCI, V47, P1510, DOI 10.1167/iovs.05-1277; Marks JR, 1997, ONCOGENE, V14, P115, DOI 10.1038/sj.onc.1200808; Martin Miguel, 2006, Clin Transl Oncol, V8, P7, DOI 10.1007/s12094-006-0089-6; Moreira-Ramos K, 2011, MEM I OSWALDO CRUZ, V106, P759, DOI 10.1590/S0074-02762011000600018; MorVaknin N, 1997, VIROLOGY, V232, P337, DOI 10.1006/viro.1997.8566; Mueller CR, 2003, BREAST CANCER RES, V5, P45, DOI 10.1186/bcr557; Ohshima K, 2007, CANCER SCI, V98, P772, DOI 10.1111/j.1349-7006.2007.00456.x; Parvin JD, 2004, CANCER BIOL THER, V3, P505, DOI 10.4161/cbt.3.6.839; Ramirez JA, 2007, J MOL BIOL, V372, P958, DOI 10.1016/j.jmb.2007.06.062; Rauch T, 2005, CELL CYCLE, V4, P1078; Grassi MFR, 2011, J MED VIROL, V83, P1269, DOI 10.1002/jmv.22087; Rosen EM, 2006, CANCER LETT, V236, P175, DOI 10.1016/j.canlet.2005.04.037; Rosen EM, 2003, J CELL PHYSIOL, V196, P19, DOI 10.1002/jcp.10257; Scoggin KES, 2001, MOL CELL BIOL, V21, P5520, DOI 10.1128/MCB.21.16.5520-5530.2001; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Southern S, 2002, ADV EXP MED BIOL, V503, P183; Southern SO, 1998, VIROLOGY, V241, P200, DOI 10.1006/viro.1997.8978; Starita LM, 2006, CANCER BIOL THER, V5, P137, DOI 10.4161/cbt.5.2.2479; Thangaraju M, 2000, J BIOL CHEM, V275, P33487, DOI 10.1074/jbc.M005824200; Torgeman A, 2001, VIROLOGY, V281, P10, DOI 10.1006/viro.2000.0779; Veprik A, 2011, AM J PHYSL ENDOCRINO; Wang A, 2000, J BIOL CHEM, V275, P4532, DOI 10.1074/jbc.275.6.4532; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yasunaga J, 2011, INT J HEMATOL, V94, P435, DOI 10.1007/s12185-011-0937-1; Zacharopoulos VR, 1997, MICROB PATHOGENESIS, V23, P225, DOI 10.1006/mpat.1997.0151; Zhang J, 2008, VIROLOGY, V379, P306, DOI 10.1016/j.virol.2008.06.035; Zhang JR, 2005, MOL CANCER RES, V3, P531, DOI 10.1158/1541-7786.MCR-05-0192	55	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89390	10.1371/journal.pone.0089390	http://dx.doi.org/10.1371/journal.pone.0089390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586743	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900089
J	Wang, Y; Jiang, Y				Wang, Ying; Jiang, Yi			Integration of 3D Structure from Disparity into Biological Motion Perception Independent of Depth Awareness	PLOS ONE			English	Article							VISUAL-CORTEX; STEREOSCOPIC DEPTH; HUMAN BRAIN; BINOCULAR DISPARITY; NEURAL INTEGRATION; PERCEIVED DEPTH; HUMAN GAIT; SHAPE; CUES; ORIENTATION	Images projected onto the retinas of our two eyes come from slightly different directions in the real world, constituting binocular disparity that serves as an important source for depth perception -the ability to see the world in three dimensions. It remains unclear whether the integration of disparity cues into visual perception depends on the conscious representation of stereoscopic depth. Here we report evidence that, even without inducing discernible perceptual representations, the disparity-defined depth information could still modulate the visual processing of 3D objects in depthirrelevant aspects. Specifically, observers who could not discriminate disparity-defined in-depth facing orientations of biological motions (i.e., approaching vs. receding) due to an excessive perceptual bias nevertheless exhibited a robust perceptual asymmetry in response to the indistinguishable facing orientations, similar to those who could consciously discriminate such 3D information. These results clearly demonstrate that the visual processing of biological motion engages the disparity cues independent of observers' depth awareness. The extraction and utilization of binocular depth signals thus can be dissociable from the conscious representation of 3D structure in high-level visual perception.	[Wang, Ying; Jiang, Yi] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Jiang, Y (corresponding author), Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	yijiang@psych.ac.cn	Jiang, Yi/I-1688-2018	Jiang, Yi/0000-0002-5746-7301; Wang, Ying/0000-0002-5756-2480	National Basic Research Program of China [2011CB711000]; National Key Technology R&D Program of China [2012BAI36B00]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB02010003]; National Natural Science Foundation of China [31100733, 31070903]	National Basic Research Program of China(National Basic Research Program of China); National Key Technology R&D Program of China(National Key Technology R&D Program); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Basic Research Program of China (No. 2011CB711000), the National Key Technology R&D Program of China (No. 2012BAI36B00), the Strategic Priority Research Program of the Chinese Academy of Sciences (No. XDB02010003), and the National Natural Science Foundation of China (No. 31100733 and No. 31070903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; Ban H, 2012, NAT NEUROSCI, V15, P636, DOI 10.1038/nn.3046; BERTENTHAL BI, 1994, PSYCHOL SCI, V5, P221, DOI 10.1111/j.1467-9280.1994.tb00504.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; Brouwer GJ, 2005, J NEUROSCI, V25, P10403, DOI 10.1523/JNEUROSCI.2408-05.2005; Bulthoff I, 1998, NAT NEUROSCI, V1, P254, DOI 10.1038/699; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Chang DHF, 2009, J VISION, V9, DOI [10.1167/9.1.19, 10.1167/9.5.8]; Clifford CWG, 2005, CURR BIOL, V15, P574, DOI 10.1016/j.cub.2005.01.055; Cumming BG, 1997, NATURE, V389, P280, DOI 10.1038/38487; Cumming BG, 2000, J NEUROSCI, V20, P4758, DOI 10.1523/JNEUROSCI.20-12-04758.2000; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; CUTTING JE, 1988, PERCEPT PSYCHOPHYS, V44, P339, DOI 10.3758/BF03210415; Doi H, 2012, PSYCHON B REV, V19, P858, DOI 10.3758/s13423-012-0284-0; Durand JB, 2009, NEUROIMAGE, V46, P1114, DOI 10.1016/j.neuroimage.2009.03.023; Georgieva S, 2009, J NEUROSCI, V29, P727, DOI 10.1523/JNEUROSCI.4753-08.2009; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gregory RL, 1997, PHILOS T ROY SOC B, V352, P1121, DOI 10.1098/rstb.1997.0095; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Hill H, 2007, PERCEPTION, V36, P199, DOI 10.1068/p5523; Jackson S, 2010, J NEUROSCI, V30, P838, DOI 10.1523/JNEUROSCI.3116-09.2010; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Masson GS, 1997, NATURE, V389, P283, DOI 10.1038/38496; NAWROT M, 1989, SCIENCE, V244, P716, DOI 10.1126/science.2717948; Neri P, 2005, J NEUROPHYSIOL, V93, P1823, DOI 10.1152/jn.01068.2004; Pagano RR, 2012, UNDERSTANDING STAT B; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Rajimehr R, 2004, NEURON, V41, P663, DOI 10.1016/S0896-6273(04)00041-8; Schouten B, 2013, PLOS ONE, V8; Schouten B, 2011, ATTEN PERCEPT PSYCHO, V73, P130, DOI 10.3758/s13414-010-0018-1; Schouten B, 2010, ATTEN PERCEPT PSYCHO, V72, P1256, DOI 10.3758/APP.72.5.1256; Sweeny TD, 2012, VISION RES, V64, P26, DOI 10.1016/j.visres.2012.05.008; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Vanrie J, 2004, PERCEPTION, V33, P547, DOI 10.1068/p5004; Vanrie J, 2011, VIS COGN, V19, P1158, DOI 10.1080/13506285.2011.614381; Welchman AE, 2005, NAT NEUROSCI, V8, P820, DOI 10.1038/nn1461; Wismeijer DA, 2008, EXP BRAIN RES, V184, P61, DOI 10.1007/s00221-007-1081-2	41	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89238	10.1371/journal.pone.0089238	http://dx.doi.org/10.1371/journal.pone.0089238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3VI	24586622	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900068
J	Okumura, T; Takeda, K; Taniguchi, K; Adachi-Yamada, T				Okumura, Takashi; Takeda, Koji; Taniguchi, Kiichiro; Adachi-Yamada, Takashi			beta nu Integrin Inhibits Chronic and High Level Activation of JNK to Repress Senescence Phenotypes in Drosophila Adult Midgut	PLOS ONE			English	Article							STEM-CELL PROLIFERATION; SELF-RENEWAL; TERMINAL DIFFERENTIATION; INTESTINAL HOMEOSTASIS; BACTERIAL-INFECTION; SIGNAL-TRANSDUCTION; CANCER; GROWTH; WINGLESS; DIVISION	Proper control of adult stem cells including their proliferation and differentiation is crucial in maintaining homeostasis of well-organized tissues/organs throughout an organism's life. The Drosophila adult midgut has intestinal stem cells (ISCs), which have been exploited as a simple model system to investigate mechanisms controlling adult tissue homeostasis. Here, we found that a viable mutant of beta nu integrin (beta int-nu), encoding one of two Drosophila integrin beta subunits, showed a short midgut and abnormal multilayered epithelia accompanied by an increase in ISC proliferation and misdifferentiation defects. The increase in ISC proliferation and misdifferentiation was due to frequent ISC duplication expanding a pool of ISCs, which was caused by depression of the Notch signalling, and up-regulation of unpaired (upd), a gene encoding an extracellular ligand in the JAK/STAT signalling pathway. In addition, we observed that abnormally high accumulation of filamentous actin (F-actin) was caused in the beta int-nu mutant enterocytes. Furthermore, the defects were rescued by suppressing c-Jun N-terminal kinase (JNK) signalling, which was up-regulated in a manner correlated with the defect levels in the above-mentioned beta int-nu mutant phenotype. These symptoms observed in young beta int-nu mutant midgut were very similar to those in the aged midgut in wild type. Our results suggested that beta int-nu has a novel function for the Drosophila adult midgut homeostasis under normal conditions and provided a new insight into possible age-related diseases caused by latent abnormality of an integrin function.	[Okumura, Takashi; Takeda, Koji; Taniguchi, Kiichiro; Adachi-Yamada, Takashi] Gakushuin Univ, Fac Sci, Dept Life Sci, Tokyo 171, Japan; [Takeda, Koji; Adachi-Yamada, Takashi] Gakushuin Univ, Grad Sch Sci, Grad Course Life Sci, Tokyo 171, Japan; [Adachi-Yamada, Takashi] Gakushuin Univ, Inst Biomol Sci, Tokyo 171, Japan	Gakushuin University; Gakushuin University; Gakushuin University	Adachi-Yamada, T (corresponding author), Gakushuin Univ, Fac Sci, Dept Life Sci, Tokyo 171, Japan.	Takashi.Adachi-Yamada@gakushuin.ac.jp	TAKEDA-URA, KOJI/HCI-5907-2022; Taniguchi, Kiichiro/ACL-8906-2022	Taniguchi, Kiichiro/0000-0003-2321-7280	Naito Foundation and the MEXT*-Supported Program for the Strategic Research Foundation at Private Universities (*Ministry of Education, Culture, Sports, Science and Technology)	Naito Foundation and the MEXT*-Supported Program for the Strategic Research Foundation at Private Universities (*Ministry of Education, Culture, Sports, Science and Technology)	This work was supported by grants from the Naito Foundation and the MEXT*-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012 (*Ministry of Education, Culture, Sports, Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Balducci L, 2005, NAT REV CANCER, V5, P655, DOI 10.1038/nrc1675; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Beebe K, 2010, DEV BIOL, V338, P28, DOI 10.1016/j.ydbio.2009.10.045; Bell DR, 2004, ONCOGENE, V23, P7290, DOI 10.1038/sj.onc.1207949; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Boggiano JC, 2012, DEV CELL, V22, P695, DOI 10.1016/j.devcel.2012.03.013; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; de Navascues J, 2012, EMBO J, V31, P2473, DOI 10.1038/emboj.2012.106; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Fre S, 2011, EXP CELL RES, V317, P2740, DOI 10.1016/j.yexcr.2011.06.012; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Ito K, 1997, DEVELOPMENT, V124, P761; Jiang H, 2012, CURR OPIN GENET DEV; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Lee SH, 2012, EXP CELL RES, V318, P670, DOI 10.1016/j.yexcr.2012.01.004; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin G, 2013, DEV BIOL; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Lowell CA, 2011, METHODS MOL BIOL, V757, P369, DOI 10.1007/978-1-61779-166-6_22; MACKRELL AJ, 1988, P NATL ACAD SCI USA, V85, P2633, DOI 10.1073/pnas.85.8.2633; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; MICHELSON AM, 1994, DEVELOPMENT, V120, P755; Nagaosa K, 2011, J BIOL CHEM, V286, P25770, DOI 10.1074/jbc.M110.204503; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; O'Reilly AM, 2008, J CELL BIOL, V182, P801, DOI 10.1083/jcb.200710141; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Okumura T, 2005, DEV BIOL, V278, P576, DOI 10.1016/j.ydbio.2004.11.021; Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054; Perdigoto CN, 2011, DEVELOPMENT, V138, P4585, DOI 10.1242/dev.065292; Pignoni F, 1997, DEVELOPMENT, V124, P271; Poernbacher I, 2012, CURR BIOL, V22, P389, DOI 10.1016/j.cub.2012.01.019; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Rigby RJ, 2007, ONCOGENE, V26, P4833, DOI 10.1038/sj.onc.1210286; Shaw RL, 2010, DEVELOPMENT, V137, P4147, DOI 10.1242/dev.052506; SHELLENBARGER DL, 1975, GENETICS, V81, P143; Shiratsuchi A, 2012, J BIOL CHEM, V287, P21663, DOI 10.1074/jbc.M111.333807; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Takashima S, 2012, STEM CELL REV REP, V8, P597, DOI 10.1007/s12015-012-9351-1; Takashima S, 2011, DEV BIOL, V353, P161, DOI 10.1016/j.ydbio.2011.01.039; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; Weber U, 2000, DEVELOPMENT, V127, P3619; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018; Yarnitzky T, 1997, GENE DEV, V11, P2691, DOI 10.1101/gad.11.20.2691; YEE GH, 1993, DEVELOPMENT, V118, P845; Zeng XK, 2010, GENESIS, V48, P607, DOI 10.1002/dvg.20661	74	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89387	10.1371/journal.pone.0089387	http://dx.doi.org/10.1371/journal.pone.0089387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586740	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700115
J	Benz, N; Le Hir, S; Norez, C; Kerbiriou, M; Calvez, ML; Becq, F; Trouve, P; Ferec, C				Benz, Nathalie; Le Hir, Sophie; Norez, Caroline; Kerbiriou, Mathieu; Calvez, Marie-Laure; Becq, Frederic; Trouve, Pascal; Ferec, Claude			Improvement of Chloride Transport Defect by Gonadotropin-Releasing Hormone (GnRH) in Cystic Fibrosis Epithelial Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RIBONUCLEIC-ACID EXPRESSION; MESSENGER-RNA EXPRESSION; ENDOPLASMIC-RETICULUM; RECEPTOR EXPRESSION; CHANNEL ACTIVITY; DELTA F508-CFTR; CFTR; ATP; CHAPERONES	Cystic fibrosis (CF), the most common autosomal recessive disease in Caucasians, is due to mutations in the CFTR gene. F508del, the most frequent mutation in patients, impairs CFTR protein folding and biosynthesis. The F508del-CFTR protein is retained in the endoplasmic reticulum (ER) and its traffic to the plasma membrane is altered. Nevertheless, if it reaches the cell surface, it exhibits a Cl- channel function despite a short half-life. Pharmacological treatments may target the F508del-CFTR defect directly by binding to the mutant protein or indirectly by altering cellular proteostasis, and promote its plasma membrane targeting and stability. We previously showed that annexine A5 (AnxA5) directly binds to F508del-CFTR and, when overexpressed, promotes its membrane stability, leading to the restoration of some Cl- channel function in cells. Because Gonadotropin-Releasing Hormone (GnRH) increases AnxA5 expression in some cells, we tested it in CF cells. We showed that human epithelial cells express GnRH-receptors (GnRH-R) and that GnRH induces an AnxA5 overexpression and an increased Cl- channel function in F508del-CFTR cells, due to an increased stability of the protein in the membranes. Beside the numerous physiological implications of the GnRH-R expression in epithelial cells, we propose that a topical use of GnRH is a potential treatment in CF.	[Benz, Nathalie; Le Hir, Sophie; Kerbiriou, Mathieu; Calvez, Marie-Laure; Trouve, Pascal; Ferec, Claude] INSERM, UMR1078, Brest, France; [Benz, Nathalie] Assoc Gaetan Saleun, Brest, France; [Le Hir, Sophie; Ferec, Claude] Hop Morvan, CHU Brest, Lab Genet Mol, Brest, France; [Norez, Caroline; Becq, Frederic] Univ Poitiers, Inst Physiol & Biol Cellulaires, CNRS, FRE 3511, Poitiers, France; [Kerbiriou, Mathieu; Calvez, Marie-Laure; Ferec, Claude] Univ Bretagne Occidentale, Fac Med & Sci Sante, Brest, France; [Ferec, Claude] Etab Francais Sang Bretagne, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Universite de Bretagne Occidentale	Trouve, P (corresponding author), INSERM, UMR1078, Brest, France.	pascal.trouve@univ-brest.fr; claude.ferec@univ-brest.fr	Becq, Frederic/P-9233-2016; Norez, Caroline/P-9567-2016; Ferec, Claude/ABG-9699-2020	Becq, Frederic/0000-0003-3915-0973; Ferec, Claude/0000-0002-2325-0710	association Gaetan Salaun; SFR Scinbios (Brest); French foundation "Vaincre la Mucoviscidose"	association Gaetan Salaun; SFR Scinbios (Brest); French foundation "Vaincre la Mucoviscidose"	The authors thank the association Gaetan Salaun, the SFR Scinbios (Brest) and the French foundation "Vaincre la Mucoviscidose" for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzamora R, 2011, METHODS MOL BIOL, V741, P471, DOI 10.1007/978-1-61779-117-8_29; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Baudouin-Legros M, 2005, AM J PHYSIOL-CELL PH, V289, pC1240, DOI 10.1152/ajpcell.00595.2004; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Becq F, 1999, J BIOL CHEM, V274, P27415, DOI 10.1074/jbc.274.39.27415; Borthwick LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023226; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Cai ZW, 2002, J BIOL CHEM, V277, P19546, DOI 10.1074/jbc.M108023200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; CROMPTON MR, 1988, CELL, V55, P1, DOI 10.1016/0092-8674(88)90002-5; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Faria D, 2011, MOL MEMBR BIOL, V28, P14, DOI 10.3109/09687688.2010.506264; Farre C, 2007, EXPERT OPIN THER TAR, V11, P557, DOI 10.1517/14728222.11.4.557; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hwang TC, 1997, AM J PHYSIOL-CELL PH, V273, pC988, DOI 10.1152/ajpcell.1997.273.3.C988; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kakar SS, 1995, CANCER LETT, V98, P57, DOI 10.1016/0304-3835(95)90203-1; Kawaminami M, 2002, NEUROENDOCRINOLOGY, V75, P2, DOI 10.1159/000048216; Kawaminami M, 2002, BIOCHEM BIOPH RES CO, V291, P915, DOI 10.1006/bbrc.2002.6573; Kawaminami M, 2008, ENDOCR J, V55, P1005, DOI 10.1507/endocrj.K08E-131; Koushik K, 2004, PHARM RES-DORDR, V21, P1034, DOI 10.1023/B:PHAM.0000029294.70707.74; Le Drevo MA, 2008, BBA-MOL BASIS DIS, V1782, P605, DOI 10.1016/j.bbadis.2008.08.002; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; Norez C, 2006, FEBS LETT, V580, P2081, DOI 10.1016/j.febslet.2006.03.010; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; REUTELINGSPERGER CPM, 1994, FEBS LETT, V349, P120, DOI 10.1016/0014-5793(94)00559-1; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROJAS E, 1990, J BIOL CHEM, V265, P21207; Rowe SM, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009761; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Tieva A, 2001, PROSTATE, V47, P276; Trouve P, 2007, BBA-MOL BASIS DIS, V1772, P1121, DOI 10.1016/j.bbadis.2007.06.006; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WELSH MJ, 1993, J CELL SCI, P235; Yao B, 2008, J REPROD DEVELOP, V54, P259, DOI 10.1262/jrd.20039; Zhang LQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000155; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	53	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88964	10.1371/journal.pone.0088964	http://dx.doi.org/10.1371/journal.pone.0088964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586461	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900066
J	Dunnigan, SK; Ebadi, H; Breiner, A; Katzberg, HD; Barnett, C; Perkins, BA; Bril, V				Dunnigan, Samantha K.; Ebadi, Hamid; Breiner, Ari; Katzberg, Hans D.; Barnett, Carolina; Perkins, Bruce A.; Bril, Vera			The Characteristics of Chronic Inflammatory Demyelinating Polyneuropathy in Patients with and without Diabetes - An Observational Study	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; SCALE; NEUROPATHIES; DEFINITION; VALIDATION; SOCIETY; CIDP	Introduction: We aimed to determine whether the clinical characteristics and electrodiagnostic classification of nerve injury, and response to treatment differed in patients diagnosed with chronic inflammatory demyelinating polyneuropathy (CIDP) with and without diabetes. Methods: CIDP patients with diabetes (CIDP+DM) (n = 67) and without diabetes (CIDP-DM) (n = 67) underwent clinical examination and nerve conduction studies (NCS). CIDP-DM patients were selected using age and gender matching with the existing CIDP+DM cohort. Patients treated with immunotherapies were classified as responders (R) (n = 46) or non-responders (NR) (n = 54) based on clinical response to treatment. The groups were compared using analysis of variance, contingency tables and Kruskal-Wallis analyses. Results: CIDP+DM subjects had more severe neuropathy based on higher lower limb vibration potential thresholds (VPT)(p = 0.004), higher Toronto Clinical Neuropathy Score (TCNS) (p = 0.0009), more proximal weakness (p = 0.03), more gait abnormality (p = 0.03) and more abnormal NCS. CIDP+DM subjects had more abnormal sural NCS with lower sural sensory nerve action potential amplitudes (2.4 +/- 3.0 mu V, 6.6 +/- 6.0 mu V, p<0.0001) and slower sural nerve conduction velocities (38.+/- 65.4 m/s, 41.0 +/- 5.3 m/s, p = 0.04). CIDP-DM subjects were more likely to receive immune therapies (93% vs 57%, p = < 0.0001), despite no significant differences in treatment responder rates (p = 0.71). Patients who responded to therapy had shorter duration of CIDP than non-responders (8.0 +/- 6.0 y vs 11.9 +/- 7.6 y, p = 0.004). Discussion: The clinical phenotype and electrophysiological profile of CIDP patients differs according to the presence or absence of diabetes. Despite CIDP+DM patients having more severe clinical and electrophysiological neuropathy, they are less likely to receive disease-modifying/specific therapy, yet have similar response rates to treatment as those without diabetes. Specifically, the duration of neuropathy - not diabetes status - was associated with treatment response.	[Dunnigan, Samantha K.; Ebadi, Hamid; Breiner, Ari; Katzberg, Hans D.; Barnett, Carolina; Bril, Vera] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Perkins, Bruce A.] Univ Toronto, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada	University of Toronto; University of Toronto	Bril, V (corresponding author), Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada.	vera.bril@utoronto.ca	Barnett, Carolina/AFM-9470-2022; Perkins, Bruce A/L-3726-2017; BRIL, vera/ABA-6509-2020	Barnett, Carolina/0000-0001-5546-0221	philanthropic gifts	philanthropic gifts	The work in this manuscript was internally funded from philanthropic gifts to the Toronto General/Toronto Western Foundation. In Toronto, the academic teaching hospitals are all part of the University of Toronto. These are the University Health Network, Sunnybrook Health Science Center, an d St. Michael's Hospital and Baycrest Hospital. All are liked to the University of Toronto and it is in these centers that teaching of medical students and academic medical research take place. So, the Toronto General/Toronto Western Foundation is part of the University Health Network, and by being part of this organization, is linked directly to the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AANEM, 2004, AM ACAD NEUROMUSCULA, V1, P1; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Bolton CF, 2000, CAN J NEUROL SCI, V27, P288, DOI 10.1017/S0317167100001013; Bril V, 2002, DIABETES CARE, V25, P2048, DOI 10.2337/diacare.25.11.2048; Dunnigan SK, 2013, BRAIN BEHAV, V3, P656, DOI 10.1002/brb3.177; Dunnigan SK, 2013, DIABETES CARE, V36, P3684, DOI 10.2337/dc13-0746; Dyck PJ, 2011, DIABETES-METAB RES, V27, P620, DOI 10.1002/dmrr.1226; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; Gorson KC, 2000, MUSCLE NERVE, V23, P37, DOI 10.1002/(SICI)1097-4598(200001)23:1<37::AID-MUS5>3.0.CO;2-9; Graham RC, 2006, J NEUROL NEUROSUR PS, V77, P973, DOI 10.1136/jnnp.2005.081547; Hao RU, 2003, MUSCLE NERVE, V27, P465, DOI 10.1002/mus.1250; Hughes RAC, 2008, LANCET NEUROL, V7, P136, DOI 10.1016/S1474-4422(07)70329-0; Jann S, 2003, NEUROLOGY, V61, P1607, DOI 10.1212/01.WNL.0000096174.86850.7F; Koski CL, 2009, J NEUROL SCI, V277, P1, DOI 10.1016/j.jns.2008.11.015; KRENDEL DA, 1995, ARCH NEUROL-CHICAGO, V52, P1053, DOI 10.1001/archneur.1995.00540350039015; Latov N, 2011, J PERIPHER NERV SYST, V16, P14, DOI 10.1111/j.1529-8027.2011.00299.x; Lozeron P, 2002, J NEUROL, V249, P569, DOI 10.1007/s004150200066; Merkies ISJ, 2000, NEUROLOGY, V54, P943, DOI 10.1212/WNL.54.4.943; Rajabally YA, 2009, J NEUROL NEUROSUR PS, V80, P1364, DOI 10.1136/jnnp.2009.179358; Sharma KR, 2002, ARCH NEUROL-CHICAGO, V59, P758, DOI 10.1001/archneur.59.5.758; Stewart JD, 1996, J NEUROL SCI, V142, P59, DOI 10.1016/0022-510X(96)00126-8; Tracy JA, 2008, PHYS MED REH CLIN N, V19, P1, DOI 10.1016/j.pmr.2007.10.010; Uncini A, 1999, CLIN NEUROPHYSIOL, V110, P705, DOI 10.1016/S1388-2457(98)00028-5; Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x; van Nes SI, 2011, NEUROLOGY, V76, P337, DOI 10.1212/WNL.0b013e318208824b	25	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89344	10.1371/journal.pone.0089344	http://dx.doi.org/10.1371/journal.pone.0089344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586703	Green Submitted, gold, Green Published			2022-12-27	WOS:000331711900128
J	Ikeda, Y; Ozono, I; Tajima, S; Imao, M; Horinouchi, Y; Izawa-Ishizawa, Y; Kihira, Y; Miyamoto, L; Ishizawa, K; Tsuchiya, K; Tamaki, T				Ikeda, Yasumasa; Ozono, Iori; Tajima, Soichiro; Imao, Mizuki; Horinouchi, Yuya; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Miyamoto, Licht; Ishizawa, Keisuke; Tsuchiya, Koichiro; Tamaki, Toshiaki			Iron Chelation by Deferoxamine Prevents Renal Interstitial Fibrosis in Mice with Unilateral Ureteral Obstruction	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC HEPATITIS-C; HYPOXIA PROMOTES FIBROGENESIS; SERUM AMINOTRANSFERASE LEVELS; DIVALENT METAL TRANSPORTER; NADPH OXIDASE ACTIVITY; OXIDATIVE STRESS; ANGIOTENSIN-II; RAT-KIDNEY; UP-REGULATION	Renal fibrosis plays an important role in the onset and progression of chronic kidney diseases (CKD). Although several mechanisms underlying renal fibrosis and candidate drugs for its treatment have been identified, the effect of iron chelator on renal fibrosis remains unclear. In the present study, we examined the effect of an iron chelator, deferoxamine (DFO), on renal fibrosis in mice with surgically induced unilateral ureter obstruction (UUO). Mice were divided into 4 groups: UUO with vehicle, UUO with DFO, sham with vehicle, and sham with DFO. One week after surgery, augmented renal tubulointerstitial fibrosis and the expression of collagen I, III, and IV increased in mice with UUO; these changes were suppressed by DFO treatment. Similarly, UUO-induced macrophage infiltration of renal interstitial tubules was reduced in UUO mice treated with DFO. UUO-induced expression of inflammatory cytokines and extracellular matrix proteins was abrogated by DFO treatment. DFO inhibited the activation of the transforming growth factor-beta 1 (TGF-beta 1)-Smad3 pathway in UUO mice. UUO-induced NADPH oxidase activity and p22(phox) expression were attenuated by DFO. In the kidneys of UUO mice, divalent metal transporter 1, ferroportin, and ferritin expression was higher and transferrin receptor expression was lower than in sham-operated mice. Increased renal iron content was observed in UUO mice, which was reduced by DFO treatment. These results suggest that iron reduction by DFO prevents renal tubulointerstitial fibrosis by regulating TGF-beta-Smad signaling, oxidative stress, and inflammatory responses.	[Ikeda, Yasumasa; Ozono, Iori; Tajima, Soichiro; Horinouchi, Yuya; Izawa-Ishizawa, Yuki; Kihira, Yoshitaka; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmacol, Tokushima 770, Japan; [Ozono, Iori] Univ Tokushima, Fac Med, Student Lab, Tokushima 770, Japan; [Imao, Mizuki; Miyamoto, Licht; Ishizawa, Keisuke; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Pharmacol, Tokushima 770, Japan	Tokushima University; Tokushima University; Tokushima University	Ikeda, Y (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmacol, Tokushima 770, Japan.	yasuike@tokushima-u.ac.jp		/0000-0003-2331-964X; Ikeda, Yasumasa/0000-0003-4318-7349	Osaka Foundation for Promotion of Fundamental Medical Research; JSPS KAKENHI Grant [24591203]; Grants-in-Aid for Scientific Research [25860063] Funding Source: KAKEN	Osaka Foundation for Promotion of Fundamental Medical Research; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported by Grants for the Regional Innovation Cluster Program and the Setsuro Fujii Memorial from the Osaka Foundation for Promotion of Fundamental Medical Research to T.T. and by a JSPS KAKENHI Grant, number 24591203, to Y.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ RJ, 1992, KIDNEY INT, V41, P14, DOI 10.1038/ki.1992.3; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Azumi H, 1999, CIRCULATION, V100, P1494, DOI 10.1161/01.CIR.100.14.1494; BARRY M, 1974, BMJ-BRIT MED J, V2, P16, DOI 10.1136/bmj.2.5909.16; Cairo G, 2002, FREE RADICAL BIO MED, V32, P1237, DOI 10.1016/S0891-5849(02)00825-0; Camaschella C, 2005, BLOOD, V106, P3710, DOI 10.1182/blood-2005-05-1857; Canonne-Hergaux FS, 2002, KIDNEY INT, V62, P147, DOI 10.1046/j.1523-1755.2002.00405.x; Collins AJ, 2009, CLIN J AM SOC NEPHRO, V4, pS5, DOI 10.2215/CJN.05980809; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; Cuajungco MP, 2000, ANN NY ACAD SCI, V920, P292; Facchini FS, 2002, GASTROENTEROLOGY, V122, P931, DOI 10.1053/gast.2002.32403; Ferguson CJ, 2003, KIDNEY INT, V64, P1755, DOI 10.1046/j.1523-1755.2003.00274.x; Ferguson CJ, 2001, AM J PHYSIOL-RENAL, V280, pF803, DOI 10.1152/ajprenal.2001.280.5.F803; FULLER SD, 1986, J CELL BIOL, V103, P1767, DOI 10.1083/jcb.103.5.1767; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Harmatz P, 2000, BLOOD, V96, P76, DOI 10.1182/blood.V96.1.76.013k22_76_79; HAYASHI H, 1995, J HEPATOL, V22, P268, DOI 10.1016/0168-8278(95)80278-9; HAYASHI H, 1994, AM J GASTROENTEROL, V89, P986; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Ikeda Y, 2013, AM J PHYSIOL-RENAL, V304, pF1028, DOI 10.1152/ajprenal.00473.2012; Ikeda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040465; Inazaki K, 2004, KIDNEY INT, V66, P597, DOI 10.1111/j.1523-1755.2004.00779.x; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P2282, DOI 10.1161/01.ATV.0000181763.57495.2b; Ishizaka N, 2002, CIRCULATION, V106, P1840, DOI 10.1161/01.CIR.0000031161.77536.02; Ishizaka N, 2007, HYPERTENS RES, V30, P195, DOI 10.1291/hypres.30.195; Iwano M, 2004, CURR OPIN NEPHROL HY, V13, P279, DOI 10.1097/00041552-200405000-00003; Jung M, 2012, KIDNEY INT, V81, P969, DOI 10.1038/ki.2011.446; KANETO H, 1993, KIDNEY INT, V44, P313, DOI 10.1038/ki.1993.246; Kato J, 2001, CANCER RES, V61, P8697; Kawada N, 1999, KIDNEY INT, V56, P1004, DOI 10.1046/j.1523-1755.1999.00612.x; Kimura F, 2005, HEPATO-GASTROENTEROL, V52, P563; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Li LX, 2006, ARTERIOSCL THROM VAS, V26, P2638, DOI 10.1161/01.ATV.0000245820.34238.da; Li LX, 2009, ARTERIOSCL THROM VAS, V29, P732, DOI 10.1161/ATVBAHA.108.183210; Liu B, 2011, J BIOL CHEM, V286, P4248, DOI 10.1074/jbc.M110.158980; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Minamiyama Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1140, DOI 10.1152/ajpendo.00620.2009; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; Naito Y, 2013, J HYPERTENS, V31, P1203, DOI 10.1097/HJH.0b013e328360381d; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; Naito Y, 2011, HYPERTENSION, V57, P497, DOI 10.1161/HYPERTENSIONAHA.110.159681; Neufeld EJ, 2006, BLOOD, V107, P3436, DOI 10.1182/blood-2006-02-002394; Norman JT, 2000, KIDNEY INT, V58, P2351, DOI 10.1046/j.1523-1755.2000.00419.x; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Olivieri NF, 1998, NEW ENGL J MED, V339, P417, DOI 10.1056/NEJM199808133390701; Saito K, 2005, AM J PHYSIOL-HEART C, V288, pH1836, DOI 10.1152/ajpheart.00679.2004; Saito K, 2004, HYPERTENS RES, V27, P599, DOI 10.1291/hypres.27.599; Sartori M, 2001, DIGEST LIVER DIS, V33, P157, DOI 10.1016/S1590-8658(01)80072-4; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Sugiyama H, 2005, NEPHROL DIAL TRANSPL, V20, P2670, DOI 10.1093/ndt/gfi045; Tajima S, 2012, AM J PHYSIOL-ENDOC M, V302, pE77, DOI 10.1152/ajpendo.00033.2011; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vielhauer V, 2001, J AM SOC NEPHROL, V12, P1173, DOI 10.1681/ASN.V1261173; WANG GL, 1993, BLOOD, V82, P3610; Ward DT, 2005, BBA-MOL BASIS DIS, V1740, P79, DOI 10.1016/j.bbadis.2005.01.008; Wolff NA, 2011, J CELL MOL MED, V15, P209, DOI 10.1111/j.1582-4934.2009.00985.x; Yano M, 2002, AM J GASTROENTEROL, V97, P133, DOI 10.1111/j.1572-0241.2002.05436.x	61	58	60	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89355	10.1371/journal.pone.0089355	http://dx.doi.org/10.1371/journal.pone.0089355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586712	Green Published, gold			2022-12-27	WOS:000331711900131
J	Macfadyen, S; Hardie, DC; Fagan, L; Stefanova, K; Perry, KD; DeGraaf, HE; Holloway, J; Spafford, H; Umina, PA				Macfadyen, Sarina; Hardie, Darryl C.; Fagan, Laura; Stefanova, Katia; Perry, Kym D.; DeGraaf, Helen E.; Holloway, Joanne; Spafford, Helen; Umina, Paul A.			Reducing Insecticide Use in Broad-Acre Grains Production: An Australian Study	PLOS ONE			English	Article							INTEGRATED PEST-MANAGEMENT; PESTICIDES; RESISTANCE; MITES; POPULATIONS; TOLERANCE; SEEDLINGS; EFFICACY; SYSTEM; COTTON	Prophylactic use of broad-spectrum insecticides is a common feature of broad-acre grains production systems around the world. Efforts to reduce pesticide use in these systems have the potential to deliver environmental benefits to large areas of agricultural land. However, research and extension initiatives aimed at decoupling pest management decisions from the simple act of applying a cheap insecticide have languished. This places farmers in a vulnerable position of high reliance on a few products that may lose their efficacy due to pests developing resistance, or be lost from use due to regulatory changes. The first step towards developing Integrated Pest Management (IPM) strategies involves an increased efficiency of pesticide inputs. Especially challenging is an understanding of when and where an insecticide application can be withheld without risking yield loss. Here, we quantify the effect of different pest management strategies on the abundance of pest and beneficial arthropods, crop damage and yield, across five sites that span the diversity of contexts in which grains crops are grown in southern Australia. Our results show that while greater insecticide use did reduce the abundance of many pests, this was not coupled with higher yields. Feeding damage by arthropod pests was seen in plots with lower insecticide use but this did not translate into yield losses. For canola, we found that plots that used insecticide seed treatments were most likely to deliver a yield benefit; however other insecticides appear to be unnecessary and economically costly. When considering wheat, none of the insecticide inputs provided an economically justifiable yield gain. These results indicate that there are opportunities for Australian grain growers to reduce insecticide inputs without risking yield loss in some seasons. We see this as the critical first step towards developing IPM practices that will be widely adopted across intensive production systems.	[Macfadyen, Sarina] CSIRO Ecosyst Sci & Sustainable Agr Flagship, Canberra, ACT, Australia; [Hardie, Darryl C.] Dept Agr & Food, Perth, WA, Australia; [Hardie, Darryl C.; Fagan, Laura; Spafford, Helen] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Stefanova, Katia] Univ Western Australia, Inst Agr, Perth, WA 6009, Australia; [Perry, Kym D.; DeGraaf, Helen E.] South Australian Res & Dev Inst, Entomol Unit, Urrbrae, Australia; [Holloway, Joanne] Wagga Wagga Agr Inst, New South Wales Dept Primary Ind, Wagga Wagga, NSW, Australia; [Umina, Paul A.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Umina, Paul A.] Cesar, Melbourne, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Government of Western Australia; Department of Agriculture & Food - Western Australia; University of Western Australia; University of Western Australia; South Australian Research & Development Institute (SARDI); NSW Department of Primary Industries; University of Melbourne	Macfadyen, S (corresponding author), CSIRO Ecosyst Sci & Sustainable Agr Flagship, Canberra, ACT, Australia.	sarina.macfadyen@csiro.au	Holloway, Jo/O-5636-2016; Macfadyen, Sarina/C-1511-2008	Holloway, Jo/0000-0003-2742-4201; Macfadyen, Sarina/0000-0003-3553-4910; Umina, Paul/0000-0002-1835-3571	Grains Research and Development Corporation [UWA00134]	Grains Research and Development Corporation(Grains R&D Corp)	This project was funded by the Grains Research and Development Corporation (project UWA00134). www.grdc.com.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur AL, 2008, AUST J EXP AGR, V48, P1126, DOI 10.1071/EA07181; Brewer MJ, 2012, ANNU REV ENTOMOL, V57, P41, DOI 10.1146/annurev-ento-120709-144748; Burger J, 2012, EUR J AGRON, V40, P54, DOI 10.1016/j.eja.2012.02.008; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler DG, 2018, ASREML R REFERENCE M; Chapman R, 2000, AUST J AGR RES, V51, P361, DOI 10.1071/AR99108; Dent D., 1995, INTEGRATED PEST MANA; Downes S, 2012, J INVERTEBR PATHOL, V110, P281, DOI 10.1016/j.jip.2012.04.005; Edwards OR, 2008, AUST J EXP AGR, V48, P1523, DOI 10.1071/EA07426; Endersby NM, 2008, B ENTOMOL RES, V98, P145, DOI 10.1017/S0007485307005494; Furlong MJ, 2004, J ECON ENTOMOL, V97, P1814, DOI 10.1603/0022-0493-97.6.1814; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; GILLESPIE D J, 1991, Plant Protection Quarterly, V6, P170; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Gu H, 2008, AUST J EXP AGR, V48, P1543, DOI 10.1071/EA08027; Hillocks RJ, 2012, CROP PROT, V31, P85, DOI 10.1016/j.cropro.2011.08.008; Hoffmann AA, 2008, AUST J EXP AGR, V48, P1481, DOI 10.1071/EA08185; Jenkins S, 2013, J ECON ENTOMOL, V106, P756, DOI 10.1603/EC12088; JEPSON PC, 1990, FUNCT ECOL, V4, P349, DOI 10.2307/2389596; KHARBOUTLI MS, 1993, J ECON ENTOMOL, V86, P1802, DOI 10.1093/jee/86.6.1802; Kogan M, 1998, ANNU REV ENTOMOL, V43, P243, DOI 10.1146/annurev.ento.43.1.243; Letourneau Deborah K., 2012, P371; Liu A, 2000, AUST J EXP AGR, V40, P715, DOI 10.1071/EA99144; Macfadyen S, 2013, ANN REV ENT IN PRESS; Macfadyen S, 2013, DATA COLLECTION, DOI [10.4225/08/52B24099AC7D7, DOI 10.4225/08/52B24099AC7D7]; Martini X, 2012, PEST MANAG SCI, V68, P1471, DOI 10.1002/ps.3330; McCullagh P, 1989, GEN LINEAR MODELS; Nash MA, 2012, CROP PROT, V42, P289, DOI 10.1016/j.cropro.2012.06.017; Nicholls C. I., 2007, P431, DOI 10.1017/CBO9780511752353.015; Pretty J, 2005, ISS ENVIR SCI TECHN, V21, P1; Reddy GVP, 2011, PEST MANAG SCI, V67, P980, DOI 10.1002/ps.2142; Reisig DD, 2012, J ECON ENTOMOL, V105, P1612, DOI 10.1603/EC12124; Roberts JMK, 2009, AUST J ENTOMOL, V48, P241, DOI 10.1111/j.1440-6055.2009.00702.x; Schellhorn NA, 2008, AUST J EXP AGR, V48, P1549, DOI 10.1071/EA08112; Stefanova KT, 2009, J AGR BIOL ENVIR ST, V14, P392, DOI 10.1198/jabes.2009.07098; Thomas MB, 1999, P NATL ACAD SCI USA, V96, P5944, DOI 10.1073/pnas.96.11.5944; Umina Paul A., 2004, Experimental and Applied Acarology, V33, P1, DOI 10.1023/B:APPA.0000030014.00162.44; Umina PA, 2012, PEST MANAG SCI, V68, P889, DOI 10.1002/ps.3247; Unkovich M, 2009, CROP PASTURE SCI, V60, P617, DOI 10.1071/CP08428; Wade MR, 2006, ENTOMOL EXP APPL, V120, P139, DOI 10.1111/j.1570-7458.2006.00439.x; War AR, 2012, PLANT SIGNAL BEHAV, V7, P1306, DOI 10.4161/psb.21663; Whitehouse MEA, 2011, AGR SYST, V104, P30, DOI 10.1016/j.agsy.2010.09.002; Wilson LJ, 2009, B ENTOMOL RES, V99, P467, DOI 10.1017/S0007485308006500; Wilson LJ, 1999, AUST J ENTOMOL, V38, P242, DOI 10.1046/j.1440-6055.1999.00100.x; Wilson LJ, 1998, B ENTOMOL RES, V88, P477, DOI 10.1017/S000748530004222X; Wratten S. D., 1995, P241	46	27	28	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89119	10.1371/journal.pone.0089119	http://dx.doi.org/10.1371/journal.pone.0089119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586535	gold, Green Published			2022-12-27	WOS:000331711900090
J	Roberts, TC; Coenen-Stass, AML; Wood, MJA				Roberts, Thomas C.; Coenen-Stass, Anna M. L.; Wood, Matthew J. A.			Assessment of RT-qPCR Normalization Strategies for Accurate Quantification of Extracellular microRNAs in Murine Serum	PLOS ONE			English	Article							CIRCULATING MICRORNAS; PCR; CANCER; EXPRESSION; BIOMARKERS; PLASMA; DYSTROPHIN; PROSTATE; BLADDER; GENES	Extracellular microRNAs (miRNAs) are under investigation as minimally-invasive biomarkers for a wide range of disease conditions. We have recently shown in a mouse model of the progressive muscle-wasting condition Duchenne muscular dystrophy (DMD) that a set of highly elevated serum miRNAs reflects the regenerative status of muscle. These miRNAs are promising biomarkers for monitoring DMD disease progression and the response to experimental therapies. The gold standard miRNA detection methodology is Reverse Transcriptase-quantitative Polymerase Chain Reaction (RT-qPCR), which typically exhibits high sensitivity and wide dynamic range. Accurate determination of miRNA levels is affected by RT-qPCR normalization method and therefore selection of the optimal strategy is of critical importance. Serum miRNA abundance was measured by RT-qPCR array in 14 week old mice, and by individual RT-qPCR assays in a time course experiment spanning 48 weeks. Here we utilize these two datasets to assess the validity of three miRNA normalization strategies (a) normalization to the average of all Cq values from array experiments, (b) normalization to a stably expressed endogenous reference miRNA, and (c) normalization to an external spike-in synthetic oligonucleotide. Normalization approaches based on endogenous control miRNAs result in an under-estimation of miRNA levels by a factor of similar to 2. An increase in total RNA and total miRNA was observed in dystrophic serum which may account for this systematic bias. We conclude that the optimal strategy for this model system is to normalize to a synthetic spike-in control oligonucleotide.	[Roberts, Thomas C.; Coenen-Stass, Anna M. L.; Wood, Matthew J. A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Roberts, Thomas C.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University of Oxford; Scripps Research Institute	Roberts, TC (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	robertst@scripps.edu	Wood, Matthew/HDN-1469-2022; Roberts, Thomas/AAI-3183-2020	Roberts, Thomas/0000-0002-3313-7631; Wood, Matthew/0000-0002-5436-6011; Coenen-Stass, Anna Maria Lara/0000-0001-6949-0747	Association Francaise Contre les Myopathies (AFM) [AVRUBK0 - 14784]; Medical Research Council [1371292, G0900887] Funding Source: researchfish; MRC [G0900887] Funding Source: UKRI	Association Francaise Contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a grant from the Association Francaise Contre les Myopathies (AFM) to MJAW (grant code: AVRUBK0 - 14784). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Betts C, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.30; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Fu HJ, 2006, MOL BIOTECHNOL, V32, P197, DOI 10.1385/MB:32:3:197; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hori SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003110; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jones LJ, 1998, ANAL BIOCHEM, V265, P368, DOI 10.1006/abio.1998.2914; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mi QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031278; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Roberts TC, 2013, NUCLEIC ACIDS RES, V41, P9500, DOI 10.1093/nar/gkt724; Roberts TC, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.26; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Sanders I, 2012, INT J UROL, V19, P1017, DOI 10.1111/j.1442-2042.2012.03082.x; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Turchinovich A, 2012, RNA BIOL, V9, P1066, DOI 10.4161/rna.21083; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Vignier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055281; Wang Y, 2013, J APPL TOXICOL, V33, P1330, DOI 10.1002/jat.2864; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110	38	87	92	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89237	10.1371/journal.pone.0089237	http://dx.doi.org/10.1371/journal.pone.0089237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586621	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900112
J	Tanahashi, K; Sugiura, K; Kono, M; Takama, H; Hamajima, N; Akiyama, M				Tanahashi, Kana; Sugiura, Kazumitsu; Kono, Michihiro; Takama, Hiromichi; Hamajima, Nobuyuki; Akiyama, Masashi			Highly Prevalent LIPH Founder Mutations Causing Autosomal Recessive Woolly Hair/Hypotrichosis in Japan and the Genotype/Phenotype Correlations	PLOS ONE			English	Article							HUMAN HAIR-GROWTH; LIPASE-H; LYSOPHOSPHATIDIC ACID; HYPOTRICHOSIS; P2Y5	Mutations in LIPH cause of autosomal recessive woolly hair/hypotrichosis (ARWH), and the 2 missense mutations c.736T>A (p.Cys246Ser) and c.742C>A (p.His248Asn) are considered prevalent founder mutations for ARWH in the Japanese population. To reveal genotype/phenotype correlations in ARWH cases in Japan and the haplotypes in 14 Japanese patients from 14 unrelated Japanese families. 13 patients had woolly hair, and 1 patient had complete baldness since birth. An LIPH mutation search revealed homozygous c.736T>A mutations in 10 of the patients. Compound heterozygous c.736T>A and c.742C>A mutations were found in 3 of the patients, and homozygous c.742C>A mutation in 1 patient. The phenotype of mild hypotrichosis with woolly hair was restricted to the patients with the homozygous c.736T>A mutation. The severe phenotype of complete baldness was seen in only 1 patient with homozygous c.742C>A. Haplotype analysis revealed that the alleles containing the LIPH c.736T>A mutation had a haplotype identical to that reported previously, although 4 alleles out of 5 chromosomes containing the LIPH c.742C>A mutation had a different haplotype from the previously reported founder allele. These alleles with c.742C>A are thought to be the third founder LIPH mutation causing ARWH. To accurately determine the prevalence of the founder mutations, we investigated allele frequencies of those mutations in 819 Japanese controls. Heterozygous c.736T>A mutations were found in 13 controls (allele frequency: 0.0079; carrier rate: 0.016), and heterozygous c.742C>A mutations were found in 2 controls (allele frequency: 0.0012; carrier rate: 0.0024). In conclusion, this study confirms the more accurate allele frequencies of the pathogenic founder mutations of LIPH and shows that there is a third founder mutation in Japan. In addition, the present findings suggest that the mutation patterns of LIPH might be associated with hypotrichosis severity in ARWH.	[Tanahashi, Kana; Sugiura, Kazumitsu; Kono, Michihiro; Akiyama, Masashi] Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan; [Takama, Hiromichi] Takama Dermatol Clin, Kasugai, Aichi, Japan; [Hamajima, Nobuyuki] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Akiyama, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Dermatol, Nagoya, Aichi 4648601, Japan.	makiyama@med.nagoya-u.ac.jp	Sugiura, Kazumitsu/M-8913-2014; Hamajima, Nobuyuki/I-7237-2014; Akiyama, Masashi/I-1122-2012; Kono, Michihiro/I-1238-2012	Sugiura, Kazumitsu/0000-0002-5207-4592; Kono, Michihiro/0000-0003-2639-1583	Ministry of Education, Culture, Sports, Science and Technology of Japan [23249058]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/)(#23249058 to MA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali G, 2007, HUM GENET, V121, P319, DOI 10.1007/s00439-007-0344-0; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kono M, 2014, ALLERGY IN PRESS; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pasternack SM, 2009, J INVEST DERMATOL, V129, P2772, DOI 10.1038/jid.2009.154; Shimomura Y, 2009, J DERMATOL SCI, V56, P205, DOI 10.1016/j.jdermsci.2009.08.005; Shimomura Y, 2009, J INVEST DERMATOL, V129, P622, DOI 10.1038/jid.2008.290; Shinkuma S, 2010, HUM MUTAT, V31, P602, DOI 10.1002/humu.21235; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Suga H, 2011, ACTA DERM-VENEREOL, V91, P486, DOI 10.2340/00015555-1095; Tanahashi K, 2013, J EUR ACAD DERMATOL, V27, P1182, DOI 10.1111/j.1468-3083.2012.04526.x; Yoshimasu T, 2011, J DERMATOL, V38, P900, DOI 10.1111/j.1346-8138.2010.01101.x	12	12	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89261	10.1371/journal.pone.0089261	http://dx.doi.org/10.1371/journal.pone.0089261			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586639	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900117
J	Yin, YW; Sun, QQ; Wang, PJ; Qiao, L; Hu, AM; Liu, HL; Wang, Q; Hou, ZZ				Yin, Yan-Wei; Sun, Qian-Qian; Wang, Pei-Jian; Qiao, Li; Hu, Ai-Min; Liu, Hong-Li; Wang, Qi; Hou, Zhi-Zhen			Genetic Polymorphism of Apolipoprotein A5 Gene and Susceptibility to Type 2 Diabetes Mellitus: A Meta-Analysis of 15,137 Subjects	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; APOA5 GENE; CEREBRAL INFARCTION; ASSOCIATION; RISK; TRIGLYCERIDE; VARIANTS; LIPIDS	Background: Several studies have investigated whether the polymorphism in the apolipoprotein A5 (APOA5) is associated with type 2 diabetes mellitus (T2DM) risk. However, those studies have produced inconsistent results. The purpose of this study was to investigate whether the APOA5 -1131T/C polymorphism (rs662799) confers significant susceptibility to T2DM using a meta-analysis. Methods: PubMed, Embase, Web of Science, Cochrane database, CBMdisc, CNKI and Google Scholar were searched to get the genetic association studies. All statistical analyses were done with Stata 11.0. Results: A total of 19 studies included 4,767 T2DM cases and 10,370 controls (four studies involving 555 T2DM cases and 2958 controls were performed among Europeans and 15 studies involving 4212 T2DM cases and 7412 controls were performed among Asians) were combined showing significant association between the APOA5 -1131T/C polymorphism and T2DM risk (for C allele vs. T allele: OR = 1.28, 95% CI = 1.17-1.40, p, 0.00001; for C/C vs. T/T: OR = 1.57, 95% CI = 1.35-1.83, p, 0.00001; for C/C vs. T/C+ T/T: OR = 1.36, 95% CI = 1.18-1.57, p, 0.0001; for C/C+ T/C vs. T/T: OR = 1.32, 95% CI = 1.16-1.51, p, 0.0001). In the subgroup analysis by ethnicity, significant association was also found among Asians (for C allele vs. T allele: OR = 1.31, 95% CI = 1.22-1.40, p, 0.00001; for C/C vs. T/T: OR = 1.61, 95% CI = 1.38-1.88, p, 0.00001; for C/C vs. T/C+ T/ T: OR = 1.39, 95% CI = 1.20-1.61, p, 0.0001; for C/C+ T/C vs. T/T: OR = 1.42, 95% CI = 1.25-1.62, p, 0.00001). However, no significant association was found between the APOA5 -1131T/C polymorphism and T2DM risk among Europeans. Conclusions: The present meta-analysis suggests that the APOA5 -1131T/C polymorphism is associated with an increased T2DM risk in Asian population.	[Yin, Yan-Wei; Hu, Ai-Min; Liu, Hong-Li; Wang, Qi; Hou, Zhi-Zhen] Chinese PLA Air Force Gen Hosp, Dept Emergency, Beijing, Peoples R China; [Sun, Qian-Qian] Jinsong Sanat Beijing Air Force, Beijing, Peoples R China; [Wang, Pei-Jian] Chengdu Med Coll, Affiliated Hosp 1, Dept Cardiol, Chengdu, Sichuan, Peoples R China; [Qiao, Li] Chinese PLA Air Force Gen Hosp, Dept Dermatol, Beijing, Peoples R China	Air Force General Hospital PLA; Chengdu Medical College; Air Force General Hospital PLA	Yin, YW (corresponding author), Chinese PLA Air Force Gen Hosp, Dept Emergency, Beijing, Peoples R China.	shuaishuaijita@sohu.com						Aouizerat BE, 2003, J LIPID RES, V44, P1167, DOI 10.1194/jlr.M200480-JLR200; Austin MA, 2004, BBA-MOL BASIS DIS, V1688, P1, DOI 10.1016/j.bbadis.2003.10.003; Baum L, 2007, J DIABETES COMPLICAT, V21, P158, DOI 10.1016/j.jdiacomp.2006.02.003; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Bhaskar S, 2011, GENET TEST MOL BIOMA, V15, P507, DOI 10.1089/gtmb.2010.0207; Chaaba Raja, 2005, Lipids Health Dis, V4, P1, DOI 10.1186/1476-511X-4-1; Cheng XQ, 2007, MOL CARDIOLOGY CHINA, V7, P189; Demirdogen BC, 2012, MOL BIOL REP, V39, P10459, DOI 10.1007/s11033-012-1926-z; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng CS, 2009, THESIS QINGDAO U, P1; Freiria Barbosa FA, 2006, J ALZHEIMERS DIS, V10, P365; Gulliford MC, 2009, AM J EPIDEMIOL, V169, P455, DOI 10.1093/aje/kwn342; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Li HX, 2009, CHINA PRACTICAL MED, V4, P40; Li Jie, 2007, Zhonghua Yixue Yichuanxue Zazhi, V24, P576; Li XF, 2002, THEORY APPL TRANSIEN, P1; Li XF, 2008, J HUAZHONG U SCI-MED, V28, P653, DOI 10.1007/s11596-008-0608-5; Lin JD, 2010, METABOLISM, V59, P780, DOI 10.1016/j.metabol.2009.09.024; Liu CF, 2012, GENET TEST MOL BIOMA, V16, P1241, DOI 10.1089/gtmb.2012.0183; Liu HK, 2005, THESIS SICHUAN U, P1; Maasz A, 2007, PATHOL ONCOL RES, V13, P243, DOI 10.1007/BF02893505; Martin S, 2003, BBA-MOL BASIS DIS, V1637, P217, DOI 10.1016/S0925-4439(03)00033-4; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Qiao Yan, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P965; Soter MO, 2012, MOL BIOL REP, V39, P7541, DOI 10.1007/s11033-012-1588-x; Talmud PJ, 2006, DIABETOLOGIA, V49, P2337, DOI 10.1007/s00125-006-0387-0; Tang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070301; van der Vliet HN, 2001, J BIOL CHEM, V276, P44512, DOI 10.1074/jbc.M106888200; Wang Wei, 2012, Zhonghua Nei Ke Za Zhi, V51, P516; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Xiao Hui, 2010, Modern Preventive Medicine, V37, P722; Xu C, 2013, PLOS ONE, V8; Yan SK, 2005, CLIN CHEM LAB MED, V43, P607, DOI 10.1515/CCLM.2005.105; Yao WM, 2013, J HUM HYPERTENS, V27, P265, DOI 10.1038/jhh.2012.23; Yin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066924; Yin YW, 2013, CYTOKINE, V62, P226, DOI 10.1016/j.cyto.2013.02.025; Zhai Guang-Hua, 2007, Yichuan, V29, P541, DOI 10.1360/yc-007-0541; Zhang S.Q., 2009, THESIS I VERTEBRATE, P1; Zhou YL, 2008, J CHINESE PRACTICAL, V22, P815	43	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89167	10.1371/journal.pone.0089167	http://dx.doi.org/10.1371/journal.pone.0089167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586566	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900098
J	Hall, RA; Liebe, R; Hochrath, K; Kazakov, A; Alberts, R; Laufs, U; Bohm, M; Fischer, HP; Williams, RW; Schughart, K; Weber, SN; Lammert, F				Hall, Rabea A.; Liebe, Roman; Hochrath, Katrin; Kazakov, Andrey; Alberts, Rudi; Laufs, Ulrich; Boehm, Michael; Fischer, Hans-Peter; Williams, Robert W.; Schughart, Klaus; Weber, Susanne N.; Lammert, Frank			Systems Genetics of Liver Fibrosis: Identification of Fibrogenic and Expression Quantitative Trait Loci in the BXD Murine Reference Population	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENOME-WIDE ASSOCIATION; TENASCIN-C; INBRED MICE; VITAMIN-E; TGF-BETA; DISEASE; NETWORKS; AFAMIN; HUMANS	The progression of liver fibrosis in response to chronic injury varies considerably among individual patients. The underlying genetics is highly complex due to large numbers of potential genes, environmental factors and cell types involved. Here, we provide the first toxicogenomic analysis of liver fibrosis induced by carbon tetrachloride in the murine 'genetic reference panel' of recombinant inbred BXD lines. Our aim was to define the core of risk genes and gene interaction networks that control fibrosis progression. Liver fibrosis phenotypes and gene expression profiles were determined in 35 BXD lines. Quantitative trait locus (QTL) analysis identified seven genomic loci influencing fibrosis phenotypes (pQTLs) with genome-wide significance on chromosomes 4, 5, 7, 12, and 17. Stepwise refinement was based on expression QTL mapping with stringent selection criteria, reducing the number of 1,351 candidate genes located in the pQTLs to a final list of 11 cis-regulated genes. Our findings demonstrate that the BXD reference population represents a powerful experimental resource for shortlisting the genes within a regulatory network that determine the liver's vulnerability to chronic injury.	[Hall, Rabea A.; Liebe, Roman; Hochrath, Katrin; Weber, Susanne N.; Lammert, Frank] Univ Saarland, Med Ctr, Dept Med 2, Homburg, Germany; [Kazakov, Andrey; Laufs, Ulrich; Boehm, Michael] Univ Saarland, Med Ctr, Dept Med 3, Homburg, Germany; [Alberts, Rudi; Schughart, Klaus] Univ Vet Med Hannover, Helmholtz Ctr Infect Res, Dept Infect Genet, Braunschweig, Germany; [Alberts, Rudi; Schughart, Klaus] Univ Tennessee, Hlth Sci Ctr, Braunschweig, Germany; [Fischer, Hans-Peter] Univ Hosp Bonn, Dept Pathol, Bonn, Germany; [Williams, Robert W.] Univ Tennessee, Dept Anat & Neurobiol, Memphis, TN USA; [Liebe, Roman] Heidelberg Univ, Med Fac Mannheim, Sect Mol Hepatol, Dept Med 2, D-69115 Heidelberg, Germany	Saarland University; Saarland University; Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation; University of Bonn; University of Tennessee System; University of Tennessee Health Science Center; Ruprecht Karls University Heidelberg	Lammert, F (corresponding author), Univ Saarland, Med Ctr, Dept Med 2, Homburg, Germany.	frank.lammert@uks.eu	Böhm, Michael/C-3638-2011; Williams, Robert W./H-8789-2016	Schughart, Klaus/0000-0002-6824-7523; Liebe, Roman/0000-0002-3199-5595; Williams, Robert W./0000-0001-8924-4447	Deutsche Forschungsgemeinschaft [LA997/5-1, LA997/6-1, KFO 196, SFB/TRR 57 TP01]; Helmholtz Virtual Institute GENESYS (German Network of Systems Genetics) [VH-VI-242]; COST Action [BM0901]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662, U01AA013499] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Virtual Institute GENESYS (German Network of Systems Genetics); COST Action(European Cooperation in Science and Technology (COST)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This project was supported by Deutsche Forschungsgemeinschaft (LA997/5-1, LA997/6-1 to FL and AK, KFO 196 to UL and MB, and SFB/TRR 57 TP01 to FL), Helmholtz Virtual Institute GENESYS (German Network of Systems Genetics, VH-VI-242) and COST Action BM0901 (SYSGENET). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita K, 2002, GASTROENTEROLOGY, V123, P352, DOI 10.1053/gast.2002.34234; Alberts R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-516; Andreux PA, 2012, CELL, V150, P1287, DOI 10.1016/j.cell.2012.08.012; Anstee QM, 2013, J HEPATOL, V58, P104; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Beaven SW, 2011, GASTROENTEROLOGY, V140, P1052, DOI 10.1053/j.gastro.2010.11.053; BERGMEYER HU, 1986, J CLIN CHEM CLIN BIO, V24, P481; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2001, LAB ANIMAL, V30, P44; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; CHURCHILL GA, 1994, GENETICS, V138, P963; El-Karef A, 2007, J HEPATOL, V46, P664, DOI 10.1016/j.jhep.2006.10.011; Forsberg E, 1996, P NATL ACAD SCI USA, V93, P6594, DOI 10.1073/pnas.93.13.6594; Gatti D, 2007, HEPATOLOGY, V46, P548, DOI 10.1002/hep.21682; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599; Hillebrandt S, 2002, GASTROENTEROLOGY, V123, P2041, DOI 10.1053/gast.2002.37069; Hintermann E, 2010, J AUTOIMMUN, V35, P424, DOI 10.1016/j.jaut.2010.09.003; Hsia HC, 2005, J BIOL CHEM, V280, P26641, DOI 10.1074/jbc.R500005200; Ishak KG, 1995, GASTROENTEROL CLIN N, V24, P759; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; Kalembeyi I, 2003, INT J CANCER, V105, P53, DOI 10.1002/ijc.11037; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim BJ, 2012, BONE, V51, P431, DOI 10.1016/j.bone.2012.06.015; Krawczyk M, 2011, J HEPATOL, V55, P299, DOI 10.1016/j.jhep.2010.10.042; Krawczyk M, 2010, NAT REV GASTRO HEPAT, V7, P669, DOI 10.1038/nrgastro.2010.170; Lammert F, 2002, HEPATOLOGY, V36, P1145, DOI 10.1053/jhep.2002.36821; Leduc MS, 2012, J LIPID RES, V53, P1163, DOI 10.1194/jlr.M025833; Liu H, 2011, DNA CELL BIOL, V30, P137, DOI 10.1089/dna.2010.1097; Mhyre TR, 2005, GENES BRAIN BEHAV, V4, P209, DOI 10.1111/j.1601-183X.2004.00102.x; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Patin E, 2012, GASTROENTEROLOGY, V143, P1244, DOI 10.1053/j.gastro.2012.07.097; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Phung N, 2009, INT J MOL MED, V24, P171, DOI 10.3892/ijmm_00000220; Pingitore P, 2013, BIOCH BIOPHYS ACTA; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; TAYLOR BA, 1973, P SOC EXP BIOL MED, V143, P629, DOI 10.3181/00379727-143-37380; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Voegele AF, 2002, BIOCHEMISTRY-US, V41, P14532, DOI 10.1021/bi026513v; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Wasmuth HE, 2008, J HEPATOL, V48, P208, DOI 10.1016/j.jhep.2007.09.008; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Weber S, 2008, CLIN LIVER DIS, V12, P747, DOI 10.1016/j.cld.2008.07.012; Williams R. W., 2006, PRINCIPLES MOL MED, V2nd, P53, DOI DOI 10.1007/978-1-59259-963-9_8	53	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89279	10.1371/journal.pone.0089279	http://dx.doi.org/10.1371/journal.pone.0089279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586654	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200045
J	Haddad, M; Vali, H; Paquette, J; Guiot, SR				Haddad, Mathieu; Vali, Hojatollah; Paquette, Jeanne; Guiot, Serge R.			The Role of Carboxydothermus hydrogenoformans in the Conversion of Calcium Phosphate from Amorphous to Crystalline State	PLOS ONE			English	Article							BIOMINERALIZATION; WHITLOCKITE; CERAMICS; MICROSTRUCTURE; MINERALIZATION; BACTERIUM	Two previously unknown modes of biomineralization observed in the presence of Carboxydothermus hydrogenoformans are presented. Following the addition of NaHCO3 and the formation of an amorphous calcium phosphate precipitate in a DSMZ medium inoculated with C. hydrogenoformans, two distinct crystalline solids were recovered after 15 and 30 days of incubation. The first of these solids occurred as micrometric clusters of blocky, angular crystals, which were associated with bacterial biofilm. The second solid occurred as 30-50 nm nanorods that were found scattered among the organic products of bacterial lysis. The biphasic mixture of solids was clearly dominated by the first phase. The X-ray diffractometry (XRD) peaks and Fourier transform infrared spectroscopy (FTIR) spectrum of this biphasic material consistently showed features characteristic of Mg-whitlockite. No organic content or protein could be identified by dissolving the solids. In both cases, the mode of biomineralization appears to be biologically induced rather than biologically controlled. Since Mg is known to be a strong inhibitor of the nucleation and growth of CaP, C. hydrogenoformans may act by providing sites that chelate Mg or form complexes with it, thus decreasing its activity as nucleation and crystal growth inhibitor. The synthesis of whitlockite and nano-HAP-like material by C. hydrogenoformans demonstrates the versatility of this organism also known for its ability to perform the water-gas shift reaction, and may have applications in bacterially mediated synthesis of CaP materials, as an environmentally friendly alternative process.	[Haddad, Mathieu; Guiot, Serge R.] Natl Res Council Canada, Montreal, PQ, Canada; [Haddad, Mathieu; Guiot, Serge R.] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Vali, Hojatollah; Paquette, Jeanne] McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ, Canada; [Vali, Hojatollah] McGill Univ, Facil Electron Microscopy Res, Montreal, PQ, Canada	National Research Council Canada; Universite de Montreal; McGill University; McGill University	Guiot, SR (corresponding author), Natl Res Council Canada, Montreal, PQ, Canada.	serge.guiot@cnrc-nrc.gc.ca		Haddad, Mathieu/0000-0003-0340-1910; Guiot, Serge R/0000-0002-2532-0620	Natural Sciences and Engineering Research Council of Canada [185778-2009]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	One of the authors (M.H.) was supported by the Natural Sciences and Engineering Research Council of Canada (grant 185778-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, D5291 ASTM; ASTM, 2008, D5373 ASTM; Azari F, 2008, J STRUCT BIOL, V162, P468, DOI 10.1016/j.jsb.2008.03.003; Baeuerlein Edmund, 2007, P1; Bazylinski DA, 2003, REV MINERAL GEOCHEM, V54, P217, DOI 10.2113/0540217; Bazylinski DA, 2007, GEOMICROBIOL J, V24, P465, DOI 10.1080/01490450701572259; BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776; Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037; BLUMENTHAL NC, 1989, CLIN ORTHOP RELAT R, P279; BOSKEY AL, 1974, MATER RES BULL, V9, P907, DOI 10.1016/0025-5408(74)90169-X; CEAEQ, 2004, DET SPEC ARS METH CH; Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025; Colfen H, 2001, CHEM-EUR J, V7, P106; Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1; Eaton A. D., 2005, STANDARD METHODS EXA; Emsley J., 1991, ELEMENTS, V2nd; Epple M, 2010, KEY ENG MATER, V441, P299, DOI 10.4028/www.scientific.net/KEM.441.299; Flickinger M, 2002, ENCY BIOPROCESS TECH, V1, P267, DOI [10.1002/0471250589, DOI 10.1002/0471250589]; Frankel RB, 2003, REV MINERAL GEOCHEM, V54, P95, DOI 10.2113/0540095; Frondel C, 1943, AM MINERAL, V28, P215; GERHARDT M, 1991, FEMS MICROBIOL LETT, V83, P267, DOI 10.1111/j.1574-6968.1991.tb04475.x; GOPAL R, 1972, NATURE-PHYS SCI, V237, P30, DOI 10.1038/physci237030a0; GOPAL R, 1974, CAN J CHEM, V52, P1155, DOI 10.1139/v74-181; HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x; Henstra AM, 2004, APPL ENVIRON MICROB, V70, P7236, DOI 10.1128/AEM.70.12.7236-7240.2004; Henstra AM, 2007, CURR OPIN BIOTECH, V18, P200, DOI 10.1016/j.copbio.2007.03.008; Henstra Anne M, 2011, Int J Microbiol, V2011, P641582, DOI 10.1155/2011/641582; Huber R, 2000, FEMS MICROBIOL REV, V24, P615, DOI 10.1111/j.1574-6976.2000.tb00562.x; Kashefi K, 2000, APPL ENVIRON MICROB, V66, P1050, DOI 10.1128/AEM.66.3.1050-1056.2000; Kweh SWK, 2000, BIOMATERIALS, V21, P1223, DOI 10.1016/S0142-9612(99)00275-6; Lagier R, 2003, PATHOL RES PRACT, V199, P329, DOI 10.1078/0344-0338-00425; Layrolle P, 1998, J AM CERAM SOC, V81, P1421, DOI 10.1111/j.1151-2916.1998.tb02499.x; Ledo HM, 2008, J MATER SCI-MATER M, V19, P3419, DOI 10.1007/s10856-008-3485-3; LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Mandel S, 2010, MAT SCI ENG C-MATER, V30, P245, DOI 10.1016/j.msec.2009.10.009; MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0; NEWSOME DS, 1980, CATAL REV, V21, P275, DOI 10.1080/03602458008067535; Pfaff JD, 1993, EPA600R93100; RAMSELAAR MMA, 1991, J MATER SCI-MATER M, V2, P63, DOI 10.1007/BF00703460; REY C, 1990, CALCIFIED TISSUE INT, V46, P384, DOI 10.1007/BF02554969; ROUF MA, 1964, J BACTERIOL, V88, P1545, DOI 10.1128/JB.88.6.1545-1549.1964; Sader MS, 2009, J MATER SCI-MATER M, V20, P521, DOI 10.1007/s10856-008-3610-3; SIDAWAY DA, 1978, J PERIODONTAL RES, V13, P349, DOI 10.1111/j.1600-0765.1978.tb00189.x; STAMS AJM, 1993, APPL ENVIRON MICROB, V59, P1114, DOI 10.1128/AEM.59.4.1114-1119.1993; SVETLICHNY VA, 1991, SYST APPL MICROBIOL, V14, P254, DOI 10.1016/S0723-2020(11)80377-2; Tung MS, 1998, BIOL IND SYSTEMS, P1, DOI [10.1007/978-1-4615-5517-9, DOI 10.1007/978-1-4615-5517-9]; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047; Zhao Y, 2013, INT J HYDROGEN ENERG, V38, P2167, DOI 10.1016/j.ijhydene.2012.11.038; Zhao Y, 2011, INT J HYDROGEN ENERG, V36, P10655, DOI 10.1016/j.ijhydene.2011.05.134	52	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89480	10.1371/journal.pone.0089480	http://dx.doi.org/10.1371/journal.pone.0089480			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586811	gold, Green Submitted, Green Published			2022-12-27	WOS:000332389000047
J	Mech, LD; Christensen, BW; Asa, CS; Callahan, M; Young, JK				Mech, L. David; Christensen, Bruce W.; Asa, Cheryl S.; Callahan, Margaret; Young, Julie K.			Production of Hybrids between Western Gray Wolves and Western Coyotes	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; EVOLUTIONARY HISTORY; FERTILE ESTRUS; WOLF; EASTERN; PREGNANCY; HYBRIDIZATION; PERSPECTIVE; DESLORELIN; INDUCTION	Using artificial insemination we attempted to produce hybrids between captive, male, western, gray wolves (Canis lupus) and female, western coyotes (Canis latrans) to determine whether their gametes would be compatible and the coyotes could produce and nurture offspring. The results contribute new information to an ongoing controversy over whether the eastern wolf (Canis lycaon) is a valid unique species that could be subject to the U.S. Endangered Species Act. Attempts with transcervically deposited wolf semen into nine coyotes over two breeding seasons yielded three coyote pregnancies. One coyote ate her pups, another produced a resorbed fetus and a dead fetus by C-section, and the third produced seven hybrids, six of which survived. These results show that, although it might be unlikely for male western wolves to successfully produce offspring with female western coyotes under natural conditions, western-gray-wolf sperm are compatible with western-coyote ova and that at least one coyote could produce and nurture hybrid offspring. This finding in turn demonstrates that gamete incompatibility would not have prevented western, gray wolves from inseminating western coyotes and thus producing hybrids with coyote mtDNA, a claim that counters the view that the eastern wolf is a separate species. However, some of the difficulties experienced by the other inseminated coyotes tend to temper that finding and suggest that more experimentation is needed, including determining the behavioral and physical compatibility of western gray wolves copulating with western coyotes. Thus although our study adds new information to the controversy, it does not settle it. Further study is needed to determine whether the putative Canis lycaon is indeed a unique species.	[Mech, L. David] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND USA; [Christensen, Bruce W.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Asa, Cheryl S.] St Louis Zoo, Res Dept, St Louis, MO USA; [Callahan, Margaret] Wildlife Sci Ctr, Forest Lake, MN USA; [Young, Julie K.] Utah State Univ, Dept Wildland Resources, Natl Wildlife Res Ctr, USDA,Wildlife Serv, Logan, UT 84322 USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Davis; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University	Mech, LD (corresponding author), US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND USA.	mechx002@umn.edu		Young, Julie/0000-0003-4522-0157	Northern Prairie Wildlife Research Center, U.S.Geological Survey; U.S. Department of Agriculture Wildlife Services - National Wildlife Research Center; Wildlife Science Center; Saint Louis Zoo	Northern Prairie Wildlife Research Center, U.S.Geological Survey; U.S. Department of Agriculture Wildlife Services - National Wildlife Research Center; Wildlife Science Center; Saint Louis Zoo	This study was supported by the Northern Prairie Wildlife Research Center, U.S.Geological Survey (http://www.npwrc.usgs.gov/); the U.S. Department of Agriculture Wildlife Services - National Wildlife Research Center (http://www.aphis.usda.gov/wildlife_damage/nwrc/); the Wildlife Science Center (http://www.wildlifesciencecenter.org/), and the Saint Louis Zoo (http://www.stlzoo.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asa CS, 2006, THERIOGENOLOGY, V66, P1778, DOI 10.1016/j.theriogenology.2006.01.035; Bauman JE, 2008, ZOO BIOL, V27, P406, DOI 10.1002/zoo.20196; Butler MJ, 2006, CAN FIELD NAT, V120, P205, DOI 10.22621/cfn.v120i2.289; Carlson DA, 2007, ANIM REPROD SCI, V101, P304, DOI 10.1016/j.anireprosci.2006.07.011; Chambers S. M., 2012, North American Fauna, V77, P1, DOI 10.3996/nafa.77.0001; Cronin MA, 2009, MOL ECOL, V18, P4991, DOI 10.1111/j.1365-294X.2009.04431.x; Fain SR, 2010, CONSERV GENET, V11, P1747, DOI 10.1007/s10592-010-0068-x; Fontaine E, 2011, THERIOGENOLOGY, V76, P1561, DOI 10.1016/j.theriogenology.2011.06.031; Gier HT, 1968, B KANSAS STATE COLL, V393; Koblmuller S, 2009, MOL ECOL, V18, P2313, DOI 10.1111/j.1365-294X.2009.04176.x; KOLENOKS.GR, 1971, J MAMMAL, V52, P446, DOI 10.2307/1378689; Kolenosky G.B., 1975, P62; Kyle CJ, 2006, CONSERV GENET, V7, P273, DOI 10.1007/s10592-006-9130-0; LEHMAN N, 1991, EVOLUTION, V45, P104, DOI 10.1111/j.1558-5646.1991.tb05270.x; Leonard JA, 2008, BIOL LETTERS, V4, P95, DOI 10.1098/rsbl.2007.0354; Mech LD, 2011, NORTHEAST NAT, V18, P521, DOI 10.1656/045.018.0409; Mech LD, 2009, BIOL LETTERS, V5, P65, DOI 10.1098/rsbl.2008.0440; Mitsuzuka M., 1987, MAN WOLF ADV ISSUES, P127; Murray DL, 2007, CONSERV GENET, V8, P1483, DOI 10.1007/s10592-007-9307-1; Roy MS, 1996, CONSERV BIOL, V10, P1413, DOI 10.1046/j.1523-1739.1996.10051413.x; ROY MS, 1994, MOL BIOL EVOL, V11, P553; Rutledge LY, 2012, BIOL CONSERV, V155, P186, DOI 10.1016/j.biocon.2012.05.017; Rutledge LY, 2010, CONSERV GENET, V11, P1273, DOI 10.1007/s10592-009-9957-2; U.S. Fish and Wildlife Service, 2013, PROP RUL END THREAT; von Heimendahl A, 2012, REPROD DOMEST ANIM, V47, P398, DOI 10.1111/rda.12080; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; Way JG, 2010, NORTHEAST NAT, V17, P189, DOI 10.1656/045.017.0202; WAYNE RK, 1992, ECOLOGY MANAGEMENT E, P9; Wayne Robert K., 2003, P218; WHEELDON T, 2009, THESIS TRENT U PETER; Wheeldon T, 2010, BIOL LETTERS, V6, P246, DOI 10.1098/rsbl.2009.0822; Wheeldon T, 2009, BIOL LETTERS, V5, P101, DOI 10.1098/rsbl.2008.0516; Wilson PJ, 2009, J HERED, V100, pS80, DOI 10.1093/jhered/esp034; Wilson PJ, 2000, CAN J ZOOL, V78, P2156, DOI 10.1139/cjz-78-12-2156	34	17	18	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88861	10.1371/journal.pone.0088861	http://dx.doi.org/10.1371/journal.pone.0088861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586418	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900015
J	Phillips, S				Phillips, Steven			Analogy, Cognitive Architecture and Universal Construction: A Tale of Two Systematicities	PLOS ONE			English	Article							CONNECTIONISM	Cognitive science recognizes two kinds of systematicity: (1) as the property where certain cognitive capacities imply certain other related cognitive capacities (Fodor and Pylyshyn); and (2) as the principle that analogical mappings based on collections of connected relations are preferred over relations in isolation (Gentner). Whether these kinds of systematicity are two aspects of a deeper property of cognition is hitherto unknown. Here, it is shown that both derive from the formal, category-theoretic notion of universal construction. In conceptual/psychological terms, a universal construction is a form of optimization of cognitive resources: optimizing the re-utilization of common component processes for common task components. Systematic cognitive capacity and the capacity for analogy are hallmarks of human cognition, which suggests that universal constructions (in the category-theoretic sense) are a crucial component of human cognitive architecture.	Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Math Neuroinformat Grp, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Phillips, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Math Neuroinformat Grp, Tsukuba, Ibaraki, Japan.	steve@ni.aist.go.jp	Phillips, Steven/N-3425-2016	Phillips, Steven/0000-0002-5694-0670; Zucker-Scharff, Thomas/0000-0002-1790-7405				Aizawa K, 2003, STUDIES MIND BRAIN; AWODEY S, 2006, OXFORD LOGIC GUIDES; Bird R, 1993, LNCS, V669, P45; Bird R., 1998, PRENTICE HALL SERIES; Clark S., 2008, PROC 2 QUANTUM INTER, V1998, P133; Crole R.J., 1993, CATEGORIES TYPES; Doumas LAA, 2008, PSYCHOL REV, V115, P1, DOI 10.1037/0033-295X.115.1.1; EILENBERG S, 1945, T AM MATH SOC, V58, P231, DOI 10.2307/1990284; FODOR J, 1990, COGNITION, V35, P183, DOI 10.1016/0010-0277(90)90014-B; Fodor J. A., 2008, LOT 2 LANGUAGE THOUG; FODOR JA, 1988, COGNITION, V28, P3, DOI 10.1016/0010-0277(88)90031-5; FORBUS KD, 1995, COGNITIVE SCI, V19, P141, DOI 10.1016/0364-0213(95)90016-0; Gentner D, 2010, WILEY INTERDISCIPLIN, V2, P266; GENTNER D, 1983, COGNITIVE SCI, V7, P47, DOI DOI 10.1207/S15516709COG0702_3; Gentner D, 2003, BRADFORD BOOKS, P195; Goguen Joseph A., 1991, MATH STRUCT COMP SCI, V1, P49, DOI DOI 10.1017/S0960129500000050; Halford GraemeS., 2007, COGNITIVE NEUROSCIEN, P261; Halford GS, 1998, BEHAV BRAIN SCI, V21, P803, DOI 10.1017/S0140525X98001769; Halford GS, 2005, PSYCHOL SCI, V16, P70, DOI 10.1111/j.0956-7976.2005.00782.x; Hummel JE, 1997, PSYCHOL REV, V104, P427, DOI 10.1037/0033-295X.104.3.427; Mac Lane S, 2000, GRADUATE TEXTS MATH; Manes E. G., 1986, ALGEBRAIC APPROACHES; McLaughlin BP, 2009, SYNTHESE, V170, P251, DOI 10.1007/s11229-009-9582-0; Phillips S, 2014, SYSTEMATICI IN PRESS, pxx; Phillips S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035028; Phillips S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002102; Phillips S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000858; Phillips S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000599; VANGELDER T, 1990, COGNITIVE SCI, V14, P355, DOI 10.1016/0364-0213(90)90017-Q; Walters R.E.C., 1991, CATEGORIES COMPUTER	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89152	10.1371/journal.pone.0089152	http://dx.doi.org/10.1371/journal.pone.0089152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2ZX	24586555	Green Submitted, gold, Green Published			2022-12-27	WOS:000332385900029
J	Daraki, A; Zachaki, S; Koromila, T; Diamantopoulou, P; Pantelias, GE; Sambani, C; Aleporou, V; Kollia, P; Manola, KN				Daraki, Aggeliki; Zachaki, Sophia; Koromila, Theodora; Diamantopoulou, Paraskevi; Pantelias, Gabriel E.; Sambani, Constantina; Aleporou, Vasiliki; Kollia, Panagoula; Manola, Kalliopi N.			The G(516)T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; CYTOCHROME P4502B6; GENETIC-POLYMORPHISM; CYTOGENETIC ABNORMALITIES; METABOLIZING-ENZYMES; BENZENE METABOLITE; PROGNOSTIC IMPACT; IN-VITRO; ALLELE; CLASSIFICATION	The etiology of acute myeloid leukemia (AML) underlies the influence of genetic variants in candidate genes. The CYP2B6 enzyme detoxifies many genotoxic xenobiotics, protecting cells from oxidative damage. The CYP2B6 gene is subjected to a single-nucleotide polymorphism (G(516)T) with heterozygotes (GT) and homozygotes (TT) presenting decreased enzymatic activity. This case-control study aimed to investigate the association of CYP2B6 G(516)T polymorphism with the susceptibility of AML and its cytogenetic and clinical characteristics. Genotyping was performed on 619 AML patients and 430 healthy individuals using RCR-RFLP and a novel LightSNip assay. The major finding was a statistically higher frequency of the variant genotypes (GT and TT) in patients compared to the controls (GT: 38.8% vs 29.8% and TT:9.3% vs 5.3% respectively) (p < 0.001). More specifically, a significantly higher frequency of GT+TT genotypes in de novo AML patients (46.6%) and an immensely high frequency of TT in secondary AML (s-AML) (20.5%) were observed. The statistical analysis showed that the variant T allele was approximately 1.5-fold and 2.4-fold higher in de novo and s-AML respectively than controls. Concerning FAB subtypes, the T allele presented an almost 2-fold increased in AML-M2. Interestingly, a higher incidence of the TT genotype was observed in patients with abnormal karyotypes. In particular, positive correlations of the mutant allele were found in patients carrying specific chromosomal aberrations [-7/del(7q), -5/del(5q), +8, +21 or t(8; 21)], complex or monosomal karyotypes. Finally, a strikingly higher frequency of TT genotype was also observed in patients stratified to the poor risk group. In conclusion, our results provide evidence for the involvement of the CYP2B6 polymorphism in AML susceptibility and suggest a possible role of the CYP2B6 genetic background on the development of specific chromosomal aberrations.	[Daraki, Aggeliki; Zachaki, Sophia; Diamantopoulou, Paraskevi; Pantelias, Gabriel E.; Sambani, Constantina; Manola, Kalliopi N.] Natl Ctr Sci Res NCSR Demokritos, Lab Hlth Phys Radiobiol & Cytogenet, Athens, Greece; [Daraki, Aggeliki; Koromila, Theodora; Aleporou, Vasiliki; Kollia, Panagoula] Natl & Kapodistrian Univ Athens, Fac Biol, Dept Genet & Biotechnol, Athens 11528, Greece	National Centre of Scientific Research "Demokritos"; National & Kapodistrian University of Athens	Manola, KN (corresponding author), Natl Ctr Sci Res NCSR Demokritos, Lab Hlth Phys Radiobiol & Cytogenet, Athens, Greece.	pmanola@ipta.demokritos.gr		Koromila, Theodora/0000-0001-5504-1369				Agundez JAG, 2004, CURR DRUG METAB, V5, P211, DOI 10.2174/1389200043335621; Arber DA, 2003, AM J CLIN PATHOL, V119, P672, DOI 10.1309/EM7KCOR4GLMHRCX4; Aydin-Sayitoglu M, 2006, AM J HEMATOL, V81, P162, DOI 10.1002/ajh.20434; BAKER MT, 1995, DRUG METAB DISPOS, V23, P60; Belitsky GA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P543, DOI 10.1134/S0006297908050076; Berkoz M, 2009, LEUKEMIA RES, V33, P919, DOI 10.1016/j.leukres.2008.11.014; Bolufer P, 2007, BRIT J HAEMATOL, V136, P590, DOI 10.1111/j.1365-2141.2006.06469.x; Bozina N, 2009, ARH HIG RADA TOKSIKO, V60, P217, DOI 10.2478/10004-1254-60-2009-1885; Figueroa SC, 2010, CLIN DRUG INVEST, V30, P405, DOI 10.2165/11535320-000000000-00000; Cho JY, 2004, DRUG METAB DISPOS, V32, P1341, DOI 10.1124/dmd.104.001107; Chung HW, 2002, J TOXICOL ENV HEAL A, V65, P365, DOI 10.1080/15287390252808037; Code EL, 1997, DRUG METAB DISPOS, V25, P985; Copelan EA, 2013, BLOOD, V122, P3863, DOI 10.1182/blood-2013-07-514448; Deschler B, 2006, CANCER-AM CANCER SOC, V107, P2099, DOI 10.1002/cncr.22233; Dong LM, 2008, JAMA-J AM MED ASSOC, V299, P2423, DOI 10.1001/jama.299.20.2423; Ekins S, 1999, DRUG METAB REV, V31, P719, DOI 10.1081/DMR-100101942; Eyada TK, 2007, BLOOD COAGUL FIBRIN, V18, P489, DOI 10.1097/MBC.0b013e3281eec930; Grimwade D, 2011, HEMATOL ONCOL CLIN N, V25, P1135, DOI 10.1016/j.hoc.2011.09.018; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Guan S, 2006, EUR J PHARM SCI, V29, P14, DOI 10.1016/j.ejps.2006.04.004; Hiratsuka M, 2002, EUR J CLIN PHARMACOL, V58, P417, DOI 10.1007/s00228-002-0499-5; Hodgson E, 2007, PHARMACOL THERAPEUT, V113, P420, DOI 10.1016/j.pharmthera.2006.10.002; Hoffman SMG, 1995, J MOL EVOL, V41, P894; Hofmann MH, 2008, J PHARMACOL EXP THER, V325, P284, DOI 10.1124/jpet.107.133306; Jacob RM, 2004, CLIN CHEM, V50, P1372, DOI 10.1373/clinchem.2004.031708; Jaffe CA, 2002, AM J PHYSIOL-ENDOC M, V283, pE1008, DOI 10.1152/ajpendo.00513.2001; Jinno H, 2003, DRUG METAB DISPOS, V31, P398, DOI 10.1124/dmd.31.4.398; Johnson GG, 2013, BLOOD; Justenhoven C, 2014, INT J CANCER, V134, P426, DOI 10.1002/ijc.28356; Kayser S, 2012, BLOOD, V119, P551, DOI 10.1182/blood-2011-07-367508; Kim H, 1997, XENOBIOTICA, V27, P657, DOI 10.1080/004982597240253; Kim SY, 2004, PHARMACOGENETICS, V14, P453, DOI 10.1097/01.fpc.0000114751.08559.7b; Lamba V, 2003, J PHARMACOL EXP THER, V307, P906, DOI 10.1124/jpet.103.054866; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Liu TC, 2002, ONCOL REP, V9, P327; Majumdar S, 2008, EUR J CANCER PREV, V17, P125, DOI 10.1097/CEJ.0b013e3282b6fd68; Marchesi F, 2011, CRIT REV ONCOL HEMAT, V80, P331, DOI 10.1016/j.critrevonc.2010.11.006; Miksys S, 2003, NEUROPHARMACOLOGY, V45, P122, DOI 10.1016/S0028-3908(03)00136-9; MILES JS, 1988, NUCLEIC ACIDS RES, V16, P5783, DOI 10.1093/nar/16.13.5783; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mrozek Krzysztof, 2006, Hematology Am Soc Hematol Educ Program, P169; Mrozek K, 2012, J CLIN ONCOL, V30, P4515, DOI 10.1200/JCO.2012.43.4738; Naik Adviti, 2013, Frontiers in Genetics, V4, P2, DOI 10.3389/fgene.2013.00002; Pedersen-Bjergaard J, 2002, LEUKEMIA, V16, P2177, DOI 10.1038/sj.leu.2402764; Pedersen-Bjergaard Jens, 2007, Hematology Am Soc Hematol Educ Program, P392; Powers V, 2009, HIV MED, V10, P520, DOI 10.1111/j.1468-1293.2009.00718.x; Preiss BS, 2010, CANCER GENET CYTOGEN, V202, P108, DOI 10.1016/j.cancergencyto.2010.06.013; Roy P, 1999, DRUG METAB DISPOS, V27, P655; Shaffer LG, 2013, ISCN 2009 INT SYSTEM; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Smith MT, 1998, CANCER RES, V58, P2176; Smith MT, 2000, J TOXICOL ENV HEAL A, V61, P439, DOI 10.1080/00984100050166460; Stillman WS, 1997, LEUKEMIA, V11, P1540, DOI 10.1038/sj.leu.2400763; Stillman WS, 2000, EXP HEMATOL, V28, P169, DOI 10.1016/S0301-472X(99)00144-7; Swerdlow SH, 2008, WHO CLASSIFICATION T; Turpeinen M, 2006, CURR DRUG METAB, V7, P705, DOI 10.2174/138920006778520633; Turpeinen Miia, 2012, Drug Metabolism and Drug Interactions, V27, P185, DOI 10.1515/dmdi-2012-0027; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Voso MT, 2007, ANN ONCOL, V18, P1523, DOI 10.1093/annonc/mdm191; Walter RB, 2013, BLOOD, V121, P2424, DOI 10.1182/blood-2012-10-462440; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; Wang J, 2006, PHARMACOGENET GENOM, V16, P191; Wiktor A, 2000, GENE CHROMOSOME CANC, V27, P11, DOI 10.1002/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.0.CO;2-I; Witt M, 2012, MOL ASPECTS HEMATOLO, P29; Xu C, 2012, DRUG METAB DISPOS, V40, P717, DOI 10.1124/dmd.111.042416; Yanada M, 2005, EUR J HAEMATOL, V74, P418, DOI 10.1111/j.1600-0609.2004.00397.x; Yuan J, 2011, AIDS, V25, P1271, DOI 10.1097/QAD.0b013e32834779df; Yuan ZH, 2011, ANN HEMATOL, V90, P293, DOI 10.1007/s00277-010-1085-z; Zhang LP, 1998, CARCINOGENESIS, V19, P1955, DOI 10.1093/carcin/19.11.1955; Zhang LP, 2011, CARCINOGENESIS, V32, P605, DOI 10.1093/carcin/bgq286	71	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e88879	10.1371/journal.pone.0088879	http://dx.doi.org/10.1371/journal.pone.0088879			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586425	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700012
J	Mottola, G; Boucherit, N; Trouplin, V; Barry, AO; Soubeyran, P; Mege, JL; Ghigo, E				Mottola, Giovanna; Boucherit, Nicolas; Trouplin, Virginie; Barry, Abdoulaye Oury; Soubeyran, Philippe; Mege, Jean-Louis; Ghigo, Eric			Tropheryma whipplei, the Agent of Whipple's Disease, Affects the Early to Late Phagosome Transition and Survives in a Rab5-and Rab7-Positive Compartment	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; MATURATION; ENDOCYTOSIS; BIOGENESIS; MECHANISM; RAB7	Tropheryma whipplei, the agent of Whipple's disease, inhibits phago-lysosome biogenesis to create a suitable niche for its survival and replication in macrophages. To understand the mechanism by which it subverts phagosome maturation, we used biochemical and cell biological approaches to purify and characterise the intracellular compartment where Tropheryma whipplei resides using mouse bone-marrow-derived macrophages. We showed that in addition to Lamp-1, the Tropheryma whipplei phagosome is positive for Rab5 and Rab7, two GTPases required for the early to late phagosome transition. Unlike other pathogens, inhibition of PI(3) P production was not the mechanism for Rab5 stabilisation at the phagosome. Overexpression of the inactive, GDP-bound form of Rab5 bypassed the pathogen-induced blockade of phago-lysosome biogenesis. This suggests that Tropheryma whipplei blocks the switch from Rab5 to Rab7 by acting on the Rab5 GTPase cycle. A bio-informatic analysis of the Tropheryma whipplei genome revealed a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) homologous with the GAPDH of Listeria monocytogenes, and this may be the bacterial protein responsible for blocking Rab5 activity. To our knowledge, Tropheryma whipplei is the first pathogen described to induce a "chimeric'' phagosome stably expressing both Rab5 and Rab7, suggesting a novel and specific mechanism for subverting phagosome maturation.	[Mottola, Giovanna] Aix Marseille Univ, UMR MD2, Marseille, France; [Mottola, Giovanna] IRBA, Marseille, France; [Mottola, Giovanna] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Mottola, Giovanna; Boucherit, Nicolas; Trouplin, Virginie; Barry, Abdoulaye Oury; Mege, Jean-Louis; Ghigo, Eric] Aix Marseille Univ, CNRS UMR 7278, IRD198, INSERM U1095,UM63, Marseille, France; [Soubeyran, Philippe] Aix Marseille Univ, CRCM Inst Paoli Calmettes, INSERM U1068, CNRS UMR7258,UM105, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Naples Federico II; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Ghigo, E (corresponding author), Aix Marseille Univ, CNRS UMR 7278, IRD198, INSERM U1095,UM63, Marseille, France.	eric.ghigo@univ-amu.fr	Eric, Ghigo/N-9427-2016; Mottola, Giovanna/Y-7540-2019; MEGE, JEAN-LOUIS/O-6063-2016; Virginie, Trouplin/P-5650-2016; Soubeyran, Philippe/P-1758-2018	Mottola, Giovanna/0000-0002-7541-0472; 	Agence National de la Recherche (ANR) [ANR-Microbiology 05-MIIM-043-01]; Centre National de la Recherche Scientifique (CNRS); POR Campania [FSE 2007-2013]	Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); POR Campania(Regione Campania)	This work was supported by the Agence National de la Recherche (ANR, ANR-Microbiology 05-MIIM-043-01), the Centre National de la Recherche Scientifique (CNRS) and POR Campania FSE 2007-2013 ( Project CREME). NB was a fellow of the French Research Ministry. AOB was a fellow of the Scientific Cooperation Foundation 'Infectiopole Sud'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Moussawi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000722; Alvarez-Dominguez C, 2008, TRAFFIC, V9, P325, DOI 10.1111/j.1600-0854.2007.00683.x; Barr DJ, 2008, J CELL SCI, V121, P3155, DOI 10.1242/jcs.020404; Barry AO, 2012, CELL HOST MICROBE, V12, P751, DOI 10.1016/j.chom.2012.10.015; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Fenollar F, 2002, J CLIN MICROBIOL, V40, P1119, DOI 10.1128/JCM.40.3.1119-1120.2002; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Ghigo E, 2002, INFECT IMMUN, V70, P1501, DOI 10.1128/IAI.70.3.1501-1506.2002; Ghigo E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013561; Gillooly DJ, 2003, HISTOCHEM CELL BIOL, V120, P445, DOI 10.1007/s00418-003-0591-7; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Gutierrez MG, 2013, SMALL GTPASES, V4; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; LI GP, 1995, P NATL ACAD SCI USA, V92, P10207, DOI 10.1073/pnas.92.22.10207; Marth T, 2003, LANCET, V361, P239, DOI 10.1016/S0140-6736(03)12274-X; Mege JL, 2011, CURR OPIN INFECT DIS, V24, P230, DOI 10.1097/QCO.0b013e328344b73e; Navaroli DM, 2012, P NATL ACAD SCI USA, V109, pE471, DOI 10.1073/pnas.1115495109; Papini E, 1997, EMBO J, V16, P15, DOI 10.1093/emboj/16.1.15; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Prada-Delgado A, 2005, TRAFFIC, V6, P252, DOI 10.1111/j.1600-0854.2005.00265.x; Purdy GE, 2005, CELL MICROBIOL, V7, P1627, DOI 10.1111/j.1462-5822.2005.00580.x; Raoult D, 2000, NEW ENGL J MED, V342, P620, DOI 10.1056/NEJM200003023420903; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Roberts EA, 2006, J CELL BIOL, V174, P923, DOI 10.1083/jcb.200603026; Schneider T, 2008, LANCET INFECT DIS, V8, P179, DOI 10.1016/S1473-3099(08)70042-2; Trouplin V, 2013, JOVE-J VIS EXP, DOI 10.3791/50966; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326	36	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89367	10.1371/journal.pone.0089367	http://dx.doi.org/10.1371/journal.pone.0089367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586722	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700031
J	Ternan, NG; Jain, S; Graham, RLJ; McMullan, G				Ternan, Nigel G.; Jain, Shailesh; Graham, Robert L. J.; McMullan, Geoff			Semiquantitative Analysis of Clinical Heat Stress in Clostridium difficile Strain 630 Using a GeLC/MS Workflow with emPAI Quantitatio	PLOS ONE			English	Article							MULTIDIMENSIONAL PROTEOMIC ANALYSIS; TRIGGER FACTOR; RIBOSOMAL-PROTEIN; ESCHERICHIA-COLI; TOXIN-B; TRANSCRIPTIONAL CONTROL; CHANGING EPIDEMIOLOGY; INSOLUBLE SUBPROTEOME; OBLIGATE THERMOPHILE; SUB-PROTEOME	Clostridium difficile is considered to be the most frequent cause of infectious bacterial diarrhoea in hospitals worldwide yet its adaptive ability remains relatively uncharacterised. Here, we used GeLC/MS and the exponentially modified protein abundance index (emPAI) calculation to determine proteomic changes in response to a clinically relevant heat stress. Reproducibility between both biological and technical replicates was good, and a 37 degrees C proteome of 224 proteins was complemented by a 41 degrees C proteome of 202 proteins at a 1% false discovery rate. Overall, 236 C. difficile proteins were identified and functionally categorised, of which 178 were available for comparative purposes. A total of 65 proteins (37%) were modulated by 1.5-fold or more at 41 degrees C compared to 37 degrees C and we noted changes in the majority of proteins associated with amino acid metabolism, including upregulation of the reductive branch of the leucine fermentation pathway. Motility was reduced at 41 degrees C as evidenced by a 2.7 fold decrease in the flagellar filament protein, FliC, and a global increase in proteins associated with detoxification and adaptation to atypical conditions was observed, concomitant with decreases in proteins mediating transcriptional elongation and the initiation of protein synthesis. Trigger factor was down regulated by almost 5-fold. We propose that under heat stress, titration of the GroESL and dnaJK/grpE chaperones by misfolded proteins will, in the absence of trigger factor, prevent nascent chains from emerging efficiently from the ribosome causing translational stalling and also an increase in secretion. The current work has thus allowed development of a heat stress model for the key cellular processes of protein folding and export.	[Ternan, Nigel G.; Jain, Shailesh; McMullan, Geoff] Univ Ulster, Sch Biomed Sci, No Ireland Ctr Food & Hlth NICHE, Coleraine BT52 1SA, Londonderry, North Ireland; [Graham, Robert L. J.] Univ Manchester, Sch Med, Manchester, Greater Manches, England	Ulster University; University of Manchester	Ternan, NG (corresponding author), Univ Ulster, Sch Biomed Sci, No Ireland Ctr Food & Hlth NICHE, Coleraine BT52 1SA, Londonderry, North Ireland.	ng.ternan@ulster.ac.uk		McMullan, Geoffrey/0000-0001-6511-2925; Ternan, Nigel/0000-0002-1788-7571	University of Ulster; Northern Ireland Centre of Excellence in Functional Genomics; European Union (EU) Programme for Peace and Reconciliation, under the Technology Support for the Knowledge-Based Economy; HSC Research and Development office; Society for General Microbiology vacation studentship [VS07/49]	University of Ulster; Northern Ireland Centre of Excellence in Functional Genomics; European Union (EU) Programme for Peace and Reconciliation, under the Technology Support for the Knowledge-Based Economy; HSC Research and Development office; Society for General Microbiology vacation studentship	SJ was supported by a Vice Chancellor's Research Scholarship award (2007-2010) from the University of Ulster. RLJG was supported by the Northern Ireland Centre of Excellence in Functional Genomics, with funding from the European Union (EU) Programme for Peace and Reconciliation, under the Technology Support for the Knowledge-Based Economy. GM was supported by an Innovation Leaders award (2009) from the HSC Research and Development office (http://www.publichealth.hscni.net/directorate-public-health/hsc-research-and-development. NGT was supported by a Society for General Microbiology vacation studentship award for Peter McKee (VS07/49, 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma G, 2012, J BACTERIOL, V194, P6282, DOI 10.1128/JB.01544-12; Amadasi A, 2007, CURR MED CHEM, V14, P1291, DOI 10.2174/092986707780597899; Antunes A, 2012, NUCLEIC ACIDS RES, V40, P10701, DOI 10.1093/nar/gks864; Aoki H, 1997, J BIOL CHEM, V272, P32254, DOI 10.1074/jbc.272.51.32254; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS4, DOI 10.1086/521865; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhadauria V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036266; Boetzkes A, 2012, ARCH MICROBIOL, V194, P675, DOI 10.1007/s00203-012-0802-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown EM, 2013, J AGR FOOD IN PRESS; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Cagney Gerard, 2003, Proteome Sci, V1, P5, DOI 10.1186/1477-5956-1-5; Carter GP, 2012, TRENDS MICROBIOL, V20, P21, DOI 10.1016/j.tim.2011.11.003; Cartman ST, 2010, INT J MED MICROBIOL, V300, P387, DOI 10.1016/j.ijmm.2010.04.008; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; Chlenov M, 2005, J MOL BIOL, V353, P138, DOI 10.1016/j.jmb.2005.07.073; De Angelis M, 2004, APPL ENVIRON MICROB, V70, P1336, DOI 10.1128/AEM.70.3.1336-1346.2004; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Emerson JE, 2008, J MED MICROBIOL, V57, P757, DOI 10.1099/jmm.0.47657-0; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Fagan RP, 2011, J MED MICROBIOL, V60, P1225, DOI 10.1099/jmm.0.028472-0; Forgetta V, 2011, J CLIN MICROBIOL, V49, P2230, DOI 10.1128/JCM.00391-11; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Fu Y, 2013, NUCLEIC ACIDS RES, V41, P3491, DOI 10.1093/nar/gkt055; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Graham RLJ, 2006, J PROTEOME RES, V5, P822, DOI 10.1021/pr0504642; Graham RLJ, 2007, PROTEOMICS, V7, P82, DOI 10.1002/pmic.200600665; Graham RLJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r110; Graham RLJ, 2006, J PROTEOME RES, V5, P3145, DOI 10.1021/pr060293g; Graham RLJ, 2006, J PROTEOME RES, V5, P2465, DOI 10.1021/pr0602444; Graumann P, 1996, J BACTERIOL, V178, P4611, DOI 10.1128/jb.178.15.4611-4619.1996; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; Hockett KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059850; Hoffmann A, 2012, MOL CELL, V48, P63, DOI 10.1016/j.molcel.2012.07.018; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iyer LM, 2012, J STRUCT BIOL, V179, P299, DOI 10.1016/j.jsb.2011.12.013; Jain S, 2011, J PROTEOME RES, V10, P3880, DOI 10.1021/pr200327t; Jain S, 2010, FEMS MICROBIOL LETT, V312, P151, DOI 10.1111/j.1574-6968.2010.02111.x; Janoir C, 2013, INFECT IMMUN, V81, P3757, DOI 10.1128/IAI.00515-13; Janvilisri T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045608; Kandror O, 1997, P NATL ACAD SCI USA, V94, P4978, DOI 10.1073/pnas.94.10.4978; Karjalainen T, 2001, INFECT IMMUN, V69, P3442, DOI 10.1128/IAI.69.5.3442-3446.2001; Karlsson S, 2003, INFECT IMMUN, V71, P1784, DOI 10.1128/IAI.71.4.1784-1793.2003; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kim J, 2005, FEBS J, V272, P550, DOI 10.1111/j.1742-4658.2004.04498.x; Kim J, 2008, NATURE, V452, P239, DOI 10.1038/nature06637; Kitagawa R, 2011, MICROBIOL-SGM, V157, P3094, DOI 10.1099/mic.0.051151-0; Knauer SH, 2011, J AM CHEM SOC, V133, P4342, DOI 10.1021/ja1076537; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lawley TD, 2009, J BACTERIOL, V191, P5377, DOI 10.1128/JB.00597-09; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047521; Li X, 1997, J BACTERIOL, V179, P7046, DOI 10.1128/jb.179.22.7046-7054.1997; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Luo X, 2008, MOL CELL, V32, P791, DOI 10.1016/j.molcel.2008.10.028; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Olivares-Hernandez R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-33; Olling A, 2012, MICROB PATHOGENESIS, V52, P92, DOI 10.1016/j.micpath.2011.10.009; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Scaria J, 2011, J INFECT DIS, V203, P1613, DOI 10.1093/infdis/jir112; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Shinoda K, 2010, BIOINFORMATICS, V26, P576, DOI 10.1093/bioinformatics/btp700; Sirard S, 2011, J CLIN MICROBIOL, V49, P4040, DOI 10.1128/JCM.05053-11; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Sun XM, 2011, INFECT IMMUN, V79, P2856, DOI 10.1128/IAI.01336-10; Ternan NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042410; Tkaczuk KL, 2013, EVOL APPL, V6, P434, DOI 10.1111/eva.12057; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ulrich PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018013; Vedantam G, 2012, GUT MICROBES, V3, P121, DOI 10.4161/gmic.19399; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Wilcox MH, 2012, CLIN INFECT DIS, V55, P1056, DOI 10.1093/cid/cis614; Wright A, 2005, PROTEOMICS, V5, P2443, DOI 10.1002/pmic.200401179; Wright PC, 2012, THERIOGENOLOGY, V77, P738, DOI 10.1016/j.theriogenology.2011.11.012; Xu AT, 2013, ANAL BIOCHEM, V437, P178, DOI 10.1016/j.ab.2013.02.023; Zengel JM, 1996, J BACTERIOL, V178, P2383, DOI 10.1128/jb.178.8.2383-2387.1996; ZENGEL JM, 1985, J BACTERIOL, V163, P140, DOI 10.1128/JB.163.1.140-147.1985	100	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e88960	10.1371/journal.pone.0088960	http://dx.doi.org/10.1371/journal.pone.0088960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586458	Green Published, gold			2022-12-27	WOS:000331880700015
J	Henagan, TM; Lenard, NR; Gettys, TW; Stewart, LK				Henagan, Tara M.; Lenard, Natalie R.; Gettys, Thomas W.; Stewart, Laura K.			Dietary Quercetin Supplementation in Mice Increases Skeletal Muscle PGC1 alpha Expression, Improves Mitochondrial Function and Attenuates Insulin Resistance in a Time-Specific Manner	PLOS ONE			English	Article							FATTY-ACID OXIDATION; PGC-1-ALPHA; DYSFUNCTION; BIOGENESIS; OBESITY	Aims/Hypothesis: High fat diet (HFD)-induced insulin resistance (IR) is partially characterized by reduced skeletal muscle mitochondrial function and peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC1 alpha) expression. Our previous study showed that a high dose of the bioflavonoid quercetin exacerbated HFD-induced IR; yet, others have demonstrated that quercetin improves insulin sensitivity. The aim of this study was to investigate whether differing doses of quercetin act in a time-dependent manner to attenuate HFD-induced IR in association with improved skeletal muscle mitochondrial function and PGC1 alpha expression. Methods: C57BL/6J mice were fed HFD for 3 or 8 wks, with or without a low (50 ug/day; HF+50Q) or high (600 ug/day, HF+600Q) dose of quercetin. Whole body and metabolic phenotypes and insulin sensitivity were assessed. Skeletal muscle metabolomic analysis of acylcarnitines and PGC1 alpha mRNA expression via qRT-PCR were measured. Results: Quercetin at 50 ug/day for 8 wk attenuated HFD-induced increases in fat mass, body weight and IR and increased PGC1 alpha expression, whereas 600 ug/day of quercetin exacerbated fat mass accumulation without altering body weight, IR or PGC1 alpha. PGC1 alpha expression correlated with acylcarnitine levels similarly in HF and HF+600Q; these correlations were not present in HF+50Q. At both time points, energy expenditure increased in HF+50Q and decreased in HF+600Q, independent of PGC1 alpha and IR. Conclusions/Interpretation: Chronic dietary quercetin supplementation at low but not higher dose ameliorates the development of diet-induced IR while increasing PGC1 alpha expression in muscle, suggesting that skeletal muscle may be an important target for the insulin-sensitizing effects of a low dose of quercetin.	[Henagan, Tara M.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Lenard, Natalie R.] Our Lady Lake Coll, Dept Sci, Baton Rouge, LA USA; [Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, Baton Rouge, LA 70808 USA; [Stewart, Laura K.] Louisiana State Univ, Sch Kinesiol, Baton Rouge, LA 70803 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University	Stewart, LK (corresponding author), Louisiana State Univ, Sch Kinesiol, Baton Rouge, LA 70803 USA.	stewart6@lsu.edu	Lenard, Natalie/AFQ-8559-2022; Gettys, Thomas W/N-1964-2017	Lenard, Natalie/0000-0002-2093-4869; Gettys, Thomas W/0000-0001-7125-7995; Henagan, Tara/0000-0001-5314-0128	National Center for Complementary and Alternative Medicine pilot grants [P50 AT002776]; Botanicals Research Center at Pennington Biomedical Research Center in Baton Rouge, LA; ADA [1-12-BS-58]; NIH [RO1 DK-096311, P20-GM-103528]; National Center for Complementary & Integrative Health [P50AT002776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096311, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine pilot grants; Botanicals Research Center at Pennington Biomedical Research Center in Baton Rouge, LA; ADA(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Center for Complementary and Alternative Medicine pilot grants (P50 AT002776) to LKS and TMH from the Botanicals Research Center at Pennington Biomedical Research Center in Baton Rouge, LA. This work was also supported in part by ADA 1-12-BS-58 to TWG, NIH RO1 DK-096311 to TWG, and made use of the Genomics and/or Cell Biology and Bioimaging core facilities supported by NIH P20-GM-103528 to TWG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anhe GF, 2012, EUR J PHARMACOL, V689, P285, DOI 10.1016/j.ejphar.2012.06.007; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006; Jeong SM, 2012, NUTR RES PRACT, V6, P201, DOI 10.4162/nrp.2012.6.3.201; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liang H, 2009, AM J PHYSIOL-ENDOC M, V296, pE945, DOI 10.1152/ajpendo.90292.2008; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; Metodiewa D, 1999, FREE RADICAL BIO MED, V26, P107, DOI 10.1016/S0891-5849(98)00167-1; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Muoio Deborah M, 2007, Novartis Found Symp, V286, P24; Ortega R, 2009, J BIOENERG BIOMEMBR, V41, P41, DOI 10.1007/s10863-009-9198-6; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315; Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466; Schrauwen P, 2007, P NUTR SOC, V66, P33, DOI 10.1017/S0029665107005277; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Stewart LK, 2009, DIABETOLOGIA, V52, P514, DOI 10.1007/s00125-008-1252-0; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Vessal M, 2003, COMP BIOCHEM PHYS C, V135, P357, DOI 10.1016/S1532-0456(03)00140-6; Vidyashankar S, 2013, TOXICOL IN VITRO, V27, P945, DOI 10.1016/j.tiv.2013.01.014; Watjen W, 2005, J NUTR, V135, P525, DOI 10.1093/jn/135.3.525; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	36	44	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89365	10.1371/journal.pone.0089365	http://dx.doi.org/10.1371/journal.pone.0089365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586721	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900083
J	Khakwani, A; Rich, AL; Tata, LJ; Powell, HA; Stanley, RA; Baldwin, DR; Hubbard, RB				Khakwani, Aamir; Rich, Anna L.; Tata, Laila J.; Powell, Helen A.; Stanley, Rosamund A.; Baldwin, David R.; Hubbard, Richard B.			Small-Cell Lung Cancer in England: Trends in Survival and Chemotherapy Using the National Lung Cancer Audit	PLOS ONE			English	Article							CARCINOMA; OUTCOMES; METAANALYSIS; IRRADIATION; AGE; UK	Background: The purpose of this study was to identify trends in survival and chemotherapy use for individuals with small-cell lung cancer (SCLC) in England using the National Lung Cancer Audit (NLCA). Methods: We used data from the NLCA database to identify people with histologically proven SCLC from 2004-2011. We calculated the median survival by stage and assessed whether patient characteristics changed over time. We also assessed whether the proportion of patients with records of chemotherapy and/or radiotherapy changed over time. Results: 18,513 patients were diagnosed with SCLC in our cohort. The median survival was 6 months for all patients, 1 year for those with limited stage and 4 months for extensive stage. 69% received chemotherapy and this proportion changed very slightly over time (test for trends p = 0.055). Age and performance status of patients remained stable over the study period, but the proportion of patients staged increased (p-value<0.001), mainly because of improved data completeness. There has been an increase in the proportion of patients that had a record of receiving both chemotherapy and radiotherapy each year (from 19% to 40% in limited and from 9% to 21% in extensive stage from 2004 to 2011). Patients who received chemotherapy with radiotherapy had better survival compared with any other treatment (HR 0.24, 95% CI 0.23-0.25). Conclusion: Since 2004, when the NLCA was established, the proportion of patients with SCLC having chemotherapy has remained static. We have found an upward trend in the proportion of patients receiving both chemotherapy and radiotherapy which corresponded to a better survival in this group, but as it only applied for a small proportion of patients, it was not enough to change the overall survival.	[Khakwani, Aamir; Tata, Laila J.; Powell, Helen A.; Hubbard, Richard B.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Rich, Anna L.; Baldwin, David R.] Univ Nottingham Hosp, Dept Resp Med, Nottingham NG7 2UH, England; [Powell, Helen A.; Hubbard, Richard B.] Univ Nottingham, Nottingham Resp Res Unit, Nottingham NG7 2RD, England; [Stanley, Rosamund A.] Hlth & Social Care Informat Ctr, Leeds, W Yorkshire, England	University of Nottingham; University of Nottingham; University of Nottingham	Khakwani, A (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	mcxak14@nottingham.ac.uk	Tata, Laila/J-5227-2012	Tata, Laila/0000-0002-6404-8658	British Lung foundation chair of respiratory epidemiology; GSK; British Lung Foundation; British Lung Foundation [C05/01] Funding Source: researchfish	British Lung foundation chair of respiratory epidemiology; GSK(GlaxoSmithKline); British Lung Foundation; British Lung Foundation	RBH has a grant provided by the British Lung foundation chair of respiratory epidemiology and has a minor consultancy role with GSK concerning people with lung fibrosis where he was paid 350 pound. He is also a co-applicant on a grant for 500,000 pound from GSK to look at biomarkers for lung fibrosis. AK is also doing his PhD from the University of Nottingham on a studentship provided by the British Lung Foundation. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Brown JS, 1996, THORAX, V51, P564, DOI 10.1136/thx.51.6.564; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Crawford SM, 2009, BRIT J CANCER, V101, P897, DOI 10.1038/sj.bjc.6605257; CRUK, 2012, STAT OUTL LUNG CANC; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; GREEN RA, 1969, AM J MED, V46, P516, DOI 10.1016/0002-9343(69)90071-0; Health and Social Care Information Centre, 2011, NAT LUNG CANC AUD RE; Health and Social Care Information Centre, 2010, NAT LUNG CANC AUD 20; Janssen-Heijnen MLG, 2012, ANN ONCOL, V23, P954, DOI 10.1093/annonc/mdr303; Li J, 2010, MED ONCOL, V27, P73, DOI 10.1007/s12032-009-9174-3; Ludbrook JJS, 2003, INT J RADIAT ONCOL, V55, P1321, DOI 10.1016/S0360-3016(02)04576-5; National Clinical Analysis and Specialised Application Team (NATCANSAT), 2013, NAT RAD DAT RTDS; National Institute for Health and Care Excellence, 2005, DIAGN TREATM LUNG CA; National Institute for Health and Clinical Excellence, 2011, LUNG CANC DIAGN TREA; PERRY MC, 1987, NEW ENGL J MED, V316, P912, DOI 10.1056/NEJM198704093161504; PIGNON JP, 1992, NEW ENGL J MED, V327, P1618, DOI 10.1056/NEJM199212033272302; Riaz SP, 2012, LUNG CANCER, V75, P280, DOI 10.1016/j.lungcan.2011.08.004; Rich AL, 2011, BRIT J CANCER, V105, P746, DOI 10.1038/bjc.2011.310; Rich AL, 2011, LUNG CANCER, V72, P16, DOI 10.1016/j.lungcan.2010.07.002; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; Sobin L, 2009, TNM CLASSIFICATION M; Walters S, 2013, THORAX, V68, P551, DOI 10.1136/thoraxjnl-2012-202297; WARDE P, 1992, J CLIN ONCOL, V10, P890, DOI 10.1200/JCO.1992.10.6.890; Woolhouse I, 2011, CLIN MED, V11, P110, DOI 10.7861/clinmedicine.11-2-110	24	27	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89426	10.1371/journal.pone.0089426	http://dx.doi.org/10.1371/journal.pone.0089426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586771	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900095
J	Abe, H; Al-zi'abi, MO; Sekizawa, F; Acosta, TJ; Skarzynski, DJ; Okuda, K				Abe, Hironori; Al-zi'abi, Mohamad Omar; Sekizawa, Fumio; Acosta, Tomas J.; Skarzynski, Dariusz J.; Okuda, Kiyoshi			Lymphatic Involvement in the Disappearance of Steroidogenic Cells from the Corpus Luteum during Luteolysis	PLOS ONE			English	Article							ESTROUS-CYCLE; IMMUNE CELLS; BLOOD-FLOW; BOVINE; COW; VASCULATURE; RECEPTOR; HYALURONAN; CATTLE; LYVE-1	In mammals, the corpus luteum (CL) is an essential endocrine gland for the establishment and maintenance of pregnancy. If pregnancy is not established, the CL regresses and disappears rapidly from the ovary. A possible explanation for the rapid disappearance of the CL is that luteal cells are transported from the ovary via lymphatic vessels. Here, we report the presence of cells positive for 3b-hydroxysteroid dehydrogenase (3b-HSD), an enzyme involved in progesterone synthesis, in the lumen of lymphatic vessels at the regressing luteal stage and in the lymphatic fluid collected from the ovarian pedicle ipsilateral to the regressing CL. The 3b-HSD positive cells were alive and contained lipid droplets. The 3b-HSD positive cells in the lymphatic fluid were most abundant at days 22-24 after ovulation. These findings show that live steroidogenic cells are in the lymphatic vessels drained from the CL. The outflow of steroidogenic cells starts at the regressing luteal stage and continues after next ovulation. The overall findings suggest that the complete disappearance of the CL during luteolysis is involved in the outflow of luteal cells from the CL via ovarian lymphatic vessels.	[Abe, Hironori; Al-zi'abi, Mohamad Omar; Acosta, Tomas J.; Okuda, Kiyoshi] Okayama Univ, Grad Sch Environm & Life Sci, Reprod Physiol Lab, Okayama 7008530, Japan; [Sekizawa, Fumio] Sekizawa Anim Clin, Kanuma, Tochigi, Japan; [Skarzynski, Dariusz J.] Polish Acad Sci, Inst Anim Reprod & Food Res, Dept Reprod Immunol & Pathol, Olsztyn, Poland	Okayama University; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Okuda, K (corresponding author), Okayama Univ, Grad Sch Environm & Life Sci, Reprod Physiol Lab, Okayama 7008530, Japan.	kokuda@cc.okayama-u.ac.jp	Alzi'abi, muhammad omar/AAY-8647-2021; Skarżyński, Dariusz/H-7246-2017; OKUDA, Kiyoshi/AAC-8606-2020	Skarżyński, Dariusz/0000-0001-9537-3560; 	Challenging Exploratory Research of the Japan Society for the Promotion of Science (JSPS) [25660212]; Ministry of Agriculture, Forestry and Fisheries of Japan [REP-1002]; Grants-in-Aid for Scientific Research [26292136] Funding Source: KAKEN	Challenging Exploratory Research of the Japan Society for the Promotion of Science (JSPS); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Challenging Exploratory Research (No. 25660212) of the Japan Society for the Promotion of Science (JSPS)(http://www.jsps.go.jp/english/index.html) and by Grant-in-Aid for Research Program on Innovative Technologies for Animal Breeding, Reproduction, and Vaccine Development (REP-1002) from the Ministry of Agriculture, Forestry and Fisheries of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta TJ, 2002, BIOL REPROD, V66, P651, DOI 10.1095/biolreprod66.3.651; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Berisha B, 2013, ANAT HISTOL EMBRYOL, V42, P292, DOI 10.1111/ahe.12016; Brown HM, 2010, ENDOCRINOLOGY, V151, P5446, DOI 10.1210/en.2010-0629; DEANE HW, 1966, ACTA ENDOCRINOL-COP, V51, P245, DOI 10.1530/acta.0.0510245; DONALDSON L, 1965, J DAIRY SCI, V48, P905, DOI 10.3168/jds.S0022-0302(65)88360-6; ELEY RM, 1978, J DAIRY SCI, V61, P467, DOI 10.3168/jds.S0022-0302(78)83622-4; HEHNKE KE, 1994, BIOL REPROD, V50, P10, DOI 10.1095/biolreprod50.1.10; Hojo T, 2009, J REPROD DEVELOP, V55, P512, DOI 10.1262/jrd.20257; Marzolla V, 2012, MOL CELL ENDOCRINOL, V350, P281, DOI 10.1016/j.mce.2011.09.011; Miyamoto A, 2005, DOMEST ANIM ENDOCRIN, V29, P329, DOI 10.1016/j.domaniend.2005.03.011; Miyamoto Y, 2000, BIOL REPROD, V62, P1109, DOI 10.1095/biolreprod62.5.1109; Nitta A, 2011, REPRODUCTION, V142, P879, DOI 10.1530/REP-11-0157; OKUDA K, 1988, VET REC, V123, P180, DOI 10.1136/vr.123.7.180; Pate JL, 2001, REPRODUCTION, V122, P665, DOI 10.1530/rep.0.1220665; Penny LA, 1999, J REPROD FERTIL, V115, P87, DOI 10.1530/jrf.0.1150087; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Schams D, 2004, REPROD DOMEST ANIM, V39, P241, DOI 10.1111/j.1439-0531.2004.00509.x; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; Sugino N, 2007, J REPROD DEVELOP, V53, P977, DOI 10.1262/jrd.19047; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; WEBER DM, 1987, BIOL REPROD, V37, P685, DOI 10.1095/biolreprod37.3.685; Xu Fuhua, 2009, Lymphatic Research and Biology, V7, P159, DOI 10.1089/lrb.2009.0009	23	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88953	10.1371/journal.pone.0088953	http://dx.doi.org/10.1371/journal.pone.0088953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586455	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700043
J	Cline, AR; Skelley, PE; Kinnee, SA; Rooney-Latham, S; Winterton, SL; Borkent, CJ; Audisio, P				Cline, Andrew R.; Skelley, Paul E.; Kinnee, Scott A.; Rooney-Latham, Suzanne; Winterton, Shaun L.; Borkent, Christopher J.; Audisio, Paolo			Interactions between a Sap Beetle, Sabal Palm, Scale Insect, Filamentous Fungi and Yeast, with Discovery of Potential Antifungal Compounds	PLOS ONE			English	Article							PICHIA-GUILLIERMONDII; OAK WILT; COLEOPTERA; NITIDULIDAE; ATTRACTIVENESS; BIOCONTROL; DIVERSITY; BACTERIA; LARVAE; WATER	The multi-trophic relationship between insects, yeast, and filamentous fungi is reported on sabal palm (Sabal palmetto (Walter) Lodd. ex Schult. & Schult. f.). Gut content analyses and observations of adult and larval feeding of the sap beetle Brachypeplus glaber LeConte indicate that niche partitioning of fungal food substrata occurs between adults and larvae. This is the first report of specific mycophagous niche partitioning among beetle life stages based on gut content analyses. Fungi isolated from the beetle gut of adults, larvae, and pupae include species of Fusarium Link, Cladosporium Link, and Penicillium Link, which were differentially ingested by larvae and adults; Fusarium solani and Penicillium species in larvae, whereas F. oxysoproum, F. verticillioides, and Cladosporium in adults. These data indicate the first species-level host data for Brachypeplus Erichson species. Fusarium proliferatum (Matsush.) Nirenberg was the most commonly occurring fungal gut component, being isolated from the palm as well as gut of larvae, pupae, and adults; representing a commonly shared food resource. One species of yeast, Meyerozyma caribbica (Vaughan-Mart. et al.) Kurtzman & Suzuki (basionym = Pichia caribbica), was isolated from all life stages and is likely responsible for anti-fungal properties observed in the pupae and represents a promising source of antifungal compounds; rearing and diagnostic protocols are provided to aid biomedical researchers. Feeding and cleaning behaviors are documented using time-lapse video-micrography, and discussed in a behavioral and functional morphological context. Adults spent long periods feeding, often >1/3 of the two-hour observation period. A generic adult body posture was observed during feeding, and included substrate antennation before and after ingestion. Adult grooming behaviors were manifested in distinct antennal and tarsal cleaning mechanisms. Larval behaviors were different from adults, and larvae feeding on Fusarium fungi immediately ceased all subsequent feeding. This is the first ethogram for any adult or larval sap beetle.	[Cline, Andrew R.; Kinnee, Scott A.; Rooney-Latham, Suzanne; Winterton, Shaun L.; Borkent, Christopher J.] Calif Dept Food & Agr, Plant Pest Diagnost Ctr, Sacramento, CA 95814 USA; [Skelley, Paul E.] Florida State Collect Arthropods, Florida Dept Agr DPI, Gainesville, FL USA; [Audisio, Paolo] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy	California Department of Food & Agriculture; Sapienza University Rome	Cline, AR (corresponding author), Calif Dept Food & Agr, Plant Pest Diagnost Ctr, Sacramento, CA 95814 USA.	andrew.cline@cdfa.ca.gov	Winterton, Shaun L/C-3804-2009; Borkent, Christopher/F-3188-2013	Borkent, Christopher/0000-0001-9573-1663; AUDISIO, Paolo Aldo/0000-0002-7990-6934	Australian Biological Resource Study; Direct For Biological Sciences [1144119] Funding Source: National Science Foundation	Australian Biological Resource Study; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding came from the Australian Biological Resource Study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RS, 2000, BIODIVERS CONSERV, V9, P617, DOI 10.1023/A:1008937017058; Arras G, 1998, J HORTIC SCI BIOTECH, V73, P413, DOI 10.1080/14620316.1998.11510993; ARRAS G, 1996, ITALUS HORTUS, V3, P27; AUDISIO P, 1993, FAUNA ITALIA 32 COLE; Audisio P, 2009, ACTA ENT MUS NAT PRA, V49, P341; BARNETT JA, 2000, YEASTS CHARACTERISTI; Bartelt RJ, 1999, J AGR FOOD CHEM, V47, P2447, DOI 10.1021/jf9901340; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Cardoza YJ, 2006, ECOL ENTOMOL, V31, P636, DOI 10.1111/j.1365-2311.2006.00829.x; Cease KR, 2001, CAN J FOREST RES, V31, P635, DOI 10.1139/x00-201; Cline AR, 2013, ZOOTAXA, V3734, P259, DOI 10.11646/zootaxa.3734.2.9; Cline AR, 2013, ZOOTAXA, V3683, P101, DOI 10.11646/zootaxa.3683.2.1; Cline AR, 2005, THESIS LOUSIANA STAT; Crowson RA, 1981, BIOL COLEOPTERA; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; DORSEY CK, 1956, J ECON ENTOMOL, V49, P219, DOI 10.1093/jee/49.2.219; Galimberti R, 2012, CLIN DERMATOL, V30, P633, DOI 10.1016/j.clindermatol.2012.01.011; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Guedegbe HJ, 2009, MYCOL RES, V113, P1039, DOI 10.1016/j.mycres.2009.06.008; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Hamilton J, 1894, CAN ENTOMOL, V26, P250; Heath RN, 2009, ENVIRON ENTOMOL, V38, P356, DOI 10.1603/022.038.0207; Jain PK, 2011, ASIAN J ANIM VET ADV, V6, P201, DOI 10.3923/ajava.2011.201.227; Jelinek J, 2010, HDB ZOOLOGY, VIV; Aira MJ, 2012, GRANA, V51, P293, DOI 10.1080/00173134.2012.717636; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kaltenpoth M, 2012, APPL ENVIRON MICROB, V78, P822, DOI 10.1128/AEM.06809-11; Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006; Kirejtshuk A. G., 1997, Bonner Zoologische Beitraege, V47, P111; Lachance MA, 2001, FEMS YEAST RES, V1, P1; Leong S. L., 2012, African Journal of Biotechnology, V11, P8692; Leslie J.F., 2005, FUSARIUM LAB MANUAL; Little EL, 1971, USDA MISCELLANEOUS P, V1; Medianero E, 2007, PEDOBIOLOGIA, V51, P131, DOI 10.1016/j.pedobi.2007.03.004; Meng J, 2012, CLIN EXP ALLERGY, V42, P1448, DOI 10.1111/j.1365-2222.2012.04001.x; Meyling NV, 2012, J INVERTEBR PATHOL, V109, P76, DOI 10.1016/j.jip.2011.10.001; Miller DR, 2005, ARMORED SCALE INSPEC; Munkvold GP, 2003, EUR J PLANT PATHOL, V109, P705, DOI 10.1023/A:1026078324268; NEEL WW, 1967, J ECON ENTOMOL, V60, P1104, DOI 10.1093/jee/60.4.1104; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Donnell K, 2012, MYCOLOGIA, V104, P427, DOI 10.3852/11-179; Rao RS, 2007, CURR MICROBIOL, V55, P441, DOI 10.1007/s00284-007-9005-8; Sanchez-Rangel D, 2012, PLANTA, V235, P965, DOI 10.1007/s00425-011-1555-0; Sang H, 2012, MYCOSES, V55, P195, DOI 10.1111/j.1439-0507.2011.02057.x; SHOREY HH, 1965, J ECON ENTOMOL, V58, P522, DOI 10.1093/jee/58.3.522; Stankovic S, 2007, EUR J PLANT PATHOL, V118, P165, DOI 10.1007/s10658-007-9126-8; Suh SO, 2004, FEMS YEAST RES, V5, P87, DOI 10.1016/j.femsyr.2004.06.001; Suh Sung-Oui, 2005, P244; Vaughan-Martini A, 2005, FEMS YEAST RES, V5, P463, DOI 10.1016/j.femsyr.2004.10.008; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; WISNIEWSKI M, 1991, PHYSIOL MOL PLANT P, V39, P245, DOI 10.1016/0885-5765(91)90033-E; Wszelaki AL, 2003, POSTHARVEST BIOL TEC, V27, P255, DOI 10.1016/S0925-5214(02)00095-9	52	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89295	10.1371/journal.pone.0089295	http://dx.doi.org/10.1371/journal.pone.0089295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586669	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700092
J	Gungor, B; Imre, G; Crul, T; Ayaydin, F; Laszlo, S; Torok, Z; Lajos, M; Laszlo, V; Ibolya, H				Gungor, Burcin; Imre Gombos; Crul, Tim; Ayaydin, Ferhan; Laszlo Szabo; Toeroek, Zsolt; Lajos Mates; Laszlo Vigh; Ibolya Horvath			Rac1 Participates in Thermally Induced Alterations of the Cytoskeleton, Cell Morphology and Lipid Rafts, and Regulates the Expression of Heat Shock Proteins in B16F10 Melanoma Cells	PLOS ONE			English	Article							SMALL GTPASE RAC1; MEMBRANE-FLUIDITY; QUANTUM DOTS; STRESS; ACTIVATION; HYPERFLUIDIZATION; PALMITOYLATION; LOCALIZATION; MECHANISM; FACTOR-1	Eukaryotic cells exhibit a characteristic response to hyperthermic treatment, involving morphological and cytoskeletal alterations and the induction of heat shock protein synthesis. Small GTPases of the Ras superfamily are known to serve as molecular switches which mediate responses to extracellular stimuli. We addressed here how small GTPase Rac1 integrates signals from heat stress and simultaneously induces various cellular changes in mammalian cells. As evidence that Rac1 is implicated in the heat shock response, we first demonstrated that both mild (41.5 degrees C) and severe (43 degrees C) heat shock induced membrane translocation of Rac1. Following inhibition of the activation or palmitoylation of Rac1, the size of its plasma membrane-bound pool was significantly decreased while the heat shock-induced alterations in the cytoskeleton and cell morphology were prevented. We earlier documented that the size distribution pattern of cholesterol-rich rafts is temperature dependent and hypothesized that this is coupled to the triggering mechanism of stress sensing and signaling. Interestingly, when plasma membrane localization of Rac1 was inhibited, a different and temperature independent average domain size was detected. In addition, inhibition of the activation or palmitoylation of Rac1 resulted in a strongly decreased expression of the genes of major heat shock proteins hsp25 and hsp70 under both mild and severe heat stress conditions.	[Gungor, Burcin; Imre Gombos; Crul, Tim; Toeroek, Zsolt; Laszlo Vigh; Ibolya Horvath] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Lab Mol Stress Biol, H-6701 Szeged, Hungary; [Ayaydin, Ferhan] Hungarian Acad Sci, Biol Res Ctr, Lab Cellular Imaging, H-6701 Szeged, Hungary; [Lajos Mates] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, Lab Canc Genome Res, H-6701 Szeged, Hungary; [Laszlo Szabo] Res Ctr Nat Sci, Dept Funct & Struct Mat, Inst Mat & Environm Chem, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Ibolya, H (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Lab Mol Stress Biol, H-6701 Szeged, Hungary.	hibi@brc.hu	Güngör, Burçin/AAF-8288-2021; Ayaydin, Ferhan/C-4849-2011; Güngör, Burçin/AAF-6654-2021; Crul, Tim/AAE-8966-2020	Ayaydin, Ferhan/0000-0002-9126-0865; Güngör, Burçin/0000-0001-7725-5835; Crul, Tim/0000-0002-6053-7016; Mates, Lajos/0000-0002-0058-470X	Hungarian Basic Research Fund [OTKA NK100857, K82097, PD109539]; Hungarian National Development Agency [TAMOP-4.2.2.A-11/1/KONV-2012-0073]; New Szechenyi Plan [GOP-1.1.1-11-2012-0147]	Hungarian Basic Research Fund; Hungarian National Development Agency; New Szechenyi Plan	This study was supported by grants from the Hungarian Basic Research Fund (OTKA NK100857, K82097, PD109539), by the Hungarian National Development Agency (TAMOP-4.2.2.A-11/1/KONV-2012-0073) and the New Szechenyi Plan (GOP-1.1.1-11-2012-0147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Aranda JF, 2011, MOL BIOL CELL, V22, P1252, DOI 10.1091/mbc.E10-11-0910; Balogh G, 2005, FEBS J, V272, P6077, DOI 10.1111/j.1742-4658.2005.04999.x; Balogh G, 2013, FEBS LETT; Balogh G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021182; Balogh G, 2010, BBA-MOL CELL BIOL L, V1801, P1036, DOI 10.1016/j.bbalip.2010.04.011; Baritaki S, 2007, ADV CANCER RES, V98, P149, DOI 10.1016/S0065-230X(06)98005-1; Beuthan J, 2004, LASER PHYS, V14, P213; Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; Bustelo Xose R, 2012, Small GTPases, V3, P60, DOI 10.4161/sgtp.19111; Cadenas C, 2012, BBA-MOL CELL BIOL L, V1821, P1256, DOI 10.1016/j.bbalip.2011.11.008; Coakley W T, 1987, Symp Soc Exp Biol, V41, P187; Crul T, 2013, CURR PHARM DESIGN, V19, P309, DOI 10.2174/138161213804143716; Csoboz B, 2013, INT J HYPERTHER, V29, P491, DOI 10.3109/02656736.2013.808765; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; de Gannes FMP, 1998, NEUROCHEM INT, V33, P61, DOI 10.1016/S0197-0186(05)80010-5; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dressler C, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2001674; Escriba PV, 2008, J CELL MOL MED, V12, P829, DOI 10.1111/j.1582-4934.2008.00281.x; Gagat M, 2013, MED BIOL SCI, V27, P19; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gerber M, 2005, J BIOL CHEM, V280, P4017, DOI 10.1074/jbc.C400487200; Gombos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028818; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Han SI, 2001, J BIOL CHEM, V276, P1889, DOI 10.1074/jbc.M006042200; Holubarova A., 2000, SCRIPTA MED BRNO, V73, P381; Horvath I, 1998, P NATL ACAD SCI USA, V95, P3513, DOI 10.1073/pnas.95.7.3513; Horvath I, 2012, PROG LIPID RES, V51, P208, DOI 10.1016/j.plipres.2012.02.002; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063; Lee SC, 2007, PROTEOMICS, V7, P4112, DOI 10.1002/pmic.200700386; Malerba M, 2010, PROTOPLASMA, V239, P23, DOI 10.1007/s00709-009-0078-z; Mates L, 2011, METHODS MOL BIOL, V738, P87, DOI 10.1007/978-1-61779-099-7_6; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Mukherjee A, 2009, J BIOL CHEM, V284, P6486, DOI 10.1074/jbc.M807547200; Nagy E, 2007, P NATL ACAD SCI USA, V104, P7945, DOI 10.1073/pnas.0702557104; Navarro-Lerida I, 2012, EMBO J, V31, P534, DOI 10.1038/emboj.2011.446; Paladino S, 2007, TRAFFIC, V8, P251, DOI 10.1111/j.1600-0854.2006.00522.x; Peter M, 2012, MOL MEMBR BIOL, V29, P274, DOI 10.3109/09687688.2012.680203; Pirkkala L, 2000, MOL CELL BIOL, V20, P2670, DOI 10.1128/MCB.20.8.2670-2675.2000; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Tsai FD, 2012, EMBO J, V31, P517, DOI 10.1038/emboj.2011.481; Velaithan R, 2011, BLOOD, V117, P6214, DOI 10.1182/blood-2010-08-301283; Vigh L, 2005, PROG LIPID RES, V44, P303, DOI 10.1016/j.plipres.2005.08.001; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; Vigh L, 2007, TRENDS BIOCHEM SCI, V32, P357, DOI 10.1016/j.tibs.2007.06.009; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; WIEGANT FAC, 1987, CANCER RES, V47, P1674; Yan Y, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3164; Yuan LP, 2010, CLIN EXP METASTAS, V27, P481, DOI 10.1007/s10585-010-9337-9; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6	54	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89136	10.1371/journal.pone.0089136	http://dx.doi.org/10.1371/journal.pone.0089136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586549	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000331714700066
J	Meckbach, D; Keim, U; Richter, S; Leiter, U; Eigentler, TK; Bauer, J; Pflugfelder, A; Buttner, P; Garbe, C; Weide, B				Meckbach, Diana; Keim, Ulrike; Richter, Sabina; Leiter, Ulrike; Eigentler, Thomas K.; Bauer, Juergen; Pflugfelder, Annette; Buettner, Petra; Garbe, Claus; Weide, Benjamin			BRAF-V600 Mutations Have No Prognostic Impact in Stage IV Melanoma Patients Treated with Monochemotherapy	PLOS ONE			English	Article							BRAF V600E MUTATION; METASTATIC MELANOMA; CUTANEOUS MELANOMA; IMPROVED SURVIVAL; NRAS MUTATIONS; INHIBITION; TUMOR; GENE	Background: The impact of BRAF tumor mutations on the natural course of disease of melanoma patients is controversial. Patients and Methods: We analyzed the mutational status and overall survival of 215 patients receiving treatment with dacarbazine or temozolomide. All patients who started first-line treatment at our institution between 2000 and 2010 were included to prevent selection and bias due to thereafter arising therapeutic options. Results: No patient received BRAF-or MEK-inhibitors during follow-up. Survival was associated with the pattern of visceral involvement, the presence of brain metastases and the serum lactate dehydrogenase level (all p < 0.001). The BRAF-V600 mutational status was not associated with survival and no differences in overall survival were detected according to age, gender or to the cytotoxic agent used for therapy. In Cox regression analysis the presence of brain metastases (hazard ratio 2.3; p < 0.001) and an elevated serum LDH (hazard ratio 2.5; p < 0.001) were the only factors, which independently predicted survival. Conclusions: No differences in prognosis were observed according to the BRAF mutational status in patients with distant metastasis treated with monochemotherapy.	[Meckbach, Diana; Keim, Ulrike; Richter, Sabina; Leiter, Ulrike; Eigentler, Thomas K.; Bauer, Juergen; Pflugfelder, Annette; Garbe, Claus; Weide, Benjamin] Univ Med Ctr Tubingen, Div Dermatooncol, Dept Dermatol, Tubingen, Germany; [Buettner, Petra; Garbe, Claus] James Cook Univ, Skin Canc Res Grp, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Weide, Benjamin] German Canc Res Ctr, Heidelberg, Germany; [Weide, Benjamin] German Canc Consortium DKTK, Heidelberg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; James Cook University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Weide, B (corresponding author), Univ Med Ctr Tubingen, Div Dermatooncol, Dept Dermatol, Tubingen, Germany.	benjamin.weide@med.uni-tuebingen.de	Pflugfelder, Annette/Q-2659-2016; Eigentler, Thomas/K-8570-2015; Weide, Benjamin/N-3698-2013; Keim, Ulrike/C-4938-2017; Garbe, Claus/ABH-2128-2021; Bauer, Jurgen/B-4656-2008	Eigentler, Thomas/0000-0003-0019-2770; Garbe, Claus/0000-0001-8530-780X; Bauer, Jurgen/0000-0001-8789-1536; Keim, Ulrike/0000-0001-7236-0548; Leiter, Ulrike/0000-0002-8019-1577	Roche Pharma AG, Grenzach-Wyhlen, Germany	Roche Pharma AG, Grenzach-Wyhlen, Germany(Roche Holding)	Parts of this study were funded by Roche Pharma AG, Grenzach-Wyhlen, Germany. The study was designed in cooperation with the funding company. The funders had no role in the data collection, data analysis, data interpretation, or decision to publish. The final manuscript was provided to the funding company for notification but was not changed in any relevant part thereafter.	Akslen LA, 2005, J INVEST DERMATOL, V125, P312, DOI 10.1111/j.0022-202X.2005.23788.x; Bauer J, 2011, PIGM CELL MELANOMA R, V24, P345, DOI 10.1111/j.1755-148X.2011.00837.x; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Colombino M, 2012, J CLIN ONCOL, V30, P2522, DOI 10.1200/JCO.2011.41.2452; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Eigentler TK, 2011, CANCER-AM CANCER SOC, V117, P1697, DOI 10.1002/cncr.25631; Ellerhorst JA, 2011, CLIN CANCER RES, V17, P229, DOI 10.1158/1078-0432.CCR-10-2276; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Lasithiotakis KG, 2007, CANCER-AM CANCER SOC, V109, P1174, DOI 10.1002/cncr.22511; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mann GJ, 2013, J INVEST DERMATOL, V133, P509, DOI 10.1038/jid.2012.283; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Moreau S, 2012, ANN SURG ONCOL, V19, P4314, DOI 10.1245/s10434-012-2457-5; Satyamoorthy K, 2003, CANCER RES, V63, P756; Shinozaki M, 2004, CLIN CANCER RES, V10, P1753, DOI 10.1158/1078-0432.CCR-1169-3; Si L, 2012, EUR J CANCER, V48, P94, DOI 10.1016/j.ejca.2011.06.056; von Moos R, 2012, ANN ONCOL, V23, P531, DOI 10.1093/annonc/mdr126	22	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89218	10.1371/journal.pone.0089218	http://dx.doi.org/10.1371/journal.pone.0089218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586605	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700073
J	Bestwick, JP; Huttly, WJ; Morris, JK; Wald, NJ				Bestwick, Jonathan P.; Huttly, Wayne J.; Morris, Joan K.; Wald, Nicholas J.			Prevention of Neural Tube Defects: A Cross-Sectional Study of the Uptake of Folic Acid Supplementation in Nearly Half a Million Women	PLOS ONE			English	Article							FORTIFICATION; REDUCTION	Background: Taking folic acid supplements before pregnancy to reduce the risk of a neural tube defect (NTD) is especially important in countries without universal folic acid fortification. The extent of folic acid supplementation among women who had antenatal screening for Down's syndrome and NTDs at the Wolfson Institute of Preventive Medicine, London between 1999 and 2012 was assessed. Methods and Findings: 466,860 women screened provided details on folic acid supplementation. The proportion of women who took folic acid supplements before pregnancy was determined according to year and characteristics of the women. The proportion of women taking folic acid supplements before pregnancy declined from 35% (95% CI 34%-35%) in 1999-2001 to 31% (30%-31%) in 2011-2012. 6% (5%-6%) of women aged under 20 took folic acid supplements before pregnancy compared with 40% of women aged between 35 and 39. Non-Caucasian women were less likely to take folic acid supplements before pregnancy than Caucasian women; Afro-Caribbean 17% (16%-17%), Oriental 25% (24%-25%) and South Asian 20% (20%-21%) compared with 35% (35%-35%) for Caucasian women. 51% (48%-55%) of women who previously had an NTD pregnancy took folic acid supplements before the current pregnancy. Conclusions: The policy of folic acid supplementation is failing and has led to health inequalities. This study demonstrates the need to fortify flour and other cereal grain with folic acid in all countries of the world.	[Bestwick, Jonathan P.; Huttly, Wayne J.; Morris, Joan K.; Wald, Nicholas J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England	University of London; Queen Mary University London	Wald, NJ (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England.	n.j.wald@qmul.ac.uk	Wald, Nicholas/AAY-2814-2021; Wald, Nicholas/AAY-8924-2021; Morris, Joan/AAT-9211-2020	Morris, Joan/0000-0002-7164-612X				Bayston R, 2008, LANCET, V371, P1335, DOI 10.1016/S0140-6736(08)60591-7; Bayston R, 2007, LANCET, V370, P2004, DOI 10.1016/S0140-6736(07)61861-3; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; *EXP ADV GROUP, 1992, FOL AC PREV NEUR TUB; Flour Fortification Initiative, GLOB PROGR; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; Huttly WJ, 1999, BRIT MED J, V319, P1499, DOI 10.1136/bmj.319.7223.1499; Lopez-Camelo JS, 2005, AM J MED GENET A, V135A, P120, DOI 10.1002/ajmg.a.30651; NHS, 2012, NHS FET AN SCREEN PR; Oakley G P Jr, 1998, Bull World Health Organ, V76 Suppl 2, P116; Ray JG, 2004, BJOG-INT J OBSTET GY, V111, P399, DOI 10.1111/j.1471-0528.2004.00115.x; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; WALD N, 1991, LANCET, V338, P131; Wald NJ, 2001, LANCET, V358, P2069, DOI 10.1016/S0140-6736(01)07104-5; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	16	65	68	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89354	10.1371/journal.pone.0089354	http://dx.doi.org/10.1371/journal.pone.0089354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586711	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900130
J	Yao, JH; Cui, M; Li, MT; Liu, YN; He, QH; Xiao, JJ; Bai, Y				Yao, Jun-Hua; Cui, Ming; Li, Meng-Tao; Liu, Yi-Nan; He, Qi-Hua; Xiao, Jun-Jun; Bai, Yun			Angiopoietin1 Inhibits Mast Cell Activation and Protects against Anaphylaxis	PLOS ONE			English	Article							ALPHA-5-BETA-1 INTEGRIN; TIE2 RECEPTOR; CA2+ CHANNELS; EXPRESSION; KINASE; PHOSPHORYLATION; DEGRANULATION; MEDIATORS; RESPONSES; RELEASE	Since morbidity and mortality rates of anaphylaxis diseases have been increasing year by year, how to prevent and manage these diseases effectively has become an important issue. Mast cells play a central regulatory role in allergic diseases. Angiopoietin1 (Ang-1) exhibits anti-inflammatory properties by inhibiting vascular permeability, leukocyte migration and cytokine production. However, Ang-1's function in mast cell activation and anaphylaxis diseases is unknown. The results of our study suggest that Ang-1 decreased lipopolysaccharide (LPS)-induced pro-inflammatory cytokines production of mast cells by suppressing I kappa B phosphorylation and NF-kappa B nuclear translocation. Ang-1 also strongly inhibited compound 48/80 induced and FceRI-mediated mast cells degranulation by decreasing intracellular calcium levels in vitro. In vivo lentivirus-mediated delivery of Ang-1 in mice exhibited alleviated leakage in IgE-dependent passive cutaneous anaphylaxis (PCA). Furthermore, exogenous Ang-1 intervention treatment prevented mice from compound 48/80-induced mesentery mast cell degranulation, attenuated increases in pro-inflammatory cytokines, relieved lung injury, and improved survival in anaphylaxis shock. The results of our study reveal, for the first time, the important role of Ang-1 in the activation of mast cells, and identify a therapeutic effect of Ang-1 on anaphylaxis diseases.	[Yao, Jun-Hua; Li, Meng-Tao; Liu, Yi-Nan; He, Qi-Hua; Xiao, Jun-Jun; Bai, Yun] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Cell Biol, Beijing 100871, Peoples R China; [Cui, Ming] Peking Univ, Dept Cardiol, Hosp 3, Beijing 100871, Peoples R China	Peking University; Peking University	Bai, Y (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Cell Biol, Beijing 100871, Peoples R China.	baiyun@bjmu.edu.cn	meng, li/GVT-2063-2022		National Natural Sciences Foundation of China [31070948, 81070260, 81272432]; Beijing National Sciences Foundation [7102099]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing National Sciences Foundation	This work is supported by National Natural Sciences Foundation of China (31070948, 81070260, 81272432) and Beijing National Sciences Foundation (7102099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2010, HYPERTENSION, V56, P477, DOI 10.1161/HYPERTENSIONAHA.110.155556; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anand P, 2012, N-S ARCH PHARMACOL, V385, P657, DOI 10.1007/s00210-012-0757-8; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Ashmole I, 2012, J ALLERGY CLIN IMMUN, V129, P1628, DOI 10.1016/j.jaci.2012.01.070; Bai Y, 2009, NEUROSCIENCE, V160, P371, DOI 10.1016/j.neuroscience.2009.01.076; Byrne RD, 2007, CELL SIGNAL, V19, P321, DOI 10.1016/j.cellsig.2006.07.004; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Dallabrida SM, 2005, CIRC RES, V96, DOI 10.1161/01.RES.0000158285.57191.60; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Feistritzer C, 2004, J ALLERGY CLIN IMMUN, V114, P1077, DOI 10.1016/j.jaci.2004.06.045; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gu HP, 2010, BIOCHEM BIOPH RES CO, V392, P178, DOI 10.1016/j.bbrc.2010.01.009; Hayama K, 2011, FREE RADICAL BIO MED, V50, P1417, DOI 10.1016/j.freeradbiomed.2011.02.025; Hughes DP, 2003, CIRC RES, V92, P630, DOI 10.1161/01.RES.0000063422.38690.DC; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ilaria Cascone LN, 2005, J CELL BIOL, V176, P11; Lee JW, 2002, BBA-MOL CELL RES, V1542, P23, DOI 10.1016/S0167-4889(01)00161-6; Lee OH XJ, 2006, MOL CANCER RES, V4, P12; Lim KT, 2010, CELL IMMUNOL, V264, P78, DOI 10.1016/j.cellimm.2010.05.001; Okayama Y, 2005, CHEM IMMUNOL ALLERGY, V87, P101, DOI 10.1159/000087574; PATON WDM, 1951, BRIT J PHARM CHEMOTH, V6, P499, DOI 10.1111/j.1476-5381.1951.tb00661.x; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Simoes DCM, 2008, AM J RESP CRIT CARE, V177, P1314, DOI 10.1164/rccm.200708-1141OC; Sismanopoulos N, 2012, CURR PHARM DESIGN, V18, P2261, DOI 10.2174/138161212800165997; Stone SF, 2012, CURR ALLERGY ASTHM R, V12, P33, DOI 10.1007/s11882-011-0231-6; Sturn DH, 2005, MICROCIRCULATION, V12, P393, DOI 10.1080/10739680590960296; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Swindle EJ, 2002, J IMMUNOL, V169, P5866, DOI 10.4049/jimmunol.169.10.5866; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E; Yang CB, 2012, EXP PHYSIOL, V97, P1315, DOI 10.1113/expphysiol.2012.065854; Yang HW, 2010, CELL PHYSIOL BIOCHEM, V26, P337, DOI 10.1159/000320557; Yoshimaru T, 2009, MOL IMMUNOL, V46, P1267, DOI 10.1016/j.molimm.2008.11.011	40	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89148	10.1371/journal.pone.0089148	http://dx.doi.org/10.1371/journal.pone.0089148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586553	Green Submitted, gold, Green Published			2022-12-27	WOS:000331711900095
J	Carrillo, E; Jimenez, MA; Sanchez, C; Cunha, J; Martins, CM; Seva, AD; Moreno, J				Carrillo, Eugenia; Angeles Jimenez, Ma; Sanchez, Carmen; Cunha, Joana; Martins, Camila Marinelli; Seva, Anaia da Paixao; Moreno, Javier			Protein Malnutrition Impairs the Immune Response and Influences the Severity of Infection in a Hamster Model of Chronic Visceral Leishmaniasis	PLOS ONE			English	Article							CALORIE MALNUTRITION; CANINE LEISHMANIASIS; NITRIC-OXIDE; MICE; NUTRITION; DISEASE; IMMUNOSUPPRESSION; HEMATOPOIESIS; PARAMETERS; VACCINE	Leishmaniasis remains one of the world's most devastating neglected tropical diseases. It mainly affects developing countries, where it often co-exists with chronic malnutrition, one of the main risk factors for developing the disease. Few studies have been published, however, on the relationship between leishmaniasis progression and malnutrition. The present paper reports the influence of protein malnutrition on the immune response and visceral disease development in adult hamsters infected with Leishmania infantum fed either standard or low protein diets. The low protein diet induced severe malnutrition in these animals, and upon infection with L. infantum 33% had severe visceral leishmaniasis compared to only 8% of animals fed the standard diet. The infected, malnourished animals showed notable leukocyte depletion, mild specific antibody responses, impairment of lymphoproliferation, presence of parasites in blood (16.67% of the hamsters) and significant increase of the splenic parasite burden. Animals fed standard diet suffered agranulocytosis and monocytopenia, but showed stronger specific immune responses and had lower parasite loads than their malnourished counterparts. The present results show that protein malnutrition promotes visceral leishmaniasis and provide clues regarding the mechanisms underlying the impairment of the immune system.	[Carrillo, Eugenia; Sanchez, Carmen; Moreno, Javier] Inst Salud Carlos III, WHO Collaborating Ctr Leishmaniasis, Ctr Nacl Microbiol, Madrid, Spain; [Angeles Jimenez, Ma] Univ Complutense Madrid, Fac Vet, Dept Med & Cirugia Anim, Madrid, Spain; [Cunha, Joana] Univ Porto, Inst Ciencias Biomed Abel Salazar, Inst Biol Mol & Celular, P-4100 Oporto, Portugal; [Cunha, Joana] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Martins, Camila Marinelli; Seva, Anaia da Paixao] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, Sao Paulo, Brazil	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Complutense University of Madrid; Universidade do Porto; Universidade do Porto; Universidade de Sao Paulo	Carrillo, E (corresponding author), Inst Salud Carlos III, WHO Collaborating Ctr Leishmaniasis, Ctr Nacl Microbiol, Madrid, Spain.	ecarrillo@isciii.es	Martins, Camila M/K-5356-2016; Moreno, Javier/AAB-5386-2021; Sevá, Anaiá Paixão/J-4538-2013; Carrillo, Eugenia/F-2058-2018; Sevá, Anaiá P/E-9762-2015; Cunha, Joana/O-5847-2015	Sevá, Anaiá Paixão/0000-0001-5203-012X; Carrillo, Eugenia/0000-0002-7869-7915; Sevá, Anaiá P/0000-0001-5203-012X; Cunha, Joana/0000-0003-1445-7477; Moreno, Javier/0000-0003-0087-4659; Jimenez Martinez, Maria Angeles/0000-0001-6352-8978	Fondo de Investigacion Sanitaria [PI10/00829]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III)	This work was funded by project PI10/00829 from the Fondo de Investigacion Sanitaria, http://www.isciii.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159; Anstead GM, 2001, INFECT IMMUN, V69, P4709, DOI 10.1128/IAI.69.8.4709-4718.2001; CARVALHO EM, 1989, J CLIN INVEST, V83, P860, DOI 10.1172/JCI113969; CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030; CHANDRA RK, 1983, LANCET, V1, P688; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cunha J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-122; Dedet J.P.P.F., 2003, MANSONS TROPICAL DIS, V21st; Dondji B, 2008, INFECT IMMUN, V76, P2560, DOI 10.1128/IAI.00094-08; Dusingize JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035079; Faulk W P, 1975, Trop Dis Bull, V72, P89; FLAVELL DJ, 1980, ACTA TROP, V37, P337; Fock RA, 2012, BRAZ J MED BIOL RES, V45, P1163, DOI 10.1590/S0100-879X2012007500151; Garg R, 2006, INDIAN J MED RES, V123, P439; Gomes CMC, 2007, T ROY SOC TROP MED H, V101, P660, DOI 10.1016/j.trstmh.2007.02.017; Gomes-Silva A, 2013, PARASITOLOGY, V140, P771, DOI 10.1017/S0031182012002156; GOMEZ F, 1956, LANCET, V271, P121; Goto H, 2004, BRAZ J MED BIOL RES, V37, P615, DOI 10.1590/S0100-879X2004000400020; GROSS RL, 1980, PHYSIOL REV, V60, P188, DOI 10.1152/physrev.1980.60.1.188; HARRISON LH, 1986, REV INFECT DIS, V8, P447; Jungersen G, 2002, COMP IMMUNOL MICROB, V25, P187, DOI 10.1016/S0147-9571(01)00039-X; KEUSCH GT, 1982, ADV EXP MED BIOL, V135, P183; LAURENTI MD, 1990, INT J EXP PATHOL, V71, P791; LAW DK, 1973, ANN INTERN MED, V79, P545, DOI 10.7326/0003-4819-79-4-545; LIU H, 1990, INFECT IMMUN, V58, P1685, DOI 10.1128/IAI.58.6.1685-1690.1990; Malafaia G, 2009, PARASITE IMMUNOL, V31, P41, DOI 10.1111/j.1365-3024.2008.01069.x; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; Murray HW, 2001, INT J EXP PATHOL, V82, P249, DOI 10.1046/j.1365-2613.2001.00199.x; PEREZ H, 1984, PARASITE IMMUNOL, V6, P285, DOI 10.1111/j.1365-3024.1984.tb00801.x; Pointer E, 2013, J AM ANIM HOSP ASSOC, V49, P101, DOI 10.5326/JAAHA-MS-5762; REDMOND HP, 1991, SURGERY, V110, P311; Requena JM, 2000, VET IMMUNOL IMMUNOP, V76, P269, DOI 10.1016/S0165-2427(00)00221-X; SATYANARAYANA K, 1980, AM J CLIN NUTR, V33, P2334, DOI 10.1093/ajcn/33.11.2334; Scrimshaw NS, 1997, AM J CLIN NUTR, V66, P464; Sideris V, 1999, EUR J EPIDEMIOL, V15, P271, DOI 10.1023/A:1007526401175; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Taylor AK, 2013, J INFECT DIS, V207, P501, DOI 10.1093/infdis/jis527; TROTTER ER, 1980, ANN TROP MED PARASIT, V74, P127, DOI 10.1080/00034983.1980.11687322; World Health Organization, 2002, WORLD HLTH REP; Xavier JG, 2007, HISTOL HISTOPATHOL, V22, P651, DOI 10.14670/HH-22.651; Yan L, 2011, J AM ASSOC LAB ANIM, V50, P488	42	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89412	10.1371/journal.pone.0089412	http://dx.doi.org/10.1371/journal.pone.0089412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586759	Green Published, gold			2022-12-27	WOS:000332385900041
J	Debowski, D; Pikula, M; Lubos, M; Langa, P; Trzonkowski, P; Lesner, A; Legowska, A; Rolka, K				Debowski, Dawid; Pikula, Michal; Lubos, Marta; Langa, Paulina; Trzonkowski, Piotr; Lesner, Adam; Legowska, Anna; Rolka, Krzysztof			Inhibition of Human and Yeast 20S Proteasome by Analogues of Trypsin Inhibitor SFTI-1	PLOS ONE			English	Article							SUNFLOWER SEEDS; NONCOVALENT INHIBITORS; PROTEINASE-INHIBITOR; DRUG DEVELOPMENT; BINDING MODE; TMC-95A; SYSTEM; DESIGN; POTENT; BORTEZOMIB	Starting from the primary structure of sunflower trypsin inhibitor SFTI-1, we designed novel non-covalent inhibitors of human and yeast 20S proteasomes. Peptides with Arg residue in P-1 position and two basic amino acid residues (Lys or/and Arg) in P-2' and P-3' positions strongly inhibited chymotrypsin-like and caspase-like activities, while trypsin-like activity was poorly modified. We found that some SFTI-1 analogues up-regulated exclusively the chymotrypsin-like activity of latent yeast 20S proteasome.	[Debowski, Dawid; Lubos, Marta; Lesner, Adam; Legowska, Anna; Rolka, Krzysztof] Univ Gdansk, Dept Bioorgan Chem, Fac Chem, PL-80952 Gdansk, Poland; [Pikula, Michal; Langa, Paulina; Trzonkowski, Piotr] Med Univ Gdansk, Dept Clin Immunol & Transplantol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Debowski, D (corresponding author), Univ Gdansk, Dept Bioorgan Chem, Fac Chem, PL-80952 Gdansk, Poland.	dawid.debowski@ug.edu.pl	Lesner, Adam/M-2732-2019; Langa, Paulina/AAL-2831-2020; Trzonkowski, Piotr/U-1137-2018	Trzonkowski, Piotr/0000-0001-5287-5210; Lubos, Marta/0000-0002-2919-0085; Lesner, Adam/0000-0001-8335-3431; Legowska, Anna/0000-0003-1665-3180; Rolka, Krzysztof/0000-0002-4537-700X; Debowski, Dawid/0000-0002-5868-3276; Pikula, Michal/0000-0001-7751-9781	Polish National Science Center [UMO-2011/01/D/ST5/02778]	Polish National Science Center	This work was supported by Polish National Science Center (grant No. UMO-2011/01/D/ST5/02778). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajorek M, 2004, CELL MOL LIFE SCI, V61, P1579, DOI 10.1007/s00018-004-4131-y; Basse N, 2007, J MED CHEM, V50, P2842, DOI 10.1021/jm0701324; Blackburn C, 2010, BIOORG MED CHEM LETT, V20, P6581, DOI 10.1016/j.bmcl.2010.09.032; Blackburn C, 2010, BIOCHEM J, V430, P461, DOI 10.1042/BJ20100383; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Britton M, 2009, CHEM BIOL, V16, P1278, DOI 10.1016/j.chembiol.2009.11.015; Carli AD, 2012, FOOD CHEM TOXICOL, V50, P1405, DOI 10.1016/j.fct.2012.01.036; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chen YW, 2005, CARCINOGENESIS, V26, P1296, DOI 10.1093/carcin/bgi062; de Bettignies G, 2010, BIOCHIMIE, V92, P1530, DOI 10.1016/j.biochi.2010.06.023; Debowski D, 2012, PEPTIDES, V35, P276, DOI 10.1016/j.peptides.2012.04.001; Desvergne A, 2013, J MED CHEM, V56, P3367, DOI 10.1021/jm4002007; Formicola L, 2009, BIOORG MED CHEM LETT, V19, P83, DOI 10.1016/j.bmcl.2008.11.012; Furet P, 2004, J MED CHEM, V47, P4810, DOI 10.1021/jm049660v; Furet P, 2001, BIOORG MED CHEM LETT, V11, P1321, DOI 10.1016/S0960-894X(01)00206-2; Gaczynska M, 2003, BIOCHEMISTRY-US, V42, P8663, DOI 10.1021/bi034784f; Gallastegui N, 2012, ANGEW CHEM INT EDIT, V51, P247, DOI 10.1002/anie.201106010; Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005; Grawert MA, 2012, CHEM COMMUN, V48, P1364, DOI 10.1039/c1cc15273d; Groll M, 2005, METHOD ENZYMOL, V398, P329, DOI 10.1016/S0076-6879(05)98027-0; Groll M, 2001, J MOL BIOL, V311, P543, DOI 10.1006/jmbi.2001.4869; Groll M, 2006, CHEM BIOL, V13, P607, DOI 10.1016/j.chembiol.2006.04.005; Groll M, 2010, CHEMMEDCHEM, V5, P1701, DOI 10.1002/cmdc.201000293; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jankowska E, 2010, BIOPOLYMERS, V93, P481, DOI 10.1002/bip.21381; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Kaiser M, 2004, CHEMBIOCHEM, V5, P1256, DOI 10.1002/cbic.200400096; Koguchi Y, 2000, J ANTIBIOT, V53, P105, DOI 10.7164/antibiotics.53.105; Korsinczky MLJ, 2001, J MOL BIOL, V311, P579, DOI 10.1006/jmbi.2001.4887; Lesner A, 2011, CURR PHARM DESIGN, V17, P4308, DOI 10.2174/138161211798999393; Lin SN, 2004, J AM CHEM SOC, V126, P6347, DOI 10.1021/ja049821k; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Marechal X, 2012, EUR J MED CHEM, V52, P322, DOI 10.1016/j.ejmech.2012.02.052; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Saito T, 2007, CANCER LETT, V253, P249, DOI 10.1016/j.canlet.2007.01.021; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SHIBATANI T, 1995, ARCH BIOCHEM BIOPHYS, V321, P160, DOI 10.1006/abbi.1995.1381; Siegel DS, 2012, BLOOD, V120, P2817, DOI 10.1182/blood-2012-05-425934; Steverding D, 2011, EXP PARASITOL, V128, P444, DOI 10.1016/j.exppara.2011.03.015; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Yabe K, 2009, J BIOCHEM, V145, P217, DOI 10.1093/jb/mvn160; Yang ZQ, 2003, CHEMBIOCHEM, V4, P508, DOI 10.1002/cbic.200300560; Zablotna E, 2002, BIOCHEM BIOPH RES CO, V292, P855, DOI 10.1006/bbrc.2002.6746	45	11	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89465	10.1371/journal.pone.0089465	http://dx.doi.org/10.1371/journal.pone.0089465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586798	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900047
J	Jung, RE; Ryman, SG; Vakhtin, AA; Carrasco, J; Wertz, C; Flores, RA				Jung, Rex E.; Ryman, Sephira G.; Vakhtin, Andrei A.; Carrasco, Jessica; Wertz, Chris; Flores, Ranee A.			Subcortical Correlates of Individual Differences in Aptitude	PLOS ONE			English	Article							GRAY-MATTER; INTELLIGENCE; CREATIVITY; SEGMENTATION; PREDICTIONS; PERSONALITY; CIRCUITS	The study of individual differences encompasses broad constructs including intelligence, creativity, and personality. However, substantially less research is devoted to the study of specific aptitudes in spite of their importance to educational, occupational, and avocational success. We sought to determine subcortical brain structural correlates of several broad aptitudes including Math, Vocabulary, Foresight, Paper Folding, and Inductive Reasoning in a large (N = 107), healthy, young (age range = 16-29) cohort. Subcortical volumes were measured using an automated technique (FreeSurfer) across structures including bilateral caudate, putamen, globus pallidus, thalamus, nucleus accumbens, hippocampus, amygdala, and five equal regions of the corpus callosum. We found that performance on measures of each aptitude was predicted by different subcortical structures: Math - higher right nucleus accumbens volume; Vocabulary - higher left hippocampus volume; Paper Folding - higher right thalamus volume; Foresight - lower right thalamus and higher mid anterior corpus callosum volume; Inductive Reasoning - higher mid anterior corpus callosum volume. Our results support general findings, within the cognitive neurosciences, showing lateralization of structure-function relationships, as well as more specific relationships between individual structures (e.g., left hippocampus) and functions relevant to particular aptitudes (e.g., Vocabulary).	[Jung, Rex E.; Wertz, Chris; Flores, Ranee A.] Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA; [Ryman, Sephira G.; Vakhtin, Andrei A.; Carrasco, Jessica] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Jung, RE (corresponding author), Univ New Mexico, Dept Neurosurg, Albuquerque, NM 87131 USA.	rex.jung@gmail.com		Jung, Rex/0000-0003-3718-0597	Johnson O'Connor Research Support Corporation; John Templeton Foundation	Johnson O'Connor Research Support Corporation; John Templeton Foundation	Funding provided by the Johnson O'Connor Research Support Corporation and The John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton GS, 2001, INTELLIGENCE, V29, P263, DOI 10.1016/S0160-2896(01)00066-6; [Anonymous], 1991, CLIN PRACTICE CAREER; Breitenstein C, 2005, NEUROIMAGE, V25, P958, DOI 10.1016/j.neuroimage.2004.12.019; Burgaleta M, 2013, HUMAN BRAIN MAPPING; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CHAKOS MH, 1994, AM J PSYCHIAT, V151, P1430; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Dunai FA, 2001, MIL MED, V166, P422, DOI 10.1093/milmed/166.5.422; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gottfredson LS, 1997, INTELLIGENCE, V24, P1, DOI 10.1016/S0160-2896(97)90010-6; Haier Richard J, 2010, BMC Res Notes, V3, P206, DOI 10.1186/1756-0500-3-206; Haier RJ, 2009, INTELLIGENCE, V37, P136, DOI 10.1016/j.intell.2008.10.011; Han X, 2007, IEEE T MED IMAGING, V26, P479, DOI 10.1109/TMI.2007.893282; Hayes N, 2003, PERS INDIV DIFFER, V34, P723, DOI 10.1016/S0191-8869(02)00057-0; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jung R.E., 2013, FRONT HUM NEUROSCI, P7; JUNG RE, 2010, PLOS ONE, V5; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Lyons IM, 2012, CEREB CORTEX, V22, P2102, DOI 10.1093/cercor/bhr289; O'Boyle MW, 2005, COGNITIVE BRAIN RES, V25, P583, DOI 10.1016/j.cogbrainres.2005.08.004; PREDIGER DJ, 1989, J VOCAT BEHAV, V34, P1, DOI 10.1016/0001-8791(89)90061-4; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; RICHARDS R, 1988, J PERS SOC PSYCHOL, V54, P476, DOI 10.1037/0022-3514.54.3.476; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; Schmahmann JD, 2003, STROKE, V34, P2264, DOI 10.1161/01.STR.0000087786.38997.9E; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schroeder David H, 2012, BMC Res Notes, V5, P242, DOI 10.1186/1756-0500-5-242; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; STRICKER LJ, 1993, J EDUC PSYCHOL, V85, P710, DOI 10.1037/0022-0663.85.4.710; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Van der Werf YD, 2000, NEUROPSYCHOLOGIA, V38, P613, DOI 10.1016/S0028-3932(99)00104-9; Wright CI, 2007, NEUROIMAGE, V35, P263, DOI 10.1016/j.neuroimage.2006.11.039	43	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89425	10.1371/journal.pone.0089425	http://dx.doi.org/10.1371/journal.pone.0089425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586770	gold, Green Submitted, Green Published			2022-12-27	WOS:000332385900043
J	Kim, HJ; Chang, KA; Ha, TY; Kim, J; Ha, S; Shin, KY; Moon, C; Nacken, W; Kim, HS; Suh, YH				Kim, Hee Jin; Chang, Keun-A; Ha, Tae-Young; Kim, Jeonga; Ha, Sungji; Shin, Ki-Young; Moon, Cheil; Nacken, Wolfgang; Kim, Hye-Sun; Suh, Yoo-Hun			S100A9 Knockout Decreases the Memory Impairment and Neuropathology in Crossbreed Mice of Tg2576 and S100A9 Knockout Mice Model	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; A-BETA; ALZHEIMERS-DISEASE; MOUSE MODEL; EXPRESSION; PLAQUES; BRAIN; AGE; INFLAMMATION; PATHOGENESIS	Our previous study presented evidence that the inflammation-related S100A9 gene is significantly upregulated in the brains of Alzheimer's disease (AD) animal models and human AD patients. In addition, experiments have shown that knockdown of S100A9 expression improves cognition function in AD model mice (Tg2576), and these animals exhibit reduced amyloid plaque burden. In this study, we established a new transgenic animal model of AD by crossbreeding the Tg2576 mouse with the S100A9 knockout (KO) mouse. We observed that S100A9KO/Tg2576 (KO/Tg) mice displayed an increased spatial reference memory in the Morris water maze task and Y-maze task as well as decreased amyloid beta peptide (Ab) neuropathology because of reduced levels of A beta, C-terminal fragments of amyloid precursor protein (APP-CT) and phosphorylated tau and increased expression of anti-inflammatory IL-10 and also decreased expression of inflammatory IL-6 and tumor neurosis factor (TNF)-alpha when compared with age-matched S100A9WT/Tg2576 (WT/Tg) mice. Overall, these results suggest that S100A9 is responsible for the neurodegeneration and cognitive deficits in Tg2576 mice. The mechanism of S100A9 is able to coincide with the inflammatory process. These findings indicate that knockout of S100A9 is a potential target for the pharmacological therapy of AD.	[Kim, Hee Jin; Ha, Tae-Young; Kim, Jeonga; Shin, Ki-Young; Kim, Hye-Sun; Suh, Yoo-Hun] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Dept Pharmacol,MRC, Seoul, South Korea; [Kim, Hee Jin; Suh, Yoo-Hun] Korea Brain Res Inst, Taegu, South Korea; [Chang, Keun-A; Ha, Sungji] Gachon Univ Med & Sci, Dept Pharmacol, Inchon, South Korea; [Moon, Cheil] DGIST, Taegu, South Korea; [Nacken, Wolfgang] Univ Munster, Ctr Mol Biol Inflammat, Inst Mol Virol, D-48149 Munster, Germany	Seoul National University (SNU); Korea Brain Research Institute (KBRI); Gachon University; Daegu Gyeongbuk Institute of Science & Technology (DGIST); University of Munster	Suh, YH (corresponding author), Seoul Natl Univ, Coll Med, Neurosci Res Inst, Dept Pharmacol,MRC, Seoul, South Korea.	yhsuh@kbri.re.kr	Shin, Ki Young/AAG-4861-2020		Conversing Research Center Program [2012K001350]; Basic Science Research Program through the National Research Foundation of Korea (NRF) [2012R1A1A2020118]; Ministry of Education, Science and Technology, the Republic of Korea; Establishment and Operation of Korea Brain Research Institute (KBRI) Basic Research Program of the Ministry of Science, Ict & future Planning [2031-415]	Conversing Research Center Program; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Establishment and Operation of Korea Brain Research Institute (KBRI) Basic Research Program of the Ministry of Science, Ict & future Planning	This research was supported by the Conversing Research Center Program (2012K001350) and Basic Science Research Program (2012R1A1A2020118) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, the Republic of Korea and also supported by the Establishment and Operation of Korea Brain Research Institute (KBRI) Basic Research Program of the Ministry of Science, Ict & future Planning (2031-415). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Apelt J, 2001, BRAIN RES, V894, P21, DOI 10.1016/S0006-8993(00)03176-0; Avila J, 2002, MOL NEUROBIOL, V25, P213, DOI 10.1385/MN:25:3:213; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Boom A, 2004, BBA-MOL CELL RES, V1742, P161, DOI 10.1016/j.bbamcr.2004.09.011; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chang KA, 2012, NEURODEGENER DIS, V10, P27, DOI 10.1159/000333781; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Eggers K, 2011, EXP CLIN ENDOCR DIAB, V119, P353, DOI 10.1055/s-0030-1268426; Ferrer I., 2005, Current Alzheimer Research, V2, P3, DOI 10.2174/1567205052772713; Fritz G, 2010, FEBS J, V277, P4578, DOI 10.1111/j.1742-4658.2010.07887.x; Giannakopoulos Panteleimon, 2009, V24, P20, DOI 10.1159/000197881; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Ha TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008840; HIGGINS LS, 1994, ANN NEUROL, V35, P598, DOI 10.1002/ana.410350514; Hoyaux D, 2000, BRAIN RES, V867, P280, DOI 10.1016/S0006-8993(00)02393-3; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jung BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033312; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kayed R, 2012, J ALZHEIMERS DIS; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Li YK, 1998, J NEUROCHEM, V71, P1421; Liu JL, 2011, ARCH MED RES, V42, P1, DOI 10.1016/j.arcmed.2011.01.005; Liu L, 2005, J NEUROCHEM, V92, P546, DOI 10.1111/j.1471-4159.2004.02909.x; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Masliah E, 2001, J NEUROPATH EXP NEUR, V60, P357, DOI 10.1093/jnen/60.4.357; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mehlhorn G, 2000, INT J DEV NEUROSCI, V18, P423, DOI 10.1016/S0736-5748(00)00012-5; Mellins ED, 2011, NAT REV RHEUMATOL, V7, P416, DOI 10.1038/nrrheum.2011.68; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Nacken W, 2005, INT J BIOCHEM CELL B, V37, P1241, DOI 10.1016/j.biocel.2004.12.008; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Querfurth HW, 2010, NEW ENGL J MED, V362, P1844; Roltsch E, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-78; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; SHEN Z, 1990, PHYSIOL BEHAV, V48, P515, DOI 10.1016/0031-9384(90)90292-C; Sheng JG, 1997, J NEUROPATH EXP NEUR, V56, P285, DOI 10.1097/00005072-199703000-00007; Shepherd CE, 2006, NEUROBIOL AGING, V27, P1554, DOI 10.1016/j.neurobiolaging.2005.09.033; Shin KY, 2007, J NEUROSCI RES, V85, P2500, DOI 10.1002/jnr.21397; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Tomidokoro Y, 2001, J PATHOL, V194, P500, DOI 10.1002/path.897; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562	58	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88924	10.1371/journal.pone.0088924	http://dx.doi.org/10.1371/journal.pone.0088924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586443	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900019
J	Zhang, HX; Li, X; Huo, HQ; Liang, P; Zhang, JP; Ge, WH				Zhang, Hai-Xia; Li, Xin; Huo, Hai-Qin; Liang, Pei; Zhang, Jin-Ping; Ge, Wei-Hong			Pharmacist Interventions for Prophylactic Antibiotic Use in Urological Inpatients Undergoing Clean or Clean-Contaminated Operations in a Chinese Hospital	PLOS ONE			English	Article							CARE; INFECTIONS; GUIDELINES; COMMUNITY; OUTCOMES; SURGERY; TURKEY	Objectives: To evaluate the impact and cost-benefit value of pharmacist interventions for prophylactic antibiotic use in surgical patients undergoing clean or clean-contaminated operations. Methods: A pre-to-post intervention study was performed in the Department of Urological Surgery of a tertiary hospital. Patients admitted from January through June 2011, undergoing clean or clean-contaminated surgery, served as the pre-intervention group; patients admitted from January through June 2012 formed the post-intervention group. Pharmacist interventions were performed for the surgeries in the post-intervention group. The criteria for the rational use of antibiotic prophylaxis were established by the hospital administration. The pharmacist interventions included real-time monitoring of medical records and controlling of the prescriptions of prophylactic antibiotics against the criteria. The pre- and post-intervention groups were then compared to evaluate the outcomes of the pharmacist interventions. A cost-benefit analysis was performed to determine the economic effects of implementing the pharmacist intervention on preoperative antibiotic prophylaxis. Results: After the pharmacist intervention, a significant decrease was found in the rate of no indications for prophylactic antibiotic use (p = 0.004), the rate of broad-spectrum antibiotic use (p<0.001), the rate of drug replacement (p<0.001) and the rate of prolonged duration of prophylaxis (p<0.001). Significant reductions were observed in the mean antibiotic cost (p<0.001), the mean duration of antibiotic prophylaxis (p<0.001) and the mean number of antibiotics used (p<0.001). A significant increase was observed in the rate of correct choice of antibiotics (p<0.001). The ratio of the net mean cost savings for antibiotics to the mean cost of pharmacist time was approximately 18.79:1. Conclusion: Real-time interventions provided by a clinical pharmacist promoted rational use of prophylactic antibiotics, with a significant reduction in antibiotic costs, thus leading to favorable economic outcomes.	[Zhang, Hai-Xia; Liang, Pei; Zhang, Jin-Ping; Ge, Wei-Hong] Nanjing Univ Med Sch, Affiliated Drum Tower Hosp, Dept Pharm, Nanjing, Jiangsu, Peoples R China; [Li, Xin; Huo, Hai-Qin] Nanjing Med Univ, Sch Pharm, Dept Clin Pharm, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Li, X (corresponding author), Nanjing Med Univ, Sch Pharm, Dept Clin Pharm, Nanjing, Jiangsu, Peoples R China.	xinli@njmu.edu.cn; 6221230@sina.com	zhang, jin/GXV-9154-2022	Li, Xin/0000-0003-3951-8061	National Natural Science Foundation of China [71003055, G0308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant No. 71003055, G0308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, AM J HEALTH-SYST PH, V56, P1839; Antibiotic Writing Group, 2010, THER GUID ANT; Burke JP, 2001, CLIN INFECT DIS, V33, pS78, DOI 10.1086/321861; Chisholm MA, 2000, CLIN TRANSPLANT, V14, P304, DOI 10.1034/j.1399-0012.2000.140405.x; Choi WS, 2007, INFECT CONT HOSP EP, V28, P997, DOI 10.1086/519180; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Demir T, 2013, INT J INFECT DIS, V17, pE966, DOI 10.1016/j.ijid.2013.04.005; den Heijer CDJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060497; Ding H, 2008, PHARM WORLD SCI, V30, P787, DOI 10.1007/s11096-008-9220-9; Elbur AI, 2013, INT J CLIN PHARM-NET, V35, P149, DOI 10.1007/s11096-012-9719-y; Erbay A, 2005, J HOSP INFECT, V59, P53, DOI 10.1016/j.jhin.2004.07.026; Hand K, 2007, J ANTIMICROB CHEMOTH, V60, pI73, DOI 10.1093/jac/dkm163; Harbarth S, 2000, CIRCULATION, V101, P2916, DOI 10.1161/01.CIR.101.25.2916; [胡明 HU Ming], 2009, [中国药房, China Pharmacy], V20, P1030; Jiang L, 2010, CHIN J NOSOCOMIO, V1, P91296; Linares L, 2008, AM J TRANSPLANT, V8, P1000, DOI 10.1111/j.1600-6143.2008.02197.x; Ludbrook J, 2008, INT J EPIDEMIOL, V37, P1430, DOI 10.1093/ije/dyn162; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Martin C, 1998, J HOSP INFECT, V40, P47, DOI 10.1016/S0195-6701(98)90024-X; National Health and Family Planning Commission of the People's Republic of China, 2011, NOT REG NAT SPEC MEA; National Health and Family Planning Commission of the People's Republic of China, 2004, NATL MED J CHINA, V84, P2016; PAGE CP, 1993, ARCH SURG-CHICAGO, V128, P410; Pestotnik SL, 1996, ANN INTERN MED, V124, P884, DOI 10.7326/0003-4819-124-10-199605150-00004; Scottish Intercollegiate Guidelines Network, 2008, SCOTT INT GUID NETW; Shen J, 2011, INT J CLIN PHARM-NET, V33, P929, DOI 10.1007/s11096-011-9577-z; Shi QP, 2013, INT J CLIN PHARM TH, V51, P704, DOI 10.5414/CP201895; Stevenson KB, 2004, AM J HEALTH-SYST PH, V61, P787, DOI 10.1093/ajhp/61.8.787; Vessal C., 2011, Eastern Mediterranean Health Journal, V17, P663; von Gunten V, 2007, PHARM WORLD SCI, V29, P146, DOI 10.1007/s11096-006-9042-6; Weller TMA, 2004, J ANTIMICROB CHEMOTH, V54, P295, DOI 10.1093/jac/dkh327; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604; Zhang Yan, 2006, Aust New Zealand Health Policy, V3, P5, DOI 10.1186/1743-8462-3-5	32	25	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88971	10.1371/journal.pone.0088971	http://dx.doi.org/10.1371/journal.pone.0088971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586465	gold, Green Submitted, Green Published			2022-12-27	WOS:000332385900023
J	Enserink, R; Scholts, R; Bruijning-Verhagen, P; Duizer, E; Vennema, H; de Boer, R; Kortbeek, T; Roelfsema, J; Smit, H; Kooistra-Smid, M; van Pelt, W				Enserink, Remko; Scholts, Rianne; Bruijning-Verhagen, Patricia; Duizer, Erwin; Vennema, Harry; de Boer, Richard; Kortbeek, Titia; Roelfsema, Jeroen; Smit, Henriette; Kooistra-Smid, Mirjam; van Pelt, Wilfrid			High Detection Rates of Enteropathogens in Asymptomatic Children Attending Day Care	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; ROTAVIRUS GASTROENTERITIS; DIENTAMOEBA-FRAGILIS; ENTERIC VIRUSES; CENTERS; SURVEILLANCE; NOROVIRUS; BURDEN; TRANSMISSION; INFECTIONS	Background: Gastroenteritis morbidity is high among children under the age of four, especially amongst those who attend day care. Objective: To determine the prevalence of a range of enteropathogens in the intestinal flora of children attending day care and to relate their occurrence with characteristics of the sampled child and the sampling season. Methods: We performed three years of enteropathogen surveillance in a network of 29 child day care centers in the Netherlands. The centers were instructed to take one fecal sample from ten randomly chosen children each month, regardless of gastrointestinal symptoms at time of sampling. All samples were analyzed for the molecular detection of 16 enteropathogenic bacteria, parasites and viruses by real-time multiplex PCR. Results: Enteropathogens were detected in 78.0% of the 5197 fecal samples. Of the total, 95.4% of samples were obtained from children who had no gastroenteritis symptoms at time of sampling. Bacterial enteropathogens were detected most often (most prevalent EPEC, 19.9%), followed by parasitic enteropathogens (most prevalent: D. fragilis, 22.1%) and viral enteropathogens (most prevalent: norovirus, 9.5%). 4.6% of samples related to children that experienced symptoms of gastroenteritis at time of sampling. Only rotavirus and norovirus were significantly associated with gastroenteritis among day care attendees. Conclusions: Our study indicates that asymptomatic infections with enteropathogens in day care attendees are not a rare event and that gastroenteritis caused by infections with these enteropathogens is only one expression of their presence.	[Enserink, Remko; Bruijning-Verhagen, Patricia; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Epidemiol & Surveillance Unit, Bilthoven, Netherlands; [Duizer, Erwin; Vennema, Harry; Kortbeek, Titia; Roelfsema, Jeroen] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Lab Infect Dis & Perinatal Screening, Bilthoven, Netherlands; [Enserink, Remko; Bruijning-Verhagen, Patricia; Smit, Henriette] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Scholts, Rianne; de Boer, Richard; Kooistra-Smid, Mirjam] Dept Res & Dev, Infect Dis Lab, Groningen, Netherlands; [Kooistra-Smid, Mirjam] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; University of Groningen	Enserink, R (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Epidemiol & Surveillance Unit, Bilthoven, Netherlands.	remko.enserink@rivm.nl	Bruijning-Verhagen, Patricia C.J.L./E-4134-2015	Bruijning-Verhagen, Patricia C.J.L./0000-0003-4105-9669	Dutch National Institute for Public Health and the Environment (RIVM)	Dutch National Institute for Public Health and the Environment (RIVM)	This paper presents independent research commissioned by the Dutch National Institute for Public Health and the Environment (RIVM) and has been internally financed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayukekbong J, 2011, J MED VIROL, V83, P2135, DOI 10.1002/jmv.22243; BUTZ AM, 1990, AM J INFECT CONTROL, V18, P347, DOI 10.1016/0196-6553(90)90248-Q; Carman WF, 2007, SAMJ S AFR MED J, V97, P1169; de Boer RF, 2010, J MICROBIOL METH, V83, P59, DOI 10.1016/j.mimet.2010.07.017; de Boer RF, 2010, J CLIN MICROBIOL, V48, P4140, DOI 10.1128/JCM.01124-10; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; de Wit MAS, 2001, CLIN INFECT DIS, V33, P280, DOI 10.1086/321875; Doorduyn Y, 2012, EPIDEMIOL INFECT, V140, P1185, DOI 10.1017/S0950268811001099; Enserink R, 2013, PEDIATR INFECT DIS J, V32, pE334, DOI 10.1097/INF.0b013e318290601e; Enserink R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-259; FERGUSON JK, 1995, MED J AUSTRALIA, V163, P137, DOI 10.5694/j.1326-5377.1995.tb127962.x; Fogarty J, 1996, IRISH MED J, V89, P210; Friesema IHM, 2012, EUR J CLIN MICROBIOL, V31, P405, DOI 10.1007/s10096-011-1320-0; Gallimore CI, 2004, J CLIN MICROBIOL, V42, P2271, DOI 10.1128/JCM.42.5.2271-2274.2004; Grimprel E, 2010, HUM VACCINES, V6, P399, DOI 10.4161/hv.6.5.11021; GUERRANT RL, 1990, REV INFECT DIS, V12, pS41; Gunson R N, 2003, Commun Dis Public Health, V6, P63; HJELT K, 1987, ACTA PAEDIATR SCAND, V76, P763, DOI 10.1111/j.1651-2227.1987.tb10562.x; Huskins WC, 2000, PEDIATR INFECT DIS J, V19, pS106, DOI 10.1097/00006454-200010001-00004; Lyman WH, 2009, J PEDIATR-US, V154, P253, DOI 10.1016/j.jpeds.2008.07.057; Nagata N, 2012, INT J PARASITOL-DRUG, V2, P204, DOI 10.1016/j.ijpddr.2012.08.002; Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63; Ferreira MSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033754; RODRIGUEZ WJ, 1979, J INFECT DIS, V140, P353, DOI 10.1093/infdis/140.3.353; Sukhrie FHA, 2012, CLIN INFECT DIS, V54, P931, DOI 10.1093/cid/cir971; Svraka S, 2009, J CLIN MICROBIOL, V47, P1674, DOI 10.1128/JCM.00307-09; Van der Wielen M, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-22; Verweij JJ, 2007, MOL CELL PROBE, V21, P400, DOI 10.1016/j.mcp.2007.05.006; Verweij JJ, 2004, J CLIN MICROBIOL, V42, P1220, DOI 10.1128/JCM.42.3.1220-1223.2004	29	57	60	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89496	10.1371/journal.pone.0089496	http://dx.doi.org/10.1371/journal.pone.0089496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586825	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700053
J	Porta, A; Faes, L; Bari, V; Marchi, A; Bassani, T; Nollo, G; Perseguini, NM; Milan, J; Minatel, V; Borghi-Silva, A; Takahashi, ACM; Catai, AM				Porta, Alberto; Faes, Luca; Bari, Vlasta; Marchi, Andrea; Bassani, Tito; Nollo, Giandomenico; Perseguini, Natalia Maria; Milan, Juliana; Minatel, Vinicius; Borghi-Silva, Audrey; Takahashi, Anielle C. M.; Catai, Aparecida M.			Effect of Age on Complexity and Causality of the Cardiovascular Control: Comparison between Model-Based and Model-Free Approaches	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; BLOOD-PRESSURE VARIABILITY; SYSTOLIC ARTERIAL-PRESSURE; LEFT-VENTRICULAR FUNCTION; HEART PERIOD VARIABILITY; SHORT-TERM COMPLEXITY; TIME-SERIES; CONDITIONAL ENTROPY; SYSTEM-IDENTIFICATION; DISEASE ENTERPRISES	The proposed approach evaluates complexity of the cardiovascular control and causality among cardiovascular regulatory mechanisms from spontaneous variability of heart period (HP), systolic arterial pressure (SAP) and respiration (RESP). It relies on construction of a multivariate embedding space, optimization of the embedding dimension and a procedure allowing the selection of the components most suitable to form the multivariate embedding space. Moreover, it allows the comparison between linear model-based (MB) and nonlinear model-free (MF) techniques and between MF approaches exploiting local predictability (LP) and conditional entropy (CE). The framework was applied to study age-related modifications of complexity and causality in healthy humans in supine resting (REST) and during standing (STAND). We found that: 1) MF approaches are more efficient than the MB method when nonlinear components are present, while the reverse situation holds in presence of high dimensional embedding spaces; 2) the CE method is the least powerful in detecting age-related trends; 3) the association of HP complexity on age suggests an impairment of cardiac regulation and response to STAND; 4) the relation of SAP complexity on age indicates a gradual increase of sympathetic activity and a reduced responsiveness of vasomotor control to STAND; 5) the association from SAP to HP on age during STAND reveals a progressive inefficiency of baroreflex; 6) the reduced connection from HP to SAP with age might be linked to the progressive exploitation of Frank-Starling mechanism at REST and to the progressive increase of peripheral resistances during STAND; 7) at REST the diminished association from RESP to HP with age suggests a vagal withdrawal and a gradual uncoupling between respiratory activity and heart; 8) the weakened connection from RESP to SAP with age might be related to the progressive increase of left ventricular thickness and vascular stiffness and to the gradual decrease of respiratory sinus arrhythmia.	[Porta, Alberto] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Porta, Alberto] Galeazzi Orthoped Inst, Milan, Italy; [Faes, Luca] Univ Trento, Dept Phys, Trento, Italy; [Faes, Luca] Univ Trento, BIOtech, Trento, Italy; [Bari, Vlasta] Grp Osped San Donato Fdn, Milan, Italy; [Bari, Vlasta; Marchi, Andrea] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Marchi, Andrea] Humanitas Clin & Res Ctr, Dept Anesthesia & Intens Care, Rozzano, Italy; [Bassani, Tito] Humanitas Clin & Res Ctr, Rozzano, Italy; [Nollo, Giandomenico] Univ Trento, Dept Ind Engn, BIOtech, Trento, Italy; [Nollo, Giandomenico] IRCS PAT FBK, Trento, Italy; [Perseguini, Natalia Maria; Milan, Juliana; Minatel, Vinicius; Borghi-Silva, Audrey; Takahashi, Anielle C. M.; Catai, Aparecida M.] Univ Fed Sao Carlos, Dept Physiotherapy, BR-13560 Sao Carlos, SP, Brazil	University of Milan; IRCCS Istituto Ortopedico Galeazzi; University of Trento; University of Trento; IRCCS Policlinico San Donato; Polytechnic University of Milan; IRCCS Humanitas Research Hospital; IRCCS Humanitas Research Hospital; University of Trento; Fondazione Bruno Kessler; Universidade Federal de Sao Carlos	Porta, A (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.	alberto.porta@unimi.it	Catai, Aparecida Maria/G-4612-2012; Marchi, Andrea/J-7205-2016; Takahashi, Anielle C M/B-5957-2012; Bassani, Tito/B-2050-2017; Minatel, Vinicius/I-5157-2017; Faes, Luca/E-5156-2012; Porta, Alberto/K-4390-2016; Borghi-Silva, Audrey/F-5702-2012; Takahashi, Anielle C M/I-5880-2014; Bari, Vlasta/J-8591-2016	Marchi, Andrea/0000-0001-5846-4164; Takahashi, Anielle C M/0000-0003-1263-2833; Bassani, Tito/0000-0003-3312-1565; Minatel, Vinicius/0000-0002-0916-2546; Faes, Luca/0000-0002-3271-5348; Porta, Alberto/0000-0002-6720-9824; Borghi-Silva, Audrey/0000-0002-3891-6941; Takahashi, Anielle C M/0000-0003-1263-2833; Bari, Vlasta/0000-0002-5346-2677; Nollo, Giandomenico/0000-0002-9837-083X	Sao Paulo Foundation for Research Support/Brazil (FAPESP) [2010/52070-4]; CAPES [AUXPE-CSF-PVES-2619/2013, 23028.007721/2013-41]	Sao Paulo Foundation for Research Support/Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Sao Paulo Foundation for Research Support/Brazil (FAPESP, process number 2010/52070-4), and CAPES (AUXPE-CSF-PVES-2619/2013 process number 23028.007721/2013-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARBANEL HDI, 1994, PHYS REV E, V49, P1840, DOI 10.1103/PhysRevE.49.1840; Ahmed MU, 2012, IEEE SIGNAL PROC LET, V19, P91, DOI 10.1109/LSP.2011.2180713; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Barnett SR, 1999, HYPERTENSION, V33, P1195, DOI 10.1161/01.HYP.33.5.1195; Baselli G, 2006, IEEE T BIO-MED ENG, V53, P53, DOI 10.1109/TBME.2005.859787; BASELLI G, 1994, MED BIOL ENG COMPUT, V32, P143, DOI 10.1007/BF02518911; Beckers F, 2006, AM J PHYSIOL-HEART C, V290, pH2560, DOI 10.1152/ajpheart.00903.2005; BERTINIERI G, 1985, J HYPERTENS, V3, pS79; Blinowska KJ, 2011, MED BIOL ENG COMPUT, V49, P521, DOI 10.1007/s11517-011-0739-x; BORST C, 1983, J AUTONOM NERV SYST, V9, P399, DOI 10.1016/0165-1838(83)90004-8; Caiani EG, 2000, PHYSIOL MEAS, V21, P175, DOI 10.1088/0967-3334/21/1/321; Camm AJ, 1996, CIRCULATION, V93, P1043; Chen YH, 2004, PHYS LETT A, V324, P26, DOI 10.1016/j.physleta.2004.02.032; Cohen MA, 2002, J PHYSIOL-LONDON, V542, P669, DOI 10.1113/jphysiol.2002.017483; Cooke WH, 1999, J PHYSIOL-LONDON, V517, P617, DOI 10.1111/j.1469-7793.1999.0617t.x; Di Rienzo M, 2001, AM J PHYSIOL-REG I, V280, pR744, DOI 10.1152/ajpregu.2001.280.3.R744; Eckberg DL, 2003, J PHYSIOL-LONDON, V548, P339, DOI 10.1113/jphysiol.2002.037192; ECKBERG DL, 1976, J PHYSIOL-LONDON, V258, P769, DOI 10.1113/jphysiol.1976.sp011445; Eichler M, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0613; ELLIOTT HL, 1982, J CARDIOVASC PHARM, V4, P388, DOI 10.1097/00005344-198205000-00008; ESLER MD, 1995, CIRCULATION, V91, P351, DOI 10.1161/01.CIR.91.2.351; Faes L, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051112; FARMER JD, 1987, PHYS REV LETT, V59, P845, DOI 10.1103/PhysRevLett.59.845; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; GILBEY MP, 1984, J PHYSIOL-LONDON, V356, P65, DOI 10.1113/jphysiol.1984.sp015453; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; HRUSHESKY WJM, 1984, SCIENCE, V224, P1001, DOI 10.1126/science.6372092; Iatsenko D, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0622; INNES JA, 1993, J PHYSIOL-LONDON, V460, P487, DOI 10.1113/jphysiol.1993.sp019483; Javorka M, 2008, CLIN NEUROPHYSIOL, V119, P1071, DOI 10.1016/j.clinph.2007.12.017; Jones PP, 2003, CIRCULATION, V107, P1770, DOI 10.1161/01.CIR.0000057811.86187.88; KAPLAN DT, 1991, BIOPHYS J, V59, P945, DOI 10.1016/S0006-3495(91)82309-8; KELLY J, 1984, CLIN SCI, V66, P509, DOI 10.1042/cs0660509; Koepchen H.P., 1991, PHYSL RHYTHMS CONTRO, P3; Laitinen T, 1999, AM J PHYSIOL-HEART C, V276, pH1245, DOI 10.1152/ajpheart.1999.276.4.H1245; Laitinen T, 2004, J APPL PHYSIOL, V96, P2333, DOI 10.1152/japplphysiol.00444.2003; Laitinen T, 1998, J APPL PHYSIOL, V84, P576, DOI 10.1152/jappl.1998.84.2.576; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; Larson ED, 2013, P NATL ACAD SCI USA, V110, P18011, DOI 10.1073/pnas.1308477110; LIPSITZ LA, 1995, CHAOS, V5, P102, DOI 10.1063/1.166091; Mullen TJ, 1997, AM J PHYSIOL-HEART C, V272, pH448, DOI 10.1152/ajpheart.1997.272.1.H448; Nemati S, 2013, RESP PHYSIOL NEUROBI, V189, P27, DOI 10.1016/j.resp.2013.06.016; Nollo G, 2002, AM J PHYSIOL-HEART C, V283, pH1200, DOI 10.1152/ajpheart.00882.2001; OBRIEN IAD, 1986, BRIT HEART J, V55, P348; Pikkujamsa SM, 1999, CIRCULATION, V100, P393, DOI 10.1161/01.CIR.100.4.393; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Porta A, 2000, IEEE T BIO-MED ENG, V47, P1555, DOI 10.1109/10.887936; Porta A, 1998, BIOL CYBERN, V78, P71, DOI 10.1007/s004220050414; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Porta A, 2013, PHYSIOL MEAS, V34, P17, DOI 10.1088/0967-3334/34/1/17; Porta A, 2012, J APPL PHYSIOL, V113, P1810, DOI 10.1152/japplphysiol.00755.2012; Porta A, 2007, J APPL PHYSIOL, V103, P1143, DOI 10.1152/japplphysiol.00293.2007; Porta A, 2007, IEEE T BIO-MED ENG, V54, P94, DOI 10.1109/TBME.2006.883789; Porta A, 2014, FRONT NEUROENG, P223; Porta A, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0517; Porta A, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0161; Porta A, 2012, IEEE T BIO-MED ENG, V59, P832, DOI 10.1109/TBME.2011.2180379; Porta A, 2012, COMPUT BIOL MED, V42, P298, DOI 10.1016/j.compbiomed.2011.04.019; Porta A, 2011, AM J PHYSIOL-REG I, V300, pR378, DOI 10.1152/ajpregu.00553.2010; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riedl M, 2013, EUR PHYS J-SPEC TOP, V222, P249, DOI 10.1140/epjst/e2013-01862-7; RODEHEFFER RJ, 1984, CIRCULATION, V69, P203, DOI 10.1161/01.CIR.69.2.203; Runge J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.258701; SAUL JP, 1991, AM J PHYSIOL, V261, pH1231, DOI 10.1152/ajpheart.1991.261.4.H1231; Schelter B, 2009, J NEUROSCI METH, V179, P121, DOI 10.1016/j.jneumeth.2009.01.006; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Seals DR, 2000, J PHYSIOL-LONDON, V528, P407, DOI 10.1111/j.1469-7793.2000.00407.x; Soderstrom T., 1988, SYSTEM IDENTIFICATIO; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Takahashi ACM, 2012, INTERN EMERG MED, V7, P229, DOI 10.1007/s11739-011-0512-z; Takahashi DY, 2007, J APPL STAT, V34, P1259, DOI 10.1080/02664760701593065; THEILER J, 1986, PHYS REV A, V34, P2427, DOI 10.1103/PhysRevA.34.2427; Neves LMT, 2012, HEART LUNG, V41, P137, DOI 10.1016/j.hrtlng.2011.07.010; TOSKA K, 1993, J PHYSIOL-LONDON, V472, P501, DOI 10.1113/jphysiol.1993.sp019958; TRIEDMAN JK, 1995, AM J PHYSIOL-HEART C, V268, pH2232, DOI 10.1152/ajpheart.1995.268.6.H2232; Turianikova Z, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/9/006; VEERMAN DP, 1994, HYPERTENSION, V24, P120, DOI 10.1161/01.HYP.24.1.120; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Viola AU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019002; Vlachos I, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016207; Xiao XS, 2005, PHYSIOL MEAS, V26, pR41, DOI 10.1088/0967-3334/26/3/R01; YANA K, 1993, IEEE T BIO-MED ENG, V40, P74, DOI 10.1109/10.204773; ZIEGLER MG, 1976, NATURE, V261, P333, DOI 10.1038/261333a0	90	64	64	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89463	10.1371/journal.pone.0089463	http://dx.doi.org/10.1371/journal.pone.0089463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586796	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700048
J	Shemesh, A; Abdulla, A; Yang, FJ; Chua, SC; Pessin, JE; Zong, HH				Shemesh, Adi; Abdulla, Arian; Yang, Fajun; Chua, Streamson C.; Pessin, Jeffrey E.; Zong, Haihong			The Antidepressant Trans-2-Phenylcyclopropylamine Protects Mice from High-Fat-Diet-Induced Obesity	PLOS ONE			English	Article							NORADRENALINE; METABOLISM; INHIBITORS	Mice treated with the antidepressant trans-2-phenylcyclopropylamine (2-PCPA) were protected against diet-induced-obesity, and adiposity was reversed in pre-established diet-induced obese mice. Contrary to a recent report that inhibition of lysine-specific demethylase-1 by 2-PCPA results in increased energy expenditure, long-term 2-PCPA treatment had no such effect but its protection against obesity was associated with increased spontaneous locomotor activity, Moreover, pair feeding to assure equal caloric intake in wild type mice as well as in genetic hyperphagic mice (ob/ob) also resulted in weight reduction in 2-PCPA treated mice that correlated with increased activity but no change in energy expenditure. Similarly, short-term intraperitoneal injections of 2-PCPA did not affect food intake but caused a substantial increase in locomotor activity in the light cycle that correlated with increased energy expenditure, whereas activity and energy expenditure were unchanged in the dark cycle. Lastly, 2-PCPA was also effective in reducing obesity in genetic UCP1 null mice. These data suggest that 2-PCPA can reduce obesity by decreasing food intake in the long term while increasing activity in the short-term. However, the protective and weight loss effects of 2-PCPA are independent of UCP1-regulated thermogenesis or basal energy expenditure.	[Shemesh, Adi; Pessin, Jeffrey E.; Zong, Haihong] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Abdulla, Arian; Yang, Fajun] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Yang, Fajun; Chua, Streamson C.; Pessin, Jeffrey E.; Zong, Haihong] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zong, HH (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	haihong.zong@einstein.yu.edu	Abdulla, Arian/AAK-7722-2020	Abdulla, Arian/0000-0001-5024-030X	National Institutes of Health [DK033823]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033823, R01DK098439, R01DK093623, R37DK033823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institutes of Health (Grant Number: DK033823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; DULLOO AG, 1984, BRIT J NUTR, V52, P179, DOI 10.1079/BJN19840087; GENTIL V, 1978, BRIT J CLIN PHARMACO, V5, P536, DOI 10.1111/j.1365-2125.1978.tb01672.x; Hino S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1755; HOLTZMAN S, 1971, PSYCHOPHARMACOLOGIA, V22, P151, DOI 10.1007/BF00403623; JONES BE, 1972, BRAIN RES, V39, P121, DOI 10.1016/0006-8993(72)90789-5; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; MORY G, 1984, FEBS LETT, V166, P393, DOI 10.1016/0014-5793(84)80120-9; Riederer P, 2004, CURR MED CHEM, V11, P2033, DOI 10.2174/0929867043364775; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1	10	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89199	10.1371/journal.pone.0089199	http://dx.doi.org/10.1371/journal.pone.0089199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586592	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900061
J	Tracy, JL; Beall, AT				Tracy, Jessica L.; Beall, Alec T.			The Impact of Weather on Women's Tendency to Wear Red or Pink when at High Risk for Conception	PLOS ONE			English	Article							CONCEALED OVULATION; MENSTRUAL-CYCLE; FEMALE; ATTRACTIVENESS; EVOLUTION; COLOR; FERTILITY; BEHAVIOR; IMPRESS; CHOICE	Women are particularly motivated to enhance their sexual attractiveness during their most fertile period, and men perceive shades of red, when associated with women, as sexually attractive. Building on this research, we recently found that women are more likely to wear reddish clothing when at peak fertility (Beall & Tracy, 2013), presumably as a way of increasing their attractiveness. Here, we first report results from a methodological replication, conducted during warmer weather, which produced a null effect. Investigating this discrepancy, we considered the impact of a potentially relevant contextual difference between previous research and the replication: current weather. If the red-dress effect is driven by a desire to increase one's sexual appeal, then it should emerge most reliably when peak-fertility women have few alternative options for accomplishing this goal (e. g., wearing minimal clothing). Results from re-analyses of our previously collected data and a new experiment support this account, by demonstrating that the link between fertility and red/pink dress emerges robustly in cold, but not warm, weather. Together, these findings suggest that the previously documented red-dress effect is moderated by current climate concerns, and provide further evidence that under certain circumstances red/pink dress is reliably associated with female fertility.	[Tracy, Jessica L.; Beall, Alec T.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Tracy, JL (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	jltracy@psych.ubc.ca			Social Science and Humanitites Research Council of Canada [410-2009-2458]; Michael Smith Foundation for Health Research [CI-SCH-01862(07-1)]; Canada Institute for Health Research [FRN: 123255]	Social Science and Humanitites Research Council of Canada; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Institute for Health Research(Canadian Institutes of Health Research (CIHR))	The authors have received funding from the Social Science and Humanitites Research Council of Canada (#410-2009-2458), the Michael Smith Foundation for Health Research (CI-SCH-01862(07-1) and a Canada Institute for Health Research new investigator award and operating grant (FRN: 123255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam M. M., 2006, J MARK COMMUN, V12, P15, DOI DOI 10.1080/13527260500247827; Baker AH, 1998, PSYCHOL HEALTH, V13, P897, DOI 10.1080/08870449808407439; Beall AT, 2013, PSYCHOL SCI, V24, P1837, DOI 10.1177/0956797613476045; BEAN JA, 1979, AM J EPIDEMIOL, V109, P181, DOI 10.1093/oxfordjournals.aje.a112673; BIELERT C, 1989, J ZOOL, V219, P569, DOI 10.1111/j.1469-7998.1989.tb02601.x; Bryant GA, 2009, BIOL LETTERS, V5, P12, DOI 10.1098/rsbl.2008.0507; BURLEY N, 1979, AM NAT, V114, P835, DOI 10.1086/283532; Butler Greenfield, 2005, PERFECT RED EMPIRE E; Diamond J, 1992, 3 CHIMPANZEE EVOLUTI; Domb LG, 2001, NATURE, V410, P204, DOI 10.1038/35065597; Durante KM, 2008, PERS SOC PSYCHOL B, V34, P1451, DOI 10.1177/0146167208323103; Durante KM, 2011, J CONSUM RES, V37, P921, DOI 10.1086/656575; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Elliot AJ, 2013, J EXP SOC PSYCHOL, V49, P165, DOI 10.1016/j.jesp.2012.07.017; Elliot AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034607; Gerald MS, 2003, SEXUAL SELECTION REP, P141; Grammer K, 2004, J SEX RES, V41, P66, DOI 10.1080/00224490409552214; Haselton MG, 2007, HORM BEHAV, V51, P40, DOI 10.1016/j.yhbeh.2006.07.007; Haselton MG, 2011, CURR DIR PSYCHOL SCI, V20, P87, DOI 10.1177/0963721411402668; Haselton MG, 2006, HORM BEHAV, V49, P509, DOI 10.1016/j.yhbeh.2005.10.006; Little AC, 2008, PERS INDIV DIFFER, V45, P478, DOI 10.1016/j.paid.2008.05.024; Miller SL, 2011, J PERS SOC PSYCHOL, V100, P295, DOI 10.1037/a0020930; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pawlowski B, 1999, CURR ANTHROPOL, V40, P257, DOI 10.1086/200017; Penton-Voak IS, 2000, EVOL HUM BEHAV, V21, P39, DOI 10.1016/S1090-5138(99)00033-1; Prokop P, 2013, ETHOLOGY, V119, P605, DOI 10.1111/eth.12102; Puts DA, 2013, HORM BEHAV, V63, P13, DOI 10.1016/j.yhbeh.2012.11.007; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; SILLENTULLBERG B, 1993, AM NAT, V141, P1, DOI 10.1086/285458; Waitt C, 2006, AM J PRIMATOL, V68, P738, DOI 10.1002/ajp.20264; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301	31	18	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88852	10.1371/journal.pone.0088852	http://dx.doi.org/10.1371/journal.pone.0088852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3VI	24586414	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900031
J	Burns, TA; Dours-Zimmermann, MT; Zimmermann, DR; Krug, EL; Comte-Walters, S; Reyes, L; Davis, MA; Schey, KL; Schwacke, JH; Kern, CB; Mjaatvedt, CH				Burns, Tara A.; Dours-Zimmermann, Maria T.; Zimmermann, Dieter R.; Krug, Edward L.; Comte-Walters, Susana; Reyes, Leticia; Davis, Monica A.; Schey, Kevin L.; Schwacke, John H.; Kern, Christine B.; Mjaatvedt, Corey H.			Imbalanced Expression of Vcan mRNA Splice Form Proteins Alters Heart Morphology and Cellular Protein Profiles	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; MOUSE PG-M; EXTRACELLULAR-MATRIX; DILATED CARDIOMYOPATHY; PROTEOLYTIC CLEAVAGE; VERSICAN CLEAVAGE; EMBRYONIC HEART; PERIOSTIN; GENE; CELLS	The fundamental importance of the proteoglycan versican to early heart formation was clearly demonstrated by the Vcan null mouse called heart defect (hdf). Total absence of the Vcan gene halts heart development at a stage prior to the heart's pulmonary/aortic outlet segment growth. This creates a problem for determining the significance of versican's expression in the forming valve precursors and vascular wall of the pulmonary and aortic roots. This study presents data from a mouse model, Vcan((tm1Zim)), of heart defects that results from deletion of exon 7 in the Vcan gene. Loss of exon 7 prevents expression of two of the four alternative splice forms of the Vcan gene. Mice homozygous for the exon 7 deletion survive into adulthood, however, the inability to express the V2 or V0 forms of versican results in ventricular septal defects, smaller cushions/valve leaflets with diminished myocardialization and altered pulmonary and aortic outflow tracts. We correlate these phenotypic findings with a large-scale differential protein expression profiling to identify compensatory alterations in cardiac protein expression at E13.5 post coitus that result from the absence of Vcan exon 7. The Vcan (tm1Zim) hearts show significant changes in the relative abundance of several cytoskeletal and muscle contraction proteins including some previously associated with heart disease. These alterations define a protein fingerprint that provides insight to the observed deficiencies in pre-valvular/septal cushion mesenchyme and the stability of the myocardial phenotype required for alignment of the outflow tract with the heart ventricles.	[Burns, Tara A.; Krug, Edward L.; Reyes, Leticia; Davis, Monica A.; Schwacke, John H.; Kern, Christine B.; Mjaatvedt, Corey H.] Med Univ S Carolina, Dept Regenerat Med, Charleston, SC 29425 USA; [Burns, Tara A.; Krug, Edward L.; Reyes, Leticia; Davis, Monica A.; Schwacke, John H.; Kern, Christine B.; Mjaatvedt, Corey H.] Med Univ S Carolina, Dept Cell Biol, Charleston, SC 29425 USA; [Comte-Walters, Susana] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Dours-Zimmermann, Maria T.; Zimmermann, Dieter R.] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Schey, Kevin L.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of Zurich; University Zurich Hospital; Vanderbilt University	Mjaatvedt, CH (corresponding author), Med Univ S Carolina, Dept Regenerat Med, Charleston, SC 29425 USA.	mjaatvch@musc.edu		Krug, Edward/0000-0002-4345-6580	NIH NHLBI [66231]; American Heart Association; NIH NHLBI Cardiovascular Proteomics Center [N01-HV-28282]; NIH NCRR [C06 RR018823]; Swiss National Science Foundation; Velux Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NIH NHLBI Cardiovascular Proteomics Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation(Velux Fonden); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH NHLBI 66231 and American Heart Association Grant-in Aid to CHM; NIH NHLBI Cardiovascular Proteomics Center (contract N01-HV-28282; to ELK and KLS); NIH NCRR C06 RR018823 (to ELK); and grants from the Swiss National Science Foundation and Velux Foundation (to MTD-Z and DRZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200; ASAMI I, 1995, DEVELOPMENTAL MECHANISMS OF HEART DISEASE, P255; Bartram U, 2001, CIRCULATION, V103, P2745; Besson D, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.009712-1, 10.1074/mcp.M111.009712]; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; Brito FC, 2008, PIGM CELL MELANOMA R, V21, P464, DOI 10.1111/j.1755-148X.2008.00459.x; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camors E, 2005, CARDIOVASC RES, V65, P793, DOI 10.1016/j.cardiores.2004.11.010; Cheng HQ, 2011, HUM MOL GENET, V20, P1751, DOI 10.1093/hmg/ddr050; Conway SJ, 2008, CURR GENOMICS, V9, P548, DOI 10.2174/138920208786847917; Dours-Zimmermann MT, 2009, J NEUROSCI, V29, P7731, DOI 10.1523/JNEUROSCI.4158-08.2009; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Finsterer J, 2004, J AM COLL CARDIOL, V44, P1139, DOI 10.1016/j.jacc.2004.06.007; GALLANTI A, 1992, ACTA NEUROPATHOL, V85, P88, DOI 10.1007/BF00304637; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Gillan L, 2002, CANCER RES, V62, P5358; Graham LV, 2010, J BIOL CHEM, V285, P7067, DOI 10.1074/jbc.M109.006841; Grant JE, 2009, J PROTEOME RES, V8, P4252, DOI 10.1021/pr900297f; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Grewal T, 2006, BIOESSAYS, V28, P1211, DOI 10.1002/bies.20503; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Hatano S, 2012, GLYCOBIOLOGY, V22, P1268, DOI 10.1093/glycob/cws095; Henderson DJ, 1998, CIRC RES, V83, P523, DOI 10.1161/01.RES.83.5.523; Hill EG, 2008, J PROTEOME RES, V7, P3091, DOI 10.1021/pr070520u; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; Jonnsson-Rylander AC, 2005, ARTERIOSCL THROM VAS, V25, P180, DOI 10.1161/01.ATV.0000150045.27127.37; Kenagy RD, 2006, TRENDS CARDIOVAS MED, V16, P209, DOI 10.1016/j.tcm.2006.03.011; Kern CB, 2005, ANAT REC PART A, V284A, P415, DOI 10.1002/ar.a.20193; Kern CB, 2007, DEV DYNAM, V236, P671, DOI 10.1002/dvdy.21059; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; KRUITHOF BP, 2006, DEV BIOL; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Lemire JM, 1999, ARTERIOSCL THROM VAS, V19, P1630, DOI 10.1161/01.ATV.19.7.1630; Milev P, 1998, BIOCHEM BIOPH RES CO, V247, P207, DOI 10.1006/bbrc.1998.8759; Miller CE, 2005, MICROSC MICROANAL, V11, P216, DOI 10.1017/S1431927605050464; Mjaatvedt CH, 2005, ANAT REC PART A, V285A, P748, DOI 10.1002/ar.a.20210; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Mjaatvedt CH, 1999, HEART DEV, P159; Moore CS, 1998, DEV DYNAM, V212, P548, DOI 10.1002/(SICI)1097-0177(199808)212:4<548::AID-AJA8>3.0.CO;2-H; Mukhopadhyay A, 2006, INVEST OPHTH VIS SCI, V47, P3565, DOI 10.1167/iovs.06-0141; NAG AC, 1986, CYTOBIOS, V45, P195; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; NASO MF, 1994, J BIOL CHEM, V269, P32999; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; Phillips HM, 2007, CIRC RES, V101, P137, DOI 10.1161/CIRCRESAHA.106.142406; Phillips HM, 2005, CIRC RES, V96, P292, DOI 10.1161/01.RES.0000154912.08695.88; Poelmann RE, 1999, DEV BIOL, V207, P271, DOI 10.1006/dbio.1998.9166; Rahmani M, 2006, CAN J PHYSIOL PHARM, V84, P77, DOI 10.1139/Y05-154; Reissner KJ, 2011, J NEUROSCI, V31, P5648, DOI 10.1523/JNEUROSCI.3452-10.2011; Rhee DY, 2009, DEVELOPMENT, V136, P3185, DOI 10.1242/dev.032334; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; RUNYAN RB, 1983, DEV BIOL, V95, P108, DOI 10.1016/0012-1606(83)90010-6; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwacke JH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-342; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; SHINOMURA T, 1995, J BIOL CHEM, V270, P10328, DOI 10.1074/jbc.270.17.10328; Snarr BS, 2007, DEV DYNAM, V236, P1287, DOI 10.1002/dvdy.21074; Takagi H, 2002, J CELL SCI, V115, P3309; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; van den Hoff MJB, 2005, CIRC RES, V96, P274, DOI 10.1161/01.RES.0000157574.65952.b8; van den Hoff MJB, 1999, DEV BIOL, V212, P477, DOI 10.1006/dbio.1999.9366; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Visconti RP, 2006, CIRC RES, V98, P690, DOI 10.1161/01.RES.0000207384.81818.d4; Waller BR, 2000, ANAT REC, V260, P279, DOI 10.1002/1097-0185(20001101)260:3<279::AID-AR65>3.0.CO;2-2; Webb S, 1999, CIRC RES, V84, P897; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Wirrig EE, 2007, DEV BIOL, V310, P291, DOI 10.1016/j.ydbio.2007.07.041; Yamamura H, 1997, DEV BIOL, V186, P58, DOI 10.1006/dbio.1997.8559; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Zhao XJ, 2005, MOL VIS, V11, P603; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	86	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89133	10.1371/journal.pone.0089133	http://dx.doi.org/10.1371/journal.pone.0089133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586547	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000331714700065
J	Edsall, SC; Franz-Odendaal, TA				Edsall, Sara C.; Franz-Odendaal, Tamara A.			An Assessment of the Long-Term Effects of Simulated Microgravity on Cranial Neural Crest Cells in Zebrafish Embryos with a Focus on the Adult Skeleton	PLOS ONE			English	Article							DANIO-RERIO; GENE-EXPRESSION; MUSCLE; LARVAE; BONE; MORPHOGENESIS; OSSIFICATION; PLASTICITY; VERTEBRATE; NOTOCHORD	It is becoming increasingly important to address the long-term effects of exposure to simulated microgravity as the potential for space tourism and life in space become prominent topics amongst the World's governments. There are several studies examining the effects of exposure to simulated microgravity on various developmental systems and in various organisms; however, few examine the effects beyond the juvenile stages. In this study, we expose zebrafish embryos to simulated microgravity starting at key stages associated with cranial neural crest cell migration. We then analyzed the skeletons of adult fish. Gross observations and morphometric analyses show that exposure to simulated microgravity results in stunted growth, reduced ossification and severe distortion of some skeletal elements. Additionally, we investigated the effects on the juvenile skull and body pigmentation. This study determines for the first time the long-term effects of embryonic exposure to simulated microgravity on the developing skull and highlights the importance of studies investigating the effects of altered gravitational forces.	[Franz-Odendaal, Tamara A.] Mt St Vincent Univ, Dept Biol, Halifax, NS B3M 2J6, Canada; [Edsall, Sara C.] Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS, Canada	Mount Saint Vincent University; Dalhousie University	Franz-Odendaal, TA (corresponding author), Mt St Vincent Univ, Dept Biol, Halifax, NS B3M 2J6, Canada.	tamara.franz-odendaal@msvu.ca		Franz-Odendaal, Tamara/0000-0003-4883-2677	Canadian Space Agency [9F007-07123]; Natural Sciences and Engineering Research Council of Canada [328376]	Canadian Space Agency(Canadian Space Agency); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by the Canadian Space Agency (9F007-07123) and the Natural Sciences and Engineering Research Council of Canada (Discovery Grant: 328376 to TFO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 2000, J APPL PHYSIOL, V88, P894, DOI 10.1152/jappl.2000.88.3.894; Adriaens D, 1998, J MORPHOL, V235, P183, DOI 10.1002/(SICI)1097-4687(199803)235:3<183::AID-JMOR2>3.0.CO;2-8; Albertson RC, 2007, DEV BIOL, V306, P505, DOI 10.1016/j.ydbio.2007.03.025; BALDWIN KM, 1990, FASEB J, V4, P79, DOI 10.1096/fasebj.4.1.2136840; Carvalho AP, 2006, AQUAC RES, V37, P1107, DOI 10.1111/j.1365-2109.2006.01534.x; Chai Y, 2000, DEVELOPMENT, V127, P1671; Cleaver O, 2001, DEV BIOL, V234, P1, DOI 10.1006/dbio.2001.0214; Connolly MH, 2008, INT J DEV BIOL, V52, P71, DOI 10.1387/ijdb.062241mc; COULY GF, 1993, DEVELOPMENT, V117, P409; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Diogo R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-24; Dufton M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050308; Fleming A, 2001, J ANAT, V199, P177, DOI 10.1017/S0021878201008044; Franz-Odendaal TA, 2008, DEV DYNAM, V237, P3240, DOI 10.1002/dvdy.21754; Franz-Odendaal TA, 2007, J EXP ZOOL PART B, V308B, P709, DOI 10.1002/jez.b.21185; Gillette-Ferguson I, 2003, ADV SPACE RES-SERIES, V32, P1641, DOI 10.1016/S0273-1177(03)90405-4; Goolish EM, 1999, J FISH BIOL, V55, P1054, DOI 10.1006/jfbi.1999.1110; Gualandris-Parisot L, 2001, ADV SPACE RES, V28, P569, DOI 10.1016/S0273-1177(01)00384-2; HIKIDA RS, 1989, AVIAT SPACE ENVIR MD, V60, P664; Inobe M, 2002, J APPL PHYSIOL, V92, P1936, DOI 10.1152/japplphysiol.00742.2001; Jiang JX, 2007, FRONT BIOSCI-LANDMRK, V12, P1450, DOI 10.2741/2159; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kimmel CB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009475; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Lindsey BW, 2011, J EXP ZOOL PART A, V315A, P302, DOI 10.1002/jez.677; Moorman SJ, 2002, DEV DYNAM, V223, P285, DOI 10.1002/dvdy.10052; Moorman SJ, 1999, J NEUROBIOL, V38, P247, DOI 10.1002/(SICI)1097-4695(19990205)38:2<247::AID-NEU7>3.3.CO;2-V; NEFF AW, 1993, DEV BIOL, V155, P270, DOI 10.1006/dbio.1993.1024; Onal U, 2000, AQUACULT NUTR, V6, P159; Pourquie O, 2001, ANNU REV CELL DEV BI, V17, P311, DOI 10.1146/annurev.cellbio.17.1.311; Quigley AK, 2004, DEVELOPMENT, V131, P6053, DOI 10.1242/dev.01526; Renn J, 2006, PROTOPLASMA, V229, P209, DOI 10.1007/s00709-006-0215-x; Schilling TF, 2001, DEV BIOL, V231, P201, DOI 10.1006/dbio.2000.9997; SEROVA LV, 1982, KOSM BIOL AVIAK MED+, V16, P62; Shimada N, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-10; Shiraki T, 2010, PHOTOCH PHOTOBIO SCI, V9, P1498, DOI 10.1039/c0pp00199f; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558	38	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89296	10.1371/journal.pone.0089296	http://dx.doi.org/10.1371/journal.pone.0089296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586670	gold, Green Submitted, Green Published			2022-12-27	WOS:000331714700093
J	Li, YH; Wang, FY; Feng, CQ; Yang, XF; Sun, YH				Li, Yan-hui; Wang, Feng-yun; Feng, Chun-qing; Yang, Xia-feng; Sun, Yi-hua			Massage Therapy for Fibromyalgia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							CONNECTIVE-TISSUE MASSAGE; ALTERNATIVE MEDICINE; COMPLEMENTARY; MANAGEMENT; CLASSIFICATION; COSTS; WOMEN; PAIN	Background: Although some studies evaluated the effectiveness of massage therapy for fibromyalgia (FM), the role of massage therapy in the management of FM remained controversial. Objective: The purpose of this systematic review is to evaluate the evidence of massage therapy for patients with FM. Methods: Electronic databases (up to June 2013) were searched to identify relevant studies. The main outcome measures were pain, anxiety, depression, and sleep disturbance. Two reviewers independently abstracted data and appraised risk of bias. The risk of bias of eligible studies was assessed based on Cochrane tools. Standardised mean difference (SMD) and 95% confidence intervals (CI) were calculated by more conservative random-effects model. And heterogeneity was assessed based on the I 2 statistic. Results: Nine randomized controlled trials involving 404 patients met the inclusion criteria. The meta-analyses showed that massage therapy with duration >= 5 weeks significantly improved pain (SMD, 0.62; 95% CI 0.05 to 1.20; p = 0.03), anxiety (SMD, 0.44; 95% CI 0.09 to 0.78; p = 0.01), and depression (SMD, 0.49; 95% CI 0.15 to 0.84; p = 0.005) in patients with FM, but not on sleep disturbance (SMD, 0.19; 95% CI 20.38 to 0.75; p = 0.52). Conclusion: Massage therapy with duration >= 5 weeks had beneficial immediate effects on improving pain, anxiety, and depression in patients with FM. Massage therapy should be one of the viable complementary and alternative treatments for FM. However, given fewer eligible studies in subgroup meta-analyses and no evidence on follow-up effects, large-scale randomized controlled trials with long follow-up are warrant to confirm the current findings.	[Li, Yan-hui; Wang, Feng-yun; Feng, Chun-qing; Yang, Xia-feng; Sun, Yi-hua] Liaocheng Peoples Hosp, Dept Rehabil, Liaocheng, Shandong, Peoples R China		Wang, FY (corresponding author), Liaocheng Peoples Hosp, Dept Rehabil, Liaocheng, Shandong, Peoples R China.	fengyunwangdr@163.com						Alnigenis MNY, 2001, J MUSCULOSKELET PAIN, V9, P55, DOI 10.1300/J094v09n02_05; Bannwarth B, 2009, JOINT BONE SPINE, V76, P184, DOI 10.1016/j.jbspin.2008.06.002; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; Branco JC, 2010, SEMIN ARTHRITIS RHEU, V39, P448, DOI 10.1016/j.semarthrit.2008.12.003; Brattberg G, 1999, EUR J PAIN, V3, P235, DOI 10.1016/S1090-3801(99)90050-2; Bronfort Gert, 2010, Chiropr Osteopat, V18, P3, DOI 10.1186/1746-1340-18-3; Carville SF, 2008, ANN RHEUM DIS, V67, P536, DOI 10.1136/ard.2007.071522; Citak-Karakaya I, 2009, J MANIP PHYSIOL THER, V29, P524; Da Silva GD, 2007, J ALTERN COMPLEM MED, V13, P1107, DOI 10.1089/acm.2007.0615; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Ekici G, 2009, J MANIP PHYSIOL THER, V32, P127, DOI 10.1016/j.jmpt.2008.12.001; Ernst E, 2008, RHEUM DIS CLIN N AM, V34, P455, DOI 10.1016/j.rdc.2008.03.007; Field T, 2002, JCR-J CLIN RHEUMATOL, V8, P72, DOI 10.1097/00124743-200204000-00002; Field T.M., 1997, J CHRONIC FATIGUE SY, V3, P43, DOI [10.1300/J092v03n03_03, DOI 10.1300/J092V03N03_03]; Ge HY, 2010, J PAIN, V11, P644, DOI 10.1016/j.jpain.2009.10.006; GOATS GC, 1994, BRIT J SPORT MED, V28, P153, DOI 10.1136/bjsm.28.3.153; GOLDBERG J, 1992, PHYS THER, V72, P449, DOI 10.1093/ptj/72.6.449; Hauser W, 2010, EUR J PAIN, V14, P5, DOI 10.1016/j.ejpain.2009.01.006; Hauser W, 2009, DTSCH ARZTEBL INT, V106, P383, DOI 10.3238/arztebl.2009.0383; Imamura M., 2012, EVIDENCEBASED MANAGE, P216; Kalichman L, 2010, RHEUMATOL INT, V30, P1151, DOI 10.1007/s00296-010-1409-2; Kong LJ, 2011, ARTHRITIS RHEUM-US, V63, pS747; Lidbeck Jan, 2002, Pain Res Manag, V7, P81; Lund I, 2006, NEUROSCI LETT, V403, P166, DOI 10.1016/j.neulet.2006.04.038; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Castro-Sanchez AM, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/561753; Rossy LA, 1999, ANN BEHAV MED, V21, P180, DOI 10.1007/BF02908299; Sagar SM, 2008, CURR ONCOL, V15, P42, DOI 10.3747/co.2008.197; Stiller C, 2006, EFFECT THERAPEUTIC T; Sunshine W, 1996, J Clin Rheumatol, V2, P18, DOI 10.1097/00124743-199602000-00005; Terhorst L, 2011, J MANIP PHYSIOL THER, V34, P483, DOI 10.1016/j.jmpt.2011.05.006; Terry R, 2012, CLIN RHEUMATOL, V31, P55, DOI 10.1007/s10067-011-1783-5; Thompson JM, 2011, AM J PHYS MED REHAB, V90, P40, DOI 10.1097/PHM.0b013e3181fc7ff3; Topbas M, 2005, SCAND J RHEUMATOL, V34, P140, DOI 10.1080/03009740510026337; Wang CC, 2010, NEW ENGL J MED, V363, P743, DOI 10.1056/NEJMoa0912611; Wang J, 2010, CHIN J TRADIT MED SC, V17, P72; White LA, 2008, J OCCUP ENVIRON MED, V50, P13, DOI 10.1097/JOM.0b013e31815cff4b; Winkelmann A, 2012, SCHMERZ, V26, P276, DOI 10.1007/s00482-012-1171-3; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	39	24	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89304	10.1371/journal.pone.0089304	http://dx.doi.org/10.1371/journal.pone.0089304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586677	Green Submitted, gold, Green Published			2022-12-27	WOS:000331714700097
J	Wang, ZF; Yan, R; He, HQ; Li, Q; Chen, GH; Yang, SX; Chen, EF				Wang, Zhifang; Yan, Rui; He, Hanqing; Li, Qian; Chen, Guohua; Yang, Shengxu; Chen, Enfu			Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination	PLOS ONE			English	Article							EPIDEMIC; CHINA	Background: The reported coverage of the measles-rubella (MR) or measles-mumps-rubella (MMR) vaccine is greater than 99.0% in Zhejiang province. However, the incidence of measles, mumps, and rubella remains high. In this study, we assessed MMR seropositivity and disease distribution by age on the basis of the current vaccination program, wherein the first dose of MR is administered at 8 months and the second dose of MMR is administered at 18-24 months. Methods: Cross-sectional serological surveys of MMR antibodies were conducted by collecting epidemiological data in Zhejiang province, China in 2011. In total, 1015 participants were randomly selected from two surveillance sites. Serum MMR-specific immunoglobulin G levels were tested by enzyme-linked immunosorbent assay. The geometric mean titers and seroprevalence with 95% confidence intervals (CIs) were calculated by age and gender. Proportions of different dose of vaccine by age by vaccine were also identified. Statistically significant differences between categories were assessed by the Chi-square test. Results: Over 95% seroprevalence rates of measles were seen in all age groups except <7 months infants. Children aged 59 years were shown lower seropositivity rates of mumps while elder adolescences and young adults were presented lower rubella seroprevalence. Especially, rubella seropositivity was significantly lower in female adults than in male. Nine measles cases were unvaccinated or unknown vaccination history. Among them, 66.67% (6/9) patients were aged 20-29 years while 33.33% (3/9) were infants aged 8-12 months. In addition, 57.75% (648/1122) patients with mumps were children aged 5-9 years, and 50.54% (94/186) rubella cases were aged 15-39 years. Conclusions: A timely two-dose MMR vaccination schedule is recommended, with the first dose at 8 months and the second dose at 18-24 months. An MR vaccination speed-up campaign may be necessary for elder adolescents and young adults, particularly young females.	[Wang, Zhifang; Yan, Rui; He, Hanqing; Li, Qian; Chen, Enfu] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Chen, Guohua] Cixi City Ctr Dis Control & Prevent, Ningbo, Zhejiang, Peoples R China; [Yang, Shengxu] Sanmen Cty Ctr Dis Control & Prevent, Sanmen, Taizhou, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Chen, EF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	enfchen@cdc.zj.cn	he, hanqing/AAZ-7376-2020		Zhejiang Province Project for Medical and Health Science and Technology [2012ZDA008]	Zhejiang Province Project for Medical and Health Science and Technology	This work was supported by a grant from Zhejiang Province Project for Medical and Health Science and Technology (No.2012ZDA008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P349; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P50; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P976; Fan CX, 2007, ZHONGGUO YI MIAO HE, V13, P457; Fu CX, 2010, VACCINE, V28, P8219, DOI 10.1016/j.vaccine.2010.07.071; Hanaoka M, 2013, VACCINE, V31, P2343, DOI 10.1016/j.vaccine.2013.03.012; Hu Jia-Yu, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P645; Li X, 2012, PUBLIC HEALTH, V126, P1017, DOI 10.1016/j.puhe.2012.07.011; Liu SJ, 2013, HUM VACC IMMUNOTHER, V9, P1296, DOI 10.4161/hv.24032; Liu YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066771; Muhsen K, 2011, VACCINE, V29, P3878, DOI 10.1016/j.vaccine.2011.03.047; Poethko MC, 2012, PLOS ONE, V7, DOI [10.1371/journal.-pone.0042867, DOI 10.1371/J0URNAL.-P0NE.0042867]; Rota MC, 2008, VACCINE, V26, P4403, DOI 10.1016/j.vaccine.2008.05.094; Velicko I, 2008, VACCINE, V26, P6980, DOI 10.1016/j.vaccine.2008.09.012; World Health Organization, 2008, IMM BAS IMM SER MOD; Xu ZW, 2014, EPIDEMIOL INFECT, V142, P20, DOI 10.1017/S0950268813000411	18	8	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89361	10.1371/journal.pone.0089361	http://dx.doi.org/10.1371/journal.pone.0089361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586717	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700111
J	Roupe, KM; Veerla, S; Olson, J; Stone, EL; Sorensen, OE; Hedrick, SM; Nizet, V				Roupe, Karl Markus; Veerla, Srinivas; Olson, Joshua; Stone, Erica L.; Sorensen, Ole E.; Hedrick, Stephen M.; Nizet, Victor			Transcription Factor Binding Site Analysis Identifies FOXO Transcription Factors as Regulators of the Cutaneous Wound Healing Process	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EARLY GENE-EXPRESSION; EPITHELIAL-CELLS; HUMAN SKIN; KERATINOCYTE MIGRATION; IMMUNE-RESPONSES; UP-REGULATION; IN-VIVO; MICE; INVOLVEMENT	The search for significantly overrepresented and co-occurring transcription factor binding sites in the promoter regions of the most differentially expressed genes in microarray data sets could be a powerful approach for finding key regulators of complex biological processes. To test this concept, two previously published independent data sets on wounded human epidermis were re-analyzed. The presence of co-occurring transcription factor binding sites for FOXO1, FOXO3 and FOXO4 in the majority of the promoter regions of the most significantly differentially expressed genes between non-wounded and wounded epidermis implied an important role for FOXO transcription factors during wound healing. Expression levels of FOXO transcription factors during wound healing in vivo in both human and mouse skin were analyzed and a decrease for all FOXOs in human wounded skin was observed, with FOXO3 having the highest expression level in non wounded skin. Impaired re-epithelialization was found in cultures of primary human keratinocytes expressing a constitutively active variant of FOXO3. Conversely knockdown of FOXO3 in keratinocytes had the opposite effect and in an in vivo mouse model with FOXO3 knockout mice we detected significantly accelerated wound healing. This article illustrates that the proposed approach is a viable method for identifying important regulators of complex biological processes using in vivo samples. FOXO3 has not previously been implicated as an important regulator of wound healing and its exact function in this process calls for further investigation.	[Roupe, Karl Markus; Olson, Joshua; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Veerla, Srinivas] Lund Univ, Div Oncol, Dept Clin Sci, Lund, Sweden; [Veerla, Srinivas] Univ Lund Hosp, S-22185 Lund, Sweden; [Stone, Erica L.; Hedrick, Stephen M.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, San Diego, CA 92103 USA; [Stone, Erica L.; Hedrick, Stephen M.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA; [Sorensen, Ole E.] Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Lund University; Lund University; Skane University Hospital; University of California System; University of California San Diego; University of California System; University of California San Diego; Lund University; University of California System; University of California San Diego	Nizet, V (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Hedrick, Stephen M/E-9171-2010; Roupé, Karl/K-6502-2014; Nizet, Victor/AAF-3190-2019	Roupé, Karl/0000-0001-5472-8134; Veerla, Srinivas/0000-0001-7328-6239; Sorensen, Ole E./0000-0001-8681-6921; Nizet, Victor/0000-0003-3847-0422; Hedrick, Stephen/0000-0002-6345-8751	National Institutes of Health; Wenner-Gren Foundations, Sweden; Royal Physiographic Society in Lund, Sweden; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenner-Gren Foundations, Sweden; Royal Physiographic Society in Lund, Sweden; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (VN and SMH) Wenner-Gren Foundations, Sweden (KMR), and from the The Royal Physiographic Society in Lund, Sweden (KMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mubarak B, 2009, CHANNELS, V3, P233; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Birkenkamp KU, 2007, J BIOL CHEM, V282, P2211, DOI 10.1074/jbc.M606669200; Braff MH, 2005, INFECT IMMUN, V73, P6771, DOI 10.1128/IAI.73.10.6771-6781.2005; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cavanagh PR, 2005, LANCET, V366, P1725, DOI 10.1016/S0140-6736(05)67699-4; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Chen J, 2006, J IMMUNOL, V176, P2711, DOI 10.4049/jimmunol.176.5.2711; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cole J, 2001, WOUND REPAIR REGEN, V9, P360, DOI 10.1046/j.1524-475x.2001.00360.x; Dayem MA, 2003, COMP FUNCT GENOM, V4, P47, DOI 10.1002/cfg.239; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Dickel H, 2010, CONTACT DERMATITIS, V63, P215, DOI 10.1111/j.1600-0536.2010.01769.x; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Essaghir A, 2009, J BIOL CHEM, V284, P10334, DOI 10.1074/jbc.M808848200; Furuyama T, 2002, MICROSC RES TECHNIQ, V59, P331, DOI 10.1002/jemt.10213; Gallo Richard L, 2008, Drug Discov Today Dis Mech, V5, P145; Ganapathy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015627; Goren I, 2006, AM J PATHOL, V168, P765, DOI 10.2353/ajpath.2006.050293; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Jonasch E, 2009, J CLIN ONCOL, V27, P4076, DOI 10.1200/JCO.2008.21.3660; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kennedy-Crispin M, 2012, J INVEST DERMATOL, V132, P105, DOI 10.1038/jid.2011.262; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lees SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1238, DOI 10.1152/ajpcell.00349.2008; Lima MHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036974; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; Marionnet C, 2003, J INVEST DERMATOL, V121, P1447, DOI 10.1111/j.1523-1747.2003.12629.x; Mawal-Dewan M, 2002, J BIOL CHEM, V277, P7857, DOI 10.1074/jbc.M104515200; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Monsalve M, 2011, CURR DRUG TARGETS, V12, P1322, DOI 10.2174/138945011796150307; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Nakamura Y, 2001, EXP EYE RES, V72, P511, DOI 10.1006/exer.2000.0979; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; Oellerich MF, 2012, CIRC RES, V110, P1238, DOI 10.1161/CIRCRESAHA.111.246488; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Rennekampff HO, 2000, J SURG RES, V93, P41, DOI 10.1006/jsre.2000.5892; Rollman O, 2003, J INVEST DERMATOL, V120, P742, DOI 10.1046/j.1523-1747.2003.12129.x; Roupe KM, 2010, EXP DERMATOL, V19, pE329, DOI 10.1111/j.1600-0625.2009.01038.x; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seiler F, 2013, J IMMUNOL, V190, P1603, DOI 10.4049/jimmunol.1200596; Sextius P, 2010, EXP DERMATOL, V19, P259, DOI 10.1111/j.1600-0625.2009.00976.x; Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-y; Snoeks L, 2008, INFECT IMMUN, V76, P4677, DOI 10.1128/IAI.00227-08; Sorensen OE, 2006, J CLIN INVEST, V116, P1878, DOI 10.1172/JCI28422; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; Tanaka H, 2009, J INVEST DERM SYMP P, V14, P60, DOI 10.1038/jidsymp.2009.2; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Veerla S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-384; Veerla S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-145; Wang K, 2010, J BIOL CHEM, V285, P16958, DOI 10.1074/jbc.M109.093005; Xu KP, 2004, INVEST OPHTH VIS SCI, V45, P813, DOI 10.1167/iovs.03-0851; Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	75	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89274	10.1371/journal.pone.0089274	http://dx.doi.org/10.1371/journal.pone.0089274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586650	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900120
J	Sandor, AD; Marcutan, DI; D'Amico, G; Gherman, CM; Dumitrache, MO; Mihalca, AD				Sandor, Attila D.; Marcutan, Daniel I.; D'Amico, Gianluca; Gherman, Calin M.; Dumitrache, Mirabela O.; Mihalca, Andrei D.			Do the Ticks of Birds at an Important Migratory Hotspot Reflect the Seasonal Dynamics of Ixodes ricinus at the Migration Initiation Site? A Case Study in the Danube Delta	PLOS ONE			English	Article							BURGDORFERI-SENSU-LATO; INFECTIOUS-DISEASE RISK; GEOGRAPHICAL-DISTRIBUTION; HUMAN PATHOGENS; CLIMATE-CHANGE; WILD BIRDS; ROMANIA; EUROPE; PREVALENCE; VIRUS	Migratory birds play important roles as distributors of ticks within and between continents. In the Old World, the most important migratory route of birds links Asia, Europe and Africa. During their migration, birds use various stopover sites, where they feed and rest and where ticks may attach or detach, creating new natural foci for vector-borne diseases. Danube Delta is one of the most important migration hotspots and so far no studies were focused on ticks of migratory birds herein. The aim of the present study was to assess the species diversity and seasonal dynamics of ticks parasitizing migratory birds in Danube Delta Biosphere Reserve. Migratory birds were trapped on Grindul Lupilor (44 degrees 41'N; 28 degrees 56'E) using mist nets during 4 migratory seasons (2 spring and 2 autumn) in 2011 and 2012. From each bird, all the ticks were collected and identified based on morphological features. Epidemiological parameters (prevalence, mean abundance, mean intensity) were calculated and all data were analysed statistically based on the season (spring and autumn), regional status of birds (migrants and breeding) and foraging behaviour (ground feeders, reed-bed feeders, foliage feeders). A total of 1434 birds (46 species) were captured. Ticks were found on 94 birds (10 species). Significantly more migratory birds hosted ticks, compared to resident birds. The 400 collected ticks belonged to four species: Ixodes ricinus (92.25%), I. arboricola (6.25%), I. redikorzevi (1.00%) and Haemaphysalis punctata (0.50%). A higher prevalence was found for I. ricinus in spring, with higher prevalence of nymphs in this season, while larvae occurred with the same prevalence in both seasons. Larval intensity was higher during spring and nymphs were more abundant during autumn. The seasonal differences in our study may be related not to the local seasonal dynamics of ticks, but on the seasonal dynamics at the site of migration initiation.	[Sandor, Attila D.; Marcutan, Daniel I.; D'Amico, Gianluca; Gherman, Calin M.; Dumitrache, Mirabela O.; Mihalca, Andrei D.] Univ Agr Sci & Vet Med Cluj Napoca, Dept Parasitol & Parasit Dis, Cluj Napoca, Romania	University of Agricultural Sciences & Veterinary Medicine Cluj Napoca	Mihalca, AD (corresponding author), Univ Agr Sci & Vet Med Cluj Napoca, Dept Parasitol & Parasit Dis, Cluj Napoca, Romania.	amihalca@usamvcluj.ro	Dumitrache, Mirabela Oana/ABF-6882-2020; Mihalca, Andrei Daniel/A-1561-2008; Sándor, Attila D./A-4782-2009; D'Amico, Gianluca/A-8708-2019; gherman, calin M/P-5823-2016; Dumitrache, Mirabela/GZM-4475-2022	Dumitrache, Mirabela Oana/0000-0003-1639-123X; Mihalca, Andrei Daniel/0000-0001-6076-7914; Sándor, Attila D./0000-0001-8852-8341; gherman, calin M/0000-0002-5936-2538; 	 [CNCSIS IDEI PCCE 7/2010]		This research was funded by grant CNCSIS IDEI PCCE 7/2010. The work of CMG, MOD and ADM was done under the frame of EurNegVec COST Action TD1303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Anez G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002245; Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604; Ceianu CS, 2012, VECTOR-BORNE ZOONOT, V12, P718, DOI 10.1089/vbz.2011.0768; Dantas-Torres F, 2013, VET PARASITOL, V192, P253, DOI 10.1016/j.vetpar.2012.09.034; de la Fuente J, 2012, TICKS TICK-BORNE DIS, V3, P115, DOI 10.1016/j.ttbdis.2012.03.001; Edouard S, 2012, TICKS TICK-BORNE DIS, V3, P402, DOI 10.1016/j.ttbdis.2012.10.002; Elfving K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008572; Falchi A, 2012, EXP APPL ACAROL, V58, P167, DOI 10.1007/s10493-012-9571-8; Feider Z., 1965, ARACHNIDA ACAROMORPH; Franke J, 2013, TICKS TICK-BORNE DIS, V4, P11, DOI 10.1016/j.ttbdis.2012.06.007; Gaidet N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046049; Gherman CM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-137; Hasle G, 2011, TICKS TICK-BORNE DIS, V2, P37, DOI 10.1016/j.ttbdis.2010.10.004; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Hildebrandt A, 2010, TICKS TICK-BORNE DIS, V1, P105, DOI 10.1016/j.ttbdis.2009.12.003; Hoogstraal H., 1964, Bulletin of the World Health Organization, V30, P355; HOOGSTRAAL H, 1961, B WORLD HEALTH ORGAN, V24, P197; Ioja CI, 2010, BIOL CONSERV, V143, P2468, DOI 10.1016/j.biocon.2010.06.013; KAISER MN, 1974, B ENTOMOL RES, V64, P97, DOI 10.1017/S0007485300027024; Kalmar Z, 2013, TICKS TICK IN PRESS; Kiss T, 2011, VECTOR-BORNE ZOONOT, V11, P1259, DOI 10.1089/vbz.2010.0254; Kolonin G.V., 2009, FAUNA IXODID TICKS W; Korenberg EI, 2000, EXP APPL ACAROL, V24, P665, DOI 10.1023/A:1010798518261; Kunze Ursula, 2012, Ticks Tick Borne Dis, V3, P197, DOI 10.1016/j.ttbdis.2012.03.007; Lachish S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038316; Lindgren E, 2012, SCIENCE, V336, P418, DOI 10.1126/science.1215735; Majlathova V, 2008, INT J MED MICROBIOL, V298, P161, DOI 10.1016/j.ijmm.2008.03.005; Marsot M, 2012, INT J PARASITOL, V42, P781, DOI 10.1016/j.ijpara.2012.05.010; Mihalca AD, 2012, EXP APPL ACAROL, V58, P175, DOI 10.1007/s10493-012-9568-3; Mihalca AD, 2012, EXP APPL ACAROL, V58, P183, DOI 10.1007/s10493-012-9566-5; Mihalca AD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-266; Moller AP, 2012, OECOLOGIA, V170, P867, DOI 10.1007/s00442-012-2355-3; Movila A, 2008, INT J MED MICROBIOL, V298, P149, DOI 10.1016/j.ijmm.2007.12.009; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Norte AC, 2012, EXP APPL ACAROL, V58, P327, DOI 10.1007/s10493-012-9583-4; Nosek J., 1972, MITT ABT ZOOL LANDES, V1, P61; OLSEN B, 1995, APPL ENVIRON MICROB, V61, P3082; Oteo JA, 2012, TICKS TICK-BORNE DIS, V3, P270, DOI 10.1016/j.ttbdis.2012.10.035; Palomar AM, 2012, EMERG INFECT DIS, V18, P1188, DOI 10.3201/eid1807.111777; Pastiu AI, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-301; Poupon MA, 2006, APPL ENVIRON MICROB, V72, P976, DOI 10.1128/AEM.72.1.976-979.2006; Randolph SE, 2010, VET PARASITOL, V167, P92, DOI 10.1016/j.vetpar.2009.09.011; Smith KF, 2010, ANNU REV ECOL EVOL S, V41, P231, DOI 10.1146/annurev-ecolsys-102209-144634; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Telleria JL, 2009, J BIOGEOGR, V36, P220, DOI 10.1111/j.1365-2699.2008.01983.x; Woolhouse M, 2007, CRIT REV MICROBIOL, V33, P231, DOI 10.1080/10408410701647560	47	25	28	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89378	10.1371/journal.pone.0089378	http://dx.doi.org/10.1371/journal.pone.0089378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586732	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900135
J	Spalletta, G; Caltagirone, C; Padovani, A; Sorbi, S; Attar, M; Colombo, D; Cravello, L				Spalletta, Gianfranco; Caltagirone, Carlo; Padovani, Alessandro; Sorbi, Sandro; Attar, Mahmood; Colombo, Delia; Cravello, Luca		EVOLUTION Study Working Grp	Cognitive and Affective Changes in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A 6-Month Observational Study	PLOS ONE			English	Article							RIVASTIGMINE TRANSDERMAL PATCH; NEUROPSYCHIATRIC SYMPTOMS; DEMENTIA; DEPRESSION; DONEPEZIL; HEALTH; IMPAIRMENT; APATHY; MANAGEMENT; SERTRALINE	Patients with Alzheimer's disease after an initial response to cholinesterase inhibitors may complain a later lack of efficacy. This, in association with incident neuropsychiatric symptoms, may worsen patient quality of life. Thus, the switch to another cholinesterase inhibitor could represent a valid therapeutic strategy. The aim of this study was to investigate the effectiveness of the switch from one to another cholinesterase inhibitor on cognitive and affective symptoms in mild to moderate Alzheimer disease patients. Four hundred twenty-three subjects were included from the EVOLUTION study, an observational, longitudinal, multicentre study conducted on Alzheimer disease patients who switched to different cholinesterase inhibitor due either to lack/loss of efficacy or response, reduced tolerability or poor compliance. All patients underwent cognitive and neuropsychiatric assessments, carried out before the switch (baseline), and at 3 and 6-month follow-up. A significant effect of the different switch types was found on Mini-Mental State Examination score during time, with best effectiveness on mild Alzheimer's disease patients switching from oral cholinesterase inhibitors to rivastigmine patch. Depressive symptoms, when measured using continuous Neuropsychiatric Inventory values, decreased significantly, while apathy symptoms remained stable over the 6 months after the switch. However, frequency of both depression and apathy, when measured categorically using Neuropsychiatric Inventory cut-off scores, did not change significantly during time. In mild to moderate Alzheimer disease patients with loss of efficacy and tolerability during cholinesterase inhibitor treatment, the switch to another cholinesterase inhibitor may represent an important option for slowing cognitive deterioration. The evidence of apathy stabilization and the positive tendency of depressive symptom improvement should definitively be confirmed in double-blind controlled studies.	[Spalletta, Gianfranco; Caltagirone, Carlo; Cravello, Luca] IRCCS Santa Lucia Fdn, Neuropsychiat Lab, Dept Clin & Behav Neurol, Rome, Italy; [Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Padovani, Alessandro] Univ Brescia, Dept Clin & Expt Sci, Brescia, Italy; [Sorbi, Sandro] Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy; [Attar, Mahmood; Colombo, Delia] Novartis Farma Italia, Origgio, Varese, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata; University of Brescia; University of Florence	Spalletta, G (corresponding author), IRCCS Santa Lucia Fdn, Neuropsychiat Lab, Dept Clin & Behav Neurol, Rome, Italy.	g.spalletta@hsantalucia.it	Cravello, Luca/R-5605-2016; LOGROSCINO, GIANCARLO/K-5148-2016; Spalletta, Gianfranco/K-3828-2018; Padovani, Alessandro/ABI-7312-2020; Cravello, Luca/O-5988-2019	Cravello, Luca/0000-0002-5106-6507; LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Spalletta, Gianfranco/0000-0002-7432-4249; Padovani, Alessandro/0000-0002-0119-3639; sorbi, sandro/0000-0002-0380-6670	Novartis Farma S.p.A. Italy	Novartis Farma S.p.A. Italy	This study was entirely funded and supported by Novartis Farma S.p.A. Italy. Mahmood Attar and Delia Colombo, Novartis Farma Italia affiliated, took part in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Auriacombe S, 2002, CURR MED RES OPIN, V18, P129, DOI 10.1185/030079902125000471; Bailey JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021954; Bailey JA, 2010, J NEUROCHEM, V112, P843, DOI 10.1111/j.1471-4159.2009.06490.x; Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1; Bartorelli L, 2005, CURR MED RES OPIN, V21, P1809, DOI 10.1185/030079905X65655; Bottini G, 2012, BEHAV NEUROL, V25, P61, DOI 10.1155/2012/538542; Bullock R, 2002, INT J GERIATR PSYCH, V17, P288, DOI 10.1002/gps.542; Chilovi BV, 2009, DEMENT GERIATR COGN, V27, P390, DOI 10.1159/000210045; CUMMINGS JL, 1997, NEUROLOGY, V48, P10, DOI DOI 10.1212/WNL.48.5_SUPPL_6.10S; Dhillon S, 2011, DRUGS, V71, P1209, DOI 10.2165/11206380-000000000-00000; Di Iulio F, 2010, INT PSYCHOGERIATR, V22, P629, DOI 10.1017/S1041610210000281; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gauthier S, 2006, CURR MED RES OPIN, V22, P2251, DOI 10.1185/030079906X132749; Grossberg GT, 2000, INT J GERIATR PSYCH, V15, P242, DOI 10.1002/(SICI)1099-1166(200003)15:3<242::AID-GPS110>3.0.CO;2-7; Guillozet AL, 1997, ANN NEUROL, V42, P909, DOI 10.1002/ana.410420613; Han HJ, 2011, J CLIN NEUROL, V7, P137, DOI 10.3988/jcn.2011.7.3.137; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Marshall GA, 2006, DEMENT GERIATR COGN, V21, P144, DOI 10.1159/000090674; Mauskopf Josephine A, 2005, J Manag Care Pharm, V11, P231; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mucha L, 2008, J MANAGE CARE PHARM, V14, P451, DOI 10.18553/jmcp.2008.14.5.451; Onor ML, 2007, CLIN INTERV AGING, V2, P17, DOI 10.2147/ciia.2007.2.1.17; Palmer K, 2010, J ALZHEIMERS DIS, V20, P175, DOI 10.3233/JAD-2010-1352; Panza F, 2009, DRUG AGING, V26, P537, DOI 10.2165/11315770-000000000-00000; PERRY EK, 1978, NEUROPATH APPL NEURO, V4, P273, DOI 10.1111/j.1365-2990.1978.tb00545.x; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Rapp MA, 2006, ARCH GEN PSYCHIAT, V63, P161, DOI 10.1001/archpsyc.63.2.161; Rodda J, 2009, INT PSYCHOGERIATR, V21, P813, DOI 10.1017/S1041610209990354; Rosenberg PB, 2010, AM J GERIAT PSYCHIAT, V18, P136, DOI 10.1097/JGP.0b013e3181c796eb; Sadowsky CH, 2009, AM J ALZHEIMERS DIS, V24, P267, DOI 10.1177/1533317509333037; Schneider LS, 2001, AM J GERIAT PSYCHIAT, V9, P346, DOI 10.1176/appi.ajgp.9.4.346; Spalletta G, 2013, ALZ DIS ASSOC DIS, V27, P289, DOI 10.1097/WAD.0b013e318260ab0a; Spalletta G, 2010, AM J GERIAT PSYCHIAT, V18, P1026, DOI 10.1097/JGP.0b013e3181d6b68d; Steinberg M, 2004, INT J GERIATR PSYCH, V19, P19, DOI 10.1002/gps.1025; Tian HJ, 2013, ALZ DIS ASSOC DIS, V27, P182, DOI 10.1097/WAD.0b013e318266fb02; Venneri A, 2005, NEUROREPORT, V16, P107, DOI 10.1097/00001756-200502080-00006; Xie WH, 2000, J PHARMACOL EXP THER, V293, P896	37	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89216	10.1371/journal.pone.0089216	http://dx.doi.org/10.1371/journal.pone.0089216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586603	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900109
J	Kaever, A; Landesfeind, M; Feussner, K; Morgenstern, B; Feussner, I; Meinicke, P				Kaever, Alexander; Landesfeind, Manuel; Feussner, Kirstin; Morgenstern, Burkhard; Feussner, Ivo; Meinicke, Peter			Meta-Analysis of Pathway Enrichment: Combining Independent and Dependent Omics Data Sets	PLOS ONE			English	Article							GENE-EXPRESSION; GENOME; TOOL; IDENTIFICATION; VISUALIZATION; BIOSYNTHESIS; ENZYMES; GROWTH; TESTS; RNA	A major challenge in current systems biology is the combination and integrative analysis of large data sets obtained from different high-throughput omics platforms, such as mass spectrometry based Metabolomics and Proteomics or DNA microarray or RNA-seq-based Transcriptomics. Especially in the case of non-targeted Metabolomics experiments, where it is often impossible to unambiguously map ion features from mass spectrometry analysis to metabolites, the integration of more reliable omics technologies is highly desirable. A popular method for the knowledge-based interpretation of single data sets is the (Gene) Set Enrichment Analysis. In order to combine the results from different analyses, we introduce a methodical framework for the meta-analysis of p-values obtained from Pathway Enrichment Analysis (Set Enrichment Analysis based on pathways) of multiple dependent or independent data sets from different omics platforms. For dependent data sets, e. g. obtained from the same biological samples, the framework utilizes a covariance estimation procedure based on the nonsignificant pathways in single data set enrichment analysis. The framework is evaluated and applied in the joint analysis of Metabolomics mass spectrometry and Transcriptomics DNA microarray data in the context of plant wounding. In extensive studies of simulated data set dependence, the introduced correlation could be fully reconstructed by means of the covariance estimation based on pathway enrichment. By restricting the range of p-values of pathways considered in the estimation, the overestimation of correlation, which is introduced by the significant pathways, could be reduced. When applying the proposed methods to the real data sets, the meta-analysis was shown not only to be a powerful tool to investigate the correlation between different data sets and summarize the results of multiple analyses but also to distinguish experiment-specific key pathways.	[Kaever, Alexander; Landesfeind, Manuel; Morgenstern, Burkhard; Meinicke, Peter] Univ Gottingen, Inst Microbiol & Genet, Dept Bioinformat, D-37073 Gottingen, Germany; [Feussner, Kirstin; Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Kaever, A (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Bioinformat, D-37073 Gottingen, Germany.	alex@gobics.de	Feussner, Ivo/H-9320-2013; Morgenstern, Burkhard/A-7486-2008	Feussner, Ivo/0000-0002-9888-7003; Morgenstern, Burkhard/0000-0002-7431-2862	German Federal Ministry of Education and Research (BMBF BioFung project) [0315595A]; Biomolecules program of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB)	German Federal Ministry of Education and Research (BMBF BioFung project)(Federal Ministry of Education & Research (BMBF)); Biomolecules program of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB)	Alexander Kaever and Manuel Landesfeind were funded by the German Federal Ministry of Education and Research (BMBF BioFung project 0315595A), and were supported by the Biomolecules program of the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Draper J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-227; Duan H, 2005, PLANT PHYSIOL, V139, P1529, DOI 10.1104/pp.105.067249; Dunn WB, 2013, METABOLOMICS, V9, pS44, DOI 10.1007/s11306-012-0434-4; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Hedges LV, 2014, STAT METHODS META AN; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Kaever A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/263910; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Loughin TM, 2004, COMPUT STAT DATA AN, V47, P467, DOI 10.1016/j.csda.2003.11.020; Meinicke P, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; RICE WR, 1990, BIOMETRICS, V46, P303, DOI 10.2307/2531435; Sclep G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-400; Shen K, 2010, BIOINFORMATICS, V26, P1316, DOI 10.1093/bioinformatics/btq148; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Stouffer SA, 1949, AM SOLDIER ADJUSTMEN, V1; Stumpe Michael, 2006, Phytochemistry Reviews, V5, P347, DOI 10.1007/s11101-006-9038-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; von Malek B, 2002, PLANTA, V216, P187, DOI 10.1007/s00425-002-0906-2; Wagele B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039860; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708	44	32	34	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89297	10.1371/journal.pone.0089297	http://dx.doi.org/10.1371/journal.pone.0089297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586671	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200047
J	Kraiklang, R; Pairojkul, C; Khuntikeo, N; Imtawil, K; Wongkham, S; Wongkham, C				Kraiklang, Ratthaphol; Pairojkul, Chawalit; Khuntikeo, Narong; Imtawil, Kanokwan; Wongkham, Sopit; Wongkham, Chaisiri			A Novel Predictive Equation for Potential Diagnosis of Cholangiocarcinoma	PLOS ONE			English	Article							HUMAN INTRAHEPATIC CHOLANGIOCARCINOMA; CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; OPISTHORCHIS-VIVERRINI; GENE-EXPRESSION; IDENTIFICATION; TRANSTHYRETIN; CANCER; METASTASIS; CELLS	Cholangiocarcinoma (CCA) is the second most common-primary liver cancer. The difficulties in diagnosis limit successful treatment of CCA. At present, histological investigation is the standard diagnosis for CCA. However, there are some poor-defined tumor tissues which cannot be definitively diagnosed by general histopathology. As molecular signatures can define molecular phenotypes related to diagnosis, prognosis, or treatment outcome, and CCA is the second most common cancer found after hepatocellularcarcinoma (HCC), the aim of this study was to develop a predictive model which differentiates CCA from HCC and normal liver tissues. An in-house PCR array containing 176 putative CCA marker genes was tested with the training set tissues of 20 CCA and 10 HCC cases. The molecular signature of CCA revealed the prominent expression of genes involved in cell adhesion and cell movement, whereas HCC showed elevated expression of genes related to cell proliferation/differentiation and metabolisms. A total of 69 genes differentially expressed in CCA and HCC were optimized statistically to formulate a diagnostic equation which distinguished CCA cases from HCC cases. Finally, a four-gene diagnostic equation (CLDN4, HOXB7, TMSB4 and TTR) was formulated and then successfully validated using real-time PCR in an independent testing set of 68 CCA samples and 77 non-CCA controls. Discrimination analysis showed that a combination of these genes could be used as a diagnostic marker for CCA with better diagnostic parameters with high sensitivity and specificity than using a single gene marker or the usual serum markers (CA19-9 and CEA). This new combination marker may help physicians to identify CCA in liver tissues when the histopathology is uncertain.	[Kraiklang, Ratthaphol; Imtawil, Kanokwan; Wongkham, Sopit; Wongkham, Chaisiri] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Pairojkul, Chawalit] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand; [Khuntikeo, Narong] Khon Kaen Univ, Fac Med, Dept Surg, Khon Kaen, Thailand; [Kraiklang, Ratthaphol; Pairojkul, Chawalit; Khuntikeo, Narong; Imtawil, Kanokwan; Wongkham, Sopit; Wongkham, Chaisiri] Khon Kaen Univ, Fac Med, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Wongkham, C (corresponding author), Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand.	chaisiri@kku.ac.th	Wongkham, Sopit/ABB-6966-2021		Research Team Strengthening Grant, National Genetic Engineering and Biotechnology Center, NSTDA, Thailand; NRU Project of Thailand through SHeP-GMS, Khon Kaen University	Research Team Strengthening Grant, National Genetic Engineering and Biotechnology Center, NSTDA, Thailand; NRU Project of Thailand through SHeP-GMS, Khon Kaen University	The authors would like to thank the Research Team Strengthening Grant, National Genetic Engineering and Biotechnology Center, NSTDA, Thailand to SW; NRU Project of Thailand through SHeP-GMS, Khon Kaen University for financial support to CW and SW; the Commission on Higher Education, Thailand, under the program Strategic Scholarships for Frontier Research Network for the Ph.D. Program Thai Doctoral degree given to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Care A, 1999, ONCOGENE, V18, P1993, DOI 10.1038/sj.onc.1202498; Feldmann G, 2006, ENDOSCOPY, V38, P604, DOI 10.1055/s-2006-925065; Grant D S, 1999, Angiogenesis, V3, P125, DOI 10.1023/A:1009041911493; Hass HG, 2008, WORLD J GASTROENTERO, V14, P2501, DOI 10.3748/wjg.14.2501; Jinawath N, 2006, HEPATOLOGY, V44, P1025, DOI 10.1002/hep.21330; Jo JO, 2011, APPL IMMUNOHISTO M M, V19, P160, DOI 10.1097/PAI.0b013e3181f12237; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; Kobayashi T, 2002, AM J PATHOL, V160, P869, DOI 10.1016/S0002-9440(10)64910-3; Konstantinopoulos PA, 2010, PLOS ONE, V6; Konstantinopoulos PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009747; Kozak KR, 2005, PROTEOMICS, V5, P4589, DOI 10.1002/pmic.200500093; Liu LY, 2008, J CELL BIOCHEM, V104, P745, DOI 10.1002/jcb.21661; Nishino R, 2008, J HEPATOL, V49, P207, DOI 10.1016/j.jhep.2008.03.025; Obama K, 2005, HEPATOLOGY, V41, P1339, DOI 10.1002/hep.20718; Patel T, 2001, HEPATOLOGY, V33, P1353, DOI 10.1053/jhep.2001.25087; Power DM, 2000, GEN COMP ENDOCR, V119, P241, DOI 10.1006/gcen.2000.7520; Ritchie RF, 1999, J CLIN LAB ANAL, V13, P273, DOI 10.1002/(SICI)1098-2825(1999)13:6<273::AID-JCLA4>3.0.CO;2-X; Robertson SL, 2011, METHODS MOL BIOL, V762, P63, DOI 10.1007/978-1-61779-185-7_5; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; THAMAVIT W, 1978, CANCER RES, V38, P4634; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Wang AG, 2006, BIOCHEM BIOPH RES CO, V345, P1022, DOI 10.1016/j.bbrc.2006.04.175; Wang WS, 2004, ONCOGENE, V23, P6666, DOI 10.1038/sj.onc.1207888; Xu ZY, 2010, BIOMED PHARMACOTHER, V64, P133, DOI 10.1016/j.biopha.2009.06.021	27	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89337	10.1371/journal.pone.0089337	http://dx.doi.org/10.1371/journal.pone.0089337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586698	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200049
J	Lone, AM; Leidl, M; McFedries, AK; Horner, JW; Creemers, J; Saghatelian, A				Lone, Anna Mari; Leidl, Mathias; McFedries, Amanda K.; Horner, James W.; Creemers, John; Saghatelian, Alan			Deletion of Prepl Causes Growth Impairment and Hypotonia in Mice	PLOS ONE			English	Article							CYSTINURIA SYNDROME; OLIGOPEPTIDASE; PROTEIN; FIBROBLASTS; SECRETION; RECEPTOR; PCSK9; RAT; LDL	Genetic studies of rare diseases can identify genes of unknown function that strongly impact human physiology. Prolyl endopeptidase-like (PREPL) is an uncharacterized member of the prolyl peptidase family that was discovered because of its deletion in humans with hypotonia-cystinuria syndrome (HCS). HCS is characterized by a number of physiological changes including diminished growth and neonatal hypotonia or low muscle tone. HCS patients have deletions in other genes as well, making it difficult to tease apart the specific role of PREPL. Here, we develop a PREPL null (PREPL-/-) mouse model to address the physiological role of this enzyme. Deletion of exon 11 from the Prepl gene, which encodes key catalytic amino acids, leads to a loss of PREPL protein as well as lower Prepl mRNA levels. PREPL-/- mice have a pronounced growth phenotype, being significantly shorter and lighter than their wild type (PREPL+/+) counterparts. A righting assay revealed that PREPL-/- pups took significantly longer than PREPL+/+ pups to right themselves when placed on their backs. This deficit indicates that PREPL-/- mice suffer from neonatal hypotonia. According to these results, PREPL regulates growth and neonatal hypotonia in mice, which supports the idea that PREPL causes diminished growth and neonatal hypotonia in humans with HCS. These animals provide a valuable asset in deciphering the underlying biochemical, cellular and physiological pathways that link PREPL to HCS, and this may eventually lead to new insights in the treatment of this disease.	[Lone, Anna Mari; Leidl, Mathias; McFedries, Amanda K.; Saghatelian, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Horner, James W.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Horner, James W.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Horner, James W.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Creemers, John] Katholieke Univ Leuven, Dept Human Genet, Biochem Neuroendocrinol Lab, Louvain, Belgium	Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; KU Leuven	Saghatelian, A (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	alan.saghatelian@gmail.com	Lone, Anna Mari/AAJ-2182-2021	Lone, Anna Mari/0000-0001-5295-0559	Forris Jewitt Moore Fellowship; Amherst College; National Institutes of Health [GM007598, 1DP2OD002374]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen; Searle Scholar Award; Burroughs Wellcome Fund Career Award in the Biomedical Sciences; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002374] Funding Source: NIH RePORTER	Forris Jewitt Moore Fellowship; Amherst College; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Searle Scholar Award; Burroughs Wellcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Forris Jewitt Moore Fellowship sponsored by Amherst College (A. M. L.), an National Institutes of Health training grant (GM007598) (A. M. L), Fonds voor Wetenschappelijk Onderzoek Vlaanderen (J.C.), Searle Scholar Award (A. S.), Burroughs Wellcome Fund Career Award in the Biomedical Sciences (A. S.), National Institutes of Health Grants 1DP2OD002374 (A. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; BROWN MS, 1975, CELL, V6, P307, DOI 10.1016/0092-8674(75)90182-8; Chabrol B, 2008, J MED GENET, V45, P314, DOI 10.1136/jmg.2007.055475; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Crunkhorn S, 2012, NAT REV DRUG DISCOV, V11, P11, DOI 10.1038/nrd3633; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Font-Llitjos M, 2005, J MED GENET, V42, P58, DOI 10.1136/jmg.2004.022244; Hashemi E, 2007, BRAIN RES, V1129, P191, DOI 10.1016/j.brainres.2006.10.050; Jaeken J, 2006, AM J HUM GENET, V78, P38, DOI 10.1086/498852; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Lone AM, 2011, J AM CHEM SOC, V133, P11665, DOI 10.1021/ja2036095; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; Martens K, 2007, EUR J HUM GENET, V15, P1029, DOI 10.1038/sj.ejhg.5201881; Martens K, 2006, BIOL CHEM, V387, P879, DOI 10.1515/BC.2006.111; Mikulecka A, 2002, PSYCHOPHARMACOLOGY, V162, P364, DOI 10.1007/s00213-002-1122-2; Morawski M, 2011, CNS NEUROL DISORD-DR, V10, P327, DOI 10.2174/187152711794653805; Morawski M, 2013, NEUROSCIENCE; MOSCKOVITZ R, 1993, P NATL ACAD SCI USA, V90, P4022, DOI 10.1073/pnas.90.9.4022; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Parvari R, 2005, GENOMICS, V86, P195, DOI 10.1016/j.ygeno.2005.04.001; Radhakrishnan K, 2013, J CELL SCI, V126, P1155, DOI 10.1242/jcs.116079; Regal L, 2012, MOL GENET METAB, V107, P614, DOI 10.1016/j.ymgme.2012.06.011; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Szeltner Z, 2005, CELL MOL LIFE SCI, V62, P2376, DOI 10.1007/s00018-005-5262-5; Weber AE, 2006, DISCOVERY JANUVIA PE	29	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89160	10.1371/journal.pone.0089160	http://dx.doi.org/10.1371/journal.pone.0089160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586561	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200038
J	Mitrega, KA; Porc, M; Krzeminski, TF				Mitrega, Katarzyna A.; Porc, Maurycy; Krzeminski, Tadeusz F.			Differential Effects of Furnidipines' Metabolites on Reperfusion-Induced Arrhythmias in Rats In Vivo	PLOS ONE			English	Article							ISCHEMIA; CHANNEL; NIFEDIPINE; DERIVATIVES; MODEL	We previously established that furnidipine (FUR) and oxy dihydropyridines prevent rats mortality by strong reduction of the lethal arrhythmias in reperfusion. Therefore we decided to study the influence of three main metabolites (M-2, M-3, M-8) of FUR on ischemia-and reperfusion- induced arrhythmias and hemodynamic parameters in rat model to examine their independent activity. The metabolites (M-2, M-3, M-8) were given orally 20 mg/kg (24 and 1 h before ischemia). Mortality was significantly diminished in M-2 and M-3 treated groups with M-3 preventing animal mortality entirely. All three examined substances significantly reduced the duration and incidence of ventricular fibrillation (VF) with M-3, once again, completely preventing VF. Moreover, only M-3 significantly decreased the duration of ventricular tachycardia but had no influence on their incidence. Through the occlusion and reperfusion periods, M-2 and M-3 were markedly less hypotensive than M-8 and did not influence on heart rate. We conclude that two tested metabolites of FUR, M-3 and M-2 exhibited the most pronounced anti-arrhythmic effect being at the same time the most normotensive and therefore caused the most beneficial effects.	[Mitrega, Katarzyna A.; Porc, Maurycy; Krzeminski, Tadeusz F.] Med Univ Silesia, Chair & Dept Pharmacol, Katowice, Poland	Medical University Silesia	Mitrega, KA (corresponding author), Med Univ Silesia, Chair & Dept Pharmacol, Katowice, Poland.	kas-k2@o2.pl		Krzeminski, Tadeusz/0000-0003-3663-4518; Porc, Maurycy Pawel/0000-0001-8914-1173				BALLER D, 1981, BASIC RES CARDIOL, V76, P163, DOI 10.1007/BF01907955; BILLMAN GE, 1994, CARDIOVASC RES, V28, P762, DOI 10.1093/cvr/28.6.762; CLARK C, 1980, J PHARMACOL METHOD, V3, P357, DOI 10.1016/0160-5402(80)90077-7; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; CROME R, 1986, J CARDIOVASC PHARM, V8, P1249, DOI 10.1097/00005344-198611000-00023; Curtis MJ, 2013, PHARMACOL THERAPEUT, V139, P213, DOI 10.1016/j.pharmthera.2013.04.008; EVANS BE, 1988, J MED CHEM, V31, P2235, DOI 10.1021/jm00120a002; FAGBEMI O, 1981, EUR J PHARMACOL, V75, P179, DOI 10.1016/0014-2999(81)90543-4; FOSSET M, 1988, J BIOL CHEM, V263, P7933; GRECH ED, 1994, BRIT HEART J, V72, P94; KANE KA, 1981, BRIT J PHARMACOL, V72, pP512; Kitakaze M, 2000, CIRCULATION, V101, P311, DOI 10.1161/01.CIR.101.3.311; KODAMA I, 1984, J MOL CELL CARDIOL, V16, P247, DOI 10.1016/S0022-2828(84)80591-X; KOHLHARDT M, 1977, N-S ARCH PHARMACOL, V298, P267, DOI 10.1007/BF00500899; Krzeminski TF, 2011, J ENDOCRINOL INVEST, V34, P206, DOI [10.1007/BF03347068, 10.3275/7274]; Krzeminski TF, 2008, VASC PHARMACOL, V49, P91, DOI 10.1016/j.vph.2008.06.005; Krzeminski TF, 2006, EUR J PHARMACOL, V549, P91, DOI 10.1016/j.ejphar.2006.08.002; Krzeminski TF, 2011, J CARDIOVASC PHARM, V57, P183, DOI 10.1097/FJC.0b013e318202e2ea; Krzeminski TF, 2010, EUR J PHARMACOL, V644, P120, DOI 10.1016/j.ejphar.2010.06.036; Letelier CS, 2002, US 477 Patent, Patent No. [US 6,482,841B1, 6482841]; Mitrega K, 2011, PHARMACOL RES, V64, P218, DOI 10.1016/j.phrs.2011.04.011; Mitrega KA, 2012, PHARMACOL RES, V66, P300, DOI 10.1016/j.phrs.2012.06.008; MYERBURG RJ, 1992, NEW ENGL J MED, V326, P1451, DOI 10.1056/NEJM199205283262202; NAKAYA H, 1991, BRIT J PHARMACOL, V103, P1019, DOI 10.1111/j.1476-5381.1991.tb12294.x; Rameis H, 1993, Wien Med Wochenschr, V143, P490; Roden DM, 2003, J CARDIOVASC ELECTR, V14, P1389, DOI 10.1046/j.1540-8167.2003.03441.x; SELYE H., 1960, ANGIOLOGY, V11, P398, DOI 10.1177/000331976001100505; Stormont MF, 1930, J PHARMACOL EXP THER, V39, P165; Triggle DJ, 2003, CELL MOL NEUROBIOL, V23, P293, DOI 10.1023/A:1023632419813; TZIVONI D, 1983, AM HEART J, V105, P323, DOI 10.1016/0002-8703(83)90534-3; Vogel GH, 2002, DRUG DISCOVERY EVALU, V216, P219; WEATHERALL JAC, 1960, BRIT J PHARM CHEMOTH, V15, P454, DOI 10.1111/j.1476-5381.1960.tb01272.x; WILDE AAM, 1993, CARDIOVASC DRUG THER, V7, P521, DOI 10.1007/BF00877617; Zorniak M, 2010, J CARDIOVASC PHARM, V56, P38, DOI 10.1097/FJC.0b013e3181dd502c	34	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89477	10.1371/journal.pone.0089477	http://dx.doi.org/10.1371/journal.pone.0089477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586808	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200054
J	Ssinabulya, I; Kayima, J; Longenecker, C; Luwedde, M; Semitala, F; Kambugu, A; Ameda, F; Bugeza, S; McComsey, G; Freers, J; Nakanjako, D				Ssinabulya, Isaac; Kayima, James; Longenecker, Chris; Luwedde, Mary; Semitala, Fred; Kambugu, Andrew; Ameda, Faith; Bugeza, Sam; McComsey, Grace; Freers, Juergen; Nakanjako, Damalie			Subclinical Atherosclerosis among HIV-Infected Adults Attending HIV/AIDS Care at Two Large Ambulatory HIV Clinics in Uganda	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; CAROTID-ARTERY INTIMA; ANTIRETROVIRAL THERAPY; CARDIOVASCULAR RISK; ENDOTHELIAL ACTIVATION; SERUM-LIPIDS; INFLAMMATION	Background: The increased immune activation and inflammation of chronic HIV-infection and the characteristic dyslipidemias associated with HIV infection and antiretroviral therapy (ART) contribute to an increased risk of atherosclerotic vascular disease among HIV-infected adults. There is an emerging need to understand determinants of cardiovascular disease (CVD) among individuals aging with HIV in sub-Saharan Africa. We determined the prevalence of subclinical atherosclerosis [carotid intima media thickness (CIMT) >= 0.78 mm] and its correlation with traditional CVD risk factors among HIV-infected adults. Methods: In a cross-sectional study, HIV-infected adults (ART-naive and ART-treated) were consecutively selected from patients' enrollment registers at two large HIV clinics at Mulago Hospital, Kampala, Uganda. We measured traditional CVD risk factors including age, biophysical profile, fasting blood sugar and serum lipid profile as well as biomarkers of inflammation. High resolution ultrasound was used to measure common carotid CIMT. Results: Of 245 patients, Median age [Interquartile range (IQR)] 37 years (31-43), 168 (69%) were females; and 100 (41%) were ART-treated for at least 7 years. Overall, 34/186 (18%) had subclinical atherosclerosis; of whom 15/108 (14%) were ART-naive whereas 19/78 (24%) were ART-treated. Independent predictors of subclinical atherosclerosis included age [odds ratio (OR) 1.83 per 5-year increase in age; 95% confidence interval (CI) 1.24-2.69; p = 0.002], body mass index (BMI); OR 1.15; CI 1.01-1.31; p = 0.041 and high low density lipoprotein (LDL) [OR 2.99; CI 1.02-8.78, p = 0.046]. High sensitivity C-reactive protein (hsCRP) was positively correlated with traditional cardio-metabolic risk factors including waist circumference (r = 0.127, p = 0.05), triglycerides (r = 0.19, p = 0.003) and Total Cholesterol: High Density Lipoprotein ratio (TC: LDL) (r = 0.225, p<0.001). Conclusion: The prevalence of subclinical atherosclerosis was 18% among HIV-infected adults in Uganda. Traditional CVD risk factors were associated with subclinical atherosclerosis. We recommend routine assessment of traditional CVD risk factors within HIV care and treatment programs in sub-Saharan Africa.	[Ssinabulya, Isaac; Kayima, James; Semitala, Fred; Freers, Juergen; Nakanjako, Damalie] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Longenecker, Chris; McComsey, Grace] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Luwedde, Mary; Semitala, Fred] Makerere Univ Joint AIDS Program, Kampala, Uganda; [Kambugu, Andrew; Nakanjako, Damalie] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Ameda, Faith; Bugeza, Sam] Makerere Univ, Coll Hlth Sci, Dept Radiol, Kampala, Uganda	Makerere University; Case Western Reserve University; Makerere University; Makerere University; Makerere University	Ssinabulya, I (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda.	ssinabulyaisaac@gmail.com		Luwedde, Mary/0000-0003-1394-8768; Ssinabulya, Isaac/0000-0001-6521-7778; Nakanjako, Damalie/0000-0002-0935-2112	Fogarty International Center; National Heart Lung and Blood Institute; Common Fund of the National Institutes of Health [R24 TW008861]; FOGARTY INTERNATIONAL CENTER [R24TW008861, R25TW009343] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL123341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Common Fund of the National Institutes of Health; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the Fogarty International Center, the National Heart Lung and Blood Institute, and the Common Fund of the National Institutes of Health under Award Number R24 TW008861. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boger MS, 2009, JAIDS-J ACQ IMM DEF, V52, P480, DOI 10.1097/QAI.0b013e3181b939e5; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Calabro P, 2005, J AM COLL CARDIOL, V46, P1112, DOI 10.1016/j.jacc.2005.06.017; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; Currier JS, 2005, AIDS, V19, P927, DOI 10.1097/01.aids.0000171406.53737.f9; David MH, 2002, CLIN INFECT DIS, V34, P98, DOI 10.1086/324745; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; De Socio GVL, 2010, INT J STD AIDS, V21, P267, DOI 10.1258/ijsa.2009.009165; Dogan S, 2010, J ATHEROSCLER THROMB, V17, P526, DOI 10.5551/jat.3269; Fitch KV, 2013, AIDS, V27, P49, DOI 10.1097/QAD.0b013e328358b29c; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, UNAIDS GLOBAL REPORT; Kablak-Ziembicka A, 2004, HEART, V90, P1286, DOI 10.1136/hrt.2003.025080; Klein D, 2002, J ACQ IMMUN DEF SYND, V30, P471, DOI 10.1097/00126334-200208150-00002; Maggi P, 2004, AIDS, V18, P1023, DOI 10.1097/00002030-200404300-00010; Mangili A, 2006, CLIN INFECT DIS, V43, P1482, DOI 10.1086/509575; Mangili A, 2011, JAIDS-J ACQ IMM DEF, V58, P148, DOI [10.1097/QAI.0B013E31822D4993, 10.1097/QAI.0b013e31822d4993]; Masia M, 2007, ATHEROSCLEROSIS, V195, P167, DOI 10.1016/j.atherosclerosis.2006.09.013; Guimaraes MMM, 2008, ATHEROSCLEROSIS, V201, P434, DOI 10.1016/j.atherosclerosis.2008.02.003; Nakanjako D, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-26; Nakanjako Damalie, 2008, AIDS Res Ther, V5, P23, DOI 10.1186/1742-6405-5-23; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Parra S, 2010, HIV MED, V11, P225, DOI 10.1111/j.1468-1293.2009.00766.x; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; Rohani M, 2005, ATHEROSCLEROSIS, V179, P311, DOI 10.1016/j.atherosclerosis.2004.10.012; Roman MJ, 2006, J AM SOC ECHOCARDIOG, V19, P943, DOI 10.1016/j.echo.2006.04.020; Ross AC, 2010, ATHEROSCLEROSIS, V211, P492, DOI 10.1016/j.atherosclerosis.2010.04.008; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Shikuma CM, 2011, AIDS RES HUM RETROV, V27, P461, DOI 10.1089/aid.2010.0154; SHORPOSNER G, 1993, AM J MED, V94, P515, DOI 10.1016/0002-9343(93)90087-6; Stein JH, 2012, JAMA-J AM MED ASSOC, V308, P405, DOI 10.1001/jama.2012.8488; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Szadkowski L, 2012, AIDS RES HUM RETROV, V28, P1579, DOI [10.1089/aid.2012.0018, 10.1089/AID.2012.0018]; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Varriale P, 2004, AM HEART J, V147, P55, DOI 10.1016/j.ahj.2003.07.007; Vittecoq D, 2003, AIDS, V17, pS70, DOI 10.1097/00002030-200304001-00010	42	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89537	10.1371/journal.pone.0089537	http://dx.doi.org/10.1371/journal.pone.0089537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586854	gold, Green Published			2022-12-27	WOS:000332396200057
J	Kreuzer, I; Osthaus, WA; Schultz, A; Schultz, B				Kreuzer, Ines; Osthaus, W. Alexander; Schultz, Arthur; Schultz, Barbara			Influence of the Sevoflurane Concentration on the Occurrence of Epileptiform EEG Patterns	PLOS ONE			English	Article							MASK INDUCTION; ANESTHESIA; CHILDREN; ELECTROENCEPHALOGRAM; SEIZURES	Objectives and Aim: This study was performed to analyse the effects of different sevoflurane concentrations on the incidence of epileptiform EEG activity during induction of anaesthesia in children in the clinical routine. Background: It was suggested in the literature to use sevoflurane concentrations lower than 8% to avoid epileptiform activity during induction of anaesthesia in children. Methods: 100 children (age: 4.6 +/- 3.0 years, ASA I-III, premedication with midazolam) were anaesthetized with 8% sevoflurane for 3 min or 6% sevoflurane for 5 min in 100% O-2 via face mask followed by 4% sevoflurane until propofol and remifentanil were given for intubation. EEGs were recorded continuously and were analysed visually with regard to epileptiform EEG patterns. Results: From start of sevoflurane until propofol/remifentanil administration, 38 patients (76%) with 8% sevoflurane had epileptiform EEG patterns compared to 26 patients (52%) with 6% (p = 0.0106). Epileptiform potentials tended to appear later in the course of the induction with 6% than with 8%. Up to an endtidal concentration of 6% sevoflurane, the number of children with epileptiform potentials was similar in both groups (p = 0.3708). The cumulative number of children with epileptiform activity increased with increasing endtidal sevoflurane concentrations. The time from start of sevoflurane until loss of consciousness was similar in patients with 8% and 6% sevoflurane (42.2 +/- 17.5 s vs. 44.9 s +/- 14.0 s; p = 0.4073). An EEG stage of deep anaesthesia with continuous delta waves <2.0 Hz appeared significantly earlier in the 8% than in the 6% group (64.0 +/- 22.2 s vs. 77.9 +/- 20.0 s, p = 0.0022). Conclusion: The own analysis and data from the literature show that lower endtidal concentrations of sevoflurane and shorter administration times can be used to reduce epileptiform activity during induction of sevoflurane anaesthesia in children.	[Kreuzer, Ines; Osthaus, W. Alexander; Schultz, Arthur; Schultz, Barbara] Hannover Med Sch, Dept Anaesthesiol & Intens Care Med, Hannover, Germany	Hannover Medical School	Schultz, A (corresponding author), Hannover Med Sch, Dept Anaesthesiol & Intens Care Med, Hannover, Germany.	ab.schultz@t-online.de	RIVADULLA, CASTO/K-8425-2012	RIVADULLA, CASTO/0000-0001-5580-3917	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	Publication costs were covered by the Open Access Publication Program of the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson J, 2004, ACTA ANAESTH SCAND, V48, P405, DOI 10.1111/j.1399-6576.2004.00365.x; [Anonymous], 2012, FACHINFORMATION SEVO; Constant I, 2005, PEDIATR ANESTH, V15, P266, DOI 10.1111/j.1460-9592.2004.01538.x; Dubois MC, 1999, PAEDIATR ANAESTH, V9, P19, DOI 10.1046/j.1460-9592.1999.9120327.x; Epstein RH, 1998, J CLIN ANESTH, V10, P41, DOI 10.1016/S0952-8180(97)00218-3; Gibert S, 2012, ANESTHESIOLOGY, V117, P1253, DOI 10.1097/ALN.0b013e318273e272; Holzki J, 1999, PAEDIATR ANAESTH, V9, P283, DOI 10.1046/j.1460-9592.1999.00415.x; Iijima T, 2000, ANESTH ANALG, V91, P989, DOI 10.1097/00000539-200010000-00041; Jaaskelainen SK, 2003, NEUROLOGY, V61, P1073, DOI 10.1212/01.WNL.0000090565.15739.8D; Johr M, 2005, BEST PRACT RES-CLIN, V19, P501, DOI 10.1016/j.bpa.2005.01.001; Julliac B, 2007, ANESTHESIOLOGY, V106, P243, DOI 10.1097/00000542-200702000-00011; Nieminen K, 2002, BRIT J ANAESTH, V89, P853, DOI 10.1093/bja/aef290; Pilge S, 2013, ANESTHESIOLOGY, V119, P447, DOI 10.1097/ALN.0b013e31827335b9; Schultz A, 2000, ANAESTH INTENS CARE, V28, P205, DOI 10.1177/0310057X0002800216; Schultz B, 2003, ANAESTHESIST, V52, P1143, DOI 10.1007/s00101-003-0603-y; Schultz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040903; Sonkajarvi E, 2009, ACTA ANAESTH SCAND, V53, P77, DOI 10.1111/j.1399-6576.2008.01725.x; Vakkuri A, 2001, ACTA ANAESTH SCAND, V45, P805, DOI 10.1034/j.1399-6576.2001.045007805.x; Vakkuri A, 2000, ACTA ANAESTH SCAND, V44, P713, DOI 10.1034/j.1399-6576.2000.440609.x; Voss LJ, 2008, ANESTH ANALG, V107, P1689, DOI 10.1213/ane.0b013e3181852595; Yli-Hankala A, 1999, ANESTHESIOLOGY, V91, P1596, DOI 10.1097/00000542-199912000-00009	21	15	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89191	10.1371/journal.pone.0089191	http://dx.doi.org/10.1371/journal.pone.0089191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586585	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000031
J	Panzer, S; Peschel, O; Haas-Gebhard, B; Bachmeier, BE; Pusch, CM; Nerlich, AG				Panzer, Stephanie; Peschel, Oliver; Haas-Gebhard, Brigitte; Bachmeier, Beatrice E.; Pusch, Carsten M.; Nerlich, Andreas G.			Reconstructing the Life of an Unknown (ca. 500 Years-Old South American Inca) Mummy - Multidisciplinary Study of a Peruvian Inca Mummy Suggests Severe Chagas Disease and Ritual Homicide	PLOS ONE			English	Article							NORTHERN CHILE; STABLE-ISOTOPE; POPULATIONS; TISSUE; HAIR; BONE; DNA	The paleopathological, paleoradiological, histological, molecular and forensic investigation of a female mummy (radiocarbon dated 1451-1642 AD) provides circumstantial evidence for massive skull trauma affecting a young adult female individual shortly before death along with chronic infection by Trypanosoma cruzi (Chagas disease). The mummy (initially assumed to be a German bog body) was localized by stable isotope analysis to South America at/near the Peruvian/Northern Chilean coast line. This is further supported by New World camelid fibers attached to her plaits, typical Inca-type skull deformation and the type of Wormian bone at her occiput. Despite an only small transverse wound of the supraorbital region computed tomography scans show an almost complete destruction of face and frontal skull bones with terrace-like margins, but without evidence for tissue reaction. The type of destruction indicates massive blunt force applied to the center of the face. Stable isotope analysis indicates South American origin: Nitrogen and hydrogen isotope patterns indicate an extraordinarily high marine diet along with C4-plant alimentation which fits best to the coastal area of Pacific South America. A hair strand over the last ten months of her life indicates a shift to a more "terrestric" nutrition pattern suggesting either a move from the coast or a change in her nutrition. Paleoradiology further shows extensive hypertrophy of the heart muscle and a distended large bowel/rectum. Histologically, in the rectum wall massive fibrosis alternates with residual smooth muscle. The latter contains multiple inclusions of small intracellular parasites as confirmed by immunohistochemical and molecular ancient DNA analysis to represent a chronic Trypanosoma cruzi infection. This case shows a unique paleopathological setting with massive blunt force trauma to the skull nurturing the hypothesis of a ritual homicide as previously described in South American mummies in an individual that suffered from severe chronic Chagas disease.	[Panzer, Stephanie] Paracelsus Med Univ Salzburg, Germany & Biomech Lab, Trauma Ctr Murnau, Dept Radiol, Murnau, Germany; [Panzer, Stephanie] Trauma Ctr Murnau, Murnau, Germany; [Peschel, Oliver] Univ Munich, Inst Legal Med, Munich, Germany; [Haas-Gebhard, Brigitte] Bavarian State Archaeol Collect & Museum, Munich, Germany; [Bachmeier, Beatrice E.] Univ Munich, Inst Lab Med, D-81377 Munich, Germany; [Pusch, Carsten M.] Univ Tubingen, Inst Anthropol & Human Genet, Tubingen, Germany; [Nerlich, Andreas G.] Acad Clin Munchen Bogenhausen, Inst Pathol, Munich, Germany	University of Munich; University of Munich; Eberhard Karls University of Tubingen; Munchen Klinik	Nerlich, AG (corresponding author), Acad Clin Munchen Bogenhausen, Inst Pathol, Munich, Germany.	Andreas.Nerlich@extern.lrz-muenchen.de		Bachmeier, Beatrice/0000-0002-3592-7354; Nerlich, Andreas/0000-0001-6562-1017				Aigner R, 1977, 75 JAHRE ANTHR STAAT, V75, P159; Arriaza BT, 2008, CHUNGARA, V40, P55, DOI 10.4067/S0717-73562008000100006; Aufderheide AC, 2004, P NATL ACAD SCI USA, V101, P2034, DOI 10.1073/pnas.0307312101; Aufderheide AC, 1988, CURRENT ARCHAEOLOGIC, P301; Fernandes A, 2008, MEM I OSWALDO CRUZ, V103, P514, DOI 10.1590/S0074-02762008000500021; Gebhard R, 2014, NEUES MOORL IN PRESS; Gerszten PC, 1993, INT J OSTEOARCHEOL, V3, P87, DOI DOI 10.1002/OA.1390030205; Guhl F, 1999, AM J PHYS ANTHROPOL, V108, P401, DOI 10.1002/(SICI)1096-8644(199904)108:4&lt;401::AID-AJPA2&gt;3.0.CO;2-P; Hanihara T, 2001, J ANAT, V198, P137, DOI 10.1046/j.1469-7580.2001.19820137.x; Hawass Z, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8268; Hawass Z, 2010, JAMA-J AM MED ASSOC, V303, P638, DOI 10.1001/jama.2010.121; Knudson KJ, 2007, J ARCHAEOL SCI, V34, P451, DOI 10.1016/j.jas.2006.07.003; Lessa A, 2006, MEM I OSWALDO CRUZ, V101, P133, DOI 10.1590/S0074-02762006001000020; Macko SA, 1999, PHILOS T ROY SOC B, V354, P65, DOI 10.1098/rstb.1999.0360; Mayer E. F., 1998, VORSPANISCHE METALLW; NERLICH AG, 1993, AM J PHYS ANTHROPOL, V91, P279, DOI 10.1002/ajpa.1330910303; Nerlich AG, 1995, VIRCHOWS ARCH, V427, P423; O'Connell TC, 1999, J ARCHAEOL SCI, V26, P661, DOI 10.1006/jasc.1998.0383; Panzer S, 2013, ANN ANAT, V195, P401, DOI 10.1016/j.aanat.2013.03.009; Reinhard J., 1996, NATL GEOGR, V189, P62; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; SjOvold T, 1990, HUM EVOL, V5, P431, DOI [DOI 10.1007/%2FBF02435593, 10.1007/BF02435593, DOI 10.1007/BF02435593]; Souza SMM, 2008, MUMMIES SCI WORLD MU, P573; Standen VG, 2000, AM J PHYS ANTHROPOL, V112, P239, DOI 10.1002/(SICI)1096-8644(2000)112:2<239::AID-AJPA9>3.0.CO;2-3; Thieme D, 2013, DRUG TEST ANAL, V5, P736, DOI 10.1002/dta.1502; Wilson AS, 2007, P NATL ACAD SCI USA, V104, P16456, DOI 10.1073/pnas.0704276104; Zink A, 2003, AM J PHYS ANTHROPOL, V121, P109, DOI 10.1002/ajpa.10213; Zink AR, 2003, J CLIN MICROBIOL, V41, P359, DOI 10.1128/JCM.41.1.359-367.2003	28	20	20	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89528	10.1371/journal.pone.0089528	http://dx.doi.org/10.1371/journal.pone.0089528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24586848	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000053
J	Ishimoto, T; Nakamichi, N; Hosotani, H; Masuo, Y; Sugiura, T; Kato, Y				Ishimoto, Takahiro; Nakamichi, Noritaka; Hosotani, Hiroshi; Masuo, Yusuke; Sugiura, Tomoko; Kato, Yukio			Organic Cation Transporter-Mediated Ergothioneine Uptake in Mouse Neural Progenitor Cells Suppresses Proliferation and Promotes Differentiation into Neurons	PLOS ONE			English	Article							METHYL-D-ASPARTATE; MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; FUNCTIONAL EXPRESSION; STEM/PROGENITOR CELLS; RECEPTOR ACTIVATION; TRANSCRIPTION FACTORS; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS	The aim of the present study is to clarify the functional expression and physiological role in neural progenitor cells (NPCs) of carnitine/organic cation transporter OCTN1/SLC22A4, which accepts the naturally occurring food-derived antioxidant ergothioneine (ERGO) as a substrate in vivo. Real-time PCR analysis revealed that mRNA expression of OCTN1 was much higher than that of other organic cation transporters in mouse cultured cortical NPCs. Immunocytochemical analysis showed colocalization of OCTN1 with the NPC marker nestin in cultured NPCs and mouse embryonic carcinoma P19 cells differentiated into neural progenitor-like cells (P19-NPCs). These cells exhibited time-dependent [H-3]ERGO uptake. These results demonstrate that OCTN1 is functionally expressed in murine NPCs. Cultured NPCs and P19-NPCs formed neurospheres from clusters of proliferating cells in a culture time-dependent manner. Exposure of cultured NPCs to ERGO or other antioxidants (edaravone and ascorbic acid) led to a significant decrease in the area of neurospheres with concomitant elimination of intracellular reactive oxygen species. Transfection of P19-NPCs with small interfering RNA for OCTN1 markedly promoted formation of neurospheres with a concomitant decrease of [H-3]ERGO uptake. On the other hand, exposure of cultured NPCs to ERGO markedly increased the number of cells immunoreactive for the neuronal marker beta III-tubulin, but decreased the number immunoreactive for the astroglial marker glial fibrillary acidic protein (GFAP), with concomitant up-regulation of neuronal differentiation activator gene Math1. Interestingly, edaravone and ascorbic acid did not affect such differentiation of NPCs, in contrast to the case of proliferation. Knockdown of OCTN1 increased the number of cells immunoreactive for GFAP, but decreased the number immunoreactive for bIII-tubulin, with concomitant down-regulation of Math1 in P19-NPCs. Thus, OCTN1-mediated uptake of ERGO in NPCs inhibits cellular proliferation via regulation of oxidative stress, and also promotes cellular differentiation by modulating the expression of basic helix-loop-helix transcription factors via an unidentified mechanism different from antioxidant action.	[Ishimoto, Takahiro; Nakamichi, Noritaka; Hosotani, Hiroshi; Masuo, Yusuke; Sugiura, Tomoko; Kato, Yukio] Kanazawa Univ, Fac Pharm, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan	Kanazawa University	Kato, Y (corresponding author), Kanazawa Univ, Fac Pharm, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan.	ykato@p.kanazawa-u.ac.jp	Masuo, Yusuke/AAC-4418-2020; Ishimoto, Takahiro/AAC-4387-2020; Nakamichi, Noritaka/AAB-7388-2020; Nakamichi, Noritaka/D-8403-2015; KATO, Yukio/D-8396-2015	Nakamichi, Noritaka/0000-0002-0283-3546; Ishimoto, Takahiro/0000-0002-4799-7763	Ministry of Education, Science and Culture of Japan; Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	This study was supported in part by a Grant-in-Aid for Scientific Research provided by the Ministry of Education, Science and Culture of Japan, the Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation and a grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, NEUROSCI RES, V38, P325, DOI 10.1016/S0168-0102(00)00188-7; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Bacher P, 2009, BBA-BIOMEMBRANES, V1788, P2594, DOI 10.1016/j.bbamem.2009.09.019; Bunk EC, 2010, BRAIN RES, V1359, P22, DOI 10.1016/j.brainres.2010.05.024; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Contestabile A, 2008, PROG NEUROBIOL, V84, P317, DOI 10.1016/j.pneurobio.2008.01.002; Duan HC, 2010, J PHARMACOL EXP THER, V335, P743, DOI 10.1124/jpet.110.170142; Elkouby YM, 2012, DEVELOPMENT, V139, P1487, DOI 10.1242/dev.072934; Fukui M, 2008, J NEUROSCI RES, V86, P2615, DOI 10.1002/jnr.21708; Gilley JA, 2011, EUR J NEUROSCI, V34, P1712, DOI 10.1111/j.1460-9568.2011.07888.x; Grigat S, 2007, BIOCHEM PHARMACOL, V74, P309, DOI 10.1016/j.bcp.2007.04.015; Grundemann D, 2012, PREV MED, V54, pS71, DOI 10.1016/j.ypmed.2011.12.001; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Haines DD, 2012, ACTA PHYSIOL, V204, P487, DOI 10.1111/j.1748-1716.2011.02387.x; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hsieh J, 2013, SCIENCE, V339, P1534, DOI 10.1126/science.1237576; Inazu M, 2006, J NEUROCHEM, V97, P424, DOI 10.1111/j.1471-4159.2006.03757.x; Islam MO, 2005, NEUROSCI RES, V52, P75, DOI 10.1016/j.neures.2005.01.013; Ito H, 2003, J NEUROSCI RES, V71, P648, DOI 10.1002/jnr.10532; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Jong NN, 2011, J PHARMACOL EXP THER, V338, P537, DOI 10.1124/jpet.111.181297; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kato Y, 2010, PHARM RES-DORDR, V27, P832, DOI 10.1007/s11095-010-0076-z; Khunweeraphong N, 2012, J PHARMACOL SCI, V119, P368, DOI 10.1254/jphs.12124FP; Kitayama T, 2003, J NEUROCHEM, V84, P767, DOI 10.1046/j.1471-4159.2003.01567.x; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Lamhonwah AM, 2008, BRAIN DEV-JPN, V30, P31, DOI 10.1016/j.braindev.2007.05.005; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Lao CL, 2013, GLIA, V61, P475, DOI 10.1002/glia.22449; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee SH, 2009, J CELL BIOCHEM, V106, P787, DOI 10.1002/jcb.22013; Lewerenz J, 2012, AMINO ACIDS, V42, P171, DOI 10.1007/s00726-011-0862-x; Meier Y, 2007, DRUG METAB DISPOS, V35, P590, DOI 10.1124/dmd.106.013342; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Motohashi H, 2013, MOL ASPECTS MED, V34, P661, DOI 10.1016/j.mam.2012.11.004; Nakamichi N, 2005, J NEUROCHEM, V93, P84, DOI 10.1111/j.1471-4159.2005.02999.x; Nakamichi N, 2008, J NEUROCHEM, V105, P1996, DOI 10.1111/j.1471-4159.2008.05289.x; Nakamichi N, 2012, NEUROCHEM INT, V61, P1121, DOI 10.1016/j.neuint.2012.08.004; Nakamichi N, 2009, J PHARMACOL SCI, V110, P133, DOI 10.1254/jphs.08R03CR; Nakamura Y, 2012, NEUROCHEM INT, V60, P448, DOI 10.1016/j.neuint.2011.08.018; Nikodemus D, 2011, J PHYSIOL PHARMACOL, V62, P411; Ogura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048270; Okura T, 2008, DRUG METAB DISPOS, V36, P2005, DOI 10.1124/dmd.108.022087; Oppel F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-137; Paul BD, 2010, CELL DEATH DIFFER, V17, P1134, DOI 10.1038/cdd.2009.163; Pochini L., 2011, BIOCHIM BIOPHYS ACTA, V1818, P559; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Schumacher T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035613; Sharma M, 2011, NEUROSCI LETT, V502, P123, DOI 10.1016/j.neulet.2011.05.021; Shuto M, 2009, J PHARMACOL SCI, V109, P60, DOI 10.1254/jphs.08211FP; Sugiura T, 2010, DRUG METAB PHARMACOK, V25, P588, DOI 10.2133/dmpk.DMPK-10-RG-074; Sugiura T, 2010, DRUG METAB DISPOS, V38, P1665, DOI 10.1124/dmd.110.032763; Takarada T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046177; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Taubert D, 2009, GUT, V58, P312, DOI 10.1136/gut.2008.164418; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Wegner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036946; Yamamoto A, 2009, J NEUROSCI RES, V87, P2615, DOI 10.1002/jnr.22094; Yoneda Y, 1999, NEUROSCIENCE, V93, P19, DOI 10.1016/S0306-4522(99)00117-7; Yoneyama M, 2008, J NEUROSCI RES, V86, P2392, DOI 10.1002/jnr.21696; Yoneyama M, 2010, NEUROCHEM INT, V56, P740, DOI 10.1016/j.neuint.2009.11.018; Zhao LY, 2012, J NEUROSCI RES, V90, P447, DOI 10.1002/jnr.22751; Zhou C, 2004, CELL BIOL INT, V28, P63, DOI 10.1016/j.cellbi.2003.10.005	66	33	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89434	10.1371/journal.pone.0089434	http://dx.doi.org/10.1371/journal.pone.0089434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586778	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900044
J	Verhagen, LM; de Jonge, MI; Burghout, P; Schraa, K; Spagnuolo, L; Mennens, S; Eleveld, MJ; van der Gaast-de Jongh, CE; Zomer, A; Hermans, PWM; Bootsma, HJ				Verhagen, Lilly M.; de Jonge, Marien I.; Burghout, Peter; Schraa, Kiki; Spagnuolo, Lorenza; Mennens, Svenja; Eleveld, Marc J.; van der Gaast-de Jongh, Christa E.; Zomer, Aldert; Hermans, Peter W. M.; Bootsma, Hester J.			Genome-Wide Identification of Genes Essential for the Survival of Streptococcus pneumoniae in Human Saliva	PLOS ONE			English	Article							PENICILLIN RESISTANCE; PNEUMOCOCCAL CARRIAGE; ANTIBIOTIC TOLERANCE; MURMN OPERON; PROTEIN; PEPTIDOGLYCAN; COLONIZATION; ANTIBODIES; BIOSYNTHESIS; PHYSIOLOGY	Since Streptococcus pneumoniae transmits through droplet spread, this respiratory tract pathogen may be able to survive in saliva. Here, we show that saliva supports survival of clinically relevant S. pneumoniae strains for more than 24 h in a capsule-independent manner. Moreover, saliva induced growth of S. pneumoniae in growth-permissive conditions, suggesting that S. pneumoniae is well adapted for uptake of nutrients from this bodily fluid. By using Tn-seq, a method for genome-wide negative selection screening, we identified 147 genes potentially required for growth and survival of S. pneumoniae in saliva, among which genes predicted to be involved in cell envelope biosynthesis, cell transport, amino acid metabolism, and stress response predominated. The Tn-seq findings were validated by testing a panel of directed gene deletion mutants for their ability to survive in saliva under two testing conditions: at room temperature without CO2, representing transmission, and at 37 degrees C with CO2, representing in-host carriage. These validation experiments confirmed that the plsX gene and the amiACDEF and aroDEBC operons, involved in respectively fatty acid metabolism, oligopeptide transport, and biosynthesis of aromatic amino acids play an important role in the growth and survival of S. pneumoniae in saliva at 37 degrees C. In conclusion, this study shows that S. pneumoniae is well-adapted for growth and survival in human saliva and provides a genome-wide list of genes potentially involved in adaptation. This notion supports earlier evidence that S. pneumoniae can use human saliva as a vector for transmission.	Radboud Univ Nijmegen, Lab Pediat Infect Dis, Dept Pediat, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Zomer, Aldert] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Bootsma, HJ (corresponding author), Radboud Univ Nijmegen, Lab Pediat Infect Dis, Dept Pediat, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	Hester.Bootsma@radboudumc.nl	Hermans, Peter W.M./H-8042-2014; Verhagen, Lilly M./AAG-3044-2021; Mennens, Svenja/F-3106-2016; Eleveld, Marc J/J-9146-2016; de Jonge, Marien I./P-5869-2015; van der Gaast-de Jongh, Christa E/N-1548-2016	Verhagen, Lilly M./0000-0002-3451-9201; Mennens, Svenja/0000-0003-1099-2894; de Jonge, Marien I./0000-0003-2812-5895; Zomer, Aldert/0000-0002-0758-5190	Nano Cluster of Technology Foundation [STW FES0901: FES HTSM]; European Community [HEALTH-F3-2009-222983]; Agentschap NL [OM111009]	Nano Cluster of Technology Foundation; European Community(European Commission); Agentschap NL	This work was financially supported by Nano Cluster of Technology Foundation STW FES0901: FES HTSM, European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement number HEALTH-F3-2009-222983 (Pneumopath project), and Agentschap NL project number OM111009 (Pneumovac project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; ANDERSSON B, 1983, J EXP MED, V158, P559, DOI 10.1084/jem.158.2.559; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; BOERSMA WG, 1993, SCAND J INFECT DIS, V25, P51, DOI 10.3109/00365549309169669; Bosl B, 2006, J STRUCT BIOL, V156, P139, DOI 10.1016/j.jsb.2006.02.004; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2006, MICROBIOL-SGM, V152, P377, DOI 10.1099/mic.0.28394-0; Bruel N, 2012, J BIOL CHEM, V287, P44435, DOI 10.1074/jbc.M112.418525; Burghout P, 2007, J BACTERIOL, V189, P6540, DOI 10.1128/JB.00573-07; Burghout P, 2013, J BACTERIOL, V195, P1573, DOI 10.1128/JB.01942-12; Chicharro JL, 1999, BRIT J SPORT MED, V33, P204, DOI 10.1136/bjsm.33.3.204; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; Eckhardt TH, 2013, J BACTERIOL, V195, P1081, DOI 10.1128/JB.02043-12; Farnaud SJC, 2010, THESCIENTIFICWORLDJO, V10, P434, DOI 10.1100/tsw.2010.38; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Filipe SR, 2001, MICROB DRUG RESIST, V7, P303, DOI 10.1089/10766290152773310; Filipe SR, 2002, P NATL ACAD SCI USA, V99, P1550, DOI 10.1073/pnas.032671699; Ginsburg I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063062; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hu DK, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-14; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Johnston JW, 2006, INFECT IMMUN, V74, P1171, DOI 10.1128/IAI.74.2.1171-1180.2006; Kerr AR, 2004, INFECT IMMUN, V72, P3902, DOI 10.1128/IAI.72.7.3902-3906.2004; Komatsuzawa H, 2004, MOL MICROBIOL, V53, P1221, DOI 10.1111/j.1365-2958.2004.04200.x; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Larsson B, 1996, ARCH ORAL BIOL, V41, P105, DOI 10.1016/0003-9969(95)00077-1; Levine H, 2012, EPIDEMIOL INFECT, V140, P561, DOI 10.1017/S0950268811000884; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Noble M, 2006, BIOTECHNOL BIOENG, V95, P560, DOI 10.1002/bit.20772; Novak R, 1999, J BACTERIOL, V181, P1126, DOI 10.1128/JB.181.4.1126-1133.1999; Ogunniyi AD, 2010, J BACTERIOL, V192, P4489, DOI 10.1128/JB.00064-10; SCHEUHAMMER AM, 1985, BIOCHIM BIOPHYS ACTA, V840, P163, DOI 10.1016/0304-4165(85)90115-1; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Simell B, 2002, J INFECT DIS, V186, P1106, DOI 10.1086/344235; Simell B, 2001, J INFECT DIS, V183, P887, DOI 10.1086/319246; Simell B, 2007, J INFECT DIS, V196, P1528, DOI 10.1086/522607; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Walsh RL, 2011, MBIO, V2, DOI 10.1128/mBio.00092-11; Wu T, 2011, MICROB PATHOGENESIS, V51, P69, DOI 10.1016/j.micpath.2010.10.001; Wyllie AL, 2013, 31 ANN M EUR SOC PAE; Xie XJ, 2006, APPL MICROBIOL BIOT, V73, P703, DOI 10.1007/s00253-006-0492-5; Zomer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043012	51	30	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89541	10.1371/journal.pone.0089541	http://dx.doi.org/10.1371/journal.pone.0089541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586856	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900053
J	Yamada, S; Nakamura, J; Asada, M; Takase, M; Matsusaka, T; Iguchi, T; Yamada, R; Tanaka, M; Higashi, AY; Okuda, T; Asada, N; Fukatsu, A; Kawachi, H; Graf, D; Muso, E; Kita, T; Kimura, T; Pastan, I; Economides, AN; Yanagita, M				Yamada, Sachiko; Nakamura, Jin; Asada, Misako; Takase, Masayuki; Matsusaka, Taiji; Iguchi, Taku; Yamada, Ryo; Tanaka, Mari; Higashi, Atsuko Y.; Okuda, Tomohiko; Asada, Nariaki; Fukatsu, Atsushi; Kawachi, Hiroshi; Graf, Daniel; Muso, Eri; Kita, Toru; Kimura, Takeshi; Pastan, Ira; Economides, Aris N.; Yanagita, Motoko			Twisted Gastrulation, a BMP Antagonist, Exacerbates Podocyte Injury	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; RENAL FIBROSIS; KIDNEY; MOUSE; USAG-1; CELL; GLOMERULOSCLEROSIS; PODOCYTOPATHIES; PODOCALYXIN; INVOLVEMENT	Podocyte injury is the first step in the progression of glomerulosclerosis. Previous studies have demonstrated the beneficial effect of bone morphogenetic protein 7 (Bmp7) in podocyte injury and the existence of native Bmp signaling in podocytes. Local activity of Bmp7 is controlled by cell-type specific Bmp antagonists, which inhibit the binding of Bmp7 to its receptors. Here we show that the product of Twisted gastrulation (Twsg1), a Bmp antagonist, is the central negative regulator of Bmp function in podocytes and that Twsg1 null mice are resistant to podocyte injury. Twsg1 was the most abundant Bmp antagonist in murine cultured podocytes. The administration of Bmp induced podocyte differentiation through Smad signaling, whereas the simultaneous administration of Twsg1 antagonized the effect. The administration of Bmp also inhibited podocyte proliferation, whereas simultaneous administration of Twsg1 antagonized the effect. Twsg1 was expressed in the glomerular parietal cells (PECs) and distal nephron of the healthy kidney, and additionally in damaged glomerular cells in a murine model of podocyte injury. Twsg1 null mice exhibited milder hypoalbuminemia and hyperlipidemia, and milder histological changes while maintaining the expression of podocyte markers during podocyte injury model. Taken together, our results show that Twsg1 plays a critical role in the modulation of protective action of Bmp7 on podocytes, and that inhibition of Twsg1 is a promising means of development of novel treatment for podocyte injury.	[Yamada, Sachiko; Nakamura, Jin; Asada, Misako; Takase, Masayuki; Yamada, Ryo; Tanaka, Mari; Okuda, Tomohiko; Asada, Nariaki; Yanagita, Motoko] Kyoto Univ, Dept Nephrol, Grad Sch Med, Kyoto, Japan; [Matsusaka, Taiji] Tokai Univ, Sch Med, Dept Internal Med, Isehara, Kanagawa 25911, Japan; [Iguchi, Taku] Kyoto Univ, TMK Project, Grad Sch Med, Kyoto, Japan; [Higashi, Atsuko Y.; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Fukatsu, Atsushi] Yachiyo Hosp, Anjo, Aichi, Japan; [Kawachi, Hiroshi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cell Biol, Inst Nephrol, Niigata, Japan; [Graf, Daniel] Univ Zurich, Inst Oral Biol, Fac Med, Zurich, Switzerland; [Muso, Eri] Tazuke Kofukai Med Res Inst, Dept Nephrol & Dialysis, Kitano Hosp, Osaka, Japan; [Kita, Toru] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan; [Pastan, Ira] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Economides, Aris N.] Regeneron Pharmaceut Inc, Tarrytown, NY USA	Kyoto University; Tokai University; Kyoto University; Kyoto University; Niigata University; University of Geneva; University of Zurich; Kitano Hospital; Kobe City Medical Center General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Regeneron	Yanagita, M (corresponding author), Kyoto Univ, Dept Nephrol, Grad Sch Med, Kyoto, Japan.	motoy@kuhp.kyoto-u.ac.jp	pastan, ira/P-9319-2019; FUKATSU, ATSUSHI/R-7941-2019; Yanagita, Motoko/AAJ-7731-2021	pastan, ira/0000-0002-9223-0270; Tanaka, Mari/0000-0003-2187-1406; Economides, Aris/0000-0002-6508-8942; Yamada, Ryo/0000-0002-1587-630X; Graf, Daniel/0000-0003-1163-8117; Yanagita, Motoko/0000-0002-0339-9008	Japan Society of the Promotion of Science (JSPS) through the Funding Program for Next-Generation World-Leading Researchers (NEXT program); Ministry of Education, Culture, Sports, Science and Technology of Japan [Shin-gakujyutsu 21200080]; Astellas Foundation for Research on Metabolic Disorders; NATIONAL CANCER INSTITUTE [ZIABC008753] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22249033, 23390224] Funding Source: KAKEN	Japan Society of the Promotion of Science (JSPS) through the Funding Program for Next-Generation World-Leading Researchers (NEXT program); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation for Research on Metabolic Disorders; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society of the Promotion of Science (JSPS) through the Funding Program for Next-Generation World-Leading Researchers (NEXT program), Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Shin-gakujyutsu 21200080), and grants from the Astellas Foundation for Research on Metabolic Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpers CE, 2011, CURR OPIN NEPHROL HY, V20, P278, DOI 10.1097/MNH.0b013e3283451901; Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; D'Agati VD, 2008, KIDNEY INT, V73, P399, DOI 10.1038/sj.ki.5002655; De Petris L, 2007, NEPHROL DIAL TRANSPL, V22, P3442, DOI 10.1093/ndt/gfm503; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x; Harland RM, 2001, NATURE, V410, P423, DOI 10.1038/35068657; Hong CC, 2009, CYTOKINE GROWTH F R, V20, P409, DOI 10.1016/j.cytogfr.2009.10.021; Ikeya M, 2010, DEV BIOL, V337, P405, DOI 10.1016/j.ydbio.2009.11.013; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; KREITMAN RJ, 1994, BLOOD, V83, P426; Larman BW, 2009, J AM SOC NEPHROL, V20, P1020, DOI 10.1681/ASN.2008070768; Larrain J, 2001, DEVELOPMENT, V128, P4439; Leeuwis JW, 2011, J PATHOL, V224, P121, DOI 10.1002/path.2844; Lehir M, 2007, CURR OPIN NEPHROL HY, V16, P184, DOI 10.1097/MNH.0b013e3280c8eed3; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Massague J, 2000, GENE DEV, V14, P627; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Mitu GM, 2007, AM J PHYSIOL-RENAL, V293, pF1641, DOI 10.1152/ajprenal.00179.2007; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Ohse T, 2009, KIDNEY INT, V76, P1225, DOI 10.1038/ki.2009.386; Passa O, 2011, IMMUNOLOGY, V134, P349, DOI 10.1111/j.1365-2567.2011.03495.x; Petryk A, 2004, DEV BIOL, V267, P374, DOI 10.1016/j.ydbio.2003.11.015; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Schonenberger E, 2011, NEPHROL DIAL TRANSPL, V26, P18, DOI 10.1093/ndt/gfq617; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; Sun M, 2010, NEUROSCIENCE, V169, P920, DOI 10.1016/j.neuroscience.2010.05.026; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tanaka M, 2008, KIDNEY INT, V73, P181, DOI 10.1038/sj.ki.5002626; Tanaka M, 2010, J CLIN INVEST, V120, P768, DOI 10.1172/JCI39569; Tsalavos S, 2011, J IMMUNOL, V186, P6860, DOI 10.4049/jimmunol.1001833; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wang SN, 2006, J AM SOC NEPHROL, V17, P2504, DOI 10.1681/ASN.2006030278; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yanagita M, 2006, KIDNEY INT, V70, P989, DOI 10.1038/sj.ki.5001731; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yanagita M, 2005, CYTOKINE GROWTH F R, V16, P309, DOI 10.1016/j.cytogfr.2005.02.007; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075; Yanagita M, 2009, BIOFACTORS, V35, P113, DOI 10.1002/biof.15; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zakin L, 2004, DEVELOPMENT, V131, P413, DOI 10.1242/dev.00946; Zeisberg M, 2003, AM J PHYSIOL-RENAL, V285, pF1060, DOI 10.1152/ajprenal.00191.2002; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	50	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89135	10.1371/journal.pone.0089135	http://dx.doi.org/10.1371/journal.pone.0089135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586548	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900028
J	Bhattacharya, R; Xu, FX; Dong, GY; Li, S; Tian, C; Ponugoti, B; Graves, DT				Bhattacharya, Rupa; Xu, Fanxing; Dong, Guangyu; Li, Shuai; Tian, Chen; Ponugoti, Bhaskar; Graves, Dana T.			Effect of Bacteria on the Wound Healing Behavior of Oral Epithelial Cells	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS PROTEINASES; CYCLIN-DEPENDENT KINASES; VIRULENCE; PROGRESSION; INTEGRINS; REPAIR	Wounded tissue offers opportunity to microflora to adhere, colonize, invade and infect surrounding healthy tissue. The bacteria of the oral cavity have the potential to alter the wound healing process by interacting with keratinocytes. The aim of this study was to investigate mechanisms through which oral bacteria may influence re-epithelialization by interacting with gingival keratinocytes. By an in vitro scratch assay we demonstrate that primary gingival keratinocytes have impaired closure when exposed to two well characterized oral bacteria, P. gingivalis, and to a lesser extent, F. nucleatum. P. gingivalis reduced wound closure by similar to 40%, which was partially dependent on proteolytic activity, and bacteria was still present within infected cells 9 days later despite exposure to bacteria for only 24 h. Both oral bacteria caused keratinocyte apoptosis at the wound site with cell death being greatest at the wound edge. P. gingivalis and F. nucleatum adversely affected cell proliferation and the effect also had a spatial component being most striking at the edge. The impact of the bacteria was long lasting even when exposure was brief. Cell migration was compromised in bacteria challenged keratinocytes with P. gingivalis having more severe effect (p < 0.05) than F. nucleatum. Quantitative real time PCR of bacteria challenged cells showed that P. gingivalis and to a lesser extent F. nucleatum significantly downregulated cell cycle genes cyclin1, CDK1, and CDK4 (p < 0.05) that are critical for GI/S transition. Further, genes associated with cell migration such as integrin beta-3 and -6 were significantly downregulated by P. gingivalis (p < 0.05).	[Bhattacharya, Rupa; Xu, Fanxing; Dong, Guangyu; Tian, Chen; Ponugoti, Bhaskar; Graves, Dana T.] Univ Penn, Sch Dent Med, Dept Periodont, Philadelphia, PA 19104 USA; [Xu, Fanxing] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China; [Li, Shuai] Peking Univ, Sch & Hosp Stomatol, Dept Implant Dent, Beijing 100871, Peoples R China	University of Pennsylvania; Dalian University of Technology; Peking University	Graves, DT (corresponding author), Univ Penn, Sch Dent Med, Dept Periodont, Philadelphia, PA 19104 USA.	dtgraves@dental.upenn.edu			National Institute of Dental and Craniofacial Research [DE018307, DE019108]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018307] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by funding from the National Institute of Dental and Craniofacial Research, DE018307 and DE019108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2007, FRONT BIOSCI, V12, P3965, DOI 10.2741/2363; Aswini Y B, 2009, J Indian Soc Pedod Prev Dent, V27, P2, DOI 10.4103/0970-4388.50808; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Brozovic S, 2006, MICROBIOL-SGM, V152, P797, DOI 10.1099/mic.0.28472-0; Dale BA, 2002, PERIODONTOL 2000, V30, P70, DOI 10.1034/j.1600-0757.2002.03007.x; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; de Mendonca RJ, 2009, AN BRAS DERMATOL, V84, P257, DOI 10.1590/S0365-05962009000300007; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Furuta N, 2009, INFECT IMMUN, V77, P4761, DOI 10.1128/IAI.00841-09; Graves DT, 2011, J ORAL MICROBIOL, V3; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x; Han A, 2011, WOUND REPAIR REGEN, V19, P532, DOI 10.1111/j.1524-475X.2011.00720.x; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Hayashi C, 2011, ATHEROSCLEROSIS, V215, P52, DOI 10.1016/j.atherosclerosis.2010.12.009; HEDNER E, 1990, J ORAL PATHOL MED, V19, P471, DOI 10.1111/j.1600-0714.1990.tb00789.x; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Kadowaki T, 2000, J BIOCHEM, V128, P153, DOI 10.1093/oxfordjournals.jbchem.a022735; Kuboniwa M, 2008, MICROBES INFECT, V10, P122, DOI 10.1016/j.micinf.2007.10.011; Kuboniwa M, 2012, EXPERT REV PROTEOMIC, V9, P311, DOI [10.1586/EPR.12.16, 10.1586/epr.12.16]; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Scales BS, 2013, J PATHOL, V229, P323, DOI 10.1002/path.4118; Siddiqui AR, 2010, CLIN DERMATOL, V28, P519, DOI 10.1016/j.clindermatol.2010.03.009; Tang L, 2010, BRIT J DERMATOL, V163, P38, DOI 10.1111/j.1365-2133.2010.09748.x; Travis J, 1997, J PERIODONTAL RES, V32, P120, DOI 10.1111/j.1600-0765.1997.tb01392.x; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Yilmaz O, 2003, MICROBIOL-SGM, V149, P2417, DOI 10.1099/mic.0.26483-0	31	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89475	10.1371/journal.pone.0089475	http://dx.doi.org/10.1371/journal.pone.0089475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586806	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900103
J	Garcia-Faroldi, G; Melo, FR; Bruemmer, D; Conneely, OM; Pejler, G; Lundequist, A				Garcia-Faroldi, Gianni; Melo, Fabio R.; Bruemmer, Dennis; Conneely, Orla M.; Pejler, Gunnar; Lundequist, Anders			Nuclear Receptor 4a3 (Nr4a3) Regulates Murine Mast Cell Responses and Granule Content	PLOS ONE			English	Article							PROTEASE 6 GENE; TRANSCRIPTION FACTOR; BACTERIAL-INFECTIONS; GROWTH-FACTOR; EXPRESSION; NUR77; APOPTOSIS; NOR-1; DEGRANULATION; MACROPHAGES	Nuclear receptor 4a3 (Nr4a3) is a transcription factor implicated in various settings such as vascular biology and inflammation. We have recently shown that mast cells dramatically upregulate Nuclear receptor 4a3 upon activation, and here we investigated the functional impact of Nuclear receptor 4a3 on mast cell responses. We show that Nuclear receptor 4a3 is involved in the regulation of cytokine/chemokine secretion in mast cells following activation via the high affinity IgE receptor. Moreover, Nuclear receptor 4a3 negatively affects the transcript and protein levels of mast cell tryptase as well as the mast cell's responsiveness allergen. Together, these findings identify Nuclear receptor 4a3 as a novel regulator of mast cell function.	[Garcia-Faroldi, Gianni; Melo, Fabio R.; Pejler, Gunnar; Lundequist, Anders] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, Uppsala, Sweden; [Bruemmer, Dennis] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Wethington, KY USA; [Conneely, Orla M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Swedish University of Agricultural Sciences; University of Kentucky; Baylor College of Medicine	Lundequist, A (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, Uppsala, Sweden.	Anders.Lundequist@slu.se	Melo, Fabio Rabelo/GQP-0844-2022		Magnus Bergvall Foundation; Swedish Cancer Foundation; Swedish Research Council, Formas, King Gustaf V's; Fundacion Espanola para la Ciencia y la Tecnologia y Ministerio de Educacion, Cultura y Deporte	Magnus Bergvall Foundation; Swedish Cancer Foundation; Swedish Research Council, Formas, King Gustaf V's; Fundacion Espanola para la Ciencia y la Tecnologia y Ministerio de Educacion, Cultura y Deporte	This work was supported by grants from: Magnus Bergvall Foundation, The Swedish Cancer Foundation, The Swedish Research Council, Formas, King Gustaf V's 80-year Anniversary Fund, and Fundacion Espanola para la Ciencia y la Tecnologia y Ministerio de Educacion, Cultura y Deporte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arinobu Yojiro, 2009, Allergology International, V58, P21, DOI 10.2332/allergolint.08-RAI-0067; Beaudry G, 2000, J NEUROCHEM, V75, P1694, DOI 10.1046/j.1471-4159.2000.0751694.x; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Cerella C, 2009, ANN NY ACAD SCI, V1171, P559, DOI 10.1111/j.1749-6632.2009.04901.x; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; Duelli A, 2009, J IMMUNOL, V183, P7073, DOI 10.4049/jimmunol.0900309; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hernandez-Hansen V, 2004, J IMMUNOL, V173, P100, DOI 10.4049/jimmunol.173.1.100; Kim DK, 2004, ARCH BIOCHEM BIOPHYS, V431, P71, DOI 10.1016/j.abb.2004.07.027; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Klein M, 2006, J IMMUNOL, V177, P6667, DOI 10.4049/jimmunol.177.10.6667; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; Lundequist A, CELL MOL LIFE SCI, V68, P965; Lundequist A, 2011, MOL IMMUNOL, V48, P1753, DOI 10.1016/j.molimm.2011.04.017; Lundequist A, 2011, CELL MOL LIFE SCI, V68, P965, DOI 10.1007/s00018-010-0587-0; Maheux J, 2005, J PHARMACOL EXP THER, V313, P460, DOI 10.1124/jpet.104.080184; MARTIN SJ, 1990, J IMMUNOL, V145, P1859; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Melo FR, 2011, SCAND J IMMUNOL, V74, P354, DOI 10.1111/j.1365-3083.2011.02589.x; Melo FR, 2011, J BIOL CHEM, V286, P5423, DOI 10.1074/jbc.M110.176461; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Morii E, 1996, BLOOD, V88, P2488, DOI 10.1182/blood.V88.7.2488.bloodjournal8872488; Murakami M, 2007, MOL CELL BIOCHEM, V303, P251, DOI 10.1007/s11010-007-9474-x; Nakagomi D, 2012, INT ARCH ALLERGY IMM, V158, P92, DOI 10.1159/000337800; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Ogihara H, 1999, ONCOGENE, V18, P4632, DOI 10.1038/sj.onc.1202844; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Peng YD, 2005, J LEUKOCYTE BIOL, V77, P975, DOI 10.1189/jlb.0204115; Piliponsky AM, 2010, AM J PATHOL, V176, P926, DOI 10.2353/ajpath.2010.090342; Pols TWH, 2007, CURR OPIN LIPIDOL, V18, P515, DOI 10.1097/MOL.0b013e3282ef77d1; Pullen NA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00117; Ronnberg E, 2012, METHODS MOL BIOL, V836, P201, DOI 10.1007/978-1-61779-498-8_14; Ronnberg E, 2010, INFECT IMMUN, V78, P854, DOI 10.1128/IAI.01004-09; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Thompson J, 2010, EUR J IMMUNOL, V40, P2041, DOI 10.1002/eji.200940231; Tshori S, 2010, J LEUKOCYTE BIOL, V88, P837, DOI 10.1189/jlb.0610365; Waern I, 2012, MUCOSAL IMMUNOL; Waern I, 2012, BIOL CHEM, V393, P1555, DOI 10.1515/hsz-2012-0189; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	47	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89311	10.1371/journal.pone.0089311	http://dx.doi.org/10.1371/journal.pone.0089311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586680	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700099
J	Lyoo, CH; Zanotti-Fregonara, P; Zoghbi, SS; Liow, JS; Xu, R; Pike, VW; Zarate, CA; Fujita, M; Innis, RB				Lyoo, Chul Hyoung; Zanotti-Fregonara, Paolo; Zoghbi, Sami S.; Liow, Jeih-San; Xu, Rong; Pike, Victor W.; Zarate, Carlos A., Jr.; Fujita, Masahiro; Innis, Robert B.			Image- Derived Input Function Derived from a Supervised Clustering Algorithm: Methodology and Validation in a Clinical Protocol Using [C-11](R)-Rolipram	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DYNAMIC PET IMAGES; MICROGLIAL ACTIVATION; BRAIN; PHOSPHODIESTERASE-4; QUANTIFICATION; SEGMENTATION; RADIOLIGAND; DISEASE	Image-derived input function (IDIF) obtained by manually drawing carotid arteries (manual-IDIF) can be reliably used in [C-11](R)-rolipram positron emission tomography (PET) scans. However, manual-IDIF is time consuming and subject to interand intra-operator variability. To overcome this limitation, we developed a fully automated technique for deriving IDIF with a supervised clustering algorithm (SVCA). To validate this technique, 25 healthy controls and 26 patients with moderate to severe major depressive disorder (MDD) underwent T1-weighted brain magnetic resonance imaging (MRI) and a 90-minute [C-11](R)-rolipram PET scan. For each subject, metabolite-corrected input function was measured from the radial artery. SVCA templates were obtained from 10 additional healthy subjects who underwent the same MRI and PET procedures. ClusterIDIF was obtained as follows: 1) template mask images were created for carotid and surrounding tissue; 2) parametric image of weights for blood were created using SVCA; 3) mask images to the individual PET image were inversely normalized; 4) carotid and surrounding tissue time activity curves (TACs) were obtained from weighted and unweighted averages of each voxel activity in each mask, respectively; 5) partial volume effects and radiometabolites were corrected using individual arterial data at four points. Logan-distribution volume (VT/fP) values obtained by cluster-IDIF were similar to reference results obtained using arterial data, as well as those obtained using manual-IDIF; 39 of 51 subjects had a VT/fP error of,5%, and only one had error.10%. With automatic voxel selection, cluster-IDIF curves were less noisy than manual-IDIF and free of operator-related variability. Cluster-IDIF showed widespread decrease of about 20% [C-11](R)-rolipram binding in the MDD group. Taken together, the results suggest that cluster-IDIF is a good alternative to full arterial input function for estimating Logan-VT/fP in [C-11](R)-rolipram PET clinical scans. This technique enables fully automated extraction of IDIF and can be applied to other radiotracers with similar kinetics.	[Lyoo, Chul Hyoung] Yonsei Univ, Coll Med, Dept Neurol, Gangnam Severance Hosp, Seoul, South Korea; [Zanotti-Fregonara, Paolo; Zoghbi, Sami S.; Liow, Jeih-San; Xu, Rong; Pike, Victor W.; Fujita, Masahiro; Innis, Robert B.] NIMH, Mol Imaging Branch, NIH, Bethesda, MD 20892 USA; [Zanotti-Fregonara, Paolo] Univ Bordeaux, CNRS, INCIA, UMR 5287, Talence, France; [Zarate, Carlos A., Jr.] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, Bethesda, MD 20892 USA	Yonsei University; Yonsei University Health System; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Innis, RB (corresponding author), NIMH, Mol Imaging Branch, NIH, Bethesda, MD 20892 USA.	robert.innis@nih.gov	Pike, Victor/AAJ-4139-2020; Zarate, Carlos/ABD-6843-2021	Fujita, Masahiro/0000-0001-7078-6844; Lyoo, Chul Hyoung/0000-0003-2231-672X	Intramural Research Program of the National Institute of Mental Health, National Institutes of Health (IRP-NIMH-NIH); NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002852, ZIAMH002793] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Mental Health, National Institutes of Health (IRP-NIMH-NIH); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Intramural Research Program of the National Institute of Mental Health, National Institutes of Health (IRP-NIMH-NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 1999, NEUROPSYCHOPHARMACOL, V20, P650, DOI 10.1016/S0893-133X(98)00107-9; Boudraa AO, 1999, COMPUT MED IMAG GRAP, V23, P181, DOI 10.1016/S0895-6111(99)00017-8; Catana C, 2012, J NUCL MED, V53, P1916, DOI 10.2967/jnumed.112.105346; Chen K, 2007, PHYS MED BIOL, V52, P7055, DOI 10.1088/0031-9155/52/23/019; Chen K, 1998, J CEREBR BLOOD F MET, V18, P716, DOI 10.1097/00004647-199807000-00002; CHIOU WL, 1989, CLIN PHARMACOKINET, V17, P275, DOI 10.2165/00003088-198917040-00005; Croteau E, 2010, EUR J NUCL MED MOL I, V37, P1539, DOI 10.1007/s00259-010-1443-z; Edison P, 2013, NEUROPSYCHOPHARMACOL, V38, P938, DOI 10.1038/npp.2012.255; Fujita M, 2005, NEUROIMAGE, V26, P1201, DOI 10.1016/j.neuroimage.2005.03.017; Fujita M, 2012, BIOL PSYCHIAT, V72, P548, DOI 10.1016/j.biopsych.2012.04.030; Fung EK, 2009, IEEE NUCL SCI CONF R, P2710, DOI 10.1109/NSSMIC.2009.5401977; Juslin Anu, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1077; Kimura Y, 2002, PHYS MED BIOL, V47, P455, DOI 10.1088/0031-9155/47/3/307; Liptrot M, 2004, NEUROIMAGE, V21, P483, DOI 10.1016/j.neuroimage.2003.09.058; Litton JE, 1997, J COMPUT ASSIST TOMO, V21, P907, DOI 10.1097/00004728-199711000-00012; Manjeshwar RM, 2006, Patent, Patent No. [US 7006677 B2, 7006677]; Maroy R, 2008, IEEE T MED IMAGING, V27, P342, DOI 10.1109/TMI.2007.905106; Mateos-Perez JM, 2013, COMPUT METH PROG BIO, V111, P308, DOI 10.1016/j.cmpb.2013.04.010; Okello A, 2009, NEUROLOGY, V72, P56, DOI 10.1212/01.wnl.0000338622.27876.0d; Rizzo G., 2013, J CEREB BLOOD FLOW M; Sattler B, 2013, MAGN RESON MATER PHY, V26, P159, DOI 10.1007/s10334-012-0347-2; SAWADA Y, 1990, AM J PHYSIOL, V258, pH1585, DOI 10.1152/ajpheart.1990.258.5.H1585; Schuitemaker A, 2013, NEUROBIOL AGING, V34, P128, DOI 10.1016/j.neurobiolaging.2012.04.021; Turkheimer FE, 2007, J NUCL MED, V48, P158; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wong KP, 2002, IEEE T NUCL SCI, V49, P200, DOI 10.1109/TNS.2002.998752; Yaqub M, 2012, J CEREBR BLOOD F MET, V32, P1600, DOI 10.1038/jcbfm.2012.59; Zanotti-Fregonara P, 2012, NEUROIMAGE, V63, P1532, DOI 10.1016/j.neuroimage.2012.08.007; Zanotti-Fregonara P, 2012, NUCL MED COMMUN, V33, P982, DOI 10.1097/MNM.0b013e328356185c; Zanotti-Fregonara P, 2011, J CEREBR BLOOD F MET, V31, P1986, DOI 10.1038/jcbfm.2011.107; Zanotti-Fregonara P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017056; Zanotti-Fregonara P, 2011, NEUROIMAGE, V54, P1903, DOI 10.1016/j.neuroimage.2010.10.064; Zanotti-Fregonara P, 2009, J CEREBR BLOOD F MET, V29, P1825, DOI 10.1038/jcbfm.2009.93; Zoghbi SS, 2006, J NUCL MED, V47, P520	34	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89101	10.1371/journal.pone.0089101	http://dx.doi.org/10.1371/journal.pone.0089101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586526	Green Submitted, gold, Green Published			2022-12-27	WOS:000331714700060
J	Jung, K; LePendu, P; Chen, WS; Iyer, SV; Readhead, B; Dudley, JT; Shah, NH				Jung, Kenneth; LePendu, Paea; Chen, William S.; Iyer, Srinivasan V.; Readhead, Ben; Dudley, Joel T.; Shah, Nigam H.			Automated Detection of Off-Label Drug Use	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENE-EXPRESSION OMNIBUS; DOUBLE-BLIND; PPAR-GAMMA; SAFETY; EFFICACY; BEVACIZUMAB; VALIDATION; MIGRAINE; PATIENT	Off-label drug use, defined as use of a drug in a manner that deviates from its approved use defined by the drug's FDA label, is problematic because such uses have not been evaluated for safety and efficacy. Studies estimate that 21% of prescriptions are off-label, and only 27% of those have evidence of safety and efficacy. We describe a data-mining approach for systematically identifying off-label usages using features derived from free text clinical notes and features extracted from two databases on known usage (Medi-Span and DrugBank). We trained a highly accurate predictive model that detects novel off-label uses among 1,602 unique drugs and 1,472 unique indications. We validated 403 predicted uses across independent data sources. Finally, we prioritize well-supported novel usages for further investigation on the basis of drug safety and cost.	[Jung, Kenneth; Iyer, Srinivasan V.] Stanford Univ, Program Biomed Informat, Stanford, CA 94305 USA; [Dudley, Joel T.] Icahn Sch Med Mt Sinai, New York, NY USA; [LePendu, Paea; Chen, William S.; Shah, Nigam H.] Stanford Univ, Ctr Biomed Informat Res, Stanford, CA 94305 USA	Stanford University; Icahn School of Medicine at Mount Sinai; Stanford University	Jung, K (corresponding author), Stanford Univ, Program Biomed Informat, Stanford, CA 94305 USA.	kjung@stanford.edu		LePendu, Paea/0000-0001-7358-931X	National Institutes of Health [U54-HG004028]; Smith Stanford Graduate Fellowship; Bio-X Interdisciplinary Initiatives Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033, R01LM011369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Stanford Graduate Fellowship; Bio-X Interdisciplinary Initiatives Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors acknowledge support from National Institutes of Health grant U54-HG004028 for the National Center for Biomedical Ontology. KJ was supported by the Smith Stanford Graduate Fellowship. WC was funded by the Bio-X Interdisciplinary Initiatives Program (http://biox.stanford.edu/grant/iip_program.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Avillach P, 2013, J AM MED INFORM ASSN, V20, P446, DOI 10.1136/amiajnl-2012-001083; Banko M, 2001, 39TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P26, DOI 10.3115/1073012.1073017; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Brown SH, 2004, STUD HEALTH TECHNOL, V107, P477; Chapman WW, 2011, J AM MED INFORM ASSN, V18, P540, DOI 10.1136/amiajnl-2011-000465; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; Chen DT, 2009, PHARMACOEPIDEM DR S, V18, P1094, DOI 10.1002/pds.1825; Chen ES, 2008, J AM MED INFORM ASSN, V15, P87, DOI 10.1197/jamia.M2401; Chu D, 2007, BIONLP 2007 BIOL TRA, P81, DOI 10.3115/1572392.1572408; Dal Pan GJ, 2012, CLIN PHARMACOL THER, V91, P787, DOI 10.1038/clpt.2012.24; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Epstein RS, 2012, CLIN PHARMACOL THER, V91, P755, DOI 10.1038/clpt.2012.37; Flowers CM, 2006, NEW ENGL J MED, V354, P773, DOI 10.1056/NEJMc055301; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Grip O, 2002, INFLAMM RES, V51, P58, DOI 10.1007/BF02684000; Hagenbeek A, 2008, BLOOD, V111, P5486, DOI 10.1182/blood-2007-10-117671; Halevy A, 2009, IEEE INTELL SYST, V24, P8, DOI 10.1109/MIS.2009.36; Hayat SJ, 2007, CLIN RHEUMATOL, V26, P973, DOI 10.1007/s10067-006-0219-0; Iyer SV, 2013, AMIA SUMMITS TRANSL; Jung Kenneth, 2013, AMIA Jt Summits Transl Sci Proc, V2013, P94; Kimland E, 2012, CLIN PHARMACOL THER, V91, P796, DOI 10.1038/clpt.2012.26; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lampl C, 2005, J NEUROL NEUROSUR PS, V76, P1730, DOI 10.1136/jnnp.2005.063750; Lependu P, 2013, CLIN PHARM THER; LePendu P, 2012, ANAL PATTERNS DRUG U; Li Ying, 2011, AMIA Annu Symp Proc, V2011, P768; Liu Yi, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P47; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Meltzer DO, 2011, MED DECIS MAKING, V31, pE1, DOI 10.1177/0272989X11412975; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P3077, DOI 10.1002/art.27601; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Morris J, 2012, CLIN PHARMACOL THER, V91, P937, DOI 10.1038/clpt.2012.30; Nelson SJ, 2011, J AM MED INFORM ASSN, V18, P441, DOI 10.1136/amiajnl-2011-000116; Or R, 2003, BLOOD, V101, P441, DOI 10.1182/blood-2002-02-0535; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pizzolato R, 2011, J HEADACHE PAIN, V12, P521, DOI 10.1007/s10194-011-0338-0; Platt JC, 2000, ADV NEUR IN, P61; Platt R, 2012, PHARMACOEPIDEM DR S, V21, P1, DOI 10.1002/pds.2343; Poissant L, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-10; Poole SG, 2004, SUPPORT CARE CANCER, V12, P302, DOI 10.1007/s00520-004-0593-6; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Rindflesch Thomas C, 2005, AMIA Annu Symp Proc, P634; Shakoor N, 2002, LANCET, V359, P579, DOI 10.1016/S0140-6736(02)07714-0; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Stafford RS, 2012, CLIN PHARMACOL THER, V91, P920, DOI 10.1038/clpt.2012.22; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Tsentralfarband fun die bundistishe organisatsyonen in Amerika, 1905, KEMFER, V1, P1; Uzuner O, 2011, J AM MED INFORM ASSN, V18, P552, DOI 10.1136/amiajnl-2011-000203; Wei Wei-Qi, 2013, AMIA Jt Summits Transl Sci Proc, V2013, P172; Weiss-Smith S, 2011, ARCH INTERN MED, V171, P591, DOI 10.1001/archinternmed.2011.89; Xu R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-181	55	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89324	10.1371/journal.pone.0089324	http://dx.doi.org/10.1371/journal.pone.0089324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586689	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900124
J	Monecke, S; Stieber, B; Roberts, R; Akpaka, PE; Slickers, P; Ehricht, R				Monecke, Stefan; Stieber, Bettina; Roberts, Rashida; Akpaka, Patrick Eberechi; Slickers, Peter; Ehricht, Ralf			Population Structure of Staphylococcus aureus from Trinidad & Tobago	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; MOLECULAR EPIDEMIOLOGY; CLONES; MEC	It has been shown previously that high rates of methicillin-and mupirocin-resistant Staphylococcus aureus exist in the Caribbean islands of Trinidad and Tobago, as well as a high prevalence of Panton-Valentine leukocidin-positive S. aureus. Beyond these studies, limited typing data have been published. In order to obtain insight into the population structure not only of MRSA but also of methicillin-susceptible S. aureus, 294 clinical isolates collected in 2012/2013 were typed by microarray hybridisation. A total of 15.31% of the tested isolates were MRSA and 50.00% were PVL-positive. The most common MSSA strains were PVL-positive CC8-MSSA (20.41% of all isolates tested), PVL-positive CC152-MSSA (9.52%) and PVL-positive CC30-MSSA (8.84%) while the most common MRSA were ST239-MRSA-III&SCCmer (9.18%) and ST8-MRSA-IV, "USA300" (5.78%). 2.38% of characterised isolates belonged to distinct strains likely to be related to "Staphylococcus argenteus" lineages. The population structure of S. aureus isolates suggests an importation of strains from Africa, endemicity of PVL-positive MSSA (mainly CC8) and of ST239-MRSA-III, and a recent emergence of the PVL-positive CC8-MRSA-IV strain "USA300".	[Monecke, Stefan; Stieber, Bettina] Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany; [Monecke, Stefan; Stieber, Bettina; Slickers, Peter; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Roberts, Rashida; Akpaka, Patrick Eberechi] Univ W Indies, Dept Paraclin Sci, St Augustine, Trinidad Tobago	Technische Universitat Dresden; Alere; University West Indies Mona Jamaica; University West Indies Saint Augustine	Monecke, S (corresponding author), Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany.	monecke@rocketmail.com		Akpaka, Patrick Eberechi/0000-0001-9895-3077				Akobi B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-279; Akpaka PE, 2007, INT J INFECT DIS, V11, P544, DOI 10.1016/j.ijid.2007.03.004; Akpaka Patrick E, 2011, J Med Case Rep, V5, P157, DOI 10.1186/1752-1947-5-157; Akpaka Patrick Eberechi, 2006, Ann Clin Microbiol Antimicrob, V5, P16, DOI 10.1186/1476-0711-5-16; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Chroboczek T, 2013, J TRAVEL MED, P1195; Ditzen A, 2008, EUR J CLIN MICROBIOL; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Holt DC, 2011, GENOME BIOL EVOL, V3, P881, DOI 10.1093/gbe/evr078; HUMPHREYS H, 1990, J HOSP INFECT, V15, P127, DOI 10.1016/0195-6701(90)90121-4; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; McNeill WilliamH., 1998, PLAGUES PEOPLES; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Monecke S, 2012, EUR J CLIN MICROBIOL, V31, P1497, DOI 10.1007/s10096-011-1469-6; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2013, J CLIN MICROBIOL, V51, P487, DOI 10.1128/JCM.02285-12; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Monecke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014025; Orrett FA, 2008, JPN J INFECT DIS, V61, P107; Orrett FA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-83; Ruimy R, 2008, J BACTERIOL, V190, P3962, DOI 10.1128/JB.01947-07; Schaumburg F, 2011, CLIN MICROBIOL INFEC; Schaumburg F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001150; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; Shore A, 2005, ANTIMICROB AGENTS CH, V49, P2070, DOI 10.1128/AAC.49.5.2070-2083.2005; Swanston WH, 1999, W INDIAN MED J, V48, P20; Uhlemann AC, 2012, EUR J CLIN MICROBIOL, V31, P505, DOI 10.1007/s10096-011-1339-2	28	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89120	10.1371/journal.pone.0089120	http://dx.doi.org/10.1371/journal.pone.0089120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586536	Green Published, gold			2022-12-27	WOS:000331711900091
J	Slon, V; Sarig, R; Hershkovitz, I; Khalaily, H; Milevski, I				Slon, Viviane; Sarig, Rachel; Hershkovitz, Israel; Khalaily, Hamoudi; Milevski, Ianir			The Plastered Skulls from the Pre-Pottery Neolithic B Site of Yiftahel (Israel) - A Computed Tomography-Based Analysis	PLOS ONE			English	Article							ANATOLIA; LEVANT; PPNB; AGE	Three plastered skulls, dating to the Pre-Pottery Neolithic B, were found at the site of Yiftahel, in the Lower Galilee (Israel). The skulls underwent refitting and restoration processes, details of which are described herein. All three belong to adults, of which two appear to be males and one appears to be a female. Virtual cross-sections were studied and a density analysis of the plaster was performed using computed tomography scans. These were utilized to yield information regarding the modeling process. Similarities and differences between the Yiftahel and other plastered skulls from the Levant are examined. The possible role of skull plastering within a society undergoing a shift from a hunting-gathering way of life to a food producing strategy is discussed.	[Slon, Viviane; Sarig, Rachel; Hershkovitz, Israel] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Sarig, Rachel] Tel Aviv Univ, Dept Orthodont, Maurice & Gabriela Goldschleger Sch Dent Med, IL-69978 Tel Aviv, Israel; [Khalaily, Hamoudi; Milevski, Ianir] Israel Antiqu Author, Dept Excavat Surveys & Res, Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Hershkovitz, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.	anatom2@post.tau.ac.il	Hershkovitz, Israel/ABH-4511-2020	Hershkovitz, Israel/0000-0001-5841-6090; Sarig, Rachel/0000-0002-9323-5014	Dan David Foundation; Tassia & Dr. Joseph Meychan Chair for the History and Philosophy of Medicine	Dan David Foundation; Tassia & Dr. Joseph Meychan Chair for the History and Philosophy of Medicine	This study was supported by The Dan David Foundation; The Tassia & Dr. Joseph Meychan Chair for the History and Philosophy of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, STONE TOOLS TRANSITI; Arensburg B., 1989, BAR INT SERIES, V508, P115; Aufderheide AC, 2009, OVERMODELED SKULLS; Bar-Yosef O., 1989, BRIT ARCHAEOLOGICAL, V508, P59; Bar-Yosef O., 1988, ATIQOT, V18, P1; BELFERCOHEN A, 1992, CURR ANTHROPOL, V33, P463, DOI 10.1086/204098; Bienert H. D., 1991, J PREHISTORIC RELIG, V5, P9; Bienert H.-D., 1990, OXFORD J ARCHAEOL, V9, P257; Bonogofsky M, 2005, INT J OSTEOARCHAEOL, V15, P124, DOI 10.1002/oa.749; Bonogofsky M, 2002, J ARCHAEOL SCI, V29, P959, DOI 10.1006/jasc.2001.0792; Bonogofsky Michelle, 2003, B AM SCH ORIENT RES, V331, P1, DOI DOI 10.2307/1357755; Buikstra J. E., 1994, STANDARDS DATA COLLE; Byers S., 2004, INTRO FORENSIC ANTHR, P254, DOI 10.4324/9781315642031; Cauvin J, 1972, RELIG NEOLITHIQUES S; Cohen H, 2012, INT J OSTEO IN PRESS; Costin C., 1991, J ARCHAEOL METHOD TH, V3, P1; COSTIN Cathy Lynne, 2001, ARCHAEOLOGY MILLENNI, P273, DOI [10.1007/978-0-387-72611-3_8, DOI 10.1007/978-0-387-72611-3_8, DOI 10.1007/978-0-387-72611-3_]; Croucher K., 2012, DEATH DYING NEOLITHI; De Contenson H, 1967, ANN ARCHEOLOGIQUES A, V17, P17; Eshed V, 2010, AM J PHYS ANTHROPOL, V143, P121, DOI 10.1002/ajpa.21301; Ferembach D, 1973, PALEORIENT, V1, P223; Ferembach D., 1969, ANN ARCHEOL ARABES S, V19, P49; Garfinkel Y, 1998, CAMB ARCHAEOL J, V8, P207, DOI 10.1017/S0959774300001840; Garfinkel Y, 2012, PREPOTERY NEOLITHIC; GOREN Y, 1995, ISRAEL J CHEM, V35, P155; Goren Y, 2001, J ARCHAEOL SCI, V28, P671, DOI 10.1006/jasc.1999.0573; Goring-Morris A.N., 2000, LIFE NEOLITHIC FARMI, P103, DOI DOI 10.1007/0-306-47166-3_5; Goring-Morris AN, 2005, ARCHAEOLOGICAL PERSP, P89; Goring-Morris AN, 1995, ATIQOT, V27, P45; HERSHKOVITZ I, 1995, J ARCHAEOL SCI, V22, P779, DOI 10.1016/0305-4403(95)90007-1; HERSHKOVITZ I, 1994, PALEORIENT, V20, P59; Hershkovitz I, 1990, MITEKUFAT HAEVEN, V23, P13; Hershkovitz I, 1995, NATURE CULTURE, P669; Hershkovitz I, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P441, DOI 10.1007/978-1-4020-8539-0_17; Hodder I., 2005, ANATOLIAN ARCHAEOLOG, V11, P20; Kenyon K., 1957, DIGGING JERICHO; Khalaily H, 2007, PALEORIENT, V33, P5, DOI DOI 10.3406/PALE0.2007.5218; Khalaily H., 2008, NEOLITHICS, V2, P3; Kuijt I, 2008, CURR ANTHROPOL, V49, P171, DOI 10.1086/526097; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Milevski I., 2008, PALEORIENT, V34, P37, DOI DOI 10.3406/PALEO.2008.5255; Molleson T, 1992, CAMB ARCHAEOL J, V2, P231; Ozbek M, 2009, J ARCHAEOL SCI, V36, P379, DOI 10.1016/j.jas.2008.09.032; Poduska KM, 2012, RADIOCARBON, V54, P887, DOI 10.1017/S0033822200047536; Rollefson G.O., 1991, B AM SCH ORIENT RES, V23, P95; Rose J. C., 1998, PALEORIENT, V24, P99; SIMMONS AH, 1990, J FIELD ARCHAEOL, V17, P107, DOI 10.1179/009346990791548574; Stordeur D, 2003, PALEORIENT, V29, P109; Strouhal E., 1973, PALEORIENT, V1, P231; Verhoeven M, 2002, CAMB ARCHAEOL J, V12, P233, DOI 10.1017/S0959774302000124; Yakar R., 1988, ATIQOT, V18, P59; [No title captured]	52	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89242	10.1371/journal.pone.0089242	http://dx.doi.org/10.1371/journal.pone.0089242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586625	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900113
J	Ni, B; Chen, SM; Xie, HY; Ma, HT				Ni, Bin; Chen, Shaomu; Xie, Hongya; Ma, Haitao			Functional Polymorphisms in Interleukin-23 Receptor and Susceptibility to Esophageal Squamous Cell Carcinoma in Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER RISK; GENETIC-VARIATIONS; GASTRIC-CANCER; HEPATOCELLULAR-CARCINOMA; IDENTIFIES 2; RECEPTOR; LOCUS; VARIANTS; IL-23	Background: As a key element in the T-helper 17 (Th17) cell-mediated inflammatory process, interleukin-23 receptor (IL-23R) plays a crucial role in the pathogenesis of cancer. Single nucleotide polymorphisms (SNPs) in IL-23R have been frequently studied in several previous case-control cancer studies, but its association with esophageal squamous cell carcinoma (ESCC) in Chinese population has not been investigated. This study examined whether genetic polymorphisms in IL-23R were associated with ESCC susceptibility. Methods: A hospital-based case-control study of 684 ESCC patients and 1064 healthy controls was performed to assess the association between four previous reported IL-23R genotypes (rs6682925, rs6683039, rs1884444 and rs10889677) and ESCC risk. The results revealed that the C allele of the rs10889677A>C polymorphism in the 3'UTR of IL-23R gene was inversely associated with the risk of ESCC. Results: The rs10889677AC genotype had significantly decreased cancer risk (odds ratio [OR] = 0.85, 95% confidence interval [CI] = 0.69-1.01) compared to subjects homozygous carriers of rs10889677AA, the risk decreased even further in those carrying rs10889677CC genotype (OR = 0.64, 95% CI = 0.44-0.93). No significant association was found between the other three polymorphisms and the risk of ESCC. Conclusion: These findings indicated that rs10889677A>C polymorphism in IL-23R may play a protective role in mediating the risk of ESCC.	[Ni, Bin; Chen, Shaomu; Xie, Hongya; Ma, Haitao] Soochow Univ, Dept Cardiovasc & Thorac Surg, Affiliated Hosp 1, Suzhou, Peoples R China	Soochow University - China	Ma, HT (corresponding author), Soochow Univ, Dept Cardiovasc & Thorac Surg, Affiliated Hosp 1, Suzhou, Peoples R China.	sdfyymht@sohu.com			Science and Technology Support Program of Suzhou Science and Technology Bureau [SYS201015]	Science and Technology Support Program of Suzhou Science and Technology Bureau	This study was supported by the Science and Technology Support Program of Suzhou Science and Technology Bureau (No. SYS201015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; [Anonymous], J IMMUNOL, V186, P6182; Auderset F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002560; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Chen B, 2011, CANCER EPIDEMIOL, V35, P165, DOI 10.1016/j.canep.2010.08.006; Chen JJ, 2010, MOL CARCINOGEN, V49, P862, DOI 10.1002/mc.20661; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; Chien MH, 2012, HEAD NECK-J SCI SPEC, V34, P551, DOI 10.1002/hed.21779; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Jiang L, 2011, BREAST CANCER RES TR, V126, P487, DOI 10.1007/s10549-010-1094-6; Kiyotani K, 2012, HUM MOL GENET, V21, P1665, DOI 10.1093/hmg/ddr597; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Li Zh.M., 2011, PETROL EXPLOR DEV+, V38, P23, DOI DOI 10.1063/1.3601481; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Mayne ST, 2001, CANCER EPIDEM BIOMAR, V10, P1055; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Romagnani S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2392; Shi J, 2013, INT J CANCER, V132, P2799, DOI 10.1002/ijc.27959; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707; Sun T, 2008, CANCER RES, V68, P7025, DOI 10.1158/0008-5472.CAN-08-0806; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Traves PG, 2011, J IMMUNOL, V187, P6527, DOI 10.4049/jimmunol.1004070; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; VAUGHAN TL, 1995, CANCER EPIDEM BIOMAR, V4, P85; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wu HC, 2013, CARCINOGENESIS, V34, P2908, DOI 10.1093/carcin/bgt252; Yao ZQ, 2001, J IMMUNOL, V167, P5264, DOI 10.4049/jimmunol.167.9.5264; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zhang XJ, 2013, CARCINOGENESIS, V34, P2309, DOI 10.1093/carcin/bgt213; Zhang Z, 2010, CANCER GENET CYTOGEN, V196, P146, DOI 10.1016/j.cancergencyto.2009.09.006; Zheng J, 2013, CANCER RES, V73, P5151, DOI 10.1158/0008-5472.CAN-13-0395; Zheng J, 2013, HUM MUTAT, V34, P619, DOI 10.1002/humu.22284; Zheng J, 2012, CARCINOGENESIS, V33, P2409, DOI 10.1093/carcin/bgs307; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zhou LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064331; Zhou LQ, 2012, GENE, V506, P295, DOI 10.1016/j.gene.2012.07.007	49	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89111	10.1371/journal.pone.0089111	http://dx.doi.org/10.1371/journal.pone.0089111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586528	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200035
J	Palmer, J; Yang, JZ; Pan, TS; Court, LE				Palmer, Jacob; Yang, Jinzhong; Pan, Tinsu; Court, Laurence E.			Motion of the Esophagus Due to Cardiac Motion	PLOS ONE			English	Article							4-DIMENSIONAL COMPUTED-TOMOGRAPHY; CANCER RADIOTHERAPY; RESPIRATORY MOTION; LUNG; QUANTIFICATION; MANAGEMENT; VOLUME; ORGAN	When imaging studies (e. g. CT) are used to quantify morphological changes in an anatomical structure, it is necessary to understand the extent and source of motion which can give imaging artifacts (e. g. blurring or local distortion). The objective of this study was to assess the magnitude of esophageal motion due to cardiac motion. We used retrospective electrocardiogram-gated contrast-enhanced computed tomography angiography images for this study. The anatomic region from the carina to the bottom of the heart was taken at deep-inspiration breath hold with the patients' arms raised above their shoulders, in a position similar to that used for radiation therapy. The esophagus was delineated on the diastolic phase of cardiac motion, and deformable registration was used to sequentially deform the images in nearest-neighbor phases among the 10 cardiac phases, starting from the diastolic phase. Using the 10 deformation fields generated from the deformable registration, the magnitude of the extreme displacements was then calculated for each voxel, and the mean and maximum displacement was calculated for each computed tomography slice for each patient. The average maximum esophageal displacement due to cardiac motion for all patients was 5.8 mm (standard deviation: 1.6 mm, maximum: 10.0 mm) in the transverse direction. For 21 of 26 patients, the largest esophageal motion was found in the inferior region of the heart; for the other patients, esophageal motion was approximately independent of superior-inferior position. The esophagus motion was larger at cardiac phases where the electrocardiogram R-wave occurs. In conclusion, the magnitude of esophageal motion near the heart due to cardiac motion is similar to that due to other sources of motion, including respiratory motion and intra-fraction motion. A larger cardiac motion will result into larger esophagus motion in a cardiac cycle.	[Palmer, Jacob; Yang, Jinzhong; Pan, Tinsu; Court, Laurence E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Unit 94, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Court, LE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Unit 94, Houston, TX 77030 USA.	lecourt@mdanderson.org		Yang, Jinzhong/0000-0002-9254-4501; Court, Laurence/0000-0002-3241-6145	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn SJ, 2005, INT J RADIAT ONCOL, V61, P335, DOI 10.1016/j.ijrobp.2004.06.014; Belderbos J, 2005, RADIOTHER ONCOL, V75, P157, DOI 10.1016/j.radonc.2005.03.021; Bettinardi V, 2010, RADIOTHER ONCOL, V96, P311, DOI 10.1016/j.radonc.2010.07.014; Callahan J, 2011, CANCER IMAGING, V11, P224, DOI 10.1102/1470-7330.2011.0031; Cohen RJ, 2010, DIS ESOPHAGUS, V23, P473, DOI 10.1111/j.1442-2050.2009.01037.x; Court LE, 2013, J APPL CLIN MED PHYS, V14, P91, DOI 10.1120/jacmp.v14i3.4195; Guerrero T, 2007, INT J RADIAT ONCOL, V68, P1030, DOI 10.1016/j.ijrobp.2007.01.031; Korreman SS, 2012, PHYS MED BIOL, V57, pR161, DOI 10.1088/0031-9155/57/23/R161; Langen KM, 2001, INT J RADIAT ONCOL, V50, P265, DOI 10.1016/S0360-3016(01)01453-5; Pan CC, 2004, INT J RADIAT ONCOL, V60, pS580; Patel AA, 2009, INT J RADIAT ONCOL, V74, P290, DOI 10.1016/j.ijrobp.2008.12.060; Seppenwoolde Y, 2002, INT J RADIAT ONCOL, V53, P822, DOI 10.1016/S0360-3016(02)02803-1; Wang H, 2005, INT J RADIAT ONCOL, V61, P725, DOI 10.1016/j.ijrobp.2004.07.677; Wang XC, 2012, INT J RADIAT ONCOL, V82, P708, DOI 10.1016/j.ijrobp.2011.01.035; Werner-Wasik M, 2010, INT J RADIAT ONCOL, V76, pS86, DOI 10.1016/j.ijrobp.2009.05.070; Yaremko BP, 2008, INT J RADIAT ONCOL, V70, P145, DOI 10.1016/j.ijrobp.2007.05.031	16	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89126	10.1371/journal.pone.0089126	http://dx.doi.org/10.1371/journal.pone.0089126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586540	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200036
J	Schaefer, JR; Leussler, D; Rosin, L; Pittrow, D; Hepp, T				Schaefer, Juergen R.; Leussler, Dieter; Rosin, Ludger; Pittrow, David; Hepp, Thomas			Improved Detection of Paroxysmal Atrial Fibrillation Utilizing a Software-Assisted Electrocardiogram Approach	PLOS ONE			English	Article							ACUTE STROKE; TASK-FORCE; MANAGEMENT; MORTALITY; FLUTTER	Background: Automated complexity-based statistical stroke risk analysis (SRA) of electrocardiogram (ECG) recordings can be used to estimate the risk of paroxysmal atrial fibrillation (pAF). We investigated whether this method could improve the reliability of detection of patients at risk for pAF. Methods and Results: Data from 12-lead ECGs, 24-h Holter ECGs, and SRA based on separate 1-hour Holter ECG snips were collected from three groups: 70 patients with a history of pAF but who showed no AF episode in the 12-lead ECG at study entry; 19 patients with chronic AF (at study entry); and 100 young healthy individuals. AF episodes were detected by Holter ECG in 19 of the 70 non-chronic AF patients (27.1% overall, 18.6% in the first hour), and 37 of these 70 patients were classified as at risk for pAF by SRA (representing a sensitivity of 52.9% based on the first hour of analyzed recording). Fifty-four of the 70 patients also showed a sinus rhythm in the first hour. SRA detected pAF risk in 23 of these 54 patients (representing a sensitivity of 42.6%). The Holter data showed at least 1 AF episode and at least 1 hour of sinus rhythm in nine of the patients with pAF. For these patients, SRA classified 77.8% as being at risk in the first hour after the end of the AF episode, and 71.4% and 42.9% as being at risk in the second and third hours, respectively. SRA detected almost all cardiologist-confirmed AF episodes that had been recorded in 1-hour ECG snips (sensitivity, 99.2%; specificity, 99.2%). Conclusions: This outpatient study confirms previous findings that routine use of SRA could improve AF detection rates and thus may shorten the time between AF onset and initiation of prevention measures for patients at high risk for stroke.	[Schaefer, Juergen R.] Univ Marburg, Dept Internal Med, D-35032 Marburg, Germany; [Leussler, Dieter] Kardiol Plattform Hessen, Cardiol Clin, Marburg, Germany; [Rosin, Ludger] Sanofi Aventis, Dept Med, Berlin, Germany; [Pittrow, David] Tech Univ Dresden, Fac Med, Inst Clin Pharmacol, D-01062 Dresden, Germany; [Hepp, Thomas] Apoplex Med Technol GmbH, Pirmasens, Germany	Philipps University Marburg; Sanofi-Aventis; Technische Universitat Dresden	Schaefer, JR (corresponding author), Univ Marburg, Dept Internal Med, D-35032 Marburg, Germany.	juergen.schaefer@uni-marburg.de	Pittrow, David/AAY-5042-2021		Sanofi-Aventis, Berlin	Sanofi-Aventis, Berlin(Sanofi-Aventis)	The study was funded by Sanofi-Aventis, Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthelemy JC, 2003, ANN NONINVAS ELECTRO, V8, P194, DOI 10.1046/j.1542-474X.2003.08305.x; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Castells F, 2007, BIOMED TECH, V52, P18, DOI 10.1515/BMT.2007.005; Charitos EI, 2012, CIRCULATION, V126, P806, DOI 10.1161/CIRCULATIONAHA.112.098079; DUNING T, 2010, J CLIN EXPT CARDIOL, V2, P123; Glotzer TV, 2009, CIRC-ARRHYTHMIA ELEC, V2, P474, DOI 10.1161/CIRCEP.109.849638; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; HEATON J, 2005, INTRO NEURAL NETWORK; Jabaudon D, 2004, STROKE, V35, P1647, DOI 10.1161/01.STR.0000131269.69502.d9; Kamel H, 2010, STROKE, V41, P1514, DOI 10.1161/STROKEAHA.110.582437; Krstacic G, 2001, COMPUT CARDIOL, V28, P409, DOI 10.1109/CIC.2001.977679; Lamas G, 2012, NEW ENGL J MED, V366, P178, DOI 10.1056/NEJMe1111948; Liao J, 2007, STROKE, V38, P2935, DOI 10.1161/STROKEAHA.106.478685; Mant J, 2007, BMJ-BRIT MED J, V335, P380, DOI 10.1136/bmj.39227.551713.AE; McNamara RL, 2004, CIRCULATION, V109, P3223, DOI 10.1161/01.CIR.0000131893.41821.D1; Moody GB, 2001, COMPUT CARDIOL, V28, P113, DOI 10.1109/CIC.2001.977604; Muller A, 2009, J TELEMED TELECARE, V15, P391, DOI 10.1258/jtt.2009.090402; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Rizos T, 2010, CEREBROVASC DIS, V30, P319, DOI 10.1159/000316885; Rizos T, 2012, STROKE, V43, P2689, DOI 10.1161/STROKEAHA.112.654954; Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678; Stahrenberg R, 2010, STROKE, V41, P2884, DOI 10.1161/STROKEAHA.110.591958; Thong T, 2004, IEEE T BIO-MED ENG, V51, P561, DOI 10.1109/TBME.2003.821030; Valderrama AL, 2005, AM J PREV MED, V29, P75, DOI 10.1016/j.amepre.2005.07.021; Vidaillet H, 2002, AM J MED, V113, P365, DOI 10.1016/S0002-9343(02)01253-6; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E	28	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89328	10.1371/journal.pone.0089328	http://dx.doi.org/10.1371/journal.pone.0089328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586692	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200048
J	Stiebler, R; Majerowicz, D; Knudsen, J; Gondim, KC; Wright, DW; Egan, TJ; Oliveira, MF				Stiebler, Renata; Majerowicz, David; Knudsen, Jens; Gondim, Katia C.; Wright, David W.; Egan, Timothy J.; Oliveira, Marcus F.			Unsaturated Glycerophospholipids Mediate Heme Crystallization: Biological Implications for Hemozoin Formation in the Kissing Bug Rhodnius prolixus	PLOS ONE			English	Article							BETA-HEMATIN FORMATION; DIGESTIVE VACUOLE MEMBRANE; POSTERIOR MIDGUT CELLS; PLASMODIUM-FALCIPARUM; FERRIPROTOPORPHYRIN-IX; SCHISTOSOMA-MANSONI; ORIENTED NUCLEATION; BLOODSUCKING INSECT; LIPID-COMPOSITION; MALARIA PIGMENT	Hemozoin (Hz) is a heme crystal produced by some blood-feeding organisms, as an efficient way to detoxify heme derived from hemoglobin digestion. In the triatomine insect Rhodnius prolixus, Hz is essentially produced by midgut extracellular phospholipid membranes known as perimicrovillar membranes (PMVM). Here, we investigated the role of commercial glycerophospholipids containing serine, choline and ethanolamine as headgroups and R. prolixus midgut lipids (RML) in heme crystallization. All commercial unsaturated forms of phospholipids, as well as RML, mediated fast and efficient beta-hematin formation by means of two kinetically distinct mechanisms: an early and fast component, followed by a late and slow one. The fastest reactions observed were induced by unsaturated forms of phosphatidylethanolamine (uPE) and phosphatidylcholine (uPC), with half-lives of 0.04 and 0.7 minutes, respectively. beta-hematin crystal morphologies were strikingly distinct among groups, with uPE producing homogeneous regular brick-shaped crystals. Interestingly, uPC-mediated reactions resulted in two morphologically distinct crystal populations: one less representative group of regular crystals, resembling those induced by uPE, and the other largely represented by crystals with numerous sharp edges and tapered ends. Heme crystallization reactions induced by RML were efficient, with a heme to beta-hematin conversion rate higher than 70%, but clearly slower (t1/2 of 9.9-17.7 minutes) than those induced by uPC and uPE. Interestingly, crystals produced by RML were homogeneous in shape and quite similar to those mediated by uPE. Thus, beta-hematin formation can be rapidly and efficiently induced by unsaturated glycerophospholipids, particularly uPE and uPC, and may play a role on biological heme crystallization in R. prolixus midgut.	[Stiebler, Renata; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo, Lab Bioquim Resposta Estresse, BR-21941 Rio De Janeiro, Brazil; [Stiebler, Renata; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estruct & Bioimag, BR-21941 Rio De Janeiro, Brazil; [Stiebler, Renata; Wright, David W.] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Majerowicz, David; Gondim, Katia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo, Lab Bioquim & Fisiol Insetos, BR-21941 Rio De Janeiro, Brazil; [Majerowicz, David; Knudsen, Jens] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Majerowicz, David] Univ Fed Rio de Janeiro, Fac Farm, Dept Biotecnol Farmaceut, BR-21941 Rio De Janeiro, Brazil; [Gondim, Katia C.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil; [Egan, Timothy J.] Univ Cape Town, Dept Chem, ZA-7700 Rondebosch, South Africa	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Vanderbilt University; Universidade Federal do Rio de Janeiro; University of Southern Denmark; Universidade Federal do Rio de Janeiro; University of Cape Town	Stiebler, R (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo, Lab Bioquim Resposta Estresse, BR-21941 Rio De Janeiro, Brazil.	stiebler@bioqmed.ufrj.br; maroli@bioqmed.ufrj.br	Gondim, Katia C./AAN-4059-2020; Majerowicz, David/S-6136-2019; Oliveira, Marcus/G-3158-2011; Majerowicz, David/B-5361-2016	Majerowicz, David/0000-0001-7916-5315; Oliveira, Marcus/0000-0002-9890-8425; Majerowicz, David/0000-0001-7916-5315	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through Institutos Nacionais de Ciencia e Tecnologia; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) through Jovens Cientistas do Nosso Estado; NIH [RO1AI83145]; CNPq; CAPES; FAPERJ; Medical Research Council of South Africa; National Research Foundation of South Africa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083145] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through Institutos Nacionais de Ciencia e Tecnologia(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) through Jovens Cientistas do Nosso Estado(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Medical Research Council of South Africa(South African Medical Research Council); National Research Foundation of South Africa(National Research Foundation - South Africa); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (MFO through Institutos Nacionais de Ciencia e Tecnologia 2010), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (MFO through Jovens Cientistas do Nosso Estado 2010) and the NIH RO1AI83145 (DWW). MFO is a research scholar from CNPq. RS received scholarships from CAPES, CNPq and FAPERJ. TJE acknowledges the Medical Research Council of South Africa and the National Research Foundation of South Africa for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFT RL, 1983, J BIOL CHEM, V258, P2069; AFT RL, 1984, J BIOL CHEM, V259, P301; Ambele MA, 2013, CRYST GROWTH DES, V13, P4442, DOI 10.1021/cg4009416; BENDRAT K, 1995, NATURE, V378, P138, DOI 10.1038/378138a0; Bewley KD, 2013, BBA-BIOENERGETICS, V1827, P938, DOI 10.1016/j.bbabio.2013.03.010; BILLINGSLEY PF, 1983, CAN J ZOOL, V61, P2574, DOI 10.1139/z83-339; Bittencourt-Cunha PR, 2013, MEM I OSWALDO CRUZ, V108, P494, DOI 10.1590/S0074-0276108042013016; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen MM, 2001, MOL BIOCHEM PARASIT, V113, P1, DOI 10.1016/S0166-6851(00)00365-0; CHOU AC, 1980, J CLIN INVEST, V66, P856, DOI 10.1172/JCI109925; CHOU AC, 1981, J CLIN INVEST, V68, P672, DOI 10.1172/JCI110302; Soares JBR, 2007, FEBS LETT, V581, P1742, DOI 10.1016/j.febslet.2007.03.054; de Villiers KA, 2009, CRYST GROWTH DES, V9, P626, DOI 10.1021/cg8009755; Dorn A, 1998, BIOCHEM PHARMACOL, V55, P737, DOI 10.1016/S0006-2952(97)00509-1; Egan TJ, 2006, DALTON T, P5024, DOI 10.1039/b610866k; Egan TJ, 2006, FEBS LETT, V580, P5105, DOI 10.1016/j.febslet.2006.08.043; Egan TJ, 2001, BIOCHEMISTRY-US, V40, P204, DOI 10.1021/bi0013501; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; FERREIRA C, 1988, INSECT BIOCHEM, V18, P521, DOI 10.1016/0020-1790(88)90003-0; Fitch CD, 1999, BBA-MOL BASIS DIS, V1454, P31, DOI 10.1016/S0925-4439(99)00017-4; Fitch CD, 2000, BBA-MOL BASIS DIS, V1535, P45, DOI 10.1016/S0925-4439(00)00081-8; Garcia ES, 1975, AN ACAD BRAS CIENC, V47, P539; GINSBURG H, 1983, BIOCHIM BIOPHYS ACTA, V732, P316, DOI 10.1016/0005-2736(83)90219-5; Gorka AP, 2013, ANTIMICROB AGENTS CH, V57, P356, DOI 10.1128/AAC.01709-12; Grillo LAM, 2007, INSECT BIOCHEM MOLEC, V37, P579, DOI 10.1016/j.ibmb.2007.03.002; Haimi P, 2009, METHODS MOL BIOL, V580, P285, DOI 10.1007/978-1-60761-325-1_16; Hoang AN, 2010, BIOCHEMISTRY-US, V49, P10107, DOI 10.1021/bi101397u; Hoang AN, 2010, DALTON T, V39, P1235, DOI 10.1039/b914359a; Huy NT, 2007, ACTA TROP, V101, P130, DOI 10.1016/j.actatropica.2007.01.001; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Kapishnikov S, 2013, LANGMUIR, V29, P14595, DOI 10.1021/la402545c; Kapishnikov S, 2012, P NATL ACAD SCI USA, V109, P11188, DOI 10.1073/pnas.1118120109; Kapishnikov S, 2012, P NATL ACAD SCI USA, V109, P11184, DOI 10.1073/pnas.1118134109; LANE NJ, 1979, J CELL SCI, V39, P355; Lara FA, 2003, J EXP BIOL, V206, P1707, DOI 10.1242/jeb.00334; LIGHT WR, 1990, J BIOL CHEM, V265, P15632; Mury FB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006966; Ncokazi KK, 2005, ANAL BIOCHEM, V338, P306, DOI 10.1016/j.ab.2004.11.022; Huy NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070025; Oliveira MF, 2007, COMP BIOCHEM PHYS C, V146, P168, DOI 10.1016/j.cbpc.2006.12.007; Oliveira MF, 2000, FEBS LETT, V477, P95, DOI 10.1016/S0014-5793(00)01786-5; Oliveira MF, 2005, FEBS LETT, V579, P6010, DOI 10.1016/j.febslet.2005.09.035; Oliveira MF, 2004, J INFECT DIS, V190, P843, DOI 10.1086/422759; Oliveira MF, 1999, NATURE, V400, P517, DOI 10.1038/22910; Oliveira MF, 2000, MOL BIOCHEM PARASIT, V111, P217, DOI 10.1016/S0166-6851(00)00299-1; OLIVEIRA PL, 1995, J BIOL CHEM, V270, P10897, DOI 10.1074/jbc.270.18.10897; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pisciotta JM, 2005, INT J PARASITOL, V35, P1037, DOI 10.1016/j.ijpara.2005.03.020; Pisciotta JM, 2007, BIOCHEM J, V402, P197, DOI 10.1042/BJ20060986; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; ROSE MY, 1985, J BIOL CHEM, V260, P6632; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sandlin RD, 2011, ANTIMICROB AGENTS CH, V55, P3363, DOI 10.1128/AAC.00121-11; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; SHAKLAI N, 1985, BIOCHIM BIOPHYS ACTA, V821, P355, DOI 10.1016/0005-2736(85)90106-3; Silva JR, 2007, INSECT BIOCHEM MOLEC, V37, P523, DOI 10.1016/j.ibmb.2007.01.001; Silvius J. R., 1982, LIPID PROTEIN INTERA; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; Stiebler R, 2011, J BIOENERG BIOMEMBR, V43, P93, DOI 10.1007/s10863-011-9335-x; Stiebler R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012694; Stiebler R, 2010, INSECT BIOCHEM MOLEC, V40, P284, DOI 10.1016/j.ibmb.2009.12.013; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; TSUI FC, 1986, BIOPHYS J, V49, P459, DOI 10.1016/S0006-3495(86)83655-4; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105	67	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88976	10.1371/journal.pone.0088976	http://dx.doi.org/10.1371/journal.pone.0088976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586467	gold, Green Submitted, Green Published			2022-12-27	WOS:000332389000020
J	Gudys, A; Deorowicz, S				Gudys, Adam; Deorowicz, Sebastian			QuickProbs-A Fast Multiple Sequence Alignment Algorithm Designed for Graphics Processors	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; PROTEIN SEQUENCES; ACCURATE; HARDWARE; SEARCH; KALIGN; MAFFT	Multiple sequence alignment is a crucial task in a number of biological analyses like secondary structure prediction, domain searching, phylogeny, etc. MSAProbs is currently the most accurate alignment algorithm, but its effectiveness is obtained at the expense of computational time. In the paper we present QuickProbs, the variant of MSAProbs customised for graphics processors. We selected the two most time consuming stages of MSAProbs to be redesigned for GPU execution: the posterior matrices calculation and the consistency transformation. Experiments on three popular benchmarks (BAliBASE, PREFAB, OXBench-X) on quad-core PC equipped with high-end graphics card show QuickProbs to be 5.7 to 9.7 times faster than original CPU-parallel MSAProbs. Additional tests performed on several protein families from Pfam database give overall speed-up of 6.7. Compared to other algorithms like MAFFT, MUSCLE, or ClustalW, QuickProbs proved to be much more accurate at similar speed. Additionally we introduce a tuned variant of QuickProbs which is significantly more accurate on sets of distantly related sequences than MSAProbs without exceeding its computation time. The GPU part of QuickProbs was implemented in OpenCL, thus the package is suitable for graphics processors produced by all major vendors.	[Gudys, Adam; Deorowicz, Sebastian] Silesian Tech Univ, Fac Automat Control Elect & Comp Sci, Inst Informat, Gliwice, Poland	Silesian University of Technology	Gudys, A (corresponding author), Silesian Tech Univ, Fac Automat Control Elect & Comp Sci, Inst Informat, Gliwice, Poland.	adam.gudys@polsl.pl	Deorowicz, Sebastian/F-8386-2014	Deorowicz, Sebastian/0000-0002-9496-733X; Gudys, Adam/0000-0002-5508-0090	National Science Centre [DEC-2012/05/N/ST6/03158]; European Social Fund [UDA-POKL.04.01.01-00-106/09]	National Science Centre(National Science Centre, Poland); European Social Fund(European Social Fund (ESF))	The work was supported by National Science Centre grant upon decision DEC-2012/05/N/ST6/03158 and European Social Fund project UDA-POKL.04.01.01-00-106/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON GJ, 1987, J MOL BIOL, V198, P327, DOI 10.1016/0022-2836(87)90316-0; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blackshields G, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-21; Blazewicz J, 2013, J PARALLEL DISTR COM, V73, P32, DOI 10.1016/j.jpdc.2012.04.004; Blazewicz J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-181; Capella-Gutierrez S, 2012, THESIS P FABRA U; Dar-Jen Chang, 2010, Proceedings 2010 IEEE International Symposium on Signal Processing and Information Technology (ISSPIT 2010), P120, DOI 10.1109/ISSPIT.2010.5711746; Demouth J, 2012, P GPU TECHN C 2012 N; Deng X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-472; Deorowicz S, 2014, ADV INTEL SOFT COMPU, V242, P495, DOI 10.1007/978-3-319-02309-0_54; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Durbin R., 1998, BIOL SEQUENCE ANAL P; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2009, BENCHMARK COLLECTION; Edgar RC, 2009, QSCORE MULTIPLE ALIG; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; Gudys A, 2012, INT J FOUND COMPUT S, V23, P877, DOI 10.1142/S0129054112500098; Huerta-Cepas J, 2011, NUCLEIC ACIDS RES, V39, pD556, DOI 10.1093/nar/gkq1109; Just W, 1999, J COMPUT BIOL, V8, P615; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2007, BIOINFORMATICS, V23, P372, DOI 10.1093/bioinformatics/btl592; Khajeh-Saeed A, 2010, J COMPUT PHYS, V229, P4247, DOI 10.1016/j.jcp.2010.02.009; Khronos Group, 2013, OPENCL SPEC VERS 2 0; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Ligowski L, 2009, INT PARALL DISTRIB P, P1602, DOI 10.1109/IPDPS.2009.5160931; Lin YS, 2010, P 2010 GPU TECHN C N; Liu CM, 2012, BIOINFORMATICS, V28, P878, DOI 10.1093/bioinformatics/bts061; Liu WG, 2006, LECT NOTES COMPUT SC, V4297, P363; Liu YC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-117; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; Liu Yongchao, 2010, BMC Res Notes, V3, P93, DOI 10.1186/1756-0500-3-93; Liu YC, 2009, IEEE INT CONF ASAP, P121, DOI 10.1109/ASAP.2009.14; Manavski SA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S10; Muth R., 1996, LNCS, V1075, P75; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; NVidia, 2013, CUSP LIB VERS 0 4 0; NVidia, 2013, CUSPARSE LIB VERS 5; NVidia, 2013, CUDA PAR COMP PLATF; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; OpenMP ARB, 2013, OPENMP APPL PROGR IN; Raghava GPS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-47; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Stoye J, 1998, BIOINFORMATICS, V14, P157, DOI 10.1093/bioinformatics/14.2.157; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Thompson JD, 2005, PROTEINS, V61, P127, DOI 10.1002/prot.20527; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang L, 1994, J Comput Biol, V1, P337, DOI 10.1089/cmb.1994.1.337; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	57	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88901	10.1371/journal.pone.0088901	http://dx.doi.org/10.1371/journal.pone.0088901			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586435	gold, Green Published			2022-12-27	WOS:000332385900017
J	Savajols, E; Burguet, A; Grimaldi, M; Godoy, F; Sagot, P; Semama, DS				Savajols, Elodie; Burguet, Antoine; Grimaldi, Marianne; Godoy, Florence; Sagot, Paul; Semama, Denis S.			Maternal Haemoglobin and Short-Term Neonatal Outcome in Preterm Neonates	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; GESTATIONAL-AGE; PREGNANCY; EPIPAGE; ANEMIA; ASSOCIATION; CHILDREN; INFANTS; RISK	Objective: To determine whether there is a significant association between maternal haemoglobin measured before delivery and short-term neonatal outcome in very preterm neonates. Study design: We included prospectively all live births occurring from 25 to 32+6 weeks of gestation in a tertiary care centre between January 1st 2009 and December 31st 2011. Outborn infants and infants presenting with lethal malformations were excluded. Three hundred and thirty-nine mothers and 409 infants met the inclusion criteria. For each mother-infant pair a prospective record of epidemiologic data was performed and maternal haemoglobin concentration recorded within 24 hours before delivery was retrospectively researched. Maternal haemoglobin was divided into quartiles with the second and the third one regarded as reference as they were composed of normal haemoglobin values. Short-term outcome was defined as poor in case of death during hospital stay and/or grades III/IV intraventricular haemorrhage and/or periventricular leukomalacia and/or necessity of ventriculoperitoneal shunt. Results: The global rate of poor short-term neonatal outcome was 11.4% and was significantly associated with low maternal haemoglobin values. This association remained significant after adjustment for antenatal corticosteroids therapy, gestational age, parity, mechanism of preterm birth, mode of delivery and birth weight (aOR = 2.97 CI 95% [1.36-6.47]). There was no relation between short-term neonatal outcome and high maternal haemoglobin concentration values. Conclusion: We show that low maternal haemoglobin concentration at delivery is an independent risk factor for poor short-term neonatal outcome in very preterm neonates. This study is one of the first to show such an association within the preterm population.	[Savajols, Elodie; Burguet, Antoine; Grimaldi, Marianne; Godoy, Florence; Semama, Denis S.] Ctr Hosp Univ, Dept Paediat, Dijon, France; [Sagot, Paul] Ctr Hosp Univ, Dept Obstet, Dijon, France	CHU Dijon Bourgogne; CHU Dijon Bourgogne	Semama, DS (corresponding author), Ctr Hosp Univ, Dept Paediat, Dijon, France.	denis.semama@chu-dijon.fr		burguet, antoine/0000-0001-5140-2884				Allen LH, 2001, J NUTR, V131, p581S, DOI 10.1093/jn/131.2.581S; Amburgey OA, 2009, J MATERN-FETAL NEO M, V22, P740, DOI [10.1080/14767050902926947, 10.3109/14767050902926947]; Ancel PY, 2006, PEDIATRICS, V117, P828, DOI 10.1542/peds.2005-0091; Auger N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-67; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bondevik GT, 2001, ACTA OBSTET GYN SCAN, V80, P402, DOI 10.1034/j.1600-0412.2001.080005402.x; Charkaluk ML, 2010, ACTA PAEDIATR, V99, P684, DOI 10.1111/j.1651-2227.2010.01695.x; Ducsay CA, 1998, COMP BIOCHEM PHYS A, V119, P675, DOI 10.1016/S1095-6433(98)01004-6; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Larroque B, 2004, ARCH DIS CHILD-FETAL, V89, P139, DOI 10.1136/adc.2002.020396; Levy A, 2005, EUR J OBSTET GYN R B, V122, P182, DOI 10.1016/j.ejogrb.2005.02.015; Little MP, 2005, AM J OBSTET GYNECOL, V193, P220, DOI 10.1016/j.ajog.2004.11.053; Malhotra M, 2002, INT J GYNECOL OBSTET, V79, P93, DOI 10.1016/S0020-7292(02)00225-4; MURPHY JF, 1986, LANCET, V1, P992; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Ren A, 2007, INT J GYNECOL OBSTET, V98, P124, DOI 10.1016/j.ijgo.2007.05.011; STEER P, 1995, BMJ-BRIT MED J, V310, P489, DOI 10.1136/bmj.310.6978.489; WHO, 2001, IRON DEFICIENCY ANAE; Xiong X, 2000, AM J PERINAT, V17, P137, DOI 10.1055/s-2000-9508; Zhang QY, 2009, ANN EPIDEMIOL, V19, P793, DOI 10.1016/j.annepidem.2009.06.002; Zhang QY, 2009, INT J EPIDEMIOL, V38, P1380, DOI 10.1093/ije/dyp243; Zhou LM, 1998, AM J EPIDEMIOL, V148, P998	22	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89530	10.1371/journal.pone.0089530	http://dx.doi.org/10.1371/journal.pone.0089530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586850	Green Published, gold			2022-12-27	WOS:000332385900052
J	Bhatta, MP; Jefferis, E; Kavadas, A; Alemagno, SA; Shaffer-King, P				Bhatta, Madhav P.; Jefferis, Eric; Kavadas, Angela; Alemagno, Sonia A.; Shaffer-King, Peggy			Suicidal Behaviors among Adolescents in Juvenile Detention: Role of Adverse Life Experiences	PLOS ONE			English	Article							SEXUAL-ABUSE; RISK; DELINQUENT; PREVALENCE	Purpose: The purpose of this study was to assess the influence of multiple adverse life experiences (sexual abuse, homelessness, running away, and substance abuse in the family) on suicide ideation and suicide attempt among adolescents at an urban juvenile detention facility in the United States. Materials and Methods: The study sample included a total of 3,156 adolescents processed at a juvenile detention facility in an urban area in Ohio between 2003 and 2007. The participants, interacting anonymously with a voice enabled computer, self-administered a questionnaire with 100 items related to health risk behaviors. Results: Overall 19.0% reported ever having thought about suicide (suicide ideation) and 11.9% reported ever having attempted suicide (suicide attempt). In the multivariable logistic regression analysis those reporting sexual abuse (Odds Ratio = 2.75; 95% confidence interval = 2.08-3.63) and homelessness (1.51; 1.17-1.94) were associated with increased odds of suicide ideation, while sexual abuse (3.01; 2.22-4.08), homelessness (1.49; 1.12-1.98), and running away from home (1.38; 1.06-1.81) were associated with increased odds of a suicide attempt. Those experiencing all four adverse events were 7.81 times more likely (2.41-25.37) to report having ever attempted suicide than those who experienced none of the adverse events. Conclusions: Considering the high prevalence of adverse life experiences and their association with suicidal behaviors in detained adolescents, these factors should not only be included in the suicide screening tools at the intake and during detention, but should also be used for the intervention programming for suicide prevention.	[Bhatta, Madhav P.] Kent State Univ, Coll Publ Hlth, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44242 USA; [Jefferis, Eric; Kavadas, Angela; Shaffer-King, Peggy] Kent State Univ, Coll Publ Hlth, Dept Social & Behav Sci, Kent, OH 44242 USA; [Alemagno, Sonia A.] Kent State Univ, Coll Publ Hlth, Dept Hlth Policy & Management, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Bhatta, MP (corresponding author), Kent State Univ, Coll Publ Hlth, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44242 USA.	mbhatta@kent.edu						Abram KM, 2008, J AM ACAD CHILD PSY, V47, P291, DOI 10.1097/CHI.0b013e318160b3ce; Alemagno Sonia A, 2009, J Correct Health Care, V15, P35, DOI 10.1177/1078345808326620; ALESSI NE, 1984, AM J PSYCHIAT, V141, P286; American Association of Suicidology, 2013, US SUIC 2010 OFF FIN; Andrews G, 2005, COMP QUANTIFICATION, VI; Bolen RM, 1999, SOC SERV REV, V73, P281, DOI 10.1086/514425; Centers for Disease Control and Prevention, 2020, WEB BAS INJ STAT QUE; Chapman JF, 2008, ARCH SUICIDE RES, V12, P50, DOI 10.1080/13811110701800830; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Esposito CL, 2002, J TRAUMA STRESS, V15, P137, DOI 10.1023/A:1014860024980; Fazel S, 2005, LANCET, V366, P1301, DOI 10.1016/S0140-6736(05)67325-4; Freedenthal S, 2007, DRUG ALCOHOL DEPEN, V90, P81, DOI 10.1016/j.drugalcdep.2007.02.021; Gallagher CA, 2005, J AM ACAD CHILD PSY, V44, P485, DOI 10.1097/01.chi.0000156281.07858.52; Gallagher CA, 2006, J ADOLESCENT HEALTH, V38, P662, DOI 10.1016/j.jadohealth.2005.01.002; HARRIS TE, 1993, INT J OFFENDER THER, V37, P263, DOI 10.1177/0306624X9303700307; HAYES LM, 2004, JUVENILE SUICIDE CON; Howard J, 2003, Crisis, V24, P98, DOI 10.1027//0227-5910.24.3.98; Johnson JG, 2002, ARCH GEN PSYCHIAT, V59, P741, DOI 10.1001/archpsyc.59.8.741; Jones SE, 2008, J SCHOOL HEALTH, V78, P252, DOI 10.1111/j.1746-1561.2008.00297.x; KEMPTON T, 1992, BEHAV RES THER, V30, P537, DOI 10.1016/0005-7967(92)90038-I; Matsumoto T, 2009, PSYCHIAT CLIN NEUROS, V63, P238, DOI 10.1111/j.1440-1819.2009.01929.x; MILLER ML, 1982, J CONSULT CLIN PSYCH, V50, P491, DOI 10.1037/0022-006X.50.4.491; Morgan Jenny, 2004, Crisis, V25, P8, DOI 10.1027/0227-5910.25.1.8; Morris RE, 1995, J ADOLESCENT HEALTH, V17, P334, DOI 10.1016/1054-139X(95)00098-D; Penn JV, 2003, J AM ACAD CHILD PSY, V42, P762, DOI 10.1097/01.CHI.0000046869.56865.46; Plattner B, 2007, J CLIN PSYCHIAT, V68, P1593, DOI 10.4088/JCP.v68n1019; Putnins AL, 2005, INT J OFFENDER THER, V49, P143, DOI 10.1177/0306624X04269412; Rohde P, 1997, SUICIDE LIFE-THREAT, V27, P164; Ruchkin VV, 2003, J CHILD PSYCHOL PSYC, V44, P1058, DOI 10.1111/1469-7610.00190; Sanislow CA, 2003, J AM ACAD CHILD PSY, V42, P234, DOI 10.1097/00004583-200302000-00018; Suk E, 2009, EUR CHILD ADOLES PSY, V18, P377, DOI 10.1007/s00787-009-0740-1	31	35	35	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89408	10.1371/journal.pone.0089408	http://dx.doi.org/10.1371/journal.pone.0089408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB6EP	24586756	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700039
J	Borena, W; Edlinger, M; Bjorge, T; Haggstrom, C; Lindkvist, B; Nagel, G; Engeland, A; Stocks, T; Strohmaier, S; Manjer, J; Selmer, R; Tretli, S; Concin, H; Hallmans, G; Jonsson, H; Stattin, P; Ulmer, H				Borena, Wegene; Edlinger, Michael; Bjorge, Tone; Haggstrom, Christel; Lindkvist, Bjorn; Nagel, Gabriele; Engeland, Anders; Stocks, Tanja; Strohmaier, Susanne; Manjer, Jonas; Selmer, Randi; Tretli, Steinar; Concin, Hans; Hallmans, Goran; Jonsson, Hakan; Stattin, Par; Ulmer, Hanno			A Prospective Study on Metabolic Risk Factors and Gallbladder Cancer in the Metabolic Syndrome and Cancer (Me-Can) Collaborative Study	PLOS ONE			English	Article							BILIARY-TRACT CANCER; BODY-MASS INDEX; REGRESSION DILUTION; SERUM-CHOLESTEROL; NATIONAL-HEALTH; OBESITY; COHORT; POPULATION; MORTALITY; CARCINOMA	Objective: To investigate the association between metabolic risk factors (individually and in combination) and risk of gallbladder cancer (GBC). Methods: The metabolic syndrome and cancer project (Me-Can) includes cohorts from Norway, Austria, and Sweden with data on 578,700 men and women. We used Cox proportional hazard regression models to calculate relative risks of GBC by body mass index (BMI), blood pressure, and plasma levels of glucose, cholesterol, and triglycerides as continuous standardised variables and their standardised sum of metabolic syndrome (MetS) z-score. The risk estimates were corrected for random error in measurements. Results: During an average follow-up of 12.0 years (SD = 7.8), 184 primary gallbladder cancers were diagnosed. Relative risk of gallbladder cancer per unit increment of z-score adjusted for age, smoking status and BMI (except for BMI itself) and stratified by birth year, sex and sub-cohorts, was for BMI 1.31 (95% confidence interval 1.11, 1.57) and blood glucose 1.76 (1.10, 2.85). Further analysis showed that the effect of BMI on GBC risk is larger among women in the premenopausal age group (1.84 (1.23, 2.78)) compared to those in the postmenopausal age group (1.29 (0.93, 1.79)). For the other metabolic factors no significant association was found (mid blood pressure 0.96 (0.71, 1.31), cholesterol 0.84 (0.66, 1.06) and serum triglycerides 1.16 (0.82, 1.64)). The relative risk per one unit increment of the MetS z-score was 1.37 (1.07, 1.73). Conclusion: This study showed that increasing BMI and impaired glucose metabolism pose a possible risk for gallbladder cancer. Beyond the individual factors, the results also showed that the metabolic syndrome as an entity presents a risk constellation for the occurrence of gallbladder cancer.	[Borena, Wegene; Edlinger, Michael; Strohmaier, Susanne; Ulmer, Hanno] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Bjorge, Tone; Engeland, Anders; Selmer, Randi] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Bjorge, Tone; Engeland, Anders] Norwegian Inst Publ Hlth, Oslo, Norway; [Haggstrom, Christel; Stocks, Tanja; Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Lindkvist, Bjorn] Sahlgrens Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Gothenburg, Sweden; [Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Stocks, Tanja] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Manjer, Jonas] Lund Univ, Dept Surg, Malmo Univ Hosp, Malmo, Sweden; [Tretli, Steinar] Canc Registry Norway, Inst Populat Based Canc Res, Oslo, Norway; [Nagel, Gabriele; Concin, Hans] Agcy Prevent & Social Med, Bregenz, Austria; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Jonsson, Hakan] Umea Univ, Dept Radiat Sci, Umea, Sweden	Medical University of Innsbruck; University of Bergen; Norwegian Institute of Public Health (NIPH); Umea University; Sahlgrenska University Hospital; Ulm University; University of Copenhagen; Lund University; Skane University Hospital; University of Oslo; Umea University; Umea University	Ulmer, H (corresponding author), Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria.	Hanno.Ulmer@i-med.ac.at	vhmpp, aks/F-9756-2012; Nagel, Gabriele/C-3635-2012; Engeland, Anders/AAG-7437-2021; Ulmer, Hanno/S-6615-2019	Nagel, Gabriele/0000-0001-6185-8535; Ulmer, Hanno/0000-0001-5911-1002; Bjorge, Tone/0000-0002-9096-5257; Edlinger, Michael/0000-0001-8801-3268; Lindkvist, Bjorn/0000-0001-7485-0006	World Cancer Research Fond International [2007/09, 2010/14]; Medical University of Innsbruck (MUI START)	World Cancer Research Fond International; Medical University of Innsbruck (MUI START)	World Cancer Research Fond International 2007/09 and 2010/14 to Par Stattin and Medical University of Innsbruck (MUI START). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti G, 2008, INT J CANCER, V122, P2322, DOI 10.1002/ijc.23307; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Borena W, 2012, INT J CANCER, V131, P193, DOI 10.1002/ijc.26338; Borena W, 2009, WIEN KLIN WOCHENSCHR, V121, P623, DOI 10.1007/s00508-009-1238-z; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Cowey S, 2006, AM J PATHOL, V169, P1505, DOI 10.2353/ajpath.2006.051090; Donohoe CL, 2010, BRIT J SURG, V97, P628, DOI 10.1002/bjs.7079; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Engeland A, 2005, CANCER CAUSE CONTROL, V16, P987, DOI 10.1007/s10552-005-3638-3; Franks PW, 2007, HYPERTENSION, V49, P10, DOI 10.1161/01.HYP.0000251934.55488.ae; Gupta Parul, 2012, Gastrointest Cancer Res, V5, P41; Hsing AW, 2007, BRIT J CANCER, V97, P1577, DOI 10.1038/sj.bjc.6604047; Iglesias A, 1996, CLIN CHIM ACTA, V248, P157, DOI 10.1016/0009-8981(95)06251-3; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jee SH, 2008, INT J CANCER, V123, P1892, DOI 10.1002/ijc.23719; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; KNEKT P, 1988, J CLIN EPIDEMIOL, V41, P519, DOI 10.1016/0895-4356(88)90056-X; Kuriyama S, 2005, INT J CANCER, V113, P148, DOI 10.1002/ijc.20529; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Larsson SC, 2007, BRIT J CANCER, V96, P1457, DOI 10.1038/sj.bjc.6603703; Lazcano-Ponce EC, 2001, CA-CANCER J CLIN, V51, P349, DOI 10.3322/canjclin.51.6.349; Levy AD, 2001, RADIOGRAPHICS, V21, P295, DOI 10.1148/radiographics.21.2.g01mr16295; Mendez-Sanchez N, 2005, WORLD J GASTROENTERO, V11, P1653, DOI 10.3748/wjg.v11.i11.1653; Misra S, 2003, LANCET ONCOL, V4, P167, DOI 10.1016/S1470-2045(03)01021-0; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; Ninomiya JK, 2004, CIRCULATION, V109, P42, DOI 10.1161/01.CIR.0000108926.04022.0C; Percik R, 2009, EXP CLIN ENDOCR DIAB, V117, P563, DOI 10.1055/s-0029-1241870; Rapp K, 2006, DIABETOLOGIA, V49, P945, DOI 10.1007/s00125-006-0207-6; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Renehan AG, 2010, INT J CANCER, V126, P692, DOI 10.1002/ijc.24803; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; Roth GA, 2011, B WORLD HEALTH ORGAN, V89, P92, DOI 10.2471/BLT.10.079947; Russo A, 2008, EUR J CANCER, V44, P293, DOI 10.1016/j.ejca.2007.11.005; Schlesinger S, 2013, ANN ONCOL, V24, P2449, DOI 10.1093/annonc/mdt204; Schlesinger S, 2013, INT J CANCER, V132, P645, DOI 10.1002/ijc.27645; Shebl FM, 2011, BRIT J CANCER, V105, P1424, DOI 10.1038/bjc.2011.363; Shebl FM, 2010, BRIT J CANCER, V103, P115, DOI 10.1038/sj.bjc.6605706; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; Stocks T, 2012, HYPERTENSION, V59, P802, DOI 10.1161/HYPERTENSIONAHA.111.189258; Stocks T, 2010, INT J EPIDEMIOL, V39, P660, DOI 10.1093/ije/dyp186; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Strohmaier S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054242; Tulinius H, 1997, CANCER EPIDEM BIOMAR, V6, P863; Ulmer H, 2009, BRIT J CANCER, V101, P1202, DOI 10.1038/sj.bjc.6605264; W.H. Organization, 1999, DEFINITION DIAGNOSIS; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233; Zatonski WA, 1997, JNCI-J NATL CANCER I, V89, P1132, DOI 10.1093/jnci/89.15.1132	54	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89368	10.1371/journal.pone.0089368	http://dx.doi.org/10.1371/journal.pone.0089368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586723	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900084
J	Holcakova, J; Muller, P; Tomasec, P; Hrstka, R; Nekulova, M; Krystof, V; Strnad, M; Wilkinson, GWG; Vojtesek, B				Holcakova, Jitka; Muller, Petr; Tomasec, Peter; Hrstka, Roman; Nekulova, Marta; Krystof, Vladimir; Strnad, Miroslav; Wilkinson, Gavin W. G.; Vojtesek, Borivoj			Inhibition of Post-Transcriptional RNA Processing by CDK Inhibitors and Its Implication in Anti-Viral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LARGE T-ANTIGEN; DEPENDENT KINASE INHIBITORS; HERPES-SIMPLEX-VIRUS; P-TEFB KINASE; C-TERMINAL DOMAIN; MONOCLONAL-ANTIBODIES; TRANSCRIPTIONAL ACTIVATION; IMMUNOCHEMICAL ANALYSIS; HIV-1 PROMOTER	Cyclin-dependent kinases (CDKs) are key regulators of the cell cycle and RNA polymerase II mediated transcription. Several pharmacological CDK inhibitors are currently in clinical trials as potential cancer therapeutics and some of them also exhibit antiviral effects. Olomoucine II and roscovitine, purine-based inhibitors of CDKs, were described as effective antiviral agents that inhibit replication of a broad range of wild type human viruses. Olomoucine II and roscovitine show high selectivity for CDK7 and CDK9, with important functions in the regulation of RNA polymerase II transcription. RNA polymerase II is necessary for viral transcription and following replication in cells. We analyzed the effect of inhibition of CDKs by olomoucine II on gene expression from viral promoters and compared its effect to widely-used roscovitine. We found that both roscovitine and olomoucine II blocked the phosphorylation of RNA polymerase II C-terminal domain. However the repression of genes regulated by viral promoters was strongly dependent on gene localization. Both roscovitine and olomoucine II inhibited expression only when the viral promoter was not integrated into chromosomal DNA. In contrast, treatment of cells with genome-integrated viral promoters increased their expression even though there was decreased phosphorylation of the C-terminal domain of RNA polymerase II. To define the mechanism responsible for decreased gene expression after pharmacological CDK inhibitor treatment, the level of mRNA transcription from extrachromosomal DNA was determined. Interestingly, our results showed that inhibition of RNA polymerase II C-terminal domain phosphorylation increased the number of transcribed mRNAs. However, some of these mRNAs were truncated and lacked polyadenylation, which resulted in decreased translation. These results suggest that phosphorylation of RNA polymerase II C-terminal domain is critical for linking transcription and posttrancriptional processing of mRNA expressed from extrachromosomal DNA.	[Holcakova, Jitka; Muller, Petr; Hrstka, Roman; Nekulova, Marta; Vojtesek, Borivoj] Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol, Brno, Czech Republic; [Tomasec, Peter; Wilkinson, Gavin W. G.] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Krystof, Vladimir; Strnad, Miroslav] Palacky Univ, Fac Sci, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic; [Krystof, Vladimir; Strnad, Miroslav] Inst Expt Bot AS CR, Olomouc, Czech Republic	Masaryk Memorial Cancer Institute; Cardiff University; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Vojtesek, B (corresponding author), Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol, Brno, Czech Republic.	vojtesek@mou.cz	Nekulova, Marta/D-2334-2013; Muller, Petr/AAK-5014-2021; Muller, Petr/F-7762-2015; Krystof, Vladimir/B-9499-2009; Wilkinson, Gavin WG/J-6388-2015; Hrstka, Roman/AAM-4430-2020; Strnad, Miroslav/H-1858-2014	Muller, Petr/0000-0002-8404-4494; Muller, Petr/0000-0002-8404-4494; Krystof, Vladimir/0000-0001-5838-2118; Wilkinson, Gavin WG/0000-0002-5623-0126; Hrstka, Roman/0000-0002-6139-2664; Strnad, Miroslav/0000-0002-2806-794X	European Regional Development Fund; State Budget of the Czech Republic (RECAMO) [CZ.1.05/2.1.00/03.0101]; Czech Science Foundation [GACR P206/12/G151]; Ministry of Health, Czech Republic - conceptual development of research organization (MMCI) [00209805]; Medical Research Council [MR/L018373/1, G1000236, G0700142] Funding Source: researchfish; MRC [G1000236, G0700142] Funding Source: UKRI	European Regional Development Fund(European Commission); State Budget of the Czech Republic (RECAMO); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Health, Czech Republic - conceptual development of research organization (MMCI); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the European Regional Development Fund and the State Budget of the Czech Republic (RECAMO, CZ.1.05/2.1.00/03.0101), by Czech Science Foundation (GACR P206/12/G151) and by Ministry of Health, Czech Republic - conceptual development of research organization (MMCI, 00209805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbottah E, 2005, J BIOL CHEM, V280, P3029, DOI 10.1074/jbc.M406435200; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Ali SH, 2004, J VIROL, V78, P2749, DOI 10.1128/JVI.78.6.2749-2757.2004; Ammosova T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-78; Arris CE, 2000, J MED CHEM, V43, P2797, DOI 10.1021/jm990628o; Bresnahan WA, 1997, VIROLOGY, V231, P239, DOI 10.1006/viro.1997.8489; Casse C, 1999, J BIOL CHEM, V274, P16097, DOI 10.1074/jbc.274.23.16097; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Diwan P, 2004, J VIROL, V78, P9352, DOI 10.1128/JVI.78.17.9352-9365.2004; Fischer Peter M, 2003, Prog Cell Cycle Res, V5, P235; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Fredersdorf S, 1996, AM J PATHOL, V148, P825; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Garrido-Lecca A, 2010, MOL CELL BIOL, V30, P3887, DOI 10.1128/MCB.00325-10; Guendel I, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-7; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; Havlicek L, 1997, J MED CHEM, V40, P408, DOI 10.1021/jm960666x; Holcakova Jitka, 2010, Antiviral Chemistry & Chemotherapy, V20, P133, DOI 10.3851/IMP1460; Hong SW, 2009, P NATL ACAD SCI USA, V106, P14276, DOI 10.1073/pnas.0903642106; Kasper JS, 2005, J VIROL, V79, P11685, DOI 10.1128/JVI.79.18.11685-11692.2005; Keskin H, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-11; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Krystof V, 2005, CELL MOL LIFE SCI, V62, P1763, DOI 10.1007/s00018-005-5185-1; Krystof V, 2002, BIOORG MED CHEM LETT, V12, P3283, DOI 10.1016/S0960-894X(02)00693-5; MAIO JJ, 1988, J VIROL, V62, P1398, DOI 10.1128/JVI.62.4.1398-1407.1988; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pirngruber J, 2009, CELL CYCLE, V8, P3636, DOI 10.4161/cc.8.22.9890; Pirngruber J, 2009, EMBO REP, V10, P894, DOI 10.1038/embor.2009.108; Pisell T. L., 2001, Antiviral Chemistry and Chemotherapy, V12, P33; Sanchez V, 2004, J VIROL, V78, P11219, DOI 10.1128/JVI.78.20.11219-11232.2004; Sanchez V, 2006, J VIROL, V80, P5886, DOI 10.1128/JVI.02656-05; Schang LM, 2002, J VIROL, V76, P7874, DOI 10.1128/JVI.76.15.7874-7882.2002; Schang LM, 1999, J VIROL, V73, P2161, DOI 10.1128/JVI.73.3.2161-2172.1999; Schang Luis M., 2006, Antiviral Chemistry & Chemotherapy, V17, P293; Stubdal H, 1996, J VIROL, V70, P2781, DOI 10.1128/JVI.70.5.2781-2788.1996; Sullivan CS, 2000, MOL CELL BIOL, V20, P6233, DOI 10.1128/MCB.20.17.6233-6243.2000; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; Wang D, 2001, J VIROL, V75, P7266, DOI 10.1128/JVI.75.16.7266-7279.2001; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Zalvide J, 1998, MOL CELL BIOL, V18, P1408, DOI 10.1128/MCB.18.3.1408; Zhou MS, 2004, J VIROL, V78, P13522, DOI 10.1128/JVI.78.24.13522-13533.2004; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	50	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89228	10.1371/journal.pone.0089228	http://dx.doi.org/10.1371/journal.pone.0089228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586613	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900066
J	Zhang, HT; Sun, ZG; Wei, WJ; Liu, ZH; Fleming, J; Zhang, S; Lin, N; Wang, M; Chen, MS; Xu, YH; Zhou, J; Li, CY; Bi, LJ; Zhou, GM				Zhang, Hongtai; Sun, Zhaogang; Wei, Wenjing; Liu, Zhonghui; Fleming, Joy; Zhang, Shuai; Lin, Nan; Wang, Ming; Chen, Maoshan; Xu, Yuhui; Zhou, Jie; Li, Chuanyou; Bi, Lijun; Zhou, Guangming			Identification of Serum microRNA Biomarkers for Tuberculosis Using RNA-seq	PLOS ONE			English	Article							EXPRESSION; NFAT5; INFECTION; DIAGNOSIS; ARRAY	Tuberculosis (TB) remains a significant human health issue. More effective biomarkers for use in tuberculosis prevention, diagnosis, and treatment, including markers that can discriminate between healthy individuals and those with latent infection, are urgently needed. To identify a set of such markers, we used Solexa sequencing to examine microRNA expression in the serum of patients with active disease, healthy individuals with latent TB, and those with or without prior BCG inoculation. We identified 24 microRNAs that are up-regulated (2.85-1285.93 fold) and 6 microRNAs that are down-regulated (0.003-0.11 fold) (P < 0.05) in patients with active TB relative to the three groups of healthy controls. In addition, 75 microRNAs were up-regulated (2.05-2454.58 fold) and 11 were down-regulated (0.001-0.42 fold) (P < 0.05) in latent-TB infected individuals relative to BCG-inoculated individuals. Of interest, 134 microRNAs were differentially-expressed in BCG-inoculated relative to un-inoculated individuals (18 up-regulated 2.9-499.29 fold, 116 down-regulated 0.0002-0.5 fold), providing insights into the effects of BCG inoculation at the microRNA level. Target prediction of differentially-expressed microRNAs by microRNA-Gene Network analysis and analysis of pathways affected suggest that regulation of the host immune system by microRNAs is likely to be one of the main factors in the pathogenesis of tuberculosis. qRT-PCR validation indicated that hsa-miR-196b and hsa-miR-376c have potential as markers for active TB disease. The microRNA differential-expression profiles generated in this study provide a good foundation for the development of markers for TB diagnosis, and for investigations on the role of microRNAs in BCG-inoculated and latent-infected individuals.	[Zhang, Hongtai; Zhou, Guangming] Chinese Acad Sci, Inst Modern Phys, Key Lab Heavy Ion Radiat Biol & Med, Dept Space Radiobiol, Lanzhou, Peoples R China; [Zhang, Hongtai; Wei, Wenjing; Fleming, Joy; Zhang, Shuai; Wang, Ming; Bi, Lijun] Chinese Acad Sci, Inst Biophys, Key Lab Noncoding RNA, Beijing 100080, Peoples R China; [Zhang, Hongtai] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sun, Zhaogang; Xu, Yuhui] Capital Med Univ, Beijing Chest Hosp, Beijing Key Lab Drug Resistance TB, Beijing, Peoples R China; [Liu, Zhonghui] Huazhong Agr Univ, Wuhan, Hubei, Peoples R China; [Lin, Nan] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Chen, Maoshan] Beijing Genom Inst, Shenzhen 518083, Peoples R China; [Zhou, Jie] 4th Peoples Hosp, Foshan, Guangdong, Peoples R China; [Li, Chuanyou] Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Capital Medical University; Huazhong Agricultural University; Fujian Agriculture & Forestry University; Beijing Genomics Institute (BGI); Capital Medical University	Li, CY (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China.	lichuanyou6688@hotmail.com; blj@ibp.ac.cn; zhougm@impcas.ac.cn		CHEN, MAOSHAN/0000-0002-3827-4969	National Natural Science Foundation of China [31170132, 31070763]; National Basic Research Program of China [2009CB825402, 2010CB834201, 2012CB518700]; Chinese Academy of Sciences [KSZD-EW-Z-006]; Key Project Specialized for Infectious Diseases of the Chinese Ministry of Health [2012ZX10003002, 2013ZX10003006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Key Project Specialized for Infectious Diseases of the Chinese Ministry of Health	This work was supported by grants from the National Natural Science Foundation of China (Grant No: 31170132 and 31070763), the National Basic Research Program of China (Grant No: 2009CB825402, 2010CB834201 and 2012CB518700), the Chinese Academy of Sciences (Grant No: KSZD-EW-Z-006) and the Key Project Specialized for Infectious Diseases of the Chinese Ministry of Health (Grant No: 2012ZX10003002 and 2013ZX10003006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe W, 2013, HUM REPROD, V28, P750, DOI 10.1093/humrep/des446; Allawi HT, 2004, RNA, V10, P1153, DOI 10.1261/rna.5250604; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Guillen MA, 2011, ARCH BRONCONEUMOL, V47, P521, DOI 10.1016/j.arbres.2011.06.018; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cawood R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000440; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Guo Jigang, 2010, Cancer Biol Ther, V9, P446, DOI 10.4161/cbt.9.6.10894; Guo WR, 2010, PROTEIN CELL, V1, P419, DOI 10.1007/s13238-010-0056-4; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kaufmann SHE, 2008, CELL HOST MICROBE, V4, P219, DOI 10.1016/j.chom.2008.08.002; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lee JH, 2008, INVEST OPHTH VIS SCI, V49, P1827, DOI 10.1167/iovs.07-1142; Leidinger P, 2012, RNA BIOL, V9, P900, DOI 10.4161/rna.20107; Li DD, 2011, HUM IMMUNOL, V72, P598, DOI 10.1016/j.humimm.2011.03.004; Liu AH, 2009, INT J CLIN EXP PATHO, V2, P519; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Parida SK, 2010, DRUG DISCOV TODAY, V15, P148, DOI 10.1016/j.drudis.2009.10.005; Ranjbar S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002620; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Sylvius N, 2011, FASEB J, V25, P3966, DOI 10.1096/fj.11-182915; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wu J, 2012, HUM IMMUNOL, V73, P31, DOI 10.1016/j.humimm.2011.10.003; Yang BM, 2006, DIABETES, V55, P1450, DOI 10.2337/db05-1260; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	39	49	52	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88909	10.1371/journal.pone.0088909	http://dx.doi.org/10.1371/journal.pone.0088909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586438	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700041
J	Amathieu, R; Triba, MN; Nahon, P; Bouchemal, N; Kamoun, W; Haouache, H; Trinchet, JC; Savarin, P; Le Moyec, L; Dhonneur, G				Amathieu, Roland; Triba, Mohamed N.; Nahon, Pierre; Bouchemal, Nadia; Kamoun, Walid; Haouache, Hakim; Trinchet, Jean-Claude; Savarin, Philippe; Le Moyec, Laurence; Dhonneur, Gilles			Serum 1H-NMR Metabolomic Fingerprints of Acute-On-Chronic Liver Failure in Intensive Care Unit Patients with Alcoholic Cirrhosis	PLOS ONE			English	Article							H-1-NMR SPECTROSCOPY; HEPATIC-ENCEPHALOPATHY; NMR-SPECTROSCOPY; IDENTIFICATION; PROFILE; PLASMA; H-1	Introduction: Acute-on-chronic liver failure is characterized by acute deterioration of liver function in patients with compensated or decompensated, but stable, cirrhosis. However, there is no accurate definition of acute-on-chronic liver failure and physicians often use this term to describe different clinical entities. Metabolomics investigates metabolic changes in biological systems and identifies the biomarkers or metabolic profiles. Our study assessed the metabolomic profile of serum using proton nuclear magnetic resonance (H-1-NMR) spectroscopy to identify metabolic changes related to acute-on-chronic liver failure. Patients: Ninety-three patients with compensated or decompensated cirrhosis (CLF group) but stable liver function and 30 patients with cirrhosis and hospitalized for the management of an acute event who may be responsible of acute-on-chronic liver failure (ACLF group), were fully analyzed. Blood samples were drawn at admission, and sera were separated and stored at -80 degrees C until H-1-NMR spectral analysis. Using orthogonal projection to latent-structure discriminant analyses, various metabolites contribute to the complete separation between these both groups. Results: The predictability of the model was 0.73 (Q(2)Y) and the explained variance was 0.63 ((RY)-Y-2). The main metabolites that had increased signals related to acute-on-chronic liver failure were lactate, pyruvate, ketone bodies, glutamine, phenylalanine, tyrosine, and creatinine. High-density lipids were lower in the ALCF group than in CLF group. Conclusion: A serum metabolite fingerprint for acute-on-chronic liver failure, obtained with H-1-NMR, was identified. Metabolomic profiling may aid clinical evaluation of patients with cirrhosis admitted into intensive care units with acute-on-chronic liver failure, and provide new insights into the metabolic processes involved in acute impairment of hepatic function.	[Amathieu, Roland; Kamoun, Walid; Haouache, Hakim; Dhonneur, Gilles] Univ Paris 12, Hop Henri Mondor, AP HP, Serv Anesthesie & Reanimat Chirurg, F-94010 Creteil, France; [Amathieu, Roland; Triba, Mohamed N.; Bouchemal, Nadia; Savarin, Philippe] Univ Paris 13, Sorbonne Paris Cite, Lab Chim Struct Proprietes Biomat & Agents Therap, UMR 7244,CNRS,Equipe Spectroscopie Biomol & Milie, Bobigny, France; [Nahon, Pierre; Trinchet, Jean-Claude] Serv Hepatol, Bondy, France; [Nahon, Pierre; Trinchet, Jean-Claude] Univ Paris 13, Hop Jean Verdier, AP HP, Bondy, France; [Le Moyec, Laurence] Univ Evry, INSERM, UBIAE, U902, Evry, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Amathieu, R (corresponding author), Univ Paris 12, Hop Henri Mondor, AP HP, Serv Anesthesie & Reanimat Chirurg, F-94010 Creteil, France.	roland.amathieu@hmn.aphp.fr	Nahon, Pierre/AAM-9896-2021	Nahon, Pierre/0000-0003-2489-0768				Amathieu R, 2011, J PROTEOME RES, V10, P3239, DOI 10.1021/pr200265z; Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-7; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Jalan R, 2002, BLOOD PURIFICAT, V20, P252, DOI 10.1159/000047017; Jimenez B, 2010, J PROTEOME RES, V9, P5180, DOI 10.1021/pr100486e; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Martinez-Granados B, 2011, INT J MOL MED, V27, P111, DOI 10.3892/ijmm.2010.563; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Nahon P, 2012, CLIN CANCER RES, V18, P6714, DOI 10.1158/1078-0432.CCR-12-1099; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Olson JC, 2011, HEPATOLOGY, V54, P1864, DOI 10.1002/hep.24622; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qi SW, 2012, WORLD J GASTROENTERO, V18, P285, DOI [10.3748/wjg.v18.i3.285, 10.3748/wjg.v17.i3.285]; Qi SW, 2012, HEPATOL RES, V42, P677, DOI 10.1111/j.1872-034X.2011.00964.x; Ranjan P, 2006, LIVER INT, V26, P703, DOI 10.1111/j.1478-3231.2006.01283.x; Rastogi A, 2011, VIRCHOWS ARCH, V459, P121, DOI 10.1007/s00428-011-1115-9; ROSEN HM, 1977, GASTROENTEROLOGY, V72, P483; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Saxena V, 2006, NMR BIOMED, V19, P521, DOI 10.1002/nbm.1034; Sen S, 2004, LIVER TRANSPLANT, V10, P1109, DOI 10.1002/lt.20236; Serkova NJ, 2007, TRANSPLANTATION, V83, P517, DOI 10.1097/01.tp.0000251649.01148.f8; Shangraw RE, 1998, AM J PHYSIOL-GASTR L, V274, pG569, DOI 10.1152/ajpgi.1998.274.3.G569; Tripathi P, 2009, J GASTROINTEST LIVER, V18, P329; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; WEVERS RA, 1994, CLIN CHEM, V40, P1245; Yu K, 2007, J PROTEOME RES, V6, P2413, DOI 10.1021/pr060591d	30	38	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89230	10.1371/journal.pone.0089230	http://dx.doi.org/10.1371/journal.pone.0089230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586615	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900110
J	MdPaiman, N; Ali, SAM; MdZin, R; Kamal, MZM; Amin, WAM; Nallusamy, M; Puspanathan, P; Muhammad, R; Puteh, SEW; Das, S				MdPaiman, Noorasmaliza; Ali, Siti Aishah Md; MdZin, Reena; Kamal, Meor Zamari Meor; Amin, Wan Anna Md; Nallusamy, Mohan; Puspanathan, Pavitratha; Muhammad, Rohaizak; Puteh, Sharifa Ezat Wan; Das, Srijit			Estrogen Receptor-Negative Breast Ductal Carcinoma: Clinicopathological Features and Mib-1 (Ki-67) Proliferative Index Association	PLOS ONE			English	Article							INFLAMMATORY CELLS; ENDOCRINE THERAPY; CANCER; TUMOR; CHEMOTHERAPY; EXPRESSION; GRADE; RECURRENCE; SURVIVAL; DISEASE	Breast cancer estrogen receptor (ER) status is one of the strong additional factors in predicting response of patients towards hormonal treatment. The main aim of this study was to assess the morphological characteristics and proliferative activity using MIB-1(Ki-67) of estrogen receptor negative invasive breast ductal carcinoma (NOS type) as well as to correlate these features with clinicopathological data. We also aim to study the expression of c-erbB2 in ER negative breast tumors. High proliferative rate (MIB-1 above 20%) was observed in 63 (63.6%) of 99 ER negative tumors and that these tumors were associated with high expression of c-erbB2 (57.6%). We observed that MIB-1 is a reliable independent prognostic indicator for ER negative infiltrating ductal carcinoma in this study.	[MdPaiman, Noorasmaliza; Ali, Siti Aishah Md; MdZin, Reena] Univ Kebangsaan Malaysia, Dept Pathol, Kuala Lumpur, Malaysia; [MdPaiman, Noorasmaliza; Kamal, Meor Zamari Meor; Amin, Wan Anna Md; Puspanathan, Pavitratha] Sultanah Bahiyah Hosp, Dept Pathol, Alor Setar, Malaysia; [Nallusamy, Mohan] Sultanah Bahiyah Hosp, Dept Surg, Alor Setar, Malaysia; [Muhammad, Rohaizak] Univ Kebangsaan Malaysia, Dept Surg, Kuala Lumpur, Malaysia; [Puteh, Sharifa Ezat Wan] Univ Kebangsaan Malaysia, Dept Epidemiol, Kuala Lumpur, Malaysia; [Das, Srijit] Univ Kebangsaan Malaysia, Dept Anat, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	MdZin, R (corresponding author), Univ Kebangsaan Malaysia, Dept Pathol, Kuala Lumpur, Malaysia.	reenarahayu@ppukm.ukm.edu.my	Das, Srijit/E-8457-2017; Muhammad, Rohaizak/F-6199-2015; MdZin, Reena/ABC-6727-2020; Wan Puteh, Sharifa Ezat/ABF-8039-2021	Das, Srijit/0000-0001-8302-7257; Wan Puteh, Sharifa Ezat/0000-0001-6251-2528	UKM Medical Centre [FF-067-2007]	UKM Medical Centre	Funded by UKM Medical Centre (Grant number FF-067-2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs G, 2012, MODERN PATHOL, V25, P556, DOI 10.1038/modpathol.2011.194; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Colleoni M, 2004, CLIN CANCER RES, V10, P6622, DOI 10.1158/1078-0432.CCR-04-0380; Diaz Leslie K, 2004, Ann Diagn Pathol, V8, P23, DOI 10.1016/j.anndiagpath.2003.11.004; Dodwell D, 2008, CANCER TREAT REV, V34, P137, DOI 10.1016/j.ctrv.2007.09.004; Dowsett M, 2001, CANCER EPIDEM BIOMAR, V10, P961; DRASH A, 1970, J PEDIATR-US, V76, P585, DOI 10.1016/S0022-3476(70)80409-7; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; GILCHRIST KW, 1993, J CLIN ONCOL, V11, P1929, DOI 10.1200/JCO.1993.11.10.1929; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hayes DF, 2002, SEMIN ONCOL, V29, P231, DOI 10.1053/sonc.2002.32899; Jimenez RE, 2001, AM J SURG PATHOL, V25, P331, DOI 10.1097/00000478-200103000-00007; Mersin H, 2008, BREAST, V17, P341, DOI 10.1016/j.breast.2007.11.031; Meyer JS, 2005, MODERN PATHOL, V18, P1067, DOI 10.1038/modpathol.3800388; National Cancer Registry MoH, 2003, 2 MOH NAT CANC REG; Offersen BV, 2003, HISTOPATHOLOGY, V43, P573, DOI 10.1111/j.1365-2559.2003.01745.x; PARL FF, 1984, CANCER, V54, P2237, DOI 10.1002/1097-0142(19841115)54:10<2237::AID-CNCR2820541029>3.0.CO;2-V; Pertschuk LP, 1996, CANCER-AM CANCER SOC, V77, P2514, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2514::AID-CNCR14>3.0.CO;2-V; PRESS MF, 1993, CANCER RES, V53, P4960; Putti TC, 2005, MODERN PATHOL, V18, P26, DOI 10.1038/modpathol.3800255; Rosa FE, 2008, HUM PATHOL, V39, P720, DOI 10.1016/j.humpath.2007.09.019; Simpson JF, 2000, J CLIN ONCOL, V18, P2059, DOI 10.1200/JCO.2000.18.10.2059; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89172	10.1371/journal.pone.0089172	http://dx.doi.org/10.1371/journal.pone.0089172			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586570	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200039
J	Guo, J; Guo, HL; Wang, ZY				Guo, Jun; Guo, Hanliang; Wang, Zhanyi			Inferring the Temporal Order of Cancer Gene Mutations in Individual Tumor Samples	PLOS ONE			English	Article							SOMATIC MUTATIONS; PATHWAYS; PROGRESSION; EXPRESSION; HALLMARKS; APOPTOSIS; MODEL; APC; MAP	The temporal order of cancer gene mutations in tumors is essential for understanding and treating the disease. Existing methods are unable to infer the order of mutations that are identified at the same time in individual tumor samples, leaving the heterogeneity of the order unknown. Here, we show that through a complex network-based approach, which is based on the newly defined statistic -carcinogenesis information conductivity (CIC), the temporal order in individual samples can be effectively inferred. The results suggest that tumor-suppressor genes might more frequently initiate the order of mutations than oncogenes, and every type of cancer might have its own unique order of mutations. The initial mutations appear to be dedicated to acquiring the function of evading apoptosis, and some order constraints might reflect potential regularities. Our approach is completely data-driven without any parameter settings and can be expected to become more effective as more data will become available.	[Guo, Jun] Beijing Univ Posts & Telecommun, Sch Informat & Commun Engn, Beijing 100088, Peoples R China; [Guo, Hanliang] Univ So Calif, Viterbi Sch Engn, Dept Aerosp & Mech Engn, Los Angeles, CA USA; [Wang, Zhanyi] China Mobile Res Inst, Dept Ind & Market Res, Beijing, Peoples R China	Beijing University of Posts & Telecommunications; University of Southern California; China Mobile	Guo, J (corresponding author), Beijing Univ Posts & Telecommun, Sch Informat & Commun Engn, Beijing 100088, Peoples R China.	guojun@bupt.edu.cn	Guo, Hanliang/Y-5766-2019	Guo, Hanliang/0000-0002-1716-3805	Natural Science Foundation of China [61273217]; Chinese 111 program of 'Advanced Intelligence and Network Service' [B08004]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 program of 'Advanced Intelligence and Network Service'	Natural Science Foundation of China under grant no. 61273217; Chinese 111 program of 'Advanced Intelligence and Network Service' under grant no. B08004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Attolini CSO, 2010, P NATL ACAD SCI USA, V107, P17604, DOI 10.1073/pnas.1009117107; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barzel B, 2013, NAT BIOTECHNOL, V31, P720, DOI 10.1038/nbt.2601; Chen TA, 2003, CANCER RES, V63, P4368; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feizi S, 2013, NAT BIOTECHNOL, V31, P726, DOI 10.1038/nbt.2635; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Gerstung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027136; Gilad O, 2010, CANCER RES, V70, P9693, DOI 10.1158/0008-5472.CAN-10-2286; Guo J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00113; Haffner MC, 2011, CLIN CANCER RES, V17, P3858, DOI 10.1158/1078-0432.CCR-10-2044; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Herranz H, 2012, CURR BIOL, V22, P651, DOI 10.1016/j.cub.2012.02.050; Hsieh JS, 2005, AM SURGEON, V71, P336; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Martins FC, 2012, CANCER DISCOV, V2, P503, DOI 10.1158/2159-8290.CD-11-0325; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Nowell PC, 2002, SEMIN CANCER BIOL, V12, P261, DOI 10.1016/S1044-579X(02)00012-3; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pronier E, 2011, HAEMATOL-HEMATOL J, V96, P638, DOI 10.3324/haematol.2011.042846; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schaub FX, 2010, BLOOD, V115, P2003, DOI 10.1182/blood-2009-09-245381; Sprouffske K, 2011, CANCER PREV RES, V4, P1135, DOI 10.1158/1940-6207.CAPR-10-0374; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Westermark UK, 2011, NEURO-ONCOLOGY, V13, P1277, DOI 10.1093/neuonc/nor131	39	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89244	10.1371/journal.pone.0089244	http://dx.doi.org/10.1371/journal.pone.0089244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586626	gold, Green Submitted, Green Published			2022-12-27	WOS:000332390800012
J	Hung, MH; Liu, CY; Shiau, CY; Hsu, CY; Tsai, YF; Wang, YL; Tai, LC; King, KL; Chao, TC; Chiu, JH; Su, CH; Lo, SS; Tzeng, CH; Shyr, YM; Tseng, LM				Hung, Man-Hsin; Liu, Chun-Yu; Shiau, Cheng-Ying; Hsu, Chin-Yi; Tsai, Yi-Fang; Wang, Yu-Ling; Tai, Ling-Chen; King, Kuang-Liang; Chao, Ta-Chung; Chiu, Jen-Hwey; Su, Cheng-Hsi; Lo, Su-Shun; Tzeng, Cheng-Hwai; Shyr, Yi-Ming; Tseng, Ling-Ming			Effect of Age and Biological Subtype on the Risk and Timing of Brain Metastasis in Breast Cancer Patients	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; YOUNG AGE; SURVIVAL; IDENTIFICATION; RECURRENCE; CARCINOMA; IMPACT; WOMEN	Background: Brain metastasis is a major complication of breast cancer. This study aimed to analyze the effect of age and biological subtype on the risk and timing of brain metastasis in breast cancer patients. Patients and Methods: We identified subtypes of invasive ductal carcinoma of the breast by determining estrogen receptor, progesterone receptor and HER2 status. Time to brain metastasis according to age and cancer subtype was analyzed by Cox proportional hazard analysis. Results: Of the 2248 eligible patients, 164 (7.3%) developed brain metastasis over a median follow-up of 54.2 months. Age 35 or younger, HER2-enriched subtype, and triple-negative breast cancer were significant risk factors of brain metastasis. Among patients aged 35 or younger, the risk of brain metastasis was independent of biological subtype (P = 0.507). Among patients aged 36-59 or >60 years, those with triple-negative or HER2-enriched subtypes had consistently increased risk of brain metastasis, as compared with those with luminal A tumors. Patients with luminal B tumors had higher risk of brain metastasis than luminal A only in patients >60 years. Conclusions: Breast cancer subtypes are associated with differing risks of brain metastasis among different age groups. Patients age 35 or younger are particularly at risk of brain metastasis independent of biological subtype.	[Hung, Man-Hsin; Liu, Chun-Yu; Chao, Ta-Chung; Tzeng, Cheng-Hwai] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Tsai, Yi-Fang; Wang, Yu-Ling; Tai, Ling-Chen; King, Kuang-Liang; Shyr, Yi-Ming; Tseng, Ling-Ming] Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Shiau, Cheng-Ying] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Hung, Man-Hsin; Liu, Chun-Yu; Shiau, Cheng-Ying; Hsu, Chin-Yi; Tsai, Yi-Fang; King, Kuang-Liang; Chao, Ta-Chung; Su, Cheng-Hsi; Lo, Su-Shun; Tzeng, Cheng-Hwai; Shyr, Yi-Ming; Tseng, Ling-Ming] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Liu, Chun-Yu] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Hung, Man-Hsin] Natl Yang Ming Univ, Sch Life Sci, Program Mol Med, Taipei 112, Taiwan; [Hsu, Chin-Yi] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Chiu, Jen-Hwey] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Su, Cheng-Hsi] Cheng Hsin Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Lo, Su-Shun] Natl Yang Ming Univ Hosp, Ilan, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Cheng Hsin General Hospital	Tseng, LM (corresponding author), Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan.	lmtseng@vghtpe.gov.tw	Liu, Chun-Yu/I-4358-2015	Liu, Chun-Yu/0000-0003-2336-4731	Taiwan Clinical Oncology Research Foundation; Taipei Veterans General Hospital [V99C1-059, V100C-093, V100D-005, V102A-005]; National Science Council, Taiwan [NSC97-2314-B-075-007-MY3, NSC 101-2325-B-075-006]	Taiwan Clinical Oncology Research Foundation; Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study is supported by Taiwan Clinical Oncology Research Foundation, grants from Taipei Veterans General Hospital, Grant numbers: V99C1-059, V100C-093, V100D-005, V102A-005, and from National Science Council, Taiwan, Grant numbers NSC97-2314-B-075-007-MY3, NSC 101-2325-B-075-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi S, 2000, LANCET, V355, P1869, DOI 10.1016/S0140-6736(00)02292-3; Altundag K, 2007, CANCER-AM CANCER SOC, V110, P2640, DOI 10.1002/cncr.23088; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Arvold ND, 2011, J CLIN ONCOL, V29, P3885, DOI 10.1200/JCO.2011.36.1105; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Beadle BM, 2011, SEMIN RADIAT ONCOL, V21, P26, DOI 10.1016/j.semradonc.2010.09.001; Benjamin L, 2012, J Med Econ, V15, P493, DOI 10.3111/13696998.2012.662924; College of American Pathologists, 2012, PROT EX SPEC PAT INV; Duchnowska R, 2009, BREAST CANCER RES TR, V117, P297, DOI 10.1007/s10549-008-0275-z; El Saghir NS, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-194; Evans AJ, 2004, CLIN ONCOL-UK, V16, P345, DOI 10.1016/j.clon.2004.03.012; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gonzalez-Angulo AM, 2004, CANCER-AM CANCER SOC, V101, P1760, DOI 10.1002/cncr.20530; Heitz F, 2011, ANN ONCOL, V22, P1571, DOI 10.1093/annonc/mdq625; Heitz F, 2009, EUR J CANCER, V45, P2792, DOI 10.1016/j.ejca.2009.06.027; Kaplan MA, 2013, ONKOLOGIE, V36, P176, DOI 10.1159/000349950; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Klein A, 2009, CANCER LETT, V276, P212, DOI 10.1016/j.canlet.2008.11.017; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Marko NF, 2012, CANCER-AM CANCER SOC, V118, P3749, DOI 10.1002/cncr.26716; Mayer M, 2007, CLIN CANCER RES, V13, P1623, DOI 10.1158/1078-0432.CCR-06-2842; Miller KD, 2003, ANN ONCOL, V14, P1072, DOI 10.1093/annonc/mdg300; Nam BH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1870; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Niwinska A, 2011, EJSO-EUR J SURG ONC, V37, P635, DOI 10.1016/j.ejso.2011.05.002; Niwinska A, 2012, INT J RADIAT ONCOL, V82, P2065, DOI 10.1016/j.ijrobp.2010.10.077; Rakha EA, 2008, J CLIN ONCOL, V26, P3153, DOI 10.1200/JCO.2007.15.5986; Tham YL, 2006, CANCER, V107, P696, DOI 10.1002/cncr.22041; TSUKADA Y, 1983, CANCER-AM CANCER SOC, V52, P2349, DOI 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B	31	40	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89389	10.1371/journal.pone.0089389	http://dx.doi.org/10.1371/journal.pone.0089389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586742	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700036
J	Lu, D; Li, QY; Wu, ZB; Shang, SZ; Liu, S; Wen, X; Li, ZY; Wu, FF; Li, N				Lu, Dan; Li, Qiuyan; Wu, Zhibin; Shang, Shengzhe; Liu, Shen; Wen, Xiao; Li, Zhiyuan; Wu, Fangfang; Li, Ning			High-Level Recombinant Human Lysozyme Expressed in Milk of Transgenic Pigs Can Inhibit the Growth of Escherichia coli in the Duodenum and Influence Intestinal Morphology of Sucking Pigs	PLOS ONE			English	Article							MAMMARY-GLAND; PRION PROTEIN; GOATS; GENE; ANTIBIOTICS; CONSUMPTION; LACTOFERRIN; MODULATION; MICROBIOTA; PIGLETS	Lysozyme is often used as a feed additive and acts as an antimicrobial protein that enhances immune function and defends against pathogenic bacteria in pigs. In this study, we genetically added recombinant human lysozyme (rhLZ) to sow milk by somatic cell nuclear transfer and investigated whether the presence of recombinant human lysozyme can influence intestinal microbiota and mophology in sucking pigs. We generated transgenic cloned pigs and the first-generation hybrids (F1) produced high levels of rhLZ in milk. The average concentration of rhLZ was 116.34 +/- 24.46 mg/L in the milk of F1 sows, which was 1500-fold higher than that of the native pig lysozyme. In vitro, it was demonstrated that rhLZ in milk of transgenic pigs had enzyme levels at 92,272 +/- 26,413 U/mL. In a feeding experiment, a total of 40 newborn piglets were nursed by four transgenic sows and four sibling non-transgenic sows (F1), with five piglets per gilt. The piglets were allowed to nurse for 21 days and the sow milk was the only source of nutrition for the piglets. All piglets were slaughtered on postnatal day 22. Six types of bacteria were cultured and analyzed to detect the impact of rhLZ on gut microbiota. The number of Escherichia coli in the duodenum of piglets reared by transgenic sows was significantly decreased (p<0.001) and their villus height to crypt depth ratio in the intestine were increased due to the significant decrease of crypt depth in the duodenum, jejunum, and ileum (p<0.001). Together, we successfully generated rhLZ transgenic cloned pigs and elevated lysozyme level in nuring piglets. The results of the feeding experiments demonstrated that rhLZ-enhanced milk can inhibit the growth of E. coli in the duodenum and positively influence intestinal morphology without adversely affecting weight gain or piglet growth.	[Lu, Dan; Li, Qiuyan; Wu, Zhibin; Shang, Shengzhe; Liu, Shen; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Wen, Xiao; Li, Zhiyuan] Beijing Genfucare Biotechnol Co, Beijing, Peoples R China; [Wu, Fangfang] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Peoples R China	China Agricultural University; Yunnan Agricultural University	Li, N (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	ninglcau@cau.edu.cn	li, zhiyuan/HGD-9581-2022		National Transgenic Breeding Program of China [2011ZX08006-001]	National Transgenic Breeding Program of China	This work was supported by National Transgenic Breeding Program of China (No. 2011ZX08006-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo Frederick J, 2004, Semin Pediatr Infect Dis, V15, P78, DOI 10.1053/j.spid.2004.01.010; Baldassarre H, 2008, TRANSGENIC RES, V17, P863, DOI 10.1007/s11248-008-9184-5; Benestad SL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-87; Brundige DR, 2008, J NUTR, V138, P921, DOI 10.1093/jn/138.5.921; Carpenter JA, 2005, J SWINE HEALTH PROD, V13, P218; CHANDAN RC, 1964, NATURE, V204, P76, DOI 10.1038/204076a0; CHANDAN RC, 1968, J DAIRY SCI, V51, P606, DOI 10.3168/jds.S0022-0302(68)87036-5; Clark KJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S13; Cooper CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058409; Cooper CA, 2011, TRANSGENIC RES, V20, P1235, DOI 10.1007/s11248-011-9489-7; Ding JY, 2004, J AGR FOOD CHEM, V52, P3372, DOI 10.1021/jf049915d; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hu WP, 2012, BIOCHEM CELL BIOL, V90, P485, DOI [10.1139/o2012-003, 10.1139/O2012-003]; Humphrey BD, 2002, J NUTR, V132, P1214, DOI 10.1093/jn/132.6.1214; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kumar A, 2005, ADV DRUG DELIVER REV, V57, P1486, DOI 10.1016/j.addr.2005.04.004; Lee M, 2009, J AGR FOOD CHEM, V57, P2233, DOI 10.1021/jf803133b; Li QY, 2009, PROG NAT SCI-MATER, V19, P699, DOI 10.1016/j.pnsc.2008.04.021; Maga EA, 2006, J DAIRY SCI, V89, P518, DOI 10.3168/jds.S0022-0302(06)72114-2; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; Maga EA, 2006, TRANSGENIC RES, V15, P515, DOI 10.1007/s11248-006-0014-3; Maga EA, 2012, APPL ENVIRON MICROB, V78, P6153, DOI 10.1128/AEM.00956-12; May KD, 2012, J ANIM SCI, V90, P1118, DOI 10.2527/jas.2011-4297; Montagne L, 2003, ANIM FEED SCI TECH, V108, P95, DOI 10.1016/S0377-8401(03)00163-9; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nyachoti CM, 2012, J ANIM SCI, V90, P252, DOI 10.2527/jas.2010-3596; Ogundele MO, 1998, MEDIAT INFLAMM, V7, P363, DOI 10.1080/09629359890893; Oliver WT, 2002, J ANIM SCI, V80, P143; Oliver WT, 2013, J ANIM SCI; Palmer CA, 2003, TRANSGENIC RES, V12, P283, DOI 10.1023/A:1023398926763; Pluske JR, 1996, BRIT J NUTR, V76, P409, DOI 10.1079/BJN19960046; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Rockova S, 2011, ANAEROBE, V17, P223, DOI 10.1016/j.anaerobe.2011.07.009; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; SALTON MRJ, 1957, BACTERIOL REV, V21, P82, DOI 10.1128/MMBR.21.2.82-100.1957; Tong J, 2011, TRANSGENIC RES, V20, P417, DOI 10.1007/s11248-010-9409-2; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wei HX, 2008, PROG NAT SCI-MATER, V18, P1583, DOI 10.1016/j.pnsc.2008.05.018; Wolf E, 2013, TRANSGENIC RES; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Yu Z, 2006, J DAIRY SCI, V89, P2911, DOI 10.3168/jds.S0022-0302(06)72563-2; Zhang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049697; Zijlstra RT, 1996, J ANIM SCI, V74, P2948	43	24	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89130	10.1371/journal.pone.0089130	http://dx.doi.org/10.1371/journal.pone.0089130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586544	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900055
J	Marakeby, H; Badr, E; Torkey, H; Song, Y; Leman, S; Monteil, CL; Heath, LS; Vinatzer, BA				Marakeby, Haitham; Badr, Eman; Torkey, Hanaa; Song, Yuhyun; Leman, Scotland; Monteil, Caroline L.; Heath, Lenwood S.; Vinatzer, Boris A.			A System to Automatically Classify and Name Any Individual Genome-Sequenced Organism Independently of Current Biological Classification and Nomenclature	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; SPECIES DEFINITION; PROKARYOTES; PHYLOGENY	A broadly accepted and stable biological classification system is a prerequisite for biological sciences. It provides the means to describe and communicate about life without ambiguity. Current biological classification and nomenclature use the species as the basic unit and require lengthy and laborious species descriptions before newly discovered organisms can be assigned to a species and be named. The current system is thus inadequate to classify and name the immense genetic diversity within species that is now being revealed by genome sequencing on a daily basis. To address this lack of a general intra-species classification and naming system adequate for today's speed of discovery of new diversity, we propose a classification and naming system that is exclusively based on genome similarity and that is suitable for automatic assignment of codes to any genome-sequenced organism without requiring any phenotypic or phylogenetic analysis. We provide examples demonstrating that genome similarity-based codes largely align with current taxonomic groups at many different levels in bacteria, animals, humans, plants, and viruses. Importantly, the proposed approach is only slightly affected by the order of code assignment and can thus provide codes that reflect similarity between organisms and that do not need to be revised upon discovery of new diversity. We envision genome similarity-based codes to complement current biological nomenclature and to provide a universal means to communicate unambiguously about any genome-sequenced organism in fields as diverse as biodiversity research, infectious disease control, human and microbial forensics, animal breed and plant cultivar certification, and human ancestry research.	[Marakeby, Haitham; Badr, Eman; Torkey, Hanaa; Heath, Lenwood S.] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Song, Yuhyun; Leman, Scotland] Virginia Tech, Dept Stat, Blacksburg, VA USA; [Monteil, Caroline L.; Vinatzer, Boris A.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Monteil, Caroline L.] INRA, UR0407 Pathol Vegetale, Montfavet, France; [Heath, Lenwood S.; Vinatzer, Boris A.] Genomic Life Inc, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; INRAE	Vinatzer, BA (corresponding author), Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.	vinatzer@vt.edu	Heath, Lenwood Scott/A-5861-2008; MONTEIL, Caroline L./AAU-8284-2021; Torkey, Hanaa/GLR-0493-2022	Heath, Lenwood Scott/0000-0003-1608-431X; MONTEIL, Caroline L./0000-0002-2834-6834; Torkey, Hanaa/0000-0003-4495-225X; Badr, Eman M./0000-0001-9531-2266	National Science Foundation [IOS 0746501]	National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Science Foundation (Award IOS 0746501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cantino PD, 2004, PHYLOCODE; Cottam EM, 2006, J VIROL, V80, P11274, DOI 10.1128/JVI.01236-06; Darwin C, 1859, ORIGIN SPECIES MEANS; Enserink M, 2001, SCIENCE, V294, P1812, DOI 10.1126/science.294.5548.1812; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Linnaeus C, 1753, SPECIES PLANTARUM, V1, DOI DOI 10.5962/BHL.TITLE.669; Linnaeus C, 1766, SYSTEMA NATURAE REGN; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Norvell LL, 2011, MYCOTAXON, V116, P481, DOI 10.5248/116.481; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44; Subramaniam S, 2011, VIRUS GENES, V43, P224, DOI 10.1007/s11262-011-0622-8; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09	26	27	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89142	10.1371/journal.pone.0089142	http://dx.doi.org/10.1371/journal.pone.0089142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586551	Green Published, gold			2022-12-27	WOS:000331717900057
J	Wolowski, M; Ashman, TL; Freitas, L				Wolowski, Marina; Ashman, Tia-Lynn; Freitas, Leandro			Meta-Analysis of Pollen Limitation Reveals the Relevance of Pollination Generalization in the Atlantic Forest of Brazil	PLOS ONE			English	Article							PLANT REPRODUCTION; COMMUNITY; ECOLOGY; FLOWER; SPECIALIZATION; ANGIOSPERMS; DIVERSITY; ASSURANCE; QUANTITY; BIOLOGY	Despite the extensive knowledge of pollen limitation in angiosperms, its assessment within tropical forests is still limited. Especially lacking are large scale comparisons of species within this biome - one that is highly diverse but also becoming increasingly threatened. In fact, many tropical plant species depend upon pollinators for reproduction but evaluation of the impact of this dependence via different levels of pollination specialization has yet to be made at the biome scale. We assessed the occurrence and magnitude of pollen limitation for species in the Brazilian Atlantic forest and tested the association of pollination specialization, breeding system, and life habit with pollination efficiency. We compiled data from studies published between 1985 and 2012. We calculated species' effect size (d) from data on fruit set after hand cross-pollination and natural pollination and conducted standard and phylogenetically independent meta-analysis. Overall pollen limitation was moderate, with magnitude of 0.50, and 95% confidence interval [0.37, 0.62] for 126 species. Pollen limitation was observed in 39% of species. Pollination specialization was the factor that best explained the occurrence of pollen limitation. Specifically, phenotypic and ecological specialists (plants with zygomorphic flowers and pollinated by one species of pollinator, respectively) had higher pollen limitation than generalist plants (actinomorphic flowers and pollination by two or more species). Functional generalists (plants pollinated by three or more functional groups) were not pollen limited. On the other hand, breeding system and life habit were not associated to pollen limitation. Pollen limitation was observed in the Atlantic forest and its magnitude was comparable to that for angiosperms as a whole. The finding that pollination specialization was the strongest predictor of pollen limitation suggests that specialist plants in this biome may be most prone to the reproductive failure as a result of pollinator loss.	[Wolowski, Marina] Inst Pesquisas Jardim Bot Rio de Janeiro, Programa Posgrad Bot, Rio De Janeiro, RJ, Brazil; [Ashman, Tia-Lynn] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Freitas, Leandro] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, RJ, Brazil	Jardim Botanico do Rio de Janeiro; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jardim Botanico do Rio de Janeiro	Wolowski, M (corresponding author), Inst Pesquisas Jardim Bot Rio de Janeiro, Programa Posgrad Bot, Rio De Janeiro, RJ, Brazil.	marina.wolowski@gmail.com	Wolowski, Marina/H-1852-2013; Freitas, Leandro/E-6975-2011	Wolowski, Marina/0000-0001-5481-1472; Freitas, Leandro/0000-0002-4146-2514	CAPES	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial and logistical supports were provided by CAPES (DS and BEX 6151/11-6 scholarships to M. Wolowski), CNCFlora (Ph.D. scholarship to M. Wolowski), CNPq and FAPERJ (Research Grants to L. Freitas), NSF (DEB 1020523), Graduate Program-JBRJ and Flora Foundation (publication fees), and University of Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2007, ECOLOGY, V88, P271, DOI 10.1890/06-1017; Alonso C, 2012, NEW PHYTOL, V193, P532, DOI 10.1111/j.1469-8137.2011.03932.x; Alonso C, 2010, OIKOS, V119, P1192, DOI 10.1111/j.1600-0706.2009.18026.x; Andalo C, 2010, PLANT SYST EVOL, V286, P223, DOI 10.1007/s00606-010-0303-4; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; BAWA KS, 1985, AM J BOT, V72, P331, DOI 10.2307/2443526; BENZING DH, 2000, BROMELIACEAE PROFILE; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Burd M, 2009, AM J BOT, V96, P1159, DOI 10.3732/ajb.0800183; CONNELL J H, 1971, P298; Cooper H. M., 2009, HDB RES SYNTHESIS ME; Davila YC, 2012, BOTANY, V90, P535, DOI [10.1139/B2012-017, 10.1139/b2012-017]; de Nettancourt D., 1977, INCOMPATIBILITY ANGI; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Freitas Leandro, 2010, Oecologia Australis, V14, P251; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Ghazoul J., 2010, TROPICAL RAIN FOREST; Gomez JM, 2010, J ECOL, V98, P1243, DOI 10.1111/j.1365-2745.2010.01691.x; Gong YB, 2009, P ROY SOC B-BIOL SCI, V276, P4013, DOI 10.1098/rspb.2009.1254; Gonzalez AV, 2010, INT J PLANT SCI, V171, P607, DOI 10.1086/653135; HAIG D, 1988, AM NAT, V131, P757, DOI 10.1086/284817; Harder LD, 2010, PHILOS T R SOC B, V365, P529, DOI 10.1098/rstb.2009.0226; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hegland SJ, 2008, OIKOS, V117, P883, DOI [10.1111/j.0030-1299.2008.16561.x, 10.1111/j.2008.0030-1299.16561.x]; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; KARRON JD, 1987, BIOL CONSERV, V39, P179, DOI 10.1016/0006-3207(87)90033-4; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Knight TM, 2006, AM J BOT, V93, P271, DOI 10.3732/ajb.93.2.271; Kress W. John, 1994, P161; Lajeunesse MJ, 2009, AM NAT, V174, P369, DOI 10.1086/603628; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1111/j.1095-8312.2000.tb01221.x; LLOYD DG, 1992, INT J PLANT SCI, V153, P358, DOI 10.1086/297040; Marten-Rodriguez S, 2010, ECOLOGY, V91, P155, DOI 10.1890/08-2115.1; Martini AMZ, 2007, BIODIVERS CONSERV, V16, P3111, DOI 10.1007/s10531-007-9166-6; Maues MM, 2012, POLINIZADORES BRASIL, P49; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Mittermeier Russell A., 2004, P1; MOTTEN AF, 1986, ECOL MONOGR, V56, P21, DOI 10.2307/2937269; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Ollerton J, 2007, TAXON, V56, P717, DOI 10.2307/25065856; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; R Development Core Team, 2012, R LANG ENV STAT COMP; RAMIREZ N, 1990, AM J BOT, V77, P1260, DOI 10.2307/2444587; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rymer PD, 2005, BIOL CONSERV, V123, P521, DOI 10.1016/j.biocon.2005.01.002; SOS Mata Atlantica Instituto Nacional de Pesquisas Espaciais, 2008, ATL REM FLOR MAT ATL; Stehmann J. R., 2009, PLANTAS FLORESTA ATL; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; Ushimaru A, 2009, OECOLOGIA, V160, P667, DOI 10.1007/s00442-009-1334-9; Vamosi JC, 2013, PLANT ECOL DIVERS, V6, P171, DOI 10.1080/17550874.2013.769130; Vamosi JC, 2006, P NATL ACAD SCI USA, V103, P956, DOI 10.1073/pnas.0507165103; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Werneck MD, 2011, NAT CONSERVACAO, V9, P188, DOI 10.4322/natcon.2011.024; Wheelwright NT, 2006, AM MIDL NAT, V155, P19, DOI 10.1674/0003-0031(2006)155[0019:PLAAMI]2.0.CO;2; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; Wolowski M, 2013, ANN BOT-LONDON, V112, P903, DOI 10.1093/aob/mct140; ZAPATA TR, 1978, BIOTROPICA, V10, P221, DOI 10.2307/2387907; ZIMMERMAN M, 1988, AM NAT, V131, P723, DOI 10.1086/284815	66	27	27	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89498	10.1371/journal.pone.0089498	http://dx.doi.org/10.1371/journal.pone.0089498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586827	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000331717900107
J	Bi, Y; Chen, L; Cai, M; Zhu, SS; Pang, ZL; Liu, XL				Bi, Yang; Chen, Lei; Cai, Meng; Zhu, Shusheng; Pang, Zhili; Liu, Xili			Two Non-target Recessive Genes Confer Resistance to the Anti-Oomycete Microtubule Inhibitor Zoxamide in Phytophthora capsici	PLOS ONE			English	Article							BASE-LINE SENSITIVITY; AMIDE CAA FUNGICIDES; MULTIDRUG-RESISTANCE; BOTRYTIS-CINEREA; HOST-RANGE; INHERITANCE; MECHANISMS; PROTEIN; ACID; POPULATIONS	This study characterized isolates of P. capsici that had developed a novel mechanism of resistance to zoxamide, which altered the minimum inhibition concentration (MIC) but not the EC50. Molecular analysis revealed that the beta-tubulin gene of the resistant isolates contained no mutations and was expressed at the same level as in zoxamide-sensitive isolates. This suggested that P. capsici had developed a novel non-target-site-based resistance to zoxamide. Analysis of the segregation ratio of zoxamide-resistance in the sexual progeny of the sensitive isolates PCAS1 and PCAS2 indicated that the resistance to zoxamide was controlled by one or more recessive nuclear genes. Furthermore, the segregation of resistance in the F-1, F-2, and BC1 progeny was in accordance with the theoretical ratios of the chi(2) test (P > 0.05), which suggested that the resistance to zoxamide was controlled by two recessive genes, and that resistance to zoxamide occurred when at least one pair of these alleles was homozygous. This implies that the risk of zoxamide-resistance in P. capsici is low to moderate. Nevertheless this potential for resistance should be monitored closely, especially if two compatible mating types co-exist in the same field.	[Bi, Yang; Chen, Lei; Cai, Meng; Pang, Zhili; Liu, Xili] China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China; [Bi, Yang] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China; [Chen, Lei] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Zhu, Shusheng] Yunnan Agr Univ, Minist China, Key Lab Agrobiodivers & Pest Management Educ, Kunming, Yunnan, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Beijing Forestry University; Yunnan Agricultural University	Liu, XL (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China.	seedling@cau.edu.cn	Chen, Lei/A-2487-2015; Pang, Zhili/AFO-8248-2022	Chen, Lei/0000-0001-5331-9574; Pang, Zhili/0000-0001-8047-1272	National Science Foundation of China [30800731]; Doctor Foundation of the State Ministry of Education, China [200800190025]; special Fund for Agro-scientific Research in the Public Interest [201003004]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctor Foundation of the State Ministry of Education, China; special Fund for Agro-scientific Research in the Public Interest	This work was partially funded by the National Science Foundation of China (30800731), the Doctor Foundation of the State Ministry of Education, China (200800190025) and special Fund for Agro-scientific Research in the Public Interest (201003004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI T, 1988, PLANT CELL PHYSIOL, V29, P1053; Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI 10.1038/nrmicro1179; ANN PJ, 1988, PHYTOPATHOLOGY, V78, P335, DOI 10.1094/Phyto-78-335; BHAT RG, 1993, MYCOL RES, V97, P865, DOI 10.1016/S0953-7562(09)81164-7; Bi Y, 2011, PHYTOPATHOLOGY, V101, P1104, DOI 10.1094/PHYTO-01-11-0010; Billard A, 2012, PEST MANAG SCI; Blum M, 2010, FUNGAL GENET BIOL, V47, P499, DOI 10.1016/j.fgb.2010.02.009; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; COHEN Y, 1986, ANNU REV PHYTOPATHOL, V24, P311, DOI 10.1146/annurev.py.24.090186.001523; CRUTE IR, 1988, PLANT PATHOL, V37, P231, DOI 10.1111/j.1365-3059.1988.tb02069.x; Davidson CR, 2002, PLANT DIS, V86, P1049, DOI [10.1094/PDIS.2002.86.9.1049A, 10.1094/PDIS.2002.86.7.813B]; Deng Weiping, 2012, Chinese Journal of Pesticide Science, V14, P143, DOI 10.3969/j.issn.1008-7303.2012.02.05; Donahoo RS, 2008, MYCOLOGIA, V100, P911, DOI 10.3852/08-028; Edmonds J, 2004, 10165 PPPO, P165; Egan A. R., 1998, Brighton Crop Protection Conference: Pests & Diseases - 1998: Volume 2: Proceedings of an International Conference, Brighton, UK, 16-19 November 1998, P335; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; FARETRA F, 1991, MYCOL RES, V95, P943, DOI 10.1016/S0953-7562(09)80091-9; French-Monar RD, 2006, PLANT DIS, V90, P345, DOI 10.1094/PD-90-0345; Gevens AJ, 2008, PLANT DIS, V92, P201, DOI 10.1094/PDIS-92-2-0201; Gisi U, 2007, PLANT PATHOL, V56, P199, DOI 10.1111/j.1365-3059.2006.01512.x; Gisi U, 2002, PEST MANAG SCI, V58, P859, DOI 10.1002/ps.565; Gisi U, 2000, CROP PROT, V19, P863, DOI 10.1016/S0261-2194(00)00114-9; Gisi U, 1996, ANNU REV PHYTOPATHOL, V34, P549, DOI 10.1146/annurev.phyto.34.1.549; Gisi U, 2008, EUR J PLANT PATHOL, V122, P157, DOI 10.1007/s10658-008-9290-5; Gisi U, 2012, MODERN CROP PROTECTION COMPOUNDS, VOLS 1-3, 2ND EDITION, P807; Granke LL, 2011, PLANT DIS, V95, P1080, DOI 10.1094/PDIS-03-11-0190; Gullino ML, 2000, CROP PROT, V19, P1, DOI 10.1016/S0261-2194(99)00095-2; Gulshan K, 2007, EUKARYOT CELL, V6, P1933, DOI 10.1128/EC.00254-07; Hausbeck MK, 2004, PLANT DIS, V88, P1292, DOI 10.1094/PDIS.2004.88.12.1292; HORD MJ, 1991, PHYTOPATHOLOGY, V81, P1541, DOI 10.1094/Phyto-81-1541; Jaime M. D. L. A., 2003, Phytopathology, V93, pS39; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Keinath AP, 2007, PLANT DIS, V91, P743, DOI 10.1094/PDIS-91-6-0743; Koo BS, 2009, APPL MICROBIOL BIOT, V82, P513, DOI 10.1007/s00253-008-1821-7; Lamour KH, 2003, PLANT DIS, V87, P841, DOI 10.1094/PDIS.2003.87.7.841; Lamour KH, 2000, PHYTOPATHOLOGY, V90, P396, DOI 10.1094/PHYTO.2000.90.4.396; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Leroux P, 1999, CROP PROT, V18, P687, DOI 10.1016/S0261-2194(99)00074-5; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Malandrakis A, 2011, PESTIC BIOCHEM PHYS, V99, P118, DOI 10.1016/j.pestbp.2010.11.008; Malathrakis N., 1979, PHYTOPATHOL MEDITERR, V19, P70; Mathur S., 1995, Canadian Journal of Plant Pathology, V17, P360; Meitz JC, 2010, AUSTRALAS PLANT PATH, V39, P431, DOI 10.1071/AP09075; Meng QX, 2011, PLANT PATHOL, V60, P957, DOI 10.1111/j.1365-3059.2011.02454.x; Meng QT, 2010, PLANT MOL BIOL, V74, P537, DOI 10.1007/s11103-010-9694-4; MOSS NA, 1994, PLANT PATHOL, V43, P713, DOI 10.1111/j.1365-3059.1994.tb01611.x; Nakaune R, 2007, FUNGAL GENET BIOL, V44, P1324, DOI 10.1016/j.fgb.2007.03.007; Naoi K, 2004, PLANT CELL, V16, P1841, DOI 10.1105/tpc.021865; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quesada-Ocampo LM, 2009, PLANT DIS, V93, P135, DOI 10.1094/PDIS-93-2-0135; ROBERTS PD, 1999, FLORIDA TOMATO I P, P41; Schouten A, 2008, ENVIRON MICROBIOL, V10, P1145, DOI 10.1111/j.1462-2920.2007.01531.x; Shattock R, 2007, PLANT PATHOL, V37, P4; Sun HY, 2010, J PHYTOPATHOL, V158, P244, DOI 10.1111/j.1439-0434.2009.01606.x; Tian D, 2004, PLANT DIS, V88, P485, DOI 10.1094/PDIS.2004.88.5.485; Tran H, 2008, J APPL MICROBIOL, V104, P839, DOI 10.1111/j.1365-2672.2007.03618.x; Van Damme D, 2004, PLANT PHYSIOL, V136, P3956, DOI 10.1104/pp.104.051623; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010; Yilou P, 1997, CHIN J OIL CROP SCI, V3; Young D.H., 2005, CROSS RESISTANCE REL, P125; Young DH, 2001, PESTIC BIOCHEM PHYS, V69, P100, DOI 10.1006/pest.2000.2529; Young DH, 2001, PEST MANAG SCI, V57, P1081, DOI 10.1002/ps.399; Ziogas BN, 2006, EUR J PLANT PATHOL, V115, P283, DOI 10.1007/s10658-006-9007-6	63	12	12	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89336	10.1371/journal.pone.0089336	http://dx.doi.org/10.1371/journal.pone.0089336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586697	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700105
J	Hammond, MP; Kolasa, J				Hammond, Matthew P.; Kolasa, Jurek			Spatial Variation as a Tool for Inferring Temporal Variation and Diagnosing Types of Mechanisms in Ecosystems	PLOS ONE			English	Article							SPATIOTEMPORAL DYNAMICS; POPULATION-DYNAMICS; DISPERSAL; STABILITY; SCALE; SYNCHRONY; TIME; PATTERNS; SPACE; VARIANCE	Ecological processes, like the rise and fall of populations, leave an imprint of their dynamics as a pattern in space. Mining this spatial record for insight into temporal change underlies many applications, including using spatial snapshots to infer trends in communities, rates of species spread across boundaries, likelihood of chaotic dynamics, and proximity to regime shifts. However, these approaches rely on an inherent but undefined link between spatial and temporal variation. We present a quantitative link between a variable's spatial and temporal variation based on established variance-partitioning techniques, and test it for predictive and diagnostic applications. A strong link existed between spatial and regional temporal variation (estimated as Coefficients of Variation or CV's) in 136 variables from three aquatic ecosystems. This association suggests a basis for substituting one for the other, either quantitatively or qualitatively, when long time series are lacking. We further show that weak substitution of temporal for spatial CV results from distortion by specific spatiotemporal patterns (e.g., inter-patch synchrony). Where spatial and temporal CV's do not match, we pinpoint the spatiotemporal causes of deviation in the dynamics of variables and suggest ways that may control for them. In turn, we demonstrate the use of this framework for describing spatiotemporal patterns in multiple ecosystem variables and attributing them to types of mechanisms. Linking spatial and temporal variability makes quantitative the hitherto inexact practice of space-for-time substitution and may thus point to new opportunities for navigating the complex variation of ecosystems.	[Hammond, Matthew P.; Kolasa, Jurek] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University	Hammond, MP (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	mhammond@gmx.com		Kolasa, Jurek/0000-0003-0910-8950	Natural Sciences and Engineering Research Council of Canada (NSERC) [5-31314-6100]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Natural Sciences and Engineering Research Council of Canada (NSERC - http://www.nserc-crsng.gc.ca) grant 5-31314-6100. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbott KC, 2011, ECOL LETT, V14, P1158, DOI 10.1111/j.1461-0248.2011.01670.x; Anderson KE, 2012, ECOL LETT, V15, P209, DOI 10.1111/j.1461-0248.2011.01727.x; [Anonymous], 2007, A CHANGING WORLD; Aukema BH, 2008, ECOGRAPHY, V31, P348, DOI 10.1111/j.0906-7590.2007.05453.x; Barnes JB, 2012, GEOLOGY, V40, P1135, DOI 10.1130/G33229.1; Bascompte J, 1998, TRENDS ECOL EVOL, V13, P173, DOI 10.1016/S0169-5347(98)01325-1; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Burrows MT, 2009, ECOLOGY, V90, P1242, DOI 10.1890/08-0206.1; CHESSON PL, 1985, THEOR POPUL BIOL, V28, P263, DOI 10.1016/0040-5809(85)90030-9; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Cowles H.C., 1899, BOT GAZ, V27, P95, DOI [DOI 10.1086/327796, 10.1086/327796]; Crabtree R, 2009, REMOTE SENS ENVIRON, V113, P1486, DOI 10.1016/j.rse.2008.12.014; Dai L, 2013, NATURE, V496, P355, DOI 10.1038/nature12071; De Michele C, 2005, ATMOS RES, V77, P124, DOI 10.1016/j.atmosres.2004.10.031; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; Earn DJD, 2000, SCIENCE, V290, P1360, DOI 10.1126/science.290.5495.1360; Edwards M, 2012, LIMNOLOGY OCEANOGRAP, V51, P820; Eppinga MB, 2013, ECOGRAPHY, V36, P622, DOI 10.1111/j.1600-0587.2012.07753.x; Erisman B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00284; Ettema CH, 2000, OECOLOGIA, V125, P444, DOI 10.1007/s004420000468; Fangliang H, 2008, J VEG SCI, V8, P105; Feller W., 1950, INTRO PROBABILITY TH; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Isaak DJ, 2006, CAN J FISH AQUAT SCI, V63, P285, DOI 10.1139/F05-214; Jiang L, 2009, AM NAT, V174, P651, DOI 10.1086/605961; Jongejans E, 2005, J ECOL, V93, P681, DOI 10.1111/j.1365-2745.2005.01003.x; KAREIVA P, 1995, NATURE, V373, P299, DOI 10.1038/373299a0; Keitt TH, 2005, ECOLOGY, V86, P2497, DOI 10.1890/04-1016; Larsen DP, 2001, BIOSCIENCE, V51, P1069, DOI 10.1641/0006-3568(2001)051[1069:DFELAR]2.0.CO;2; Leavitt PR, 2009, LIMNOL OCEANOGR, V54, P2330, DOI 10.4319/lo.2009.54.6_part_2.2330; Legendre P, 2010, ECOLOGY, V91, P262, DOI 10.1890/09-0199.1; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LEWIS WM, 1978, ECOLOGY, V59, P666; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; Marcos-Nikolaus P, 2002, INT J BIFURCAT CHAOS, V12, P369, DOI 10.1142/S0218127402004371; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Micheli F, 1999, OIKOS, V85, P161, DOI 10.2307/3546802; Morfin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037907; PAINE ADM, 1985, PROG PHYS GEOG, V9, P1, DOI 10.1177/030913338500900101; Paradis E, 1999, ECOL LETT, V2, P114, DOI 10.1046/j.1461-0248.1999.22060.x; PICKETT S T A, 1989, P110; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Pysek P, 2005, ECOSCIENCE, V12, P302, DOI 10.2980/i1195-6860-12-3-302.1; Ranta E, 1997, SCIENCE, V278, P1621, DOI 10.1126/science.278.5343.1621; Reed DC, 2000, ECOLOGY, V81, P2011; Rutledge DT, 2001, CONSERV BIOL, V15, P475, DOI 10.1046/j.1523-1739.2001.015002475.x; Sciullo L, 2012, COMMUNITY ECOL, V13, P203, DOI 10.1556/ComEc.13.2012.2.10; Seabloom EW, 2005, ECOL MONOGR, V75, P199, DOI 10.1890/03-0841; Senici D, 2010, ECOSYSTEMS, V13, P1227, DOI 10.1007/s10021-010-9383-9; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; SOLE RV, 1995, J THEOR BIOL, V175, P139, DOI 10.1006/jtbi.1995.0126; Tobin PC, 2003, J ANIM ECOL, V72, P460, DOI 10.1046/j.1365-2656.2003.00715.x; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Vogwill T, 2009, ECOL LETT, V12, P1194, DOI 10.1111/j.1461-0248.2009.01374.x; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; WATSON A, 1984, J ANIM ECOL, V53, P639, DOI 10.2307/4541	66	16	16	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89245	10.1371/journal.pone.0089245	http://dx.doi.org/10.1371/journal.pone.0089245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586627	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700080
J	Feng, LY; Li, X; Yu, Q; Ning, XH; Dou, JZ; Zou, JJ; Zhang, LL; Wang, S; Hu, XL; Bao, ZM				Feng, Liying; Li, Xue; Yu, Qian; Ning, Xianhui; Dou, Jinzhuang; Zou, Jiajun; Zhang, Lingling; Wang, Shi; Hu, Xiaoli; Bao, Zhenmin			A Scallop IGF Binding Protein Gene: Molecular Characterization and Association of Variants with Growth Traits	PLOS ONE			English	Article							INSULIN-LIKE PEPTIDES; PACIFIC OYSTER; MANTLE; CELLS; TRANSCRIPTOME; EXPRESSION; MOLLUSK	Background: Scallops represent economically important aquaculture shellfish. The identification of genes and genetic variants related to scallop growth could benefit high-yielding scallop breeding. The insulin-like growth factor (IGF) system is essential for growth and development, with IGF binding proteins (IGFBPs) serving as the major regulators of IGF actions. Although an effect of IGF on growth was detected in bivalve, IGFBP has not been reported, and members of the IGF system have not been characterized in scallop. Results: We cloned and characterized an IGFBP (PyIGFBP) gene from the aquaculture bivalve species, Yesso scallop (Patinopecten yessoensis, Jay, 1857). Its full-length cDNA sequence was 1,445 bp, with an open reading frame of 378 bp, encoding 125 amino acids, and its genomic sequence was 10,193 bp, consisting of three exons and two introns. The amino acid sequence exhibited the characteristics of IGFBPs, including multiple cysteine residues and relatively conserved motifs in the N-terminal and C-terminal domains. Expression analysis indicated that PyIGFBP was expressed in all the tissues and developmental stages examined, with a significantly higher level in the mantle than in other tissues and a significantly higher level in gastrulae and trochophore larvae than in other stages. Furthermore, three single nucleotide polymorphisms (SNPs) were identified in this gene. SNP c. 1054A>G was significantly associated with both shell and soft body traits in two populations, with the highest trait values in GG type scallops and lowest in AG type ones. Conclusion: We cloned and characterized an IGFBP gene in a bivalve, and this report also represents the first characterizing an IGF system gene in scallops. A SNP associated with scallop growth for both the shell and soft body was identified in this gene. In addition to providing a candidate marker for scallop breeding, our results also suggest the role of PyIGFBP in scallop growth.	[Feng, Liying; Li, Xue; Yu, Qian; Ning, Xianhui; Dou, Jinzhuang; Zou, Jiajun; Zhang, Lingling; Wang, Shi; Hu, Xiaoli; Bao, Zhenmin] Ocean Univ China, Minist Educ, Coll Marine Life Sci, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China	Ocean University of China	Hu, XL (corresponding author), Ocean Univ China, Minist Educ, Coll Marine Life Sci, Key Lab Marine Genet & Breeding MGB, Qingdao, Peoples R China.	hxl707@ouc.edu.cn; zmbao@ouc.edu	DOU, JINZHUANG/AHA-2985-2022; zhang, lingling/HDM-2189-2022		National High-Tech R&D Program (863 Program) [2012AA10A402]; National Natural Science Foundation of China [31272656]; National Basic Research Program of China (973 Program) [2010CB126406]; Natural Science Foundation for Distinguished Young Scholars of Shandong Province [JQ201308]	National High-Tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation for Distinguished Young Scholars of Shandong Province	This work was supported by National High-Tech R&D Program (863 Program, 2012AA10A402), National Natural Science Foundation of China (31272656), National Basic Research Program of China (973 Program, 2010CB126406), and Natural Science Foundation for Distinguished Young Scholars of Shandong Province (JQ201308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Cong RH, 2013, BIOCHEM SYST ECOL, V46, P36, DOI 10.1016/j.bse.2012.09.008; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; Feng LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075609; Giard W, 1998, J COMP PHYSIOL B, V168, P81, DOI 10.1007/s003600050123; Gricourt L, 2003, GEN COMP ENDOCR, V134, P44, DOI 10.1016/S0016-6480(03)00217-X; Guo HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051005; Hamano K, 2002, FISHERIES SCI, V68, P769, DOI 10.2331/fishsci.68.sup1_769; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; KELLNERCOUSIN K, 1994, TISSUE CELL, V26, P891, DOI 10.1016/0040-8166(94)90038-8; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Luther GA, 2013, CANCER LETT, V336, P222, DOI 10.1016/j.canlet.2013.05.002; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; MCCARTHY TL, 1989, CONNECT TISSUE RES, V20, P277, DOI 10.3109/03008208909023897; MOHAN S, 1991, CLIN ORTHOP RELAT R, P30; Niemann I, 2013, BONE, V56, P184, DOI 10.1016/j.bone.2013.06.013; Oh Y, 1998, MOL MECH REGULATE AC, P123; Rosenzweig SA, 2004, GROWTH HORM IGF RES, V14, P329, DOI 10.1016/j.ghir.2004.02.003; Sambrook J., 2001, MOL CLONING LAB MANU; Sarashina Isao, 2006, Paleontological Research, V10, P311; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Shi YH, 2013, MAR BIOTECHNOL, V15, P175, DOI 10.1007/s10126-012-9476-x; Shipilov VN, 2005, ANN NY ACAD SCI, V1040, P464, DOI 10.1196/annals.1327.091; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang QC, 1984, FISHERIES SCI, V3, P24; Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063927; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	31	27	32	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89039	10.1371/journal.pone.0089039	http://dx.doi.org/10.1371/journal.pone.0089039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586493	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900077
J	Ilott, NE; Schneider, T; Mill, J; Schalkwyk, L; Brolese, G; Bizarro, L; Stolerman, IP; Dempster, E; Asherson, P				Ilott, Nicholas E.; Schneider, Tomasz; Mill, Jonathan; Schalkwyk, Leonard; Brolese, Giovana; Bizarro, Lisiane; Stolerman, Ian P.; Dempster, Emma; Asherson, Philip			Long-Term Effects of Gestational Nicotine Exposure and Food-Restriction on Gene Expression in the Striatum of Adolescent Rats	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MESSENGER-RNA EXPRESSION; IMMEDIATE-EARLY GENES; PRENATAL NICOTINE; MATERNAL SMOKING; DIFFERENTIAL REGULATION; BRAIN-REGIONS; C-FOS	Gestational exposure to environmental toxins such as nicotine may result in detectable gene expression changes in later life. To investigate the direct toxic effects of prenatal nicotine exposure on later brain development, we have used transcriptomic analysis of striatal samples to identify gene expression differences between adolescent Lister Hooded rats exposed to nicotine in utero and controls. Using an additional group of animals matched for the reduced food intake experienced in the nicotine group, we were also able to assess the impact of imposed food-restriction on gene expression profiles. We found little evidence for a role of gestational nicotine exposure on altered gene expression in the striatum of adolescent offspring at a significance level of p<0.01 and | log2 fold change >0.5|, although we cannot exclude the possibility of nicotine-induced changes in other brain regions, or at other time points. We did, however, find marked gene expression differences in response to imposed food-restriction. Food-restriction resulted in significant group differences for a number of immediate early genes (IEGs) including Fos, Fosb, Fosl2, Arc, Junb, Nr4a1 and Nr4a3. These genes are associated with stress response pathways and therefore may reflect long-term effects of nutritional deprivation on the development of the stress system.	[Ilott, Nicholas E.; Mill, Jonathan; Schalkwyk, Leonard; Dempster, Emma; Asherson, Philip] Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Psychiat SGDP Ctr, London WC2R 2LS, England; [Ilott, Nicholas E.] Univ Oxford, MRC, Funct Genom Unit, Dept Physiol Anat & Genet, Oxford, England; [Schneider, Tomasz; Stolerman, Ian P.] Kings Coll London, Inst Psychiat, Dept addict, London WC2R 2LS, England; [Schneider, Tomasz] Univ Oxford, Oxford, England; [Mill, Jonathan; Dempster, Emma] Univ Exeter, Sch Med, Exeter, Devon, England; [Brolese, Giovana; Bizarro, Lisiane] Univ Fed Rio Grande do Sul, Inst Psicol, Dept Psicol Desenvolvimento & Personalidade, Porto Alegre, RS, Brazil	University of London; King's College London; University of Oxford; University of London; King's College London; University of Oxford; University of Exeter; Universidade Federal do Rio Grande do Sul	Ilott, NE (corresponding author), Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Psychiat SGDP Ctr, London WC2R 2LS, England.	Nicholas.ilott@dpag.ox.ac.uk	Schalkwyk, Leonard C/A-2150-2010; BIZARRO, LISIANE/F-7872-2012; Dempster, Emma L/C-8592-2014; Mill, Jonathan/B-5678-2014; BIZARRO, LISIANE/AAS-6424-2021	Schalkwyk, Leonard C/0000-0001-7030-5756; BIZARRO, LISIANE/0000-0003-3070-5944; Dempster, Emma L/0000-0003-1257-5314; Mill, Jonathan/0000-0003-1115-3224; BIZARRO, LISIANE/0000-0003-3070-5944; Asherson, Philip/0000-0003-2667-2254; Stolerman, Ian/0000-0002-2703-5137; Ilott, Nicholas/0000-0002-8432-8622	Wellcome Trust; Medical Research Council [G9817803B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Villaca Y, 2011, BEHAV BRAIN RES, V221, P367, DOI 10.1016/j.bbr.2009.12.049; Allen JK, 2010, NEUROSCIENCE, V169, P1901, DOI 10.1016/j.neuroscience.2010.06.029; Altmann S, 2012, BRIT J NUTR, V107, P791, DOI 10.1017/S0007114511003667; Badlissi D, 2001, CAN J PUBLIC HEALTH, V92, P272, DOI 10.1007/BF03404959; Banerjee PS, 2009, EUR J NEUROSCI, V29, P465, DOI 10.1111/j.1460-9568.2008.06601.x; Beauvais G, 2010, BRAIN RES, V1318, P1, DOI 10.1016/j.brainres.2009.12.083; Blake KV, 2000, EARLY HUM DEV, V57, P137, DOI 10.1016/S0378-3782(99)00064-X; Cao JR, 2011, INT J NEUROPSYCHOPH, V14, P157, DOI 10.1017/S1461145710000179; Carmona S, 2009, BIOL PSYCHIAT, V66, P972, DOI 10.1016/j.biopsych.2009.05.013; Chen H, 2005, EUR J NEUROSCI, V22, P380, DOI 10.1111/j.1460-9568.2005.04229.x; Cubillo A, 2011, PSYCHIAT RES-NEUROIM, V193, P17, DOI 10.1016/j.pscychresns.2010.12.014; Cubillo A, 2010, J PSYCHIATR RES, V44, P629, DOI 10.1016/j.jpsychires.2009.11.016; Daberkow DP, 2008, NEUROTOX RES, V14, P307, DOI 10.1007/BF03033855; Das Banerjee T, 2007, ACTA PAEDIATR, V96, P1269, DOI 10.1111/j.1651-2227.2007.00430.x; Fernandes C, 2004, EUR J NEUROSCI, V19, P2576, DOI 10.1111/j.0953-816X.2004.03358.x; GRUNBERG NE, 1987, PSYCHOPHARMACOLOGY, V91, P221; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KAMME F, 1995, EUR J NEUROSCI, V7, P2007, DOI 10.1111/j.1460-9568.1995.tb00623.x; Kane VB, 2004, J PHARMACOL EXP THER, V308, P521, DOI 10.1124/jpet.103.059899; Karimi M, 2006, EPIGENETICS-US, V1, P45; Kirbach BB, 2011, J NEUROSCI RES, V89, P162, DOI 10.1002/jnr.22536; Laborie C, 2011, J NEUROENDOCRINOL, V23, P711, DOI 10.1111/j.1365-2826.2011.02159.x; LAM SK, 1992, AUST NZ J OBSTET GYN, V32, P125, DOI 10.1111/j.1479-828X.1992.tb01923.x; Langley K, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-26; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Lv JX, 2008, NEUROTOXICOLOGY, V29, P722, DOI 10.1016/j.neuro.2008.04.015; Manuel-Apolinar L, 2010, ARCH MED RES, V41, P240, DOI 10.1016/j.arcmed.2010.06.002; Mao CP, 2008, BRAIN RES, V1189, P43, DOI 10.1016/j.brainres.2007.10.089; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Morrow BA, 1999, J NEUROSCI, V19, P5666; MURRIN LC, 1987, LIFE SCI, V40, P1699, DOI 10.1016/0024-3205(87)90020-8; Ons S, 2010, EUR J NEUROSCI, V31, P2043, DOI 10.1111/j.1460-9568.2010.07242.x; Palou M, 2012, BR J NUTR, V28, P1; Paloyelis Yannis, 2007, Expert Rev Neurother, V7, P1337, DOI 10.1586/14737175.7.10.1337; Park MK, 2006, BRAIN RES, V1094, P119, DOI 10.1016/j.brainres.2006.04.001; Parker CC, 2012, BEHAV GENET, V42, P437, DOI 10.1007/s10519-011-9524-8; Pauly JR, 2004, INT J DEV NEUROSCI, V22, P329, DOI 10.1016/j.ijdevneu.2004.05.009; Pavlovsky AA, 2013, NEUROSCIENCE, V246, P160, DOI 10.1016/j.neuroscience.2013.04.057; Perlov E, 2009, WORLD J BIOL PSYCHIA, V10, P355, DOI 10.1080/15622970802176032; PETERS MA, 1982, ARCH INT PHARMACOD T, V257, P155; Pinaud R, 2001, MOL BRAIN RES, V91, P50, DOI 10.1016/S0169-328X(01)00121-8; Salas R, 2008, NEUROSCI LETT, V440, P32, DOI 10.1016/j.neulet.2008.05.038; Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1; Sanghavi D M, 1995, J Ky Med Assoc, V93, P286; Sarkisian MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044207; Schneider T, 2012, PSYCHOPHARMACOLOGY B; Schneider T, 2011, NEUROPSYCHOPHARMACOL, V36, P1114, DOI 10.1038/npp.2010.249; Schneider T, 2010, BEHAV PHARMACOL, V21, P206, DOI 10.1097/FBP.0b013e32833a5bb5; Sebert SP, 2010, REPRODUCTION, V139, P265, DOI 10.1530/REP-09-0173; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Smith MA, 1997, ENDOCRINOLOGY, V138, P4622, DOI 10.1210/en.138.11.4622; Sora I, 2009, INT REV NEUROBIOL, V85, P29, DOI 10.1016/S0074-7742(09)85003-4; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Thapar A, 2003, AM J PSYCHIAT, V160, P1985, DOI 10.1176/appi.ajp.160.11.1985; Thiriet N, 2001, BRAIN RES, V919, P31, DOI 10.1016/S0006-8993(01)02991-2; Tirosh I, 2011, P NATL ACAD SCI USA, V108, P16693, DOI 10.1073/pnas.1113718108; Tizabi Y, 1997, PHARMACOL BIOCHEM BE, V58, P141, DOI 10.1016/S0091-3057(96)00461-3; UMEMOTO S, 1994, NEUROREPORT, V6, P201, DOI 10.1097/00001756-199412300-00051; Vaglenova J, 2004, BEHAV BRAIN RES, V150, P159, DOI 10.1016/j.bbr.2003.07.005; Ventura SJ, 2003, PEDIATRICS, V111, P1176; Wang JQ, 1996, BRAIN RES BULL, V39, P349, DOI 10.1016/0361-9230(96)00002-0; Wei JX, 2011, INT J NEUROPSYCHOPH, V14, P91, DOI 10.1017/S1461145710000416; Winzer-Serhan UH, 2008, FRONT BIOSCI-LANDMRK, V13, P636, DOI 10.2741/2708; Zeng XS, 2013, FREE RADIC BIOL MED	67	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88896	10.1371/journal.pone.0088896	http://dx.doi.org/10.1371/journal.pone.0088896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586432	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000331711900059
J	Maastrup, R; Hansen, BM; Kronborg, H; Bojesen, SN; Hallum, K; Frandsen, A; Kyhnaeb, A; Svarer, I; Hallstrom, I				Maastrup, Ragnhild; Hansen, Bo Moelholm; Kronborg, Hanne; Bojesen, Susanne Norby; Hallum, Karin; Frandsen, Annemi; Kyhnaeb, Anne; Svarer, Inge; Hallstrom, Inger			Factors Associated with Exclusive Breastfeeding of Preterm Infants. Results from a Prospective National Cohort Study	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; NEONATAL INTENSIVE-CARE; KANGAROO MOTHER CARE; PREMATURE-INFANTS; MILK VOLUME; FOLLOW-UP; TERM; DURATION; OUTCOMES; PREDICTORS	Background and Aim: Evidence-based knowledge of how to guide the mothers of preterm infants in breastfeeding establishment is contradictive or sparse. The aim was to investigate the associations between pre-specified clinical practices for facilitating breastfeeding, and exclusive breastfeeding at discharge as well as adequate duration thereof. Methods: A prospective survey based on questionnaires was conducted with a Danish national cohort, comprised of 1,221 mothers and their 1,488 preterm infants with a gestational age of 24-36 weeks. Adjusted for covariates, the pre-specified clinical practices were analysed by multiple logistic regression analyses. Results: At discharge 68% of the preterm infants were exclusively breastfed and 17% partially. Test-weighing the infant, and minimizing the use of a pacifier, showed a protective effect to exclusive breastfeeding at discharge (OR 0.6 (95% CI 0.4-0.8) and 0.4 (95% CI 0.3-0.6), respectively). The use of nipple shields (OR 2.3 (95% CI 1.6-3.2)) and the initiation of breast milk expression later than 48 hours postpartum (OR 4.9 (95% CI 1.9-12.6)) were associated with failure of exclusive breastfeeding at discharge. The clinical practices associated with an inadequate breastfeeding duration were the initiation of breast milk expression at 12-24 hours (OR 1.6 (95% CI 1.0-2.4)) and 24-48 hours (OR 1.8 (95% CI 1.0-3.1)) vs. before six hours postpartum, and the use of nipple shields (OR 1.4 (95% CI 1.1-1.9)). Conclusion: Early initiation of breast milk pumping before 12 hours postpartum may increase breastfeeding rates, and it seems that the use of nipple shields should be restricted. The use of test-weighing and minimizing the use of a pacifier may promote the establishment of exclusive breastfeeding, but more research is needed regarding adequate support to the mother when test-weighing is ceased, as more of these mothers ceased exclusive breastfeeding at an early stage after discharge.	[Maastrup, Ragnhild] Rigshosp, Copenhagen Univ Hosp, Knowledge Ctr Breastfeeding Infants Special Needs, Dept Neonatol, DK-2100 Copenhagen, Denmark; [Maastrup, Ragnhild; Hallstrom, Inger] Lund Univ, Fac Med, Dept Hlth Sci, Lund, Sweden; [Maastrup, Ragnhild; Bojesen, Susanne Norby; Hallum, Karin; Frandsen, Annemi; Kyhnaeb, Anne; Svarer, Inge] Copenhagen Univ Hosp, Danish Natl Panel Experts Breastfeeding Infants S, Herlev, Denmark; [Hansen, Bo Moelholm; Bojesen, Susanne Norby] Copenhagen Univ Hosp, Dept Neonatol, Herlev, Denmark; [Kronborg, Hanne] Univ Aarhus, Sect Nursing, Dept Publ Hlth, Aarhus, Denmark; [Hallum, Karin] Viborg Reg Hosp, Dept Neonatol, Viborg, Denmark; [Frandsen, Annemi] Holbaek Univ Hosp, Dept Paediat, Holbaek, Denmark; [Kyhnaeb, Anne] Copenhagen Univ Hosp, Dept Neonatol, Hvidovre, Denmark; [Svarer, Inge] Odense Univ Hosp, Dept Neonatol, DK-5000 Odense, Denmark	Rigshospitalet; University of Copenhagen; Lund University; University of Copenhagen; University of Copenhagen; Aarhus University; Aarhus University; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Maastrup, R (corresponding author), Rigshosp, Copenhagen Univ Hosp, Knowledge Ctr Breastfeeding Infants Special Needs, Dept Neonatol, DK-2100 Copenhagen, Denmark.	Ragnhild.maastrup@regionh.dk		Hansen, Bo Molholm/0000-0002-3087-3983; Maastrup, Ragnhild/0000-0001-8719-5717; Kristensson Hallstrom, Inger/0000-0002-9402-6230	Swedish Research Council; Soester Marie Dalgaards Foundation; Neonatal Department	Swedish Research Council(Swedish Research CouncilEuropean Commission); Soester Marie Dalgaards Foundation; Neonatal Department	The authors disclosed receipt of the following financial support for the research and authorship of this article: Funding to support the research was received from The Swedish Research Council, http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html; Soester Marie Dalgaards Foundation, http://www.diakonissestiftelsen.dk/Default.aspx?ID = 1177; and the Neonatal Department, http://www.rigshospitalet.dk/menu/AFDELINGER/Juliane+Marie+Centret/Klinikker/Neonatalklinikken/; and the Juliane Marie Centre at Rigshospitalet Copenhagen, http://www.rigshospitalet.dk/menu/ AFDELINGER/Juliane+Marie+Centret/In+English/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom S, 2007, ACTA PAEDIATR, V96, P1450, DOI 10.1111/j.1651-2227.2007.00502.x; Allerman Beck S, 2009, J NEONATAL NURSING, V15, P88, DOI DOI 10.1016/J.JNN.2009.01.006; Altman D.G., 1991, PRACTICAL STATISTIC; [Anonymous], 2013, ETH PRINC MED RES IN; de Oliveira MMB, 2007, J HUM LACT, V23, P269, DOI 10.1177/0890334407304235; Bragelien R, 2007, ACTA PAEDIATR, V96, P1430, DOI 10.1111/j.1651-2227.2007.00448.x; Callen Jennifer, 2005, Adv Neonatal Care, V5, P93, DOI 10.1016/j.adnc.2004.12.005; Centuori S, 1999, J Hum Lact, V15, P125, DOI 10.1177/089033449901500210; Cignacco E, 2007, EUR J PAIN, V11, P139, DOI 10.1016/j.ejpain.2006.02.010; Clum D, 1996, J Hum Lact, V12, P287, DOI 10.1177/089033449601200413; Collins CT, 2004, BMJ-BRIT MED J, V329, P193, DOI 10.1136/bmj.38131.675914.55; Dougherty D, 2008, NEONATAL NETW, V27, P371, DOI 10.1891/0730-0832.27.6.371; ELANDER G, 1986, ACTA PAEDIATR SCAND, V75, P708, DOI 10.1111/j.1651-2227.1986.tb10278.x; Ericson J, 2013, JOGNN-J OBST GYN NEO, V42, P29, DOI 10.1111/j.1552-6909.2012.01423.x; Flacking R, 2007, EUR J PUBLIC HEALTH, V17, P579, DOI 10.1093/eurpub/ckm019; Flacking R, 2011, JOGNN-J OBST GYN NEO, V40, P190, DOI 10.1111/j.1552-6909.2011.01226.x; Funkquist Eva-Lotta, 2010, Adv Neonatal Care, V10, P33, DOI 10.1097/ANC.0b013e3181cbf910; Furman L, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.4.e57; Hake-Brooks SJ, 2008, NEONATAL NETW, V27, P151, DOI 10.1891/0730-0832.27.3.151; Hill PD, 2007, J HUM LACT, V23, P32, DOI 10.1177/0890334406297277; Hill PD, 2005, J PERINAT NEONAT NUR, V19, P273, DOI 10.1097/00005237-200507000-00014; Howard CR, 2003, PEDIATRICS, V111, P511, DOI 10.1542/peds.111.3.511; Howe LD, 2013, EPIDEMIOLOGY, V24, P1, DOI 10.1097/EDE.0b013e31827623b1; Koch B, 2005, RECOMMENDATIONS INFA; Kronborg H, 2004, SCAND J PUBLIC HEALT, V32, P210, DOI 10.1080/14034940310019218; Lee HC, 2009, J PEDIATR-US, V155, P657, DOI 10.1016/j.jpeds.2009.04.064; Maastrup R, 2012, J HUM LACT, V28, P370, DOI 10.1177/0890334412440846; Maastrup R, 2010, ACTA PAEDIATR, V99, P1145, DOI 10.1111/j.1651-2227.2010.01806.x; McKechnie AC, 2010, BREASTFEED MED, V5, P309, DOI 10.1089/bfm.2010.0003; Meier P P, 2000, J Hum Lact, V16, P106, DOI 10.1177/089033440001600205; Meier PP, 2013, PEDIATR CLIN N AM, V60, P209, DOI 10.1016/j.pcl.2012.10.007; Moore ER, 2012, COCHRANE DB SYST REV, V16; Nagai S, 2011, ACTA PAEDIATR, V100, pE241, DOI 10.1111/j.1651-2227.2011.02372.x; Nyqvist Kerstin Hedberg, 2002, J Pediatr Nurs, V17, P246, DOI 10.1053/jpdn.2002.126716; Nystrom K, 2002, JOGNN, V31, P275, DOI 10.1111/j.1552-6909.2002.tb00049.x; Ostlund A, 2010, J HUM LACT, V26, P235, DOI 10.1177/0890334409359627; Parker LA, 2012, J PERINATOL, V32, P205, DOI 10.1038/jp.2011.78; Pechlivani F, 2005, ACTA PAEDIATR, V94, P928, DOI 10.1080/08035250410023746; Perrella SL, 2012, BREASTFEED MED, V7, P255, DOI 10.1089/bfm.2011.0118; Pineda RG, 2011, BREASTFEED MED, V6, P15, DOI 10.1089/bfm.2010.0010; Pinelli J, 2002, JOGNN-J OBST GYN NEO, V31, P582, DOI 10.1111/j.1552-6909.2002.tb00084.x; Ramanathan K., 2001, Indian Journal of Pediatrics, V68, P1019, DOI 10.1007/BF02722345; Schanler RJ, 1999, PEDIATRICS, V103, P1150, DOI 10.1542/peds.103.6.1150; Smith MM, 2003, AM J EPIDEMIOL, V158, P1075, DOI 10.1093/aje/kwg257; Smith MM, 2003, PEDIATRICS, V111, P1337, DOI 10.1542/peds.111.6.1337; Spatz DL, 2004, J PERINAT NEONAT NUR, V18, P385, DOI 10.1097/00005237-200410000-00009; WHO UNICEF, 1989, PROT PROM SUPP BREAS; Zachariassen G, 2010, ACTA PAEDIATR, V99, P1000, DOI 10.1111/j.1651-2227.2010.01721.x	48	83	89	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89077	10.1371/journal.pone.0089077	http://dx.doi.org/10.1371/journal.pone.0089077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586513	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900085
J	Liu, Y; Chi, HJ; Cui, LF; Yang, XC; Wu, YT; Huang, Z; Zhao, HY; Gao, JS; Wu, SL; Cai, J				Liu, Yan; Chi, Hong-jie; Cui, Liu-fu; Yang, Xin-chun; Wu, Yun-tao; Huang, Zhe; Zhao, Hai-yan; Gao, Jing-sheng; Wu, Shou-ling; Cai, Jun			The Ideal Cardiovascular Health Metrics Associated Inversely with Mortality from All Causes and from Cardiovascular Diseases among Adults in a Northern Chinese Industrial City	PLOS ONE			English	Article							PREVALENCE; SYSTEM	Background and Aims: The American Heart Association has recently established seven ideal cardiovascular health metrics for cardiovascular health promotion and disease reduction (i.e., non-smoking, normal body mass index, physically active, healthy diet, and normal levels of cholesterol, blood pressure and fasting blood glucose). The present study seeks to evaluate how well these metrics predict mortality from all causes and cardiovascular diseases in adult Chinese living in a northern industrial city. Methods and Results: Data of 95,429 adults who participated in the Kailuan cohort study from June 2006 to October 2007 was analyzed. All participants underwent questionnaire assessment, clinical examination, laboratory assessments and were followed up biannually. During a median follow-up of 4.02 years, 1,843 deaths occurred, with 597 deaths resulting from cardiovascular diseases. Lower mortality rates from all causes and cardiovascular diseases were observed among the subjects who met a higher number of the ideal health metrics. Compared to the participants who met none or one ideal health metric, those meeting >= 5 ideal health metrics had a lower risk of all-cause mortality by 30% (adjusted hazard ratio, 0.70; 95% confidence interval, 0.56-0.88) and a lower risk of mortality from cardiovascular diseases by 39% (adjusted hazard ratio, 0.61; 95% confidence interval, 0.41-0.89). Four metrics (smoking status, physical activity, blood pressure and fasting blood glucose) were significantly associated with all-cause mortality. Three metrics (physical activity, blood pressure and fasting blood glucose) were significantly associated with mortality from cardiovascular diseases. Conclusion: The number of ideal health metrics is negatively associated with mortality rates from all causes and cardiovascular diseases among adults in a Northern Chinese industrial city. The data supports the AHA recommendation of ideal health metrics for adults from Northern China.	[Liu, Yan; Wu, Yun-tao; Huang, Zhe; Zhao, Hai-yan; Gao, Jing-sheng; Wu, Shou-ling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China; [Chi, Hong-jie; Cai, Jun] Capital Med Univ, Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China; [Cui, Liu-fu; Yang, Xin-chun] Hebei United Univ, Kailuan Hosp, Dept Rheumatism & Immunol, Tangshan, Peoples R China	North China University of Science & Technology; Capital Medical University; North China University of Science & Technology	Wu, SL (corresponding author), Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China.	drwusl@163.com; caijun7879@yahoo.com.cn			Beijing Municipal Natural Science Foundation [7111002]; National Natural Science Foundation of China [81100168]; Scientific Research Common Program of Beijing Municipal Commission of Education [KM201110025016]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Common Program of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	This work was supported by grants from Beijing Municipal Natural Science Foundation (Grand No. 7111002), National Natural Science Foundation of China (Grand No. 81100168) and Scientific Research Common Program of Beijing Municipal Commission of Education (Grand No. KM201110025016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 3 REPORT NATL MORTAL; [Anonymous], INT J CARDIOL; Bambs C, 2011, CIRCULATION, V123, P850, DOI 10.1161/CIRCULATIONAHA.110.980151; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Ford ES, 2011, AM J PUBLIC HEALTH, V101, P1922, DOI [10.2105/AJPH.2011.300167, 10.2105//AJPH.2011.300167]; Institute of Medicine, 2010, PROMOTING CARDIOVASC; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Moran Andrew, 2008, BMC Public Health, V8, P394, DOI 10.1186/1471-2458-8-394; *NAT BUR STAT CHIN, 2006, CHIN STAT YB 2006; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Wang F, 2009, NUTR METAB CARDIOVAS, V19, P542, DOI 10.1016/j.numecd.2008.11.006; World Health Organization, 2008, The global burden of disease: 2004 update; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Wu SL, 2012, INT J CARDIOL, V157, P75, DOI 10.1016/j.ijcard.2010.12.019; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5	16	9	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89161	10.1371/journal.pone.0089161	http://dx.doi.org/10.1371/journal.pone.0089161			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586562	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700019
J	Cooper, DL; Murrell, DE; Conder, CM; Palau, VE; Campbell, GE; Lynch, SP; Denham, JW; Hanley, AV; Bullins, KW; Panus, PC; Singh, K; Harirforoosh, S				Cooper, Dustin L.; Murrell, Derek E.; Conder, Christopher M.; Palau, Victoria E.; Campbell, Grace E.; Lynch, Shaun P.; Denham, James W.; Hanley, Angela V.; Bullins, Kenny W.; Panus, Peter C.; Singh, Krishna; Harirforoosh, Sam			Exacerbation of Celecoxib-Induced Renal Injury by Concomitant Administration of Misoprostol in Rats	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; THICK ASCENDING LIMB; WELL-COMPENSATED CIRRHOSIS; CARDIAC TROPONIN-I; KIDNEY INJURY; DOUBLE-BLIND; URINARY SODIUM; GASTROINTESTINAL COMPLICATIONS; PROSTAGLANDIN-E1 ANALOG; CARDIOVASCULAR EVENTS	Nonsteroidal anti-inflammatory drugs (NSAIDs) can produce adverse effects by inhibiting prostaglandin (PG) synthesis. A PGE1 analogue, misoprostol, is often utilized to alleviate NSAID-related gastrointestinal side effects. This study examined the effect of misoprostol on celecoxib renal toxicity. Additionally, the effects of these drugs on cardiovascular parameters were evaluated. Four randomized rat groups were orally gavaged for 9 days, two groups receiving vehicle and two groups receiving misoprostol (100 mu g/kg) twice daily. Celecoxib (40 mg/kg) was co-administered once daily to one vehicle and one misoprostol group from days 3 to 9. Urine and blood samples were collected and blood pressure parameters were measured during the study period. Hearts and kidneys were harvested on final day. Day 2 urinary electrolyte samples revealed significant reductions in sodium excretion in misoprostol (0.12 +/- 0.05 mu mol/min/100 g) and misoprostol+celecoxib groups (0.07 +/-.02 mu mol/min/100 g). At day 3, all treatment groups showed significantly reduced sodium excretion. Potassium excretion diminished significantly in vehicle+celecoxib and misoprostol+celecoxib groups from day 3 onward. Urinary kidney injury molecule-1 levels were significantly increased in vehicle+celecoxib (0.65 +/- 0.02 vs. 0.35 +/- 0.07 ng/mL, p = 0.0002) and misoprostol+celecoxib (0.61 +/- 0.06 vs. 0.37 +/- 0.06 ng/mL, p = 0.0015) groups when compared to baseline; while plasma levels of cardiac troponin I increased significantly in vehicle+celecoxib (p = 0.0040) and misoprostol+misoprostol (p = 0.0078) groups when compared to vehicle+vehicle. Blood pressure parameters increased significantly in all misoprostol treated groups. Significant elevation in diastolic (p = 0.0071) and mean blood pressure (p = 0.0153) was noted in misoprostol+ celecoxib compared to vehicle+celecoxib. All treatments produced significant tubular dilatation/necrosis compared to control. No significant myocardial changes were noticed; however, three animals presented with pericarditis. Kidney, heart, and plasma celecoxib levels revealed no significant change between vehicle+celecoxib and misoprostol+celecoxib. Concomitant misoprostol administration did not prevent celecoxib renal toxicity, and instead exacerbated renal side effects. Misoprostol did not alter plasma or tissue celecoxib concentrations suggesting no pharmacokinetic interaction between celecoxib and misoprostol.	[Cooper, Dustin L.; Murrell, Derek E.; Palau, Victoria E.; Hanley, Angela V.; Bullins, Kenny W.; Panus, Peter C.; Harirforoosh, Sam] E Tennessee State Univ, Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA; [Conder, Christopher M.; Campbell, Grace E.; Lynch, Shaun P.] E Tennessee State Univ, Gatton Coll Pharm, Johnson City, TN 37614 USA; [Denham, James W.] E Tennessee State Univ, Quillen Coll Med, Dept Pathol, Johnson City, TN 37614 USA; [Singh, Krishna] E Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA	East Tennessee State University; East Tennessee State University; East Tennessee State University; East Tennessee State University	Harirforoosh, S (corresponding author), E Tennessee State Univ, Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA.	harirfor@etsu.edu	Harirforoosh, Sam/J-9493-2013; Palau, Victoria E/F-3520-2012	Harirforoosh, Sam/0000-0002-2631-3756; Palau, Victoria E/0000-0003-2761-7003	East Tennessee State University, Department of Pharmaceutical Sciences Faculty Startup Funds	East Tennessee State University, Department of Pharmaceutical Sciences Faculty Startup Funds	This study was funded by East Tennessee State University, Department of Pharmaceutical Sciences Faculty Startup Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTILLON M, 1990, J RHEUMATOL, V17, P46; BENNETT PN, 1988, POSTGRAD MED J, V64, P21; Bertinchant JP, 2003, CLIN CHIM ACTA, V329, P39, DOI 10.1016/S0009-8981(03)00013-5; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Brater D. Craig, 1999, American Journal of Medicine, V107, p65S; Braunwald E, 2012, HARRISONS PRINCIPLES; Carlsson AC, 2013, EUR J HEART FAIL, V15, P441, DOI 10.1093/eurjhf/hfs187; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; Chiusolo A, 2010, TOXICOL PATHOL, V38, P338, DOI 10.1177/0192623310362244; DAJANI EZ, 1995, DIGEST DIS, V13, P48, DOI 10.1159/000171526; DAJANI EZ, 1985, DIGEST DIS SCI, V30, pS194, DOI 10.1007/BF01309408; Davies NM, 2004, J PHARM PHARM SCI, V7, P332; DUNN M, 1987, DRUGS, V33, P56, DOI 10.2165/00003495-198700331-00009; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Fernandez-Llama P, 1999, AM J PHYSIOL-RENAL, V277, pF219, DOI 10.1152/ajprenal.1999.277.2.F219; Gamba G, 2009, PFLUG ARCH EUR J PHY, V458, P61, DOI 10.1007/s00424-008-0607-1; Goodman L.S., 2011, GOODMAN GILMANS PHAR, V13th ed.; Graham DY, 2002, ARCH INTERN MED, V162, P169, DOI 10.1001/archinte.162.2.169; GRAHAM DY, 1993, ANN INTERN MED, V119, P257, DOI 10.7326/0003-4819-119-4-199308150-00001; Griffin M, 1998, AM J MED, V104, p41S; Griffin Marie R., 1998, American Journal of Medicine, V104, p23S, DOI 10.1016/S0002-9343(97)00207-6; Griffin MR, 2000, AM J EPIDEMIOL, V151, P488; Harirforoosh S, 2005, CAN J PHYSIOL PHARM, V83, P85, DOI 10.1139/Y04-129; Harirforoosh S, 2006, CLIN EXP PHARMACOL P, V33, P917, DOI 10.1111/j.1440-1681.2006.04464.x; Harirforoosh S, 2009, EXPERT OPIN DRUG SAF, V8, P669, DOI 10.1517/14740330903311023; HASEGAWA Y, 1991, ENDOCRINOL JAPON, V38, P451; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; Hocherl K, 2002, BRIT J PHARMACOL, V136, P1117, DOI 10.1038/sj.bjp.0704821; Hoffmann D, 2010, TOXICOLOGY, V277, P49, DOI 10.1016/j.tox.2010.08.013; Jungbauer CG, 2011, EUR J HEART FAIL, V13, P1104, DOI 10.1093/eurjhf/hfr102; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kaji DM, 1996, AM J PHYSIOL-CELL PH, V271, pC354, DOI 10.1152/ajpcell.1996.271.1.C354; Kismet K, 2004, CANCER DETECT PREV, V28, P127, DOI 10.1016/j.cdp.2003.12.005; Kockaya EA, 2010, DRUG CHEM TOXICOL, V33, P410, DOI 10.3109/01480540903575691; Kreydiyyeh SI, 2006, CYTOKINE, V33, P138, DOI 10.1016/j.cyto.2005.12.007; Kumar G, 2010, EXP TOXICOL PATHOL, V62, P653, DOI 10.1016/j.etp.2009.08.011; Lee KN, 2011, J KOREAN MED SCI, V26, P1074, DOI 10.3346/jkms.2011.26.8.1074; Lekawanvijit S, 2012, AM J PHYSIOL-HEART C, V302, pH1884, DOI 10.1152/ajpheart.00967.2011; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; MORAN M, 1990, NEW ENGL J MED, V322, P1183, DOI 10.1056/NEJM199004263221703; MURRAY MD, 1993, ANNU REV PHARMACOL, V33, P434; NATOV S, 1994, KIDNEY INT, V45, P1457, DOI 10.1038/ki.1994.190; O'Brien PJ, 2006, LAB ANIM-UK, V40, P153, DOI 10.1258/002367706776319042; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Ozer MK, 2011, FOOD CHEM TOXICOL, V49, P1556, DOI 10.1016/j.fct.2011.03.051; Park SH, 2007, J CLIN BIOCHEM NUTR, V40, P148, DOI 10.3164/jcbn.40.148; Raskin JB, 1996, AM J GASTROENTEROL, V91, P223; Rostom A, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002296, DOI 10.1002/14651858.CD002296]; Salam OMEA, 2009, FUND CLIN PHARMACOL, V23, P179, DOI 10.1111/j.1472-8206.2008.00654.x; Sarko J, 2002, J EMERG MED, V23, P57, DOI 10.1016/S0736-4679(02)00463-8; Satoh H, 2012, CURR MED CHEM, V19, P82, DOI 10.2174/092986712803413980; Serra M, 2010, VET J, V185, P50, DOI 10.1016/j.tvjl.2010.04.013; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Solomon SD, 2008, CIRCULATION, V117, P2104, DOI 10.1161/CIRCULATIONAHA.108.764530; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Sonmez AS, 1999, FERTIL STERIL, V72, P518, DOI 10.1016/S0015-0282(99)00286-1; Sostres C, 2010, BEST PRACT RES CL GA, V24, P121, DOI 10.1016/j.bpg.2009.11.005; TANAKA S, 1985, JPN J MED, V24, P30; Tang OS, 2007, INT J GYNECOL OBSTET, V99, pS160, DOI 10.1016/j.ijgo.2007.09.004; Topcu I, 2007, ACTA HISTOCHEM, V109, P322, DOI 10.1016/j.acthis.2006.10.007; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; WHELTON A, 1991, J CLIN PHARMACOL, V31, P588, DOI 10.1002/j.1552-4604.1991.tb03743.x; Whelton PK, 2011, JAMA-J AM MED ASSOC, V306, P2262, DOI 10.1001/jama.2011.1746; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; WONG F, 1995, J HEPATOL, V23, P1, DOI 10.1016/0168-8278(95)80303-3; WONG F, 1995, AM J GASTROENTEROL, V90, P1465; Zadrazil J, 2006, Vnitr Lek, V52, P686	69	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89087	10.1371/journal.pone.0089087	http://dx.doi.org/10.1371/journal.pone.0089087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586517	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900047
J	Guha, A; Vasconcelos, M; Zhao, R; Gower, AC; Rajagopal, J; Cardoso, WV				Guha, Arjun; Vasconcelos, Michelle; Zhao, Rui; Gower, Adam C.; Rajagopal, Jayaraj; Cardoso, Wellington V.			Analysis of Notch Signaling-Dependent Gene Expression in Developing Airways Reveals Diversity of Clara Cells	PLOS ONE			English	Article							PROGENITOR CELLS; LUNG; INJURY; REPAIR; MICE; REGENERATION; MAINTENANCE; ALVEOLAR	Clara cells (CCs) are a morphologically and operationally heterogeneous population of Secretoglobin Scgb1a1-expressing secretory cells that are crucial for airway homeostasis and post-injury repair. Analysis of the extent and origin of CC diversity are limited by knowledge of genes expressed in these cells and their precursors. To identify novel putative markers of CCs and explore the origins of CC diversity, we characterized global changes in gene expression in embryonic lungs in which CCs do not form due to conditional disruption of Notch signaling (Rbpjk(CNULL)). Microarray profiling, Real Time PCR (qRTPCR), and RNA in situ hybridization (ISH) identified eleven genes downregulated in the E18.5 airways of Rbpjk(cnull) compared to controls, nearly half not previously known to mark CCs. ISH revealed that several genes had overlapping but distinct domains of expression of in the normal developing lung (E18.5). Notably, Reg3g, Chad, Gabrp and Lrrc26 were enriched in proximal airways, Hp in the distal airways and Upk3a in clusters of cells surrounding Neuroepithelial Bodies (NEBs). Seven of the eleven genes, including Reg3g, Hp, and Upk3a, were expressed in the adult lung in CCs in a pattern similar to that observed in the developing airways. qRT-PCR-based analysis of gene expression of CCs isolated from different airway regions of B1-EGFP reporter mice corroborated the spatial enrichment in gene expression observed by ISH. Our study identifies candidate markers for CC-precursors and CCs and supports the idea that the diversification of the CC phenotype occurs already during embryonic development.	[Guha, Arjun; Vasconcelos, Michelle; Cardoso, Wellington V.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Zhao, Rui; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Zhao, Rui; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Dept Internal Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Zhao, Rui; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Dept Pediat, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Gower, Adam C.] Boston Univ, Clin & Translat Sci Inst, Boston, MA 02215 USA	Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University	Guha, A (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.	aguha@bu.edu; wvc2104@columbia.edu	Zhao, Rui/J-7110-2014	Gower, Adam/0000-0002-6122-7511	NIH-NHLBI [PO1 HL47049, R01 HL105971-01]; BUMC start-up grant; CTSA grant [UL1-TR000157]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116756, R01HL105971, P01HL047049] Funding Source: NIH RePORTER	NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BUMC start-up grant; CTSA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NIH-NHLBI (PO1 HL47049, R01 HL105971-01 to WVC) and a BUMC start-up grant (to A. Guha, A.) and CTSA grant #UL1-TR000157 (A. Gower). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARDOSO WV, 1993, AM J PHYSIOL, V264, pL543, DOI 10.1152/ajplung.1993.264.6.L543; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chen HY, 2012, STEM CELLS, V30, P1948, DOI 10.1002/stem.1150; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249; Kim JK, 2012, AM J RESP CELL MOL, V47, P864, DOI 10.1165/rcmb.2012-0164OC; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Reynolds SD, 2002, AM J RESP CRIT CARE, V166, P1498, DOI 10.1164/rccm.200204-285OC; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Shi SR, 2001, J HISTOCHEM CYTOCHEM, V49, P931, DOI 10.1177/002215540104900801; Singh G, 1997, AM J RESP CELL MOL, V17, P141, DOI 10.1165/ajrcmb.17.2.f138; Stripp BR, 1995, AM J PHYSIOL-LUNG C, V269, pL791, DOI 10.1152/ajplung.1995.269.6.L791; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; vanWinkle LS, 1995, AM J PHYSIOL-LUNG C, V269, pL800, DOI 10.1152/ajplung.1995.269.6.L800; Zemke AC, 2009, AM J RESP CELL MOL, V40, P340, DOI 10.1165/rcmb.2007-0380OC	20	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88848	10.1371/journal.pone.0088848	http://dx.doi.org/10.1371/journal.pone.0088848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586412	Green Published, gold			2022-12-27	WOS:000331717900030
J	Ort, BS; Cohen, CS; Boyer, KE; Reynolds, LK; Tam, SM; Wyllie-Echeverria, S				Ort, Brian S.; Cohen, C. Sarah; Boyer, Katharyn E.; Reynolds, Laura K.; Tam, Sheh May; Wyllie-Echeverria, Sandy			Conservation of Eelgrass (Zostera marina) Genetic Diversity in a Mesocosm-Based Restoration Experiment	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENOTYPIC DIVERSITY; SEAGRASSES; ECOSYSTEM; BAY; CLONALITY; SOFTWARE; EXTREMES; PROGRAM; BIOLOGY	Eelgrass (Zostera marina) forms the foundation of an important shallow coastal community in protected estuaries and bays. Widespread population declines have stimulated restoration efforts, but these have often overlooked the importance of maintaining the evolutionary potential of restored populations by minimizing the reduction in genetic diversity that typically accompanies restoration. In an experiment simulating a small-scale restoration, we tested the effectiveness of a buoy-deployed seeding technique to maintain genetic diversity comparable to the seed source populations. Seeds from three extant source populations in San Francisco Bay were introduced into eighteen flow-through baywater mesocosms. Following seedling establishment, we used seven polymorphic microsatellite loci to compare genetic diversity indices from 128 shoots to those found in the source populations. Importantly, allelic richness and expected heterozygosity were not significantly reduced in the mesocosms, which also preserved the strong population differentiation present among source populations. However, the inbreeding coefficient FIS was elevated in two of the three sets of mesocosms when they were grouped according to their source population. This is probably a Wahlund effect from confining all half-siblings within each spathe to a single mesocosm, elevating FIS when the mesocosms were considered together. The conservation of most alleles and preservation of expected heterozygosity suggests that this seeding technique is an improvement over wholeshoot transplantation in the conservation of genetic diversity in eelgrass restoration efforts.	[Ort, Brian S.; Cohen, C. Sarah; Boyer, Katharyn E.; Reynolds, Laura K.; Tam, Sheh May] San Francisco State Univ, Dept Biol, Romberg Tiburon Ctr Environm Studies, Tiburon, CA 94920 USA; [Wyllie-Echeverria, Sandy] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA	California State University System; San Francisco State University; University of Washington	Ort, BS (corresponding author), San Francisco State Univ, Dept Biol, Romberg Tiburon Ctr Environm Studies, Tiburon, CA 94920 USA.	ort@berkeley.edu		Cohen, C. Sarah/0000-0003-1188-1854; Reynolds, Laura K/0000-0002-4498-4641; Boyer, Katharyn/0000-0003-2680-2493	California Coastal Conservancy/California Ocean Protection Council [05-103]; NOAA Restoration Center [NA05NMF4631220]; National Science Foundation; Field Stations and Marine Laboratories [0435033]; SFSU College of Science and Engineering; Romberg Tiburon Center at SFSU	California Coastal Conservancy/California Ocean Protection Council; NOAA Restoration Center(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF)); Field Stations and Marine Laboratories; SFSU College of Science and Engineering; Romberg Tiburon Center at SFSU	This work was supported by the California Coastal Conservancy/California Ocean Protection Council #05-103 to K.E.B., C.S.C., and S.W.-E.; NOAA Restoration Center #NA05NMF4631220 to K.E.B. and S.W.-E.; National Science Foundation, Field Stations and Marine Laboratories #0435033 to C.S.C.; and SFSU College of Science and Engineering and the Romberg Tiburon Center at SFSU for equipment, student support, and new faculty start-up funds (C.S.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Bangert RK, 2005, CONSERV BIOL, V19, P379, DOI 10.1111/j.1523-1739.2005.00450.x; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Boyer K.E., 2010, EELGRASS CONSERVATIO; Boyer KE, 2007, ESTABLISHING EELGRAS; Campanella JJ, 2013, POPUL ECOL, V55, P121, DOI 10.1007/s10144-012-0351-4; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Cornuet JM, 1996, GENETICS, V144, P2001; Crumb EK, 2009, THESIS SAN FRANCISCO; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; DECOCK AWAM, 1980, AQUAT BOT, V9, P201, DOI 10.1016/0304-3770(80)90023-6; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falk Donald A., 2006, P14; Fonseca M. S., 1998, NOAA COASTAL OCEAN P, V12; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes AR, 2009, FRONT ECOL ENVIRON, V7, P242, DOI 10.1890/080041; Hughes AR, 2009, ECOLOGY, V90, P1412, DOI 10.1890/07-2030.1; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kamel SJ, 2012, MAR ECOL PROG SER, V447, P127, DOI 10.3354/meps09447; Kendrick GA, 2005, MAR ECOL PROG SER, V290, P291, DOI 10.3354/meps290291; Kenworthy WJ, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P595; Merkel KW, 2004, BAYWIDE EELGRASS ZOS; Montalvo AM, 1997, RESTOR ECOL, V5, P277, DOI 10.1046/j.1526-100X.1997.00542.x; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; Ort BS, 2012, J HERED, V103, P533, DOI 10.1093/jhered/ess022; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pickerell CH, 2005, ECOL ENG, V25, P127, DOI 10.1016/j.ecoleng.2005.03.005; Pritchard JK, 2000, GENETICS, V155, P945; Procaccini G, 2007, J EXP MAR BIOL ECOL, V350, P234, DOI 10.1016/j.jembe.2007.05.035; Reid PC, 2012, J MAR BIOL ASSOC UK, V92, P1435, DOI 10.1017/S0025315412000549; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Reynolds LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038397; Reynolds LK, 2012, MAR ECOL PROG SER, V448, P223, DOI 10.3354/meps09386; Rhode JM, 2004, AM J BOT, V91, P192, DOI 10.3732/ajb.91.2.192; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RUCKELSHAUS MH, 1995, MAR BIOL, V123, P583, DOI 10.1007/BF00349237; Shearer TL, 2009, CORAL REEFS, V28, P727, DOI 10.1007/s00338-009-0520-x; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Short FT, 2002, FISHERIES SCI, V68, P1759, DOI DOI 10.2331/FISHSCI.68.SUP2_1759; SINNOCK P, 1975, AM NAT, V109, P565, DOI 10.1086/283027; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Tang X, 2012, THESIS SAN FRANCISCO; van Katwijk MM, 2009, MAR POLLUT BULL, V58, P179, DOI 10.1016/j.marpolbul.2008.09.028; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Williams SL, 2001, ECOL APPL, V11, P1472, DOI 10.1890/1051-0761(2001)011[1472:RGDIET]2.0.CO;2; Williams SL, 1996, RESTOR ECOL, V4, P163, DOI 10.1111/j.1526-100X.1996.tb00117.x	56	8	8	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89316	10.1371/journal.pone.0089316	http://dx.doi.org/10.1371/journal.pone.0089316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586683	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900080
J	Cai, PL; Gu, RM; Wang, B; Li, JG; Wan, L; Tian, CG; Ma, YH				Cai, Pengli; Gu, Ruimeng; Wang, Bang; Li, Jingen; Wan, Li; Tian, Chaoguang; Ma, Yanhe			Evidence of a Critical Role for Cellodextrin Transporte 2 (CDT-2) in Both Cellulose and Hemicellulose Degradation and Utilization in Neurospora crassa	PLOS ONE			English	Article							TRICHODERMA-REESEI; RNA-SEQ; INDUCTION; EXPRESSION; HYDROLYSIS; XYLANASE; MECHANISMS; ENZYMES; FUNGUS; GENES	CDT-1 and CDT-2 are two cellodextrin transporters discovered in the filamentous fungus Neurospora crassa. Previous studies focused on characterizing the role of these transporters in only a few conditions, including cellulose degradation, and the function of these two transporters is not yet completely understood. In this study, we show that deletion of cdt-2, but not cdt-1, results in growth defects not only on Avicel but also on xylan. cdt-2 can be highly induced by xylan, and this mutant has a xylodextrin consumption defect. Transcriptomic analysis of the cdt-2 deletion strain on Avicel and xylan showed that major cellulase and hemicellulase genes were significantly down-regulated in the cdt-2 deletion strain and artificial over expression of cdt-2 in N. crassa increased cellulase and hemicellulase production. Together, these data clearly show that CDT-2 plays a critical role in hemicellulose sensing and utilization. This is the first time a sugar transporter has been assigned a function in the hemicellulose degradation pathway. Furthermore, we found that the transcription factor XLR-1 is the major regulator of cdt-2, while cdt-1 is primarily regulated by CLR-1. These results deepen our understanding of the functions of both cellodextrin transporters, particularly for CDT-2. Our study also provides novel insight into the mechanisms for hemicellulose sensing and utilization in N. crassa, and may be applicable to other cellulolytic filamentous fungi.	[Cai, Pengli; Gu, Ruimeng; Wang, Bang; Li, Jingen; Wan, Li; Tian, Chaoguang; Ma, Yanhe] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Tian, CG (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China.	tian_cg@tib.cas.cn	wan, li/GRY-7634-2022; MA, YAN/HHN-2912-2022	Wang, Bang/0000-0003-4223-3040	973 program of China [2013CB733600, 2011CB707400]; Natural Science Foundation of China [31171207]; Energy Biosciences Institute (EBI)	973 program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Energy Biosciences Institute (EBI)	This study was supported by 973 program of China (2013CB733600 and 2011CB707400), the Natural Science Foundation of China (Grant No. 31171207) and a sub-award from Energy Biosciences Institute (EBI) to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlin A, 2007, BIOTECHNOL BIOENG, V97, P287, DOI 10.1002/bit.21238; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brienzo M, 2012, WORLD J MICROB BIOT, V28, P113, DOI 10.1007/s11274-011-0798-z; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Dien BS, 2008, BIORESOURCE TECHNOL, V99, P5216, DOI 10.1016/j.biortech.2007.09.030; Ebringerova A, 2000, MACROMOL RAPID COMM, V21, P542; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Ivanova C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062631; Jones CB, 2012, TRAFFIC, V13, P468, DOI 10.1111/j.1600-0854.2011.01314.x; KUBICEK CP, 1993, ENZYME MICROB TECH, V15, P90, DOI 10.1016/0141-0229(93)90030-6; Li J, 2013, APPL MICROBIOL BIOTE; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; MCNALLY MT, 1988, CURR GENET, V14, P545, DOI 10.1007/BF00434079; PINAGA F, 1994, FEMS MICROBIOL LETT, V115, P319, DOI 10.1016/0378-1097(94)90033-7; POUTANEN K, 1988, APPL MICROBIOL BIOT, V28, P425, DOI 10.1007/BF00268208; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Stricker AR, 2006, EUKARYOT CELL, V5, P2128, DOI 10.1128/EC.00211-06; Sun JP, 2012, EUKARYOT CELL, V11, P482, DOI 10.1128/EC.05327-11; Sun JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025654; Sun JP, 2011, PROTEIN EXPRES PURIF, V75, P147, DOI 10.1016/j.pep.2010.08.016; Suto M, 2001, J BIOSCI BIOENG, V92, P305, DOI 10.1263/jbb.92.305; Takahashi M, 2010, BIOSCI BIOTECH BIOCH, V74, P746, DOI 10.1271/bbb.90790; Tian CG, 2011, MICROBIOL-SGM, V157, P747, DOI 10.1099/mic.0.045468-0; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VAHERI MP, 1979, EUR J APPL MICROBIOL, V8, P73, DOI 10.1007/BF00510268; van Peij NNME, 1998, MOL MICROBIOL, V27, P131, DOI 10.1046/j.1365-2958.1998.00666.x; Vann DC, 1995, FUNGAL GENET NEWSL A, V42, P53; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WOOD TM, 1986, PHYTOCHEMISTRY, V25, P1053, DOI 10.1016/S0031-9422(00)81552-6; Xu JP, 1998, BIOSCI BIOTECH BIOCH, V62, P1555, DOI 10.1271/bbb.62.1555; Zhang WX, 2013, J BIOL CHEM, V288, P32861, DOI 10.1074/jbc.M113.505826; Znameroski EA, 2013, J BIOL CHEM; Znameroski EA, 2012, P NATL ACAD SCI USA, V109, P6012, DOI 10.1073/pnas.1118440109	42	21	23	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89330	10.1371/journal.pone.0089330	http://dx.doi.org/10.1371/journal.pone.0089330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586693	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700103
J	Hoffman, S; Martin, D; Melendez, A; Bargonetti, J				Hoffman, Sandy; Martin, Daniel; Melendez, Alicia; Bargonetti, Jill			C. elegans CEP-1/p53 and BEC-1 Are Involved in DNA Repair	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; AUTOPHAGY GENES FUNCTION; CAENORHABDITIS-ELEGANS; INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; CELL-DEATH; TRANSCRIPTIONAL CONTROL; GERMLINE APOPTOSIS; LIFE-SPAN; P53	p53 is a transcription factor that regulates the response to cellular stress. Mammalian p53 functions as a tumor suppressor. The C. elegans p53, cep-1, regulates DNA-damage induced germline cell death by activating the transcription of egl-1 and ced-13. We used the C. elegans model to investigate how, in the whole animal, different forms of DNA damage can induce p53-dependent versus p53-independent cell death and DNA repair. DNA damage was induced by ultraviolet type C (UVC) radiation, or 10-decarbamoyl mitomycin C (DMC, an agent known to induce mammalian p53-independent cell death). Wildtype or cep-1 loss-of-function mutant animals were assayed for germline cell death and DNA lesions. Wild-type animals displayed greater removal of UVC-lesions over time, whereas cep-1 mutant animals displayed increased UVC-lesion retention. The cep-1 mutation increased UVC-lesion retention directly correlated with a reduction of progeny viability. Consistent with DMC inducing p53-independent cell death in mammalian cells DMC induced a C. elegans p53-independent germline cell death pathway. To examine the influence of wild-type CEP-1 and DNA damage on C. elegans tumors we used glp-1(ar202gf)/Notch germline tumor mutants. UVC treatment of glp-1 mutant animals activated the CEP-1 target gene egl-1 and reduced tumor size. In cep-1(gk138); glp-1(ar202gf) animals, UVC treatment resulted in increased susceptibility to lesions and larger tumorous germlines. Interestingly, the partial knockdown of bec-1 in adults resulted in a CEP-1-dependent increase in germline cell death and an increase in DNA damage. These results strongly support cross-talk between BEC-1 and CEP-1 to protect the C. elegans genome.	[Hoffman, Sandy; Martin, Daniel; Bargonetti, Jill] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Melendez, Alicia] CUNY Queens Coll, Dept Biol Sci, Queens, NY USA; [Hoffman, Sandy; Melendez, Alicia; Bargonetti, Jill] CUNY, Grad Ctr, Dept Biol, New York, NY USA; [Hoffman, Sandy; Melendez, Alicia; Bargonetti, Jill] CUNY, Grad Ctr, Dept Biochem, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System	Bargonetti, J (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	bargonetti@genectr.hunter.cuny.edu		Bargonetti, Jill/0000-0003-2692-0991	NIH SCORE Award [1SC1CA137843]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [RR003037]; NATIONAL CANCER INSTITUTE [SC1CA137843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM102846] Funding Source: NIH RePORTER	NIH SCORE Award; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH SCORE Award 1SC1CA137843 to J. Bargonetti. It was also made possible in part by an infrastructure award to Hunter College, Grant Number RR003037 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Berry LW, 1997, DEVELOPMENT, V124, P925; Boamah EK, 2007, ACS CHEM BIOL, V2, P399, DOI 10.1021/cb700060t; Boamah EK, 2010, CHEM RES TOXICOL, V23, P1151, DOI 10.1021/tx900420k; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; BRENNER S, 1974, GENETICS, V77, P71; Burns AR, 2010, NAT CHEM BIOL, V6, P549, DOI [10.1038/NCHEMBIO.380, 10.1038/nchembio.380]; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Deng XZ, 2004, NAT GENET, V36, P906, DOI 10.1038/ng1396; Derry WB, 2007, CELL DEATH DIFFER, V14, P662, DOI 10.1038/sj.cdd.4402075; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Erdelyi P, 2011, J CELL SCI, V124, P1510, DOI 10.1242/jcs.080192; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Greiss S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-334; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Huang S, 2013, AUTOPHAGY, V9, P138, DOI 10.4161/auto.22352; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kimble Judith, 2005, WormBook, P1; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Li W, 2012, J CELL BIOL, V197, P27, DOI 10.1083/jcb.201111053; Li ZK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028326; Lu WJ, 2006, CELL DEATH DIFFER, V13, P909, DOI 10.1038/sj.cdd.4401922; Mathew R, 2007, AUTOPHAGY, V3, P502, DOI 10.4161/auto.4605; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Melendez Alicia, 2009, WormBook, P1, DOI 10.1895/wormbook.1.147.1; Meyer JN, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r70; Meyer JN, 2010, ECOTOXICOLOGY, V19, P804, DOI 10.1007/s10646-009-0457-4; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Pepper ASR, 2003, GENETICS, V163, P115; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Quevedo C, 2007, CURR BIOL, V17, P286, DOI 10.1016/j.cub.2006.12.038; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Ruck A, 2011, AUTOPHAGY, V7, P386, DOI 10.4161/auto.7.4.14391; Samara C, 2008, CURR PHARM DESIGN, V14, P97, DOI 10.2174/138161208783378770; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shaham S, 2006, WORMBOOK, P1; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Smith ML, 1996, ONCOGENE, V13, P2255; Stergiou L, 2007, CELL DEATH DIFFER, V14, P1129, DOI 10.1038/sj.cdd.4402115; Stergiou L, 2011, CELL DEATH DIFFER, V18, P897, DOI 10.1038/cdd.2010.158; Takacs-Vellai K, 2005, CURR BIOL, V15, P1513, DOI 10.1016/j.cub.2005.07.035; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	51	13	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88828	10.1371/journal.pone.0088828	http://dx.doi.org/10.1371/journal.pone.0088828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586407	gold, Green Published			2022-12-27	WOS:000331714700036
J	Kapoor, R; Singh, S; Tripathi, M; Bhatnagar, P; Kakkar, P; Gupta, KC				Kapoor, Radhika; Singh, Shruti; Tripathi, Madhulika; Bhatnagar, Priyanka; Kakkar, Poonam; Gupta, Kailash Chand			O-Hexadecyl-Dextran Entrapped Berberine Nanoparticles Abrogate High Glucose Stress Induced Apoptosis in Primary Rat Hepatocytes	PLOS ONE			English	Article							IN-VITRO; POLYMERS; HYPERGLYCEMIA; ACTIVATION; ASSAY	Nanotized phytochemicals are being explored by researchers for promoting their uptake and effectiveness at lower concentrations. In this study, O-hexadecyl-dextran entrapped berberine chloride nanoparticles (BC-HDD NPs) were prepared, and evaluated for their cytoprotective efficacy in high glucose stressed primary hepatocytes and the results obtained compared with bulk berberine chloride (BBR) treatment. The nanotized formulation treated primary hepatocytes that were exposed to high glucose (40 mM), showed increased viability compared to the bulk BBR treated cells. BC-HDD NPs reduced the ROS generation by similar to 3.5 fold during co-treatment, prevented GSH depletion by similar to 1.6 fold, reduced NO formation by similar to 5 fold and significantly prevented decline in SOD activity in stressed cells. Lipid peroxidation was also prevented by similar to 1.9 fold in the presence of these NPs confirming the antioxidant capacity of the formulation. High glucose stress increased Bax/Bcl2 ratio followed by mitochondrial depolarization and activation of caspase-9/-3 confirming involvement of mitochondrial pathway of apoptosis in the exposed cells. Co- and post-treatment of BC-HDD NPs prevented depolarization of mitochondrial membrane, reduced Bax/Bcl2 ratio and prevented externalization of phosphatidyl-serine confirming their anti-apoptotic capacity in those cells. Sub-G1 phase apparent in high glucose stressed cells was not seen in BC-HDD NPs treated cells. The present study reveals that BC-HDD NPs at similar to 20 fold lower concentration are as effective as BBR in preventing high glucose induced oxidative stress, mitochondrial depolarization and downstream events of apoptotic cell death.	[Kapoor, Radhika; Singh, Shruti; Tripathi, Madhulika; Kakkar, Poonam; Gupta, Kailash Chand] CSIR IITR, Food Drug & Chem Toxicol Div, Lucknow, Uttar Pradesh, India; [Bhatnagar, Priyanka; Gupta, Kailash Chand] CSIR Inst Genom & Integrat Biol, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Kakkar, P (corresponding author), CSIR IITR, Food Drug & Chem Toxicol Div, Lucknow, Uttar Pradesh, India.	poonam_kakkar@yahoo.com; kcgupta@iitr.res.in			CSIR-network project [BSC-0112]; Council of Scientific and Industrial Research (CSIR), New Delhi	CSIR-network project(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Financial support from CSIR-network project No. BSC-0112, Nanomaterials: Applications and Impact on Safety, Health and Environment (NanoSHE) is gratefully acknowledged. SS and PB thank the Council of Scientific and Industrial Research (CSIR), New Delhi for the award of Senior Research Fellowship (SRF) to carry out this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward GW, 2005, EYE, V19, P1115, DOI 10.1038/sj.eye.6701969; BarathManiKanth Selvaraj, 2010, Journal of Nanobiotechnology, V8, P16, DOI 10.1186/1477-3155-8-16; Bertholon I, 2006, PHARM RES-DORDR, V23, P1313, DOI 10.1007/s11095-006-0069-0; Cesaratto Laura, 2004, Ann Hepatol, V3, P86; Cicero Arrigo F G, 2012, Hosp Pract (1995), V40, P56, DOI 10.3810/hp.2012.04.970; Cok A, 2011, BIOCHIMIE, V93, P1187, DOI 10.1016/j.biochi.2011.04.013; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Derosa G, 2012, EXPERT OPIN BIOL TH, V12, P1113, DOI 10.1517/14712598.2012.704014; Durand A, 2004, LANGMUIR, V20, P6956, DOI 10.1021/la0490341; FEELISCH M, 1987, EUR J PHARMACOL, V142, P465, DOI 10.1016/0014-2999(87)90090-2; Goyal R, 2012, NANOMED-NANOTECHNOL, V8, P167, DOI 10.1016/j.nano.2011.06.001; Guo Y, 2012, EUR J CLIN PHARMACOL, V68, P213, DOI 10.1007/s00228-011-1108-2; Guo Y, 2011, J ETHNOPHARMACOL, V138, P111, DOI 10.1016/j.jep.2011.08.058; Han JL, 2011, MED SCI MONITOR, V17, pRA164, DOI 10.12659/MSM.881842; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kapoor R, 2013, APOPTOSIS, V18, P9, DOI 10.1007/s10495-012-0781-7; Kapoor R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041663; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0; Lemarchand C, 2003, PHARMACEUT RES, V20, P1284, DOI 10.1023/A:1025017502379; Li YX, 1998, POLYMER, V39, P3087, DOI 10.1016/S0032-3861(97)10048-9; Li ZQ, 2012, J ETHNOPHARMACOL, V142, P474, DOI 10.1016/j.jep.2012.05.022; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nigam N, 2010, CANCER CHEMOTH PHARM, V65, P687, DOI 10.1007/s00280-009-1074-x; OKADA H, 1995, CRIT REV THER DRUG, V12, P1; OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610; Park JH, 2005, MOLECULES, V10, P146, DOI 10.3390/10010146; Passirani C, 1998, PHARM RES-DORDR, V15, P1046, DOI 10.1023/A:1011930127562; Rouzes C, 2000, J BIOMED MATER RES, V50, P557, DOI 10.1002/(SICI)1097-4636(20000615)50:4<557::AID-JBM11>3.0.CO;2-R; Seglen PO, 1976, METHOD CELL BIOL, V19, P187; Serafim TL, 2008, CANCER CHEMOTH PHARM, V61, P1007, DOI 10.1007/s00280-007-0558-9; Sharikabad MN, 2001, AM J PHYSIOL-HEART C, V280, pH344, DOI 10.1152/ajpheart.2001.280.1.H344; Tiwari M, 2009, TOXICOL IN VITRO, V23, P295, DOI 10.1016/j.tiv.2008.12.014; Torchilin VP, 2006, ADV DRUG DELIVER REV, V58, P1532, DOI 10.1016/j.addr.2006.09.009; Tripathi M, 2010, TOXICOL IN VITRO, V24, P495, DOI 10.1016/j.tiv.2009.09.011; Vauthier C, 2003, ADV DRUG DELIVER REV, V55, P519, DOI 10.1016/S0169-409X(03)00041-3; Vittaz M, 1996, BIOMATERIALS, V17, P1575, DOI 10.1016/0142-9612(95)00322-3; Voehringer DW, 1999, FREE RADICAL BIO MED, V27, P945, DOI 10.1016/S0891-5849(99)00174-4; WALLIN B, 1993, ANAL BIOCHEM, V208, P10, DOI 10.1006/abio.1993.1002; Wang CM, 2009, EUR J PHARMACOL, V620, P131, DOI 10.1016/j.ejphar.2009.07.027; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xie X, 2011, ENDOCR J, V58, P761, DOI 10.1507/endocrj.K11E-024; Yen FL, 2009, PHARM RES-DORDR, V26, P893, DOI 10.1007/s11095-008-9791-0	45	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89124	10.1371/journal.pone.0089124	http://dx.doi.org/10.1371/journal.pone.0089124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586539	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700064
J	Mussar, K; Tucker, A; McLennan, L; Gearhart, A; Jimenez-Caliani, AJ; Cirulli, V; Crisa, L				Mussar, Kristin; Tucker, Andrew; McLennan, Linsey; Gearhart, Addie; Jimenez-Caliani, Antonio J.; Cirulli, Vincenzo; Crisa, Laura			Macrophage/Epithelium Cross-Talk Regulates Cell Cycle Progression and Migration in Pancreatic Progenitors	PLOS ONE			English	Article							GROWTH-FACTOR ALPHA; BETA-CELL; ENDOCRINE-CELLS; PAIRED DOMAIN; BINDING-SITE; ACTIVATED MACROPHAGES; HOMEODOMAIN PROTEINS; SEQUENCE RECOGNITION; TRANSCRIPTION FACTOR; ADHESION MOLECULE	Macrophages populate the mesenchymal compartment of all organs during embryogenesis and have been shown to support tissue organogenesis and regeneration by regulating remodeling of the extracellular microenvironment. Whether this mesenchymal component can also dictate select developmental decisions in epithelia is unknown. Here, using the embryonic pancreatic epithelium as model system, we show that macrophages drive the epithelium to execute two developmentally important choices, i.e. the exit from cell cycle and the acquisition of a migratory phenotype. We demonstrate that these developmental decisions are effectively imparted by macrophages activated toward an M2 fetal-like functional state, and involve modulation of the adhesion receptor NCAM and an uncommon "paired-less'' isoform of the transcription factor PAX6 in the epithelium. Over-expression of this PAX6 variant in pancreatic epithelia controls both cell motility and cell cycle progression in a gene-dosage dependent fashion. Importantly, induction of these phenotypes in embryonic pancreatic transplants by M2 macrophages in vivo is associated with an increased frequency of endocrine-committed cells emerging from ductal progenitor pools. These results identify M2 macrophages as key effectors capable of coordinating epithelial cell cycle withdrawal and cell migration, two events critical to pancreatic progenitors' delamination and progression toward their differentiated fates.	[Mussar, Kristin; Tucker, Andrew; McLennan, Linsey; Gearhart, Addie; Jimenez-Caliani, Antonio J.; Cirulli, Vincenzo; Crisa, Laura] Univ Washington, Dept Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Crisa, L (corresponding author), Univ Washington, Dept Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	lcrisa@uw.edu			NIH [RO1 HL075270]; LSDF; JDRF [17-2011-620, 1-2005-1084]; ADA [1-11-BS-28]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LSDF; JDRF(Juvenile Diabetes Research Foundation); ADA(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	L. Crisa was supported by NIH RO1 HL075270, LSDF Program Project grant, and JDRF grant #17-2011-620. V. Cirulli was supported by ADA Basic Research Award 1-11-BS-28 and JDRF Research Grants #1-2005-1084 and #17-2011-620, and LSDF Program Project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2004, AM J RESP CRIT CARE, V170, P1158, DOI 10.1164/rccm.200307-908OC; Arda HE, 2013, DEV CELL, V25, P5, DOI 10.1016/j.devcel.2013.03.016; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Banaei-Bouchareb L, 2004, J LEUKOCYTE BIOL, V76, P359, DOI 10.1189/jlb.1103591; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Bruun JA, 2005, NUCLEIC ACIDS RES, V33, P2661, DOI 10.1093/nar/gki562; CARRIERE C, 1993, MOL CELL BIOL, V13, P7257, DOI 10.1128/MCB.13.12.7257; Cirulli V, 2006, DIABETES, V55, P1214, DOI 10.2337/db05-0731; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cvekl A, 1999, INVEST OPHTH VIS SCI, V40, P1343; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dohrmann C, 2000, MECH DEVELOP, V92, P47, DOI 10.1016/S0925-4773(99)00324-X; Doyle MJ, 2007, DIABETES, V56, P1999, DOI 10.2337/db06-1766; Edelman GM, 1998, BRAIN RES REV, V26, P337, DOI 10.1016/S0165-0173(97)00034-9; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030; Georgia S, 2006, DIABETES, V55, P2950, DOI 10.2337/db06-0249; Geutskens SB, 2005, J LEUKOCYTE BIOL, V78, P845, DOI 10.1189/jlb.1004624; Gittes GK, 1996, DEVELOPMENT, V122, P439; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GU DL, 1993, DEVELOPMENT, V118, P33; Guo S., 2013, J CLIN INVEST; Hart AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054173; Hebrok M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007674; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; HIRSCH MR, 1991, FEBS LETT, V287, P197, DOI 10.1016/0014-5793(91)80050-D; Holst BD, 1997, P NATL ACAD SCI USA, V94, P1465, DOI 10.1073/pnas.94.4.1465; Hsieh YW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-32; Kim J, 2006, DEV BIOL, V292, P486, DOI 10.1016/j.ydbio.2005.12.041; Kim J, 2008, DEV BIOL, V313, P434, DOI 10.1016/j.ydbio.2007.10.043; Kleinjan DA, 2004, DEV BIOL, V265, P462, DOI 10.1016/j.ydbio.2003.09.011; Kritzik MR, 2000, MOL CELL ENDOCRINOL, V164, P99, DOI 10.1016/S0303-7207(00)00234-3; Krizik MR, 1999, J ENDOCRINOL, V163, P523, DOI 10.1677/joe.0.1630523; Landsman L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001143; LANGLEY OK, 1987, FEBS LETT, V220, P108, DOI 10.1016/0014-5793(87)80885-2; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mascarenhas JB, 2009, J BIOL CHEM, V284, P27524, DOI 10.1074/jbc.M109.047209; MAYERHOFER A, 1991, ENDOCRINOLOGY, V129, P792, DOI 10.1210/endo-129-2-792; Michaelson MD, 1996, DEVELOPMENT, V122, P2661; Mikkola I, 2001, J BIOL CHEM, V276, P4109, DOI 10.1074/jbc.M008882200; Miller R, 2008, DIABETES, V57, P2402, DOI 10.2337/db08-0244; Miralles F, 1998, DEVELOPMENT, V125, P1017; Mishra R, 2002, J BIOL CHEM, V277, P49488, DOI 10.1074/jbc.M206478200; MORRIS L, 1991, DEVELOPMENT, V112, P517; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Otonkoski T, 2005, ANN MED, V37, P513, DOI 10.1080/07853890500300279; Pagliuca FW, 2013, DEVELOPMENT, V140, P2472, DOI 10.1242/dev.093187; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rachdi L, 2006, DIABETES, V55, P3520, DOI 10.2337/db06-0861; Rae F, 2007, DEV BIOL, V308, P232, DOI 10.1016/j.ydbio.2007.05.027; Rao S, 2007, DEVELOPMENT, V134, P4449, DOI 10.1242/dev.012187; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Schaffer AE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003274; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Song SY, 1999, GASTROENTEROLOGY, V117, P1416, DOI 10.1016/S0016-5085(99)70292-1; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; TURQUE N, 1994, MOL ENDOCRINOL, V8, P929, DOI 10.1210/me.8.7.929; Tyas DA, 2003, CEREB CORTEX, V13, P612, DOI 10.1093/cercor/13.6.612; Van Nguyen A, 2002, DEV BIOL, V247, P11, DOI 10.1006/dbio.2002.0669; Verbruggen V, 2010, J BIOL CHEM, V285, P13863, DOI 10.1074/jbc.M110.108019; WANG TC, 1993, J CLIN INVEST, V92, P1349, DOI 10.1172/JCI116708; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yan Q, 2010, P NATL ACAD SCI USA, V107, P21034, DOI 10.1073/pnas.1007866107; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363	83	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89492	10.1371/journal.pone.0089492	http://dx.doi.org/10.1371/journal.pone.0089492			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586821	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900150
J	Bian, ZY; Huang, J; Ma, JH; Lu, LJ; Niu, SZ; Zeng, D; Feng, QJ; Chen, WF				Bian, Zhaoying; Huang, Jing; Ma, Jianhua; Lu, Lijun; Niu, Shanzhou; Zeng, Dong; Feng, Qianjin; Chen, Wufan			Dynamic Positron Emission Tomography Image Restoration via a Kinetics-Induced Bilateral Filter	PLOS ONE			English	Article							A-POSTERIORI RECONSTRUCTION; PARAMETRIC IMAGE; INPUT FUNCTION; PET; MODEL; QUANTIFICATION; RESOLUTION; BINDING	Dynamic positron emission tomography (PET) imaging is a powerful tool that provides useful quantitative information on physiological and biochemical processes. However, low signal-to-noise ratio in short dynamic frames makes accurate kinetic parameter estimation from noisy voxel-wise time activity curves (TAC) a challenging task. To address this problem, several spatial filters have been investigated to reduce the noise of each frame with noticeable gains. These filters include the Gaussian filter, bilateral filter, and wavelet-based filter. These filters usually consider only the local properties of each frame without exploring potential kinetic information from entire frames. Thus, in this work, to improve PET parametric imaging accuracy, we present a kinetics-induced bilateral filter (KIBF) to reduce the noise of dynamic image frames by incorporating the similarity between the voxel-wise TACs using the framework of bilateral filter. The aim of the proposed KIBF algorithm is to reduce the noise in homogeneous areas while preserving the distinct kinetics of regions of interest. Experimental results on digital brain phantom and in vivo rat study with typical F-18-FDG kinetics have shown that the present KIBF algorithm can achieve notable gains over other existing algorithms in terms of quantitative accuracy measures and visual inspection.	[Bian, Zhaoying; Huang, Jing; Ma, Jianhua; Lu, Lijun; Niu, Shanzhou; Zeng, Dong; Feng, Qianjin; Chen, Wufan] Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Ma, JH (corresponding author), Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China.	jhma@smu.edu.cn	feng, qianjin/GNM-7856-2022; Feng, Qianjin/Y-5438-2019	feng, qianjin/0000-0002-3830-5120; 	National Natural Science Foundation of China [81000613, 81101046]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI12B03]; Science and Technology Program of Guangdong Province of China [2011A030300005]; National Key Scientific Instrument and Equipment Development Project of China [2011YQ03011404]; 973 Program of China [2010CB732504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Science and Technology Program of Guangdong Province of China; National Key Scientific Instrument and Equipment Development Project of China; 973 Program of China(National Basic Research Program of China)	This work was partially supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under grants No. 81000613 and No. 81101046; the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (http://kjzc.jhgl.org/) under grant No. 2011BAI12B03; the Science and Technology Program of Guangdong Province of China (http://www.gdstc.gov.cn/) under grant No. 2011A030300005; National Key Scientific Instrument and Equipment Development Project of China (http://www.nmp.gov.cn/) under grant No. 2011YQ03011404; and the 973 Program of China (http://www.973.gov.cn/) under grant No. 2010CB732504. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert NM, 2006, NEUROIMAGE, V30, P444, DOI 10.1016/j.neuroimage.2005.09.031; Bian Z., 2011, P FULL 3D 2011, P407; Chen K, 1998, J CEREBR BLOOD F MET, V18, P716, DOI 10.1097/00004647-199807000-00002; Chen Y, 2008, J MATH IMAGING VIS, V30, P133, DOI 10.1007/s10851-007-0042-5; Christian BT, 2010, J NUCL MED, V51, P1147, DOI 10.2967/jnumed.109.073999; Comtat C, 2002, PHYS MED BIOL, V47, P1, DOI 10.1088/0031-9155/47/1/301; Fang YHD, 2010, J NUCL MED, V51, P77, DOI 10.2967/jnumed.109.064824; Feng D, 1997, IEEE Trans Inf Technol Biomed, V1, P243, DOI 10.1109/4233.681168; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; GREEN PJ, 1990, IEEE T MED IMAGING, V9, P84, DOI 10.1109/42.52985; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Hofheinz F, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-23; Hsiao IT, 2003, IEEE T MED IMAGING, V22, P580, DOI 10.1109/TMI.2003.812249; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; IIDA H, 1992, J NUCL MED, V33, P1669; Kadrmas DJ, 2001, PHYS MED BIOL, V46, P1553, DOI 10.1088/0031-9155/46/5/315; Kamasak ME, 2005, IEEE T MED IMAGING, V24, P636, DOI 10.1109/TMI.2005.845317; Kishan H, 2012, INT CONF ACOUST SPEE, P1129, DOI 10.1109/ICASSP.2012.6288085; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Leahy RM, 2000, STAT COMPUT, V10, P147, DOI 10.1023/A:1008946426658; Lin JW, 2001, IEEE T BIO-MED ENG, V48, P202, DOI 10.1109/10.909641; Links JM, 1992, EUR J NUCL MED, V19; Litton JE, 1997, J COMPUT ASSIST TOMO, V21, P907, DOI 10.1097/00004728-199711000-00012; Lu L, 2012, PHYS MED BIOL, V57; Lu L., 2011, P FULLY 3D, P233; Ma JH, 2010, COMPUT BIOL MED, V40, P565, DOI 10.1016/j.compbiomed.2010.03.012; Mohy-ud-Din H, 2012, IEEE NUCL SCI CONF R, P3067; Mumcuoglu EU, 1996, PHYS MED BIOL, V41, P1777, DOI 10.1088/0031-9155/41/9/015; Muzic RF, 2001, J NUCL MED, V42, P636; O'Sullivan F, 1999, IEEE T MED IMAGING, V18, P115, DOI 10.1109/42.759111; Peng HH, 2010, IEEE IMAGE PROC, P3293, DOI 10.1109/ICIP.2010.5651045; Phelps M. E, 2004, PET MOL IMAGING ITS; Qi JY, 2000, IEEE T MED IMAGING, V19, P493, DOI 10.1109/42.870259; Rahmim A, 2008, IEEE T MED IMAGING, V27, P1018, DOI 10.1109/TMI.2008.917248; Rahmim A, 2012, PHYS MED BIOL, V57, P733, DOI 10.1088/0031-9155/57/3/733; Rahmim A, 2009, MED PHYS, V36, P3654, DOI 10.1118/1.3160108; Sanabria-Bohorquez Sandra M, 2003, Mol Imaging Biol, V5, P72, DOI 10.1016/S1536-1632(03)00046-5; So HC, 2002, 2002 IEEE NUCL SCI S, V2, P1341; Somayajula S, 2011, IEEE T MED IMAGING, V30, P537, DOI 10.1109/TMI.2010.2076827; STEIN CM, 1981, ANN STAT, V9, P1135, DOI 10.1214/aos/1176345632; Tang J, 2009, PHYS MED BIOL, V54, P7063, DOI 10.1088/0031-9155/54/23/002; Tauber C, 2011, PHYS MED BIOL, V56, P6583, DOI 10.1088/0031-9155/56/20/004; Tian LL, 2011, IEEE NUCL SCI CONF R, P2587, DOI 10.1109/NSSMIC.2011.6152697; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; Tsoumpas C, 2008, MED PHYS, V35, P3963, DOI 10.1118/1.2966349; Tsoumpas C, 2008, MED PHYS, V35, P1299, DOI 10.1118/1.2885369; Van De Ville D, 2009, IEEE SIGNAL PROC LET, V16, P973, DOI 10.1109/LSP.2009.2027669; Vunckx K, 2012, IEEE T MED IMAGING, V31, P599, DOI 10.1109/TMI.2011.2173766; Wang GB, 2008, PHYS MED BIOL, V53, P593, DOI 10.1088/0031-9155/53/3/006; Wang GB, 2009, IEEE T MED IMAGING, V28, P1717, DOI 10.1109/TMI.2009.2021851; Wang GB, 2009, IEEE T MED IMAGING, V28, P608, DOI 10.1109/TMI.2008.2008971; Wu Y, 2002, J CEREB BLOOD FLOW M, V35, P660	52	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89282	10.1371/journal.pone.0089282	http://dx.doi.org/10.1371/journal.pone.0089282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586657	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800013
J	Campbell, RAA; Eifert, RW; Turner, GC				Campbell, Robert A. A.; Eifert, Robert W.; Turner, Glenn C.			Openstage: A Low-Cost Motorized Microscope Stage with Sub-Micron Positioning Accuracy	PLOS ONE			English	Article								Recent progress in intracellular calcium sensors and other fluorophores has promoted the widespread adoption of functional optical imaging in the life sciences. Home-built multiphoton microscopes are easy to build, highly customizable, and cost effective. For many imaging applications a 3-axis motorized stage is critical, but commercially available motorization hardware (motorized translators, controller boxes, etc) are often very expensive. Furthermore, the firmware on commercial motor controllers cannot easily be altered and is not usually designed with a microscope stage in mind. Here we describe an open-source motorization solution that is simple to construct, yet far cheaper and more customizable than commercial offerings. The cost of the controller and motorization hardware are under $1000. Hardware costs are kept low by replacing linear actuators with high quality stepper motors. Electronics are assembled from commonly available hobby components, which are easy to work with. Here we describe assembly of the system and quantify the positioning accuracy of all three axes. We obtain positioning repeatability of the order of 1 mu m in X/Y and 0.1 mu m in Z. A hand-held control-pad allows the user to direct stagemotion precisely over a wide range of speeds (10(-1) to 10(2) mu m: s(-1)), rapidly store and return to different locations, and execute "jumps" of a fixed size. In addition, the system can be controlled from a PC serial port. Our "OpenStage" controller is sufficiently flexible that it could be used to drive other devices, such as micro-manipulators, with minimal modifications.	[Campbell, Robert A. A.; Eifert, Robert W.; Turner, Glenn C.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Campbell, RAA (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	campbell@cshl.edu		Campbell, Robert/0000-0002-8330-4477; Turner, Glenn/0000-0002-5341-2784	National Institutes of Health [R01 DC010403-01A1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Institutes of Health (www.nih.gov; Grant #R01 DC010403-01A1 to G. C. T.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell RAA, 2013, J NEUROSCI, V33, P10568, DOI 10.1523/JNEUROSCI.0682-12.2013; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Nguyen QT, 2006, J NEUROSCI METH, V156, P351, DOI 10.1016/j.jneumeth.2006.03.001; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2	11	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88977	10.1371/journal.pone.0088977	http://dx.doi.org/10.1371/journal.pone.0088977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586468	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000332389000021
J	Tedesco, L; Vichi, M				Tedesco, Letizia; Vichi, Marcello			Sea Ice Biogeochemistry: A Guide for Modellers	PLOS ONE			English	Article							MCMURDO SOUND; TEMPERATURE; ECOSYSTEM; OCEAN; PHYTOPLANKTON; GROWTH; PHOTOSYNTHESIS; MICROALGAE; NUTRIENT; CLIMATE	Sea ice is a fundamental component of the climate system and plays a key role in polar trophic food webs. Nonetheless sea ice biogeochemical dynamics at large temporal and spatial scales are still rarely described. Numerical models may potentially contribute integrating among sparse observations, but available models of sea ice biogeochemistry are still scarce, whether their relevance for properly describing the current and future state of the polar oceans has been recently addressed. A general methodology to develop a sea ice biogeochemical model is presented, deriving it from an existing validated model application by extension of generic pelagic biogeochemistry model parameterizations. The described methodology is flexible and considers different levels of ecosystem complexity and vertical representation, while adopting a strategy of coupling that ensures mass conservation. We show how to apply this methodology step by step by building an intermediate complexity model from a published realistic application and applying it to analyze theoretically a typical season of first-year sea ice in the Arctic, the one currently needing the most urgent understanding. The aim is to (1) introduce sea ice biogeochemistry and address its relevance to ocean modelers of polar regions, supporting them in adding a new sea ice component to their modelling framework for a more adequate representation of the sea ice-covered ocean ecosystem as a whole, and (2) extend our knowledge on the relevant controlling factors of sea ice algal production, showing that beyond the light and nutrient availability, the duration of the sea ice season may play a key-role shaping the algal production during the on going and upcoming projected changes.	[Tedesco, Letizia] Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland; [Vichi, Marcello] Ist Nazl Geofis & Vulcanol, Bologna, Italy; [Vichi, Marcello] Ctr Euromediterraneo Cambiamenti Climat, Bologna, Italy	Finnish Environment Institute; Istituto Nazionale Geofisica e Vulcanologia (INGV)	Tedesco, L (corresponding author), Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland.	letizia.tedesco@environment.fi	Vichi, Marcello/B-8719-2008; Tedesco, Letizia/B-2884-2013	Vichi, Marcello/0000-0002-0686-9634; Tedesco, Letizia/0000-0001-9051-8177	Maj and Tor Nessling Foundation [2010357]; Estonian Science Foundation [MJD62]; Italian Ministry of Education, University and Research; Ministry for Environment, Land and Sea	Maj and Tor Nessling Foundation; Estonian Science Foundation; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Ministry for Environment, Land and Sea	LT acknowledges the support from the Maj and Tor Nessling Foundation (http://www.nessling.fi), project 2010357, and the Estonian Science Foundation (http://www.etf.ee), project MJD62. MV acknowledges the support of the Italian Ministry of Education, University and Research and Ministry for Environment, Land and Sea through the project GEMINA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alou-Font E, 2013, MAR ECOL PROG SER, V474, P89, DOI 10.3354/meps10107; Arrigo K. R, 2003, J GEOPHYS RES OCEANS, V108; Arrigo KR, 1997, SCIENCE, V276, P394, DOI 10.1126/science.276.5311.394; ARRIGO KR, 1995, MAR ECOL PROG SER, V127, P255, DOI 10.3354/meps127255; ARRIGO KR, 1992, J PHYCOL, V28, P746, DOI 10.1111/j.0022-3646.1992.00746.x; ARRIGO KR, 1993, J GEOPHYS RES-OCEANS, V98, P6929, DOI 10.1029/93JC00141; Arrigo KR., 2010, SEA ICE, P283, DOI DOI 10.1002/9781444317145.CH8; Assur A, 1958, ARCTIC SEA ICE, V598, P106; Bluhm B. A., 2010, SEA ICE, P357, DOI DOI 10.1002/9781444317145.CH10; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Comiso JC, 2010, SEA ICE, P205, DOI DOI 10.1002/9781444317145.CH6; CURRY JA, 1995, J CLIMATE, V8, P240, DOI 10.1175/1520-0442(1995)008<0240:SIACFM>2.0.CO;2; Deal C, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006409; Eilola K, 2013, GEOPHYS RES LETT, V40, P149, DOI 10.1029/2012GL054375; Elliott S, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001649; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Flynn KJ, 2003, PROG OCEANOGR, V56, P249, DOI 10.1016/S0079-6611(03)00006-5; Hunke EC, 2011, CRYOSPHERE, V5, P989, DOI 10.5194/tc-5-989-2011; Jeffery N, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006527; Ji RB, 2013, GLOBAL CHANGE BIOL, V19, P734, DOI 10.1111/gcb.12074; Jin M, 2006, ANN GLACIOL-SER, V44, P63, DOI 10.3189/172756406781811709; Jin MB, 2012, DEEP-SEA RES PT II, V81-84, P28, DOI 10.1016/j.dsr2.2011.06.003; Krell A, 2007, J PHYCOL, V43, P753, DOI 10.1111/j.1529-8817.2007.00366.x; Lancelot C, 2009, BIOGEOSCIENCES, V6, P2861, DOI 10.5194/bg-6-2861-2009; Lannuzel D, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001031; Lavoie D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002922; Lavoie D, 2009, J MARINE SYST, V75, P17, DOI 10.1016/j.jmarsys.2008.07.007; MAYKUT GA, 1978, J GEOPHYS RES-OCEANS, V83, P3646, DOI 10.1029/JC083iC07p03646; Meiners KM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053478; Mikkelsen DM, 2008, MAR ECOL PROG SER, V368, P65, DOI 10.3354/meps07627; Mock T, 2005, PHOTOSYNTH RES, V85, P307, DOI 10.1007/s11120-005-5668-9; Nikiforov SL, 2001, HYDROCHEMICAL ATLAS; Nishi Y, 2005, J MARINE SYST, V55, P249, DOI 10.1016/j.jmarsys.2004.08.002; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; PALMISANO AC, 1985, J PHYCOL, V21, P341; Platt T, 2008, REMOTE SENS ENVIRON, V112, P3426, DOI 10.1016/j.rse.2007.10.016; Pogson L, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006119; Popova EE, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007112; Post E, 2013, SCIENCE, V341, P519, DOI 10.1126/science.1235225; Poulin Michel, 2011, Marine Biodiversity, V41, P13, DOI 10.1007/s12526-010-0058-8; Ralph PJ, 2005, J PHYCOL, V41, P763, DOI 10.1111/j.1529-8817.2005.00106.x; Rysgaard S, 2007, J GEOPHYS RES, V83; Saenz BT, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007544; Sakshaug E, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P57; SEMTNER AJ, 1976, J PHYS OCEANOGR, V6, P379, DOI 10.1175/1520-0485(1976)006<0379:AMFTTG>2.0.CO;2; Sibert V, 2011, J MARINE SYST, V88, P401, DOI 10.1016/j.jmarsys.2011.03.014; Stefels J, 2007, BIOGEOCHEMISTRY, V83, P245, DOI 10.1007/s10533-007-9091-5; Stroeve JC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052676; Sturm M., 2017, SNOW SEA ICE, V2nd ed., P153, DOI [10.1002/9781444317145.ch5, DOI 10.1002/9781444317145.CH5]; Tedesco L, 2010, CMCC RES PAPERS, P17; Tedesco L, 2012, ECOL MODEL, V226, P120, DOI 10.1016/j.ecolmodel.2011.11.011; Tedesco L, 2010, OCEAN MODEL, V35, P89, DOI 10.1016/j.ocemod.2010.06.008; Tedesco L, 2009, BOREAL ENVIRON RES, V14, P68; Thomas DN, 2012, LIFE AT EXTREMES: ENVIRONMENTS, ORGANISMS AND STRATEGIES FOR SURVIVAL, P62, DOI 10.1079/9781845938147.0062; Thomas DN, 2010, SEA ICE, P425, DOI DOI 10.1002/9781444317145.CH12; Thomas DN, 2014, SEA ICE IN PRESS, P400; Tison JL, 2008, DEEP-SEA RES PT II, V55, P975, DOI 10.1016/j.dsr2.2007.12.021; UNTERSTEINER N, 1964, J GEOPHYS RES, V69, P4755, DOI 10.1029/JZ069i022p04755; Vancoppenolle M, 2013, QUATERNARY IN PRESS; Vancoppenolle M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005369; Wassmann P, 2006, J MARINE SYST, V59, P1, DOI 10.1016/j.jmarsys.2005.05.006	62	30	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89217	10.1371/journal.pone.0089217	http://dx.doi.org/10.1371/journal.pone.0089217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586604	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900036
J	Xu, Q; Liu, JW; He, CY; Sun, LP; Gong, YH; Jing, JJ; Xing, CZ; Yuan, Y				Xu, Qian; Liu, Jing-wei; He, Cai-yun; Sun, Li-ping; Gong, Yue-hua; Jing, Jing-jing; Xing, Cheng-zhong; Yuan, Yuan			The Interaction Effects of pri-let-7a-1 rs10739971 with PGC and ERCC6 Gene Polymorphisms in Gastric Cancer and Atrophic Gastritis	PLOS ONE			English	Article							MULTIPLE INTERACTION ANALYSIS; CHINESE POPULATION; HUMAN-DISEASES; HEPATOCELLULAR-CARCINOMA; RISK; SUSCEPTIBILITY; ASSOCIATION; CARCINOGENESIS; MICRORNA	Background: The aim of this study was to investigate the interaction effects of pri-let-7a-1 rs10739971 with pepsinogen C (PGC) and excision repair cross complementing group 6 (ERCC6) gene polymorphisms and its association with the risks of gastric cancer and atrophic gastritis. We hoped to identify miRNA polymorphism or a combination of several polymorphisms that could serve as biomarkers for predicting the risk of gastric cancer and its precancerous diseases. Methods: Sequenom MassARRAY platform method was used to detect polymorphisms of pri-let-7a-1 rs10739971 G -> A, PGC rs4711690 C -> G, PGC rs6458238 G -> A, PGC rs9471643 G -> C, and ERCC6 rs1917799 in 471 gastric cancer patients, 645 atrophic gastritis patients and 717 controls. Results: An interaction effect of pri-let-7a-1 rs10739971 polymorphism with ERCC6 rs1917799 polymorphism was observed for the risk of gastric cancer (P-interaction = 0.026); and interaction effects of pri-let-7a-1 rs10739971 polymorphism with PGC rs6458238 polymorphism (P-interaction = 0.012) and PGC rs9471643 polymorphism (P-interaction = 0.039) were observed for the risk of atrophic gastritis. Conclusion: The combination of pri-let-7a-1 rs10739971 polymorphism and ERCC6 and PGC polymorphisms could provide a greater prediction potential than a single polymorphism on its own. Large-scale studies and molecular mechanism research are needed to confirm our findings.	[Xu, Qian; Liu, Jing-wei; He, Cai-yun; Sun, Li-ping; Gong, Yue-hua; Jing, Jing-jing; Xing, Cheng-zhong; Yuan, Yuan] China Med Univ, Tumor Etiol & Screening Dept, Affiliated Hosp 1, Inst Canc, Shenyang, Liaoning, Peoples R China; [Xu, Qian; Liu, Jing-wei; He, Cai-yun; Sun, Li-ping; Gong, Yue-hua; Jing, Jing-jing; Xing, Cheng-zhong; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Xu, Qian; Liu, Jing-wei; He, Cai-yun; Sun, Li-ping; Gong, Yue-hua; Jing, Jing-jing; Xing, Cheng-zhong; Yuan, Yuan] China Med Univ, Key Lab Canc Etiol & Prevent, Liaoning Prov Educ Dept, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Yuan, Y (corresponding author), China Med Univ, Tumor Etiol & Screening Dept, Affiliated Hosp 1, Inst Canc, Shenyang, Liaoning, Peoples R China.	yyuan3@mail.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Key Basic Research Program of China (973 Program) [2010CB529304]; National Natural Science Foundation of China [31200968]; Science Technology Project in Liaoning Province [2011225002]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Project in Liaoning Province	This work was supported by grants from the National Key Basic Research Program of China (973 Program ref no. 2010CB529304), the National Natural Science Foundation of China (Ref No. 31200968), and the Science Technology Project in Liaoning Province (Ref No. 2011225002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Arisawa T, 2012, HUM IMMUNOL, V73, P747, DOI 10.1016/j.humimm.2012.04.011; Chen W, 2013, BREAST CANCER RES TR, V142, P637, DOI 10.1007/s10549-013-2775-8; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Gong YH, 2010, EUR J CLIN MICROBIOL, V29, P907, DOI 10.1007/s10096-010-0944-9; He CY, 2011, J GASTROEN HEPATOL, V26, P1039, DOI 10.1111/j.1440-1746.2011.06692.x; He CY, 2013, CARCINOGENESIS, V34, P1450, DOI 10.1093/carcin/bgt079; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Link A, 2012, DIGEST DIS, V30, P255, DOI 10.1159/000336919; Liu J, 2013, ASIAN PACIF IN PRESS; Liu JW, 2013, ASIAN PAC J CANCER P, V14, P6103, DOI 10.7314/APJCP.2013.14.10.6103; Liu L, 2013, MOL CARCINOGEN, V52, P923, DOI 10.1002/mc.21942; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Ning PF, 2005, WORLD J GASTROENTERO, V11, P2545, DOI 10.3748/wjg.v11.i17.2545; Pines A, 2010, J INVEST DERMATOL, V130, P1746, DOI 10.1038/jid.2010.18; Sapkota Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064896; Wang WN, 2013, TUMOR BIOL, V34, P1865, DOI 10.1007/s13277-013-0728-9; Xu Q, 2009, INT J ONCOL, V35, P1313, DOI 10.3892/ijo_00000449; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Zhang LS, 2012, DNA CELL BIOL, V31, P761, DOI 10.1089/dna.2011.1326; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zhu YM, 2010, WORLD J GASTROENTERO, V16, P3325, DOI 10.3748/wjg.v16.i26.3325	25	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89203	10.1371/journal.pone.0089203	http://dx.doi.org/10.1371/journal.pone.0089203			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586594	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900035
J	Farooq, MS; Khan, SA; Ahmad, F; Islam, S; Abid, A				Farooq, Muhammad Shoaib; Khan, Sher Afzal; Ahmad, Farooq; Islam, Saeed; Abid, Adnan			An Evaluation Framework and Comparative Analysis of the Widely Used First Programming Languages	PLOS ONE			English	Article							JAVA	Computer programming is the core of computer science curriculum. Several programming languages have been used to teach the first course in computer programming, and such languages are referred to as first programming language (FPL). The pool of programming languages has been evolving with the development of new languages, and from this pool different languages have been used as FPL at different times. Though the selection of an appropriate FPL is very important, yet it has been a controversial issue in the presence of many choices. Many efforts have been made for designing a good FPL, however, there is no ample way to evaluate and compare the existing languages so as to find the most suitable FPL. In this article, we have proposed a framework to evaluate the existing imperative, and object oriented languages for their suitability as an appropriate FPL. Furthermore, based on the proposed framework we have devised a customizable scoring function to compute a quantitative suitability score for a language, which reflects its conformance to the proposed framework. Lastly, we have also evaluated the conformance of the widely used FPLs to the proposed framework, and have also computed their suitability scores.	[Farooq, Muhammad Shoaib; Khan, Sher Afzal] Abdul Wali Khan Univ, Dept Comp Sci, Mardan, Pakistan; [Farooq, Muhammad Shoaib; Ahmad, Farooq; Abid, Adnan] Univ Cent Punjab, Fac Informat Technol, Lahore, Pakistan; [Islam, Saeed] Abdul Wali Khan Univ, Dept Math, Mardan, Pakistan	Abdul Wali Khan University; University of Central Punjab; Abdul Wali Khan University	Abid, A (corresponding author), Univ Cent Punjab, Fac Informat Technol, Lahore, Pakistan.	adnan.abid@ucp.edu.pk	Khan, Sher Afzal/H-2958-2012; Farooq, Muhammad Shoaib/AAC-8760-2020; Saeed, Islam/AAD-6067-2020; Abid, Adnan/AAM-4134-2020	Khan, Sher Afzal/0000-0003-0273-1248; Farooq, Muhammad Shoaib/0000-0002-4095-8868; Saeed, Islam/0000-0001-5263-4871; 				[Anonymous], 1997, JAVA CODE CONVENTION; [Anonymous], 1985, PC LINT C C; [Anonymous], 2000, C COD STAND; Ari B, 1982, PRINCIPLES CONCURREN; Bennedsen J, 2008, THESIS U OSLO; Bennedsen J., 2010, ACM T COMPUT EDUC, V10, P1, DOI DOI 10.1145/1789934.1789938; Biddle R., 1998, SIGCSE Bulletin, V30, P48, DOI 10.1145/292422.292441; Brusilovsky P., 1997, Education and Information Technologies, V2, P65, DOI 10.1023/A:1018636507883; Clarke S., 2001, 13 WORKSH PSYCH PROG, P275; Davies S, 2011, SIGCSE 11: PROCEEDINGS OF THE 42ND ACM TECHNICAL SYMPOSIUM ON COMPUTER SCIENCE EDUCATION, P625; Deissenboeck F, 2006, SOFTWARE QUAL J, V14, P261, DOI 10.1007/s11219-006-9219-1; Denvir B. T., 1979, SIGPLAN Notices, V14, P18, DOI 10.1145/954245.954246; Dijkstra E, 1979, CLASSICS SOFTWARE EN, P111; Donovan A, 2004, OOPSLA 04; Eckel B, 2000, THINKING JAVA; Farooq M. S., 2012, J BASIC APPL SCI RES, V2, P8144; FELDMAN MB, 1992, COMMUN ACM, V35, P53, DOI 10.1145/138844.138847; General Software Development Standards and Guidelines, 2007, GEN SOFTW DEV STAND; GOODENOUGH JB, 1975, COMMUN ACM, V18, P683, DOI 10.1145/361227.361230; Gries D, 1974, ACM SIGCSE B, P81; Gupta Diwaker, 2004, CROSSROADS, V10, P7; Hadjerrouit S., 1998, SIGCSE Bulletin, V30, P43, DOI 10.1145/292422.292440; Hoare C. A. R., 1973, TECHNICAL REPORT; HOARE CAR, 1978, COMMUN ACM, V21, P666, DOI 10.1145/359576.359585; Hoare CAR, 1980, ACM TUR AW LECT; HOLTZ NM, 1988, ENG COMPUT, V3, P183, DOI 10.1007/BF01202140; Howell K, 2003, J COMPUTING SCI COLL, V18, P317; Jacquot JP, 2002, P INT C PRINC PRACT, P119; Johnson K A, 1997, LECT NOTES COMPUTER; Jones C, 1996, APPL SOFTWARE MEASUR; Kelleher C, 2005, ACM COMPUT SURV, V37, P83, DOI 10.1145/1089733.1089734; Knuth D, 2003, CSLI LECT NOTES, V139; Kolling M, 1999, J OBJECT-ORIENT PROG, V11, P6; Kolling M, 1999, J OBJECT-ORIENT PROG, V11, P8; Kolling M., 1995, SIGCSE Bulletin, V27, P173, DOI 10.1145/199691.199770; Kolling M, 2013, P 44 ACM TECHN S COM, P5; Ku┬lling M., 2012, P 43 ACM TECHN S COM, P323, DOI [10.1145/2157136.2157234, DOI 10.1145/2157136.2157234]; Li Xiaosong, 2005, P 6 C INFORM TECHNOL, P239; Mahmoud Q. H., 2004, Computer, V37, P106, DOI 10.1109/MC.2004.1266305; Martin P, 1998, ACM SIGPLAN NOTICES, V33, P34, DOI 10.1145/278283.278288; McIver L., 2002, 14 ANN WORKSH PSYCH, P100; Michael Siegfried Robert, 2012, INF SYST ED J, V10, P24; MISRA, 2008, C GUID US C LANG CRI; PALUMBO DB, 1990, REV EDUC RES, V60, P65, DOI 10.3102/00346543060001065; Parker KR, 2006, J INF TECHNOL EDUC-R, V5, P133; Parnin C., 2011, P 8 WORK C MIN SOFTW, P3, DOI DOI 10.1145/1985441.1985446; Pears Arnold, 2007, SIGCSE Bulletin, V39, P204, DOI 10.1145/1345375.1345441; Philips Healthcare, 2009, C COD STAND VERS 2 0; Phipps G, 1999, SOFTWARE PRACT EXPER, V29, P345, DOI 10.1002/(SICI)1097-024X(19990410)29:4<345::AID-SPE238>3.0.CO;2-C; Pirkelbauer P, 2011, LECT NOTES COMPUT SC, V6563, P123, DOI 10.1007/978-3-642-19440-5_8; POHL I, 1988, COMPUT LANG, V13, P51, DOI 10.1016/0096-0551(88)90009-4; Reid R J, 1 COURSE LANGUGE COM; Reiss S, 2007, P 22 IEEE ACM INT C, P74, DOI DOI 10.1145/1321631.1321645; Rendel T, 2010, ACM SIGPLAN NOTICES, V45, P1; Roberts E. S., 1993, SIGCSE Bulletin, V25, P117, DOI 10.1145/169073.169361; Ryder BG, 2005, ACM T SOFTW ENG METH, V14, P431, DOI 10.1145/1101815.1101818; Salus HP, 1998, HDB PROGRAMMING LANG, VI; Samak M, 2008, PRACTICAL UML STATEC; Schneider G. M., 1978, SIGCSE 78 SIGCSE CSA, P107; Scoy FV, 2006, REID LIST 25; Sebesta R. W., 2012, CONCEPTS PROGRAMMING; SHANI U, 1983, SIGPLAN NOTICES, V18, P35, DOI 10.1145/948093.948098; Stephenson C., 1998, Journal of Research on Computing in Education, V31, P89; Stroustrup B, 1995, DESIGN EVALUATION C; Stroustrup B., 2013, C PROGRAMMING LANGUA; Stroustrup B, 2012, LECT NOTES COMPUT SC, V7211, P1, DOI 10.1007/978-3-642-28869-2_1; Stroustrup B, 2012, COMPUTER, V45, P47, DOI 10.1109/MC.2011.353; Stroustrup B, 2010, COMMUN ACM, V53, P40, DOI 10.1145/1629175.1629192; Stroustrup Bjarne, 2009, P 14 W CANADIAN C CO, P82, DOI [10.1145/1536274, DOI 10.1145/1536274]; Tucker AB, 2009, PROGRAMMING LANGUAGE; University R., 1993, SIGPLAN FORTRAN FORU, V12, P1, DOI DOI 10.1145/174223.158909; Vandevoorde D., 2002, C TEMPLATES COMPLETE; Vollebregt T, 2012, P 12 WORKSH LANG DES; Weimer W, 2008, ACM T PROGR LANG SYS, V30, DOI 10.1145/1330017.1330019; Wheeler D. A., 1997, Ada Letters, V17, P88; Wirth N., 1975, IEEE Transactions on Software Engineering, VSE-1, P192, DOI 10.1109/TSE.1975.6312839; Wirth N, 2002, PASCAL ITS SUCCESSOR; Wirth N, 1974, IFIP C, P386	78	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e88941	10.1371/journal.pone.0088941	http://dx.doi.org/10.1371/journal.pone.0088941			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586449	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700013
J	Roperto, S; Russo, V; Borzacchiello, G; Urraro, C; Luca, R; Esposito, I; Riccardi, MG; Raso, C; Gaspari, M; Ceccarelli, DM; Galasso, R; Roperto, F				Roperto, Sante; Russo, Valeria; Borzacchiello, Giuseppe; Urraro, Chiara; Luca, Roberta; Esposito, Iolanda; Riccardi, Marita Georgia; Raso, Cinzia; Gaspari, Marco; Ceccarelli, Dora Maria; Galasso, Rocco; Roperto, Franco			Bovine Papillomavirus Type 2 (BPV-2) E5 Oncoprotein Binds to the Subunit D of the V-1-ATPase Proton Pump in Naturally Occurring Urothelial Tumors of the Urinary Bladder of Cattle	PLOS ONE			English	Article							WATER-BUFFALO; BRACKEN-FERN; ASSOCIATION; PROTEINS; EXPRESSION; INFECTION; RECEPTOR; COMPLEX; CANCER; BLOOD	Background: Active infection by bovine papillomavirus type 2 (BPV-2) was documented for fifteen urinary bladder tumors in cattle. Two were diagnosed as papillary urothelial neoplasm of low malignant potential (PUNLMP), nine as papillary and four as invasive urothelial cancers. Methods and Findings: In all cancer samples, PCR analysis revealed a BPV-2-specific 503 bp DNA fragment. E5 protein, the major oncoprotein of the virus, was shown both by immunoprecipitation and immunohistochemical analysis. E5 was found to bind to the activated (phosphorylated) form of the platelet derived growth factor beta receptor. PDGF beta R immunoprecipitation from bladder tumor samples and from normal bladder tissue used as control revealed a protein band which was present in the pull-down from bladder cancer samples only. The protein was identified with mass spectrometry as "V-1-ATPase subunit D", a component of the central stalk of the V-1-ATPase vacuolar pump. The subunit D was confirmed in this complex by coimmunoprecipitation investigations and it was found to colocalize with the receptor. The subunit D was also shown to be overexpressed by Western blot, RT-PCR and immunofluorescence analyses. Immunoprecipitation and immunofluorescence also revealed that E5 oncoprotein was bound to the subunit D. Conclusion: For the first time, a tri-component complex composed of E5/PDGF beta R/subunit D has been documented in vivo. Previous in vitro studies have shown that the BPV-2 E5 oncoprotein binds to the proteolipid c ring of the V-0-ATPase sector. We suggest that the E5/PDGF beta R/subunit D complex may perturb proteostasis, organelle and cytosol homeostasis, which can result in altered protein degradation and in autophagic responses.	[Roperto, Sante] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Settore Malattie Infett, Naples, Italy; [Russo, Valeria; Borzacchiello, Giuseppe; Urraro, Chiara; Luca, Roberta; Esposito, Iolanda; Riccardi, Marita Georgia; Raso, Cinzia; Ceccarelli, Dora Maria] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Settore Patol Gen, Naples, Italy; [Gaspari, Marco] Univ Catanzaro Magna Graecia, Dipartimento Med Clin & Sperimentale, Catanzaro, Italy; [Galasso, Rocco] IRCCS CROB, Unit Clin Epidemiol Biostat & Canc Registry, Potenza, Italy; [Roperto, Franco] Univ Naples Federico II, Dipartimento Biol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Magna Graecia University of Catanzaro; IRCCS CROB; University of Naples Federico II	Roperto, S (corresponding author), Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Settore Malattie Infett, Naples, Italy.	sante.roperto@unina.it	Vecchio, Domenico/I-4102-2013; Gaspari, Marco/ABE-1539-2020; Galasso, Rocco/AAL-2150-2020; Gaspari, Marco/HGB-2399-2022; Gaspari, Marco/C-2756-2009; riccardi, marita georgia/AAD-3454-2020	Vecchio, Domenico/0000-0002-8766-7224; Gaspari, Marco/0000-0002-5411-8800; Galasso, Rocco/0000-0003-4831-6437; Gaspari, Marco/0000-0002-5411-8800; riccardi, marita georgia/0000-0002-9097-8939; roperto, sante/0000-0001-6210-5519; Borzacchiello, Giuseppe/0000-0003-3943-2604	Ministero Italiano dell'Universita e della Ricerca Scientifica (MIUR); Ministero Italiano delle Politiche Agricole, Agroalimentari e Forestali (MIPAAF); Assessorato alla Sanita della Regione Basilicata	Ministero Italiano dell'Universita e della Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministero Italiano delle Politiche Agricole, Agroalimentari e Forestali (MIPAAF); Assessorato alla Sanita della Regione Basilicata	This work was sponsored by grants from the Ministero Italiano dell'Universita e della Ricerca Scientifica (MIUR), Ministero Italiano delle Politiche Agricole, Agroalimentari e Forestali (MIPAAF) and Assessorato alla Sanita della Regione Basilicata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESSON T, 1995, J BIOL CHEM, V270, P6830, DOI 10.1074/jbc.270.12.6830; Ashrafi GH, 2002, ONCOGENE, V21, P248; Balcos LGF, 2008, RES VET SCI, V85, P145, DOI 10.1016/j.rvsc.2007.10.002; Borzacchiello G, 2006, ONCOGENE, V25, P1251, DOI 10.1038/sj.onc.1209152; Borzacchiello G, 2003, J GEN VIROL, V84, P2921, DOI 10.1099/vir.0.19412-0; Borzacchiello G, 2008, VET RES, V39, DOI 10.1051/vetres:2008022; CAIRNEY M, 1995, CARCINOGENESIS, V16, P1997, DOI 10.1093/carcin/16.8.1997; Campo MS, 1997, VET J, V154, P175, DOI 10.1016/S1090-0233(97)80019-6; CAMPO MS, 1992, CANCER RES, V52, P6898; CONRAD M, 1993, J VIROL, V67, P6170, DOI 10.1128/JVI.67.10.6170-6178.1993; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; EVANS IA, 1965, NATURE, V208, P913, DOI 10.1038/208913a0; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GOLDSTEIN DJ, 1990, EMBO J, V9, P137, DOI 10.1002/j.1460-2075.1990.tb08089.x; GOLDSTEIN DJ, 1992, EMBO J, V11, P4851, DOI 10.1002/j.1460-2075.1992.tb05591.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Juhasz G, 2012, AUTOPHAGY, V8, P1875, DOI 10.4161/auto.21544; Maiolino P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/937918; Martano M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/814635; Meuten DJ, 2002, TUMORS DOMESTIC ANIM, P524; Ozkul IA, 1996, BRIT VET J, V152, P473, DOI 10.1016/S0007-1935(96)80041-8; PAMUKCU AM, 1976, VET PATHOL, V13, P110, DOI 10.1177/030098587601300205; Peters LZ, 2013, J CELL BIOL, V201, P663, DOI 10.1083/jcb.201211146; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Rapino F, 2013, ONCOGENE, DOI [10.1038/onc.2013.110, DOI 10.1038/0NC.2013.110]; Resendes AR, 2011, RES VET SCI, V90, P526, DOI 10.1016/j.rvsc.2010.02.001; Romanucci M, 2012, CELL STRESS CHAPERON, V17, P683, DOI 10.1007/s12192-012-0342-6; Roperto S, 2013, J COMP PATHOL, V148, P49, DOI 10.1016/j.jcpa.2012.11.018; Roperto S, 2010, J COMP PATHOL, V142, P95, DOI 10.1016/j.jcpa.2009.08.156; Roperto S, 2008, J GEN VIROL, V89, P3027, DOI 10.1099/vir.0.2008/004457-0; Roperto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062227; Roperto S, 2013, J GEN VIROL, V94, P403, DOI 10.1099/vir.0.047662-0; Roperto S, 2011, J GEN VIROL, V92, P1787, DOI 10.1099/vir.0.031740-0; Roperto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010299; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Shafti-Keramat S, 2009, VIROLOGY, V393, P1, DOI 10.1016/j.virol.2009.07.036; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Suprynowicz FA, 2006, PAPILLOMAVIRUS RESEARCH: FROM NATURAL HISTORY TO VACCINES AND BEYOND, P97; Wosiacki SR, 2005, J VIROL METHODS, V126, P215, DOI 10.1016/j.jviromet.2005.01.021	39	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e88860	10.1371/journal.pone.0088860	http://dx.doi.org/10.1371/journal.pone.0088860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586417	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700011
J	Kukaswadia, A; Pickett, W; Janssen, I				Kukaswadia, Atif; Pickett, William; Janssen, Ian			Time Since Immigration and Ethnicity as Predictors of Physical Activity among Canadian Youth: A Cross-Sectional Study	PLOS ONE			English	Article							SEDENTARY BEHAVIORS; MULTILEVEL ANALYSIS; ACTIVITY GUIDELINES; LEISURE-TIME; ACCULTURATION; CHILDREN; ADOLESCENTS; HEALTH; PARTICIPATION; OBESITY	Background: Little is known about patterns of physical activity engaged in by youth after they immigrate to a new country. This study aims to investigate relationships between immigrant generation and ethnicity with physical activity, and to determine if the relationship between immigrant generation and physical activity was modified by ethnicity. Methods: The data sources were Cycle 6 (2009-2010) of the Canadian Health Behaviour in School-Aged Children Study and the 2006 Canada Census of Population. Participants (weighted n = 23,124) were young people from grades 6-10 in 436 schools. Students were asked where they were born, how long ago they moved to Canada, their ethnicity, and how many days a week they accumulated at least 60 minutes of moderate-to-vigorous physical activity (MVPA). Results: Youth born outside of Canada were less likely to be active than peers born in Canada; 11% vs 15% reported 7 days/week of at least 60 minutes of MVPA (p =.001). MVPA increased with time since immigration. Compared to Canadian-born youth, youth who immigrated within the last 1-2 years were less likely to get sufficient MVPA on 4-6 days/week (odds ratio: 0.66, 95% confidence interval: 0.53-0.82) and 7 days/week (0.62; 0.43-0.89). East and South-East Asian youth were less active, regardless of time since immigration: 4-6 days/week (0.67; 0.58-0.79) and 7 days/week (0.37; 0.29-0.48). Conclusion: Time since immigration and ethnicity were associated with MVPA among Canadian youth. Mechanisms by which these differences occur need to be uncovered in order to identify barriers to physical activity participation among youth.	[Kukaswadia, Atif; Pickett, William; Janssen, Ian] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Pickett, William] Kingston Gen Hosp, Clin Res Ctr, Kingston, ON K7L 2V7, Canada; [Janssen, Ian] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Kukaswadia, A (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.	atif.kukaswadia@queensu.ca	Janssen, Ian/B-7700-2009	Janssen, Ian/0000-0003-2159-3012	Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award; Tier 2 Canada Research Chair in Physical Activity and Obesity	Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award(Canadian Institutes of Health Research (CIHR)); Tier 2 Canada Research Chair in Physical Activity and Obesity	The HBSC is a WHO/Euro collaborative study; International Coordinator of the 2009-2010 study is Candace Currie, St. Andrews University, Scotland; Data Bank Manager is Oddrun Samdal, University of Bergen, Norway. The Canadian HBSC study (PI: John Freeman, William Pickett) was funded by the Public Health Agency of Canada, Health Canada, the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada (MOP 97961; PCR 101415). Atif Kukaswadia was supported by a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award and Ian Janssen was supported by a Tier 2 Canada Research Chair in Physical Activity and Obesity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizlewood A, 2006, J IMMIGR REFUG STUD, V4, P1, DOI 10.1300/J500v04n03_01; Bryan SN, 2006, CAN J PUBLIC HEALTH, V97, P271, DOI 10.1007/BF03405602; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council, 2010, RES INV 1 NAT IN MET; Canadian Society for Exercise Physiology, 2011, CAN PHYS ACT GUID YO; Canadian Society of Exercise Physiology, 2011, CAN PHYS ACT GUID CH; Carvajal SC, 2002, ETHNIC HEALTH, V7, P181, DOI 10.1080/1355785022000042015; Celenk O., 2011, ONLINE READINGS PSYC, V8, DOI [10.9707/2307-0919.1105, DOI 10.9707/2307-0919.1105]; Choi JW, 2008, WESTERN J NURS RES, V30, P620, DOI 10.1177/0193945907310645; Citizenship and Immigration Canada, 2011, FACTS FIG IMM OV PER; Clark W., 2008, Canadian Social Trends, P54; Colley Rachel C, 2011, Health Rep, V22, P15; Daniel M, 2011, PUBLIC HEALTH NURS, V28, P389, DOI 10.1111/j.1525-1446.2010.00932.x; Darling N, 2005, J YOUTH ADOLESCENCE, V34, P493, DOI 10.1007/s10964-005-7266-8; De Meij JSB, 2010, BRIT J SPORT MED, V44, P879, DOI 10.1136/bjsm.2008.053827; Dogra Shilpa, 2010, Int J Behav Nutr Phys Act, V7, P75, DOI 10.1186/1479-5868-7-75; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Freeman J.G., 2011, HLTH CANADAS YOUNG P, P1; Gentile DA, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-49; Gil AG, 2000, J COMMUNITY PSYCHOL, V28, P443, DOI 10.1002/1520-6629(200007)28:4<443::AID-JCOP6>3.0.CO;2-A; Griebler R, 2010, HLTH BEHAV SCH AGED; Haerens L, 2007, J ADOLESCENT HEALTH, V40, P258, DOI 10.1016/j.jadohealth.2006.09.028; Hosper K, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-230; Janssen I, 2007, APPL PHYSIOL NUTR ME, V32, pS109, DOI 10.1139/H07-109; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kahlin Yvonne, 2009, Int J Adolesc Med Health, V21, P327, DOI 10.1515/IJAMH.2009.21.3.327; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Liu JH, 2009, ETHNIC HEALTH, V14, P509, DOI 10.1080/13557850902890209; Martinez SM, 2008, PREV MED, V47, P313, DOI 10.1016/j.ypmed.2008.01.018; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Monger R., 2013, US LEGAL PERMANENT R; Newbold B, 2009, ETHNIC HEALTH, V14, P315, DOI 10.1080/13557850802609956; O'Loughlin J, 1999, ANN EPIDEMIOL, V9, P397, DOI 10.1016/S1047-2797(99)00030-7; Prochaska JJ, 2001, ARCH PEDIAT ADOL MED, V155, P554, DOI 10.1001/archpedi.155.5.554; Renzaho AMN, 2008, INT J OBESITY, V32, P594, DOI 10.1038/ijo.2008.2; Ridgers ND, 2012, J SCI MED SPORT, V15, P136, DOI 10.1016/j.jsams.2011.09.003; Sagatun A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-419; Sam DL, 2010, PERSPECT PSYCHOL SCI, V5, P472, DOI 10.1177/1745691610373075; Schnohr CW, 2008, SOC INDIC RES, V89, P79, DOI 10.1007/s11205-007-9221-4; Schwartz SJ, 2010, AM PSYCHOL, V65, P237, DOI 10.1037/a0019330; Setia MS, 2012, J IMMIGR MINOR HEALT, V14, P156, DOI 10.1007/s10903-010-9408-7; Simon C, 2008, INT J OBESITY, V32, P1489, DOI 10.1038/ijo.2008.99; Simpson K, 2005, J EPIDEMIOL COMMUN H, V59, P1072, DOI 10.1136/jech.2005.036723; Singh GK, 2008, ARCH PEDIAT ADOL MED, V162, P756, DOI 10.1001/archpedi.162.8.756; Smokowski PR, 2009, CHILD PSYCHIAT HUM D, V40, P589, DOI 10.1007/s10578-009-0146-9; Spence JC, 2003, PSYCHOL SPORT EXERC, V4, P7, DOI 10.1016/S1469-0292(02)00014-6; Statistics Canada, 2006, 2006 CENS POP; Taverno SE, 2010, AM J PREV MED, V38, P145, DOI 10.1016/j.amepre.2009.09.041; Tortolero SR, 1999, WOMEN HEALTH ISS, V9, P135, DOI 10.1016/S1049-3867(99)00004-3; Tremblay MS, 2006, CAN J PUBLIC HEALTH, V97, P277, DOI 10.1007/BF03405603; Unger JB, 2004, J COMMUN HEALTH, V29, P467, DOI 10.1007/s10900-004-3395-3; United Nations Department of Economic and Social Affairs Population Division, 2008, TRENDS INT MIGR STOC; VanSelm K, 1997, SCAND J PSYCHOL, V38, P143, DOI 10.1111/1467-9450.00020; Vasileva K., 2011, POPULATION SOCIAL CO	53	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89509	10.1371/journal.pone.0089509	http://dx.doi.org/10.1371/journal.pone.0089509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3VI	24586835	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900111
J	Sauer, AK; Liang, CH; Stech, J; Peeters, B; Quere, P; Schwegmann-Wessels, C; Wu, CY; Wong, CH; Herrler, G				Sauer, Anne-Kathrin; Liang, Chi-Hui; Stech, Juergen; Peeters, Ben; Quere, Pascale; Schwegmann-Wessels, Christel; Wu, Chung-Yi; Wong, Chi-Huey; Herrler, Georg			Characterization of the Sialic Acid Binding Activity of Influenza A Viruses Using Soluble Variants of the H7 and H9 Hemagglutinins	PLOS ONE			English	Article							INFECTIOUS-BRONCHITIS-VIRUS; RECEPTOR SPECIFICITY; EPITHELIAL-CELLS; CLEAVAGE SITE; DETERMINANTS; POULTRY; CHICKEN; HUMANS; LINE	Binding of influenza viruses to target cells is mediated by the viral surface protein hemagglutinin. To determine the presence of binding sites for influenza A viruses on cells and tissues, soluble hemagglutinins of the H7 and H9 subtype were generated by connecting the hemagglutinin ectodomain to the Fc portion of human immunoglobulin G (H7Fc and H9Fc). Both chimeric proteins bound to different cells and tissues in a sialic acid-dependent manner. Pronounced differences were observed between H7Fc and H9Fc, in the binding both to different mammalian and avian cultured cells and to cryosections of the respiratory epithelium of different virus host species (turkey, chicken and pig). Binding of the soluble hemagglutinins was similar to the binding of virus particles, but showed differences in the binding pattern when compared to two sialic acid-specific plant lectins. These findings were substantiated by a comparative glycan array analysis revealing a very narrow recognition of sialoglycoconjugates by the plant lectins that does not reflect the glycan structures preferentially recognized by H7Fc and H9Fc. Thus, soluble hemagglutinins may serve as sialic acid-specific lectins and are a more reliable indicator of the presence of binding sites for influenza virus HA than the commonly used plant lectins.	[Sauer, Anne-Kathrin; Schwegmann-Wessels, Christel; Herrler, Georg] Univ Vet Med, Inst Virol, Hannover, Germany; [Liang, Chi-Hui; Wu, Chung-Yi; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Stech, Juergen] Friedrich Loeffler Inst, Inst Mol Biol, Greifswald Insel Riems, Germany; [Peeters, Ben] Cent Vet Inst, Lelystad, Netherlands; [Quere, Pascale] INRA, Ctr Val Loire, Unite Mixte Rech 1282, Nouzilly, France	University of Veterinary Medicine Hannover, Foundation; Academia Sinica - Taiwan; Friedrich Loeffler Institute; Wageningen University & Research; INRAE	Herrler, G (corresponding author), Univ Vet Med, Inst Virol, Hannover, Germany.	georg.herrler@tiho-hannover.de	Quéré, Pascale/G-6590-2019; Wu, Chung-Yi/K-8334-2018	Quéré, Pascale/0000-0001-7763-3867; Stech, Juergen/0000-0002-3187-702X	German FluResearchNet; Ministry of Education and Research; DFG [SFB587, TPA1, SFB621, TPB7]	German FluResearchNet; Ministry of Education and Research; DFG(German Research Foundation (DFG))	This work was supported by a fund to G.H. and C.S.-W. from the German FluResearchNet, a nationwide research network on zoonotic influenza sponsored by the Ministry of Education and Research. Further financial support to G. H. was provided by DFG (SFB587, TPA1, and SFB621, TPB7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Rahman S, 2010, J VIROL, V84, P8949, DOI 10.1128/JVI.00463-10; Ayora-Talavera G, 2009, PLOS ONE, V4, DOI [10.1371/journal.-pone.0007836, DOI 10.1371/J0URNAL.-P0NE.0007836]; Butt AM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-319; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; de Vries RP, 2011, J BIOL CHEM, V286, P5868, DOI 10.1074/jbc.M110.193557; Dong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017212; Esnault E, 2011, VIRUS RES, V159, P32, DOI 10.1016/j.virusres.2011.04.022; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Gohrbandt S, 2011, J GEN VIROL, V92, P1843, DOI 10.1099/vir.0.031591-0; HIGA HH, 1985, VIROLOGY, V144, P279, DOI 10.1016/0042-6822(85)90325-3; HIRABAYASHI Y, 1983, J BIOCHEM-TOKYO, V94, P327, DOI 10.1093/oxfordjournals.jbchem.a134350; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; KLENK E, 1955, H-S Z PHYSIOL CHEM, V301, P235, DOI 10.1515/bchm2.1955.301.1-2.235; KNIBBS RN, 1991, J BIOL CHEM, V266, P83; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Liao HY, 2010, J AM CHEM SOC, V132, P14849, DOI 10.1021/ja104657b; Lin YP, 2000, PNAS, V97, P1; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Pillai SPS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-5; Punyadarsaniya D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028429; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Shelton H, 2011, J VIROL, V85, P1875, DOI 10.1128/JVI.01822-10; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Van Poucke SGM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-38; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Winter C, 2006, J GEN VIROL, V87, P1209, DOI 10.1099/vir.0.81651-0; Winter C, 2008, MICROBES INFECT, V10, P367, DOI 10.1016/j.micinf.2007.12.009; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Zimmer G, 1999, BIOCHEM J, V341, P277, DOI 10.1042/0264-6021:3410277; ZIMMER G, 1995, J BIOL CHEM, V270, P17815, DOI 10.1074/jbc.270.30.17815	37	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89529	10.1371/journal.pone.0089529	http://dx.doi.org/10.1371/journal.pone.0089529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586849	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900116
J	De Smet, L; De Koker, D; Hawley, AK; Foster, LJ; De Vos, P; de Graaf, DC				De Smet, Lina; De Koker, Dieter; Hawley, Alyse K.; Foster, Leonard J.; De Vos, Paul; de Graaf, Dirk C.			Effect of Bodily Fluids from Honey Bee (Apis mellifera) Larvae on Growth and Genome-Wide Transcriptional Response of the Causal Agent of American Foulbrood Disease (Paenibacillus Iarvae)	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; ESCHERICHIA-COLI; IN-VITRO; ANNOTATION; EXPRESSION; MANAGEMENT; DATABASE; HEALTH; OXYTETRACYCLINE; SUSCEPTIBILITY	Paenibacillus larvae, the causal agent of American Foulbrood disease (AFB), affects honey bee health worldwide. The present study investigates the effect of bodily fluids from honey bee larvae on growth velocity and transcription for this Grampositive, endospore-forming bacterium. It was observed that larval fluids accelerate the growth and lead to higher bacterial densities during stationary phase. The genome-wide transcriptional response of in vitro cultures of P. larvae to larval fluids was studied by microarray technology. Early responses of P. larvae to larval fluids are characterized by a general downregulation of oligopeptide and sugar transporter genes, as well as by amino acid and carbohydrate metabolic genes, among others. Late responses are dominated by general down-regulation of sporulation genes and up-regulation of phage-related genes. A theoretical mechanism of carbon catabolite repression is discussed.	[De Smet, Lina; De Koker, Dieter; de Graaf, Dirk C.] Univ Ghent, Dept Physiol, Lab Zoophysiol, B-9000 Ghent, Belgium; [Hawley, Alyse K.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [De Vos, Paul] Univ Ghent, Microbiol Lab, Dept Biochem & Microbiol, B-9000 Ghent, Belgium	Ghent University; University of British Columbia; University of British Columbia; Ghent University	de Graaf, DC (corresponding author), Univ Ghent, Dept Physiol, Lab Zoophysiol, B-9000 Ghent, Belgium.	Dirk.deGraaf@UGent.be	de Graaf, Dirk C./HGD-4017-2022		Research Foundation of Flanders [FWO-Vlaanderen G. 0163.11]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)	Research Foundation of Flanders(FWO); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	The authors gratefully acknowledge the Research Foundation of Flanders (FWO-Vlaanderen G. 0163.11). DDK was funded by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Barajas E, 2011, BIOMETALS, V24, P687, DOI 10.1007/s10534-011-9421-x; Antunez K, 2011, MICROBIOL-SGM, V157, P1474, DOI 10.1099/mic.0.044321-0; Antunez K, 2009, J INVERTEBR PATHOL, V102, P129, DOI 10.1016/j.jip.2009.07.010; Antunez M, 2010, VET MICROBIOL, V141, P385, DOI 10.1016/j.vetmic.2009.09.006; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; Bastos EMAF, 2008, J INVERTEBR PATHOL, V97, P273, DOI 10.1016/j.jip.2007.10.007; Beck BJ, 1998, J BACTERIOL, V180, P885, DOI 10.1128/JB.180.4.885-891.1998; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BHUMIRATANA A, 1974, J BACTERIOL, V119, P484, DOI 10.1128/JB.119.2.484-493.1974; Blatt J, 2001, J EXP BIOL, V204, P2709; Bock A, 1996, CELLULAR MOL BIOL; Bogdanov S, 2008, J AM COLL NUTR, V27, P677, DOI 10.1080/07315724.2008.10719745; Bokori-Brown M, 2011, FEBS J, V278, P4589, DOI 10.1111/j.1742-4658.2011.08140.x; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Brodsgaard CJ, 1998, APIDOLOGIE, V29, P569, DOI 10.1051/apido:19980609; Buczek K, 2011, MED WETER, V67, P87; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CALESNICK EJ, 1952, J BACTERIOL, V64, P9, DOI 10.1128/JB.64.1.9-15.1952; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chan QWT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-450; Chandel AK, 2008, ENZYME MICROB TECH, V42, P199, DOI 10.1016/j.enzmictec.2007.11.013; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crailsheim K, 1997, AMINO ACIDS, V13, P141, DOI 10.1007/BF01373212; Crailsheim K, 2001, APIDOLOGIE, V32, P91, DOI 10.1051/apido:2001114; de Graaf DC, 2001, APIDOLOGIE, V32, P587, DOI 10.1051/apido:2001146; de Graaf DC, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.11; De Guzman ZM, 2011, APPL RADIAT ISOTOPES, V69, P1374, DOI 10.1016/j.apradiso.2011.05.032; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; FELDLAUFER MF, 1993, APIDOLOGIE, V24, P95, DOI 10.1051/apido:19930202; Finke MD, 2005, ECOL FOOD NUTR, V44, P257, DOI 10.1080/03670240500187278; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Funfhaus A, 2012, ENV MICROBIOL REP, V4, P194, DOI 10.1111/j.1758-2229.2011.00320.x; Fuselli SR, 2008, J ESSENT OIL RES, V20, P464, DOI 10.1080/10412905.2008.9700060; Genersch E, 2006, INT J SYST EVOL MICR, V56, P501, DOI 10.1099/ijs.0.63928-0; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh D, 2009, APPL ENVIRON MICROB, V75, P7142, DOI 10.1128/AEM.00950-09; GILLIAM M, 1972, EXPERIENTIA, V28, P142, DOI 10.1007/BF01935717; Giraud MF, 2000, CURR OPIN STRUC BIOL, V10, P687, DOI 10.1016/S0959-440X(00)00145-7; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hasemann L., 1961, AM BEE J, V101, P298; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Inaoka T, 2011, BIOSCI BIOTECH BIOCH, V75, P618, DOI 10.1271/bbb.100854; Jandu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004889; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kemperman R, 2003, APPL ENVIRON MICROB, V69, P1589, DOI 10.1128/AEM.69.3.1589-1597.2003; Krieger CJ, 2004, NUCLEIC ACIDS RES, V32, pD438, DOI 10.1093/nar/gkh100; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Maqueda M, 2004, CURR PROTEIN PEPT SC, V5, P399, DOI 10.2174/1389203043379567; Mattinen L, 2008, MICROBIOL-SGM, V154, P2387, DOI 10.1099/mic.0.2008/017582-0; Mikulskis A, 1997, J BACTERIOL, V179, P7129, DOI 10.1128/jb.179.22.7129-7134.1997; Miyagi T, 2000, J INVERTEBR PATHOL, V75, P95, DOI 10.1006/jipa.1999.4888; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nakano MM, 1998, ANNU REV MICROBIOL, V52, P165, DOI 10.1146/annurev.micro.52.1.165; Narumi S., 2004, Honeybee Science, V25, P119; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Pernal SF, 2008, J ECON ENTOMOL, V101, P1095, DOI 10.1603/0022-0493(2008)101[1095:EOTSTF]2.0.CO;2; Poppinga L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002716; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; Ramadan MF, 2012, J FUNCT FOODS, V4, P39, DOI 10.1016/j.jff.2011.12.007; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rawlings ND, 2002, NUCLEIC ACIDS RES, V30, P343, DOI 10.1093/nar/30.1.343; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Reynaldi FJ, 2010, REV ARGENT MICROBIOL, V42, P279, DOI 10.1590/S0325-75412010000400008; Sakurai J, 2009, TOXINS, V1, P208, DOI 10.3390/toxins1020208; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Sturtevant AP, 1932, J AGRIC RES, V45, P0257; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tojo S, 2011, J BACTERIOL, V193, P2388, DOI 10.1128/JB.00016-11; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Winston M.L., 1991, BIOL HONEY BEE; Wirawan RE, 2007, MICROBIOL-SGM, V153, P1619, DOI 10.1099/mic.0.2006/005967-0; WYATT GR, 1961, ANNU REV ENTOMOL, V6, P75, DOI 10.1146/annurev.en.06.010161.000451; Yi SM, 2010, J BIOL CHEM, V285, P18241, DOI 10.1074/jbc.M110.116186; Yue D, 2008, ENVIRON MICROBIOL, V10, P1612, DOI 10.1111/j.1462-2920.2008.01579.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	88	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89175	10.1371/journal.pone.0089175	http://dx.doi.org/10.1371/journal.pone.0089175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586572	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700069
J	Puller, C; Haverkamp, S; Neitz, M; Neitz, J				Puller, Christian; Haverkamp, Silke; Neitz, Maureen; Neitz, Jay			Synaptic Elements for GABAergic Feed-Forward Signaling between HII Horizontal Cells and Blue Cone Bipolar Cells Are Enriched beneath Primate S-Cones	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; MACAQUE MONKEY RETINA; OUTER PLEXIFORM LAYER; WAVELENGTH-SENSITIVE CONES; GABA-LIKE IMMUNOREACTIVITY; RECEPTIVE-FIELD STRUCTURE; GANGLION-CELLS; MOUSE RETINA; MAMMALIAN RETINA; GUINEA-PIG	The functional roles and synaptic features of horizontal cells in the mammalian retina are still controversial. Evidence exists for feedback signaling from horizontal cells to cones and feed-forward signaling from horizontal cells to bipolar cells, but the details of the latter remain elusive. Here, immunohistochemistry and confocal microscopy were used to analyze the expression patterns of the SNARE protein syntaxin-4, the GABA receptor subunits alpha 1 and rho, and the cation-chloride cotransporters NKCC and KCC2 in the outer plexiform layer of primate retina. In macaque retina, as observed previously in other species, syntaxin-4 was expressed on dendrites and axon terminals of horizontal cells at cone pedicles and rod spherules. At cones, syntaxin-4 appeared densely clustered in two bands, at horizontal cell dendritic tips and at the level of desmosome-like junctions. Interestingly, in the lower band where horizontal cells may synapse directly onto bipolar cells, syntaxin-4 was highly enriched beneath short-wavelength sensitive (S) cones and colocalized with calbindin, a marker for HII horizontal cells. The enrichment at S-cones was not observed in either mouse or ground squirrel. Furthermore, high amounts of both GABA receptor and cation-chloride cotransporter subunits were found beneath primate S-cones. Finally, while syntaxin-4 was expressed by both HI and HII horizontal cell types, the intense clustering and colocalization with calbindin at S-cones indicated an enhanced expression in HII cells. Taken together, GABA receptors beneath cone pedicles, chloride transporters, and syntaxin-4 are putative constituents of a synaptic set of proteins which would be required for a GABA-mediated feed-forward pathway via horizontal cells carrying signals directly from cones to bipolar cells.	[Puller, Christian; Neitz, Maureen; Neitz, Jay] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Haverkamp, Silke] Max Planck Inst Brain Res, Frankfurt, Germany	University of Washington; University of Washington Seattle; Max Planck Society	Puller, C (corresponding author), Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.	cpuller@uw.edu; jneitz@uw.edu		Neitz, Maureen/0000-0002-5404-3343; Puller, Christian/0000-0003-1730-8733; Neitz, Jay/0000-0003-3877-6712	NIH [R01EY009303, R01EY016861, P30 EY001730, P51 OD010425]; Research to Prevent Blindness; DFG [HA-5277/2-2]; NATIONAL EYE INSTITUTE [R01EY009303, P30EY001730] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); DFG(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH (http://www.nih.gov/) grants R01EY009303, R01EY016861, P30 EY001730, P51 OD010425, Research to Prevent Blindness (https://www.rpbusa.org/rpb/), and DFG (http://www.dfg.de/en/) grant HA-5277/2-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARDH E, 1987, HISTOCHEMISTRY, V86, P485, DOI 10.1007/BF00500621; AHNELT P, 1994, J COMP NEUROL, V343, P406, DOI 10.1002/cne.903430306; AHNELT P, 1994, J COMP NEUROL, V343, P387, DOI 10.1002/cne.903430305; BARLOW HB, 1957, J PHYSIOL-LONDON, V137, P338, DOI 10.1113/jphysiol.1957.sp005817; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; BENKE D, 1991, J BIOL CHEM, V266, P4478; Berglund K, 2006, BRAIN CELL BIOL, V35, P207, DOI 10.1007/s11068-008-9019-6; Breuninger T, 2011, J NEUROSCI, V31, P6504, DOI 10.1523/JNEUROSCI.0616-11.2011; Calkins DJ, 1998, J NEUROSCI, V18, P3373; Carolina V, 2005, VISION RES, V45, P2659, DOI 10.1016/j.visres.2005.03.020; Chaffiol AJ, 2012, INVEST OPHTH VIS SCI, V53, P4306; Chan TL, 1998, J COMP NEUROL, V393, P196; Chiang PH, 2012, J NEUROSCI, V32, P62, DOI 10.1523/JNEUROSCI.3393-11.2012; Chiquet C, 2005, BRAIN RES BULL, V68, P185, DOI 10.1016/j.brainresbull.2005.08.010; Crook JD, 2009, J NEUROSCI, V29, P8372, DOI 10.1523/JNEUROSCI.1218-09.2009; Cueva JG, 2002, J COMP NEUROL, V445, P227, DOI 10.1002/cne.10166; Dacey D, 2000, VISION RES, V40, P1801, DOI 10.1016/S0042-6989(00)00039-0; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; Dacey DM, 1996, SCIENCE, V271, P656, DOI 10.1126/science.271.5249.656; DACEY DM, 1993, VISUAL NEUROSCI, V10, P1081, DOI 10.1017/S0952523800010191; DACHEUX RF, 1981, J COMP NEUROL, V198, P307, DOI 10.1002/cne.901980209; Davenport CM, 2008, J NEUROSCI, V28, P456, DOI 10.1523/JNEUROSCI.2735-07.2008; Delgado LM, 2009, J COMP NEUROL, V514, P459, DOI 10.1002/cne.22023; DEMONASTERIO FM, 1981, SCIENCE, V213, P1278, DOI 10.1126/science.7268439; Deniz S, 2011, J NEUROCHEM, V116, P350, DOI 10.1111/j.1471-4159.2010.07114.x; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; DOWLING JE, 1966, SCIENCE, V153, P1639, DOI 10.1126/science.153.3744.1639; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Dumitrescu ON, 2009, J COMP NEUROL, V517, P226, DOI 10.1002/cne.22158; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P551, DOI 10.1113/jphysiol.1975.sp010947; Enz R, 1996, J NEUROSCI, V16, P4479; Fahey PK, 2003, VISUAL NEUROSCI, V20, P1, DOI 10.1017/S0952523803201012; Field GD, 2007, J NEUROSCI, V27, P13261, DOI 10.1523/JNEUROSCI.3437-07.2007; FISHER SK, 1974, PROC R SOC SER B-BIO, V186, P317, DOI 10.1098/rspb.1974.0052; Ghosh KK, 1999, J COMP NEUROL, V413, P417, DOI 10.1002/(SICI)1096-9861(19991025)413:3<417::AID-CNE5>3.0.CO;2-H; Goodchild AK, 1996, VISUAL NEUROSCI, V13, P833, DOI 10.1017/S0952523800009093; GRUNERT U, 1990, J COMP NEUROL, V297, P509, DOI 10.1002/cne.902970405; Guo CY, 2010, J COMP NEUROL, V518, P1647, DOI 10.1002/cne.22294; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Haverkamp S, 2001, J COMP NEUROL, V436, P471, DOI 10.1002/cne.1081; Haverkamp S, 2001, J NEUROSCI, V21, P2488, DOI 10.1523/JNEUROSCI.21-07-02488.2001; Haverkamp S, 2000, NEURON, V27, P85, DOI 10.1016/S0896-6273(00)00011-8; Herr S, 2003, J COMP NEUROL, V457, P185, DOI 10.1002/cne.10553; Herrmann R, 2011, NEURON, V72, P101, DOI 10.1016/j.neuron.2011.07.030; Hirano AA, 2007, VISUAL NEUROSCI, V24, P489, DOI 10.1017/S0952523807070198; Hirano AA, 2011, J COMP NEUROL, V519, P972, DOI 10.1002/cne.22562; Hirasawa H, 2012, J PHYSIOL SCI, V62, P359, DOI 10.1007/s12576-012-0220-0; Jellali A, 2002, J COMP NEUROL, V449, P76, DOI 10.1002/cne.10272; Kalloniatis M, 1996, J NEUROSCI, V16, P6807; KANEKO A, 1973, J PHYSIOL-LONDON, V235, P133, DOI 10.1113/jphysiol.1973.sp010381; KANEKO A, 1986, J PHYSIOL-LONDON, V373, P443, DOI 10.1113/jphysiol.1986.sp016057; Kao YH, 2004, J COMP NEUROL, V478, P207, DOI 10.1002/cne.20221; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Klaassen LJ, 2012, BRAIN RES, V1487, P25, DOI 10.1016/j.brainres.2012.04.059; KOLB H, 1977, J NEUROCYTOL, V6, P131, DOI 10.1007/BF01261502; KOLB H, 1980, J COMP NEUROL, V189, P31; KOUYAMA N, 1992, J NEUROSCI, V12, P1233; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lee H, 2010, EUR J NEUROSCI, V31, P1388, DOI 10.1111/j.1460-9568.2010.07181.x; Li BQ, 2008, VISUAL NEUROSCI, V25, P109, DOI 10.1017/S0952523808080164; Li W, 2004, NAT NEUROSCI, V7, P751, DOI 10.1038/nn1275; Linberg KA, 1996, J COMP NEUROL, V365, P173, DOI 10.1002/(SICI)1096-9861(19960205)365:2<173::AID-CNE1>3.0.CO;2-2; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; MacNeil MA, 2008, J COMP NEUROL, V506, P6, DOI 10.1002/cne.21491; Martin PR, 1999, J COMP NEUROL, V406, P1, DOI 10.1002/(SICI)1096-9861(19990329)406:1<1::AID-CNE1>3.0.CO;2-1; McMahon MJ, 2004, J NEUROSCI, V24, P3736, DOI 10.1523/JNEUROSCI.5252-03.2004; MILLER RF, 1983, VISION RES, V23, P399, DOI 10.1016/0042-6989(83)90087-1; Missotten L, 1965, ULTRASTRUCTURE HUMAN; Packer OS, 2010, J NEUROSCI, V30, P568, DOI 10.1523/JNEUROSCI.4738-09.2010; PEICHL L, 1994, VISUAL NEUROSCI, V11, P501, DOI 10.1017/S095252380000242X; Peichl L, 2010, ENCY EYE, V3; Percival KA, 2009, J COMP NEUROL, V517, P655, DOI 10.1002/cne.22183; Picaud S, 1998, J PHYSIOL-LONDON, V513, P33, DOI 10.1111/j.1469-7793.1998.033by.x; Pow DV, 1996, NEUROSCIENCE, V73, P1129, DOI 10.1016/0306-4522(96)00097-8; Puller C, 2007, J COMP NEUROL, V502, P442, DOI 10.1002/cne.21315; Puller C, 2011, J COMP NEUROL, V519, P467, DOI 10.1002/cne.22528; Puller C, 2011, J COMP NEUROL, V519, P759, DOI 10.1002/cne.22546; Puller C, 2011, VISUAL NEUROSCI, V28, P51, DOI 10.1017/S0952523810000271; Puller C, 2009, J NEUROSCI, V29, P6266, DOI 10.1523/JNEUROSCI.5867-08.2009; ROHRENBECK J, 1989, EUR J NEUROSCI, V1, P407, DOI 10.1111/j.1460-9568.1989.tb00349.x; Sandmann D, 1996, J NEUROSCI, V16, P3381; SCHOCH P, 1985, NATURE, V314, P168, DOI 10.1038/314168a0; SCHWARTZ EA, 1987, SCIENCE, V238, P350, DOI 10.1126/science.2443977; Sherry DM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-54; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; THORESON WB, 1990, VISUAL NEUROSCI, V5, P571, DOI 10.1017/S0952523800000730; VARDI N, 1994, VISION RES, V34, P1235, DOI 10.1016/0042-6989(94)90198-8; Vardi N, 2000, J NEUROSCI, V20, P7657; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; Verweij J, 2003, J NEUROSCI, V23, P10249; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; WASSLE H, 1989, EUR J NEUROSCI, V1, P421, DOI 10.1111/j.1460-9568.1989.tb00350.x; WASSLE H, 1989, J COMP NEUROL, V279, P43, DOI 10.1002/cne.902790105; Wassle H, 2000, VISUAL NEUROSCI, V17, P591, DOI 10.1017/S0952523800174097; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; Zhang LL, 2007, J NEUROPHYSIOL, V98, P266, DOI 10.1152/jn.00288.2007; Zhang LL, 2006, J COMP NEUROL, V499, P132, DOI 10.1002/cne.21100	99	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88963	10.1371/journal.pone.0088963	http://dx.doi.org/10.1371/journal.pone.0088963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586460	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700045
J	Cheng, J; Wang, YL; Zhou, KN; Wang, LY; Li, JF; Zhuang, QD; Xu, XT; Xu, LT; Zhang, K; Dai, DJ; Zheng, RJ; Li, GX; Zhang, AP; Gao, SG; Duan, SW				Cheng, Jia; Wang, Yunliang; Zhou, Kena; Wang, Lingyan; Li, Jinfeng; Zhuang, Qidong; Xu, Xuting; Xu, Leiting; Zhang, Kai; Dai, Dongjun; Zheng, Rongjiong; Li, Guangxue; Zhang, Aiping; Gao, Shugui; Duan, Shiwei			Male-Specific Association between Dopamine Receptor D4 Gene Methylation and Schizophrenia	PLOS ONE			English	Article							DNA-METHYLATION; PSYCHIATRIC-DISORDERS; DRD4 GENE; POLYMORPHISMS; DISEASE; POPULATION; EXPRESSION; CLOZAPINE; ESTROGEN; GENDER	Objective: The goal of our study was to investigate whether DRD4 gene DNA methylation played an important role in the susceptibility of Han Chinese SCZ. Methods: Using the bisulphite pyrosequencing technology, DNA methylation levels of 6 CpG dinucleotides in DRD4 CpG island were measured among 30 paranoid SCZ patients, 30 undifferentiated SCZ patients, and 30 age-and gender-matched healthy controls. Results: Strong correlation was observed among the six CpG sites (r > 0.5, P < 0.01), thus average methylation levels were applied thereafter. Our results indicated that there was a significant association between DRD4 methylation and the risk of SCZ (P = 0.003), although there was no significant difference in DRD4 methylation between the two SCZ subtypes (P = 0.670). A breakdown analysis by gender showed that the significant association of DRD4 methylation and SCZ was driven by males (P < 0.001) but not by females (P = 0.835). DRD4 methylation was significantly associated with p300 in male SCZ patients (r = 20.543, P = 0.005) but not in female SCZ patients (r = 0.110, P = 0.599). Moreover, receiver operating characteristic (ROC) curves showed DRD4 methylation was able to predict the status of SCZ in males [area under curve (AUC) = 0.832, P = 0.002] but not in females (AUC = 0.483, P = 0.876). Finally, a further expression experiment showed that DRD4 methylation in the gene body was positively associated with gene expression, although the exact mechanism of gene regulation remained unknown for this interesting DRD4 methylation. Conclusion: The gender disparity in the DRD4 DNA methylation provides novel insights into the pathogenesis of SCZ.	[Cheng, Jia; Zhou, Kena; Zhuang, Qidong; Xu, Xuting; Xu, Leiting; Zhang, Kai; Dai, Dongjun; Zheng, Rongjiong; Li, Guangxue; Duan, Shiwei] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China; [Cheng, Jia; Li, Guangxue; Gao, Shugui] Ningbo Kangning Hosp, Dept Psychiat, Ningbo, Zhejiang, Peoples R China; [Wang, Yunliang; Li, Jinfeng] 148th Hosp PLA, Dept Neurol, Zibo, Shandong, Peoples R China; [Wang, Lingyan] Ningbo 2 Hosp, Bank Blood Prod, Ningbo, Zhejiang, Peoples R China; [Zhang, Aiping] Shanghai Jiao Tong Univ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Minist Educ, Shanghai 200030, Peoples R China	Ningbo University; Shanghai Jiao Tong University	Wang, YL (corresponding author), 148th Hosp PLA, Dept Neurol, Zibo, Shandong, Peoples R China.	wangyunliang81@163.com; gaoshugui@sina.com; duanshiwei@nbu.edu.cn	li, jinfeng/GVS-5425-2022; Duan, Shiwei/AAA-4782-2022; Cheng, Jia/AAD-8016-2019	Cheng, Jia/0000-0003-3116-4035; Duan, Shiwei/0000-0001-7682-2877	National Natural Science Foundation of China [31100919, 81371469]; Zhejiang Provincial Natural Science Foundation [LR13H020003]; Natural Science Foundation of Ningbo [2013A610249]; Ningbo Social Development Research Projects [2012C50032]; Research Fund in Ningbo University [XKL11D2117, XKL11D2118]; K.C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of Ningbo; Ningbo Social Development Research Projects; Research Fund in Ningbo University; K.C. Wong Magna Fund in Ningbo University	This work was supported by the National Natural Science Foundation of China (No. 31100919 and 81371469), the Zhejiang Provincial Natural Science Foundation (No. LR13H020003), Natural Science Foundation of Ningbo (No. 2013A610249), the Ningbo Social Development Research Projects (2012C50032), the Research Fund in Ningbo University (XKL11D2117 and XKL11D2118), and the K.C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2011, SCHIZOPHR RES, V129, P183, DOI 10.1016/j.schres.2011.04.007; Andersson RH, 2012, P NATL ACAD SCI USA, V109, P13118, DOI 10.1073/pnas.1201011109; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Bestelmeyer PEG, 2009, PSYCHIAT RES, V169, P212, DOI 10.1016/j.psychres.2008.06.035; Bondy B, 1996, J NEUROIMMUNOL, V71, P139, DOI 10.1016/S0165-5728(96)00148-8; Chen C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-199; Dmitrieva J, 2011, SOC COGN AFFECT NEUR, V6, P82, DOI 10.1093/scan/nsq020; Docherty SJ, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-31; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Ekstrom TJ, 2012, EPIGENOMICS-UK, V4, P359, DOI [10.2217/EPI.12.33, 10.2217/epi.12.33]; Fanous Ayman H, 2008, Curr Psychiatry Rep, V10, P164, DOI 10.1007/s11920-008-0028-z; Gao SG, 2012, CLIN BIOCHEM, V45, P787, DOI 10.1016/j.clinbiochem.2012.04.016; Gavin DP, 2010, NEUROSCI BIOBEHAV R, V34, P882, DOI 10.1016/j.neubiorev.2009.10.010; Grigoriadis S, 2002, CAN J PSYCHIAT, V47, P437, DOI 10.1177/070674370204700504; Guay SP, 2012, EPIGENETICS-US, V7, P464, DOI 10.4161/epi.19633; Jiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059752; Lee KY, 2011, EXP MOL MED, V43, P44, DOI 10.3858/emm.2011.43.1.005; Lindamer LA, 1997, PSYCHOPHARMACOL BULL, V33, P221; Melas PA, 2012, FASEB J, V26, P2712, DOI 10.1096/fj.11-202069; Mellios N, 2012, SCHIZOPHRENIA BULL, V38, P433, DOI 10.1093/schbul/sbq091; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Mulle JG, 2012, CURR OPIN GENET DEV, V22, P238, DOI 10.1016/j.gde.2012.02.011; O'Donovan MC, 2003, HUM MOL GENET, V12, pR125, DOI 10.1093/hmg/ddg302; Okuyama Y, 1999, BIOCHEM BIOPH RES CO, V258, P292, DOI 10.1006/bbrc.1999.0630; Pal P, 2009, CROAT MED J, V50, P361, DOI 10.3325/cmj.2009.50.361; Picchioni MM, 2007, BMJ-BRIT MED J, V335, P91, DOI 10.1136/bmj.39227.616447.BE; Pinsonneault J, 2003, AAPS PHARMSCI, V5; Prata DP, 2009, BIOL PSYCHIAT, V65, P473, DOI 10.1016/j.biopsych.2008.09.027; Ptacek R, 2011, MED SCI MONITOR, V17, pRA215, DOI 10.12659/MSM.881925; Roth TL, 2009, BBA-GEN SUBJECTS, V1790, P869, DOI 10.1016/j.bbagen.2009.06.009; S Docherty JM, 2008, PSYCHIATRY, V7, P500; Schmidt-Kastner R, 2012, MOL PSYCHIATR, V17, P1194, DOI 10.1038/mp.2011.183; Stahl SM, 2010, CNS SPECTRUMS, V15, P358, DOI 10.1017/S1092852900029229; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; Zai CC, 2009, PHARMACOGENOMICS J, V9, P168, DOI 10.1038/tpj.2009.2; Zhang LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063455	37	41	41	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89128	10.1371/journal.pone.0089128	http://dx.doi.org/10.1371/journal.pone.0089128			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586542	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900093
J	Sakamoto, M; Utsumi, A				Sakamoto, Maki; Utsumi, Akira			Adjective Metaphors Evoke Negative Meanings	PLOS ONE			English	Article							REPRESENTATION; COMPREHENSION; APPRECIATION; SIMILARITY	Previous metaphor studies have paid much attention to nominal metaphors and predicative metaphors, but little attention has been given to adjective metaphors. Although some studies have focused on adjective metaphors, they only examined differences in the acceptability of various types of adjective metaphors. This paper explores the cognitive effects evoked by adjective metaphors. Three psychological experiments revealed that (1) adjective metaphors, especially those modified by color adjectives, tend to evoke negative effect; (2) although the meanings of metaphors are basically affected by the meanings of their vehicles, when a vehicle has a neutral meaning, negative meanings are evoked most frequently for adjective metaphors compared to nominal and predicative metaphors; (3) negative meanings evoked by adjective metaphors are related to poeticness, and poetic metaphors evoke negative meanings more easily than less poetic metaphors. Our research sheds new light on studies of the use of metaphor, which is one of the most basic human cognitive abilities.	[Sakamoto, Maki; Utsumi, Akira] Univ Electrocommun, Dept Informat & Engn, Tokyo, Japan	University of Electro-Communications - Japan	Sakamoto, M (corresponding author), Univ Electrocommun, Dept Informat & Engn, Tokyo, Japan.	sakamoto@inf.uec.ac.jp		Utsumi, Akira/0000-0002-7328-4417	Japan Society for the Promotion of Science [23300098, 20520350]; Grants-in-Aid for Scientific Research [23300098] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grant-in-Aid for Scientific Research (No. 23300098) and (No. 20520350) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2005, NTT DATABASE SERIES, V1; Becker A. H., 1997, METAPHOR SYMBOL, V12, P243; Black M., 1979, DIALECTICA, P19; Black M., 1962, MODELS METAPHOR; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Bowdle BF, 2005, PSYCHOL REV, V112, P193, DOI 10.1037/0033-295X.112.1.193; Day S., 1996, PSYCHE, V2; Gibbs Jr WR, 1996, COGNITION, V61, P309; Gibbs R., 2006, EMBODIMENT COGNITIVE; Gibbs Raymond W., 1999, METAPHOR COGNITIVE L; GLUCKSBERG S, 1990, PSYCHOL REV, V97, P3, DOI 10.1037/0033-295X.97.1.3; Glucksberg S., 2001, UNDERSTANDING FIGURA, DOI [10.1093/acprof:oso/9780195111095.001.0001, DOI 10.1093/ACPROF:OSO/9780195111095.001.0001]; Grady J, 2005, J PRAGMATICS, V37, P1595, DOI [10.1016/j.pragma.20004.03.012, 10.1016/j.pragma.2004.03.012]; Grady JE, 1997, COGN LINGUIST, V8, P267, DOI 10.1515/cogl.1997.8.4.267; Grady JE, 1999, AMST STUD THEORY HIS, V175, P79; Indurkhya B, 1991, METAPHOR COGNITION I; Jones LL, 2006, J MEM LANG, V55, P18, DOI 10.1016/j.jml.2006.02.004; Kovecses Z., 2002, METAPHOR PRACTICAL I; Kovecses Zoltan, 2006, LANGUAGE MIND CULTUR; KUSUMI T, 1987, J PSYCHOLINGUIST RES, V16, P577, DOI 10.1007/BF01067086; Lakoff George, 2003, METAPHOR WE LIVE BY; Lakoff George, 1987, CULTURAL MODELS LANG, P195; MARTIN JH, 1992, COGNITIVE SCI, V16, P233, DOI 10.1207/s15516709cog1602_4; Murphy GL, 1996, COGNITION, V60, P173, DOI 10.1016/0010-0277(96)00711-1; Murphy GL, 1997, COGNITION, V62, P99, DOI 10.1016/S0010-0277(96)00725-1; National Institute for Japanese Language, 1964, BUNR WORLD LIST SEM; Osgood Charles E., 1980, COGNITION FIGURATIVE, P203; Sakamoto M, 2005, P 9 INT COGN LING C, P409; Sakamoto M, 2008, P 6 INT C COGN SCI I, P390; Sakamoto M, 2003, GERMAN LIT, V115, P95; Taylor John R., 2003, LINGUISTIC CATEGORIZ; TOURANGEAU R, 1982, COGNITION, V11, P203, DOI 10.1016/0010-0277(82)90016-6; Trakl G, 1964, GEDICHTE; Ullmann S., 1959, PRINCIPLES SEMANTICS; Utsumi A, 2005, METAPHOR SYMBOL, V20, P151, DOI 10.1207/s15327868ms2003_1; Utsumi A., 2007, P 2 EUR COGN SCI C E, P77; Utsumi A., 2007, P 29 ANN C COGN SCI, P1587; Utsumi A, 2012, P 34 ANN M COGN SCI, P2475; Utsumi A, 2007, METAPHOR SYMBOL, V22, P291, DOI 10.1080/10926480701528071; Utsumi A, 2011, METAPHOR SYMBOL, V26, P299, DOI 10.1080/10926488.2011.609120; Werning M., 2006, P 28 ANN C COGN SCI, P236; Wescott R, 1983, 1 DEL S LANG STUD, P87; Wierzbicka Anna., 1996, SEMANTICS PRIMES UNI; WILLIAMS JM, 1976, LANGUAGE, V52, P461, DOI 10.2307/412571; Yamaguchi T, 2003, NIHONGO DAI THESAURU; Yu N, 2003, J LITERARY SEMANTICS, V32, P19, DOI 10.1515/jlse.2003.001	46	13	13	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89008	10.1371/journal.pone.0089008	http://dx.doi.org/10.1371/journal.pone.0089008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586480	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900069
J	Shih, CC; Hsu, YT; Wang, HH; Chen, TL; Tsai, CC; Lane, HL; Yeh, CC; Sung, FC; Chiu, WT; Cherng, YG; Liao, CC				Shih, Chun-Chuan; Hsu, Yi-Ting; Wang, Hwang-Huei; Chen, Ta-Liang; Tsai, Chin-Chuan; Lane, Hsin-Long; Yeh, Chun-Chieh; Sung, Fung-Chang; Chiu, Wen-Ta; Cherng, Yih-Giun; Liao, Chien-Chang			Decreased Risk of Stroke in Patients with Traumatic Brain Injury Receiving Acupuncture Treatment: A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; ADVERSE OUTCOMES; WEIGHT-LOSS; TAIWAN; COUNTRIES; EPILEPSY; STRATEGY; CHILDREN; RECOVERY	Background: Patients with traumatic brain injury (TBI) face increased risk of stroke. Whether acupuncture can help to protect TBI patients from stroke has not previously been studied. Methods: Taiwan's National Health Insurance Research Database was used to conduct a retrospective cohort study of 7409 TBI patients receiving acupuncture treatment and 29,636 propensity-score-matched TBI patients without acupuncture treatment in 2000-2008 as controls. Both TBI cohorts were followed until the end of 2010 and adjusted for immortal time to measure the incidence and adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) of new-onset stroke in the multivariable Cox proportional hazard models. Results: TBI patients with acupuncture treatment (4.9 per 1000 person-years) had a lower incidence of stroke compared with those without acupuncture treatment (7.5 per 1000 person-years), with a HR of 0.59 (95% CI = 0.50-0.69) after adjustment for sociodemographics, coexisting medical conditions and medications. The association between acupuncture treatment and stroke risk was investigated by sex and age group (20-44, 45-64, and >= 65 years). The probability curve with log-rank test showed that TBI patients receiving acupuncture treatment had a lower probability of stroke than those without acupuncture treatment during the follow-up period (p < 0.0001). Conclusion: Patients with TBI receiving acupuncture treatment show decreased risk of stroke compared with those without acupuncture treatment. However, this study was limited by lack of information regarding lifestyles, biochemical profiles, TBI severity, and acupuncture points used in treatments.	[Shih, Chun-Chuan; Tsai, Chin-Chuan; Lane, Hsin-Long] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Hsu, Yi-Ting] China Med Univ Hosp, Neurosci Lab, Dept Neurol, Taichung, Taiwan; [Wang, Hwang-Huei] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Cherng, Yih-Giun] Taipei Med Univ, Dept Anesthesiol, Shuang Ho Hosp, New Taipei City, Taiwan; [Liao, Chien-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan	I Shou University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; China Medical University Taiwan; China Medical University Taiwan; Taipei Medical University; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.	jacky48863027@yahoo.com.tw	Yeh, Chun Chieh/I-4893-2019; Yeh, Chun Chieh/Y-3304-2019	Yeh, Chun Chieh/0000-0001-6753-7564; Hsu, Yi-ting/0000-0002-8552-131X; Cherng, Yih-Giun/0000-0002-0201-4380	Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan [CCMP98-RD-038, CCMP99-RD-035]; National Science Council, Taiwan [102-2314-B-038-021-MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence	This study is supported in part by a Grant from the Committee on Chinese Medicine and Pharmacy, Department of Health, Taiwan (CCMP98-RD-038 and CCMP99-RD-035), the National Science Council, Taiwan (102-2314-B-038-021-MY3), and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Cabioglu MT, 2005, AM J CHINESE MED, V33, P525, DOI 10.1142/S0192415X05003132; Chang CC, 2013, BRIT J SURG, V100, P684, DOI 10.1002/bjs.9065; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Choi DC, 2010, NEUROBIOL DIS, V39, P272, DOI 10.1016/j.nbd.2010.04.003; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Feigin VL, 2007, LANCET NEUROL, V6, P94, DOI 10.1016/S1474-4422(07)70007-8; Flachskampf FA, 2007, CIRCULATION, V115, P3121, DOI 10.1161/CIRCULATIONAHA.106.661140; He Jing, 2005, J Tradit Chin Med, V25, P171; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hsieh CH, 2010, AM J CHINESE MED, V38, P675, DOI 10.1142/S0192415X10008147; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; Kim DD, 2006, MICROCIRCULATION, V13, P577, DOI 10.1080/10739680600885210; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Liao CC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/387164; Liao CC, 2012, J TRAUMA ACUTE CARE, V73, P1327, DOI 10.1097/TA.0b013e31826fc87f; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Liao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031527; Lin JA, 2013, ANN RHEUMATOL DIS; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Quah-Smith I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012619; Shih CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/262039; Shih CC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-191; Shih CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032540; Shih CC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-27; Shih CC, 2009, CHINESE MED J-PEKING, V122, P1544, DOI 10.3760/cma.j.issn.0366-6999.2009.13.013; Sze FKH, 2002, STROKE, V33, P2604, DOI 10.1161/01.STR.0000035908.74261.C9; Tseng YJ, 2013, J ALTERN COMPLEM MED, V19, P474, DOI 10.1089/acm.2012.0163; Wong V, 2013, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007700.PUB3; Wu P, 2010, STROKE, V41, pE171, DOI 10.1161/STROKEAHA.109.573576; Yeh CC, 2013, MAYO CLIN PROC, V88, P1091, DOI 10.1016/j.mayocp.2013.06.024; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zollman FS, 2012, J HEAD TRAUMA REHAB, V27, P135, DOI 10.1097/HTR.0b013e3182051397	40	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89208	10.1371/journal.pone.0089208	http://dx.doi.org/10.1371/journal.pone.0089208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586597	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900105
J	Smith, RM; Mba-Jonas, A; Tourdjman, M; Schimek, T; DeBess, E; Marsden-Haug, N; Harris, JR				Smith, Rachel M.; Mba-Jonas, Adamma; Tourdjman, Mathieu; Schimek, Trisha; DeBess, Emilio; Marsden-Haug, Nicola; Harris, Julie R.			Treatment and Outcomes among Patients with Cryptococcus gattii Infections in the United States Pacific Northwest	PLOS ONE			English	Article							NEOFORMANS VAR GATTII; AMPHOTERICIN-B; BRITISH-COLUMBIA; ANTIRETROVIRAL THERAPY; PRACTICE GUIDELINES; HIGH PREVALENCE; 2 VARIETIES; MENINGITIS; FLUCONAZOLE; MANAGEMENT	Background: Cryptococcus gattii is a fungal pathogen causing an emerging outbreak in the United States Pacific Northwest (PNW). Treatment guidelines for cryptococcosis are primarily based on data from C. neoformans infections; applicability to PNW C. gattii infection is unknown. We evaluated the relationship between initial antifungal treatment and outcomes for PNW C. gattii patients. Methods: Cases were defined as culture-confirmed invasive C. gattii infections among residents of Oregon and Washington States during 2004-2011. Clinical data were abstracted from medical records through one year of follow-up. Recommended initial treatment for central nervous system (CNS), bloodstream, and severe pulmonary infections is amphotericin B and 5flucytosine; for non-severe pulmonary infections, recommended initial treatment is fluconazole. Alternative initial treatment was defined as any other initial antifungal treatment. Results: Seventy patients survived to diagnosis; 50 (71%) received the recommended initial treatment and 20 (29%) received an alternative. Fewer patients with pulmonary infections [21 (64%)] than CNS infections [25 (83%)] received the recommended initial treatment (p = 0.07). Among patients with pulmonary infections, those with severe infections received the recommended initial treatment less often than those with non-severe infections (11% vs. 83%, p<0.0001). Eight patients with severe pulmonary infections received alternative initial treatments; three died. Four patients with non-severe pulmonary infections received alternative initial treatments; two died. There was a trend towards increased three-month mortality among patients receiving alternative vs. recommended initial treatment (30% vs. 14%, p = 0.12), driven primarily by increased mortality among patients with pulmonary disease receiving alternative vs. recommended initial treatment (42% vs. 10%, p = 0.07). Conclusions: C. gattii patients with pulmonary infections - especially severe infections - may be less likely to receive recommended treatment than those with CNS infections; alternative treatment may be associated with increased mortality. Reasons for receipt of alternative treatment among C. gattii patients in this area should be investigated, and clinician awareness of recommended treatment reinforced.	[Smith, Rachel M.; Mba-Jonas, Adamma; Schimek, Trisha; Harris, Julie R.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA; [Tourdjman, Mathieu] Ctr Dis Control & Prevent, Sci Educ & Profess Dev Off, Atlanta, GA USA; [Tourdjman, Mathieu; DeBess, Emilio] Oregon Publ Hlth Div, Portland, OR USA; [Marsden-Haug, Nicola] Washington State Dept Hlth, Shoreline, WA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Smith, RM (corresponding author), Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA.	Vih9@cdc.gov			Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselman V, 2010, AIDS, V24, P2871, DOI 10.1097/QAD.0b013e328340fe76; BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; BUTLER WT, 1964, NEW ENGL J MED, V270, P59, DOI 10.1056/NEJM196401092700201; Byrnes EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005851; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Castanon-Olivares L R, 2000, Rev Latinoam Microbiol, V42, P35; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chen SCA, 2013, CLIN INFECT DIS, V57, P543, DOI 10.1093/cid/cit341; Coenjaerts FEJ, 2004, J INFECT DIS, V190, P1310, DOI 10.1086/423849; Sidrim JJC, 2010, CAN J MICROBIOL, V56, P445, DOI [10.1139/W10-030, 10.1139/w10-030]; DeBess E, 2011, CLIN INFECT DIS; ELLIS DH, 1987, J CLIN MICROBIOL, V25, P430, DOI 10.1128/JCM.25.2.430-431.1987; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fujimoto Hiroyuki, 2012, Kyobu Geka, V65, P493; Fyfe M, 2008, Can Commun Dis Rep, V34, P1; Galanis E, 2010, EMERG INFECT DIS, V16, P251, DOI [10.3201/eid1602.090900, 10.3201/eid1601.090900]; Garvey L, 2011, EUR J NEUROL, V18, P527, DOI 10.1111/j.1468-1331.2010.03291.x; Harris J, 2011, MED MYCOL; Harris JR, 2012, CLIN INFECT DIS, V54, pe43, DOI 10.1093/cid/cir903; Harris JR, 2013, EMERG INFECT DIS, V19, P1620, DOI 10.3201/eid1910.130441; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Kidd SE, 2005, EUKARYOT CELL, V4, P1629, DOI 10.1128/EC.4.10.1629-1638.2005; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kim YS, 2012, TUBERC RESPIR DIS, V73, P182, DOI 10.4046/trd.2012.73.3.182; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; KWONCHUNG KJ, 1984, ZBL BAKT-INT J MED M, V257, P213, DOI 10.1016/S0174-3031(84)80074-8; LALLOO D, 1994, Q J MED, V87, P343; LARSEN RA, 1990, ANN INTERN MED, V113, P183, DOI 10.7326/0003-4819-113-3-183; Leenders ACAP, 1997, AIDS, V11, P1463, DOI 10.1097/00002030-199712000-00010; LopezMartinez R, 1996, MYCOPATHOLOGIA, V134, P61, DOI 10.1007/BF00436865; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; McCulloh RJ, 2011, PEDIATR INFECT DIS J, V30, P1111, DOI 10.1097/INF.0b013e31822d14fd; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Nakamura S, 2005, SCAND J INFECT DIS, V37, P932, DOI 10.1080/00365540410025195; Netea MG, 2004, CLIN INFECT DIS, V39, pE83, DOI 10.1086/425121; Perfect JR, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P17; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; POWDERLY WG, 1992, NEW ENGL J MED, V326, P793, DOI 10.1056/NEJM199203193261203; SAAG MS, 1992, NEW ENGL J MED, V326, P83, DOI 10.1056/NEJM199201093260202; Saag MS, 2000, CLIN INFECT DIS, V30, P710, DOI 10.1086/313757; Seaton RA, 1996, QJM-MON J ASSOC PHYS, V89, P423; Seaton RA, 1997, T ROY SOC TROP MED H, V91, P44, DOI 10.1016/S0035-9203(97)90391-6; SPEED B, 1995, CLIN INFECT DIS, V21, P28, DOI 10.1093/clinids/21.1.28; Taniguchi Daisuke, 2012, Kyobu Geka, V65, P804; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Wadhwa A, 2008, NEUROLOGIST, V14, P247, DOI 10.1097/NRL.0b013e3181678a7a; Walraven CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028625	51	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88875	10.1371/journal.pone.0088875	http://dx.doi.org/10.1371/journal.pone.0088875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586423	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900055
J	Janecka, JE; Tewes, ME; Laack, L; Caso, A; Grassman, LI; Honeycutt, RL				Janecka, Jan E.; Tewes, Michael E.; Laack, Linda; Caso, Arturo; Grassman, Lon I.; Honeycutt, Rodney L.			Loss of Genetic Diversity among Ocelots in the United States during the 20th Century Linked to Human Induced Population Reductions	PLOS ONE			English	Article							LEOPARDUS-PARDALIS-ALBESCENS; DNA CONTROL REGION; INBREEDING DEPRESSION; CONSERVATION BIOLOGY; EXTINCTION RISK; LIFE-HISTORY; FITNESS; WILD; CONSEQUENCES; RESTORATION	Ocelots (Leopardus pardalis) in the United States currently exhibit low levels of genetic diversity. One hypothesis for this observation is that habitat fragmentation, resulting from human induced changes in the landscape during the 20th century, created island populations with highly reduced gene flow and increased genetic drift and inbreeding. In an effort to investigate this, we used a portion of the mitochondrial control region and 11 autosomal microsatellite loci to examine historical levels of genetic diversity and infer temporal changes in ocelot populations between 1853 and 2005. Levels of genetic diversity were higher in historical ocelot populations than in extant populations from Texas. The earliest documented loss of mitochondrial haplotype diversity occurred at Laguna Atascosa National Wildlife Refuge. The second extant population inhabiting private lands in Willacy County retained higher levels of genetic diversity through the 1990s, but subsequently lost diversity over the next decade. A similar pattern was observed for autosomal microsatellite loci. This supports the argument that low levels of genetic diversity in Texas are related to human induced population reductions and fragmentation, both of which threaten the remaining ocelots in the United States. At this time, the best means of mitigating the continued erosion of genetic variation are translocation of individuals either from larger populations in Mexico to Texas, or between the Texas populations.	[Janecka, Jan E.; Tewes, Michael E.; Caso, Arturo; Grassman, Lon I.] Texas A&M Univ, Caesar Kleberg Wildlife Res Inst, Kingsville, TX USA; [Laack, Linda] Laguna Atascosa Natl Wildlife Refuge, Rio Hondo, TX USA; [Honeycutt, Rodney L.] Pepperdine Univ, Div Nat Sci, Malibu, CA 90265 USA	Texas A&M University System; Texas A&M University Kingsville; Pepperdine University	Janecka, JE (corresponding author), Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA.	janeckaj@duq.edu			Rob and Bessie Welder Wildlife Foundation; Texas Parks and Wildlife Department; United States Fish and Wildlife Service; Tim and Karen Hixon Foundation; Mr. Frank Yturria	Rob and Bessie Welder Wildlife Foundation; Texas Parks and Wildlife Department; United States Fish and Wildlife Service(US Fish & Wildlife Service); Tim and Karen Hixon Foundation; Mr. Frank Yturria	This study was funded by Rob and Bessie Welder Wildlife Foundation, Texas Parks and Wildlife Department, United States Fish and Wildlife Service, The Tim and Karen Hixon Foundation and Mr. Frank Yturria. One of the co-authors was an employee of the United States Fish and Wildlife Service (Linda Laack), other than that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAIR W. FRANK, 1950, TEXAS JOUR SCI, V2, P93; Brook BW, 2002, CONSERV ECOL, V6; Bureau USC, 2005, 2000 CENS; Caso A, 1995, HOME RANGE HABITAT U; Coltman DW, 1998, P ROY SOC B-BIOL SCI, V265, P803, DOI 10.1098/rspb.1998.0363; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Eizirik E, 1998, J MOL EVOL, V47, P613, DOI 10.1007/PL00006418; Excoffier L, 2006, ARLEQUIN VER 3 01 IN; FERRERAS P, 1992, BIOL CONSERV, V61, P197, DOI 10.1016/0006-3207(92)91116-A; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Frankham R, 2010, HEREDITY, V104, P124, DOI 10.1038/hdy.2009.155; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; FU YX, 1993, GENETICS, V133, P693; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Haines AM, 2006, BIOL CONSERV, V132, P424, DOI 10.1016/j.biocon.2006.04.035; Haines AM, 2006, EUR J WILDLIFE RES, V52, P216, DOI 10.1007/s10344-006-0043-5; Haines AM, 2006, ORYX, V40, P90, DOI 10.1017/S0030605306000044; Haines AM, 2005, BIOL CONSERV, V126, P512, DOI 10.1016/j.biocon.2005.06.032; Haines AM, 2005, J WILDLIFE MANAGE, V69, P255, DOI 10.2193/0022-541X(2005)069<0255:SASOMI>2.0.CO;2; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Jae-Heup K, 2001, MITOCHONDRION, V1, P279, DOI 10.1016/S1567-7249(01)00027-7; Jahrsdoerfer S. E., 1988, US FISH WILDLIFE SER, V88, P36; Janecka JE, 2011, ANIM CONSERV, V14, P608, DOI 10.1111/j.1469-1795.2011.00475.x; Janecka JE, 2008, CONSERV GENET, V9, P869, DOI 10.1007/s10592-007-9412-1; Janecka JE, 2007, SOUTHWEST NAT, V52, P89, DOI 10.1894/0038-4909(2007)52[89:PROOLP]2.0.CO;2; Johnson JA, 2006, CONSERV GENET, V7, P37, DOI 10.1007/s10592-005-7856-8; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; LAACK L, 1991, ECOLOGY OCELOT FELIS; Laack LL, 2005, ACTA THERIOL, V50, P505, DOI 10.1007/BF03192643; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Liberg O, 2005, BIOL LETT-UK, V1, P17, DOI 10.1098/rsbl.2004.0266; Lopez JV, 1996, GENOMICS, V33, P229, DOI 10.1006/geno.1996.0188; Lynch M, 1999, EVOLUTION, V53, P100, DOI 10.1111/j.1558-5646.1999.tb05336.x; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Murray Julie L., 1997, Mammalian Species, V548, P1; Newman D, 2001, CONSERV BIOL, V15, P1054, DOI 10.1046/j.1523-1739.2001.0150041054.x; Nystrom V, 2006, OIKOS, V114, P84, DOI 10.1111/j.2006.0030-1299.14701.x; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pertoldi C, 2001, P ROY SOC B-BIOL SCI, V268, P1775, DOI 10.1098/rspb.2001.1762; RALLS K, 1988, Conservation Biology, V2, P185, DOI 10.1111/j.1523-1739.1988.tb00169.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2008, ECOL ENTOMOL, V33, P488, DOI 10.1111/j.1365-2311.2008.00994.x; Reed DH, 2007, CONSERV GENET, V8, P1061, DOI 10.1007/s10592-006-9260-4; Reed DH, 2004, ANIM CONSERV, V7, P181, DOI 10.1017/S1367943004001313; Reed DH, 2003, CONSERV GENET, V4, P405, DOI 10.1023/A:1024081416729; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reed DH, 2002, CONSERV GENET, V3, P301, DOI 10.1023/A:1019948130263; Reed DH, 2001, ZOO BIOL, V20, P145, DOI 10.1002/zoo.1016; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Rowe G, 1999, ANIM CONSERV, V2, P85, DOI 10.1111/j.1469-1795.1999.tb00053.x; ROYCHOUDHURY AK, 1979, P INDIAN AS-ANIM SCI, V88, P311, DOI 10.1007/BF03179109; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SAGE RD, 1986, EVOLUTION, V40, P1092, DOI 10.1111/j.1558-5646.1986.tb00576.x; Schwartz MK, 2003, MOL ECOL, V12, P1807, DOI 10.1046/j.1365-294X.2003.01878.x; Shindle DB, 2000, J WILDLIFE DIS, V36, P546, DOI 10.7589/0090-3558-36.3.546; Sunquist ME, 2002, WILD CATS WORLD; TAJIMA F, 1989, GENETICS, V123, P585; Tewes M.E., 1986, P147; Tewes M.E., 1986, ECOLOGICAL BEHAV COR, p128 PP; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uphyrkina O, 2002, J HERED, V93, P303, DOI 10.1093/jhered/93.5.303; USFWS, 1999, END THREAT WILDL PLA; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; WILDT DE, 1987, NATURE, V329, P328, DOI 10.1038/329328a0; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231; Wright S., 1978, EVOLUTION GENETIC PO; Wright S., 1977, EVOLUTION GENETICS P, V3; Young JH, 1994, PROCEEDINGS OF THE FORTY-EIGHTH ANNUAL CONFERENCE - SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P336	79	15	18	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89384	10.1371/journal.pone.0089384	http://dx.doi.org/10.1371/journal.pone.0089384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586737	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000043
J	Soltis, J; King, LE; Douglas-Hamilton, I; Vollrath, F; Savage, A				Soltis, Joseph; King, Lucy E.; Douglas-Hamilton, Iain; Vollrath, Fritz; Savage, Anne			African Elephant Alarm Calls Distinguish between Threats from Humans and Bees	PLOS ONE			English	Article							LOXODONTA-AFRICANA; ACOUSTIC PARAMETERS; VOCALIZATIONS; CUES; COMMUNICATION; EXPRESSION; CLASSIFICATION; CONSERVATION; IDENTITY; AROUSAL	The Samburu pastoralists of Northern Kenya co-exist with African elephants, Loxodonta africana, and compete over resources such as watering holes. Audio playback experiments demonstrate that African elephants produce alarm calls in response to the voices of Samburu tribesmen. When exposed to adult male Samburu voices, listening elephants exhibited vigilance behavior, flight behavior, and produced vocalizations (rumbles, roars and trumpets). Rumble vocalizations were most common and were characterized by increased and more variable fundamental frequencies, and an upward shift in the first [F1] and second [F2] formant locations, compared to control rumbles. When exposed to a sequence of these recorded rumbles, roars and trumpets, listening elephants also exhibited vigilance and flight behavior. The same behavior was observed, in lesser degrees, both when the roars and trumpets were removed, and when the second formants were artificially lowered to levels typical of control rumbles. The "Samburu alarm rumble" is acoustically distinct from the previously described "bee alarm rumble." The bee alarm rumbles exhibited increased F2, while Samburu alarm rumbles exhibited increased F1 and F2, compared to controls. Moreover, the behavioral reactions to the two threats were different. Elephants exhibited vigilance and flight behavior in response to Samburu and bee stimuli and to both alarm calls, but headshaking behavior only occurred in response to bee sounds and bee alarm calls. In general, increasingly threatening stimuli elicited alarm calls with increases in F-0 and in formant locations, and increasing numbers of these acoustic cues in vocal stimuli elicited increased vigilance and flight behavior in listening elephants. These results show that African elephant alarm calls differentiate between two types of threat and reflect the level of urgency of threats.	[Soltis, Joseph] Disneys Anim Kingdom, Educ & Sci Dept, Lake Buena Vista, FL 32830 USA; [King, Lucy E.; Douglas-Hamilton, Iain; Vollrath, Fritz] Save Elephants, Nairobi, Kenya; [King, Lucy E.; Douglas-Hamilton, Iain; Vollrath, Fritz] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Savage, Anne] Disneys Anim Kingdom, Conservat Dept, Lake Buena Vista, FL USA	Walt Disney Company; University of Oxford; Walt Disney Company	Soltis, J (corresponding author), Disneys Anim Kingdom, Educ & Sci Dept, Lake Buena Vista, FL 32830 USA.	joseph.soltis@disney.com		Vollrath, Fritz/0000-0003-3484-9005; King, Dr Lucy/0000-0002-2877-5225	Disney's Worlwide Conservation Fund; Dinsey's Animal Kingdom Cast Conservation Program	Disney's Worlwide Conservation Fund; Dinsey's Animal Kingdom Cast Conservation Program	The Disney's Worlwide Conservation Fund, and the Dinsey's Animal Kingdom Cast Conservation Program supported the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachorowski JA, 1999, CURR DIR PSYCHOL SCI, V8, P53, DOI 10.1111/1467-8721.00013; Bastian A, 2008, J ACOUST SOC AM, V124, P598, DOI 10.1121/1.2924123; Bates LA, 2007, CURR BIOL, V17, P1938, DOI 10.1016/j.cub.2007.09.060; BAYART F, 1990, BEHAV NEUROSCI, V104, P98, DOI 10.1037/0735-7044.104.1.98; BERG JK, 1983, Z TIERPSYCHOL, V63, P63; Blumstein DT, 1997, ANIM BEHAV, V53, P143, DOI 10.1006/anbe.1996.0285; Charous SJ, 2001, LARYNGOSCOPE, V111, P2028, DOI 10.1097/00005537-200111000-00030; Denes P.B., 1993, SPEECH CHAIN PHYS BI; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Fitch WT., 2013, EVOLUTION EMOTIONAL, P26, DOI [10.1093/acprof:oso/9780199583560.003.0002, DOI 10.1093/ACPROF:OSO/9780199583560.003.0002]; Granados A, 2012, TROP CONSERV SCI, V5, P150, DOI 10.1177/194008291200500205; Guerbois C, 2012, J APPL ECOL, V49, P1149, DOI 10.1111/j.1365-2664.2012.02192.x; Herbst CT, 2012, SCIENCE, V337, P595, DOI 10.1126/science.1219712; Kahindi O, 2001, THESIS U STRATHCLYDE; Kangwana Kadzo, 2011, P307; King LE, 2007, CURR BIOL, V17, pR832, DOI 10.1016/j.cub.2007.07.038; King LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010346; Kuriyan R, 2002, SOC NATUR RESOUR, V15, P949, DOI 10.1080/08941920290107675; Loveridge AJ, 2006, J ZOOL, V270, P523, DOI 10.1111/j.1469-7998.2006.00181.x; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Manser MB, 2002, TRENDS COGN SCI, V6, P55, DOI 10.1016/S1364-6613(00)01840-4; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; McComb K, 2011, P ROY SOC B-BIOL SCI, V278, P3270, DOI 10.1098/rspb.2011.0168; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P1; Monticelli PE, 2004, AN ACAD BRAS CIENC, V76, P368, DOI 10.1590/S0001-37652004000200027; Pavitt N, 1991, SAMBURU; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Poole JH, 2005, NATURE, V434, P455, DOI 10.1038/434455a; Poole Joyce H., 2011, P125; Poole Joyce H., 2011, P109; PORTER FL, 1988, CHILD DEV, V59, P495, DOI 10.1111/j.1467-8624.1988.tb01483.x; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Riede T, 2003, J ACOUST SOC AM, V114, P1132, DOI 10.1121/1.1580812; ROBINSON SR, 1980, ANIM BEHAV, V28, P840, DOI 10.1016/S0003-3472(80)80144-8; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; Shoshani J, 1998, TRENDS ECOL EVOL, V13, P480, DOI 10.1016/S0169-5347(98)01491-8; Shoshani J, 2005, QUATERN INT, V126, P5, DOI 10.1016/j.quaint.2004.04.011; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Soltis J., 2013, EVOLUTION EMOTIONAL, P105, DOI 10.1093/acprof:oso/9780199583560.003.0007; Soltis J, 2011, J ACOUST SOC AM, V129, P1059, DOI 10.1121/1.3531798; Soltis J, 2010, ZOO BIOL, V29, P192, DOI 10.1002/zoo.20251; Soltis J, 2009, ANIM BEHAV, V78, P1485, DOI 10.1016/j.anbehav.2009.09.030; Soltis J, 2009, J COMP PSYCHOL, V123, P222, DOI 10.1037/a0015223; Stoeger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048907; Stoeger AS, 2012, CURR BIOL, V22, P2144, DOI 10.1016/j.cub.2012.09.022; Stoeger AS, 2011, J ACOUST SOC AM, V130, P1700, DOI 10.1121/1.3605538; Stoeger-Horwath AS, 2007, J ACOUST SOC AM, V121, P3922, DOI 10.1121/1.2722216; TARTTER VC, 1980, PERCEPT PSYCHOPHYS, V27, P24, DOI 10.3758/BF03199901; Titze IR, 1994, PRINCIPLES VOICE PRO; Townsend SW, 2013, ETHOLOGY, V119, P1, DOI 10.1111/eth.12015; Townsend SW, 2011, BIOL LETTERS, V7, P47, DOI 10.1098/rsbl.2010.0537; Trivedi A.S., 2013, EVOLUTION EMOTIONAL; Watts JM, 1999, APPL ANIM BEHAV SCI, V62, P125, DOI 10.1016/S0168-1591(98)00222-6; Wesolek CM, 2009, BIOACOUSTICS, V18, P227, DOI 10.1080/09524622.2009.9753603; Wittemyer G, 2007, ANIM BEHAV, V73, P671, DOI 10.1016/j.anbehav.2006.10.008; Wittemyer G, 2001, AFR J ECOL, V39, P357, DOI 10.1046/j.1365-2028.2001.00324.x; Wittemyer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053726; Wittemyer G, 2011, NATURE, V476, P282, DOI 10.1038/476282c; Wood JD, 2005, BIOACOUSTICS, V15, P143, DOI 10.1080/09524622.2005.9753544; Zeskind P.S., 2013, EVOLUTION EMOTIONAL, P155, DOI DOI 10.1093/ACPROF:OSO/9780199583560.001.0001; Zuberbuhler K, 2001, BEHAV ECOL SOCIOBIOL, V50, P414, DOI 10.1007/s002650100383; Zuberbuhler K, 1997, ANIM BEHAV, V53, P589, DOI 10.1006/anbe.1996.0334; Zuberbuhler K, 2000, ANIM BEHAV, V59, P917, DOI 10.1006/anbe.1999.1317	67	32	32	65	574	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89403	10.1371/journal.pone.0089403	http://dx.doi.org/10.1371/journal.pone.0089403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586753	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000045
J	Franke, RP; Scharnweber, T; Fuhrmann, R; Wenzel, F; Kruger, A; Mrowietz, C; Jung, F				Franke, Ralf-Peter; Scharnweber, Tim; Fuhrmann, Rosemarie; Wenzel, Folker; Krueger, Anne; Mrowietz, Christof; Jung, Friedrich			Effect of Radiographic Contrast Media on the Spectrin/Band3-Network of the Membrane Skeleton of Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; VENOUS ENDOTHELIAL-CELLS; CARBONIC-ANHYDRASE-II; IN-VITRO; COMPLEMENT ACTIVATION; EXTRACELLULAR-MATRIX; ECHINOCYTE FORMATION; TRANSPORT METABOLON; CYTOPLASMIC DOMAIN; OXYGEN-TENSION	The membrane of red blood cells consists of a phospholipid bilayer with embedded membrane proteins and is associated on the cytoplasmatic side with a network of proteins, the membrane skeleton. Band3 has an important role as centre of the functional complexes e. g. gas exchange complex and as element of attachment for the membrane skeleton maintaining membrane stability and flexibility. Up to now it is unclear if band3 is involved in the morphology change of red blood cells after contact with radiographic contrast media. The study revealed for the first time that Iopromide induced markedly more severe alterations of the membrane skeleton compared to Iodixanol whose effects were similar to erythrocytes suspended in autologous plasma. A remarkable clustering of band3 was found associated with an accumulation of band3 in spicules and also a sequestration of band3 to the extracellular space. This was evidently accompanied by a gross reduction of functional band3 complexes combined with a dissociation of spectrin from band3 leading to a loss of homogeneity of the spectrin network. It could be demonstrated for the first time that RCM not only induced echinocyte formation but also exocytosis of particles at least coated with band3.	[Franke, Ralf-Peter; Fuhrmann, Rosemarie] Univ Ulm, Dept Biomat, ZBMT, D-89069 Ulm, Germany; [Scharnweber, Tim] Karlsruhe Inst Technol, Inst Biol Interfaces, D-76021 Karlsruhe, Germany; [Wenzel, Folker] Univ Dusseldorf, Med Ctr, Inst Transplantat Diagnost & Cell Therapeut, Dusseldorf, Germany; [Krueger, Anne; Jung, Friedrich] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Teltow, Germany; [Krueger, Anne; Jung, Friedrich] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Teltow, Germany; [Mrowietz, Christof] Inst Heart & Circulat Res, Hamburg, Germany	Ulm University; Helmholtz Association; Karlsruhe Institute of Technology; Heinrich Heine University Dusseldorf; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Jung, F (corresponding author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Teltow, Germany.	friedrich.jung@hzg.de	Jung, Friedrich FJ/L-1301-2013	Jung, Friedrich FJ/0000-0001-8098-7180; Mrowietz, Christof/0000-0003-4277-4680	Bundesministerium fur Bildung und Forschung (BMBF) [0315696A "Poly4Bio BB'']	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors thank the Bundesministerium fur Bildung und Forschung (BMBF) for funding within project number 0315696A "Poly4Bio BB''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Antonelou MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026033; ASPELIN P, 1979, ACTA RADIOL DIAGN, V20, P1; ASPELIN P, 1978, ACTA RADIOL DIAGN, V19, P766, DOI 10.1177/028418517801900507; Aspelin P, 1987, Acta Radiol Suppl, V370, P79; Aspelin P, 2006, EUR RADIOL, V16, P1041, DOI 10.1007/s00330-005-0081-5; Bach R, 1996, ACTA RADIOL, V37, P214; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; BECKER PS, 1985, CLIN HAEMATOL, V14, P15; Bell AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060300; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Benninghoff A, 1994, ANATOMIE, V1; Blanc L, 2010, BIOCHEMISTRY-US, V49, P4516, DOI 10.1021/bi1003684; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; CHASIS JA, 1986, J CELL BIOL, V103, P343, DOI 10.1083/jcb.103.2.343; Chu HY, 2012, P NATL ACAD SCI USA, V109, P12794, DOI 10.1073/pnas.1209014109; Connes P, 2011, CLIN HEMORHEOL MICRO, V49, P151, DOI 10.3233/CH-2011-1465; Deftereos S, 2009, J INVASIVE CARDIOL, V21, P473; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; Ferru E, 2011, BLOOD, V117, P5998, DOI 10.1182/blood-2010-11-317024; Franke RP, 2007, CLIN HEMORHEOL MICRO, V37, P329; Franke RP, 2013, CLIN HEMORHEOL MICRO, V54, P273, DOI 10.3233/CH-131733; Franke RP, 2011, CLIN HEMORHEOL MICRO, V48, P41, DOI 10.3233/CH-2011-1404; Franke RP, 2010, CLIN HEMORHEOL MICRO, V46, P225, DOI 10.3233/CH-2010-1349; Gershon D, 1988, BLOOD CELLS RHEOLOGY, P42; HARDEMAN MR, 1991, INVEST RADIOL, V26, P810, DOI 10.1097/00004424-199109000-00006; Hoffman JF, 2009, J GEN PHYSIOL, V134, P351, DOI 10.1085/jgp.200910270; JACKSON CJ, 1990, J CELL SCI, V96, P257; Jiang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055408; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Jung F, 2008, CLIN HEMORHEOL MICRO, V38, P1; Jung F, 2003, CLIN HEMORHEOL MICRO, V29, P53; Kerl JM, 2008, ACTA RADIOL, V49, P337, DOI 10.1080/02841850801885978; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Lamarre Y, 2012, CLIN HEMORHEOL MICRO, V51, P229, DOI 10.3233/CH-2011-1525; LERCHE D, 1992, CLIN HEMORHEOL, V12, P341; de Almeida JPL, 2012, CLIN HEMORHEOL MICRO, V50, P213, DOI 10.3233/CH-2010-1433; Losco P, 2001, AM J HEMATOL, V68, P149, DOI 10.1002/ajh.1171; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; Luginbuhl A, 2007, INFECT IMMUN, V75, P1771, DOI 10.1128/IAI.01514-06; Matschke K, 2007, ACTA RADIOL, V48, P292, DOI 10.1080/02841850701209956; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Mrowietz C, 2008, CLIN HEMORHEOL MICRO, V39, P281, DOI 10.3233/CH-2008-1097; Mrowietz C, 2012, CLIN HEMORHEOL MICRO, V50, P35, DOI 10.3233/CH-2011-1441; Nestor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016197; Nightingale TD, 2012, TRENDS CELL BIOL, V22, P329, DOI 10.1016/j.tcb.2012.03.003; Noria S, 2004, AM J PATHOL, V164, P1211, DOI 10.1016/S0002-9440(10)63209-9; PALEK J, 1992, BLOOD, V80, P308; Platt D., 1988, BLOOD CELLS RHEOLOGY, P29; Puchulu-Campanella E, 2013, J BIOL CHEM, V288, P848, DOI 10.1074/jbc.M112.428573; Ramponi S, 2007, TOXICOL IN VITRO, V21, P191, DOI 10.1016/j.tiv.2006.09.018; Reinhart WH, 2011, CLIN HEMORHEOL MICRO, V49, P11, DOI 10.3233/CH-2011-1453; Reinhart WH, 2005, CLIN HEMORHEOL MICRO, V32, P227; REINHART WH, 1988, AM J HEMATOL, V29, P195, DOI 10.1002/ajh.2830290404; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Sega MF, 2012, BIOCHEMISTRY-US, V51, P3264, DOI 10.1021/bi201623v; Southgate CD, 1996, NAT GENET, V14, P227, DOI 10.1038/ng1096-227; Sowah D, 2011, AM J PHYSIOL-CELL PH, V301, pC336, DOI 10.1152/ajpcell.00005.2011; Spitzer S, 1999, CLIN HEMORHEOL MICRO, V20, P49; Sprague RS, 2007, TRENDS ENDOCRIN MET, V18, P350, DOI 10.1016/j.tem.2007.08.008; Stefanovic M, 2007, P NATL ACAD SCI USA, V104, P13972, DOI 10.1073/pnas.0706266104; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; STRICKLAND NH, 1992, CLIN RADIOL, V45, P240, DOI 10.1016/S0009-9260(05)80005-4; Sumimura T, 2003, INVEST RADIOL, V38, P366, DOI 10.1097/01.RLI.0000066249.29279.1e; Tiffert T, 2011, J GEN PHYSIOL, V138, P381, DOI 10.1085/jgp.201110660; Vik H, 1995, ACTA RADIOL, V36, P83, DOI 10.1177/0284185195036S39910; Wolny M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021538	68	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89512	10.1371/journal.pone.0089512	http://dx.doi.org/10.1371/journal.pone.0089512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586837	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700056
J	Graff, I; Goldschmidt, B; Glien, P; Bogdanow, M; Fimmers, R; Hoeft, A; Kim, SC; Grigutsch, D				Graeff, Ingo; Goldschmidt, Bernd; Glien, Procula; Bogdanow, Manuela; Fimmers, Rolf; Hoeft, Andreas; Kim, Se-Chan; Grigutsch, Daniel			The German Version of the Manchester Triage System and Its Quality Criteria - First Assessment of Validity and Reliability	PLOS ONE			English	Article							EMERGENCY SEVERITY INDEX; OBSERVER AGREEMENT; SIMULATION; MORTALITY; ADMISSION	Background: The German Version of the Manchester Triage System (MTS) has found widespread use in EDs across Germans-peaking Europe. Studies about the quality criteria validity and reliability of the MTS currently only exist for the English-language version. Most importantly, the content of the German version differs from the English version with respect to presentation diagrams and change indicators, which have a significant impact on the category assigned. This investigation offers a preliminary assessment in terms of validity and inter-rater reliability of the German MTS. Methods: Construct validity of assigned MTS level was assessed based on comparisons to hospitalization (general / intensive care), mortality, ED and hospital length of stay, level of prehospital care and number of invasive diagnostics. A sample of 45,469 patients was used. Inter-rater agreement between an expert and triage nurses (reliability) was calculated separately for a subset group of 167 emergency patients. Results: For general hospital admission the area under the curve (AUC) of the receiver operating characteristic was 0.749; for admission to ICU it was 0.871. An examination of MTS-level and number o`f deceased patients showed that the higher the priority derived from MTS, the higher the number of deaths (p<0.0001 / chi(2) Test). There was a substantial difference in the 30-day survival among the 5 MTS categories (p<0.0001 / log-rank test). The AUC for the predict 30-day mortality was 0.613. Categories orange and red had the highest numbers of heart catheter and endoscopy. Category red and orange were mostly accompanied by an emergency physician, whereas categories blue and green were walk-in patients. Inter-rater agreement between expert triage nurses was almost perfect (kappa = 0.954). Conclusion: The German version of the MTS is a reliable and valid instrument for a first assessment of emergency patients in the emergency department.	[Graeff, Ingo; Glien, Procula] Univ Bonn, Emergency Dept, Bonn, Germany; [Goldschmidt, Bernd] Univ Bonn, Bonn, Germany; [Bogdanow, Manuela; Fimmers, Rolf] Univ Bonn, Inst Med Biometry Informat & Epidemiol, German Ctr Neurodegenerat Dis, Bonn, Germany; [Hoeft, Andreas; Kim, Se-Chan; Grigutsch, Daniel] Univ Bonn, Dept Anesthesiol, Bonn, Germany	University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn	Graff, I (corresponding author), Univ Bonn, Emergency Dept, Bonn, Germany.	info@medingo.de		Kim, Se-Chan/0000-0003-3456-5440				Australasian College for Emergency Medicine, 2002, Emerg Med (Fremantle), V14, P335; Bey TA, 2008, INT J EMERG MED, V1, P273, DOI 10.1007/s12245-008-0076-5; Christ M, 2010, DTSCH ARZTEBL INT, V107, P892, DOI 10.3238/arztebl.2010.0892; Cooke MW, 1999, J ACCID EMERG MED, V16, P179; Fernandes CMB, 2005, J EMERG NURS, V31, P39, DOI 10.1016/j.jen.2004.11.002; Graff I, 2011, NOTFALL RETTUNGSMED, V14, P202, DOI 10.1007/s10049-010-1286-y; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mackway-Jones K, 2020, ERSTEINSCHATZUNG NOT; Martins HMG, 2009, EMERG MED J, V26, P183, DOI 10.1136/emj.2008.060780; Murray Michael, 2004, CJEM, V6, P421; Pinto D, 2012, REV LAT-AM ENFERM, V20, P1041, DOI 10.1590/S0104-11692012000600005; Schopke T, 2011, NOTFALL RETTUNGSMED, V14, P371, DOI 10.1007/s10049-011-1435-y; Sieber R, 2008, ANN EMERG MED, V51, P531, DOI 10.1016/j.annemergmed.2008.01.168; Storm-Versloot MN, 2009, EMERG MED J, V26, P556, DOI 10.1136/emj.2008.059378; Storm-Versloot MN, 2011, ACAD EMERG MED, V18, P822, DOI 10.1111/j.1553-2712.2011.01122.x; van der Wulp I, 2008, EMERG MED J, V25, P431, DOI 10.1136/emj.2007.055228; van der Wulp I, 2009, EMERG MED J, V26, P506, DOI 10.1136/emj.2008.063768	17	59	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e88995	10.1371/journal.pone.0088995	http://dx.doi.org/10.1371/journal.pone.0088995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586477	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700017
J	Talebzadeh, M; Zare-Mirakabad, F				Talebzadeh, Mohammad; Zare-Mirakabad, Fatemeh			Transcription Factor Binding Sites Prediction Based on Modified Nucleosomes	PLOS ONE			English	Article							CHIP-SEQ DATA; HUMAN GENOME; CHROMATIN-IMMUNOPRECIPITATION; HISTONE MODIFICATIONS; GENE-EXPRESSION; STEM-CELLS; DIFFERENTIATION; PROFILES	In computational methods, position weight matrices (PWMs) are commonly applied for transcription factor binding site (TFBS) prediction. Although these matrices are more accurate than simple consensus sequences to predict actual binding sites, they usually produce a large number of false positive (FP) predictions and so are impoverished sources of information. Several studies have employed additional sources of information such as sequence conservation or the vicinity to transcription start sites to distinguish true binding regions from random ones. Recently, the spatial distribution of modified nucleosomes has been shown to be associated with different promoter architectures. These aligned patterns can facilitate DNA accessibility for transcription factors. We hypothesize that using data from these aligned and periodic patterns can improve the performance of binding region prediction. In this study, we propose two effective features, "modified nucleosomes neighboring'' and "modified nucleosomes occupancy'', to decrease FP in binding site discovery. Based on these features, we designed a logistic regression classifier which estimates the probability of a region as a TFBS. Our model learned each feature based on Sp1 binding sites on Chromosome 1 and was tested on the other chromosomes in human CD4+T cells. In this work, we investigated 21 histone modifications and found that only 8 out of 21 marks are strongly correlated with transcription factor binding regions. To prove that these features are not specific to Sp1, we combined the logistic regression classifier with the PWM, and created a new model to search TFBSs on the genome. We tested the model using transcription factors MAZ, PU. 1 and ELF1 and compared the results to those using only the PWM. The results show that our model can predict Transcription factor binding regions more successfully. The relative simplicity of the model and capability of integrating other features make it a superior method for TFBS prediction.	[Talebzadeh, Mohammad; Zare-Mirakabad, Fatemeh] Amirkabir Univ Technol, Dept Math & Comp Sci, Tehran, Iran	Amirkabir University of Technology	Zare-Mirakabad, F (corresponding author), Amirkabir Univ Technol, Dept Math & Comp Sci, Tehran, Iran.	f.zare@aut.ac.ir	Zare-Mirakabad, Fatemeh/T-2862-2019; Zare-Mirakabad, Fatemeh/AAH-7191-2021	Zare-Mirakabad, Fatemeh/0000-0003-2849-3778				Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; BARASH Y, 2003, P 7 ANN INT C RES CO, P28; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Cuellar-Partida G, 2012, BIOINFORMATICS, V28, P56, DOI 10.1093/bioinformatics/btr614; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Duan J, 2010, THESIS AARHUS U; Ernst J, 2010, GENOME RES, V20, P526, DOI 10.1101/gr.096305.109; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Holloway Dustin T, 2005, Genome Inform, V16, P83; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Ji HK, 2010, METHODS MOL BIOL, V674, P143, DOI 10.1007/978-1-60761-854-6_9; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kratz A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-257; Lahdesmaki H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001820; Lenhard Boris, 2003, J Biol, V2, P13, DOI 10.1186/1475-4924-2-13; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Ma WX, 2011, METHOD ENZYMOL, V497, P51, DOI 10.1016/B978-0-12-385075-1.00003-2; Mount D. W., 2004, SEQUENCE GENOME ANAL, P2; Nozaki T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-416; Ramsey SA, 2010, BIOINFORMATICS, V26, P2071, DOI 10.1093/bioinformatics/btq405; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Whitington T, 2009, NUCLEIC ACIDS RES, V37, P14, DOI 10.1093/nar/gkn866; Won KJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r7; Won KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005501; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-537; Zhang ZH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-155; Zhou Q, 2004, BIOINFORMATICS, V20, P909, DOI 10.1093/bioinformatics/bth006	38	11	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89226	10.1371/journal.pone.0089226	http://dx.doi.org/10.1371/journal.pone.0089226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586611	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900064
J	Yang, SP; Zhang, B; Zhao, JZ; Wang, J; Flick, LM; Qian, Z; Zhang, D; Mei, H				Yang, Shaoping; Zhang, Bin; Zhao, Jinzhu; Wang, Jing; Flick, Louise; Qian, Zhengmin; Zhang, Dan; Mei, Hui			Progress on the Maternal Mortality Ratio Reduction in Wuhan, China in 2001-2012	PLOS ONE			English	Article							POPULATION; SHANGHAI; WOMEN	Background: Most maternal deaths occur in developing countries and most maternal deaths are avoidable. China has made a great effort to reduce MMR by three quarters to meet the fifth Millennium Development Goal (MDG5). Methods: This retrospective study reviewed and analyzed maternal death data in Wuhan from 2001 to 2012. Joinpoint regression and multivariate Poisson regression was conducted using the log-linear model to measure the association of the number of maternal deaths with time, cause of death, where the death occurred, and cognitive factors including knowledge, attitude, resource, and management stratified. Results: The MMR declined from 33.41 per 100,000 live births in 2001 to 10.63 per 100,000 live births in 2012, with a total decline of 68.18% and an average annual decline of 9.89%. From 2001-2012, the four major causes of maternal death were obstetric hemorrhage (35.16%), pregnancy complications (28.57%), amniotic fluid embolism (16.48%) and gestational hypertension (8.79%). Multivariate Poisson regression showed on average the MMR decreased by. 17% each year from 2001-2006 and stayed stagnant since 2007-2012. Conclusions: With the reduction in MMR in obstetric death (e. g. obstetric hemorrhage), there had been a remarkable reduction in MMR in Wuhan in 2001-2012, which may be due to (1) the improvement in the obstetric quality of perinatal care service on prevention and treatment of obstetric hemorrhage and emergency care skills, and (2) the improvement in the maternal health management and quality of prenatal care. Interventions to further reduce the MMR include several efforts such as the following: (1) designing community-based interventions, (2) providing subsidies to rural women and/ hospitals for hospital delivery, (3) screening for pregnancy complications, and (4) establishing an emergency rescue system for critically ill pregnant women.	[Yang, Shaoping; Zhang, Bin; Zhao, Jinzhu; Zhang, Dan; Mei, Hui] Wuhan Women & Children Hlth Care Ctr, Dept Primary Guidance, Wuhan, Hubei Province, Peoples R China; [Wang, Jing; Flick, Louise; Qian, Zhengmin] St Louis Univ, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA	Saint Louis University	Zhang, B (corresponding author), Wuhan Women & Children Hlth Care Ctr, Dept Primary Guidance, Wuhan, Hubei Province, Peoples R China.	mchwhzb@163.com			Health Department of Hubei Province	Health Department of Hubei Province	This study was funded by the Health Department of Hubei Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CHINA HLTH YB 2011; [Anonymous], 2012, MATERNAL MORTALITY; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; Du L, 2012, REPROD HEALTH MATTER, V20, P73, DOI 10.1016/S0968-8080(12)39608-0; Du Q, 2009, HEALTH CARE WOMEN IN, V30, P957, DOI 10.1080/07399330903052137; Gao YQ, 2009, B WORLD HEALTH ORGAN, V87, P913, DOI 10.2471/BLT.08.060426; Gao Y, 2009, INT J GYNECOL OBSTET, V104, P128, DOI 10.1016/j.ijgo.2008.10.004; Harris A, 2010, HEALTH POLICY PLANN, V25, P311, DOI 10.1093/heapol/czp062; Koch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036613; Li S, 2005, CHINA HUMAN DEV REPO; Liang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037458; Liang J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-243; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Rai Sanjay K, 2012, Indian J Public Health, V56, P196, DOI 10.4103/0019-557X.104231; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Shiffman J, 2007, J INFORM, V97; Siu SC, 2001, HEART, V85, P710, DOI 10.1136/heart.85.6.710; Wang B, 2008, MATERN CHILD HLTH J, V23, P4813; WHO Unicef UNFPA The World Bank estimates. The World Bank. Trends in maternal mortality: 1990 to 2010, 2012, WORLD BANK TRENDS MA; [杨惠娟 Yang Huijuan], 2011, [中华流行病学杂志, Chinese Journal of Epidemiology], V32, P1131; Yin H, 2008, MATERNITY CHILD HLTH, V23, P2778; You FZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047153; Zhou Yuan-yang, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P934; Zhu L, 2009, BJOG-INT J OBSTET GY, V116, P401, DOI 10.1111/j.1471-0528.2008.01979.x	24	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89510	10.1371/journal.pone.0089510	http://dx.doi.org/10.1371/journal.pone.0089510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586836	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900112
J	Schrumpf, M; Kaiser, K; Schulze, ED				Schrumpf, Marion; Kaiser, Klaus; Schulze, Ernst-Detlef			Soil Organic Carbon and Total Nitrogen Gains in an Old Growth Deciduous Forest in Germany	PLOS ONE			English	Article							TERRESTRIAL ECOSYSTEMS; CLIMATE-CHANGE; STORAGE; DYNAMICS; MATTER; SEQUESTRATION; RESPIRATION; MANAGEMENT; ADDITIONS; ENGLAND	Temperate forests are assumed to be organic carbon (OC) sinks, either because of biomass increases upon elevated CO2 in the atmosphere and large nitrogen deposition, or due to their age structure. Respective changes in soil OC and total nitrogen (TN) storage have rarely been proven. We analysed OC, TN, and bulk densities of 100 soil cores sampled along a regular grid in an old-growth deciduous forest at the Hainich National Park, Germany, in 2004 and again in 2009. Concentrations of OC and TN increased significantly from 2004 to 2009, mostly in the upper 0-20 cm of the mineral soil. Changes in the fine earth masses per soil volume impeded the detection of OC changes based on fixed soil volumes. When calculated on average fine earth masses, OC stocks increased by 323 +/- 146 g m(-2) and TN stocks by 39 +/- 10 g m(-2) at 0-20 cm soil depth from 2004 to 2009, giving average annual accumulation rates of 65 +/- 29 g OC m(-2) yr(-1) and 7.862 g N m(-2) yr(-1). Accumulation rates were largest in the upper part of the B horizon. Regional increases in forest biomass, either due to recovery of forest biomass from previous forest management or to fertilization by elevated CO2 and N deposition, are likely causes for the gains in soil OC and TN. As TN increased stronger (1.3% yr(-1) of existing stocks) than OC (0.9% yr(-1)), the OC-to-TN ratios declined significantly. Results of regression analyses between changes in OC and TN stocks suggest that at no change in OC, still 3.8 g TN m(-2) yr(-1) accumulated. Potential causes for the increase in TN in excess to OC are fixation of inorganic N by the clay-rich soil or changes in microbial communities. The increase in soil OC corresponded on average to 6-13% of the estimated increase in net biome productivity.	[Schrumpf, Marion; Schulze, Ernst-Detlef] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Kaiser, Klaus] Univ Halle Wittenberg, D-06120 Halle, Saale, Germany	Max Planck Society; Martin Luther University Halle Wittenberg	Schrumpf, M (corresponding author), Max Planck Inst Biogeochem, Hans Knoll Str 10, D-07745 Jena, Germany.	mschrumpf@bgc-jena.mpg.de	Schrumpf, Marion/C-1671-2013; Kaiser, Klaus/J-1726-2014; Schulze, Ernst-Detlef/K-9627-2014	Kaiser, Klaus/0000-0001-7376-443X; Schrumpf, Marion/0000-0003-4219-4125	EU (CarboEurope-IP) [GOGC-CT-2003n505572]; Max-Planck Society	EU (CarboEurope-IP); Max-Planck Society(Max Planck SocietyFoundation CELLEX)	This study was funded by the EU (CarboEurope-IP, Project No. GOGC-CT-2003n505572) and the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CR, 1998, SOIL BIOL BIOCHEM, V30, P767, DOI 10.1016/S0038-0717(97)00168-5; [Anonymous], 1990, PFLANZENSOZIOLOGISCH; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; Berg B, 2009, CAN J FOREST RES, V39, P962, DOI 10.1139/X09-022; Booth MS, 2005, ECOL MONOGR, V75, P139, DOI 10.1890/04-0988; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; de Vries W, 2009, FOREST ECOL MANAG, V258, P1814, DOI 10.1016/j.foreco.2009.02.034; Ellert BH, 1995, CAN J SOIL SCI, V75, P529, DOI 10.4141/cjss95-075; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Hagedorn F, 2003, SOIL BIOL BIOCHEM, V35, P1683, DOI 10.1016/j.soilbio.2003.08.015; Hahn V, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002115; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hessenmoller D, 2008, ALLG FORST JAGDZTG, V179, P209; Hopkins DW, 2009, GLOBAL CHANGE BIOL, V15, P1739, DOI 10.1111/j.1365-2486.2008.01809.x; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Johnson DW, 2001, FOREST ECOL MANAG, V140, P227, DOI 10.1016/S0378-1127(00)00282-6; Kiser LC, 2009, SOIL SCI SOC AM J, V73, P647, DOI 10.2136/sssaj2008.0102; Knohl A, 2003, AGR FOREST METEOROL, V118, P151, DOI 10.1016/S0168-1923(03)00115-1; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Kutsch WL, 2008, ECOL APPL, V18, P1391, DOI 10.1890/06-1301.1; Kutsch WL, 2010, BIOGEOCHEMISTRY, V100, P167, DOI 10.1007/s10533-010-9414-9; Lettens S, 2005, GLOBAL CHANGE BIOL, V11, P2128, DOI 10.1111/j.1365-2486.2005.001074.x; Levin I, 2012, NATURE, V488, P35, DOI 10.1038/488035a; Luyssaert S, 2010, GLOBAL CHANGE BIOL, V16, P1429, DOI 10.1111/j.1365-2486.2009.02056.x; Mund M., 2004, CARBON POOLS EUROPEA; Nadelhoffer KJ, 2004, FOREST ECOL MANAG, V196, P89, DOI 10.1016/j.foreco.2004.03.014; Nieder R, 2011, BIOL FERT SOILS, V47, P1, DOI 10.1007/s00374-010-0506-4; Oehmichen K, 2011, INVENTARSTUDIE 2008; Olsson P, 2005, GLOBAL CHANGE BIOL, V11, P1745, DOI 10.1111/j.1365-2486.2005.001033.x; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Phoenix GK, 2012, GLOBAL CHANGE BIOL, V18, P1197, DOI 10.1111/j.1365-2486.2011.02590.x; Prietzel J, 2006, PLANT SOIL, V289, P153, DOI 10.1007/s11104-006-9120-5; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Rustad LE, 2008, SCI TOTAL ENVIRON, V404, P222, DOI 10.1016/j.scitotenv.2008.04.050; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Schrumpf M, 2013, BIOGEOSCIENCES, V10, P1675, DOI 10.5194/bg-10-1675-2013; Schrumpf M, 2011, BIOGEOSCIENCES, V8, P1193, DOI 10.5194/bg-8-1193-2011; Schulze ED, 2009, NAT GEOSCI, V2, P842, DOI 10.1038/ngeo686; Smith P, 2007, GLOBAL CHANGE BIOL, V13, P2605, DOI 10.1111/j.1365-2486.2007.01458.x; Stevens A, 2008, SOIL USE MANAGE, V24, P69, DOI 10.1111/j.1475-2743.2007.00135.x; Tefs C, 2012, FOREST ECOL MANAG, V263, P131, DOI 10.1016/j.foreco.2011.09.010; Templer PH, 2012, ECOLOGY, V93, P1816, DOI 10.1890/11-1146.1; Waldchen J, 2012, J PLANT NUTR SOIL SC, V175, P367, DOI 10.1002/jpln.201100066; Waldchen J., 2011, Forstarchiv, V82, P35; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; WRB. I.W.G, 2007, WORLD REF BAS SOIL R; Wuest SB, 2009, SOIL SCI SOC AM J, V73, P312, DOI 10.2136/sssaj2008.0063; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168	52	24	27	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89364	10.1371/journal.pone.0089364	http://dx.doi.org/10.1371/journal.pone.0089364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586720	Green Submitted, gold, Green Published			2022-12-27	WOS:000331714700112
J	Yang, B; Yu, JK; Zheng, ZZ; Lu, ZH; Zhang, JY				Yang, Bo; Yu, Jia-Kuo; Zheng, Zhuo-Zhao; Lu, Zhi-Hua; Zhang, Ji-Ying			Comparative Study of Sex Differences in Distal Femur Morphology in Osteoarthritic Knees in a Chinese Population	PLOS ONE			English	Article							ANTHROPOMETRIC MEASUREMENTS; GENDER-DIFFERENCES; FEMALE KNEE; ARTHROPLASTY; ANATOMY; MORPHOMETRY; REPLACEMENT; DESIGN	Objectives: The purpose of this study was to investigate sex differences in resected distal femoral morphology in Chinese osteoarthritic knees. Methods: The study included 130 osteoarthritic knees in 65 men and 65 women in China. None had anterior femoral osteophyte or serious patellar femoral joint degeneration. The following were measured using computed tomography and analyzed to identify morphological differences according to sex in the resected distal femurs: anterior lateral condylar height (ALCH), anterior medial condylar height (AMCH), and mediolateral (ML) and anteroposterior (AP) dimensions. The ML/AP aspect ratio was calculated. Results: The average ALCH and AMCH were 8.2 +/- 1.8 mm, 3.1 +/- 1.5 mm for men and 7.4 +/- 1.7 mm, 3.6 +/- 1.5 mm for women. There were significant differences between men and women in ALCH values (P = 0.014) but not in AMCH values (P = 0.09). Women had smaller ML/AP aspect ratios than men for a given AP dimension. This indicated that the femoral ML dimension of a prosthesis with a given AP dimension may have overhang in women. Conclusions: This study suggested that sex differences should be taken into account in the design of femoral prosthesis for Chinese men and women.	[Yang, Bo; Yu, Jia-Kuo; Lu, Zhi-Hua; Zhang, Ji-Ying] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100871, Peoples R China; [Zheng, Zhuo-Zhao] Peking Univ, Hosp 3, Dept Radiol, Beijing 100871, Peoples R China	Peking University; Peking University	Yu, JK (corresponding author), Peking Univ, Hosp 3, Inst Sports Med, Beijing 100871, Peoples R China.	yujiakuo@126.com		Yu, Jia-Kuo/0000-0001-6260-7017	Department of International Cooperation of the Ministry of Science and Technology of china [2011DFA31340]; science and technology plan projects of Beijing [Z131100005213004]; National Natural Science Foundation [81327001]	Department of International Cooperation of the Ministry of Science and Technology of china; science and technology plan projects of Beijing; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was funded by the Sino-Germany Cooperation Project of the Department of International Cooperation of the Ministry of Science and Technology of china (No. 2011DFA31340); the science and technology plan projects of Beijing (No. Z131100005213004); Instrument Research Project of the National Natural Science Foundation (No. 81327001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bong MR, 2004, J AM ACAD ORTHOP SUR, V12, P164, DOI 10.5435/00124635-200405000-00004; Chaichankul C, 2011, KNEE, V18, P5, DOI 10.1016/j.knee.2009.12.005; Cheng CK, 1999, CLIN BIOMECH, V14, P112, DOI 10.1016/S0268-0033(98)00054-0; Cheng FB, 2009, KNEE, V16, P341, DOI 10.1016/j.knee.2008.12.019; Chin PL, 2011, J ARTHROPLASTY, V26, P984, DOI 10.1016/j.arth.2010.11.012; Clarke HD, 2008, CLIN ORTHOP RELAT R, V466, P2711, DOI 10.1007/s11999-008-0454-6; Conley S, 2007, J AM ACAD ORTHOP SUR, V15, pS31, DOI 10.5435/00124635-200700001-00009; Dargel J, 2011, J ARTHROPLASTY, V26, P346, DOI 10.1016/j.arth.2009.12.019; Fehring TK, 2009, J BONE JOINT SURG AM, V91A, P2335, DOI 10.2106/JBJS.H.00834; Guy SP, 2012, KNEE, V19, P28, DOI 10.1016/j.knee.2010.12.005; Hitt K, 2003, J BONE JOINT SURG AM, V85A, P115, DOI 10.2106/00004623-200300004-00015; Ho WP, 2006, KNEE, V13, P12, DOI 10.1016/j.knee.2005.05.002; Iorio Richard, 2007, J Surg Orthop Adv, V16, P164; Kim HA, 2008, RHEUMATOLOGY, V47, P88, DOI 10.1093/rheumatology/kem308; Lim HC, 2013, KNEE, V20, P26, DOI 10.1016/j.knee.2012.05.010; Lonner JH, 2008, CLIN ORTHOP RELAT R, V466, P2724, DOI 10.1007/s11999-008-0415-0; MacDonald SJ, 2008, CLIN ORTHOP RELAT R, V466, P2612, DOI 10.1007/s11999-008-0430-1; Mahfouz M, 2012, CLIN ORTHOP RELAT R, V470, P172, DOI 10.1007/s11999-011-2089-2; Mahoney OM, 2010, J BONE JOINT SURG AM, V92A, P1115, DOI 10.2106/JBJS.H.00434; Merchant AC, 2008, CLIN ORTHOP RELAT R, V466, P3059, DOI 10.1007/s11999-008-0536-5; Mihalko W, 2006, CLIN ORTHOP RELAT R, P283, DOI 10.1097/01.blo.0000218756.89439.06; Pierson JL, 2007, J BONE JOINT SURG AM, V89A, P2195, DOI 10.2106/JBJS.E.01223; Plaster Rodney L, 2010, Am J Orthop (Belle Mead NJ), V39, P9; Poilvache PL, 1996, CLIN ORTHOP RELAT R, P35; Vaidya SV, 2000, J ARTHROPLASTY, V15, P79, DOI 10.1016/S0883-5403(00)91285-3; Yang B, 2013, J ARTHROPLASTY, V28, P1117, DOI 10.1016/j.arth.2012.07.036; Yang B, 2012, CHINESE MED J-PEKING, V125, P3952, DOI 10.3760/cma.j.issn.0366-6999.2012.22.007; Yue B, 2011, J ARTHROPLASTY, V26, P124, DOI 10.1016/j.arth.2009.11.020	28	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89394	10.1371/journal.pone.0089394	http://dx.doi.org/10.1371/journal.pone.0089394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586746	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900139
J	Evans, AH; Kettlewell, J; McGregor, S; Kotschet, K; Griffiths, RI; Horne, M				Evans, Andrew H.; Kettlewell, Jade; McGregor, Sarah; Kotschet, Katya; Griffiths, Robert I.; Horne, Malcolm			A Conditioned Response as a Measure of ImpulsiveCompulsive Behaviours in Parkinson's Disease	PLOS ONE			English	Article							IMPULSE CONTROL DISORDERS; HEDONISTIC HOMEOSTATIC DYSREGULATION; MOTOR FLUCTUATIONS; DOPAMINE RELEASE; DRUG-USE; COMPULSIVE BEHAVIORS; LEVODOPA; DYSKINESIAS; REWARD; PREVALENCE	Objectives: Parkinson's Disease patients wore a device on the wrist that gave reminders to take levodopa and also measured bradykinesia and dyskinesia. Consumption of medications was acknowledged by placing the thumb on the device. Some patients performed this acknowledgement repeatedly and unconsciously. This study examines whether this behaviour reflected increased impulsivity. Methods and Results: Twenty five participants were selected because they had i) excess acknowledgements described above or ii) Impulsive-Compulsive Behaviours or iii) neither of these. A blinded assessor applied clinical scales to measure Impulsive-Compulsive Behaviours, cognition, depression, anxiety and apathy. A Response Ratio, representing the number of acknowledgements/number of doses (expressed as a percentage) was tightly correlated with ratings of Impulsive Compulsive Behaviours (r(2) = 0.79) in 19/25 subjects. Some of these patients had dyskinesia, which was higher with extraneous responses than with response indicating medication consumption. Six of the 25 subjects had high ImpulsiveCompulsive Behaviour Scores, higher apathy scores, low levels of dyskinesia and normal Response Ratios. Patients without ICB (low RR) also had low dyskinesia levels regardless of the relevance of the response. Conclusion: An elevated Response Ratio is a specific measure of a type of ICB where increased incentive salience is attributed to cues by the presence of high striatal dopamine levels, manifested by high levels of dyskinesia. This study also points to a second form of ICBs which occur in the absence of dyskinesia, has normal Response Ratios and higher apathy scores, and may represent prefrontal pathology.	[Kettlewell, Jade; Kotschet, Katya; Griffiths, Robert I.; Horne, Malcolm] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [McGregor, Sarah; Kotschet, Katya; Horne, Malcolm] St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Evans, Andrew H.] Royal Melbourne Hosp, Parkville, Vic 3050, Australia; [Horne, Malcolm] St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; St Vincent's Hospital Melbourne; Royal Melbourne Hospital; St Vincent's Hospital Melbourne	Horne, M (corresponding author), Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia.	malcolm.horne@florey.edu.au	Horne, Malcolm/AAL-5214-2020; Kettlewell, Jade/AAV-6072-2020	Horne, Malcolm/0000-0001-9427-2100; Kettlewell, Jade/0000-0002-6713-4551	Medical Research Council Funds; National Health and Medical Research Council of Australia	Medical Research Council Funds; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by the Medical Research Council Funds. MH is a Medical Practitioner Fellow supported by the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bienfait KL, 2010, J CLIN NEUROSCI, V17, P539, DOI 10.1016/j.jocn.2009.09.001; Bonfanti AB, 2010, PARKINSONISM RELAT D, V16, P358, DOI 10.1016/j.parkreldis.2010.02.004; Claassen DO, 2011, BEHAV NEUROSCI, V125, P492, DOI 10.1037/a0023795; Evans AH, 2006, ANN NEUROL, V59, P852, DOI 10.1002/ana.20822; Evans AH, 2004, MOVEMENT DISORD, V19, P397, DOI 10.1002/mds.20045; Evans AH, 2005, NEUROLOGY, V65, P1570, DOI 10.1212/01.wnl.0000184487.72289.f0; Evans AH, 2012, PARKINSONISM RELAT D, V18, P514, DOI 10.1016/j.parkreldis.2012.01.020; Evans AH, 2010, MOVEMENT DISORD, V25, P867, DOI 10.1002/mds.22898; Fabbrini G, 2007, MOVEMENT DISORD, V22, P1379, DOI 10.1002/mds.21475; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Giovannoni G, 2000, J NEUROL NEUROSUR PS, V68, P423, DOI 10.1136/jnnp.68.4.423; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Griffiths RI, 2012, J PARKINSON DIS, V2, P47, DOI 10.3233/JPD-2012-11071; HELY MA, 1994, J NEUROL NEUROSUR PS, V57, P903, DOI 10.1136/jnnp.57.8.903; Kempster PA, 2007, BRAIN, V130, P2123, DOI 10.1093/brain/awm142; Lee J, 2008, BRAIN, V131, P1574, DOI 10.1093/brain/awn085; Leentjens AFG, 2000, MOVEMENT DISORD, V15, P1221, DOI 10.1002/1531-8257(200011)15:6<1221::AID-MDS1024>3.0.CO;2-H; Macphee GJA, 2013, BRIT J HOSP MED, V74, P160, DOI 10.12968/hmed.2013.74.3.160; Marinus J, 2003, NEUROLOGY, V61, P1222, DOI 10.1212/01.WNL.0000091864.39702.1C; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; McColl CD, 2002, MOVEMENT DISORD, V17, P1227, DOI 10.1002/mds.10244; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Miyasaki JM, 2007, MOVEMENT DISORD, V22, P1179, DOI 10.1002/mds.21296; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; NUTT JG, 1995, CLIN EXP PHARMACOL P, V22, P837, DOI 10.1111/j.1440-1681.1995.tb01946.x; O'Sullivan SS, 2011, J NEUROL NEUROSUR PS, V82, P620, DOI 10.1136/jnnp.2009.186874; O'Sullivan SS, 2011, BRAIN, V134, P969, DOI 10.1093/brain/awr003; O'Sullivan SS, 2010, MOVEMENT DISORD, V25, P1026, DOI 10.1002/mds.23016; Pavese N, 2006, NEUROLOGY, V67, P1612, DOI 10.1212/01.wnl.0000242888.30755.5d; Pezzella FR, 2005, MOVEMENT DISORD, V20, P77, DOI 10.1002/mds.20288; Porrino LJ, 2007, PROG NEURO-PSYCHOPH, V31, P1593, DOI 10.1016/j.pnpbp.2007.08.040; Rabinak CA, 2010, ARCH NEUROL-CHICAGO, V67, P58, DOI 10.1001/archneurol.2009.294; Randolph JJ, 2008, ONLINE KAPPA CALCULA; Reardon KA, 1999, MOVEMENT DISORD, V14, P605, DOI 10.1002/1531-8257(199907)14:4<605::AID-MDS1009>3.0.CO;2-H; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Shotbolt P, 2012, PARKINSONISM RELAT D, V18, P10, DOI 10.1016/j.parkreldis.2011.08.016; SIEMERS ER, 1993, MOVEMENT DISORD, V8, P501, DOI 10.1002/mds.870080415; Silveira-Moriyama L, 2006, MOVEMENT DISORD, V21, P2214, DOI 10.1002/mds.21118; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; Varanese S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017846; Voon V, 2006, NEUROLOGY, V66, P1750, DOI 10.1212/01.wnl.0000218206.20920.4d; Voon V, 2011, CURR OPIN NEUROL, V24, P324, DOI 10.1097/WCO.0b013e3283489687; Voon V, 2011, ANN NEUROL, V69, P986, DOI 10.1002/ana.22356; Voon V, 2009, LANCET NEUROL, V8, P1140, DOI 10.1016/S1474-4422(09)70287-X; Weintraub D, 2006, ARCH NEUROL-CHICAGO, V63, P969, DOI 10.1001/archneur.63.7.969; Weintraub D, 2009, MOVEMENT DISORD, V24, P1461, DOI 10.1002/mds.22571; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	50	12	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89319	10.1371/journal.pone.0089319	http://dx.doi.org/10.1371/journal.pone.0089319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB6EP	24586685	Green Published, gold			2022-12-27	WOS:000331880700028
J	Montalvo, I; Gutierrez-Zotes, A; Creus, M; Monseny, R; Ortega, L; Franch, J; Lawrie, SM; Reynolds, RM; Vilella, E; Labad, J				Montalvo, Itziar; Gutierrez-Zotes, Alfonso; Creus, Marta; Monseny, Rosa; Ortega, Laura; Franch, Joan; Lawrie, Stephen M.; Reynolds, Rebecca M.; Vilella, Elisabet; Labad, Javier			Increased Prolactin Levels Are Associated with Impaired Processing Speed in Subjects with Early Psychosis	PLOS ONE			English	Article							CONSENSUS COGNITIVE BATTERY; ANTIPSYCHOTIC-DRUGS; SCHIZOPHRENIA; HYPERPROLACTINEMIA; METAANALYSIS; HALOPERIDOL; PERFORMANCE; OLANZAPINE; LESSONS; WOMEN	Hyperprolactinaemia, a common side effect of some antipsychotic drugs, is also present in drug-native psychotic patients and subjects at risk for psychosis. Recent studies in non-psychiatric populations suggest that increased prolactin may have negative effects on cognition. The aim of our study was to explore whether high plasma prolactin levels are associated with poorer cognitive functioning in subjects with early psychoses. We studied 107 participants: 29 healthy subjects and 78 subjects with an early psychosis (55 psychotic disorders with <3 years of illness, 23 high-risk subjects). Cognitive assessment was performed with the MATRICS Cognitive Consensus Cognitive Battery, and prolactin levels were determined as well as total cortisol levels in plasma. Psychopathological status was assessed and the use of psychopharmacological treatments (antipsychotics, antidepressants, benzodiazepines) recorded. Prolactin levels were negatively associated with cognitive performance in processing speed, in patients with a psychotic disorder and high-risk subjects. In the latter group, increased prolactin levels were also associated with impaired reasoning and problem solving and poorer general cognition. In a multiple linear regression analysis conducted in both high-risk and psychotic patients, controlling for potential confounders, prolactin and benzodiazepines were independently related to poorer cognitive performance in the speed of processing domain. A mediation analysis showed that both prolactin and benzodiazepine treatment act as mediators of the relationship between risperidone/paliperidone treatment and speed of processing. These results suggest that increased prolactin levels are associated with impaired processing speed in early psychosis. If these results are confirmed in future studies, strategies targeting reduction of prolactin levels may improve cognition in this population.	[Montalvo, Itziar; Gutierrez-Zotes, Alfonso; Creus, Marta; Monseny, Rosa; Ortega, Laura; Franch, Joan; Vilella, Elisabet; Labad, Javier] Univ Rovira & Virgili, IISPV, Hosp Univ Inst Pere Mata, Early Psychosis Program,CIBERSAM, E-43201 Reus, Spain; [Montalvo, Itziar; Gutierrez-Zotes, Alfonso; Creus, Marta; Monseny, Rosa; Ortega, Laura; Franch, Joan; Vilella, Elisabet; Labad, Javier] Univ Rovira & Virgili, IISPV, Hosp Univ Inst Pere Mata, Res Dept,CIBERSAM, E-43201 Reus, Spain; [Lawrie, Stephen M.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland; [Reynolds, Rebecca M.] Univ Edinburgh, Queens Med Res Inst, Endocrinol Unit, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Labad, J (corresponding author), Univ Rovira & Virgili, IISPV, Hosp Univ Inst Pere Mata, Early Psychosis Program,CIBERSAM, C St Llorenc 21, E-43201 Reus, Spain.	labadj@peremata.com	Reynolds, Rebecca M/C-3044-2008; Lawrie, Stephen MacGregor/AAD-1607-2021; Ortega, Laura/M-7042-2019; Ortega, Laura/AAC-5621-2021; Labad, Javier/AAF-6632-2020	Reynolds, Rebecca M/0000-0001-6226-8270; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Ortega, Laura/0000-0003-2476-7700; Labad, Javier/0000-0003-2214-1886; Montalvo, Itziar/0000-0002-7320-5109	Fundacio La Marato de TV3 [092230/092231]; Instituto de Salud Carlos III (FIS) [PI10/01607]; Intensification of Research Activity [I3SNS-INT11/323]; Instituto de Salud Carlos III (Spain)	Fundacio La Marato de TV3; Instituto de Salud Carlos III (FIS)(Instituto de Salud Carlos III); Intensification of Research Activity; Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III)	This work was supported by grants from Fundacio La Marato de TV3 (092230/092231) and from Instituto de Salud Carlos III (FIS, PI10/01607). JL has received an Intensification of Research Activity grant (Programme I3SNS-INT11/323) from the Instituto de Salud Carlos III (Spain) during 2012 and 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDINGTON D, 1990, SCHIZOPHR RES, V3, P247, DOI 10.1016/0920-9964(90)90005-R; Aston J, 2010, PROG NEURO-PSYCHOPH, V34, P1342, DOI 10.1016/j.pnpbp.2010.02.019; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bilder RM, 2002, AM J PSYCHIAT, V159, P1018, DOI 10.1176/appi.ajp.159.6.1018; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Carpenter WT, 2002, BIOL PSYCHIAT, V51, P969, DOI 10.1016/S0006-3223(02)01399-9; Chew ML, 2006, SCHIZOPHR RES, V88, P63, DOI 10.1016/j.schres.2006.07.011; Cookson J, 2012, J PSYCHOPHARMACOL, V26, P42, DOI 10.1177/0269881112442016; Cuesta MJ, 2012, SCHIZOPHR RES, V141, P222, DOI 10.1016/j.schres.2012.08.019; Davidson M, 1999, AM J PSYCHIAT, V156, P1328; Dickinson D, 2008, BRIT J PSYCHIAT, V193, P354, DOI 10.1192/bjp.bp.108.049387; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Fitzgerald Peter, 2008, J Psychopharmacol, V22, P12, DOI 10.1177/0269216307087148; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P220, DOI 10.1001/archgenpsychiatry.2011.1472; Garcia-Rizo C, 2012, SCHIZOPHR RES, V134, P16, DOI 10.1016/j.schres.2011.07.025; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Green MF, 1996, AM J PSYCHIAT, V153, P321; Halbreich Uriel, 2003, J Psychiatr Pract, V9, P344, DOI 10.1097/00131746-200309000-00003; Harvey PD, 2001, AM J PSYCHIAT, V158, P176, DOI 10.1176/appi.ajp.158.2.176; Harvey PD, 2003, J CLIN PSYCHIAT, V64, P33; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Henry JF, 2012, BEHAV NEUROSCI, V126, P73, DOI 10.1037/a0025540; Inder WJ, 2011, AUST NZ J PSYCHIAT, V45, P830, DOI 10.3109/00048674.2011.589044; Johnsen E, 2011, ADV UROL, V2011, DOI 10.1155/2011/686924; KAY SR, 1990, J NERV MENT DIS, V178, P510, DOI 10.1097/00005053-199017880-00007; Keefe RSE, 1999, SCHIZOPHRENIA BULL, V25, P201, DOI 10.1093/oxfordjournals.schbul.a033374; Keefe RSE, 2004, AM J PSYCHIAT, V161, P985, DOI 10.1176/appi.ajp.161.6.985; Kelleher I, 2012, COGN NEUROPSYCHIATRY; Lee BJ, 2013, CLIN PSYCHOPHARM NEU, V11, P60, DOI 10.9758/cpn.2013.11.2.60; Lennartsson AK, 2011, PSYCHONEUROENDOCRINO, V36, P1530, DOI 10.1016/j.psyneuen.2011.04.007; Maguire GA, 2002, J CLIN PSYCHIAT, V63, P56; Mishara AL, 2004, BIOL PSYCHIAT, V55, P1013, DOI 10.1016/j.biopsych.2004.01.027; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Ojeda N, 2008, SCHIZOPHR RES, V101, P225, DOI 10.1016/j.schres.2007.12.483; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Purdon SE, 2001, J PSYCHIATR NEUROSCI, V26, P137; Reichenberg A, 2005, ARCH GEN PSYCHIAT, V62, P1297, DOI 10.1001/archpsyc.62.12.1297; Riecher-Rossler A, 2009, BIOL PSYCHIAT, V66, P1023, DOI 10.1016/j.biopsych.2009.07.020; Riecher-Rossler A, 2013, PSYCHOL MED, P1; Rodriguez-Jimenez R, 2012, SCHIZOPHR RES, V134, P279, DOI 10.1016/j.schres.2011.11.026; Segarra R, 2011, EUR ARCH PSY CLIN N, V261, P241, DOI 10.1007/s00406-010-0146-6; Sherwin BB, 2012, BEHAV NEUROSCI, V126, P123, DOI 10.1037/a0025539; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Stewart SA, 2005, J CLIN PSYCHIAT, V66, P9; Torner L, 2013, BEHAV BRAIN RES, V252, P32, DOI 10.1016/j.bbr.2013.05.031; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Wolf OT, 2002, HORM BEHAV, V41, P259, DOI 10.1006/hbeh.2002.1770; Woodward ND, 2007, SCHIZOPHR RES, V89, P211, DOI 10.1016/j.schres.2006.08.021; Yung AR, 1998, BRIT J PSYCHIAT, V172, P14, DOI 10.1192/S0007125000297602; Zhang XB, 2013, PSYCHIAT RES, V209, P239, DOI 10.1016/j.psychres.2013.04.026	50	26	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89428	10.1371/journal.pone.0089428	http://dx.doi.org/10.1371/journal.pone.0089428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586772	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700042
J	Pan, S; Wu, DJ; Teschendorff, AE; Hong, T; Wang, LY; Qian, MJ; Wang, CS; Wang, XD				Pan, Sun; Wu, Duojiao; Teschendorff, Andrew E.; Hong, Tao; Wang, Linyan; Qian, Mengjia; Wang, Chunsheng; Wang, Xiangdong			JAK2-Centered Interactome Hotspot Identified by an Integrative Network Algorithm in Acute Stanford Type A Aortic Dissection	PLOS ONE			English	Article							GENE-EXPRESSION; INTERLEUKIN-6; INFLAMMATION; ABNORMALITIES; ANEURYSMS; PCR	The precise mechanisms underlying dissections, especially those without connective tissue diseases or congenital vascular diseases, are incompletely understood. This study attempted to identify both the expression profile of the dissected ascending aorta and the interactome hotspots associated with the disease, using microarray technology and gene regulatory network analysis. There were 2,737 genes differentially expressed between patients with acute Stanford type A aortic dissection and controls. Eight interactome hotspots significantly associated with aortic dissection were identified by an integrative network algorithm. In particular, we identified a JAK2-centered expression module, which was validated in an independent gene expression microarray data set, and which was characterized by over-expressed cytokines and receptors in acute aortic dissection cases, indicating that JAK2 may play a key role in the inflammatory process, which potentially contributes to the occurrence of acute aortic dissection. Overall, the analytical strategy used in this study offered the possibility to identify functional relevant network modules and subsequently facilitated the biological interpretation in the complicated disease.	[Pan, Sun; Hong, Tao; Wang, Chunsheng] Fudan Univ, Zhongshan Hosp, Dept Cardiac Surg, Shanghai 200433, Peoples R China; [Wu, Duojiao; Wang, Linyan; Qian, Mengjia; Wang, Xiangdong] Fudan Univ, Biomed Res Ctr, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Teschendorff, Andrew E.] UCL, UCL Canc Inst, London, England; [Teschendorff, Andrew E.] CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China	Fudan University; Fudan University; University of London; University College London; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Wang, CS (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Cardiac Surg, Shanghai 200433, Peoples R China.	wangchunsheng1964@163.com; xiangdong.wang@clintransmed.org	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341	National Key Technologies R & D Program of China [2011BA11B20]	National Key Technologies R & D Program of China(National Key Technology R&D Program)	This work was supported by a grant from the National Key Technologies R & D Program of China during the Twelfth Five-Year Plan Period (No. 2011BA11B20) (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057739; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Canadas V, 2010, NAT REV CARDIOL, V7, P256, DOI 10.1038/nrcardio.2010.30; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chandesris MO, 2012, CIRC-CARDIOVASC GENE, V5, P25, DOI 10.1161/CIRCGENETICS.111.961235; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Dawson J, 2007, J VASC SURG, V45, P350, DOI 10.1016/j.jvs.2006.09.049; Del Porto F, 2010, ANN MED, V42, P622, DOI 10.3109/07853890.2010.518156; Freeman AF, 2011, J CLIN IMMUNOL, V31, P338, DOI 10.1007/s10875-011-9515-9; Golledge J, 2008, LANCET, V372, P55, DOI 10.1016/S0140-6736(08)60994-0; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; Ikeda U, 2001, CLIN CARDIOL, V24, P701, DOI 10.1002/clc.4960241103; Jones KG, 2001, CIRCULATION, V103, P2260; Liu ZP, 2012, IET SYST BIOL, V6, P22, DOI 10.1049/iet-syb.2010.0052; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; Meszaros I, 2000, CHEST, V117, P1271, DOI 10.1378/chest.117.5.1271; Nespital T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049374; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; O'Keefe JH, 2009, MAYO CLIN PROC, V84, P741, DOI 10.1016/S0025-6196(11)60525-9; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Schieffer B, 2000, CIRCULATION, V101, P1372, DOI 10.1161/01.CIR.101.12.1372; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutton SA, 2005, CLIN IMMUNOL, V115, P51, DOI 10.1016/j.clim.2005.02.006; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Weis-Muller BT, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-29; West J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01630; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253	34	16	17	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89406	10.1371/journal.pone.0089406	http://dx.doi.org/10.1371/journal.pone.0089406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586754	gold, Green Submitted, Green Published			2022-12-27	WOS:000331880700038
J	Chognard, G; Bellemare, L; Pelletier, AN; Dominguez-Punaro, MC; Beauchamp, C; Guyon, MJ; Charron, G; Morin, N; Sivanesan, D; Kuchroo, V; Xavier, R; Michnick, SW; Chemtob, S; Rioux, JD; Lesage, S				Chognard, Gaelle; Bellemare, Lisa; Pelletier, Adam-Nicolas; Dominguez-Punaro, Maria C.; Beauchamp, Claudine; Guyon, Marie-Josee; Charron, Guy; Morin, Nicolas; Sivanesan, Durga; Kuchroo, Vijay; Xavier, Ramnik; Michnick, Stephen W.; Chemtob, Sylvain; Rioux, John D.; Lesage, Sylvie			The Dichotomous Pattern of IL-12R and IL-23R Expression Elucidates the Role of IL-12 and IL-23 in Inflammation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PRIMARY BILIARY-CIRRHOSIS; IL-17-PRODUCING T-CELLS; INNATE LYMPHOID-CELLS; TISSUE-INDUCER CELLS; BOWEL-DISEASE GENE; ROR-GAMMA-T; SUSCEPTIBILITY LOCI; DENDRITIC CELLS; CROHNS-DISEASE	IL-12 and IL-23 cytokines respectively drive Th1 and Th17 type responses. Yet, little is known regarding the biology of these receptors. As the IL-12 and IL-23 receptors share a common subunit, it has been assumed that these receptors are co-expressed. Surprisingly, we find that the expression of each of these receptors is restricted to specific cell types, in both mouse and human. Indeed, although IL-12R beta 2 is expressed by NK cells and a subset of gamma delta T cells, the expression of IL-23R is restricted to specific T cell subsets, a small number of B cells and innate lymphoid cells. By exploiting an IL-12- and IL-23-dependent mouse model of innate inflammation, we demonstrate an intricate interplay between IL-12R beta 2 NK cells and IL-23R innate lymphoid cells with respectively dominant roles in the regulation of systemic versus local inflammatory responses. Together, these findings support an unforeseen lineage-specific dichotomy in the in vivo role of both the IL-12 and IL-23 pathways in pathological inflammatory states, which may allow more accurate dissection of the roles of these receptors in chronic inflammatory diseases in humans.	[Chognard, Gaelle; Bellemare, Lisa; Pelletier, Adam-Nicolas; Dominguez-Punaro, Maria C.; Guyon, Marie-Josee; Lesage, Sylvie] Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada; [Chognard, Gaelle; Bellemare, Lisa; Pelletier, Adam-Nicolas; Lesage, Sylvie] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Beauchamp, Claudine; Charron, Guy; Morin, Nicolas; Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Sivanesan, Durga; Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Kuchroo, Vijay] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA USA; [Xavier, Ramnik] Harvard Univ, Sch Med, Div Med Sci, Boston, MA USA; [Chemtob, Sylvain] Ctr Hosp Univ Ste Justine Res Ctr, Dept Pediat, Montreal, PQ, Canada; [Chemtob, Sylvain] Ctr Hosp Univ Ste Justine Res Ctr, Dept Ophthalmol, Montreal, PQ, Canada; [Chemtob, Sylvain] Ctr Hosp Univ Ste Justine Res Ctr, Dept Pharmacol, Montreal, PQ, Canada; [Rioux, John D.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Universite de Montreal	Lesage, S (corresponding author), Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada.	Sylvie.lesage@umontreal.ca	Rioux, John D/A-9599-2015	Rioux, John D/0000-0001-7560-8326; Lesage, Sylvie/0000-0002-0968-2795	Canadian Institutes of Health Research [102170]; Crohn's and Colitis Foundation of Canada; Pfizer-FRSQ Innovation Fund [17199]; Universite de Montreal Faculte de medecine Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Foundation of Canada; Pfizer-FRSQ Innovation Fund; Universite de Montreal Faculte de medecine Scholarship	This work was supported by an award (CIHR # 102170) from the Canadian Institutes of Health Research to the "CIHR Emerging Team in Integrative Biology of Inflammatory Diseases'' (awarded to JDR, SC, SL, SM), with co-funding from the Crohn's and Colitis Foundation of Canada made possible by a generous donation from the Ross McMaster Memorial Fund, and by an award (FRSQ# 17199) from the Pfizer-FRSQ Innovation Fund (awarded to JDR, SC, SL, SM). LB and ANP are recipients of a Universite de Montreal Faculte de medecine Scholarship. SL holds a CIHR New Investigator Award. JDR holds the Canada Research Chair in Genetics and Genomic Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi I, 2005, BLOOD, V106, P3846, DOI 10.1182/blood-2005-05-2034; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Belladonna ML, 2002, J IMMUNOL, V168, P5448, DOI 10.4049/jimmunol.168.11.5448; Benson JM, 2011, NAT BIOTECHNOL, V29, P615, DOI 10.1038/nbt.1903; Buonocore S, 2010, NATURE; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Chakir H, 2000, J IMMUNOL, V165, P4985, DOI 10.4049/jimmunol.165.9.4985; Cocco C, 2011, J LEUKOCYTE BIOL, V89, P729, DOI 10.1189/jlb.1210660; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Cox JH, 2012, MUCOSAL IMMUNOL, V5, P99, DOI 10.1038/mi.2011.54; Cummings JAF, 2007, INFLAMM BOWEL DIS, V13, P1063, DOI 10.1002/ibd.20180; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eisenring M, 2010, NAT IMMUNOL, V11, P1030, DOI 10.1038/ni.1947; Eken A, 2013, MUCOSAL IMMUNOL; Filer C, 2008, ARTHRITIS RHEUM-US, V58, P3705, DOI 10.1002/art.24128; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hoeman CM, 2013, J IMMUNOL, V190, P6155, DOI 10.4049/jimmunol.1202207; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kim SW, 2011, GUT, V60, P1527, DOI 10.1136/gut.2011.238477; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; KORN T, 2009, ANN REV IMMUNOL; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Ludviksson BR, 1999, J IMMUNOL, V163, P4349; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Novick D, 2013, SEMIN IMMUNOL; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Puren AJ, 1999, P NATL ACAD SCI USA, V96, P2256, DOI 10.1073/pnas.96.5.2256; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Riol-Blanco L, 2010, J IMMUNOL, V184, P1710, DOI 10.4049/jimmunol.0902796; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Sarin R, 2011, P NATL ACAD SCI USA, V108, P9560, DOI 10.1073/pnas.1017854108; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Smeltz RB, 2002, J IMMUNOL, V168, P6165, DOI 10.4049/jimmunol.168.12.6165; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Takeuchi M, 1997, CELL TISSUE RES, V289, P499, DOI 10.1007/s004410050895; Tokumasa N, 2007, BLOOD, V110, P553, DOI 10.1182/blood-2006-11-059246; Torti DC, 2007, J AM ACAD DERMATOL, V57, P1059, DOI 10.1016/j.jaad.2007.07.016; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri Giorgio, 1992, Progress in Growth Factor Research, V4, P355, DOI 10.1016/0955-2235(92)90016-B; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Wong RH, 2012, J RHEUMATOL, V39, P135, DOI 10.3899/jrheum.110613; Yamazaki K, 2007, J HUM GENET, V52, P575, DOI 10.1007/s10038-007-0156-z; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	59	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89092	10.1371/journal.pone.0089092	http://dx.doi.org/10.1371/journal.pone.0089092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586521	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900049
J	Krepelova, A; Neri, F; Maldotti, M; Rapelli, S; Oliviero, S				Krepelova, Anna; Neri, Francesco; Maldotti, Mara; Rapelli, Stefania; Oliviero, Salvatore			Myc and Max Genome-Wide Binding Sites Analysis Links the Myc Regulatory Network with the Polycomb and the Core Pluripotency Networks in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							C-MYC; SELF-RENEWAL; TRANSCRIPTION; GENE; EXPRESSION; EVOLUTION; ENHANCERS; PROTEIN	Myc is a master transcription factor that has been demonstrated to be required for embryonic stem cell (ESC) pluripotency, self-renewal, and inhibition of differentiation. Although recent works have identified several Myc-targets in ESCs, the list of Myc binding sites is largely incomplete due to the low sensitivity and specificity of the antibodies available. To systematically identify Myc binding sites in mouse ESCs, we used a stringent streptavidin-based genome-wide chromatin immunoprecipitation (ChIP-Seq) approach with biotin-tagged Myc (Bio-Myc) as well as a ChIP-Seq of the Myc binding partner Max. This analysis identified 4325 Myc binding sites, of which 2885 were newly identified. The identified sites overlap with more than 85% of the Max binding sites and are enriched for H3K4me3-positive promoters and active enhancers. Remarkably, this analysis unveils that Myc/Max regulates chromatin modifiers and transcriptional regulators involved in stem cell self-renewal linking the Myc-centered network with the Polycomb and the Core networks. These results provide insights into the contribution of Myc and Max in maintaining stem cell self-renewal and keeping these cells in an undifferentiated state.	[Krepelova, Anna; Neri, Francesco; Maldotti, Mara; Rapelli, Stefania; Oliviero, Salvatore] Human Genet Fdn HuGeF, Turin, Italy; [Krepelova, Anna; Neri, Francesco; Rapelli, Stefania; Oliviero, Salvatore] Univ Siena, Dipartimento Biotecnol Chim & Farm, I-53100 Siena, Italy; [Krepelova, Anna; Neri, Francesco; Oliviero, Salvatore] Dipartimento Sci Vita & Biol Sistemi, Turin, Italy	University of Siena	Oliviero, S (corresponding author), Human Genet Fdn HuGeF, Turin, Italy.	salvatore.oliviero@hugef-torino.org	oliviero, salvatore/R-6657-2019; Neri, Francesco/A-3321-2014	oliviero, salvatore/0000-0002-3405-765X; Neri, Francesco/0000-0003-3903-1974; Maldotti, Mara/0000-0002-3299-9053; Krepelova, Anna/0000-0002-2775-1336	Associazione Italiana Ricerca sul Cancro (AIRC) [IG 2011-11982]; Regione Toscana programma salute; Ministero della Salute Bando Cellule Staminali	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Regione Toscana programma salute(Regione Toscana); Ministero della Salute Bando Cellule Staminali	This work was supported by the Associazione Italiana Ricerca sul Cancro (AIRC) IG 2011-11982; Regione Toscana programma salute; and Ministero della Salute Bando Cellule Staminali. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Evellin S, 2013, MOL CELL BIOL, V33, P1198, DOI 10.1128/MCB.01054-12; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; KATO GJ, 1992, GENE DEV, V6, P81, DOI 10.1101/gad.6.1.81; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Neri F, 2012, MOL CELL BIOL, V32, P840, DOI 10.1128/MCB.06148-11; Smith KN, 2011, CELL CYCLE, V10, P592, DOI 10.4161/cc.10.4.14792; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	26	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88933	10.1371/journal.pone.0088933	http://dx.doi.org/10.1371/journal.pone.0088933			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586446	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900040
J	Yang, LL; Leung, H; Peterson, DA; Sejnowski, TJ; Poizner, H				Yang, Lingling; Leung, Howard; Peterson, David A.; Sejnowski, Terrence J.; Poizner, Howard			Toward a Semi-Self-Paced EEG Brain Computer Interface: Decoding Initiation State from Non-Initiation State in Dedicated Time Slots	PLOS ONE			English	Article							ASYNCHRONOUS BCI; MOTOR IMAGERY; COMMUNICATION	dBrain computer interfaces (BCIs) offer a broad class of neurologically impaired individuals an alternative means to interact with the environment. Many BCIs are "synchronous'' systems, in which the system sets the timing of the interaction and tries to infer what control command the subject is issuing at each prompting. In contrast, in "asynchronous'' BCIs subjects pace the interaction and the system must determine when the subject's control command occurs. In this paper we propose a new idea for BCI which draws upon the strengths of both approaches. The subjects are externally paced and the BCI is able to determine when control commands are issued by decoding the subject's intention for initiating control in dedicated time slots. A single task with randomly interleaved trials was designed to test whether it can be used as stimulus for inducing initiation and non-initiation states when the sensory and motor requirements for the two types of trials are very nearly identical. Further, the essential problem on the discrimination between initiation state and non-initiation state was studied. We tested the ability of EEG spectral power to distinguish between these two states. Among the four standard EEG frequency bands, beta band power recorded over parietal-occipital cortices provided the best performance, achieving an average accuracy of 86% for the correct classification of initiation and non-initiation states. Moreover, delta band power recorded over parietal and motor areas yielded a good performance and thus could also be used as an alternative feature to discriminate these two mental states. The results demonstrate the viability of our proposed idea for a BCI design based on conventional EEG features. Our proposal offers the potential to mitigate the signal detection challenges of fully asynchronous BCIs, while providing greater flexibility to the subject than traditional synchronous BCIs.	[Yang, Lingling; Leung, Howard] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Peterson, David A.; Poizner, Howard] Univ Calif San Diego, Inst Neural Computat, La Jolla, CA 92093 USA; [Peterson, David A.; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Poizner, Howard] Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA	City University of Hong Kong; University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Yang, LL (corresponding author), City Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China.	linglyang2-c@my.cityu.edu.hk	Sejnowski, Terrence/AAV-5558-2021	LEUNG, Wing Ho Howard/0000-0002-2633-2965	National Science Foundation (NSF) [SMA-1041755, NSF ENG-1137279]; ONR MURI Award [N00014-10-1-0072]; Emerging Frontiers & Multidisciplinary Activities [1137279] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); ONR MURI Award(MURI); Emerging Frontiers & Multidisciplinary Activities(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding from National Science Foundation (NSF) grant # SMA-1041755 & NSF ENG-1137279 (EFRI M3C), ONR MURI Award No.: N00014-10-1-0072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Borisoff JF, 2006, IEEE T NEUR SYS REH, V14, P160, DOI 10.1109/TNSRE.2006.875526; Cecotti H, 2010, IEEE T NEUR SYS REH, V18, P127, DOI 10.1109/TNSRE.2009.2039594; Chae Y, 2012, IEEE T ROBOT, V28, P1131, DOI 10.1109/TRO.2012.2201310; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cincotti F, 2008, BRAIN RES BULL, V75, P796, DOI 10.1016/j.brainresbull.2008.01.007; Delorme A, 2007, J NEUROSCI METH, V134, P9; Diez PF, 2013, MED ENG PHYS, V35, P1155, DOI 10.1016/j.medengphy.2012.12.005; Diez PF, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-39; Dobkin BH, 2007, J PHYSIOL-LONDON, V579, P637, DOI 10.1113/jphysiol.2006.123067; Garrett D, 2003, IEEE T NEUR SYS REH, V11, P141, DOI 10.1109/TNSRE.2003.814441; Hasan BAS, 2012, COMPUT BIOL MED, V42, P598, DOI 10.1016/j.compbiomed.2012.02.004; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Kus R, 2012, IEEE T NEUR SYS REH, V20, P823, DOI 10.1109/TNSRE.2012.2214789; Leeb Robert, 2007, Comput Intell Neurosci, P79642, DOI 10.1155/2007/79642; Mason SG, 2000, IEEE T BIO-MED ENG, V47, P1297, DOI 10.1109/10.871402; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; Millan JD, 2003, IEEE T NEUR SYS REH, V11, P159, DOI 10.1109/TNSRE.2003.814435; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2002, HUM BRAIN MAPP, V17, P179, DOI 10.1002/hbm.10061; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Parra LC, 2008, IEEE SIGNAL PROC MAG, V25, P107, DOI 10.1109/MSP.2008.4408447; Peterson DA, 2009, NEUROSCIENCE, V163, P1092, DOI 10.1016/j.neuroscience.2009.07.033; Peterson DA, 2011, NEUROIMAGE, V54, P1385, DOI 10.1016/j.neuroimage.2010.09.051; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Power SD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066004; Ramos-Murguialday A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047048; Scherer R, 2008, IEEE T BIO-MED ENG, V55, P675, DOI 10.1109/TBME.2007.903709; Scholler S, 2012, IEEE T IMAGE PROCESS, V21, P2619, DOI 10.1109/TIP.2012.2187672; Subha DP, 2010, J MED SYST, V34, P195, DOI 10.1007/s10916-008-9231-z; Townsend G, 2004, IEEE T NEUR SYS REH, V12, P258, DOI 10.1109/TNSRE.2004.827220; Tuladhar AM, 2007, HUM BRAIN MAPP, V28, P785, DOI 10.1002/hbm.20306; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Zhang D, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026016	36	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88915	10.1371/journal.pone.0088915	http://dx.doi.org/10.1371/journal.pone.0088915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586440	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900039
J	Johnson, JL; Shi, Y; Snipes, R; Janmohamed, S; Rolfe, TE; Davis, B; Postle, A; Macphee, CH				Johnson, Joel L.; Shi, Yi; Snipes, Rose; Janmohamed, Salim; Rolfe, Timothy E.; Davis, Bill; Postle, Anthony; Macphee, Colin H.		Study Investigators	Effect of Darapladib Treatment on Endarterectomy Carotid Plaque Lipoprotein-Associated Phospholipase A(2) Activity: A Randomized, Controlled Trial	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ATHEROSCLEROTIC PLAQUE; RISK; EXPRESSION; LYSOPHOSPHATIDYLCHOLINE; STABILIZATION; INHIBITION; RATIONALE; LP-PLA(2); BIOLOGY	Background: The aim of this study was to assess the effects of darapladib, a selective oral investigational lipoprotein-associated phospholipase A(2) inhibitor, on both plasma and plaque lipoprotein-associated phospholipase A(2) activity. Methods: Patients undergoing elective carotid endarterectomy were randomized to darapladib 40 mg (n = 34), 80 mg (n = 34), or placebo (n = 34) for 14 days, followed by carotid endarterectomy 24 hours after the last dose of study medication. Results: Darapladib 40 mg and 80 mg reduced plasma lipoprotein-associated phospholipase A(2) activity by 52% and 81%, respectively, versus placebo (both P < 0.001). Significant reductions in plaque lipoprotein-associated phospholipase A(2) activity were also observed compared with placebo (P < 0.0001), which equated to a 52% and 80% decrease compared with placebo. No significant differences were observed between groups in plaque lysophosphatidylcholine content or other biomarkers, although a dose-dependent decrease in plaque matrix metalloproteinase-9 mRNA expression was observed with darapladib 80 mg (P = 0.053 vs placebo). In a post-hoc analysis, plaque caspase-3 (P < 0.001) and caspase-8 (P < 0.05) activity were found to be significantly lower in the darapladib 80-mg group versus placebo. No major safety concerns were identified in the study. Conclusions: Short-term treatment (14 +/- 64 days) with darapladib produced a robust, dose-dependent reduction in plasma lipoprotein-associated phospholipase A(2) activity. More importantly, darapladib demonstrated placebo-corrected reductions in carotid plaque lipoprotein-associated phospholipase A(2) activity of similar magnitude. Darapladib was generally well tolerated and no safety concerns were identified. Additional studies of longer duration are needed to explore whether these pharmacodynamic effects are associated with improved clinical outcomes, as might be hypothesized.	[Johnson, Joel L.; Snipes, Rose] GlaxoSmithKline, Res Triangle Pk, NC USA; [Shi, Yi] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Janmohamed, Salim; Rolfe, Timothy E.] GlaxoSmithKline, Stockley Pk, Middx, England; [Davis, Bill] GlaxoSmithKline, Addenbrook, Cambridge, England; [Postle, Anthony] Univ Southampton, Southampton, Hants, England; [Macphee, Colin H.] GlaxoSmithKline, King Of Prussia, PA 19406 USA	GlaxoSmithKline; Jefferson University; GlaxoSmithKline; GlaxoSmithKline; University of Southampton; GlaxoSmithKline	Macphee, CH (corresponding author), GlaxoSmithKline, King Of Prussia, PA 19406 USA.	Colin.H.Macphee@gsk.com		Rolfe, Timothy/0000-0001-8798-840X; Postle, Anthony/0000-0001-7361-0756	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	Funding for this study was provided by GlaxoSmithKline (www.gsk.com). The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Carpenter KLH, 2001, FEBS LETT, V505, P357, DOI 10.1016/S0014-5793(01)02840-X; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Davis B, 2008, J BIOL CHEM, V283, P6428, DOI 10.1074/jbc.M709970200; Dembowski E, 2009, J CARDIOPULM REHABIL, V29, P2, DOI 10.1097/HCR.0b013e318192754e; Ferguson JF, 2012, J AM COLL CARDIOL, V59, P764, DOI 10.1016/j.jacc.2011.11.019; Fiotti N, 2011, ATHEROSCLEROSIS, V215, P153, DOI 10.1016/j.atherosclerosis.2010.12.010; Goncalves I, 2012, ARTERIOSCL THROM VAS, V32, P1505, DOI 10.1161/ATVBAHA.112.249854; Herrmann J, 2009, EUR HEART J, V30, P2930, DOI 10.1093/eurheartj/ehp309; Johnson A, 2004, CIRCULATION, V110, P590; Kolodgie FD, 2006, ARTERIOSCL THROM VAS, V26, P2523, DOI 10.1161/01.ATV.0000244681.72738.bc; Mannheim D, 2008, STROKE, V39, P1448, DOI 10.1161/STROKEAHA.107.503193; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; O'Donoghue ML, 2011, AM HEART J, V162, P613, DOI 10.1016/j.ahj.2011.07.018; Oei HHS, 2005, CIRCULATION, V111, P570, DOI 10.1161/01.CIR.0000154553.12214.CD; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Sluijter JPG, 2006, STROKE, V37, P235, DOI 10.1161/01.STR.0000196986.50059.e0; Stafforini DM, 2009, CARDIOVASC DRUG THER, V23, P73, DOI 10.1007/s10557-008-6133-8; STAFFORINI DM, 1990, J BIOL CHEM, V265, P9682; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; Vickers KC, 2009, J LIPID RES, V50, P1735, DOI 10.1194/jlr.M800342-JLR200; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023425; White H, 2010, AM HEART J, V160, P655, DOI 10.1016/j.ahj.2010.07.006; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870; Wilensky RL, 2009, CURR OPIN LIPIDOL, V20, P415, DOI 10.1097/MOL.0b013e3283307c16; Zalewski A, 2005, ARTERIOSCL THROM VAS, V25, P923, DOI 10.1161/01.ATV.0000160551.21962.a7	26	10	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89034	10.1371/journal.pone.0089034	http://dx.doi.org/10.1371/journal.pone.0089034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586490	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000331714700052
J	Baby, N; Li, YL; Ling, EA; Lu, J; Dheen, ST				Baby, Nimmi; Li, Yali; Ling, Eng-Ang; Lu, Jia; Dheen, S. Thameem			Runx1t1 (Runt-Related Transcription Factor 1; Translocated to, 1) Epigenetically Regulates the Proliferation and Nitric Oxide Production of Microglia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITOR; CELL-CYCLE PROGRESSION; TRAUMATIC BRAIN-INJURY; FUSION PARTNER; AMYLOID-BETA; ETO; ACTIVATION; COREPRESSOR; EXPRESSION	Background: Microglia, the resident immune cells of the brain, undergo rapid proliferation and produce several proinflammatory molecules and nitric oxide (NO) when activated in neuropathological conditions. Runx1t1 (Runt-related transcription factor 1, translocated to 1) has been implicated in recruiting histone deacetylases (HDACs) for transcriptional repression, thereby regulating cell proliferation. In the present study, Runx1t1 expression was shown to localize in amoeboid microglial cells of the postnatal rat brain, being hardly detectable in ramified microglia of the adult brain. Moreover, a marked expression of Runx1t1 was induced and translocated to nuclei in activated microglia in vitro and in vivo. In view of these findings, it was hypothesized that Runx1t1 regulates microglial functions during development and in neuropathological conditions. Methods and Findings: siRNA-mediated knockdown of Runx1t1 significantly decreased the expression level of cell cycle-related gene, cyclin-dependent kinase 4 (Cdk4) and proliferation index in activated BV2 microglia. It was also shown that HDAC inhibitor (HDACi) treatment mimics the effects of Runx1t1 knockdown on microglial proliferation, confirming that microglial proliferation is associated with Runx1t1 expression and HDACs activity. Further, Runx1t1 and HDACs were shown to promote neurotoxic effect of microglia by repressing expression of LAT2, L-aminoacid transporter-2 (cationic amino acid transporter, y+ system), which normally inhibits NO production. This was confirmed by chromatin immunoprecipitation (ChIP) assay, which revealed that Runx1t1 binds to the promoter region of LAT2 and this binding increased upon microglial activation. However, the enhanced binding of Runx1t1 to the LAT2 promoter could not repress the LAT2 expression when the BV2 microglia cells were treated with HDACi, indicating that Runx1t1 requires HDACs to transcriptionally repress the expression of LAT2. Conclusion/Interpretation: In conclusion, it is suggested that Runx1t1 controls proliferation and the neurotoxic effect of microglia by epigenetically regulating Cdk4 and LAT2 via its interaction with HDACs.	[Baby, Nimmi; Li, Yali; Ling, Eng-Ang; Dheen, S. Thameem] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Lu, Jia] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore	National University of Singapore	Dheen, ST (corresponding author), Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117548, Singapore.	antstd@nus.edu.sg	Dheen, S. Thameem/AAU-8627-2020; BABY, NIMMI/AAK-2245-2020	BABY, NIMMI/0000-0001-8344-8684; Dheen, S. Thameem/0000-0001-9600-6789	ASTAR-MINDEF-NUS, Singapore [09/1/50/19/621, R-181-000-141-305]	ASTAR-MINDEF-NUS, Singapore	This research was supported by the joint ASTAR-MINDEF-NUS grant (09/1/50/19/621 and R-181-000-141-305), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdanipour Alireza, 2012, Iranian Biomedical Journal, V16, P90, DOI 10.6091/ibj.1060.2012; Baumann P, 2012, BRIT J HAEMATOL, V156, P633, DOI 10.1111/j.1365-2141.2011.08983.x; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; Dalmau I, 1998, HIPPOCAMPUS, V8, P458, DOI 10.1002/(SICI)1098-1063(1998)8:5<458::AID-HIPO6>3.0.CO;2-N; Das SK, 2005, BBA-GEN SUBJECTS, V1726, P328, DOI 10.1016/j.bbagen.2005.09.007; Davis JN, 2003, GENE, V303, P1, DOI 10.1016/S0378-1119(02)01172-1; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Faraco G, 2009, NEUROBIOL DIS, V36, P269, DOI 10.1016/j.nbd.2009.07.019; Ferreira R, 2001, EMBO REP, V2, P794, DOI 10.1093/embo-reports/kve173; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; HAGOPIAN HK, 1977, CELL, V12, P855, DOI 10.1016/0092-8674(77)90284-7; Huo YQ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-49; Kaur C, 2007, ACTA PHARMACOL SIN, V28, P1087, DOI 10.1111/j.1745-7254.2007.00625.x; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Mathew OP, 2010, BIOMED PHARMACOTHER, V64, P733, DOI 10.1016/j.biopha.2010.09.017; Melnick AM, 2000, MOL CELL BIOL, V20, P2075, DOI 10.1128/MCB.20.6.2075-2086.2000; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Nakamura Y, 1999, NEUROSCI RES, V35, P95, DOI 10.1016/S0168-0102(99)00071-1; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Oakford PC, 2010, LEUKEMIA RES, V34, P1203, DOI 10.1016/j.leukres.2010.03.029; Okumura AJ, 2007, EXP HEMATOL, V35, P978, DOI 10.1016/j.exphem.2007.03.002; Parakalan R, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-64; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Soliman ML, 2012, J NEUROCHEM, V123, P555, DOI 10.1111/j.1471-4159.2012.07955.x; THOMAS WE, 1992, BRAIN RES REV, V17, P61; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Zhang JS, 2001, MOL CELL BIOL, V21, P156, DOI 10.1128/MCB.21.1.156-163.2001; Zhang LT, 2009, EUR J HUM GENET, V17, P1010, DOI 10.1038/ejhg.2008.269; Zhou Q, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-50; Zielinska M, 2011, NEUROCHEM INT, V58, P190, DOI 10.1016/j.neuint.2010.11.015	44	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89326	10.1371/journal.pone.0089326	http://dx.doi.org/10.1371/journal.pone.0089326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586690	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900125
J	Fujiwara, T; Kazawa, T; Haupt, SS; Kanzaki, R				Fujiwara, Terufumi; Kazawa, Tomoki; Haupt, Stephan Shuichi; Kanzaki, Ryohei			Inhibition Controls Temporal Properties of Spike Responses of Projection Neurons in the Moth Antennal Lobe	PLOS ONE			English	Article							SEX-PHEROMONE; OLFACTORY-BULB; MACROGLOMERULAR COMPLEX; AGROTIS-IPSILON; ODOR; DROSOPHILA; INFORMATION; MECHANISMS; IDENTIFICATION; TRANSFORMATION	Although odorant concentration-response characteristics of olfactory neurons have been widely investigated in a variety of animal species, the effect of odorant concentration on neural processing at circuit level is still poorly understood. Using calcium imaging in the silkmoth (Bombyx mori) pheromone processing circuit of the antennal lobe (AL), we studied the effect of odorant concentration on second-order projection neuron (PN) responses. While PN calcium responses of dendrites showed monotonic increases with odorant concentration, calcium responses of somata showed decreased responses at higher odorant concentrations due to postsynaptic inhibition. Simultaneous calcium imaging and electrophysiology revealed that calcium responses of PN somata but not dendrites reflect spiking activity. Inhibition shortened spike response duration rather than decreasing peak instantaneous spike frequency (ISF). Local interneurons (LNs) that were specifically activated at high odorant concentrations at which PN responses were suppressed are the putative source of inhibition. Our results imply the existence of an intraglomerular mechanism that preserves time resolution in olfactory processing over a wide odorant concentration range.	[Fujiwara, Terufumi; Kanzaki, Ryohei] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo, Japan; [Kazawa, Tomoki; Haupt, Stephan Shuichi; Kanzaki, Ryohei] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan	University of Tokyo; University of Tokyo	Haupt, SS (corresponding author), Univ Bielefeld, Fac Biol, Dept Biol Cybernet, D-33615 Bielefeld, Germany.	stephan.haupt@uni-bielefeld.de; kanzaki@rcast.u-tokyo.ac.jp	Fujiwara, Terufumi/AAL-3934-2020	Fujiwara, Terufumi/0000-0001-7022-3259; Kazawa, Tomoki/0000-0002-9050-3079	Research and Development of the Next-Generation Integrated Simulation of Living Matter, part of the Development and Use of the Next-Generation Supercomputer Project; JSPS [P07144]; Ministry of Education, Culture, Sports, Science and Technology (MEXT);  [21370029];  [24370031]	Research and Development of the Next-Generation Integrated Simulation of Living Matter, part of the Development and Use of the Next-Generation Supercomputer Project; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; 	This research was supported by: Research and Development of the Next-Generation Integrated Simulation of Living Matter, part of the Development and Use of the Next-Generation Supercomputer Project; a Grant-in-Aid for Scientific Research (B) (21370029 and 24370031), a JSPS postdoctoral scholarship (P07144), and a Grant-in-Aid for JSPS fellows (22.6410) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai H, 2004, J EXP BIOL, V207, P633, DOI 10.1242/jeb.00784; Anton S, 1997, J EXP BIOL, V200, P1073; Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; Asahina Kenta, 2009, J Biol, V8, P9, DOI 10.1186/jbiol108; Barrozo RB, 2011, EUR J NEUROSCI, V33, P1841, DOI 10.1111/j.1460-9568.2011.07678.x; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; BOECKH J, 1979, J COMP PHYSIOL, V132, P235, DOI 10.1007/BF00614495; Carlsson MA, 2003, CHEM SENSES, V28, P269, DOI 10.1093/chemse/28.4.269; CHRISTENSEN TA, 1988, CHEM SENSES, V13, P123, DOI 10.1093/chemse/13.1.123; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Christensen TA, 1998, J NEUROSCI, V18, P5999; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Fujiwara T, 2009, NEUROREPORT, V20, P1061, DOI 10.1097/WNR.0b013e32832e7d93; Goldberg F, 1999, J PHYSIOL-LONDON, V514, P759, DOI 10.1111/j.1469-7793.1999.759ad.x; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; Hartlieb E, 1997, J COMP PHYSIOL A, V181, P469, DOI 10.1007/s003590050130; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Iwano M, 2005, ZOOL SCI, V22, P199, DOI 10.2108/zsj.22.199; Jarriault D, 2010, CHEM SENSES, V35, P705, DOI 10.1093/chemse/bjq069; Jarriault D, 2009, J EXP BIOL, V212, P1191, DOI 10.1242/jeb.024166; KANZAKI R, 1986, BRAIN RES, V377, P378, DOI 10.1016/0006-8993(86)90885-1; Kanzaki R, 2003, CHEM SENSES, V28, P113, DOI 10.1093/chemse/28.2.113; Khan AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1712; Kloppenburg P, 1999, J NEUROSCI, V19, P8172; Lei H, 1999, J NEUROPHYSIOL, V81, P1113, DOI 10.1152/jn.1999.81.3.1113; Lei Hong, 2009, Journal of Biology (London), V8, P21, DOI 10.1186/jbiol120; Meeks JP, 2010, NAT NEUROSCI, V13, P723, DOI 10.1038/nn.2546; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Oertner TG, 2001, J NEUROPHYSIOL, V85, P439, DOI 10.1152/jn.2001.85.1.439; Oertner TG, 1999, NEUROSCI LETT, V274, P95, DOI 10.1016/S0304-3940(99)00694-1; Oizumi M, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00014; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; Sakurai T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002115; Seki Y, 2008, J COMP NEUROL, V506, P93, DOI 10.1002/cne.21528; Shao ZY, 2012, J NEUROPHYSIOL, V108, P782, DOI 10.1152/jn.00119.2012; Silbering AF, 2008, J NEUROSCI, V28, P13075, DOI 10.1523/JNEUROSCI.2973-08.2008; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Tanaka NK, 2009, J NEUROSCI, V29, P8595, DOI 10.1523/JNEUROSCI.1455-09.2009; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Yamagata N, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.016.2009; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Zube C, 2008, J COMP NEUROL, V506, P425, DOI 10.1002/cne.21548	49	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89132	10.1371/journal.pone.0089132	http://dx.doi.org/10.1371/journal.pone.0089132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586546	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900094
J	Kamimura, Y; Mitsumoto, H; Lee, CY				Kamimura, Yoshitaka; Mitsumoto, Hiroyuki; Lee, Chow-Yang			Duplicated Female Receptacle Organs for Traumatic Insemination in the Tropical Bed Bug Cimex hemipterus: Adaptive Variation or Malformation?	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; EVOLUTION; CONFLICT; BEHAVIOR; BEDBUGS	During mating, male bed bugs (Cimicidae) pierce the female abdomen to inject sperm using their needle-like genitalia. Females evolved specialized paragenital organs (the spermalege and associated structures) to receive traumatically injected ejaculates. In Leptocimex duplicatus, the spermalege is duplicated, but the evolutionary significance of this is unclear. In Cimex hemipterus and C. lectularius, in which females normally develop a single spermalege on the right side of the abdomen, similar duplication sometimes occurs. Using these aberrant morphs (D-females) of C. hemipterus, we tested the hypothesis that both of the duplicated spermaleges are functionally competent. Scars on female abdominal exoskeletons indicated frequent misdirected piercing by male genitalia. However, the piercing sites showed a highly biased distribution towards the right side of the female body. A mating experiment showed that when the normal insemination site (the right-side spermalege) was artificially covered, females remained unfertilized. This was true even when females also had a spermalege on the left side (D-females). This result was attributed to handedness in male mating behavior. Irrespective of the observed disuse of the left-side spermalege by males for insemination, histological examination failed to detect any differences between the right-side and left-side spermaleges. Moreover, an artificial insemination experiment confirmed that spermatozoa injected into the left-side spermalege show apparently normal migration behavior to the female reproductive organs, indicating an evolutionary potential for functionally-competent duplicated spermaleges. We discuss possible mechanisms for the evolutionary maintenance of D-females and propose a plausible route to the functionally-competent duplicated spermaleges observed in L. duplicatus.	[Kamimura, Yoshitaka; Lee, Chow-Yang] Univ Sains Malaysia, Urban Entomol Lab, Vector Control Res Unit, Sch Biol Sci, Minden, Penang, Malaysia; [Kamimura, Yoshitaka; Mitsumoto, Hiroyuki] Keio Univ, Dept Biol, Yokohama, Kanagawa 223, Japan	Universiti Sains Malaysia; Keio University	Kamimura, Y (corresponding author), Univ Sains Malaysia, Urban Entomol Lab, Vector Control Res Unit, Sch Biol Sci, Minden, Penang, Malaysia.	kamimura@fbc.keio.ac.jp	Lee, Chow-Yang/C-7129-2009	Lee, Chow-Yang/0000-0001-8279-4104; Kamimura, Yoshitaka/0000-0003-2882-491X	Keio University; Japan Society for the Promotion of Science [22770058]	Keio University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partly supported by a grant for overseas researches from Keio University, and a Grant-in-Aid for Scientific Research (Kakenhi, No. 22770058) from the Japan Society for the Promotion of Science to Y.K. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R., 1934, Zeitschrift fuer Parasitenkunde, V6, P559, DOI 10.1007/BF02123766; Burns J. M., 1970, Psyche Camb, V77, P430, DOI 10.1155/1970/89419; CARAYON J, 1954, CR HEBD ACAD SCI, V239, P1542; Carayon J., 1959, Revue de Zoologie et de Botanique Africaines, V60, P81; Carayon J., 1966, MONOGRAPH CIMICIDAE, P81, DOI DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Carayon J, 1964, PSYCHIATRIE ANIMALE, P283; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Christophers S. R., 1922, Indian Journal of Medical Research, V9, P445; Cragg F. W., 1920, Indian Journal of Medical Research, V8; DAVIS NORMAN T., 1956, ANN ENT SOC AMER, V49, P466; DAVIS NORMAN T., 1965, J INSECT PHYSIOL, V11, P355, DOI 10.1016/0022-1910(65)90083-1; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; HASE A, 1918, SITZUNGSBERICHTE GES, V8, P311; How YF, 2010, MED VET ENTOMOL, V24, P108, DOI 10.1111/j.1365-2915.2010.00852.x; How Y-F, 2009, J VECTOR ECOL, V35, P108; How YF, 2010, J MED ENTOMOL, V47, P987, DOI 10.1603/ME10018; How YF, 2010, J MED ENTOMOL, V47, P305, DOI 10.1603/ME10004; Huber BA, 2007, BIOL REV, V82, P647, DOI 10.1111/j.1469-185X.2007.00029.x; KEMPER H, 1933, Z PARASITENKD, V5, P112; Klass Klaus-Dieter, 2006, Entomologische Abhandlungen (Dresden), V63, P3; Lange R, 2013, BIOL REV, V88, P585, DOI 10.1111/brv.12018; Ludwig W., 1937, Zeitschrift Naturw Halle, V91, P136; Ludwig W., 1937, Archiv fuer Entwicklungsmechanik der Organismen Berlin, V136, P294; Ludwig W., 1932, RECHTS LINKS PROBLEM; Morrow EH, 2003, P ROY SOC B-BIOL SCI, V270, P2377, DOI 10.1098/rspb.2003.2514; Patton W.S., 1913, TXB MED ENTOMOLOGY; R Core Team, 2021, R LANGUAGE ENV STAT; RAO HV, 1972, INDIAN J EXP BIOL, V10, P295; Reinhardt K, 2005, ECOL ENTOMOL, V30, P607, DOI 10.1111/j.0307-6946.2005.00730.x; Reinhardt K, 2003, P ROY SOC B-BIOL SCI, V270, P2371, DOI 10.1098/rspb.2003.2515; Reinhardt K, 2009, EVOLUTION, V63, P29, DOI 10.1111/j.1558-5646.2008.00502.x; Reinhardt K, 2007, AM NAT, V170, P931, DOI 10.1086/522844; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Reinhardt K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022082; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ross Edward S., 2000, Occasional Papers California Academy of Sciences, V149, P1; RUKNUDIN A, 1988, J INSECT PHYSIOL, V34, P137, DOI 10.1016/0022-1910(88)90166-7; Ryne C, 2009, ANIM BEHAV, V78, P1471, DOI 10.1016/j.anbehav.2009.09.033; SCHUH RT, 1991, J NEW YORK ENTOMOL S, V99, P298; Siva-Jothy MT, 2006, PHILOS T ROY SOC B, V361, P269, DOI 10.1098/rstb.2005.1789; Siva-Jothy MT, 2003, P ROY SOC B-BIOL SCI, V270, P649, DOI 10.1098/rspb.2002.2260; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Tatarnic NJ, 2006, BIOL LETTERS, V2, P58, DOI 10.1098/rsbl.2005.0394; Tatarnic NJ, 2014, ANNU REV ENTOMOL, V59, P245, DOI 10.1146/annurev-ento-011613-162111; Tatarnic NJ, 2013, AM NAT, V182, P542, DOI 10.1086/671931; WATTAL B. L., 1961, INDIAN JOUR MALARIOL, V15, P157	46	4	5	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89265	10.1371/journal.pone.0089265	http://dx.doi.org/10.1371/journal.pone.0089265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586643	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900118
J	Khor, S				Khor, Susan			Inferring Domain-Domain Interactions from Protein-Protein Interactions with Formal Concept Analysis	PLOS ONE			English	Article								Identifying reliable domain-domain interactions will increase our ability to predict novel protein-protein interactions, to unravel interactions in protein complexes, and thus gain more information about the function and behavior of genes. One of the challenges of identifying reliable domain-domain interactions is domain promiscuity. Promiscuous domains are domains that can occur in many domain architectures and are therefore found in many proteins. This becomes a problem for a method where the score of a domain-pair is the ratio between observed and expected frequencies because the protein-protein interaction network is sparse. As such, many protein-pairs will be non-interacting and domain-pairs with promiscuous domains will be penalized. This domain promiscuity challenge to the problem of inferring reliable domain-domain interactions from protein-protein interactions has been recognized, and a number of work-arounds have been proposed. This paper reports on an application of Formal Concept Analysis to this problem. It is found that the relationship between formal concepts provides a natural way for rare domains to elevate the rank of promiscuous domain-pairs and enrich highly ranked domain-pairs with reliable domain-domain interactions. This piggybacking of promiscuous domainpairs onto less promiscuous domain-pairs is possible only with concept lattices whose attribute-labels are not reduced and is enhanced by the presence of proteins that comprise both promiscuous and rare domains.	Mem Univ Newfoundland, Dept Comp Sci, St John, NF A1C 5S7, Canada	Memorial University Newfoundland	Khor, S (corresponding author), Mem Univ Newfoundland, Dept Comp Sci, St John, NF A1C 5S7, Canada.	slc.khor@gmail.com			Memorial University Libraries	Memorial University Libraries	Open Access fee funded by Memorial University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Davey B., 2002, INTRO LATTICES ORDER, V2, DOI DOI 10.1017/CBO9780511809088; Deng MH, 2002, GENOME RES, V12, P1540, DOI 10.1101/gr.153002; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Ganter B., 1999, FORMAL CONCEPT ANAL; Guimaraes KS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-171; Guimaraes KS, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r104; Hader T, 2003, EMBO REP, V4, P511, DOI 10.1038/sj.embor.embor837; Itzhaki Z, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r125; Itzhaki Z, 2010, BIOINFORMATICS, V26, P2564, DOI 10.1093/bioinformatics/btq495; Lee H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-269; Lindig C., COLIBRI CONCEPTS VER; Mosca R, 2014, NUCLEIC ACIDS RES, V42, pD374, DOI 10.1093/nar/gkt887; Nye TMW, 2005, BIOINFORMATICS, V21, P993, DOI 10.1093/bioinformatics/bti086; Park Y, 2012, NAT METHODS, V9, P1134, DOI 10.1038/nmeth.2259; Riley R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r89; Schuster-Bockler B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-259; Sprinzak E, 2001, J MOL BIOL, V311, P681, DOI 10.1006/jmbi.2001.4920; Yellaboina S, 2011, NUCLEIC ACIDS RES, V39, pD730, DOI 10.1093/nar/gkq1229	22	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88943	10.1371/journal.pone.0088943	http://dx.doi.org/10.1371/journal.pone.0088943			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586450	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900064
J	Li, ZS; Xie, J; Wu, JT; Li, WJ; Nie, LP; Sun, XJ; Tang, AF; Li, XX; Liu, R; Mei, HB; Wang, F; Wang, ZP; Gui, YT; Cai, ZM				Li, Zesong; Xie, Jun; Wu, Jianting; Li, Wenjie; Nie, Liping; Sun, Xiaojuan; Tang, Aifa; Li, Xianxin; Liu, Ren; Mei, Hongbing; Wang, Feng; Wang, Zhiping; Gui, Yaoting; Cai, Zhiming			CMTM3 Inhibits Human Testicular Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis	PLOS ONE			English	Article							CHEMOKINE-LIKE FACTOR; GENE-EXPRESSION; MOLECULAR-CLONING; DNA METHYLATION; CPG METHYLATION; TUMORS; SITE; RECEPTOR; TESTIS; IDENTIFICATION	Human CMTM3 has been proposed as a putative tumor suppressor gene. The loss of CMTM3 has been found in several carcinomas. However, the regulation of CMTM3 expression and its function in tumor progression remain largely unknown. Here, we investigated the regulation of CMTM3 expression, function and molecular mechanism in human testicular cancer cells. CMTM3 was frequently downregulated or silenced in testicular cancer cell lines and tumor tissues but highly expressed in normal testis tissues. The re-expression of CMTM3 significantly suppressed the colony formation, proliferation, and migration capacity of testicular cancer cells by inducing a G2 cell cycle arrest and apoptosis. Moreover, the re-expression of CMTM3 activated the transcription of p53, induced p53 accumulation, up-regulated the expression of p21, and increased the cleavage of caspase 9, 8, 3, and PARP. The downregulation of CMTM3 in clinical tumor tissues was associated with the methylation of a single CpG site located within the Sp1/Sp3-responsive region of the core promoter. These results indicate that CMTM3 can function as tumor suppressor through the induction of a G2 cell cycle arrest and apoptosis. CMTM3 is thus involved in testicular cancer pathogenesis, and it is frequently at least partially silenced by the methylation of a single, specific CpG site in tumor tissues.	[Li, Zesong; Sun, Xiaojuan; Tang, Aifa; Liu, Ren; Mei, Hongbing; Wang, Feng; Cai, Zhiming] Shenzhen Univ, Shenzhen Key Lab Genitourinary Tumor, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Shenzhen, Peoples R China; [Xie, Jun; Wu, Jianting; Gui, Yaoting] Peking Univ, Shenzhen Hosp, Shenzhen PKU HKUST Med Ctr, Guandong Key Lab Male Reprod Med & Genet, Shenzhen, Peoples R China; [Xie, Jun; Nie, Liping; Li, Xianxin] Peking Univ, Shenzhen Hosp, Dept Clin Lab, Shenzhen, Peoples R China; [Li, Wenjie] Suzhou Municipal Hosp, Dept Urol, Suzhou, Anhui, Peoples R China; [Wang, Zhiping] Lanzhou Univ, Hosp 2, Dept Urol, Lanzhou 730000, Peoples R China	Shenzhen University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Peking University; Lanzhou University	Li, ZS (corresponding author), Shenzhen Univ, Shenzhen Key Lab Genitourinary Tumor, Shenzhen Peoples Hosp 2, Affiliated Hosp 1, Shenzhen, Peoples R China.	lzssc@yahoo.com; caizhiming2000@yahoo.com.cn	gui, yaoting/GLT-3684-2022	Mei, Hongbing/0000-0002-6009-4753	National Basic Research Program of China [2014CD745200]; National Natural Science Foundation of China [81272840]; Young Scientists Fund of the National Natural Science Foundation of China [81201579]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (Grant No. 2014CD745200, http://www.973.gov.cn/AreaAppl.aspx), the National Natural Science Foundation of China (Grant No. 81272840, http://www.nsfc.gov.cn/Portal0/default152.htm), and the Young Scientists Fund of the National Natural Science Foundation of China (Grant No. 81201579, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carver BS, 2005, ANN SURG ONCOL, V12, P871, DOI 10.1245/ASO.2005.01.013; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Claus R, 2012, J CLIN ONCOL, V30, P2483, DOI 10.1200/JCO.2011.39.3090; Furst RW, 2012, J STEROID BIOCHEM, V130, P96, DOI 10.1016/j.jsbmb.2012.01.009; Gillham Charles M, 2007, World J Surg Oncol, V5, P97, DOI 10.1186/1477-7819-5-97; Guo XH, 2009, BIOCHEM BIOPH RES CO, V387, P139, DOI 10.1016/j.bbrc.2009.06.148; Han WL, 2003, GENOMICS, V81, P609, DOI 10.1016/S0888-7543(03)00095-8; Harris CC, 1996, JNCI-J NATL CANCER I, V88, P1442, DOI 10.1093/jnci/88.20.1442; Huyghe E, 2003, J UROLOGY, V170, P5, DOI 10.1097/01.ju.0000053866.68623.da; Imamura Y, 2004, J BIOL CHEM, V279, P26425, DOI 10.1074/jbc.M403685200; Jin CN, 2007, J CELL PHYSIOL, V211, P112, DOI 10.1002/jcp.20914; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Lessel D, 2012, CARCINOGENESIS, V33, P1548, DOI 10.1093/carcin/bgs218; Li D, 2007, INT J BIOCHEM CELL B, V39, P2107, DOI 10.1016/j.biocel.2007.06.002; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li ZS, 2011, CELL BIOL INT, V35, P671, DOI 10.1042/CBI20100568; Li ZS, 2011, GENE, V475, P49, DOI 10.1016/j.gene.2011.01.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou YX, 2003, GENE, V307, P125, DOI 10.1016/S0378-1119(03)00450-5; Mamrut S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056869; Mancarelli MM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-172; Michelotti GA, 2007, FASEB J, V21, P1979, DOI 10.1096/fj.06-7118com; Mostofi F K, 1985, Prog Clin Biol Res, V203, P1; Nakamura J, 2011, AM J PATHOL, V178, P515, DOI 10.1016/j.ajpath.2010.10.010; Niu JH, 2011, LEUKEMIA RES, V35, P771, DOI 10.1016/j.leukres.2010.11.023; Okamoto K, 2012, INT J UROL, V19, P504, DOI 10.1111/j.1442-2042.2012.02986.x; Pogribny IP, 2000, CANCER RES, V60, P588; Port M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-52; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rui M, 2003, MOL BIOL REP, V30, P229, DOI 10.1023/A:1026308129769; Shao L, 2007, CLIN CANCER RES, V13, P5756, DOI 10.1158/1078-0432.CCR-06-3082; Shao LN, 2009, BIOCHEM BIOPH RES CO, V379, P866, DOI 10.1016/j.bbrc.2008.12.126; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shi S, 2005, INT J BIOCHEM CELL B, V37, P1633, DOI 10.1016/j.biocel.2004.04.028; Smith FM, 2006, EJSO-EUR J SURG ONC, V32, P55, DOI 10.1016/j.ejso.2005.09.010; Sohn BH, 2010, GASTROENTEROLOGY, V138, P1898, DOI 10.1053/j.gastro.2009.12.044; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Spizzo G, 2011, J CLIN PATHOL, V64, P415, DOI 10.1136/jcp.2011.090274; Ushida H, 2012, MOL CARCINOGEN, V51, P711, DOI 10.1002/mc.20831; Wang L, 2004, INT J BIOCHEM CELL B, V36, P1492, DOI 10.1016/j.biocel.2003.11.017; Wang Y, 2008, BIOCHEM BIOPH RES CO, V371, P54, DOI 10.1016/j.bbrc.2008.03.143; Wang Y, 2009, CANCER RES, V69, P5194, DOI 10.1158/0008-5472.CAN-08-3694; Xie J, 2013, CLIN TRANSL ONCOL; Zelko IN, 2010, FREE RADICAL BIO MED, V48, P895, DOI 10.1016/j.freeradbiomed.2010.01.007; Zhang X, 2010, PROSTATE, V70, P765, DOI 10.1002/pros.21109; Zhong J, 2006, J BIOCHEM MOL BIOL, V39, P537; Zou B, 2006, GASTROENTEROLOGY, V131, P1835, DOI 10.1053/j.gastro.2006.09.050	47	28	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88965	10.1371/journal.pone.0088965	http://dx.doi.org/10.1371/journal.pone.0088965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586462	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200031
J	Yang, Y; Zhao, M; Xu, XT; Sun, ZZ; Yin, GD; Piao, SL				Yang, Yan; Zhao, Miao; Xu, Xiangtao; Sun, Zhenzhong; Yin, Guodong; Piao, Shilong			Diurnal and Seasonal Change in Stem Respiration of Larix principis-rupprechtii Trees, Northern China	PLOS ONE			English	Article							CO2 EFFLUX; MAINTENANCE RESPIRATION; WOODY-TISSUE; TEMPERATURE SENSITIVITY; SOIL RESPIRATION; CARBON-DIOXIDE; CLIMATE-CHANGE; ELEVATED CO2; GROWTH; STAND	Stem respiration is a critical and uncertain component of ecosystem carbon cycle. Few studies reported diurnal change in stem respiration as well as its linkage with climate. In this study, we investigated the diurnal and seasonal change in stem respiration and its linkage with environmental factors, in larch plantations of northern China from 2010 to 2012. The stem respiration per unit surface area (R-S) showed clear diurnal cycles, ranging from 1.65 +/- 0.10 to 2.69 +/- 0.15 mu mol m(-2) s(-1), increased after 6:00, peaked at 15:00 and then decreased. Both stem temperature and air temperature show similar diurnal pattern, while the diurnal pattern of air relative humidity is just the opposite to Rs. Similar to the diurnal cycles, seasonal change in R-S followed the pattern of stem temperature. R-S increased from May (1.28 +/- 0.07 mmol m(-2) s(-1)) when the stem temperature was relatively low and peaked in July (3.02 +/- 0.10 mmol m(-2) s(-1)) when the stem temperature was also the highest. Further regression analyses show that R-S exponentially increases with increasing temperature, and the Q(10) of Rs at mid daytime (1.97 +/- 0.17 at 12:00 and 1.9 +/- 0.10 at 15:00) is significantly lower than that of mid nighttime (2.60 +/- 0.14 at 00:00 and 2.71 +/- 0.25 at 03:00) Q(10). This result not only implies that Rs is more sensitive to night than day warming, but also highlights that temperature responses of Rs estimated by only daytime measurement can lead to underestimated stem respiration increase under global warming, especially considering that temperature increase is faster during nighttime.	[Yang, Yan; Zhao, Miao; Xu, Xiangtao; Sun, Zhenzhong; Yin, Guodong; Piao, Shilong] Peking Univ, Dept Ecol, Coll Urban & Environm Sci, Beijing 100871, Peoples R China; [Yang, Yan; Zhao, Miao; Xu, Xiangtao; Sun, Zhenzhong; Yin, Guodong; Piao, Shilong] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Xu, Xiangtao] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Peking University; Peking University; Princeton University	Piao, SL (corresponding author), Peking Univ, Dept Ecol, Coll Urban & Environm Sci, Beijing 100871, Peoples R China.	slpiao@pku.edu.cn	Xu, Xiangtao/AAO-7401-2021	Xu, Xiangtao/0000-0002-9402-9474; yin, guodong/0000-0003-3926-2609	National Natural Science Foundation of China [41171202, 41125004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (41171202 and 41125004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta M, 2010, BIOL PLANTARUM, V54, P773, DOI 10.1007/s10535-010-0140-x; Acosta M, 2008, ANN BOT-LONDON, V101, P469, DOI 10.1093/aob/mcm304; Acosta M, 2011, EUR J FOREST RES, V130, P649, DOI 10.1007/s10342-010-0456-2; Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Amthor J.S., 1989, RESP CROP PRODUCTIVI, DOI [10.1007/978-1-4615-9667-7, DOI 10.1007/978-1-4615-9667-7]; AZCONBIETO J, 1983, PLANT PHYSIOL, V72, P598, DOI 10.1104/pp.72.3.598; Bolstad PV, 2004, TREE PHYSIOL, V24, P493, DOI 10.1093/treephys/24.5.493; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Bowman WP, 2008, TREE PHYSIOL, V28, P1553, DOI 10.1093/treephys/28.10.1553; Brito P, 2013, TREES-STRUCT FUNCT, V27, P999, DOI 10.1007/s00468-013-0851-7; Carey EV, 1997, OECOLOGIA, V111, P19, DOI 10.1007/s004420050203; Cavaleri MA, 2008, PLANT CELL ENVIRON, V31, P473, DOI 10.1111/j.1365-3040.2008.01775.x; Cerasoli S, 2009, J EXP BOT, V60, P99, DOI 10.1093/jxb/ern272; Clinton BD, 2011, TREES-STRUCT FUNCT, V25, P997, DOI 10.1007/s00468-011-0574-6; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Damesin C, 2012, NEW PHYTOL, V153, P159; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gou XH, 2008, SCI CHINA SER D, V51, P41, DOI 10.1007/s11430-007-0154-1; Gruber A, 2009, TREE PHYSIOL, V29, P641, DOI 10.1093/treephys/tpp001; Holtta T, 2009, TREE PHYSIOL, V29, P1447, DOI 10.1093/treephys/tpp073; IPCC, 2007, PHYS SCI BASIC CONTR, P235; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Kim MH, 2007, FOREST ECOL MANAG, V243, P283, DOI 10.1016/j.foreco.2007.03.017; King AW, 2006, SCIENCE, V312, P536, DOI 10.1126/science.1114166; Lavigne MB, 1996, TREE PHYSIOL, V16, P847; Lavigne MB, 2004, NEW PHYTOL, V162, P81, DOI 10.1111/j.1469-8137.2004.01004.x; Lavigne MB, 1997, TREE PHYSIOL, V17, P543; Levy PE, 1998, FUNCT ECOL, V12, P107, DOI 10.1046/j.1365-2435.1998.00156.x; Liberloo M, 2008, BIOL PLANTARUM, V52, P299, DOI 10.1007/s10535-008-0063-y; Ma YC, 2014, AGR FOREST METEOROL, V184, P179, DOI 10.1016/j.agrformet.2013.10.008; Ma YM, 2013, J FUNCT SPACE APPL, DOI 10.1155/2013/394216; Maier CA, 1998, TREE PHYSIOL, V18, P11; MARTIN TA, 1994, TREE PHYSIOL, V14, P481, DOI 10.1093/treephys/14.5.481; Maseyk K, 2008, GLOBAL CHANGE BIOL, V14, P1553, DOI 10.1111/j.1365-2486.2008.01604.x; McGuire MA, 2007, J EXP BOT, V58, P2159, DOI 10.1093/jxb/erm069; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Moore DJP, 2008, OECOLOGIA, V158, P1, DOI 10.1007/s00442-008-1118-7; PAEMBONAN SA, 1991, TREE PHYSIOL, V8, P399, DOI 10.1093/treephys/8.4.399; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peng SS, 2013, NATURE, V501, P88, DOI 10.1038/nature12434; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; PENNINGDEVRIES FW, 1974, J THEOR BIOL, V45, P339; Peters J, 2003, TREES-STRUCT FUNCT, V17, P492, DOI 10.1007/s00468-003-0261-3; Piao SL, 2010, ECOLOGY, V91, P652, DOI 10.1890/08-2176.1; RYAN MG, 1994, OECOLOGIA, V100, P213, DOI 10.1007/BF00316947; RYAN MG, 1995, OECOLOGIA, V101, P133, DOI 10.1007/BF00317276; RYAN MG, 1991, ECOL APPL, V1, P157, DOI 10.2307/1941808; Ryan MG, 1996, TREE PHYSIOL, V16, P333; Ryan MG, 2009, TREE PHYSIOL, V29, P1213, DOI 10.1093/treephys/tpp059; Saveyn A, 2008, OECOLOGIA, V154, P637, DOI 10.1007/s00442-007-0868-y; Stockfors J, 2000, TREE PHYSIOL, V20, P1057; Stockfors J, 1998, TREE PHYSIOL, V18, P155; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Vose JM, 2002, GLOBAL CHANGE BIOL, V8, P182, DOI 10.1046/j.1365-2486.2002.00464.x; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang M, 2010, TREE PHYSIOL, V30, P149, DOI 10.1093/treephys/tpp098; Wang WJ, 2003, ACTA BOT SIN, V45, P1387; Wittmann C, 2007, J EXP BOT, V58, P4293, DOI 10.1093/jxb/erm313; Xu M, 2000, CAN J FOREST RES, V30, P1555, DOI 10.1139/cjfr-30-10-1555; Yang JY, 2012, TREES-STRUCT FUNCT, V26, P1225, DOI 10.1007/s00468-012-0698-3; Zha TS, 2004, ANN BOT-LONDON, V94, P889, DOI 10.1093/aob/mch218; Zhu LW, 2012, BIOGEOSCIENCES, V9, P3729, DOI 10.5194/bg-9-3729-2012	64	7	12	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89294	10.1371/journal.pone.0089294	http://dx.doi.org/10.1371/journal.pone.0089294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586668	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000035
J	Vejdemo-Johansson, M; Vejdemo, S; Ek, CH				Vejdemo-Johansson, Mikael; Vejdemo, Susanne; Ek, Carl-Henrik			Comparing Distributions of Color Words: Pitfalls and Metric Choices	PLOS ONE			English	Article								Computational methods have started playing a significant role in semantic analysis. One particularly accessible area for developing good computational methods for linguistic semantics is in color naming, where perceptual dissimilarity measures provide a geometric setting for the analyses. This setting has been studied first by Berlin & Kay in 1969, and then later on by a large data collection effort: the World Color Survey (WCS). From the WCS, a dataset on color naming by 2 616 speakers of 110 different languages is made available for further research. In the analysis of color naming from WCS, however, the choice of analysis method is an important factor of the analysis. We demonstrate concrete problems with the choice of metrics made in recent analyses of WCS data, and offer approaches for dealing with the problems we can identify. Picking a metric for the space of color naming distributions that ignores perceptual distances between colors assumes a decorrelated system, where strong spatial correlations in fact exist. We can demonstrate that the corresponding issues are significantly improved when using Earth Mover's Distance, or Quadratic x-square Distance, and we can approximate these solutions with a kernel-based analysis method.	[Vejdemo-Johansson, Mikael; Ek, Carl-Henrik] KTH Royal Inst Technol, Comp Vis & Act Percept Lab, Stockholm, Sweden; [Vejdemo, Susanne] Stockholm Univ, Dept Linguist, S-10691 Stockholm, Sweden	Royal Institute of Technology; Stockholm University	Vejdemo-Johansson, M (corresponding author), KTH Royal Inst Technol, Comp Vis & Act Percept Lab, Stockholm, Sweden.	mvj@kth.se	Vejdemo-Johansson, Mikael/P-8742-2019; Vejdemo-Johansson, Mikael/B-6799-2013	Vejdemo-Johansson, Mikael/0000-0001-6322-7542; Vejdemo-Johansson, Mikael/0000-0001-6322-7542; Ek, Carl Henrik/0000-0003-1302-6309	Toposys [FP7-ICT-318493-STREP]; Knut och Alice Wallenbergs Stiftelse: Unga Forskare; Stockholm University; FoSprak graduate school; Tomsy [IST-FP7-270436]	Toposys; Knut och Alice Wallenbergs Stiftelse: Unga Forskare; Stockholm University; FoSprak graduate school; Tomsy	MVJ was mostly supported by the 7th Framework Programme through the project Toposys (FP7-ICT-318493-STREP, http://www.toposys.eu) and partially by Knut och Alice Wallenbergs Stiftelse: Unga Forskare (http://www.wallenberg.com/kaw). SV was supported through Stockholm University and the FoSprak graduate school. CHE was supported through the project Tomsy (IST-FP7-270436, http://www.tomsy.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CPLEX V12 5 1; Berlin B, 1969, BASIC COLOUR TERMS; Berlin B., 1991, BASIC COLOR TERMS TH; Cha S.-H., 2008, INT J MATH MODELS ME, V1, P300; CIE, 1978, CIE PUBL S2; Cleland TM, 1937, PRACTICAL DESCRIPTIO; Cristianini N, 2000, INTRO SUPPORT VECTOR; Jager G, 2012, J SEMANT, V29, P521, DOI 10.1093/jos/ffs006; Kay P, 2003, P NATL ACAD SCI USA, V100, P9085, DOI 10.1073/pnas.1532837100; Kay P., 2009, WORLD COLOR SURVEY; Kay P., 1991, J LINGUIST ANTHROPOL, V1, P12, DOI [10.1525/jlin.1991.1.1.12, DOI 10.1525/JLIN.1991.1.1.12]; Lindsey DT, 2006, P NATL ACAD SCI USA, V103, P16608, DOI 10.1073/pnas.0607708103; Majid Asifa, 2011, EVOLUTION SEMANTIC S; Mohri M., 2018, FDN MACHINE LEARNING; Pele O, 2010, LECT NOTES COMPUT SC, V6312, P749, DOI 10.1007/978-3-642-15552-9_54; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; Vejdemo-Johansson M, 2013, EARTH MOVERS DISTANC, DOI DOI 10.6084/M9.FIGSHARE.796378	17	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89184	10.1371/journal.pone.0089184	http://dx.doi.org/10.1371/journal.pone.0089184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586580	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900033
J	Xu, GR; Strong, MJ; Lacey, MR; Baribault, C; Flemington, EK; Taylor, CM				Xu, Guorong; Strong, Michael J.; Lacey, Michelle R.; Baribault, Carl; Flemington, Erik K.; Taylor, Christopher M.			RNA CoMPASS: A Dual Approach for Pathogen and Host Transcriptome Analysis of RNA-Seq Datasets	PLOS ONE			English	Article							NF-KAPPA-B; C-MYC; BURKITTS-LYMPHOMA; DOSE INTENSITY; SEQUENCES; IDENTIFICATION; SURVIVAL; PROGRAM; SEARCH	High-throughput RNA sequencing (RNA-seq) has become an instrumental assay for the analysis of multiple aspects of an organism's transcriptome. Further, the analysis of a biological specimen's associated microbiome can also be performed using RNA-seq data and this application is gaining interest in the scientific community. There are many existing bioinformatics tools designed for analysis and visualization of transcriptome data. Despite the availability of an array of next generation sequencing (NGS) analysis tools, the analysis of RNA-seq data sets poses a challenge for many biomedical researchers who are not familiar with command-line tools. Here we present RNA CoMPASS, a comprehensive RNA-seq analysis pipeline for the simultaneous analysis of transcriptomes and metatranscriptomes from diverse biological specimens. RNA CoMPASS leverages existing tools and parallel computing technology to facilitate the analysis of even very large datasets. RNA CoMPASS has a web-based graphical user interface with intrinsic queuing to control a distributed computational pipeline. RNA CoMPASS was evaluated by analyzing RNA-seq data sets from 45 B-cell samples. Twenty-two of these samples were derived from lymphoblastoid cell lines (LCLs) generated by the infection of naive B-cells with the Epstein Barr virus (EBV), while another 23 samples were derived from Burkitt's lymphomas (BL), some of which arose in part through infection with EBV. Appropriately, RNA CoMPASS identified EBV in all LCLs and in a fraction of the BLs. Cluster analysis of the human transcriptome component of the RNA CoMPASS output clearly separated the BLs (which have a germinal center-like phenotype) from the LCLs (which have a blast-like phenotype) with evidence of activated MYC signaling and lower interferon and NF-kB signaling in the BLs. Together, this analysis illustrates the utility of RNA CoMPASS in the simultaneous analysis of transcriptome and metatranscriptome data. RNA CoMPASS is freely available at http://rnacompass.sourceforge.net/.	[Xu, Guorong] Univ New Orleans Lakefront, Dept Comp Sci, New Orleans, LA USA; [Strong, Michael J.; Flemington, Erik K.] Tulane Univ, Dept Pathol, New Orleans, LA 70118 USA; [Lacey, Michelle R.; Baribault, Carl] Tulane Univ, Dept Math, New Orleans, LA 70118 USA; [Taylor, Christopher M.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Taylor, Christopher M.] Childrens Hosp New Orleans, Res Inst Children, New Orleans, LA USA	University of Louisiana System; University of New Orleans; Tulane University; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans	Taylor, CM (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA.	ctay15@lsuhsc.edu	Taylor, Christopher M./AAF-5480-2020	Taylor, Christopher M./0000-0002-7983-5275; Strong, Michael/0000-0001-9930-3578	Children's Hospital of New Orleans; National Institutes of Health [R01CA124311, R01CA130752, R01CA130752-S1, R01CA138268, F30CA177267]; NATIONAL CANCER INSTITUTE [R01CA124311, F30CA177267, R01CA130752, R01CA138268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101046] Funding Source: NIH RePORTER	Children's Hospital of New Orleans; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by intramural funding from Children's Hospital of New Orleans to CMT and by the National Institutes of Health grants R01CA124311, R01CA130752, R01CA130752-S1, and R01CA138268 to EKF and F30CA177267 to MJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Azim HA, 2010, ANN ONCOL, V21, P1064, DOI 10.1093/annonc/mdp425; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Castellarin M, 2011, GENOME RES; Coco Joseph R., 2011, Proceedings of the ISCA 3rd International Conference on Bioinformatics and Computational Biology, P196; Concha M, 2012, J VIROL, V86, P1458, DOI 10.1128/JVI.06537-11; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Deng N, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr042; Faumont N, 2009, J VIROL, V83, P5014, DOI 10.1128/JVI.02264-08; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Feng HC, 2007, J VIROL, V81, P11332, DOI 10.1128/JVI.00875-07; HUEN DS, 1995, ONCOGENE, V10, P549; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; KWAK LW, 1990, J CLIN ONCOL, V8, P963, DOI 10.1200/JCO.1990.8.6.963; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Moore RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019838; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schlee M, 2007, ADV CANCER RES, V97, P167, DOI 10.1016/S0065-230X(06)97007-9; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Strong MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003341; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Nguyen TC, 2011, IEEE INT C BIO BIO W, P1048, DOI 10.1109/BIBMW.2011.6112556; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Weber G, 2002, NAT GENET, V30, P141, DOI 10.1038/ng818; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Xu GR, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-2; Xu YH, 2003, GENOMICS, V81, P329, DOI 10.1016/S0888-7543(02)00043-5	35	62	65	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89445	10.1371/journal.pone.0089445	http://dx.doi.org/10.1371/journal.pone.0089445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586784	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900045
J	Guerra, CR; Seabra, SH; de Souza, W; Rozental, S				Guerra, Caroline Rezende; Seabra, Sergio Henrique; de Souza, Wanderley; Rozental, Sonia			Cryptococcus neoformans Is Internalized by Receptor-Mediated or 'Triggered' Phagocytosis, Dependent on Actin Recruitment	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; BRAIN; CELLS; GLUCURONOXYLOMANNAN; PATHOGEN; ENTRY; MECHANISMS; INVASION; PATHWAY	Cryptococcosis by the encapsulated yeast Cryptococcus neoformans affects mostly immunocompromised individuals and is a frequent neurological complication in AIDS patients. Recent studies support the idea that intracellular survival of Cryptococcus yeast cells is important for the pathogenesis of cryptococcosis. However, the initial steps of Cryptococcus internalization by host cells remain poorly understood. Here, we investigate the mechanism of Cryptococcus neoformans phagocytosis by peritoneal macrophages using confocal and electron microscopy techniques, as well as flow cytometry quantification, evaluating the importance of fungal capsule production and of host cell cytoskeletal elements for fungal phagocytosis. Electron microscopy analyses revealed that capsular and acapsular strains of C. neoformans are internalized by macrophages via both 'zipper' (receptor-mediated) and 'trigger' (membrane ruffle-dependent) phagocytosis mechanisms. Actin filaments surrounded phagosomes of capsular and acapsular yeasts, and the actin depolymerizing drugs cytochalasin D and latrunculin B inhibited yeast internalization and actin recruitment to the phagosome area. In contrast, nocodazole and paclitaxel, inhibitors of microtubule dynamics decreased internalization but did not prevent actin recruitment to the site of phagocytosis. Our results show that different uptake mechanisms, dependent on both actin and tubulin dynamics occur during yeast internalization by macrophages, and that capsule production does not affect the mode of Cryptococcus uptake by host cells.	[Guerra, Caroline Rezende; Rozental, Sonia] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Biol Celular Fungos, BR-21941 Rio De Janeiro, RJ, Brazil; [Seabra, Sergio Henrique] Ctr Univ Estadual Zona Oeste, Colegiado Ciencias Biol & Saude, Lab Tecnol Bioquim & Microscopia, Campo Grande, RJ, Brazil; [de Souza, Wanderley] Inst Nacl Metrol Qualidade & Tecnol, Duque De Caxias, RJ, Brazil; [de Souza, Wanderley] Univ Fed Rio de Janeiro, Inst Nacl Biol Estrutural & Bioimagens, BR-21941 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Centro Universitario Estadual da Zona Oeste; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro	Rozental, S (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Biol Celular Fungos, BR-21941 Rio De Janeiro, RJ, Brazil.	rozental@biof.ufrj.br	Rozental, Sonia/A-8537-2013; Guerra, Caroline/B-6627-2016; Guerra, Caroline Rezende/ABA-3511-2020	Rozental, Sonia/0000-0002-3659-5945; Guerra, Caroline/0000-0002-0250-6203; Guerra, Caroline Rezende/0000-0002-9968-593X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas filho de amparo a Pesquisa do Rio de Janeiro (FAPERJ); Fundacao de Aperfeicoamento de Pessoal de nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas filho de amparo a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Aperfeicoamento de Pessoal de nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas filho de amparo a Pesquisa do Rio de Janeiro (FAPERJ) and Fundacao de Aperfeicoamento de Pessoal de nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiastui A, 2010, INFECT IMMUN, V78, P2700, DOI 10.1128/IAI.01389-09; Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Barbosa FM, 2006, MICROBES INFECT, V8, P493, DOI 10.1016/j.micinf.2005.07.027; Barrias ES, 2012, MICROBES INFECT, V14, P1340, DOI 10.1016/j.micinf.2012.08.003; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; CHAKA W, 1995, CLIN DIAGN LAB IMMUN, V2, P753, DOI 10.1128/CDLI.2.6.753-759.1995; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chang ZL, 2006, INFECT IMMUN, V74, P144, DOI 10.1128/IAI.74.1.144-151.2006; Chun CD, 2011, CELL HOST MICROBE, V9, P243, DOI 10.1016/j.chom.2011.02.003; Del Valle L, 2006, FRONT BIOSCI-LANDMRK, V11, P718, DOI 10.2741/1830; Feldmesser M, 2000, INFECT IMMUN, V68, P4225, DOI 10.1128/IAI.68.7.4225-4237.2000; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Harrison RE, 2002, BIOCHEM CELL BIOL, V80, P509, DOI 10.1139/O02-142; Huang SH, 2011, J BIOL CHEM, V286, P34761, DOI 10.1074/jbc.M111.219378; JACOBSON ES, 1982, J BACTERIOL, V152, P932; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; Kuhn M, 1998, FEMS MICROBIOL LETT, V160, P87, DOI 10.1016/S0378-1097(98)00017-2; Long M, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-19; Luther K, 2008, MICROBES INFECT, V10, P175, DOI 10.1016/j.micinf.2007.11.001; Ma HS, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-15; May RC, 2001, J CELL SCI, V114, P1061; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Monari C, 2005, J INFECT DIS, V191, P127, DOI 10.1086/426511; Moreno-ruiz E, 2009, CELL MICROBIOL, P1; Moyrand F, 2004, EUKARYOT CELL, V3, P1601, DOI 10.1128/EC.3.6.1601-1608.2004; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Sabiiti W, 2012, MECH INFECT HUMAN FU, P1297; SALKOWSKI CA, 1991, CAN J MICROBIOL, V37, P834, DOI 10.1139/m91-144; Stano P, 2009, J IMMUNOL, V182, P84, DOI 10.4049/jimmunol.182.1.84; Svitkina T, 2009, METHODS MOL BIOL, V586, P187, DOI 10.1007/978-1-60761-376-3_10; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P89, DOI 10.1016/S0962-8924(00)88956-4; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	36	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89250	10.1371/journal.pone.0089250	http://dx.doi.org/10.1371/journal.pone.0089250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586631	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900070
J	Holderried, F; Heine, D; Wagner, R; Mahling, M; Fenik, Y; Herrmann-Werner, A; Riessen, R; Weyrich, P; Zipfel, S; Celebi, N				Holderried, Friederike; Heine, Daniel; Wagner, Robert; Mahling, Moritz; Fenik, Yelena; Herrmann-Werner, Anne; Riessen, Reimer; Weyrich, Peter; Zipfel, Stephan; Celebi, Nora			Problem-Based Training Improves Recognition of Patient Hazards by Advanced Medical Students during Chart Review: A Randomized Controlled Crossover Study	PLOS ONE			English	Article							COMMON PRESCRIPTION ERRORS; ADVERSE EVENTS; SAFETY; CLERKSHIPS; COMMUNICATION; UNDERGRADUATE; SUPERVISION; INFORMATION	Background: Patient chart review is the gold standard for detection of potential patient hazards (i.e. medication errors or failure to follow up actionable results) in both routine clinical care and patient safety research. However, advanced medical students' ability to read patient charts and to identify patient hazards is rather poor. We therefore investigated whether it is possible to teach advanced medical students how to identify patient hazards independent of context (i.e. cancer versus cardiac failure) in patient charts. Methods: All fifth-year medical students in one semester (n = 123) were randomized into two groups. One group (IC) received a patient chart review-training first and then a control-intervention and the other group (CI) received the control-intervention first and then the patient chart review-training. Before and after the teaching sessions, students reviewed different scenarios with standardized fictional patient charts containing 12 common patient hazards. Two blinded raters rated the students' notes for any patient hazard addressed in the notes using a checklist. The students were blinded to the study question and design. There was no external funding and no harm for the participating students. Results: A total of 35 data sets had to be excluded because of missing data. Overall, the students identified 17% (IQR 8-29%) of the patient hazards before the training and 56% (IQR 41-66%) of the patient hazards after the training. At the second assessment students identified more patient hazards than at the first. They identified even more in the third. The effect was most pronounced after the patient chart review training (all p < .01). Conclusion: Patient chart review exercises and problem-based patient chart review training improve students' abilities to recognize patient hazards independent of context during patient chart review.	[Holderried, Friederike] Univ Tubingen, Sch Med, Off Dean Student Affairs, Tubingen, Germany; [Heine, Daniel] Univ Hosp Tuebingen, Dept Anaesthesiol, Tubingen, Germany; [Mahling, Moritz; Fenik, Yelena] Univ Tubingen, Sch Med, Tubingen, Germany; [Herrmann-Werner, Anne; Zipfel, Stephan] Univ Hosp Tuebingen, Dept Internal Med 6, Tubingen, Germany; [Riessen, Reimer] Univ Hosp Tuebingen, Med Intens Care Unit, Tubingen, Germany; [Wagner, Robert; Weyrich, Peter] Univ Hosp Tuebingen, Dept Internal Med 4, Tubingen, Germany; [Celebi, Nora] Nephrol Ctr Marienpk, Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Herrmann-Werner, A (corresponding author), Univ Hosp Tuebingen, Dept Internal Med 6, Tubingen, Germany.	anne.herrmann-werner@med.uni-tuebingen.de	Riessen, Reimer/AFR-0686-2022; Wagner, Robert/B-3689-2012	Wagner, Robert/0000-0002-6120-0191; /0000-0001-7960-4015; Herrmann-Werner, Anne/0000-0003-2413-7047; Holderried, Friederike/0000-0003-1828-0920; Zipfel, Stephan/0000-0003-1659-4440				Callen J, 2011, BMJ QUAL SAF, V20, P194, DOI 10.1136/bmjqs.2010.044339; Celebi N, 2010, N-S ARCH PHARMACOL, V382, P171, DOI 10.1007/s00210-010-0530-9; Celebi N, 2012, MED TEACH, V34, P1087, DOI 10.3109/0142159X.2012.716570; Celebi N, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-24; Celebi N, 2009, MED EDUC, V43, P1010, DOI 10.1111/j.1365-2923.2009.03452.x; Chapman N E, 2001, Healthc Inform, V18, P37; Chapman NE, 2001, HEALTHC INFORM, V18, P42; de Feijter JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031125; de Feijter JM, 2011, ADV HEALTH SCI EDUC, V16, P347, DOI 10.1007/s10459-010-9266-z; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Grant J, 2003, MED EDUC, V37, P140, DOI 10.1046/j.1365-2923.2003.01415.x; Heaton A, 2008, BRIT J CLIN PHARMACO, V66, P128, DOI 10.1111/j.1365-2125.2008.03197.x; Howley LD, 2004, ACAD MED, V79, P276, DOI 10.1097/00001888-200403000-00017; Kolb DA FR, 1975, TOWARD AN APPLIED TH; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; Lesar TS, 1997, ARCH INTERN MED, V157, P1569, DOI 10.1001/archinte.157.14.1569; MARQUIS Y, 1984, MED EDUC, V18, P117, DOI 10.1111/j.1365-2923.1984.tb00984.x; Murff HJ, 2003, J BIOMED INFORM, V36, P131, DOI 10.1016/j.jbi.2003.08.003; Nikendei C, 2008, MED TEACH, V30, P88, DOI 10.1080/01421590701753468; Rancourt Carol, 2004, BMC Geriatr, V4, P9, DOI 10.1186/1471-2318-4-9; Remmen R, 1999, MED EDUC, V33, P600, DOI 10.1046/j.1365-2923.1999.00467.x; Vincent C., 2010, PATIENT SAFETY, V2nd Ed.; Vogt EM, 2002, DRUG SAFETY, V25, P313, DOI 10.2165/00002018-200225050-00002; Zwaan L, 2010, ARCH INTERN MED, V170, P1015, DOI 10.1001/archinternmed.2010.146	26	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89198	10.1371/journal.pone.0089198	http://dx.doi.org/10.1371/journal.pone.0089198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586591	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700071
J	Lee, WP; Jena, S; Doherty, D; Ventakesh, J; Schimdt, J; Furmick, J; Widener, T; Lemau, J; Jurutka, PW; Thompson, PD				Lee, Wai-Ping; Jena, Sarita; Doherty, Declan; Ventakesh, Jaganathan; Schimdt, Joachim; Furmick, Julie; Widener, Tim; Lemau, Jana; Jurutka, Peter W.; Thompson, Paul D.			Sentrin/SUMO Specific Proteases as Novel Tissue-Selective Modulators of Vitamin D Receptor-Mediated Signaling	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVITY; INFLAMMATORY RESPONSE; HISTONE DEACETYLASE-1; SUMO-1 MODIFICATION; ANDROGEN RECEPTOR; DNA-BINDING; PPAR-GAMMA; SUMOYLATION; TRANSREPRESSION; DESUMOYLATION	Vitamin D receptor (VDR) is a substrate for modification with small ubiquitin- like modifier (SUMO). To further assess the role of reversible SUMOylation within the vitamin D hormonal response, we evaluated the effects of sentrin/SUMO-specific proteases (SENPs) that can function to remove small ubiquitin- like modifier (SUMO) from target proteins upon the activities of VDR and related receptors. We report that SENP1 and SENP2 strikingly potentiate ligand-mediated transactivation of VDR and also its heterodimeric partner, retinoid X receptor (RXR alpha) with depletion of cellular SENP1 significantly diminishing the hormonal responsiveness of the endogenous vitamin D target gene CYP24A1. We find that SENP-directed modulation of VDR activity is cell line-dependent, achieving potent modulatory effects in Caco-2 and HEK-293 cells, while in MCF-7 cells the vitamin D signal is unaffected by any tested SENP. In support of their function as novel modulators of the vitamin D hormonal pathway we demonstrate that both SENP1 and SENP2 can interact with VDR and reverse its modification with SUMO2. In a preliminary analysis we identify lysine 91, a residue known to be critical for formation and DNA binding of the VDR-RXR heterodimer, as a minor SUMO acceptor site within VDR. In combination, our results support a repressor function for SUMOylation of VDR and reveal SENPs as a novel class of VDR/RXR co-regulatory protein that significantly modulate the vitamin D response and which could also have important impact upon the functionality of both RXR-containing homo and heterodimers.	[Lee, Wai-Ping; Jena, Sarita; Doherty, Declan; Ventakesh, Jaganathan; Schimdt, Joachim; Thompson, Paul D.] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Furmick, Julie; Widener, Tim; Lemau, Jana; Jurutka, Peter W.] Arizona State Univ, Div Math & Nat Sci, Glendale, AZ USA	Ulster University; Arizona State University	Thompson, PD (corresponding author), Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	p.thompson@ulster.ac.uk		Jurutka, Peter/0000-0002-4950-9161	Action Cancer Northern Ireland; Society of Endocrinology	Action Cancer Northern Ireland; Society of Endocrinology	Research supported through funding from Action Cancer Northern Ireland (http://www.actioncancer.org/home.aspx) and Society of Endocrinology (http://www.endocrinology.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Anderson MG, 2006, CANCER CHEMOTH PHARM, V57, P234, DOI 10.1007/s00280-005-0059-7; Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Bawa-Khalfe T, 2010, J BIOL CHEM, V285, P25859, DOI 10.1074/jbc.M110.134874; Chauchereau A, 2003, J BIOL CHEM, V278, P12335, DOI 10.1074/jbc.M207148200; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Choi SJ, 2006, J BIOL CHEM, V281, P30669, DOI 10.1074/jbc.M604033200; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Devoy A, 2005, ESSAYS BIOCHEM, V41, P187, DOI 10.1042/EB0410187; Dunnebier T, 2009, INT J CANCER, V125, P596, DOI 10.1002/ijc.24286; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Hattori N, 2004, LANCET, V364, P722, DOI 10.1016/S0140-6736(04)16901-8; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; HSIEH JC, 1995, BIOCHEM BIOPH RES CO, V215, P1, DOI 10.1006/bbrc.1995.2426; Hsieh JC, 1999, BIOCHEMISTRY-US, V38, P16347, DOI 10.1021/bi9916574; Hu G, 2010, J PHARMACOL EXP THER, V335, P342, DOI 10.1124/jpet.110.171744; Jena S, 2012, J STEROID BIOCHEM, V132, P24, DOI 10.1016/j.jsbmb.2012.04.006; Jurutka PW, 2005, J CELL BIOCHEM, V94, P917, DOI 10.1002/jcb.20359; Kim JH, 2009, BBA-MOL BASIS DIS, V1792, P155, DOI 10.1016/j.bbadis.2008.12.008; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Peleg S, 2010, J CELL BIOCHEM, V110, P926, DOI 10.1002/jcb.22606; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Pourcet B, 2010, J BIOL CHEM, V285, P5983, DOI 10.1074/jbc.M109.078311; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhang YQ, 2008, BIOCHEM BIOPH RES CO, V374, P673, DOI 10.1016/j.bbrc.2008.07.109	36	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89506	10.1371/journal.pone.0089506	http://dx.doi.org/10.1371/journal.pone.0089506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586832	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700124
J	Laksanalamai, P; Huang, BX; Sabo, J; Burall, LS; Zhao, SH; Bates, J; Datta, AR				Laksanalamai, Pongpan; Huang, Bixing; Sabo, Jonathan; Burall, Laurel S.; Zhao, Shaohua; Bates, John; Datta, Atin R.			Genomic Characterization of Novel Listeria monocytogenes Serotype 4b Variant Strains	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; TANDEM-REPEAT ANALYSIS; MULTIPLEX PCR; UNITED-STATES; NUMBER; OUTBREAK; IDENTIFICATION; VIRULENCE; MICROARRAYS; DIVERSITY	Over 90% of the human listeriosis cases are caused by Listeria monocytogenes serotypes 1/2a, 1/2b and 4b strains. As an alternative to antigen-antibody based serotyping, a PCR-based method for serogrouping has been developed and validated. In this communication, we report an in-depth analysis of five 4b variant strains, four clinical isolates from Australia and one environmental isolate from USA. Although these five strains were serotype 4b by classical serotyping method, the serogrouping PCR profiles of these strains show the presence of a 1/2a-3a specific amplicon in addition to the standard 4b-4d-4e specific amplicons. These strains were further analyzed by pulsed field gel electrophoresis, binary gene typing, multilocus variable-number-tandem-repeat analysis and a high density pan-genomic Listeria microarray. Using these sub-typing results, the clinical isolates were grouped into two distinct genomic groups-one of which could be part of an unidentified outbreak. The microarray results when compared with our database of other 4b outbreak isolates indicated that the serotype 4b variant strains represent very different genotypic profiles than the known reported 4b outbreak strains representing major epidemic clones. The acquisition of serotype 1/2a gene clusters by the 4b variant strains appears to be independent in origin, spanning large areas of geographical and temporal space and may indicate predisposition of some 4b strains towards accepting DNA from related organisms.	[Laksanalamai, Pongpan; Burall, Laurel S.; Datta, Atin R.] US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD 20708 USA; [Huang, Bixing; Bates, John] Queensland Hlth Forens & Sci Serv, Publ Hlth Microbiol Lab, Coopers Plains, Qld, Australia; [Sabo, Jonathan; Zhao, Shaohua] US FDA, Ctr Vet Med, Laurel, MD USA	US Food & Drug Administration (FDA); Queensland Health; US Food & Drug Administration (FDA)	Datta, AR (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD 20708 USA.	atin.datta@fda.hhs.gov						Affymetrix, 2005, AFF GENECHIP EXPR AN; Aureli P, 2000, NEW ENGL J MED, V342, P1236, DOI 10.1056/NEJM200004273421702; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borucki MK, 2004, J CLIN MICROBIOL, V42, P5270, DOI 10.1128/JCM.42.11.5270-5276.2004; Burall LS, 2011, J FOOD PROTECT, V74, P403, DOI 10.4315/0362-028X.JFP-10-355; Call DR, 2003, J MICROBIOL METH, V53, P235, DOI 10.1016/S0167-7012(03)00027-7; Call DR, 2003, J CLIN MICROBIOL, V41, P632, DOI 10.1128/JCM.41.2.632-639.2003; Cantinelli T, 2013, J CLIN MICROBIOL, V51, P3770, DOI 10.1128/JCM.01874-13; Chen J, 2009, SCIENCE, V323, P139, DOI 10.1126/science.1164783; Chenal-Francisque V, 2011, EMERG INFECT DIS, V17, P1110, DOI [10.3201/eid/1706.101778, 10.3201/eid1706.101778]; Cheng Ying, 2008, P337, DOI 10.1201/9781420051414.ch11; Cosgrove Shaun, 2011, Morbidity and Mortality Weekly Report, V60, P1357; Datta AR, 2012, FOOD ADDIT CONTAM A; Doumith M, 2004, INFECT IMMUN, V72, P1072, DOI 10.1128/IAI.72.2.1072-1083.2004; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Ferreira V, 2011, APPL ENVIRON MICROB, V77, P2701, DOI 10.1128/AEM.02553-10; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; Graves L. M., 2007, LISTERIA LISTERIOSIS, P283; Halpin JL, 2010, FOODBORNE PATHOG DIS, V7, P293, DOI 10.1089/fpd.2009.0394; Huang B, 2007, BINARY TYPING LISTER, P136; Huang BX, 2011, J CLIN MICROBIOL, V49, P426, DOI 10.1128/JCM.01207-10; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-349; Jadhav S, 2012, J MICROBIOL METH, V88, P327, DOI 10.1016/j.mimet.2012.01.002; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Laksanalamai P, 2013, GENOME ANNOUNC, V1; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042448; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032896; Leclercq A, 2011, INT J FOOD MICROBIOL, V147, P74, DOI 10.1016/j.ijfoodmicro.2011.03.010; Lee S, 2012, APPL ENVIRON MICROB, V78, P2623, DOI 10.1128/AEM.07203-11; Lee S, 2012, APPL ENVIRON MICROB, V78, P660, DOI 10.1128/AEM.06378-11; Li XJ, 2013, DIAGN MICR INFEC DIS, V75, P203, DOI 10.1016/j.diagmicrobio.2012.11.007; Lindstedt BA, 2008, J MICROBIOL METH, V72, P141, DOI 10.1016/j.mimet.2007.11.012; Liu Donyou, 2008, P27, DOI 10.1201/9781420051414.ch2; Mead PS, 2006, EPIDEMIOL INFECT, V134, P744, DOI 10.1017/S0950268805005376; Milillo SR, 2009, FOOD MICROBIOL, V26, P212, DOI 10.1016/j.fm.2008.08.010; Miya S, 2008, INT J FOOD MICROBIOL, V124, P239, DOI 10.1016/j.ijfoodmicro.2008.03.023; Mook P, 2011, EMERG INFECT DIS, V17, P38, DOI 10.3201/eid1701.101174; Murphy M, 2007, INT J FOOD MICROBIOL, V115, P187, DOI 10.1016/j.ijfoodmicro.2006.10.022; Orsi RH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-539; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Roberts AJ, 2009, APPL ENVIRON MICROB, V75, P5647, DOI 10.1128/AEM.00367-09; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Seeliger H.P.R., 1979, METHOD MICROBIOL, V13, P31, DOI [10.1016/S0580-9517(08)70372-6, DOI 10.1016/S0580-9517(08)70372-6]; Silk BJ, 2012, CLIN INFECT DIS, V54, pS396, DOI 10.1093/cid/cis268; Sperry KEV, 2008, J CLIN MICROBIOL, V46, P1435, DOI 10.1128/JCM.02207-07; Todd ECD, 2011, FOOD CONTROL, V22, P1484, DOI 10.1016/j.foodcont.2010.07.021; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Volokhov D, 2002, J CLIN MICROBIOL, V40, P4720, DOI 10.1128/JCM.40.12.4720-4728.2002; Yildirim S, 2010, APPL ENVIRON MICROB, V76, P5577, DOI 10.1128/AEM.00648-10; Zhang CM, 2003, J BACTERIOL, V185, P5573, DOI 10.1128/JB.185.18.5573-5584.2003	56	22	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89024	10.1371/journal.pone.0089024	http://dx.doi.org/10.1371/journal.pone.0089024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586485	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900071
J	Campos, Z; Mourao, G; Coutinho, M; Magnusson, WE				Campos, Zilca; Mourao, Guilherme; Coutinho, Marcos; Magnusson, William E.			Growth of Caiman crocodilus yacare in the Brazilian Pantanal	PLOS ONE			English	Article							PALEOSUCHUS-PALPEBROSUS; CROCODYLUS-JOHNSTONI; AMERICAN ALLIGATORS; MELANOSUCHUS-NIGER; RATES; AGE; HABITAT; RIVER	We studied growth of the caiman, Caiman crocodilus yacare, in the Brazilian Pantanal for 27 years between 1987 and 2013. We recaptured 647 of 7769 C. c. yacare initially marked in an area of 50 km 2, in two ranches. We were able to determine size at age accurately for 24 male and 17 female caimans that had been marked at hatching or less than 1 year old, and recaptured over periods of 5 to 24 years. The other 606 caimans were used to evaluate short-term growth rates. Age-size relationships were estimated using growth models from the Richards family of curves (full model, von Bertalanffy and monomolecular). The form of the relationships differed between analyses based on caimans of known age and analyses based on integration of growth rate on size relationships for caimans whose ages were not known. Individuals showed large variation in short-term growth rates, but data on known-age animals indicated little between-individual variability in long-term growth rates. There was evidence of a small effect of rainfall, but not temperature, on short-term growth of small caimans, but most variation in growth rates was unexplained by variables other than age and sex. Data on known-age individuals indicated that female C. c. yacare generally reach sexual maturity between 10 and 15 years of age. Because of the asymptotic relationship between age and size, deviations of observations from the model for age are larger than for size, and estimates of age at a given size have greater errors than estimates of size at a given age. Integration of growth rate on size relationships may be adequate for estimating size from age in many cases, but accurate estimates of age from size require data on known-age individuals over the size range of the species.	[Campos, Zilca; Mourao, Guilherme] Embrapa Pantanal, Corumba, MS, Brazil; [Coutinho, Marcos] Inst Chico Mendes Conservacao Biodiversidade Base, Lagoa Santa, MG, Brazil; [Magnusson, William E.] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Institute Nacional de Pesquisas da Amazonia	Campos, Z (corresponding author), Embrapa Pantanal, Corumba, MS, Brazil.	zilca.campos@embrapa.br	Magnusson, William E/J-9408-2014; Mourão, Guilherme M/C-3319-2013	Magnusson, William E/0000-0003-1988-3950; Mourão, Guilherme M/0000-0002-8300-4191	Embrapa; WWF-USA; Conservation International-USA; Fundacao O Boticario; Fundect	Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); WWF-USA; Conservation International-USA; Fundacao O Boticario; Fundect(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	The study was funded by Embrapa, WWF-USA, Conservation International-USA, Fundacao O Boticario and Fundect. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie C.L. III, 1989, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series, P1; Andrews R.M., 1982, Biology of Reptilia, V13, P273; Brisbin I.L. Jr, 1990, P116; BRISBIN IL, 1986, GROWTH DEVELOP AGING, V50, P1; BRISBIN IL, 1987, AUK, V104, P552, DOI 10.2307/4087567; Campos Z, 2003, COPEIA, P628; CAMPOS Z, 1995, J TROP ECOL, V11, P351, DOI 10.1017/S0266467400008828; CAMPOS Z, 1993, J HERPETOL, V27, P127, DOI 10.2307/1564927; Campos Z, 2006, HERPETOL J, V16, P123; Campos Z, 2013, HERPETOLOGICA, V69, P405; Campos Z, 2011, HERPETOL J, V21, P91; Campos Z, 2010, AMPHIBIA-REPTILIA, V31, P439, DOI 10.1163/156853810791769392; CHABRECK RH, 1979, HERPETOLOGICA, V35, P51; Coutinho M, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P229; Da Silveira R, 2013, AMPHIBIA-REPTILIA, V34, P437, DOI 10.1163/15685381-00002896; Da Silveira Ronis, 2011, Herpetological Review, V42, P424; Eaton MJ, 2011, ECOL APPL, V21, P2487, DOI 10.1890/10-0626.1; Garcia-Grajales J, 2012, HERPETOL CONSERV BIO, V7, P330; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; JACOBSEN T, 1989, J ZOOL, V219, P309, DOI 10.1111/j.1469-7998.1989.tb02583.x; Magnusson W., 2012, CROC SPEC GROUP NEWS, V31, P13; MAGNUSSON WE, 1995, COPEIA, P498; MAGNUSSON WE, 1991, J HERPETOL, V25, P41, DOI 10.2307/1564793; Magnusson William E., 1997, Herpetological Review, V28, P183; Moulton TP, 1999, J HERPETOL, V33, P479, DOI 10.2307/1565647; REBELO GH, 1997, VIDA SILVESTRE NEOTR, V6, P29; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Soriano BMA, 2000, B AGROMETEREOLOGICO, V4; Soriano BMA, 1997, B AGROMETEREOLOGICO, V3; Soriano BMA, 2000, B AGROMETEREOLOGICO, V5; Tucker AD, 1997, MAR FRESHWATER RES, V48, P343, DOI 10.1071/MF96113; Tucker AD, 2006, AUST J ZOOL, V54, P409, DOI 10.1071/ZO06099; WEBB GJW, 1983, AUST WILDLIFE RES, V10, P383, DOI 10.1071/WR9830383; WEBB GJW, 1978, AUST WILDLIFE RES, V5, P385; Wilkinson PM, 1997, J WILDLIFE MANAGE, V61, P397, DOI 10.2307/3802596	35	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89363	10.1371/journal.pone.0089363	http://dx.doi.org/10.1371/journal.pone.0089363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586719	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200050
J	Guerrero, F; Herencia, C; Almaden, Y; Martinez-Moreno, JM; de Oca, AM; Rodriguez-Ortiz, ME; Diaz-Tocados, JM; Canalejo, A; Florio, M; Lopez, I; Richards, WG; Rodriguez, M; Aguilera-Tejero, E; Munoz-Castaneda, JR				Guerrero, Fatima; Herencia, Carmen; Almaden, Yolanda; Martinez-Moreno, Julio M.; Montes de Oca, Addy; Encarnacion Rodriguez-Ortiz, Maria; Diaz-Tocados, Juan M.; Canalejo, Antonio; Florio, Monica; Lopez, Ignacio; Richards, William G.; Rodriguez, Mariano; Aguilera-Tejero, Escolastico; Munoz-Castaneda, Juan R.			TGF-beta Prevents Phosphate-Induced Osteogenesis through Inhibition of BMP and Wnt/beta-Catenin Pathways	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-BETA; VASCULAR CALCIFICATION; IN-VITRO; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; WNT	Background: Transforming growth factor-beta (TGF-beta) is a key cytokine during differentiation of mesenchymal stem cells (MSC) into vascular smooth muscle cells (VSMC). High phosphate induces a phenotypic transformation of vascular smooth muscle cells (VSMC) into osteogenic-like cells. This study was aimed to evaluate signaling pathways involved during VSMC differentiation of MSC in presence or not of high phosphate. Results: Our results showed that TGF-b induced nuclear translocation of Smad3 as well as the expression of vascular smooth muscle markers, such as smooth muscle alpha actin, SM22 alpha, myocardin, and smooth muscle-myosin heavy chain. The addition of high phosphate to MSC promoted nuclear translocation of Smad1/5/8 and the activation of canonical Wnt/beta-catenin in addition to an increase in BMP-2 expression, calcium deposition and alkaline phosphatase activity. The administration of TGF-beta to MSC treated with high phosphate abolished all these effects by inhibiting canonical Wnt, BMP and TGF-beta pathways. A similar outcome was observed in high phosphate-treated cells after the inhibition of canonical Wnt signaling with Dkk-1. Conversely, addition of both Wnt/beta-catenin activators CHIR98014 and lithium chloride enhanced the effect of high phosphate on BMP-2, calcium deposition and alkaline phosphatase activity. Conclusions: Full VSMC differentiation induced by TGF-beta may not be achieved when extracellular phosphate levels are high. Moreover, TGF-beta prevents high phosphate-induced osteogenesis by decreasing the nuclear translocation of Smad 1/5/8 and avoiding the activation of Wnt/b-catenin pathway.	[Guerrero, Fatima; Herencia, Carmen; Martinez-Moreno, Julio M.; Montes de Oca, Addy; Encarnacion Rodriguez-Ortiz, Maria; Diaz-Tocados, Juan M.; Rodriguez, Mariano; Munoz-Castaneda, Juan R.] Univ Cordoba, Hosp Reina Sofia, Inst Maimonides Invest Biomed IMIB, Cordoba, Spain; [Almaden, Yolanda] Univ Cordoba, Reina Sofi Univ Hospital, Lipid & Atherosclerosis Unit IMIBIC, Cordoba, Spain; [Almaden, Yolanda] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Cordoba, Spain; [Canalejo, Antonio] Univ Huelva, Dept Biol Ambiental & Salud Publ, Huelva, Spain; [Florio, Monica; Richards, William G.] Amgen Inc, Metab Disorders Dept, Thousand Oaks, CA 91320 USA; [Lopez, Ignacio; Aguilera-Tejero, Escolastico] Univ Cordoba, Dept Med & Cirugia Anim, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Huelva; Amgen; Universidad de Cordoba	Munoz-Castaneda, JR (corresponding author), Univ Cordoba, Hosp Reina Sofia, Inst Maimonides Invest Biomed IMIB, Cordoba, Spain.	juanr.munoz.exts@juntadeandalucia.es	Martínez, Julio Manuel/AAA-6724-2020; Canalejo, Antonio/L-8407-2014; Muñoz-Castañeda, Juan R./AFQ-3443-2022; Herencia, Carmen/AAA-6843-2020; Tocados, Juan Miguel Díaz/I-8254-2018	Martínez, Julio Manuel/0000-0002-1945-5078; Canalejo, Antonio/0000-0003-2098-8960; Guerrero Pavon, Fatima/0000-0003-1306-0574; Munoz-Castaneda, Juan R/0000-0002-9341-0724; Diaz Tocados, Juan Miguel/0000-0001-5192-5212; Rodriguez, Mariano/0000-0002-9380-6614	Consejeria de Economia, Ciencia y Empresa from Junta de Andalucia [P09-CTS-5205]; FIS from Instituto de Salud Carlos III [PI11/02055]; Consejeria de Salud, Junta de Andalucia [PI-0127]	Consejeria de Economia, Ciencia y Empresa from Junta de Andalucia; FIS from Instituto de Salud Carlos III(Instituto de Salud Carlos III); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia)	Sources of Funding: This study has been carried out with the funding of "Proyecto de Excelencia P09-CTS-5205'' from Consejeria de Economia, Ciencia y Empresa from Junta de Andalucia, FIS PI11/02055 from Instituto de Salud Carlos III and PI-0127 from Consejeria de Salud, Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Davies MR, 2003, J AM SOC NEPHROL, V14, P1559, DOI 10.1097/01.ASN.0000068404.57780.DD; Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001; Ehnert S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-101; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Itasaki N, 2010, DEV DYNAM, V239, P16, DOI 10.1002/dvdy.22009; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kalra SS, 2012, ANN MED, V44, pS85, DOI 10.3109/07853890.2012.660498; Kramann R, 2011, ARTERIOSCL THROM VAS, V31, pE45, DOI 10.1161/ATVBAHA.111.228601; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lee KM, 2012, BIOCHEM BIOPH RES CO, V428, P50, DOI 10.1016/j.bbrc.2012.09.145; Li RD, 2012, BMB REP, V45, P509, DOI 10.5483/BMBRep.2012.45.9.053; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Lopez I, 2009, AM J PHYSIOL-RENAL, V296, pF1376, DOI 10.1152/ajprenal.90737.2008; Martinez-Moreno JM, 2012, AM J PHYSIOL-RENAL, V303, pF1136, DOI 10.1152/ajprenal.00684.2011; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Montes de OA, 2010, J BONE MINER RES, V25, P1996; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Roarty K, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2244; Sage AP, 2011, KIDNEY INT, V79, P414, DOI 10.1038/ki.2010.390; Shalhoub V, 2010, J CELL BIOCHEM, V111, P911, DOI 10.1002/jcb.22779; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Wilkinson FL, 2007, J PATHOL, V211, P362, DOI 10.1002/path.2114; Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017; Yagi K, 2003, J CELL BIOCHEM, V88, P1077, DOI 10.1002/jcb.10467; Yu Z, 2010, J PHARMACOL EXP THER, V337, P16; Zhang C, 2013, CARDIOVASC RES, V99, P251, DOI 10.1093/cvr/cvt061; Zhang RR, 2013, BONE, V52, P145, DOI 10.1016/j.bone.2012.09.029; Zhou SH, 2011, J CELL BIOCHEM, V112, P1651, DOI 10.1002/jcb.23079	36	41	44	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89179	10.1371/journal.pone.0089179	http://dx.doi.org/10.1371/journal.pone.0089179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586576	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800010
J	Chen, HM; Zhu, BZ; Chen, RJ; Wang, B; Wang, YJ				Chen, Hsiu-Min; Zhu, Ben-Zhan; Chen, Rong-Jane; Wang, Bour-Jr; Wang, Ying-Jan			The Pentachlorophenol Metabolite Tetrachlorohydroquinone Induces Massive ROS and Prolonged p-ERK Expression in Splenocytes, Leading to Inhibition of Apoptosis and Necrotic Cell Death	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; N-ACETYLCYSTEINE; MAP KINASES; IN-VIVO; HYDROGEN-PEROXIDE; MAJOR METABOLITE; PHOSPHATIDYLSERINE EXPOSURE; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; TUMOR PROMOTION	Pentachlorophenol (PCP) has been used extensively as a biocide and a wood preservative and has been reported to be immunosuppressive in rodents and humans. Tetrachlorohydroquinone (TCHQ) is a major metabolite of PCP. TCHQ has been identified as the main cause of PCP-induced genotoxicity due to reactive oxidant stress (ROS). However, the precise mechanisms associated with the immunotoxic effects of PCP and TCHQ remain unclear. The aim of this study was to examine the effects of PCP and TCHQ on the induction of ROS and injury to primary mouse splenocytes. Our results shown that TCHQ was more toxic than PCP and that a high dose of TCHQ led to necrotic cell death of the splenocytes through induction of massive and sudden ROS and prolonged ROS-triggered ERK activation. Inhibition of ROS production by N-acetyl-cysteine (NAC) partially restored the mitochondrial membrane potential, inhibited ERK activity, elevated caspase-3 activity and PARP cleavage, and, eventually, switched the TCHQ-induced necrosis to apoptosis. We suggest that prolonged ERK activation is essential for TCHQ-induced necrosis, and that ROS play a pivotal role in the different TCHQ-induced cell death mechanisms.	[Chen, Hsiu-Min; Chen, Rong-Jane; Wang, Ying-Jan] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Zhu, Ben-Zhan] Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Wang, Bour-Jr] Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan; [Wang, Bour-Jr] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci, Tainan, Taiwan; [Wang, Bour-Jr] Chia Nan Univ Pharm & Sci, Inst Cosmet Sci, Tainan, Taiwan	National Cheng Kung University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); National Cheng Kung University; National Cheng Kung University Hospital; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science	Wang, B (corresponding author), Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med, Tainan 70428, Taiwan.	pochih.wang@msa.hinet.net; yjwang@mail.ncku.edu.tw			National Science Council, Taiwan [NSC 102-2314-B-006-034]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Taiwan (NSC 102-2314-B-006-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akool ES, 2012, BIOCHEM PHARMACOL, V83, P286, DOI 10.1016/j.bcp.2011.11.001; Andreassen OA, 2000, NEUROREPORT, V11, P2491, DOI 10.1097/00001756-200008030-00029; [Anonymous], 1991, IARC Monogr Eval Carcinog Risks Hum, V53, P371; Appelt U, 2005, CELL DEATH DIFFER, V12, P194, DOI 10.1038/sj.cdd.4401527; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; ARUOMA OI, 1991, BIOCHEM J, V273, P601, DOI 10.1042/bj2730601; Aydin S, 2002, TOHOKU J EXP MED, V198, P71, DOI 10.1620/tjem.198.71; Bai JX, 2001, BIOL SIGNAL RECEPT, V10, P189; Bevenue A, 1967, Residue Rev, V19, P83; Blakley BR, 1998, TOXICOLOGY, V125, P141, DOI 10.1016/S0300-483X(97)00154-6; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; CARSTENS CP, 1990, CHEM-BIOL INTERACT, V74, P305, DOI 10.1016/0009-2797(90)90047-Q; Chang WC, 2003, MOL CARCINOGEN, V36, P161, DOI 10.1002/mc.10113; Chen HM, 2013, CHEM-BIOL INTERACT, V206, P166, DOI 10.1016/j.cbi.2013.09.005; Chen SY, 2011, AUTOPHAGY, V7, P217, DOI 10.4161/auto.7.2.14212; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Chhabra RS, 1999, TOXICOL SCI, V48, P14, DOI 10.1093/toxsci/48.1.14; COLUMBANO A, 1995, J CELL BIOCHEM, V58, P181, DOI 10.1002/jcb.240580207; CORCORAN GB, 1994, TOXICOL APPL PHARM, V128, P169, DOI 10.1006/taap.1994.1195; DAHLHAUS M, 1994, TOXICOL LETT, V74, P265, DOI 10.1016/0378-4274(94)90085-X; DANIEL V, 1995, ARCH ENVIRON HEALTH, V50, P287, DOI 10.1080/00039896.1995.9935956; Daniel V, 2001, ARCH ENVIRON HEALTH, V56, P77, DOI 10.1080/00039890109604057; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Flora S, 2001, CARCINOGENESIS, V22, P999, DOI 10.1093/carcin/22.7.999; de Groot RP, 1998, CELL SIGNAL, V10, P619, DOI 10.1016/S0898-6568(98)00023-0; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; DYPBUKT JM, 1994, J BIOL CHEM, V269, P30553; Ercal N, 1996, FREE RADICAL BIO MED, V21, P157, DOI 10.1016/0891-5849(96)00020-2; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Gate L, 2003, BIOCHEM PHARMACOL, V65, P1611, DOI 10.1016/S0006-2952(03)00152-7; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griendling KK, 2005, ARTERIOSCL THROM VAS, V25, P272, DOI 10.1161/01.ATV.0000153515.72375.3b; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; Han KS, 2001, J NEUROCHEM, V78, P230, DOI 10.1046/j.1471-4159.2001.00394.x; Hetz CA, 2005, BIOCHEM CELL BIOL, V83, P579, DOI 10.1139/o05-065; Hirt UA, 2003, CELL DEATH DIFFER, V10, P1156, DOI 10.1038/sj.cdd.4401286; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Kamboj A, 2006, EXP BRAIN RES, V170, P567, DOI 10.1007/s00221-005-0241-5; Koppal T, 1999, BBA-MOL BASIS DIS, V1453, P407, DOI 10.1016/S0925-4439(99)00014-9; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Krysko O, 2004, APOPTOSIS, V9, P495, DOI 10.1023/B:APPT.0000031452.75162.75; Law WM, 2003, CHEMOSPHERE, V52, P1531, DOI 10.1016/S0045-6535(03)00492-2; Lin PH, 2002, CARCINOGENESIS, V23, P365, DOI 10.1093/carcin/23.2.365; Lin PH, 2001, CARCINOGENESIS, V22, P627, DOI 10.1093/carcin/22.4.627; Lin YP, 2004, MOL CARCINOGEN, V40, P24, DOI 10.1002/mc.20021; Maheshwari A, 2012, APOPTOSIS, V17, P551, DOI 10.1007/s10495-012-0703-8; Matsuda N, 1998, BIOCHEM BIOPH RES CO, V249, P350, DOI 10.1006/bbrc.1998.9151; MCCONNACHIE PR, 1991, ARCH ENVIRON HEALTH, V46, P249, DOI 10.1080/00039896.1991.9937456; MENEGHINI R, 1988, MUTAT RES, V195, P215, DOI 10.1016/0165-1110(88)90001-2; Mycroft FJ, 1986, HAZARD REV, V3, P1; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; NOSE K, 1991, EUR J BIOCHEM, V201, P99, DOI 10.1111/j.1432-1033.1991.tb16261.x; Okeke BC, 1997, APPL MICROBIOL BIOT, V48, P563, DOI 10.1007/s002530051097; Pocernich CB, 2000, NEUROCHEM INT, V36, P185, DOI 10.1016/S0197-0186(99)00126-6; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; Ramos B, 2003, MOL PHARMACOL, V64, P502, DOI 10.1124/mol.64.2.502; REIGNER BG, 1992, HUM EXP TOXICOL, V11, P17, DOI 10.1177/096032719201100103; Roberts H J, 1990, J Fla Med Assoc, V77, P86; Robertson JD, 2000, CRIT REV TOXICOL, V30, P609, DOI 10.1080/10408440008951122; SAIKATO K, 1995, FOOD CHEM TOXICOL, V33, P877, DOI 10.1016/0278-6915(95)00056-8; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SEILER JP, 1991, MUTAT RES, V257, P27, DOI 10.1016/0165-1110(91)90018-Q; Shelton JG, 2003, ONCOGENE, V22, P2478, DOI 10.1038/sj.onc.1206321; Soderstrom TS, 2002, J IMMUNOL, V169, P2851, DOI 10.4049/jimmunol.169.6.2851; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Tran SEF, 2001, J BIOL CHEM, V276, P16484, DOI 10.1074/jbc.M010384200; Umemura T, 1996, FUND APPL TOXICOL, V30, P285, DOI 10.1006/faat.1996.0066; Umemura T, 1999, CARCINOGENESIS, V20, P1115, DOI 10.1093/carcin/20.6.1115; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Villena J, 2008, FREE RADICAL BIO MED, V44, P1146, DOI 10.1016/j.freeradbiomed.2007.12.017; Wang BJ, 2010, EXP DERMATOL, V19, pE191, DOI 10.1111/j.1600-0625.2009.01045.x; Wang YJ, 2008, FOOD CHEM TOXICOL, V46, P3739, DOI 10.1016/j.fct.2008.09.064; Wang YJ, 2001, TOXICOL LETT, V122, P157, DOI 10.1016/S0378-4274(01)00361-7; Wang YJ, 1997, CHEM-BIOL INTERACT, V105, P1, DOI 10.1016/S0009-2797(97)00023-9; WANG YJ, 1995, ARCH ENVIRON CON TOX, V28, P537; Wang YJ, 2000, CHEM-BIOL INTERACT, V128, P173, DOI 10.1016/S0009-2797(00)00194-0; Waring P, 1999, CELL DEATH DIFFER, V6, P624, DOI 10.1038/sj.cdd.4400540; Wispriyono B, 2002, ENVIRON HEALTH PERSP, V110, P139, DOI 10.1289/ehp.02110139; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yan CYI, 1998, J NEUROSCI, V18, P4042; Zachwieja J, 2005, PEDIATR NEPHROL, V20, P725, DOI 10.1007/s00467-004-1806-4; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	91	14	14	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89483	10.1371/journal.pone.0089483	http://dx.doi.org/10.1371/journal.pone.0089483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586814	Green Submitted, gold, Green Published			2022-12-27	WOS:000332389000049
J	Bondarenko, VE				Bondarenko, Vladimir E.			A Compartmentalized Mathematical Model of the beta(1)-Adrenergic Signaling System in Mouse Ventricular Myocytes	PLOS ONE			English	Article							CARDIAC RYANODINE RECEPTOR; BETA-ADRENERGIC STIMULATION; RECTIFIER POTASSIUM CURRENT; TROPONIN-I PHOSPHORYLATION; PROTEIN-KINASE; HEART-FAILURE; ADENYLYL-CYCLASE; TRANSGENIC MICE; PHOSPHOLAMBAN PHOSPHORYLATION; SODIUM-CHANNEL	The beta(1)-adrenergic signaling system plays an important role in the functioning of cardiac cells. Experimental data shows that the activation of this system produces inotropy, lusitropy, and chronotropy in the heart, such as increased magnitude and relaxation rates of [Ca2+](i) transients and contraction force, and increased heart rhythm. However, excessive stimulation of beta(1)-adrenergic receptors leads to heart dysfunction and heart failure. In this paper, a comprehensive, experimentally based mathematical model of the beta(1)-adrenergic signaling system for mouse ventricular myocytes is developed, which includes major subcellular functional compartments (caveolae, extracaveolae, and cytosol). The model describes biochemical reactions that occur during stimulation of beta(1)-adrenoceptors, changes in ionic currents, and modifications of Ca2+ handling system. Simulations describe the dynamics of major signaling molecules, such as cyclic AMP and protein kinase A, in different subcellular compartments; the effects of inhibition of phosphodiesterases on cAMP production; kinetics and magnitudes of phosphorylation of ion channels, transporters, and Ca2+ handling proteins; modifications of action potential shape and duration; magnitudes and relaxation rates of [Ca2+](i) transients; changes in intracellular and transmembrane Ca2+ fluxes; and [Na+](i) fluxes and dynamics. The model elucidates complex interactions of ionic currents upon activation of beta(1)-adrenoceptors at different stimulation frequencies, which ultimately lead to a relatively modest increase in action potential duration and significant increase in [Ca2+](i) transients. In particular, the model includes two subpopulations of the L-type Ca2+ channels, in caveolae and extracaveolae compartments, and their effects on the action potential and [Ca2+](i) transients are investigated. The presented model can be used by researchers for the interpretation of experimental data and for the developments of mathematical models for other species or for pathological conditions.	[Bondarenko, Vladimir E.] Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA; [Bondarenko, Vladimir E.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Bondarenko, VE (corresponding author), Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA.	vbondarenko@gsu.edu			American Heart Association [10GRNT4720012]; Georgia State University Seed Grant from Brain and Behavior Program; Research Initiation Grant	American Heart Association(American Heart Association); Georgia State University Seed Grant from Brain and Behavior Program; Research Initiation Grant	This work was supported by the American Heart Association (http://www.heart.org/HEARTORG/) (10GRNT4720012), Georgia State University (http://www.gsu.edu) Seed Grant from Brain and Behavior Program, and Research Initiation Grant to V. E. Bondarenko. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Char J, 2007, J PHYSIOL-LONDON, V582, P1205, DOI 10.1113/jphysiol.2007.134809; ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; Baba S, 2004, CARDIOVASC RES, V64, P260, DOI 10.1016/j.cardiores.2004.06.021; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; BEAVO JA, 1974, P NATL ACAD SCI USA, V71, P3580, DOI 10.1073/pnas.71.9.3580; Benkusky NA, 2007, CIRC RES, V101, P819, DOI 10.1161/CIRCRESAHA.107.153007; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BERS DM, 1993, AM J PHYSIOL, V264, pC1587, DOI 10.1152/ajpcell.1993.264.6.C1587; Bers DM, 2001, EXCITATION CONTRACTI; Bers DM, 2012, CIRC RES, V110, P796, DOI 10.1161/CIRCRESAHA.112.265579; Best JM, 2012, J MOL CELL CARDIOL, V52, P376, DOI 10.1016/j.yjmcc.2011.08.014; BODE DC, 1991, CIRC RES, V68, P1070, DOI 10.1161/01.RES.68.4.1070; Bondarenko VE, 2004, AM J PHYSIOL-HEART C, V287, pH1378, DOI 10.1152/ajpheart.00185.2003; Bondarenko VE, 2004, AM J PHYSIOL-HEART C, V286, pH1154, DOI 10.1152/ajpheart.00168.2003; Bondarenko VE, 2007, AM J PHYSIOL-HEART C, V293, pH1816, DOI 10.1152/ajpheart.00471.2007; Bondarenko VE, 2010, AM J PHYSIOL-HEART C, V299, pH454, DOI 10.1152/ajpheart.00907.2009; Bracken N, 2006, BRIT J PHARMACOL, V148, P1108, DOI 10.1038/sj.bjp.0706809; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; Chen-Goodspeed M, 2005, J BIOL CHEM, V280, P1808, DOI 10.1074/jbc.M409172200; Chu GX, 1996, CIRC RES, V79, P1064, DOI 10.1161/01.RES.79.6.1064; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2008, CIRCULATION, V117, P1849, DOI 10.1161/CIRCULATIONAHA.107.754051; Despa S, 2013, J MOL CELL CARDIOL, V61, P2, DOI 10.1016/j.yjmcc.2013.04.011; DOSTMANN WRG, 1991, BIOCHEMISTRY-US, V30, P8710, DOI 10.1021/bi00099a032; Dubell WH, 2002, AM J PHYSIOL-HEART C, V282, pH38, DOI 10.1152/ajpheart.00536.2001; Eisner D, 2013, J MOL CELL CARDIOL, V58, P110, DOI 10.1016/j.yjmcc.2012.11.017; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Fernandez-Velasco M, 2009, CIRC RES, V104, P201, DOI 10.1161/CIRCRESAHA.108.177493; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Folco EJ, 2004, AM J PHYSIOL-HEART C, V287, pH681, DOI 10.1152/ajpheart.00152.2004; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Fuller W, 2013, CELL MOL LIFE SCI, V70, P1357, DOI 10.1007/s00018-012-1134-y; Fuller W, 2001, ANAL BIOCHEM, V293, P216, DOI 10.1006/abio.2001.5127; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; GAO J, 1992, J PHYSIOL-LONDON, V449, P689, DOI 10.1113/jphysiol.1992.sp019109; Gao X, 2007, J BIOL CHEM, V282, P294, DOI 10.1074/jbc.M607522200; Georget M, 2003, FASEB J, V17, P1380, DOI 10.1096/fj.02-0784com; Gottle M, 2009, J PHARMACOL EXP THER, V329, P1156, DOI 10.1124/jpet.109.150953; de la Fuente MG, 2013, CARDIOVASC RES, V97, P379, DOI 10.1093/cvr/cvs313; Harvey RD, 2012, J MOL CELL CARDIOL, V52, P366, DOI 10.1016/j.yjmcc.2011.07.007; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Heijman J, 2011, J MOL CELL CARDIOL, V50, P863, DOI 10.1016/j.yjmcc.2011.02.007; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; HESCHELER J, 1987, EUR J BIOCHEM, V165, P261, DOI 10.1111/j.1432-1033.1987.tb11436.x; Hilal-Dandan R, 2000, J MOL CELL CARDIOL, V32, P1211, DOI 10.1006/jmcc.2000.1156; Ho D, 2010, HEART FAIL REV, V15, P495, DOI 10.1007/s10741-010-9183-5; Hoffman DA, 1998, J NEUROSCI, V18, P3521; HOFMANN F, 1975, J BIOL CHEM, V250, P7795; HOHL CM, 1991, CIRC RES, V69, P1369, DOI 10.1161/01.RES.69.5.1369; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Iancu RV, 2008, AM J PHYSIOL-CELL PH, V295, pC414, DOI 10.1152/ajpcell.00038.2008; Iancu RV, 2007, BIOPHYS J, V92, P3317, DOI 10.1529/biophysj.106.095356; Jayasinghe ID, 2009, BIOPHYS J, V97, P2664, DOI 10.1016/j.bpj.2009.08.036; KAMEYAMA M, 1986, PFLUG ARCH EUR J PHY, V407, P123, DOI 10.1007/BF00580662; KARCZEWSKI P, 1990, BIOCHEM J, V266, P115, DOI 10.1042/bj2660115; Kim SJ, 1999, J CLIN INVEST, V103, P1089, DOI 10.1172/JCI4848; Kirstein M, 1996, PFLUG ARCH EUR J PHY, V431, P395, DOI 10.1007/BF02207277; Knollmann BC, 2003, CIRC RES, V92, P428, DOI 10.1161/01.RES.0000059562.91384.1A; Kuschel M, 1999, AM J PHYSIOL-HEART C, V276, pH1625, DOI 10.1152/ajpheart.1999.276.5.H1625; Kuzumoto M, 2008, PROG BIOPHYS MOL BIO, V96, P171, DOI 10.1016/j.pbiomolbio.2007.07.005; Lemire I, 1998, J MOL CELL CARDIOL, V30, P1827, DOI 10.1006/jmcc.1998.0746; Leroy J, 2008, CIRC RES, V102, P1091, DOI 10.1161/CIRCRESAHA.107.167817; Li GR, 1996, CIRC RES, V78, P903, DOI 10.1161/01.RES.78.5.903; Li L, 2000, AM J PHYSIOL-HEART C, V278, pH769, DOI 10.1152/ajpheart.2000.278.3.H769; Lin G, 2001, CIRC RES, V89, P343, DOI 10.1161/hh1601.095912; LINDEMANN JP, 1983, J BIOL CHEM, V258, P464; Liu LJ, 2006, AM J PHYSIOL-CELL PH, V291, pC569, DOI 10.1152/ajpcell.00002.2006; Liu N, 2011, CIRC RES, V109, P291, DOI 10.1161/CIRCRESAHA.111.247338; Lohse MJ, 2008, BRIT J PHARMACOL, V153, pS125, DOI 10.1038/sj.bjp.0707656; MACDOUGALL LK, 1991, EUR J BIOCHEM, V196, P725, DOI 10.1111/j.1432-1033.1991.tb15871.x; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; Makarewich CA, 2012, CIRC RES, V110, P669, DOI 10.1161/CIRCRESAHA.111.264028; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; Martinez-Marmol R, 2008, J CELL PHYSIOL, V217, P667, DOI 10.1002/jcp.21538; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; MATSUDA JJ, 1993, CIRC RES, V72, P517, DOI 10.1161/01.RES.72.3.517; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Mitarai S, 2000, AM J PHYSIOL-HEART C, V279, pH139, DOI 10.1152/ajpheart.2000.279.1.H139; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; Mongillo M, 2004, CIRC RES, V95, P67, DOI 10.1161/01.RES.0000134629.84732.11; Muller FU, 2005, J BIOL CHEM, V280, P6906, DOI 10.1074/jbc.M407864200; NEUMANN J, 1993, AM J PHYSIOL, V265, pH257, DOI 10.1152/ajpheart.1993.265.1.H257; NEUMANN J, 1991, CIRC RES, V69, P1450, DOI 10.1161/01.RES.69.6.1450; Nicolaou P, 2009, J MOL CELL CARDIOL, V47, P365, DOI 10.1016/j.yjmcc.2009.05.010; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; O'Connell TD, 2003, AFCS RES REPORTS, V1, P1; ONO K, 1993, CIRC RES, V72, P807, DOI 10.1161/01.RES.72.4.807; Osadchii OE, 2007, CARDIOVASC DRUG THER, V21, P171, DOI 10.1007/s10557-007-6014-6; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Palygin OA, 2008, AM J PHYSIOL-HEART C, V294, pH1693, DOI 10.1152/ajpheart.01337.2007; Petkova-Kirova PS, 2012, AM J PHYSIOL-HEART C, V302, pH934, DOI 10.1152/ajpheart.00493.2011; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; POST SR, 1995, BIOCHEM J, V311, P75, DOI 10.1042/bj3110075; Ravens U, 2011, CARDIOVASC RES, V89, P776, DOI 10.1093/cvr/cvq398; Reinkober J, 2012, GENE THER, V19, P686, DOI 10.1038/gt.2012.9; Richter W, 2011, BASIC RES CARDIOL, V106, P249, DOI 10.1007/s00395-010-0138-8; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Rochais F, 2006, CIRC RES, V98, P1081, DOI 10.1161/01.RES.0000218493.09370.8e; Roman BB, 2004, AM J PHYSIOL-HEART C, V286, pH2089, DOI 10.1152/ajpheart.00582.2003; Rook MB, 2012, CARDIOVASC RES, V93, P12, DOI 10.1093/cvr/cvr252; Rudy Y, 2008, CIRCULATION, V118, P1202, DOI 10.1161/CIRCULATIONAHA.108.772715; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Sako H, 1997, AM J PHYSIOL-CELL PH, V273, pC1666, DOI 10.1152/ajpcell.1997.273.5.C1666; Saucerman JJ, 2004, CIRC RES, V95, P1216, DOI 10.1161/01.RES.0000150055.06226.4e; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Schaub MC, 2006, J MOL CELL CARDIOL, V41, P183, DOI 10.1016/j.yjmcc.2006.04.005; Scriven DRL, 2010, BIOPHYS J, V99, P3923, DOI 10.1016/j.bpj.2010.11.008; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Shibata Erwin F, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS34, DOI 10.1111/j.1540-8167.2006.00387.x; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Soltis AR, 2011, BIOINFORMATICS, V27, P2888, DOI 10.1093/bioinformatics/btr496; Song JL, 2012, AM J PHYSIOL-HEART C, V302, pH770, DOI 10.1152/ajpheart.00733.2011; Steinberg SE, 2004, J MOL CELL CARDIOL, V37, P407, DOI 10.1016/j.yjmcc.2004.04.018; SULAKHE PV, 1995, MOL CELL BIOCHEM, V149, P103, DOI 10.1007/BF01076569; TAKASAGO T, 1991, J BIOCHEM-TOKYO, V109, P163, DOI 10.1093/oxfordjournals.jbchem.a123339; Tang MX, 2010, AM J PHYSIOL-HEART C, V299, pH519, DOI 10.1152/ajpheart.00265.2010; Tang T, 2008, CIRCULATION, V117, P61, DOI 10.1161/CIRCULATIONAHA.107.730069; Tepe NM, 1999, FEBS LETT, V458, P236, DOI 10.1016/S0014-5793(99)01147-3; Tong XY, 2006, AM J PHYSIOL-HEART C, V291, pH543, DOI 10.1152/ajpheart.00051.2006; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; Vaidyanathan R, 2010, J BIOL CHEM, V285, P28000, DOI 10.1074/jbc.M110.110858; Volders PGA, 2003, CIRCULATION, V107, P2753, DOI 10.1161/01.CIR.0000068344.54010.B3; Wachter SB, 2012, CARDIOLOGY, V122, P104, DOI 10.1159/000339271; Wang H, 2008, AM J PHYSIOL-HEART C, V294, pH1473, DOI 10.1152/ajpheart.01249.2007; Weiss S, 2013, CIRC RES, V113, P617, DOI 10.1161/CIRCRESAHA.113.301781; Wolska BM, 2009, AM J PHYSIOL-HEART C, V297, pH1576, DOI 10.1152/ajpheart.00833.2009; Wong J, 2013, BIOPHYS J, V104, pL22, DOI 10.1016/j.bpj.2013.02.059; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Xiao BL, 2007, J BIOL CHEM, V282, P30256, DOI 10.1074/jbc.M703510200; Xiao BL, 2006, BIOCHEM J, V396, P7, DOI 10.1042/BJ20060116; Xiao JM, 2007, J BIOL CHEM, V282, P34828, DOI 10.1074/jbc.M707423200; Xiao RP, 2004, TRENDS PHARMACOL SCI, V25, P358, DOI 10.1016/j.tips.2004.05.007; Xiao RP, 1999, CIRC RES, V84, P43; YAMADA KA, 1992, J CARDIOVASC ELECTR, V3, P209, DOI 10.1111/j.1540-8167.1992.tb00968.x; Yang JH, 2012, J MOL CELL CARDIOL, V52, P1048, DOI 10.1016/j.yjmcc.2011.12.015; Yarbrough TL, 2002, CIRC RES, V90, P443, DOI 10.1161/hh0402.105177; Yue LX, 1999, J PHYSIOL-LONDON, V516, P385, DOI 10.1111/j.1469-7793.1999.0385v.x; Zhang HY, 2012, CIRC RES, V110, P831, DOI 10.1161/CIRCRESAHA.111.255158; Zhang M, 2009, AM J PHYSIOL-CELL PH, V296, pC1364, DOI 10.1152/ajpcell.00014.2009; Zhou JS, 2000, CIRC RES, V87, P33, DOI 10.1161/01.RES.87.1.33; Zimmermann G, 1996, J BIOL CHEM, V271, P27161, DOI 10.1074/jbc.271.43.27161	148	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89113	10.1371/journal.pone.0089113	http://dx.doi.org/10.1371/journal.pone.0089113			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586529	gold, Green Published			2022-12-27	WOS:000331717900051
J	Bondar, C; Araya, RE; Guzman, L; Rua, EC; Chopita, N; Chirdo, FG				Bondar, Constanza; Araya, Romina E.; Guzman, Luciana; Cueto Rua, Eduardo; Chopita, Nestor; Chirdo, Fernando G.			Role of CXCR3/CXCL10 Axis in Immune Cell Recruitment into the Small Intestine in Celiac Disease	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR3; INFLAMMATORY-BOWEL-DISEASE; PLASMA-CELLS; INTRAEPITHELIAL LYMPHOCYTES; AUTOIMMUNE-DISEASES; EPITHELIAL-CELLS; CXCL10; EXPRESSION; CHEMOATTRACTANTS; IMMUNOPATHOLOGY	Lymphocytic infiltration in the lamina propria (LP), which is primarily composed of CD4(+) Th1 cells and plasma cells, and increased numbers of intraepithelial lymphocytes (IELs), is a characteristic finding in active celiac disease (CD). Signals for this selective cell recruitment have not been fully established. CXCR3 and its ligands, particularly CXCL10, have been suggested to be one of the most relevant pathways in the attraction of cells into inflamed tissues. In addition, CXCR3 is characteristically expressed by Th1 cells. The aim of this work was to investigate the participation of the chemokine CXCL10/CXCR3 axis in CD pathogenesis. A higher concentration of CXCL10 was found in the serum of untreated CD patients. The mRNA levels of CXCL10 and CXCL11 but not CXCL9 were significantly higher in duodenal biopsies from untreated CD patients compared with non-CD controls or treated patients. The results demonstrate that CXCL10 is abundantly produced in untreated CD and reduced in treated patients, and the expression of CXCL10 was found to be correlated with the IFN gamma levels in the tissue. Plasma cells and enterocytes were identified as CXCL10-producing cells. Moreover, the CXCL10 expression in intestinal tissues was upregulated by poly I: C and IL-15. IELs, LP T lymphocytes, and plasma cells, which infiltrate the intestinal mucosa in untreated CD, express CXCR3. The CXCR3/CXCL10 signalling axis is overactivated in the small intestinal mucosa in untreated patients, and this finding explains the specific recruitment of the major cell populations that infiltrate the epithelium and the LP in CD.	[Bondar, Constanza; Araya, Romina E.; Chirdo, Fernando G.] Univ Nacl La Plata, Fac Ciencias Exactas, Lab Invest Sistema Inmune LISIN, La Plata, Buenos Aires, Argentina; [Guzman, Luciana; Cueto Rua, Eduardo] Hosp Ninos Sor Maria Ludovica, Serv Gastroenterol, La Plata, Buenos Aires, Argentina; [Chopita, Nestor] Hosp San Martin, Serv Gastroenterol, La Plata, Buenos Aires, Argentina	National University of La Plata	Chirdo, FG (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Lab Invest Sistema Inmune LISIN, La Plata, Buenos Aires, Argentina.	fchirdo@biol.unlp.edu.ar	Chirdo, Fernando/AAL-7928-2020	Araya, Romina Elizabeth/0000-0001-9787-2670; Chirdo, Fernando/0000-0002-7099-9142	CONICET [PIP719]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was covered by a Grant from CONICET PIP719. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Antonelli A, 2008, DIABETIC MED, V25, P1349, DOI 10.1111/j.1464-5491.2008.02577.x; Cakir M, 2011, AUTOIMMUNITY, V44, P496, DOI 10.3109/08916934.2011.561818; Christen U, 2003, J IMMUNOL, V171, P6838, DOI 10.4049/jimmunol.171.12.6838; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Dwinell MB, 2001, GASTROENTEROLOGY, V120, P49, DOI 10.1053/gast.2001.20914; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hosomi S, 2011, CLIN EXP IMMUNOL, V163, P215, DOI 10.1111/j.1365-2249.2010.04290.x; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Laragione T, 2011, ARTHRITIS RHEUM-US, V63, P3274, DOI 10.1002/art.30573; Lebreton C, 2012, GASTROENTEROLOGY, V143, P698, DOI 10.1053/j.gastro.2012.05.051; Lee EY, 2013, AUTOIMMUN REV, V12, P554, DOI 10.1016/j.autrev.2012.10.001; Lee EY, 2009, AUTOIMMUN REV, V8, P379, DOI 10.1016/j.autrev.2008.12.002; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Nicoletti F, 2002, DIABETOLOGIA, V45, P1107, DOI 10.1007/s00125-002-0879-5; Ostvik AE, 2013, INFLAMM BOWEL DIS, V19, P265, DOI 10.1002/ibd.23034; Qiao SW, 2012, SEMIN IMMUNOPATHOL, V34, P523, DOI 10.1007/s00281-012-0314-z; Rabquer BJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3242; Rhode A, 2005, J IMMUNOL, V175, P3516, DOI 10.4049/jimmunol.175.6.3516; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Schroepf S, 2010, INFLAMM BOWEL DIS, V16, P1882, DOI 10.1002/ibd.21312; Shibahara T, 2001, GASTROENTEROLOGY, V120, P60, DOI 10.1053/gast.2001.20904; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Xu W, 2012, J EXP MED, V209, P1813, DOI 10.1084/jem.20112142	35	46	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89068	10.1371/journal.pone.0089068	http://dx.doi.org/10.1371/journal.pone.0089068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586509	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700057
J	Chiu, WT; Lin, CM; Tsai, TC; Wu, CW; Tsai, CL; Lin, SH; Chen, JJJ				Chiu, Wen-Tai; Lin, Che-Ming; Tsai, Tien-Chun; Wu, Chun-Wei; Tsai, Ching-Lin; Lin, Sheng-Hsiang; Chen, Jia-Jin Jason			Real-Time Electrochemical Recording of Dopamine Release under Optogenetic Stimulation	PLOS ONE			English	Article							SELF-ASSEMBLED MONOLAYERS; PC12 CELLS; SELECTIVE DETERMINATION; CALCIUM; INDICATORS; RECEPTOR; NEURONS; DISEASE; SYSTEM; MODEL	Dopaminergic PC12 cells can synthesize and release dopamine, providing a good cellular model for investigating dopamine regulation. Optogenetic stimulation of channelrhodopsin-2 provides high spatial and temporal precision for selective stimulation as a powerful neuromodulation tool for neuroscience studies. The aim of this study is to measure dopamine release from dopaminergic PC12 cells under optogenetic stimulation using electrochemical recording of self-assembled monolayers modified microelectrode with amperometric measurement in real time. The activation of PC12 cells under various optogenetic stimulation schemes are characterized by measuring single-cell Ca2+ imaging. After 10 seconds of optogenetic stimulation, the evoked intracellular Ca2+ level and dopamine current of channelrhodopsin-2-transfected PC12 cells were 1.6- and 3.5-fold higher than those of the control cells. The optogenetic stimulation effects on Ca2+ influx and dopamine release were 81% and 63% inhibition by using a Ca2+ channel antagonist Nifedipine. The results indicate that optogenetic stimulation can evoke voltage-gated Ca2+ channel-dependent dopamine exocytosis from PC12 cells in a cell specific, temporally precise and dose-dependent manner. This proposed dopamine recording system can be developed to be a good cell model for dopamine regulation and drug screening in vitro, or dopaminergic cell implantation therapy in vivo using optogenetic stimulation in a precise and convenient way.	[Chiu, Wen-Tai; Lin, Che-Ming; Tsai, Tien-Chun; Wu, Chun-Wei; Chen, Jia-Jin Jason] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Chiu, Wen-Tai] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chiu, Wen-Tai; Chen, Jia-Jin Jason] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 70101, Taiwan; [Tsai, Ching-Lin] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Lin, Sheng-Hsiang] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Chen, Jia-Jin Jason] Natl Appl Res Labs, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Sun Yat Sen University; National Cheng Kung University; National Applied Research Laboratories - Taiwan	Chen, JJJ (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan.	chenjj@mail.ncku.edu.tw			National Health Research Institutes of Taiwan [NHRI-EX-101-10139EI]; National Science Council [101-2320-B-006-018-MY3]	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Health Research Institutes of Taiwan (NHRI-EX-101-10139EI) and National Science Council (101-2320-B-006-018-MY3) for financially supporting this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raya S, 1999, J PHARMACOL EXP THER, V288, P399; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Bass CE, 2010, J NEUROCHEM, V114, P1344, DOI 10.1111/j.1471-4159.2010.06850.x; Bazzu G, 2010, CNS NEUROL DISORD-DR, V9, P482, DOI 10.2174/187152710791556177; Chang YF, 2012, NEUROSCI RES, V73, P341, DOI 10.1016/j.neures.2012.05.007; Chen Y, 2008, ANAL CHEM, V80, P1133, DOI 10.1021/ac071182j; Dalmia A, 1997, J ELECTROANAL CHEM, V430, P205, DOI 10.1016/S0022-0728(97)00223-4; Deng C, 2012, MOL MED REP, V5, P847, DOI 10.3892/mmr.2011.731; Hallett Mark, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS85, DOI 10.1016/S1353-8020(11)70027-X; Hondebrink L, 2011, NEUROPHARMACOLOGY, V61, P202, DOI 10.1016/j.neuropharm.2011.03.028; HSUEH CC, 1994, ANAL CHEM, V66, P2458, DOI 10.1021/ac00087a009; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kobayashi K, 2006, BRAIN RES, V1102, P1, DOI 10.1016/j.brainres.2006.04.078; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kumar SS, 2005, J ELECTROANAL CHEM, V578, P95, DOI 10.1016/j.jelechem.2004.12.023; Lassiter TL, 2009, BRAIN RES BULL, V78, P313, DOI 10.1016/j.brainresbull.2008.09.020; Lindvall O, 2008, EXP NEUROL, V209, P82, DOI 10.1016/j.expneurol.2007.08.019; MALEM F, 1993, ANAL CHEM, V65, P37, DOI 10.1021/ac00049a009; Meyer JH, 2012, CLIN PHARMACOL THER, V91, P201, DOI 10.1038/clpt.2011.285; Morikawa H, 2011, NEUROSCIENCE, V198, P95, DOI 10.1016/j.neuroscience.2011.08.023; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Opler M, 1997, BIOELECTROCH BIOENER, V42, P235, DOI 10.1016/S0302-4598(96)05115-X; Perry SW, 2010, J NEUROSCI, V30, P14153, DOI 10.1523/JNEUROSCI.1042-10.2010; Qiu HJ, 2009, COLLOID SURFACE B, V69, P105, DOI 10.1016/j.colsurfb.2008.11.007; Romito LM, 2010, J NEUROL, V257, pS298, DOI 10.1007/s00415-010-5720-3; Saito K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2248; SHAFER TJ, 1991, NEUROTOXICOLOGY, V12, P473; Speelman AD, 2011, NAT REV NEUROL, V7, P528, DOI 10.1038/nrneurol.2011.107; Tatard VM, 2004, CELL TRANSPLANT, V13, P573, DOI 10.3727/000000004783983675; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Uezato T, 2012, BIOMED RES-TOKYO, V33, P25, DOI 10.2220/biomedres.33.25; Wei D, 2009, LAB CHIP, V9, P2123, DOI 10.1039/b903118a; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Xia R, 2007, ACTA NEUROCHIR, V149, P67, DOI 10.1007/s00701-006-1058-0; Xiao YH, 2007, ANAL BIOCHEM, V371, P229, DOI 10.1016/j.ab.2007.07.025; Xu F, 2012, TOXICOL MECH METHOD, V22, P309, DOI 10.3109/15376516.2012.657260; Yoshida H, 2003, J NEUROSURG, V98, P874, DOI 10.3171/jns.2003.98.4.0874; Zhang M, 2012, NEUROPHARMACOLOGY, V62, P2219, DOI 10.1016/j.neuropharm.2012.01.012; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zhu TG, 2012, NEUROSCI LETT, V506, P175, DOI 10.1016/j.neulet.2011.10.075	40	9	9	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89293	10.1371/journal.pone.0089293	http://dx.doi.org/10.1371/journal.pone.0089293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586667	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700091
J	Ramos-Rodriguez, JJ; Molina-Gil, S; Ortiz-Barajas, O; Jimenez-Palomares, M; Perdomo, G; Cozar-Castellano, I; Lechuga-Sancho, AM; Garcia-Alloza, M				Jose Ramos-Rodriguez, Juan; Molina-Gil, Sara; Ortiz-Barajas, Oscar; Jimenez-Palomares, Margarita; Perdomo, German; Cozar-Castellano, Irene; Maria Lechuga-Sancho, Alfonso; Garcia-Alloza, Monica			Central Proliferation and Neurogenesis Is Impaired in Type 2 Diabetes and Prediabetes Animal Models	PLOS ONE			English	Article							HIGH-FAT DIET; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; HIPPOCAMPAL NEUROGENESIS; COGNITIVE IMPAIRMENT; DEFECTIVE INSULIN; MOUSE MODEL; BRAIN; DEMENTIA; DEFICITS	Type 2 diabetes (T2D) is an important risk factor to suffer dementia, including Alzheimer's disease (AD), and some neuropathological features observed in dementia could be mediated by T2D metabolic alterations. Since brain atrophy and impaired neurogenesis have been observed both T2D and AD we analyzed central nervous system (CNS) morphological alterations in the db/db mice (leptin receptor KO mice), as a model of long-term insulin resistance and T2D, and in C57Bl6 mice fed with high fat diet (HFD), as a model of diet induced insulin resistance and prediabetes. Db/db mice showed an age-dependent cortical and hippocampal atrophy, whereas in HFD mice cortex and hippocampus were preserved. We also detected increased neurogenesis and cell proliferation rates in young db/db mice when compared with control littermates. Our study shows that metabolic parameters serve as predictors of both atrophy and altered proliferation and neurogenesis in the CNS. Moreover in the cortex, atrophy, cell proliferation and neurogenesis were significantly correlated. Our data suggest that T2D may underline some of the pathological features observed in the dementia process. They also support that blood glucose control in elderly patients could help to slow down dementia evolution and maybe, improve its prognosis.	[Jose Ramos-Rodriguez, Juan; Molina-Gil, Sara; Ortiz-Barajas, Oscar; Garcia-Alloza, Monica] Univ Cadiz, Sch Med, Inst Biomol INBIO, Div Physiol,Dpt Biomed Biotechnol & Publ Hlth, Cadiz, Spain; [Jimenez-Palomares, Margarita; Cozar-Castellano, Irene] Univ Valladolid, CSIC, Inst Biol & Mol Genet, Valladolid, Spain; [Perdomo, German] Univ Castilla La Mancha, Dpt Inorgan & Organ Chem & Biochem, Toledo, Spain; [Maria Lechuga-Sancho, Alfonso] Univ Cadiz, Sch Med, Dept Pediat, Cadiz, Spain	Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Valladolid; Universidad de Castilla-La Mancha; Universidad de Cadiz	Garcia-Alloza, M (corresponding author), Univ Cadiz, Sch Med, Inst Biomol INBIO, Div Physiol,Dpt Biomed Biotechnol & Publ Hlth, Cadiz, Spain.	monica.garcia@uca.es	Lechuga-Sancho, Alfonso/M-2712-2015; Ramos-Rodriguez, Juan Jose/B-7459-2017; Perdomo, German/K-6703-2014; Garcia-Alloza, Monica/AAN-9799-2021; Garcia-Alloza, Monica/F-3313-2016; Jimenez-Palomares, Margarita/ABG-8855-2020; Cozar-Castellano, Irene/B-5625-2015	Lechuga-Sancho, Alfonso/0000-0001-5861-6041; Ramos-Rodriguez, Juan Jose/0000-0001-9081-5366; Perdomo, German/0000-0002-2301-0012; Garcia-Alloza, Monica/0000-0003-1610-4114; Garcia-Alloza, Monica/0000-0003-1610-4114; Cozar-Castellano, Irene/0000-0002-6065-5362; Jimenez-Palomares, Margarita/0000-0002-3051-194X; Molina-Gil, Sara/0000-0003-0352-6449	Fondo Europeo de Desarrollo Regional "Una manera de hacer Europa" [PI12/00675]	Fondo Europeo de Desarrollo Regional "Una manera de hacer Europa"	RYC-2008-02333, Junta de Andalucia, Proyectos de Excelencia (P11-CTS-7847), Instituto de Salud Carlos III and FEDER (European Union), cofinanced by Fondo Europeo de Desarrollo Regional "Una manera de hacer Europa" PI12/00675 (Monica Garcia-Alloza) IC-C: RYC-2011-08101, ISCIIISubdireccion General de Evaluacion y Fomento de la Investigacion, Spain (PS09/00671), Europe-FP7 Marie Curie grant (IRG-247835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alosco ML, 2013, J CLIN EXP NEUROPSYC, V35, P309, DOI 10.1080/13803395.2013.771617; Arvanitidis AP, 2009, BRAIN RES, V1252, P192, DOI 10.1016/j.brainres.2008.11.058; Barella LF, 2012, HORM METAB RES, V44, P458, DOI 10.1055/s-0032-1306300; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Brundel M, 2010, J NEUROL SCI, V299, P126, DOI 10.1016/j.jns.2010.08.048; Camargo N, 2012, FASEB J, V26, P4302, DOI 10.1096/fj.12-205807; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; de la Monte Suzanne M, 2012, Front Biosci (Elite Ed), V4, P1582; Dinel AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024325; Doherty GH, 2008, NEUROSCIENCE, V154, P1297, DOI 10.1016/j.neuroscience.2008.04.052; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gault VA, 2008, EUR J PHARMACOL, V587, P112, DOI 10.1016/j.ejphar.2008.03.025; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Hamilton A, 2011, J NEUROSCI RES, V89, P481, DOI 10.1002/jnr.22565; Hamilton A, 2012, BRAIN RES, V1449, P83, DOI 10.1016/j.brainres.2012.02.015; Heyward FD, 2012, NEUROBIOL LEARN MEM, V98, P25, DOI 10.1016/j.nlm.2012.04.005; Hiltunen M, 2012, J CELL MOL MED, V16, P1206, DOI 10.1111/j.1582-4934.2011.01384.x; Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33; Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201; Jimenez-Palomares M., 2012, AM J PHYSIOL-ENDOC M, V11, P1373; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787; Ramos-Rodriguez JJ, 2013, PSYCHONEUROENDOCRINO, V38, P2462, DOI 10.1016/j.psyneuen.2013.05.010; Ramos-Rodriguez JJ, 2013, J NEUROPATH EXP NEUR, V72, P272, DOI 10.1097/NEN.0b013e318288a8dd; Kim B, 2012, TRENDS ENDOCRIN MET, V23, P133, DOI 10.1016/j.tem.2011.12.004; Kim B, 2009, ENDOCRINOLOGY, V150, P5294, DOI 10.1210/en.2009-0695; Kuljis RO, 2011, J ALZHEIMERS DIS, V25, P29, DOI 10.3233/JAD-2011-101392; Lang BT, 2009, BRAIN RES, V1258, P25, DOI 10.1016/j.brainres.2008.12.026; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; Machida M, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/959737; Manschot SM, 2007, DIABETOLOGIA, V50, P2388, DOI 10.1007/s00125-007-0792-z; Manschot SM, 2006, DIABETES, V55, P1106, DOI 10.2337/diabetes.55.04.06.db05-1323; McClean PL, 2010, EUR J PHARMACOL, V630, P158, DOI 10.1016/j.ejphar.2009.12.023; Mcnay EC, 2007, CURR OPIN PHARMACOL, V7, P628, DOI 10.1016/j.coph.2007.10.009; Mielke JG, 2006, BEHAV BRAIN RES, V175, P374, DOI 10.1016/j.bbr.2006.09.010; Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588; Pan WH, 2012, ANN NY ACAD SCI, V1264, P64, DOI 10.1111/j.1749-6632.2012.06472.x; Plastino M, 2010, J NEUROL SCI, V288, P112, DOI 10.1016/j.jns.2009.09.022; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Uetsuka K, 2005, EXP MOL PATHOL, V79, P51, DOI 10.1016/j.yexmp.2005.02.002; Varela-Nallar L, 2010, BIRTH DEFECTS RES C, V90, P284, DOI 10.1002/bdrc.20193; Wang Y, 2011, DIABETOLOGIA, V54, P440, DOI 10.1007/s00125-010-1956-9; Weng Z, 2007, J BIOL CHEM, V282, P34479, DOI 10.1074/jbc.M705426200; Williamson R, 2012, BIOCHEM PHARMACOL, V84, P737, DOI 10.1016/j.bcp.2012.05.007; Zhao ZS, 2012, J BIOL CHEM, V287, P5562, DOI 10.1074/jbc.M111.305359	50	67	69	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89229	10.1371/journal.pone.0089229	http://dx.doi.org/10.1371/journal.pone.0089229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586614	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700077
J	Kamisah, Y; Lim, JJ; Lim, CL; Asmadi, AY				Kamisah, Yusof; Lim, Jing Jye; Lim, Chew-Lian; Asmadi, Ahmad Y.			Inhibitory Effects of Palm Tocotrienol-Rich Fraction Supplementation on Bilirubin-Metabolizing Enzymes in Hyperbilirubinemic Adult Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; VITAMIN-E; BILIVERDIN REDUCTASE; HEME OXYGENASE-1; GLUTATHIONE-PEROXIDASE; MEDIATED INDUCTION; PHENYLHYDRAZINE; LIVER; SUPEROXIDE; PALMVITEE	Background: Phenylhydrazine, a hemolytic agent, is widely used as a model of experimental hyperbilirubinemia. Palm tocotrienol-rich fraction (TRF) was shown to exert beneficial effects in hyperbilirubinemic rat neonates. Aim: To investigate the effects of palm TRF supplementation on hepatic bilirubin-metabolizing enzymes and ocidative stress status in rats administered phenylhydrazine. Methods: Twenty-four male Wistar rats were divided into two groups; one group was intraperitoneally injected with palm TRF at the dose of 30 mg/kg/day, while another group was only given vehicle (control) (vitamin E-free palm oil) for 14 days. Twenty-four hours after the last dose, each group was further subdivided into another two groups. One group was administered phenylhydrazine (100 mg/kg, intraperitoneally) and another group was administered normal saline. Twenty-four hours later, blood and liver were collected for biochemical parameter measurements. Results: Phenylhydrazine increased plasma total bilirubin level and oxidative stress in the erythrocytes as well as in the liver, which were reduced by the pretreatment of palm TRF. Palm TRF also prevented the increases in hepatic heme oxygenase, biliverdin reductase and UDP-glucuronyltransferase activities induced by phenylhydrazine. Conclusion: Palm tocotrienol-rich fraction was able to afford protection against phenylhydrazine-induced hyperbilirubinemia, possibly by reducing oxidative stress and inhibiting bilirubin-metabolizing enzymes in the liver.	[Kamisah, Yusof] Univ Kebangsaan Malaysia, UKM Med Ctr, Fac Med, Dept Pharmacol, Kuala Lumpur, Malaysia; [Lim, Jing Jye; Lim, Chew-Lian] Univ Kebangsaan Malaysia, Fac Hlth Sci, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Asmadi, Ahmad Y.] Cyberjaya Univ, Coll Med Sci, Fac Tradit & Complementary Med, Cyberjaya, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Kamisah, Y (corresponding author), Univ Kebangsaan Malaysia, UKM Med Ctr, Fac Med, Dept Pharmacol, Kuala Lumpur, Malaysia.	kamisah_y@yahoo.com	Kamisah, Yusof/D-8054-2012; Lim, Jing Jye/C-7348-2012	Kamisah, Yusof/0000-0002-9363-8235; Lim, Jing Jye/0000-0002-8551-7759; yusof, ahmad asmadi/0000-0003-4098-4000	Faculty of Medicine, Universiti Kebangsaan Malaysia [FF-240-2009]	Faculty of Medicine, Universiti Kebangsaan Malaysia	The study was supported by a fund from Faculty of Medicine, Universiti Kebangsaan Malaysia (FF-240-2009 grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ambali SF, 2010, FOOD CHEM TOXICOL, V48, P3477, DOI 10.1016/j.fct.2010.09.026; Anbarasu C., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P511, DOI 10.1016/S2221-1691(12)60087-2; Barannik T. V., 2005, Ukrainskii Biokhimicheskii Zhurnal, V77, P120; Mejia GB, 2008, J NEUROSCI METH, V168, P35, DOI 10.1016/j.jneumeth.2007.09.003; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Das M, 2008, CELL PHYSIOL BIOCHEM, V22, P287, DOI 10.1159/000149807; Diallo A, 2008, FITOTERAPIA, V79, P332, DOI 10.1016/j.fitote.2008.02.005; Ferrali M, 1997, BIOCHEM PHARMACOL, V53, P1743, DOI 10.1016/S0006-2952(97)82456-2; Gapor MT, 1993, Malaysian Patent, Patent No. [MY- 110779- A, 110779A]; Gapor MT, 1993, US Patent, Patent No. [5,190,618, 51906182]; Grattagliano I, 2005, CLIN PHARMACOL THER, V78, P422, DOI 10.1016/j.clpt.2005.07.002; HILL HAO, 1981, FEBS LETT, V125, P235, DOI 10.1016/0014-5793(81)80727-2; Kaliman PA, 2005, CELL BIOL INT, V29, P9, DOI 10.1016/j.cellbi.2004.11.004; Kamisah Y., 2011, Journal of Applied Pharmaceutical Science, V1, P118; Kamisah Y, 2008, ARCH MED SCI, V4, P32; Kamisah Y, 2009, ARCH MED SCI, V5, P329; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Kim HB, 2011, FREE RADICAL RES, V45, P1000, DOI 10.3109/10715762.2011.590137; Kim YW, 2009, FREE RADICAL BIO MED, V47, P1082, DOI 10.1016/j.freeradbiomed.2009.07.018; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; LEDWOZYW A, 1986, CLIN CHIM ACTA, V155, P275, DOI 10.1016/0009-8981(86)90247-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luangaram S, 2007, FOOD CHEM TOXICOL, V45, P448, DOI 10.1016/j.fct.2006.09.008; MAINES MD, 1984, BIOCHEM J, V217, P409, DOI 10.1042/bj2170409; Maity S, 2013, J PHYSIOL BIOCHEM, V69, P467, DOI 10.1007/s13105-013-0234-y; MARVER HS, 1966, J BIOL CHEM, V241, P2803; Masaratana P, 2012, BLOOD CELL MOL DIS, V49, P85, DOI 10.1016/j.bcmd.2012.04.003; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; MISRA HP, 1976, BIOCHEMISTRY-US, V15, P681, DOI 10.1021/bi00648a036; MITOMA C, 1956, ARCH BIOCHEM BIOPHYS, V61, P431, DOI 10.1016/0003-9861(56)90366-6; Niittynen M, 2008, TOXICOLOGY, V250, P132, DOI 10.1016/j.tox.2008.06.014; Norsidah KZ, 2013, J PHYSIOL BIOCHEM, V69, P441, DOI 10.1007/s13105-012-0226-3; Norsidah KZ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/976967; Radulovic NS, 2012, NAT PROD COMMUN, V7, P1609; Sen CK, 2010, J AM COLL NUTR, V29, p314S, DOI 10.1080/07315724.2010.10719846; Shoolingin-Jordan PM, 2003, BBA-PROTEINS PROTEOM, V1647, P361, DOI 10.1016/S1570-9639(03)00095-5; STDIMITROVA M, 1994, COMP BIOCHEM PHYS C, V108, P43, DOI 10.1016/1367-8280(94)90087-6; Taylor JL, 1998, AM J PHYSIOL-LUNG C, V274, pL582, DOI 10.1152/ajplung.1998.274.4.L582; TEMPLE AR, 1971, J LAB CLIN MED, V77, P1015; TOMARO ML, 1991, ARCH BIOCHEM BIOPHYS, V286, P610, DOI 10.1016/0003-9861(91)90088-Z; TOMARO ML, 1990, FEBS LETT, V263, P38, DOI 10.1016/0014-5793(90)80700-S; URANO S, 1992, J BIOL CHEM, V267, P18365	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89248	10.1371/journal.pone.0089248	http://dx.doi.org/10.1371/journal.pone.0089248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586630	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700082
J	Xie, H; Wang, HM; An, WM; Ma, W; Qi, RP; Yang, B; Liu, CZ; Gao, YZ; Xu, BB; Wang, WH				Xie, Hui; Wang, Huaming; An, Weimin; Ma, Wei; Qi, Ruping; Yang, Bin; Liu, Chunzi; Gao, Yuanzhi; Xu, Beibei; Wang, Wenhong			The Efficacy of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma in a Cohort of 487 Patients	PLOS ONE			English	Article							MICROWAVE COAGULATION THERAPY; TRANSARTERIAL CHEMOEMBOLIZATION; COMBINATION THERAPY; THERMAL ABLATION; RESECTION; CIRRHOSIS; EMBOLIZATION; SURVIVAL; CM	Although diagnostic methods, surgical techniques, and perioperative care have undergone significant advancement over the past decades, the prognosis of primary hepatocellular carcinoma (HCC) remains discouraged because of the high postoperative recurrence rate and high cancer mortality. Radiofrequency ablation (RFA) combined with transcatheter arterial chemoembolization (TACE) is a recently developed means for the treatment of HCC. In this study, we analyzed the efficacy of RFA plus TACE in 487 cases of HCC in our institution. We observed that the 1-, 2-, 3-, 4-and 5-year rates of overall survival rates after RFA and TACE treatment were 97.5% (475/487), 89.4% (277/310), 84.2% (181/215), 80.4% (150/186) and 78.7% (141/177), respectively. We did not find that age or tumor location (the caudate group or non-caudate group) plays a role in this cohort. However, we have identified that tumor recurrent status, the number of tumors, albumin (ALB), prothrombin time (PT) and platelet count (PLT) were significantly associated with poor overall survival in HCC patients receiving RFA combined with TACE. Interestingly, tumor size did not significantly impact overall survival, indicating that RFA combined with TACE for HCC treatment has the same efficiency for different sizes of tumors. Our results provide evidence for the rationale for using combined RFA and TACE in the treatment of primary HCC.	[Xie, Hui] Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China; [Xie, Hui; Wang, Huaming; An, Weimin; Ma, Wei; Qi, Ruping; Yang, Bin; Liu, Chunzi; Gao, Yuanzhi; Xu, Beibei] 302 Hosp Chinese Peoples Liberat Army, Med Imaging Ctr, Beijing, Peoples R China; [Wang, Wenhong] Tianjin Union Med Ctr, Dept Radiol, Tianjin, Peoples R China	Tianjin Medical University; Fifth Medical Center of Chinese PLA General Hospital	Wang, WH (corresponding author), Tianjin Union Med Ctr, Dept Radiol, Tianjin, Peoples R China.	wangwenhong1970@gmail.com						Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Cheng BQ, 2008, JAMA-J AM MED ASSOC, V299, P1669, DOI 10.1001/jama.299.14.1669; Choi SB, 2009, J KOREAN MED SCI, V24, P242, DOI 10.3346/jkms.2009.24.2.242; Curley SA, 2000, ANN SURG, V232, P381, DOI 10.1097/00000658-200009000-00010; Ercolani G, 2003, ANN SURG, V237, P536, DOI 10.1097/00000658-200304000-00016; Fong YM, 1999, ANN SURG, V229, P790, DOI 10.1097/00000658-199906000-00005; Fortune BE, 2013, J CLIN GASTROENTEROL, V47, pS37, DOI 10.1097/MCG.0b013e318286ff8e; Fujimori M, 2013, J VASC INTERV RADIOL, V24, P655, DOI 10.1016/j.jvir.2012.12.009; Georgiades CS, 2008, CANCER J, V14, P117, DOI 10.1097/PPO.0b013e31816a0fac; Guan Yong-Song, 2012, ISRN Gastroenterol, V2012, P480650, DOI 10.5402/2012/480650; Gupta S, 2006, INVEST RADIOL, V41, P516, DOI 10.1097/01.rli.0000209663.00629.8a; Huang GT, 2005, ANN SURG, V242, P36, DOI 10.1097/01.sla.0000167925.90380.fe; Idee JM, 2013, CRIT REV ONCOL HEMAT, V3; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kao WY, 2012, J CLIN GASTROENTEROL, V46, P62, DOI 10.1097/MCG.0b013e31822b36cc; Kim DY, 2013, AM J CLIN ONCOL; Kim YH, 2013, ONCOLOGY-BASEL, V84, P34, DOI 10.1159/000345887; Lencioni R, 2010, ONCOLOGIST, V15, P42, DOI 10.1634/theoncologist.2010-S4-42; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Maluccio MA, 2008, J VASC INTERV RADIOL, V19, P862, DOI 10.1016/j.jvir.2008.02.013; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; N'Kontchou G, 2009, HEPATOLOGY, V50, P1475, DOI 10.1002/hep.23181; Ni JY, 2013, WORLD J GASTROENTERO, V19, P3872, DOI 10.3748/wjg.v19.i24.3872; Nishigaki Y, 2013, HEPATOL RES, V43, P467, DOI 10.1111/j.1872-034X.2012.01095.x; Peng ZW, 2013, J CLIN ONCOL, V31, P426, DOI 10.1200/JCO.2012.42.9936; Poon RTP, 2001, ANN SURG, V234, P63, DOI 10.1097/00000658-200107000-00010; Rossi S, 2000, RADIOLOGY, V217, P119, DOI 10.1148/radiology.217.1.r00se02119; Rossi S, 1996, AM J ROENTGENOL, V167, P759, DOI 10.2214/ajr.167.3.8751696; Rossi S, 2011, HEPATOLOGY, V53, P136, DOI 10.1002/hep.23965; Seki T, 2000, CANCER, V89, P1245, DOI 10.1002/1097-0142(20000915)89:6<1245::AID-CNCR8>3.0.CO;2-F; SEKI T, 1994, CANCER, V74, P817, DOI 10.1002/1097-0142(19940801)74:3<817::AID-CNCR2820740306>3.0.CO;2-8; Shibata T, 2009, RADIOLOGY, V252, P905, DOI 10.1148/radiol.2523081676; Takayasu K, 2012, JPN J CLIN ONCOL, V42, P247, DOI 10.1093/jjco/hys020; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wang Shiying, 2013, ISRN Gastroenterol, V2013, P526024, DOI 10.1155/2013/526024; WHO, 2013, DEF OLD ELD PERS	38	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89081	10.1371/journal.pone.0089081	http://dx.doi.org/10.1371/journal.pone.0089081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586515	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700059
J	Ahasic, AM; Zhao, Y; Su, L; Sheu, CC; Thompson, BT; Christiani, DC				Ahasic, Amy M.; Zhao, Yang; Su, Li; Sheu, Chau-Chyun; Thompson, B. Taylor; Christiani, David C.			Adiponectin Gene Polymorphisms and Acute Respiratory Distress Syndrome Susceptibility and Mortality	PLOS ONE			English	Article							ACUTE LUNG INJURY; SERUM ADIPONECTIN; ASSOCIATION; RISK; ADIPOSE; IDENTIFICATION; EXPRESSION; PREDICTION; VARIANTS; RESISTIN	Rationale: Adiponectin is an anti-inflammatory adipokine that is the most abundant gene product of adipose tissue. Lower levels have been observed in obesity, insulin resistance, and in critical illness. However, elevated levels early in acute respiratory failure have been associated with mortality. Polymorphisms in adiponectin-related genes (ADIPOQ, ADIPOR1, ADIPOR2) have been examined for relationships with obesity, insulin resistance and diabetes, cardiovascular disease, and to circulating adipokine levels, but many gaps in knowledge remain. The current study aims to assess the association between potentially functional polymorphisms in adiponectin-related genes with acute respiratory distress syndrome (ARDS) risk and mortality. Methods: Consecutive patients with risk factors for ARDS admitted to the ICU were enrolled and followed prospectively for development of ARDS. ARDS cases were followed through day 60 for all-cause mortality. 2067 patients were successfully genotyped using the Illumina CVD BeadChip high-density platform. Of these, 567 patients developed ARDS. Forty-four single nucleotide polymorphisms (SNPs) on ADIPOQ, ADIPOR1 and ADIPOR2 were successfully genotyped. Of these, 9 SNPs were hypothesized to be functional based on their location (promoter, exon, or 39 untranslated region). These 9 SNPs were analyzed for association with ARDS case status and mortality among ARDS cases. Results: After multivariable analysis and adjustment for multiple comparisons, no SNPs were significantly associated with ARDS case status. Among ARDS cases, homozygotes for the minor allele of rs2082940 (ADIPOQ) had increased mortality (hazard ratio 2.61, 95% confidence interval 1.36-5.00, p = 0.0039) after adjustment for significant covariates. The significance of this association persisted after adjustment for multiple comparisons (FDR_q = 0.029). Conclusions: A common and potentially functional polymorphism in ADIPOQ may impact survival in ARDS. Further studies are required to replicate these results and to correlate genotype with circulating adiponectin levels.	[Ahasic, Amy M.] Yale Univ, Sch Med, Dept Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06510 USA; [Zhao, Yang] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Su, Li; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Environm & Occupat Med & Epidemiol Program, Boston, MA 02115 USA; [Sheu, Chau-Chyun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Thompson, B. Taylor; Christiani, David C.] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA	Yale University; Nanjing Medical University; Harvard University; Harvard T.H. Chan School of Public Health; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Harvard University; Massachusetts General Hospital	Ahasic, AM (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06510 USA.	amy.ahasic@yale.edu	zhao, yang/GXF-4424-2022; Sheu, Chau-Chyun/AAC-7244-2020	Sheu, Chau-Chyun/0000-0002-7979-3749	American Heart Association [10FTF3440007]; National Institutes of Health/NIH Heart, Lung and Blood Institute [R01 HL60710]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060710] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health/NIH Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded in part by the following grants: American Heart Association (www.heart.org) 10FTF3440007 (PI: Ahasic); National Institutes of Health/NIH Heart, Lung and Blood Institute (www.nhlbi.nih.gov) R01 HL60710 (PI: Christiani). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Dastani Z, 2013, ATHEROSCLEROSIS, V229, P145, DOI 10.1016/j.atherosclerosis.2013.03.034; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Dhillon PK, 2011, CANCER EPIDEM BIOMAR, V20, P2618, DOI 10.1158/1055-9965.EPI-11-0434; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Frank AJ, 2012, CRIT CARE MED, V40, P2116, DOI 10.1097/CCM.0b013e3182514bca; Gajic O, 2011, AM J RESP CRIT CARE, V183, P462, DOI 10.1164/rccm.201004-0549OC; Garaulet M, 2007, PUBLIC HEALTH NUTR, V10, P1145, DOI 10.1017/S1368980007000638; Gong MN, 2010, THORAX, V65, P44, DOI 10.1136/thx.2009.117572; Gong MN, 2005, CRIT CARE MED, V33, P1191, DOI 10.1097/01.CCM.0000165566.82925.14; Heid IM, 2010, ATHEROSCLEROSIS, V208, P412, DOI 10.1016/j.atherosclerosis.2009.11.035; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Jernas M, 2009, METABOLISM, V58, P102, DOI 10.1016/j.metabol.2008.08.012; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Koch A, 2011, J CRIT CARE, V26, P166, DOI 10.1016/j.jcrc.2010.07.015; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Langouche L, 2009, CRIT CARE, V13, DOI 10.1186/cc7956; Lau CH, 2011, ANN HUM GENET, V75, P370, DOI 10.1111/j.1469-1809.2010.00635.x; Ling H, 2009, OBESITY, V17, P737, DOI 10.1038/oby.2008.625; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Marques MB, 2013, CRIT CARE MED, V41, P317, DOI 10.1097/CCM.0b013e318265f21c; Matsumoto M, 2008, METABOLISM, V57, P811, DOI 10.1016/j.metabol.2008.01.024; National Institutes of Health, 1998, CLIN GUID ID EV TREA; Potapov Viktor A, 2008, Rev Diabet Stud, V5, P28, DOI 10.1900/RDS.2008.5.28; Shehzad A, 2012, HORM-INT J ENDOCRINO, V11, P8, DOI 10.1007/BF03401534; Siitonen N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-5; Stapleton RD, 2010, CHEST, V138, P568, DOI 10.1378/chest.10-0014; Swarbrick Michael M., 2008, Metabolic Syndrome and Related Disorders, V6, P87, DOI 10.1089/met.2007.0029; Tejera P, 2012, J MED GENET, V49, P671, DOI 10.1136/jmedgenet-2012-100972; Teoh H, 2008, AM J PHYSIOL-ENDOC M, V295, pE658, DOI 10.1152/ajpendo.90384.2008; Tilg H, 2008, CLIN SCI, V114, P275, DOI 10.1042/CS20070196; Vendrell J, 2004, OBES RES, V12, P962, DOI 10.1038/oby.2004.118; Venkatesh B, 2009, CRIT CARE, V13, DOI 10.1186/cc7941; Walkey AJ, 2010, CRIT CARE MED, V38, P2329, DOI 10.1097/CCM.0b013e3181fa0561; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yu S, 2013, CRIT CARE MED, V41, P2720, DOI 10.1097/CCM.0b013e318298a2eb	40	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89170	10.1371/journal.pone.0089170	http://dx.doi.org/10.1371/journal.pone.0089170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586568	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900099
J	Fang, X; Murakami, H; Demura, S; Hayashi, K; Matsubara, H; Kato, S; Yoshioka, K; Inoue, K; Ota, T; Shinmura, K; Tsuchiya, H				Fang, Xiang; Murakami, Hideki; Demura, Satoru; Hayashi, Katsuhiro; Matsubara, Hidenori; Kato, Satoshi; Yoshioka, Katsuhito; Inoue, Kei; Ota, Takashi; Shinmura, Kazuya; Tsuchiya, Hiroyuki			A Novel Method to Apply Osteogenic Potential of Adipose Derived Stem Cells in Orthopaedic Surgery	PLOS ONE			English	Article							BONE-MARROW; ASCORBIC-ACID; STROMAL CELLS; IN-VITRO; MYOCARDIAL-INFARCTION; RAT MODEL; TISSUE; DIFFERENTIATION; REPAIR; TRANSPLANTATION	Background: A number of publications have reported that adipose derived stem cells (ADSCs) have the capacity to be induced to differentiate into osteoblasts both in vitro and in vivo. However, it has been difficult to use separate ADSCs for cortical bone regeneration and bone reconstruction so far. Inspired by the research around stromal stem cells and cell sheets, we developed a new method to fabricate ADSCs sheets to accelerate and enhance the bone regeneration and bone reconstruction. Purpose: To fabricate ADSCs sheets and evaluate their capacity to be induced to differentiate to osteoblasts in vitro. Methods: Human adipose derived stem cells (hADSCs) were employed in this research. The fabricating medium containing 50 mM ascorbate-2-phosphate was used to enhance the secretion of collagen protein by the ADSCs and thus to make the cell sheets of ADSCs. As the separate ADSCs were divided into osteo-induction group and control group, the ADSCs sheets were also divided into two groups depending on induction by osteogenesis medium or no induction. The osteogenic capacity of each group was evaluated by ALP staining, Alizarin Red staining and ALP activity. Results: The ADSCs sheets were fabricated after one-week culture in the fabricating medium. The ALP staining of ADSCs sheets showed positive results after 5 days osteo-induction and the Alizarin Red staining of ADSCs sheets showed positive results after 1 week osteo-induction. The ALP activity showed significant differences between these four groups. The ALP activity of ADSCs sheets groups showed higher value than that of separate ADSCs. Conclusion: The experiments demonstrated that ADSCs sheets have better capacity than separate ADSCs to be induced to differentiate into osteoblasts. This indicates that it is possible to use the ADSCs sheets as a source of mesenchymal stem cells for bone regeneration and bone reconstruction.	[Fang, Xiang; Murakami, Hideki; Demura, Satoru; Hayashi, Katsuhiro; Matsubara, Hidenori; Kato, Satoshi; Yoshioka, Katsuhito; Inoue, Kei; Ota, Takashi; Shinmura, Kazuya; Tsuchiya, Hiroyuki] Kanazawa Univ, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan	Kanazawa University	Tsuchiya, H (corresponding author), Kanazawa Univ, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan.	tsuchi@med.kanazawa-u.ac.jp	Hayashi, K/C-4685-2015; DEMURA, Satoru/X-8589-2019	Hayashi, K/0000-0001-8665-2154; Kato, Satoshi/0000-0003-4762-5932	Grants-in-Aid for Scientific Research [23791630] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abudusaimi A, 2011, J INT MED RES, V39, P1852, DOI 10.1177/147323001103900528; Albersen M, 2010, J SEX MED, V7, P3331, DOI 10.1111/j.1743-6109.2010.01875.x; Arana M, 2013, ACTA BIOMATER, V9, P6075, DOI 10.1016/j.actbio.2012.12.014; Carinci F, 2005, ARCH ORAL BIOL, V50, P481, DOI 10.1016/j.archoralbio.2004.11.006; Ciapetti G, 2006, BIOMATERIALS, V27, P6150, DOI 10.1016/j.biomaterials.2006.08.025; Cousin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006278; Danisovic L, 2012, EXP BIOL MED, V237, P10, DOI 10.1258/ebm.2011.011229; Do EK, 2012, INT J BIOCHEM CELL B, V44, P2069, DOI 10.1016/j.biocel.2012.08.004; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; El Backly RM, 2013, TISSUE ENG PT A, V19, P152, DOI [10.1089/ten.tea.2012.0357, 10.1089/ten.TEA.2012.0357]; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0; Guasti L, 2012, STEM CELL TRANSL MED, V1, P384, DOI 10.5966/sctm.2012-0009; Hamdi H, 2011, CARDIOVASC RES, V91, P483, DOI 10.1093/cvr/cvr099; Hayashi K, 2008, INT ORTHOP, V32, P63, DOI 10.1007/s00264-006-0289-2; Hayashi T, 2012, CELL TRANSPLANT, V21, P591, DOI 10.3727/096368911X605529; Iraj K, 2008, ARCH MED SCI, V5, P149; Kaneshiro N, 2007, EUR CELLS MATER, V13, P87, DOI 10.22203/eCM.v013a09; Kikuchi A, 1998, J BIOMAT SCI-POLYM E, V9, P1331, DOI 10.1163/156856298X00424; Kim D, 2010, CELL TISSUE RES, V341, P359, DOI 10.1007/s00441-010-1015-3; Kim H, 2012, J DERMATOL SCI, V68, P149, DOI 10.1016/j.jdermsci.2012.09.013; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110; Leonardi D, 2012, BURNS, V38, P1143, DOI 10.1016/j.burns.2012.07.028; Lin GT, 2010, PROSTATE, V70, P1066, DOI 10.1002/pros.21140; Lin YC, 2013, ACTA BIOMATER, V9, P5243, DOI 10.1016/j.actbio.2012.09.028; Liu GB, 2011, ARCH MED SCI, V7, P592, DOI 10.5114/aoms.2011.24127; Liu J, 2012, BIOMATERIALS, V33, P5036, DOI 10.1016/j.biomaterials.2012.03.050; Marino G, 2010, J MATER SCI-MATER M, V21, P353, DOI 10.1007/s10856-009-3840-z; Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; MURAD S, 1981, P NATL ACAD SCI-BIOL, V78, P2879, DOI 10.1073/pnas.78.5.2879; Natesan S, 2010, TISSUE ENG PT A, V16, P1369, DOI [10.1089/ten.tea.2009.0404, 10.1089/ten.TEA.2009.0404]; Nii M, 2013, ACTA BIOMATER, V9, P5475, DOI 10.1016/j.actbio.2012.11.002; OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E; Pak Jaewoo, 2011, J Med Case Rep, V5, P296, DOI 10.1186/1752-1947-5-296; Philandrianos C, 2012, BURNS, V38, P820, DOI 10.1016/j.burns.2012.02.008; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Stubbs SL, 2011, HEART LUNG CIRC, V20, P173, DOI 10.1016/j.hlc.2010.06.661; SUGIMOTO T, 1986, CALCIFIED TISSUE INT, V39, P171, DOI 10.1007/BF02555114; Tsuchiya H, 2005, J BONE JOINT SURG BR, V87B, P218, DOI 10.1302/0301-620X.87B2.15325; Wen Y, 2012, ORAL SURG ORAL  0726; Wu YJ, 2007, WOUND REPAIR REGEN, V15, pS18, DOI 10.1111/j.1524-475X.2007.00221.x; Yamamoto Norio, 2003, J Orthop Sci, V8, P374, DOI 10.1007/s10776-002-0626-3; Yamamoto T, 2010, INT J UROL, V17, P75, DOI 10.1111/j.1442-2042.2009.02429.x; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456; Zhao YN, 2009, TISSUE ENG PT A, V15, P13, DOI 10.1089/ten.tea.2008.0039; zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1	49	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88874	10.1371/journal.pone.0088874	http://dx.doi.org/10.1371/journal.pone.0088874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586422	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900054
J	Gautam, L; Sharratt, SD; Cole, MD				Gautam, Lata; Sharratt, Sarah D.; Cole, Michael D.			Drug Facilitated Sexual Assault: Detection and Stability of Benzodiazepines in Spiked Drinks Using Gas Chromatography-Mass Spectrometry	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BLOOD	Benzodiazepines are detected in a significant number of drug facilitated sexual assaults (DFSA). Whilst blood and urine from the victim are routinely analysed, due to the delay in reporting DFSA cases and the short half lives of most of these drugs in blood and urine, drug detection in such samples is problematic. Consideration of the drinks involved and analysis for drugs may start to address this. Here we have reconstructed the 'spiking' of three benzodiazepines (diazepam, flunitrazepam and temazepam) into five drinks, an alcopop (flavoured alcoholic drink), a beer, a white wine, a spirit, and a fruit based nonalcoholic drink (J2O) chosen as representative of those drinks commonly used by women in 16-24 year old age group. Using a validated GC-MS method for the simultaneous detection of these drugs in the drinks we have studied the storage stability of the benzodiazepines under two different storage conditions, uncontrolled room temperature and refrigerator (4 degrees C) over a 25 day period. All drugs could be detected in all beverages over this time period. Diazepam was found to be stable in all of the beverages, except the J2O, under both storage conditions. Flunitrazepam and temazepam were found not to be stable but were detectable (97% loss of temazepam and 39% loss of flunitrazepam from J2O). The recommendations from this study are that there should be a policy change and that drinks thought to be involved in DFSA cases should be collected and analysed wherever possible to support other evidence types.	[Gautam, Lata; Sharratt, Sarah D.; Cole, Michael D.] Anglia Ruskin Univ, Fac Sci & Technol, Dept Life Sci, Cambridge, England	Anglia Ruskin University	Gautam, L (corresponding author), Anglia Ruskin Univ, Fac Sci & Technol, Dept Life Sci, Cambridge, England.	Lata.Gautam@anglia.ac.uk		Gautam, Lata/0000-0002-0409-4724				Acikkol M, 2009, CHROMATOGRAPHIA, V70, P1295, DOI 10.1365/s10337-009-1278-6; Advisory council on the misuse of drugs (ACMD), 2007, DRUGS FAC SEX ASS; [Anonymous], 2009, BBC NEWS; B, 2011, BBC NEWS; Beynon C., 2005, DRINK SPIKING REPORT; Birkler RID, 2012, FORENSIC SCI INT, V222, P154, DOI 10.1016/j.forsciint.2012.05.019; British Broadcasting Corporation (BBC), 2005, BBC NEWS; Caroline N., 2008, EMERGENCY CARE STREE; Dorandeu Anne H, 2006, J Clin Forensic Med, V13, P253, DOI 10.1016/j.jcfm.2005.11.013; Du Mont J, 2010, J FORENSIC LEG MED, V17, P333, DOI 10.1016/j.jflm.2010.05.004; El Mahjoub A, 2000, J PHARMACEUT BIOMED, V23, P1057, DOI 10.1016/S0731-7085(00)00393-9; ElSohly MA, 1999, J ANAL TOXICOL, V23, P141, DOI 10.1093/jat/23.3.141; Gottwald MD, 1999, AM J EMERG MED, V17, P333, DOI 10.1016/S0735-6757(99)90079-7; Grossin C, 2003, FORENSIC SCI INT, V131, P125, DOI 10.1016/S0379-0738(02)00427-9; Hall J A, 2008, J Forensic Leg Med, V15, P291, DOI 10.1016/j.jflm.2007.12.005; Hall Janet, 2008, J Forensic Leg Med, V15, P497, DOI 10.1016/j.jflm.2008.05.006; Hindmarch I, 2001, J Clin Forensic Med, V8, P197, DOI 10.1054/jcfm.2001.0513; Jones AW, 2008, FORENSIC SCI INT, V181, P40, DOI 10.1016/j.forsciint.2008.08.010; JOYCE JR, 1984, BIOMED MASS SPECTROM, V11, P284, DOI 10.1002/bms.1200110607; LeBeau M, 1999, J FORENSIC SCI, V44, P227; LESOLLEU H, 1993, J PHARMACEUT BIOMED, V11, P771, DOI 10.1016/0731-7085(93)80187-6; Mocak J, 1997, PURE APPL CHEM, V69, P297, DOI 10.1351/pac199769020297; Montgomery M A, 2010, Forensic Sci Rev, V22, P33; Peters FT, 2007, ANAL BIOANAL CHEM, V388, P1505, DOI 10.1007/s00216-007-1267-2; Scott KS, 2009, SCI JUSTICE, V49, P250, DOI 10.1016/j.scijus.2009.09.013; Scott-Ham Michael, 2005, J Clin Forensic Med, V12, P175, DOI 10.1016/j.jcfm.2005.03.009; Skopp G, 1998, INT J LEGAL MED, V111, P1; Stark M M, 1999, J Clin Forensic Med, V6, P53, DOI 10.1016/S1353-1131(99)90177-3	28	27	27	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89031	10.1371/journal.pone.0089031	http://dx.doi.org/10.1371/journal.pone.0089031			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586489	gold, Green Published, Green Accepted			2022-12-27	WOS:000331711900074
J	Girges, C; Wright, MJ; Spencer, JV; O'Brien, JMD				Girges, Christine; Wright, Michael J.; Spencer, Janine V.; O'Brien, Justin M. D.			Event-Related Alpha Suppression in Response to Facial Motion	PLOS ONE			English	Article							MEDIAL PARIETOOCCIPITAL CORTEX; SUPERIOR TEMPORAL SULCUS; HUMAN FUSIFORM GYRUS; BIOLOGICAL-MOTION; FACE RECOGNITION; CONTRAST POLARITY; SPATIAL ATTENTION; VISUOSPATIAL ATTENTION; BRAIN OSCILLATIONS; SOCIAL COGNITION	While biological motion refers to both face and body movements, little is known about the visual perception of facial motion. We therefore examined alpha wave suppression as a reduction in power is thought to reflect visual activity, in addition to attentional reorienting and memory processes. Nineteen neurologically healthy adults were tested on their ability to discriminate between successive facial motion captures. These animations exhibited both rigid and non-rigid facial motion, as well as speech expressions. The structural and surface appearance of these facial animations did not differ, thus participants decisions were based solely on differences in facial movements. Upright, orientation-inverted and luminance-inverted facial stimuli were compared. At occipital and parieto-occipital regions, upright facial motion evoked a transient increase in alpha which was then followed by a significant reduction. This finding is discussed in terms of neural efficiency, gating mechanisms and neural synchronization. Moreover, there was no difference in the amount of alpha suppression evoked by each facial stimulus at occipital regions, suggesting early visual processing remains unaffected by manipulation paradigms. However, upright facial motion evoked greater suppression at parieto-occipital sites, and did so in the shortest latency. Increased activity within this region may reflect higher attentional reorienting to natural facial motion but also involvement of areas associated with the visual control of body effectors.	[Girges, Christine; Wright, Michael J.; Spencer, Janine V.; O'Brien, Justin M. D.] Brunel Univ, Dept Psychol, London, England	Brunel University	Girges, C (corresponding author), Brunel Univ, Dept Psychol, London, England.	christine.girges@brunel.ac.uk	O'Brien, Justin/C-7707-2016	O'Brien, Justin/0000-0001-5713-9634; Wright, Michael/0000-0001-8969-6830				Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Balconi M, 2008, INT J NEUROSCI, V118, P1412, DOI 10.1080/00207450601047119; Balconi M, 2009, INT J PSYCHOPHYSIOL, V74, P158, DOI 10.1016/j.ijpsycho.2009.08.006; Basar E, 2008, BRAIN RES, V1214, P105, DOI 10.1016/j.brainres.2008.03.042; Basar E, 2006, PROG BRAIN RES, V159, P43, DOI 10.1016/S0079-6123(06)59004-1; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Blanke O, 2002, EUR J NEUROSCI, V15, P2043, DOI 10.1046/j.1460-9568.2002.02038.x; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Ciavarro M, 2013, J COGNITIVE NEUROSCI, V25, P1453, DOI 10.1162/jocn_a_00409; COLE HW, 1985, INT J PSYCHOPHYSIOL, V3, P33, DOI 10.1016/0167-8760(85)90017-0; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Fattori P, 2010, J NEUROSCI, V30, P342, DOI 10.1523/JNEUROSCI.3800-09.2010; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; GASTAUT MH, 1952, REV NEUROL, V87, P176; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Goffaux V, 2003, COGNITIVE BRAIN RES, V16, P416, DOI 10.1016/S0926-6410(03)00056-9; Grinter EJ, 2010, BRAIN RES BULL, V82, P147, DOI 10.1016/j.brainresbull.2010.02.016; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; Grossman E, 2010, AM POETRY REV, V39, P15; Gunji A, 2009, BRAIN DEV-JPN, V31, P139, DOI 10.1016/j.braindev.2008.04.011; Guntekin B, 2007, INT J PSYCHOPHYSIOL, V64, P91, DOI 10.1016/j.ijpsycho.2006.07.003; Herrington JD, 2011, BRAIN COGNITION, V77, P372, DOI 10.1016/j.bandc.2011.09.001; Hill H, 2001, CURR BIOL, V11, P880, DOI 10.1016/S0960-9822(01)00243-3; Hirai M, 2006, COGNITION, V99, pB15, DOI 10.1016/j.cognition.2005.05.003; Hirai M, 2005, COGNITIVE BRAIN RES, V23, P387, DOI 10.1016/j.cogbrainres.2004.11.005; Hirai M, 2003, NEUROSCI LETT, V344, P41, DOI 10.1016/S0304-3940(03)00413-0; Hirai M, 2006, NEUROSCI LETT, V403, P299, DOI 10.1016/j.neulet.2006.05.002; Hirai M, 2011, PSYCHOL SCI, V22, P1543, DOI 10.1177/0956797611417257; Hsiao FJ, 2006, INT J PSYCHOPHYSIOL, V61, P113, DOI 10.1016/j.ijpsycho.2005.08.001; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jokisch D, 2005, EUR J NEUROSCI, V21, P3439, DOI 10.1111/j.1460-9568.2005.04145.x; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Kawasaki H, 2012, J COGNITIVE NEUROSCI, V24, P1358, DOI 10.1162/jocn_a_00175; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Kemp R, 1996, PERCEPTION, V25, P37, DOI 10.1068/p250037; Klimesch W, 1997, INT J PSYCHOPHYSIOL, V26, P319, DOI 10.1016/S0167-8760(97)00773-3; Kostandov A, 2010, NEUROSCI BEHAV PHYSL, V40, P197; Kostandov EA, 2007, ZH VYSSH NERV DEYAT+, V57, P33; Krakowski AI, 2011, NEUROIMAGE, V56, P373, DOI 10.1016/j.neuroimage.2011.01.058; Lehky SR, 2000, J COGNITIVE NEUROSCI, V12, P848, DOI 10.1162/089892900562453; Lorincz ML, 2009, NEURON, V63, P683, DOI 10.1016/j.neuron.2009.08.012; Matsumoto R, 2004, CLIN NEUROPHYSIOL, V115, P2056, DOI 10.1016/j.clinph.2004.03.030; May ES, 2012, NEUROIMAGE, V62, P1965, DOI 10.1016/j.neuroimage.2012.05.071; McGlothlin B., 2012, PSI CHI J PSYCHOL RE, V17, P68; Miller LE, 2013, COGNITION, V128, P140, DOI 10.1016/j.cognition.2013.03.013; Mizuhara H, 2012, NEUROIMAGE, V62, P1884, DOI 10.1016/j.neuroimage.2012.05.072; Monaco S, 2011, J NEUROPHYSIOL; O'Toole AJ, 2002, TRENDS COGN SCI, V6, P261, DOI 10.1016/S1364-6613(02)01908-3; Parron C, 2008, AUTISM, V12, P261, DOI 10.1177/1362361307089520; Pavlova M, 2004, CEREB CORTEX, V14, P181, DOI 10.1093/cercor/bhg117; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Perry A, 2010, PSYCHONEUROENDOCRINO, V35, P1446, DOI 10.1016/j.psyneuen.2010.04.011; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Pitcher D, 2011, NEUROPSYCHOLOGIA, V49, P3448, DOI 10.1016/j.neuropsychologia.2011.08.020; Pollick FE, 2005, J EXP PSYCHOL HUMAN, V31, P1247, DOI 10.1037/0096-1523.31.6.1247; Puce A, 2000, COGNITIVE NEUROPSYCH, V17, P221, DOI 10.1080/026432900380580; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; Rossit S, 2011, NEUROPSYCHOLOGIA, V49, P2498, DOI 10.1016/j.neuropsychologia.2011.04.030; Sadeh B, 2010, HUM BRAIN MAPP, V31, P1490, DOI 10.1002/hbm.20952; Sakihara K, 2012, CLIN NEUROPHYSIOL, V123, P270, DOI 10.1016/j.clinph.2011.06.023; Saunier G, 2013, BEHAV BRAIN RES, V236, P166, DOI 10.1016/j.bbr.2012.08.038; Schouten B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056978; Snyder AC, 2010, J NEUROSCI, V30, P4024, DOI 10.1523/JNEUROSCI.5684-09.2010; Sokolov AA, 2012, NEUROIMAGE, V59, P2824, DOI 10.1016/j.neuroimage.2011.08.039; Sokolov AA, 2010, CEREB CORTEX, V20, P486, DOI 10.1093/cercor/bhp117; Stiers P, 2006, NEUROIMAGE, V29, P74, DOI 10.1016/j.neuroimage.2005.07.033; Taubert J, 2011, PERCEPTION, V40, P422, DOI 10.1068/p6874; Thornton IM, 2011, PSIHOLOGIJA, V44, P5, DOI 10.2298/PSI1101005T; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Tikhonov A, 2004, NEUROIMAGE, V21, P593, DOI 10.1016/j.neuroimage.2003.09.045; Tomalski P, 2012, BRAIN IMAGING BEHAV, V6, P88, DOI 10.1007/s11682-012-9147-6; Toscani M, 2010, EXP BRAIN RES, V207, P213, DOI 10.1007/s00221-010-2444-7; Tosoni A, 2013, CORTEX, V49, P1733, DOI 10.1016/j.cortex.2012.03.022; Tuladhar AM, 2007, HUM BRAIN MAPP, V28, P785, DOI 10.1002/hbm.20306; Ulloa ER, 2007, BEHAV BRAIN RES, V183, P188, DOI 10.1016/j.bbr.2007.06.007; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Vander Wyk BC, 2012, DEV COGN NEUROS-NETH, V2, P409, DOI 10.1016/j.dcn.2012.04.004; Wyk BCV, 2009, PSYCHOL SCI, V20, P771, DOI 10.1111/j.1467-9280.2009.02359.x; Zion-Golumbic E, 2010, J COGNITIVE NEUROSCI, V22, P263, DOI 10.1162/jocn.2009.21251	89	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89382	10.1371/journal.pone.0089382	http://dx.doi.org/10.1371/journal.pone.0089382			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586735	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900136
J	Li, QL; Guo, HT; Chou, DW; Berndt, A; Sundberg, JP; Uitto, J				Li, Qiaoli; Guo, Haitao; Chou, David W.; Berndt, Annerose; Sundberg, John P.; Uitto, Jouni			Mouse Models for Pseudoxanthoma Elasticum: Genetic and Dietary Modulation of the Ectopic Mineralization Phenotypes	PLOS ONE			English	Article							CONNECTIVE-TISSUE MINERALIZATION; GENERALIZED ARTERIAL CALCIFICATION; ABCC6 GENE; MICE; MUTATIONS; PROTEIN	Pseudoxanthoma elasticum (PXE), a heritable ectopic mineralization disorder, is caused by mutations in the ABCC6 gene. Null mice (Abcc6(-/-)) recapitulate the genetic, histopathologic and ultrastructural features of PXE, and they demonstrate early and progressive mineralization of vibrissae dermal sheath, which serves as a biomarker of the overall mineralization process. Recently, as part of a mouse aging study at The Jackson Laboratory, 31 inbred mouse strains were necropsied, and two of them, KK/HlJ and 129S1/SvImJ, were noted to have vibrissae dermal mineralization similar to Abcc6(-/-) mice. These two strains were shown to harbor a single nucleotide polymorphism (rs32756904) in the Abcc6 gene, which resulted in out-of-frame splicing and marked reduction in ABCC6 protein expression in the liver of these mice. The same polymorphism is present in two additional mouse strains, DBA/2J and C3H/HeJ, with similar reduction in Abcc6 protein levels, yet these mice did not demonstrate tissue mineralization when kept on standard rodent diet. However, all four mouse strains, when placed on experimental diet enriched in phosphate and low in magnesium, developed extensive ectopic mineralization. These results indicate that the genetic background of mice and the mineral composition of their diet can profoundly modulate the ectopic mineralization process predicated on mutations in the Abcc6 gene. These mice provide novel model systems to study the pathomechanisms and the reasons for strain background on phenotypic variability of PXE.	[Li, Qiaoli; Guo, Haitao; Chou, David W.; Uitto, Jouni] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Berndt, Annerose] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA	Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jackson Laboratory	Uitto, J (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA.	Jouni.uitto@jefferson.edu		Li, Qiaoli/0000-0002-8495-7103; Chou, David/0000-0003-4050-8178	NIH/NIAMS [R01 AR28450]; Ellison Medical Foundatino; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055225, R21AR063781, R01AR028450] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Ellison Medical Foundatino; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the NIH/NIAMS grants R01 AR28450 (JU) and Ellison Medical Foundatino (JPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherrahrou Z, 2008, J BIOL CHEM, V283, P7608, DOI 10.1074/jbc.M708290200; Berndt A, 2013, J INVEST DERMATOL, V133, P833, DOI 10.1038/jid.2012.340; Chassaing N, 2004, J INVEST DERMATOL, V122, P608, DOI 10.1111/j.0022-202X.2004.22312.x; Gorgels TGMF, 2005, HUM MOL GENET, V14, P1763, DOI 10.1093/hmg/ddi183; Jiang QJ, 2007, J INVEST DERMATOL, V127, P1392, DOI 10.1038/sj.jid.5700729; Klement JF, 2005, MOL CELL BIOL, V25, P8299, DOI 10.1128/MCB.25.18.8299-8310.2005; LaRusso J, 2009, J INVEST DERMATOL, V129, P1388, DOI 10.1038/jid.2008.391; Le Boulanger G, 2010, AM J MED GENET A, V152A, P118, DOI 10.1002/ajmg.a.33162; Li QL, 2014, J INVEST DERMATOL, V134, P658, DOI 10.1038/jid.2013.370; Li QL, 2012, AM J PATHOL, V181, P1190, DOI 10.1016/j.ajpath.2012.06.014; Li QL, 2010, J MOL MED, V88, P173, DOI 10.1007/s00109-009-0522-8; Li QL, 2009, CTS-CLIN TRANSL SCI, V2, P398, DOI 10.1111/j.1752-8062.2009.00161.x; Martin L, 2011, AM J PATHOL, V178, P774, DOI 10.1016/j.ajpath.2010.10.004; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Neldner K H, 1988, Clin Dermatol, V6, P1; Nitschke Y, 2012, AM J HUM GENET, V90, P25, DOI 10.1016/j.ajhg.2011.11.020; Pfendner EG, 2007, J MED GENET, V44, P621, DOI 10.1136/jmg.2007.051094; PRPIC V, 1984, J BIOL CHEM, V259, P1382; Schurgers LJ, 2013, TRENDS MOL MED, V19, P217, DOI 10.1016/j.molmed.2012.12.008; Sundberg JP, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7179; Uitto J, 2013, J INVEST DERMATOL, V133, P1444, DOI 10.1038/jid.2013.20; Uitto J, 2012, J INVEST DERMATOL, V132, P1029, DOI 10.1038/jid.2011.401; Uitto J, 2010, J INVEST DERMATOL, V130, P661, DOI 10.1038/jid.2009.411	23	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89268	10.1371/journal.pone.0089268	http://dx.doi.org/10.1371/journal.pone.0089268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586646	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000331711900119
J	Manaskova, SH; Nazmi, K; van Belkum, A; Bikker, FJ; van Wamel, WJB; Veerman, ECI				Manaskova, Silvie Hansenova; Nazmi, Kamran; van Belkum, Alex; Bikker, Floris J.; van Wamel, Willem J. B.; Veerman, Enno C. I.			Synthetic LPETG-Containing Peptide Incorporation in the Staphylococcus aureus Cell-Wall in a Sortase A- and Growth Phase-Dependent Manner	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; SURFACE-PROTEINS; ANTIBODY-RESPONSES; CLUMPING FACTOR; UNITED-STATES; LPXTG MOTIF; IN-VITRO; INFECTION; HETEROGENEITY; PATHOGENESIS	The majority of Staphylococcus aureus virulence-and colonization-associated surface proteins contain a pentapeptide recognition motif (LPXTG). This motif can be recognized and cleaved by sortase A (SrtA) which is a membrane-bound transpeptidase. After cleavage these proteins are covalently incorporated into the peptidoglycan. Therefore, SrtA plays a key role in S. aureus virulence. We aimed to generate a substrate mimicking this SrtA recognition motif for several purposes: to incorporate this substrate into the S. aureus cell-wall in a SrtA-dependent manner, to characterize this incorporation and to determine the effect of substrate incorporation on the incorporation of native SrtA-dependent cell-surface-associated proteins. We synthesized substrate containing the specific LPXTG motif, LPETG. As a negative control we used a scrambled version of this substrate, EGTLP and a S. aureus srtA knockout strain. Both substrates contained a fluorescence label for detection by FACScan and fluorescence microscope. A spreading assay and a competitive Luminex assay were used to determine the effect of substrate treatment on native LPXTG containing proteins deposition in the bacterial cell-wall. We demonstrate a SrtA-dependent covalent incorporation of the LPETG-containing substrate in wild type S. aureus strains and several other Gram-positive bacterial species. LPETG-containing substrate incorporation in S. aureus was growth phase-dependent and peaked at the stationary phase. This incorporation negatively correlated with srtA mRNA expression. Exogenous addition of the artificial substrate did not result in a decreased expression of native SrtA substrates (e. g. clumping factor A/B and protein A) nor induced a srtA knockout phenotype.	[Manaskova, Silvie Hansenova; Nazmi, Kamran; Bikker, Floris J.; Veerman, Enno C. I.] Univ Amsterdam, Dept Oral Biochem, Acad Ctr Dent Amsterdam, Amsterdam, Netherlands; [Manaskova, Silvie Hansenova; Nazmi, Kamran; Bikker, Floris J.; Veerman, Enno C. I.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Manaskova, Silvie Hansenova; van Belkum, Alex; van Wamel, Willem J. B.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Manaskova, SH (corresponding author), Univ Amsterdam, Dept Oral Biochem, Acad Ctr Dent Amsterdam, Amsterdam, Netherlands.	s.hansenovamanaskova@erasmusmc.nl	Bikker, Floris/B-1187-2012; Bikker, Floris/R-1941-2019	Bikker, Floris/0000-0002-9453-4630; van Wamel, Willem/0000-0001-9145-9121	ZonMW [50-51700-98-055]	ZonMW(Netherlands Organization for Health Research and Development)	This work was supported by ZonMW; grant title: Exploiting Staphylococcus aureus sortase for anti-infective purposes with the project number: 50-51700-98-055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Dreisbach A, 2011, PROTEOMICS, V11, P3154, DOI 10.1002/pmic.201000823; Fischetti V., 2006, GRAM POSITIVE PATHOG, V2nd; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Jansen KU, 2013, VACCINE, V31, P2723, DOI 10.1016/j.vaccine.2013.04.002; Jonsson IM, 2002, J INFECT DIS, V185, P1417, DOI 10.1086/340503; Jonsson IM, 2003, MICROBES INFECT, V5, P775, DOI 10.1016/S1286-4579(03)00143-6; Josefsson E, 2008, MICROB PATHOGENESIS, V44, P103, DOI 10.1016/j.micpath.2007.08.010; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manaskova SH, 2013, J IMMUNOL METHODS, V397, P18, DOI 10.1016/j.jim.2013.07.016; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Martins TB, 2006, J IMMUNOL METHODS, V316, P97, DOI 10.1016/j.jim.2006.08.007; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nelson JW, 2010, ACS CHEM BIOL, V5, P1147, DOI 10.1021/cb100195d; Popp M, 2009, CURR PROTOC PROTEIN; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Tsompanidou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044646; Turner RD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1025; Verkaik NJ, 2010, EUR J CLIN MICROBIOL, V29, P509, DOI 10.1007/s10096-010-0888-0; Verkaik N, 2008, J IMMUNOL METHODS, V335, P121, DOI 10.1016/j.jim.2008.02.022; Weiss WJ, 2004, J ANTIMICROB CHEMOTH, V53, P480, DOI 10.1093/jac/dkh078; Wolz C, 2002, INFECT IMMUN, V70, P2758, DOI 10.1128/IAI.70.6.2758-2762.2002; Zhou XX, 2012, BIOCHEMISTRY-US, V51, P8143, DOI 10.1021/bi3012115; Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313	39	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89260	10.1371/journal.pone.0089260	http://dx.doi.org/10.1371/journal.pone.0089260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586638	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900116
J	Rajamuthiah, R; Fuchs, BB; Jayamani, E; Kim, Y; Larkins-Ford, J; Conery, A; Ausubel, FM; Mylonakis, E				Rajamuthiah, Rajmohan; Fuchs, Beth Burgwyn; Jayamani, Elamparithi; Kim, Younghoon; Larkins-Ford, Jonah; Conery, Annie; Ausubel, Frederick M.; Mylonakis, Eleftherios			Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS INFECTION; WALL TEICHOIC-ACID; CIPROFLOXACIN-RESISTANT; ANTIBACTERIAL AGENTS; INVITRO ACTIVITY; MODEL HOST; VIRULENCE; SUSCEPTIBILITY; VANCOMYCIN; BACTERIAL	Staphylococcus aureus, the leading cause of hospital-acquired infections in the United States, is also pathogenic to the model nematode Caenorhabditis elegans. The C. elegans-S. aureus infection model was previously carried out on solid agar plates where the bacteriovorous C. elegans feeds on a lawn of S. aureus. However, agar-based assays are not amenable to large scale screens for antibacterial compounds. We have developed a high throughput liquid screening assay that uses robotic instrumentation to dispense a precise amount of methicillin resistant S. aureus (MRSA) and worms in 384-well assay plates, followed by automated microscopy and image analysis. In validation of the liquid assay, an MRSA cell wall defective mutant, MW2 Delta tarO, which is attenuated for killing in the agar-based assay, was found to be less virulent in the liquid assay. This robust assay with a Z'-factor consistently greater than 0.5 was utilized to screen the Biomol 4 compound library consisting of 640 small molecules with well characterized bioactivities. As proof of principle, 27 of the 30 clinically used antibiotics present in the library conferred increased C. elegans survival and were identified as hits in the screen. Surprisingly, the antihelminthic drug closantel was also identified as a hit in the screen. In further studies, we confirmed the antistaphylococcal activity of closantel against vancomycin-resistant S. aureus isolates and other Gram-positive bacteria. The liquid C. elegans - S. aureus assay described here allows screening for anti-staphylococcal compounds that are not toxic to the host.	[Rajamuthiah, Rajmohan; Fuchs, Beth Burgwyn; Jayamani, Elamparithi; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Div Infect Dis, Alpert Med Sch, Providence, RI 02903 USA; [Rajamuthiah, Rajmohan; Fuchs, Beth Burgwyn; Jayamani, Elamparithi; Larkins-Ford, Jonah; Conery, Annie; Ausubel, Frederick M.; Mylonakis, Eleftherios] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Kim, Younghoon] Chonbuk Natl Univ, Dept Anim Sci, Jeonju, South Korea	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Jeonbuk National University	Mylonakis, E (corresponding author), Brown Univ, Rhode Isl Hosp, Div Infect Dis, Alpert Med Sch, Providence, RI 02903 USA.	Eleftherios_Mylonakis@Brown.edu	; Raja Muthiah, Raj Mohan/D-3932-2014	Larkins-Ford, Jonah/0000-0001-9123-9508; Raja Muthiah, Raj Mohan/0000-0002-6956-3130	National Institutes of Health [P01 AI083214, U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, P01AI083214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant P01 AI083214 to EM and FA and grant U54 AI057159 to NERCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abdullah ES, 2012, PROF DRUG SUB EXCIP, V37, P183, DOI 10.1016/B978-0-12-397220-0.00005-2; Alba V, 2009, INT J ANTIMICROB AG, V33, P272, DOI 10.1016/j.ijantimicag.2008.08.024; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Barrett JF, 1998, P NATL ACAD SCI USA, V95, P5317, DOI 10.1073/pnas.95.9.5317; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Bishburg E, 2009, INT J ANTIMICROB AG, V34, P395, DOI 10.1016/j.ijantimicag.2009.06.021; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; BRUN Y, 1988, PATHOL BIOL, V36, P613; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Champney WS, 2000, CURR MICROBIOL, V41, P126, DOI 10.1007/s002840010106; CLARKE AM, 1989, EUR J CLIN MICROBIOL, V8, P164, DOI 10.1007/BF01963905; Cuddy Suzanne M, 2008, Plast Surg Nurs, V28, P168, DOI 10.1097/PSN.0b013e31818ea7ca; Daum RS, 2007, NEW ENGL J MED, V357, P380, DOI 10.1056/NEJMcp070747; Day SR, 2012, VIRULENCE, V3, P576, DOI 10.4161/viru.22120; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; Fox PM, 2006, ANTIMICROB AGENTS CH, V50, P2951, DOI 10.1128/AAC.00232-06; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; FUKUOKA Y, 1993, ANTIMICROB AGENTS CH, V37, P384, DOI 10.1128/AAC.37.3.384; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; GILBERT M, 1986, ANTIMICROB AGENTS CH, V29, P461, DOI 10.1128/AAC.29.3.461; Gloeckner C, 2010, P NATL ACAD SCI USA, V107, P3424, DOI 10.1073/pnas.0915125107; Gottlieb GS, 2000, J AM COLL SURGEONS, V190, P50, DOI 10.1016/S1072-7515(99)00211-2; HALL WH, 1980, ANTIMICROB AGENTS CH, V17, P273, DOI 10.1128/AAC.17.2.273; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hlasta DJ, 1998, BIOORG MED CHEM LETT, V8, P1923, DOI 10.1016/S0960-894X(98)00326-6; HoogkampKorstanje JAA, 1997, J ANTIMICROB CHEMOTH, V40, P427, DOI 10.1093/jac/40.3.427; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Isnansetyo A, 2001, J ANTIMICROB CHEMOTH, V47, P724; Jones ME, 1999, ANTIMICROB AGENTS CH, V43, P421, DOI 10.1128/AAC.43.2.421; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; KIELHOFNER MA, 1990, TEX HEART I J, V17, P86; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kirienko NV, 2013, CELL HOST MICROBE, V13, P406, DOI 10.1016/j.chom.2013.03.003; Lindsay JA, 2010, INT J MED MICROBIOL, V300, P98, DOI 10.1016/j.ijmm.2009.08.013; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; MAPLE PAC, 1991, ANTIMICROB AGENTS CH, V35, P345, DOI 10.1128/AAC.35.2.345; Martin RJ, 1997, VET J, V154, P11, DOI 10.1016/S1090-0233(05)80005-X; MICHIELS M, 1987, DRUG METAB REV, V18, P235, DOI 10.3109/03602538708998307; Moy TI, 2009, ACS CHEM BIOL, V4, P527, DOI 10.1021/cb900084v; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Mulazimoglu L, 1996, ANTIMICROB AGENTS CH, V40, P1534, DOI 10.1128/AAC.40.6.1534; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; POHLOD DJ, 1988, J ANTIMICROB CHEMOTH, V22, P35, DOI 10.1093/jac/22.Supplement_D.35; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; QADRI SMH, 1993, EUR J CLIN MICROBIOL, V12, P372, DOI 10.1007/BF01964437; Rubin JE, 2011, CAN VET J, V52, P153; Saravu K, 2012, SCAND J INFECT DIS, V44, P544, DOI 10.3109/00365548.2012.657233; Schito GC, 1996, J ANTIMICROB CHEMOTH, V38, P97, DOI 10.1093/jac/38.suppl_A.97; Schmalreck AF, 1997, J ANTIMICROB CHEMOTH, V40, P179, DOI 10.1093/jac/40.2.179; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; SMITH SM, 1986, ANTIMICROB AGENTS CH, V29, P325, DOI 10.1128/AAC.29.2.325; Stephenson K, 2002, PHARMACOL THERAPEUT, V93, P293, DOI 10.1016/S0163-7258(02)00198-5; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sultana Yasmin, 2005, Acta Pharmaceutica (Zagreb), V55, P305; Suzuki T, 2012, J ANTIMICROB CHEMOTH, V67, P2143, DOI 10.1093/jac/dks184; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tanaka-Hino M, 2002, EMBO REP, V3, P56, DOI 10.1093/embo-reports/kvf001; Van Voorhies WA, 2000, J EXP BIOL, V203, P2467; WALSH TJ, 1985, J ANTIMICROB CHEMOTH, V15, P435, DOI 10.1093/jac/15.4.435; Watanabe T, 2008, ADV EXP MED BIOL, V631, P229, DOI 10.1007/978-0-387-78885-2_16; WILLIAMSON RL, 1967, SCIENCE, V158, P1694, DOI 10.1126/science.158.3809.1694; Wu KY, 2012, CAN J INFECT DIS MED, V23, P130, DOI 10.1155/2012/543817; Yang JP, 2013, LAB CHIP, V13, P3373, DOI 10.1039/c3lc50264c; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zuo GY, 2012, MOLECULES, V17, P10322, DOI 10.3390/molecules170910322	74	67	73	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89189	10.1371/journal.pone.0089189	http://dx.doi.org/10.1371/journal.pone.0089189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586584	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900102
J	Zhai, H; Lu, SX; Liang, S; Wu, HY; Zhang, XZ; Liu, BH; Kong, FJ; Yuan, XH; Li, J; Xia, ZJ				Zhai, Hong; Lu, Shixiang; Liang, Shuang; Wu, Hongyan; Zhang, Xingzheng; Liu, Baohui; Kong, Fanjiang; Yuan, Xiaohui; Li, Jing; Xia, Zhengjun			GmFT4, a Homolog of FLOWERING LOCUS T, Is Positively Regulated by E1 and Functions as a Flowering Repressor in Soybean	PLOS ONE			English	Article							LONG-JUVENILE TRAIT; MAP-BASED CLONING; PHOTOPERIOD-SENSITIVITY; FLORAL INDUCTION; FT PROTEIN; REPRODUCTIVE DEVELOPMENT; ARABIDOPSIS-THALIANA; CIRCADIAN CLOCK; GENETIC-CONTROL; MOLECULAR-BASIS	The major maturity gene E1 has the most prominent effect on flowering time and photoperiod sensitivity of soybean, but the pathway mediated by E1 is largely unknown. Here, we found the expression of GmFT4, a homolog of Flowering Locus T, was strongly up-regulated in transgenic soybean overexpressing E1, whereas expression of flowering activators, GmFT2a and GmFT5a, was suppressed. GmFT4 expression was strongly up-regulated by long days exhibiting a diurnal rhythm, but down-regulated by short days. Notably, the basal expression level of GmFT4 was elevated when transferred to continous light, whereas repressed when transferred to continuous dark. GmFT4 was primarily expressed in fully expanded leaves. Transcript abundance of GmFT4 was significantly correlated with that of functional E1, as well as flowering time phenotype in different cultivars. Overexpression of GmFT4 delayed the flowering time in transgenic Arabidopsis. Taken together, we propose that GmFT4 acts downstream of E1 and functions as a flowering repressor, and the balance of two antagonistic factors (GmFT4 vs GmFT2a/5a) determines the flowering time of soybean.	[Zhai, Hong; Lu, Shixiang; Wu, Hongyan; Zhang, Xingzheng; Liu, Baohui; Kong, Fanjiang; Yuan, Xiaohui; Xia, Zhengjun] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Heilongjiang, Peoples R China; [Liang, Shuang; Li, Jing] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Northeast Agricultural University - China	Xia, ZJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Heilongjiang, Peoples R China.	Xiazhj@neigaehrb.ac.cn	Kong, Fanjiang/AGQ-2334-2022	Kong, Fanjiang/0000-0001-7138-1478	National Natural Science Foundation of China [31271742, 31301338]; Chinese Academy of Sciences (Hundred Talents Program) [KZCX2-EW-303, XDA08010105]; Natural Science Foundation of Heilongjiang Province of China [ZD201120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (Hundred Talents Program)(Chinese Academy of Sciences); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province)	This work was supported by National Natural Science Foundation of China (31271742 and 31301338), Chinese Academy of Sciences (Hundred Talents Program, KZCX2-EW-303, XDA08010105), and Natural Science Foundation of Heilongjiang Province of China (ZD201120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2003, CROP SCI, V43, P1300, DOI 10.2135/cropsci2003.1300; Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Blackman BK, 2010, CURR BIOL, V20, P629, DOI 10.1016/j.cub.2010.01.059; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Carpentleri-Pipolo V, 2002, GENET MOL BIOL, V25, P463, DOI 10.1590/S1415-47572002000400016; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cober ER, 2011, CROP SCI, V51, P140, DOI 10.2135/cropsci2010.05.0262; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Cober ER, 1996, CROP SCI, V36, P606, DOI 10.2135/cropsci1996.0011183X003600030014x; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; David KM, 2006, FEBS LETT, V580, P1193, DOI 10.1016/j.febslet.2006.01.016; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; Hecht V, 2007, PLANT PHYSIOL, V144, P648, DOI 10.1104/pp.107.096818; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Lazakis CM, 2011, J EXP BOT, V62, P4833, DOI 10.1093/jxb/err129; Ledger S, 2001, PLANT J, V26, P14; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; MCBLAIN BA, 1987, CROP SCI, V27, P1127, DOI 10.2135/cropsci1987.0011183X002700060008x; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Ohshima S, 1997, MOL GEN GENET, V254, P186, DOI 10.1007/s004380050407; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Ratcliffe OJ, 1998, DEVELOPMENT, V125, P1609; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; SAINDON G, 1989, CROP SCI, V29, P1361, DOI 10.2135/cropsci1989.0011183X002900060006x; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; SHANNON S, 1991, PLANT CELL, V3, P877, DOI 10.1105/tpc.3.9.877; SINCLAIR TR, 1992, CROP SCI, V32, P1242, DOI 10.2135/cropsci1992.0011183X003200050036x; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Tomkins JP, 1996, CROP SCI, V36, P1144, DOI 10.2135/cropsci1996.0011183X003600050013x; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Watanabe S, 2004, BREEDING SCI, V54, P399, DOI 10.1270/jsbbs.54.399; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yamagishi N, 2011, PLANTA, V233, P561, DOI 10.1007/s00425-010-1318-3; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yamanaka N, 2001, DNA RES, V8, P61, DOI 10.1093/dnares/8.2.61; Yamashino T, 2013, BIOSCI BIOTECH BIOCH, V77, P747, DOI 10.1271/bbb.120871; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	67	69	77	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89030	10.1371/journal.pone.0089030	http://dx.doi.org/10.1371/journal.pone.0089030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586488	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900073
J	Hartwig, FP; Entiauspe, LG; Nunes, EM; Rodrigues, FM; Collares, T; Seixas, FK; da Silveira, MF				Hartwig, Fernando Pires; Entiauspe, Ludmila Goncalves; Nunes, Emily Montosa; Rodrigues, Fernanda Martins; Collares, Tiago; Seixas, Fabiana Koemmling; da Silveira, Mariangela Freitas			Evidence for an Epistatic Effect between TP53 R72P and MDM2 T309G SNPs in HIV Infection: A Cross-Sectional Study in Women from South Brazil	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISM; CERVICAL-CANCER; HUMAN-PAPILLOMAVIRUS; P53 CODON-72; HOST CONTROL; DETERMINANTS; PROGRESSION; APOPTOSIS; VARIANTS	Objective: To investigate the associations of TP53 R72P and MDM2 T309G SNPs with HPV infection status, HPV oncogenic risk and HIV infection status. Design: Cross-sectional study combining two groups (150 HIV-negative and 100 HIV-positive) of women. Methods: Data was collected using a closed questionnaire. DNA was extracted from cervical samples. HPV infection status was determined by nested-PCR, and HPV oncogenic risk group by Sanger sequencing. Both SNPS were genotyped by PCR-RFLP. Crude and adjusted associations involving each exposure (R72P and T309G SNPs, as well as 13 models of epistasis) and each outcome (HPV status, HPV oncogenic risk group and HIV infection) were assessed using logistic regression. Results: R72P SNP was protectively associated with HPV status (overdominant model), as well as T309G SNP with HPV oncogenic risk (strongest in the overdominant model). No epistatic model was associated with HPV status, but a dominant (R72P over T309G) protective epistatic effect was observed for HPV oncogenic risk. HIV status was strongly associated (risk factor) with different epistatic models, especially in models based on a visual inspection of the results. Moreover, HIV status was evidenced to be an effect mediator of the associations involving HPV oncogenic risk. Conclusions: We found evidence for a role of R72P and T309G SNPs in HPV status and HPV oncogenic risk (respectively), and strong associations were found for an epistatic effect in HIV status. Prospective studies in larger samples are warranted to validate our findings, which point to a novel role of these SNPs in HIV infection.	[Hartwig, Fernando Pires; da Silveira, Mariangela Freitas] Univ Fed Pelotas, Fac Med, Dept Social Med, Postgrad Program Epidemiol, Pelotas, RS, Brazil; [Entiauspe, Ludmila Goncalves; Collares, Tiago; Seixas, Fabiana Koemmling] Univ Fed Pelotas, Biotechnol Unit, Technol Dev Ctr, Postgrad Program Biotechnol, Pelotas, RS, Brazil; [Hartwig, Fernando Pires; Entiauspe, Ludmila Goncalves; Nunes, Emily Montosa; Rodrigues, Fernanda Martins; Collares, Tiago; Seixas, Fabiana Koemmling] Univ Fed Pelotas, Biotechnol Unit, Technol Dev Ctr, Mol & Cellular Oncol Res Grp, Pelotas, RS, Brazil; [da Silveira, Mariangela Freitas] Univ Fed Pelotas, Fac Med, Maternal & Child Dept, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade Federal de Pelotas	Hartwig, FP (corresponding author), Univ Fed Pelotas, Fac Med, Dept Social Med, Postgrad Program Epidemiol, Pelotas, RS, Brazil.	fernandophartwig@gmail.com	Nunes, Emily Montosa/G-6095-2015; Collares, Tiago/S-2117-2016; Hartwig, Fernando/AAG-5578-2020; Nunes, Emily Montosa/AAR-6907-2021; Silveira, Mariangela F/L-6868-2013; Collares, Tiago/K-2779-2019; Seixas, Fabiana Kommling/X-2706-2018	Nunes, Emily Montosa/0000-0002-7475-9007; Collares, Tiago/0000-0002-1535-3795; Nunes, Emily Montosa/0000-0002-7475-9007; Silveira, Mariangela F/0000-0002-3551-9713; Collares, Tiago/0000-0002-1535-3795; Seixas, Fabiana Kommling/0000-0003-4204-2500; Martins Rodrigues, Fernanda/0000-0002-2140-0690	Brazilian National Council for Scientific and Technological Development (CNPq)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian National Council for Scientific and Technological Development (CNPq; http://memoria.cnpq.br/english/cnpq/index.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Alsbeih G, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-15; Bond GL, 2005, CANCER RES, V65, P5481, DOI 10.1158/0008-5472.CAN-05-0825; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Chansaenroj J, 2013, ASIAN PAC J CANCER P, V14, P341, DOI 10.7314/APJCP.2013.14.1.341; da Silveira MF, 2006, J EVAL CLIN PRACT, V12, P102, DOI 10.1111/j.1365-2753.2005.00626.x; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Duncan SR, 2005, J MED GENET, V42, P205, DOI 10.1136/jmg.2004.025346; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Habbous S, 2012, CLIN CANCER RES, V18, P6407, DOI 10.1158/1078-0432.CCR-12-1983; Hartwig F.P., 2013, J GENET SYNDR GENE T, V4, P10, DOI [10.4172/2157-7412.1000189., DOI 10.4172/2157-7412.1000189]; Herbeck JT, 2010, J INFECT DIS, V201, P618, DOI 10.1086/649842; Husnjak K, 2000, J VIROL METHODS, V88, P125, DOI 10.1016/S0166-0934(00)00194-4; Joubert BR, 2010, GENOME MED, V2, DOI 10.1186/gm138; Lane J, 2013, HUM MOL GENET, V22, P1903, DOI 10.1093/hmg/ddt033; Le Clerc S, 2011, JAIDS-J ACQ IMM DEF, V56, P279, DOI 10.1097/QAI.0b013e318204982b; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Lin YC, 2008, ORAL ONCOL, V44, P798, DOI 10.1016/j.oraloncology.2007.10.006; Lingappa JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028632; Luo M, 2012, J VIROL, V86, P11899, DOI 10.1128/JVI.01499-12; Macias D, 2009, HUM GENE THER, V20, P1259, DOI 10.1089/hum.2009.059; MANOS MM, 1989, CANCER CEL, V7, P209; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; McLaren PJ, 2012, HUM MOL GENET, V21, P4334, DOI 10.1093/hmg/dds226; Nelson Ronald M, 2013, Methods Mol Biol, V1019, P499, DOI 10.1007/978-1-62703-447-0_24; Pan Qinxin, 2013, Methods Mol Biol, V1019, P465, DOI 10.1007/978-1-62703-447-0_22; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; Petrovski S, 2011, AIDS, V25, P513, DOI 10.1097/QAD.0b013e328343817b; Sato Y, 2013, REV MED VIROL, V23, P213, DOI 10.1002/rmv.1738; Singhal P, 2013, DNA CELL BIOL, V32, P19, DOI 10.1089/dna.2012.1718; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; SNIJDERS PJF, 1990, J GEN VIROL, V71, P173, DOI 10.1099/0022-1317-71-1-173; Sotamaa K, 2005, CLIN CANCER RES, V11, P6840, DOI 10.1158/1078-0432.CCR-05-1139; Steinberger P, 2000, P NATL ACAD SCI USA, V97, P805, DOI 10.1073/pnas.97.2.805; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Thurow HS, 2013, MOL BIOL REP, V40, P4929, DOI 10.1007/s11033-013-2593-4; Tun C, 2007, J NEUROCHEM, V102, P1206, DOI 10.1111/j.1471-4159.2007.04609.x; van Manen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022208; Verma S, 2011, BLOOD, V117, P6600, DOI 10.1182/blood-2011-01-333427; Wang ZQ, 2012, INT J CANCER, V131, pE251, DOI 10.1002/ijc.27335; Yang J, 2013, CANC EPIDEMIOL	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89489	10.1371/journal.pone.0089489	http://dx.doi.org/10.1371/journal.pone.0089489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586820	Green Submitted, gold, Green Published			2022-12-27	WOS:000332396200056
J	Li, AZ; Shao, ZZ				Li, Anzhang; Shao, Zongze			Biochemical Characterization of a Haloalkane Dehalogenase DadB from Alcanivorax dieselolei B-5	PLOS ONE			English	Article							SPHINGOMONAS-PAUCIMOBILIS UT26; BRADYRHIZOBIUM-JAPONICUM; DEGRADING BACTERIUM; CRYSTAL-STRUCTURE; PURIFICATION; EXPRESSION; EVOLUTION; CLONING; GENE; DEGRADATION	Recently, we found that Alcanivorax bacteria from various marine environments were capable of degrading halogenated alkanes. Genome sequencing of A. dieselolei B-5 revealed two putative haloalkane dehalogenase (HLD) genes, which were supposed to be involved in degradation of halogenated compounds. In this report, we confirm for the first time that the Alcanivorax bacterium encodes a truly functional HLD named DadB. An activity assay with 46 halogenated substrates indicated that DadB possesses broad substrate range and has the highest overall activity among the identified HLDs. DadB prefers brominated substrates; chlorinated alkenes; and the C-2-C-3 substrates, including the persistent pollutants of 1, 2-dichloroethane, 1,2-dichloropropane and 1,2,3-trichloropropane. As DadB displays no detectable activity toward long-chain haloalkanes such as 1-chlorohexadecane and 1-chlorooctadecane, the degradation of them in A. dieselolei B-5 might be attributed to other enzymes. Kinetic constants were determined with 6 substrates. DadB has highest affinity and largest k(cat)/K-m value toward 1,3-dibromopropane (K-m = 0.82 mM, k(cat)/K-m = 16.43 mM(-1).s(-1)). DadB aggregates fast in the buffers with pH <= 7.0, while keeps stable in monomer form when pH >= 7.5. According to homology modeling, DadB has an open active cavity with a large access tunnel, which is supposed important for larger molecules as opposed to C-2-C-3 substrates. Combined with the results for other HLDs, we deduce that residue I247 plays an important role in substrate selection. These results suggest that DadB and its host, A. dieselolei B-5, are of potential use for biocatalysis and bioremediation applications.	[Li, Anzhang] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Li, Anzhang; Shao, Zongze] State Ocean Adm, Key Lab Marine Biogenet Resources, State Key Lab Breeding Base, Inst Oceanog 3,Collaborat Innovat Ctr Deep Sea Bi, Xiamen, Peoples R China; [Li, Anzhang; Shao, Zongze] Key Lab Marine Biogenet Resources Fujian Prov, Xiamen, Peoples R China	Xiamen University; State Oceanic Administration	Shao, ZZ (corresponding author), State Ocean Adm, Key Lab Marine Biogenet Resources, State Key Lab Breeding Base, Inst Oceanog 3,Collaborat Innovat Ctr Deep Sea Bi, Xiamen, Peoples R China.	shaozz@163.com	Shao, Zongze/T-6682-2017; Li, Anzhang/AAF-4531-2019	Shao, Zongze/0000-0002-4784-090X; 	National Science Foundation of China [41176154]; Public Welfare Project of SOA [201005032]; COMRA project [DY125-15-R-01]; International Sci & Tech Cooperation Program of China [2010DFB23320]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Project of SOA; COMRA project; International Sci & Tech Cooperation Program of China	This work was financially supported by the National Science Foundation of China (41176154) (http://www.nsfc.gov.cn), Public Welfare Project of SOA (201005032) (http://www.soa.gov.cn/), the COMRA project (DY125-15-R-01) (http://www.comra.org/), and the International Sci & Tech Cooperation Program of China (2010DFB23320) (http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde M, 2006, TRENDS BIOTECHNOL, V24, P281, DOI 10.1016/j.tibtech.2006.04.002; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bidmanova S, 2010, ANAL BIOANAL CHEM, V398, P1891, DOI 10.1007/s00216-010-4083-z; Bosma T, 2002, APPL ENVIRON MICROB, V68, P3582, DOI 10.1128/AEM.68.7.3582-3587.2002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carr PD, 2009, PROTEIN PEPTIDE LETT, V16, P1137; Chaloupkova R, 2003, J BIOL CHEM, V278, P52622, DOI 10.1074/jbc.M306762200; Chaloupkova R, 2011, FEBS J, V278, P2728, DOI 10.1111/j.1742-4658.2011.08203.x; Chovancova E, 2007, PROTEINS, V67, P305, DOI 10.1002/prot.21313; CURRAGH H, 1994, MICROBIOL-UK, V140, P1433, DOI 10.1099/00221287-140-6-1433; Dravis BC, 2000, BIOTECHNOL BIOENG, V69, P235, DOI 10.1002/1097-0290(20000805)69:3<235::AID-BIT1>3.0.CO;2-D; Drienovska I, 2012, APPL ENVIRON MICROB, V78, P4995, DOI 10.1128/AEM.00485-12; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Gehret JJ, 2012, PROTEIN SCI, V21, P239, DOI 10.1002/pro.2009; Gray KA, 2001, ADV SYNTH CATAL, V343, P607, DOI 10.1002/1615-4169(200108)343:6/7<607::AID-ADSC607>3.0.CO;2-M; Hasan K, 2011, APPL ENVIRON MICROB, V77, P1881, DOI 10.1128/AEM.02109-10; Hesseler M, 2011, APPL MICROBIOL BIOT, V91, P1049, DOI 10.1007/s00253-011-3328-x; Janssen DB, 2005, ENVIRON MICROBIOL, V7, P1868, DOI 10.1111/j.1462-2920.2005.00966.x; JANSSEN DB, 1988, EUR J BIOCHEM, V171, P67, DOI 10.1111/j.1432-1033.1988.tb13759.x; Janssen DB, 2004, CURR OPIN CHEM BIOL, V8, P150, DOI 10.1016/j.cbpa.2004.02.012; Jesenska A, 2005, APPL ENVIRON MICROB, V71, P6736, DOI 10.1128/AEM.71.11.6736-6745.2005; Jesenska A, 2002, APPL ENVIRON MICROB, V68, P3724, DOI 10.1128/AEM.68.8.3724-3730.2002; Jesenska A, 2009, APPL ENVIRON MICROB, V75, P5157, DOI 10.1128/AEM.00199-09; KEUNING S, 1985, J BACTERIOL, V163, P635, DOI 10.1128/JB.163.2.635-639.1985; Koudelakova T, 2011, BIOCHEM J, V435, P345, DOI 10.1042/BJ20101405; Kulakova AN, 1997, MICROBIOL-SGM, V143, P109, DOI 10.1099/00221287-143-1-109; Lai QL, 2012, J BACTERIOL, V194, P6674, DOI 10.1128/JB.01813-12; Li A, 2013, THESIS XIAMEN U; Liu CL, 2011, ENVIRON MICROBIOL, V13, P1168, DOI 10.1111/j.1462-2920.2010.02416.x; Liu CL, 2005, INT J SYST EVOL MICR, V55, P1181, DOI 10.1099/ijs.0.63443-0; Liu DS, 2012, ACS NANO; Marek J, 2000, BIOCHEMISTRY-US, V39, P14082, DOI 10.1021/bi001539c; N Peterson Scott, 2012, Curr Chem Genomics, V6, P8, DOI 10.2174/1875397301206010008; Nagata Y, 1997, APPL ENVIRON MICROB, V63, P3707, DOI 10.1128/AEM.63.9.3707-3710.1997; Newman J, 1999, BIOCHEMISTRY-US, V38, P16105, DOI 10.1021/bi9913855; Oakley AJ, 2004, BIOCHEMISTRY-US, V43, P870, DOI 10.1021/bi034748g; Oakley AJ, 2002, BIOCHEMISTRY-US, V41, P4847, DOI 10.1021/bi015734i; Ohana RF, 2009, PROTEIN EXPRES PURIF, V68, P110, DOI 10.1016/j.pep.2009.05.010; Otyepka M, 2002, PROTEIN SCI, V11, P1206, DOI 10.1110/ps.ps3830102; Pavlova M, 2009, NAT CHEM BIOL, V5, P727, DOI 10.1038/nchembio.205; Prokop Zbynek, 2006, Biotechnology Journal, V1, P1370, DOI 10.1002/biot.200600166; Prokop Z, 2010, ANGEW CHEM INT EDIT, V49, P6111, DOI 10.1002/anie.201001753; Sato Y, 2005, APPL ENVIRON MICROB, V71, P4372, DOI 10.1128/AEM.71.8.4372-4379.2005; Silberstein M, 2007, BIOCHEMISTRY-US, V46, P9239, DOI 10.1021/bi700336y; STUCKI G, 1995, ENVIRON SCI TECHNOL, V29, P2339, DOI 10.1021/es00009a028; Swanson PE, 1999, CURR OPIN BIOTECH, V10, P365, DOI 10.1016/S0958-1669(99)80066-4; Wang J, 2012, ACTA MICROBIOLOGICA, V8, P012; Wang LP, 2010, ENVIRON MICROBIOL, V12, P1230, DOI 10.1111/j.1462-2920.2010.02165.x	48	27	31	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89144	10.1371/journal.pone.0089144	http://dx.doi.org/10.1371/journal.pone.0089144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586552	gold, Green Published, Green Submitted			2022-12-27	WOS:000332396200037
J	Ezcurra, MD; Scheyer, TM; Butler, RJ				Ezcurra, Martin D.; Scheyer, Torsten M.; Butler, Richard J.			The Origin and Early Evolution of Sauria: Reassessing the Permian Saurian Fossil Record and the Timing of the Crocodile-Lizard Divergence	PLOS ONE			English	Article							TRIASSIC MANDA BEDS; POSTCRANIAL SKELETON; ARCHOSAUROMORPH REPTILE; EARLY HISTORY; FUNCTIONAL-MORPHOLOGY; THERAPSIDA CYNODONTIA; EOSUCHIAN REPTILE; TAXONOMIC STATUS; USILI FORMATION; AXIAL SKELETON	Sauria is the crown-group of Diapsida and is subdivided into Lepidosauromorpha and Archosauromorpha, comprising a high percentage of the diversity of living and fossil tetrapods. The split between lepidosauromorphs and archosauromorphs (the crocodile-lizard, or bird-lizard, divergence) is considered one of the key calibration points for molecular analyses of tetrapod phylogeny. Saurians have a very rich Mesozoic and Cenozoic fossil record, but their late Paleozoic (Permian) record is problematic. Several Permian specimens have been referred to Sauria, but the phylogenetic affinity of some of these records remains questionable. We reexamine and review all of these specimens here, providing new data on early saurian evolution including osteohistology, and present a new morphological phylogenetic dataset. We support previous studies that find that no valid Permian record for Lepidosauromorpha, and we also reject some of the previous referrals of Permian specimens to Archosauromorpha. The most informative Permian archosauromorph is Protorosaurus speneri from the middle Late Permian of Western Europe. A historically problematic specimen from the Late Permian of Tanzania is redescribed and reidentified as a new genus and species of basal archosauromorph: Aenigmastropheus parringtoni. The supposed protorosaur Eorasaurus olsoni from the Late Permian of Russia is recovered among Archosauriformes and may be the oldest known member of the group but the phylogenetic support for this position is low. The assignment of Archosaurus rossicus from the latest Permian of Russia to the archosauromorph clade Proterosuchidae is supported. Our revision suggests a minimum fossil calibration date for the crocodile-lizard split of 254.7 Ma. The occurrences of basal archosauromorphs in the northern (30 degrees N) and southern (55 degrees S) parts of Pangea imply a wider paleobiogeographic distribution for the group during the Late Permian than previously appreciated. Early archosauromorph growth strategies appear to be more diverse than previously suggested based on new data on the osteohistology of Aenigmastropheus.	[Ezcurra, Martin D.; Butler, Richard J.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Ezcurra, Martin D.; Butler, Richard J.] Univ Munich, GeoBioctr, Munich, Germany; [Scheyer, Torsten M.] Univ Zurich, Palaontol Inst & Museum, Zurich, Switzerland	University of Birmingham; University of Munich; University of Zurich	Ezcurra, MD (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	martindezcurra@yahoo.com.ar	Butler, Richard J./A-5239-2011	Butler, Richard J./0000-0003-2136-7541; Scheyer, Torsten M./0000-0002-6301-8983	Synthesys Programm; DFG Emmy Noether Programme [BU 2587/3-1]; Swiss National Science Foundation [31003A_146440/1]	Synthesys Programm; DFG Emmy Noether Programme(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding was provided by the Synthesys Programm (to MDE), DFG Emmy Noether Programme (BU 2587/3-1 to RJB), and Swiss National Science Foundation (31003A_146440/1 to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala Fernando, 2005, Palaeontologia Africana, V41, P45; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Alroy J., 2013, ONLINE PALEOGEOGRAPH; Angielczyk K. D., EARLY EVOLUTIONARY H; Angielczyk KD, 2007, J VERTEBR PALEONTOL, V27, P116, DOI 10.1671/0272-4634(2007)27[116:NSOTTD]2.0.CO;2; Angielczyk KD, 2009, J VERTEBR PALEONTOL, V29, P1174, DOI 10.1671/039.029.0427; [Anonymous], 2006, SPECIAL PUBLICATION; [Anonymous], 2003, MEMORIE SOCIET ITALI; Arcucci A, 1998, J VERTEBR PALEONTOL, V18, P228, DOI 10.1080/02724634.1998.10011046; Avanzini M, 2011, EARTH AND ENVIRONMENTAL SCIENCES, P591; Bassani F., 1886, ATTI SOCIETA ITALIAN, V29, P15; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BENTON MJ, 1983, PHILOS T ROY SOC B, V302, P605, DOI 10.1098/rstb.1983.0079; BENTON MJ, 1985, ZOOL J LINN SOC-LOND, V84, P97, DOI 10.1111/j.1096-3642.1985.tb01796.x; Benton MJ, 1997, PALAEONTOLOGY, V40, P931; Benton MJ, 2004, NATURE, V432, P97, DOI 10.1038/nature02950; BERMAN D S, 1982, Annals of Carnegie Museum, V51, P423; Bhullar Bhart-Anjan S., 2009, Breviora, V518, P1, DOI 10.3099/0006-9698-518.1.1; Bickelmann C, 2009, CAN J EARTH SCI, V46, P651, DOI 10.1139/E09-038; Borsuk-Bialynicka Magdalena, 2009, Palaeontologia Polonica, P203; Bossi J, 2003, REV SOC URUGUAYA GEO, P1; Botha-Brink J, 2011, J VERTEBR PALEONTOL, V31, P1238, DOI 10.1080/02724634.2011.621797; Brauns C.M., 2003, INT C CARBONIFEROUS, P66; Broom R., 1914, Proceedings of the Zoological Society of London, V1914; Broom R, 1925, P ZOOL SOC LOND, V1925, P1; Broom R, 1926, P ZOOL SOC LOND, V1926, P487; Broom R., 1903, ANN S AFR MUS, V4, P159; Bulanov VV, 2010, PALEONTOL J+, V44, P682, DOI 10.1134/S0031030110060109; Butler RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034094; Butler RJ, 2009, J VERTEBR PALEONTOL, V29, P1022, DOI 10.1671/039.029.0404; Campione NE, 2010, J VERTEBR PALEONTOL, V30, P724, DOI 10.1080/02724631003762914; CARROLL R L, 1975, Palaeontologia Africana, V18, P71; CARROLL R L, 1976, Annals of the South African Museum, V72, P37; Carroll R.L., 1976, ATHLON ESSAYS PALAEO, P58; CARROLL RL, 1982, J PALEONTOL, V56, P1; CARROLL RL, 1981, PHILOS T ROY SOC B, V293, P315, DOI 10.1098/rstb.1981.0079; Charig AJ, 1976, HDB PALAOHERPETOLOGI, V13, P11; Chatterjee S., 1986, Journal of Vertebrate Paleontology, V6, P297; Cisneros JC, 2008, J SYST PALAEONTOL, V6, P345, DOI 10.1017/S1477201907002350; Clements JF, 2007, CLEMENTS CHECKLIST B; CODDINGTON J, 1994, CLADISTICS, V10, P415; Colbert E.H., 1973, P395; Colbert Edwin H., 2001, American Museum Novitates, V3334, P1, DOI 10.1206/0003-0082(2001)334<0001:ANAUAR>2.0.CO;2; CONTI MA, 2000, DINOSAURI ITALIA ORM, P297; COX C. BARRY, 1964, AMER MUS NOVITATES, V2171, P1; COX CB, 1965, PHILOS T ROY SOC B, V248, P457, DOI 10.1098/rstb.1965.0005; Cruickshank A.R.I., 1972, P89; CURREY JD, 1985, J ZOOL, V206, P453; CURRIE P J, 1981, Palaeontologia Africana, V24, P99; CURRIE P J, 1982, Annals of the South African Museum, V86, P247; CURRIE PJ, 1980, CAN J EARTH SCI, V17, P500, DOI 10.1139/e80-046; Dalla Vecchia FM, 2006, RIV ITAL PALEONTOL S, V112, P207, DOI 10.13130/2039-4942/6337; Damiani R, 2000, GEOL MAG, V137, P659, DOI 10.1017/S0016756800004660; De Buffrenil V, 2000, J HERPETOL, V34, P414, DOI 10.2307/1565365; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; deBraga M, 1997, ZOOL J LINN SOC-LOND, V120, P281, DOI 10.1111/j.1096-3642.1997.tb01280.x; deBraga M, 2003, CAN J EARTH SCI, V40, P527, DOI 10.1139/E02-082; Desojo JB, 2011, J VERTEBR PALEONTOL, V31, P596, DOI 10.1080/02724634.2011.572936; Dias-Da-Silva S, 2006, CAN J EARTH SCI, V43, P1685, DOI 10.1139/e06-043; DILKES DW, 1995, PALAEONTOLOGY, V38, P665; Dilkes DW, 1998, PHILOS T ROY SOC B, V353, P501, DOI 10.1098/rstb.1998.0225; Efremov J. A., 1938, ACAD SCI URSS CR, V19, P121; Estes R., 1983, HDB PALAOHERPETOLO A; Evans S.E., 1993, Proceedings of the Yorkshire Geological Society, V49, P229; Evans S.E., 1988, Systematics Association Special Volume Series, P221; EVANS SE, 1987, S AFR J SCI, V83, P724; Evans SE, 2003, BIOL REV, V78, P513, DOI 10.1017/S1464793103006134; EVANS SE, 1981, ZOOL J LINN SOC-LOND, V73, P81, DOI 10.1111/j.1096-3642.1981.tb01580.x; EVANS SE, 1980, ZOOL J LINN SOC-LOND, V70, P203, DOI 10.1111/j.1096-3642.1980.tb00852.x; EVANS SE, 1987, ZOOL J LINN SOC-LOND, V90, P275, DOI 10.1111/j.1096-3642.1987.tb01356.x; EVANS SE, 1984, ZOOL J LINN SOC-LOND, V82, P87, DOI 10.1111/j.1096-3642.1984.tb00537.x; Evans Susan E., 2010, P27; Evans Susan E., 2009, Palaeontologia Polonica, P179; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Ezcurra MD, 2013, GEOL SOC SPEC PUBL, V379, P9, DOI 10.1144/SP379.11; Ezcurra MD, 2010, J VERTEBR PALEONTOL, V30, P1433, DOI 10.1080/02724634.2010.501446; Fox R. C., 1966, Paleontological Contributions University of Kansas, V11, P1; FRASER NC, 1984, PALAEONTOLOGY, V27, P575; Frobisch J, 2009, EARTH-SCI REV, V95, P119, DOI 10.1016/j.earscirev.2009.04.001; Gaffney E.S., 1980, Systematics Association Special Volume Series, P593; Gardner JD, 2003, J VERTEBR PALEONTOL, V23, P769, DOI 10.1671/1828-4; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gauthier J, 1984, THESIS U CALIFORNIA; Gay SA, 1999, J AFR EARTH SCI, V29, P195, DOI 10.1016/S0899-5362(99)00089-5; Germain D, 2005, ZOOL SCR, V34, P335, DOI 10.1111/j.1463-6409.2005.00198.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gottmann-Quesada A, 2009, PALAEONTOGR ABT A, V287, P123; GOW C E, 1975, Palaeontologia Africana, V18, P89; Gower David J., 2000, P140; Gower David John, 2003, Annals of the South African Museum, V110, P1; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; GREGORY WK, 1946, B AM MUS NAT HIST, V86, P281; Groenewald G.H., 1995, S AFRICAN COMMITTEE, V1, P35; Haeckel Ernst, 1866, GENERELLE MORPHOLOGI; Hancock A, 1870, Q J GEOL SOC LOND, V26, P565; Haughton S. H., 1924, Annals of the Transvaal Museum, V11, P93; Heckert AB, 2010, J VERTEBR PALEONTOL, V30, P619, DOI 10.1080/02724631003763524; Hill RV, 2005, SYST BIOL, V54, P530, DOI 10.1080/10635150590950326; HOLMES R, 1977, J MORPHOL, V152, P101, DOI 10.1002/jmor.1051520107; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Hughes B., 1963, South African Journal of Science, V59, P221; HUNT AP, 1991, PALAEONTOLOGY, V34, P927; Huxley T. H., 1868, GEOLOGICAL MAGAZINE, V47, DOI 10.1017/S0016756800207784; Huxley TH., 1871, MANUAL ANATOMY VERTE; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Ivachnenko MF, 1978, PERMIAN TRIASSIC PRO, V164, P1; Jalil NE, 1997, J VERTEBR PALEONTOL, V17, P506, DOI 10.1080/02724634.1997.10010998; Trotteyn MJ, 2013, GEOL SOC SPEC PUBL, V379, P59, DOI 10.1144/SP379.23; Jones MEH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-208; KEMP TS, 1969, PHILOS T ROY SOC B, V256, P1, DOI 10.1098/rstb.1969.0036; Kitching JW, 1977, BERNARD PRICE I PALA, V1, P1; Krassilov V, 2009, PALAEOGEOGR PALAEOCL, V284, P326, DOI 10.1016/j.palaeo.2009.10.012; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Laurenti JN, 1768, SPECIMEN MED EXHIBEN; LAURIN M, 1991, ZOOL J LINN SOC-LOND, V101, P59, DOI 10.1111/j.1096-3642.1991.tb00886.x; Lee MSY, 2011, CURRENTLY BIOL, V23, P513; Legler B, 2005, INT J EARTH SCI, V94, P851, DOI 10.1007/s00531-005-0002-5; Legler B, 2008, PALAEOGEOGR PALAEOCL, V267, P102, DOI 10.1016/j.palaeo.2008.06.009; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Lucas SG, 2010, GEOL SOC SPEC PUBL, V334, P447, DOI 10.1144/SP334.15; Lydekker R., 1888, CATALOGUE FOSSIL R 1; Lyson TR, 2013, CURR BIOL, V23, P1113, DOI 10.1016/j.cub.2013.05.003; Lyson TR, 2010, BIOL LETTERS, V6, P830, DOI 10.1098/rsbl.2010.0371; M?ller J., 2004, RECENT ADV ORIGIN EA, P379; Maisch MW, 2002, NEUES JAHRB GEOL P-M, P237; Marsicano CA, 2000, ALCHERINGA, V24, P119, DOI 10.1080/03115510008619528; Meyer H.von., 1830, ISIS OKEN, V1830, P517; Modesto SP, 2002, J VERTEBR PALEONTOL, V22, P851, DOI 10.1671/0272-4634(2002)022[0851:AENDRF]2.0.CO;2; Modesto SR, 2004, ZOOL J LINN SOC-LOND, V140, P335, DOI 10.1111/j.1096-3642.2003.00102.x; Montefeltro FC, 2013, J VERTEBR PALEONTOL, V33, P67, DOI 10.1080/02724634.2012.710285; Moss J.L., 1972, University of California Publications in Geological Sciences, V98, P1; Muller J, 2006, J PALEONTOL, V80, P726, DOI 10.1666/0022-3360(2006)80[726:TBRTMA]2.0.CO;2; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Munk Wolfgang, 1993, Palaeontologische Zeitschrift, V67, P169; Neenan JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2633; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072753; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nosotti Stefania, 2007, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V35, P1; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; Osborn HF, 1903, MEM AM MUS NAT HIST, V1, P449; Ouwens P. A., 1912, Buitenzorg Bull Jard Bot, V6; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Parrington F. R., 1935, Annals & Magazine of Natural History, V16, P197; PARRINGTON F. R., 1956, ANN AND MAG NAT HIST, V9, P333; Peyer B., 1937, Abhandlungen der Schweizerischen Palaeontologischen Gesellschaft, V59, P1; Peyer B., 1955, ABHANDLUNGEN SCHWEIZ, V72, P3; Piechowski R, 2010, J VERTEBR PALEONTOL, V30, P1127, DOI 10.1080/02724634.2010.483547; Pineiro G, 2004, J VERTEBR PALEONTOL, V24, P814, DOI 10.1671/0272-4634(2004)024[0814:ANPRPF]2.0.CO;2; Pineiro G, 2003, J PALEONTOL, V77, P389, DOI 10.1666/0022-3360(2003)077<0389:FBSPFT>2.0.CO;2; Pinna G., 1980, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V121, P181; Piveteau J., 1926, ANN PALEONTOL, V15, P55; Platz JE, 1997, NATURE, V389, P246, DOI 10.1038/38425; Ponton F, 2004, ACTA ORNITHOL, V39, P137, DOI 10.3161/068.039.0210; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; REIG O, 1970, Bulletin of the Museum of Comparative Zoology, V139, P229; Reisz R.R., 1981, University of Kansas Publications of the Museum of Natural History, P1; Reisz RR, 2007, J VERTEBR PALEONTOL, V27, P734, DOI 10.1671/0272-4634(2007)27[734:HSFTPO]2.0.CO;2; Reisz RR, 2011, P ROY SOC B-BIOL SCI, V278, P3731, DOI 10.1098/rspb.2011.0439; Reisz RR, 2010, J VERTEBR PALEONTOL, V30, P1628, DOI 10.1080/02724634.2010.501441; Reisz RR, 2000, S AFR J SCI, V96, P443; Reisz RR, 2003, CAN J EARTH SCI, V40, P667, DOI 10.1139/E02-063; Reisz RR, 2001, ANN CARNEGIE MUS, V70, P113; Reisz RR, 2004, TRENDS GENET, V20, P237, DOI 10.1016/j.tig.2004.03.007; RENESTO S, 1992, RIV ITAL PALEONTOL S, V97, P409; REWCASTLE SC, 1980, J ZOOL, V191, P147; Rieppel O, 1999, ANNU REV ECOL SYST, V30, P1, DOI 10.1146/annurev.ecolsys.30.1.1; RIEPPEL O, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V208, P123; Rieppel O, 1996, NATURE, V384, P453, DOI 10.1038/384453a0; Rieppel O., 1989, Journal of Vertebrate Paleontology, V9, P373; Rieppel Olivier, 2003, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V144, P359; Romer A, 1956, OSTEOLOGY REPTILES; Romer A. S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI DOI 10.1130/SPE28-P1; Romer AS, 1944, AM J SCI, V242, P139, DOI 10.2475/ajs.242.3.139; Roscher M, 2006, GEOL SOC LOND SPEC P, V265, P95, DOI DOI 10.1144/GSL.SP.2006.265.01.05; Rubidge B.S., 1995, S AFRICAN COMMITTEE, V1; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Sanders KL, 2007, BIOLOGY LETT, V3, P275, DOI 10.1098/rsbl.2007.0063; Schluter Thomas, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V204, P1; Sen K, 2003, J ASIAN EARTH SCI, V21, P663, DOI 10.1016/S1367-9120(02)00110-4; Sennikov AG, 2006, PALEONTOL J+, V40, pS475, DOI 10.1134/S0031030106100078; Sennikov AG, 2012, PALEONTOL J+, V46, P313, DOI 10.1134/S003103011203015X; Sennikov AG, 2011, PALEONTOL J+, V45, P90, DOI 10.1134/S0031030111010151; Sennikov A.G., 1997, PALEONTOL J, V31, P94; Sennikov AG, 2005, PALEONTOL J+, V39, P199; SENNIKOV AG, 1988, PALEONTOL ZH, P78; Sennikov AG., 2008, FOSSIL VERTEBRATES 1, P266; Senter Phil, 2004, Journal of Systematic Palaeontology, V2, P257, DOI 10.1017/S1477201904001427; SHAROV A G, 1971, Trudy Paleontologicheskogo Instituta Akademiya Nauk SSSR, V130, P104; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; Sidor CA, 2010, J VERTEBR PALEONTOL, V30, P696, DOI 10.1080/02724631003758086; Sood M. S., 1948, Proceedings of the Indian Academy of Sciences, V28B, P1; Sookias RB, 2013, GEOL SOC SPEC PUBL, V379, P35, DOI 10.1144/SP379.6; Spener CM, 1710, DISQUISTIO CROCODILE, VI, P92; Spielmann J.A., 2008, NEW MEXICO MUSEUM NA, V43, P1; Spielmann Justin A., 2009, Palaeodiversity, P283; STEIN BR, 1989, J MAMMAL, V70, P467, DOI 10.2307/1381418; Stockley G.M., 1932, Q J GEOL SOC LOND, V88, P610, DOI DOI 10.1016/S0031-0182(03)00230-X; STORRS GW, 1993, J GEOL SOC LONDON, V150, P1103, DOI 10.1144/gsjgs.150.6.1103; Strohmenger C, 1996, SEDIMENT GEOL, V102, P33, DOI 10.1016/0037-0738(95)00058-5; Sues HD, 2013, GEOL SOC SPEC PUBL, V379, P49, DOI 10.1144/SP379.13; Sues Hans-Dieter, 1996, Palaeontologische Zeitschrift, V70, P213; Sues HD, 2003, CAN J EARTH SCI, V40, P635, DOI 10.1139/E02-048; Sumida SS, 1991, U CALIF PUBL ZOOL, V122, P1; Tatarinov LP., 1960, PALEONTOL J, V1960, P74; Taylor GK, 2009, EARTH PLANET SC LETT, V281, P36, DOI 10.1016/j.epsl.2009.02.002; Vaughn P. P., 1955, Bulletin of the Museum of Comparative Zoology, V113, P305; von Huene FRF, 1946, BIOL ZBL, V65, P268; von Meyer H, 1856, FAUNA VORWELT SAURIE, P1; von Meyer H., 1832, PALAEOLOGICA GESCH E; WALL WP, 1983, J PALEONTOL, V57, P197; WATSON DMS, 1957, PHILOS T ROY SOC B, V240, P325, DOI 10.1098/rstb.1957.0003; Watson DMS, 1912, RECORDS ALBANY MUSEU, V2, P298; Wedel M, 2007, SPEC PAP PALAEONTOL, P207; Weide D. Marie, 2009, Palaeontologia Africana, V44, P21; Weigelt Johannes, 1989, RECENT VERTEBRATE CA, DOI DOI 10.7208/CHICAGO/9780226881683.001.0001; Welman J, 1998, J VERTEBR PALEONTOL, V18, P340, DOI 10.1080/02724634.1998.10011062; Werning S., 2010, J VERTEBR PALEONTOL, V30, p185A; Wild R., 1973, ABHANDLUNGEN SCHWEIZ, V95, P1; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6; WOPFNER H, 1991, J SEDIMENT PETROL, V61, P65; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Young C. C., 1964, Palaeontologia Sinica No 151 NS G, VNo. 19, P1; Zardoya R, 1998, P NATL ACAD SCI USA, V95, P14226, DOI 10.1073/pnas.95.24.14226	228	90	90	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89165	10.1371/journal.pone.0089165	http://dx.doi.org/10.1371/journal.pone.0089165			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586565	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000332390800009
J	Ihara, M; Nishino, M; Taguchi, A; Yamamoto, Y; Hattori, Y; Saito, S; Takahashi, Y; Tsuji, M; Kasahara, Y; Takata, Y; Okada, M				Ihara, Masafumi; Nishino, Madoka; Taguchi, Akihiko; Yamamoto, Yumi; Hattori, Yorito; Saito, Satoshi; Takahashi, Yukako; Tsuji, Masahiro; Kasahara, Yukiko; Takata, Yu; Okada, Masahiro			Cilostazol Add-On Therapy in Patients with Mild Dementia Receiving Donepezil: A Retrospective Study	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; CEREBROVASCULAR-DISEASE; ALZHEIMERS-DISEASE; PHOSPHODIESTERASE; INHIBITOR; IMPAIRMENT; PATHOLOGY; PATHWAYS	Goal: Combinatorial therapy directed at both vascular and neurodegenerative aspects of dementia may offer a promising strategy for treatment of dementia, which often has a multifactorial basis in the elderly. We investigated whether the phosphodiesterase III inhibitor cilostazol, which is often used in the prevention of stroke and peripheral artery disease, may delay cognitive decline in the elderly receiving donepezil. Methods: Medical records were retrospectively surveyed to identify patients who had received donepezil for more than one year and had undergone Mini-Mental State Examination (MMSE) at least at two time points. Those with an initial MMSE score of less than 27 points were subjected to analysis (n = 156), with a cut-point of 21/22 applied to assign them to mild (n = 70) and moderate/severe (n = 86) dementia. The change of total MMSE score per year was compared between patients who had received donepezil and those given both donepezil and cilostazol. Findings: In patients with mild dementia who had received donepezil and cilostazol (n = 34; 77.2 +/- 6.8 years old), the annual change in MMSE score was -0.5 +/- 1.6 during an observational period of 28.6 +/- 11.7 months, with those receiving donepezil only (n = 36; 78.4 +/- 6.5 years old) scoring less (-2.2 +/- 4.1) during 30.4 +/- 12.8 months with a statistical intergroup difference (p = 0.022). Multivariate analysis showed that absence of cilostazol treatment was the only significant predictor of MMSE decline. A positive effect of cilostazol was found in three subscale scores of MMSE, orientation for time or place and delayed recall. By clear contrast, in patients with moderate/severe dementia, there were no intergroup differences in decrease of total or subscale MMSE scores between the two groups. Conclusions: These results suggest potential for cilostazol treatment in the suppression of cognitive decline in patients receiving donepezil with mild dementia but not in those with moderate/severe dementia.	[Ihara, Masafumi; Takahashi, Yukako] Natl Cerebral & Cardiovasc Ctr Hosp, Dept Stroke & Cerebrovasc Dis, Osaka, Japan; [Ihara, Masafumi; Yamamoto, Yumi; Hattori, Yorito; Saito, Satoshi; Tsuji, Masahiro] Natl Cerebral & Cardiovasc Ctr, Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Regenerat Med & Tissue Engn, Osaka, Japan; [Nishino, Madoka; Takata, Yu; Okada, Masahiro] Sumoto Itsuki Hosp, Dept Neurosurg, Sumoto, Hyogo, Japan; [Taguchi, Akihiko; Kasahara, Yukiko] Inst Biomed Res & Innovat, Dept Regenerat Med & Res, Kobe, Hyogo, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Institute for Biomedical Research & Innovation (IBRI)	Ihara, M (corresponding author), Natl Cerebral & Cardiovasc Ctr Hosp, Dept Stroke & Cerebrovasc Dis, Osaka, Japan.	ihara@ncvc.go.jp; kmokada@sumoto.gr.jp	Tsuji, Masahiro/J-1201-2019; Ihara, Masafumi/O-5020-2019	Ihara, Masafumi/0000-0002-7102-4048; Yamamoto, Yumi/0000-0001-7188-9618; Tsuji, Masahiro/0000-0002-1540-3641	Takeda Science Foundation; JSPS KAKENHI [23390233]; Grants-in-Aid for Scientific Research [23390233] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Takeda Visionary Research Grant from the Takeda Science Foundation (MI) and JSPS KAKENHI Grant Number 23390233 (MI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2009, AM J GERIAT PSYCHIAT, V17, P353, DOI 10.1097/JGP.0b013e31819431ea; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Fujita Y, 2008, BRAIN RES, V1203, P170, DOI 10.1016/j.brainres.2008.01.103; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hiramatsu M, 2010, BRIT J PHARMACOL, V161, P1899, DOI 10.1111/j.1476-5381.2010.01014.x; Kalaria RN, 2013, NAT REV NEUROL, V9, P487, DOI 10.1038/nrneurol.2013.164; Kalaria RN, 2012, J NEUROL SCI, V322, P141, DOI 10.1016/j.jns.2012.07.032; Kamiyama K, 2010, JPN J RADIOL, V28, P266, DOI 10.1007/s11604-009-0416-2; Kim KY, 2002, J PHARMACOL EXP THER, V300, P709, DOI 10.1124/jpet.300.2.709; Liu YG, 2001, CARDIOVASC DRUG REV, V19, P369, DOI 10.1111/j.1527-3466.2001.tb00076.x; Park SH, 2011, BIOCHEM BIOPH RES CO, V408, P602, DOI 10.1016/j.bbrc.2011.04.068; Sakurai H, 2013, GERIATR GERONTOL INT, V13, P90, DOI 10.1111/j.1447-0594.2012.00866.x; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Taguchi A, 2013, PSYCHOGERIATRICS, V13, P164, DOI 10.1111/psyg.12021; TANAKA K, 1989, STROKE, V20, P668, DOI 10.1161/01.STR.20.5.668; Toledo JB, 2013, BRAIN, V136, P2697, DOI 10.1093/brain/awt188; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	18	57	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89516	10.1371/journal.pone.0089516	http://dx.doi.org/10.1371/journal.pone.0089516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586841	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000051
J	Hampton, SE; Gray, DK; Izmest'eva, LR; Moore, MV; Ozersky, T				Hampton, Stephanie E.; Gray, Derek K.; Izmest'eva, Lyubov R.; Moore, Marianne V.; Ozersky, Tedy			The Rise and Fall of Plankton: Long-Term Changes in the Vertical Distribution of Algae and Grazers in Lake Baikal, Siberia	PLOS ONE			English	Article							CLIMATE-CHANGE; ZOOPLANKTON COMMUNITY; TRADE-OFFS; FOOD-WEB; PHYTOPLANKTON; BAICALENSIS; TEMPERATURE; SUCCESSION; TANGANYIKA; MIGRATION	Both surface water temperatures and the intensity of thermal stratification have increased recently in large lakes throughout the world. Such physical changes can be accompanied by shifts in plankton community structure, including changes in relative abundances and depth distributions. Here we analyzed 45 years of data from Lake Baikal, the world's oldest, deepest, and most voluminous lake, to assess long-term trends in the depth distribution of pelagic phytoplankton and zooplankton. Surface water temperatures in Lake Baikal increased steadily between 1955 and 2000, resulting in a stronger thermal gradient within the top 50 m of the water column. In conjunction with these physical changes our analyses reveal significant shifts in the daytime depth distribution of important phytoplankton and zooplankton groups. The relatively heavy diatoms, which often rely on mixing to remain suspended in the photic zone, shifted downward in the water column by 1.90 m y(-1), while the depths of other phytoplankton groups did not change significantly. Over the same time span the density-weighted average depth of most major zooplankton groups, including cladocerans, rotifers, and immature copepods, exhibited rapid shifts toward shallower positions (0.57-0.75 m y(-1)). As a result of these depth changes the vertical overlap between herbivorous copepods (Epischura baikalensis) and their algal food appears to have increased through time while that for cladocerans decreased. We hypothesize that warming surface waters and reduced mixing caused these ecological changes. Future studies should examine how changes in the vertical distribution of plankton might impact energy flow in this lake and others.	[Hampton, Stephanie E.; Gray, Derek K.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Izmest'eva, Lyubov R.] Irkutsk State Univ, Sci Res Inst Biol, Irkutsk 664003, Russia; [Moore, Marianne V.; Ozersky, Tedy] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Irkutsk State University; Wellesley College	Hampton, SE (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.	s.hampton@wsu.edu		Hampton, Stephanie/0000-0003-2389-4249	National Science Foundation Dimensions of Biodiversity program [DEB-1136637]; Brachman Hoffman Fund at Wellesley College; Direct For Biological Sciences [1136657] Funding Source: National Science Foundation; Division Of Environmental Biology [1136706, 1136637] Funding Source: National Science Foundation	National Science Foundation Dimensions of Biodiversity program(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Brachman Hoffman Fund at Wellesley College; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by the National Science Foundation Dimensions of Biodiversity program (DEB-1136637; http://www.nsf.gov/) and the Brachman Hoffman Fund at Wellesley College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Afanasyeva EL, 2006, LONG TERM ZOOPLANKTO, P253; Alekseeva SA, 2005, APPL BIOCHEM MICRO+, V41, P185, DOI 10.1007/s10438-005-0033-5; Babanazarova OV, 1996, PHYCOLOGIA, V35, P113, DOI 10.2216/i0031-8884-35-2-113.1; Belykh O. I., 2003, Aquatic Ecosystem Health & Management, V6, P251, DOI 10.1080/14634980301489; Birge E, 1916, T WIS ACAD SCI, V18, P341; BURNS CW, 1980, NEW ZEAL J MAR FRESH, V14, P189, DOI 10.1080/00288330.1980.9515860; Callieri Cristiana, 2002, Journal of Limnology, V61, P1; Coats R., 2012, CLIMATIC CHANGE GLOB, P231, DOI [10.1002/9781118470596.ch14, DOI 10.1002/9781118470596.CH14/SUMMARY.ACCESSED]; Coats R, 2006, CLIMATIC CHANGE, V76, P121, DOI 10.1007/s10584-005-9006-1; COLE GA, 1975, TXB LIMNOLOGY; DeStasio BT, 1996, LIMNOL OCEANOGR, V41, P1136, DOI 10.4319/lo.1996.41.5.1136; Diehl S, 2002, ECOLOGY, V83, P386, DOI 10.1890/0012-9658(2002)083[0386:PLANIA]2.0.CO;2; EPP RW, 1980, ECOLOGY, V61, P259, DOI 10.2307/1935183; Hampton SE, 2008, GLOBAL CHANGE BIOL, V14, P1947, DOI 10.1111/j.1365-2486.2008.01616.x; Hampton SE, 2006, LIMNOL OCEANOGR, V51, P2042, DOI 10.4319/lo.2006.51.5.2042; Helland IP, 2007, OECOLOGIA, V151, P322, DOI 10.1007/s00442-006-0541-x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huisman J, 2004, ECOLOGY, V85, P2960, DOI 10.1890/03-0763; Jewson DH, 2008, LIMNOL OCEANOGR, V53, P1125, DOI 10.4319/lo.2008.53.3.1125; Johnson CR, 2007, J PLANKTON RES, V29, P275, DOI 10.1093/plankt/fbm014; Jung J., 2004, ECOSYSTEMS NATURAL R, P131; Klausmeier CA, 2001, LIMNOL OCEANOGR, V46, P1998, DOI 10.4319/lo.2001.46.8.1998; Kozhov M., 1963, LAKE BAIKAL ITS LIFE, DOI 10.1007/978-94-015-7388-7; Kozhova O. M., 1998, LAKE BAIKAL EVOLUTIO; Lampert W, 2003, P ROY SOC B-BIOL SCI, V270, P765, DOI 10.1098/rspb.2002.2291; Leibold MA, 1997, EVOLUTIONARY ECOLOGY; Livingstone DM, 2003, CLIMATIC CHANGE, V57, P205, DOI 10.1023/A:1022119503144; LOOSE CJ, 1994, ECOLOGY, V75, P2255, DOI 10.2307/1940881; Mackay AW, 2006, GLOBAL CHANGE BIOL, V12, P2297, DOI 10.1111/j.1365-2486.2006.01270.x; Mackay AW, 1998, PHILOS T R SOC B, V353, P1011, DOI 10.1098/rstb.1998.0264; MARCOGLIESE DJ, 1992, AM MIDL NAT, V128, P139, DOI 10.2307/2426420; MELNIK NG, 1993, LIMNOL OCEANOGR, V38, P425, DOI 10.4319/lo.1993.38.2.0425; Moore MV, 2009, BIOSCIENCE, V59, P405, DOI 10.1525/bio.2009.59.5.8; NAGATA T, 1994, J PLANKTON RES, V16, P945, DOI 10.1093/plankt/16.8.945; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; Olenina I., 2006, HELCON BALTIC SEA EN, P144; Popovskaya G.I., 2000, Aquatic Ecosystem Health & Management, V3, P215, DOI 10.1016/S1463-4988(00)00021-X; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; Sheveleva NG, 1992, HYDROBIOLOGIA, V28, P19; Shimaraev MN, 2012, DOKL EARTH SCI, V442, P272, DOI 10.1134/S1028334X12020183; Shimaraev M. N., 2012, CLIMATIC CHANGE GLOB, P43, DOI [DOI 10.1002/9781118470596.CH3/SUMMARY.ACCESSED, 10.1002/9781118470596.ch3.]; SHIMARAEV MN, 1993, LIMNOL OCEANOGR, V38, P1068, DOI 10.4319/lo.1993.38.5.1068; Shimoda Y, 2011, J GREAT LAKES RES, V37, P173, DOI 10.1016/j.jglr.2010.10.004; SMOL JP, 1984, VERH INT VEREIN LIMN, V22, P1361, DOI DOI 10.1080/03680770.1983.11897500; Straskrabova V, 2005, GLOBAL PLANET CHANGE, V46, P57, DOI 10.1016/j.gloplacha.2004.11.006; Tereza ER, 2007, FUND APPL LIMNOL, V169, P211, DOI 10.1127/1863-9135/2007/0169-0211; Thackeray SJ, 2006, AQUAT ECOL, V40, P23, DOI 10.1007/s10452-005-9021-3; Thackeray SJ, 2005, ARCH HYDROBIOL, V164, P257, DOI 10.1127/0003-9136/2005/0164-0257; Titelman J, 2004, MAR ECOL PROG SER, V284, P49, DOI 10.3354/meps284049; Todd MC, 2003, J CLIMATE, V16, P3186, DOI 10.1175/1520-0442(2003)016<3186:LCCOLB>2.0.CO;2; Vadadi-Fulop C, 2012, AQUAT ECOL, V46, P501, DOI 10.1007/s10452-012-9418-8; Verburg P, 2003, SCIENCE, V301, P505, DOI 10.1126/science.1084846; Vincent W.F., 2012, CLIMATIC CHANGE GLOB, P27, DOI DOI 10.1002/9781118470596.CH2; WILLIAMSON CE, 1990, HYDROBIOLOGIA, V198, P125, DOI 10.1007/BF00048629; Winder M, 2009, P ROY SOC B-BIOL SCI, V276, P427, DOI 10.1098/rspb.2008.1200; WORTHINGTON E. B., 1931, INTERNAT REV GES HYDROBIOL U HYDROGRAPH, V25, P394, DOI 10.1002/iroh.19310250510; Yoshii K, 1999, LIMNOL OCEANOGR, V44, P502, DOI 10.4319/lo.1999.44.3.0502; Yoshioka Takahito, 2002, Limnology, V3, P159, DOI 10.1007/s102010200019	59	40	41	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88920	10.1371/journal.pone.0088920	http://dx.doi.org/10.1371/journal.pone.0088920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586441	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900018
J	Liu, B; Tahk, S; Yee, KM; Yang, R; Yang, YH; Mackie, R; Hsu, C; Chernishof, V; O'Brien, N; Jin, YS; Fan, GP; Lane, TF; Rao, JY; Slamon, D; Shuai, K				Liu, Bin; Tahk, Samuel; Yee, Kathleen M.; Yang, Randy; Yang, Yonghui; Mackie, Ryan; Hsu, Cary; Chernishof, Vasili; O'Brien, Neil; Jin, Yusheng; Fan, Guoping; Lane, Timothy F.; Rao, Jianyu; Slamon, Dennis; Shuai, Ke			PIAS1 Regulates Breast Tumorigenesis through Selective Epigenetic Gene Silencing	PLOS ONE			English	Article							CYCLIN D2 EXPRESSION; CANCER STEM-CELLS; NF-KAPPA-B; PROMOTER HYPERMETHYLATION; TUMOR-SUPPRESSOR; SELF-RENEWAL; WNT5A; METHYLATION; PROTEIN; ACTIVATION	Epigenetic gene silencing by histone modifications and DNA methylation is essential for cancer development. The molecular mechanism that promotes selective epigenetic changes during tumorigenesis is not understood. We report here that the PIAS1 SUMO ligase is involved in the progression of breast tumorigenesis. Elevated PIAS1 expression was observed in breast tumor samples. PIAS1 knockdown in breast cancer cells reduced the subpopulation of tumor-initiating cells, and inhibited breast tumor growth in vivo. PIAS1 acts by delineating histone modifications and DNA methylation to silence the expression of a subset of clinically relevant genes, including breast cancer DNA methylation signature genes such as cyclin D2 and estrogen receptor, and breast tumor suppressor WNT5A. Our studies identify a novel epigenetic mechanism that regulates breast tumorigenesis through selective gene silencing.	[Liu, Bin; Tahk, Samuel; Yang, Yonghui; Mackie, Ryan; Chernishof, Vasili; O'Brien, Neil; Slamon, Dennis; Shuai, Ke] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Yee, Kathleen M.; Yang, Randy; Shuai, Ke] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Hsu, Cary] Univ Calif Los Angeles, Dept Gen Surg, Los Angeles, CA USA; [Jin, Yusheng; Rao, Jianyu] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Fan, Guoping] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Lane, Timothy F.] Univ Calif Los Angeles, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liu, B (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA.	bliu@ucla.edu; kshuai@mednet.ucla.edu		Lane, Timothy F./0000-0002-0210-970X	NIH [R01AI063286, R01GM085797]; Margaret E. Early Medical Research Trust; UCLA Jonsson Comprehensive Cancer Center; Research Scientist Development Award from the NIH [K01 AR52717-01]; UCLA Tumor Immunology Training Fellowship; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR052717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085797] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Margaret E. Early Medical Research Trust; UCLA Jonsson Comprehensive Cancer Center; Research Scientist Development Award from the NIH; UCLA Tumor Immunology Training Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the NIH (R01AI063286 and R01GM085797), Margaret E. Early Medical Research Trust, and the UCLA Jonsson Comprehensive Cancer Center (K.S.). B.L. was supported by a Research Scientist Development Award from the NIH (K01 AR52717-01). S.T. was supported by a UCLA Tumor Immunology Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Bin L, 2008, TRENDS PHARMACOL SCI, V29, P505, DOI 10.1016/j.tips.2008.07.008; Blanc E, 2005, CANCER LETT, V228, P117, DOI 10.1016/j.canlet.2004.11.061; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Connolly R, 2012, J MAMMARY GLAND BIOL; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dedeurwaerder S, 2011, CURR OPIN ONCOL, V23, P559, DOI 10.1097/CCO.0b013e32834bd481; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Evron E, 2001, CANCER RES, V61, P2782; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hautala LC, 2008, INT J CANCER, V123, P2279, DOI 10.1002/ijc.23773; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Huang Y, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2925; Inoue M, 2005, FEBS LETT, V579, P604, DOI 10.1016/j.febslet.2004.12.030; Jansson M, 2001, J CELL SCI, V114, P2043; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jonsson M, 2002, CANCER RES, V62, P409; Jovanovic J, 2010, MOL ONCOL, V4, P242, DOI 10.1016/j.molonc.2010.04.002; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li LC, 2000, CANCER RES, V60, P702; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Liu B, 2008, CURR OPIN CELL BIOL, V20, P288, DOI 10.1016/j.ceb.2008.03.014; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787; LOKE SL, 1988, AM J PATHOL, V131, P29; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mandelin E, 2003, CANCER RES, V63, P6258; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mimeault M, 2007, J CELL MOL MED, V11, P981, DOI 10.1111/j.1582-4934.2007.00088.x; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Olson DJ, 1997, CELL GROWTH DIFFER, V8, P417; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Sakuma M, 2007, CANCER SCI, V98, P380, DOI 10.1111/j.1349-7006.2007.00394.x; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Szyf M, 2012, GENOME MED, V4, DOI 10.1186/gm325; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Wang DL, 2013, P NATL ACAD SCI USA, V110, P5516, DOI 10.1073/pnas.1216596110; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644; Ying J, 2007, BLOOD, V110, P4130, DOI 10.1182/blood-2007-06-094870; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu J, 2003, BRIT J CANCER, V88, P1560, DOI 10.1038/sj.bjc.6600940	52	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89464	10.1371/journal.pone.0089464	http://dx.doi.org/10.1371/journal.pone.0089464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586797	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700049
J	Rattanapak, T; Birchall, JC; Young, K; Kubo, A; Fujimori, S; Ishii, M; Hook, S				Rattanapak, Teerawan; Birchall, James C.; Young, Katherine; Kubo, Atsuko; Fujimori, Sayumi; Ishii, Masaru; Hook, Sarah			Dynamic Visualization of Dendritic Cell-Antigen Interactions in the Skin Following Transcutaneous Immunization	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; EPIDERMAL LANGERHANS CELLS; MONOPHOSPHORYL-LIPID-A; VIRUS-LIKE PARTICLES; IN-VIVO; PERCUTANEOUS-ABSORPTION; TRANSDERMAL DELIVERY; 2-PHOTON MICROSCOPY; MICRONEEDLE ARRAYS; IMMUNE-RESPONSES	Delivery of vaccines into the skin provides many advantages over traditional parenteral vaccination and is a promising approach due to the abundance of antigen presenting cells (APC) residing in the skin including Langerhans cells (LC) and dermal dendritic cells (DDC). However, the main obstacle for transcutaneous immunization (TCI) is the effective delivery of the vaccine through the stratum corneum (SC) barrier to the APC in the deeper skin layers. This study therefore utilized microneedles (MN) and a lipid-based colloidal delivery system (cubosomes) as a synergistic approach for the delivery of vaccines to APC in the skin. The process of vaccine uptake and recruitment by specific types of skin APC was investigated in real-time over 4 hours in B6. Cg-Tg (Itgax-EYFP) 1 Mnz/J mice by two-photon microscopy. Incorporation of the vaccine into a particulate delivery system and the use of MN preferentially increased vaccine antigen uptake by a highly motile subpopulation of skin APC known as CD207(+) DC. No uptake of antigen or any response to immunisation by LC could be detected.	[Rattanapak, Teerawan; Young, Katherine; Hook, Sarah] Univ Otago, Sch Pharm, Dunedin, New Zealand; [Birchall, James C.] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff CF10 3AX, S Glam, Wales; [Kubo, Atsuko; Fujimori, Sayumi; Ishii, Masaru] Osaka Univ, Immunol Frontier Res Ctr, Lab Cellular Dynam, Osaka, Japan; [Ishii, Masaru] Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Immunol & Cell Biol, Osaka, Japan	University of Otago; Cardiff University; Osaka University; Osaka University	Hook, S (corresponding author), Univ Otago, Sch Pharm, Dunedin, New Zealand.	sarah.hook@.otago.ac.nz	Birchall, James/N-1711-2014	Birchall, James/0000-0001-8521-6924; Hook, Sarah/0000-0001-9634-8594	University of Otago Research Grant; Maurice Wilkins Centre for Molecular Biodiscovery; NZ-JSPS Bilateral Partnerships & Scientist Exchange; Scientific Research on Innovative Areas [22113007]; Ministry of Education, Science, Sports and Culture of Japan;  [22689030]	University of Otago Research Grant; Maurice Wilkins Centre for Molecular Biodiscovery; NZ-JSPS Bilateral Partnerships & Scientist Exchange; Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This research was supported by a University of Otago Research Grant, the Maurice Wilkins Centre for Molecular Biodiscovery, a NZ-JSPS Bilateral Partnerships & Scientist Exchange; Grants-in-Aid for Encouragement of Young Scientists (A) (22689030), for Scientific Research on Innovative Areas (22113007), and by the FIRST Program from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks SL, 2010, J PHARM SCI-US, V99, P3072, DOI 10.1002/jps.22083; Birchall JC, 2011, PHARM RES-DORDR, V28, P95, DOI 10.1007/s11095-010-0101-2; Bouwstra JA, 2003, PROG LIPID RES, V42, P1, DOI 10.1016/S0163-7827(02)00028-0; BRONAUGH RL, 1982, TOXICOL APPL PHARM, V62, P481, DOI 10.1016/0041-008X(82)90149-1; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Chen MK, 2011, INT IMMUNOPHARMACOL, V11, P549, DOI 10.1016/j.intimp.2010.11.025; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Coulman Sion A., 2006, Current Drug Delivery, V3, P65, DOI 10.2174/156720106775197510; Coulman SA, 2011, PHARM RES-DORDR, V28, P66, DOI 10.1007/s11095-010-0167-x; Dean CH, 2005, HUM VACCINES, V1, P106, DOI 10.4161/hv.1.3.1797; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Dupasquier M, 2004, J INVEST DERMATOL, V123, P876, DOI 10.1111/j.0022-202X.2004.23427.x; Elnekave M, 2010, J IMMUNOL, V185, P3463, DOI 10.4049/jimmunol.1001825; Esposito E, 2005, PHARM RES-DORDR, V22, P2163, DOI 10.1007/s11095-005-8176-x; Etchart N, 2001, J IMMUNOL, V167, P384, DOI 10.4049/jimmunol.167.1.384; Gauderon R, 2001, MICRON, V32, P691, DOI 10.1016/S0968-4328(00)00066-4; Hadjantonakis AK, 2003, NAT REV GENET, V4, P613, DOI 10.1038/nrg1126; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hirschberg H, 2012, EUR J PHARM SCI, V46, P1, DOI 10.1016/j.ejps.2012.01.013; Igyarto Botond Z, 2011, IMMUNITY, V35, P260; Kaushik S, 2001, ANESTH ANALG, V92, P502, DOI 10.1213/00000539-200102000-00041; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kwon TK, 2010, COLLOID J+, V72, P205, DOI 10.1134/S1061933X10020092; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Masters BR, 2001, OPT EXPRESS, V8, P2, DOI 10.1364/OE.8.000002; Matriano JA, 2002, PHARMACEUT RES, V19, P63, DOI 10.1023/A:1013607400040; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Mikszta JA, 2005, J INFECT DIS, V191, P278, DOI 10.1086/426865; Mikszta JA, 2002, NAT MED, V8, P415, DOI 10.1038/nm0402-415; Mikszta JA, 2006, INFECT IMMUN, V74, P6806, DOI 10.1128/IAI.01210-06; Mohler W, 2003, METHODS, V29, P97, DOI 10.1016/S1046-2023(02)00292-X; Murzina TV, 2008, OPT LETT, V33, P2581, DOI 10.1364/OL.33.002581; Myschik J, 2008, J DRUG TARGET, V16, P224, DOI [10.1080/10611860701848886, 10.1080/10611860701848886 ]; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Norlen L, 2004, J INVEST DERMATOL, V123, P715, DOI 10.1111/j.0022-202X.2004.23213.x; Pearton M, 2010, PLOS ONE, DOI [10.1371/journal.pone.0012410, DOI 10.1371/J0URNAL.P0NE.0012410]; Pearton M, 2010, VACCINE, V28, P6104, DOI 10.1016/j.vaccine.2010.05.055; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Rattanapak T, 2013, J CONTROL RELEASE, V172, P894, DOI 10.1016/j.jconrel.2013.08.018; Rattanapak T, 2012, J PHARM PHARMACOL, V64, P1560, DOI 10.1111/j.2042-7158.2012.01535.x; Ratzinger G, 2002, J IMMUNOL, V168, P4361, DOI 10.4049/jimmunol.168.9.4361; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Rizwan SB, 2011, EUR J PHARM BIOPHARM, V79, P15, DOI 10.1016/j.ejpb.2010.12.034; Rizwan SB, 2009, J PHARM SCI-US, V98, P4191, DOI 10.1002/jps.21724; Romani N, 2010, IMMUNOL REV, V234, P120, DOI 10.1111/j.0105-2896.2009.00886.x; Ryan EJ, 2001, TRENDS BIOTECHNOL, V19, P293, DOI 10.1016/S0167-7799(01)01670-5; Sen D, 2010, P NATL ACAD SCI USA, V107, P8334, DOI 10.1073/pnas.0912817107; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shiozuka M, 2010, J BIOCHEM, V147, P463, DOI 10.1093/jb/mvp185; Shklovskaya E, 2008, J IMMUNOL, V181, P418, DOI 10.4049/jimmunol.181.1.418; Song JM, 2010, CLIN VACCINE IMMUNOL, V17, P1381, DOI 10.1128/CVI.00100-10; Stoecklinger A, 2011, J IMMUNOL, V186, P1377, DOI 10.4049/jimmunol.1002557; Stoitzner P, 2006, P NATL ACAD SCI USA, V103, P7783, DOI 10.1073/pnas.0509307103; Ulrich J T, 1995, Pharm Biotechnol, V6, P495; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Valladeau J, 2005, SEMIN IMMUNOL, V17, P273, DOI 10.1016/j.smim.2005.05.009; Wester RC, 2001, J TOXICOL-CUTAN OCUL, V20, P411, DOI 10.1081/CUS-120001866; Widera G, 2006, VACCINE, V24, P1653, DOI 10.1016/j.vaccine.2005.09.049; Yu Z, 2011, J PHARM PHARMACOL, V63, P199, DOI 10.1111/j.2042-7158.2010.01219.x; Zaric M, 2013, ACS NANO, V7, P2042, DOI 10.1021/nn304235j; Zinchuk V, 2001, CURRENT PROTOCOLS CE	67	22	26	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89503	10.1371/journal.pone.0089503	http://dx.doi.org/10.1371/journal.pone.0089503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586830	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000331880700054
J	Jubeau, M; Rupp, T; Perrey, S; Temesi, J; Wuyam, B; Levy, P; Verges, S; Millet, GY				Jubeau, Marc; Rupp, Thomas; Perrey, Stephane; Temesi, John; Wuyam, Bernard; Levy, Patrick; Verges, Samuel; Millet, Guillaume Y.			Changes in Voluntary Activation Assessed by Transcranial Magnetic Stimulation during Prolonged Cycling Exercise	PLOS ONE			English	Article							HUMAN KNEE EXTENSORS; NEUROMUSCULAR FATIGUE; MOTOR CORTEX; PERIPHERAL CONTRIBUTIONS; RUNNING EXERCISE; HEALTHY HUMANS; MUSCLE FATIGUE; EXCITABILITY; OXYGENATION; INCREASE	Maximal central motor drive is known to decrease during prolonged exercise although it remains to be determined whether a supraspinal deficit exists, and if so, when it appears. The purpose of this study was to evaluate corticospinal excitability and muscle voluntary activation before, during and after a 4-h cycling exercise. Ten healthy subjects performed three 80-min bouts on an ergocycle at 45% of their maximal aerobic power. Before exercise and immediately after each bout, neuromuscular function was evaluated in the quadriceps femoris muscles under isometric conditions. Transcranial magnetic stimulation was used to assess voluntary activation at the cortical level (VA(TMS)), corticospinal excitability via motor-evoked potential (MEP) and intracortical inhibition by cortical silent period (CSP). Electrical stimulation of the femoral nerve was used to measure voluntary activation at the peripheral level (VA(FNES)) and muscle contractile properties. Maximal voluntary force was significantly reduced after the first bout (1369%, P < 0.01) and was further decreased (25611%, P < 0.001) at the end of exercise. CSP remained unchanged throughout the protocol. Rectus femoris and vastus lateralis but not vastus medialis MEP normalized to maximal M-wave amplitude significantly increased during cycling. Finally, significant decreases in both VA(TMS) and VA(FNES) (similar to 8%, P < 0.05 and similar to 14%, P < 0.001 post-exercise, respectively) were observed. In conclusion, reductions in VA(FNES) after a prolonged cycling exercise are partly explained by a deficit at the cortical level accompanied by increased corticospinal excitability and unchanged intracortical inhibition. When comparing the present results with the literature, this study highlights that changes at the cortical and/or motoneuronal levels depend not only on the type of exercise (single-joint vs. whole-body) but also on exercise intensity and/or duration.	[Jubeau, Marc; Rupp, Thomas; Wuyam, Bernard; Levy, Patrick; Verges, Samuel; Millet, Guillaume Y.] INSERM, U1042, Grenoble, France; [Jubeau, Marc; Temesi, John; Millet, Guillaume Y.] Univ Lyon, St Etienne, France; [Jubeau, Marc] MIP, Nantes, France; [Rupp, Thomas; Wuyam, Bernard; Levy, Patrick; Verges, Samuel] Grenoble Alpes Univ, Lab HP2, Grenoble, France; [Perrey, Stephane] Univ Montpellier I, F-34006 Montpellier, France; [Millet, Guillaume Y.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Montpellier; University of Calgary	Millet, GY (corresponding author), INSERM, U1042, Grenoble, France.	gmillet@ucalgary.ca	Millet, Guillaume/AAO-6520-2020; perrey, stephane/B-7483-2008; LEVY, Patrick/AAX-2802-2020; wuyam, bernard MF/M-7438-2014; Verges, Samuel/M-7040-2014	Millet, Guillaume/0000-0002-6395-0762; perrey, stephane/0000-0002-8741-629X; LEVY, Patrick/0000-0003-3174-7935; Verges, Samuel/0000-0002-0831-9222; Temesi, John/0000-0002-5086-6350	French National Research Agency [NT09_653348]; Rhone-Alpes Region	French National Research Agency(French National Research Agency (ANR)); Rhone-Alpes Region(Region Auvergne-Rhone-Alpes)	Financial support was provided by the French National Research Agency (grant number NT09_653348). John Temesi was supported by a doctoral research grant from the Rhone-Alpes Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2011, MED SCI SPORT EXER, V43, P2039, DOI 10.1249/MSS.0b013e31821f59ab; Brainbridge FA, 1931, PHYSL MUSCULAR EXERC; de Morree HM, 2012, PSYCHOPHYSIOLOGY, V49, P1242, DOI 10.1111/j.1469-8986.2012.01399.x; Decorte N, 2012, SCAND J MED SCI SPOR, V22, P381, DOI 10.1111/j.1600-0838.2010.01167.x; Froyd C, 2012, J PHYSL, V591, P1339; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; Goodall S, 2009, EXP PHYSIOL, V94, P995, DOI 10.1113/expphysiol.2009.047902; Goodall S, 2012, J PHYSIOL-LONDON, V590, P2767, DOI 10.1113/jphysiol.2012.228890; Gruet M, 2012, NEUROSCIENCE; Hermens HJ., 1999, ROESSINGH RES DEV, V8, P13; Hilty L, 2011, EXP PHYSIOL, V96, P505, DOI 10.1113/expphysiol.2010.056226; Kent-Braun JA, 1999, EUR J APPL PHYSIOL O, V80, P57, DOI 10.1007/s004210050558; Klass M, 2012, MED SCI SPORT EXER, V44, P2299, DOI 10.1249/MSS.0b013e318265f356; Lepers R, 2000, MED SCI SPORT EXER, V32, P1880, DOI 10.1097/00005768-200011000-00010; Lepers R, 2002, J APPL PHYSIOL, V92, P1487, DOI 10.1152/japplphysiol.00880.2001; Martin V, 2010, J APPL PHYSIOL, V108, P1224, DOI 10.1152/japplphysiol.01202.2009; MERTON PA, 1954, J PHYSIOL-LONDON, V123, P553, DOI 10.1113/jphysiol.1954.sp005070; Millet GY, 2011, EUR J APPL PHYSIOL, V111, P2489, DOI 10.1007/s00421-011-1996-y; Millet GY, 2011, SPORTS MED, V41, P489, DOI 10.2165/11588760-000000000-00000; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Millet GY, 2004, SPORTS MED, V34, P105, DOI 10.2165/00007256-200434020-00004; Millet GY, 2003, INT J SPORTS MED, V24, P190, DOI 10.1055/s-2003-39088; NEELY G, 1992, INT J SPORTS MED, V13, P133, DOI 10.1055/s-2007-1021244; NICOL C, 1991, Scandinavian Journal of Medicine and Science in Sports, V1, P10; Paavolainen L, 1999, INT J SPORTS MED, V20, P516; Place N, 2004, MED SCI SPORT EXER, V36, P1347, DOI 10.1249/01.MSS.0000135786.22996.77; Poulet JFA, 2007, TRENDS NEUROSCI, V30, P14, DOI 10.1016/j.tins.2006.11.005; Racinais S, 2007, J NEUROPHYSIOL, V97, P596, DOI 10.1152/jn.00903.2006; Rasmussen P, 2010, J PHYSIOL-LONDON, V588, P1985, DOI 10.1113/jphysiol.2009.186767; Ross EZ, 2007, EXP PHYSIOL, V92, P417, DOI 10.1113/expphysiol.2006.035972; Ross EZ, 2010, MED SCI SPORT EXER, V42, P1184, DOI 10.1249/MSS.0b013e3181c91f4e; Rupp T, 2012, J NEUROPHYSIOL, V108, P1270, DOI 10.1152/jn.01162.2011; Rupp T, 2013, ADV EXP MED IN PRESS; Rupp T, 2008, EUR J APPL PHYSIOL, V102, P153, DOI 10.1007/s00421-007-0568-7; Rupp T, 2013, ADV EXP MED BIOL, V789, P149, DOI 10.1007/978-1-4614-7411-1_21; Sidhu SK, 2012, J APPL PHYSIOL, V113, P401, DOI 10.1152/japplphysiol.00486.2012; Sidhu SK, 2009, J APPL PHYSIOL, V106, P556, DOI 10.1152/japplphysiol.90911.2008; Sidhu SK, 2009, MUSCLE NERVE, V39, P186, DOI 10.1002/mus.21064; Temesi J, 2013, MED SCI SPORTS EXERC; Temesi J, 2013, MED SCI SPORT EXER, V45, P2243, DOI 10.1249/MSS.0b013e31829ce379; Todd G, 2004, J APPL PHYSIOL, V97, P236, DOI 10.1152/japplphysiol.01336.2003; Todd G, 2003, J PHYSIOL-LONDON, V551, P661, DOI 10.1113/jphysiol.2003.044099; Verges S, 2009, J APPL PHYSIOL, V106, P701, DOI 10.1152/japplphysiol.01051.2007	43	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89157	10.1371/journal.pone.0089157	http://dx.doi.org/10.1371/journal.pone.0089157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586559	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900059
J	Li, XS; Xue, YL; Zhou, LM; Lin, Y; Yu, XL; Wang, XQ; Zhen, XH; Zhang, W; Ning, Z; Yue, Q; Fu, J; Shen, FW; Gai, J; Xu, YQ; Mao, JW; Gao, XM; Shen, XP; Kang, LY; Vanham, G; Cheng, H; Wang, Y; Zhuang, MH; Zhuang, X; Pan, QC; Zhong, P				Li, Xiaoshan; Xue, Yile; Zhou, Leiming; Lin, Yi; Yu, Xiaolei; Wang, Xuqin; Zhen, Xiaohong; Zhang, Wei; Ning, Zhen; Yue, Qing; Fu, Jie; Shen, Fangwei; Gai, Jing; Xu, Yuqing; Mao, Jiawen; Gao, Xianming; Shen, Xiaopei; Kang, Laiyi; Vanham, Guido; Cheng, Hua; Wang, Ying; Zhuang, Minghua; Zhuang, Xun; Pan, Qichao; Zhong, Ping			Evidence That HIV-1 CRF01_AE Is Associated with Low CD4+T Cell Count and CXCR4 Co-Receptor Usage in Recently Infected Young Men Who Have Sex with Men (MSM) in Shanghai, China	PLOS ONE			English	Article							DRUG-RESISTANCE; SELECTIVE TRANSMISSION; HIGH PREVALENCE; SUBTYPE; EPIDEMIC; GATEKEEPER; DIVERSITY; THAILAND; SYPHILIS; CITIES	Men who have sex with men (MSM) have recently accounted for an alarmingly increasing proportion of HIV-1 transmission in China. In order to investigate the immune status as a result of CRF01_AE infection and CXCR4 co-receptor usage in a young Shanghai-based HIV-1-infected MSM population in Shanghai, 364 HIV-1-infected MSM with average age of 22.7 years old, newly diagnosed between Jan 2009 and Jul 2013 were analyzed for CD4+T cell count, subtyping using phylogenetic analysis, and viral co-receptor tropism using Geno2pheno and webPSSM in combination. A total of 276 individuals were identified as recently infected. Subtype assignment were as follows: 176 (63.8%) CRF01_AE, 77 (27.9%) CRF07_BC, and 23 (8.3%) subtype B. Besides, 24 second-generation recombinant strains were identified. A lower CD4+T cell count at baseline survey was observed among CRF01_AE strain-infected individuals, compared to those who were infected with CRF07_BC (P < 0.01). The frequency of baseline CD4+T cell count,200 was higher and the frequency of CD4+T counts >500 lower in CRF01_AE infection than CRF07_BC infection. It is worth noting that 32.4%-40.9% of CRF01_AE strain-infected individuals were predicted to carry CXCR4-tropic viruses whereas none of CRF07_BC and subtype B were found to be as CXCR4-tropic viruses (P < 0.001). As could be expected CXCR4 tropism was associated with lower CD4 T counts. This study revealed that CRF01_AE strains with high frequency of CXCR4 tropism are prevailing in the young MSM population in China and could potentially cause a severe loss of CD4+T cell count and rapid disease progression. A regular surveillance of HIV-1 subtypes, CD4+T cell count and viral co-receptor usage would be greatly beneficial for effectively monitoring disease progression, improvement of antiretroviral therapy strategy and prompt intervention of transmission.	[Li, Xiaoshan; Xue, Yile; Zhou, Leiming; Lin, Yi; Yu, Xiaolei; Wang, Xuqin; Zhen, Xiaohong; Zhang, Wei; Ning, Zhen; Yue, Qing; Fu, Jie; Shen, Fangwei; Gai, Jing; Xu, Yuqing; Mao, Jiawen; Gao, Xianming; Shen, Xiaopei; Kang, Laiyi; Cheng, Hua; Wang, Ying; Zhuang, Minghua; Pan, Qichao; Zhong, Ping] Shanghai Municipal Ctr Dis Control & Prevent, Dept AIDS & STD, Shanghai, Peoples R China; [Li, Xiaoshan; Zhuang, Xun] Nantong Univ, Coll Publ Hlth, Nantong, Peoples R China; [Vanham, Guido] Inst Trop Med, Dept Biomed Sci, Immunovirol Grp, B-2000 Antwerp, Belgium	Shanghai Center for Disease Control & Prevention; Nantong University; Institute of Tropical Medicine (ITM)	Zhuang, X (corresponding author), Nantong Univ, Coll Publ Hlth, Nantong, Peoples R China.	ntzhuang@163.com; qcpan@scdc.sh.cn; zhongp56@hotmail.com			National Science and Technology Major Project for Infectious Disease Control and Prevention [2012-ZX10001-002]	National Science and Technology Major Project for Infectious Disease Control and Prevention	This work was supported by the National Science and Technology Major Project for Infectious Disease Control and Prevention (2012-ZX10001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha A, 2009, J VIROL, V83, P5592, DOI 10.1128/JVI.02051-08; Bennett DE, 2008, ANTIVIR THER, V13, P1; Chalmet K, 2012, J INFECT DIS, V205, P174, DOI 10.1093/infdis/jir714; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Cornelissen M, 2012, CLIN INFECT DIS, V54, P539, DOI 10.1093/cid/cir849; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Frange P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031695; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; Han XX, 2013, JAIDS-J ACQ IMM DEF, V64, P16, DOI 10.1097/QAI.0b013e3182932210; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Huang ZJ, 2012, AIDS BEHAV, V16, P858, DOI 10.1007/s10461-011-0119-4; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Maldarelli F, 2010, ANTIVIR THER, V15, pA97; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Ministry of Health of the People's Republic of China, 2012 CHIN AIDS RESP, P5; Mulinge M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060566; Nelson KE, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000299410.37152.17; Ng KY, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-90; Ng OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015738; Rangsin R, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000299409.29528.23; Ruan Y, 2002, CHINESE J AIDS STD, V8, P200; Shi GuoZheng, 2012, Journal of Environmental & Occupational Medicine, V29, P331; Tarosso LF, 2013, AIDS RES HUM RETROVI, V29; To SWC, 2013, AIDS RES HUM RETROV, V29, P1123, DOI [10.1089/aid.2013.0067, 10.1089/AID.2013.0067]; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Wambui V, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-22; Wang L, 2012, CHINESE MED J-PEKING, V125, P1857, DOI 10.3760/cma.j.issn.0366-6999.2012.11.003; Wu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054322; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Xing Hui, 2004, Zhonghua Yufang Yixue Zazhi, V38, P300; Yin N, 2012, CHINESE J AIDS STD, P728; Yuan D, 2011, CHINESE J AIDS STD, V17, P447; Yuan D, 2011, CHINESE J STD AIDS P, V17, P410; Zhang XY, 2007, AIDS, V21, pS59, DOI 10.1097/01.aids.0000304698.47261.b1; Zhang Yong, 2012, Journal of Environmental & Occupational Medicine, V29, P326; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196	38	38	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89462	10.1371/journal.pone.0089462	http://dx.doi.org/10.1371/journal.pone.0089462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586795	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900101
J	Qiu, XD; Johnson, JR; Wilson, BS; Gammon, ST; Piwnica-Worms, D; Barnett, EM				Qiu, Xudong; Johnson, James R.; Wilson, Bradley S.; Gammon, Seth T.; Piwnica-Worms, David; Barnett, Edward M.			Single-Cell Resolution Imaging of Retinal Ganglion Cell Apoptosis In Vivo Using a Cell-Penetrating CaspaseActivatable Peptide Probe	PLOS ONE			English	Article							RED FLUORESCENT PEPTIDE; MEMBRANE-PERMEANT; DRUG DISCOVERY; ANNEXIN-V; GLAUCOMA; PHOSPHATIDYLSERINE; RETINOPATHY; TARGETS; MODELS; CANCER	Peptide probes for imaging retinal ganglion cell (RGC) apoptosis consist of a cell-penetrating peptide targeting moiety and a fluorophore-quencher pair flanking an effector caspase consensus sequence. Using ex vivo fluorescence imaging, we previously validated the capacity of these probes to identify apoptotic RGCs in cell culture and in an in vivo rat model of Nmethyl- D-aspartate (NMDA)-induced neurotoxicity. Herein, using TcapQ488, a new probe designed and synthesized for compatibility with clinically-relevant imaging instruments, and real time imaging of a live rat RGC degeneration model, we fully characterized time-and dose-dependent probe activation, signal-to-noise ratios, and probe safety profiles in vivo. Adult rats received intravitreal injections of four NMDA concentrations followed by varying TcapQ488 doses. Fluorescence fundus imaging was performed sequentially in vivo using a confocal scanning laser ophthalmoscope and individual RGCs displaying activated probe were counted and analyzed. Rats also underwent electroretinography following intravitreal injection of probe. In vivo fluorescence fundus imaging revealed distinct single-cell probe activation as an indicator of RGC apoptosis induced by intravitreal NMDA injection that corresponded to the identical cells observed in retinal flat mounts of the same eye. Peak activation of probe in vivo was detected 12 hours post probe injection. Detectable fluorescent RGCs increased with increasing NMDA concentration; sensitivity of detection generally increased with increasing TcapQ488 dose until saturating at 0.387 nmol. Electroretinography following intravitreal injections of TcapQ488 showed no significant difference compared with control injections. We optimized the signal-to-noise ratio of a caspase-activatable cell penetrating peptide probe for quantitative non-invasive detection of RGC apoptosis in vivo. Full characterization of probe performance in this setting creates an important in vivo imaging standard for functional evaluation of future probe analogues and provides a basis for extending this strategy into glaucoma-specific animal models.	[Qiu, Xudong; Wilson, Bradley S.; Barnett, Edward M.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Qiu, Xudong; Johnson, James R.; Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, BRIGHT Inst,Mol Imaging Ctr, St Louis, MO 63130 USA; [Qiu, Xudong; Gammon, Seth T.; Piwnica-Worms, David] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA	Washington University (WUSTL); Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center	Piwnica-Worms, D (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, BRIGHT Inst,Mol Imaging Ctr, St Louis, MO 63130 USA.	dpiwnica-worms@mdanderson.org; embarnett@eyeboston.com		Gammon, Seth/0000-0001-8647-0975	NIH [NIH R01 EY019587, P30 EY 02687]; AGS Clinician Scientist Award; Lacy Glaucoma Research Fund; Department of Ophthalmology & Visual Sciences from RPB;  [F32 EY20051-01];  [P50 CA94056]; NATIONAL CANCER INSTITUTE [T32CA113275, P50CA094056] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019587, P30EY002687, F32EY020051] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGS Clinician Scientist Award; Lacy Glaucoma Research Fund; Department of Ophthalmology & Visual Sciences from RPB; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	F32 EY20051-01 (J.R.J.), NIH R01 EY019587 (D.P.-W.) and P50 CA94056 (D.P.-W.), AGS Clinician Scientist Award (E.M.B.), Lacy Glaucoma Research Fund (E.M.B.), and awards to the Department of Ophthalmology & Visual Sciences from RPB and NIH (P30 EY 02687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett EM, 2009, P NATL ACAD SCI USA, V106, P9391, DOI 10.1073/pnas.0812884106; Barnett EM, 2006, INVEST OPHTH VIS SCI, V47, P2589, DOI 10.1167/iovs.05-1470; Berkowitz BA, 1998, INVEST OPHTH VIS SCI, V39, P391; Brauer M, 2003, PROG NEURO-PSYCHOPH, V27, P323, DOI 10.1016/S0278-5846(03)00026-5; Bullok K, 2005, J MED CHEM, V48, P5404, DOI 10.1021/jm050008p; Bullok KE, 2002, BIOCONJUGATE CHEM, V13, P1226, DOI 10.1021/bc025573a; Bullok KE, 2007, BIOCHEMISTRY-US, V46, P4055, DOI 10.1021/bi061959n; Bullok KE, 2006, MOL IMAGING, V5, P1, DOI 10.2310/7290.2006.00001; Calkins DJ, 2012, INVEST OPHTH VIS SCI, V53, P2482, DOI 10.1167/iovs.12-9483i; Cordeiro MF, 2011, EYE, V25, P545, DOI 10.1038/eye.2011.64; Cordeiro MF, 2004, P NATL ACAD SCI USA, V101, P13352, DOI 10.1073/pnas.0405479101; FADOK VA, 1992, J IMMUNOL, V148, P2207; Ferrari G, 2007, INVEST OPHTHALMOL VI, V48; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Johnson JR, 2012, BIOCONJUGATE CHEM, V23, P1783, DOI 10.1021/bc300036z; Kemerink GJ, 2003, J NUCL MED, V44, P947; Maxwell D, 2009, BIOCONJUGATE CHEM, V20, P702, DOI 10.1021/bc800516n; MILLER RF, 1970, J NEUROPHYSIOL, V33, P323, DOI 10.1152/jn.1970.33.3.323; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; OAKLEY B, 1977, J GEN PHYSIOL, V70, P405, DOI 10.1085/jgp.70.4.405; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Pang IH, 2007, J GLAUCOMA, V16, P483, DOI 10.1097/IJG.0b013e3181405d4f; Perlman I, 1995, ELECTRORETINOGRAM ER; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Reed JC, 2001, TRENDS MOL MED, V7, P314, DOI 10.1016/S1471-4914(01)02026-3; Roh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040065; Schellenberger EA, 2003, NEOPLASIA, V5, P187, DOI 10.1016/S1476-5586(03)80050-7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoenberger J, 2008, CURR MED CHEM, V15, P187, DOI 10.2174/092986708783330647; Van der Reis MI, 2011, RETINA-J RET VIT DIS, V31, P1449, DOI 10.1097/IAE.0b013e3182278ab4; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Zhang K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/nrd3745	35	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88855	10.1371/journal.pone.0088855	http://dx.doi.org/10.1371/journal.pone.0088855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586415	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900032
J	Simpson, SL; Edwards, LJ; Styner, MA; Muller, KE				Simpson, Sean L.; Edwards, Lloyd J.; Styner, Martin A.; Muller, Keith E.			Kronecker Product Linear Exponent AR(1) Correlation Structures for Multivariate Repeated Measures	PLOS ONE			English	Article							LIKELIHOOD RATIO TEST; UNIT-ROOT TESTS; LONGITUDINAL DATA; COVARIANCE; FAMILY; SHAPE	Longitudinal imaging studies have moved to the forefront of medical research due to their ability to characterize spatiotemporal features of biological structures across the lifespan. Credible models of the correlations in longitudinal imaging require two or more pattern components. Valid inference requires enough flexibility of the correlation model to allow reasonable fidelity to the true pattern. On the other hand, the existence of computable estimates demands a parsimonious parameterization of the correlation structure. For many one-dimensional spatial or temporal arrays, the linear exponent autoregressive (LEAR) correlation structure meets these two opposing goals in one model. The LEAR structure is a flexible two-parameter correlation model that applies to situations in which the within-subject correlation decreases exponentially in time or space. It allows for an attenuation or acceleration of the exponential decay rate imposed by the commonly used continuous-time AR(1) structure. We propose the Kronecker product LEAR correlation structure for multivariate repeated measures data in which the correlation between measurements for a given subject is induced by two factors (e. g., spatial and temporal dependence). Excellent analytic and numerical properties make the Kronecker product LEAR model a valuable addition to the suite of parsimonious correlation structures for multivariate repeated measures data. Longitudinal medical imaging data of caudate morphology in schizophrenia illustrates the appeal of the Kronecker product LEAR correlation structure.	[Simpson, Sean L.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27103 USA; [Simpson, Sean L.; Edwards, Lloyd J.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Styner, Martin A.] Univ N Carolina, Dept Psychiat & Comp Sci, Chapel Hill, NC USA; [Muller, Keith E.] Univ Florida, Dept Hlth Outcomes & Policy, Gainesville, FL USA	Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida	Simpson, SL (corresponding author), Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27103 USA.	slsimpso@wakehealth.edu	Edwards, Lloyd/N-2759-2019; Styner, Martin/AAS-9949-2020	Edwards, Lloyd/0000-0002-7788-4575; Styner, Martin/0000-0002-8747-5118	Translational Scholar Award from the Translational Science Institute of Wake Forest School of Medicine [NIBIB K25 EB012236-01A1]; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000083]; NIDCR [R01 DE020832, R01 DE020832-01A1S1, U54 DE019261]; NICHD [P01 HD065647]; NCRR [3UL1RR029890-03S1]; NHLBI [R01 HL091005]; NIAAA [R01 AA016549]; NIDA [R01 DA031017]; NIDDK [R01 DK072398]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K25EB012236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020832, U54DE019261] Funding Source: NIH RePORTER	Translational Scholar Award from the Translational Science Institute of Wake Forest School of Medicine; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Sean Simpson's support includes the Translational Scholar Award from the Translational Science Institute of Wake Forest School of Medicine and NIBIB K25 EB012236-01A1. Lloyd Edwards was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Award Number UL1TR000083. Keith Muller's support includes NIDCR R01 DE020832, R01 DE020832-01A1S1, U54 DE019261, NICHD P01 HD065647, NCRR 3UL1RR029890-03S1, NHLBI R01 HL091005, NIAAA R01 AA016549, NIDA R01 DA031017, and NIDDK R01 DK072398. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, STAT METHODS; Baltagi BH, 2007, J APPL ECONOMET, V22, P339, DOI 10.1002/jae.950; Cressie N, 1999, J AM STAT ASSOC, V94, P1330, DOI 10.2307/2669946; Davis P.J., 1972, HDB MATH FUNCTIONS F, V10; Deniss J.E., 1983, NUMERICAL METHODS UN; DIGGLE PJ, 1988, BIOMETRICS, V44, P959, DOI 10.2307/2531727; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; Fan JQ, 2007, J AM STAT ASSOC, V102, P632, DOI 10.1198/016214507000000095; GALECKI AT, 1994, COMMUN STAT THEORY, V23, P3105, DOI 10.1080/03610929408831436; Genton MG, 2007, ENVIRONMETRICS, V18, P681, DOI 10.1002/env.854; GILL PE, 1984, ACM T MATH SOFTWARE, V10, P282, DOI 10.1145/1271.1276; Gurka MJ, 2011, STAT MED, V30, P2696, DOI 10.1002/sim.4293; Huizenga HM, 2002, IEEE T BIO-MED ENG, V49, P533, DOI 10.1109/TBME.2002.1001967; Im KS, 2003, J ECONOMETRICS, V115, P53, DOI 10.1016/S0304-4076(03)00092-7; Komro KA, 2007, ADDICTION, V102, P1597, DOI 10.1111/j.1360-0443.2007.01941.x; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; Lin JH, 2013, APPL ECON LETT, V20, P288, DOI 10.1080/13504851.2012.695067; LOUIS TA, 1988, STAT MED, V7, P29, DOI 10.1002/sim.4780070108; Lu N, 2005, STAT PROBABIL LETT, V73, P449, DOI 10.1016/j.spl.2005.04.020; McClure RK, 2013, PSYCHIAT RES-NEUROIM, V211, P1, DOI 10.1016/j.pscychresns.2012.07.001; Mitchell MW, 2006, J MULTIVARIATE ANAL, V97, P1025, DOI 10.1016/j.jmva.2005.07.005; Moon HR, 2012, J ECONOMETRICS, V169, P29, DOI 10.1016/j.jeconom.2012.01.008; Muller KE, 2006, LINEAR MODEL THEORY; Muller KE, 2007, STAT MED, V26, P3639, DOI 10.1002/sim.2827; MUNOZ A, 1992, BIOMETRICS, V48, P733, DOI 10.2307/2532340; Naik DN, 2001, J APPL STAT, V28, P91, DOI 10.1080/02664760120011626; Pizer SM, 2002, P GEN MOD BAS VIS GM; Powell JMD, 1982, LECT NOTES CONTROL I, V38, P529; Powell JMD, 1982, 1982NA4 DAMTP; Powell M. J. D., 1978, Proceedings of the Biennial Conference on numerical analysis, P144; POWELL MJD, 1978, MATH PROGRAM, V14, P224, DOI 10.1007/BF01588967; Roy A., 2003, J APPL STAT SCI, V12, P91; Roy A., 2005, P 30 ANN SAS US GROU; Roy A., 2005, STAT METHODOL, V2, P297, DOI [DOI 10.1016/J.STAMET.2005.07.003, 10.1016/j.stamet.2005.07.003]; Roy A, 2008, STAT PROBABIL LETT, V78, P1971, DOI 10.1016/j.spl.2008.01.066; SAS Institute, 2002, SAS IML VERS 9; Schabenberger O., 2005, STAT METHODS SPATIAL; Schott J. R., 1997, MATRIX ANAL STAT; Simpson SL, 2010, STAT MED, V29, P1825, DOI 10.1002/sim.3928; Styner M, 2001, PROC CVPR IEEE, P651; Wang NY, 2003, BIOMETRIKA, V90, P43, DOI 10.1093/biomet/90.1.43; Werner K, 2008, IEEE T SIGNAL PROCES, V56, P478, DOI 10.1109/TSP.2007.907834; Westerlund J, 2012, J ECONOMETRICS, V167, P254, DOI 10.1016/j.jeconom.2011.11.009	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88864	10.1371/journal.pone.0088864	http://dx.doi.org/10.1371/journal.pone.0088864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586419	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900033
J	Yu, S; Long, H; Lyu, QF; Zhang, QH; Yan, ZG; Liang, HX; Chai, WR; Yan, Z; Kuang, YP; Qi, C				Yu, Sha; Long, Hui; Lyu, Qi-feng; Zhang, Qin-hua; Yan, Zhi-guang; Liang, Hong-xing; Chai, Wei-ran; Yan, Zheng; Kuang, Yan-ping; Qi, Cong			Protective Effect of Quercetin on the Development of Preimplantation Mouse Embryos against Hydrogen Peroxide-Induced Oxidative Injury	PLOS ONE			English	Article							IN-VITRO DEVELOPMENT; MITOCHONDRIAL DYSFUNCTION; OXYGEN CONCENTRATION; EPIGALLOCATECHIN GALLATE; BLASTOCYST CULTURE; INDUCED APOPTOSIS; SIBLING OOCYTES; HUMAN CATALASE; CELL-DEATH; STRESS	Quercetin, a plant-derived flavonoid in Chinese herbs, fruits and wine, displays antioxidant properties in many pathological processes associated with oxidative stress. However, the effect of quercetin on the development of preimplantation embryos under oxidative stress is unclear. The present study sought to determine the protective effect and underlying mechanism of action of quercetin against hydrogen peroxide (H2O2)-induced oxidative injury in mouse zygotes. H2O2 treatment impaired the development of mouse zygotes in vitro, decreasing the rates of blastocyst formation and hatched, and increasing the fragmentation, apoptosis and retardation in blastocysts. Quercetin strongly protected zygotes from H2O2-induced oxidative injury by decreasing the reactive oxygen species level, maintaining mitochondrial function and modulating total antioxidant capability, the activity of the enzymatic antioxidants, including glutathione peroxidase and catalase activity to keep the cellular redox environment. Additionally, quercetin had no effect on the level of glutathione, the main non-enzymatic antioxidant in embryos.	[Yu, Sha; Zhang, Qin-hua; Qi, Cong] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Gynecol, Shanghai, Peoples R China; [Long, Hui; Lyu, Qi-feng; Yan, Zhi-guang; Liang, Hong-xing; Chai, Wei-ran; Yan, Zheng; Kuang, Yan-ping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Assisted Reprod, Shanghai 200030, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai Jiao Tong University	Kuang, YP (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Assisted Reprod, Shanghai 200030, Peoples R China.	kuangyanp@126.com; qicongxzq@163.com			National Natural Foundation of China [31071275, 81270749]; Natural Science Foundation of Shanghai, China [12ZR1416600, 11411950105, 11411950106]; Shanghai Leading Academic Discipline Project, China [S30303]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai, China(Natural Science Foundation of Shanghai); Shanghai Leading Academic Discipline Project, China(Shanghai Leading Academic Discipline Project)	Financial support for this research was provided by the National Natural Foundation of China (31071275 to QFL, 81270749 to YPK), the Natural Science Foundation of Shanghai, China (12ZR1416600 to HL, 11411950105 to YPK, 11411950106 to CQ) and Shanghai Leading Academic Discipline Project, China (S30303 to CQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov JP, 2011, FASEB J, V25, P2188, DOI 10.1096/fj.11-182444; Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Anjaneyulu M, 2004, CLIN EXP PHARMACOL P, V31, P244, DOI 10.1111/j.1440-1681.2004.03982.x; Baek IJ, 2005, ANAT EMBRYOL, V209, P315, DOI 10.1007/s00429-004-0447-5; Bayir H, 2008, CRIT CARE, V12, DOI 10.1186/cc6779; Blake DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002118.pub3; Carrasco-Pozo C, 2012, CHEM-BIOL INTERACT, V195, P199, DOI 10.1016/j.cbi.2011.12.007; Ciray HN, 2009, FERTIL STERIL, V91, P1459, DOI 10.1016/j.fertnstert.2008.07.1707; Devine PJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095224; Ghosh A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082529, 10.1371/journal.pone.0057735]; Gitika B, 2006, FREE RADICAL RES, V40, P95, DOI 10.1080/10715760500335447; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Guzy J, 2003, PHYSIOL RES, V52, P773; He ZY, 2008, CELL BIOL INT, V32, P367, DOI 10.1016/j.cellbi.2007.12.003; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Ishige K, 2001, FREE RADICAL BIO MED, V30, P433, DOI 10.1016/S0891-5849(00)00498-6; Jembrek MJ, 2012, J MOL NEUROSCI, V47, P286, DOI 10.1007/s12031-012-9737-1; Jeong SM, 2012, NUTR RES PRACT, V6, P201, DOI 10.4162/nrp.2012.6.3.201; Johnson MK, 2000, MUTAT RES-DNA REPAIR, V459, P211, DOI 10.1016/S0921-8777(99)00074-9; Kelly GS, 2011, ALTERN MED REV, V16, P263; Kimura N, 2010, MOL HUM REPROD, V16, P441, DOI 10.1093/molehr/gaq007; Kitagawa Y, 2004, THERIOGENOLOGY, V62, P1186, DOI 10.1016/j.theriogenology.2004.01.011; Kovacic B, 2008, REPROD BIOMED ONLINE, V17, P229, DOI 10.1016/S1472-6483(10)60199-X; Kumar Mishra S, 2013, MALAR RES TREAT, V2013, DOI DOI 10.1155/2013/141734; Liu L, 2000, BIOL REPROD, V62, P1745, DOI 10.1095/biolreprod62.6.1745; Lopes AS, 2010, HUM REPROD, V25, P2762, DOI 10.1093/humrep/deq221; Mi YL, 2007, J REPROD DEVELOP, V53, P749, DOI 10.1262/jrd.19001; Mi YL, 2010, BIOSCI BIOTECH BIOCH, V74, P934, DOI 10.1271/bbb.90740; Morales H, 1999, MOL REPROD DEV, V52, P149, DOI 10.1002/(SICI)1098-2795(199902)52:2&lt;149::AID-MRD5&gt;3.0.CO;2-4; Nabavi SF, 2012, PHARM BIOL, V50, P1380, DOI 10.3109/13880209.2012.675341; Ou XH, 2012, HUM REPROD, V27, P2130, DOI 10.1093/humrep/des137; Papanikolaou EG, 2008, HUM REPROD, V23, P91, DOI 10.1093/humrep/dem339; Park C, 2003, BIOCHEM PHARMACOL, V66, P1287, DOI 10.1016/S0006-2952(03)00478-7; Perez-Pasten R, 2010, J PHARM PHARMACOL, V62, P1003, DOI 10.1111/j.2042-7158.2010.01118.x; Sandhir R, 2013, BBA-MOL BASIS DIS, V1832, P421, DOI 10.1016/j.bbadis.2012.11.018; Sepulveda S, 2009, FERTIL STERIL, V91, P1765, DOI 10.1016/j.fertnstert.2008.02.169; Sills ES, 2010, ROM J MORPHOL EMBRYO, V51, P441; Suematsu N, 2011, NEUROSCI LETT, V504, P223, DOI 10.1016/j.neulet.2011.09.028; Suzuki C, 2007, ZYGOTE, V15, P317, DOI 10.1017/S0967199407004273; Tangsaengvit N, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/838051; Thiyagarajan B, 2009, J ASSIST REPROD GEN, V26, P217, DOI 10.1007/s10815-009-9302-1; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Waldenstrom U, 2009, FERTIL STERIL, V91, P2461, DOI 10.1016/j.fertnstert.2008.03.051; Youl E, 2010, BRIT J PHARMACOL, V161, P799, DOI 10.1111/j.1476-5381.2010.00910.x; Zhang CL, 2010, J CELL PHYSIOL, V222, P444, DOI 10.1002/jcp.21966; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063472	47	41	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89520	10.1371/journal.pone.0089520	http://dx.doi.org/10.1371/journal.pone.0089520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586844	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900113
J	Ma, Y; Wang, YH; Liu, JR; Lv, FJ; Chen, J; Zhou, ZG				Ma, Yina; Wang, Youhua; Liu, Jingran; Lv, Fengjuan; Chen, Ji; Zhou, Zhiguo			The Effects of Fruiting Positions on Cellulose Synthesis and Sucrose Metabolism during Cotton (Gossypium hirsutum L.) Fiber Development	PLOS ONE			English	Article							PHOSPHATE SYNTHASE; COOL TEMPERATURE; GENE-EXPRESSION; BOLL SIZE; INVERTASE; QUALITY; YIELD; GROWTH; ELONGATION; CARBON	Cotton (Gossypium hirsutum L.) boll positions on a fruiting branch vary in their contribution to yield and fiber quality. Fiber properties are dependent on deposition of cellulose in the fiber cell wall, but information about the enzymatic differences in sucrose metabolism between these fruiting positions is lacking. Therefore, two cotton cultivars with different sensitivities to low temperature were tested in 2010 and 2011 to quantify the effect of fruit positions (FPs) on fiber quality in relation to sucrose content, enzymatic activities and sucrose metabolism. The indices including sucrose content, sucrose transformation rate, cellulose content, and the activities of the key enzymes, sucrose phosphate synthase (SPS), acid invertase (AI) and sucrose synthase (SuSy) which inhibit cellulose synthesis and eventually affect fiber quality traits in cotton fiber, were determined. Results showed that as compared with those of FP1, cellulose content, sucrose content, and sucrose transformation rate of FP3 were all decreased, and the variations of cellulose content and sucrose transformation rate caused by FPs in Sumian 15 were larger than those in Kemian 1. Under FP effect, activities of SPS and AI in sucrose regulation were decreased, while SuSy activity in sucrose degradation was increased. The changes in activities of SuSy and SPS in response to FP effect displayed different and large change ranges between the two cultivars. These results indicate that restrained cellulose synthesis and sucrose metabolism in distal FPs are mainly attributed to the changes in the activities of these enzymes. The difference in fiber quality, cellulose synthesis and sucrose metabolism in response to FPs in fiber cells for the two cotton cultivars was mainly determined by the activities of both SuSy and SPS.	[Ma, Yina; Wang, Youhua; Liu, Jingran; Lv, Fengjuan; Chen, Ji; Zhou, Zhiguo] Nanjing Agr Univ, Minist Agr, Key Lab Crop Growth Regulat, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Zhou, ZG (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Crop Growth Regulat, Nanjing, Jiangsu, Peoples R China.	giscott@njau.edu.cn			National Natural Science Foundation of China [30971735]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant number 30971735) (http://isisn.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Anjum R., 2001, PAK J BIOL SCI, V4, P960; Baraiya B. R., 2009, Annals of Plant Physiology, V23, P144; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Battal P, 2008, ANN BOT FENN, V45, P173, DOI 10.5735/085.045.0302; Boquet DJ, 2003, CROP SCI, V43, P195, DOI 10.2135/cropsci2003.0195; Bradow J. M., 1997, 1997 Proceedings Beltwide Cotton Conferences, New Orleans, LA, USA, January 6-10, 1997: Volume 2., P1491; Bradow J. M., 2000, Journal of Cotton Science, V4, P34; Dagdelen N, 2009, AGR WATER MANAGE, V96, P111, DOI 10.1016/j.agwat.2008.07.003; Davidonis GH, 2004, AGRON J, V96, P42, DOI 10.2134/agronj2004.0042; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Delmer DP, 2002, METAB ENG, V4, P22, DOI 10.1006/mben.2001.0206; Dong HZ, 2006, FIELD CROP RES, V98, P106, DOI 10.1016/j.fcr.2005.12.008; Essmann J, 2008, PLANT PHYSIOL, V147, P1288, DOI 10.1104/pp.108.121418; Gao XB, 2012, J PLANT NUTR SOIL SC, V175, P152, DOI 10.1002/jpln.201100050; Gu L, 2010, CHINA COTTON, V37, P14; Haigler CH, 2007, PLANT MOL BIOL, V63, P815, DOI 10.1007/s11103-006-9127-6; Haigler Candace H., 2007, P147, DOI 10.1007/978-1-4020-5380-1_9; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; HEITHOLT JJ, 1993, CROP SCI, V33, P486, DOI 10.2135/cropsci1993.0011183X003300030014x; Heitholt JJ, 1997, CROP SCI, V37, P826, DOI 10.2135/cropsci1997.0011183X003700030022x; HENDRIX DL, 1993, CROP SCI, V33, P1306, DOI 10.2135/cropsci1993.0011183X003300060037x; HUBER SC, 1986, PLANT PHYSIOL, V81, P1008, DOI 10.1104/pp.81.4.1008; Huber SC, 1996, ANNU REV PLANT PHYS, V47, P431, DOI 10.1146/annurev.arplant.47.1.431; JENKINS JN, 1990, CROP SCI, V30, P857, DOI 10.2135/cropsci1990.0011183X003000040018x; Jiang GuangHua, 2006, Scientia Agricultura Sinica, V39, P265; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; King SP, 1997, PLANT PHYSIOL, V114, P153, DOI 10.1104/pp.114.1.153; Kutschera U, 2002, PHYSIOL PLANTARUM, V114, P372, DOI 10.1034/j.1399-3054.2002.1140306.x; Li WF, 2009, FIELD CROP RES, V112, P131, DOI 10.1016/j.fcr.2009.02.009; Liakatas A, 1998, J AGR SCI-CAMBRIDGE, V130, P463, DOI 10.1017/S0021859698005413; Lingle S. E., 2004, Journal - American Society of Sugar Cane Technologists, V24, P132; Liu JR, 2013, FIELD CROP RES, V144, P200, DOI 10.1016/j.fcr.2013.02.003; Livingston DP, 1998, PLANT PHYSIOL, V116, P403, DOI 10.1104/pp.116.1.403; Marangoni AG, 1996, BIOPHYS CHEM, V61, P177, DOI 10.1016/S0301-4622(96)02202-8; Martin LK, 2004, CELLULOSE, V11, P339, DOI 10.1023/B:CELL.0000046420.10403.15; May OL, 1996, COTTON FIBERS, P183; McLaughlin JE, 2004, ANN BOT-LONDON, V94, P675, DOI 10.1093/aob/mch193; Oosterhuis DM, 1991, NITROGEN NUTRITION C, P1; Pettigrew WT, 2008, CROP SCI, V48, P278, DOI 10.2135/cropsci2007.05.0261; PETTIGREW WT, 1995, AGRON J, V87, P947, DOI 10.2134/agronj1995.00021962008700050029x; Pettigrew WT, 2001, CROP SCI, V41, P1108, DOI 10.2135/cropsci2001.4141108x; Read JJ, 2006, EUR J AGRON, V24, P282, DOI 10.1016/j.eja.2005.10.004; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Salnikov VV, 2003, PROTOPLASMA, V221, P175, DOI 10.1007/s00709-002-0079-7; Shu HM, 2009, EUR J AGRON, V31, P61, DOI 10.1016/j.eja.2009.03.004; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; THAKER VS, 1992, ACTA PHYSIOL PLANT, V14, P11; Thomasson JA, 2009, APPL SPECTROSC, V63, P321, DOI 10.1366/000370209787598870; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Wang YH, 2009, SCI CHINA SER C, V52, P1065, DOI 10.1007/s11427-009-0147-8; Wang YouHua, 2008, Scientia Agricultura Sinica, V41, P3865; Wang YH, 2009, PLANT GROWTH REGUL, V57, P203, DOI 10.1007/s10725-008-9337-9; Williamson RE, 2002, TRENDS PLANT SCI, V7, P461, DOI 10.1016/S1360-1385(02)02335-X; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Wrather JA, 2008, J COTTON SCI, V12, P1; Yeates SJ, 2010, FIELD CROP RES, V116, P300, DOI 10.1016/j.fcr.2010.01.006; Zhao WenQing, 2012, American Journal of Experimental Agriculture, V2, P133; Zhao WenQing, 2012, African Journal of Agricultural Research, V7, P6073; Zhao WQ, 2012, ECOL MODEL, V243, P112, DOI 10.1016/j.ecolmodel.2012.06.015; Zheng M, 2012, J PLANT PHYSIOL, V169, P399, DOI 10.1016/j.jplph.2011.09.014; Zhou ZhiGuo, 2011, American Journal of Experimental Agriculture, V1, P331	63	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89476	10.1371/journal.pone.0089476	http://dx.doi.org/10.1371/journal.pone.0089476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586807	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700122
J	Toivonen, JM; Manzano, R; Olivan, S; Zaragoza, P; Garcia-Redondo, A; Osta, R				Toivonen, Janne M.; Manzano, Raquel; Olivan, Sara; Zaragoza, Pilar; Garcia-Redondo, Alberto; Osta, Rosario			MicroRNA-206: A Potential Circulating Biomarker Candidate for Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							NEURON-SPECIFIC EXPRESSION; MUSCLE-SPECIFIC MICRORNAS; TRANSGENIC MOUSE MODEL; MOTOR UNIT LOSS; ALPHA ER-ALPHA; SKELETAL-MUSCLE; SUPEROXIDE-DISMUTASE; DOWN-REGULATION; NEUROTROPHIC FACTOR; CELL-PROLIFERATION	Amyotrophic lateral sclerosis (ALS) is a lethal motor neuron disease that progressively debilitates neuronal cells that control voluntary muscle activity. Biomarkers are urgently needed to facilitate ALS diagnosis and prognosis, and as indicators of therapeutic response in clinical trials. microRNAs (miRNAs), small posttranscriptional modifiers of gene expression, are frequently altered in disease conditions. Besides their important regulatory role in variety of biological processes, miRNAs can also be released into the circulation by pathologically affected tissues and display remarkable stability in body fluids. In a mouse model of ALS that expresses mutated human superoxide dismutase 1 (SOD1-G93A) skeletal muscle is one of the tissues affected early by mutant SOD1 toxicity. To find biomarkers for ALS, we studied miRNA alterations from skeletal muscle and plasma of SOD1-G93A mice, and subsequently tested the levels of the affected miRNAs in the serum from human ALS patients. Fast-twitch and slow-twitch muscles from symptomatic SOD1-G93A mice (age 90 days) and their control littermates were first studied using miRNA microarrays and then evaluated with quantitative PCR from five age groups from neonatal to the terminal disease stage (10-120 days). Among those miRNA changed in various age/gender/muscle groups (miR-206, -1, -133a, -133b, -145, -21, -24), miR-206 was the only one consistently altered during the course of the disease pathology. In both sexes, mature miR-206 was increased in fast-twitch muscles preferably affected in the SOD1-G93A model, with highest expression towards the most severely affected animals. Importantly, miR-206 was also increased in the circulation of symptomatic animals and in a group of 12 definite ALS patients tested. We conclude that miR-206 is elevated in the circulation of symptomatic SOD1-G93A mice and possibly in human ALS patients. Although larger scale studies on ALS patients are warranted, miR-206 is a promising candidate biomarker for this motor neuron disease.	[Toivonen, Janne M.; Manzano, Raquel; Olivan, Sara; Zaragoza, Pilar; Osta, Rosario] Univ Zaragoza, Lab Genet Bioquim LAGENBIO I3A, Dept Anat Embriol & Genet Anim, Zaragoza, Spain; [Garcia-Redondo, Alberto] Hosp 12 Octubre, SERMAS, Inst Invest, Unidad ELA, E-28041 Madrid, Spain; [Garcia-Redondo, Alberto] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain	University of Zaragoza; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Toivonen, JM (corresponding author), Univ Zaragoza, Lab Genet Bioquim LAGENBIO I3A, Dept Anat Embriol & Genet Anim, Zaragoza, Spain.	toivonen@unizar.es	Toivonen, Janne M./E-5691-2011; REDONDO, ALBERTO GARCÍA/AAD-9453-2020; Osta, Rosario/R-5410-2019; zaragoza, pilar/AAN-9479-2021; martinez, manzano/ACS-3663-2022; MANZANO, RAQUEL/AAB-1709-2020; OLIVAN, SARA/AAR-6768-2020	Toivonen, Janne M./0000-0002-7243-1737; martinez, manzano/0000-0002-7477-8742; MANZANO, RAQUEL/0000-0002-7477-8742; OLIVAN, SARA/0000-0003-0156-4230; Osta, Rosario/0000-0001-5687-6704	ALS Association [S54406]; Government of Spain [RYC-2011-08363]; University of Zaragoza [JIUZ-2012-IO-06]	ALS Association; Government of Spain(Spanish Government); University of Zaragoza	This work was funded by The ALS Association (http://www.alsa.org/, grant S54406), Government of Spain (grant RYC-2011-08363) and University of Zaragoza (grant JIUZ-2012-IO-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Adams BD, 2009, MOL ENDOCRINOL, V23, P1215, DOI 10.1210/me.2009-0062; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Alonso A, 2009, EUR J NEUROL, V16, P745, DOI 10.1111/j.1468-1331.2009.02586.x; Alteri A, 2013, CELL CYCLE, V12, P3781, DOI 10.4161/cc.26674; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bernardini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057739; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Bowser R, 2011, NAT REV NEUROL, V7, P631, DOI 10.1038/nrneurol.2011.151; BRADLEY WG, 1983, ANN NEUROL, V14, P267, DOI 10.1002/ana.410140304; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; CHIU AY, 1995, MOL CELL NEUROSCI, V6, P349, DOI 10.1006/mcne.1995.1027; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dong HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012136; Dupuis L, 2004, NEURODEGENER DIS, V1, P245, DOI 10.1159/000085063; Fernandez-Hernando C, 2013, ARTERIOSCL THROM VAS, V33, P178, DOI 10.1161/ATVBAHA.112.300144; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Goljanek-Whysall K, 2011, P NATL ACAD SCI USA, V108, P11936, DOI 10.1073/pnas.1105362108; Greco SJ, 2007, P NATL ACAD SCI USA, V104, P15484, DOI 10.1073/pnas.0703037104; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020171; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hayworth CR, 2009, NEUROSCIENCE, V164, P975, DOI 10.1016/j.neuroscience.2009.08.031; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Hinits Y, 2011, DEV BIOL, V358, P102, DOI 10.1016/j.ydbio.2011.07.015; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Jaarsma D, 2008, J NEUROSCI, V28, P2075, DOI 10.1523/JNEUROSCI.5258-07.2008; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Jin XF, 2013, CELL MOL NEUROBIOL, V33, P601, DOI 10.1007/s10571-013-9940-9; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Leger B, 2006, FASEB J, V20, P583, DOI 10.1096/fj.05-5249fje; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li L, 2012, LAB INVEST, V92, P571, DOI 10.1038/labinvest.2012.10; Limana F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019845; Lin CC, 2011, MOL CELL BIOL, V31, P2513, DOI 10.1128/MCB.01189-10; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Liu H, 2010, TUMORI J, V96, P751, DOI 10.1177/030089161009600518; Liu N, 2012, J CLIN INVEST, V122, P2054, DOI 10.1172/JCI62656; Liu XL, 2012, MOL CELL BIOL, V32, P2934, DOI 10.1128/MCB.00134-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunetta C, 2012, MUSCLE NERVE, V45, P200, DOI 10.1002/mus.22288; Maciotta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043464; Manzano R, 2012, STEM CELL REV REP, V8, P279, DOI 10.1007/s12015-011-9268-0; Manzano R, 2011, NEURODEGENER DIS, V8, P386, DOI 10.1159/000324159; Marcuzzo S, 2011, EXP NEUROL, V231, P30, DOI 10.1016/j.expneurol.2011.05.007; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miura P, 2012, J NEUROCHEM, V120, P230, DOI 10.1111/j.1471-4159.2011.07583.x; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; Nohata N, 2012, ONCOTARGET, V3, P9; Parasramka MA, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-16; Pradat PF, 2011, AMYOTROPH LATERAL SC, V12, P264, DOI 10.3109/17482968.2011.566618; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Radzikinas K, 2011, J NEUROSCI, V31, P15407, DOI 10.1523/JNEUROSCI.2745-11.2011; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Roberts TC, 2013, NUCL ACIDS RES; Roberts TC, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.26; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Soleimani VD, 2012, MOL CELL, V47, P457, DOI 10.1016/j.molcel.2012.05.046; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006880; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Taulli R, 2013, ONCOGENE; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vignier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055281; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wang R, 2012, CELL PHYSIOL BIOCHEM, V29, P381, DOI 10.1159/000338493; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Winbanks CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073589; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Witkos TM, 2011, CURR MOL MED, V11, P93; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; Wootz H, 2013, J COMP NEUROL, V521, P1449, DOI 10.1002/cne.23266; Wu H, 2012, CELL SIGNAL, V24, P2179, DOI 10.1016/j.cellsig.2012.07.001; Wu Y, 2013, BIOCHEM BIOPH RES CO, V438, P575, DOI 10.1016/j.bbrc.2013.08.016; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yue J, 2013, LAB INVEST; Zhang BH, 2009, ENVIRON HEALTH PERSP, V117, P231, DOI 10.1289/ehp.11841; Zhang L, 2013, CANCER LETT, V332, P94, DOI 10.1016/j.canlet.2013.01.023; Zhang TH, 2011, ANTICANCER RES, V31, P3859; Zhang X, 2013, PLOS ONE, V8; Zhou W, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-141	116	125	129	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89065	10.1371/journal.pone.0089065	http://dx.doi.org/10.1371/journal.pone.0089065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586506	Green Published, gold			2022-12-27	WOS:000331714700056
J	Zhu, LQ; Hu, NJ; Yang, MF; Zhan, XH; Zhang, ZW				Zhu, Liqun; Hu, Naijuan; Yang, Minfang; Zhan, Xinhua; Zhang, Zhengwen			Effects of Different Tillage and Straw Return on Soil Organic Carbon in a Rice-Wheat Rotation System	PLOS ONE			English	Article							NO-TILLAGE; MATTER FRACTIONS; PADDY SOIL; FERTILIZATION; NITROGEN; QUALITY; MANAGEMENT; SEQUESTRATION; CULTIVATION; AGGREGATE	Soil management practices, such as tillage method or straw return, could alter soil organic carbon (C) contents. However, the effects of tillage method or straw return on soil organic C (SOC) have showed inconsistent results in different soil/climate/cropping systems. The Yangtze River Delta of China is the main production region of rice and wheat, and rice-wheat rotation is the most important cropping system in this region. However, few studies in this region have been conducted to assess the effects of different tillage methods combined with straw return on soil labile C fractions in the rice-wheat rotation system. In this study, a field experiment was used to evaluate the effects of different tillage methods, straw return and their interaction on soil total organic C (TOC) and labile organic C fractions at three soil depths (0-7, 7-14 and 14-21 cm) for a rice-wheat rotation in Yangzhong of the Yangtze River Delta of China. Soil TOC, easily oxidizable C (EOC), dissolved organic C (DOC) and microbial biomass C (MBC) contents were measured in this study. Soil TOC and labile organic C fractions contents were significantly affected by straw returns, and were higher under straw return treatments than non-straw return at three depths. At 0-7 cm depth, soil MBC was significantly higher under plowing tillage than rotary tillage, but EOC was just opposite. Rotary tillage had significantly higher soil TOC than plowing tillage at 7-14 cm depth. However, at 14-21 cm depth, TOC, DOC and MBC were significantly higher under plowing tillage than rotary tillage except for EOC. Consequently, under short-term condition, rice and wheat straw both return in rice-wheat rotation system could increase SOC content and improve soil quality in the Yangtze River Delta.	[Zhu, Liqun; Hu, Naijuan; Zhang, Zhengwen] Nanjing Agr Univ, Coll Agr, Nanjing, Jiangsu, Peoples R China; [Yang, Minfang; Zhan, Xinhua] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Zhu, LQ (corresponding author), Nanjing Agr Univ, Coll Agr, Nanjing, Jiangsu, Peoples R China.	zhulq@njau.edu.cn	Zhu, Li/GXH-9801-2022		Special Fund for Agro-scientific Research in the Public Interest [201103001]	Special Fund for Agro-scientific Research in the Public Interest	This work was supported by Special Fund for Agro-scientific Research in the Public Interest (201103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CHINESE J ECOAGRI; BEARE MH, 1994, SOIL SCI SOC AM J, V58, P777, DOI 10.2136/sssaj1994.03615995005800030020x; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; Chen HQ, 2009, SOIL TILL RES, V106, P85, DOI 10.1016/j.still.2009.09.009; [陈尚洪 CHEN Shanghong], 2008, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V14, P806; Dai Z.G, 2009, STUDY NUTR RELEASE C; Diekow J, 2005, SOIL TILL RES, V81, P87, DOI 10.1016/j.still.2004.05.003; Ding Le-Le, 2013, Plant Science Journal, V31, P49, DOI 10.3724/SP.J.1142.2013.10049; Dou F, 2008, SOIL SCI SOC AM J, V72, P1445, DOI 10.2136/sssaj2007.0230; [段华平 Duan Huaping], 2012, [水土保持通报, Bulletin of Soil and Water Conservation], V32, P23; Editorial Board of China Agriculture Yearbook, 2012, CHIN AGR YB 2009; Galantini JA, 2004, GEODERMA, V123, P143, DOI 10.1016/j.geoderma.2004.02.008; Gao YJ, 2000, SOIL ENV SCI, V9, P27; Ghani A, 2003, SOIL BIOL BIOCHEM, V35, P1231, DOI 10.1016/S0038-0717(03)00186-X; Ghimire R, 2012, PADDY WATER ENVIRON, V10, P95, DOI 10.1007/s10333-011-0268-0; Govaerts B, 2007, PLANT SOIL, V291, P39, DOI 10.1007/s11104-006-9172-6; GREGORICH EG, 1994, CAN J SOIL SCI, V74, P367, DOI 10.4141/cjss94-051; [郝建华 Hao Jianhua], 2010, [南京农业大学学报, Journal of Nanjing Agricultural University], V33, P13; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; Hernanz JL, 2002, SOIL TILL RES, V66, P129, DOI 10.1016/S0167-1987(02)00021-1; Jastrow JD, 1996, SOIL BIOL BIOCHEM, V28, P665, DOI 10.1016/0038-0717(95)00159-X; Jiang PK, 2006, FOREST ECOL MANAG, V236, P30, DOI 10.1016/j.foreco.2006.06.010; Leng SC, 1992, BIOL SCI FIELD EXPT; Li CF, 2012, SOIL TILL RES, V119, P31, DOI 10.1016/j.still.2011.12.005; Li X.J., 1999, TERRITORY NATURAL RE, V1, P43; Liu DY, 2009, PHYSL ECOLOGICAL MEC; Liu ShiPing, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P48; LOGINOW W, 1987, Polish Journal of Soil Science, V20, P47; Lu R K., 1999, SOIL AGR CHEM ANAL, P106; Mikha MM, 2004, SOIL SCI SOC AM J, V68, P809, DOI 10.2136/sssaj2004.0809; Miller AJ, 2004, BIOGEOCHEMISTRY, V67, P57, DOI 10.1023/B:BIOG.0000015302.16640.a5; Ouedraogo E, 2006, SOIL TILL RES, V91, P57, DOI 10.1016/j.still.2005.11.004; Paustian K., 1997, SOIL ORGANIC MATTER; Puget P, 2005, SOIL TILL RES, V80, P201, DOI 10.1016/j.still.2004.03.018; Rudrappa L, 2006, SOIL TILL RES, V88, P180, DOI 10.1016/j.still.2005.05.008; Shan YH, 2005, AGR ECOSYST ENVIRON, V111, P270, DOI 10.1016/j.agee.2005.05.011; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song MingWei, 2008, RDA Journal of Agro-Environment Science, V27, P622; Stockfisch N, 1999, SOIL TILL RES, V52, P91, DOI 10.1016/S0167-1987(99)00063-X; Tian Shen-zhong, 2010, Yingyong Shengtai Xuebao, V21, P373; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P697, DOI 10.1016/0038-0717(87)90051-4; [王丹丹 Wang Dandan], 2013, [农业环境科学学报, Journal of Agro-Environment Science], V32, P735; [王晶 WANG Jing], 2008, [干旱地区农业研究, Agricultural Research in the Arid Areas], V26, P8; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wu TY, 2004, SOIL TILL RES, V77, P59, DOI 10.1016/j.still.2003.10.002; Yamashita T, 2006, SOIL BIOL BIOCHEM, V38, P3222, DOI 10.1016/j.soilbio.2006.04.013; Yang CM, 2005, GEODERMA, V124, P133, DOI 10.1016/j.geoderma.2004.04.008; [杨景成 Yang Jingcheng], 2003, [生态学报, Acta Ecologica Sinica], V23, P787; Zhang Peng, 2011, Journal of Agro-Environment Science, V30, P2518; Zhang ZJ, 1998, CHINESE J SOIL SCI, V29, P154; [朱利群 Zhu Liqun], 2011, [土壤通报, Journal of Soil Science], V42, P81; [左玉萍 Zuo Yuping], 2004, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V32, P61	53	47	58	13	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88900	10.1371/journal.pone.0088900	http://dx.doi.org/10.1371/journal.pone.0088900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586434	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700040
J	Kozak, A; Schedlbauer, G; Peters, C; Nienhaus, A				Kozak, Agnessa; Schedlbauer, Grita; Peters, Claudia; Nienhaus, Albert			Self-Reported Musculoskeletal Disorders of the Distal Upper Extremities and the Neck in German Veterinarians: A Cross-Sectional Study	PLOS ONE			English	Article							WORK-RELATED ACCIDENTS; RISK-FACTORS; AUSTRALIAN VETERINARIANS; OCCUPATIONAL-DISEASES; UPPER-LIMB; BACK-PAIN; POPULATION; INJURIES; HAZARDS; PREVALENCE	Background: Veterinary work is a physically demanding profession and entails the risk of injuries and diseases of the musculoskeletal system, particularly in the upper body. The prevalence of musculoskeletal disorders (MSD), the consequences and work-related accidents in German veterinarians were investigated. Work-related and individual factors associated with MSD of upper extremities and the neck were analyzed. Methods: In 2011, a self-reporting Standardized Nordic Questionnaire was mailed to registered veterinarians in seven federal medical associations in Germany. A total of 3174 (38.4%) veterinarians responded. Logistic regression analysis was used to determine the association between risk factors and MSD-related impairment of daily activities. Results: MSD in the neck (66.6%) and shoulder (60.5%) were more prevalent than in the hand (34.5%) or elbow (24.5%). Normal activities were affected in 28.7% (neck), 29.5% (shoulder), 19.4% (hand) and 14% (elbow) of the respondents. MSD in the upper body occurred significantly more often in large animal practitioners. Accidents that resulted in MSD were most frequently reported in the hand/wrist (14.3%) or in the shoulder (10.8%). The majority of all accidents in the distal upper extremities were caused by animals than by other factors (19% vs. 9.2%). For each area of the body, a specific set of individual and work-related factors contributed significantly to severe MSD: Older age, gender, previous injuries, BMI, practice type, veterinary procedures such as dentistry, rectal procedures and obstetric procedures as well as high demands and personal burnout. Conclusion: From the perspective of occupational health and safety, it seems to be necessary to improve accident prevention and to optimize the ergonomics of specific tasks. Our data suggest the need for target group-specific preventive measures that also focus on the psychological factors at work.	[Kozak, Agnessa; Peters, Claudia; Nienhaus, Albert] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Hamburg, Germany; [Schedlbauer, Grita; Nienhaus, Albert] Inst Statutory Accid Insurance & Prevent Healthca, Dept Occupat Hlth Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Kozak, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Hamburg, Germany.	a.kozak@uke.de			German Federal Chamber of Veterinary Surgeons	German Federal Chamber of Veterinary Surgeons	The authors would like to thank the German Federal Chamber of Veterinary Surgeons for their cooperation and support. We specifically acknowledge the Veterinary Medical Associations from Berlin, Brandenburg, Baden-Wurttemberg Lower Saxony, Bavaria, Westphalia-Lippe, and Schleswig-Holstein for the provision of addresses and/or consignment of the questionnaires. We thank all veterinarians for their substantial participation in the study.	Ailsby RL, 1996, CAN VET J, V37, P411; Aptel M, 2002, JOINT BONE SPINE, V69, P546, DOI 10.1016/S1297-319X(02)00450-5; Beermann B, 2007, ARBEITSBEDINGUNGEN D; Berry SL, 2012, AM J IND MED, V55, P855, DOI 10.1002/ajim.22076; Bongers PM, 2006, J OCCUP REHABIL, V16, P279, DOI 10.1007/s10926-006-9044-1; Cattell Marguerita B., 2000, Bovine Practitioner, V34, P1; de Zwart BCH, 2001, INT ARCH OCC ENV HEA, V74, P21; DeForge DH, 2002, J VET DENT, V19, P196, DOI 10.1177/089875640201900402; Deutsches Tierarzteblatt, 2012, STAT 2011 TIER BUND; deZwart BCH, 1995, INT ARCH OCC ENV HEA, V68, P1; Epp T, 2012, CAN VET J, V53, P151; Fritschi L, 2006, OCCUP MED-OXFORD, V56, P199, DOI 10.1093/occmed/kqj037; Gabel CL, 2002, EPIDEMIOLOGY, V13, P80, DOI 10.1097/00001648-200201000-00013; Harling Melanie, 2009, J Occup Med Toxicol, V4, P4, DOI 10.1186/1745-6673-4-4; Hayes MJ, 2009, INT J DENT HYG, V7, P159, DOI 10.1111/j.1601-5037.2009.00395.x; Hengel KMO, 2011, INT ARCH OCC ENV HEA, V84, P115, DOI 10.1007/s00420-010-0565-8; Jeyaretnam J, 2000, AUST VET J, V78, P751, DOI 10.1111/j.1751-0813.2000.tb10446.x; Kostelnik K, 2009, DEUT TIERARZTL WOCH, V116, P412, DOI 10.2376/0341-6593-116-412; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; Kristensen TS, 2005, WORK STRESS, V19, P192, DOI 10.1080/02678370500297720; Kristensen TS, 2004, WORK STRESS, V18, P305, DOI 10.1080/02678370412331314005; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; LANDERCASPER J, 1988, J TRAUMA, V28, P1255, DOI 10.1097/00005373-198808000-00020; Langley RL, 2001, WILD ENVIRON MED, V12, P168, DOI 10.1580/1080-6032(2001)012[0168:OFDTAR]2.0.CO;2; Lee CE, 2001, ARCH PHYS MED REHAB, V82, P227, DOI 10.1053/apmr.2001.18214; Lipscomb J, 2004, AM J PUBLIC HEALTH, V94, P1431, DOI 10.2105/AJPH.94.8.1431; Loomans JBA, 2008, EQUINE VET EDUC, V20, P597, DOI 10.2746/095777308X360177; Iglesias MEL, 2011, MED LAV, V102, P502; Lucas M, 2009, OCCUP MED-OXFORD, V59, P327, DOI 10.1093/occmed/kqp070; Meers C, 2008, VLAAMS DIERGEN TIJDS, V77, P40; Michel A, 1997, SPINE, V22, P296, DOI 10.1097/00007632-199702010-00013; Nienhaus A, 2005, INT ARCH OCC ENV HEA, V78, P230, DOI 10.1007/s00420-004-0583-5; Norwood S, 2000, J TRAUMA, V48, P740, DOI 10.1097/00005373-200004000-00025; Nubling M, 2006, GMS PSYCHO SOC MED, V3; Poole AG, 1999, J AM VET MED ASSOC, V215, P1433; Randall E, 2012, VET RADIOL ULTRASOUN, V53, P459, DOI 10.1111/j.1740-8261.2012.01942.x; Rejula K, 2003, AM J IND MED, V44, P46, DOI 10.1002/ajim.10228; Roquelaure Y, 2006, ARTHRIT RHEUM-ARTHR, V55, P765, DOI 10.1002/art.22222; Scuffham AM, 2010, NEW ZEAL VET J, V58, P37, DOI 10.1080/00480169.2010.64872; Scuffham AM, 2010, APPL ERGON, V41, P444, DOI 10.1016/j.apergo.2009.09.009; Singleton G, 2005, VET REC, V157, P491, DOI 10.1136/vr.157.16.491-b; Smith DR, 2009, AUST VET J, V87, P260, DOI 10.1111/j.1751-0813.2009.00435.x; Stoltzfus JC, 2011, ACAD EMERG MED, V18, P1099, DOI 10.1111/j.1553-2712.2011.01185.x; Toomingas A, 1995, J CLIN EPIDEMIOL, V48, P1473, DOI 10.1016/0895-4356(95)00061-5; Walker-Bone K, 2002, OCCUP MED-OXFORD, V52, P441, DOI 10.1093/occmed/52.8.441; Wijnhoven HAH, 2006, CLIN J PAIN, V22, P717, DOI 10.1097/01.ajp.0000210912.95664.53	46	15	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89362	10.1371/journal.pone.0089362	http://dx.doi.org/10.1371/journal.pone.0089362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586718	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900133
J	Maeda, Y; Terasawa, H; Nakano, Y; Monde, K; Yusa, K; Oka, S; Takiguchi, M; Harada, S				Maeda, Yosuke; Terasawa, Hiromi; Nakano, Yusuke; Monde, Kazuaki; Yusa, Keisuke; Oka, Shinichi; Takiguchi, Masafumi; Harada, Shinji			V3-Independent Competitive Resistance of a Dual-X4 HIV-1 to the CXCR4 Inhibitor AMD3100	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GP120 ENVELOPE GLYCOPROTEIN; AMINO-ACID SUBSTITUTION; N-LINKED GLYCOSYLATION; SMALL-MOLECULE; CORECEPTOR USAGE; ENTRY INHIBITOR; CCR5; RECEPTOR; V3	A CXCR4 inhibitor-resistant HIV-1 was isolated from a dual-X4 HIV-1 in vitro. The resistant variant displayed competitive resistance to the CXCR4 inhibitor AMD3100, indicating that the resistant variant had a higher affinity for CXCR4 than that of the wild-type HIV-1. Amino acid sequence analyses revealed that the resistant variant harbored amino acid substitutions in the V2, C2, and C4 regions, but no remarkable changes in the V3 loop. Site-directed mutagenesis confirmed that the changes in the C2 and C4 regions were principally involved in the reduced sensitivity to AMD3100. Furthermore, the change in the C4 region was associated with increased sensitivity to soluble CD4, and profoundly enhanced the entry efficiency of the virus. Therefore, it is likely that the resistant variant acquired the higher affinity for CD4/CXCR4 by the changes in non-V3 regions. Taken together, a CXCR4 inhibitor-resistant HIV-1 can evolve using a non-V3 pathway.	[Maeda, Yosuke; Terasawa, Hiromi; Nakano, Yusuke; Monde, Kazuaki; Harada, Shinji] Kumamoto Univ, Fac Life Sci, Dept Med Virol, Kumamoto, Japan; [Yusa, Keisuke] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo, Japan; [Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Takiguchi, Masafumi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	Kumamoto University; National Institute of Health Sciences - Japan; National Center for Global Health & Medicine - Japan; Kumamoto University	Maeda, Y (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Med Virol, Kumamoto, Japan.	ymaeda@kumamoto-u.ac.jp	Takiguchi, Masafumi/E-7468-2013; Monde, Kazuaki/I-6493-2019	Monde, Kazuaki/0000-0002-8314-5306; Oka, Shinichi/0000-0002-9283-2167	Institute of Tropical Medicine, Nagasaki University; Global COE program "Global Education and Research Center Aiming at the control of AIDS''; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23590548] Funding Source: KAKEN	Institute of Tropical Medicine, Nagasaki University; Global COE program "Global Education and Research Center Aiming at the control of AIDS''; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Joint Research Grant from the Institute of Tropical Medicine, Nagasaki University, and the Global COE program "Global Education and Research Center Aiming at the control of AIDS'' supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassopoulou CG, 2007, PLOS PATHOG, V3, P720, DOI 10.1371/journal.ppat.0030079; Anastassopoulou CG, 2009, P NATL ACAD SCI USA, V106, P5318, DOI 10.1073/pnas.0811713106; Arakaki R, 1999, J VIROL, V73, P1719, DOI 10.1128/JVI.73.2.1719-1723.1999; Armand-Ugon M, 2003, ANTIVIR THER, V8, P1; Casper C, 2002, AIDS RES HUM RETROV, V18, P343, DOI 10.1089/088922202753519124; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Delobel P, 2010, AIDS, V24, P1382, DOI 10.1097/QAD.0b013e328338b7a6; DeVreese K, 1996, J VIROL, V70, P689, DOI 10.1128/JVI.70.2.689-696.1996; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Este JA, 1999, J VIROL, V73, P5577; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Harrison JE, 2008, J VIROL, V82, P11695, DOI 10.1128/JVI.01303-08; Hatse S, 2001, MOL PHARMACOL, V60, P164, DOI 10.1124/mol.60.1.164; Hoffman TL, 1999, MOL MEMBR BIOL, V16, P57, DOI 10.1080/096876899294760; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Huang W, 2007, J VIROL, V81, P7885, DOI 10.1128/JVI.00218-07; Jinno A, 1998, BIOCHEM BIOPH RES CO, V243, P497, DOI 10.1006/bbrc.1998.8130; Kajumo F, 2000, VIROLOGY, V271, P240, DOI 10.1006/viro.2000.0308; Kanbara K, 2001, AIDS RES HUM RETROV, V17, P615, DOI 10.1089/088922201300119716; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Maeda Y, 2000, J VIROL, V74, P1787, DOI 10.1128/JVI.74.4.1787-1793.2000; Maeda Y, 2008, ANTIVIR RES, V77, P128, DOI 10.1016/j.antiviral.2007.11.001; Marozsan AJ, 2005, VIROLOGY, V338, P182, DOI 10.1016/j.virol.2005.04.035; Moncunill G, 2008, MOL PHARMACOL, V73, P1264, DOI 10.1124/mol.107.042911; Ogert RA, 2001, J VIROL, V75, P5998, DOI 10.1128/JVI.75.13.5998-6006.2001; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Polzer S, 2001, GLYCOBIOLOGY, V11, P11, DOI 10.1093/glycob/11.1.11; Pramanik L, 2011, J GEN VIROL, V92, P1917, DOI 10.1099/vir.0.029447-0; Pugach P, 2007, VIROLOGY, V361, P212, DOI 10.1016/j.virol.2006.11.004; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Schols D, 1997, ANTIVIR RES, V35, P147, DOI 10.1016/S0166-3542(97)00025-9; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Suphaphiphat P, 2003, J VIROL, V77, P3832, DOI 10.1128/JVI.77.6.3832-3837.2003; Suphaphiphat P, 2007, VIROLOGY, V360, P182, DOI 10.1016/j.virol.2006.10.019; Symons J, 2011, J ANTIMICROB CHEMOTH, V66, P890, DOI 10.1093/jac/dkq535; Toma J, 2010, AIDS, V24, P2181, DOI 10.1097/QAD.0b013e32833c543f; Trkola A, 2002, P NATL ACAD SCI USA, V99, P395, DOI 10.1073/pnas.012519099; Watanabe K, 2013, MICROBES INFECT, V15, P874, DOI 10.1016/j.micinf.2013.08.002; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yuan Y, 2013, PLOS ONE, V8; Yuan YZ, 2011, VIROLOGY, V413, P293, DOI 10.1016/j.virol.2011.02.019; Yusa K, 2005, J BIOL CHEM, V280, P30083, DOI 10.1074/jbc.M414360200; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89515	10.1371/journal.pone.0089515	http://dx.doi.org/10.1371/journal.pone.0089515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586840	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900151
J	Gupta, S; Wilejto, M; Pole, JD; Guttmann, A; Sung, LL				Gupta, Sumit; Wilejto, Marta; Pole, Jason D.; Guttmann, Astrid; Sung, Lillian			Low Socioeconomic Status Is Associated with Worse Survival in Children with Cancer: A Systematic Review	PLOS ONE			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; CLINICAL-TRIALS; CHILDHOOD; ABANDONMENT; PREDICTORS; MORTALITY; HODGKINS; INEQUALITIES; PREVALENCE	Background: While low socioeconomic status (SES) has been associated with inferior cancer outcome among adults, its impact in pediatric oncology is unclear. Our objective was therefore to conduct a systematic review to determine the impact of SES upon outcome in children with cancer. Methods: We searched Ovid Medline, EMBASE and CINAHL from inception to December 2012. Studies for which survival-related outcomes were reported by socioeconomic subgroups were eligible for inclusion. Two reviewers independently assessed articles and extracted data. Given anticipated heterogeneity, no quantitative meta-analyses were planned a priori. Results: Of 7,737 publications, 527 in ten languages met criteria for full review; 36 studies met final inclusion criteria. In low-and middle-income countries (LMIC), lower SES was uniformly associated with inferior survival, regardless of the measure chosen. The majority of associations were statistically significant. Of 52 associations between socioeconomic variables and outcome among high-income country (HIC) children, 38 (73.1%) found low SES to be associated with worse survival, 15 of which were statistically significant. Of the remaining 14 (no association or high SES associated with worse survival), only one was statistically significant. Both HIC studies examining the effect of insurance found uninsured status to be statistically associated with inferior survival. Conclusions: Socioeconomic gradients in which low SES is associated with inferior childhood cancer survival are ubiquitous in LMIC and common in HIC. Future studies should elucidate mechanisms underlying these gradients, allowing the design of interventions mediating socioeconomic effects. Targeting the effect of low SES will allow for further improvements in childhood cancer survival.	[Gupta, Sumit; Wilejto, Marta; Sung, Lillian] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada; [Gupta, Sumit; Guttmann, Astrid; Sung, Lillian] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Pole, Jason D.] Pediat Oncol Grp Ontario, Toronto, ON, Canada; [Pole, Jason D.; Guttmann, Astrid] Inst Clin & Evaluat Sci, Toronto, ON, Canada; [Guttmann, Astrid] Hosp Sick Children, Div Paediat Med, Toronto, ON M5G 1X8, Canada; [Gupta, Sumit; Wilejto, Marta; Sung, Lillian] Hosp Sick Children, Program Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Gupta, Sumit; Guttmann, Astrid; Sung, Lillian] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Gupta, S (corresponding author), Hosp Sick Children, Div Haematol Oncol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sumit.gupta@sickkids.ca	Pole, Jason D./AAD-9148-2020	Pole, Jason D./0000-0002-0413-5434; Gupta, Sumit/0000-0003-1334-3670				Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395; Bhatia S, 2012, J CLIN ONCOL, V30, P2094, DOI 10.1200/JCO.2011.38.9924; Birch JM, 2008, BRIT J CANCER, V99, P830, DOI 10.1038/sj.bjc.6604460; Bonilla M, 2010, EUR J CANCER, V46, P3280, DOI 10.1016/j.ejca.2010.07.001; Bonilla M, 2009, INT J CANCER, V125, P2144, DOI 10.1002/ijc.24534; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Carlos LL, 2002, MED PEDIATR ONCOL, V38, P211, DOI 10.1002/mpo.1314; Charalampopoulou A, 2004, EUR J CANCER PREV, V13, P397, DOI 10.1097/00008469-200410000-00007; Chen IM, 2012, BLOOD, V119, P3512, DOI 10.1182/blood-2011-11-394221; Croucher C, 2009, CLIN ONCOL-UK, V21, P417, DOI 10.1016/j.clon.2009.02.006; Dinand V, 2007, EUR J CANCER, V43, P161, DOI 10.1016/j.ejca.2006.08.036; Drotar D, 2004, ETHICS BEHAV, V14, P1, DOI 10.1207/s15327019eb1401_1; Frederiksen BL, 2009, EUR J CANCER, V45, P1248, DOI 10.1016/j.ejca.2008.11.035; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Gupta S, 2009, BRIT J CANCER, V100, P1026, DOI 10.1038/sj.bjc.6604895; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hord MH, 1996, CANCER-AM CANCER SOC, V77, P563; Hsieh MH, 2009, J PEDIAT HEMATOL ONC, V31, P942, DOI 10.1097/MPH.0b013e3181bcc809; Kent EE, 2009, CANCER CAUSE CONTROL, V20, P1409, DOI 10.1007/s10552-009-9367-2; Kulkarni KP, 2010, ASIAN PAC J CANCER P, V11, P1435; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lightfoot TJ, 2012, EUR J CANCER, V48, P263, DOI 10.1016/j.ejca.2011.10.007; Luo ZC, 2006, CAN MED ASSOC J, V174, P1415, DOI 10.1503/cmaj.051096; Marmot MG, 2003, PERSPECT BIOL MED, V46, pS9, DOI 10.1353/pbm.2003.0056; MCWHIRTER WR, 1983, MED J AUSTRALIA, V2, P319, DOI 10.5694/j.1326-5377.1983.tb122488.x; Metzger ML, 2008, J CLIN ONCOL, V26, P1282, DOI 10.1200/JCO.2007.14.0699; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mostert S, 2010, ARCH DIS CHILD, V95, P20, DOI 10.1136/adc.2008.154138; Mostert S, 2006, PEDIATRICS, V118, pE1600, DOI 10.1542/peds.2005-3015; Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0; Pedrosa MF, 2007, J PEDIAT-BRAZIL, V83, P547, DOI [10.2223/JPED.1726, 10.1590/S0021-75572007000800012]; PETRIDOU E, 1994, ONCOLOGY, V51, P391; Rabi DM, 2010, CIRC-CARDIOVASC QUAL, V3, P48, DOI 10.1161/CIRCOUTCOMES.108.840611; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rondelli R, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-44; Schillinger JA, 1999, ARCH DIS CHILD, V80, P311, DOI 10.1136/adc.80.4.311; Simon C, 2003, J CLIN ONCOL, V21, P2173, DOI 10.1200/JCO.2003.03.003; Stiller CA, 2008, BRIT J CANCER, V98, P1006, DOI 10.1038/sj.bjc.6604237; Syse A, 1870, INT J CANCER, V130, P1870; SZKLO M, 1978, CANCER, V42, P59, DOI 10.1002/1097-0142(197807)42:1<59::AID-CNCR2820420109>3.0.CO;2-J; Tang YM, 2008, PEDIATR BLOOD CANCER, V51, P380, DOI 10.1002/pbc.21629; The World Bank, 2012, DAT SHORT HIST; Viana MB, 1998, INT J CANCER, V78, P56, DOI 10.1002/(SICI)1097-0215(1998)78:11+<56::AID-IJC16>3.0.CO;2-X; WALTERS TR, 1972, CANCER, V29, P210, DOI 10.1002/1097-0142(197201)29:1<210::AID-CNCR2820290131>3.0.CO;2-U; Wang YR, 2011, LEUKEMIA RES, V35, P1628, DOI 10.1016/j.leukres.2011.07.004; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007; Youlden DR, 1649, CANCER EPIDEM BIOMAR, V20, P1649	49	71	71	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89482	10.1371/journal.pone.0089482	http://dx.doi.org/10.1371/journal.pone.0089482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586813	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000048
J	Chapalamadugu, KC; VandeVoort, CA; Settles, ML; Robison, BD; Murdoch, GK				Chapalamadugu, Kalyan C.; VandeVoort, Catherine A.; Settles, Matthew L.; Robison, Barrie D.; Murdoch, Gordon K.			Maternal Bisphenol A Exposure Impacts the Fetal Heart Transcriptome	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; MONKEYS MACACA-MULATTA; THYROID-HORMONE; GENE-EXPRESSION; RHESUS-MONKEYS; DIFFERENTIAL REGULATION; WIDESPREAD EXPOSURE; GLUCOSE-HOMEOSTASIS; CARDIAC-HYPERTROPHY; SKELETAL-MUSCLE	Conditions during fetal development influence health and disease in adulthood, especially during critical windows of organogenesis. Fetal exposure to the endocrine disrupting chemical, bisphenol A (BPA) affects the development of multiple organ systems in rodents and monkeys. However, effects of BPA exposure on cardiac development have not been assessed. With evidence that maternal BPA is transplacentally delivered to the developing fetus, it becomes imperative to examine the physiological consequences of gestational exposure during primate development. Herein, we evaluate the effects of daily, oral BPA exposure of pregnant rhesus monkeys (Macaca mulatta) on the fetal heart transcriptome. Pregnant monkeys were given daily oral doses (400 mu g/kg body weight) of BPA during early (50-100 +/- 2 days post conception, dpc) or late (100 +/- 2 dpc - term), gestation. At the end of treatment, fetal heart tissues were collected and chamber specific transcriptome expression was assessed using genome-wide microarray. Quantitative real-time PCR was conducted on select genes and ventricular tissue glycogen content was quantified. Our results show that BPA exposure alters transcription of genes that are recognized for their role in cardiac pathophysiologies. Importantly, myosin heavy chain, cardiac isoform alpha (Myh6) was down-regulated in the left ventricle, and 'A Disintegrin and Metalloprotease 12', long isoform (Adam12-I) was up-regulated in both ventricles, and the right atrium of the heart in BPA exposed fetuses. BPA induced alteration of these genes supports the hypothesis that exposure to BPA during fetal development may impact cardiovascular fitness. Our results intensify concerns about the role of BPA in the genesis of human metabolic and cardiovascular diseases.	[Chapalamadugu, Kalyan C.; Murdoch, Gordon K.] Univ Idaho, Dept Anim & Vet Sci, Moscow, ID 83843 USA; [VandeVoort, Catherine A.] Univ Calif Davis, Dept Obstet & Gynecol, Davis, CA 95616 USA; [Settles, Matthew L.] Univ Idaho, Dept Comp Sci, Moscow, ID 83843 USA; [Robison, Barrie D.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Settles, Matthew L.; Robison, Barrie D.] Univ Idaho, Program Bioinformat & Computat Biol, Moscow, ID 83843 USA; [VandeVoort, Catherine A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA	Idaho; University of Idaho; University of California System; University of California Davis; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; University of California System; University of California Davis	Murdoch, GK (corresponding author), Univ Idaho, Dept Anim & Vet Sci, Moscow, ID 83843 USA.	gmurdoch@uidaho.edu	Robison, Barrie/AGW-1927-2022; Settles, Matthew L/F-2031-2011	Settles, Matthew L/0000-0002-3424-1086	Passport Foundation-Environmental Health Science Innovation Fund [D4B873, 02ORO]; NIH [ES016770, OD011107]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016770] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	Passport Foundation-Environmental Health Science Innovation Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Experimental work was supported by The Passport Foundation-Environmental Health Science Innovation Fund under the grant D4B873 program 02ORO. Animal costs were supported by NIH grant ES016770 to CAV and OD011107 to CNPRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Balakrishnan B, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.025; Barker DJP, 2010, EUR J HEART FAIL, V12, P819, DOI 10.1093/eurjhf/hfq069; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Barth AS, 2005, PFLUG ARCH EUR J PHY, V450, P201, DOI 10.1007/s00424-005-1404-8; Buterin T, 2006, CARCINOGENESIS, V27, P1567, DOI [10.1093/carcin/bci339, 10.1093/carcin/bgi339]; Cardin S, 2008, J MOL CELL CARDIOL, V45, P821, DOI 10.1016/j.yjmcc.2008.08.007; Chapalamadugu KC, 2009, COMP BIOCHEM PHYS B, V153, P66, DOI 10.1016/j.cbpb.2009.01.013; Cheng C Yan, 2011, Spermatogenesis, V1, P105; D'Cruz SC, 2012, REPROD SCI, V19, P163, DOI 10.1177/1933719111415547; D'Cruz SC, 2012, FOOD CHEM TOXICOL, V50, P1124, DOI 10.1016/j.fct.2011.11.041; Danzi S, 2008, THYROID, V18, P761, DOI 10.1089/thy.2008.0043; Fedak PWM, 2006, CIRCULATION, V113, P238, DOI 10.1161/CIRCULATIONAHA.105.571414; Fukushima A, 2007, NEUROSCI LETT, V411, P81, DOI 10.1016/j.neulet.2006.10.010; Gould JC, 1998, MOL CELL ENDOCRINOL, V142, P203, DOI 10.1016/S0303-7207(98)00084-7; Grohe C, 1997, FEBS LETT, V416, P107, DOI 10.1016/S0014-5793(97)01179-4; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Hengstler JG, 2011, CRIT REV TOXICOL, V41, P263, DOI 10.3109/10408444.2011.558487; Hunt PA, 2012, P NATL ACAD SCI USA, V109, P17525, DOI 10.1073/pnas.1207854109; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; Jimenez DF, 2003, J MED PRIMATOL, V32, P315, DOI 10.1046/j.1600-0684.2003.00041.x; Jung KK, 2007, ARCH PHARM RES, V30, P616, DOI 10.1007/BF02977657; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Landles C, 2003, MOL ENDOCRINOL, V17, P2418, DOI 10.1210/me.2003-0097; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Le Pabic H, 2005, J HEPATOL, V43, P1038, DOI 10.1016/j.jhep.2005.05.025; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; MACCHIA E, 1990, ENDOCRINOLOGY, V126, P3232, DOI 10.1210/endo-126-6-3232; Mai W, 2004, P NATL ACAD SCI USA, V101, P10332, DOI 10.1073/pnas.0401843101; Marsh JD, 1998, CIRCULATION, V98, P256, DOI 10.1161/01.CIR.98.3.256; Matthews JB, 2001, CHEM RES TOXICOL, V14, P149, DOI 10.1021/tx0001833; Melzer D, 2012, CIRCULATION, V125, P1482, DOI 10.1161/CIRCULATIONAHA.111.069153; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Morkin E, 2000, MICROSC RES TECHNIQ, V50, P522, DOI 10.1002/1097-0029(20000915)50:6<522::AID-JEMT9>3.0.CO;2-U; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Naciff JM, 2005, TOXICOL SCI, V86, P396, DOI 10.1093/toxsci/kfi198; Naciff JM, 2010, TOXICOLOGY, V270, P137, DOI 10.1016/j.tox.2010.02.008; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Nishikawa M, 2010, ENVIRON HEALTH PERSP, V118, P1196, DOI 10.1289/ehp.0901575; OJAMAA K, 1991, BIOCHEM BIOPH RES CO, V179, P1269, DOI 10.1016/0006-291X(91)91710-T; Pantos C, 2008, PHARMACOL THERAPEUT, V118, P277, DOI 10.1016/j.pharmthera.2008.02.011; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reiser PJ, 2001, AM J PHYSIOL-HEART C, V280, pH1814, DOI 10.1152/ajpheart.2001.280.4.H1814; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Singleton DW, 2006, ENVIRON RES, V100, P86, DOI 10.1016/j.envres.2005.05.004; Solomon E, 2010, J BIOL CHEM, V285, P21969, DOI 10.1074/jbc.M110.133314; STRAIT KA, 1990, J BIOL CHEM, V265, P10514; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tabibiazar R, 2003, CIRC RES, V93, P1193, DOI 10.1161/01.RES.0000103171.42654.DD; TARANTAL AF, 1988, J MED PRIMATOL, V17, P105; Tarantal AF, 2005, MOL THER, V12, P87, DOI 10.1016/j.ymthe.2005.01.019; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Tharp AP, 2012, P NATL ACAD SCI USA, V109, P8190, DOI 10.1073/pnas.1120488109; Torrado M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/603159; TSIKA RW, 1990, P NATL ACAD SCI USA, V87, P379, DOI 10.1073/pnas.87.1.379; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2012, CIENC SAUDE COLETIVA, V17, P407, DOI 10.1590/S1413-81232012000200015; vom Saal FS, 2008, JAMA-J AM MED ASSOC, V300, P1353, DOI 10.1001/jama.300.11.1353; Wang X, 2009, HYPERTENSION, V54, P575, DOI 10.1161/HYPERTENSIONAHA.108.127670; Wang X, 2009, CIRCULATION, V119, P2480, DOI 10.1161/CIRCULATIONAHA.108.835488; Xu LC, 2005, TOXICOLOGY, V216, P197, DOI 10.1016/j.tox.2005.08.006; Yamada H, 2002, REPROD TOXICOL, V16, P735, DOI 10.1016/S0890-6238(02)00051-5; Yan S, 2011, PLOS ONE, V6, P27; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432	72	42	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89096	10.1371/journal.pone.0089096	http://dx.doi.org/10.1371/journal.pone.0089096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586524	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900027
J	Garg, R; Kumari, R; Tiwari, S; Goyal, S				Garg, Rohini; Kumari, Romika; Tiwari, Sneha; Goyal, Shweta			Genomic Survey, Gene Expression Analysis and Structural Modeling Suggest Diverse Roles of DNA Methyltransferases in Legumes	PLOS ONE			English	Article							TRANSCRIPTOME ANALYSIS; GLYCINE-MAX; HUMAN DNMT2; METHYLATION; ATLAS; SEQUENCE; CHICKPEA; DOMAINS; MET1; MAINTENANCE	DNA methylation plays a crucial role in development through inheritable gene silencing. Plants possess three types of DNA methyltransferases (MTases), namely Methyltransferase (MET), Chromomethylase (CMT) and Domains Rearranged Methyltransferase (DRM), which maintain methylation at CG, CHG and CHH sites. DNA MTases have not been studied in legumes so far. Here, we report the identification and analysis of putative DNA MTases in five legumes, including chickpea, soybean, pigeonpea, Medicago and Lotus. MTases in legumes could be classified in known MET, CMT, DRM and DNA nucleotide methyltransferases (DNMT2) subfamilies based on their domain organization. First three MTases represent DNA MTases, whereas DNMT2 represents a transfer RNA (tRNA) MTase. Structural comparison of all the MTases in plants with known MTases in mammalian and plant systems have been reported to assign structural features in context of biological functions of these proteins. The structure analysis clearly specified regions crucial for protein-protein interactions and regions important for nucleosome binding in various domains of CMT and MET proteins. In addition, structural model of DRM suggested that circular permutation of motifs does not have any effect on overall structure of DNA methyltransferase domain. These results provide valuable insights into role of various domains in molecular recognition and should facilitate mechanistic understanding of their function in mediating specific methylation patterns. Further, the comprehensive gene expression analyses of MTases in legumes provided evidence of their role in various developmental processes throughout the plant life cycle and response to various abiotic stresses. Overall, our study will be very helpful in establishing the specific functions of DNA MTases in legumes.	[Garg, Rohini; Kumari, Romika; Tiwari, Sneha; Goyal, Shweta] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Garg, R (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	rohini@nipgr.ac.in		Kumari, Romika/0000-0001-5347-7038	Department of Science and Technology, Government of India, under the INSPIRE Faculty Award [IFA-LSPA-05]	Department of Science and Technology, Government of India, under the INSPIRE Faculty Award	This work was funded by the Department of Science and Technology, Government of India, under the INSPIRE Faculty Award (grant number IFA-LSPA-05) to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Buryanov YI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P730, DOI 10.1007/s10541-005-0178-0; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dai Y, 2005, BBA-GENE STRUCT EXPR, V1729, P118, DOI 10.1016/j.bbaexp.2005.04.001; Dangwal M, 2013, J MOL BIOL, V425, P2853, DOI 10.1016/j.jmb.2013.05.021; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Durdevic Z, 2013, EMBO REP, V14, P269, DOI 10.1038/embor.2013.3; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Frauer C, 2011, P NATL ACAD SCI USA, V108, P8919, DOI 10.1073/pnas.1105804108; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Gutzat R, 2012, CURR OPIN PLANT BIOL, V15, P568, DOI 10.1016/j.pbi.2012.08.007; Henderson IR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001182; Henikoff S, 1998, GENETICS, V149, P307; Holec S, 2012, PLANT PHYSIOL, V158, P35, DOI 10.1104/pp.111.186445; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; Jurkowski TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028104; Kamiya N, 2003, PLANT J, V35, P429, DOI 10.1046/j.1365-313X.2003.01816.x; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Ko JH, 2006, MOL GENET GENOMICS, V276, P517, DOI 10.1007/s00438-006-0157-1; Kohler C, 2012, ANNU REV PLANT BIOL, V63, P331, DOI 10.1146/annurev-arplant-042811-105514; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu XC, 2012, PLANT PHYSIOL, V158, P119, DOI 10.1104/pp.111.184275; Luo M, 2004, TRAFFIC, V5, P847, DOI 10.1111/j.1600-0854.2004.00227.x; Malik G, 2012, FEBS J, V279, P4081, DOI 10.1111/febs.12002; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Naumann U, 2011, GENETICS, V187, P977, DOI 10.1534/genetics.110.125401; Pavlopoulou A, 2007, GENOMICS, V90, P530, DOI 10.1016/j.ygeno.2007.06.011; Roulin A, 2013, PLANT J, V73, P143, DOI 10.1111/tpj.12026; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Schmidt A, 2013, PLANT J, V73, P776, DOI 10.1111/tpj.12070; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Sharma R, 2013, PLANTA, V238, P871, DOI 10.1007/s00425-013-1940-y; Sharma R, 2009, FEBS J, V276, P6301, DOI 10.1111/j.1742-4658.2009.07338.x; Singh VK, 2013, PLANT BIOTECHNOL J, V11, P691, DOI 10.1111/pbi.12059; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Thiagarajan D, 2011, EPIGENETICS-US, V6, P103, DOI 10.4161/epi.6.1.13418; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Varshney RK, 2013, BIOTECHNOL ADV, V31, P1120, DOI 10.1016/j.biotechadv.2013.01.001; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Verdier J, 2013, PLANT J, V74, P351, DOI 10.1111/tpj.12119; Wada Y, 2003, J BIOL CHEM, V278, P42386, DOI 10.1074/jbc.M303892200; Wada Y, 2005, PLANT BIOTECHNOL, V22, P71, DOI DOI 10.5511/plantbiotechnology.22.71; Woo HR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000156; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; Yang N, 2013, CRIT REV BIOCHEM MOL, V48, P211, DOI 10.3109/10409238.2012.742035; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033	62	32	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88947	10.1371/journal.pone.0088947	http://dx.doi.org/10.1371/journal.pone.0088947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586452	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900021
J	Yokomichi, H; Kurihara, S; Yokoyama, T; Inoue, E; Tanaka-Taya, K; Kono, S; Yamagata, Z				Yokomichi, Hiroshi; Kurihara, Shintaro; Yokoyama, Tetsuji; Inoue, Eisuke; Tanaka-Taya, Keiko; Kono, Shigeru; Yamagata, Zentaro			The Pandemic Influenza A (H1N1) 2009 Vaccine Does Not Increase the Mortality Rate of Idiopathic Interstitial Pneumonia: A Matched Case-Control Study	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; FATAL ADVERSE EVENTS; IMMUNE-RESPONSE; ANTIBODY-RESPONSE; HEMODIALYSIS-PATIENTS; RHEUMATOID-ARTHRITIS; MONOVALENT VACCINES; PREGNANT-WOMEN; UNITED-STATES; SAFETY	Background: Evidence regarding the mortality rate after administration of the pandemic influenza A (H1N1) 2009 vaccine on patients with underlying diseases is currently scarce. We conducted a case-control study in Japan to compare the mortality rates of patients with idiopathic interstitial pneumonia after the vaccines were administered and were not administered. Methods: Between October 2009 and March 2010, we collected clinical records in Japan and conducted a 1:1 matched case-control study. Patients with idiopathic interstitial pneumonia who died during this period were considered case patients, and those who survived were considered control patients. We determined and compared the proportion of each group that received the pandemic influenza A (H1N1) 2009 vaccine and estimated the odds ratio. Finally, we conducted simulations that compensated for the shortcomings of the study associated with adjusted severity of idiopathic interstitial pneumonia. Results: The case and control groups each comprised of 75 patients with idiopathic interstitial pneumonia. The proportion of patients who received the pandemic influenza A (H1N1) 2009 vaccine was 30.7% and 38.7% for the case and control groups, respectively. During that winter, the crude conditional odds ratio of mortality was 0.63 (95% confidence interval, 0.25-1.47) and the adjusted conditional odds ratio was 1.18 (95% confidence interval, 0.33-4.49); neither was significant. The simulation study showed more accurate conditional odds ratios of 0.63-0.71. Conclusions: In our study, we detected no evidence that the influenza A (H1N1) 2009 vaccine increased the mortality rate of patients with idiopathic interstitial pneumonia. The results, however, are limited by the small sample size and low statistical power. A larger-scale study is required.	[Yokomichi, Hiroshi; Yamagata, Zentaro] Univ Yamanashi, Dept Hlth Sci, Interdisciplinary Grad Sch Med & Engn, Chuo City, Yamanashi, Japan; [Kurihara, Shintaro] Nagasaki Univ, Infect Control & Educ Ctr, Nagasaki 852, Japan; [Yokoyama, Tetsuji] Natl Inst Publ Hlth, Dept Hlth Promot, Wako, Saitama 3510197, Japan; [Inoue, Eisuke] Kitasato Univ, Sch Pharm, Dept Clin Med Biostatist, Minato Ward, Tokyo, Japan; [Tanaka-Taya, Keiko] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Shinjuku Ward, Tokyo, Japan; [Kono, Shigeru] Nagasaki Univ Sch Med, Dept Internal Med 2, Nagasaki, Japan	University of Yamanashi; Nagasaki University; National Institute of Public Health - Japan; Kitasato University; National Institute of Infectious Diseases (NIID); Nagasaki University	Yokomichi, H (corresponding author), Univ Yamanashi, Dept Hlth Sci, Interdisciplinary Grad Sch Med & Engn, Chuo City, Yamanashi, Japan.	hyokomichi@yamanashi.ac.jp; zenymgt@yamanashi.ac.jp	Yokomichi, Hiroshi/B-2816-2013	Yokomichi, Hiroshi/0000-0001-7369-155X	Ministry of Health, Labour and Welfare, Japan [201005002A]; Grants-in-Aid for Scientific Research [24790614] Funding Source: KAKEN	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by a research grant from The Ministry of Health, Labour and Welfare, Japan (Grant Number 201005002A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shakra M, 2002, J RHEUMATOL, V29, P2555; Amendola A, 2001, J MED VIROL, V65, P644, DOI 10.1002/jmv.2085; Berlin JA, 2008, AM J PUBLIC HEALTH, V98, P1366, DOI 10.2105/AJPH.2007.124537; Borba EF, 2012, RHEUMATOLOGY, V51, P1061, DOI 10.1093/rheumatology/ker427; Broder K., 2009, Morbidity and Mortality Weekly Report, V58, P1351; BRODMAN R, 1978, ANN INTERN MED, V88, P735, DOI 10.7326/0003-4819-88-6-735; Busse WW, 2011, J ALLERGY CLIN IMMUN, V127, P130, DOI 10.1016/j.jaci.2010.11.014; Cecil RL, 2012, GOLDMANS CECIL MED, P646; Cecil RL, 2004, CECIL TXB MED, P526; Centers for Disease Control and Prevention, 2013, SEAS FLU SHOT; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; CHALMERS A, 1994, J RHEUMATOL, V21, P1203; Chang YT, 2012, VACCINE, V30, P5009, DOI 10.1016/j.vaccine.2012.05.016; de Roux A, 2006, VACCINE, V24, P1537, DOI 10.1016/j.vaccine.2005.10.007; Del Porto F, 2006, VACCINE, V24, P3217, DOI 10.1016/j.vaccine.2006.01.028; DeStefano F, 2010, LANCET, V375, P1146, DOI 10.1016/S0140-6736(09)61917-6; Eurich DT, 2008, AM J RESP CRIT CARE, V178, P527, DOI 10.1164/rccm.200802-282OC; Flynn PM, 2012, J INFECT DIS, V206, P421, DOI 10.1093/infdis/jis360; Folkenberg M, 2011, VACCINE, V29, P1180, DOI 10.1016/j.vaccine.2010.12.008; Geier MR, 2003, CLIN IMMUNOL, V107, P116, DOI 10.1016/S1521-6616(03)00046-9; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hanania NA, 2004, J ALLERGY CLIN IMMUN, V113, P717, DOI 10.1016/j.jaci.2003.12.584; HERRON A, 1979, JAMA-J AM MED ASSOC, V242, P53, DOI 10.1001/jama.242.1.53; Holvast A, 2006, ANN RHEUM DIS, V65, P913, DOI 10.1136/ard.2005.043943; Jackson LA, 2011, J INFECT DIS, V204, P854, DOI 10.1093/infdis/jir440; Jacobsen SJ, 2011, VACCINE, V29, P9573, DOI 10.1016/j.vaccine.2011.10.078; Kubiet MA, 1996, CHEST, V110, P367, DOI 10.1378/chest.110.2.367; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lachtin JM, 2011, WILEY SER PROBAB ST, P201; Lagler H, 2012, VACCINE, V30, P6864, DOI 10.1016/j.vaccine.2012.09.005; Lagler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036773; Lash TL., 2008, MODERN EPIDEMIOLOGY, pX; Launay O, 2011, J INFECT DIS, V204, P124, DOI 10.1093/infdis/jir211; Lertdumrongluk P, 2012, VACCINE, V30, P1108, DOI 10.1016/j.vaccine.2011.12.023; Liang XF, 2011, NEW ENGL J MED, V364, P638, DOI 10.1056/NEJMoa1008553; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Little R.J.A., 2002, STAT ANAL MISSING DA; Longo DL, 2012, HARRISONS PRINCIPLES, P2165; LOUIE JS, 1978, ANN INTERN MED, V88, P790, DOI 10.7326/0003-4819-88-6-790; Lu CC, 2011, VACCINE, V29, P444, DOI 10.1016/j.vaccine.2010.10.081; Mallory RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013755; Mamula P, 2007, CLIN GASTROENTEROL H, V5, P851, DOI 10.1016/j.cgh.2007.02.035; Manuel O, 2011, CLIN INFECT DIS, V52, P248, DOI 10.1093/cid/ciq104; Manzoli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024384; McNeil MM, 2010, CLIN INFECT DIS, V51, P871, DOI 10.1086/656295; Munoz FM, 2012, AM J OBSTET GYNECOL, V207, pS33, DOI 10.1016/j.ajog.2012.06.072; Nakada H, 2010, CLIN INFECT DIS, V51, P873, DOI 10.1086/656297; Nakada H, 2010, CLIN INFECT DIS, V50, P1548, DOI 10.1086/652719; Ortqvist A, 2007, EUR RESPIR J, V30, P414, DOI 10.1183/09031936.00135306; Parretta E, 2011, VACCINE, V29, P3708, DOI 10.1016/j.vaccine.2011.02.097; Phongsamart W, 2011, VACCINE, V29, P8705, DOI 10.1016/j.vaccine.2011.08.101; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; RISTOW SC, 1978, ANN INTERN MED, V88, P786, DOI 10.7326/0003-4819-88-6-786; Rousseau B, 2012, ANN ONCOL, V23, P450, DOI 10.1093/annonc/mdr141; SAITO H, 1980, ARCH NEUROL-CHICAGO, V37, P564, DOI 10.1001/archneur.1980.00500580060009; Shrank WH, 2011, J GEN INTERN MED, V26, P546, DOI 10.1007/s11606-010-1609-1; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Tavares F, 2011, VACCINE, V29, P6358, DOI 10.1016/j.vaccine.2011.04.114; Vajo Z, 2010, LANCET, V375, P49, DOI 10.1016/S0140-6736(09)62039-0; Vellozzi C, 2010, VACCINE, V28, P7248, DOI 10.1016/j.vaccine.2010.09.021; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; WILLIAMS GW, 1978, ANN INTERN MED, V88, P729, DOI 10.7326/0003-4819-88-6-729; World Health Organization, 2009, EXP ADV WHO PAND VAC; Yanagisawa N, 2011, VACCINE, V29, P5694, DOI 10.1016/j.vaccine.2011.06.003	64	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88927	10.1371/journal.pone.0088927	http://dx.doi.org/10.1371/journal.pone.0088927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586445	gold, Green Published, Green Submitted			2022-12-27	WOS:000332385900020
J	Kiffer-Moreira, T; Sheen, CR; Gasque, KCD; Bolean, M; Ciancaglini, P; van Elsas, A; Hoylaerts, MF; Millan, JL				Kiffer-Moreira, Tina; Sheen, Campbell R.; Gasque, Kellen Cristina da Silva; Bolean, Mayte; Ciancaglini, Pietro; van Elsas, Andrea; Hoylaerts, Marc F.; Millan, Jose Luis			Catalytic Signature of a Heat-Stable, Chimeric Human Alkaline Phosphatase with Therapeutic Potential	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; ACUTE KIDNEY INJURY; MURINE HYPOPHOSPHATASIA; BONE MINERALIZATION; GUT MICROBIOTA; KNOCKOUT MICE; SWISS-MODEL; METAL-IONS; SEPSIS; SITE	Recombinant alkaline phosphatases are becoming promising protein therapeutics to prevent skeletal mineralization defects, inflammatory bowel diseases, and treat acute kidney injury. By substituting the flexible crown domain of human intestinal alkaline phosphatase (IAP) with that of the human placental isozyme (PLAP) we generated a chimeric enzyme (ChimAP) that retains the structural folding of IAP, but displays greatly increased stability, active site Zn2+ binding, increased transphosphorylation, a higher turnover number and narrower substrate specificity, with comparable selectivity for bacterial lipopolysaccharide (LPS), than the parent IAP isozyme. ChimAP shows promise as a protein therapeutic for indications such as inflammatory bowel diseases, gut dysbioses and acute kidney injury.	[Kiffer-Moreira, Tina; Sheen, Campbell R.; Gasque, Kellen Cristina da Silva; Millan, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA; [Bolean, Mayte; Ciancaglini, Pietro] FFCLRP USP, Dept Quim, Sao Paulo, Brazil; [van Elsas, Andrea] AM Pharma BV, Bunnik, Netherlands; [Hoylaerts, Marc F.] Univ Louvain, Dept Cardiovasc Sci, Ctr Mol & Vasc Biol, Louvain, Belgium	Sanford Burnham Prebys Medical Discovery Institute; Universidade de Sao Paulo	Millan, JL (corresponding author), Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA.	millan@sanfordburnham.org	Bolean, Mayte/A-1484-2014; CIANCAGLINI, PIETRO/X-7410-2019; Ciancaglini, Pietro/C-4842-2012; Gasque, Kellen Cristina da Silva/I-7155-2016	Bolean, Mayte/0000-0002-8307-1298; CIANCAGLINI, PIETRO/0000-0002-2785-1345; Ciancaglini, Pietro/0000-0002-2785-1345; Hoylaerts, Marc/0000-0002-6474-3933; Gasque, Kellen Cristina da Silva/0000-0003-2015-2717	National Institutes of Health, USA [R01 DE12889]; AM Pharma; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012889] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AM Pharma; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by grant R01 DE12889 from the National Institutes of Health, USA, and a small grant from AM Pharma. The funder provided support in the form of salaries for authors [TKM, KCDSG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Bentala H, 2002, SHOCK, V18, P561, DOI 10.1097/00024382-200212000-00013; Bortolato M, 1999, PROTEINS, V37, P310; BOSSI M, 1993, J BIOL CHEM, V268, P25409; Chen KT, 2011, DIGEST DIS SCI, V56, P1020, DOI 10.1007/s10620-010-1396-x; Ciancaglini P, 1997, J INORG BIOCHEM, V66, P51, DOI 10.1016/S0162-0134(96)00159-6; Ciancaglini P, 2010, J BONE MINER RES, V25, P716, DOI 10.1359/jbmr.091023; Foster BL, 2013, J BONE MINER RES, V28, P271, DOI 10.1002/jbmr.1767; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heemskerk S, 2009, CRIT CARE MED, V37, P417, DOI 10.1097/CCM.0b013e31819598af; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hoylaerts MF, 2006, BIOCHEMISTRY-US, V45, P9756, DOI 10.1021/bi052471+; HOYLAERTS MF, 1992, BIOCHEM J, V286, P23, DOI 10.1042/bj2860023; Hoylaerts MF, 1997, J BIOL CHEM, V272, P22781, DOI 10.1074/jbc.272.36.22781; HOYLAERTS MF, 1991, EUR J BIOCHEM, V202, P605, DOI 10.1111/j.1432-1033.1991.tb16414.x; Hung HC, 2001, PROTEIN SCI, V10, P34, DOI 10.1110/ps.35201; Ince C, 2013, AM SOC NEPHROL, V24; Kaliannan K, 2013, P NATL ACAD SCI USA, V110, P7003, DOI 10.1073/pnas.1220180110; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kozlenkov A, 2004, J BONE MINER RES, V19, P1862, DOI 10.1359/JBMR.040608; Kozlenkov A, 2002, J BIOL CHEM, V277, P22992, DOI 10.1074/jbc.M202298200; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Le Du MH, 2002, J BIOL CHEM, V277, P49808, DOI 10.1074/jbc.M207394200; Lei W, 2013, REPRODUCTION, V146, P419, DOI 10.1530/REP-13-0153; Llinas P, 2005, J MOL BIOL, V350, P441, DOI 10.1016/j.jmb.2005.04.068; Lukas M, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3046690; Malo MS, 2010, GUT, V59, P1476, DOI 10.1136/gut.2010.211706; Manes T, 1998, J BIOL CHEM, V273, P23353, DOI 10.1074/jbc.273.36.23353; McKee MD, 2011, J DENT RES, V90, P470, DOI 10.1177/0022034510393517; MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4; Millan J.L., 2006, MAMMALIAN ALKALINE P; Millan JL, 2008, J BONE MINER RES, V23, P777, DOI 10.1359/JBMR.071213; Moss AK, 2013, AM J PHYSIOL-GASTR L, V304, pG597, DOI 10.1152/ajpgi.00455.2012; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Nakano T, 2007, AM J PHYSIOL-GASTR L, V292, pG1439, DOI 10.1152/ajpgi.00331.2006; Narisawa S, 2003, MOL CELL BIOL, V23, P7525, DOI 10.1128/MCB.23.21.7525-7530.2003; Narisawa S, 2001, J PATHOL, V193, P125, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH722&gt;3.0.CO;2-Y; Narisawa S, 2007, AM J PHYSIOL-GASTR L, V293, pG1068, DOI 10.1152/ajpgi.00073.2007; Peters E, 2013, J PHARMACOL EXP THER, V344, P2, DOI 10.1124/jpet.112.198226; Pettengill M, 2013, J BIOL CHEM, V288, P27315, DOI 10.1074/jbc.M113.484212; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickkers P, 2012, CRIT CARE, V16, DOI 10.1186/cc11159; Ramasamy S, 2011, INFLAMM BOWEL DIS, V17, P532, DOI 10.1002/ibd.21377; Stec B, 2010, ACTA CRYSTALLOGR F, V66, P866, DOI 10.1107/S1744309110019767; Street SE, 2013, J NEUROSCI, V33, P11314, DOI 10.1523/JNEUROSCI.0133-13.2013; VERPOOTEN GF, 1989, KIDNEY INT, V36, P617, DOI 10.1038/ki.1989.238; WAYMIRE KG, 1995, NAT GENET, V11, P45, DOI 10.1038/ng0995-45; Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173; Whyte MP, 2012, PEDIATRIC BONE: BIOLOGY & DISEASES, 2ND EDITION, P771, DOI 10.1016/B978-0-12-382040-2.10028-0; Yadav MC, 2012, J BONE MINER RES, V27, P1722, DOI 10.1002/jbmr.1619; Yadav MC, 2011, BONE, V49, P250, DOI 10.1016/j.bone.2011.03.770	52	48	52	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89374	10.1371/journal.pone.0089374	http://dx.doi.org/10.1371/journal.pone.0089374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586729	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700034
J	Ortega-Ramos, M; Jittawuttipoka, T; Saenkham, P; Czarnecka-Kwasiborski, A; Bottin, H; Cassier-Chauvat, C; Chauvat, F				Ortega-Ramos, Marcia; Jittawuttipoka, Thichakorn; Saenkham, Panatda; Czarnecka-Kwasiborski, Aurelia; Bottin, Herve; Cassier-Chauvat, Corinne; Chauvat, Franck			Engineering Synechocystis PCC6803 for Hydrogen Production: Influence on the Tolerance to Oxidative and Sugar Stresses	PLOS ONE			English	Article							CYANOBACTERIUM SYNECHOCYSTIS; BIDIRECTIONAL HYDROGENASE; SP PCC-6803; STRAIN PCC-6803; H-2 PRODUCTION; TRANSCRIPTION; PROMOTER; LEXA; MUTAGENESIS; REGULATOR	In the prospect of engineering cyanobacteria for the biological photoproduction of hydrogen, we have studied the hydrogen production machine in the model unicellular strain Synechocystis PCC6803 through gene deletion, and overexpression (constitutive or controlled by the growth temperature). We demonstrate that the hydrogenase-encoding hoxEFUYH operon is dispensable to standard photoautotrophic growth in absence of stress, and it operates in cell defense against oxidative (H2O2) and sugar (glucose and glycerol) stresses. Furthermore, we showed that the simultaneous overproduction of the proteins HoxEFUYH and HypABCDE (assembly of hydrogenase), combined to an increase in nickel availability, led to an approximately 20-fold increase in the level of active hydrogenase. These novel results and mutants have major implications for those interested in hydrogenase, hydrogen production and redox metabolism, and their connections with environmental conditions.	[Ortega-Ramos, Marcia; Jittawuttipoka, Thichakorn; Saenkham, Panatda; Czarnecka-Kwasiborski, Aurelia; Cassier-Chauvat, Corinne; Chauvat, Franck] Univ Paris 11, Inst Biol & Technol Saclay, Lab Biol & Biotechnol Cyanobacteries, UMR8221,CEA,CNRS,CEA Saclay, Gif Sur Yvette, France; [Bottin, Herve] Univ Paris 11, Inst Biol & Technol Saclay, Lab Mecanismes Fondamentaux Bioenerget, UMR8221,CEA,CNRS,CEA Saclay, Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cassier-Chauvat, C (corresponding author), Univ Paris 11, Inst Biol & Technol Saclay, Lab Biol & Biotechnol Cyanobacteries, UMR8221,CEA,CNRS,CEA Saclay, Gif Sur Yvette, France.	corinne-cassier.chauvat@cea.fr; franck.chauvat@cea.fr	CASSIER-CHAUVAT, Corinne/E-7505-2010; Cassier-Chauvat, Corinnne/ABB-4815-2021; Chauvat, Franck/E-7394-2010	CASSIER-CHAUVAT, Corinne/0000-0001-6901-5559; Cassier-Chauvat, Corinnne/0000-0001-6901-5559; Chauvat, Franck/0000-0002-9151-7667	CEA; CNRS (Centre national de la recherche scientifique); Agence Nationale de la Recherche [ANR-09-BIOE002-01 (EngineeringH2cyano)]	CEA(French Atomic Energy Commission); CNRS (Centre national de la recherche scientifique)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the CEA, CNRS (Centre national de la recherche scientifique), and Agence Nationale de la Recherche Grant ANR-09-BIOE002-01 (EngineeringH2cyano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agervald A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-69; Aubert-Jousset E, 2011, FEBS J, V278, P4035, DOI 10.1111/j.1742-4658.2011.08308.x; Bandyopadhyay A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1139; Carrieri D, 2008, INT J HYDROGEN ENERG, V33, P2014, DOI 10.1016/j.ijhydene.2008.02.022; Carrieri D, 2011, BIORESOURCE TECHNOL, V102, P8368, DOI 10.1016/j.biortech.2011.03.103; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; da Silva GP, 2009, BIOTECHNOL ADV, V27, P30, DOI 10.1016/j.biotechadv.2008.07.006; Domain F, 2004, MOL MICROBIOL, V53, P65, DOI 10.1111/j.1365-2958.2004.04100.x; Dutheil J, 2012, J BACTERIOL, V194, P5423, DOI 10.1128/JB.00543-12; Eckert C, 2012, J BIOL CHEM, V287, P43502, DOI 10.1074/jbc.M112.392407; FERINO F, 1989, GENE, V84, P257, DOI 10.1016/0378-1119(89)90499-X; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; GRIGORIEVA G, 1982, FEMS MICROBIOL LETT, V13, P367, DOI 10.1111/j.1574-6968.1982.tb08289.x; Gutekunst K, 2005, MOL MICROBIOL, V58, P810, DOI 10.1111/j.1365-2958.2005.04867.x; Gutekunst K, 2006, INT J HYDROGEN ENERG, V31, P1452, DOI 10.1016/j.ijhydene.2006.06.010; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jittawuttipoka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055564; LABARRE J, 1989, J BACTERIOL, V171, P3449, DOI 10.1128/jb.171.6.3449-3457.1989; Leplat C, 2013, INT J HYDROGEN ENERG, V38, P1866, DOI 10.1016/j.ijhydene.2012.11.118; Maeda T, 2008, MICROB BIOTECHNOL, V1, P30, DOI 10.1111/j.1751-7915.2007.00003.x; Marteyn B, 2013, J BACTERIOL, V195, P4138, DOI 10.1128/JB.00272-13; McIntosh CL, 2011, J AM CHEM SOC, V133, P11308, DOI 10.1021/ja203376y; MERMETBOUVIER P, 1994, CURR MICROBIOL, V28, P145, DOI 10.1007/BF01571055; Narainsamy K, 2013, ADV BOT RES, V65, P157, DOI 10.1016/B978-0-12-394313-2.00005-6; Narainsamy K, 2013, METABOLOMICS, V9, P21, DOI 10.1007/s11306-011-0382-4; Oliveira P, 2005, FEMS MICROBIOL LETT, V251, P59, DOI 10.1016/j.femsle.2005.07.024; Pinto F, 2012, MICROBIOL-SGM, V158, P448, DOI 10.1099/mic.0.052282-0; Poncelet M, 1998, MOL MICROBIOL, V28, P813, DOI 10.1046/j.1365-2958.1998.00844.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sakr S, 2013, INT J HYDROGEN ENERG, V38, P13547, DOI 10.1016/j.ijhydene.2013.07.124	31	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89372	10.1371/journal.pone.0089372	http://dx.doi.org/10.1371/journal.pone.0089372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586727	gold, Green Submitted, Green Published			2022-12-27	WOS:000331880700032
J	Song, YW; Mu, KT; Wang, JM; Lin, FC; Chen, ZQ; Yan, XQ; Hao, YH; Zhu, WZ; Zhang, H				Song, Yinwei; Mu, Ketao; Wang, Junming; Lin, Fuchun; Chen, Zhiqi; Yan, Xiaoqin; Hao, Yonghong; Zhu, Wenzhen; Zhang, Hong			Altered Spontaneous Brain Activity in Primary Open Angle Glaucoma: A Resting-State Functional Magnetic Resonance Imaging Study	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; RETINOTOPIC ORGANIZATION; CORTICAL FUNCTION; FMRI MEASUREMENTS; OPTIC-NERVE; PATHWAY; FIELD; NETWORKS; ATROPHY	Background: Previous studies demonstrated that primary open angle glaucoma (POAG) is associated with abnormal brain structure; however, little is known about the changes in the local synchronization of spontaneous activity. The main objective of this study was to investigate spontaneous brain activity in patients with POAG using regional homogeneity (ReHo) analysis based on resting state functional magnetic resonance imaging (rs-fMRI). Methodology/Principal Findings: Thirty-nine POAG patients and forty-one age-and gender-matched healthy controls were finally included in the study. ReHo values were used to evaluate spontaneous brain activity and whole brain voxel-wise analysis of ReHo was carried out to detect differences by region in spontaneous brain activity between groups. Compared to controls, POAG patients showed increased ReHo in the right dorsal anterior cingulated cortex, the bilateral medial frontal gyrus and the right cerebellar anterior lobe, and decreased ReHo in the bilateral calcarine, bilateral precuneus gryus, bilateral pre/postcentral gyrus, left inferior parietal lobule and left cerebellum posterior lobe. A multiple linear regression analysis was performed to explore the relationships between clinical measures and ReHo by region showed significant group differences in the POAG group. Negative correlations were found between age and the ReHo values of the superior frontal gyrus (r = -0.323, p = 0.045), left calcarine (r = -0.357, p = 0.026) and inferior parietal lobule (r = -0.362, p = 0.024). A negative correlation was found between the ReHo values of the left precuneus and the cumulative mean defect (r = -0.400, p = 0.012). Conclusions: POAG was associated with abnormal brain spontaneous activity in some brain regions and such changed regional activity may be associated with clinical parameters. Spontaneous brain activity may play a role in POAG initiation and progression.	[Song, Yinwei; Wang, Junming; Chen, Zhiqi; Yan, Xiaoqin; Zhang, Hong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Ophthalmol, Wuhan 430074, Peoples R China; [Mu, Ketao; Hao, Yonghong; Zhu, Wenzhen] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Radiol, Wuhan 430074, Peoples R China; [Lin, Fuchun] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan Ctr Magnet Resonance, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Zhang, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Ophthalmol, Wuhan 430074, Peoples R China.	fclin@wipm.ac.cn; zhuwenzhen@hotmail.com; dr_zhanghong@126.com	Wang, Junming/AAD-9636-2019; Song, Yinwei/H-3371-2014; Lin, Fuchun/D-2371-2012; Lin, Fuchun/M-2789-2019	Song, Yinwei/0000-0001-5546-9808; Lin, Fuchun/0000-0002-2282-6474; Lin, Fuchun/0000-0002-2282-6474	National Natural Science Foundation of China [81170842, 81171308]; National Program of the Ministry of Science and Technology of China [2011BAI08B10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program of the Ministry of Science and Technology of China	This study was supported by National Natural Science Foundation(Grants No 81170842 and 81171308) of China, and National Program of the Ministry of Science and Technology of China during the "12th Five-year Plan'' (Grants No 2011BAI08B10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid H, 2009, MOL VIS, V15, P2074; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen WW, 2013, INVEST OPHTH VIS SCI, V54, P545, DOI 10.1167/iovs.12-9893; Chen ZQ, 2013, J NEURORADIOLOGY, V40, P281, DOI 10.1016/j.neurad.2012.10.004; Chen ZQ, 2013, CLIN EXP OPHTHALMOL, V41, P43, DOI 10.1111/j.1442-9071.2012.02832.x; Dai H, 2011, AM J NEURORADIOL, V32, P1347, DOI 10.3174/ajnr.A2486; Dai H, 2013, HUM BRAIN MAPP, V34, P2455, DOI 10.1002/hbm.22079; Dai H, 2013, NEURORADIOLOGY, V55, P233, DOI 10.1007/s00234-012-1122-9; Dai Y, 2012, VET OPHTHALMOL, V15, P23, DOI 10.1111/j.1463-5224.2011.00906.x; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Ding JH, 2009, HUM BRAIN MAPP, V30, P3541, DOI 10.1002/hbm.20777; Duncan RO, 2007, INVEST OPHTH VIS SCI, V48, P733, DOI 10.1167/iovs.06-0773; Duncan RO, 2007, PROG RETIN EYE RES, V26, P38, DOI 10.1016/j.preteyeres.2006.10.001; Duncan RO, 2012, VISION RES, V60, P51, DOI 10.1016/j.visres.2012.03.012; Ghiso Jorge A, 2013, J Glaucoma, V22 Suppl 5, pS36, DOI 10.1097/IJG.0b013e3182934af6; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Gupta N, 2007, EXP EYE RES, V84, P176, DOI 10.1016/j.exer.2006.09.013; Hernowo AT, 2011, INVEST OPHTH VIS SCI, V52, P2758, DOI 10.1167/iovs.10-5682; Ito Y, 2011, EUR J NEUROSCI, V33, P843, DOI 10.1111/j.1460-9568.2010.07578.x; Ito Y, 2009, EXP EYE RES, V89, P246, DOI 10.1016/j.exer.2009.03.013; Johansen-Berg H, 2007, CURR BIOL, V17, pR141, DOI 10.1016/j.cub.2006.12.022; Kamada K, 2007, NEUROSURGERY, V60, P296, DOI 10.1227/01.NEU.0000249262.03451.0E; LEICHNETZ GR, 1987, EXP BRAIN RES, V68, P355; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Mazzarella E, 2013, SOC NEUROSCI-UK, V8, P248, DOI 10.1080/17470919.2012.761160; Nucci C, 2013, CURR OPIN PHARMACOL, V13, P128, DOI 10.1016/j.coph.2012.08.004; Nucci C, 2012, BRIT J OPHTHALMOL, V96, P976, DOI 10.1136/bjophthalmol-2011-301280; Qing GP, 2010, INVEST OPHTH VIS SCI, V51, P4627, DOI 10.1167/iovs.09-4834; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; Rauscher FG, 2013, CELL TISSUE RES, V353, P297, DOI 10.1007/s00441-013-1675-x; Sang L, 2012, NEUROIMAGE, V61, P1213, DOI 10.1016/j.neuroimage.2012.04.011; Schettino A, 2011, NEUROIMAGE, V55, P1227, DOI 10.1016/j.neuroimage.2011.01.009; Shinoura N, 2013, NEUROL RES, V35, P65, DOI 10.1179/1743132812Y.0000000101; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; STEINMETZ MA, 1995, CEREB CORTEX, V5, P448, DOI 10.1093/cercor/5.5.448; Stiers P, 2006, NEUROIMAGE, V29, P74, DOI 10.1016/j.neuroimage.2005.07.033; Urner M, 2013, NEUROPSYCHOLOGIA, V51, P1630, DOI 10.1016/j.neuropsychologia.2013.05.005; Wang K, 2008, CEREB CORTEX, V18, P697, DOI 10.1093/cercor/bhm105; Williams AL, 2013, INVEST OPHTH VIS SCI, V54, P5880, DOI 10.1167/iovs.13-11776; Yucel YH, 2001, INVEST OPHTH VIS SCI, V42, P3216; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zikou AK, 2012, AM J NEURORADIOL, V33, P128, DOI 10.3174/ajnr.A2714	45	42	51	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89493	10.1371/journal.pone.0089493	http://dx.doi.org/10.1371/journal.pone.0089493			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586822	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700052
J	Xu, CL; Loftis, A; Ahluwalia, SK; Gao, DY; Verma, A; Wang, CM; Kaltenboeck, B				Xu, Chuanling; Loftis, Amanda; Ahluwalia, Sudhir K.; Gao, Dongya; Verma, Ashutosh; Wang, Chengming; Kaltenboeck, Bernhard			Diagnosis of Canine Leptospirosis by a Highly Sensitive FRET-PCR Targeting the lig Genes	PLOS ONE			English	Article							REAL-TIME PCR; PATHOGENIC LEPTOSPIRA; QUANTITATIVE PCR; INTERROGANS; DOGS; HYBRIDIZATION; PREVALENCE; PROTEIN; PROBES; ASSAY	Canine leptospirosis is underdiagnosed due to its wide spectrum of clinical presentations and the lack of a rapid and sensitive test for the accurate diagnosis of acute and chronic infections. In this study, we developed a highly sensitive and specific fluorescence resonance energy transfer (FRET)-PCR to detect common pathogenic leptospires in dogs, including Leptospira interrogans serovars Autumnalis, Canicola, Copenhageni (Icterohaemorrhagiae serogroup) and Pomona, and Leptospira kirschneri serovar Grippotyphosa. This PCR targets the lig genes, exclusively found in the pathogenic Leptospira species but not in saprophytic species (L. biflexa). A robust, high-stringency step-down real-time platform was coupled to the highly specific detection of leptospiral DNA by fluorescently labeled FRET probes. This enabled the detection of a single copy of the lig gene in a PCR containing DNA from up to 50 mu L canine blood or 400 mu L urine. Sensitivity determination by use of limiting serial dilutions of extracted leptospiral DNA indicated that the lig FRET-PCR we established was almost 100-fold more sensitive than the widely accepted lipL32 SYBR assay and 10-fold more sensitive than a 16S rRNA TaqMan assay. Application of this method to 207 dogs with potential leptospiral infection enabled us to diagnose three cases of canine leptospirosis characterized by low amounts of leptospiral DNA in body fluids. Detection of canine leptospirosis with the lig FRET-PCR was more sensitive with the lig FRET-PCR than with the 16S rRNA TaqMan PCR, which detected only 2 of the 3 cases, and the lipL32 SYBR PCR, which detected none of the 3 dogs with leptospirosis.	[Xu, Chuanling; Ahluwalia, Sudhir K.; Gao, Dongya; Wang, Chengming; Kaltenboeck, Bernhard] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA; [Loftis, Amanda; Verma, Ashutosh] Ross Univ, Sch Vet Med, Dept Biomed Sci, Basseterre, St Kitts & Nevi	Auburn University System; Auburn University	Kaltenboeck, B (corresponding author), Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA.	kaltebe@auburn.edu			Molecular Diagnostics Laboratory at the College of Veterinary Medicine at Auburn University; Ross University School of Veterinary Medicine	Molecular Diagnostics Laboratory at the College of Veterinary Medicine at Auburn University; Ross University School of Veterinary Medicine	This study was funded by the Molecular Diagnostics Laboratory at the College of Veterinary Medicine at Auburn University and by the Ross University School of Veterinary Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093; Ahmed SA, 2012, MALAYS J MED SCI, V19, P9; Baneth G, 2009, VET MICROBIOL, V136, P321, DOI 10.1016/j.vetmic.2008.11.022; Cermakova Z, 2013, SCAND J INFECT DIS, V45, P593, DOI 10.3109/00365548.2013.795656; COLE JR, 1973, APPL MICROBIOL, V25, P976, DOI 10.1128/AEM.25.6.976-980.1973; Greene C.E., 2006, INFECT DIS DOG CAT, V3rd ed., P402; Harkin KR, 2003, J AM VET MED ASSOC, V222, P1230, DOI 10.2460/javma.2003.222.1230; Hartskeerl RA, 2011, MOLECULAR DETECTION OF HUMAN BACTERIAL PATHOGENS, P1169; Kaltenboeck B, 2005, ADV CLIN CHEM, V40, P219, DOI 10.1016/S0065-2423(05)40006-2; Kelly PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053450; Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007; Koizumi N, 2013, J MED MICROBIOL, V62, P630, DOI 10.1099/jmm.0.050039-0; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Lin XP, 2008, J VET SCI, V9, P133; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Quinn P., 2002, VET MICROBIOLOGY MIC; Reller ME, 2011, EMERG INFECT DIS, V17, P1678, DOI [10.3201/eid1709.100915, 10.3201/eid1709.100915.]; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; TERPSTRA WJ, 1986, J MED MICROBIOL, V22, P23, DOI 10.1099/00222615-22-1-23; TERPSTRA WJ, 1987, J GEN MICROBIOL, V133, P911; Wang CM, 2010, VET PARASITOL, V168, P11, DOI 10.1016/j.vetpar.2009.10.015; Ward MP, 2004, JAVMA-J AM VET MED A, V224, P1958, DOI 10.2460/javma.2004.224.1958; Zhong Y, 2011, CELL RES, V21, P1210, DOI 10.1038/cr.2011.46	28	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89507	10.1371/journal.pone.0089507	http://dx.doi.org/10.1371/journal.pone.0089507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586833	Green Published, gold			2022-12-27	WOS:000331880700055
J	Yu, GH; Tan, YP; He, XZ; Qin, YH; Liang, JG				Yu, Guanghui; Tan, Yanping; He, Xiangzhu; Qin, Yonghua; Liang, Jiangong			CLAVATA3 Dodecapeptide Modified CdTe Nanoparticles: A Biocompatible Quantum Dot Probe for In Vivo Labeling of Plant Stem Cells	PLOS ONE			English	Article							SILVER NANOPARTICLES; LONG-TERM; RECEPTORS; MEMBRANE; PEPTIDES; CADMIUM; SURFACE	CLAVATA3 (CLV3) dodecapeptides function in plant stem cell maintenance, but CLV3 function in cell-cell communication remains less clear. Here, we coupled CLV3 dodecapeptides to synthesized CdTe nanoparticles to track their bioactivity on stem cells in the root apical meristem. To achieve this, we first synthesized CdTe quantum dots (QDs) using a one-pot method, and then evaluated the cytotoxicity of the QDs in BY-2 cells. The results showed that QDs in plant cells must be used at low concentrations and for short treatment time. To make biocompatible probes to track stem cell fate, we conjugated CLV3 dodecapeptides to the QDs by the zero-coupling method; this modification greatly reduced the cytotoxicity of the QDs. Furthermore, we detected CLV3-QDs localized on the cell membrane, consistent with the known localization of CLV3. Our results indicate that using surface-modified QDs at low concentrations and for short time treatment can improve their utility for plant cell imaging.	[Yu, Guanghui; Tan, Yanping; Qin, Yonghua] South Cent Univ Nationalities, Key Lab Biotechnol State Ethn Affairs Commiss, Coll Life Sci, Hubei Prov Key Lab Protect & Applicat Special Pla, Wuhan, Hubei, Peoples R China; [He, Xiangzhu] South Cent Univ Nationalities, Coll Elect & Informat Engn, Wuhan, Hubei, Peoples R China; [Liang, Jiangong] Huazhong Agr Univ, Inst Chem Biol, State Key Lab Agr Microbiol, Coll Sci, Wuhan, Hubei, Peoples R China	South Central Minzu University; South Central Minzu University; Huazhong Agricultural University	Yu, GH (corresponding author), South Cent Univ Nationalities, Key Lab Biotechnol State Ethn Affairs Commiss, Coll Life Sci, Hubei Prov Key Lab Protect & Applicat Special Pla, Wuhan, Hubei, Peoples R China.	yusheen@163.com; liangjg@mail.hzau.edu.cn	Liang, Jiangong/AAO-1308-2021		Outstanding Young Talent Fund from Key Projects in Hubei Province Natural Science Foundation (NSF) [2010CDA099]; China Scholarship Council Project for young outstanding talents; National Natural Science Foundation of China [31270361, 20905028]; Academic Innovation Team for Plant Development and Genetics in South-Central University for Nationalities	Outstanding Young Talent Fund from Key Projects in Hubei Province Natural Science Foundation (NSF); China Scholarship Council Project for young outstanding talents(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Innovation Team for Plant Development and Genetics in South-Central University for Nationalities	This work was supported by Outstanding Young Talent Fund from Key Projects in Hubei Province Natural Science Foundation (NSF) (2010CDA099), China Scholarship Council Project for young outstanding talents, and the National Natural Science Foundation of China (31270361; 20905028), and Academic Innovation Team for Plant Development and Genetics in South-Central University for Nationalities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichinger E, 2012, ANNU REV PLANT BIOL, V63, P615, DOI 10.1146/annurev-arplant-042811-105555; Banu NA, 2009, J PLANT PHYSIOL, V166, P146, DOI 10.1016/j.jplph.2008.03.002; Bar-Ilan O, 2009, SMALL, V5, P1897, DOI 10.1002/smll.200801716; Biju V, 2010, CHEM SOC REV, V39, P3031, DOI 10.1039/b926512k; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Butenko MA, 2009, TRENDS PLANT SCI, V14, P255, DOI 10.1016/j.tplants.2009.02.002; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chen FQ, 2004, NANO LETT, V4, P1827, DOI 10.1021/nl049170q; Cho SJ, 2007, LANGMUIR, V23, P1974, DOI 10.1021/la060093j; Christensen EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044355; Clarke S, 2010, NANO LETT, V10, P2147, DOI 10.1021/nl100825n; DalCorso G, 2008, J INTEGR PLANT BIOL, V50, P1268, DOI 10.1111/j.1744-7909.2008.00737.x; Darvill D, 2013, PHYS CHEM CHEM PHYS, V15, P15709, DOI 10.1039/c3cp50415h; Gagne JM, 2010, PLANT CELL, V22, P729, DOI 10.1105/tpc.109.068734; Gaponik N, 2002, J PHYS CHEM B, V106, P7177, DOI 10.1021/jp025541k; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Hao YZ, 2013, BOTANY, V91, P457, DOI 10.1139/cjb-2012-0281; Hauck TS, 2010, SMALL, V6, P138, DOI 10.1002/smll.200900626; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P215; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Hsieh SC, 2006, BIOMATERIALS, V27, P1656, DOI 10.1016/j.biomaterials.2005.09.004; Iranfar H, 2012, J PHYS CHEM B, V116, P1951, DOI 10.1021/jp210685q; Kannan P, 2013, ACS APPL MATER INTER, V5, P3508, DOI 10.1021/am4007758; Katsir L, 2011, CURR BIOL, V21, pR356, DOI 10.1016/j.cub.2011.03.012; Li DY, 2013, ACS APPL MATER INTER, V5, P12609, DOI 10.1021/am403942y; Liu W, 2008, J AM CHEM SOC, V130, P1274, DOI 10.1021/ja076069p; Lovric J, 2005, CHEM BIOL, V12, P1227, DOI 10.1016/j.chembiol.2005.09.008; Lu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012075; Ma ZW, 2010, J PLANT PHYSIOL, V167, P216, DOI 10.1016/j.jplph.2009.08.008; MATHUR J, 1995, PLANT CELL REP, V14, P221, DOI 10.1007/BF00233637; Murphy E, 2012, PLANT CELL, V24, P3198, DOI 10.1105/tpc.112.099010; Nechyporuk-Zloy V, 2008, AM J PHYSIOL-CELL PH, V294, pC1096, DOI 10.1152/ajpcell.00252.2007; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Pinaud F, 2004, J AM CHEM SOC, V126, P6115, DOI 10.1021/ja031691c; Potocky M, 2007, NEW PHYTOL, V174, P742, DOI 10.1111/j.1469-8137.2007.02042.x; Rakovich YP, 2007, J PHYS CHEM C, V111, P18927, DOI 10.1021/jp076622p; Song JJ, 2013, J NANOSCI NANOTECHNO, V13, P6924, DOI 10.1166/jnn.2013.8064; van der Weerden NL, 2008, J BIOL CHEM, V283, P14445, DOI 10.1074/jbc.M709867200; Vu TQ, 2005, NANO LETT, V5, P603, DOI 10.1021/nl047977c; Xu SF, 2013, ACS APPL MATER INTER, V5, P8146, DOI 10.1021/am4022076; Yadav RK, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.8; Yu GH, 2006, CHEM BIOL, V13, P723, DOI 10.1016/j.chembiol.2006.05.007; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Zhang CL, 2013, ANAL CHEM, V85, P5843, DOI 10.1021/ac400606e; Zhang H, 2003, J PHYS CHEM B, V107, P8, DOI 10.1021/jp025910c; Zhang MZ, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/48/485104	47	7	8	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89241	10.1371/journal.pone.0089241	http://dx.doi.org/10.1371/journal.pone.0089241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586624	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700025
J	Chen, SY; Cai, YY; Zhang, LX; Yan, XQ; Cheng, LQ; Qi, DM; Zhou, QY; Li, XX; Liu, GS				Chen, Shuangyan; Cai, Yueyue; Zhang, Lexin; Yan, Xueqing; Cheng, Liqin; Qi, Dongmei; Zhou, Qingyuan; Li, Xiaoxia; Liu, Gongshe			Transcriptome Analysis Reveals Common and Distinct Mechanisms for Sheepgrass (Leymus chinensis) Responses to Defoliation Compared to Mechanical Wounding	PLOS ONE			English	Article							DOWN-REGULATION; PERENNIAL RYEGRASS; LOLIUM-PERENNE; RNA-SEQ; BIOSYNTHESIS; EXPRESSION; ARABIDOPSIS; HERBIVORY; LIGNIN; GROWTH	Background: Herbivore grazing is a multiple-component process that includes wounding, defoliation, and saliva deposition. Despite the extensive published research on mechanical wounding and defoliation, no analysis to identify the genes that specify defoliation and mechanical wounding has been performed. Moreover, the influence of the expression of these genes on plant regrowth after defoliation remains poorly understood. Results: Seven cDNA libraries for RNA samples collected from stubble tissues that had been mechanically wounded or defoliated at 2, 6 and 24 h along with the control were sequenced using the Illumina/Solexa platform. A comparative transcriptomic analysis of the sequencing data was conducted. In total, 1,836 and 3,238 genes were detected with significant differential expression levels after wounding and defoliation, respectively, during one day. GO, KOG and pathway-based enrichment analyses were performed to determine and further understand the biological functions of those differentially expressed genes (DEGs). The results demonstrated that both wounding and defoliation activated the systemic synthesis of jasmonate (JA). However, defoliation specifically reduced the expression levels of ribosomal protein genes, cell division or cell expansion-related genes, and lignin biosynthesis genes and may have negatively affected plant growth. Further analysis revealed that the regrowth of elongating leaves was significantly retarded after defoliation at 6 h through the following 7 days of measurement, suggesting that the gene expression pattern and phenotype are consistent. Fifteen genes were selected, and their expression levels were confirmed by quantitative RT-PCR (qRT-PCR). Thirteen of them exhibited expression patterns consistent with the digital gene expression (DGE) data. Conclusions: These sequencing datasets allowed us to elucidate the common and distinct mechanisms of plant responses to defoliation and wounding. Additionally, the distinct DEGs represent a valuable resource for novel gene discovery that may improve plant resistance to defoliation from various processes.	[Chen, Shuangyan; Cai, Yueyue; Zhang, Lexin; Yan, Xueqing; Cheng, Liqin; Qi, Dongmei; Zhou, Qingyuan; Li, Xiaoxia; Liu, Gongshe] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Cai, Yueyue; Yan, Xueqing] Chinese Acad Sci, Grad Schoo1, Beijing, Peoples R China; [Zhang, Lexin] Entry Exit Inspect & Quarantine Bur, Heze, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences	Chen, SY (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	sychen@ibcas.ac.cn; lixx258258@163.com; liugs@ibcas.ac.cn			National Basic Research Program of China ("973'') [2014CB138704]; National High Technology Research and Development Program of China ("863'') [2011AA100209]; Ningxia Agricultural Comprehensive Development Office [NTKJ-2013-03 (1), NTKJ-2013-04]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-B-05]	National Basic Research Program of China ("973'')(National Basic Research Program of China); National High Technology Research and Development Program of China ("863''); Ningxia Agricultural Comprehensive Development Office; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China ("973'', 2014CB138704), the National High Technology Research and Development Program of China ("863'', 2011AA100209), the Project of Ningxia Agricultural Comprehensive Development Office (NTKJ-2013-03 (1), NTKJ-2013-04), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-B-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030015; Castrillon-Arbelaez PA, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-163; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-26; Benjamini Y, 2001, ANN STAT, V29, P1165; Berthier A, 2009, PLANT CELL PHYSIOL, V50, P1329, DOI 10.1093/pcp/pcp081; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Chen ShuangYan, 2013, PLoS ONE, V8, pe67974, DOI 10.1371/journal.pone.0067974; Chen SY, 2009, CURR ISSUES MOL BIOL, V11, P81; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Day A, 2009, PLANT PHYSIOL BIOCH, V47, P9, DOI 10.1016/j.plaphy.2008.09.011; de Villalobos AE, 2011, ENVIRON RES, V111, P953, DOI 10.1016/j.envres.2011.03.011; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Furet PM, 2012, PLANT PHYSIOL BIOCH, V61, P88, DOI 10.1016/j.plaphy.2012.09.011; Gallego-Giraldo L, 2011, NEW PHYTOL, V190, P627, DOI 10.1111/j.1469-8137.2010.03621.x; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; Horiguchi G, 2012, PLANT SCI, V191, P24, DOI 10.1016/j.plantsci.2012.04.008; Ida TY, 2012, ANN BOT-LONDON, V109, P237, DOI 10.1093/aob/mcr273; Koo AJK, 2009, PHYTOCHEMISTRY, V70, P1571, DOI 10.1016/j.phytochem.2009.07.018; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lapointe L, 2010, AM J BOT, V97, P913, DOI 10.3732/ajb.0900200; Lee JM, 2011, FUNCT PLANT BIOL, V38, P808, DOI 10.1071/FP11048; Lothier J, 2010, FUNCT PLANT BIOL, V37, P1151, DOI 10.1071/FP10086; Lyons R, 2013, PLANT CELL REP, V32, P815, DOI 10.1007/s00299-013-1400-y; Meers Trevor, 2003, Ecological Management & Restoration, V4, P126, DOI 10.1046/j.1442-8903.2003.00147.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; O'Mara FP, 2012, ANN BOT-LONDON, V110, P1263, DOI 10.1093/aob/mcs209; Roche LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035734; Rueda M, 2013, OECOLOGIA, V172, P449, DOI 10.1007/s00442-012-2501-y; Schippers JHM, 2010, PLANT SCI, V179, P307, DOI 10.1016/j.plantsci.2010.06.012; Scohier A, 2012, ANIMAL, V6, P1129, DOI 10.1017/S1751731111002618; Strassner J, 2002, PLANT J, V32, P585, DOI 10.1046/j.1365-313X.2002.01449.x; Tamura K, 2011, J EXP BOT, V62, P3421, DOI 10.1093/jxb/err018; Vargas-Ortiz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067879; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Zhang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003699	39	28	33	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89495	10.1371/journal.pone.0089495	http://dx.doi.org/10.1371/journal.pone.0089495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586824	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900106
J	Yiu, WH; Wong, DWL; Chan, LYY; Leung, JCK; Chan, KW; Lan, HY; Lai, KN; Tang, SCW				Yiu, Wai Han; Wong, Dickson W. L.; Chan, Loretta Y. Y.; Leung, Joseph C. K.; Chan, Kwok Wah; Lan, Hui Yao; Lai, Kar Neng; Tang, Sydney C. W.			Tissue Kallikrein Mediates Pro-Inflammatory Pathways and Activation of Protease-Activated Receptor-4 in Proximal Tubular Epithelial Cells	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; RENAL FIBROSIS; PROLIFERATIVE RESPONSES; PROINFLAMMATORY ROLE; GAMMA AGONIST; KININ SYSTEM; DB/DB MICE; THROMBIN; EXPRESSION; BRADYKININ	Tissue kallikrein (KLK1) expression is up-regulated in human diabetic kidney tissue and induced by high glucose (HG) in human proximal tubular epithelial cells (PTEC). Since the kallikrein-kinin system (KKS) has been linked to cellular inflammatory process in many diseases, it is likely that KLK1 expression may mediate the inflammatory process during the development of diabetic nephropathy. In this study, we explored the role of KLK1 in tubular pro-inflammatory responses under the diabetic milieu. Recombinant KLK1 stimulated the production of inflammatory cytokines in PTEC via the activation of p42/ 44 and p38 MAPK signaling pathways. Molecular knockdown of endogenous KLK1 expression by siRNA transfection in PTEC attenuated advanced glycation end-products (AGE)-induced IL-8 and ICAM-1 productions in vitro. Interestingly, exposure of PTEC to KLK1 induced the expression of protease-activated receptors (PARs). There was a 2.9-fold increase in PAR-4, 1.4-fold increase in PAR-1 and 1.2-fold increase in PAR-2 mRNA levels. Activation of PAR-4 by a selective agonist was found to elicit the pro-inflammatory and pro-fibrotic phenotypes in PTEC while blockade of the receptor by specific antagonist attenuated high glucose-induced IL-6, CCL-2, CTGF and collagen IV expression. Calcium mobilization by the PAR-4 agonist in PTEC was desensitized by pretreatment with KLK1. Consistent with these in vitro findings, there was a markedly up-regulation of tubular PAR-4 expression in human diabetic renal cortical tissues. Together, these results suggest that up-regulation of KLK1 in tubular epithelial cells may mediate pro-inflammatory	[Yiu, Wai Han; Wong, Dickson W. L.; Chan, Loretta Y. Y.; Leung, Joseph C. K.; Lai, Kar Neng; Tang, Sydney C. W.] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok Wah] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lan, Hui Yao] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Lan, Hui Yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Tang, SCW (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.	scwtang@hku.hk	Lan, Hui Yao/C-9734-2015; Tang, Sydney Chi Wai/C-4411-2009; Wong, Dickson/F-8855-2013	Lan, Hui Yao/0000-0003-4283-9755; Tang, Sydney Chi Wai/0000-0002-6862-1941; Wong, Dickson/0000-0002-4798-2908	Research Grants Council of Hong Kong [HKU 779611M]; National Basic Research Program of China 973 program [2012CB517600, 2012CB517606]; University of Hong Kong [201109176044]; Endowment Fund; Hong Kong Concrete; Continental Cement; Gypsum Co. Ltd.	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Basic Research Program of China 973 program(National Basic Research Program of China); University of Hong Kong(University of Hong Kong); Endowment Fund; Hong Kong Concrete; Continental Cement; Gypsum Co. Ltd.	This study was supported by a General Research Fund from the Research Grants Council of Hong Kong (Grant number: HKU 779611M), the National Basic Research Program of China 973 program no. 2012CB517600 (no. 2012CB517606) and Small Project Funding (Project code: 201109176044) from the University of Hong Kong. W.H.Y. is partially supported by an Endowment Fund established for the 'Yu Professorship in Nephrology' awarded to S.C.W.T., and the Hong Kong Concrete and the Continental Cement and Gypsum Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Part of the results from this manuscript has been presented in abstract form at the American Society of Nephrology Kidney Week, 8-13 Nov, 2011, Philadelphia, PA, USA.	Badeanlou L, 2011, NAT MED, V17, P1490, DOI 10.1038/nm.2461; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Biyashev D, 2006, AM J PHYSIOL-HEART C, V290, pH1244, DOI 10.1152/ajpheart.00934.2005; Bledsoe G, 2006, HUM GENE THER, V17, P545, DOI 10.1089/hum.2006.17.545; Braga AD, 2010, PHARMACOLOGY, V86, P224, DOI 10.1159/000319751; Brown HJ, 2007, J AM SOC NEPHROL, V18, P1732, DOI 10.1681/ASN.2006060634; Chambers RC, 2000, J BIOL CHEM, V275, P35584, DOI 10.1074/jbc.M003188200; Chao JL, 2008, HYPERTENSION, V52, P715, DOI 10.1161/HYPERTENSIONAHA.108.114587; Chao J, 2010, BIOL CHEM, V391, P345, DOI 10.1515/BC.2010.042; Chung ACK, 2011, J AM SOC NEPHROL, V22, P802, DOI 10.1681/ASN.2010050510; Gao L, 2010, BIOL CHEM, V391, P803, DOI 10.1515/BC.2010.084; Gao L, 2010, EXP CELL RES, V316, P376, DOI 10.1016/j.yexcr.2009.10.022; Grandaliano G, 2003, J AM SOC NEPHROL, V14, P2072, DOI 10.1097/01.ASN.0000080315.37254.A1; Hamilton JR, 2001, CIRC RES, V89, P92, DOI 10.1161/hh1301.092661; Hollenberg MD, 2008, BIOL CHEM, V389, P643, DOI 10.1515/BC.2008.077; Houle S, 2005, BRIT J PHARMACOL, V146, P670, DOI 10.1038/sj.bjp.0706371; Kakoki M, 2009, KIDNEY INT, V75, P1019, DOI 10.1038/ki.2008.647; Kelso EB, 2006, J PHARMACOL EXP THER, V316, P1017, DOI 10.1124/jpet.105.093807; Kelso EB, 2007, ARTHRITIS RHEUM, V56, P765, DOI 10.1002/art.22423; Kobayashi Tatsuya, 2005, Clin Exp Nephrol, V9, P114, DOI 10.1007/s10157-005-0347-x; Kontos CK, 2012, CLIN CHEM LAB MED, V50, P1877, DOI 10.1515/cclm-2012-0247; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; McDougall JJ, 2009, ARTHRITIS RHEUM-US, V60, P728, DOI 10.1002/art.24300; Morcos M, 2002, DIABETES, V51, P3532, DOI 10.2337/diabetes.51.12.3532; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Okada H, 2005, J AM SOC NEPHROL, V16, P133, DOI 10.1681/ASN.2004040339; Ortiz-Stern A, 2012, J CELL PHYSIOL, V227, P3575, DOI 10.1002/jcp.24061; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Rodriguez-Iturbe B, 2010, NEPHRON CLIN PRACT, V116, pC81, DOI 10.1159/000314656; Russell FA, 2010, J NEUROPHYSIOL, V103, P155, DOI 10.1152/jn.00486.2009; Russo LM, 2009, J AM SOC NEPHROL, V20, P489, DOI 10.1681/ASN.2008050503; Sakai T, 2009, BIOCHEM BIOPH RES CO, V384, P173, DOI 10.1016/j.bbrc.2009.04.105; Slofstra SH, 2007, BLOOD, V110, P3176, DOI 10.1182/blood-2007-02-075440; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Suen JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013809; Sumi A, 2011, BIOL PHARM BULL, V34, P824, DOI 10.1248/bpb.34.824; TAFT JL, 1994, DIABETES, V43, P1046, DOI 10.2337/diabetes.43.8.1046; Tan Y, 2007, AM J PHYSIOL-RENAL, V293, pF1026, DOI 10.1152/ajprenal.00203.2007; Tang SC, 2011, ADDITIVE RENOPROTECT; Tang SCW, 2006, J AM SOC NEPHROL, V17, P1633, DOI 10.1681/ASN.2005101113; Tang SCW, 2011, LAB INVEST, V91, P1351, DOI 10.1038/labinvest.2011.81; Tang SCW, 2011, NEPHROLOGY, V16, P417, DOI 10.1111/j.1440-1797.2010.01437.x; Tang SCW, 2010, NEPHROL DIAL TRANSPL, V25, P698, DOI 10.1093/ndt/gfp599; Tesch GH, 2011, AM J PHYSIOL-RENAL, V300, pF301, DOI 10.1152/ajprenal.00607.2010; Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010; Vergnolle N, 2002, J IMMUNOL, V169, P1467, DOI 10.4049/jimmunol.169.3.1467; Vesey DA, 2005, KIDNEY INT, V67, P1315, DOI 10.1111/j.1523-1755.2005.00209.x; Vesey DA, 2007, AM J PHYSIOL-RENAL, V293, pF1441, DOI 10.1152/ajprenal.00088.2007; Yao YY, 2008, CARDIOVASC RES, V80, P354, DOI 10.1093/cvr/cvn223; Zhao CX, 2003, HYPERTENSION, V42, P1026, DOI 10.1161/01.HYP.0000097603.55404.35	54	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88894	10.1371/journal.pone.0088894	http://dx.doi.org/10.1371/journal.pone.0088894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586431	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900036
J	Alexander, M; Mainkar, M; Deshpande, S; Chidrawar, S; Sane, S; Mehendale, S				Alexander, Mallika; Mainkar, Mandar; Deshpande, Sucheta; Chidrawar, Shweta; Sane, Suvarna; Mehendale, Sanjay			Heterosexual Anal Sex among Female Sex Workers in High HIV Prevalence States of India: Need for Comprehensive Intervention	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RISK BEHAVIOR; TRANSMISSION RISK; SOUTH-AFRICA; DRUG-USERS; CAPE-TOWN; INTERCOURSE; WOMEN; INFECTION; PREVENTION	Introduction: Role of vaginal sex in heterosexual transmission of HIV has been investigated but that of heterosexual anal sex (HAS) is not fully understood. This paper examines practice of HAS among Female Sex Workers (FSWs) and its correlates in India where the HIV epidemic is being primarily driven by core groups like FSWs. Methods: Data for this paper are drawn from Round I survey of 9667 FSWs in the Integrated Biological and Behavioral Assessment (IBBA) from 23 districts of 4 high HIV prevalent states of India. Bivariate and multivariate analysis identified factors associated with HAS. Results: Ever having anal sex was reported by 11.9% FSWs (95% CI: 11.3%-12.6%). Typology (AOR 2.20, 95% CI 1.64-2.95) and literacy (AOR 1.28, 95% CI 1.10-1.49) were positively associated with practice of HAS. Longer duration in sex trade (AOR 1.69, 95% CI 1.44-1.99), entertaining larger number of clients the previous week (AOR 1.78, 95% CI 1.47-2.15), alcohol consumption (AOR 1.21, 95% CI 1.03-1.42) and inability to negotiate condom use (AOR 1.53, 95% CI 1.28-1.83) were also correlated with HAS. Self-risk perception for HIV (AOR 1.46, 95% CI 1.25-1.71) did not impede HAS. Although symptoms of sexually transmitted infections (STIs) in the last 12 months were associated with anal sex (AOR 1.39, 95% CI 1.13-1.72) there was no significant association between laboratory confirmed HIV and other STIs with HAS. Conclusion: Practice of HAS by FSWs might significantly contribute to HIV transmission in India. This study also shows that despite self-risk perception for HIV, even literate FSWs with longer duration in sex work report HAS. General messages on condom use may not influence safe HAS. FSWs need to be targeted with specific messages on HIV transmission during anal sex. Women controlled prevention methods, such as rectal microbicides and vaginal microbicides are needed.	[Alexander, Mallika; Mainkar, Mandar; Chidrawar, Shweta] Natl AIDS Res Inst, Clin Trials Unit, Pune, Maharashtra, India; [Deshpande, Sucheta] Natl AIDS Res Inst, Integrated Behav & Biol Assessment Project, Pune, Maharashtra, India; [Sane, Suvarna] Natl AIDS Res Inst, Dept Biostat & Epidemiol, Pune, Maharashtra, India; [Mehendale, Sanjay] Natl Inst Epidemiol, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE)	Alexander, M (corresponding author), Natl AIDS Res Inst, Clin Trials Unit, Pune, Maharashtra, India.	mallikaalexander@gmail.com	Sane, Suvarna/AAN-5475-2021		Bill and Melinda Foundation; AVAHAN; Indian Council of Medical Research	Bill and Melinda Foundation; AVAHAN; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This paper is based on secondary data analysis with no funding. The funder of the original study, Bill and Melinda Foundation, AVAHAN and Indian Council of Medical Research, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript drawn from secondary data analysis of the survey data.	[Anonymous], 2012, GUID IND VAG MICR; Auslander BA, 2009, J PEDIATR ADOL GYNEC, V22, P33, DOI 10.1016/j.jpag.2008.01.075; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baldwin JI, 2000, ARCH SEX BEHAV, V29, P357, DOI 10.1023/A:1001918504344; Barta WD, 2008, AIDS BEHAV, V12, P729, DOI 10.1007/s10461-007-9342-4; Boily MC, 2009, SEX TRANSM INFECT, V85, P408, DOI 10.1136/sti.2009.037499; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bradley J, 2011, BMC PUBLIC HLTH S6, V11; Centers for Disease Control and Prevention, 2003, MMWR-MORBID MORTAL W, V52, P1; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Chirgwin KD, 1999, J ACQ IMMUN DEF SYND, V20, P295, DOI 10.1097/00042560-199903010-00013; Dandona R, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-87; DEVINCENZI I, 1989, BRIT MED J, V298, P411; DiClemente RJ, 2009, SEX HEALTH, V6, P111, DOI 10.1071/SH08062; Erickson PI, 1995, AIDS EDUC PREV, V7, P477; Friedman SR, 2001, AIDS, V15, P2057, DOI 10.1097/00002030-200110190-00025; Gorbach PM, 2009, SEX TRANSM DIS, V36, P193, DOI 10.1097/OLQ.0b013e3181901ccf; Government of India Ministry of Health and Family Welfare, 2012, HIV EST REP; Gross M, 2000, J ACQ IMMUN DEF SYND, V24, P393, DOI 10.1097/00126334-200008010-00015; Halperin DT, 1999, AIDS PATIENT CARE ST, V13, P717, DOI 10.1089/apc.1999.13.717; Houston AM, 2007, J PEDIATR ADOL GYNEC, V20, P299, DOI 10.1016/j.jpag.2007.01.006; Integrated Behavioral and Biological Assessment, 2011, GUID SURV POP RISK H; Kalichman SC, 2009, SEX TRANSM INFECT, V85, P411, DOI 10.1136/sti.2008.035287; Kalichman SC, 2002, ANN BEHAV MED, V24, P229, DOI 10.1207/S15324796ABM2403_08; Kalichman SC, 2008, PREV SCI, V9, P55, DOI 10.1007/s11121-008-0085-x; Kalichman SC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-807; Karim SSA, 1998, AM J PUBLIC HEALTH, V88, P1265, DOI 10.2105/AJPH.88.8.1265-a; Kloos Helmut, 2007, Ethiop Med J, V45, P103; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Lungi Langa, 2010, INT MICR C; Mackesy-Amiti ME, 2010, SEX TRANSM DIS, V37, P346, DOI [10.1097/OLQ.0b013e3181c71d617, 10.1097/OLQ.0b013e3181c71d61]; Mahapatra B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062167; Maynard E, 2009, PERSPECT SEX REPRO H, V41, P142, DOI 10.1363/4114209; Misegades L, 2001, AIDS, V15, P534, DOI 10.1097/00002030-200103090-00017; NARAYANAN P, 2012, J AIDS CLIN RES; National AIDS Control Organisation, 2012, HIV SENT SURV 2010 1; National AIDS Control Organisation, 2006, FEM SEX WORK FSWS TH; National AIDS Control Organization, 2008, TECHNICAL REPORT; Patra RK, 2012, SEX HEALTH, V9, P430, DOI 10.1071/SH11155; Rajaram S, 2010, 12 CHARME; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Reynolds GL, 2008, AIDS BEHAV, V12, P796, DOI 10.1007/s10461-007-9271-2; Risser JMH, 2009, INT J STD AIDS, V20, P310, DOI 10.1258/ijsa.2008.008394; Schwandt M, 2006, SEX TRANSM INFECT, V82, P392, DOI 10.1136/sti.2006.019794; Skurnick JH, 1998, CLIN INFECT DIS, V26, P855, DOI 10.1086/513929; Somanath RP, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/108630; Thomas B, 2011, INDIAN J MED RES, V134, P920, DOI 10.4103/0971-5916.92637; Tian LH, 2008, SEX TRANSM DIS, V35, P905, DOI 10.1097/OLQ.0b013e318181294b; Tucker Saroj, 2012, Indian J Sex Transm Dis AIDS, V33, P9, DOI 10.4103/0253-7184.93787; van Veen MG, 2010, ARCH SEX BEHAV, V39, P714, DOI 10.1007/s10508-008-9396-z; VOELLER B, 1991, ARCH SEX BEHAV, V20, P233, DOI 10.1007/BF01541846; WHO, 2005, ALC US SEX RISK BEH	52	18	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88858	10.1371/journal.pone.0088858	http://dx.doi.org/10.1371/journal.pone.0088858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586416	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700037
J	Blin, K; Kazempour, D; Wohlleben, W; Weber, T				Blin, Kai; Kazempour, Daniyal; Wohlleben, Wolfgang; Weber, Tilmann			Improved Lanthipeptide Detection and Prediction for antiSMASH	PLOS ONE			English	Article							GENE-CLUSTER; BIOSYNTHESIS; IDENTIFICATION; PEPTIDE; NISIN; MICROBISPORICIN; PURIFICATION; ORGANIZATION; ACTAGARDINE; CLONING	Lanthipeptides are a class of ribosomally synthesised and post-translationally modified peptide (RiPP) natural products from the bacterial secondary metabolism. Their name is derived from the characteristic lanthionine or methyl-lanthionine residues contained in the processed peptide. Lanthipeptides that possess an antibacterial activity are called lantibiotics. Whereas multiple tools exist to identify lanthipeptide gene clusters from genomic data, no programs are available to predict the post-translational modifications of lanthipeptides, such as the proteolytic cleavage of the leader peptide part or tailoring modifications based on the analysis of the gene cluster sequence. antiSMASH is a software pipeline for the identification of secondary metabolite biosynthetic clusters from genomic input and the prediction of products produced by the identified clusters. Here we present a novel antiSMASH module using a rule-based approach to combine signature motifs for biosynthetic enzymes and lanthipeptide-specific cleavage site motifs to identify lanthipeptide clusters in genomic data, assign the specific lanthipeptide class, predict prepeptide cleavage, tailoring reactions, and the processed molecular weight of the mature peptide products.	[Blin, Kai; Kazempour, Daniyal; Wohlleben, Wolfgang; Weber, Tilmann] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Blin, Kai; Wohlleben, Wolfgang; Weber, Tilmann] German Ctr Infect Res, Tubingen, Germany	Eberhard Karls University of Tubingen; German Center for Infection Research	Weber, T (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark.	tilmann.weber@biotech.uni-tuebingen.de	Blin, Kai/ABD-5377-2021; Weber, Tilmann/C-7159-2009	Blin, Kai/0000-0003-3764-6051; Weber, Tilmann/0000-0002-8260-5120	German Ministry of Education and Research (BMBF) [0315585A]; German Centre for Infection Research (DZIF) [8000-402-2]; LAPTOP [245066]; Deutsche Forschungsgemeinschaft (DFG); Tubingen University	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Centre for Infection Research (DZIF); LAPTOP; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Tubingen University	Funding was provided by the German Ministry of Education and Research (BMBF) (Grant 0315585A to TW), German Centre for Infection Research (DZIF) (8000-402-2 to TW and WW), LAPTOP (Grant 245066 to WW). Funding for open access charge: Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altena K, 2000, APPL ENVIRON MICROB, V66, P2565, DOI 10.1128/AEM.66.6.2565-2571.2000; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Birri DJ, 2012, APPL ENVIRON MICROB, V78, P402, DOI 10.1128/AEM.06588-11; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Boakes S, 2009, MOL MICROBIOL, V72, P1126, DOI 10.1111/j.1365-2958.2009.06708.x; Castiglione F, 2008, CHEM BIOL, V15, P22, DOI 10.1016/j.chembiol.2007.11.009; Crowther GS, 2013, J ANTIMICROB CHEMOTH, V68, P168, DOI 10.1093/jac/dks359; Dischinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006788; Durbin R., 1998, BIOL SEQUENCE ANAL P; Foulston LC, 2010, P NATL ACAD SCI USA, V107, P13461, DOI 10.1073/pnas.1008285107; Fuchs SW, 2011, APPL ENVIRON MICROB, V77, P1698, DOI 10.1128/AEM.01962-10; Garg N, 2012, P NATL ACAD SCI USA, V109, P5241, DOI 10.1073/pnas.1116815109; Heidrich C, 1998, APPL ENVIRON MICROB, V64, P3140; Herzner AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022389; Holtsmark I, 2006, APPL ENVIRON MICROB, V72, P5814, DOI 10.1128/AEM.00639-06; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; HYNES WL, 1993, APPL ENVIRON MICROB, V59, P1969, DOI 10.1128/AEM.59.6.1969-1971.1993; Kabuki T, 2009, J APPL MICROBIOL, V106, P853, DOI 10.1111/j.1365-2672.2008.04059.x; KELLNER R, 1988, EUR J BIOCHEM, V177, P53, DOI 10.1111/j.1432-1033.1988.tb14344.x; Knerr PJ, 2012, ANNU REV BIOCHEM, V81, P479, DOI 10.1146/annurev-biochem-060110-113521; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; NOVAK J, 1994, J BACTERIOL, V176, P4316, DOI 10.1128/jb.176.14.4316-4320.1994; Plat A, 2011, APPL ENVIRON MICROB, V77, P604, DOI 10.1128/AEM.01503-10; Ryan MP, 1999, J BIOL CHEM, V274, P37544, DOI 10.1074/jbc.274.53.37544; Sherwood EJ, 2013, P NATL ACAD SCI USA, V110, pE2500, DOI 10.1073/pnas.1305392110; Sit CS, 2011, ACCOUNTS CHEM RES, V44, P261, DOI 10.1021/ar1001395; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; Velasquez JE, 2011, CHEM BIOL, V18, P857, DOI 10.1016/j.chembiol.2011.05.007; Wescombe PA, 2006, APPL ENVIRON MICROB, V72, P1459, DOI 10.1128/AEM.72.2.1459-1466.2006; Wescombe PA, 2003, APPL ENVIRON MICROB, V69, P2737, DOI 10.1128/AEM.69.5.2737-2747.2003; Widdick DA, 2003, P NATL ACAD SCI USA, V100, P4316, DOI 10.1073/pnas.0230516100; Wirawan RE, 2006, APPL ENVIRON MICROB, V72, P1148, DOI 10.1128/AEM.72.2.1148-1156.2006; Zendo T, 2003, BIOSCI BIOTECH BIOCH, V67, P1616, DOI 10.1271/bbb.67.1616	34	35	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89420	10.1371/journal.pone.0089420	http://dx.doi.org/10.1371/journal.pone.0089420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586765	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700117
J	Huang, Q; Liu, L; Hu, BH; Di, XD; Brennecke, SP; Liu, HS				Huang, Qian; Liu, Lei; Hu, Bihui; Di, Xiaodan; Brennecke, Shaun Patrick; Liu, Huishu			Decreased Seizure Threshold in an Eclampsia-Like Model Induced in Pregnant Rats with Lipopolysaccharide and Pentylenetetrazol Treatments	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; PLACENTAL GROWTH-FACTOR; MAGNESIUM-SULFATE; PREECLAMPSIA-ECLAMPSIA; ELECTRICAL-STIMULATION; BLOOD-PRESSURE; ANIMAL-MODELS; SERUM-LEVELS; TNF-ALPHA; ANTICONVULSANT	Objective: Eclampsia is a poorly understood but potentially fatal complication of pregnancy. Research to date on this disorder has been hampered by the lack of a suitable animal model. To correct this deficiency, this report describes the generation of a rat eclampsia-like model using pentylenetetrazol (PTZ) in a previously established rat preeclampsia model. Method: Rats were administered lipopolysaccharide (1.0 mu g/kg) by tail vein injection on gestational day 14 to establish preeclampsia (PE). PE and control rats (non-pregnant, NP; normal-pregnant, P) were injected intraperitoneally (i.p.) with PTZ (40 mg/kg) to induce seizures. In separate experiments, MgSO4 (270 mg/kg IP) was injected in advance of PTZ into PE rats to observe its effect on PTZ-induced seizures. Results: PE conditions were verified in rats after LPS administration by significantly higher blood pressure (P < 0.01) and urinary albumin excretion (P < 0.05), elevated sFlt-1 (P < 0.05) and decreased PlGF serum levels (P < 0.05), and evidence of hepatic dysfunction compared to control groups. PTZ successfully induced seizure activity in all groups studied. Latency to seizure was significantly (P < 0.01) less in the PE-PTZ group (73.2 +/- 6.6 sec.) than in PTZ-treated controls (107.0 +/- 7.4 sec.). Pretreatment with MgSO4 prolonged (P < 0.05) latency to seizure, shortened seizure duration and decreased seizure rates. Significant increased (P < 0.05) in the serum levels of the inflammatory cytokines TNF-alpha and IL-1 beta in PE and PE-PTZ groups, and decreased (P < 0.05) in their levels following MgSO4 administration. Conclusion: This PTZ-induced eclampsia-like rat model is comparable to the human condition of eclampsia and may serve as a useful research tool for future studies of this disease. The increased inflammatory cytokines in preeclampsia are coincident with a decreased threshold for PTZ-induced seizures, suggesting that an inflammatory mechanism may contribute to the susceptibility to seizure activity and inflammation might have an important role in eclampsia.	[Huang, Qian; Liu, Lei; Hu, Bihui; Di, Xiaodan; Liu, Huishu] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Obstet, Guangzhou, Guangdong, Peoples R China; [Di, Xiaodan] Jinan Univ, Sch Med, Guangzhou, Guangdong, Peoples R China; [Brennecke, Shaun Patrick] Pregnancy Res Ctr, Dept Perinatal Med, Parkville, Vic, Australia; [Brennecke, Shaun Patrick] Univ Melbourne, Dept Obstet & Gynaecol, Royal Womens Hosp, Parkville, Vic 3052, Australia	Guangzhou Medical University; Jinan University; University of Melbourne	Liu, HS (corresponding author), Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Obstet, Guangzhou, Guangdong, Peoples R China.	huishuliu@hotmail.com	Brennecke, Shaun/AFV-3919-2022	Brennecke, Shaun/0000-0003-3070-6971	National Natural Sciences Foundation of China [81170594, 30471828, 30973206]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Sciences Foundation of China (81170594, 30471828, and 30973206). http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; Alanbay I, 2012, ARCH GYNECOL OBSTET, V285, P1505, DOI 10.1007/s00404-011-2157-6; Amash A, 2012, J INTERF CYTOK RES, V32, P432, DOI 10.1089/jir.2012.0013; Bell MJ, 2010, JOGNN-J OBST GYN NEO, V39, P510, DOI 10.1111/j.1552-6909.2010.01172.x; Cipolla MJ, 2012, EXP NEUROL, V234, P398, DOI 10.1016/j.expneurol.2012.01.005; COTTON DB, 1992, AM J OBSTET GYNECOL, V166, P1127, DOI 10.1016/S0002-9378(11)90599-7; COTTON DB, 1993, AM J OBSTET GYNECOL, V168, P974, DOI 10.1016/S0002-9378(12)90855-8; CRAIG CR, 1988, PHARMACOL BIOCHEM BE, V31, P867, DOI 10.1016/0091-3057(88)90397-8; De Vivo A, 2008, ACTA OBSTET GYN SCAN, V87, P837, DOI 10.1080/00016340802253759; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; Dowling O, 2012, PLACENTA, V33, P392, DOI 10.1016/j.placenta.2012.01.013; DULEY L, 1995, LANCET, V345, P1455; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; FAAS MM, 1994, AM J OBSTET GYNECOL, V171, P158, DOI 10.1016/0002-9378(94)90463-4; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Holcberg G, 2008, PLACENTA, V29, P593, DOI 10.1016/j.placenta.2008.03.008; Kalinderis M, 2011, AM J REPROD IMMUNOL, V66, P468, DOI 10.1111/j.1600-0897.2011.01019.x; Konishi Y, 2001, MOL BRAIN RES, V97, P129, DOI 10.1016/S0169-328X(01)00308-4; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lu JF, 2002, CLIN PHARMACOKINET, V41, P1105, DOI 10.2165/00003088-200241130-00007; McCarthy FP, 2011, PLACENTA, V32, P413, DOI 10.1016/j.placenta.2011.03.010; Melgert BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045229; Paller MS, 1998, J AM SOC NEPHROL, V9, P314; Pandhi P., 2002, Indian Journal of Experimental Biology, V40, P349; RACINE RJ, 1975, ELECTROEN CLIN NEURO, V38, P1, DOI 10.1016/0013-4694(75)90204-7; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Rocha L, 1996, EPILEPSY RES, V26, P105, DOI 10.1016/S0920-1211(96)00046-0; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Rusterholz C, 2007, SEMIN IMMUNOPATHOL, V29, P151, DOI 10.1007/s00281-007-0071-6; Seki H, 2007, J OBSTET GYNAECOL RE, V33, P408, DOI 10.1111/j.1447-0756.2007.00551.x; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P1141, DOI 10.1016/0002-9378(90)90002-O; Spencer S.S., 2009, TREATMENT EPILEPSY, P767; Standley CA, 2006, J MATERN-FETAL NEO M, V19, P171, DOI 10.1080/14767050500448005; Sunderland N, 2011, AM J REPROD IMMUNOL, V65, P533, DOI 10.1111/j.1600-0897.2010.00929.x; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Tam HBT, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.006; Tosun M, 2010, J MATERN-FETAL NEO M, V23, P880, DOI 10.3109/14767051003774942; Verlohren S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.037; Xu YL, 2012, NEUROCHEM RES, V37, P665, DOI 10.1007/s11064-011-0646-4; YALLAMPALLI C, 1993, AM J OBSTET GYNECOL, V169, P1316, DOI 10.1016/0002-9378(93)90299-X; You Y, 2011, BRAIN RES, V1381, P208, DOI 10.1016/j.brainres.2011.01.011; Zienowicz M, 2005, NEUROSCI LETT, V373, P226, DOI 10.1016/j.neulet.2004.10.009	43	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89333	10.1371/journal.pone.0089333	http://dx.doi.org/10.1371/journal.pone.0089333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586695	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700104
J	La Rosa, P; Pellegrini, M; Totta, P; Acconcia, F; Marino, M				La Rosa, Piergiorgio; Pellegrini, Marco; Totta, Pierangela; Acconcia, Filippo; Marino, Maria			Xenoestrogens Alter Estrogen Receptor (ER) alpha Intracellular Levels	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; CANCER-CELL-GROWTH; BETA; PHOSPHORYLATION; NARINGENIN; TURNOVER; SIGNALS; PROTEIN; PALMITOYLATION; DEGRADATION	17 beta-estradiol (E2)-dependent estrogen receptor (ER) a intracellular concentration is a well recognized critical step in the pleiotropic effects elicited by E2 in several target tissues. Beside E2, a class of synthetic and plant-derived chemicals collectively named endocrine disruptors (EDs) or xenoestrogens bind to and modify both nuclear and extra-nuclear ER alpha activities. However, at the present no information is available on the ability of EDs to hamper ER alpha intracellular concentration. Here, the effects of bisphenol A (BPA) and naringenin (Nar), prototypes of synthetic and plant-derived ER alpha ligands, have been evaluated on ER alpha levels in MCF-7 cells. Both EDs mimic E2 in triggering ER alpha Ser118 phosphorylation and gene transcription. However, only E2 or BPA induce an increase of cell proliferation; whereas 24 hrs after Nar stimulation a dose-dependent decrease in cell number is reported. E2 or BPA treatment reduces ER alpha protein and mRNA levels after 24 hrs. Contrarily, Nar stimulation does not alter ER alpha content but reduces ER alpha mRNA levels like other ligands. Co-stimulation experiments indicate that 48 hrs of Nar treatment prevents the E2-induced ER alpha degradation and hijacks the physiological ability of E2:ER alpha complex to regulate gene transcription. Mechanistically, Nar induces ER alpha protein accumulation by preventing proteasomal receptor degradation via persistent activation of p38/MAPK pathway. As a whole these data demonstrate that ER alpha intracellular concentration is an important target through which EDs hamper the hormonal milieu of E2 target cells driving cells to different outcomes or mimicking E2 even in the absence of the hormone.	[La Rosa, Piergiorgio; Pellegrini, Marco; Totta, Pierangela; Acconcia, Filippo; Marino, Maria] Univ Roma Tre, Dept Sci, Rome, Italy	Italfarmaco; Roma Tre University	Acconcia, F (corresponding author), Univ Roma Tre, Dept Sci, Rome, Italy.	filippo.acconcia@uniroma3.it; maria.marino@uniroma3.it	Acconcia, Filippo/AAB-6247-2022; La Rosa, Piergiorgio/K-9670-2016; Acconcia, Filippo/K-4960-2016; Pellegrini, Marco/AAD-1918-2021; Totta, Pierangela/I-3251-2018	Acconcia, Filippo/0000-0002-4651-2509; La Rosa, Piergiorgio/0000-0002-9723-2363; Pellegrini, Marco/0000-0002-3724-6640; Totta, Pierangela/0000-0001-7826-4733	Ateneo Roma Tre; AIRC-Associazione Italiana Ricerca sul Cancro [MFAG12756]	Ateneo Roma Tre; AIRC-Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This study was supported by grants from Ateneo Roma Tre to MM and by AIRC-Associazione Italiana Ricerca sul Cancro (MFAG12756) to FA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, J CELL PHYSIOL, V203, P193, DOI 10.1002/jcp.20219; ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001; Bhatt S, 2012, MOL CELL BIOL, V32, P1928, DOI 10.1128/MCB.06561-11; Bolli A, 2010, IUBMB LIFE, V62, P684, DOI 10.1002/iub.370; Bolli A, 2008, IUBMB LIFE, V60, P843, DOI 10.1002/iub.130; Bulzomi P, 2012, IUBMB LIFE, V64, P690, DOI 10.1002/iub.1049; Bulzomi P, 2012, J CELL PHYSIOL, V227, P1891, DOI 10.1002/jcp.22917; Bulzomi P, 2010, IUBMB LIFE, V62, P51, DOI 10.1002/iub.279; Caiazza F, 2007, BIOCHEM BIOPH RES CO, V359, P102, DOI 10.1016/j.bbrc.2007.05.059; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Galluzzo P, 2008, ENDOCRINOLOGY, V149, P2567, DOI 10.1210/en.2007-1173; La Rosa P, 2012, MOL ENDOCRINOL, V26, P762, DOI 10.1210/me.2011-1208; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Leclercq G, 2006, CURR CANCER DRUG TAR, V6, P39, DOI 10.2174/156800906775471716; Lee H, 2002, MOL CELL BIOL, V22, P5835, DOI 10.1128/MCB.22.16.5835-5845.2002; Li YW, 2010, PHARM RES-DORDR, V27, P1027, DOI 10.1007/s11095-010-0105-y; Manavathi B, 2013, ENDOCR REV, V34, P1, DOI 10.1210/er.2011-1057; Marino M, 2012, STEROIDS, V77, P910, DOI 10.1016/j.steroids.2012.02.019; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Roger P, 2001, CANCER RES, V61, P2537; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Totta P, 2004, IUBMB LIFE, V56, P491, DOI 10.1080/15216540400010792; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422	26	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88961	10.1371/journal.pone.0088961	http://dx.doi.org/10.1371/journal.pone.0088961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586459	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700044
J	Opaluch, AM; Schneider, M; Chiang, CY; Nguyen, QT; Maestre, AM; Mulder, LCF; Secundino, I; De Jesus, PD; Konig, R; Simon, V; Nizet, V; MacLeod, G; Varmuza, S; Fernandez-Sesma, A; Chanda, SK				Opaluch, Amanda M.; Schneider, Monika; Chiang, Chih-yuan; Nguyen, Quy T.; Maestre, Ana M.; Mulder, Lubbertus C. F.; Secundino, Ismael; De Jesus, Paul D.; Koenig, Renate; Simon, Viviana; Nizet, Victor; MacLeod, Graham; Varmuza, Susannah; Fernandez-Sesma, Ana; Chanda, Sumit K.			Positive Regulation of TRAF6-Dependent Innate Immune Responses by Protein Phosphatase PP1-gamma	PLOS ONE			English	Article							NF-KAPPA-B; UBIQUITIN-CONJUGATING ENZYME; TOLL-LIKE RECEPTORS; DEFECTIVE INTERLEUKIN-1; PATHOGEN RECOGNITION; RIG-I; ACTIVATION; KINASE; TRAF6; TAK1	Innate immune sensors such as Toll-like receptors (TLRs) differentially utilize adaptor proteins and additional molecular mediators to ensure robust and precise immune responses to pathogen challenge. Through a gain-of-function genetic screen, we identified the gamma catalytic subunit of protein phosphatase 1 (PP1-gamma) as a positive regulator of MyD88-dependent proinflammatory innate immune activation. PP1-gamma physically interacts with the E3 ubiquitin ligase TRAF6, and enhances the activity of TRAF6 towards itself and substrates such as IKK gamma, whereas enzymatically inactive PP1-gamma represses these events. Importantly, these activities were found to be critical for cellular innate responses to pathogen challenge and microbial clearance in both mouse macrophages and human monocyte lines. These data indicate that PP1-gamma phosphatase activity regulates overall TRAF6 E3 ubiquitin ligase function and promotes NF-kappa B-mediated innate signaling responses.	[Opaluch, Amanda M.; Schneider, Monika; Chiang, Chih-yuan; Nguyen, Quy T.; De Jesus, Paul D.; Koenig, Renate; Chanda, Sumit K.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Maestre, Ana M.; Mulder, Lubbertus C. F.; Simon, Viviana; Fernandez-Sesma, Ana] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Maestre, Ana M.; Mulder, Lubbertus C. F.; Simon, Viviana; Fernandez-Sesma, Ana] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA; [Secundino, Ismael; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Koenig, Renate] Paul Ehrlich Inst, Fed Inst Vaccines & Biomed, Res Grp Host Pathogen Interact, Langen, Germany; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [MacLeod, Graham; Varmuza, Susannah] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	Sanford Burnham Prebys Medical Discovery Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego; Paul Ehrlich Institute; University of California System; University of California San Diego; University of Toronto	Chanda, SK (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA.	chanda_office@sanfordburnham.org	simon, viviana/A-9131-2008; Merens, Ana Maestre/I-2445-2019; König, Renate/AAB-8918-2019; Nizet, Victor/AAF-3190-2019	simon, viviana/0000-0002-6416-5096; Merens, Ana Maestre/0000-0002-2494-0879; König, Renate/0000-0003-4882-9179; Fernandez-Sesma, Ana/0000-0002-3405-6702; Nizet, Victor/0000-0003-3847-0422	NIH [AG032171, AI77780, AI77781, AI77782]; NIH NAID [AI77782, AI096943bold]; NIH/NIAID (HIV immune networks team, HINT) [AI77782, 1P01AI90935-01, 1R011AI073450-01A2, R01 AI089246bold];  [1 P50 NIGMS085764-01A2]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI096943, R01AI064001, P01AI090935, R01AI073450, R01AI089246, R01AI077780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG032171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID (HIV immune networks team, HINT); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by 1 P50 NIGMS085764-01A2, NIH F31 grant AG032171 (to AMO), NIH NAID grant AI096943 (to LM), NIH/NIAID grant 1P01AI90935-01 (HIV immune networks team, HINT), NIH/NIAID 1R011AI073450-01A2 (to AFS), R01 AI089246 (to VS), and NIH grant AI77780 (to VN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BARTON GJ, 1994, EUR J BIOCHEM, V220, P225, DOI 10.1111/j.1432-1033.1994.tb18618.x; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chiang CY, 2012, CELL HOST MICROBE, V11, P306, DOI 10.1016/j.chom.2012.02.002; Cohen PTW, 2002, J CELL SCI, V115, P241; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Melchjorsen J, 2005, J VIROL, V79, P12944, DOI 10.1128/JVI.79.20.12944-12951.2005; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Okabe Y, 2009, NATURE, V460, P520, DOI 10.1038/nature08138; Oppedisano-Wells L, 2003, MOL REPROD DEV, V65, P157, DOI 10.1002/mrd.10284; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Rudolph D, 2000, GENE DEV, V14, P854; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SIMON D, 1991, FEMS MICROBIOL LETT, V82, P219, DOI 10.1016/0378-1097(91)90336-9; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang KZQ, 2010, J CELL BIOCHEM, V110, P763, DOI 10.1002/jcb.22589; Werts C, 2006, CELL DEATH DIFFER, V13, P798, DOI 10.1038/sj.cdd.4401890; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yang K, 2004, BIOCHEM BIOPH RES CO, V324, P432, DOI 10.1016/j.bbrc.2004.09.070; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zinkernagel AS, 2011, J INNATE IMMUNITY	47	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89284	10.1371/journal.pone.0089284	http://dx.doi.org/10.1371/journal.pone.0089284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586659	gold, Green Submitted, Green Published			2022-12-27	WOS:000331714700087
J	Silvani, A; Berteotti, C; Bastianini, S; Lo Martire, V; Mazza, R; Pagotto, U; Quarta, C; Zoccoli, G				Silvani, Alessandro; Berteotti, Chiara; Bastianini, Stefano; Lo Martire, Viviana; Mazza, Roberta; Pagotto, Uberto; Quarta, Carmelo; Zoccoli, Giovanna			Multiple Sleep Alterations in Mice Lacking Cannabinoid Type 1 Receptors	PLOS ONE			English	Article							INCREASES REM-SLEEP; ENDOCANNABINOID SYSTEM; ENERGY-BALANCE; KNOCKOUT MICE; WEIGHT-LOSS; CB1; NEURONS; BRAIN; RATS; EXPRESSION	Cannabinoid type 1 (CB1) receptors are highly expressed in the brain and play a role in behavior control. Endogenous cannabinoid signaling is modulated by high-fat diet (HFD). We investigated the consequences of congenital lack of CB1 receptors on sleep in mice fed standard diet (SD) and HFD. CB1 cannabinoid receptor knock-out (KO) and wild-type (WT) mice were fed SD or HFD for 4 months (n = 9-10 per group). Mice were instrumented with electroencephalographic (EEG) and electromyographic electrodes. Recordings were performed during baseline (48 hours), sleep deprivation (gentle handling, 6 hours), sleep recovery (18 hours), and after cage switch (insomnia model paradigm, 6 hours). We found multiple significant effects of genotype on sleep. In particular, KO spent more time awake and less time in non-rapid-eye-movement sleep (NREMS) and rapid-eye-movement sleep (REMS) than WT during the dark (active) period but not during the light (rest) period, enhancing the day-night variation of wake-sleep amounts. KO had slower EEG theta rhythm during REMS. REMS homeostasis after sleep deprivation was less effective in KO than in WT. Finally, KO habituated more rapidly to the arousing effect of the cage-switch test than WT. We did not find any significant effects of diet or of diet x genotype interaction on sleep. The occurrence of multiple sleep alterations in KO indicates important roles of CB1 cannabinoid receptors in limiting arousal during the active period of the day, in sleep regulation, and in sleep EEG in mice.	[Silvani, Alessandro; Berteotti, Chiara; Bastianini, Stefano; Lo Martire, Viviana; Zoccoli, Giovanna] Univ Bologna, Alma Mater Studiorum, Dept Biomed & Neuromotor Sci, PRISM Lab, Bologna, Italy; [Mazza, Roberta; Pagotto, Uberto; Quarta, Carmelo] Univ Bologna, Endocrinol Unit, Alma Mater Studiorum, S Orsola Univ Hosp, Bologna, Italy; [Mazza, Roberta; Pagotto, Uberto; Quarta, Carmelo] Univ Bologna, Endocrinol Unit, Alma Mater Studiorum, Ctr Appl Biomed Res,Dept Med & Surg Sci, Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna	Zoccoli, G (corresponding author), Univ Bologna, Alma Mater Studiorum, Dept Biomed & Neuromotor Sci, PRISM Lab, Bologna, Italy.	giovanna.zoccoli@unibo.it	Zoccoli, Giovanna/CAH-3382-2022; Quarta, Carmelo/AAC-1629-2020; Silvani, Alessandro/A-1027-2015; berteotti, chiara/AAK-9065-2020; Bastianini, Stefano/AAO-7982-2020	Silvani, Alessandro/0000-0003-3992-3892; Bastianini, Stefano/0000-0003-2468-1704; Quarta, Carmelo/0000-0002-1352-4239; Zoccoli, Giovanna/0000-0002-9670-9959; Lo Martire, Viviana/0000-0001-8696-0835; BERTEOTTI, CHIARA/0000-0002-4143-9445	Bologna University	Bologna University	This work was funded by Bologna University (RFO 2010 and 2011 http:// www.unibo.it/Portale/Ricerca/Servizi+Docenti+Ricercatori/finanziamentinaz/RFO+-+Finanziamento+alla+ricerca+di+base.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2010, J NEUROSCI, V30, P10061, DOI 10.1523/JNEUROSCI.5838-09.2010; Bastianini S, 2011, SLEEP, V34, P213, DOI 10.1093/sleep/34.2.213; Bellocchio L, 2013, P NATL ACAD SCI USA, V110, P4786, DOI 10.1073/pnas.1218573110; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cano G, 2008, J NEUROSCI, V28, P10167, DOI 10.1523/JNEUROSCI.1809-08.2008; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Cota D, 2007, ENDOCRINOLOGY, V148, P1574, DOI 10.1210/en.2005-1649; Cristino L, 2013, P NATL ACAD SCI USA, V110, pE2229, DOI 10.1073/pnas.1219485110; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Rueda-Orozco PE, 2010, NEUROSCI LETT, V473, P158, DOI 10.1016/j.neulet.2010.02.044; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Guan Z, 2008, SLEEP, V31, P627, DOI 10.1093/sleep/31.5.627; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Herrera-Solis A, 2010, PHARMACOL BIOCHEM BE, V95, P106, DOI 10.1016/j.pbb.2009.12.014; Hill MN, 2011, J NEUROSCI, V31, P10506, DOI 10.1523/JNEUROSCI.0496-11.2011; Huestis MA, 2001, ARCH GEN PSYCHIAT, V58, P322, DOI 10.1001/archpsyc.58.4.322; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Mongrain V, 2010, SLEEP, V33, P1147, DOI 10.1093/sleep/33.9.1147; Murillo-Rodriguez E, 2008, NEUROSCIENCE, V157, P1, DOI 10.1016/j.neuroscience.2008.08.056; Navarro L, 2003, NEUROSCIENCE, V120, P855, DOI 10.1016/S0306-4522(03)00339-7; Nyiri G, 2005, EUR J NEUROSCI, V21, P3034, DOI 10.1111/j.1460-9568.2005.04146.x; Quarta C, 2011, TRENDS MOL MED, V17, P518, DOI 10.1016/j.molmed.2011.05.002; Quarta C, 2010, CELL METAB, V11, P273, DOI 10.1016/j.cmet.2010.02.015; Reibaud M, 1999, EUR J PHARMACOL, V379, pR1, DOI 10.1016/S0014-2999(99)00496-3; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Santucci V, 1996, LIFE SCI, V58, pPL103, DOI 10.1016/0024-3205(95)02319-4; Silvani A, 2009, HYPERTENSION, V53, P251, DOI 10.1161/HYPERTENSIONAHA.108.125542; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; South T, 2008, J NEUROENDOCRINOL, V20, P1288, DOI 10.1111/j.1365-2826.2008.01785.x; Wu CS, 2010, EUR J NEUROSCI, V32, P693, DOI 10.1111/j.1460-9568.2010.07337.x; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	38	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89432	10.1371/journal.pone.0089432	http://dx.doi.org/10.1371/journal.pone.0089432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586776	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700119
J	Fan, XL; Zhang, ZS; Gao, HY; Yang, C; Liu, MJ; Li, YT; Li, PM				Fan, Xingli; Zhang, Zishan; Gao, Huiyuan; Yang, Cheng; Liu, Meijun; Li, Yuting; Li, Pengmin			Photoinhibition-Like Damage to the Photosynthetic Apparatus in Plant Leaves Induced by Submergence Treatment in the Dark	PLOS ONE			English	Article							CHLOROPHYLL-A FLUORESCENCE; PHOTOSYSTEM-II; ANOXIA TOLERANCE; GAS-EXCHANGE; MECHANISMS; GROWTH; LEAF; MAINTENANCE; SENESCENCE; SEEDLINGS	Submergence is a common type of environmental stress for plants. It hampers survival and decreases crop yield, mainly by inhibiting plant photosynthesis. The inhibition of photosynthesis and photochemical efficiency by submergence is primarily due to leaf senescence and excess excitation energy, caused by signals from hypoxic roots and inhibition of gas exchange, respectively. However, the influence of mere leaf-submergence on the photosynthetic apparatus is currently unknown. Therefore, we studied the photosynthetic apparatus in detached leaves from four plant species under dark-submergence treatment (DST), without influence from roots and light. Results showed that the donor and acceptor sides, the reaction center of photosystem II (PSII) and photosystem I (PSI) in leaves were significantly damaged after 36 h of DST. This is a photoinhibition-like phenomenon similar to the photoinhibition induced by high light, as further indicated by the degradation of PsaA and D1, the core proteins of PSI and PSII. In contrast to previous research, the chlorophyll content remained unchanged and the H2O2 concentration did not increase in the leaves, implying that the damage to the photosynthetic apparatus was not caused by senescence or over-accumulation of reactive oxygen species (ROS). DST-induced damage to the photosynthetic apparatus was aggravated by increasing treatment temperature. This type of damage also occurred in the anaerobic environment (N-2) without water, and could be eliminated or restored by supplying air to the water during or after DST. Our results demonstrate that DST-induced damage was caused by the hypoxic environment. The mechanism by which DST induces the photoinhibition-like damage is discussed below.	[Fan, Xingli; Zhang, Zishan; Gao, Huiyuan; Yang, Cheng; Liu, Meijun; Li, Yuting] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Li, Pengmin] Northwest A&F Unit, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shanxi, Peoples R China	Shandong Agricultural University; Northwest A&F University - China	Gao, HY (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	gaohy@sdau.edu.cn	Zhang, zs/GXN-3521-2022	Li, Pengmin/0000-0003-3514-0153	National Natural Science Foundation of China [31370276]; Specialized Research Foundation for the Doctoral Program of Higher Education of China [20113702110008]; Research Foundation of the State Key Laboratory of Crop Plant Biology in Shandong Agricultural University [2011KF03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Research Foundation of the State Key Laboratory of Crop Plant Biology in Shandong Agricultural University	This work was supported by the National Natural Science Foundation of China (No. 31370276), the Specialized Research Foundation for the Doctoral Program of Higher Education of China (No. 20113702110008) and the Research Foundation of the State Key Laboratory of Crop Plant Biology in Shandong Agricultural University (No. 2011KF03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2002, PLANT SCI, V163, P117, DOI 10.1016/S0168-9452(02)00080-8; Arbona V, 2009, ENVIRON EXP BOT, V66, P135, DOI 10.1016/j.envexpbot.2008.12.011; BRENNAN T, 1977, PLANT PHYSIOL, V59, P411, DOI 10.1104/pp.59.3.411; BuchananWollaston V, 1997, J EXP BOT, V48, P181, DOI 10.1093/jxb/48.2.181; Dai J, 2004, PLANT BIOLOGY, V6, P171, DOI 10.1055/s-2004-817845; DeLaune R.D., 1991, TRENDS SOIL SCI, V1, P101; Else MA, 2009, ANN BOT-LONDON, V103, P313, DOI 10.1093/aob/mcn208; Gibbs J, 2003, FUNCT PLANT BIOL, V30, P1, DOI [10.1071/PP98095_ER, 10.1071/PP98095]; Goh CH, 2012, J PLANT BIOL, V55, P93, DOI 10.1007/s12374-011-9195-2; Greenway H, 2003, FUNCT PLANT BIOL, V30, P999, DOI 10.1071/PP98096; Haldimann P, 1999, PHOTOSYNTH RES, V62, P67, DOI 10.1023/A:1006321126009; Hossain MA, 2011, AUST J CROP SCI, V5, P1094; Hossain Z, 2009, J PLANT PHYSIOL, V166, P1391, DOI 10.1016/j.jplph.2009.02.012; Hussner A, 2010, AQUAT BOT, V93, P17, DOI 10.1016/j.aquabot.2010.02.003; Kozlowski TT, 1997, TREE PHYSL MONOGR, V1, P1, DOI [DOI 10.1093/TREEPHYS/17.7.490, 10.1093/treephys/17.7.490]; Kumagai E, 2009, PLANT PROD SCI, V12, P285, DOI 10.1626/pps.12.285; Luo FL, 2009, ANN BOT-LONDON, V104, P1435, DOI 10.1093/aob/mcp257; Mathur S, 2010, BIOCHIM BIOPHYS ACTA, V1807, P22; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Oukarroum A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059433; Parolin P, 2010, AQUAT BOT, V93, P83, DOI 10.1016/j.aquabot.2010.03.008; Pezeshki SR, 1996, TREE PHYSIOL, V16, P453; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Rochaix JD, 2011, PLANT PHYSIOL, V155, P1493, DOI 10.1104/pp.110.169839; Schansker G, 2003, FUNCT PLANT BIOL, V30, P785, DOI 10.1071/FP03032; Sone C, 2012, J AGRON CROP SCI, V198, P152, DOI 10.1111/j.1439-037X.2011.00494.x; Srivastava A, 1998, BBA-BIOENERGETICS, V1364, P326, DOI 10.1016/S0005-2728(98)00014-0; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; Strasser BJ, 1997, PHOTOSYNTH RES, V52, P147, DOI 10.1023/A:1005896029778; Strasser RJ, 2010, BBA-BIOENERGETICS, V1797, P1313, DOI 10.1016/j.bbabio.2010.03.008; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; TERASHIMA I, 1994, PLANTA, V193, P300, DOI 10.1007/BF00192544; TERAZAWA K, 1992, ECOL RES, V7, P193, DOI 10.1007/BF02348500; Toth SZ, 2005, J PLANT PHYSIOL, V162, P181, DOI 10.1016/j.jplph.2004.06.010; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; Waldhoff D, 2002, ENVIRON EXP BOT, V48, P225, DOI 10.1016/S0098-8472(02)00037-0; Yusuf MA, 2010, BBA-BIOENERGETICS, V1797, P1428, DOI 10.1016/j.bbabio.2010.02.002; Zhang LT, 2011, PHYSIOL PLANTARUM, V143, P396, DOI 10.1111/j.1399-3054.2011.01514.x; Zhang ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042936	39	18	23	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89067	10.1371/journal.pone.0089067	http://dx.doi.org/10.1371/journal.pone.0089067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586508	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900082
J	Scholten, EWM; Schrijvers, CTM; Nederkoorn, C; Kremers, SPJ; Rodenburg, G				Scholten, Eline W. M.; Schrijvers, Carola T. M.; Nederkoorn, Chantal; Kremers, Stef P. J.; Rodenburg, Gerda			Relationship between Impulsivity, Snack Consumption and Children's Weight	PLOS ONE			English	Article							BODY-MASS INDEX; LABELED WATER METHOD; DIETARY-INTAKE; ENERGY-INTAKE; RESPONSE PERSEVERATION; REWARD SENSITIVITY; MIDDLE CHILDHOOD; EATING PATTERNS; OVERWEIGHT; OBESITY	Background: Childhood overweight is a public health problem associated with psychosocial and physical problems. Personality traits, such as impulsivity, may contribute to the development of overweight. Objective: This study examines 1) the association between general impulsivity traits (reward sensitivity and disinhibition) and children's weight, 2) the association between impulsivity traits and unhealthy snack consumption, and 3) the potential mediating role of unhealthy snack consumption in the relationship between impulsivity traits and children's weight. Methods: Included were 1,377 parent-child dyads participating in the IVO Nutrition and Physical Activity Child cohorT (INPACT). Children had a mean age of 10 years. Parents completed a questionnaire to measure children's unhealthy snack consumption. Children completed a door-opening task to assess reward sensitivity and completed a questionnaire to measure disinhibition. Children's height and weight were measured to calculate their BMI z-scores. Cross-sectional linear regression analyses were performed to test the associations. Results: Disinhibition was positively associated with unhealthy snack consumption but not with BMI z-scores. Reward sensitivity was not related to unhealthy snack consumption or to BMI z-scores. Conclusions: No evidence was found for a mediating effect of unhealthy snack consumption in the relation between impulsivity traits and children's weight. However, disinhibition appears to have a negative influence on children's unhealthy snack consumption. Future research focusing on food-related impulsivity in addition to general impulsivity will provide additional insight into factors that influence children's unhealthy snack consumption and weight.	[Scholten, Eline W. M.; Schrijvers, Carola T. M.; Rodenburg, Gerda] IVO Addict Res Inst, Rotterdam, Netherlands; [Scholten, Eline W. M.; Schrijvers, Carola T. M.; Rodenburg, Gerda] Erasmus MC, Rotterdam, Netherlands; [Nederkoorn, Chantal] Maastricht Univ, Dept Expt Psychol, Maastricht, Netherlands; [Kremers, Stef P. J.] Maastricht Univ, Dept Hlth Promot, Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Maastricht University; Maastricht University	Rodenburg, G (corresponding author), IVO Addict Res Inst, Rotterdam, Netherlands.	Rodenburg@ivo.nl	Scholten, Eline/AAN-6746-2021	Nederkoorn, Chantal/0000-0002-5522-3944; Scholten, Eline/0000-0003-3846-0419	ZonMW, The Netherlands Organisation for Health Research and Development [115100004]	ZonMW, The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	Financial support for the INPACT study was provided by ZonMW, The Netherlands Organisation for Health Research and Development (grant ID no. 115100004; www.zonmw.nl/en/). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123; Brants H., 2006, VOEDING NU, V2, P25; Carnell S, 2011, APPETITE, V57, P665, DOI 10.1016/j.appet.2011.08.009; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cruz Martha L, 2004, Curr Diab Rep, V4, P53, DOI 10.1007/s11892-004-0012-x; DAUGHERTY TK, 1991, J CHILD PSYCHOL PSYC, V32, P453, DOI 10.1111/j.1469-7610.1991.tb00323.x; Davis C, 2008, APPETITE, V50, P43, DOI 10.1016/j.appet.2007.05.007; Deckelbaum RJ, 2001, OBES RES, V9, p239S, DOI 10.1038/oby.2001.125; Dutman AE, 2011, PUBLIC HEALTH NUTR, V14, P410, DOI 10.1017/S1368980010002119; Ebbeling CB, 2013, JAMA-J AM MED ASSOC, V291, P2828; Farrow CV, 2012, EAT BEHAV, V13, P150, DOI 10.1016/j.eatbeh.2011.11.015; Field AE, 2004, INT J OBESITY, V28, P1210, DOI 10.1038/sj.ijo.0802762; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Giesen JCAH, 2009, PSYCHOL GEZONDH, V39, P70; Guerrieri R., 2008, PSIHOLOGIJSKE TEME, V17, P265; Hampl JS, 2003, J HUM NUTR DIET, V16, P3, DOI 10.1046/j.1365-277X.2003.00417.x; Haraldsdottir J, 2005, ANN NUTR METAB, V49, P221, DOI 10.1159/000087276; Harvard School of Public Health, 2013, CHILD OB; Hise ME, 2002, AM J CLIN NUTR, V75, P263, DOI 10.1093/ajcn/75.2.263; Huang TTK, 2004, OBES RES, V12, P1875, DOI 10.1038/oby.2004.233; Jasinska AJ, 2012, APPETITE, V59, P738, DOI 10.1016/j.appet.2012.08.001; Keij I., 2000, INDEX FEITEN CIJFERS, V7, P24; Keller KL, 2006, INT J OBESITY, V30, P1670, DOI 10.1038/sj.ijo.0803318; Kerver JM, 2006, J AM DIET ASSOC, V106, P46, DOI 10.1016/j.jada.2005.09.045; Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151; Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169; Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318; Maffeis C, 2008, J PEDIATR GASTR NUTR, V46, P429, DOI 10.1097/MPG.0b013e318163b850; Martin LE, 2004, NEUROREPORT, V15, P1519, DOI 10.1097/01.wnr.0000132920.12990.b9; Matthys W, 1998, J CHILD PSYCHOL PSYC, V39, P643, DOI 10.1017/S0021963098002534; Moreno LA, 2007, CURR OPIN CLIN NUTR, V10, P336, DOI 10.1097/MCO.0b013e3280a94f59; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Nederkoorn C, 2006, APPETITE, V47, P253, DOI 10.1016/j.appet.2006.05.008; Nederkoorn C, 2012, APPETITE, V59, P409, DOI 10.1016/j.appet.2012.05.028; Nederkoorn C, 2010, HEALTH PSYCHOL, V29, P389, DOI 10.1037/a0019921; Oellingrath IM, 2010, EUR J CLIN NUTR, V64, P1272, DOI 10.1038/ejcn.2010.152; Oellingrath IM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-106; Olson SL, 1999, J ABNORM CHILD PSYCH, V27, P151, DOI 10.1023/A:1021915615677; Puder JJ, 2010, INT J OBESITY, V34, P37; Rodenburg G, 2014, PUBLIC HEALTH NUTR, V17, P960, DOI 10.1017/S1368980013000712; Schonbeck Y, 2010, FACTSHEET RESULTATEN; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Schroder H, 2007, BRIT J NUTR, V98, P1274, DOI 10.1017/S0007114507781436; SHAPIRO SK, 1988, J ABNORM PSYCHOL, V97, P371, DOI 10.1037/0021-843X.97.3.371; Simonds J., 2004, OCC TEMP C ATH GA; Simonds J, 2006, THESIS U OREGON OREG; Sleddens EFC, 2013, EUR J DEV PSYCHOL, V10, P392, DOI 10.1080/17405629.2012.688102; Sundquist J, 1998, INT J EPIDEMIOL, V27, P57, DOI 10.1093/ije/27.1.57; Temple JL, 2008, AM J CLIN NUTR, V87, P1121, DOI 10.1093/ajcn/87.5.1121; Tiggemann M, 2002, APPETITE, V39, P1, DOI 10.1006/appe.2002.0487; Trost SG, 2001, INT J OBESITY, V25, P822, DOI 10.1038/sj.ijo.0801621; Tucker LA, 1997, J AM DIET ASSOC, V97, P981, DOI 10.1016/S0002-8223(97)00237-X; van den Berg L, 2011, INT J OBESITY, V35, P1301, DOI 10.1038/ijo.2011.116; Verbeken S, 2012, APPETITE, V58, P478, DOI 10.1016/j.appet.2011.11.018; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Webber L, 2010, AM J CLIN NUTR, V92, P1423, DOI 10.3945/ajcn.2010.30112; Webber L, 2010, J AM DIET ASSOC, V110, P1718, DOI 10.1016/j.jada.2010.08.007; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Wells JCK, 1999, AM J CLIN NUTR, V69, P904; Winkleby MA, 1996, PREV MED, V25, P203, DOI 10.1006/pmed.1996.0047; World Health Organisation, 2013, FACTSH OB OV	63	16	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88851	10.1371/journal.pone.0088851	http://dx.doi.org/10.1371/journal.pone.0088851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586413	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900052
J	Torphy, RJ; Tignanelli, CJ; Kamande, JW; Moffitt, RA; Loeza, SGH; Soper, SA; Yeh, JJ				Torphy, Robert J.; Tignanelli, Christopher J.; Kamande, Joyce W.; Moffitt, Richard A.; Loeza, Silvia G. Herrera; Soper, Steven A.; Yeh, Jen Jen			Circulating Tumor Cells as a Biomarker of Response to Treatment in Patient-Derived Xenograft Mouse Models of Pancreatic Adenocarcinoma	PLOS ONE			English	Article							CANCER-PATIENTS; PROGNOSTIC-SIGNIFICANCE; ANTITUMOR-ACTIVITY; ONCOGENIC RAS; INHIBITOR; MUTATIONS; SURVIVAL; PREDICT; ENUMERATION; PROGRESSION	Circulating tumor cells (CTCs) are cells shed from solid tumors into circulation and have been shown to be prognostic in the setting of metastatic disease. These cells are obtained through a routine blood draw and may serve as an easily accessible marker for monitoring treatment effectiveness. Because of the rapid progression of pancreatic ductal adenocarcinoma (PDAC), early insight into treatment effectiveness may allow for necessary and timely changes in treatment regimens. The objective of this study was to evaluate CTC burden as a biomarker of response to treatment with a oral phosphatidylinositol-3-kinase inhibitor, BKM120, in patient-derived xenograft (PDX) mouse models of PDAC. PDX mice were randomized to receive vehicle or BKM120 treatment for 28 days and CTCs were enumerated from whole blood before and after treatment using a microfluidic chip that selected for EpCAM (epithelial cell adhesion molecule) positive cells. This microfluidic device allowed for the release of captured CTCs and enumeration of these cells via their electrical impedance signatures. Median CTC counts significantly decreased in the BKM120 group from pre- to post-treatment (26.61 to 2.21 CTCs/250 mu L, p = 0.0207) while no significant change was observed in the vehicle group (23.26 to 11.89 CTCs/250 mu L, p = 0.8081). This reduction in CTC burden in the treatment group correlated with tumor growth inhibition indicating CTC burden is a promising biomarker of response to treatment in preclinical models. Mutant enriched sequencing of isolated CTCs confirmed that they harbored KRAS G12V mutations, identical to the matched tumors. In the long-term, PDX mice are a useful preclinical model for furthering our understanding of CTCs. Clinically, mutational analysis of CTCs and serial monitoring of CTC burden may be used as a minimally invasive approach to predict and monitor treatment response to guide therapeutic regimens.	[Torphy, Robert J.; Yeh, Jen Jen] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA; [Tignanelli, Christopher J.; Yeh, Jen Jen] Univ N Carolina, Dept Surg, Chapel Hill, NC USA; [Kamande, Joyce W.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA; [Moffitt, Richard A.; Loeza, Silvia G. Herrera] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Soper, Steven A.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC USA; [Soper, Steven A.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [Yeh, Jen Jen] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Louisiana State University System; Louisiana State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Yeh, JJ (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA.	jjyeh@med.unc.edu	, Animal Studies Core/ADK-4234-2022; , Animal Studies Core/AAF-4432-2022	Moffitt, Richard/0000-0003-2723-5902; Tignanelli, Christopher/0000-0002-8079-5565; Torphy, Robert J/0000-0003-3941-0886	NIH [5T35DK007386-32, R01-EB010087]; NATIONAL CANCER INSTITUTE [T32CA009156, R01CA140424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007386, P30DK034987] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this work was supported by the NIH T35 grant (5T35DK007386-32). Partial funding was provided by the NIH R01 grant(R01-EB010087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AA, 2008, J AM CHEM SOC, V130, P8633, DOI 10.1021/ja8015022; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Cohen SJ, 2009, ANN ONCOL, V20, P1223, DOI 10.1093/annonc/mdn786; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Der CJ, 2007, CELL, V129, P855, DOI 10.1016/j.cell.2007.05.031; Dharmasiri U, 2011, ANAL CHEM, V83, P2301, DOI 10.1021/ac103172y; Eliane JP, 2008, CANCER RES, V68, P5529, DOI 10.1158/0008-5472.CAN-08-0630; Feldmann G, 2007, J HEPATO-BILIARY-PAN, V14, P224, DOI 10.1007/s00534-006-1166-5; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Hofmann I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044146; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kamande JW, 2013, ANAL CHEM, V85, P9092, DOI 10.1021/ac401720k; Koul D, 2012, CLIN CANCER RES, V18, P184, DOI 10.1158/1078-0432.CCR-11-1558; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; LEVI S, 1991, CANCER RES, V51, P3497; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Marchetti A, 2009, NEOPLASIA, V11, P1084, DOI 10.1593/neo.09814; Moreno JG, 2005, UROLOGY, V65, P713, DOI 10.1016/j.urology.2004.11.006; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Tjensvoll K, 2014, INT J CANCER, V134, P1, DOI 10.1002/ijc.28134; Voliva CF, 2010, CANCER RES, V70, P1; Yeh JJ, 2007, EXPERT OPIN THER TAR, V11, P673, DOI 10.1517/14728222.11.5.673; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	31	39	41	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89474	10.1371/journal.pone.0089474	http://dx.doi.org/10.1371/journal.pone.0089474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586805	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900147
J	Huh, JH; Kim, KJ; Lee, BW; Kim, DW; Kang, ES; Cha, BS; Lee, HC				Huh, Ji Hye; Kim, Kwang Joon; Lee, Byung-Wan; Kim, Dong Wook; Kang, Eun Seok; Cha, Bong Soo; Lee, Hyun Chul			The Relationship between BMI and Glycated Albumin to Glycated Hemoglobin (GA/A1c) Ratio According to Glucose Tolerance Status	PLOS ONE			English	Article							INSULIN-SECRETION; DIABETES-MELLITUS; GLYCEMIC CONTROL; INFLAMMATION; OBESE	Glycated albumin to glycated hemoglobin (GA/A1c) ratio is known to be inversely related with body mass index (BMI) and insulin secretory capacity. However, the reasons for this association remain unknown. We aimed to investigate whether BMI directly or indirectly influences GA/A1c by exerting effects on insulin secretion or resistance and to confirm whether these associations differ according to glucose tolerance status. We analyzed a total of 807 subjects [242 drug-naive type 2 diabetes (T2D), 378 prediabetes, and 187 normal glucose tolerance (NGT)]. To assess the direct and indirect effects of BMI on GA/A1c ratio, structural equation modeling (SEM) was performed. GA/A1c ratio was set as a dependent variable, BMI was used as the independent variable, and homeostasis model assessment-pancreatic beta-cell function (HOMA-beta), homeostasis model assessment-insulin resistance (HOMA-IR), glucose level were used as mediator variables. The estimates of a direct effect of BMI on GA/A1c to be the strongest in NGT and weakest in T2D (-0.375 in NGT, -0.244 in prediabetes, and -0.189 in T2D). Conversely, the indirect effect of BMI on GA/A1c exerted through HOMA-beta and HOMA-IR was not statistically significant in NGT group, but significant in prediabetes and T2D groups (0.089 in prediabetes, -0.003 in T2D). It was found that HOMA-beta or HOMA-IR indirectly influences GA/A1c in T2D and prediabetes group through affecting fasting and postprandial glucose level. The relationship between GA/A1c and BMI is due to the direct effect of BMI on GA/A1c in NGT group, while in T2D and prediabetes groups, this association is mostly a result of BMI influencing blood glucose through insulin resistance or secretion.	[Huh, Ji Hye; Lee, Byung-Wan; Kang, Eun Seok; Cha, Bong Soo; Lee, Hyun Chul] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Kim, Kwang Joon] Severance Hosp, Severance Execut Healthcare Clin, Seoul, South Korea; [Kim, Dong Wook] Yonsei Univ, Coll Med, Div Med Stat, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, BW (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.	bwanlee@yuhs.ac	Wan, Lee Byung/K-2649-2019	Lee, Byung-Wan/0000-0002-9899-4992; Kang, Eun Seok/0000-0002-0364-4675; Cha, Bong-Soo/0000-0003-0542-2854				Abdul-Ghani MA, 2008, AM J PHYSIOL-ENDOC M, V295, pE401, DOI 10.1152/ajpendo.00674.2007; Furusyo N, 2011, DIABETOLOGIA, V54, P3028, DOI 10.1007/s00125-011-2310-6; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; Kim D, 2012, CLIN ENDOCRINOL, V77, P679, DOI 10.1111/j.1365-2265.2011.04312.x; Kim JH, 2012, DIABETES METAB J, V36, P37, DOI 10.4093/dmj.2012.36.1.37; Kim KJ, 2012, DIABETES METAB J, V36, P98, DOI 10.4093/dmj.2012.36.2.98; Ko SH, 2011, DIABETES METAB J, V35, P431, DOI 10.4093/dmj.2011.35.5.431; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Koga M, 2007, CLIN CHIM ACTA, V378, P48, DOI 10.1016/j.cca.2006.10.013; Koga M, 2006, ENDOCR J, V53, P387, DOI 10.1507/endocrj.K05-137; Koga M, 2010, ENDOCR J, V57, P751, DOI 10.1507/endocrj.K10E-138; Koga M, 2010, DIABETES CARE, V33, P270, DOI 10.2337/dc09-1002; Lee EY, 2011, ACTA DIABETOL, V48, P167, DOI 10.1007/s00592-010-0242-0; Lee YH, 2011, INT J CLIN PRACT, V65, P1076, DOI 10.1111/j.1742-1241.2011.02755.x; Miyashita Y, 2007, DIABETES RES CLIN PR, V78, P51, DOI 10.1016/j.diabres.2007.02.021; Nishimura R, 2006, DIABETES RES CLIN PR, V71, P334, DOI 10.1016/j.diabres.2005.07.008; Salas-Salvado J, 2006, INT J OBESITY, V30, P1714, DOI 10.1038/sj.ijo.0803348; Stein Catherine M, 2012, Methods Mol Biol, V850, P495, DOI 10.1007/978-1-61779-555-8_27; Wang FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051098; Won HK, 2012, DIABETIC MED, V29, P74, DOI 10.1111/j.1464-5491.2011.03386.x; Yoshiuchi K, 2008, ENDOCR J, V55, P503, DOI 10.1507/endocrj.K07E-089	21	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89478	10.1371/journal.pone.0089478	http://dx.doi.org/10.1371/journal.pone.0089478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586809	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200055
J	Hsu, M; Keele, BF; Aravantinou, M; Krawczyk, N; Seidor, S; Abraham, CJ; Zhang, S; Rodriguez, A; Kizima, L; Derby, N; Jean-Pierre, N; Mizenina, O; Gettie, A; Grasperge, B; Blanchard, J; Piatak, MJ; Lifson, JD; Fernandez-Romero, JA; Zydowsky, TM; Robbiani, M				Hsu, Mayla; Keele, Brandon F.; Aravantinou, Meropi; Krawczyk, Noa; Seidor, Samantha; Abraham, Ciby J.; Zhang, Shimin; Rodriguez, Aixa; Kizima, Larisa; Derby, Nina; Jean-Pierre, Ninochka; Mizenina, Olga; Gettie, Agegnehu; Grasperge, Brooke; Blanchard, James; Piatak, Michael J., Jr.; Lifson, Jeffrey D.; Fernandez-Romero, Jose A.; Zydowsky, Thomas M.; Robbiani, Melissa			Exposure to MIV-150 from a High-Dose Intravaginal Ring Results in Limited Emergence of Drug Resistance Mutations in SHIV-RT Infected Rhesus Macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; PREEXPOSURE PROPHYLAXIS; CARRAGEENAN GEL; HIV-1 INFECTION; MODEL; MICROBICIDES; TRANSMISSION; EVOLUTION; INDIVIDUALS; RILPIVIRINE	When microbicides used for HIV prevention contain antiretroviral drugs, there is concern for the potential emergence of drug-resistant HIV following use in infected individuals who are either unaware of their HIV infection status or who are aware but still choose to use the microbicide. Resistant virus could ultimately impact their responsiveness to treatment and/or result in subsequent transmission of drug-resistant virus. We tested whether drug resistance mutations (DRMs) would emerge in macaques infected with simian immunodeficiency virus expressing HIV reverse transcriptase (SHIV-RT) after sustained exposure to the potent non-nucleoside reverse transcriptase inhibitor (NNRTI) MIV-150 delivered via an intravaginal ring (IVR). We first treated 4 SHIV-RT-infected animals with daily intramuscular injections of MIV-150 over two 21 day (d) intervals separated by a 7 d drug hiatus. In all 4 animals, NNRTI DRMs (single and combinations) were detected within 14 d and expanded in proportion and diversity with time. Knowing that we could detect in vivo emergence of NNRTI DRMs in response to MIV-150, we then tested whether a high-dose MIV-150 IVR (loaded with >10 times the amount being used in a combination microbicide IVR in development) would select for resistance in 6 infected animals, modeling use of this prevention method by an HIV-infected woman. We previously demonstrated that this MIV-150 IVR provides significant protection against vaginal SHIV-RT challenge. Wearing the MIV-150 IVR for 56 d led to only 2 single DRMs in 2 of 6 animals (430 RT sequences analyzed total, 0.46%) from plasma and lymph nodes despite MIV-150 persisting in the plasma, vaginal fluids, and genital tissues. Only wild type virus sequences were detected in the genital tissues. These findings indicate a low probability for the emergence of DRMs after topical MIV-150 exposure and support the advancement of MIV-150-containing microbicides.	[Hsu, Mayla; Aravantinou, Meropi; Krawczyk, Noa; Seidor, Samantha; Abraham, Ciby J.; Zhang, Shimin; Rodriguez, Aixa; Kizima, Larisa; Derby, Nina; Jean-Pierre, Ninochka; Mizenina, Olga; Fernandez-Romero, Jose A.; Zydowsky, Thomas M.; Robbiani, Melissa] Populat Council, Ctr Biomed Res, New York, NY 10021 USA; [Keele, Brandon F.; Piatak, Michael J., Jr.; Lifson, Jeffrey D.] Leidos Biomedical Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD USA; [Keele, Brandon F.; Piatak, Michael J., Jr.; Lifson, Jeffrey D.] SAIC Frederick Inc, Frederick, MD USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Grasperge, Brooke; Blanchard, James] Tulane Natl Primate Res Ctr, Covington, LA USA	Population Council; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Rockefeller University; Tulane University	Robbiani, M (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.	mrobbiani@popcouncil.org			United States Agency for International Development (USAID) [GPO-A-00-04-00019-00]; NIH [3P51 OD011104-51]; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR021309] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104, T32OD011124] Funding Source: NIH RePORTER	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded with the support of the United States Agency for International Development (USAID) Cooperative Agreement GPO-A-00-04-00019-00, the NIH base grant 3P51 OD011104-51, and with federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E. This research is made possible by the generous support of the American people through the USAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2013, J INFECT DIS; Abram ME, 2013, ANTIMICROB AGENTS CH, V57, P2654, DOI 10.1128/AAC.02568-12; Alencar C, 2013, J ACQUIR IMMUNE DEFI; Ambrose Z, 2007, J VIROL, V81, P12145, DOI 10.1128/JVI.01301-07; [Anonymous], 2011, GUIDE CARE USE LAB A; Aravantinou M, 2012, AIDS RES HUM RETROV, V28, P1467, DOI [10.1089/aid.2012.0080, 10.1089/AID.2012.0080]; Arts EJ, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-114; Boltz VF, 2012, J VIROL, V86, P12525, DOI 10.1128/JVI.01963-12; Celum C, 2012, CURR OPIN INFECT DIS, V25, P51, DOI 10.1097/QCO.0b013e32834ef5ef; Cherutich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036797; Cline AN, 2005, J MED PRIMATOL, V34, P303; Coetzer M, 2013, AIDS RES HUM RETROVI; Crostarosa F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008060; de Bethune MP, 2010, ANTIVIR RES, V85, P75, DOI 10.1016/j.antiviral.2009.09.008; Derby N, 2013, EXPERT REV ANTI-INFE, V11, P5, DOI [10.1586/ERI.12.155, 10.1586/eri.12.155]; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; Dupnik K, 2001, ANTIVIR THER S, V6, P42; Fernandez-Romero JA, 2007, SEX TRANSM DIS, V34, P9, DOI 10.1097/01.olq.0000223287.46097.4b; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Frost SDW, 2000, J VIROL, V74, P6262, DOI 10.1128/JVI.74.14.6262-6268.2000; Gianella S, 2011, J VIROL, V85, P8359, DOI 10.1128/JVI.02582-10; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamers RL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4159; Hardy E, 2007, CONTRACEPTION, V76, P126, DOI 10.1016/j.contraception.2007.04.013; Hsu M, 2013, AIDS RES HUM RETROVI; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kearney M, 2011, J VIROL, V85, P1067, DOI 10.1128/JVI.01701-10; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kenney J, 2012, AIDS RES HUM RETROV, V28, P1476, DOI [10.1089/aid.2012.0087, 10.1089/AID.2012.0087]; Kenney J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015835; Kulkarni R, 2012, JAIDS-J ACQ IMM DEF, V59, P47, DOI 10.1097/QAI.0b013e31823aca74; KUMAR N, 1990, J STEROID BIOCHEM, V37, P587, DOI 10.1016/0960-0760(90)90405-A; Manasa J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072152; McCallum M, 2013, ANTIMICROB AGENTS CH, V57, P4681, DOI 10.1128/AAC.01029-13; Mesplede T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-22; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Rath BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061102; Saenz RA, 2013, EPIDEMICS-NETH, V5, P34, DOI 10.1016/j.epidem.2012.11.002; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Singer R, 2011, J VIROL, V85, P5504, DOI 10.1128/JVI.02422-10; Singer R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003936; Supervie V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00185; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Tsibris AMN, 2012, J VIROL, V86, P6416, DOI 10.1128/JVI.00286-12; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Weiss J, 2013, INT J ANTIMICROB AG, V41, P484, DOI 10.1016/j.ijantimicag.2013.01.004; Xu H.-T., 2013, ANTIMICROB AGENTS CH; Xu HT, 2012, J VIROL, V86, P12983, DOI 10.1128/JVI.02005-12	49	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89300	10.1371/journal.pone.0089300	http://dx.doi.org/10.1371/journal.pone.0089300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586674	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800015
J	La Manna, G; Ghinatti, G; Tazzari, PL; Alviano, F; Ricci, F; Capelli, I; Cuna, V; Todeschini, P; Brunocilla, E; Pagliaro, P; Bonsi, L; Stefoni, S				La Manna, Gaetano; Ghinatti, Giulia; Tazzari, Pier Luigi; Alviano, Francesco; Ricci, Francesca; Capelli, Irene; Cuna, Vania; Todeschini, Paola; Brunocilla, Eugenio; Pagliaro, Pasqualepaolo; Bonsi, Laura; Stefoni, Sergio			Neutrophil Gelatinase-Associated Lipocalin Increases HLA-G(+)/FoxP3(+) T-Regulatory Cell Population in an In Vitro Model of PBMC	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CHRONIC MYELOID-LEUKEMIA; EARLY URINARY BIOMARKER; ISCHEMIC RENAL INJURY; CARDIORENAL SYNDROME; EPITHELIAL-CELLS; GENE-EXPRESSION; KAPPA-B; HLA-G; IRON	Background: Neutrophil gelatinase-associated lipocalin (NGAL) is emerging as a mediator of various biological and pathological states. However, the specific biological role of this molecule remains unclear, as it serves as a biomarker for many conditions. The high sensitivity of NGAL as a biomarker coupled with relatively low specificity may hide important biological roles. Data point toward an acute compensatory, protective role for NGAL in response to adverse cellular stresses, including inflammatory and oxidative stress. The aim of this study was to understand whether NGAL modulates the T-cell response through regulation of the human leukocyte antigen G (HLA-G) complex, which is a mediator of tolerance. Methodology/Principal Findings: Peripheral blood mononuclear cells (PBMCs) were obtained from eight healthy donors and isolated by centrifugation on a Ficoll gradient. All donors gave informed consent. PBMCs were treated with four different concentrations of NGAL (40-320 ng/ml) in an iron-loaded or iron-free form. Changes in cell phenotype were analyzed by flow cytometry. NGAL stimulated expression of HLA-G on CD4+ T cells in a dose-and iron-dependent manner. Iron deficiency prevented NGAL-mediated effects, such that HLA-G expression was unaltered. Furthermore, NGAL treatment affected stimulation of regulatory T cells and in vitro expansion of CD4(+) CD25(+) FoxP3(+) cells. An NGAL neutralizing antibody limited HLA-G expression and significantly decreased the percentage of CD4(+) CD25(+) FoxP3(+) cells. Conclusions/Significance: We provide in vitro evidence that NGAL is involved in cellular immunity. The potential role of NGAL as an immunomodulatory molecule is based on its ability to induce immune tolerance by upregulating HLA-G expression and expansion of T-regulatory cells in healthy donors. Future studies should further evaluate the role of NGAL in immunology and immunomodulation and its possible relationship to immunosuppressive therapy efficacy, tolerance induction in transplant patients, and other immunological disorders.	[La Manna, Gaetano; Capelli, Irene; Cuna, Vania; Todeschini, Paola; Stefoni, Sergio] St Orsola Hosp, Dept Expt Diagnost & Specialty Med, Dialysis Nephrol & Transplantat Unit, Bologna, Italy; [Ghinatti, Giulia] Univ Naples 2, Dept Internal & Expt Med, Naples, Italy; [Tazzari, Pier Luigi; Ricci, Francesca; Pagliaro, Pasqualepaolo] St Orsola Hosp, Dept Hematol Oncol & Lab Med, Serv Immunohematol & Transfus Med, Bologna, Italy; [Alviano, Francesco; Stefoni, Sergio] Univ Bologna, Dept Expt Diagnost & Specialty Med, Sect Histol Embryol & Appl Biol, Bologna, Italy; [Brunocilla, Eugenio] St Orsola Hosp, Dept Expt Diagnost & Specialty Med, Urol Unit, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; Universita della Campania Vanvitelli; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna	La Manna, G (corresponding author), St Orsola Hosp, Dept Expt Diagnost & Specialty Med, Dialysis Nephrol & Transplantat Unit, Bologna, Italy.	gaetano.lamanna@unibo.it	TAZZARI, PIER LUIGI/HGC-8394-2022	TAZZARI, PIER LUIGI/0000-0002-8789-657X; Capelli, Irene/0000-0003-4829-5664; La Manna, Gaetano/0000-0001-5473-8551; Ricci, Francesca/0000-0003-4387-1415	University of Bologna Institutional Grant	University of Bologna Institutional Grant	This work was supported by a University of Bologna Institutional Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiyanti Sri S, 2012, Acta Med Indones, V44, P246; Akagi R, 2005, CONTRIB NEPHROL, V148, P70, DOI 10.1159/000086044; Alonci A, 2012, ACTA HAEMATOL-BASEL, V127, P1, DOI 10.1159/000330948; An SX, 2013, RENAL FAILURE, V35, P143, DOI 10.3109/0886022X.2012.741877; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Byrne SL, 2013, ANNU REV PHARMACOL, V53, P17, DOI 10.1146/annurev-pharmtox-010611-134648; Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Christiansen OB, 2013, MOL IMMUNOL, V55, P8, DOI 10.1016/j.molimm.2012.08.025; Costa D, 2010, CYTOKINE, V51, P47, DOI 10.1016/j.cyto.2010.02.009; Costantino CM, 2008, EUR J IMMUNOL, V38, P921, DOI 10.1002/eji.200738104; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; D'Arena G, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.053; Dejaco C, 2006, IMMUNOLOGY, V117, P289, DOI 10.1111/j.1365-2567.2005.02317.x; Devarajan P, 2003, MOL GENET METAB, V80, P365, DOI 10.1016/j.ymgme.2003.09.012; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Dummer CD, 2012, TRANSPL IMMUNOL, V26, P1, DOI 10.1016/j.trim.2011.08.009; Entin-Meer M, 2012, AM J NEPHROL, V36, P190, DOI 10.1159/000341651; Evstatiev R, 2012, GUT, V61, P933, DOI 10.1136/gut.2010.214312; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Hammerman MR, 2000, KIDNEY INT, V57, P742, DOI 10.1046/j.1523-1755.2000.00896.x; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Heyne N, 2012, TRANSPLANTATION, V93, P1252, DOI 10.1097/TP.0b013e31824fd892; Issa F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00254; Johnson ACM, 2010, AM J PHYSIOL-RENAL, V299, pF426, DOI 10.1152/ajprenal.00248.2010; Le Rond S, 2006, J IMMUNOL, V176, P3266, DOI 10.4049/jimmunol.176.5.3266; LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101; LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547; Li L, 2012, J CLIN INVEST, V122, P3931, DOI 10.1172/JCI63170; Mao SS, 2011, INT J MOL MED, V27, P555, DOI 10.3892/ijmm.2011.613; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Mishra J, 2004, AM J NEPHROL, V24, P307, DOI 10.1159/000078452; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Naji A, 2007, BLOOD, V110, P3936, DOI 10.1182/blood-2007-04-083139; Ohta A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00190; Parikh CR, 2006, AM J TRANSPLANT, V6, P1639, DOI 10.1111/j.1600-6143.2006.01352.x; Ronco C, 2012, SEMIN NEPHROL, V32, P121, DOI 10.1016/j.semnephrol.2011.11.015; Roudkenar MH, 2011, FREE RADICAL RES, V45, P810, DOI 10.3109/10715762.2011.581279; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Villalva C, 2008, LEUKEMIA LYMPHOMA, V49, P984, DOI 10.1080/10428190801942360; Xu SY, 2000, BBA-PROTEIN STRUCT M, V1482, P298, DOI 10.1016/S0167-4838(00)00163-1; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Zhang PX, 2012, MOL MED REP, V6, P716, DOI 10.3892/mmr.2012.980	49	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89497	10.1371/journal.pone.0089497	http://dx.doi.org/10.1371/journal.pone.0089497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586826	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800024
J	Liang, L; Gao, F; Xu, QY; Zhang, M				Liang, Liang; Gao, Fei; Xu, Qunyuan; Zhang, Ming			Configuration of Fibrous and Adipose Tissues in the Cavernous Sinus	PLOS ONE			English	Article							LATERAL SELLAR COMPARTMENT; CAROTID COLLAR; ANATOMY; WALL; HISTORY; PLEXUS; HUMANS	Objective: Three-dimensional anatomical appreciation of the matrix of the cavernous sinus is one of the crucial necessities for a better understanding of tissue patterning and various disorders in the sinus. The purpose of this study was to reveal configuration of fibrous and adipose components in the cavernous sinus and their relationship with the cranial nerves and vessels in the sinus and meningeal sinus wall. Materials and Methods: Nineteen cadavers (8 females and 11 males; age range, 54-89 years; mean age, 75 years) were prepared as transverse (6 sets), coronal (3 sets) and sagittal (10 sets) plastinated sections that were examined at both macroscopic and microscopic levels. Results: Two types of the web-like fibrous networks were identified and localized in the cavernous sinus. A dural trabecular network constituted a skeleton-frame in the sinus and contributed to the sleeves of intracavernous cranial nerves III, IV, V-1, V-2 and VI. A fine trabecular network, or adipose tissue, was the matrix of the sinus and was mainly distributed along the medial side of the intracavernous cranial nerves, forming a dumbbell-shaped adipose zone in the sinus. Conclusions: This study revealed the nature, fine architecture and localization of the fine and dural trabecular networks in the cavernous sinus and their relationship with intracavernous cranial nerves and vessels. The results may be valuable for better understanding of tissue patterning in the cranial base and better evaluation of intracavernous disorders, e.g. the growth direction and extent of intracavernous tumors.	[Liang, Liang] Capital Med Univ, Dept Anat, Beijing, Peoples R China; [Gao, Fei; Xu, Qunyuan] Capital Med Univ, Dept Neurobiol, Beijing, Peoples R China; [Zhang, Ming] Univ Otago, Dept Anat, Dunedin, New Zealand	Capital Medical University; Capital Medical University; University of Otago	Xu, QY (corresponding author), Capital Med Univ, Dept Neurobiol, Beijing, Peoples R China.	xuqy@ccmu.edu.cn; ming.zhang@anatomy.otago.ac.nz	Zhang, Ming/A-3719-2008; fei, Gao/GQQ-8024-2022	Zhang, Ming/0000-0002-5251-5810; Liang, Liang/0000-0001-7065-4075	New Zealand Lottery Health Research Grant [279585]; National Natural Science Foundation of China [31071051]; Beijing Natural Science Foundation [7132024]; Specialized Research Fund for the Doctoral Program of Higher Education, China [20101107110012]	New Zealand Lottery Health Research Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education, China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The project was funded by the New Zealand Lottery Health Research Grant (Reference No: 279585), the National Natural Science Foundation of China (Reference No: 31071051), Beijing Natural Science Foundation (Reference No: 7132024), and the Specialized Research Fund for the Doctoral Program of Higher Education, China (Reference No: 20101107110012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri A, 2001, NEUROSURGERY, V48, P827, DOI 10.1097/00006123-200104000-00027; Bleys RLAW, 2001, J NEUROSURG, V95, P102, DOI 10.3171/jns.2001.95.1.0102; Campero A, 2010, J CLIN NEUROSCI, V17, P746, DOI 10.1016/j.jocn.2009.10.015; Cavallo Luigi Maria, 2005, Neurosurgery, V56, P379, DOI 10.1227/01.NEU.0000156548.30011.D4; DIAO Y, 2013, NEUROSURGERY, V73, P10; DIAO Y, 2013, NEUROSURGERY, V73, pNS110; Francois P, 2010, J NEUROSURG, V113, P1045, DOI 10.3171/2010.1.JNS081701; Goel A, 1997, BRIT J NEUROSURG, V11, P134, DOI 10.1080/02688699746483; HARRIS FS, 1976, J NEUROSURG, V45, P169, DOI 10.3171/jns.1976.45.2.0169; Janjua RM, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.12.E2; Kawase T, 1996, NEUROSURGERY, V39, P527, DOI 10.1097/00006123-199609000-00019; Kehrli P, 1997, NEUROL RES, V19, P571; Kehrli P, 1998, NEUROL RES, V20, P585; Korchi AM, 2014, DIAGN INTERV IMAG, V95, P849, DOI 10.1016/j.diii.2013.04.013; Miyazaki Yoshihiro, 1994, Neurologia Medico-Chirurgica, V34, P150, DOI 10.2176/nmc.34.150; Nash L, 2005, ANESTHESIOLOGY, V103, P962, DOI 10.1097/00000542-200511000-00010; Parkinson D, 1998, ANAT REC, V251, P486; PARKINSON D, 1995, J CRANIOFAC SURG, V6, P55, DOI 10.1097/00001665-199501000-00016; Rhoton A L Jr, 1977, Clin Neurosurg, V24, P54; Rhoton AL, 2002, NEUROSURGERY, V51, pS375, DOI 10.1227/01.NEU.0000028833.01529.E7; SANSONE BC, 2001, PHYS REV E, V64; Seoane E, 1998, NEUROSURGERY, V42, P869, DOI 10.1097/00006123-199804000-00108; Tang Y, 2010, CLIN RADIOL, V65, P937, DOI 10.1016/j.crad.2010.06.009; Tuccar E, 2000, NEUROSURG REV, V23, P45, DOI 10.1007/s101430050031; UMANSKY F, 1982, J NEUROSURG, V56, P228, DOI 10.3171/jns.1982.56.2.0228; Yasuda Alexandre, 2005, Neurosurgery, V56, P4; Yokoyama S, 2001, NEUROSURGERY, V49, P857, DOI 10.1097/00006123-200110000-00014; Youssef S, 2006, NEUROSURGERY, V59, P270, DOI 10.1227/01.NEU.0000227580.70254.02; Zhang M, 2000, NEUROSURGERY, V47, P902, DOI 10.1097/00006123-200010000-00021	29	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89182	10.1371/journal.pone.0089182	http://dx.doi.org/10.1371/journal.pone.0089182			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586578	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000029
J	Shi, W; Xu, B; Wu, LM; Jin, RT; Luan, HB; Luo, LH; Zhu, Q; Johansson, L; Liu, YS; Tong, XH				Shi, Wei; Xu, Bo; Wu, Li-Min; Jin, Ren-Tao; Luan, Hong-Bing; Luo, Li-Hua; Zhu, Qing; Johansson, Lars; Liu, Yu-Sheng; Tong, Xian-Hong			Oocytes with a Dark Zona Pellucida Demonstrate Lower Fertilization, Implantation and Clinical Pregnancy Rates in IVF/ICSI Cycles	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; IN-VITRO FERTILIZATION; HUMAN MATURE OOCYTES; EMBRYO QUALITY; THICKNESS VARIATION; MORPHOLOGY; MITOCHONDRIA; FERTILITY; IMPACT; MICE	The morphological assessment of oocytes is important for embryologists to identify and select MII oocytes in IVF/ICSI cycles. Dysmorphism of oocytes decreases viability and the developmental potential of oocytes as well as the clinical pregnancy rate. Several reports have suggested that oocytes with a dark zona pellucida (DZP) correlate with the outcome of IVF treatment. However, the effect of DZP on oocyte quality, fertilization, implantation, and pregnancy outcome were not investigated in detail. In this study, a retrospective analysis was performed in 268 infertile patients with fallopian tube obstruction and/or male factor infertility. In 204 of these patients, all oocytes were surrounded by a normal zona pellucida (NZP, control group), whereas 46 patients were found to have part of their retrieved oocytes enclosed by NZP and the other by DZP (Group A). In addition, all oocytes enclosed by DZP were retrieved from 18 patients (Group B). No differences were detected between the control and group A. Compared to the control group, the rates of fertilization, good quality embryos, implantation and clinical pregnancy were significantly decreased in group B. Furthermore, mitochondria in oocytes with a DZP in both of the two study groups (A and B) were severely damaged with several ultrastructural alterations, which were associated with an increased density of the zona pellucida and vacuolization. Briefly, oocytes with a DZP affected the clinical outcome in IVF/ICSI cycles and appeared to contain more ultrastructural alterations. Thus, DZP could be used as a potential selective marker for embryologists during daily laboratory work.	[Shi, Wei; Xu, Bo; Wu, Li-Min; Jin, Ren-Tao; Luan, Hong-Bing; Luo, Li-Hua; Zhu, Qing; Liu, Yu-Sheng; Tong, Xian-Hong] Anhui Med Univ, Anhui Prov Hosp, Ctr Reprod Med, Hefei, Peoples R China; [Johansson, Lars] Codra Hosp, Ctr Assisted Reprod, Podgorica, Montenegro	Anhui Medical University	Xu, B (corresponding author), Anhui Med Univ, Anhui Prov Hosp, Ctr Reprod Med, Hefei, Peoples R China.	bio_xubo@163.com; shengzhizhongxin@126.com; tong68xianhong@163.com			National Natural Science Foundation of China [81000237]; Natural Science Foundation of Anhui Provincial of China [1308085QH131]; Natural Science Research Project of Anhui Provincial Education Department [KJ2013Z134]; Medical research project Foundation of Department of Health of Anhui Provincial [13ZC028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Provincial of China; Natural Science Research Project of Anhui Provincial Education Department; Medical research project Foundation of Department of Health of Anhui Provincial	This research was supported by the National Natural Science Foundation of China (81000237), the Natural Science Foundation of Anhui Provincial of China (1308085QH131), Natural Science Research Project of Anhui Provincial Education Department (KJ2013Z134), and Medical research project Foundation of Department of Health of Anhui Provincial (13ZC028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikani M, 1995, ZYGOTE, V3, P283, DOI 10.1017/S0967199400002707; Au HK, 2005, ANN NY ACAD SCI, V1042, P177, DOI 10.1196/annals.1338.020; Balaban B, 2006, REPROD BIOMED ONLINE, V12, P608, DOI 10.1016/S1472-6483(10)61187-X; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Coticchio G, 2010, J ASSIST REPROD GEN, V27, P131, DOI 10.1007/s10815-010-9394-7; DeMola JRL, 1997, J ASSIST REPROD GEN, V14, P332; DeSutter P, 1996, HUM REPROD, V11, P595; DOZORTSEV D, 1994, HUM REPROD, V9, P2139, DOI 10.1093/oxfordjournals.humrep.a138406; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Ebner T, 2008, HUM REPROD, V23, P62, DOI 10.1093/humrep/dem280; Ebner T, 2010, FERTIL STERIL, V94, P913, DOI 10.1016/j.fertnstert.2009.03.106; Eichenlaub-Ritter U, 2011, MITOCHONDRION, V11, P783, DOI 10.1016/j.mito.2010.08.011; El Shafie M, 2000, ATLAS ULTRASTRUCTURE; Esfandiari N, 2006, FERTIL STERIL, V86, P1522, DOI 10.1016/j.fertnstert.2006.03.056; Familiari G, 2006, INT REV CYTOL, V249, P53, DOI 10.1016/S0074-7696(06)49002-1; Gabrielsen A, 2001, HUM REPROD, V16, P2166, DOI 10.1093/humrep/16.10.2166; Hoodbhoy T, 2004, REPRODUCTION, V127, P417, DOI 10.1530/rep.1.00181; Keefe D, 1997, HUM REPROD, V12, P1250; Liu CY, 1996, P NATL ACAD SCI USA, V93, P5431, DOI 10.1073/pnas.93.11.5431; Liu DY, 2000, HUM REPROD, V15, P702, DOI 10.1093/humrep/15.3.702; Marco-Jimenez F, 2012, ANIM REPROD SCI, V132, P96, DOI 10.1016/j.anireprosci.2012.04.008; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Mikkelsen AL, 2001, HUM REPROD, V16, P1714, DOI 10.1093/humrep/16.8.1714; Montag M, 2008, REPROD BIOMED ONLINE, V16, P239, DOI 10.1016/S1472-6483(10)60580-9; Motta P M, 2000, Hum Reprod, V15 Suppl 2, P129; MOTTA PM, 1988, ANN NY ACAD SCI, V541, P367, DOI 10.1111/j.1749-6632.1988.tb22274.x; Nagano M, 2006, ZYGOTE, V14, P299, DOI 10.1017/S0967199406003807; Nottola SA, 2007, HUM REPROD, V22, P1123, DOI 10.1093/humrep/del463; Nottola SA, 2009, REPROD BIOMED ONLINE, V19, P17, DOI 10.1016/S1472-6483(10)60280-5; Nottola SA, 2005, ARCH HISTOL CYTOL, V68, P133, DOI 10.1679/aohc.68.133; Otsuki J, 2007, J ASSIST REPROD GEN, V24, P263, DOI 10.1007/s10815-007-9130-0; Palmstierna M, 1998, J ASSIST REPROD GEN, V15, P70, DOI 10.1007/BF02766828; Rankin TL, 2001, DEVELOPMENT, V128, P1119; Rienzi L, 2008, FERTIL STERIL, V90, P1692, DOI 10.1016/j.fertnstert.2007.09.024; Rienzi L, 2012, HUM REPROD, V27, P2, DOI 10.1093/humrep/des200; Sa R, 2011, FERTIL STERIL, V96, P143, DOI 10.1016/j.fertnstert.2011.04.088; Shen Y, 2005, HUM REPROD, V20, P1596, DOI 10.1093/humrep/deh811; Silva RC, 2011, THERIOGENOLOGY, V76, P1647, DOI 10.1016/j.theriogenology.2011.06.029; Sousa M., 2013, ZYGOTE, P1; Ten J, 2007, REPROD BIOMED ONLINE, V14, P40, DOI 10.1016/S1472-6483(10)60762-6; Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240; VANBLERKOM J, 1992, HUM REPROD, V7, P379, DOI 10.1093/oxfordjournals.humrep.a137655; Verlhac MH, 2000, CURR BIOL, V10, P1303, DOI 10.1016/S0960-9822(00)00753-3; Windt ML, 2001, HUM REPROD, V16, P2394, DOI 10.1093/humrep/16.11.2394; Xia P, 1997, HUM REPROD, V12, P1750, DOI 10.1093/humrep/12.8.1750	45	26	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89409	10.1371/journal.pone.0089409	http://dx.doi.org/10.1371/journal.pone.0089409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586757	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700040
J	Arons, AMM; Krabbe, PFM				Arons, Alexander M. M.; Krabbe, Paul F. M.			Quantification of Health by Scaling Similarity Judgments	PLOS ONE			English	Article							UNKNOWN DISTANCE FUNCTION; VISUAL ANALOG SCALES; COST-EFFECTIVENESS; STATES; METHODOLOGY; PREFERENCES; PROXIMITIES; OUTCOMES; MODELS; VALUES	Objective: A new methodology is introduced to scale health states on an interval scale based on similarity responses. It could be well suited for valuation of health states on specific regions of the health continuum that are problematic when applying conventional valuation techniques. These regions are the top-end, bottom-end, and states around 'dead'. Methods: Three samples of approximately 500 respondents were recruited via an online survey. Each sample received a different judgmental task in which similarity data were elicited for the top seven health states in the dementia quality of life instrument (DQI). These states were '111111' (no problems on any domain) and six others with some problems (level 2) on one domain. The tasks presented two (dyads), three (triads), or four (quads) DQI health states. Similarity data were transformed into interval-level scales with metric and non-metric multidimensional scaling algorithms. The three response tasks were assessed for their feasibility and comprehension. Results: In total 532, 469, and 509 respondents participated in the dyads, triads, and quads tasks respectively. After the scaling procedure, in all three response tasks, the best health state '111111' was positioned at one end of the health-state continuum and state '111211' was positioned at the other. The correlation between the metric scales ranged from 0.73 to 0.95, while the non-metric scales ranged from 0.76 to 1.00, indicating strong to near perfect associations. There were no apparent differences in the reported difficulty of the response tasks, but the triads had the highest number of drop-outs. Discussion: Multidimensional scaling proved to be a feasible method to scale health-state similarity data. The dyads and especially the quads response tasks warrant further investigation, as these tasks provided the best indications of respondent comprehension.	[Arons, Alexander M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands; [Krabbe, Paul F. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	Radboud University Nijmegen; University of Groningen	Arons, AMM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands.	s.arons@ebh.umcn.nl	Krabbe, Paul/AAO-6590-2020; Krabbe, Paul/B-2563-2013	Krabbe, Paul/0000-0001-6042-1243; Krabbe, Paul/0000-0001-6042-1243	ZonMw (The Netherlands Organization for Health Research and Development) [152002024]	ZonMw (The Netherlands Organization for Health Research and Development)(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This work was supported by ZonMw (The Netherlands Organization for Health Research and Development; project number 152002024) (http://www.zonmw.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arons AMM, 2013, EXPERT REV PHARM OUT, V13, P93, DOI [10.1586/erp.12.85, 10.1586/ERP.12.85]; Arons AMM, 2013, DEV VALUATION UNPUB; Attema AE, 2012, HLTH EC; Attema AE, 2013, EUR J HEALTH ECON, V14, pS53, DOI 10.1007/s10198-013-0508-x; Bansback N, 2012, J HEALTH ECON, V31, P306, DOI 10.1016/j.jhealeco.2011.11.004; Ben-Akiva ME., 1985, DISCRETE CHOICE ANAL; Bleichrodt H, 1997, MED DECIS MAKING, V17, P208, DOI 10.1177/0272989X9701700212; Borg I, 2010, MODERN MULTIDIMENSIO; Coast J, 2008, SOC SCI MED, V67, P874, DOI 10.1016/j.socscimed.2008.05.015; Coombs CH, 1964, THEORY DATA, DOI 10.1177/001316446502500236; Devlin N, 2012, HLTH EC; Devlin NJ, 2011, HEALTH ECON, V20, P348, DOI 10.1002/hec.1596; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Flynn Terry N, 2008, Popul Health Metr, V6, P6, DOI 10.1186/1478-7954-6-6; FROBERG DG, 1989, J CLIN EPIDEMIOL, V42, P459, DOI 10.1016/0895-4356(89)90136-4; Green C, 2000, PHARMACOECONOMICS, V17, P151, DOI 10.2165/00019053-200017020-00004; Hakim Z, 1999, HEALTH ECON, V8, P103; Krabbe PFM, 2008, MED CARE, V46, P357, DOI 10.1097/MLR.0b013e31815ceca9; Krabbe PFM, 2007, MED DECIS MAKING, V27, P395, DOI 10.1177/0272989X07302131; Krabbe PFM, 2006, QUAL LIFE RES, V15, P1651, DOI 10.1007/s11136-006-0027-7; Krabbe PFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079494; Krabbe PFM, 2006, MED DECIS MAKING, V26, P30, DOI 10.1177/0272989X05284106; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P115, DOI 10.1007/BF02289694; McCabe C, 2006, J HEALTH ECON, V25, P418, DOI 10.1016/j.jhealeco.2005.07.008; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Neumann J. V., 1944, THEORY GAMES EC BEHA; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Robinson A, 2006, HEALTH ECON, V15, P393, DOI 10.1002/hec.1069; Robinson A, 2001, MED DECIS MAKING, V21, P17, DOI 10.1177/0272989X0102100103; Salomon JA, 2003, POPUL HEALTH METR, V1, P1; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P219, DOI 10.1007/BF02289621; SHEPARD RN, 1966, J MATH PSYCHOL, V3, P287, DOI 10.1016/0022-2496(66)90017-4; Stolk EA, 2010, VALUE HEALTH, V13, P1005, DOI 10.1111/j.1524-4733.2010.00783.x; THURSTONE LL, 1994, PSYCHOL REV, V101, P266, DOI 10.1037/0033-295X.101.2.266; TORGERSON W, 1958, THEORY METHODS SCALI; Torrance G W, 1972, Health Serv Res, V7, P118; TORRANCE GW, 1982, OPER RES, V30, P1043, DOI 10.1287/opre.30.6.1043; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304	43	5	5	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89091	10.1371/journal.pone.0089091	http://dx.doi.org/10.1371/journal.pone.0089091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3VI	24586520	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900048
J	Kim, H; Kim, M; Kwak, C; Kim, HH; Ku, JH				Kim, Hwanik; Kim, Myong; Kwak, Cheol; Kim, Hyeon Hoe; Ku, Ja Hyeon			Prognostic Significance of Lymphovascular Invasion in Radical Cystectomy on Patients with Bladder Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; CLINICOPATHOLOGICAL FEATURES; RISK-FACTORS; SURVIVAL; TUMOR; EXPRESSION; LYMPHANGIOGENESIS; METASTASIS	Purpose: The objective of the present study was to conduct a systematic review and meta-analysis of published literature to appraise the prognostic value of lymphovascular invasion (LVI) in radical cystectomy specimens. Materials and Methods: Following the PRISMA statement, PubMed, Cochrane Library, and SCOPUS database were searched from the respective dates of inception until June 2013. Results: A total of 21 articles met the eligibility criteria for this systematic review, which included a total of 12,527 patients ranging from 57 to 4,257 per study. LVI was detected in 34.6% in radical cystectomy specimens. LVI was associated with higher pathological T stage and tumor grade, as well as lymph node metastasis. The pooled hazard ratio (HR) was statistically significant for recurrence-free survival (pooled HR, 1.61; 95% confidence interval [CI], 1.26-2.06), cancer-specific survival (pooled HR, 1.67; 95% CI, 1.38-2.01), and overall survival (pooled HR, 1.67; 95% CI, 1.38-2.01), despite the heterogeneity among included studies. On sensitivity analysis, the pooled HRs and 95% CIs were not significantly altered when any one study was omitted. The funnel plot for overall survival demonstrated a certain degree of asymmetry, which showed slight publication bias. Conclusions: This meta-analysis indicates that LVI is significantly associated with poor outcome in patients with bladder cancer who underwent radical cystectomy. Adequately designed prospective studies are required to provide the precise prognostic significance of LVI in bladder cancer.	[Kim, Hwanik; Kim, Myong; Kwak, Cheol; Kim, Hyeon Hoe; Ku, Ja Hyeon] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea	Seoul National University (SNU)	Ku, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea.	kuuro70@snu.ac.kr	Ku, Ja Hyeon/E-6682-2016	Kim, Hwanik/0000-0001-5201-2490; Kim, Myong/0000-0001-6995-6850				Afonso J, 2013, VIRCHOWS ARCH, V462, P445, DOI 10.1007/s00428-013-1388-2; Akao J, 2008, BJU INT, V102, P572, DOI 10.1111/j.1464-410X.2008.07749.x; Albers P, 2003, J CLIN ONCOL, V21, P1505, DOI 10.1200/JCO.2003.07.169; Alexander-Sefre F, 2003, J CLIN PATHOL, V56, P786, DOI 10.1136/jcp.56.10.786; Alitalo Kari, 2004, Cancer Res, V64, P9225, DOI 10.1158/0008-5472.CAN-04-2475; Canter D, 2008, BJU INT, V102, P952, DOI 10.1111/j.1464-410X.2008.07732.x; Capdet J, 2009, EJSO-EUR J SURG ONC, V35, P1245, DOI 10.1016/j.ejso.2009.06.002; Chromecki TF, 2011, NAT REV UROL, V8, P440, DOI 10.1038/nrurol.2011.96; de Graeff P, 2009, BRIT J CANCER, V101, P149, DOI 10.1038/sj.bjc.6605112; Dicken BJ, 2004, ANN SURG ONCOL, V11, P629, DOI 10.1245/ASO.2004.09.002; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Eisenberg MS, 2013, J UROLOGY, V190, P2005, DOI 10.1016/j.juro.2013.06.022; Fairey AS, 2009, J UROLOGY, V182, P85, DOI 10.1016/j.juro.2008.11.111; Font A, 2011, ANN ONCOL, V22, P139, DOI 10.1093/annonc/mdq333; GASPARINI G, 1994, J CLIN ONCOL, V12, P454, DOI 10.1200/JCO.1994.12.3.454; Gondo T, 2012, INT J CLIN ONCOL, V17, P456, DOI 10.1007/s10147-011-0310-7; Herman CM, 2000, AM J SURG PATHOL, V24, P859, DOI 10.1097/00000478-200006000-00012; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hugen CM, 2010, J SURG ONCOL, V102, P334, DOI 10.1002/jso.21642; Kauffman EC, 2011, BJU INT, V107, P628, DOI 10.1111/j.1464-410X.2010.09577.x; Kikuchi E, 2005, J UROLOGY, V174, P2120, DOI 10.1097/01.ju.0000181801.22474.8b; Kikuchi E, 2009, J CLIN ONCOL, V27, P612, DOI 10.1200/JCO.2008.17.2361; Kim DS, 2010, J KOREAN MED SCI, V25, P369, DOI 10.3346/jkms.2010.25.3.369; Ku JH, 2013, EUR J CANCER, V49, P2665, DOI 10.1016/j.ejca.2013.04.016; Ku JH, 2010, TUMORI J, V96, P699, DOI 10.1177/030089161009600510; Lee KB, 2009, ANN SURG ONCOL, V16, P2882, DOI 10.1245/s10434-009-0535-0; Lotan Y, 2013, EUR UROL, V64, P465, DOI 10.1016/j.eururo.2013.03.043; Manoharan M, 2010, WORLD J UROL, V28, P233, DOI 10.1007/s00345-009-0448-3; Margulis V, 2008, BJU INT, V102, P15, DOI 10.1111/j.1464-410X.2008.07594.x; Matsumoto K, 2008, UROLOGY, V72, P444, DOI 10.1016/j.urology.2007.11.128; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Meier I, 2008, INT J RADIAT ONCOL, V70, P1408, DOI 10.1016/j.ijrobp.2007.08.053; Miyata Y, 2006, J UROLOGY, V176, P348, DOI 10.1016/S0022-5347(06)00520-9; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Otto W, 2012, GENDER MED, V9, P481, DOI 10.1016/j.genm.2012.11.001; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Palmieri F, 2010, ANTICANCER RES, V30, P2973; Park E, 2011, INT UROL NEPHROL, V43, P1059, DOI 10.1007/s11255-011-9920-2; Park J, 2011, WORLD J UROL, V29, P443, DOI 10.1007/s00345-011-0644-9; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Shariat SF, 2010, BJU INT, V105, P1402, DOI 10.1111/j.1464-410X.2010.09217.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stephenson AJ, 2010, UROLOGY, V75, P382, DOI 10.1016/j.urology.2009.07.1259; Straume O, 2003, CLIN CANCER RES, V9, P250; Streeper NM, 2009, BJU INT, V103, P475, DOI 10.1111/j.1464-410X.2008.08011.x; Turkolmez K, 2007, UROLOGY, V70, P477, DOI 10.1016/j.urology.2007.05.008; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Woo CS, 2002, AM J SURG, V184, P337, DOI 10.1016/S0002-9610(02)00950-9	48	27	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89259	10.1371/journal.pone.0089259	http://dx.doi.org/10.1371/journal.pone.0089259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586637	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900074
J	Leuchtweis, J; Boettger, MK; Niv, F; Redecker, C; Schaible, HG				Leuchtweis, Johannes; Boettger, Michael K.; Niv, Fanny; Redecker, Christoph; Schaible, Hans-Georg			Enhanced Neurogenesis in the Hippocampal Dentate Gyrus during Antigen-Induced Arthritis in Adult Rat - A Crucial Role of Immunization	PLOS ONE			English	Article							GRANULE CELL NEUROGENESIS; KNEE-JOINT ARTHRITIS; ABERRANT NEUROGENESIS; ENRICHED ENVIRONMENT; PSYCHOSOCIAL STRESS; CORTICAL INFARCTS; FUTURE-DIRECTIONS; BRAIN IRRADIATION; X-IRRADIATION; PROLIFERATION	Neurogenesis in the subgranular zone of the mammalian hippocampal dentate gyrus contributes significantly to brain neuroplasticity. There is evidence that inflammation of the central nervous system inhibits neurogenesis but peripheral inflammation such as antigen-induced arthritis may rather enhance neurogenesis. Manifest arthritis is associated with symptoms such as pain and altered locomotion indicating that peripheral inflammation is associated with changes of both the immune system and the nervous system. This raises the intriguing question whether immune or neuronal factors or both actually drive changes of neurogenesis. Here we explored hippocampal neurogenesis in the rat during chronic antigen-induced arthritis in the knee joint. We analyzed neurogenesis in control rats, and in rats which were immunized for the antigen producing arthritis but which did not show arthritis and neurological symptoms, and in rats in which antigen injection into the knee produced manifest local inflammation and symptoms such as pain at the inflamed knee and altered locomotor behavior. Neurogenesis was assessed by quantifying bromodeoxyuridine-positive cells in sections of the complete hippocampal dentate gyrus. Compared to control animals, rats with antigen-induced arthritis presenting manifest local inflammation, hyperalgesia at the inflamed knee and significantly altered locomotion exhibited a significant increase of bromodeoxyuridine-positive cells. However, a similar increase in the number of such cells was found in rats which were only immunized against the antigen, but in which no local inflammatory response was induced and which thereby neither showed hyperalgesia nor alterations of locomotion. Thus we conclude that in peripheral immune-mediated arthritis the activation of the immune system in the process of immunization is the causal factor driving enhanced neurogenesis, and neither the local enhancement of inflammation nor the activation of the nervous system leading to neurological symptoms such as pain and altered locomotion. It seems noteworthy to further explore the clinical importance of this neuroimmune interaction.	[Leuchtweis, Johannes; Boettger, Michael K.; Schaible, Hans-Georg] Univ Jena, Jena Univ Hosp, Inst Physiol Neurophysiol 1, Jena, Germany; [Niv, Fanny; Redecker, Christoph] Univ Jena, Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Schaible, HG (corresponding author), Univ Jena, Jena Univ Hosp, Inst Physiol Neurophysiol 1, Jena, Germany.	Hans-Georg.Schaible@med.uni-jena.de		Boettger, Michael/0000-0002-6123-2142	Junior Project Grant	Junior Project Grant	This study was in part funded by a Junior Project Grant issued to MKB by the Interdisciplinary Center for Clinical Research (IZKF) of the Friedrich Schiller University Jena. No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Bellinzona M, 1996, NEUROSCI LETT, V208, P163, DOI 10.1016/0304-3940(96)12572-6; Boettger MK, 2008, ARTHRITIS RHEUM-US, V58, P2368, DOI 10.1002/art.23608; Boettger MK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3342; Boettger MK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3079; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cacci E, 2005, J NEUROSCI RES, V80, P789, DOI 10.1002/jnr.20531; Czeh B, 2002, BIOL PSYCHIAT, V52, P1057, DOI 10.1016/S0006-3223(02)01457-9; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Duric V, 2006, J PAIN, V7, P544, DOI 10.1016/j.jpain.2006.01.458; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Ekstrand J, 2008, NEUROSCI LETT, V442, P203, DOI 10.1016/j.neulet.2008.06.085; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gould E, 1997, J NEUROSCI, V17, P2492; GRIFFITHS RJ, 1992, AGENTS ACTIONS, V35, P88, DOI 10.1007/BF01990957; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Inokuchi K, 2011, CURR OPIN NEUROBIOL, V21, P360, DOI 10.1016/j.conb.2011.02.006; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jessberger S, 2007, J NEUROSCI, V27, P5967, DOI 10.1523/JNEUROSCI.0110-07.2007; Kaneko N, 2006, NEUROPSYCHOPHARMACOL, V31, P2619, DOI 10.1038/sj.npp.1301137; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kluska MM, 2005, NEUROSCIENCE, V135, P723, DOI 10.1016/j.neuroscience.2005.06.082; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lampa J, 2012, P NATL ACAD SCI USA, V109, P12728, DOI 10.1073/pnas.1118748109; Leuchtweis J, 2010, METHOD FIND EXP CLIN, V32, P575, DOI 10.1358/mf.2010.32.8.1532102; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Niv F, 2012, STROKE, V43, P2468, DOI 10.1161/STROKEAHA.112.660977; Parent JM, 1999, J NEUROSCI, V19, P4508; Parent JM, 1997, J NEUROSCI, V17, P3727; Peissner W, 1999, MOL BRAIN RES, V71, P61, DOI 10.1016/S0169-328X(99)00170-9; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; Phillips K, 2013, ARTHRITIS RHEUM-US, V65, P291, DOI 10.1002/art.37739; Schaible HG, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3305; Schaible HG, 2009, EXP BRAIN RES, V196, P153, DOI 10.1007/s00221-009-1782-9; Schurigt Uta, 2005, Arthritis Res Ther, V7, pR174, DOI 10.1186/ar1466; Shinohara C, 1997, CANCER RES, V57, P2694; Straub RH, 2001, ARTHRITIS RHEUM-US, V44, P493, DOI 10.1002/1529-0131(200103)44:3<493::AID-ANR95>3.0.CO;2-U; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Urbach A, 2008, STROKE, V39, P3064, DOI 10.1161/STROKEAHA.108.518076; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Vollmayr B, 2003, BIOL PSYCHIAT, V54, P1035, DOI 10.1016/S0006-3223(03)00527-4; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Wolf SA, 2009, FASEB J, V23, P3121, DOI 10.1096/fj.08-113944; Wong EYH, 2004, EUR J NEUROSCI, V20, P2491, DOI 10.1111/j.1460-9568.2004.03717.x; Wu CW, 2007, J NEUROCHEM, V103, P2471, DOI 10.1111/j.1471-4159.2007.04987.x; Wurm F, 2007, STROKE, V38, P2833, DOI 10.1161/STROKEAHA.107.485524	60	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89258	10.1371/journal.pone.0089258	http://dx.doi.org/10.1371/journal.pone.0089258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586636	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900073
J	Mallya, S; Fitch, BA; Lee, JS; So, L; Janes, MR; Fruman, DA				Mallya, Sharmila; Fitch, Briana A.; Lee, J. Scott; So, Lomon; Janes, Matthew R.; Fruman, David A.			Resistance to mTOR Kinase Inhibitors in Lymphoma Cells Lacking 4EBP1	PLOS ONE			English	Article							CANCER; GENERATION; INITIATION; LEUKEMIA; EFFICACY; GROWTH; MODELS	Inhibitors of the mechanistic target of rapamycin (mTOR) hold promise for treatment of hematological malignancies. Analogs of the allosteric mTOR inhibitor rapamycin are approved for mantle cell lymphoma but have limited efficacy in other blood cancers. ATP-competitive "active-site'' mTOR inhibitors produce more complete mTOR inhibition and are more effective than rapamycin in preclinical models of leukemia, lymphoma and multiple myeloma. In parallel to clinical trials of active-site mTOR inhibitors, it will be important to identify resistance mechanisms that might limit drug efficacy in certain patients. From a panel of diffuse large B-cell lymphoma cell lines, we found that the VAL cell line is particularly resistant to apoptosis in the presence of active-site mTOR inhibitors. Mechanistic investigation showed that VAL does not express eukaryotic initiation factor 4E-binding protein-1 (4EBP1), a key negative regulator of translation controlled by mTOR. Although VAL cells express the related protein 4EBP2, mTOR inhibitor treatment fails to displace eukaryotic initiation factor 4G from the mRNA cap-binding complex. Knockdown of eukaryotic initiation factor 4E, or re-expression of 4EBP1, sensitizes cells to apoptosis when treated with active-site mTOR inhibitors. These findings provide a naturally occurring example of 4EBP deficiency driving lymphoma cell resistance to active-site mTOR inhibitors.	[Fruman, David A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; Univ Calif Irvine, Inst Immunol, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Fruman, DA (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	dfruman@uci.edu			National Institutes of Health [T32-CA009054, R01-CA158383]; National Science Foundation Undergraduate Research and Mentoring in the Biological Sciences [DBI-0731655]; DLBCL research (DAF); NATIONAL CANCER INSTITUTE [P30CA062203, T32CA009054, R01CA158383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Undergraduate Research and Mentoring in the Biological Sciences; DLBCL research (DAF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health training grant T32-CA009054 (MRJ), National Science Foundation Undergraduate Research and Mentoring in the Biological Sciences Grant DBI-0731655 (BAF), National Institutes of Health grant R01-CA158383 (DAF) and a charitable gift for DLBCL research (DAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain T, 2012, ONCOTARGET, V3, P1491; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bhende PM, 2010, LEUKEMIA, V24, P1781, DOI 10.1038/leu.2010.154; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Ducker GS, 2014, ONCOGENE, V33, P1590, DOI 10.1038/onc.2013.92; Feldman ME, 2011, CURR TOP MICROBIOL, V347, P241, DOI 10.1007/82_2010_64; Foon KA, 2012, ADV HEMATOL, V2012; Garcia-Garcia C, 2012, CLIN CANCER RES, V18, P2603, DOI 10.1158/1078-0432.CCR-11-2750; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gupta M, 2009, BLOOD, V114, P2926, DOI 10.1182/blood-2009-05-220889; Hagner PR, 2010, BLOOD, V115, P2127, DOI 10.1182/blood-2009-09-220020; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Janes MR, 2013, LEUKEMIA, V27, P586, DOI 10.1038/leu.2012.276; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jang GM, 2004, J BIOL CHEM, V279, P47419, DOI 10.1074/jbc.M405885200; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Malina A, 2011, ONCOTARGET, V2, P76; Martineau Y, 2014, ONCOGENE, V33, P1367, DOI 10.1038/onc.2013.100; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Vu C, 2010, CLIN CANCER RES, V16, P5374, DOI 10.1158/1078-0432.CCR-10-0480; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	28	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88865	10.1371/journal.pone.0088865	http://dx.doi.org/10.1371/journal.pone.0088865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586420	Green Published, gold			2022-12-27	WOS:000331717900034
J	Calvet, GA; Velasque, L; Luz, PM; Cardoso, SW; Derrico, M; Moreira, RI; de Andrade, ACV; Cytryn, A; Pires, E; Veloso, VG; Grinsztejn, B; Friedman, RK				Calvet, Guilherme Amaral; Velasque, Luciane; Luz, Paula Mendes; Cardoso, Sandra Wagner; Derrico, Monica; Moreira, Ronaldo Ismerio; Vasconcelos de Andrade, Angela Cristina; Cytryn, Andrea; Pires, Elaine; Veloso, Valdilea Goncalves; Grinsztejn, Beatriz; Friedman, Ruth Khalili			Absence of Effect of Menopause Status at Initiation of First-Line Antiretroviral Therapy on Immunologic or Virologic Responses: A Cohort Study from Rio de Janeiro, Brazil	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; 1ST YEAR; HIV-1-INFECTED WOMEN; HAART REGIMEN; OLDER AGE; SEX; GENDER; CD4; TOLERABILITY; METAANALYSIS	Objective: To compare the effectiveness of first-line combination antiretroviral therapy (cART) between premenopausal and postmenopausal women. Methods: ART-naive women initiating cART between January 2000/June 2010 at the Instituto de Pesquisa Clinica Evandro Chagas Cohort were studied. Women were defined as postmenopausal after 12 consecutive months of amenorrhea. CD4 cell counts and HIV-1 RNA viral load (VL) measurements were compared between pre- and postmenopausal at 6, 12 and 24 months after cART initiation. Women who modified/discontinued a drug class or died due to an AIDS defining illness were classified as ART-failures. Variables were compared using Wilcoxon test, chi(2) or Fisher's exact test. The odds of cART effectiveness (VL, 400 copies/mL and/or no need to change cART) were compared using logistic regression. Linear model was used to access relationship between CD4 change and menopause. Results: Among 383 women, 328 (85%) were premenopausal and 55 (15%) postmenopausal. Median pre cART CD4 counts were 231 and 208 cells/mm 3 (p = 0.14) in pre- and postmenopausal women, respectively. No difference in the median pre cART VL was found (both 4.8 copies/mL). Median CD4 changes were similar at 6 and 12 months. At 24 months after cART initiation, CD4 changes among postmenopausal women were significantly lower among premenopausal women (p = 0.01). When the analysis was restricted to women with VL, 400 copies/mL, no statistical difference was observed. Overall, 63.7% achieved cART effectiveness at 24 months without differences between groups at 6, 12 and 24 months. Conclusion: Menopause status at the time of first-line cART initiation does not impact CD4 cell changes at 24 months among women with a virologic response. No relationship between menopause status and virologic response was observed.	[Calvet, Guilherme Amaral; Velasque, Luciane; Luz, Paula Mendes; Cardoso, Sandra Wagner; Derrico, Monica; Moreira, Ronaldo Ismerio; Vasconcelos de Andrade, Angela Cristina; Cytryn, Andrea; Pires, Elaine; Veloso, Valdilea Goncalves; Grinsztejn, Beatriz; Friedman, Ruth Khalili] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas IPEC, Rio De Janeiro, Brazil; [Velasque, Luciane] Univ Fed Estado Rio de Janeiro, Dept Matemat & Estat, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Estado do Rio de Janeiro	Calvet, GA (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas IPEC, Rio De Janeiro, Brazil.	guilherme.calvet@ipec.fiocruz.br	Calvet, GA/G-6959-2013; Cardoso, Sandra W/D-7965-2015	Calvet, GA/0000-0002-3545-5238; Cardoso, Sandra W/0000-0001-5230-0003; Luz, Paula/0000-0001-9746-719X				Abrogoua DP, 2012, PATIENT PREFER ADHER, V6, P227, DOI 10.2147/PPA.S26507; Althoff KN, 2010, AIDS, V24, P2467, DOI 10.1097/QAD.0b013e32833e6d14; [Anonymous], 1996, World Health Organ Tech Rep Ser, V866, P1; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2011, UNAIDS WORLD AIDS DA; Balestre E, 2012, AIDS, V26, P951, DOI 10.1097/QAD.0b013e3283528ad4; Barber TJ, 2011, ANTIVIR THER, V16, P805, DOI 10.3851/IMP1818; Blanco JR, 2012, AIDS RES HUM RETROV, V28, P800, DOI [10.1089/aid.2011.0377, 10.1089/AID.2011.0377]; Cardoso SW, 2010, AIDS RES HUM RETROV, V26, P865, DOI 10.1089/aid.2009.0274; Cejtin HE, 2012, AM J OBSTET GYNECOL, V207, P87, DOI 10.1016/j.ajog.2011.12.031; Friedman RK, 2011, REV SAUDE PUBL, V45, P373, DOI 10.1590/S0034-89102011000200016; Gameiro CM, 2010, MATURITAS, V67, P316, DOI 10.1016/j.maturitas.2010.08.003; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Greenbaum AH, 2008, AIDS, V22, P2331, DOI 10.1097/QAD.0b013e32831883f9; Grinsztejn B, 2006, INT J STD AIDS, V17, P473, DOI 10.1258/095646206777689071; Grinsztejn B, 2011, ANTIVIR THER, V16, P1057, DOI 10.3851/IMP1872; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Hermes A, 2012, HIV CLIN TRIALS, V13, P308, DOI 10.1310/hct1306-308; IBGE, 2002, PERF ID RESP PEL DOM; Lazarus JV, 2010, HIV MED, V11, P479, DOI 10.1111/j.1468-1293.2009.00810.x; Maman D, 2012, AIDS, V26, P1393, DOI 10.1097/QAD.0b013e328352d054; Moreira RI, 2011, JAIDS-J ACQ IMM DEF, V57, pS171, DOI 10.1097/QAI.0b013e31821e9d59; Napravnik S, 2002, JAIDS-J ACQ IMM DEF, V31, P11, DOI 10.1097/00126334-200209010-00002; Newman J, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/725713; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA479, DOI 10.1016/j.autrev.2011.11.022; Patterson K, 2007, HIV MED, V8, P406, DOI 10.1111/j.1468-1293.2007.00485.x; Patterson KB, 2009, CLIN INFECT DIS, V49, P473, DOI 10.1086/600398; Raboud J, 2010, HIV CLIN TRIALS, V11, P340, DOI 10.1310/hct1106-340; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Torres TS, 2014, BRAZ J INFECT DIS, V18, P34, DOI 10.1016/j.bjid.2013.04.005; Tumbarello M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-46; van Benthem BHB, 2002, AIDS, V16, P919, DOI 10.1097/00002030-200204120-00012; Wellons MF, 2002, J AM GERIATR SOC, V50, P603, DOI 10.1046/j.1532-5415.2002.50152.x; Yan J, 2013, REV ANTIVIRAL THERAP, V1, pO; Yao Genhong, 2004, Wei Sheng Yan Jiu, V33, P759; Young J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001194	37	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89299	10.1371/journal.pone.0089299	http://dx.doi.org/10.1371/journal.pone.0089299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586673	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700095
J	Quon, BS; Ngan, DA; Wilcox, PG; Man, SFP; Sin, DD				Quon, Bradley S.; Ngan, David A.; Wilcox, Pearce G.; Man, S. F. Paul; Sin, Don D.			Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; SOLUBLE CD14; HOSPITALIZATION; MARKER; IMPACT	Background: One in four cystic fibrosis (CF) patients diagnosed with a pulmonary exacerbation will not recover their baseline lung function despite standard treatment. This highlights the importance of preventing such events. Clinical decision-making can be improved through a simple blood test that predicts individuals at elevated short-term risk of an exacerbation. Methods: We obtained plasma samples from 30 stable CF patients from the St. Paul's Hospital Adult CF Clinic (Vancouver, Canada). For 15 patients, an additional plasma sample was obtained during an exacerbation. Soluble CD14 (sCD14) and C-reactive protein (CRP) were quantified using ELISA kits. Myeloperoxidase (MPO), interleukin(IL)-6, IL-1 beta, monocyte chemoattractant protein-1 (MCP-1), vascular endothelial growth factor (VEGF), and granulocyte colony-stimulating factor (G-CSF) were quantified using Luminex (TM) immunoassays. Stable state biomarker levels were examined in their ability to predict individuals that would experience a pulmonary exacerbation requiring intravenous (IV) antibiotics within 4 months. Paired stable and exacerbation plasma biomarker levels were also compared. Results: sCD14 levels were significantly higher in patients that experienced a pulmonary exacerbation requiring IV antibiotics within 4 months (p = 0.001). sCD14 cut-off value of 1450 ng/mL was associated with an area under the curve of 0.91 (95% CI 0.83-0.99) for predicting an exacerbation within 4 months of a stable visit, with a sensitivity of 100% and specificity of 82%. Plasma sCD14 levels were significantly higher during exacerbations than during periods of clinical stability (p = 0.03). Conclusions: Plasma sCD14 is a promising biomarker for identifying CF patients who will exacerbate within 4 months of a stable visit but requires further study in larger, independent cohorts.	[Quon, Bradley S.; Ngan, David A.; Wilcox, Pearce G.; Man, S. F. Paul; Sin, Don D.] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada; [Quon, Bradley S.; Wilcox, Pearce G.; Man, S. F. Paul; Sin, Don D.] Univ British Columbia, Div Resp Med, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Quon, BS (corresponding author), Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada.	bradley.quon@hli.ubc.ca	Sin, Don/AAC-2219-2021		British Columbia Lung Association	British Columbia Lung Association	This study was supported by a British Columbia Lung Association Grant-in-Aid (http://www.bc.lung.ca/association_and_services/research.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, Am Rev Respir Dis, V136, P1285; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Bilton D, 2011, J CYST FIBROS, V10, pS79, DOI 10.1016/S1569-1993(11)60012-X; Britto MT, 2002, CHEST, V121, P64, DOI 10.1378/chest.121.1.64; Burgmann H, 1996, CLIN IMMUNOL IMMUNOP, V80, P307, DOI 10.1006/clin.1996.0128; Davidson SJ, 2009, BLOOD COAGUL FIBRIN, V20, P400, DOI 10.1097/MBC.0b013e3283249ac6; Eichler I, 1999, EUR RESPIR J, V14, P1145, DOI 10.1183/09031936.99.14511459; Ellaffi M, 2005, AM J RESP CRIT CARE, V171, P158, DOI 10.1164/rccm.200405-667OC; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Hakimi Shoki A, 2013, CHEST; Hegarty M, 2009, CHILD CARE HLTH DEV, V35, P462, DOI 10.1111/j.1365-2214.2008.00900.x; Hendry J, 1999, EUR RESPIR J, V14, P435, DOI 10.1034/j.1399-3003.1999.14b32.x; LANDMANN R, 1995, J INFECT DIS, V171, P639, DOI 10.1093/infdis/171.3.639; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Marcos V, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-32; Mayer-Hamblett N, 2002, AM J RESP CRIT CARE, V166, P1550, DOI 10.1164/rccm.200202-087OC; RAYNER RJ, 1991, RESP MED, V85, P139, DOI 10.1016/S0954-6111(06)80292-1; Roderfeld M, 2009, J CYST FIBROS, V8, P338, DOI 10.1016/j.jcf.2009.06.001; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; WRIGHT SD, 1995, J IMMUNOL, V155, P6; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yi MS, 2004, J PEDIATR-US, V144, P711, DOI 10.1016/j.jpeds.2004.02.032	23	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89341	10.1371/journal.pone.0089341	http://dx.doi.org/10.1371/journal.pone.0089341			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586701	gold, Green Submitted, Green Published			2022-12-27	WOS:000331714700107
J	Zeng, XH; Li, JH; Peng, LB; Wang, YH; Tan, CQ; Chen, GN; Wan, XM; Lu, Q; Yi, LD				Zeng, Xiaohui; Li, Jianhe; Peng, Liubao; Wang, Yunhua; Tan, Chongqing; Chen, Gannong; Wan, Xiaomin; Lu, Qiong; Yi, Lidan			Economic Outcomes of Maintenance Gefitinib for Locally Advanced/Metastatic Non-Small-Cell Lung Cancer with Unknown EGFR Mutations: A Semi-Markov Model Analysis	PLOS ONE			English	Article							COST-EFFECTIVENESS; 1ST-LINE CHEMOTHERAPY; SUPPORTIVE CARE; DOUBLE-BLIND; PHASE-III; THERAPY; ERLOTINIB; CISPLATIN; PLACEBO; MULTICENTER	Background: Maintenance gefitinib significantly prolonged progression-free survival (PFS) compared with placebo in patients from eastern Asian with locally advanced/metastatic non-small-cell lung cancer (NSCLC) after four chemotherapeutic cycles (21 days per cycle) of first-line platinum-based combination chemotherapy without disease progression. The objective of the current study was to evaluate the cost-effectiveness of maintenance gefitinib therapy after four chemotherapeutic cycle's stand first-line platinum-based chemotherapy for patients with locally advanced or metastatic NSCLC with unknown EGFR mutations, from a Chinese health care system perspective. Methods and Findings: A semi-Markov model was designed to evaluate cost-effectiveness of the maintenance gefitinib treatment. Two-parametric Weibull and Log-logistic distribution were fitted to PFS and overall survival curves independently. One-way and probabilistic sensitivity analyses were conducted to assess the stability of the model designed. The model base-case analysis suggested that maintenance gefitinib would increase benefits in a 1, 3, 6 or 10-year time horizon, with incremental $184,829, $19,214, $19,328, and $ 21,308 per quality-adjusted life-year (QALY) gained, respectively. The most sensitive influential variable in the cost-effectiveness analysis was utility of PFS plus rash, followed by utility of PFS plus diarrhoea, utility of progressed disease, price of gefitinib, cost of follow-up treatment in progressed survival state, and utility of PFS on oral therapy. The price of gefitinib is the most significant parameter that could reduce the incremental cost per QALY. Probabilistic sensitivity analysis indicated that the cost-effective probability of maintenance gefitinib was zero under the willingness-to-pay (WTP) threshold of $16,349 (3xper-capita gross domestic product of China). The sensitivity analyses all suggested that the model was robust. Conclusions: Maintenance gefitinib following first-line platinum-based chemotherapy for patients with locally advanced/metastatic NSCLC with unknown EGFR mutations is not cost-effective. Decreasing the price of gefitinib may be a preferential choice for meeting widely treatment demands in China.	[Zeng, Xiaohui; Wang, Yunhua] Cent South Univ, Xiangya Hosp 2, PET CT Ctr, Changsha, Hunan, Peoples R China; [Li, Jianhe; Peng, Liubao; Tan, Chongqing; Wan, Xiaomin; Lu, Qiong; Yi, Lidan] Cent South Univ, Xiangya Hosp 2, Dept Pharm, Changsha, Hunan, Peoples R China; [Li, Jianhe; Tan, Chongqing; Wan, Xiaomin] Cent South Univ, Sch Pharmaceut Sci, Changsha, Hunan, Peoples R China; [Chen, Gannong] Cent South Univ, Xiangya Hosp 2, Dept Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Peng, LB (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Pharm, Changsha, Hunan, Peoples R China.	pengliubao@126.com	Wan, Xiaomin/GPX-4388-2022	/0000-0001-5315-8141	National Natural Science Foundation of China [81173028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (No. 81173028) (URL: http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Bareschino Maria Anna, 2011, J Thorac Dis, V3, P122, DOI 10.3978/j.issn.2072-1439.2010.12.08; Brodowicz T, 2006, LUNG CANCER, V52, P155, DOI 10.1016/j.lungcan.2006.01.006; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; China Center for Health Economic Research, 2010, CHIN GUID PHARM EC E; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Cohen MH, 2010, ONCOLOGIST, V15, P1344, DOI 10.1634/theoncologist.2010-0257; Cohen MH, 2010, ONCOLOGIST, V15, P1352, DOI 10.1634/theoncologist.2010-0224; D'Addario G, 2009, ANN ONCOL, V20, P68, DOI 10.1093/annonc/mdp132; Fathi AT, 2008, SEMIN THORAC CARDIOV, V20, P210, DOI 10.1053/j.semtcvs.2008.09.002; Fidias PM, 2009, J CLIN ONCOL, V27, P591, DOI 10.1200/JCO.2008.17.1405; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Greenhalgh J, 2010, HEALTH TECHNOL ASSES, V14, P33, DOI 10.3310/hta14suppl2/05; Jackson CH, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1269; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Klein R, 2010, J THORAC ONCOL, V5, P1263, DOI 10.1097/JTO.0b013e3181e15d16; Latimer N., 2011, NICE DSU TECHNICAL S; Latimer NR, 2013, MED DECIS MAKING, V33, P743, DOI 10.1177/0272989X12472398; Liu Q, 2011, LANCET, V377, P2064, DOI 10.1016/S0140-6736(11)60167-0; Matter-Walstra K, 2012, VALUE HEALTH, V15, P65, DOI 10.1016/j.jval.2011.08.1737; Nafees B, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-84; Nation Comprehensive Cancer Network, 2013, NONSM CELL LUNG CANC; National Bureau of Statistics of China, 2012, CHIN STAT YB 2012; National Cancer Institute, 2013, SEER STAT FACT SHEET; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Tsuchiya T, 2011, LUNG CANCER, V74, P521, DOI 10.1016/j.lungcan.2011.04.002; Vergnenegre A, 2012, CLINICOECONOMIC OUTC, V4, P31, DOI 10.2147/CEOR.S25923; Walleser S, 2012, CLINICOECONOMIC OUTC, V4, P269, DOI 10.2147/CEOR.S31794; WHO, COST EFF THRESH; Wu B, 2011, CLIN THER, V33, P1446, DOI 10.1016/j.clinthera.2011.09.016; Zeng X, 2013, CLIN THER, V35, P54, DOI 10.1016/j.clinthera.2012.12.013; Zeng XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048323; Zhang L, 2012, LANCET ONCOL, V13, P466, DOI 10.1016/S1470-2045(12)70117-1; Zhu J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-39	34	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88881	10.1371/journal.pone.0088881	http://dx.doi.org/10.1371/journal.pone.0088881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586426	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700038
J	McManus, H; Petoumenos, K; Franic, T; Kelly, MD; Watson, J; O'Connor, CC; Jeanes, M; Hoy, J; Cooper, DA; Law, MG				McManus, Hamish; Petoumenos, Kathy; Franic, Teo; Kelly, Mark D.; Watson, Jo; O'Connor, Catherine C.; Jeanes, Mark; Hoy, Jennifer; Cooper, David A.; Law, Matthew G.		Australian HIV Observational	Determinants of Suicide and Accidental or Violent Death in the Australian HIV Observational Database	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; GENERAL-POPULATION; RISK-FACTORS; ERA; IMMUNODEFICIENCY; INFECTION; ADULTS; AIDS; BEHAVIOR; PEOPLE	Background: Rates of suicide and accidental or violent death remain high in HIV-positive populations despite significantly improved prognosis since the introduction of cART. Methods: We conducted a nested case-control study of suicide and accidental or violent death in the Australian HIV Observational Database (AHOD) between January 1999 and March 2012. For each case, 2 controls were matched by clinic, age, sex, mode of exposure and HIV-positive date to adjust for potential confounding by these covariates. Risk of suicide and accidental or violent death was estimated using conditional logistic regression. Results: We included 27 cases (17 suicide and 10 violent/accidental death) and 54 controls. All cases were men who have sex with men (MSM) or MSM/injecting drug use (IDU) mode of exposure. Increased risk was associated with unemployment (Odds Ratio (OR) 5.86, 95% CI: 1.69-20.37), living alone (OR 3.26, 95% CI: 1.06-10.07), suicidal ideation (OR 6.55, 95% CI: 1.70-25.21), and >2 psychiatric/cognitive risk factors (OR 4.99, 95% CI: 1.17-30.65). CD4 cell count of >500 cells/mu L (OR 0.25, 95% CI: 0.07-0.87) and HIV-positive date >= 1990 (1990-1999 (OR 0.31, 95% CI: 0.11-0.89), post-2000 (OR 0.08, 95% CI: 0.010.84)) were associated with decreased risk. CD4 cell count >= 500 cells/mu L remained a significant predictor of reduced risk (OR 0.15, 95% CI: 0.03-0.70) in a multivariate model adjusted for employment status, accommodation status and HIV-positive date. Conclusions: After adjustment for psychosocial factors, the immunological status of HIV-positive patients contributed to the risk of suicide and accidental or violent death. The number of psychiatric/cognitive diagnoses contributed to the level of risk but many psychosocial factors were not individually significant. These findings indicate a complex interplay of factors associated with risk of suicide and accidental or violent death.	[McManus, Hamish; Petoumenos, Kathy; O'Connor, Catherine C.; Cooper, David A.; Law, Matthew G.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Franic, Teo] Holdsworth House GP, Sydney, NSW, Australia; [Kelly, Mark D.] Brisbane Sexual Hlth & HIV Serv, Brisbane, Qld, Australia; [Watson, Jo] Natl Assoc People HIV Australia, Sydney, NSW, Australia; [O'Connor, Catherine C.] Royal Prince Alfred Hosp, RPA Sexual Hlth, Sydney, NSW, Australia; [O'Connor, Catherine C.] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Jeanes, Mark; Hoy, Jennifer] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia	University of New South Wales Sydney; Kirby Institute; University of Sydney; University of Sydney; Monash University	McManus, H (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	hmcmanus@kirby.unsw.edu.au	Hoy, Jennifer/AAK-7968-2020; LA SRI PONNAMPALAVANAR, SASHEELA SRI/B-9703-2010	Templeton, David/0000-0003-2157-9587; Law, Matthew/0000-0002-3540-8837; Hoy, Jennifer/0000-0002-6948-7086; Boyd, Mark/0000-0002-6848-3307; McManus, Hamish/0000-0002-7264-8848	U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) [U01-AI069907]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Australian HIV Observational Database is funded as part of the Asia Pacific HIV Observational Database, a program of The Foundation for AIDS Research, amfAR, and is supported in part by a grant from the U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) (Grant No. U01-AI069907) and by unconditional grants from Merck Sharp & Dohme; Gilead; Bristol-Myers Squibb; Boehringer Ingelheim; Roche; Pfizer; GlaxoSmithKline; Janssen-Cilag. The Kirby Institute is funded by The Australian Government Department of Health and Ageing, and is affiliated with the Faculty of Medicine, The University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnert AS, 2013, INJ PREV; Bonnet F, 2004, CANCER-AM CANCER SOC, V101, P317, DOI 10.1002/cncr.20354; Cantor CH, 1999, MED J AUSTRALIA, V171, P137, DOI 10.5694/j.1326-5377.1999.tb123565.x; Carrico AW, 2010, AM J PSYCHIAT, V167, P117, DOI 10.1176/appi.ajp.2009.09111565; Catalan J, 2011, PSYCHOL HEALTH MED, V16, P588, DOI 10.1080/13548506.2011.582125; Chiao EY, 2003, CURR OPIN ONCOL, V15, P389, DOI 10.1097/00001622-200309000-00008; Falster K, 2009, AIDS, V23, P2323, DOI 10.1097/QAD.0b013e328331910c; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Gunnell D, 2004, BRIT J PSYCHIAT, V185, P385, DOI 10.1192/bjp.185.5.385; HARRIS EC, 1994, MEDICINE, V73, P281, DOI 10.1097/00005792-199411000-00001; Jia CX, 2012, J CLIN PSYCHIAT, V73, P1315, DOI 10.4088/JCP.12m07814; Keiser O, 2010, AM J PSYCHIAT, V167, P143, DOI 10.1176/appi.ajp.2009.09050651; Komiti A, 2001, AUST NZ J PSYCHIAT, V35, P747, DOI 10.1046/j.1440-1614.2001.00943.x; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Letendre S, 2010, CORRELATES TIME TO L; Lewden C, 2005, INT J EPIDEMIOL, V34, P121, DOI 10.1093/ije/dyh307; Logan J, 2011, ARCH GEN PSYCHIAT, V68, P935, DOI 10.1001/archgenpsychiatry.2011.85; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Monforte AD, 2007, HIV INDUCED IMMUNODE; Nock MK, 2006, J ABNORM PSYCHOL, V115, P616, DOI 10.1037/0021-843X.115.3.616; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Petoumenos Kathy, 2006, Sex Health, V3, P103, DOI 10.1071/SH05045; Preau M, 2008, AIDS CARE, V20, P917, DOI 10.1080/09540120701777249; Rice BD, 2010, AIDS, V24, P1795, DOI 10.1097/QAD.0b013e32833af878; Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1; Schroecksnadel S., 2012, NEUROBEHAV, V4, P1; Vance DE, 2008, J ASSOC NURSE AIDS C, V19, P375, DOI 10.1016/j.jana.2008.04.011; Warriner EM, 2010, J NEUROPSYCH CLIN N, V22, P321, DOI 10.1176/appi.neuropsych.22.3.321; Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS11, DOI 10.1016/j.drugalcdep.2004.08.003; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918	30	16	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89089	10.1371/journal.pone.0089089	http://dx.doi.org/10.1371/journal.pone.0089089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586519	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900087
J	Joensuu, T; Tegelberg, S; Reinmaa, E; Segerstrale, M; Hakala, P; Pehkonen, H; Korpi, ER; Tyynela, J; Taira, T; Hovatta, I; Kopra, O; Lehesjoki, AE				Joensuu, Tarja; Tegelberg, Saara; Reinmaa, Eva; Segerstrale, Mikael; Hakala, Paula; Pehkonen, Heidi; Korpi, Esa R.; Tyynela, Jaana; Taira, Tomi; Hovatta, Iiris; Kopra, Outi; Lehesjoki, Anna-Elina			Gene Expression Alterations in the Cerebellum and Granule Neurons of Cstb(-/-) Mouse Are Associated with Early Synaptic Changes and Inflammation	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; B-DEFICIENT MICE; CYSTATIN-B; GABA(A) RECEPTOR; CEROID-LIPOFUSCINOSIS; CATHEPSIN-B; EPM1; MODEL; ACTIVATION; DISEASE	Progressive myoclonus epilepsy of Unverricht-Lundborg type (EPM1) is an autosomal recessively inherited neurodegenerative disease, manifesting with myoclonus, seizures and ataxia, caused by mutations in the cystatin B (CSTB) gene. With the aim of understanding the molecular basis of pathogenetic events in EPM1 we characterized gene expression changes in the cerebella of pre-symptomatic postnatal day 7 (P7) and symptomatic P30 cystatin B -deficient (Cstb(-/-)) mice, a model for the disease, and in cultured Cstb(-/-) cerebellar granule cells using a pathway-based approach. Differentially expressed genes in P7 cerebella were connected to synaptic function and plasticity, and in cultured cerebellar granule cells, to cell cycle, cytoskeleton, and intracellular transport. In particular, the gene expression data pinpointed alterations in GABAergic pathway. Electrophysiological recordings from Cstb(-/-) cerebellar Purkinje cells revealed a shift of the balance towards decreased inhibition, yet the amount of inhibitory interneurons was not declined in young animals. Instead, we found diminished number of GABAergic terminals and reduced ligand binding to GABA(A) receptors in Cstb(-/-) cerebellum. These results suggest that alterations in GABAergic signaling could result in reduced inhibition in Cstb(-/-) cerebellum leading to the hyperexcitable phenotype of Cstb(-/-) mice. At P30, the microarray data revealed a marked upregulation of immune and defense response genes, compatible with the previously reported early glial activation that precedes neuronal degeneration. This further implies the role of early-onset neuroinflammation in the pathogenesis of EPM1.	[Joensuu, Tarja; Tegelberg, Saara; Reinmaa, Eva; Hakala, Paula; Kopra, Outi; Lehesjoki, Anna-Elina] Folkhalsan Inst Genet, Helsinki, Finland; [Joensuu, Tarja; Tegelberg, Saara; Hakala, Paula; Kopra, Outi; Lehesjoki, Anna-Elina] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Joensuu, Tarja; Tegelberg, Saara; Hakala, Paula; Kopra, Outi; Lehesjoki, Anna-Elina] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Joensuu, Tarja; Tegelberg, Saara; Segerstrale, Mikael; Hakala, Paula; Taira, Tomi; Kopra, Outi; Lehesjoki, Anna-Elina] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Segerstrale, Mikael; Hovatta, Iiris] Univ Helsinki, Fac Biol & Environm Sci, Dept Biosci, Helsinki, Finland; [Segerstrale, Mikael; Taira, Tomi] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Pehkonen, Heidi; Korpi, Esa R.] Univ Helsinki, Inst Biomed Pharmacol, Helsinki, Finland; [Tyynela, Jaana] Univ Helsinki, Inst Biomed Biochem & Dev Biol, Helsinki, Finland; [Hovatta, Iiris] Natl Inst Hlth & Welf, Mental Hlth & Substance Abuse Serv, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare	Joensuu, T (corresponding author), Folkhalsan Inst Genet, Helsinki, Finland.	tarja.joensuu@helsinki.fi	Joensuu, Tarja/F-3059-2011; Hovatta, Iiris/D-6871-2012	Hovatta, Iiris/0000-0002-5990-7892; Korpi, Esa R./0000-0003-0683-4009	Folkhalsan Research Foundation; Sigrid Juselius Foundation; Academy of Finland [137950]	Folkhalsan Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	This study was funded by the Folkhalsan Research Foundation, the Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation) and the Academy of Finland (grant # 137950) (http://www.aka.fi/en-GB/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakurtti K, 2005, EUR J HUM GENET, V13, P208, DOI 10.1038/sj.ejhg.5201300; Becker EBE, 2005, SEMIN CELL DEV BIOL, V16, P439, DOI 10.1016/j.semcdb.2005.02.006; Ben-Ari Yehezkel, 2006, Critical Reviews in Neurobiology, V18, P135; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Borrell V, 2012, NEURON, V76, P338, DOI 10.1016/j.neuron.2012.08.003; Briggs SW, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/527605; Buzzi A, 2012, NEUROBIOL DIS, V47, P216, DOI 10.1016/j.nbd.2012.04.005; Ceru S, 2010, J BIOL CHEM, V285, P10078, DOI 10.1074/jbc.M109.034793; Chandra D, 2010, NEUROPSYCHOPHARMACOL, V35, P999, DOI 10.1038/npp.2009.203; Chen Y, 2007, J CELL BIOCHEM, V100, P1337, DOI 10.1002/jcb.21194; Chiu C, 2008, ANN NEUROL, V64, P284, DOI 10.1002/ana.21440; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Graber S, 2004, NEUROPHARMACOLOGY, V47, P706, DOI 10.1016/j.neuropharm.2004.08.004; Grusser-Cornehls U, 2001, PROG NEUROBIOL, V63, P489, DOI 10.1016/S0301-0082(00)00024-1; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Hruska M, 2012, MOL CELL NEUROSCI, V50, P35, DOI 10.1016/j.mcn.2012.03.004; Ippolito D.M., 2010, J VIS EXP; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaworski A, 2012, NAT NEUROSCI, V15, P367, DOI 10.1038/nn.3037; Kalviainen R, 2008, EPILEPSIA, V49, P549, DOI 10.1111/j.1528-1167.2008.01546.x; Kaur G, 2010, AM J PATHOL, V177, P2256, DOI 10.2353/ajpath.2010.100461; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; KORPI ER, 1993, NATURE, V361, P356, DOI 10.1038/361356a0; Lalioti MD, 1997, NATURE, V386, P847, DOI 10.1038/386847a0; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; Lieuallen K, 2001, HUM MOL GENET, V10, P1867, DOI 10.1093/hmg/10.18.1867; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; Makela R, 1997, MOL PHARMACOL, V52, P380, DOI 10.1124/mol.52.3.380; Manninen O, 2013, RADIOLOGY, V269, P232, DOI 10.1148/radiol.13122458; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Riccio M, 2001, EXP CELL RES, V262, P84, DOI 10.1006/excr.2000.5085; Rinne R, 2002, ANN MED, V34, P380, DOI 10.1080/078538902320772124; Tegelberg S, 2012, J NEUROPATH EXP NEUR, V71, P40, DOI 10.1097/NEN.0b013e31823e68e1; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; Uusi-Oukari M, 2000, MOL CELL NEUROSCI, V16, P34, DOI 10.1006/mcne.2000.0856; Yagi T, 2000, GENE DEV, V14, P1169; Yang Y, 2009, SCIENCE, V326, P575, DOI 10.1126/science.1177087; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	48	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89321	10.1371/journal.pone.0089321	http://dx.doi.org/10.1371/journal.pone.0089321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586687	Green Published, gold			2022-12-27	WOS:000332390800016
J	Raizada, N; Sachdeva, KS; Sreenivas, A; Vadera, B; Gupta, RS; Parmar, M; Kulsange, S; Babre, A; Thakur, R; Gray, C; Ramachandran, R; Alavadi, U; Ghedia, M; Vollepore, B; Dewan, P; Boehme, C; Paramsivan, CN				Raizada, Neeraj; Sachdeva, K. S.; Sreenivas, Achuthan; Vadera, Bhavin; Gupta, R. S.; Parmar, Malik; Kulsange, Shubhangi; Babre, Ameet; Thakur, Rahul; Gray, Christen; Ramachandran, Ranjani; Alavadi, Umesh; Ghedia, Mayank; Vollepore, Balasangameshwara; Dewan, Puneet; Boehme, Catharina; Paramsivan, C. N.			Feasibility of Decentralised Deployment of Xpert MTB/RIF Test at Lower Level of Health System in India	PLOS ONE			English	Article							TUBERCULOSIS	Background: Xpert MTB/RIF is an automated cartridge-based nucleic acid amplification test that has demonstrated its potential to detect tuberculosis and rifampicin resistance with high accuracy. To assist scale-up decisions in India, a feasibility assessment of Xpert MTB/RIF implementation was conducted within microscopy centres of 18 RNTCP TB units. Methods: As part of programme-based demonstration of Xpert MTB/RIF implementation, we recorded and analysed association between key implementation factors and the ability of test to produce valid results. Factors contributing to test failures were analysed from GeneXpert software data which provides 'failure codes' and causes for test failures. Results: From March'12 to January'13, total 40,035 suspects were tested by Xpert MTB/RIF, and 39,680 (99.1%) received valid results (Cumulative: 37157 (92.8%) on first attempt, 39410 (98.4%) on second attempt, 39637 (99.0%) on third attempt and 39680 (99.1%) on more attempts). Overall initial test failure was 2,878 (7.2% (4%-17%)); of these, 2,594 (90.1%) were re-tested and produced valid results. Most frequent reason of test failure was inadequate sample processing or equipment malfunction (3.9%). Other reasons included power failure (1.1%), cartridge integrity/component failure (0.8%), device-computer communication error (0.5%), and temperature-related errors (0.08%). Significant variation was observed in failure rates both across instruments and over time; furthermore, substantial variation was observed in failure rate in two cartridges lots. Conclusion: Installation required minimal infrastructure modifications and concerns about adequacy of human resources under public sector facilities and temperature extremes proved unfounded. Under routine conditions, Xpert MTB/RIF provided 99.1% valid results in TB suspects with low overall failure rates (7.2% initial failure, 0.9% final failure); devices provided valuable real-time feedback on reasons for test failure, which were used for rapid corrective action. High modular replacement (32%) and inter-lot cartridge performance variation remain sources of concern, and warrant close monitoring of failure rates as a key quality indicator.	[Raizada, Neeraj; Vadera, Bhavin; Kulsange, Shubhangi; Babre, Ameet; Thakur, Rahul; Alavadi, Umesh; Vollepore, Balasangameshwara; Paramsivan, C. N.] Fdn Innovat New Diagnost, New Delhi, India; [Sachdeva, K. S.; Gupta, R. S.] Govt India, Cent TB Div, New Delhi, India; [Sreenivas, Achuthan; Parmar, Malik; Ramachandran, Ranjani; Ghedia, Mayank; Dewan, Puneet] WHO, India Country Off, New Delhi, India; [Gray, Christen; Boehme, Catharina] Fdn Innovat New Diagnost, Geneva, Switzerland	Foundation For Innovative New Diagnostics; World Health Organization; Foundation For Innovative New Diagnostics	Raizada, N (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	drneerajraizada@gmail.com		Nair, Sreenivas/0000-0002-2586-6797; Gray, Christen/0000-0002-9723-3032; Raizada, Neeraj/0000-0003-2116-332X	United States Agency for International Development (USAID) through World Health Organization (WHO)	United States Agency for International Development (USAID) through World Health Organization (WHO)(United States Agency for International Development (USAID))	The study was funded by United States Agency for International Development (USAID) through World Health Organization (WHO). FIND was responsible for study design, implementation, training, study coordination and monitoring, data analysis, and writing of the report in close coordination with WHO and Central TB Division. The funder had no participation in the design, implementation, analysis, or preparation of any reports or manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; ANDRE E, 2013, 19 C UN AFR REG KIG, P31246; [Anonymous], 2011, AUT REAL TIM NUCL AC; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Central TB Division Ministry of Health and Family Welfare, 2009, TRAIN MAN MYC TUB CU; *CEPH, 2013, IMPR YOUR EXP XPERT, P31246; Cepheid, 2009, XPERT MTB RIF 2 HOUR; CHEMHURU M, 2013, IMPLEMENTATION XPERT, P31246; Evans CA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001064; *NAT HLTH LAB SERV, 2013, GENEXPERT MTB RIF PR, P31246; Nikolayevskyy V, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-2; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; Tukvadze N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031563; *WHO, 2010, FREQ ASK QUEST XPERT, P31246; *WHO STOP TB DEP, 2012, UPD IMPL ROLL OUT XP, P31246; *WHO STOP TB DEP, 2010, ROADM ROLL XPERT MTB, P31246; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2007, US LIQ TB CULT DRUG	21	50	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89301	10.1371/journal.pone.0089301	http://dx.doi.org/10.1371/journal.pone.0089301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586675	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000036
J	Wieczor, M; Tobiszewski, A; Wityk, P; Tomiczek, B; Czub, J				Wieczor, Milosz; Tobiszewski, Adrian; Wityk, Pawel; Tomiczek, Bartlomiej; Czub, Jacek			Molecular Recognition in Complexes of TRF Proteins with Telomeric DNA	PLOS ONE			English	Article							MAMMALIAN TELOMERES; BINDING; PROTECTION; RESOLUTION; SHELTERIN; DYNAMICS; REPEATS; ACIDS; SITE; ATM	Telomeres are specialized nucleoprotein assemblies that protect the ends of linear chromosomes. In humans and many other species, telomeres consist of tandem TTAGGG repeats bound by a protein complex known as shelterin that remodels telomeric DNA into a protective loop structure and regulates telomere homeostasis. Shelterin recognizes telomeric repeats through its two major components known as Telomere Repeat-Binding Factors, TRF1 and TRF2. These two homologous proteins are therefore essential for the formation and normal function of telomeres. Indeed, TRF1 and TRF2 are implicated in a plethora of different cellular functions and their depletion leads to telomere dysfunction with chromosomal fusions, followed by apoptotic cell death. More specifically, it was found that TRF1 acts as a negative regulator of telomere length, and TRF2 is involved in stabilizing the loop structure. Consequently, these proteins are of great interest, not only because of their key role in telomere maintenance and stability, but also as potential drug targets. In the current study, we investigated the molecular basis of telomeric sequence recognition by TRF1 and TRF2 and their DNA binding mechanism. We used molecular dynamics (MD) to calculate the free energy profiles for binding of TRFs to telomeric DNA. We found that the predicted binding free energies were in good agreement with experimental data. Further, different molecular determinants of binding, such as binding enthalpies and entropies, the hydrogen bonding pattern and changes in surface area, were analyzed to decompose and examine the overall binding free energies at the structural level. With this approach, we were able to draw conclusions regarding the consecutive stages of sequence-specific association, and propose a novel aspartate-dependent mechanism of sequence recognition. Finally, our work demonstrates the applicability of computational MD-based methods to studying protein-DNA interactions.	[Wieczor, Milosz; Tobiszewski, Adrian; Wityk, Pawel; Czub, Jacek] Gdansk Univ Technol, Fac Chem, Dept Phys Chem, Gdansk, Poland; [Tomiczek, Bartlomiej] UCL, Dept Genet Evolut & Environm, London, England	Fahrenheit Universities; Gdansk University of Technology; University of London; University College London	Czub, J (corresponding author), Gdansk Univ Technol, Fac Chem, Dept Phys Chem, Gdansk, Poland.	jacczub@pg.gda.pl	Wieczór, Miłosz/O-6562-2019; Wityk, Paweł/AAA-6421-2021	Wieczór, Miłosz/0000-0003-4990-8629; Czub, Jacek/0000-0003-3639-6935; Wityk, Pawel/0000-0001-8612-727X	PL-Grid Infrastructure; Foundation for Polish Science (FNP) [HOMING PLUS/2011-4/3]; European Union	PL-Grid Infrastructure; Foundation for Polish Science (FNP)(Foundation for Polish Science); European Union(European Commission)	This research was partially supported by the PL-Grid Infrastructure. The work was financially supported by the Foundation for Polish Science (FNP, grant HOMING PLUS/2011-4/3), co-financed from the European Union's Regional Development Fund within the Operational Programme Innovative Economy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bidzinska J, 2009, ACTA BIOCH POL S3, V56, P27; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Bouvier B, 2009, J AM CHEM SOC, V131, P9864, DOI 10.1021/ja901761a; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Coulocheri SA, 2007, BIOCHIMIE, V89, P1291, DOI 10.1016/j.biochi.2007.07.020; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hanaoka S, 2005, PROTEIN SCI, V14, P119, DOI 10.1110/ps.04983705; HENDERSON ER, 1989, MOL CELL BIOL, V9, P345, DOI 10.1128/MCB.9.1.345; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2003, CANCER LETT, V194, P189, DOI 10.1016/S0304-3835(02)00706-1; Konig P, 1998, NUCLEIC ACIDS RES, V26, P1731, DOI 10.1093/nar/26.7.1731; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lemke K, 2005, NUCLEIC ACIDS RES, V33, P6034, DOI 10.1093/nar/gki904; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; McKerlie M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1372; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Muftuoglu M, 2006, CANCER RES, V66, P113, DOI 10.1158/0008-5472.CAN-05-2742; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; Nishikawa T, 2001, STRUCTURE, V9, P1237, DOI 10.1016/S0969-2126(01)00688-8; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Potoyan DA, 2012, P NATL ACAD SCI USA, V109, P17857, DOI 10.1073/pnas.1201805109; Reddy CK, 2001, J MOL BIOL, V314, P619, DOI 10.1006/jmbi.2001.5154; SAIKUMAR P, 1990, P NATL ACAD SCI USA, V87, P8452, DOI 10.1073/pnas.87.21.8452; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; VONHIPPEL PH, 1994, SCIENCE, V263, P769, DOI 10.1126/science.8303292; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	45	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89460	10.1371/journal.pone.0089460	http://dx.doi.org/10.1371/journal.pone.0089460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586793	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000046
J	Liu, Y; Xu, ZH; Wang, Y; Li, XD; Liu, LM; Chen, L; Xin, SJ; Xu, DP				Liu, Yan; Xu, Zhihui; Wang, Yan; Li, Xiaodong; Liu, Liming; Chen, Li; Xin, Shaojie; Xu, Dongping			rtM204Q May Serve as a Novel Lamivudine-Resistance-Associated Mutation of Hepatitis B Virus	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; ADEFOVIR DIPIVOXIL; DRUG-RESISTANCE; STERIC HINDRANCE; HBV POLYMERASE; 3TC RESISTANCE; YMDD MOTIF; EVOLUTION; INFECTION; THERAPY	Background and Aims: Lamivudine (LAM) is still widely used for anti-HBV therapy in China. The study aimed to clarify whether a newly-found rtM204Q mutation from patients was associated with the drug resistance. Methods: HBV complete reverse-transcriptase region was screened by direct sequencing and verified by clonal sequencing. Replication-competent plasmids containing patient-derived 1.1mer mutant or wild-type viral genome were constructed and transfected into HepG2 cells. After cultured with or without serially-diluted antiviral drugs, intracellular HBV replicative intermediates were quantitated for calculating the 50% effective concentration of drug (EC50). Results: A total of 12,000 serum samples of 9,830 patients with chronic HBV infection were screened. rtM204Q mutation was detected in seven LAM-refractory patients. By contrast, rtM204I/rtM204V mutations were detected in 2,502 patients' samples. The rtM204Q emerged either alone or in concomitance with rtM204I/rtM204V, and all were accompanied with virologic breakthrough in clinical course. Clonal sequencing verified that rtM204Q mutant was predominant in viral quasispecies of these samples. Phenotypic analysis showed that rtM204Q mutant had 89.9% of replication capacity and 76-fold increased LAM EC50 of the concomitant wild-type strain. By contrast, rtM204I mutant in the sample had lower replication capacity and higher LAM resistance (46.3% and 1396-fold increased LAM EC50 of the wild-type strain) compared to rtM204Q mutant. rtM204Q mutant was susceptible to adefovir dipivoxil (ADV) in vitro and ADV/ADV+LAM rescue therapy in clinic. Conclusion: rtM204Q is suggested to be a novel LAM-resistance-associated mutation. It conferred a moderate resistance with higher competent natural replication capacity compared to rtM204I mutation.	[Liu, Yan; Xu, Zhihui; Wang, Yan; Li, Xiaodong; Liu, Liming; Chen, Li; Xin, Shaojie; Xu, Dongping] Beijing 302 Hosp, Liver Failure Med Ctr, Inst Infect Dis, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital	Xin, SJ (corresponding author), Beijing 302 Hosp, Liver Failure Med Ctr, Inst Infect Dis, Beijing, Peoples R China.	xinshaojie302@163.com; xudongping302@sina.com			National Natural Science Foundation of China [81371852, 81271847]; Beijing Natural Science Foundation [7132224]; National 12th Five-Year Special Grand Project for Infectious Diseases [2012ZX10004503, 2012ZX10002004-005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National 12th Five-Year Special Grand Project for Infectious Diseases	This work was supported by the National Natural Science Foundation of China (81371852, 81271847), Beijing Natural Science Foundation (7132224), and National 12th Five-Year Special Grand Project for Infectious Diseases (2012ZX10004503, 2012ZX10002004-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozdayi AM, 2003, J VIRAL HEPATITIS, V10, P256, DOI 10.1046/j.1365-2893.2003.00435.x; Chao DC, 2013, DRUG DES DEV THER, V7, P777, DOI 10.2147/DDDT.S33947; Chinese Association of Infectious Diseases and Parasitology Hepatology, 2000, CHINESE J HEPATOLOGY, V6, P324; Frost SDW, 2000, J VIROL, V74, P6262, DOI 10.1128/JVI.74.14.6262-6268.2000; Gao HQ, 2000, J MOL BIOL, V300, P403, DOI 10.1006/jmbi.2000.3823; Gerolami R, 2006, ANTIVIR THER, V11, P1103; Ghany MG, 2009, HEPATOLOGY, V49, pS174, DOI 10.1002/hep.22900; Thai H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1794; Ji D, 2012, J CLIN VIROL, V54, P66, DOI 10.1016/j.jcv.2012.02.003; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; Lacombe K, 2010, ANTIVIR THER, V15, P493, DOI 10.3851/IMP1495; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Lai CL, 2003, CLIN INFECT DIS, V36, P687, DOI 10.1086/368083; Liu Y, 2011, J VIRAL HEPATITIS, V18, pe29, DOI 10.1111/j.1365-2893.2010.01360.x; Locarnini S, 2006, J HEPATOL, V44, P422, DOI 10.1016/j.jhep.2005.11.036; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Ma H, 2013, LIVER INT, V33, P133, DOI 10.1111/liv.12065; Nebbia G, 2012, QJM-INT J MED, V105, P109, DOI 10.1093/qjmed/hcr270; Ono-Nita SK, 1999, HEPATOLOGY, V29, P939, DOI 10.1002/hep.510290340; Osiowy C, 2006, J CLIN MICROBIOL, V44, P1994, DOI 10.1128/JCM.02477-05; Patterson SJ, 2011, GUT, V60, P247, DOI 10.1136/gut.2010.223206; Rodriguez-Frias F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037874; Sarafianos SG, 1999, P NATL ACAD SCI USA, V96, P10027, DOI 10.1073/pnas.96.18.10027; Schildgen V, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-167; Soriano V, 2013, ANTIVIR RES, V100, P435, DOI 10.1016/j.antiviral.2013.08.026; van Bommel F, 2012, ANTIVIR THER, V17, P1049, DOI 10.3851/IMP2307; Wang Y, 2012, MED J CHIN PLA, V37, P446; World Health Organization, 2012, HEP B FACT SHEETS; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Xu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072799; Yang HL, 2002, HEPATOLOGY, V36, P464, DOI 10.1053/jhep.2002.34740; Yatsuji H, 2006, ANTIMICROB AGENTS CH, V50, P3867, DOI 10.1128/AAC.00239-06; Yuen LKW, 2009, J HEPATOL, V50, P445, DOI 10.1016/j.jhep.2008.12.005; Zoulim F, 2006, SEMIN LIVER DIS, V26, P171, DOI 10.1055/s-2006-939759; Zoulim F, 2013, LIVER INT, V33, P116, DOI 10.1111/liv.12069	36	4	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89015	10.1371/journal.pone.0089015	http://dx.doi.org/10.1371/journal.pone.0089015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586482	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700018
J	Sanchez-Lockhart, M; Rojas, AV; Fettis, MM; Bauserman, R; Higa, TR; Miao, HY; Waugh, RE; Miller, J				Sanchez-Lockhart, Mariano; Rojas, Ana V.; Fettis, Margaret M.; Bauserman, Richard; Higa, Trissha R.; Miao, Hongyu; Waugh, Richard E.; Miller, Jim			T Cell Receptor Signaling Can Directly Enhance the Avidity of CD28 Ligand Binding	PLOS ONE			English	Article							KINASE-C-THETA; IMMUNOLOGICAL SYNAPSE; COSTIMULATORY MOLECULES; HUMAN EOSINOPHILS; CRYSTAL-STRUCTURE; VACCINIA VIRUS; CUTTING EDGE; PKC-THETA; IN-VIVO; EXPRESSION	T cell activation takes place in the context of a spatial and kinetic reorganization of cell surface proteins and signaling molecules at the contact site with an antigen presenting cell, termed the immunological synapse. Coordination of the activation, recruitment, and signaling from T cell receptor (TCR) in conjunction with adhesion and costimulatory receptors regulates both the initiation and duration of signaling that is required for T cell activation. The costimulatory receptor, CD28, is an essential signaling molecule that determines the quality and quantity of T cell immune responses. Although the functional consequences of CD28 engagement are well described, the molecular mechanisms that regulate CD28 function are largely unknown. Using a micropipet adhesion frequency assay, we show that TCR signaling enhances the direct binding between CD28 and its ligand, CD80. Although CD28 is expressed as a homodimer, soluble recombinant CD28 can only bind ligand monovalently. Our data suggest that the increase in CD28-CD28 binding is mediated through a change in CD28 valency. Molecular dynamic simulations and in vitro mutagenesis indicate that mutations at the base of the CD28 homodimer interface, distal to the ligand-binding site, can induce a change in the orientation of the dimer that allows for bivalent ligand binding. When expressed in T cells, this mutation allows for high avidity CD28-CD80 interactions without TCR signaling. Molecular dynamic simulations also suggest that wild type CD28 can stably adopt a bivalent conformation. These results support a model whereby inside-out signaling from the TCR can enhance CD28 ligand interactions by inducing a change in the CD28 dimer interface to allow for bivalent ligand binding and ultimately the transduction of CD28 costimulatory signals that are required for T cell activation.	[Sanchez-Lockhart, Mariano; Fettis, Margaret M.; Higa, Trissha R.; Miller, Jim] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14627 USA; [Sanchez-Lockhart, Mariano; Fettis, Margaret M.; Higa, Trissha R.; Miller, Jim] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA; [Rojas, Ana V.; Miao, Hongyu] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA; [Bauserman, Richard; Waugh, Richard E.] Univ Rochester, Dept Biomed Engn, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Miller, J (corresponding author), Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14627 USA.	jim_miller@urmc.rochester.edu	Sanchez-Lockhart, Mariano/M-6446-2019; Sanchez-Lockhart, Mariano/H-1321-2019; Waugh, Richard/D-2684-2014	Sanchez-Lockhart, Mariano/0000-0001-8009-7540; Sanchez-Lockhart, Mariano/0000-0001-8009-7540; Waugh, Richard/0000-0003-2084-5740	National Institute of Health [AI-83206, AI-090259, AI-105621, PO1 HL018208]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105621, T32AI083206, R21AI090259] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Health (AI-83206, AI-090259, AI-105621, and PO1 HL018208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre ML, 1996, J IMMUNOL, V157, P4762; Bakema JE, 2008, J IMMUNOL, V181, P4080, DOI 10.4049/jimmunol.181.6.4080; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bhatia S, 2006, IMMUNOL LETT, V104, P70, DOI 10.1016/j.imlet.2005.11.019; Boesteanu AC, 2009, SEMIN IMMUNOL, V21, P69, DOI 10.1016/j.smim.2009.02.005; Boomer JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002436; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Bracke M, 1997, J IMMUNOL, V159, P1459; Case DA, 2012, AMBER 12; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Chen MM, 2010, MOL BIOL CELL, V21, P1671, DOI 10.1091/mbc.E09-10-0900; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Erbe DV, 2002, J BIOL CHEM, V277, P7363, DOI 10.1074/jbc.M110162200; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Gizinski AM, 2010, BEST PRACT RES CL RH, V24, P463, DOI 10.1016/j.berh.2009.12.015; Good-Jacobson KL, 2012, J IMMUNOL, V188, P4217, DOI 10.4049/jimmunol.1102885; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huang JY, 2002, P NATL ACAD SCI USA, V99, P9369, DOI 10.1073/pnas.142298399; Huxley P, 2004, CHEM BIOL, V11, P1651, DOI 10.1016/j.chembiol.2004.09.011; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Judge TA, 1999, J IMMUNOL, V162, P1947; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; KOENDERMAN L, 1993, BLOOD, V81, P2413; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LaBelle JL, 2002, BLOOD, V99, P2146, DOI 10.1182/blood.V99.6.2146; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054; Li S, 2000, EUR J IMMUNOL, V30, P1394, DOI 10.1002/(SICI)1521-4141(200005)30:5<1394::AID-IMMU1394>3.0.CO;2-O; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; Lomakina EB, 2004, BIOPHYS J, V86, P1223, DOI 10.1016/S0006-3495(04)74196-X; Lomakina EB, 2006, ANN BIOMED ENG, V34, P1553, DOI 10.1007/s10439-006-9172-y; Lomakina EB, 2010, CELL MOL BIOENG, V3, P106, DOI 10.1007/s12195-009-0099-x; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Patel PC, 2013, J BIOL CHEM, V288, P29654, DOI 10.1074/jbc.M113.504639; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Petrova YI, 2012, MOL BIOL CELL, V23, P2092, DOI 10.1091/mbc.E11-12-1060; Poirier N, 2011, TRANSPL INT, V24, P2, DOI 10.1111/j.1432-2277.2010.01176.x; Riley JL, 2005, BLOOD, V105, P13, DOI 10.1182/blood-2004-04-1596; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salek-Ardakani S, 2011, J IMMUNOL, V186, P5294, DOI 10.4049/jimmunol.1100406; Salek-Ardakani S, 2009, J IMMUNOL, V182, P2909, DOI 10.4049/jimmunol.0803545; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; Sanchez-Lockhart M, 2011, J IMMUNOL, V187, P5515, DOI 10.4049/jimmunol.1102497; Sanchez-Lockhart M, 2008, J IMMUNOL, V181, P7639, DOI 10.4049/jimmunol.181.11.7639; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Sorensen P, 2004, J IMMUNOL, V172, P6803, DOI 10.4049/jimmunol.172.11.6803; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Srinivasan M, 2005, J BIOL CHEM, V280, P10149, DOI 10.1074/jbc.M409521200; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; ten Hove W, 2006, J IMMUNOL, V177, P6108, DOI 10.4049/jimmunol.177.9.6108; Tseng SY, 2008, J IMMUNOL, V181, P4852, DOI 10.4049/jimmunol.181.7.4852; Wahl DR, 2012, IMMUNOL REV, V249, P104, DOI 10.1111/j.1600-065X.2012.01148.x; Yokosuka T, 2008, IMMUNITY, V29, P589, DOI 10.1016/j.immuni.2008.08.011; Yu C, 2011, J BIOL CHEM, V286, P6685, DOI 10.1074/jbc.M110.182394	64	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89263	10.1371/journal.pone.0089263	http://dx.doi.org/10.1371/journal.pone.0089263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586641	gold, Green Submitted, Green Published			2022-12-27	WOS:000331880700026
J	Urbanelli, L; Magini, A; Ercolani, L; Sagini, K; Polchi, A; Tancini, B; Brozzi, A; Armeni, T; Principato, G; Emiliani, C				Urbanelli, Lorena; Magini, Alessandro; Ercolani, Luisa; Sagini, Krizia; Polchi, Alice; Tancini, Brunella; Brozzi, Alessandro; Armeni, Tatiana; Principato, Giovanni; Emiliani, Carla			Oncogenic H-Ras Up-Regulates Acid beta-Hexosaminidase by a Mechanism Dependent on the Autophagy Regulator TFEB	PLOS ONE			English	Article							N-ACETYLHEXOSAMINIDASE; INDUCED SENESCENCE; DOWN-REGULATION; GALACTOSIDASE; FIBROBLASTS; GLYCOHYDROLASES; BIOGENESIS; ACTIVATION; EXOCYTOSIS; SUBUNITS	The expression of constitutively active H-RasV12 oncogene has been described to induce proliferative arrest and premature senescence in many cell models. There are a number of studies indicating an association between senescence and lysosomal enzyme alterations, e.g. lysosomal beta-galactosidase is the most widely used biomarker to detect senescence in cultured cells and we previously reported that H-RasV12 up-regulates lysosomal glycohydrolases enzymatic activity in human fibroblasts. Here we investigated the molecular mechanisms underlying lysosomal glycohydrolase beta-hexosaminidase up-regulation in human fibroblasts expressing the constitutively active H-RasV12. We demonstrated that H-Ras activation increases beta-hexosaminidase expression and secretion by a Raf/extracellular signal-regulated protein kinase dependent pathway, through a mechanism that relies on the activity of the transcription factor EB (TFEB). Because of the pivotal role of TFEB in the regulation of lysosomal system biogenesis and function, our results suggest that this could be a general mechanism to enhance lysosomal enzymes activity during oncogene-induced senescence.	[Urbanelli, Lorena; Magini, Alessandro; Sagini, Krizia; Polchi, Alice; Tancini, Brunella; Brozzi, Alessandro; Emiliani, Carla] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Magini, Alessandro] Univ Udine, Dept Med & Biol Sci DSMB, I-33100 Udine, Italy; [Ercolani, Luisa; Armeni, Tatiana; Principato, Giovanni] Marche Polytech Univ, Dept Clin Sci, Sect Biochem Biol & Phys, Ancona, Italy; [Brozzi, Alessandro; Emiliani, Carla] Univ Perugia, CEMIN, I-06100 Perugia, Italy	University of Perugia; University of Udine; Marche Polytechnic University; University of Perugia	Urbanelli, L (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.	lorena.urbanelli@unipg.it; carla.emiliani@unipg.it	Magini, Alessandro/P-1201-2019; Emiliani, Carla/G-3738-2010; Magini, Alessandro/L-9175-2015; SAGINI, Krizia/Z-1629-2019; Armeni, Tatiana/J-8228-2013; Tancini, Brunella/F-6467-2014	Emiliani, Carla/0000-0002-6368-1515; Magini, Alessandro/0000-0002-2750-6226; SAGINI, Krizia/0000-0003-3357-2171; Armeni, Tatiana/0000-0003-0931-1342; Tancini, Brunella/0000-0001-9070-5765; Ercolani, Luisa/0000-0002-0418-3460; PRINCIPATO, Giovanni/0000-0001-8800-0301; Urbanelli, Lorena/0000-0003-0621-8476	ELA (European Leukodistrophies Association) [2011-037C1B]; Fondazione Cassa di Risparmio di Perugia [2013-0043-021]	ELA (European Leukodistrophies Association); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This work was supported by ELA (European Leukodistrophies Association) Grant no. 2011-037C1B and Fondazione Cassa di Risparmio di Perugia Grant no. 2013-0043-021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armeni T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052151; BOS JL, 1989, CANCER RES, V49, P4682; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Emiliani C, 2003, J BIOL CHEM, V278, P38453, DOI 10.1074/jbc.M303030200; EMILIANI C, 1992, INT J BIOCHEM, V24, P539, DOI 10.1016/0020-711X(92)90324-T; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; FISHER DE, 1991, GENE DEV, V5, P2342, DOI 10.1101/gad.5.12a.2342; Jones DT, 2012, PLOS ONE; Kohsaka S, 2011, BIOCHEM BIOPH RES CO, V410, P878, DOI 10.1016/j.bbrc.2011.06.082; KORNELUK RG, 1986, J BIOL CHEM, V261, P8407; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Magini A, 2008, BIOSCIENCE REP, V28, P229, DOI 10.1042/BSR20080075; Magini A, 2013, BIOCHEM BIOPH RES CO, V440, P251, DOI 10.1016/j.bbrc.2013.09.060; Magini A, 2012, BIOCHIMIE, V94, P684, DOI 10.1016/j.biochi.2011.09.021; Martino S, 1997, BBA-GEN SUBJECTS, V1335, P5, DOI 10.1016/S0304-4165(96)00116-X; McCubrey JA, 2012, ONCOTARGET, V3, P954, DOI 10.18632/oncotarget.652; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Norflus F, 1996, DNA CELL BIOL, V15, P89, DOI 10.1089/dna.1996.15.89; ODOWD BF, 1985, P NATL ACAD SCI USA, V82, P1184, DOI 10.1073/pnas.82.4.1184; Pang J, 2010, J PROTEOME RES, V9, P216, DOI 10.1021/pr900953s; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Premzl A, 2001, BIOL CHEM, V382, P853, DOI 10.1515/BC.2001.104; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ramjaun AR, 2007, CELL CYCLE, V6, P2902, DOI 10.4161/cc.6.23.4996; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Sardiello M, 2009, CELL CYCLE, V8, P4021, DOI 10.4161/cc.8.24.10263; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sebastian T, 2009, CANCER RES, V69, P2588, DOI 10.1158/0008-5472.CAN-08-2312; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Tancini B, 2010, MOL CELL BIOCHEM, V335, P273, DOI 10.1007/s11010-009-0277-0; Urbanelli L, 2008, NEUROBIOL AGING, V29, P12, DOI 10.1016/j.neurobiolaging.2006.09.005; Urbanelli L, 2011, BIOSCIENCE REP, V31, P477, DOI 10.1042/BSR20110020; Urbanelli Lorena, 2011, Recent Pat CNS Drug Discov, V6, P1, DOI 10.2174/157488911794079127; Urbanelli L, 2010, MOL CELL BIOCHEM, V343, P49, DOI 10.1007/s11010-010-0497-3; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Wolthuis RMF, 1999, CURR OPIN GENET DEV, V9, P112, DOI 10.1016/S0959-437X(99)80016-1; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	46	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89485	10.1371/journal.pone.0089485	http://dx.doi.org/10.1371/journal.pone.0089485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586816	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700051
J	Zhang, L; Xiao, D; Pang, B; Zhang, Q; Zhou, HJ; Zhang, LJ; Zhang, JZ; Kan, B				Zhang, Li; Xiao, Di; Pang, Bo; Zhang, Qian; Zhou, Haijian; Zhang, Lijuan; Zhang, Jianzhong; Kan, Biao			The Core Proteome and Pan Proteome of Salmonella Paratyphi A Epidemic Strains	PLOS ONE			English	Article							GEL-ELECTROPHORESIS PROTOCOLS; ESCHERICHIA-COLI; OMPA PROTEIN; ENTERICA; TYPHI; GENES; RPOS; TYPHIMURIUM; FEVER; HAPLOTYPES	Comparative proteomics of the multiple strains within the same species can reveal the genetic variation and relationships among strains without the need to assess the genomic data. Similar to comparative genomics, core proteome and pan proteome can also be obtained within multiple strains under the same culture conditions. In this study we present the core proteome and pan proteome of four epidemic Salmonella Paratyphi A strains cultured under laboratory culture conditions. The proteomic information was obtained using a Two-dimensional gel electrophoresis (2-DE) technique. The expression profiles of these strains were conservative, similar to the monomorphic genome of S. Paratyphi A. Few strain-specific proteins were found in these strains. Interestingly, non-core proteins were found in similar categories as core proteins. However, significant fluctuations in the abundance of some core proteins were also observed, suggesting that there is elaborate regulation of core proteins in the different strains even when they are cultured in the same environment. Therefore, core proteome and pan proteome analysis of the multiple strains can demonstrate the core pathways of metabolism of the species under specific culture conditions, and further the specific responses and adaptations of the strains to the growth environment.	[Zhang, Li; Xiao, Di; Pang, Bo; Zhang, Qian; Zhou, Haijian; Zhang, Lijuan; Zhang, Jianzhong; Kan, Biao] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Pang, Bo; Zhang, Jianzhong; Kan, Biao] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Kan, B (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	kanbiao@icdc.cn	Zhang, Li/GWM-7501-2022; Zhang, Jianzhong/AAM-6179-2021	Zhang, Jianzhong/0000-0001-7056-8206	Priority Project on Infectious Disease Control and Prevention [2012ZX10004215]	Priority Project on Infectious Disease Control and Prevention	This study was supported by the Priority Project on Infectious Disease Control and Prevention (2012ZX10004215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSABE M, 1982, J BACTERIOL, V150, P762; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Baker S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110008; Chen CX, 2012, FOODBORNE PATHOG DIS, V9, P325, DOI 10.1089/fpd.2011.1023; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Dong BQ, 2010, B WORLD HEALTH ORGAN, V88, P689, DOI [10.2471/BLT.09.069310, 10.1590/S0042-96862010000900013]; Encheva V, 2007, MICROBIOL-SGM, V153, P4183, DOI 10.1099/mic.0.2007/010140-0; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000929; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; Ibanez-Ruiz M, 2000, J BACTERIOL, V182, P5749, DOI 10.1128/JB.182.20.5749-5756.2000; IIDA A, 1984, J BACTERIOL, V158, P674, DOI 10.1128/JB.158.2.674-682.1984; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; JAP BK, 1990, Q REV BIOPHYS, V23, P367, DOI 10.1017/S003358350000559X; Khan AQ, 1998, FEMS MICROBIOL LETT, V161, P201, DOI 10.1111/j.1574-6968.1998.tb12949.x; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-88; Liang WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045346; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; Meysman P, 2013, MOL BIOL EVOL, V30, P1302, DOI 10.1093/molbev/mst029; Naaby-Hansen S, 2001, TRENDS PHARMACOL SCI, V22, P376, DOI 10.1016/S0165-6147(00)01663-1; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168; ONEAL CR, 1994, J BACTERIOL, V176, P4610, DOI 10.1128/JB.176.15.4610-4616.1994; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Sevcik M, 2001, MICROBIOL-UK, V147, P701, DOI 10.1099/00221287-147-3-701; Singh SP, 2003, INFECT IMMUN, V71, P3937, DOI 10.1128/IAI.71.7.3937-3946.2003; Sood S, 1999, EMERG INFECT DIS, V5, P483, DOI 10.3201/eid0503.990329; Steel LF, 2005, J CHROMATOGR B, V815, P275, DOI 10.1016/j.jchromb.2004.10.072; SUGAWARA E, 1994, J BIOL CHEM, V269, P17981; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; Talukder AA, 1996, FEBS LETT, V386, P177, DOI 10.1016/0014-5793(96)00426-7; Yan MY, 2005, DIS SURVEILLANCE, V20, P401; Ying TY, 2005, PROTEOMICS, V5, P4777, DOI 10.1002/pmic.200401326; Yuan J, 2006, MOL CELL PROTEOMICS, V5, P1105, DOI 10.1074/mcp.M500410-MCP200; Zhang MJ, 2009, J BASIC MICROB, V49, P482, DOI 10.1002/jobm.200800372	40	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89197	10.1371/journal.pone.0089197	http://dx.doi.org/10.1371/journal.pone.0089197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586590	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700024
J	Willems, S; van der Velden, D; Quax, PHA; de Borst, GJ; de Vries, JPPM; Moll, FL; Kuiper, J; Toes, REM; de Jager, SCA; de Kleijn, DPV; Hoefer, IE; Pasterkamp, G; Bot, I				Willems, Sanne; van der Velden, Daniei; Quax, Paul H. A.; de Borst, Gert Jan; de Vries, Jean-Paul P. M.; Moll, Frans L.; Kuiper, Johan; Toes, Rene E. M.; de Jager, Saskia C. A.; de Kleijn, Dominique P. V.; Hoefer, Imo E.; Pasterkamp, Gerard; Bot, Ilze			Circulating Immunoglobulins Are Not Associated with Intraplaque Mast Cell Number and Other Vulnerable Plaque Characteristics in Patients with Carotid Artery Stenosis	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; OXIDIZED LDL; ENDARTERECTOMY; DISEASE; IGG; DESTABILIZATION; ATHEROSCLEROSIS; ATHEROGENESIS; INFLAMMATION	Background: Recently, we have shown that intraplaque mast cell numbers are associated with atherosclerotic plaque vulnerability and with future cardiovascular events, which renders inhibition of mast cell activation of interest for future therapeutic interventions. However, the endogenous triggers that activate mast cells during the progression and destabilization of atherosclerotic lesions remain unidentified. Mast cells can be activated by immunoglobulins and in the present study, we aimed to establish whether specific immunoglobulins in plasma of patients scheduled for carotid endarterectomy were related to (activated) intraplaque mast cell numbers and plasma tryptase levels. In addition, the levels were related to other vulnerable plaque characteristics and baseline clinical data. Methods and Results: OxLDL-IgG, total IgG and total IgE levels were measured in 135 patients who underwent carotid endarterectomy. No associations were observed between the tested plasma immunoglobulin levels and total mast cell numbers in atherosclerotic plaques. Furthermore, no associations were found between IgG levels and the following plaque characteristics: lipid core size, degree of calcification, number of macrophages or smooth muscle cells, amount of collagen and number of microvessels. Interestingly, statin use was negatively associated with plasma IgE and oxLDL-IgG levels. Conclusions: In patients suffering from carotid artery disease, total IgE, total IgG and oxLDL-IgG levels do not associate with plaque mast cell numbers or other vulnerable plaque histopathological characteristics. This study thus does not provide evidence that the immunoglobulins tested in our cohort play a role in intraplaque mast cell activation or grade of atherosclerosis.	[Willems, Sanne; de Jager, Saskia C. A.; de Kleijn, Dominique P. V.; Hoefer, Imo E.; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [van der Velden, Daniei; Kuiper, Johan; Bot, Ilze] Gorlaeus Labs, Leiden Acad Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands; [Quax, Paul H. A.; Bot, Ilze] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Quax, Paul H. A.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [de Borst, Gert Jan; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [de Vries, Jean-Paul P. M.] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands; [Toes, Rene E. M.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [de Kleijn, Dominique P. V.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [de Kleijn, Dominique P. V.] Natl Univ Singapore Hosp, Cardiovasc Res Inst & Surg, Singapore 117548, Singapore	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; National University of Singapore	Bot, I (corresponding author), Gorlaeus Labs, Leiden Acad Ctr Drug Res, Div Biopharmaceut, POB 9502, NL-2300 RA Leiden, Netherlands.	i.bot@lacdr.leidenuniv.nl	Quax, Paul/W-8520-2019; Quax, Paul/ABD-5294-2020; de+Jager, Saskia/AAE-1132-2022; de+Jager, Saskia/ABC-4264-2020	Quax, Paul/0000-0002-6853-5760; de Jager, Saskia/0000-0002-5233-0066; Toes, Rene/0000-0002-9618-6414; Bot, Ilze/0000-0002-1242-1959	Dutch Ministry of Economic Affairs, Agriculture and Innovation; LCTD3 program; Netherlands CardioVascular Research Initiative; Dutch Heart Foundation; Dutch Federation of University Medical Centres; Netherlands Organisation for Health Research and Development; Royal Netherlands Academy of Sciences; GENIUS project	Dutch Ministry of Economic Affairs, Agriculture and Innovation; LCTD3 program; Netherlands CardioVascular Research Initiative; Dutch Heart Foundation(Netherlands Heart Foundation); Dutch Federation of University Medical Centres; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences; GENIUS project	This research forms part of the Project P1.03 PENT of the research program of the BioMedical Materials Institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. DvdV was financed by the LCTD3 program. We acknowledge the support from the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences, for the GENIUS project "Generating the best evidence-based pharmaceutical targets for atherosclerosis'' (CVON2011-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bot I, 2007, CIRCULATION, V115, P2516, DOI 10.1161/CIRCULATIONAHA.106.660472; Bot I, 2010, CIRC RES, V106, P89, DOI 10.1161/CIRCRESAHA.109.204875; Bot M, 2013, J LIPID RES, V54, P1265, DOI 10.1194/jlr.M032862; COYNE TJ, 1994, CAN J NEUROL SCI, V21, P129, DOI 10.1017/S0317167100049052; CRIQUI MH, 1987, AM J MED, V82, P964, DOI 10.1016/0002-9343(87)90159-8; de Vries MR, 2013, CARDIOVASC RES, V97, P311, DOI 10.1093/cvr/cvs312; Halliday A, 2004, LANCET, V363, P1491; Hellings WE, 2010, CIRCULATION, V121, P1941, DOI 10.1161/CIRCULATIONAHA.109.887497; KAARTINEN M, 1994, CIRCULATION, V90, P1669, DOI 10.1161/01.CIR.90.4.1669; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; KORKMAZ ME, 1991, INT J CARDIOL, V31, P199, DOI 10.1016/0167-5273(91)90216-C; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Kovanen PT, 1998, ARCH INTERN MED, V158, P1434, DOI 10.1001/archinte.158.13.1434; Laczik R, 2011, LUPUS, V20, P730, DOI 10.1177/0961203311398884; Laine P, 1999, CIRCULATION, V124, P297; Lappalainen J, 2011, ATHEROSCLEROSIS, V214, P357, DOI 10.1016/j.atherosclerosis.2010.11.024; Malbec O, 2007, IMMUNOL REV, V217, P206, DOI 10.1111/j.1600-065X.2007.00510.x; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Toole JF, 1996, LANCET, V347, P12; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wang J, 2011, J CLIN INVEST, V121, P3564, DOI 10.1172/JCI46028; Willems S, 2013, EUR HEART J, V34, P3699, DOI 10.1093/eurheartj/eht186; YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32, DOI 10.1161/01.ATV.14.1.32	25	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88984	10.1371/journal.pone.0088984	http://dx.doi.org/10.1371/journal.pone.0088984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586471	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900043
J	Chen, MN; Rao, YH; Zheng, Y; Wei, SQ; Li, Y; Guo, T; Yin, P				Chen, Meinan; Rao, Yanhua; Zheng, Yi; Wei, Shiqing; Li, Ye; Guo, Tong; Yin, Ping			Association between Soy Isoflavone Intake and Breast Cancer Risk for Pre- and Post-Menopausal Women: A Meta-Analysis of Epidemiological Studies	PLOS ONE			English	Article							FOOD-INTAKE; PHYTOESTROGEN INTAKE; RECEPTOR STATUS; SOYFOOD INTAKE; CHINESE WOMEN; COHORT; ADOLESCENCE; DIAGNOSIS; SURVIVAL; URINARY	Background: Conclusions drawn from meta-analyses on the association between soy isoflavone intake and breast cancer risk for pre-and post-menopausal women are not fully consistent. These meta-analyses did not explore the influence of different study designs on the pooled results on the basis of distinguishing between pre-and post-menopausal women. Methodology and Principal Findings: We performed a meta-analysis of 35 studies which reported results of association between soy isoflavone intake and breast cancer risk for pre- and/or post-menopausal women, calculated pooled odds ratios and their 95% confidence intervals of pre-and post-menopausal women respectively, and further explored soy isoflavone-breast cancer association on the basis of considering different study regions and designs. Summary results suggested that soy isoflavone intake has a protective effect against breast cancer for both pre- and post-menopausal women. However, they are influenced by study design and region. Pooled ORs of studies carried out in Asian countries suggested that soy isoflavone's protective effect exist in both pre-and post-menopausal women (OR = 0.59, 95% CI: 0.48-0.69 for premenopausal women; OR = 0.59, 95% CI: 0.44-0.74 for postmenopausal women). However, there are some differences between the results pooled from different study designs for women in Asian countries (test for consistency, P = 0.04). Pooled OR of studies on postmenopausal women in Western countries suggested that soy isoflavone intake has a marginally significant protective effect (OR = 0.92; 95% CI: 0.83 similar to 1.00), but further analyses stratifying by study design found no statistically significant association. Conclusions: We meta-analyzed more and newer research results, and separated women according to menopausal status to explore soy isoflavone-breast cancer association. We founded that soy isoflavone intake could lower the risk of breast cancer for both pre-and post-menopausal women in Asian countries. However, for women in Western countries, pre- or postmenopausal, there is no evidence to suggest an association between intake of soy isoflavone and breast cancer.	[Chen, Meinan; Zheng, Yi; Wei, Shiqing; Li, Ye; Yin, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Guo, Tong] WuXiPRA Clin Res Shanghai Co Ltd, Shanghai, Peoples R China; [Rao, Yanhua] Jiangxia Maternal & Child Hlth Hosp, Wuhan, Peoples R China	Huazhong University of Science & Technology	Yin, P (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	ping_y2000@163.com						Anderson LN, 2013, INT J CANCER, V132, P1683, DOI 10.1002/ijc.27788; Brasky TM, 2010, CANCER EPIDEM BIOMAR, V19, P1696, DOI 10.1158/1055-9965.EPI-10-0318; Chi F, 2013, ASIAN PAC J CANCER P, V14, P2407, DOI 10.7314/APJCP.2013.14.4.2407; Cho YA, 2010, EUR J CLIN NUTR, V64, P924, DOI 10.1038/ejcn.2010.95; Delaune A, 2009, WORLDV EVID-BASED NU, V6, P160, DOI 10.1111/j.1741-6787.2008.00128.x; den Tonkelaar I, 2001, CANCER EPIDEM BIOMAR, V10, P223; Dong JY, 2011, BREAST CANCER RES TR, V125, P315, DOI 10.1007/s10549-010-1270-8; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Hooper L, 2010, HUM REPROD UPDATE, V16, P745, DOI 10.1093/humupd/dmq011; Iwasaki M, 2009, BREAST CANCER RES TR, V116, P401, DOI 10.1007/s10549-008-0168-1; Kang XM, 2010, CAN MED ASSOC J, V182, P1857, DOI 10.1503/cmaj.091298; Kim MK, 2008, NUTR CANCER, V60, P568, DOI 10.1080/01635580801966203; LEE HP, 1991, LANCET, V337, P1197, DOI 10.1016/0140-6736(91)92867-2; Lee SA, 2009, AM J CLIN NUTR, V89, P1920, DOI 10.3945/ajcn.2008.27361; Linseisen J, 2004, INT J CANCER, V110, P284, DOI 10.1002/ijc.20119; Messina M, 2004, AM J CLIN NUTR, V80, P528, DOI 10.1093/ajcn/80.2.528; Nechuta SJ, 2012, AM J CLIN NUTR, V96, P123, DOI 10.3945/ajcn.112.035972; Qin LQ, 2006, J NUTR SCI VITAMINOL, V52, P428, DOI 10.3177/jnsv.52.428; Shu XO, 2001, CANCER EPIDEM BIOMAR, V10, P483; Suzuki T, 2008, INT J CANCER, V123, P1674, DOI 10.1002/ijc.23644; Trock BJ, 2006, JNCI-J NATL CANCER I, V98, P459, DOI 10.1093/jnci/djj102; Verheus M, 2007, J CLIN ONCOL, V25, P648, DOI 10.1200/JCO.2006.06.0244; Ward H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1995; Wu AH, 2008, BRIT J CANCER, V98, P9, DOI 10.1038/sj.bjc.6604145; Xie Q, 2013, ASIA PAC J CLIN NUTR, V22, P118, DOI 10.6133/apjcn.2013.22.1.16; Zhang M, 2009, BREAST CANCER RES TR, V118, P553, DOI 10.1007/s10549-009-0354-9; Zhong Xiao, 2012, Wei Sheng Yan Jiu, V41, P670	27	79	82	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89288	10.1371/journal.pone.0089288	http://dx.doi.org/10.1371/journal.pone.0089288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586662	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700090
J	Chen, X; Liao, CY; Chu, QQ; Zhou, GX; Lin, X; Li, XB; Lu, HJ; Xu, BH; Yue, ZC				Chen, Xi; Liao, Chunyan; Chu, Qiqi; Zhou, Guixuan; Lin, Xiang; Li, Xiaobo; Lu, Haijie; Xu, Benhua; Yue, Zhicao			Dissecting the Molecular Mechanism of Ionizing Radiation-Induced Tissue Damage in the Feather Follicle	PLOS ONE			English	Article							X-IRRADIATION; FRACTIONATION SCHEDULES; MAMMALIAN-CELLS; BONE-MARROW; CHICK LIMB; STEM-CELLS; RADIOTHERAPY; PATHWAY; GROWTH; SKIN	Ionizing radiation (IR) is a common therapeutic agent in cancer therapy. It damages normal tissue and causes side effects including dermatitis and mucositis. Here we use the feather follicle as a model to investigate the mechanism of IR-induced tissue damage, because any perturbation of feather growth will be clearly recorded in its regular yet complex morphology. We find that IR induces defects in feather formation in a dose-dependent manner. No abnormality was observed at 5 Gy. A transient, reversible perturbation of feather growth was induced at 10 Gy, leading to defects in the feather structure. This perturbation became irreversible at 20 Gy. Molecular and cellular analysis revealed P53 activation, DNA damage and repair, cell cycle arrest and apoptosis in the pathobiology. IR also induces patterning defects in feather formation, with disrupted branching morphogenesis. This perturbation is mediated by cytokine production and Stat1 activation, as manipulation of cytokine levels or ectopic Stat1 over-expression also led to irregular feather branching. Furthermore, AG-490, a chemical inhibitor of Stat1 signaling, can partially rescue IR-induced tissue damage. Our results suggest that the feather follicle could serve as a useful model to address the in vivo impact of the many mechanisms of IR-induced tissue damage.	[Chen, Xi; Liao, Chunyan; Chu, Qiqi; Zhou, Guixuan; Lin, Xiang; Yue, Zhicao] Fuzhou Univ, Inst Life Sci, Fuzhou 350002, Fujian, Peoples R China; [Li, Xiaobo; Lu, Haijie; Xu, Benhua] Fujian Med Univ, Union Hosp, Dept Radiat Oncol, Fuzhou, Fujian, Peoples R China	Fuzhou University; Fujian Medical University	Xu, BH (corresponding author), Fujian Med Univ, Union Hosp, Dept Radiat Oncol, Fuzhou, Fujian, Peoples R China.	benhuaxu@163.com; raw600@gmail.com	yue, zhicao/AAJ-4636-2020; Yue, ZhiCao/A-5075-2016	Yue, ZhiCao/0000-0001-5729-3842	Fuzhou University; Natural Science Foundation of China [NSFC31071285, 31371472]; Natural Science Foundation of Fujian Province [2013J05051]	Fuzhou University; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work is supported by startup funds from Fuzhou University (to Z Yue, G Zhou, and X Lin), Natural Science Foundation of China to Z Yue (NSFC31071285, 31371472), and Natural Science Foundation of Fujian Province to G Zhou (2013J05051). Z Yue is a Minjiang Scholar honored by Fuzhou University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker-Kubiczek E. K., 2012, Experimental Oncology, V34, P277; Belyakov OV, 2001, BRIT J CANCER, V84, P674, DOI 10.1054/bjoc.2000.1665; Cao X, 2011, P NATL ACAD SCI USA, V108, P1609, DOI 10.1073/pnas.1015350108; Chang CH, 2004, J INVEST DERMATOL, V122, P1348, DOI 10.1111/j.0022-202X.2004.22611.x; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Dent P, 1999, MOL BIOL CELL, V10, P2493, DOI 10.1091/mbc.10.8.2493; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Formenti SC, 2013, JNCI-J NATL CANCER I, V105, P256, DOI 10.1093/jnci/djs629; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Fowler JF, 2003, RADIOTHER ONCOL, V69, P161, DOI 10.1016/S0167-8140(03)00231-7; Gallet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029399; Galloway JL, 2009, NATURE, V460, P400, DOI 10.1038/nature08117; GOFF RA, 1962, J EXP ZOOL, V151, P177, DOI 10.1002/jez.1401510208; Haviland JS, 2013, LANCET ONCOL, V14, P1086, DOI 10.1016/S1470-2045(13)70386-3; Hei Tom K, 2011, Curr Mol Pharmacol, V4, P96; Holler V, 2009, J INVEST DERMATOL, V129, P1280, DOI 10.1038/jid.2008.360; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Jung HS, 1999, INT J DEV BIOL, V43, P117; Kao GD, 2007, J BIOL CHEM, V282, P21206, DOI 10.1074/jbc.M703042200; Kiang JG, 2010, RADIAT RES, V173, P319, DOI 10.1667/RR1892.1; Leach JK, 2001, CANCER RES, V61, P3894; Lin SJ, 2013, SCIENCE, V340, P1442, DOI 10.1126/science.1230374; Lin SJ, 2013, DEV GROWTH DIFFER, V55, P139, DOI 10.1111/dgd.12024; Lu XY, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-36; Lucas A.M., 1972, AGR HDB, V362; Moller AP, 2013, MUTAT RES-GEN TOX EN, V757, P52, DOI 10.1016/j.mrgentox.2013.04.019; Niemoeller OM, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-8; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Pineda JR, 2013, EMBO MOL MED, V5, P548, DOI 10.1002/emmm.201202197; Prum RO, 2001, J EXP ZOOL, V291, P30, DOI 10.1002/jez.4; Quaas M, 2012, CELL CYCLE, V11, P4661, DOI 10.4161/cc.22917; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Rube CE, 2000, INT J RADIAT ONCOL, V47, P1033, DOI 10.1016/S0360-3016(00)00482-X; Ryan JL, 2012, J INVEST DERMATOL, V132, P985, DOI 10.1038/jid.2011.411; Schaue D, 2012, RADIAT RES, V178, P505, DOI 10.1667/RR3031.1; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Wang C, 2013, INT J RADIAT ONCOL, V86, P440, DOI 10.1016/j.ijrobp.2013.01.011; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; WOLPERT L, 1979, J EMBRYOL EXP MORPH, V50, P175; Yu MK, 2004, INT J DEV BIOL, V48, P181, DOI 10.1387/ijdb.15272383; Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196; Yue ZC, 2006, P NATL ACAD SCI USA, V103, P951, DOI 10.1073/pnas.0506894103; Yue ZC, 2005, NATURE, V438, P1026, DOI 10.1038/nature04222; Yue ZC, 2012, DEV BIOL, V372, P45, DOI 10.1016/j.ydbio.2012.09.004; Zhang B, 2010, INT J RADIAT BIOL, V86, P429, DOI 10.3109/09553001003668014; Zhang XP, 2010, J BIOL CHEM, V285, P31571, DOI 10.1074/jbc.M110.134650	48	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89234	10.1371/journal.pone.0089234	http://dx.doi.org/10.1371/journal.pone.0089234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586618	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700078
J	Croxatto, D; Vacca, P; Canegallo, F; Conte, R; Venturini, PL; Moretta, L; Mingari, MC				Croxatto, Daniele; Vacca, Paola; Canegallo, Francesca; Conte, Romana; Venturini, Pier Luigi; Moretta, Lorenzo; Mingari, Maria Cristina			Stromal Cells from Human Decidua Exert a Strong Inhibitory Effect on NK Cell Function and Dendritic Cell Differentiation	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MESENCHYMAL STEM-CELLS; ANTIGEN-PRESENTING CELLS; REGULATORY T-CELLS; HUMAN-PREGNANCY; PERIPHERAL-BLOOD; GENE-EXPRESSION; MELANOMA-CELLS; NOTCH LIGANDS; RECEPTORS	Stromal cells (SC) are an important component of decidual tissues where they are in strict proximity with both NK and CD14(+) myelomonocytic cells that play a role in the maintenance of pregnancy. In this study we analyzed whether decidual SC (DSC) could exert a regulatory role on NK and CD14(+) cells that migrate from peripheral blood (PB) to decidua during pregnancy. We show that DSCs inhibit the IL15-mediated up-regulation of major activating NK receptors in PB-derived NK cells. In addition, the IL15-induced NK cell proliferation, cytolytic activity and IFN-gamma production were severely impaired. DSCs sharply inhibited dendritic cells differentiation and their ability to induce allogeneic T cell proliferation. Indoleamine 2,3-dioxygenase (IDO) and prostaglandin E2 (PGE2) mediated the inhibitory effect of DSCs. Our results strongly suggest an important role of DSCs in preventing potentially dangerous immune response, thus contributing to maintenance of pregnancy.	[Croxatto, Daniele; Vacca, Paola; Mingari, Maria Cristina] Univ Genoa, Dept Expt Med, Genoa, Italy; [Canegallo, Francesca; Moretta, Lorenzo] Giannina Gaslini Inst, Genoa, Italy; [Conte, Romana; Venturini, Pier Luigi; Mingari, Maria Cristina] Natl Inst Canc Res, IRCCS AOU San Martino IST, Genoa, Italy; [Venturini, Pier Luigi] Univ Genoa, DINOGMI, Genoa, Italy	University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS AOU San Martino IST; University of Genoa	Moretta, L (corresponding author), Giannina Gaslini Inst, Genoa, Italy.	lorenzomoretta@ospedale-gaslini.ge.it	Vacca, Paola/ABC-9416-2021; Mingari, Maria Cristina/AAB-1315-2019; Moretta, Lorenzo/AAA-7239-2020	Vacca, Paola/0000-0002-0757-0108; Moretta, Lorenzo/0000-0003-4658-1747	Associazione Italiana Ricerca sul Cancro (AIRC): IG [10225]; "Special Program Molecular Clinical Oncology 561000' [9962]; Ministero dell'Istruzione, Universita e Ricerca (MIUR) [RBLA039LSF-001]; MIURPRIN2009 [2009T4TC33_004]; Ministero della Salute: RF2006-Ricerca Oncologica-Project of Integrated Program [3/07, 8/07]	Associazione Italiana Ricerca sul Cancro (AIRC): IG(Fondazione AIRC per la ricerca sul cancro); "Special Program Molecular Clinical Oncology 561000'; Ministero dell'Istruzione, Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); MIURPRIN2009; Ministero della Salute: RF2006-Ricerca Oncologica-Project of Integrated Program	This work was supported by grants awarded by Associazione Italiana Ricerca sul Cancro (AIRC): IG 2010 project n. 10225 (LM), and "Special Program Molecular Clinical Oncology 561000'' project n. 9962 (LM), Ministero dell'Istruzione, Universita e Ricerca (MIUR): MIUR-FIRB 2003 project RBLA039LSF-001 (LM), MIURPRIN2009 project 2009T4TC33_004 (MCM), Ministero della Salute: RF2006-Ricerca Oncologica-Project of Integrated Program 2006-08, agreements n. RO strategici 3/07 (LM) and RO strategici 8/07 (MCM), RF-IG-2008-1200689 (MCM), and Progetto Ricerca Ateneo 2013 (PV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Balsamo M, 2009, P NATL ACAD SCI USA, V106, P20847, DOI 10.1073/pnas.0906481106; Bulmer JN, 2010, INT J DEV BIOL, V54, P281, DOI 10.1387/ijdb.082763jb; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; CAN A, 1995, PLACENTA, V16, P261, DOI 10.1016/0143-4004(95)90113-2; Carlino C, 2008, BLOOD, V111, P3108, DOI 10.1182/blood-2007-08-105965; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dokic J, 2013, EUR J IMMUNOL, V43, P1862, DOI 10.1002/eji.201243010; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Erkers T, 2013, STEM CELLS DEV, V22, P2596, DOI 10.1089/scd.2013.0079; Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Hanna J, 2007, TRENDS IMMUNOL, V28, P201, DOI 10.1126/scitranslmed.3006850; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; He YY, 2012, CLIN IMMUNOL, V145, P161, DOI 10.1016/j.clim.2012.07.017; Heikkinen J, 2004, CLIN EXP IMMUNOL, V136, P373, DOI 10.1111/j.1365-2249.2004.02441.x; Kammerer U, 2003, AM J PATHOL, V162, P887, DOI 10.1016/S0002-9440(10)63884-9; Kayisli UA, 2003, J IMMUNOL, V171, P2305, DOI 10.4049/jimmunol.171.5.2305; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Kopcow HD, 2005, P NATL ACAD SCI USA, V102, P15563, DOI 10.1073/pnas.0507835102; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Laskarin G, 2005, HUM REPROD, V20, P1057, DOI 10.1093/humrep/deh740; Laskarin G, 2008, AM J REPROD IMMUNOL, V59, P433, DOI 10.1111/j.1600-0897.2008.00599.x; Le Bouteiller P, 2006, NAT MED, V12, P991, DOI 10.1038/nm0906-991; Liotta F, 2008, STEM CELLS, V26, P279, DOI 10.1634/stemcells.2007-0454; Male V, 2010, J IMMUNOL, V185, P3913, DOI 10.4049/jimmunol.1001637; Manaster I, 2008, J IMMUNOL, V181, P1869, DOI 10.4049/jimmunol.181.3.1869; Manaster I, 2010, AM J REPROD IMMUNOL, V63, P434, DOI 10.1111/j.1600-0897.2009.00794.x; Manaster I, 2010, J REPROD IMMUNOL, V84, P1, DOI 10.1016/j.jri.2009.10.009; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Olivares EG, 1997, BIOL REPROD, V57, P609, DOI 10.1095/biolreprod57.3.609; Oliver C, 1999, HUM REPROD, V14, P1599, DOI 10.1093/humrep/14.6.1599; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Robson A, 2012, FASEB J, V26, P4876, DOI 10.1096/fj.12-210310; Rutz S, 2005, EUR J IMMUNOL, V35, P2443, DOI 10.1002/eji.200526294; Saito S, 2007, J REPROD IMMUNOL, V76, P30, DOI 10.1016/j.jri.2007.08.002; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Vacca P, 2008, INT IMMUNOL, V20, P1395, DOI 10.1093/intimm/dxn105; Vacca P, 2006, BLOOD, V108, P4078, DOI 10.1182/blood-2006-04-017343; Vacca P, 2013, J REPROD IMMUNOL, V97, P14, DOI 10.1016/j.jri.2012.10.008; Vacca P, 2011, TRENDS IMMUNOL, V32, P517, DOI 10.1016/j.it.2011.06.013; Vacca P, 2011, P NATL ACAD SCI USA, V108, P2402, DOI 10.1073/pnas.1016257108; Vacca P, 2010, P NATL ACAD SCI USA, V107, P11918, DOI 10.1073/pnas.1001749107; WANG ZG, 1993, CANCER RES, V53, P4303; Xu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041869	57	56	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89006	10.1371/journal.pone.0089006	http://dx.doi.org/10.1371/journal.pone.0089006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586479	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700050
J	Kim, MJ; Son, HJ; Kim, Y; Kweon, HJ; Suh, BC; Lyall, V; Rhyu, MR				Kim, Min Jung; Son, Hee Jin; Kim, Yiseul; Kweon, Hae-Jin; Suh, Byung-Chang; Lyall, Vijay; Rhyu, Mee-Ra			Selective Activation of hTRPV1 by N-Geranyl Cyclopropylcarboxamide, an Amiloride-Insensitive Salt Taste Enhancer	PLOS ONE			English	Article							CHORDA TYMPANI RESPONSES; ION CHANNELS; SOUR TASTE; DIETARY-SODIUM; C57BL/6J MICE; TRPA1; RECEPTOR; TRANSDUCTION; HUMANS; TRPV1	TRPV1t, a variant of the transient receptor potential vanilloid-1 (TRPV1) has been proposed as a constitutively active, nonselective cation channel as a putative amiloride-insensitive salt taste receptor and shares many properties with TRPV1. Based on our previous chorda tympani taste nerve recordings in rodents and human sensory evaluations, we proposed that N-geranylcyclopropylcarboxamide (NGCC), a novel synthetic compound, acts as a salt taste enhancer by modulating the amiloride/benzamil-insensitive Na+ entry pathways. As an extension of this work, we investigated NGCC-induced human TRPV1 (hTRPV1) activation using a Ca2+-flux signaling assay in cultured cells. NGCC enhanced Ca2+ influx in hTRPV1-expressing cells in a dose-dependent manner (EC50 = 115 mu M). NGCC-induced Ca2+ influx was significantly attenuated by ruthenium red (RR; 30 mM), a non-specific blocker of TRP channels and capsazepine (CZP; 5 mu M), a specific antagonist of TRPV1, implying that NGCC directly activates hTRPV1. TRPA1 is often co-expressed with TRPV1 in sensory neurons. Therefore, we also investigated the effects of NGCC on hTRPA1-expressing cells. Similar to hTRPV1, NGCC enhanced Ca2+ influx in hTRPA1-expressing cells (EC50 = 83.65 mu M). The NGCC-induced Ca2+ influx in hTRPA1-expressing cells was blocked by RR (30 mu M) and HC-030031 (100 mu M), a specific antagonist of TRPA1. These results suggested that NGCC selectively activates TRPV1 and TRPA1 in cultured cells. These data may provide additional support for our previous hypothesis that NGCC interacts with TRPV1 variant cation channel, a putative amiloride/benzamil-insensitive salt taste pathway in the anterior taste receptive field.	[Kim, Min Jung; Son, Hee Jin; Kim, Yiseul; Rhyu, Mee-Ra] Korea Food Res Inst, Div Metab & Funct Res, Songnam, Gyeonggi Do, South Korea; [Kweon, Hae-Jin; Suh, Byung-Chang] DaeguGyeongbuk Inst Sci & Technol DGIST, Dept Brain Sci, Taegu, South Korea; [Lyall, Vijay] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA	Korea Food Research Institute (KFRI); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Virginia Commonwealth University	Rhyu, MR (corresponding author), Korea Food Res Inst, Div Metab & Funct Res, Songnam, Gyeonggi Do, South Korea.	mrrhyu@kfri.re.kr	Kweon, Hae-Jin/AAP-9842-2021		Korea Food Research Institute [E0121201, E0131201]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A2044699]; NIH/NIDCD grant [DC011569]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011569] Funding Source: NIH RePORTER	Korea Food Research Institute; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NIH/NIDCD grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by Korea Food Research Institute (E0121201, E0131201), the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (No. 2012R1A1A2044699), and NIH/NIDCD grant DC011569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Batenburg M, 2011, J FOOD SCI, V76, pS280, DOI 10.1111/j.1750-3841.2011.02198.x; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Cherukuri CM, 2013, NEUROSCI RES, V75, P283, DOI 10.1016/j.neures.2013.02.003; DeSimone JA, 2006, AM J PHYSIOL-GASTR L, V291, pG1005, DOI 10.1152/ajpgi.00235.2006; Dewis ML, 2013, J NEUROPHYSIOL, V109, P1078, DOI 10.1152/jn.00124.2012; Dias AG, 2013, CHEM SENSES, V38, P137, DOI 10.1093/chemse/bjs090; Evans CEL, 1997, EUR J CLIN NUTR, V51, P394, DOI 10.1038/sj.ejcn.1600420; Feldman GM, 2003, J NEUROPHYSIOL, V90, P2060, DOI 10.1152/jn.00158.2003; Fielding S, 1993, Choline-containing compositions as salt substitutes and enhancers and a method of preparation, Patent No. [US5206049A, 5206049]; Glendinning JI, 2012, EXP BIOL MED, V237, P236, DOI 10.1258/ebm.2011.011345; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048072; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hellekant G, 1997, PHYSIOL BEHAV, V61, P829, DOI 10.1016/S0031-9384(96)00562-8; Huque T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007347; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Katsumata T, 2008, CHEM SENSES, V33, P665, DOI 10.1093/chemse/bjn033; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Kweon HJ, 2013, BMB REP, V46, P295, DOI 10.5483/BMBRep.2013.46.6.121; Leonard AS, 2003, P NATL ACAD SCI USA, V100, P2029, DOI 10.1073/pnas.252782799; Lin WH, 2002, J NEUROPHYSIOL, V88, P133, DOI 10.1152/jn.2002.88.1.133; LOCKE KW, 1994, PHYSIOL BEHAV, V55, P1039, DOI 10.1016/0031-9384(94)90385-9; Logan AG, 2006, J AM COLL NUTR, V25, P165, DOI 10.1080/07315724.2006.10719528; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Lyall V, 2005, J GEN PHYSIOL, V125, P587, DOI 10.1085/jgp.200509264; Lyall V, 2004, J PHYSIOL-LONDON, V558, P147, DOI 10.1113/jphysiol.2004.065656; Lyall V, 2007, J NEUROPHYSIOL, V98, P1662, DOI 10.1152/jn.00366.2007; Lyall V, 2010, J NEUROPHYSIOL, V103, P1337, DOI 10.1152/jn.00883.2009; Lyall V, 2009, J NEUROPHYSIOL, V102, P1591, DOI 10.1152/jn.91301.2008; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Morgan CR, 2009, NEUROSCI LETT, V465, P189, DOI 10.1016/j.neulet.2009.08.055; Nagatomo K, 2008, P NATL ACAD SCI USA, V105, P17373, DOI 10.1073/pnas.0809769105; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; Ren ZJ, 2013, AM J PHYSIOL-GASTR L, V305, pG106, DOI 10.1152/ajpgi.00053.2013; Rhyu M, 2009, CHEM SENSES, V34, pA41; Richter TA, 2004, J NEUROSCI, V24, P4088, DOI 10.1523/JNEUROSCI.0653-04.2004; Riera CE, 2009, BRIT J PHARMACOL, V157, P1398, DOI 10.1111/j.1476-5381.2009.00307.x; Smith KR, 2012, AM J PHYSIOL-REG I, V303, pR1195, DOI 10.1152/ajpregu.00154.2012; Stewart RE, 1997, AM J PHYSIOL-CELL PH, V272, pC1, DOI 10.1152/ajpcell.1997.272.1.C1; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tominaga M., 2007, V179, P489; Wang XQ, 2009, WORLD J GASTROENTERO, V15, P2204, DOI 10.3748/wjg.15.2204; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010	47	18	18	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89062	10.1371/journal.pone.0089062	http://dx.doi.org/10.1371/journal.pone.0089062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586504	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700055
J	Cadot, B; Gache, V; Gomes, ER				Cadot, Bruno; Gache, Vincent; Gomes, Edgar R.			Fast, Multi-Dimensional and Simultaneous Kymograph-Like Particle Dynamics (SkyPad) Analysis	PLOS ONE			English	Article							AXONAL-TRANSPORT; VISUALIZATION; MICROTUBULE; ASSEMBLIES; TRACKING; KINESIN	Background: Kymograph analysis is a method widely used by researchers to analyze particle dynamics in one dimensional (1D) trajectories. Results: Here we provide a Visual Basic-coded algorithm to use as a Microsoft Excel add-in that automatically analyzes particles in 2D trajectories with all the advantages of kymograph analysis. Conclusions: This add-in, which we named SkyPad, leads to significant time saving and higher accuracy of particle analysis. Finally, SkyPad can also be used for 3D trajectories analysis.	[Cadot, Bruno; Gache, Vincent; Gomes, Edgar R.] Univ Paris 06, INSERM, UMRS 787, Paris, France; [Cadot, Bruno; Gomes, Edgar R.] Grp Hosp Pitie Salpetriere, Inst Myol, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Cadot, B (corresponding author), Univ Paris 06, INSERM, UMRS 787, Paris, France.	cadot@myologygroup.net	GACHE, Vincent/M-9556-2015; GACHE, vincent/L-1990-2019; CADOT, bruno/E-1710-2013; Gomes, Edgar r/D-9000-2015; Gomes, Edgar/ABH-7441-2020	GACHE, Vincent/0000-0002-2928-791X; GACHE, vincent/0000-0002-2928-791X; CADOT, bruno/0000-0002-1888-3898; Gomes, Edgar r/0000-0002-6941-4872; Gomes, Edgar/0000-0002-6941-4872	Muscular Dystrophy Association (MDA); INSERM Avenir programme and Agence Nationale de la Recherche (ANR); Fondation pour la Recherche Medicale (FRM) fellowship; Region Ile-de-France fellowship	Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); INSERM Avenir programme and Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM) fellowship; Region Ile-de-France fellowship(Region Ile-de-France)	This work was supported by Muscular Dystrophy Association (MDA), INSERM Avenir programme and Agence Nationale de la Recherche (ANR) grants to E.R.G. B.C. was supported initially by a Fondation pour la Recherche Medicale (FRM) fellowship. V.G. was supported initially by a Region Ile-de-France fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadot B, 2012, EMBO REP, V13, P741, DOI 10.1038/embor.2012.89; Carpenter AE, 2012, NAT METHODS, V9, P666, DOI 10.1038/nmeth.2073; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Hameed FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045843; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Karle KN, 2012, NEUROGENETICS, V13, P169, DOI 10.1007/s10048-012-0324-y; Kim-Han JS, 2011, J NEUROSCI, V31, P7212, DOI 10.1523/JNEUROSCI.0711-11.2011; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Park JJ, 2011, METHODS MOL BIOL, V789, P137, DOI 10.1007/978-1-61779-310-3_8; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Tseng Y, 2002, BIOPHYS J, V83, P3162, DOI 10.1016/S0006-3495(02)75319-8; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Veale KJ, 2011, EXP CELL RES, V317, P1817, DOI 10.1016/j.yexcr.2011.04.016; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5	16	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89073	10.1371/journal.pone.0089073	http://dx.doi.org/10.1371/journal.pone.0089073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586511	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900084
J	Marino, A; Baldi, R				Marino, Andrea; Baldi, Ricardo			Ecological Correlates of Group-Size Variation in a Resource-Defense Ungulate, the Sedentary Guanaco	PLOS ONE			English	Article							BEHAVIORAL PLASTICITY; SOCIAL-ORGANIZATION; LAMA-GUANICOE; HERD SIZE; ROE DEER; PREDATION; VIGILANCE; HABITAT; RISK; HERBIVORES	For large herbivores, predation-risk, habitat structure and population density are often reported as major determinants of group size variation within and between species. However, whether the underlying causes of these relationships imply an ecological adaptation or are the result of a purely mechanistic process in which fusion and fragmentation events only depend on the rate of group meeting, is still under debate. The aim of this study was to model guanaco family and bachelor group sizes in contrasting ecological settings in order to test hypotheses regarding the adaptive significance of group-size variation. We surveyed guanaco group sizes within three wildlife reserves located in eastern Patagonia where guanacos occupy a mosaic of grasslands and shrublands. Two of these reserves have been free from predators for decades while in the third, pumas often prey on guanacos. All locations have experienced important changes in guanaco abundance throughout the study offering the opportunity to test for density effects. We found that bachelor group size increased with increasing density, as expected by the mechanistic approach, but was independent of habitat structure or predation risk. In contrast, the smaller and territorial family groups were larger in the predator-exposed than in the predator-free locations, and were larger in open grasslands than in shrublands. However, the influence of population density on these social units was very weak. Therefore, family group data supported the adaptive significance of group-size variation but did not support the mechanistic idea. Yet, the magnitude of the effects was small and between-population variation in family group size after controlling for habitat and predation was negligible, suggesting that plasticity of these social units is considerably low. Our results showed that different social units might respond differentially to local ecological conditions, supporting two contrasting hypotheses in a single species, and highlight the importance of taking into account the proximate interests and constraints to which group members may be exposed to when deriving predictions about group-size variation.	[Marino, Andrea; Baldi, Ricardo] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, UI Ecol Terr, Puerto Madryn, Argentina; [Baldi, Ricardo] Wildlife Conservat Soc, Patagonian & Andean Steppe Program, Caba, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Marino, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, UI Ecol Terr, Puerto Madryn, Argentina.	marino@cenpat.edu.ar			Rufford Small Grant Foundation; Fundacion Vida Silvestre Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas CONICET; HSBC	Rufford Small Grant Foundation; Fundacion Vida Silvestre Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); HSBC	This study was possible thanks to the financial support provided by the Rufford Small Grant Foundation, Fundacion Vida Silvestre Argentina and HSBC, and the scholarships awarded by the Consejo Nacional de Investigaciones Cientificas y Tecnicas CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTMANN SA, 1974, AM ZOOL, V14, P221; Barja I, 2008, CAN J ZOOL, V86, P170, DOI 10.1139/Z07-129; Beeskow A.M., 1987, SISTEMAS FISIOGRAFIC; BEESKOW AM, 1995, J RANGE MANAGE, V48, P517, DOI 10.2307/4003063; Bellati T., 1990, Proceedings of the Vertebrate Pest Conference, V14, P263; Blank D, 2012, EUR J WILDLIFE RES, V58, P981, DOI 10.1007/s10344-012-0641-3; Brashares JS, 2002, J ANIM ECOL, V71, P626, DOI 10.1046/j.1365-2656.2002.00633.x; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Burgi V, 2005, THESIS U NACL PATAGO; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caughley G., 1964, Journal of Mammalogy, V45, P429, DOI 10.2307/1377416; Codesido M, 2005, RELEVAMIENTO AMBIENT; Crawley M.J., 2007, R BOOK; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Escobar JM, 2004, INVENTARIO EVALUACIO; FITZGIBBON CD, 1989, ANIM BEHAV, V37, P508, DOI 10.1016/0003-3472(89)90098-5; Franklin W.L., 1983, Special Publication American Society of Mammalogists, P573; Franklin WL, 1999, BIOL CONSERV, V90, P33, DOI 10.1016/S0006-3207(99)00008-7; Gerard JF, 2002, BIOL BULL, V202, P275, DOI 10.2307/1543479; GRANT JWA, 1992, BEHAV ECOL SOCIOBIOL, V31, P149; Hewison AJM, 1998, SOCIAL ORG EUROPEAN, P189; ILLIUS AW, 1994, ANIM BEHAV, V47, P481, DOI 10.1006/anbe.1994.1067; Isvaran K, 2007, OECOLOGIA, V154, P435, DOI 10.1007/s00442-007-0840-x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jepsen JU, 2004, CAN J ZOOL, V82, P1528, DOI 10.1139/Z04-131; Kie JG, 1999, J MAMMAL, V80, P1114, DOI 10.2307/1383163; Leon Rolando J. C., 1998, Ecologia Austral, V8, P125; Marino A, 2008, ETHOLOGY, V114, P413, DOI 10.1111/j.1439-0310.2008.01485_1.x; Marino A, 2012, WILDLIFE RES, V39, P503, DOI 10.1071/WR11174; Marino A, 2012, J ETHOL, V30, P83, DOI 10.1007/s10164-011-0299-4; Marino A, 2010, ETHOLOGY, V116, P999, DOI 10.1111/j.1439-0310.2010.01812.x; MCCULLAGH, 1983, GEN LINEAR MODELS; Novaro AJ, 1999, PROYECTO INTEGRADO I; Pays O, 2007, ANIM BEHAV, V74, P1429, DOI 10.1016/j.anbehav.2007.02.012; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; POWELL GVN, 1974, ANIM BEHAV, V22, P501, DOI 10.1016/S0003-3472(74)80049-7; Puig S., 1995, TECNICAS MANEJO GUAN, P97; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; Pulliam HR, 1984, BEHAV ECOLOGY EVOLUT, P122; Raedeke K.J., 1979, POPULATION DYNAMICS; Rajlevsky J, 1998, DISTRIBUCION GUANACO; Raman TRS, 1997, J BIOSCIENCES, V22, P203, DOI 10.1007/BF02704733; Reyna-Hurtado R, 2010, ORYX, V44, P89, DOI 10.1017/S0030605309990664; RUBENSTEIN DI, 1989, J ARID ENVIRON, V17, P145, DOI 10.1016/S0140-1963(18)30901-7; Thaker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012758; Vander Wal E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053777; Burgi MV, 2012, ORYX, V46, P99, DOI 10.1017/S0030605311000214	48	32	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89060	10.1371/journal.pone.0089060	http://dx.doi.org/10.1371/journal.pone.0089060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586503	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900080
J	Xu, H; Hao, WJ; Zhou, Q; Wang, WH; Xia, ZK; Liu, C; Chen, XC; Qin, M; Chen, F				Xu, He; Hao, Wenjing; Zhou, Qiong; Wang, Wenhong; Xia, Zhongkui; Liu, Chuan; Chen, Xiaochi; Qin, Man; Chen, Feng			Plaque Bacterial Microbiome Diversity in Children Younger than 30 Months with or without Caries Prior to Eruption of Second Primary Molars	PLOS ONE			English	Article							SP NOV.; CHILDHOOD CARIES; ORAL MICROBIOTA; DENTAL-CARIES; INFANTS; SALIVA; HEALTH; MUTANS; TOOL	Objective: Our primary objective is to phylogenetically characterize the supragingival plaque bacterial microbiome of children prior to eruption of second primary molars by pyrosequencing method for studying etiology of early childhood caries. Methods: Supragingival plaque samples were collected from 10 caries children and 9 caries-free children. Plaque DNA was extracted, used to generate DNA amplicons of the V1-V3 hypervariable region of the bacterial 16S rRNA gene, and subjected to 454-pyrosequencing. Results: On average, over 22,000 sequences per sample were generated. High bacterial diversity was noted in the plaque of children with caries [170 operational taxonomical units (OTU) at 3% divergence] and caries-free children (201 OTU at 3% divergence) with no significant difference. A total of 8 phyla, 15 classes, 21 orders, 30 families, 41 genera and 99 species were represented. In addition, five predominant phyla (Firmicute, Fusobacteria, Proteobacteria, Bacteroidetes and Actinobacteria) and seven genera (Leptotrichia, Streptococcus, Actinomyces, Prevotella, Porphyromonas, Neisseria, and Veillonella) constituted a majority of contents of the total microbiota, independent of the presence or absence of caries. Principal Component Analysis (PCA) presented that caries-related genera included Streptococcus and Veillonella; while Leptotrichia, Selenomonas, Fusobacterium, Capnocytophaga and Porphyromonas were more related to the caries-free samples. Neisseria and Prevotella presented approximately in between. In both groups, the degree of shared organism lineages (as defined by species-level OTUs) among individual supragingival plaque microbiomes was minimal. Conclusion: Our study represented for the first time using pyrosequencing to elucidate and monitor supragingival plaque bacterial diversity at such young age with second primary molar unerrupted. Distinctions were revealed between caries and caries-free microbiomes in terms of microbial community structure. We observed differences in abundance for several microbial groups between the caries and caries-free host populations, which were consistent with the ecological plaque hypothesis. Our approach and findings could be extended to correlating microbiomic changes after occlusion establishment and caries treatment.	[Xu, He; Hao, Wenjing; Zhou, Qiong; Qin, Man] Peking Univ, Sch Stomatol, Dept Pediat Dent, Beijing 100871, Peoples R China; [Wang, Wenhong] Maternal & Child Care Serv Ctr Haidian Dist, Dept Pediat Dent, Beijing, Peoples R China; [Xia, Zhongkui; Liu, Chuan] BGI, Shenzhen, Guangdong, Peoples R China; [Xia, Zhongkui] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Ctr Bioinformat, Chengdu 610054, Sichuan, Peoples R China; [Xia, Zhongkui] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab Neuroinformat, Minist Educ, Chengdu 610054, Sichuan, Peoples R China; [Chen, Xiaochi] Peking Univ, Dept Oral Microorganism, Sch Stomatol, Beijing 100871, Peoples R China; [Chen, Feng] Peking Univ, Sch Stomatol, Cent Lab, Beijing 100871, Peoples R China	Peking University; Beijing Genomics Institute (BGI); University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; Peking University; Peking University	Qin, M (corresponding author), Peking Univ, Sch Stomatol, Dept Pediat Dent, Beijing 100871, Peoples R China.	qinman@gmail.com; moleculecf@gmail.com	qin, man/AAD-3710-2020	Liu, Chuan/0000-0003-3716-7050	Fund of Capital Medical Development and Research [2009-2032]; National Natural Science Foundation of China [81200762]	Fund of Capital Medical Development and Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants 2009-2032 from Fund of Capital Medical Development and Research, and 81200762 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Ahn J, 2012, CANCER CAUSE CONTROL, V23, P399, DOI 10.1007/s10552-011-9892-7; Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; BOUE D, 1987, J DENT RES, V66, P23, DOI 10.1177/00220345870660010501; CAUFIELD PW, 1993, J DENT RES, V72, P37, DOI 10.1177/00220345930720010501; Corby PM, 2005, J CLIN MICROBIOL, V43, P5753, DOI 10.1128/JCM.43.11.5753-5759.2005; Douglass JM, 2001, COMMUNITY DENT ORAL, V29, P14, DOI 10.1034/j.1600-0528.2001.029001014.x; Downes J, 2008, INT J SYST EVOL MICR, V58, P1788, DOI 10.1099/ijs.0.65656-0; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; Hagelskjaer L, 1998, SCAND J INFECT DIS, V30, P309, DOI 10.1080/00365549850161016; Hepburn MJ, 2003, RHEUMATOL INT, V23, P255, DOI 10.1007/s00296-003-0305-4; Huang S, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-33; Jiang W, 2013, CURR MICROBIOL; Kanasi E, 2010, J DENT RES, V89, P378, DOI 10.1177/0022034509360010; KOHLER B, 1995, CARIES RES, V29, P402; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Luo AH, 2012, ORAL DIS, V18, P595, DOI 10.1111/j.1601-0825.2012.01915.x; Marchant S, 2001, CARIES RES, V35, P397, DOI 10.1159/000047482; Marsh P D, 1994, Adv Dent Res, V8, P263; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Pushalkar S, 2011, FEMS IMMUNOL MED MIC, V61, P269, DOI 10.1111/j.1574-695X.2010.00773.x; Radford JR, 2000, J DENT, V28, P307, DOI 10.1016/S0300-5712(00)00012-9; Renvoise A, 2010, INT J SYST EVOL MICR, V60, P1516, DOI 10.1099/ijs.0.012914-0; Reynaud AH, 2001, J CLIN PERIODONTOL, V28, P860, DOI 10.1034/j.1600-051x.2001.028009860.x; Romen F, 2004, ARCH MICROBIOL, V182, P157, DOI 10.1007/s00203-004-0684-2; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Simon-Soro A, 2013, J DENT RES, V92, P616, DOI 10.1177/0022034513488119; Siqueira JF, 2001, ORAL SURG ORAL MED O, V92, P451, DOI 10.1067/moe.2001.118620; Spring S, 2004, INT J SYST EVOL MICR, V54, P99, DOI 10.1099/ijs.0.02727-0; Tao Y, 2013, ARCH ORAL BIOL, V58, P1129, DOI 10.1016/j.archoralbio.2013.04.005; Twetman Svante, 2012, Braz. oral res., V26, P64, DOI 10.1590/S1806-83242012000700010; van Houte J, 1993, Adv Dent Res, V7, P87; Woo PCY, 2010, J ZHEJIANG UNIV-SC B, V11, P391, DOI 10.1631/jzus.B1000056; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang KG, 2009, INT J SYST EVOL MICR, V59, P2080, DOI 10.1099/ijs.0.007641-0	44	127	135	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89269	10.1371/journal.pone.0089269	http://dx.doi.org/10.1371/journal.pone.0089269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586647	Green Submitted, gold, Green Published			2022-12-27	WOS:000332396200043
J	Guo, ZQ; Wang, X; Cheng, DL; Xia, ZJ; Luan, M; Zhang, SL				Guo, Zhiqiang; Wang, Xin; Cheng, Dali; Xia, Zhijun; Luan, Meng; Zhang, Shulan			PD-1 Blockade and OX40 Triggering Synergistically Protects against Tumor Growth in a Murine Model of Ovarian Cancer	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; T-CELL SUBSETS; INFILTRATING LYMPHOCYTES; ANTITUMOR IMMUNITY; MOUSE MODEL; IMMUNOTHERAPY; ANTIBODY; IMMUNOGENICITY; STATISTICS; ACTIVATION	The co-inhibitory receptor Programmed Death-1 (PD-1) curtails immune responses and prevent autoimmunity, however, tumors exploit this pathway to escape from immune destruction. The co-stimulatory receptor OX40 is upregulated on T cells following activation and increases their clonal expansion, survival and cytokine production when engaged. Although antagonistic anti-PD-1 or agonistic anti-OX40 antibodies can promote the rejection of several murine tumors, some poorly immunogenic tumors were refractory to this treatment. In the present study, we evaluated the antitumor effects and mechanisms of combinatorial PD-1 blockade and OX40 triggering in a murine ID8 ovarian cancer model. Although individual anti-PD-1 or OX40 mAb treatment was ineffective in tumor protection against 10-day established ID8 tumor, combined anti-PD-1/OX40 mAb treatment markedly inhibited tumor outgrowth with 60% of mice tumor free 90 days after tumor inoculation. Tumor protection was associated with a systemic immune response with memory and antigen specificity and required CD4(+) cells and CD8(+) T cells. The anti-PD-1/OX40 mAb treatment increased CD4(+) and CD8(+) cells and decreased immunosuppressive CD4(+) FoxP3(+) regulatory T (Treg) cells and CD11b(+)Gr-1(+) myeloid suppressor cells (MDSC), giving rise to significantly higher ratios of both effector CD4(+) and CD8(+) cells to Treg and MDSC in peritoneal cavity; Quantitative RT-PCR data further demonstrated the induction of a local immunostimulatory milieu by anti-PD-1/OX40 mAb treatment. The splenic CD8(+) T cells from combined mAb treated mice produced high levels of IFN-gamma upon tumor antigen stimulation and exhibited antigen-specific cytolytic activity. To our knowledge, this is the first study testing the antitumor effects of combined anti-PD-1/OX40 mAb in a murine ovarian cancer model, and our results provide a rationale for clinical trials evaluating ovarian cancer immunotherapy using this combination of mAb.	[Guo, Zhiqiang; Cheng, Dali; Xia, Zhijun; Zhang, Shulan] China Med Univ, Shengjing Hosp, Dept Gynecol & Obstet, Shenyang, Peoples R China; [Wang, Xin] 306 Hosp PLA, Dept Gynecol & Obstet, Beijing, Peoples R China; [Luan, Meng] China Med Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, Shenyang, Peoples R China	China Medical University; China Medical University	Guo, ZQ (corresponding author), China Med Univ, Shengjing Hosp, Dept Gynecol & Obstet, Shenyang, Peoples R China.	zqg_cmu@163.com; slz_cmu@163.com			Free Researcher Project of Shengjing Hospital [200806]	Free Researcher Project of Shengjing Hospital	This work was supported by the Free Researcher Project of Shengjing Hospital (No. 200806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chang CL, 2007, GENE THER, V14, P1189, DOI 10.1038/sj.gt.3302974; Charlton JJ, 2013, J IMMUNOL, V190, P6104, DOI 10.4049/jimmunol.1201617; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Cubillos-Ruiz JR, 2009, J CLIN INVEST, V119, P2231, DOI 10.1172/JCI37716; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; Dai M, 2013, J IMMUNOTHER, V36, P248, DOI 10.1097/CJI.0b013e3182943549; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Duraiswamy J., 2013, CANC RES; Gramaglia I, 2000, J IMMUNOL, V165, P3043, DOI 10.4049/jimmunol.165.6.3043; Guo ZQ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-215; Hirschhorn-Cymerman D, 2009, J EXP MED, V206, P1103, DOI 10.1084/jem.20082205; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; Houot R, 2009, BLOOD, V113, P3546, DOI 10.1182/blood-2008-07-170274; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jensen SM, 2010, SEMIN ONCOL, V37, P524, DOI 10.1053/j.seminoncol.2010.09.013; Johnston FM, 2009, CLIN CANCER RES, V15, P6511, DOI 10.1158/1078-0432.CCR-09-0565; Kandalaft LE, 2011, J CLIN ONCOL, V29, P925, DOI 10.1200/JCO.2009.27.2369; Kjaergaard J, 2000, CANCER RES, V60, P5514; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; Mantia-Smaldone GM, 2012, HUM VACC IMMUNOTHER, V8, P1179, DOI 10.4161/hv.20738; Melero I, 2013, CLIN CANCER RES, V19, P1044, DOI 10.1158/1078-0432.CCR-12-2065; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Pardee AD, 2010, CANCER RES, V70, P9041, DOI 10.1158/0008-5472.CAN-10-1369; Pardoll D, 2012, J EXP MED, V209, P201, DOI 10.1084/jem.20112275; Piconese S, 2008, J EXP MED, V205, P825, DOI 10.1084/jem.20071341; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Ramakrishna V, 2003, INT IMMUNOL, V15, P751, DOI 10.1093/intimm/dxg074; Redmond WL, 2009, CRIT REV IMMUNOL, V29, P187, DOI 10.1615/CritRevImmunol.v29.i3.10; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Ruby CE, 2009, J IMMUNOL, V183, P4853, DOI 10.4049/jimmunol.0901112; Santin AD, 2001, GYNECOL OBSTET INVES, V51, P254, DOI 10.1159/000058060; Schondorf T, 1998, J SOC GYNECOL INVEST, V5, P102, DOI 10.1016/S1071-5576(97)00112-3; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Verbrugge I, 2012, CANCER RES, V72, P3163, DOI 10.1158/0008-5472.CAN-12-0210; Vermeij R, 2012, CURR PHARM DESIGN, V18, P3804, DOI 10.2174/138161212802002805; von Boehmer H, 2013, NAT REV DRUG DISCOV, V12, P51, DOI 10.1038/nrd3683; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; Wei HF, 2012, J IMMUNOTHER, V35, P267, DOI 10.1097/CJI.0b013e31824d72ee; Weinberg AD, 2000, J IMMUNOL, V164, P2160, DOI 10.4049/jimmunol.164.4.2160; Weinberg AD, 2006, J IMMUNOTHER, V29, P575, DOI 10.1097/01.cji.0000211319.00031.fc; Xiao H, 2007, CLIN CANCER RES, V13, P1823, DOI 10.1158/1078-0432.CCR-06-2154; Xiao X, 2012, J IMMUNOL, V188, P892, DOI 10.4049/jimmunol.1101373; Yao S, 2013, NAT REV DRUG DISCOV, V12, P130, DOI 10.1038/nrd3877; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	54	45	72	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89350	10.1371/journal.pone.0089350	http://dx.doi.org/10.1371/journal.pone.0089350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586709	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800018
J	da Costa, KS; Leal, E; dos Santos, AM; Lima, AHLE; Alves, CN; Lameira, J				da Costa, Kaue Santana; Leal, Elcio; dos Santos, Alberto Monteiro; Lima e Lima, Anderson Henrique; Alves, Claudio Nahum; Lameira, Jeronimo			Structural Analysis of Viral Infectivity Factor of HIV Type 1 and Its Interaction with A3G, EloC and EloB	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; E3 UBIQUITIN LIGASE; MOLECULAR-DYNAMICS SIMULATION; APOBEC3 CYTIDINE DEAMINASES; SOLVATED INTERACTION ENERGY; I VIF PROTEIN; ZINC-BINDING; HCCH MOTIF; SOCS BOX; COMPLEX	Background: The virion infectivity factor (Vif) is an accessory protein, which is essential for HIV replication in host cells. Vif neutralizes the antiviral host protein APOBEC3 through recruitment of the E3 ubiquitin ligase complex. Methodology: Fifty thousand Vif models were generated using the ab initio relax protocol of the Rosetta algorithm from sets of three-and nine-residue fragments using the fragment Monte Carlo insertion-simulated annealing strategy, which favors protein-like features, followed by an all-atom refinement. In the protocol, a constraints archive was used to define the spatial relationship between the side chains from Cys/His residues and zinc ions that formed the zinc-finger motif that is essential for Vif function. We also performed centroids analysis and structural analysis with respect to the formation of the zinc-finger, and the residue disposal in the protein binding domains. Additionally, molecular docking was used to explore details of Vif-A3G and Vif-EloBC interactions. Furthermore, molecular dynamics simulation was used to evaluate the stability of the complexes Vif-EloBC-A3G and Vif-EloC. Principal Findings: The zinc in the HCCH domain significantly alters the folding of Vif and changes the structural dynamics of the HCCH region. Ab initio modeling indicated that the Vif zinc-finger possibly displays tetrahedral geometry as suggested by Mehle et al. (2006). Our model also showed that the residues L146 and L149 of the BC-box motif bind to EloC by hydrophobic interactions, and the residue P162 of the PPLP motif is important to EloB binding. Conclusions/ Significance: The model presented here is the first complete three-dimensional structure of the Vif. The interaction of Vif with the A3G protein and the EloBC complex is in agreement with empirical data that is currently available in the literature and could therefore provide valuable structural information for advances in rational drug design.	[da Costa, Kaue Santana; dos Santos, Alberto Monteiro; Lima e Lima, Anderson Henrique; Alves, Claudio Nahum; Lameira, Jeronimo] Fed Univ Para, ICEN, Lab Planejamento & Desenvolvimento Farmacos, BR-66059 Belem, Para, Brazil; [da Costa, Kaue Santana; dos Santos, Alberto Monteiro; Lima e Lima, Anderson Henrique; Alves, Claudio Nahum; Lameira, Jeronimo] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Leal, Elcio; Lameira, Jeronimo] Fed Univ Para, Fac Biotecnol, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para	Leal, E (corresponding author), Fed Univ Para, Fac Biotecnol, BR-66059 Belem, Para, Brazil.	elcioleal@gmail.com; lameira@ufpa.br	Santos, Alberto Dos/AAU-1771-2020; Leal, Elcio/J-6236-2016; Lameira, Jerônimo/AAN-6293-2021; Alves, Cláudio N/P-8973-2014; Leal, Elcio/M-5275-2019; Lima, Anderson/T-6315-2019; Santana da Costa, Kaue/V-8913-2019	Santos, Alberto Dos/0000-0002-7033-3922; Leal, Elcio/0000-0003-3463-0492; Lameira, Jerônimo/0000-0001-7270-1517; Alves, Cláudio N/0000-0001-6576-4229; Leal, Elcio/0000-0003-3463-0492; Lima, Anderson/0000-0002-8451-9912; Santana da Costa, Kaue/0000-0002-2735-8016	Fundacao de Amparo e Desenvolvimento da Pesquisa (FADESP); Pro-Reitoria de Pesquisa e Pos-Graduacao (PROPESP) [01/2014]; Brazilian funding agency CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Fundacao de Amparo e Desenvolvimento da Pesquisa (FADESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Pro-Reitoria de Pesquisa e Pos-Graduacao (PROPESP); Brazilian funding agency CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	This work was partially supported by the Fundacao de Amparo e Desenvolvimento da Pesquisa (FADESP) and Pro-Reitoria de Pesquisa e Pos-Graduacao (PROPESP) (grant no. 01/2014). KSC received a scholarship from the Brazilian funding agency CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Auclair JR, 2007, PROTEINS, V69, P270, DOI 10.1002/prot.21471; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Balaji S, 2006, BIOINFORMATION, V1, P290, DOI 10.6026/97320630001290; Barraud P, 2008, CURR HIV RES, V6, P91, DOI 10.2174/157016208783885056; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Bergeron JRC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000925; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bizinoto MC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-173; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bouyac M, 1997, J VIROL, V71, P9358, DOI 10.1128/JVI.71.12.9358-9365.1997; Cancio R, 2004, BIOCHEM J, V383, P475, DOI 10.1042/BJ20040914; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen GY, 2009, J VIROL, V83, P8674, DOI 10.1128/JVI.00653-09; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; Dang Y, 2009, J VIROL, V83, P8544, DOI 10.1128/JVI.00651-09; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; de Alencar NAN, 2012, J CHEM INF MODEL, V52, P2775, DOI 10.1021/ci2006005; Dettenhofer M, 2000, J VIROL, V74, P8938, DOI 10.1128/JVI.74.19.8938-8945.2000; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Giri K, 2009, BIOPOLYMERS, V92, P417, DOI 10.1002/bip.21209; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Henriet S, 2007, NUCLEIC ACIDS RES, V35, P5141, DOI 10.1093/nar/gkm542; Henriet S, 2005, J MOL BIOL, V354, P55, DOI 10.1016/j.jmb.2005.09.025; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Khan MA, 2001, J VIROL, V75, P7252, DOI 10.1128/JVI.75.16.7252-7265.2001; Kopietz F, 2012, J GEN VIROL, V93, P2425, DOI 10.1099/vir.0.043273-0; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lima AH, 2012, CHEM BIOL DRUG DES, V80, P114, DOI 10.1111/j.1747-0285.2012.01380.x; Lu ZS, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130100; Lv W, 2007, ORG BIOMOL CHEM, V5, P617, DOI 10.1039/b612050d; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marcsisin SR, 2011, J MOL BIOL, V410, P1008, DOI 10.1016/j.jmb.2011.04.053; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Miller JH, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-81; Moraes G, 2012, J MOL MODEL, V18, P1219, DOI 10.1007/s00894-011-1145-x; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Pang YP, 2000, PROTEIN SCI, V9, P1857; Pang YP, 2001, PROTEINS, V45, P183, DOI 10.1002/prot.1138; Patel K, 2007, BBA-PROTEINS PROTEOM, V1774, P1247, DOI 10.1016/j.bbapap.2007.07.010; Paul I, 2006, P NATL ACAD SCI USA, V103, P18475, DOI 10.1073/pnas.0604150103; Pery E, 2009, J VIROL, V83, P2374, DOI 10.1128/JVI.01898-08; Reingewertz TH, 2009, PROTEIN ENG DES SEL, V22, P281, DOI 10.1093/protein/gzp004; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Sakai K, 2006, P NATL ACAD SCI USA, V103, P3369, DOI 10.1073/pnas.0509417103; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Schrodinger L., 2020, PYMOL; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Thippeshappa R, 2011, J VIROL, V85, P3767, DOI 10.1128/JVI.02438-10; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Tsai J, 2003, PROTEINS, V53, P76, DOI 10.1002/prot.10454; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Wang C, 2010, PROTEIN SCI, V19, P494, DOI 10.1002/pro.327; Wang XD, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-94; Wissing S, 2010, MOL ASPECTS MED, V31, P383, DOI 10.1016/j.mam.2010.06.001; Wolfe LS, 2010, J VIROL, V84, P7135, DOI 10.1128/JVI.00031-10; Xiao Z, 2007, J MOL BIOL, V373, P541, DOI 10.1016/j.jmb.2007.07.029; Xiao ZX, 2006, VIROLOGY, V349, P290, DOI 10.1016/j.virol.2006.02.002; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yamashita T, 2008, MICROBES INFECT, V10, P1142, DOI 10.1016/j.micinf.2008.06.003; Yang B, 2003, J BIOL CHEM, V278, P6596, DOI 10.1074/jbc.M210164200; Yang SC, 2001, J BIOL CHEM, V276, P4889, DOI 10.1074/jbc.M004895200; Yang X, 1996, J BIOL CHEM, V271, P10121, DOI 10.1074/jbc.271.17.10121; Yang XY, 1998, J BIOL CHEM, V273, P29879, DOI 10.1074/jbc.273.45.29879; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Yuan Z, 2005, PROTEINS, V58, P905, DOI 10.1002/prot.20375; Zhang H, 2000, J VIROL, V74, P8252, DOI 10.1128/JVI.74.18.8252-8261.2000; Zhou XB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1949	87	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89116	10.1371/journal.pone.0089116	http://dx.doi.org/10.1371/journal.pone.0089116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586532	Green Published, gold, Green Submitted			2022-12-27	WOS:000332389000026
J	Alfonso, JCL; Jagiella, N; Nunez, L; Herrero, MA; Drasdo, D				Lopez Alfonso, Juan Carlos; Jagiella, Nick; Nunez, Luis; Herrero, Miguel A.; Drasdo, Dirk			Estimating Dose Painting Effects in Radiotherapy: A Mathematical Model	PLOS ONE			English	Article							CANCER STEM-CELLS; TUMOR-GROWTH; INTRATUMOR HETEROGENEITY; COMPUTER-SIMULATION; LUNG-CANCER; IN-VITRO; STRATEGIES; DIVISION; THERAPY; STATE	Tumor heterogeneity is widely considered to be a determinant factor in tumor progression and in particular in its recurrence after therapy. Unfortunately, current medical techniques are unable to deduce clinically relevant information about tumor heterogeneity by means of non-invasive methods. As a consequence, when radiotherapy is used as a treatment of choice, radiation dosimetries are prescribed under the assumption that the malignancy targeted is of a homogeneous nature. In this work we discuss the effects of different radiation dose distributions on heterogeneous tumors by means of an individual cell-based model. To that end, a case is considered where two tumor cell phenotypes are present, which we assume to strongly differ in their respective cell cycle duration and radiosensitivity properties. We show herein that, as a result of such differences, the spatial distribution of the corresponding phenotypes, whence the resulting tumor heterogeneity can be predicted as growth proceeds. In particular, we show that if we start from a situation where a majority of ordinary cancer cells (CCs) and a minority of cancer stem cells (CSCs) are randomly distributed, and we assume that the length of CSC cycle is significantly longer than that of CCs, then CSCs become concentrated at an inner region as tumor grows. As a consequence we obtain that if CSCs are assumed to be more resistant to radiation than CCs, heterogeneous dosimetries can be selected to enhance tumor control by boosting radiation in the region occupied by the more radioresistant tumor cell phenotype. It is also shown that, when compared with homogeneous dose distributions as those being currently delivered in clinical practice, such heterogeneous radiation dosimetries fare always better than their homogeneous counterparts. Finally, limitations to our assumptions and their resulting clinical implications will be discussed.	[Lopez Alfonso, Juan Carlos; Herrero, Miguel A.] Univ Complutense Madrid, Fac Math, Dept Appl Math, Madrid, Spain; [Jagiella, Nick; Drasdo, Dirk] INRIA, Domaine Voluceau Rocquencourt, Paris, France; [Jagiella, Nick] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Computat Biol, Neuherberg, Germany; [Nunez, Luis] Hosp Univ Puerta Hierro, Radiophys Dept, Madrid, Spain; [Drasdo, Dirk] Univ Paris 06, CNRS UMR 7598, Lab Jacques Louis Lions, Paris, France; [Drasdo, Dirk] Univ Leipzig, Interdisciplinary Ctr Bioinformat IZBI, D-04109 Leipzig, Germany	Complutense University of Madrid; Inria; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hospital Puerta de Hierro-Majadahonda; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Leipzig University	Herrero, MA (corresponding author), Univ Complutense Madrid, Fac Math, Dept Appl Math, Madrid, Spain.	herrero@mat.ucm.es		Lopez Alfonso, Juan Carlos/0000-0003-2432-5953	MINECO [2011-22656]; LUNGSYS II (BMBF); PhysCancer; INVADE (INSERM)	MINECO(Spanish Government); LUNGSYS II (BMBF)(Federal Ministry of Education & Research (BMBF)); PhysCancer; INVADE (INSERM)	Juan Carlos Lopez Alfonso, Luis Nunez, and Miguel A. Herrero have been supported in part by MINECO Grant 2011-22656. Nick Jagiella and Dirk Drasdo gratefully acknowledge support by LUNGSYS II (BMBF), PhysCancer and INVADE (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agur Z, 2012, MOL THER, V20, P1, DOI 10.1038/mt.2011.272; ALLALUNISTURNER MJ, 1992, INT J RADIAT ONCOL, V23, P339, DOI 10.1016/0360-3016(92)90751-3; ALLAM A, 1993, INT J RADIAT ONCOL, V27, P303, DOI 10.1016/0360-3016(93)90241-M; Amini A, 2013, ANN SURG ONCOL, V20, P1934, DOI 10.1245/s10434-012-2800-x; Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Anderson RA, 2007, SINGLE CELL BASED MO; [Anonymous], 1993, 50 ICRU; [Anonymous], 1999, 62 ICRU; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Bansal A, 2013, IMMUNOGASTROENTEROLO, V2, P9; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BARENDSEN GW, 1982, INT J RADIAT ONCOL, V8, P1981, DOI 10.1016/0360-3016(82)90459-X; Barendsen GW, 2001, INT J ONCOL, V19, P247; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bellomo N, 2008, PHYS LIFE REV, V5, P183, DOI 10.1016/j.plrev.2008.07.001; Bentzen SM, 2011, SEMIN RADIAT ONCOL, V21, P101, DOI 10.1016/j.semradonc.2010.10.001; Block M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.248101; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; BORTZ AB, 1975, J COMPUT PHYS, V17, P10, DOI 10.1016/0021-9991(75)90060-1; Buatti JM, 1996, INT J RADIAT ONCOL, V34, P785, DOI 10.1016/0360-3016(95)02157-4; BURSCH W, 1990, BIOCHEM CELL BIOL, V68, P1071, DOI 10.1139/o90-160; Cappuccio A, 2009, CONTEMP MATH, V492, P77; Cappuccio A, 2009, MED PHYS, V36, P98, DOI 10.1118/1.2986141; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dahlberg WK, 1999, CANCER RES, V59, P5365; Dale RG, 2007, RADIOBIOLOGICAL MODE; Das S, 2008, NAT CLIN PRACT NEURO, V4, P427, DOI 10.1038/ncpneuro0862; Dembinski JL, 2009, CLIN EXP METASTAS, V26, P611, DOI 10.1007/s10585-009-9260-0; Dionysiou D D, 2008, Open Biomed Eng J, V2, P43, DOI 10.2174/1874120700802010043; Dormann Sabine, 2002, In Silico Biology, V2, P393; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; DUCHTING W, 1989, STRAHLENTHER ONKOL, V165, P873; DUCHTING W, 1985, BIOSYSTEMS, V18, P79, DOI 10.1016/0303-2647(85)90061-9; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Enderling H, 2009, MATH MODEL NAT PHENO, V4, P117, DOI 10.1051/mmnp/20094305; Enderling H, 2009, BRIT J CANCER, V100, P1917, DOI 10.1038/sj.bjc.6605071; ENDERLING H, 2013, FRONT ONCOL, V3; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Enderling H, 2006, J THEOR BIOL, V241, P158, DOI 10.1016/j.jtbi.2005.11.015; Enderling H, 2010, ACTA BIOTHEOR, V58, P341, DOI 10.1007/s10441-010-9111-z; FOWLER JF, 1989, BRIT J RADIOL, V62, P679, DOI 10.1259/0007-1285-62-740-679; Fuller CD, 2007, RAD ONCOL, V2; Gao XF, 2013, CANCER RES, V73, P1481, DOI 10.1158/0008-5472.CAN-12-3429; Gatenby RA, 2009, NATURE, V459, P508, DOI 10.1038/459508a; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; GOERGEN JL, 1993, CYTOTECHNOLOGY, V11, P189, DOI 10.1007/BF00749869; Grimm J, 2011, J APPL CLIN MED PHYS, V12, P267, DOI 10.1120/jacmp.v12i2.3368; Hegedus B, 2000, J NEUROSURG, V92, P428, DOI 10.3171/jns.2000.92.3.0428; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; International Commission on Radiation Units and Measurements, 2010, J ICRU, V10, P1; Kempf H, 2010, EUR PHYS J D, V60, P177, DOI 10.1140/epjd/e2010-00178-4; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Korolev KS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/2/026008; LEE SP, 1995, INT J RADIAT ONCOL, V33, P375, DOI 10.1016/0360-3016(95)00162-R; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li LH, 2006, CANCER RES, V66, P4553, DOI 10.1158/0008-5472.CAN-05-3986; Alfonso JCL, 2012, DISCRETE CONT DYN-B, V17, P1651, DOI 10.3934/dcdsb.2012.17.1651; Lowengrub JS, 2010, NONLINEARITY, V23, pR1, DOI 10.1088/0951-7715/23/1/R01; Maini PK, 2006, CANC BIOINFORMATICS, P95, DOI DOI 10.1002/0470032898.CH5; Malinen E, 2006, PHYS MED BIOL, V51, P4903, DOI 10.1088/0031-9155/51/19/012; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Moding EJ, 2013, NAT REV DRUG DISCOV, V12, P526, DOI 10.1038/nrd4003; Moore N, 2012, STEM CELLS DEV, V21, P1822, DOI 10.1089/scd.2011.0477; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Narayana A, 2006, INT J RADIAT ONCOL, V64, P892, DOI 10.1016/j.ijrobp.2005.05.067; O'Rourke SFC, 2009, J MATH BIOL, V58, P799, DOI 10.1007/s00285-008-0222-y; Paulsson AK, 2012, AM J CLIN ONCOL-CANC, V1; Piccirillo SGM, 2009, ONCOGENE, V28, P1807, DOI 10.1038/onc.2009.27; Pine SR, 2010, P NATL ACAD SCI USA, V107, P2195, DOI 10.1073/pnas.0909390107; Preziosi L, 2011, MATH MOD METH APPL S, V21, P1901, DOI 10.1142/S0218202511005593; Radszuweit M, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051907; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Ribba B, 2005, B MATH BIOL, V67, P79, DOI 10.1016/j.bulm.2004.06.007; Richichi C, 2013, NEOPLASIA, V15, P840, DOI 10.1593/neo.13662; Rietman EA, 2013, THEOR BIOL MED MODEL, V10; Rockne R, 2010, PHYS MED BIOL, V55, P3271, DOI 10.1088/0031-9155/55/12/001; Rockne R, 2009, J MATH BIOL, V58, P561, DOI 10.1007/s00285-008-0219-6; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Silva AS, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-25; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Stamatakos GS, 2006, BRIT J RADIOL, V79, P389, DOI 10.1259/bjr/30604050; Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187; Stupp R, 2007, NAT BIOTECHNOL, V25, P193, DOI 10.1038/nbt0207-193; TAGHIAN A, 1993, INT J RADIAT ONCOL, V25, P243, DOI 10.1016/0360-3016(93)90345-V; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vainstein V, 2012, J THEOR BIOL, V298, P32, DOI 10.1016/j.jtbi.2011.12.016; Van Cruchten S, 2002, ANAT HISTOL EMBRYOL, V31, P214, DOI 10.1046/j.1439-0264.2002.00398.x; van der Heide UA, 2012, MAGN RESON IMAGING, V30, P1216, DOI 10.1016/j.mri.2012.04.010; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wells JE, 1996, APPL ENVIRON MICROB, V62, P1342, DOI 10.1128/AEM.62.4.1342-1346.1996; Zacharaki EI, 2004, COMPUT METH PROG BIO, V76, P193, DOI 10.1016/j.cmpb.2004.07.003	103	38	38	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89380	10.1371/journal.pone.0089380	http://dx.doi.org/10.1371/journal.pone.0089380			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586734	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000042
J	Mascalchi, M; Diciotti, S; Giannelli, M; Ginestroni, A; Soricelli, A; Nicolai, E; Aiello, M; Tessa, C; Galli, L; Dotti, MT; Piacentini, S; Salvatore, E; Toschi, N				Mascalchi, Mario; Diciotti, Stefano; Giannelli, Marco; Ginestroni, Andrea; Soricelli, Andrea; Nicolai, Emanuele; Aiello, Marco; Tessa, Carlo; Galli, Lucia; Dotti, Maria Teresa; Piacentini, Silvia; Salvatore, Elena; Toschi, Nicola			Progression of Brain Atrophy in Spinocerebellar Ataxia Type 2: A Longitudinal Tensor-Based Morphometry Study	PLOS ONE			English	Article							DOMINANT CEREBELLAR-ATAXIA; DEFORMATION-BASED MORPHOMETRY; POSITRON-EMISSION-TOMOGRAPHY; VOXEL-BASED MORPHOMETRY; ALZHEIMERS-DISEASE; NATURAL-HISTORY; CLINICAL-TRIALS; MR-IMAGES; SCA2; REGISTRATION	Spinocerebellar ataxia type 2 (SCA2) is the second most frequent autosomal dominant inherited ataxia worldwide. We investigated the capability of magnetic resonance imaging (MRI) to track in vivo progression of brain atrophy in SCA2 by examining twice 10 SCA2 patients (mean interval 3.6 years) and 16 age- and gender-matched healthy controls (mean interval 3.3 years) on the same 1.5 T MRI scanner. We used T1-weighted images and tensor-based morphometry (TBM) to investigate volume changes and the Inherited Ataxia Clinical Rating Scale to assess the clinical deficit. With respect to controls, SCA2 patients showed significant higher atrophy rates in the midbrain, including substantia nigra, basis pontis, middle cerebellar peduncles and posterior medulla corresponding to the gracilis and cuneatus tracts and nuclei, cerebellar white matter (WM) and cortical gray matter (GM) in the inferior portions of the cerebellar hemisphers. No differences in WM or GM volume loss were observed in the supratentorial compartment. TBM findings did not correlate with modifications of the neurological deficit. In conclusion, MRI volumetry using TBM is capable of demonstrating the progression of pontocerebellar atrophy in SCA2, supporting a possible role of MRI as biomarker in future trials.	[Mascalchi, Mario] Meyer Children Hosp, Quantitat & Funct Neuroradiol Res Program, Florence, Italy; [Mascalchi, Mario] Careggi Gen Hosp, Florence, Italy; [Mascalchi, Mario; Diciotti, Stefano] Univ Florence, Mario Serio Dept Expt & Clin Biomed Sci, Florence, Italy; [Diciotti, Stefano] Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Cesena, Italy; [Giannelli, Marco] Azienda Osped Univ Pisana, Pisa Univ Hosp, Unit Med Phys, Pisa, Italy; [Ginestroni, Andrea] Careggi Gen Hosp, Neuroradiol Unit, Florence, Italy; [Soricelli, Andrea; Nicolai, Emanuele; Aiello, Marco] IRCSS SDN Fdn, Naples, Italy; [Soricelli, Andrea] Univ Naples Parthenope, Naples, Italy; [Tessa, Carlo] Azienda USL 12 Viareggio, Radiol Unit, Versilia Hosp, Lido Di Camaiore, Lu, Italy; [Galli, Lucia] Le Scotte Univ Hosp, Mol Med Unit, Siena, Italy; [Dotti, Maria Teresa] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy; [Piacentini, Silvia] Univ Florence, Dept NEUROFARBA, Florence, Italy; [Salvatore, Elena] Univ Naples Federico II, Dept Neurol Sci, Naples, Italy; [Toschi, Nicola] Univ Roma Tor Vergata, Med Phys Sect, Dept Biomed & Prevent, Rome, Italy; [Toschi, Nicola] Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA USA; [Toschi, Nicola] Harvard Univ, Sch Med, Boston, MA USA	University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; University of Bologna; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Parthenope University Naples; Ospedale Versilia; University of Siena; University Hospital of Siena; University of Siena; University of Florence; University of Naples Federico II; University of Rome Tor Vergata; Harvard University; Harvard Medical School	Mascalchi, M (corresponding author), Meyer Children Hosp, Quantitat & Funct Neuroradiol Res Program, Florence, Italy.	m.mascalchi@dfc.unifi.it	Toschi, Nicola/J-2555-2012; Nicolai, Emanuele/K-6678-2016; Diciotti, Stefano/C-4167-2008; Giannelli, Marco/AAO-5778-2020; Aiello, Marco/K-3896-2016; Soricelli, Andrea/C-1133-2009	Toschi, Nicola/0000-0003-1929-5833; Nicolai, Emanuele/0000-0003-3171-368X; Diciotti, Stefano/0000-0001-8778-7819; Aiello, Marco/0000-0002-3676-0664; Giannelli, Marco/0000-0002-4061-0490; SALVATORE, Elena/0000-0003-1493-5133; PIACENTINI, SILVIA/0000-0002-2749-6785; Soricelli, Andrea/0000-0001-7011-7667				Ashburner J, 2003, HUMAN BRAIN FUNCTION; Auburger Georg W J, 2012, Handb Clin Neurol, V103, P423, DOI 10.1016/B978-0-444-51892-7.00026-7; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Borghammer P, 2010, EUR J NEUROL, V17, P314, DOI 10.1111/j.1468-1331.2009.02807.x; Brenneis C, 2003, NEUROREPORT, V14, P1799, DOI 10.1097/00001756-200310060-00008; Brenneis C, 2007, J NEUROL, V254, P191, DOI 10.1007/s00415-006-0325-6; Burk K, 1996, BRAIN, V119, P1497, DOI 10.1093/brain/119.5.1497; Chung MK, 2001, NEUROIMAGE, V14, P595, DOI 10.1006/nimg.2001.0862; D'Abreu A, 2012, J NEUROIMAGING, V22, P285, DOI 10.1111/j.1552-6569.2011.00614.x; D'Agata F, 2011, BRAIN STRUCT FUNCT, V216, P275, DOI 10.1007/s00429-011-0310-4; Della Nave R, 2008, NEUROIMAGE, V43, P10, DOI 10.1016/j.neuroimage.2008.06.036; Della Nave R, 2008, MOVEMENT DISORD, V23, P900, DOI 10.1002/mds.21982; du Montcel ST, 2012, ARCH NEUROL-CHICAGO, V69, P500, DOI 10.1001/archneurol.2011.2713; Durr A, 1995, BRAIN, V118, P1573, DOI 10.1093/brain/118.6.1573; Estrada R, 1999, ACTA NEUROPATHOL, V97, P306, DOI 10.1007/s004010050989; FILLA A, 1990, J NEUROL, V237, P345, DOI 10.1007/BF00315657; Fox NC, 2001, LANCET, V358, P201, DOI 10.1016/S0140-6736(01)05408-3; Freeborough PA, 1998, J COMPUT ASSIST TOMO, V22, P838, DOI 10.1097/00004728-199809000-00031; Giuffrida S, 1999, J NEUROL, V246, P383, DOI 10.1007/s004150050368; Goel G, 2011, PARKINSONISM RELAT D, V17, P521, DOI 10.1016/j.parkreldis.2011.04.008; Guerrini L, 2004, BRAIN, V127, P1785, DOI 10.1093/brain/awh201; Hua X, 2013, NEUROIMAGE, V66, P648, DOI 10.1016/j.neuroimage.2012.10.086; Hua X, 2011, NEUROIMAGE, V57, P5, DOI 10.1016/j.neuroimage.2011.01.079; Hua X, 2009, NEUROIMAGE, V48, P668, DOI 10.1016/j.neuroimage.2009.07.011; Inagaki A, 2005, EUR J NEUROL, V12, P725, DOI 10.1111/j.1468-1331.2005.01011.x; Ishida C, 2011, NEUROPATHOLOGY, V31, P510, DOI 10.1111/j.1440-1789.2010.01176.x; Iwabuchi K, 1999, REV NEUROL-FRANCE, V155, P255; Jacobi H, 2011, NEUROLOGY, V77, P1035, DOI 10.1212/WNL.0b013e31822e7ca0; Jacobi H, 2013, LANCET NEUROL, V12, P650, DOI 10.1016/S1474-4422(13)70104-2; Jacobi H, 2012, CEREBELLUM, V11, P155, DOI 10.1007/s12311-011-0292-z; Jung BC, 2012, CEREBELLUM, V11, P887, DOI 10.1007/s12311-011-0334-6; Kipps CM, 2005, J NEUROL NEUROSUR PS, V76, P650, DOI 10.1136/jnnp.2004.047993; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Klockgether T, 1998, BRAIN, V121, P1687, DOI 10.1093/brain/121.9.1687; Lastres-Becker I, 2008, CEREBELLUM, V7, P115, DOI 10.1007/s12311-008-0019-y; Orr HT, 2012, J CELL BIOL, V197, P167, DOI 10.1083/jcb.201105092; Pang JT, 2002, BRAIN, V125, P656, DOI 10.1093/brain/awf060; Pareyson D, 1999, J NEUROL, V246, P389, DOI 10.1007/s004150050369; Ramani A, 2006, RADIOLOGY, V241, P26, DOI 10.1148/radiol.2411050628; Reetz K, 2013, BRAIN, V136, P905, DOI 10.1093/brain/aws369; Reetz K, 2010, CEREBELLUM, V9, P210, DOI 10.1007/s12311-009-0150-4; Riddle WR, 2004, MAGN RESON IMAGING, V22, P769, DOI 10.1016/j.mri.2004.01.078; Rub U, 2007, BRAIN RES REV, V53, P235, DOI 10.1016/j.brainresrev.2006.08.003; Sakai T, 2002, ARCH NEUROL-CHICAGO, V59, P1044, DOI 10.1001/archneur.59.6.1044; Schmitz-Hubsch T, 2010, NEUROLOGY, V74, P678, DOI 10.1212/WNL.0b013e3181d1a6c9; Seidel K, 2012, ACTA NEUROPATHOL, V124, P1, DOI 10.1007/s00401-012-1000-x; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Studholme C, 2001, MICCAI, P41; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Takahashi T, 2010, J MOL CELL BIOL, V2, P180, DOI 10.1093/jmcb/mjq005; Tessa C, 2014, HUM BRAIN MAPP, V35, P3932, DOI 10.1002/hbm.22449; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Varrone A, 2004, ANN NEUROL, V55, P426, DOI 10.1002/ana.20054; Velazquez-Perez L, 2011, CEREBELLUM, V10, P184, DOI 10.1007/s12311-011-0265-2; Wullner U, 2005, ARCH NEUROL-CHICAGO, V62, P1280, DOI 10.1001/archneur.62.8.1280; Ying SH, 2006, NEUROLOGY, V66, P424, DOI 10.1212/01.wnl.0000196464.47508.00	58	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89410	10.1371/journal.pone.0089410	http://dx.doi.org/10.1371/journal.pone.0089410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586758	gold, Green Published			2022-12-27	WOS:000332385900040
J	de Oca, AM; Guerrero, F; Martinez-Moreno, JM; Madueno, JA; Herencia, C; Peralta, A; Almaden, Y; Lopez, I; Aguilera-Tejero, E; Gundlach, K; Buchel, J; Peter, ME; Passlick-Deetjen, J; Rodriguez, M; Munoz-Castaneda, JR				Montes de Oca, Addy; Guerrero, Fatima; Martinez-Moreno, Julio M.; Madueno, Juan A.; Herencia, Carmen; Peralta, Alan; Almaden, Yolanda; Lopez, Ignacio; Aguilera-Tejero, Escolastico; Gundlach, Kristina; Buechel, Janine; Peter, Mirjam E.; Passlick-Deetjen, Jutta; Rodriguez, Mariano; Munoz-Castaneda, Juan R.			Magnesium Inhibits Wnt/beta-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells	PLOS ONE			English	Article							PHOSPHATE-INDUCED CALCIFICATION; CORONARY-ARTERY CALCIFICATION; HEMODIALYSIS-PATIENTS; PARATHYROID-HORMONE; CALCIUM; MODULATION; SEVELAMER; BINDER; OSTEOPROTEGERIN; HOMEOSTASIS	Magnesium reduces vascular smooth muscle cell (VSMC) calcification in vitro but the mechanism has not been revealed so far. This work used only slightly increased magnesium levels and aimed at determining: a) whether inhibition of magnesium transport into the cell influences VSMC calcification, b) whether Wnt/beta-catenin signaling, a key mediator of osteogenic differentiation, is modified by magnesium and c) whether magnesium can influence already established vascular calcification. Human VSMC incubated with high phosphate (3.3 mM) and moderately elevated magnesium (1.4 mM) significantly reduced VSMC calcification and expression of the osteogenic transcription factors Cbfa-1 and osterix, and upregulated expression of the natural calcification inhibitors matrix Gla protein (MGP) and osteoprotegerin (OPG). The protective effects of magnesium on calcification and expression of osteogenic markers were no longer observed in VSMC cultured with an inhibitor of cellular magnesium transport (2-aminoethoxy-diphenylborate [2-APB]). High phosphate induced activation of Wnt/beta-catenin pathway as demonstrated by the translocation of beta-catenin into the nucleus, increased expression of the frizzled-3 gene, and downregulation of Dkk-1 gene, a specific antagonist of the Wnt/beta-catenin signaling pathway. The addition of magnesium however inhibited phosphate-induced activation of Wnt/beta-catenin signaling pathway. Furthermore, TRPM7 silencing using siRNA resulted in activation of Wnt/beta-catenin signaling pathway. Additional experiments were performed to test the ability of magnesium to halt the progression of already established VSMC calcification in vitro. The delayed addition of magnesium decreased calcium content, down-regulated Cbfa-1 and osterix and up-regulated MGP and OPG, when compared with a control group. This effect was not observed when 2-APB was added. In conclusion, magnesium transport through the cell membrane is important to inhibit VSMC calcification in vitro. Inhibition of Wnt/beta-catenin by magnesium is one potential intracellular mechanism by which this anti-calcifying effect is achieved.	[Montes de Oca, Addy; Guerrero, Fatima; Martinez-Moreno, Julio M.; Madueno, Juan A.; Herencia, Carmen; Almaden, Yolanda; Rodriguez, Mariano; Munoz-Castaneda, Juan R.] Hosp Univ Reina Sofia, IMIBIC, REDInRen, Cordoba, Spain; [Montes de Oca, Addy; Guerrero, Fatima; Peralta, Alan; Lopez, Ignacio; Aguilera-Tejero, Escolastico] Univ Cordoba, Depto Med & Cirugia Anim, Cordoba, Spain; [Gundlach, Kristina; Buechel, Janine; Peter, Mirjam E.] Fresenius Med Care, Bad Homburg, Germany; [Passlick-Deetjen, Jutta] Univ Dusseldorf, Dept Nephrol, Dusseldorf, Germany; [Rodriguez, Mariano] Hosp Univ Reina Sofia, Serv Nefrol, REDInRen, Cordoba, Spain; [Almaden, Yolanda] Univ Cordoba, Lipid & Atherosclerosis Unit, IMIBIC, Reina Sofia Univ Hosp, Cordoba, Spain; [Almaden, Yolanda] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Cordoba, Spain	Universidad de Cordoba; Heinrich Heine University Dusseldorf; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Almaden, Y (corresponding author), Hosp Univ Reina Sofia, IMIBIC, REDInRen, Cordoba, Spain.	yalmaden.exts@juntadeandalucia.es	Herencia, Carmen/AAA-6843-2020; Martínez, Julio Manuel/AAA-6724-2020; Peralta-Ramírez, Alan/AAV-1632-2020; Muñoz-Castañeda, Juan R./AFQ-3443-2022	Martínez, Julio Manuel/0000-0002-1945-5078; Peralta-Ramírez, Alan/0000-0002-3253-4731; Munoz-Castaneda, Juan R/0000-0002-9341-0724; Guerrero Pavon, Fatima/0000-0003-1306-0574; Rodriguez, Mariano/0000-0002-9380-6614	Instituto Carlos III [FIS 07/0287, FIS 07/0315, 010/1311]; Consejeria de Salud [JA 0127/2008]; UE Grant from Framework Programme 7 Syskid [FP7-241544]; Consejeria de Innovacion, Ciencia y Empresa of Junta de Andalucia [CTS-5205, CTS-179]; Fresenius Medical Care Deutschland GmbH	Instituto Carlos III(Instituto de Salud Carlos III); Consejeria de Salud; UE Grant from Framework Programme 7 Syskid; Consejeria de Innovacion, Ciencia y Empresa of Junta de Andalucia(Junta de Andalucia); Fresenius Medical Care Deutschland GmbH	This study was supported by Instituto Carlos III (FIS 07/0287, FIS 07/0315, 010/1311), Consejeria de Salud (JA 0127/2008), a UE Grant from Framework Programme 7 Syskid (FP7-241544), and Consejeria de Innovacion, Ciencia y Empresa (CTS-5205 and CTS-179) of Junta de Andalucia. The study has been also financed in part by Fresenius Medical Care Deutschland GmbH. The external funders (Fresenius Medical Care Deutschland GmbH) participated in part of study design and revision of final version of manuscript. They had no role in data collection, analysis, preparation of manuscript and decision to publish.	Block GA, 2000, AM J KIDNEY DIS, V35, P1226, DOI 10.1016/S0272-6386(00)70064-3; Block GA, 2005, KIDNEY INT, V68, P1815, DOI 10.1111/j.1523-1755.2005.00600.x; Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Cheng SL, 2010, CIRC RES, V107, P271, DOI 10.1161/CIRCRESAHA.110.219899; Cozzolino M, 2005, KIDNEY INT, V68, P429, DOI 10.1111/j.1523-1755.2005.00421.x; de Francisco ALM, 2010, NEPHROL DIAL TRANSPL, V25, P3707, DOI 10.1093/ndt/gfq292; De Schutter TM, 2013, KIDNEY INT, V83, P1109, DOI 10.1038/ki.2013.34; Engelse MA, 2001, CARDIOVASC RES, V52, P281, DOI 10.1016/S0008-6363(01)00375-3; ENNEVER J, 1981, J DENT RES, V60, P838, DOI 10.1177/00220345810600041301; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; Giachelli CM, 2005, CIRC RES, V96, P717, DOI 10.1161/01.RES.0000161997.24797.c0; HAMAD M, 1986, J CRYST GROWTH, V79, P192, DOI 10.1016/0022-0248(86)90435-5; Harteneck C, 2011, CURR PHARM BIOTECHNO, V12, P35, DOI 10.2174/138920111793937943; He Y, 2005, CIRC RES, V96, P207, DOI 10.1161/01.RES.0000152967.88472.3e; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Ishimura E, 2007, CLIN NEPHROL, V68, P222; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kircelli F, 2012, NEPHROL DIAL TRANSPL, V27, P514, DOI 10.1093/ndt/gfr321; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Lagier R, 2003, PATHOL RES PRACT, V199, P329, DOI 10.1078/0344-0338-00425; Lee KM, 2012, BIOCHEM BIOPH RES CO, V428, P50, DOI 10.1016/j.bbrc.2012.09.145; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Louvet L, 2013, NEPHROL DIAL TRANSPL, V28, P869, DOI 10.1093/ndt/gfs520; Martinez-Moreno JM, 2012, AM J PHYSIOL-RENAL, V303, pF1136, DOI 10.1152/ajprenal.00684.2011; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Mikhaylova L, 2007, CALCIFIED TISSUE INT, V81, P372, DOI 10.1007/s00223-007-9073-6; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Mohammed I, 2009, J RENAL CARE, V35, P65, DOI 10.1111/j.1755-6686.2009.00052.x; de Oca AM, 2010, J BONE MINER RES, V25, P1996, DOI 10.1002/jbmr.93; Montezano AC, 2010, HYPERTENSION, V56, P453, DOI 10.1161/HYPERTENSIONAHA.110.152058; Navarro-Gonzalez JF, 2009, SEMIN DIALYSIS, V22, P37, DOI 10.1111/j.1525-139X.2008.00530.x; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Paravicini TM, 2012, INT J BIOCHEM CELL B, V44, P1381, DOI 10.1016/j.biocel.2012.05.010; Peters F, 2001, Z Kardiol, V90 Suppl 3, P81; Qunibi W, 2008, AM J KIDNEY DIS, V51, P952, DOI 10.1053/j.ajkd.2008.02.298; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Salem S, 2012, AM J NEPHROL, V35, P31, DOI 10.1159/000334742; Sato K, 2006, J EXP MED, V203, P239, DOI 10.1084/jem.20051062; Shalhoub V, 2006, CALCIFIED TISSUE INT, V79, P431, DOI 10.1007/s00223-006-0126-z; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Son BK, 2008, J ATHEROSCLER THROMB, V15, P63, DOI 10.5551/jat.E545; Spiegel DM, 2007, J RENAL NUTR, V17, P416, DOI 10.1053/j.jrn.2007.08.005; Spiegel DM, 2009, HEMODIAL INT, V13, P453, DOI 10.1111/j.1542-4758.2009.00364.x; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Taylor J, 2011, J CELL BIOCHEM, V112, P581, DOI 10.1002/jcb.22948; Turgut F, 2008, INT UROL NEPHROL, V40, P1075, DOI 10.1007/s11255-008-9410-3; Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033; Verberckmoes SC, 2007, KIDNEY INT, V71, P298, DOI 10.1038/sj.ki.5002028	49	106	108	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89525	10.1371/journal.pone.0089525	http://dx.doi.org/10.1371/journal.pone.0089525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586847	Green Published, gold			2022-12-27	WOS:000332385900051
J	Gao, XX; Cao, YN; Staloch, DA; Gonzales, MA; Aronson, JF; Chao, C; Hellmich, MR; Ko, TC				Gao, Xuxia; Cao, Yanna; Staloch, Dustin A.; Gonzales, Michael A.; Aronson, Judith F.; Chao, Celia; Hellmich, Mark R.; Ko, Tien C.			Bone Morphogenetic Protein Signaling Protects against Cerulein-Induced Pancreatic Fibrosis	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA(1); ERK-DEPENDENT PATHWAYS; STELLATE CELLS; TGF-BETA; PULMONARY-HYPERTENSION; AUTOCRINE LOOP; II RECEPTOR; MOUSE MODEL; MICE; GROWTH-FACTOR-BETA-1	Bone morphogenetic proteins (BMPs) have an anti-fibrogenic function in the kidney, lung, and liver. However, their role in chronic pancreatitis (CP) is unknown. The aim of this study was to define the anti-fibrogenic role of BMP signaling in the pancreas in vivo under CP induction. Mice with a deletion of BMP type II receptor (BMPR2(+/-)) were used in this study in comparison with wild-type mice. CP was induced by repetitive cerulein injection intraperitoneally for 4 weeks, and the severity of CP was evaluated. Pancreatic stellate cells (PSCs) were isolated from the mice and treated with BMP2 and TGF-beta in vitro, and extracellular matrix protein (ECM) production was measured. Smad and mitogen-activated protein kinase (MAPK) signaling was also evaluated. BMPR2(+/-) mice revealed a greater pancreatic fibrosis, PSC activation and leukocyte infiltration after CP induction compared to wild-type mice (P<0.05). Under CP induction, phospho (p) Smad1/5/8 was elevated in wildtype mice and this effect was abolished in BMPR2(+/-) mice; pSmad2 and pp38(MAPK) were further enhanced in BMPR2(+/-)mice compared to wild-type mice (P<0.05). In vitro, BMP2 inhibited TGF-beta-induced ECM protein fibronectin production in wildtype PSCs; this effect was abolished in BMPR2(+/-) PSCs (P<0.05). In BMPR2(+/-) PSCs, pSmad1/5/8 level was barely detectable upon BMP2 stimulation, while pSmad2 level was further enhanced by TGF-beta stimulation, compared to wild-type PSCs (P< 0.05). BMPR2/Smad1/5/8 signaling plays a protective role against cerulein-induced pancreatic fibrosis by inhibiting Smad2 and p38(MAPK) signaling pathways.	[Gao, Xuxia; Cao, Yanna; Staloch, Dustin A.; Gonzales, Michael A.; Ko, Tien C.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA; [Aronson, Judith F.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Cao, Yanna; Chao, Celia; Hellmich, Mark R.; Ko, Tien C.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Ko, TC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA.	Tien.C.Ko@uth.tmc.edu			National Institutes of Health [P01 DK035608]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	work is supported by National Institutes of Health grant P01 DK035608. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghdassi AA, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-26; Ahnfelt-Ronne J, 2010, DIABETES, V59, P1948, DOI 10.2337/db09-1010; Aoki H, 2006, AM J PHYSIOL-CELL PH, V290, pC1100, DOI 10.1152/ajpcell.00465.2005; Aoki H, 2006, J CELL BIOCHEM, V99, P221, DOI 10.1002/jcb.20906; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Bush KT, 2004, DEV BIOL, V266, P285, DOI 10.1016/j.ydbio.2003.10.023; Cao YN, 2007, AM J PHYSIOL-GASTR L, V292, pG28, DOI 10.1152/ajpgi.00437.2005; Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011; Gao XX, 2013, AM J PHYSIOL-GASTR L, V304, pG804, DOI 10.1152/ajpgi.00306.2012; Gukovsky I, 2013, GASTROENTEROLOGY, V144, P1199, DOI 10.1053/j.gastro.2013.02.007; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Kordes C, 2005, PANCREAS, V31, P156, DOI 10.1097/01.mpa.0000168222.05591.a0; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Masamune A, 2009, GUT, V58, P550, DOI 10.1136/gut.2008.154401; Ohnishi H, 2004, J BIOL CHEM, V279, P8873, DOI 10.1074/jbc.M309698200; Perides G, 2005, GUT, V54, P1461, DOI 10.1136/gut.2004.062919; Rickels MR, 2013, PANCREATOLOGY, V13, P336, DOI 10.1016/j.pan.2013.05.002; Saeki K, 2012, GASTROENTEROLOGY, V142, P1010, DOI 10.1053/j.gastro.2011.12.054; Shek FWT, 2002, AM J PATHOL, V160, P1787, DOI 10.1016/S0002-9440(10)61125-X; Shlyonsky V, 2011, AM J RESP CELL MOL, V45, P1154, DOI 10.1165/rcmb.2010-0443OC; Shrikhande SV, 2003, BRIT J SURG, V90, P1565, DOI 10.1002/bjs.4353; Shu B, 2011, J CELL SCI, V124, P3428, DOI 10.1242/jcs.083659; Song YL, 2005, CIRCULATION, V112, P553, DOI 10.1161/CIRCULATIONAHA.104.492488; Spanler BWM, 2008, EUR J GASTROEN HEPAT, V20, P653, DOI 10.1097/MEG.0b013e3282f52f83; Tarantal AF, 2010, EUR RESPIR J, V36, P907, DOI 10.1183/09031936.00011810; Vogelmann R, 2001, AM J PHYSIOL-GASTR L, V280, pG164, DOI 10.1152/ajpgi.2001.280.1.G164; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang DP, 2013, AM J PHYSIOL-RENAL, V304, pF938, DOI 10.1152/ajprenal.00706.2012; Wang SJ, 2012, J CELL MOL MED, V16, P2301, DOI 10.1111/j.1582-4934.2012.01538.x; Xu B, 2012, AM J PHYSIOL-LUNG C, V303, pL89, DOI 10.1152/ajplung.00060.2012; Yang L, 2013, GASTROENTEROLOGY, V144, P1042, DOI 10.1053/j.gastro.2013.01.056; Yang YL, 2011, J CELL BIOCHEM, V112, P2558, DOI 10.1002/jcb.23180; Yang YL, 2009, ENDOCRINOLOGY, V150, P727, DOI 10.1210/en.2008-0090; Yoo BM, 2005, PANCREAS, V30, pE71, DOI 10.1097/01.mpa.0000157388.54016.0a; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	36	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89114	10.1371/journal.pone.0089114	http://dx.doi.org/10.1371/journal.pone.0089114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586530	gold, Green Submitted, Green Published			2022-12-27	WOS:000331717900052
J	Kruger, DM; Garzon, JI; Chacon, P; Gohlke, H				Krueger, Dennis M.; Ignacio Garzon, Jose; Chacon, Pablo; Gohlke, Holger			DrugScore(PPI) Knowledge-Based Potentials Used as Scoring and Objective Function in Protein-Protein Docking	PLOS ONE			English	Article							CONFORMATIONAL-CHANGES; PAIR-POTENTIALS; STRUCTURAL BASIS; LIGAND DOCKING; HOT-SPOTS; BINDING; FLEXIBILITY; ENERGY; COMPLEXES; PREDICTIONS	The distance-dependent knowledge-based DrugScore(PPI) potentials, previously developed for in silico alanine scanning and hot spot prediction on given structures of protein-protein complexes, are evaluated as a scoring and objective function for the structure prediction of protein-protein complexes. When applied for ranking "unbound perturbation" ("unbound docking") decoys generated by Baker and coworkers a 4-fold (1.5-fold) enrichment of acceptable docking solutions in the top ranks compared to a random selection is found. When applied as an objective function in FRODOCK for bound protein-protein docking on 97 complexes of the ZDOCK benchmark 3.0, DrugScore(PPI)/FRODOCK finds up to 10% (15%) more high accuracy solutions in the top 1 (top 10) predictions than the original FRODOCK implementation. When used as an objective function for global unbound protein-protein docking, fair docking success rates are obtained, which improve by similar to 2-fold to 18% (58%) for an at least acceptable solution in the top 10 (top 100) predictions when performing knowledge-driven unbound docking. This suggests that DrugScore(PPI) balances well several different types of interactions important for protein-protein recognition. The results are discussed in view of the influence of crystal packing and the type of protein-protein complex docked. Finally, a simple criterion is provided with which to estimate a priori if unbound docking with DrugScore(PPI)/FRODOCK will be successful.	[Krueger, Dennis M.; Gohlke, Holger] Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany; [Ignacio Garzon, Jose; Chacon, Pablo] CSIC, Rocasolano Phys Chem Inst, Madrid, Spain	Heinrich Heine University Dusseldorf; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Gohlke, H (corresponding author), Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany.	gohlke@uni-duesseldorf.de	Chacon, Pablo/B-4211-2014	Chacon, Pablo/0000-0002-3168-4826	 [BFU2009-09552];  [CAM S2010/BMD]	; 	This study was supported by grants BFU2009-09552 and CAM S2010/BMD to P.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2005, FEBS LETT, V579, P1854, DOI 10.1016/j.febslet.2005.02.014; Andrusier N, 2008, PROTEINS, V73, P271, DOI 10.1002/prot.22170; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; [Anonymous], [No title captured]; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Basdevant N, 2007, J PHYS CHEM B, V111, P9390, DOI 10.1021/jp0727190; Bertonati C, 2007, BIOPHYS J, V92, P1891, DOI 10.1529/biophysj.106.092122; Betts MJ, 1999, PROTEIN ENG, V12, P271, DOI 10.1093/protein/12.4.271; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Brinda KV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-296; Camacho CJ, 2005, PROTEINS, V60, P245, DOI 10.1002/prot.20565; Cavasotto CN, 2005, J AM CHEM SOC, V127, P9632, DOI 10.1021/ja042260c; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; Chuang GY, 2008, BIOPHYS J, V95, P4217, DOI 10.1529/biophysj.108.135814; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cole JC, 1998, ACTA CRYSTALLOGR D, V54, P1183, DOI 10.1107/S0907444998008932; Danley DE, 2006, ACTA CRYSTALLOGR D, V62, P569, DOI 10.1107/S0907444906012601; Dotan-Cohen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005313; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; Fernandez-Recio J, 2003, PROTEINS, V52, P113, DOI 10.1002/prot.10383; Fernandez-Recio J, 2002, PROTEIN SCI, V11, P280, DOI 10.1110/ps.19202; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Gohlke H, 2002, J MED CHEM, V45, P4153, DOI 10.1021/jm020808p; Gonzalez-Ruiz D, 2006, CURR MED CHEM, V13, P2607, DOI 10.2174/092986706778201530; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hinsen K, 2008, BIOINFORMATICS, V24, P521, DOI 10.1093/bioinformatics/btm625; Huang SY, 2008, PROTEINS, V72, P557, DOI 10.1002/prot.21949; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; Garzon JI, 2009, BIOINFORMATICS, V25, P2544, DOI 10.1093/bioinformatics/btp447; Jackson RM, 1999, PROTEIN SCI, V8, P603; Janin J, 1995, PROTEINS, V23, P580, DOI 10.1002/prot.340230413; Kazemi S, 2009, CHEMMEDCHEM, V4, P1264, DOI 10.1002/cmdc.200900146; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kruger DM, 2012, J CHEM INF MODEL, V52, P2807, DOI 10.1021/ci3003599; Kruger DM, 2011, ACS MED CHEM LETT, V2, P489, DOI 10.1021/ml100217h; Kruger DM, 2010, NUCLEIC ACIDS RES, V38, pW480, DOI 10.1093/nar/gkq471; Kurcinski M, 2007, J MOL MODEL, V13, P691, DOI 10.1007/s00894-007-0177-8; Lalonde S, 2008, PLANT J, V53, P610, DOI 10.1111/j.1365-313X.2007.03332.x; Li YC, 2008, PROTEIN PEPTIDE LETT, V15, P223; Liu SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-280; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Maestro, 2009, MAESTR VERS 9 1; Marsh JA, 2012, CURR OPIN STRUC BIOL, V22, P643, DOI 10.1016/j.sbi.2012.08.008; Marsh JA, 2011, STRUCTURE, V19, P859, DOI 10.1016/j.str.2011.03.010; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; Metz A, 2012, CURR PHARM DESIGN, V18, P4630, DOI 10.2174/138161212802651553; Metz A, 2012, J CHEM INF MODEL, V52, P120, DOI 10.1021/ci200322s; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Moal IH, 2013, CURR OPIN STRUC BIOL, V23, P862, DOI 10.1016/j.sbi.2013.06.017; Moont G, 1999, PROTEINS, V35, P364, DOI 10.1002/(SICI)1097-0134(19990515)35:3<364::AID-PROT11>3.0.CO;2-4; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; Nissink JWM, 2002, PROTEINS, V49, P457, DOI 10.1002/prot.10232; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pfeffer P, 2007, J CHEM INF MODEL, V47, P1868, DOI 10.1021/ci700134p; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Rajgaria R, 2006, PROTEINS, V65, P726, DOI 10.1002/prot.21149; Ramaraj T, 2012, BBA-PROTEINS PROTEOM, V1824, P520, DOI 10.1016/j.bbapap.2011.12.007; Rarey M, 1999, PROTEINS, V34, P17, DOI 10.1002/(SICI)1097-0134(19990101)34:1<17::AID-PROT3>3.0.CO;2-1; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6; Smith GR, 2005, PROTEINS, V60, P263, DOI 10.1002/prot.20568; Smith GR, 2005, J MOL BIOL, V347, P1077, DOI 10.1016/j.jmb.2005.01.058; Smith GR, 2002, CURR OPIN STRUC BIOL, V12, P28, DOI 10.1016/S0959-440X(02)00285-3; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tobi D, 2006, PROTEINS, V62, P970, DOI 10.1002/prot.20859; Tobi D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-40; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Ubbink M, 2009, FEBS LETT, V583, P1060, DOI 10.1016/j.febslet.2009.02.046; Vajda S, 1997, CURR OPIN STRUC BIOL, V7, P222, DOI 10.1016/S0959-440X(97)80029-2; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Verkhivker GM, 2002, CURR OPIN STRUC BIOL, V12, P197, DOI 10.1016/S0959-440X(02)00310-X; Viswanath S, 2013, PROTEINS, V81, P592, DOI 10.1002/prot.24214; Wang J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.188101; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Zacharias M, 2003, PROTEIN SCI, V12, P1271, DOI 10.1110/ps.0239303; ZACHARIAS M, 2010, PROTEIN PROTEIN COMP, P236; Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d	93	18	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89466	10.1371/journal.pone.0089466	http://dx.doi.org/10.1371/journal.pone.0089466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586799	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900102
J	Prior, S; Kim, A; Yoshihara, T; Tobita, S; Takeuchi, T; Higuchi, M				Prior, Sara; Kim, Ara; Yoshihara, Toshitada; Tobita, Seiji; Takeuchi, Toshiyuki; Higuchi, Masahiro			Mitochondrial Respiratory Function Induces Endogenous Hypoxia	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; INDUCED APOPTOSIS; OXYGEN; PIMONIDAZOLE; ACTIVATION; FLUTAMIDE; BETA; LINE	Hypoxia influences many key biological functions. In cancer, it is generally believed that hypoxic condition is generated deep inside the tumor because of the lack of oxygen supply. However, consumption of oxygen by cancer should be one of the key means of regulating oxygen concentration to induce hypoxia but has not been well studied. Here, we provide direct evidence of the mitochondrial role in the induction of intracellular hypoxia. We used Acetylacetonatobis [2-(2'-benzothienyl) pyridinato-kN, kC3'] iridium (III) (BTP), a novel oxygen sensor, to detect intracellular hypoxia in living cells via microscopy. The well-differentiated cancer cell lines, LNCaP and MCF-7, showed intracellular hypoxia without exogenous hypoxia in an open environment. This may be caused by high oxygen consumption, low oxygen diffusion in water, and low oxygen incorporation to the cells. In contrast, the poorly-differentiated cancer cell lines: PC-3 and MDAMB231 exhibited intracellular normoxia by low oxygen consumption. The specific complex I inhibitor, rotenone, and the reduction of mitochondrial DNA (mtDNA) content reduced intracellular hypoxia, indicating that intracellular oxygen concentration is regulated by the consumption of oxygen by mitochondria. HIF-1 alpha was activated in endogenously hypoxic LNCaP and the activation was dependent on mitochondrial respiratory function. Intracellular hypoxic status is regulated by glucose by parabolic dose response. The low concentration of glucose (0.045 mg/ml) induced strongest intracellular hypoxia possibly because of the Crabtree effect. Addition of FCS to the media induced intracellular hypoxia in LNCaP, and this effect was partially mimicked by an androgen analog, R1881, and inhibited by the anti-androgen, flutamide. These results indicate that mitochondrial respiratory function determines intracellular hypoxic status and may regulate oxygen-dependent biological functions.	[Prior, Sara; Kim, Ara; Higuchi, Masahiro] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Yoshihara, Toshitada; Tobita, Seiji] Gunma Univ, Grad Sch Engn, Dept Chem & Chem Biol, Kiryu, Gunma 376, Japan; [Takeuchi, Toshiyuki] Gunma Univ, Inst Mol & Cellular Regulat, Dept Mol Med, Maebashi, Gunma 371, Japan	University of Arkansas System; University of Arkansas Medical Sciences; Gunma University; Gunma University	Higuchi, M (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	mhiguchi@uams.edu			State of Arkansas Tobacco Settlement; National Institutes of Health [CA100846]; NATIONAL CANCER INSTITUTE [R01CA100846] Funding Source: NIH RePORTER	State of Arkansas Tobacco Settlement; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by State of Arkansas Tobacco Settlement and National Institutes of Health grants CA100846 to M.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cook CC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.141; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; EINARSDOTTIR O, 1995, BBA-BIOENERGETICS, V1229, P129, DOI 10.1016/0005-2728(94)00196-C; Fradette C, 2004, CURR DRUG METAB, V5, P257, DOI 10.2174/1389200043335577; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gusarova GA, 2011, MOL CELL BIOL, V31, P3546, DOI 10.1128/MCB.05114-11; Hagen T, 2004, BIOCHEM BIOPH RES CO, V322, P923, DOI 10.1016/j.bbrc.2004.07.204; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Higuchi M, 2006, ONCOGENE, V25, P1437, DOI 10.1038/sj.onc.1209190; Higuchi M, 2002, ANTIOXID REDOX SIGN, V4, P945, DOI 10.1089/152308602762197489; Higuchi M, 1997, J CLIN INVEST, V99, P1751, DOI 10.1172/JCI119339; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Kaanders JHAM, 2002, CANCER RES, V62, P7066; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kieda C, 2006, P NATL ACAD SCI USA, V103, P15576, DOI 10.1073/pnas.0607109103; KNOBLAUCH A, 1981, J APPL PHYSIOL, V51, P1635, DOI 10.1152/jappl.1981.51.6.1635; Lamansky S, 2001, J AM CHEM SOC, V123, P4304, DOI 10.1021/ja003693s; Li Y, 2012, TOXICOL SCI, V127, P582, DOI 10.1093/toxsci/kfs100; Lu WQ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001326; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697; Moran AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012113; Mucaj V, 2012, INT J HEMATOL, V95, P464, DOI 10.1007/s12185-012-1070-5; Naito A, 2008, CANCER SCI, V99, P1584, DOI 10.1111/j.1349-7006.2008.00879.x; Naviaux RK, 2012, J PHARMACOL EXP THER, V342, P608, DOI 10.1124/jpet.112.192120; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Page EL, 2008, MOL BIOL CELL, V19, P86, DOI 10.1091/mbc.E07-06-0612; Psarra AMG, 2008, IUBMB LIFE, V60, P210, DOI 10.1002/iub.37; Rosenberger Christian, 2009, V466, P161, DOI 10.1007/978-1-59745-352-3_12; Sedelaar JPM, 2009, PROSTATE, V69, P1724, DOI 10.1002/pros.21028; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Solakidi S, 2005, HUM REPROD, V20, P3481, DOI 10.1093/humrep/dei267; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; SUFRIN G, 1976, INVEST UROL, V13, P429; Suzuki S, 2008, CANCER LETT, V268, P31, DOI 10.1016/j.canlet.2008.03.020; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; VASCONSUELO A, 2013, AGEING RES REV, DOI DOI 10.1038/NREND0.2013.73; Wang Y, 2005, ASIAN J ANDROL, V7, P375, DOI 10.1111/j.1745-7262.2005.00031.x; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Xie CH, 2007, BIOCHEM BIOPH RES CO, V364, P656, DOI 10.1016/j.bbrc.2007.10.047; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948; Zhou ZQ, 2012, BIOCHEM BIOPH RES CO, V427, P305, DOI 10.1016/j.bbrc.2012.09.047; Zhou ZQ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011056	46	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e88911	10.1371/journal.pone.0088911	http://dx.doi.org/10.1371/journal.pone.0088911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586439	gold, Green Submitted, Green Published			2022-12-27	WOS:000331717900038
J	Shi, XD; Chen, GJ; Guo, LW; Si, Y; Zhu, M; Pilla, S; Liu, B; Gong, SQ; Kent, KC				Shi, Xudong; Chen, Guojun; Guo, Lian-Wang; Si, Yi; Zhu, Men; Pilla, Srikanth; Liu, Bo; Gong, Shaoqin; Kent, K. Craig			Periadventitial Application of Rapamycin-Loaded Nanoparticles Produces Sustained Inhibition of Vascular Restenosis	PLOS ONE			English	Article							MUSCLE-CELL PROLIFERATION; DRUG-ELUTING STENTS; IN-VIVO; NEOINTIMAL HYPERPLASIA; RE-ENDOTHELIALIZATION; PERIVASCULAR DELIVERY; PLGA NANOPARTICLES; DENDRITIC CELLS; GENE-TRANSFER; TGF-BETA	Open vascular reconstructions frequently fail due to the development of recurrent disease or intimal hyperplasia (IH). This paper reports a novel drug delivery method using a rapamycin-loaded poly(lactide-co-glycolide) (PLGA) nanoparticles (NPs)/pluronic gel system that can be applied periadventitially around the carotid artery immediately following the open surgery. In vitro studies revealed that rapamycin dispersed in pluronic gel was rapidly released over 3 days whereas release of rapamycin from rapamycin-loaded PLGA NPs embedded in pluronic gel was more gradual over 4 weeks. In cultured rat vascular smooth muscle cells (SMCs), rapamycin-loaded NPs produced durable (14 days versus 3 days for free rapamycin) inhibition of phosphorylation of S6 kinase (S6K1), a downstream target in the mTOR pathway. In a rat balloon injury model, periadventitial delivery of rapamycin-loaded NPs produced inhibition of phospho-S6K1 14 days after balloon injury. Immunostaining revealed that rapamycin-loaded NPs reduced SMC proliferation at both 14 and 28 days whereas rapamycin alone suppressed proliferation at day 14 only. Moreover, rapamycin-loaded NPs sustainably suppressed IH for at least 28 days following treatment, whereas rapamycin alone produced suppression on day 14 with rebound of IH by day 28. Since rapamycin, PLGA, and pluronic gel have all been approved by the FDA for other human therapies, this drug delivery method could potentially be translated into human use quickly to prevent failure of open vascular reconstructions.	[Shi, Xudong; Guo, Lian-Wang; Si, Yi; Liu, Bo; Kent, K. Craig] Univ Wisconsin Hosp & Clin, Dept Surg, Madison, WI 53792 USA; [Chen, Guojun; Zhu, Men; Pilla, Srikanth; Gong, Shaoqin] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Chen, Guojun; Zhu, Men; Gong, Shaoqin] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA; [Gong, Shaoqin] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gong, SQ (corresponding author), Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA.	sgong@engr.wisc.edu; kent@surgery.wisc.edu	Pilla, Srikanth/F-4622-2011	Pilla, Srikanth/0000-0003-3728-6578; Zhu, Men/0000-0001-9399-8444	National Heart, Lung, Blood Institute [R01-HL-068673]; National Science Foundation [DMR 1032187]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068673] Funding Source: NIH RePORTER	National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, Blood Institute Grant R01-HL-068673 (to KCK) and a grant from National Science Foundation (DMR 1032187 to SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2010, CIRC-CARDIOVASC INTE, V3, P384, DOI 10.1161/CIRCINTERVENTIONS.109.891192; Acharya S, 2011, ADV DRUG DELIVER REV, V63, P170, DOI 10.1016/j.addr.2010.10.008; Avgoustakis K, 2002, J CONTROL RELEASE, V79, P123, DOI 10.1016/S0168-3659(01)00530-2; Brown MA, 2010, ARTERIOSCL THROM VAS, V30, P2150, DOI 10.1161/ATVBAHA.110.207076; Cartiera MS, 2009, BIOMATERIALS, V30, P2790, DOI 10.1016/j.biomaterials.2009.01.057; Chorny M, 2000, CRIT REV THER DRUG, V17, P249; CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; Daemen J, 2008, AM J CARDIOL, V101, P1105, DOI 10.1016/j.amjcard.2007.11.074; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Ding M, 2011, ARTERIOSCL THROM VAS, V31, P1403, DOI 10.1161/ATVBAHA.110.216804; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Guzman LA, 1996, CIRCULATION, V94, P1441, DOI 10.1161/01.CIR.94.6.1441; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Jhunjhunwala S, 2009, J CONTROL RELEASE, V133, P191, DOI 10.1016/j.jconrel.2008.10.011; Jim J, 2012, J VASC SURG, V55, P1394, DOI 10.1016/j.jvs.2011.11.061; Kawatsu S, 2007, ANN THORAC SURG, V84, P560, DOI 10.1016/j.athoracsur.2007.02.034; Kundi R, 2009, CARDIOVASC RES, V84, P326, DOI 10.1093/cvr/cvp220; Liuzzo John P, 2005, J Invasive Cardiol, V17, P497; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; Lutsiak MEC, 2002, PHARM RES-DORDR, V19, P1480, DOI 10.1023/A:1020452531828; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Martin-Banderas L, 2013, MINI-REV MED CHEM, V13, P58, DOI 10.2174/138955713804484721; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Pires NMM, 2005, BIOMATERIALS, V26, P5386, DOI 10.1016/j.biomaterials.2005.01.063; Rajathurai T, 2010, CIRC-CARDIOVASC INTE, V3, P157, DOI 10.1161/CIRCINTERVENTIONS.109.864660; Reddy MK, 2008, CIRC-CARDIOVASC INTE, V1, P209, DOI 10.1161/CIRCINTERVENTIONS.108.830018; Rosner D, 2005, CARDIOVASC RES, V66, P601, DOI 10.1016/j.cardiores.2005.01.006; Seedial SM, 2013, J VASC SURG, V57, P1403, DOI 10.1016/j.jvs.2012.12.069; Semete B, 2010, NANOMED-NANOTECHNOL, V6, P662, DOI 10.1016/j.nano.2010.02.002; Si Y, 2012, ARTERIOSCL THROM VAS, V32, P943, DOI 10.1161/ATVBAHA.111.244921; Siow RCM, 2003, CARDIOVASC RES, V59, P212, DOI 10.1016/S0008-6363(03)00292-X; Siqueira DA, 2007, EUR HEART J, V28, P1304, DOI 10.1093/eurheartj/ehm114; Tian W, 2006, J ENDOVASC THER, V13, P616, DOI 10.1583/05-1802MR.1; Tsai S, 2009, AM J PHYSIOL-HEART C, V297, pH540, DOI 10.1152/ajpheart.91478.2007; Virmani R, 2004, CORONARY ARTERY DIS, V15, P313, DOI 10.1097/00019501-200409000-00003; Yang J, 2013, BIOMATERIALS, V34, P1635, DOI 10.1016/j.biomaterials.2012.11.006; Zhu WW, 2006, J BIOMED MATER RES B, V77B, P135, DOI 10.1002/jbm.b.30412; Zohlnhofer D, 2004, MOL PHARMACOL, V65, P880, DOI 10.1124/mol.65.4.880	40	30	34	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89227	10.1371/journal.pone.0089227	http://dx.doi.org/10.1371/journal.pone.0089227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586612	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900065
J	Frohnert, C; Hutten, S; Walde, S; Nath, A; Kehlenbach, RH				Frohnert, Cornelia; Hutten, Saskia; Waelde, Sarah; Nath, Annegret; Kehlenbach, Ralph H.			Importin 7 and Nup358 Promote Nuclear Import of the Protein Component of Human Telomerase	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; PORE COMPLEX; CATALYTIC SUBUNIT; LOCALIZATION; TRANSPORT; RANGAP1; EXPORT; PHOSPHORYLATION; BIOGENESIS; RECEPTOR	In actively dividing eukaryotic cells, chromosome ends (telomeres) are subject to progressive shortening, unless they are maintained by the action of telomerase, a dedicated enzyme that adds DNA sequence repeats to chromosomal 3'end. For its enzymatic function on telomeres, telomerase requires nuclear import of its protein component (hTERT in human cells) and assembly with the RNA component, TERC. We now confirm a major nuclear localization signal (NLS) in the N-terminal region of hTERT and describe a novel one in the C-terminal part. Using an siRNA approach to deplete several import receptors, we identify importin 7 as a soluble nuclear transport factor that is required for efficient import. At the level of the nuclear pore complex (NPC), Nup358, a nucleoporin that forms the cytoplasmic filaments of the NPC, plays an important role in nuclear import of hTERT. A structure-function analysis of Nup358 revealed that the zinc finger region of the nucleoporin is of particular importance for transport of hTERT. Together, our study sheds light on the nuclear import pathway of hTERT.	[Frohnert, Cornelia; Hutten, Saskia; Waelde, Sarah; Nath, Annegret; Kehlenbach, Ralph H.] Univ Gottingen, Fac Med, Inst Mol Biol, D-37073 Gottingen, Germany	University of Gottingen	Kehlenbach, RH (corresponding author), Univ Gottingen, Fac Med, Inst Mol Biol, D-37073 Gottingen, Germany.	rkehlen@gwdg.de		Kehlenbach, Ralph/0000-0003-4920-9916; Walde, Sarah/0000-0001-8544-2323	Deutsche Forschungsgemeinschaft (DFG) [KE 660/5-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The project was funded by a grant from the Deutsche Forschungsgemeinschaft (DFG; KE 660/5-2) and by intramural funds to RHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Akiyama M, 2003, CANCER RES, V63, P18; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Baake M, 2001, EUR J CELL BIOL, V80, P669, DOI 10.1078/0171-9335-00208; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Blackburn EH, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003558; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Chen XC, 2010, MOL CELL BIOL, V30, P4022, DOI 10.1128/MCB.00124-10; Chuderland D, 2008, MOL CELL, V28, P28; Chung J, 2012, J CELL SCI, V125, P2684, DOI 10.1242/jcs.099267; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Ferrezuelo F, 2002, MOL CELL BIOL, V22, P6046, DOI 10.1128/MCB.22.17.6046-6055.2002; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003; Hirano M, 2006, P NATL ACAD SCI USA, V103, P2298, DOI 10.1073/pnas.0505598103; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Iannilli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066602; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Khurts S, 2004, J BIOL CHEM, V279, P51508, DOI 10.1074/jbc.M407643200; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Li SR, 2000, BIOCHEM BIOPH RES CO, V271, P537, DOI 10.1006/bbrc.2000.2666; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Listerman I, 2013, CANCER RES, V73, P2817, DOI 10.1158/0008-5472.CAN-12-3082; Liu KB, 2001, J IMMUNOL, V166, P4826, DOI 10.4049/jimmunol.166.8.4826; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Rosenfeld KK, 2011, J MOL BIOL, V410, P77, DOI 10.1016/j.jmb.2011.04.040; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Saijou E, 2007, J BIOL CHEM, V282, P32327, DOI 10.1074/jbc.M706793200; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Smith ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009295; Walde S, 2012, TRAFFIC, V13, P218, DOI 10.1111/j.1600-0854.2011.01302.x; Waldmann I, 2012, J CELL SCI, V125, P144, DOI 10.1242/jcs.090316; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562	53	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88887	10.1371/journal.pone.0088887	http://dx.doi.org/10.1371/journal.pone.0088887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586428	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700039
J	Guo, YG; Li, R; Song, XP; Zhong, YJ; Wang, CG; Jia, H; Wu, LD; Wang, D; Fang, F; Ma, J; Kang, WY; Sun, J; Tian, ZG; Xiao, WH				Guo, Yugang; Li, Rui; Song, Xiaoping; Zhong, Yongjun; Wang, Chenguang; Jia, Hao; Wu, Lidan; Wang, Dong; Fang, Fang; Ma, Jiajia; Kang, Wenyao; Sun, Jie; Tian, Zhigang; Xiao, Weihua			The Expression and Characterization of Functionally Active Soluble CD83 by Pichia pastoris Using High-Density Fermentation	PLOS ONE			English	Article							TOLEROGENIC DENDRITIC CELLS; T-CELLS; ALLOGRAFT-REJECTION; IMMUNE-RESPONSES; B-CELL; MATURATION; STIMULATION; MARKER; PROLIFERATION; SUPERFAMILY	CD83 is a highly glycosylated type I transmembrane glycoprotein that belongs to the immunoglobulin superfamily. CD83 is upregulated during dendritic cell (DC) maturation, which is critical for the initiation of adaptive immune responses. The soluble isoform of CD83 (sCD83) is encoded by alternative splicing from full-length CD83 mRNA and inhibits DC maturation, which suggests that sCD83 acts as a potential immune suppressor. In this study, we developed a sound strategy to express functional sCD83 from Pichia pastoris in extremely high-density fermentation. Purified sCD83 was expressed as a monomer at a yield of more than 200 mg/L and contained N-linked glycosylation sites that were characterized by PNGase F digestion. In vitro tests indicated that recombinant sCD83 bound to its putative counterpart on monocytes and specifically blocked the binding of anti-CD83 antibodies to cell surface CD83 on DCs. Moreover, sCD83 from yeast significantly suppressed ConA-stimulated PBMC proliferation. Therefore, sCD83 that was expressed from the P. pastoris was functionally active and may be used for in vivo and in vitro studies as well as future clinical applications.	[Guo, Yugang; Li, Rui; Zhong, Yongjun; Wang, Chenguang; Jia, Hao; Wu, Lidan; Wang, Dong; Fang, Fang; Kang, Wenyao; Sun, Jie; Tian, Zhigang; Xiao, Weihua] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Innovat Ctr Cell Biol, Sch Life Sci, Hefei 230026, Peoples R China; [Guo, Yugang; Ma, Jiajia; Sun, Jie; Tian, Zhigang; Xiao, Weihua] Univ Sci & Technol China, Ctr Med Biotechnol Anhui Prov, Hefei 230026, Peoples R China; [Song, Xiaoping] Anhui Med Coll, Dept Pharm, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical College	Xiao, WH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Innovat Ctr Cell Biol, Sch Life Sci, Hefei 230026, Peoples R China.	xiaow@ustc.edu.cn	Xiao, Weihua/N-2775-2013; Tian, Zhigang/J-3512-2013	Xiao, Weihua/0000-0001-9102-6326; /0000-0003-3150-6170	National Natural Science Foundation of China [81071683, 91029710, 81272327]; National Basic Research Program of China [2013CB944903, 2012CB825806]; China Postdoctoral Science Foundation [2013 M541843]; Education Science Foundation of Anhui Province [KJ2013A099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Education Science Foundation of Anhui Province	This work was supported in part by funds from the National Natural Science Foundation of China (Grant No. 81071683, 91029710 and 81272327), the National Basic Research Program of China (2013CB944903 and 2012CB825806), the China Postdoctoral Science Foundation (Grant No. 2013 M541843), and the Education Science Foundation of Anhui Province (Grant No. KJ2013A099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts-Toegaert C, 2007, EUR J IMMUNOL, V37, P686, DOI 10.1002/eji.200636535; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Chen LW, 2011, P NATL ACAD SCI USA, V108, P18778, DOI 10.1073/pnas.1018994108; Dudziak D, 2005, J IMMUNOL, V174, P6672, DOI 10.4049/jimmunol.174.11.6672; Fang F, 2010, J IMMUNOL, V184, P6084, DOI 10.4049/jimmunol.0902561; Fujimoto Y, 2002, CELL, V108, P755, DOI 10.1016/S0092-8674(02)00673-6; Ge W, 2010, TRANSPLANTATION, V90, P1145, DOI 10.1097/TP.0b013e3181f95718; Hock BD, 2009, LEUKEMIA RES, V33, P1089, DOI 10.1016/j.leukres.2009.01.001; Hock BD, 2006, TISSUE ANTIGENS, V67, P57, DOI 10.1111/j.1399-0039.2005.00524.x; Hock BD, 2001, INT IMMUNOL, V13, P959, DOI 10.1093/intimm/13.7.959; Lan Z, 2010, TRANSPLANTATION, V90, P1286, DOI 10.1097/TP.0b013e3182007bbf; Lan Z, 2010, TRANSPLANTATION, V90, P1278, DOI 10.1097/TP.0b013e318200005c; Lechmann M, 2005, BIOCHEM BIOPH RES CO, V329, P132, DOI 10.1016/j.bbrc.2005.01.114; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lechmann M, 2002, PROTEIN EXPRES PURIF, V24, P445, DOI 10.1006/prep.2001.1594; Lechmann M, 2001, J EXP MED, V194, P1813, DOI 10.1084/jem.194.12.1813; Luthje K, 2008, INT IMMUNOL, V20, P949, DOI 10.1093/intimm/dxn054; Prazma CM, 2008, IMMUNOL LETT, V115, P1, DOI 10.1016/j.imlet.2007.10.001; Prazma CM, 2007, J IMMUNOL, V179, P4550, DOI 10.4049/jimmunol.179.7.4550; Prechtel AT, 2007, ARCH DERMATOL RES, V299, P59, DOI 10.1007/s00403-007-0743-z; Prechtel AT, 2007, J IMMUNOL, V178, P5454, DOI 10.4049/jimmunol.178.9.5454; Reinwald S, 2008, J IMMUNOL, V180, P5890, DOI 10.4049/jimmunol.180.9.5890; Scholler N, 2002, J IMMUNOL, V168, P2599, DOI 10.4049/jimmunol.168.6.2599; Scholler N, 2001, J IMMUNOL, V166, P3865, DOI 10.4049/jimmunol.166.6.3865; Senechal B, 2004, BLOOD, V103, P4207, DOI 10.1182/blood-2003-12-4350; Staab C, 2010, IMMUNOBIOLOGY, V215, P849, DOI 10.1016/j.imbio.2010.05.029; Yuan Y, 2013, APPL MICROBIOL BIOTE; ZHOU LJ, 1992, J IMMUNOL, V149, P735; ZHOU LJ, 1995, J IMMUNOL, V154, P3821; Zinser E, 2004, J EXP MED, V200, P345, DOI 10.1084/jem.20030973	30	11	11	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89264	10.1371/journal.pone.0089264	http://dx.doi.org/10.1371/journal.pone.0089264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586642	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700083
J	Scardoni, G; Montresor, A; Tosadori, G; Laudanna, C				Scardoni, Giovanni; Montresor, Alessio; Tosadori, Gabriele; Laudanna, Carlo			Node Interference and Robustness: Performing Virtual Knock-Out Experiments on Biological Networks: The Case of Leukocyte Integrin Activation Network	PLOS ONE			English	Article							ATTACK TOLERANCE; CENTRALITY; CHEMOKINES; ADHESION; AFFINITY; BLOCKS; ERROR	The increasing availability of large network datasets derived from high-throughput experiments requires the development of tools to extract relevant information from biological networks, and the development of computational methods capable of detecting qualitative and quantitative changes in the topological properties of biological networks is of critical relevance. We introduce the notions of node interference and robustness as measures of the reciprocal influence between nodes within a network. We examine the theoretical significance of these new, centrality-based, measures by characterizing the topological relationships between nodes and groups of nodes. Node interference analysis allows topologically determining the context of functional influence of single nodes. Conversely, the node robustness analysis allows topologically identifying the nodes having the highest functional influence on a specific node. A new Cytoscape plug-in calculating these measures was developed and applied to a protein-protein interaction network specifically regulating integrin activation in human primary leukocytes. Notably, the functional effects of compounds inhibiting important protein kinases, such as SRC, HCK, FGR and JAK2, are predicted by the interference and robustness analysis, are in agreement with previous studies and are confirmed by laboratory experiments. The interference and robustness notions can be applied to a variety of different contexts, including, for instance, the identification of potential side effects of drugs or the characterization of the consequences of genes deletion, duplication or of proteins degradation, opening new perspectives in biological network analysis.	[Scardoni, Giovanni; Tosadori, Gabriele; Laudanna, Carlo] Univ Verona, CBMC, I-37100 Verona, Italy; [Montresor, Alessio; Laudanna, Carlo] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy	University of Verona; University of Verona	Scardoni, G (corresponding author), Univ Verona, CBMC, I-37100 Verona, Italy.	giovanni.scardoni@gmail.com	tosadori, gabriele/GXH-6684-2022; tosadori, gabriele/ABB-7383-2021	tosadori, gabriele/0000-0001-5971-4815; tosadori, gabriele/0000-0001-5971-4815	Fondazione Cariverona; AIRC	Fondazione Cariverona(Fondazione Cariverona); AIRC(Fondazione AIRC per la ricerca sul cancro)	Funded by Fondazione Cariverona and AIRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Arsenio Rodriguez DI, 2011, NETWORK BIOL, V1, P34; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bolomini-Vittori M, 2009, NATURE IMMUNOLOGY; Brouwers L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022187; Caldarelli G, 2007, SCALE FREE NETWORKS; Higareda-Almaraz JC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-96; Choura M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-58; Constantin G, 1998, EUR J IMMUNOL, V28, P3523, DOI 10.1002/(SICI)1521-4141(199811)28:11<3523::AID-IMMU3523>3.0.CO;2-X; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Crucitti P, 2004, PHYSICA A, V340, P388, DOI 10.1016/j.physa.2004.04.031; Emmert-Streib F, 2010, WILEY INTERDISCIP RE, V3, P379; Feltes BC, 2011, BIOGERONTOLOGY, V12, P293, DOI 10.1007/s10522-011-9325-8; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1991, SOC NETWORKS, V13, P141, DOI 10.1016/0378-8733(91)90017-N; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Giagulli C, 2006, J IMMUNOL, V177, P604, DOI 10.4049/jimmunol.177.1.604; Goguen J. A., 1982, Proceedings of the 1982 Symposium on Security and Privacy, P11; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Holme P, 2003, BIOINFORMATICS, V19, P532, DOI 10.1093/bioinformatics/btg033; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Junker B. H., 2006, BMC BIOINFORMATICS, V7; Kinashi T, 2004, IMMUNOL LETT, V93, P1, DOI 10.1016/j.imlet.2004.02.008; Koschutzki D, 2005, LECT NOTES COMPUT SC, V3418, P16; Ladha J, 2010, CANCER RES, V70, P6437, DOI 10.1158/0008-5472.CAN-10-0819; Laudanna C, 2009, WIRES SYST BIOL MED, V1, P116, DOI 10.1002/wsbm.9; Lepp Z, 2009, J CHEM INF MODEL; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; McCulloh I., 2011, J SOCIAL STRUCTURE, V12; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Missiuro PV, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000350; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Sengupta U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008100; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weber K, 2001, MOL BIOL CELL, V12; Wuchty S, 2003, J THEOR BIOL, V223, P45, DOI 10.1016/S0022-5193(03)00071-7; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787	47	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88938	10.1371/journal.pone.0088938	http://dx.doi.org/10.1371/journal.pone.0088938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586448	gold, Green Published			2022-12-27	WOS:000331714700042
J	Steinhardt, LC; Chinkhumba, J; Wolkon, A; Luka, M; Luhanga, M; Sande, J; Oyugi, J; Ali, D; Mathanga, D; Skarbinski, J				Steinhardt, Laura C.; Chinkhumba, Jobiba; Wolkon, Adam; Luka, Madalitso; Luhanga, Misheck; Sande, John; Oyugi, Jessica; Ali, Doreen; Mathanga, Don; Skarbinski, Jacek			Quality of Malaria Case Management in Malawi: Results from a Nationally Representative Health Facility Survey	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; FEBRILE ILLNESS; OLDER CHILDREN; TANZANIA; KENYA; AFRICA; MICROSCOPY; ADHERENCE; EFFICACY; POLICY	Background: Malaria is endemic throughout Malawi, but little is known about quality of malaria case management at publicly-funded health facilities, which are the major source of care for febrile patients. Methods: In April-May 2011, we conducted a nationwide, geographically-stratified health facility survey to assess the quality of outpatient malaria diagnosis and treatment. We enrolled patients presenting for care and conducted exit interviews and re-examinations, including reference blood smears. Moreover, we assessed health worker readiness (e.g., training, supervision) and health facility capacity (e.g. availability of diagnostics and antimalarials) to provide malaria case management. All analyses accounted for clustering and unequal selection probabilities. We also used survey weights to produce estimates of national caseloads. Results: At the 107 facilities surveyed, most of the 136 health workers interviewed (83%) had received training on malaria case management. However, only 24% of facilities had functional microscopy, 15% lacked a thermometer, and 19% did not have the first-line artemisinin-based combination therapy (ACT), artemether-lumefantrine, in stock. Of 2,019 participating patients, 34% had clinical malaria (measured fever or self-reported history of fever plus a positive reference blood smear). Only 67% (95% confidence interval (CI): 59%, 76%) of patients with malaria were correctly prescribed an ACT, primarily due to missed malaria diagnosis. Among patients without clinical malaria, 31% (95% CI: 24%, 39%) were prescribed an ACT. By our estimates, 1.5 million of the 4.4 million malaria patients seen in public facilities annually did not receive correct treatment, and 2.7 million patients without clinical malaria were inappropriately given an ACT. Conclusions: Malawi has a high burden of uncomplicated malaria but nearly one-third of all patients receive incorrect malaria treatment, including under-and over-treatment. To improve malaria case management, facilities must at minimum have basic case management tools, and health worker performance in diagnosing malaria must be improved.	[Steinhardt, Laura C.; Wolkon, Adam; Oyugi, Jessica; Skarbinski, Jacek] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Atlanta, GA 30329 USA; [Chinkhumba, Jobiba; Luka, Madalitso; Mathanga, Don] Coll Med, Malaria Alert Ctr, Blantyre, Malawi; [Luhanga, Misheck; Sande, John; Ali, Doreen] Minist Hlth, Natl Malaria Control Programme, Lilongwe, Malawi	Centers for Disease Control & Prevention - USA; University of Malawi	Steinhardt, LC (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA 30329 USA.	iyp6@cdc.gov			United States President's Malaria Initiative; U.S. Agency for International Development, under the terms of an Interagency Agreement with the Centers for Disease Control and Prevention (CDC) [5U01CK000135]	United States President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); U.S. Agency for International Development, under the terms of an Interagency Agreement with the Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USAUnited States Agency for International Development (USAID))	This publication was made possible through support provided by the United States President's Malaria Initiative, U.S. Agency for International Development, under the terms of an Interagency Agreement with the Centers for Disease Control and Prevention (CDC) and through a Cooperative Agreement (Number 5U01CK000135) between the CDC and the Malaria Alert Centre, College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaens GJH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-76; BLOLAND PB, 1993, J INFECT DIS, V167, P932, DOI 10.1093/infdis/167.4.932; Chandler CIR, 2008, TROP MED INT HEALTH, V13, P1131, DOI 10.1111/j.1365-3156.2008.02118.x; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Ewing VL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-32; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Leonard K, 2006, SOC SCI MED, V63, P2330, DOI 10.1016/j.socscimed.2006.06.003; Mace KE, 2011, CLIN INFECT DIS, V53, P772, DOI 10.1093/cid/cir498; Malawi Ministry of Health, 2012, MAL MAL IND SURV 201; Malawi Ministry of Health, 2010, MAL NAT MAL IND SURV; Masanja IM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-221; Mathanga DP, 2012, ACTA TROP, V121, P212, DOI 10.1016/j.actatropica.2011.06.017; Ministry of Health [Malawi], 2011, MAL HLTH SECT STRAT; National Statistical Office, 2011, MAL DEM HLTH SURV 20; Ngasala B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-199; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; Rao VB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069654; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Rowe AK, 2002, TROP DOCT, V32, P166, DOI 10.1177/004947550203200317; Rowe SY, 2007, T ROY SOC TROP MED H, V101, P188, DOI 10.1016/j.trstmh.2006.02.023; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Thwing J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S14; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, GUID TREATM MAL, V2nd; Yukich JO, 2012, AM J TROP MED HYG, V87, P437, DOI 10.4269/ajtmh.2012.12-0127; Zurovac D, 2006, ANN TROP MED PARASIT, V100, P283, DOI 10.1179/136485906X105633; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884	29	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89050	10.1371/journal.pone.0089050	http://dx.doi.org/10.1371/journal.pone.0089050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586497	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700054
J	Tong, ZC; Zhang, YJ; Ling, JQ; Ma, JL; Huang, LJ; Zhang, LD				Tong, Zhongchun; Zhang, Yuejiao; Ling, Junqi; Ma, Jinglei; Huang, Lijia; Zhang, Luodan			An In Vitro Study on the Effects of Nisin on the Antibacterial Activities of 18 Antibiotics against Enterococcus faecalis	PLOS ONE			English	Article							ANTIMICROBIAL CATIONIC PEPTIDES; LIPID-II; METHICILLIN-RESISTANT; BACTERICIDAL ACTIVITY; VANCOMYCIN; COMBINATION; MECHANISMS; SUSCEPTIBILITY; GENTAMICIN; DAPTOMYCIN	Enterococcus faecalis rank among the leading causes of nosocomial infections worldwide and possesses both intrinsic and acquired resistance to a variety of antibiotics. Development of new antibiotics is limited, and pathogens continually generate new antibiotic resistance. Many researchers aim to identify strategies to effectively kill this drug-resistant pathogen. Here, we evaluated the effect of the antimicrobial peptide nisin on the antibacterial activities of 18 antibiotics against E. faecalis. The MIC and MBC results showed that the antibacterial activities of 18 antibiotics against E. faecalis OG1RF, ATCC 29212, and strain E were significantly improved in the presence of 200 U/ml nisin. Statistically significant differences were observed between the results with and without 200 U/ml nisin at the same concentrations of penicillin or chloramphenicol (p < 0.05). The checkerboard assay showed that the combination of nisin and penicillin or chloramphenicol had a synergetic effect against the three tested E. faecalis strains. The transmission electron microscope images showed that E. faecalis was not obviously destroyed by penicillin or chloramphenicol alone but was severely disrupted by either antibiotic in combination with nisin. Furthermore, assessing biofilms by a confocal laser scanning microscope showed that penicillin, ciprofloxacin, and chloramphenicol all showed stronger antibiofilm actions in combination with nisin than when these antibiotics were administered alone. Therefore, nisin can significantly improve the antibacterial and antibiofilm activities of many antibiotics, and certain antibiotics in combination with nisin have considerable potential for use as inhibitors of this drug-resistant pathogen.	[Tong, Zhongchun; Zhang, Yuejiao; Ling, Junqi; Ma, Jinglei; Huang, Lijia; Zhang, Luodan] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, Guangzhou 510275, Guangdong, Peoples R China; [Tong, Zhongchun; Ling, Junqi] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Ling, JQ (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, Guangzhou 510275, Guangdong, Peoples R China.	Junqi_Ling@hotmail.com			Fundamental Research Funds for the Central Universities, China [12ykpy64]; China Postdoctoral Science Foundation [2013M542229]	Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research is supported by the Fundamental Research Funds for the Central Universities, China (number 12ykpy64), and China Postdoctoral Science Foundation Funded Project (project number 2013M542229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Barnes AMT, 2012, MBIO, V3, DOI 10.1128/mBio.00193-12; Boneca IG, 2003, EXPERT OPIN THER TAR, V7, P311, DOI 10.1517/14728222.7.3.311; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Christ K, 2007, BBA-BIOMEMBRANES, V1768, P694, DOI 10.1016/j.bbamem.2006.12.003; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Cottagnoud P, 2003, ANTIMICROB AGENTS CH, V47, P144, DOI 10.1128/AAC.47.1.144-147.2003; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Dosler S, 2012, J CHEMOTHERAPY, V24, P137, DOI 10.1179/1973947812Y.0000000007; Dosler S, 2011, CHEMOTHERAPY, V57, P511, DOI 10.1159/000335598; Dufour M, 2007, APPL ENVIRON MICROB, V73, P5507, DOI 10.1128/AEM.01013-07; EAGLE H, 1948, J EXP MED, V88, P99, DOI 10.1084/jem.88.1.99; FDA, 1988, NIS PREP AFF GRAS ST; Fuchs PC, 2002, J ANTIMICROB CHEMOTH, V49, P467, DOI 10.1093/jac/49.3.467; Grandiere-Perez L, 2005, J INFECT DIS, V191, P2118, DOI 10.1086/430350; Hadley EB, 2010, CURR TOP MED CHEM, V10, P1872; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Kim EB, 2012, J BACTERIOL, V194, P6006, DOI 10.1128/JB.01423-12; Kondo N, 2001, ANTIMICROB AGENTS CH, V45, P815, DOI 10.1128/AAC.45.3.815-824.2001; Lemaitre N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052503; Martin NI, 2007, FUTURE MICROBIOL, V2, P513, DOI 10.2217/17460913.2.5.513; Mataraci E, 2012, ANTIMICROB AGENTS CH, V56, P6366, DOI 10.1128/AAC.01180-12; Naghmouchi K, 2013, ANTIMICROB AGENTS CH, V57, P2719, DOI 10.1128/AAC.02328-12; Naghmouchi K, 2012, RES MICROBIOL, V163, P101, DOI 10.1016/j.resmic.2011.11.002; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Ouhara K, 2008, J ANTIMICROB CHEMOTH, V61, P1266, DOI 10.1093/jac/dkn106; Pai MP, 2000, ANN PHARMACOTHER, V34, P495, DOI 10.1345/aph.19138; Palmer AC, 2013, NAT REV GENET, V14, P243, DOI 10.1038/nrg3351; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Sengupta S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00047; Severina E, 1998, J ANTIMICROB CHEMOTH, V41, P341, DOI 10.1093/jac/41.3.341; SHAH PM, 1982, J ANTIMICROB CHEMOTH, V10, P259, DOI 10.1093/jac/10.4.259; Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007; Tafin UF, 2011, ANTIMICROB AGENTS CH, V55, P4821, DOI 10.1128/AAC.00141-11; Tong ZX, 2013, J ENDODONT, V39, P674, DOI 10.1016/j.joen.2012.12.010; Tong ZC, 2011, PEPTIDES, V32, P2021, DOI 10.1016/j.peptides.2011.09.002; Tong ZC, 2011, J ENDODONT, V37, P1116, DOI 10.1016/j.joen.2011.03.020; Vickerman MM, 2010, J BACTERIOL, V192, P2535, DOI 10.1128/JB.01689-09; Weinstein MP, 2001, J CLIN MICROBIOL, V39, P2729, DOI 10.1128/JCM.39.7.2729-2731.2001; Wilson APR, 2006, J ANTIMICROB CHEMOTH, V58, P470, DOI 10.1093/jac/dkl233; YOURASSOWSKY E, 1986, ANTIMICROB AGENTS CH, V30, P258, DOI 10.1128/AAC.30.2.258	48	53	57	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89209	10.1371/journal.pone.0089209	http://dx.doi.org/10.1371/journal.pone.0089209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586598	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700072
J	Wang, J; Zhao, JQ; Shi, MJ; Ding, Y; Sun, HQ; Yuan, FH; Zou, ZM				Wang, Jian; Zhao, Jiqing; Shi, Mengjing; Ding, Yu; Sun, Huiqin; Yuan, Fahuan; Zou, Zhongmin			Elevated Expression of miR-210 Predicts Poor Survival of Cancer Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CELL-CYCLE; CIRCULATING MIR-210; PROGNOSTIC-FACTOR; GENE-EXPRESSION; GROWTH-FACTOR; UP-REGULATION; LUNG-CANCER; STEM-CELLS; HYPOXIA; MICRORNA-210	Background: MiRNAs are important regulators of different biological processes, including tumorigenesis. MiR-210 is a potential prognostic factor for survival in patients with cancer according to previous clinical researches. We conducted a systematic review and meta-analysis to summarize the significance of increased miR-210 expression in the prognosis of indicated cancers. Methodology/Principal Findings: The present systematic review and meta-analysis of 16 researches included 1809 patients with 7 different types of cancers from 7 countries, and aimed to explore the association between miR-210 expression and the survival of cancer patients. Over-expression of miR-210 may predict poor overall survival (OS, HR = 1.33, 95% CI: 0.85-2.09, P = 0.210), but the effect was not significant. While the predictive effect on disease-free survival (DFS, HR = 1.89, 95% CI: 1.30-2.74, P = 0.001), progression-free survival (PFS, HR = 1.20, 95% CI: 1.05-1.38, P = 0.007) and relapse-free survival(RFS, HR = 4.42, 95% CI: 2.14-9.15, P = 0.000) for patients with breast cancer, primary head and neck squamous cell carcinoma (HNSCC), renal cancer, soft-tissue sarcoma, pediatric osteosarcoma, bladder cancer or glioblastoma was certain. Subgroup analysis showed the limited predictive effect of over-expressed miR-210 on breast cancer OS (HR = 1.63, 95% CI: 0.47-5.67, P = 0.443), breast cancer DFS (HR = 2.03, 95% CI: 0.90-4.57, P = 0.088), sarcoma OS (HR = 1.24, 95% CI: 0.20-7.89, P = 0.818) and renal cancer OS (HR = 1.16, 95% CI: 0.27-4.94, P = 0.842). Conclusions/Significance: This systematic review and meta-analysis suggests that miR-210 has a predictive effect on survival of patients with studied cancer types as indexed by disease-free survival, progression-free survival and relapse-free survival. While the predictive effect on overall survival, breast cancer overall survival, breast cancer disease-free survival, sarcoma overall survival and renal cancer overall survival was not statistically significant.	[Wang, Jian; Zhao, Jiqing; Shi, Mengjing; Sun, Huiqin; Zou, Zhongmin] Third Mil Med Univ, Sch Prevent Med, Inst Toxicol, Chongqing, Peoples R China; [Ding, Yu; Yuan, Fahuan] Xinqiao Hosp, Dept Nephrol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zou, ZM (corresponding author), Third Mil Med Univ, Sch Prevent Med, Inst Toxicol, Chongqing, Peoples R China.	zouzhmin@yahoo.com			Major Military Medical S & T Project of PLA [AWS11C004]; Key Program of the "Twelfth Five-year Plan" for Medical Science Development of PLA [BWS11R02]	Major Military Medical S & T Project of PLA; Key Program of the "Twelfth Five-year Plan" for Medical Science Development of PLA	This work was supported by the Major Military Medical S & T Project of PLA for the "Twelfth Five-year Plan"(AWS11C004), and the Key Program of the "Twelfth Five-year Plan" for Medical Science Development of PLA (BWS11R02). The funder has no proper website to publish. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Cai H, 2013, MED ONCOLOGY, V30; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Chang W, 2013, J VET SCI, V14, P69, DOI 10.4142/jvs.2013.14.1.69; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Dirks PB, 1998, ONCOGENE, V17, P867, DOI 10.1038/sj.onc.1202008; Duncavage EJ, 2009, LAB INVEST, V89, p352A; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Gaca S, 2012, J MICROENCAPSUL, V29, P685, DOI 10.3109/02652048.2012.680511; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Greither T, 2012, INT J CANCER, V130, P1230, DOI 10.1002/ijc.26109; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Grosso S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.71; Ho AS, 2009, J CLIN ONCOL, V27; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Hong L, 2013, EXPERT OPIN THER TAR, V17, P21, DOI 10.1517/14728222.2012.732066; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Kheirelseid EAH, 2013, INT J COLORECTAL DIS, V28, P247, DOI 10.1007/s00384-012-1549-9; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kopriva SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067760; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Lou YL, 2012, MOL CELL BIOCHEM, V370, P45, DOI 10.1007/s11010-012-1396-6; Madhavan D, 2012, CLIN CANCER RES, V18, P5972, DOI 10.1158/1078-0432.CCR-12-1407; Markou A, 2013, CLIN CHEM; McCormick RI, 2013, BRIT J CANCER, V108, P1133, DOI 10.1038/bjc.2013.56; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Mohankumar KM, 2007, ONCOGENE, V26, P3998, DOI 10.1038/sj.onc.1210180; Mortensen UH, 2009, CURR BIOL, V19, pR676, DOI 10.1016/j.cub.2009.06.001; Nakada C, 2011, J PATHOL, V224, P280, DOI 10.1002/path.2860; Neal CS, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-64; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Qiu SW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-10; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Sand M, 2009, J DERMATOL SCI, V53, P169, DOI 10.1016/j.jdermsci.2008.10.004; Scarpati GD, 2012, INT J RADIAT ONCOL, V83, P1113, DOI 10.1016/j.ijrobp.2011.09.030; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Toyama T, 2012, JPN J CLIN ONCOL, V42, P256, DOI 10.1093/jjco/hys001; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang F, 2013, STEM CELL RES, V11, P657, DOI 10.1016/j.scr.2013.04.005; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wotschofsky Z, 2013, CLIN CHIM ACTA, V416, P5, DOI 10.1016/j.cca.2012.11.010; Yang M, 2013, ONCOL REP, V29, P169, DOI 10.3892/or.2012.2105; Zang W, 2013, TUMOUR BIOL; Zaravinos A, 2012, J UROLOGY, V188, P615, DOI 10.1016/j.juro.2012.03.122; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387; Zhao A, 2013, EXP MOL PATHOL, V94, P115, DOI 10.1016/j.yexmp.2012.10.005	68	50	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89223	10.1371/journal.pone.0089223	http://dx.doi.org/10.1371/journal.pone.0089223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586608	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700076
J	Bao, Y; Tian, D; Zheng, YY; Xi, HL; Liu, D; Yu, M; Xu, XY				Bao, Yi; Tian, Di; Zheng, Ying-Ying; Xi, Hong-Li; Liu, Dan; Yu, Min; Xu, Xiao-Yuan			Characteristics of HIV-1 Natural Drug Resistance-Associated Mutations in Former Paid Blood Donors in Henan Province, China	PLOS ONE			English	Article							TREATMENT-NAIVE INDIVIDUALS; ANTIRETROVIRAL THERAPY; CROSS-RESISTANCE; INFECTED INDIVIDUALS; ENTRY INHIBITORS; PREVALENCE; SUBTYPE; VIRUS; TRANSMISSION; REGIMENS	Background: Natural drug resistance is a major cause of antiviral treatment failure. The characteristics of HIV-1 natural drug resistance-associated mutations in former paid blood donors in Henan Province remain unclear. Methods: One hundred and fifty HIV-1-positive plasma samples were collected. Plasma viral RNA was extracted for pol gene amplification and sequencing. The sequencing results were submitted to the HIV-1 drug resistance database for drug-resistance analysis. Results: The rates of natural drug resistance and resistance-associated mutations were 17.7% (19/107) and 40.2% (43/107), respectively. The rates of PI major, PI minor, NRTI, and NNRTI mutations were: 0, 30.8% (33/107), 10.3% (11/107), and 18.7% (20/107), respectively. Nine cases (8.4%) had both NRTI and NNRTI resistance-associated mutations. Seven cases (6.5%) had PI minor, NRTI and NNRTI resistance-associated mutations. NNRTI resistance was the most serious, followed by NRTI resistance and PI resistance. Polymorphism mutation sites with mutation rates in the protease region higher than 60.0% were: L63A/P/S/T 89.7%, V77I 82.2%, I72E/M/K/T/V 80.4%, I93L 75.7%, and E35D 72.9%. Polymorphism mutation sites with mutation rates in the RT region higher than 60.0% were: I135A/L/M/R/T/V 93.5%, T200A/E/I/P/V 89.7%, Q278E/K/N/T 88.8%, S162C/Y 82.2%, and K277R/S 66.4%. The distribution of 107 gene sequences was scattered, with some drug-resistant strains grouped in the same cluster. Conclusion: The natural drug resistance mutation rate of HIV-1 in former paid blood donors in Henan Province was 17.7%, with NNRTI resistance the most serious. The distribution of drug-resistant strains was scattered, with some correlations found in certain resistance loci.	[Bao, Yi; Tian, Di; Zheng, Ying-Ying; Xi, Hong-Li; Liu, Dan; Yu, Min; Xu, Xiao-Yuan] Peking Univ, Hosp 1, Dept Infect Dis, Beijing 100871, Peoples R China	Peking University	Xu, XY (corresponding author), Peking Univ, Hosp 1, Dept Infect Dis, Beijing 100871, Peoples R China.	yangpin@public3.bta.net.cn			National Natural Science Foundation of China [30771906]; 11th Five-Year Plan of the National Major Project for Infectious Diseases Control [2008ZX10002-013]; Ph.D. Programs Foundation of Ministry of Education of China [20090001110081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 11th Five-Year Plan of the National Major Project for Infectious Diseases Control; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This study was supported by National Natural Science Foundation of China (No. 30771906), the 11th Five-Year Plan of the National Major Project for Infectious Diseases Control (No. 2008ZX10002-013) and the Ph.D. Programs Foundation of Ministry of Education of China (No. 20090001110081). Funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Anta L, 2013, AIDS, V27, P81, DOI 10.1097/QAD.0b013e3283584500; Antinori A, 2013, CLIN INFECT DIS, V56, P1004, DOI 10.1093/cid/cis975; Asahchop EL, 2011, ANTIMICROB AGENTS CH, V55, P600, DOI 10.1128/AAC.01192-10; Bennet DE, 2003, ANTIVIR THER, V8, pU116; Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989; Chaix M, 2003, ANTIVIR THER, V8, pS137; Chilton DN, 2010, ANTIVIR THER, V15, P985, DOI 10.3851/IMP1658; Crum-Cianflone N, 2009, AIDS, V23, P41, DOI 10.1097/QAD.0b013e328317cc2d; Descamps D, 2010, J ANTIMICROB CHEMOTH, V65, P2620, DOI 10.1093/jac/dkq380; Dolling DI, 2013, CLIN INFECT DIS, V56, P162, DOI 10.1093/cid/cis884; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Eberle J, 2012, INTERVIROLOGY, V55, P79, DOI 10.1159/000331993; Engelman A, 2012, NAT REV MICROBIOL, V10, P279, DOI 10.1038/nrmicro2747; Garrido C, 2012, ANTIMICROB AGENTS CH, V56, P2873, DOI 10.1128/AAC.06170-11; Gibson RM, 2012, CURR HIV RES, V10, P19, DOI 10.2174/157016212799304616; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Hamers RL, 2012, LANCET INFECT DIS, V12, P307, DOI 10.1016/S1473-3099(11)70255-9; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson VA, 2013, TOP ANTIVIR MED, V21, P4; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, GLOB REP GLOB AIDS E, P1; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Li JY, 2005, CELL RES, V15, P843, DOI 10.1038/sj.cr.7290356; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Ma LY, 2010, AIDS RES HUM RETROV, V26, P1007, DOI 10.1089/aid.2009.0252; McMahon DK, 2013, CLIN INFECT DIS, V56, P1044, DOI 10.1093/cid/cis1219; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Mulder M, 2013, HIV 1 DRUG RESISTANC; Novak RM, 2005, CLIN INFECT DIS, V40, P468, DOI 10.1086/427212; Pennings PS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002527; Perales C, 2012, TRENDS MICROBIOL, V20, P595, DOI 10.1016/j.tim.2012.08.010; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Race E, 1999, AIDS, V13, P2061, DOI 10.1097/00002030-199910220-00008; Sepkowitz KA, 2002, CLIN INFECT DIS, V34, P1098, DOI 10.1086/339548; Shah PS, 2012, MOL THER, V20, P840, DOI 10.1038/mt.2012.3; Su R, 2003, AIDS, V17, P2515, DOI 10.1097/00002030-200311210-00015; Tian D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050343; von Wyl V, 2012, CLIN INFECT DIS, V54, P131, DOI 10.1093/cid/cir728; Wang X, 2012, AIDS RES HUM RETROV, V28, P1637, DOI [10.1089/aid.2012.0164, 10.1089/AID.2012.0164]; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062408; Ye JR, 2012, AIDS RES HUM RETROV, V28, P418, DOI 10.1089/aid.2011.0097; Yu F, 2013, VIRUSES-BASEL, V5, P127, DOI 10.3390/v5010127; Zeng PB, 2012, TRANSFUSION, V52, P1041, DOI 10.1111/j.1537-2995.2011.03415.x	44	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89291	10.1371/journal.pone.0089291	http://dx.doi.org/10.1371/journal.pone.0089291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586665	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900122
J	Feigl, B; Morris, CP; Voisey, J; Kwan, A; Zele, AJ				Feigl, Beatrix; Morris, C. Phillip; Voisey, Joanne; Kwan, Anthony; Zele, Andrew J.			The Relationship between BCMO1 Gene Variants and Macular Pigment Optical Density in Persons with and without Age-Related Macular Degeneration	PLOS ONE			English	Article							HETEROCHROMATIC FLICKER PHOTOMETRY; LUTEIN SUPPLEMENTATION; BETA-CAROTENE; BINDING PROTEIN; VISUAL-ACUITY; ZEAXANTHIN; SERUM; EYE; ASSOCIATION; MACULOPATHY	Background: Recent evidence indicates that gene variants related to carotenoid metabolism play a role in the uptake of macular pigments lutein (L) and zeaxanthin (Z). Moreover, these pigments are proposed to reduce the risk for advanced age-related macular degeneration (AMD). This study provides the initial examination of the relationship between the gene variants related to carotenoid metabolism, macular pigment optical density (MPOD) and their combined expression in healthy humans and patients with AMD. Participants and Methods: Forty-four participants were enrolled from a general population and a private practice including 20 healthy participants and 24 patients with advanced (neovascular) AMD. Participants were genotyped for the three single nucleotide polymorphisms (SNPs) upstream from BCMO1, rs11645428, rs6420424 and rs6564851 that have been shown to either up or down regulate beta-carotene conversion efficiency in the plasma. MPOD was determined by heterochromatic flicker photometry. Results: Healthy participants with the rs11645428 GG genotype, rs6420424 AA genotype and rs6564851 GG genotype all had on average significantly lower MPOD compared to those with the other genotypes (p, 0.01 for all three comparisons). When combining BCMO1 genotypes reported to have "high" (rs11645428 AA/rs6420424 GG/rs6564851 TT) and "low" (rs11645428 GG/rs6420424 AA/rs6564851 GG) beta-carotene conversion efficiency, we demonstrate clear differences in MPOD values (p < 0.01). In patients with AMD there were no significant differences in MPOD for any of the three BCMO1 gene variants. Conclusion: In healthy participants MPOD levels can be related to high and low beta-carotene conversion BCMO1 genotypes. Such relationships were not found in patients with advanced neovascular AMD, indicative of additional processes influencing carotenoid uptake, possibly related to other AMD susceptibility genes. Our findings indicate that specific BCMO1 SNPs should be determined when assessing the effects of carotenoid supplementation on macular pigment and that their expression may be influenced by retinal disease.	[Feigl, Beatrix; Morris, C. Phillip; Voisey, Joanne; Zele, Andrew J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Feigl, Beatrix; Morris, C. Phillip; Voisey, Joanne] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4001, Australia; [Zele, Andrew J.] Queensland Univ Technol, Sch Optometry & Vis Sci, Brisbane, Qld 4001, Australia; [Feigl, Beatrix; Kwan, Anthony] Queensland Eye Inst, Brisbane, Qld, Australia; [Kwan, Anthony] Univ Queensland, Fac Hlth Sci, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland Eye Institute; University of Queensland	Feigl, B (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	b.feigl@qut.edu.au		Morris, Phillip/0000-0001-8976-619X; Zele, Andrew/0000-0003-0291-9929; Voisey, Joanne/0000-0001-6645-6164; Feigl, Beatrix/0000-0001-7198-7373	QUT ECARD grant	QUT ECARD grant	The project was funded by a QUT ECARD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Berendschot TT, 2005, EXP EYE RES, V81, P602, DOI 10.1016/j.exer.2005.03.019; Bernstein PS, 2002, OPHTHALMOLOGY, V109, P1780, DOI 10.1016/S0161-6420(02)01173-9; Bhosale P, 2004, J BIOL CHEM, V279, P49447, DOI 10.1074/jbc.M405334200; Borel P, 2012, MOL NUTR FOOD RES, V56, P228, DOI 10.1002/mnfr.201100322; Carroll YL, 1999, EUR J CLIN NUTR, V53, P644, DOI 10.1038/sj.ejcn.1600827; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Connolly EE, 2010, CURR EYE RES, V35, P335, DOI 10.3109/02713680903521951; Dawczynski J, 2013, GRAEF ARCH CLIN EXP, V251, P2711, DOI 10.1007/s00417-013-2376-6; Dietzel M, 2011, INVEST OPHTH VIS SCI, V52, P3452, DOI 10.1167/iovs.10-6713; During A, 2002, J LIPID RES, V43, P1086, DOI 10.1194/jlr.M200068-JLR200; Feeney J, 2013, NEUROBIOL AGING, V34, P2449, DOI 10.1016/j.neurobiolaging.2013.05.007; Feigl B, 2012, ARCH OPHTHALMOL-CHIC, V130, P1402, DOI 10.1001/archophthalmol.2012.1940; Feigl B, 2011, INVEST OPHTH VIS SCI, V52, P1145, DOI 10.1167/iovs.10-5967; Hammond BR, 2013, INVEST OPHTH VIS SCI, V54, P476, DOI 10.1167/iovs.12-10411; Hammond BR, 1996, VISION RES, V36, P2001, DOI 10.1016/0042-6989(95)00290-1; Hammond BR, 2000, INVEST OPHTH VIS SCI, V41, P1492; Hammond CJ, 2012, INVEST OPHTH VIS SCI, V53, P4963, DOI 10.1167/iovs.12-9618; Howells O, 2013, INVEST OPHTH VIS SCI, V54, P2211; Kaya S, 2012, ACTA OPHTHALMOL, V90, pe399, DOI 10.1111/j.1755-3768.2012.02423.x; Khachik F, 1997, INVEST OPHTH VIS SCI, V38, P1802; Kijlstra A, 2012, PROG RETIN EYE RES, V31, P303, DOI 10.1016/j.preteyeres.2012.03.002; Koh HH, 2004, EXP EYE RES, V79, P21, DOI 10.1016/j.exer.2004.03.001; KOSTIC D, 1995, AM J CLIN NUTR, V62, P604, DOI 10.1093/ajcn/62.3.604; Kvansakul J, 2006, OPHTHAL PHYSL OPT, V26, P362, DOI 10.1111/j.1475-1313.2006.00387.x; Li BX, 2011, BIOCHEMISTRY-US, V50, P2541, DOI 10.1021/bi101906y; Lietz G, 2012, J NUTR, V142, p161S, DOI 10.3945/jn.111.140756; Liew SHM, 2005, INVEST OPHTH VIS SCI, V46, P4430, DOI 10.1167/iovs.05-0519; Loane E, 2011, EXP EYE RES, V93, P592, DOI 10.1016/j.exer.2011.07.005; Loughman J, 2010, VISION RES, V50, P1249, DOI 10.1016/j.visres.2010.04.009; Ma L, 2012, OPHTHALMOLOGY, V119, P2290, DOI 10.1016/j.ophtha.2012.06.014; Mares JA, 2006, AM J CLIN NUTR, V84, P1107; Meyers KJ, 2013, INVEST OPHTH VIS SCI, DOI [10.1167/iovs.13-13216, DOI 10.1167/I0VS.13-13216.[]; Meyers KJ, 2013, INVEST OPHTH VIS SCI, V54, P2333, DOI [10.1167/iovs.12-10867, 10.1167/iovs.13-13216]; Mitchell P, 2010, BRIT J OPHTHALMOL, V94, P2, DOI 10.1136/bjo.2009.159160; Murray IJ, 2013, INVEST OPHTH VIS SCI, V54, P1781, DOI 10.1167/iovs.12-10715; Nolan JM, 2011, VISION RES, V51, P459, DOI 10.1016/j.visres.2010.12.016; Nolan JM, 2010, OPHTHALMIC RES, V44, P131, DOI 10.1159/000315531; Obana A, 2008, OPHTHALMOLOGY, V115, P147, DOI 10.1016/j.ophtha.2007.02.028; Ott J., 1988, UTILITY PROGRAMS ANA; Quaggin SE, 2012, J CLIN INVEST, V122, P3849, DOI 10.1172/JCI65509; Raman R, 2012, EYE, V26, P950, DOI 10.1038/eye.2012.69; Renzi LM, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-33; Richer Stuart, 2004, Optometry, V75, P216, DOI 10.1016/S1529-1839(04)70049-4; Rodriguez-Carmona M, 2006, OPHTHAL PHYSL OPT, V26, P137, DOI 10.1111/j.1475-1313.2006.00386.x; Rosenthal JM, 2006, INVEST OPHTH VIS SCI, V47, P5227, DOI 10.1167/iovs.05-1513; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Snodderly DM, 2004, INVEST OPHTH VIS SCI, V45, P531, DOI 10.1167/iovs.03-0762; Stringham JM, 2008, EXP EYE RES, V87, P445, DOI 10.1016/j.exer.2008.08.005; Thurnham DI, 2007, NUTR RES REV, V20, P163, DOI 10.1017/S0954422407842235; Trieschmann M, 2007, EXP EYE RES, V84, P718, DOI 10.1016/j.exer.2006.12.010; Vachali PP, 2013, ARCH BIOCHEM BIOPHYS, V539, P181, DOI 10.1016/j.abb.2013.07.008; Weigert G, 2011, INVEST OPHTH VIS SCI, V52, P8174, DOI 10.1167/iovs.11-7522; Wooten BR, 1999, INVEST OPHTH VIS SCI, V40, P2481; Yonova-Doing E, 2013, EXP EYE RES, V115, P172, DOI 10.1016/j.exer.2013.07.020	56	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89069	10.1371/journal.pone.0089069	http://dx.doi.org/10.1371/journal.pone.0089069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586510	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900083
J	Pittet, LF; Emonet, S; Francois, P; Bonetti, EJ; Schrenzel, J; Hug, M; Altwegg, M; Siegrist, CA; Posfay-Barbe, KM				Pittet, Laure F.; Emonet, Stephane; Francois, Patrice; Bonetti, Eve-Julie; Schrenzel, Jacques; Hug, Melanie; Altwegg, Martin; Siegrist, Claire-Anne; Posfay-Barbe, Klara M.			Diagnosis of Whooping Cough in Switzerland: Differentiating Bordetella pertussis from Bordetella holmesii by Polymerase Chain Reaction	PLOS ONE			English	Article							REAL-TIME PCR; SUSPECTED PERTUSSIS; BACTEREMIA; OUTBREAK; TRANSMISSION; INFECTION; SPECIMENS; SYMPTOMS; INFANTS; ASSAY	Bordetella holmesii, an emerging pathogen, can be misidentified as Bordetella pertussis by routine polymerase chain reaction (PCR). In some reports, up to 29% of the patients diagnosed with pertussis have in fact B. holmesii infection and invasive, non-respiratory B. holmesii infections have been reported worldwide. This misdiagnosis undermines the knowledge of pertussis' epidemiology, and may lead to misconceptions on pertussis vaccine's efficacy. Recently, the number of whooping cough cases has increased significantly in several countries. The aim of this retrospective study was to determine whether B. holmesii was contributing to the increase in laboratory-confirmed cases of B. pertussis in Switzerland. A multiplex species-specific quantitative PCR assay was performed on 196 nasopharyngeal samples from Swiss patients with PCR-confirmed Bordetella infection (median age: 6 years-old, minimum 21 days-old, maximum 86 years-old), formerly diagnosed as Bordetella pertussis (IS481+). No B. holmesii (IS481+, IS10012, hIS1001+) was identified. We discuss whether laboratories should implement specific PCR to recognize different Bordetella species. We conclude that in Switzerland B. holmesii seems to be circulating less than in neighboring countries and that specific diagnostic procedures are not necessary routinely. However, as the epidemiological situation may change rapidly, periodic reevaluation is suggested.	[Pittet, Laure F.; Siegrist, Claire-Anne; Posfay-Barbe, Klara M.] Univ Hosp Geneva, Childrens Hosp, Div Gen Paediat, Dept Paediat, Geneva, Switzerland; [Emonet, Stephane; Schrenzel, Jacques] Univ Geneva, Univ Hosp Geneva, Dept Med Specialties, Lab Bacteriol,Dept Genet & Lab Med, Geneva, Switzerland; [Francois, Patrice; Bonetti, Eve-Julie] Univ Geneva, Univ Hosp Geneva, Dept Med Specialties, Genom Res Lab,Dept Genet & Lab Med, Geneva, Switzerland; [Hug, Melanie; Altwegg, Martin] Bioanalytica AG, Luzern, Switzerland; [Siegrist, Claire-Anne] Univ Geneva, Ctr Vaccinol & Neonatal Immunol, Dept Pathol Immunol, Geneva, Switzerland; [Siegrist, Claire-Anne] Univ Geneva, Ctr Vaccinol & Neonatal Immunol, Dept Paediat, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Posfay-Barbe, KM (corresponding author), Univ Hosp Geneva, Childrens Hosp, Div Gen Paediat, Dept Paediat, Geneva, Switzerland.	Klara.PosfayBarbe@hcuge.ch	Pittet, Laure F/AAH-4955-2021; francois, patrice/AAL-5583-2020; Posfay-Barbe, Klara M/E-9131-2013; Schrenzel, Jacques/AAC-5685-2021; Posfay-Barbe, Klara M./AAV-2515-2021; Schrenzel, Jacques/P-8525-2017	Pittet, Laure F/0000-0002-2395-4574; Posfay-Barbe, Klara M/0000-0001-9464-5704; Schrenzel, Jacques/0000-0001-5464-7764; Posfay-Barbe, Klara M./0000-0001-9464-5704; Schrenzel, Jacques/0000-0001-5464-7764; francois, patrice/0000-0002-0540-750X	Genomic Research Laboratory (Division of Infectious Diseases, Geneva University Hospitals); Centre for Vaccinology and Neonatal Immunology (Geneva University Hospitals); Centre for Vaccinology and Neonatal Immunology (Faculty of Medicine of the University of Geneva)	Genomic Research Laboratory (Division of Infectious Diseases, Geneva University Hospitals); Centre for Vaccinology and Neonatal Immunology (Geneva University Hospitals); Centre for Vaccinology and Neonatal Immunology (Faculty of Medicine of the University of Geneva)	Research funds were provided by the Genomic Research Laboratory (Division of Infectious Diseases, Geneva University Hospitals) and from the Centre for Vaccinology and Neonatal Immunology (Geneva University Hospitals and Faculty of Medicine of the University of Geneva). The funders were involved in the study design, and data collection, but did not interfere with the analysis and the decision to publish.	Antila M, 2006, J MED MICROBIOL, V55, P1043, DOI 10.1099/jmm.0.46331-0; Bottero D, 2013, EPIDEMIOL INFECT, V141, P714, DOI 10.1017/S095026881200132X; Clare S, 2010, BMJ CASE REP; Cox HC, 2013, PATHOLOGY, V45, P202, DOI 10.1097/PAT.0b013e32835cc2d7; Dalby T, 2013, EUR J CLIN MICROBIOL, V32, P1285, DOI 10.1007/s10096-013-1874-0; Guthrie JL, 2010, J CLIN MICROBIOL, V48, P1435, DOI 10.1128/JCM.02417-09; Jonckheere S, 2012, J MED MICROBIOL, V61, P874, DOI 10.1099/jmm.0.038695-0; Kamiya H, 2012, EMERG INFECT DIS, V18, P1166, DOI 10.3201/eid1807.120130; Kanji J, 2011, CAN J INFECT DIS MED, V22, p22A; Knorr L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-62; Lavine J, 2010, VACCINE, V29, P11, DOI 10.1016/j.vaccine.2010.10.029; Loeffelholz M, 2012, J CLIN MICROBIOL, V50, P2186, DOI 10.1128/JCM.00612-12; Miranda C, 2013, REV CHIL INFECTOL, V30, P237, DOI 10.4067/S0716-10182013000300001; Morris JT, 1998, CLIN INFECT DIS, V27, P912, DOI 10.1086/517173; Nei T, 2012, J CLIN MICROBIOL, V50, P1815, DOI 10.1128/JCM.06772-11; Njamkepo E, 2011, J CLIN MICROBIOL, V49, P4347, DOI 10.1128/JCM.01272-11; Office Federal de la Sante Publique, 2013, B OFSP, V9, P118; Pittet LF, 2013, SWISS MED WKLY, V143, p50S; Rodgers L, 2013, CLIN INFECT DIS, V56, P322, DOI 10.1093/cid/cis888; Russell FM, 2001, CLIN INFECT DIS, V33, P129, DOI 10.1086/320892; Shepard CW, 2004, CLIN INFECT DIS, V38, P799, DOI 10.1086/381888; Tartof SY, 2014, CLIN INFECT DIS, V58, pE39, DOI 10.1093/cid/cit669; Tatti KM, 2011, J CLIN MICROBIOL, V49, P4059, DOI 10.1128/JCM.00601-11; Tizolova A, 2013, EUR J CLIN MICROBIOL, V32, P89, DOI 10.1007/s10096-012-1718-3; Weber DJ, 2010, INFECT CONT HOSP EP, V31, P306, DOI 10.1086/650760; Wei Q, 2010, J MOL DIAGN, V12, P883; Yih WK, 1999, EMERG INFECT DIS, V5, P441, DOI 10.3201/eid0503.990317; Zhang XQ, 2012, EMERG INFECT DIS, V18, P1771, DOI 10.3201/eid1811.111544; Zouari A, 2012, DIAGN MICR INFEC DIS, V72, P303, DOI 10.1016/j.diagmicrobio.2012.01.002	29	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88936	10.1371/journal.pone.0088936	http://dx.doi.org/10.1371/journal.pone.0088936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586447	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900063
J	Volkmann, L; Martyn, I; Moulton, V; Spillner, A; Mooers, AO				Volkmann, Logan; Martyn, Iain; Moulton, Vincent; Spillner, Andreas; Mooers, Arne O.			Prioritizing Populations for Conservation Using Phylogenetic Networks	PLOS ONE			English	Article							MOUNTAIN PYGMY-POSSUM; GENETIC-STRUCTURE; BURRAMYS-PARVUS; SHAPLEY VALUE; DIVERSITY; BIODIVERSITY; EXTINCTION; PROBABILITIES; SYSTEMATICS; SCENARIOS	In the face of inevitable future losses to biodiversity, ranking species by conservation priority seems more than prudent. Setting conservation priorities within species (i.e., at the population level) may be critical as species ranges become fragmented and connectivity declines. However, existing approaches to prioritization (e. g., scoring organisms by their expected genetic contribution) are based on phylogenetic trees, which may be poor representations of differentiation below the species level. In this paper we extend evolutionary isolation indices used in conservation planning from phylogenetic trees to phylogenetic networks. Such networks better represent population differentiation, and our extension allows populations to be ranked in order of their expected contribution to the set. We illustrate the approach using data from two imperiled species: the spotted owl Strix occidentalis in North America and the mountain pygmy-possum Burramys parvus in Australia. Using previously published mitochondrial and microsatellite data, we construct phylogenetic networks and score each population by its relative genetic distinctiveness. In both cases, our phylogenetic networks capture the geographic structure of each species: geographically peripheral populations harbor less-redundant genetic information, increasing their conservation rankings. We note that our approach can be used with all conservation-relevant distances (e. g., those based on whole-genome, ecological, or adaptive variation) and suggest it be added to the assortment of tools available to wildlife managers for allocating effort among threatened populations.	[Volkmann, Logan; Mooers, Arne O.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Martyn, Iain; Mooers, Arne O.] Simon Fraser Univ, Interdisciplinary Res Math & Computat Sci IRMACS, Burnaby, BC V5A 1S6, Canada; [Moulton, Vincent] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England; [Spillner, Andreas] Ernst Moritz Arndt Univ Greifswald, Dept Math & Comp Sci, Greifswald, Germany	Simon Fraser University; Simon Fraser University; University of East Anglia; Ernst Moritz Arndt Universitat Greifswald	Mooers, AO (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	amooers@sfu.ca		Moulton, Vincent/0000-0001-9371-6435	Natural Sciences and Engineering Research Council of Canada; Simon Fraser University; Yale University (YIBS fellowship)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Simon Fraser University; Yale University (YIBS fellowship)	Funded by the Natural Sciences and Engineering Research Council of Canada (Discovery grant to AOM), http://www.nserc-crsng.gc.ca/, Simon Fraser University (fellowship to LAV and IM), and Yale University (YIBS fellowship, AOM). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barrowclough GF, 2006, AUK, V123, P1090, DOI 10.1642/0004-8038(2006)123[1090:GSOMSO]2.0.CO;2; Barrowclough GF, 2005, MOL ECOL, V14, P1109, DOI 10.1111/j.1365-294X.2005.02465.x; Barrowclough GF, 1999, EVOLUTION, V53, P919, DOI 10.1111/j.1558-5646.1999.tb05385.x; Bonin A, 2007, CONSERV BIOL, V21, P697, DOI 10.1111/j.1523-1739.2007.00685.x; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Bowen BW, 2005, CONSERV BIOL, V19, P1037, DOI 10.1111/j.1523-1739.2005.00100.x; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Buneman P., 1971, MATH ARCHAEOLOGICAL, P387; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Dickerman RW, 1997, TIMBER MANAGEMENT WO, P45; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; Faith DP, 2004, CONSERV BIOL, V18, P255, DOI 10.1111/j.1523-1739.2004.00330.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FAITH DP, 1994, PHILOS T R SOC B, V345, P45, DOI 10.1098/rstb.1994.0085; Faith DP, 1996, CONSERV BIOL, V10, P1286, DOI 10.1046/j.1523-1739.1996.10041286.x; Faith DP, 1996, BIORAP, V3, P63; Fay JJ, 1983, US FED REG, V48, P43098; FERGUSON A, 1989, FRESHWATER BIOL, V21, P35, DOI 10.1111/j.1365-2427.1989.tb01346.x; Firestone KB, 1999, MOL ECOL, V8, P1613, DOI 10.1046/j.1365-294x.1999.00745.x; Fitch WM, 1997, J MOL EVOL, V44, pS65, DOI 10.1007/PL00000059; Fontaine PM, 1997, CAN J FISH AQUAT SCI, V54, P2434, DOI 10.1139/cjfas-54-10-2434; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Geffen E, 2007, MOL ECOL, V16, P4241, DOI 10.1111/j.1365-294X.2007.03507.x; Gorbics CS, 2001, MAR MAMMAL SCI, V17, P632, DOI 10.1111/j.1748-7692.2001.tb01009.x; Gould G.I. Jr, 1985, U S Forest Service General Technical Report PNW, P21; Gutierrez RJ, 1995, BIRDS N AM ONLINE; Haake CJ, 2008, J MATH BIOL, V56, P479, DOI 10.1007/s00285-007-0126-2; Haig SM, 2001, CONSERV GENET, V2, P25, DOI 10.1023/A:1011561101460; Hartmann K, 2013, J MATH BIOL, V67, P1163, DOI 10.1007/s00285-012-0585-y; Heinze Dean, 2004, P254; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Jensen EL, 2014, CONSERV GENET, V15, P261, DOI 10.1007/s10592-013-0535-2; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lande R., 1987, P87, DOI 10.1017/CBO9780511623400.007; MANSERGH IM, 1994, MOUNTAIN PYGMY POSSU; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; Martyn I, 2012, ALGORITHM MOL BIOL, V7, DOI 10.1186/1748-7188-7-6; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; Menkhorst P., 2008, IUCN RED LIST THREAT; Minh BQ, 2007, NI07090PLG I NEWT I; Minh BQ, 2009, SYST BIOL, V58, P586, DOI 10.1093/sysbio/syp058; Minh BQ, 2009, IEEE ACM T COMPUT BI, V6, P22, DOI 10.1109/TCBB.2008.54; Mitrovski P, 2008, BIOL LETTERS, V4, P134, DOI 10.1098/rsbl.2007.0454; Mitrovski P, 2007, MOL ECOL, V16, P75, DOI 10.1111/j.1365-294X.2006.03125.x; Mitrovski P, 2005, MOL ECOL NOTES, V5, P395, DOI 10.1111/j.1471-8286.2005.00939.x; Mooers AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003700; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Osborne MJ, 2000, MOL ECOL, V9, P609, DOI 10.1046/j.1365-294x.2000.00908.x; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Poczai P, 2011, PLANT MOL BIOL REP, V29, P906, DOI 10.1007/s11105-011-0302-9; R Core Team, 2020, R LANG ENV STAT COMP; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Redding David W., 2010, Systematist, V32, P4; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Steel M, 2007, EVOL BIOINFORM, V3, P237; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; *US FISH WILDL SER, 2011, REV REC PLAN NO SPOT; US Geological Service, 2013, NAT ATL US AM; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Waples R.S., 1991, MAR FISH REV, V53, P11; Ward RD, 1995, J FISH BIOL, V47, P259, DOI 10.1111/j.1095-8649.1995.tb06060.x; WEITZMAN ML, 1992, Q J ECON, V107, P363, DOI 10.2307/2118476; Weitzman ML, 1998, ECONOMETRICA, V66, P1279, DOI 10.2307/2999617; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N	73	33	35	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e88945	10.1371/journal.pone.0088945	http://dx.doi.org/10.1371/journal.pone.0088945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586451	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000332396200030
J	Sureda, X; Martinez-Sanchez, JM; Fu, M; Perez-Ortuno, R; Martinez, C; Carabasa, E; Lopez, MJ; Salto, E; Pascual, JA; Fernandez, E				Sureda, Xisca; Martinez-Sanchez, Jose M.; Fu, Marcela; Perez-Ortuno, Raul; Martinez, Cristina; Carabasa, Esther; Lopez, Maria J.; Salto, Esteve; Pascual, Jose A.; Fernandez, Esteve p			Impact of the Spanish Smoke-Free Legislation on Adult, Non-Smoker Exposure to Secondhand Smoke: Cross-Sectional Surveys before (2004) and after (2012) Legislation	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; CHILD EXPOSURE; 2ND-HAND SMOKE; IMPLEMENTATION; SPAIN; LAW; SCOTLAND; HEALTH	Background: In 2006, Spain implemented a national smoke-free legislation that prohibited smoking in enclosed public places and workplaces (except in hospitality venues). In 2011, it was extended to all hospitality venues and selected outdoor areas (hospital campuses, educational centers, and playgrounds). The objective of the study is to evaluate changes in exposure to secondhand smoke among the adult non-smoking population before the first law (2004-05) and after the second law (2011-12). Methods: Repeated cross-sectional survey (2004-2005 and 2011-2012) of a representative sample of the adult (>= 16 years) non-smoking population in Barcelona, Spain. We assess self-reported exposure to secondhand smoke (at home, the workplace, during leisure time, and in public/private transportation vehicles) and salivary cotinine concentration. Results: Overall, the self-reported exposure to secondhand smoke fell from 75.7% (95% CI: 72.6 to 78.8) in 2004-05 to 56.7% (95% CI: 53.4 to 60.0) in 2011-12. Self-reported exposure decreased from 32.5% to 27.6% (-15.1%, p<0.05) in the home, from 42.9% to 37.5% (-12.6%, p = 0.11) at work/education venues, from 61.3% to 38.9% (-36.5%, p<0.001) during leisure time, and from 12.3% to 3.7% (-69.9%, p<0.001) in public transportation vehicles. Overall, the geometric mean of the salivary cotinine concentration in adult non-smokers fell by 87.2%, from 0.93 ng/mL at baseline to 0.12 ng/mL after legislation (p<0.001). Conclusions: Secondhand smoke exposure among non-smokers, assessed both by self-reported exposure and salivary cotinine concentration, decreased after the implementation of a stepwise, comprehensive smoke-free legislation. There was a high reduction in secondhand smoke exposure during leisure time and no displacement of secondhand smoke exposure at home.	[Sureda, Xisca; Martinez-Sanchez, Jose M.; Fu, Marcela; Martinez, Cristina; Carabasa, Esther; Fernandez, Esteve p] ICO, Canc Control & Prevent Programme, Tobacco Control Unit, Barcelona, Spain; [Sureda, Xisca; Martinez-Sanchez, Jose M.; Fu, Marcela; Martinez, Cristina; Carabasa, Esther; Fernandez, Esteve p] Inst Invest Biomed Bellvitge IDIBELL, Canc Control & Prevent Grp, Barcelona, Spain; [Sureda, Xisca; Fu, Marcela; Fernandez, Esteve p] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Martinez-Sanchez, Jose M.] Univ Int Catalunya, Sch Med & Hlth Sci, Dept Basic Sci, Biostat Unit, Satn Cugat Del Valles, Spain; [Perez-Ortuno, Raul; Pascual, Jose A.] IMIM, Hosp Mar Res Inst, Parc Recerca Biomed Barcelona, Bioanalysis Res Grp,Neuropsychopharmacol Programm, Barcelona, Spain; [Martinez, Cristina; Carabasa, Esther; Fernandez, Esteve p] Inst Catala Oncol, Catalan Network Smoke Free Hosp, Barcelona, Spain; [Martinez, Cristina] Univ Int Catalunya, Sch Med & Hlth Sci, Dept Nursing, Sant Cugat Del Valles, Spain; [Lopez, Maria J.] Agencia Salut Publ Barcelona, Evaluat & Intervent Methods Serv, Barcelona, Spain; [Lopez, Maria J.] Agencia Salut Publ Barcelona, CIBERESP, Biomed Res Ctr Network Epidemiol & Publ Hlth, Barcelona, Spain; [Lopez, Maria J.] Inst Invest Biomed IBB, Barcelona, Spain; [Salto, Esteve] Publ Hlth Agcy, Minist Hlth, Barcelona, Spain; [Salto, Esteve] Univ Barcelona, Sch Med, Dept Publ Hlth, Barcelona, Spain; [Pascual, Jose A.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Universitat Internacional de Catalunya (UIC); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Catalan Institute of Oncology; Universitat Internacional de Catalunya (UIC); Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Agency of Barcelona; Public Health Agency of Barcelona; University of Barcelona; Pompeu Fabra University	Fernandez, E (corresponding author), ICO, Canc Control & Prevent Programme, Tobacco Control Unit, Barcelona, Spain.	efernandez@iconcologia.net	Pérez-Ortuño, Raúl/AAB-6105-2019; Pascual, José Antonio/F-3884-2015; Lopez, Maria/HHC-3659-2022; Martínez-Sánchez, Jose/AAA-6343-2019; Martínez, Cristina/H-6103-2017; Martínez-Sánchez, Jose M/ABH-3093-2020; Fernandez, Esteve/A-9750-2008; Martinez, Cristina/AAG-4172-2020	Pérez-Ortuño, Raúl/0000-0002-1837-5447; Pascual, José Antonio/0000-0003-0837-4026; Martínez, Cristina/0000-0002-0108-3288; Martínez-Sánchez, Jose M/0000-0002-9632-5701; Fernandez, Esteve/0000-0003-4239-723X; Martinez, Cristina/0000-0002-0108-3288; Salto, Esteve/0000-0002-6739-8936; Sureda Llull, Francisca/0000-0002-6262-2257; Lopez Medina, Maria Jose/0000-0003-4402-2239; Fu, Marcela/0000-0002-4962-0927	Instituto de Salud Carlos III [PI020261, PI081436, RD06/0020/0089, RD12/0036/0053]; Department of Universities and Research, Government of Catalonia [2009SGR192]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Department of Universities and Research, Government of Catalonia(Generalitat de Catalunya)	This study was partly funded by the Instituto de Salud Carlos III (PI020261, PI081436, RD06/0020/0089, and RD12/0036/0053) and the Department of Universities and Research, Government of Catalonia (grant 2009SGR192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar PC, 2007, BMJ-BRIT MED J, V335, P545, DOI 10.1136/bmj.39311.550197.AE; Avila-Tang E, 2013, TOB CONTROL, V22, P164, DOI 10.1136/tobaccocontrol-2011-050298; Avila-Tang E, 2013, TOB CONTROL, V22, P156, DOI 10.1136/tobaccocontrol-2011-050296; Bauer U., 2007, Morbidity and Mortality Weekly Report, V56, P705; Cheng KW, 2011, AM J PREV MED, V41, P566, DOI 10.1016/j.amepre.2011.08.014; Cheng KW, 2013, TOB CONTROL, DOI [10.1136/tobaccocontrol-2013-051121, DOI 10.1136/T0BACC0C0NTR0L-2013-0]; Cordoba R, 2013, GAC SANIT, V27, P161, DOI 10.1016/j.gaceta.2012.03.007; Fernandez E, 2006, TOB CONTROL, V15, P79; Fernandez E, 2013, MONITORING IMPLEMENT; Fernandez E, 2011, TOB CONTROL, V20; Fernandez E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004244; Fu M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-320; Galan I, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-224; Gruer L, 2012, PUBLIC HEALTH, V126, P227, DOI 10.1016/j.puhe.2011.12.005; Haw SJ, 2007, BRIT MED J, V335, P549, DOI 10.1136/bmj.39315.670208.47; Holliday JC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-430; Jarvis MJ, 2008, ADDICTION, V103, P1553, DOI 10.1111/j.1360-0443.2008.02297.x; Lopez MJ, 2007, TOB CONTROL, V16, P373, DOI 10.1136/tc.2006.019679; Lopez MJ, 2013, NICOTINE TOB RES, V15, P992, DOI 10.1093/ntr/nts218; Lushchenkova O, 2008, REV ESP CARDIOL, V61, P687, DOI 10.1016/S1885-5857(08)60205-4; Martinez-Sanchez JM, 2013, TOB CONTROL, DOI [10.1136/tobaccocon-trol-2012-050877, DOI 10.1136/T0BACC0C0N-TR0L-2012-050877]; Martinez-Sanchez JM, 2009, GAC SANIT, V23, P501, DOI 10.1016/j.gaceta.2009.03.003; Martinez-Sanchez JM, 2009, PREV MED, V48, P218, DOI 10.1016/j.ypmed.2008.12.020; Nebot M, 2009, ENVIRON HEALTH PERSP, V117, P344, DOI 10.1289/ehp.11845; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Perez-Rios M, 2014, GAC SANIT, V28, P20, DOI 10.1016/j.gaceta.2013.04.010; Sims M, 2012, ENVIRON HEALTH PERSP, V120, P425, DOI 10.1289/ehp.1103680; Thun M, 2012, TOB CONTROL, V21, P96, DOI 10.1136/tobaccocontrol-2011-050294; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO	29	42	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89430	10.1371/journal.pone.0089430	http://dx.doi.org/10.1371/journal.pone.0089430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24586774	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800021
J	Furukawa, E; Bado, P; Tripp, G; Mattos, P; Wickens, JR; Bramati, IE; Alsop, B; Ferreira, FM; Lima, D; Tovar-Moll, F; Sergeant, JA; Moll, J				Furukawa, Emi; Bado, Patricia; Tripp, Gail; Mattos, Paulo; Wickens, Jeff R.; Bramati, Ivanei E.; Alsop, Brent; Ferreira, Fernanda Meireles; Lima, Debora; Tovar-Moll, Fernanda; Sergeant, Joseph A.; Moll, Jorge			Abnormal Striatal BOLD Responses to Reward Anticipation and Reward Delivery in ADHD	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; DELAY AVERSION; DOPAMINE INNERVATION; VOXEL VOLUME; SELF-CONTROL; DSM-IV; CHILDREN; SENSITIVITY; INHIBITION	Altered reward processing has been proposed to contribute to the symptoms of attention deficit hyperactivity disorder (ADHD). The neurobiological mechanism underlying this alteration remains unclear. We hypothesize that the transfer of dopamine release from reward to reward-predicting cues, as normally observed in animal studies, may be deficient in ADHD. Functional magnetic resonance imaging (fMRI) was used to investigate striatal responses to reward-predicting cues and reward delivery in a classical conditioning paradigm. Data from 14 high-functioning and stimulant-naive young adults with elevated lifetime symptoms of ADHD (8 males, 6 females) and 15 well-matched controls (8 males, 7 females) were included in the analyses. During reward anticipation, increased blood-oxygen-level-dependent (BOLD) responses in the right ventral and left dorsal striatum were observed in controls, but not in the ADHD group. The opposite pattern was observed in response to reward delivery; the ADHD group demonstrated significantly greater BOLD responses in the ventral striatum bilaterally and the left dorsal striatum relative to controls. In the ADHD group, the number of current hyperactivity/impulsivity symptoms was inversely related to ventral striatal responses during reward anticipation and positively associated with responses to reward. The BOLD response patterns observed in the striatum are consistent with impaired predictive dopamine signaling in ADHD, which may explain altered reward-contingent behaviors and symptoms of ADHD.	[Furukawa, Emi; Tripp, Gail; Wickens, Jeff R.] Okinawa Inst Sci & Technol Grad Univ OIST, Okinawa, Japan; [Bado, Patricia; Mattos, Paulo; Bramati, Ivanei E.; Ferreira, Fernanda Meireles; Lima, Debora; Tovar-Moll, Fernanda; Moll, Jorge] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil; [Bado, Patricia; Mattos, Paulo; Bramati, Ivanei E.; Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Alsop, Brent] Univ Otago, Dunedin, New Zealand; [Sergeant, Joseph A.] Vrije Univ Amsterdam, Amsterdam, Netherlands	Okinawa Institute of Science & Technology Graduate University; IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro; University of Otago; Vrije Universiteit Amsterdam	Furukawa, E (corresponding author), Okinawa Inst Sci & Technol Grad Univ OIST, Okinawa, Japan.	furukawa@oist.jp	Moll, Fernanda Tovar/N-3320-2018; Moll, Fernanda Tovar/AAF-8477-2021; Furukawa, Emi/I-8387-2015; Hassan, Randa/AAW-3624-2021; BADO, PATRICIA/AAF-6217-2021; Wickens, Jeffery R/N-6055-2014; de Mattos, Paulo Eduardo Luiz/D-2328-2014; Moll, Jorge/AAF-8388-2021	Moll, Fernanda Tovar/0000-0002-0292-5985; Moll, Fernanda Tovar/0000-0002-0292-5985; BADO, PATRICIA/0000-0001-8543-2547; Wickens, Jeffery R/0000-0002-8795-1209; de Mattos, Paulo Eduardo Luiz/0000-0003-0709-3783; Moll, Jorge/0000-0002-4297-591X	OIST (Okinawa Institute of Science and Technology Graduate University); IDOR (D'Or Institute for Research and Education)	OIST (Okinawa Institute of Science and Technology Graduate University); IDOR (D'Or Institute for Research and Education)	This study was supported by a joint research agreement between OIST (Okinawa Institute of Science and Technology Graduate University) and IDOR (D'Or Institute for Research and Education). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106; Antrop I, 2006, J CHILD PSYCHOL PSYC, V47, P1152, DOI 10.1111/j.1469-7610.2006.01619.x; Barkley RA, 2002, J CLIN PSYCHIAT, V63, P36; Bellgowan PSF, 2006, NEUROIMAGE, V29, P1244, DOI 10.1016/j.neuroimage.2005.08.042; Bitsakou P, 2009, NEUROPSYCHOLOGIA, V47, P446, DOI 10.1016/j.neuropsychologia.2008.09.015; Bobb AJ, 2005, AM J MED GENET B, V132B, P109; Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039; Bullmore ET, 1999, HUM BRAIN MAPP, V7, P38, DOI 10.1002/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.3.CO;2-H; Carlson CL, 2000, J CONSULT CLIN PSYCH, V68, P73, DOI 10.1037/0022-006X.68.1.73; Carmona S, 2012, HUM BRAIN MAPP, V33, P2350, DOI 10.1002/hbm.21368; Clark JJ, 2013, J NEUROSCI, V33, P3526, DOI 10.1523/JNEUROSCI.5119-12.2013; Crone EA, 2003, J CHILD PSYCHOL PSYC, V44, P214, DOI 10.1111/1469-7610.00115; del Campo N, 2013, BRAIN, V136, P3252, DOI 10.1093/brain/awt263; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; DESCARRIES L, 1987, NEUROSCIENCE, V21, P807, DOI 10.1016/0306-4522(87)90038-8; DOUCET G, 1986, NEUROSCIENCE, V19, P427, DOI 10.1016/0306-4522(86)90272-1; DOUGLAS VI, 1994, J ABNORM CHILD PSYCH, V22, P281, DOI 10.1007/BF02168075; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Epstein JN, 2007, PSYCHIAT RES-NEUROIM, V155, P75, DOI 10.1016/j.pscychresns.2006.12.009; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; FERSTER CB, 1953, PSYCHOL BULL, V50, P263, DOI 10.1037/h0055514; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Galvan A, 2005, J NEUROSCI, V25, P8650, DOI 10.1523/JNEUROSCI.2431-05.2005; GARRUD P, 1981, Q J EXP PSYCHOL-B, V33, P123, DOI 10.1080/14640748108400817; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Grevet EH, 2005, ARQ NEURO-PSIQUIAT, V63, P307, DOI 10.1590/S0004-282X2005000200019; HAENLEIN M, 1987, J AM ACAD CHILD PSY, V26, P356, DOI 10.1097/00004583-198705000-00014; Hoerger ML, 2006, J APPL BEHAV ANAL, V39, P147, DOI 10.1901/jaba.2006.171-04; Hoogman M, 2011, AM J PSYCHIAT, V168, P1099, DOI 10.1176/appi.ajp.2011.10101446; Iaboni F, 1997, PSYCHOPHYSIOLOGY, V34, P116, DOI 10.1111/j.1469-8986.1997.tb02422.x; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; KIMURA M, 1986, Neuroscience Research, V3, P436, DOI 10.1016/0168-0102(86)90035-0; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Kuntsi J, 2001, J CHILD PSYCHOL PSYC, V42, P199, DOI 10.1111/1469-7610.00711; Li JA, 2011, P NATL ACAD SCI USA, V108, P55, DOI 10.1073/pnas.1014938108; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Luman M, 2008, J CHILD PSYCHOL PSYC, V49, P712, DOI 10.1111/j.1469-7610.2008.01910.x; Luman M, 2008, J ABNORM CHILD PSYCH, V36, P445, DOI 10.1007/s10802-007-9190-8; Luman M, 2007, J CHILD PSYCHOL PSYC, V48, P890, DOI 10.1111/j.1469-7610.2007.01769.x; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Marx I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067002; Marx I, 2010, J NEURAL TRANSM, V117, P403, DOI 10.1007/s00702-009-0345-3; Mattos P, 2006, REV PSIQUIATR 150 N, V33, P188, DOI [DOI 10.1590/S0101-60832006000400004, DOI 10.1590/S0101-60832006000]; McInerney RJ, 2003, CHILD NEUROPSYCHOL, V9, P91, DOI 10.1076/chin.9.2.91.14506; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Paloyelis Y, 2012, J AM ACAD CHILD PSY, V51, P722, DOI 10.1016/j.jaac.2012.05.006; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Plichta MM, 2014, NEUROSCI BIOBEHAV R, V38, P125, DOI 10.1016/j.neubiorev.2013.07.012; Plichta MM, 2013, J NEUROSCI, V33, P14526, DOI 10.1523/JNEUROSCI.0631-13.2013; Plichta MM, 2009, BIOL PSYCHIAT, V65, P7, DOI 10.1016/j.biopsych.2008.07.008; Sacchet MD, 2013, NEUROIMAGE, V66, P270, DOI 10.1016/j.neuroimage.2012.10.056; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Scheres A, 2006, NEUROPSYCHOLOGIA, V44, P2092, DOI 10.1016/j.neuropsychologia.2005.10.012; Scheres A, 2010, BIOL PSYCHIAT, V67, P641, DOI 10.1016/j.biopsych.2009.10.033; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 1999, NEWS PHYSIOL SCI, V14, P249; SCHWEITZER JB, 1995, J CHILD PSYCHOL PSYC, V36, P671, DOI 10.1111/j.1469-7610.1995.tb02321.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Slusarek M, 2001, J AM ACAD CHILD PSY, V40, P355, DOI 10.1097/00004583-200103000-00016; Solanto MV, 2001, J ABNORM CHILD PSYCH, V29, P215, DOI 10.1023/A:1010329714819; Sonuga-Barke EJS, 2008, CHILD ADOL PSYCH CL, V17, P367, DOI 10.1016/j.chc.2007.11.008; Sonuga-Barke EJS, 2002, BEHAV BRAIN RES, V130, P29, DOI 10.1016/S0166-4328(01)00432-6; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Stark R, 2011, NEUROPSYCHOLOGIA, V49, P426, DOI 10.1016/j.neuropsychologia.2010.12.012; Stoy M, 2011, PSYCHOPHARMACOLOGY, V215, P467, DOI 10.1007/s00213-011-2166-y; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Swanson JM, 2000, NEUROSCI BIOBEHAV R, V24, P21, DOI 10.1016/S0149-7634(99)00062-7; Swanson JM, 1998, MOL PSYCHIATR, V3, P38, DOI 10.1038/sj.mp.4000354; Tripp G, 1999, J CLIN CHILD PSYCHOL, V28, P366, DOI 10.1207/S15374424jccp280309; Tripp G, 2001, J CHILD PSYCHOL PSYC, V42, P691, DOI 10.1111/1469-7610.00764; Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Wilbertz G, 2012, NEUROIMAGE, V60, P353, DOI 10.1016/j.neuroimage.2011.12.011; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yates DB., 2006, AVALIA O PSICOL GICA, V5, P227, DOI DOI 10.14393/UFU.DI.2001.46; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	93	52	54	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89129	10.1371/journal.pone.0089129	http://dx.doi.org/10.1371/journal.pone.0089129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BC	24586543	gold, Green Submitted, Green Published			2022-12-27	WOS:000332389000027
J	Luo, YP; Li, C; Landis, AG; Wang, GL; Stoeckel, J; Peatman, E				Luo, Yupeng; Li, Chao; Landis, Andrew Gascho; Wang, Guiling; Stoeckel, James; Peatman, Eric			Transcriptomic Profiling of Differential Responses to Drought in Two Freshwater Mussel Species, the Giant Floater Pyganodon grandis and the Pondhorn Uniomerus tetralasmus	PLOS ONE			English	Article							OYSTER CRASSOSTREA-GIGAS; HEAT-SHOCK PROTEINS; ZEBRA MUSSEL; STRESS; EXPRESSION; UBIQUITIN; TOLERANCE; SIGNATURES; COMMUNITY; DEFENSIN	The southeastern US has experienced recurrent drought during recent decades. Increasing demand for water, as precipitation decreases, exacerbates stress on the aquatic biota of the Southeast: a global hotspot for freshwater mussel, crayfish, and fish diversity. Freshwater unionid mussels are ideal candidates to study linkages between ecophysiological and behavioral responses to drought. Previous work on co-occurring mussel species suggests a coupling of physiology and behavior along a gradient ranging from intolerant species such as Pyganodon grandis (giant floater) that track receding waters and rarely burrow in the substrates to tolerant species such as Uniomerus tetralasmus (pondhorn) that rarely track receding waters, but readily burrow into the drying sediments. We utilized a next-generation sequencing-based RNA-Seq approach to examine heat/desiccation-induced transcriptomic profiles of these two species in order to identify linkages between patterns of gene expression, physiology and behavior. Sequencing produced over 425 million 100 bp reads. Using the de novo assembly package Trinity, we assembled the short reads into 321,250 contigs from giant floater (average length 835 bp) and 385,735 contigs from pondhorn (average length 929 bp). BLAST-based annotation and gene expression analysis revealed 2,832 differentially expressed genes in giant floater and 2,758 differentially expressed genes in pondhorn. Trancriptomic responses included changes in molecular chaperones, oxidative stress profiles, cell cycling, energy metabolism, immunity, and cytoskeletal rearrangements. Comparative analyses between species indicated significantly higher induction of molecular chaperones and cytoskeletal elements in the intolerant P. grandis as well as important differences in genes regulating apoptosis and immunity.	[Luo, Yupeng; Li, Chao; Stoeckel, James; Peatman, Eric] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL USA; [Luo, Yupeng; Wang, Guiling] Shanghai Ocean Univ, Key Lab Freshwater Aquat Genet Resources, Minist Agr, Shanghai, Peoples R China; [Landis, Andrew Gascho] Georgia Dept Nat Resources, Wildlife Resources Div, Nongame Conservat Sect, Social Circle, GA USA	Auburn University System; Auburn University; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University	Peatman, E (corresponding author), Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL USA.	peatmer@auburn.edu	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210; Li, Chao/0000-0002-1950-0190				Archambault JM, 2013, MAR FRESHW BEHAV PHY, P1; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Cheng HYM, 2006, SEMIN CELL DEV BIOL, V17, P345, DOI 10.1016/j.semcdb.2006.03.006; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; De Wit P, 2013, MOL ECOL, V22, P2884, DOI 10.1111/mec.12081; Doshi BM, 2010, ANN NY ACAD SCI, V1197, P76, DOI 10.1111/j.1749-6632.2010.05191.x; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Fields PA, 2012, INTEGR COMP BIOL, V52, P636, DOI 10.1093/icb/ics086; Galbraith HS, 2010, BIOL CONSERV, V143, P1175, DOI 10.1016/j.biocon.2010.02.025; Gantayet A, 2013, BIOFOULING, V29, P77, DOI 10.1080/08927014.2012.746672; Gough HM, 2012, FRESHWATER BIOL, V57, P2356, DOI 10.1111/fwb.12015; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Haag WR, 2008, T AM FISH SOC, V137, P1165, DOI 10.1577/T07-100.1; Holland DF, 1991, PROLONGED EMERSION T; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Lang RP, 2009, MAR BIOTECHNOL, V11, P650, DOI 10.1007/s10126-009-9181-6; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lockwood BL, 2010, J EXP BIOL, V213, P3548, DOI 10.1242/jeb.046094; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Meistertzheim AL, 2007, FEBS J, V274, P6392, DOI 10.1111/j.1742-4658.2007.06156.x; Mitta G, 2000, FEBS LETT, V486, P185, DOI 10.1016/S0014-5793(00)02192-X; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Oudshoorn D, 2012, CYTOKINE GROWTH F R, V23, P273, DOI 10.1016/j.cytogfr.2012.08.003; Peatman E, 2013, MOL IMMUNOL, V56, P317, DOI 10.1016/j.molimm.2013.04.014; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Roberts RJ, 2010, J FISH DIS, V33, P789, DOI 10.1111/j.1365-2761.2010.01183.x; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schmukle AC, 2012, J CELL SCI, V125, P549, DOI 10.1242/jcs.091793; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Spicer Judson F. Jr., 2007, Transactions of the Kansas Academy of Science, V110, P30, DOI 10.1660/0022-8443(2007)110[30:TANDIT]2.0.CO;2; Spooner DE, 2008, OECOLOGIA, V158, P307, DOI 10.1007/s00442-008-1132-9; Stempin CC, 2011, J BIOL CHEM, V286, P37147, DOI 10.1074/jbc.M111.263384; Strayer DL, 2004, BIOSCIENCE, V54, P429, DOI 10.1641/0006-3568(2004)054[0429:CPOPMN]2.0.CO;2; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Syed NA, 2006, APOPTOSIS, V11, P2147, DOI 10.1007/s10495-006-0197-3; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Tomanek L, 2012, INTEGR COMP BIOL, V52, P648, DOI 10.1093/icb/ics114; Tomanek L, 2010, J EXP BIOL, V213, P3559, DOI 10.1242/jeb.041228; Varotto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054602; Vaughn CC, 2008, J N AM BENTHOL SOC, V27, P409, DOI 10.1899/07-058.1; Wang RJ, 2012, FRESHW SCI, V31, P695, DOI 10.1899/11-149.1; Xu W, 2010, MOL IMMUNOL, V47, P2138, DOI 10.1016/j.molimm.2010.01.025; Xu W, 2010, MOL GENET GENOMICS, V283, P327, DOI 10.1007/s00438-010-0517-8; Xu W, 2009, GENE, V436, P71, DOI 10.1016/j.gene.2009.01.007; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang LL, 2011, DEV COMP IMMUNOL, V35, P603, DOI 10.1016/j.dci.2011.01.005	54	21	21	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89481	10.1371/journal.pone.0089481	http://dx.doi.org/10.1371/journal.pone.0089481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586812	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900048
J	Hunsaker, MR; Amaral, DG				Hunsaker, Michael R.; Amaral, David G.			A Semi-Automated Pipeline for the Segmentation of Rhesus Macaque Hippocampus: Validation across a Wide Age Range	PLOS ONE			English	Article							MESIAL TEMPORAL SCLEROSIS; DEFORMATION-BASED SEGMENTATION; AUTOMATED SEGMENTATION; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; BRAIN-DEVELOPMENT; MACACA-MULATTA; SHAPE-ANALYSIS; LOBE EPILEPSY; AMYGDALA	This report outlines a neuroimaging pipeline that allows a robust, high-throughput, semi-automated, template-based protocol for segmenting the hippocampus in rhesus macaque (Macaca mulatta) monkeys ranging from 1 week to 260 weeks of age. The semiautomated component of this approach minimizes user effort while concurrently maximizing the benefit of human expertise by requiring as few as 10 landmarks to be placed on images of each hippocampus to guide registration. Any systematic errors in the normalization process are corrected using a machine-learning algorithm that has been trained by comparing manual and automated segmentations to identify systematic errors. These methods result in high spatial overlap and reliability when compared with the results of manual tracing protocols. They also dramatically reduce the time to acquire data, an important consideration in large-scale neuroradiological studies involving hundreds of MRI scans. Importantly, other than the initial generation of the unbiased template, this approach requires only modest neuroanatomical training. It has been validated for high-throughput studies of rhesus macaque hippocampal anatomy across a broad age range.	[Hunsaker, Michael R.; Amaral, David G.] Univ Calif Davis, Davis Med Ctr, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; [Hunsaker, Michael R.; Amaral, David G.] Univ Calif Davis, Davis Med Ctr, UC Davis MIND Inst, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hunsaker, MR (corresponding author), Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA.	ryanhunsaker@icloud.com	Hunsaker, Michael Ryan/H-5975-2019	Hunsaker, Michael Ryan/0000-0001-9210-2458	NIH [R01 NS016980, R37 MH57502]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016980] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The MRI scans used to validate the methods described in this report were collected under NIH Grants R01 NS016980 and R37 MH57502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avants B, 2010, LECT NOTES COMPUT SC, V6361, P324; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Chupin M, 2007, LECT NOTES COMPUT SC, V4791, P875; Ellegood J, 2013, NEUROIMAGE, V70, P288, DOI 10.1016/j.neuroimage.2012.12.029; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Flahault A, 2012, PSYCHIAT RES-NEUROIM, V203, P1, DOI 10.1016/j.pscychresns.2011.09.003; Hogan RE, 2000, RADIOLOGY, V216, P291, DOI 10.1148/radiology.216.1.r00jl41291; Hogan RE, 2000, J DIGIT IMAGING, V13, P39, DOI 10.1053/jdim.2000.6822; Hogan RE, 2000, J DIGIT IMAGING, V13, P217, DOI 10.1007/BF03167670; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Knickmeyer RC, 2010, CEREB CORTEX, V20, P1053, DOI 10.1093/cercor/bhp166; Koolschijn PCMP, 2010, J CLIN PSYCHIAT, V71, P737, DOI 10.4088/JCP.08m04574yel; Malkova L, 2006, EUR J NEUROSCI, V24, P3204, DOI 10.1111/j.1460-9568.2006.05175.x; Maltbie E, 2012, NEUROIMAGE, V59, P1315, DOI 10.1016/j.neuroimage.2011.08.025; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mungas D, 2005, NEUROLOGY, V65, P565, DOI 10.1212/01.wnl.0000172913.88973.0d; Payne C, 2010, HIPPOCAMPUS, V20, P922, DOI 10.1002/hipo.20688; Pluta J, 2009, HIPPOCAMPUS, V19, P565, DOI 10.1002/hipo.20619; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Shamy JLT, 2006, NEUROBIOL AGING, V27, P1405, DOI 10.1016/j.neurobiolaging.2005.07.019; Shen DG, 2002, NEUROIMAGE, V15, P422, DOI 10.1006/nimg.2001.0987; Teipel SJ, 2013, J ALZHEIMERS DIS, V33, pS329, DOI 10.3233/JAD-2012-129030; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wang HZ, 2011, NEUROIMAGE, V55, P968, DOI 10.1016/j.neuroimage.2011.01.006; Xie J, 2009, HIPPOCAMPUS, V19, P526, DOI 10.1002/hipo.20618	27	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89456	10.1371/journal.pone.0089456	http://dx.doi.org/10.1371/journal.pone.0089456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586791	Green Published, Green Submitted, gold			2022-12-27	WOS:000331880700047
J	Zhang, J; Zhang, SG; Wang, YY; Xu, WY; Zhang, JR; Jiang, HB; Huang, FS				Zhang, Jian; Zhang, Shuguang; Wang, Yanyan; Xu, Wenyue; Zhang, Jingru; Jiang, Haobo; Huang, Fusheng			Modulation of Anopheles stephensi Gene Expression by Nitroquine, an Antimalarial Drug against Plasmodium yoelii Infection in the Mosquito	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; COMPLEMENT-LIKE PROTEIN; INNATE IMMUNE-RESPONSE; DROSOPHILA-MELANOGASTER; SERINE-PROTEASE; MANDUCA-SEXTA; SIGNALING PATHWAYS; APIS-MELLIFERA; AEDES-AEGYPTI; GAMBIAE	Background: Antimalarial drugs may impact mosquito's defense against Plasmodium parasites. Our previous study showed nitroquine significantly reduced infection of Anopheles stephensi by Plasmodium yoelii, but the underlying mechanism remains unclear. In order to understand how transmission capacity of An. stephensi was affected by nitroquine, we explored the transcriptome of adult females after different treatments, examined changes in gene expression profiles, and identified transcripts affected by the drug and parasite. Methodology/Principal Findings: We extended massively parallel sequencing and data analysis (including gene discovery, expression profiling, and function prediction) to An. stephensi before and after Plasmodium infection with or without nitroquine treatment. Using numbers of reads assembled into specific contigs to calculate relative abundances (RAs), we categorized the assembled contigs into four groups according to the differences in RA values infection induced, infection suppressed, drug induced, and drug suppressed. We found both nitroquine in the blood meal and Plasmodium infection altered transcription of mosquito genes implicated in diverse processes, including pathogen recognition, signal transduction, prophenoloxidase activation, cytoskeleton assembling, cell adhesion, and oxidative stress. The differential gene expression may have promoted certain defense responses of An. stephensi against the parasite and decreased its infectivity. Conclusions/Significance: Our study indicated that nitroquine may regulate several immune mechanisms at the level of gene transcription in the mosquito against Plasmodium infection. This highlights the need for better understanding of antimalarial drug's impact on parasite survival and transmission. In addition, our data largely enriched the existing sequence information of An. stephensi, an epidemiologically important vector species.	[Zhang, Jian; Wang, Yanyan; Xu, Wenyue; Zhang, Jingru; Huang, Fusheng] Third Mil Med Univ, Dept Pathobiol, Chongqing, Peoples R China; [Zhang, Shuguang; Jiang, Haobo] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA	Army Medical University; Oklahoma State University System; Oklahoma State University - Stillwater	Jiang, HB (corresponding author), Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA.	haobo.jiang@okstate.edu; fushenghster@gmail.com		Jiang, Haobo/0000-0003-1357-1315; Xu, Wenyue/0000-0003-3681-5052	Natural Science Foundation of China [81371844]; Natural Science Foundation of Chongqing [cstc2013jcyjA1360]; Youth Science Foundation of Third Military Medical University [2009XQN01]; National Institutes of Health [GM58643]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI112662] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); Youth Science Foundation of Third Military Medical University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants 81371844 (to JZ) of Natural Science Foundation of China, cstc2013jcyjA1360 (to JZ) of Natural Science Foundation of Chongqing, 2009XQN01 (to JZ) of Youth Science Foundation of Third Military Medical University, and GM58643 (to HJ) of National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002587; Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554; Barillas-Mury C, 2007, TRENDS PARASITOL, V23, P297, DOI 10.1016/j.pt.2007.05.001; Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Billings PC, 2002, J BIOL CHEM, V277, P28003, DOI 10.1074/jbc.M106837200; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Champagne MB, 2000, J MOL BIOL, V300, P759, DOI 10.1006/jmbi.2000.3802; Chatterjee P, 2006, LANCET INFECT DIS, V6, P324, DOI 10.1016/S1473-3099(06)70476-5; Chen XH, 1998, ACTA PHARMACOL SIN, V19, P390; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Chung YSA, 2011, J BIOL CHEM, V286, P26524, DOI 10.1074/jbc.M110.214007; Colpitts TM, 2011, VIROLOGY, V417, P179, DOI 10.1016/j.virol.2011.06.002; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Dash AP, 2007, CURR SCI INDIA, V92, P1571; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Fabian L, 2007, J CELL SCI, V120, P2190, DOI 10.1242/jcs.03465; Gonzalez-Lazaro M, 2009, INSECT BIOCHEM MOLEC, V39, P395, DOI 10.1016/j.ibmb.2009.03.008; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; *GROUP 523 MIL MED, 1979, ACTA ACAD MIDICINAE, V4, P1; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Huang Y, 2013, FISH SHELLFISH IMMUN, V35, P1155, DOI 10.1016/j.fsi.2013.07.025; Jaramillo-Gutierrez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-154; Kanost MR, 2001, ADV EXP MED BIOL, V484, P319; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Machnicka B, 2012, CELL MOL LIFE SCI, V69, P191, DOI 10.1007/s00018-011-0804-5; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Mendes AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000069; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Molina CA, 2008, J BIOL CHEM, V283, P3217; Mwangi S, 2011, INFECT GENET EVOL, V11, P740, DOI 10.1016/j.meegid.2010.10.006; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Oliveira JHM, 2011, INSECT BIOCHEM MOLEC, V41, P349, DOI 10.1016/j.ibmb.2011.02.001; Oshaghi MA, 2006, ACTA TROP, V99, P226, DOI 10.1016/j.actatropica.2006.08.005; Osta MA, 2004, J EXP BIOL, V207, P2551, DOI 10.1242/jeb.01066; Padash-Barmchi M, 2010, J CELL SCI, V123, P4052, DOI 10.1242/jcs.066605; PANG LH, 1988, ACTA PHARMACOL SIN, V9, P349; Papadopoulos AI, 2004, COMP BIOCHEM PHYS C, V139, P93, DOI 10.1016/j.cca.2004.09.010; Paskewitz SM, 2006, INSECT BIOCHEM MOLEC, V36, P701, DOI 10.1016/j.ibmb.2006.06.001; Patil DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-386; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Roper K, 2003, J CELL BIOL, V162, P1305, DOI 10.1083/jcb.200307089; Rottschaefer SM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000600; Sinden RE, 2001, TRENDS PARASITOL, V17, P209, DOI 10.1016/S1471-4922(01)01928-6; THOMPSON PE, 1970, AM J TROP MED HYG, V19, P12, DOI 10.4269/ajtmh.1970.19.12; Toure F, 2012, CIRC RES, V110, P1279, DOI 10.1161/CIRCRESAHA.111.262519; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Weng XH, 2008, J EXP BIOL, V211, P409, DOI 10.1242/jeb.011213; Wu SA, 2009, ARCH INSECT BIOCHEM, V70, P136, DOI 10.1002/arch.20285; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang J, 2008, EXP PARASITOL, V118, P308, DOI 10.1016/j.exppara.2007.08.017; Zhang SG, 2011, INSECT BIOCHEM MOLEC, V41, P733, DOI 10.1016/j.ibmb.2011.05.005; ZHOU SW, 1991, ACTA PHARMACOL SIN, V12, P372	64	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89473	10.1371/journal.pone.0089473	http://dx.doi.org/10.1371/journal.pone.0089473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586804	Green Submitted, Green Published, gold			2022-12-27	WOS:000331880700050
J	Burnside, ES; Lin, YZ; del Rio, AM; Pickhardt, PJ; Wu, YR; Strigel, RM; Elezaby, MA; Kerr, EA; Miglioretti, DL				Burnside, Elizabeth S.; Lin, Yunzhi; del Rio, Alejandro Munoz; Pickhardt, Perry J.; Wu, Yirong; Strigel, Roberta M.; Elezaby, Mai A.; Kerr, Eve A.; Miglioretti, Diana L.			Addressing the Challenge of Assessing Physician-Level Screening Performance: Mammography as an Example	PLOS ONE			English	Article							ADENOMA DETECTION; OUTLIER CLINICS; SURGICAL TRIALS; BREAST; SENSITIVITY; CARE; RADIOLOGISTS; VARIABILITY; QUALITY; PROGRAM	Background: Motivated by the challenges in assessing physician-level cancer screening performance and the negative impact of misclassification, we propose a method (using mammography as an example) that enables confident assertion of adequate or inadequate performance or alternatively recognizes when more data is required. Methods: Using established metrics for mammography screening performance-cancer detection rate (CDR) and recall rate (RR)-and observed benchmarks from the Breast Cancer Surveillance Consortium (BCSC), we calculate the minimum volume required to be 95% confident that a physician is performing at or above benchmark thresholds. We graphically display the minimum observed CDR and RR values required to confidently assert adequate performance over a range of interpretive volumes. We use a prospectively collected database of consecutive mammograms from a clinical screening program outside the BCSC to illustrate how this method classifies individual physician performance as volume accrues. Results: Our analysis reveals that an annual interpretive volume of 2770 screening mammograms, above the United States' (US) mandatory (480) and average (1777) annual volumes but below England's mandatory (5000) annual volume is necessary to confidently assert that a physician performed adequately. In our analyzed US practice, a single year of data uniformly allowed confident assertion of adequate performance in terms of RR but not CDR, which required aggregation of data across more than one year. Conclusion: For individual physician quality assessment in cancer screening programs that target low incidence populations, considering imprecision in observed performance metrics due to small numbers of patients with cancer is important.	[Burnside, Elizabeth S.; del Rio, Alejandro Munoz; Pickhardt, Perry J.; Wu, Yirong; Strigel, Roberta M.; Elezaby, Mai A.] Univ Wisconsin, Dept Radiol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Burnside, Elizabeth S.; Lin, Yunzhi] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA; [del Rio, Alejandro Munoz] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; [Kerr, Eve A.] VA Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Kerr, Eve A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Miglioretti, Diana L.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Group Health Cooperative	Burnside, ES (corresponding author), Univ Wisconsin, Dept Radiol, Sch Med & Publ Hlth, E3-311 Clin Sci Ctr, Madison, WI 53706 USA.	eburnside@uwhealth.org	Burnside, Elizabeth S/M-9414-2014	Burnside, Elizabeth S/0000-0002-6600-435X	National Institute of Health [R01 LM010921, R01 CA165229, P01 CA154292]; NATIONAL CANCER INSTITUTE [P01CA154292, R01CA165229] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010921] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institute of Health (grant number R01 LM010921, R01 CA165229 and P01 CA154292). The funders provided unrestricted funds for research infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Radiology, 2003, BREAST IM REP DAT SY; Austin PC, 2005, MED DECIS MAKING, V25, P11, DOI 10.1177/0272989X04273142; Austin PC, 2001, J EVAL CLIN PRACT, V7, P35, DOI 10.1046/j.1365-2753.2001.00261.x; Balsamo R R, 1995, Physician Exec, V21, P38; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Bassett LW, 1994, AHCPR PUBLICATION; Bennett RL, 2007, J MED SCREEN, V14, P200, DOI 10.1258/096914107782912068; Blanks RG, 2010, CYTOPATHOLOGY, V21, P379, DOI 10.1111/j.1365-2303.2010.00771.x; Blanks R G, 1996, J Med Screen, V3, P79; Blanks RG, 2001, J MED SCREEN, V8, P24, DOI 10.1136/jms.8.1.24; Brown LD, 2002, ANN STAT, V30, P60; CANNER PL, 1981, CONTROL CLIN TRIALS, V2, P231, DOI 10.1016/0197-2456(81)90013-1; CANNER PL, 1981, CONTROL CLIN TRIALS, V2, P241, DOI 10.1016/0197-2456(81)90014-3; Carney PA, 2010, RADIOLOGY, V255, P354, DOI 10.1148/radiol.10091636; Chen SC, 2007, AM J GASTROENTEROL, V102, P856, DOI 10.1111/j.1572-0241.2006.01054.x; Cornford E, 2011, CLIN RADIOL, V66, P103, DOI 10.1016/j.crad.2010.09.014; Elmore JG, 2002, JNCI-J NATL CANCER I, V94, P1373; Elmore JG, 2009, RADIOLOGY, V253, P641, DOI 10.1148/radiol.2533082308; FLETCHER SW, 1993, J NATL CANCER I, V85, P1644, DOI 10.1093/jnci/85.20.1644; Foote M, 1999, WMJ, V98, P17; Gur D, 2008, RADIOLOGY, V249, P47, DOI 10.1148/radiol.2491072025; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Jiang YL, 2007, RADIOLOGY, V243, P360, DOI 10.1148/radiol.2432060253; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; Nass S., 2005, IMPROVING BREAST IMA; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Normand SLT, 2012, CIRC-CARDIOVASC QUAL, V5, pE42, DOI 10.1161/CIRCOUTCOMES.112.968792; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; R Development Core Team, 2012, R LANG ENV STAT COMP; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Rosenthal MB, 2008, NEW ENGL J MED, V359, P1197, DOI 10.1056/NEJMp0804658; Scholle SH, 2008, AM J MANAG CARE, V14, P829; Smith-Bindman R, 2005, JNCI-J NATL CANCER I, V97, P358, DOI 10.1093/jnci/dji060; Smith-Bindman R, 2008, AM J ROENTGENOL, V190, P526, DOI 10.2214/AJR.07.2500; Thurfjell MG, 2000, ACTA RADIOL, V41, P52, DOI 10.1258/rsmacta.41.1.52; Yankaskas BC, 2001, AM J ROENTGENOL, V177, P543, DOI 10.2214/ajr.177.3.1770543	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89418	10.1371/journal.pone.0089418	http://dx.doi.org/10.1371/journal.pone.0089418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586763	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900092
J	Lee, JT; Chung, WT; Lin, JD; Peng, GS; Muo, CH; Lin, CC; Wen, CP; Wang, IK; Tseng, CH; Kao, CH; Hsu, CY				Lee, Jiunn-Tay; Chung, Wen Ting; Lin, Jin-Ding; Peng, Giia-Sheun; Muo, Chih-Hsin; Lin, Che-Chen; Wen, Chi-Pang; Wang, I-Kuan; Tseng, Chun-Hung; Kao, Chia-Hung; Hsu, Chung Y.			Increased Risk of Stroke after Septicaemia: A Population-Based Longitudinal Study in Taiwan	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; CEREBROVASCULAR ISCHEMIA; MYOCARDIAL-INFARCTION; ACUTE INFECTION; SECULAR TRENDS; INFLAMMATION; HEALTH; ATHEROSCLEROSIS; PREVENTION; VALIDATION	Inflammation and infection have been noted to increase stroke risk. However, the association between septicaemia and increased risk of stroke remains unclear. This population-based cohort study, using a National Health Insurance database, aimed to investigate whether patients with septicaemia are predisposed to increased stroke risk. The study included all patients hospitalised for septicaemia for the first time between 2000 and 2003 without prior stroke. Patients were followed until the end of 2010 to evaluate incidence of stroke. An age-, gender-and co-morbidities-matched cohort without prior stroke served as the control. Cox's proportional hazards regressions were used to assess differences in stroke risk between groups. Based on hazard ratios (HRs), patients with septicaemia had greater stroke risk, especially in the younger age groups (age <45: HR = 4.16, 95% CI: 2.39-7.24, p<0.001; age 45-64: HR = 1.76, 95% CI: 1.41-2.19, p<0.001; age >= 65: HR = 1.05, 95% CI: 0.91-1.22, p>0.05). Haemorrhagic stroke was the dominant type (ischaemic stroke: HR = 1.20, 95% CI: 1.06-1.37, p<0.01; haemorrhagic stroke: HR = 1.82, 95% CI: 1.35-2.46, p<0.001) and patients without co-morbidities were at slightly higher risk (without co-morbidities: HR = 1.49, 95% CI: 1.02-2.17, p<0.05; with co-morbidities: HR = 1.24, 95% CI: 1.10-1.41, p<0.001). The impact of septicaemia on stroke risk was highest within 6 months of the event and gradually declined over time. Our results suggest that septicaemia is associated with an increase in stroke risk, which is greatest in haemorrhagic stroke. Closer attention to patients with history of septicaemia may be warranted for stroke preventive measures, especially for younger patients without co-morbidities.	[Lee, Jiunn-Tay; Peng, Giia-Sheun] Natl Def Med Ctr, Dept Neurol, Triserv Gen Hosp, Taipei, Taiwan; [Chung, Wen Ting] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Lin, Jin-Ding] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Dept Publ Hlth, Taichung, Taiwan; [Muo, Chih-Hsin; Lin, Che-Chen] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wen, Chi-Pang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Wang, I-Kuan; Hsu, Chung Y.] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wang, I-Kuan; Tseng, Chun-Hung] China Med Univ, Coll Med, Dept Internal Med, Taichung, Taiwan; [Wang, I-Kuan] China Med Univ Hosp, Div Kidney Dis, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; National Defense Medical Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, JT (corresponding author), Natl Def Med Ctr, Dept Neurol, Triserv Gen Hosp, Taipei, Taiwan.	jiunntay@gmail.com	Peng, Giia-Sheun/AAE-4778-2022	Hsu, Chung Y./0000-0002-5632-2733	Tri-Service General Hospital [TSGH-C98-11-S02, TSGH-C99-010-11-S02, TSGH-C100-006-010-11-S02]; Ministry of Health and Welfare [DOH101-TD-B-111-004]; Academia Sinica Taiwan Biobank - Stroke Biosignature Project [BM102021169]; Tseng-Lien Lin Foundation; Taiwan Brain Disease Foundation; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Tri-Service General Hospital; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Academia Sinica Taiwan Biobank - Stroke Biosignature Project; Tseng-Lien Lin Foundation; Taiwan Brain Disease Foundation; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported in part by the Tri-Service General Hospital grants (TSGH-C98-11-S02; TSGH-C99-010-11-S02; TSGH-C100-006-010-11-S02), Ministry of Health and Welfare grant (DOH101-TD-B-111-004), Academia Sinica Taiwan Biobank - Stroke Biosignature Project (BM102021169), Tseng-Lien Lin Foundation, Taiwan Brain Disease Foundation and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DATABASE NHIR; Bernard AM, 2012, INT J INFLAM, V2012; Bova IY, 1996, STROKE, V27, P2204, DOI 10.1161/01.STR.27.12.2204; Brown RD, 1996, STROKE, V27, P373; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Elkind MSV, 2011, STROKE, V42, P1851, DOI 10.1161/STROKEAHA.110.608588; Elkind MSV, 2010, ARCH NEUROL-CHICAGO, V67, P33, DOI 10.1001/archneurol.2009.271; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Fonarow GC, 2010, CIRCULATION, V121, P879, DOI 10.1161/CIRCULATIONAHA.109.892497; Goldstein L B, 2000, Curr Atheroscler Rep, V2, P110, DOI 10.1007/s11883-000-0104-2; Grau AJ, 1997, NEUROLOGY, V49, pS47, DOI 10.1212/WNL.49.5_Suppl_4.S47; Grau AJ, 1998, NEUROLOGY, V50, P196, DOI 10.1212/WNL.50.1.196; GRAU AJ, 1995, STROKE, V26, P373, DOI 10.1161/01.STR.26.3.373; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Jeng Jiann-Shing, 2007, Acta Neurol Taiwan, V16, P190; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Lindsberg PJ, 2003, STROKE, V34, P2518, DOI 10.1161/01.STR.0000089015.51603.CC; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; Marinigh R, 2010, J AM COLL CARDIOL, V56, P827, DOI 10.1016/j.jacc.2010.05.028; Mattila KJ, 1998, CLIN INFECT DIS, V26, P719, DOI 10.1086/514570; McColl BW, 2009, NEUROSCIENCE, V158, P1049, DOI 10.1016/j.neuroscience.2008.08.019; O'Keefe JH, 2009, MAYO CLIN PROC, V84, P741, DOI 10.1016/S0025-6196(11)60525-9; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Palm F, 2009, CURR VASC PHARMACOL, V7, P146, DOI 10.2174/157016109787455707; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sharshar T, 2004, BRAIN PATHOL, V14, P21, DOI 10.1111/j.1750-3639.2004.tb00494.x; Silva GS, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0350-8; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; SYRJANEN J, 1988, BRIT MED J, V296, P1156, DOI 10.1136/bmj.296.6630.1156; Whisnant JP, 1997, STROKE, V28, P1840, DOI 10.1161/01.STR.28.9.1840; WOLF PA, 1992, STROKE, V23, P1551, DOI 10.1161/01.STR.23.11.1551	34	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89386	10.1371/journal.pone.0089386	http://dx.doi.org/10.1371/journal.pone.0089386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586739	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900088
J	Liu, J; Zhan, W; Kim, CJ; Clayton, K; Zhao, HQ; Lee, E; Cao, JC; Ziegler, B; Gregor, A; Yue, FY; Huibner, S; MacParland, S; Schwartz, J; Song, HH; Benko, E; Gyenes, G; Kovacs, C; Kaul, R; Ostrowski, M				Liu, Jun; Zhan, Wei; Kim, Connie J.; Clayton, Kiera; Zhao, Hanqi; Lee, Erika; Cao, Jin Chao; Ziegler, Blake; Gregor, Alexander; Yue, Feng Yun; Huibner, Sanja; MacParland, Sonya; Schwartz, Jordan; Song, Hai Han; Benko, Erika; Gyenes, Gabor; Kovacs, Colin; Kaul, Rupert; Ostrowski, Mario			IL-10-Producing B Cells Are Induced Early in HIV-1 Infection and Suppress HIV-1-Specific T Cell Responses	PLOS ONE			English	Article							VIRAL PERSISTENCE; IMMUNE-SYSTEM; EXPRESSION; DISEASE; AUTOIMMUNITY; FREQUENCY; MEMORY; SUBSET; TIM-1; IL-10	A rare subset of IL-10-producing B cells, named regulatory B cells (Bregs), suppresses adaptive immune responses and inflammation in mice. In this study, we examined the role of IL-10-producing B cells in HIV-1 infection. Compared to uninfected controls, IL-10-producing B cell frequencies were elevated in both blood and sigmoid colon during the early and chronic phase of untreated HIV-1 infection. Ex vivo IL-10-producing B cell frequency in early HIV-1 infection directly correlated with viral load. IL-10-producing B cells from HIV-1 infected individuals were enriched in CD19(+) TIM-1(+) B cells and were enriched for specificity to trimeric HIV-1 envelope protein. Anti-retroviral therapy was associated with reduced IL-10-producing B cell frequencies. Treatment of B cells from healthy donors with microbial metabolites and Toll-like receptor (TLR) agonists could induce an IL-10-producing phenotype, suggesting that the elevated bacterial translocation characteristic of HIV-1 infection may promote IL-10-producing B cell development. Similar to regulatory B cells found in mice, IL-10-producing B cells from HIV-1-infected individuals suppressed HIV-1-specific T cell responses in vitro, and this suppression is IL-10-dependent. Also, ex vivo IL-10-producing B cell frequency inversely correlated with contemporaneous ex vivo HIV-1-specific T cell responses. Our findings show that IL-10-producing B cells are induced early in HIV-1 infection, can be HIV-1 specific, and are able to inhibit effective anti-HIV-1 T cell responses. HIV-1 may dysregulate B cells toward Bregs as an immune evasion strategy.	[Liu, Jun; Yue, Feng Yun; Huibner, Sanja; MacParland, Sonya; Song, Hai Han; Kaul, Rupert; Ostrowski, Mario] Univ Toronto, Div Clin Sci, Toronto, ON, Canada; [Zhan, Wei; Kim, Connie J.; Clayton, Kiera; Zhao, Hanqi; Lee, Erika; Cao, Jin Chao; Ziegler, Blake; Gregor, Alexander; Schwartz, Jordan; Kaul, Rupert; Ostrowski, Mario] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Benko, Erika; Gyenes, Gabor; Kovacs, Colin] Maple Leaf Clin, Toronto, ON, Canada; [Ostrowski, Mario] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Liu, J (corresponding author), Univ Toronto, Div Clin Sci, Toronto, ON, Canada.	junut.liu@gmail.com; mario.ostrowski@gmail.com		Schwartz, Jordan/0000-0001-9658-5282; MacParland, Sonya/0000-0002-8036-1425; Kaul, Rupert/0000-0002-1586-4093	Canadian Institutes of Health Research (CIHR); Ontario HIV Treatment Network (OHTN)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network (OHTN)	This study was supported by The Ontario HIV Treatment Network (OHTN) and Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Das A, 2012, J IMMUNOL, V189, P3925, DOI 10.4049/jimmunol.1103139; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Ho J, 2006, P NATL ACAD SCI USA, V103, P19436, DOI 10.1073/pnas.0609515103; Inoue S, 2006, CANCER RES, V66, P7741, DOI 10.1158/0008-5472.CAN-05-3766; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; Jones RB, 2009, J VIROL, V83, P8722, DOI 10.1128/JVI.00433-09; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Jude BA, 2003, NAT IMMUNOL, V4, P573, DOI 10.1038/ni926; Kim CJ, 2012, MUCOSAL IMMUNOL; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuchroo VK, 2008, NAT REV IMMUNOL, V8, P577, DOI 10.1038/nri2366; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Liu J, 2013, AIDS RES HUM RETROV, V29, pA160; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Malaspina A, 2005, J INFECT DIS, V191, P1442, DOI 10.1086/429298; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; McKinnon LR, 2012, IMMUNOL CELL BIOL, V90, P346, DOI 10.1038/icb.2011.44; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2008, J INFECT DIS, V197, P572, DOI 10.1086/526789; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Ranasinghe S, 2012, J VIROL, V86, P277, DOI 10.1128/JVI.05577-11; Rigaud M, 2008, J INFECT DIS, V198, P1123, DOI 10.1086/592050; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sayi A, 2011, J IMMUNOL, V186, P878, DOI 10.4049/jimmunol.1002269; SHIRAI A, 1992, J CLIN INVEST, V89, P561, DOI 10.1172/JCI115621; Siewe B, 2013, J LEUKOCYTE BIOL, V93, P811, DOI 10.1189/jlb.0912436; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Wang C, 2012, J EXP MED, V209, P77, DOI 10.1084/jem.20110675; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wong SH, 2010, IMMUNOLOGY, V131, P77, DOI 10.1111/j.1365-2567.2010.03276.x; Xiao S, 2012, P NATL ACAD SCI USA, V109, P12105, DOI 10.1073/pnas.1120914109; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	56	64	68	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89236	10.1371/journal.pone.0089236	http://dx.doi.org/10.1371/journal.pone.0089236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586620	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900067
J	Estevez, N; Eich-Hochli, D; Dey, M; Gmel, G; Studer, J; Mohler-Kuo, M				Estevez, Natalia; Eich-Hoechli, Dominique; Dey, Michelle; Gmel, Gerhard; Studer, Joseph; Mohler-Kuo, Meichun			Prevalence of and Associated Factors for Adult Attention Deficit Hyperactivity Disorder in Young Swiss Men	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; MAJOR DEPRESSION INVENTORY; REPORT SCALE ASRS; DEFICIT/HYPERACTIVITY DISORDER; PSYCHIATRIC-DISORDERS; SELF-REPORT; EXTERNAL VALIDITY; COLLEGE-STUDENTS; ADHD; DSM	Objective: The present study aimed to measure the prevalence of adult attention deficit hyperactivity disorder (ADHD) in a large, representative sample of young Swiss men and to assess factors associated with this disorder. Methods: Our sample consisted of 5656 Swiss men (mean age 20 years) who participated in the Cohort Study on Substance Use Risk Factors (C-SURF). ADHD was assessed with the World Health Organization (WHO) adult ADHD Self Report Screener (ASRS). Logistic regression analyses were conducted to assess the association between ADHD and several socio-demographic, clinical and familial factors. Results: The prevalence of ADHD was 4.0%, being higher in older and French-speaking conscripts. A higher prevalence also was identified among men whose mothers had completed primary or high school/university and those with a family history of alcohol or psychiatric problems. Additionally, adults with ADHD demonstrated impairment in their professional life, as well as considerable mental health impairment. Conclusion: Our results demonstrate that ADHD is common among young Swiss men. The impairments in function and mental health we observed highlight the need for further support and interventions to reduce burden in affected individuals. Interventions that incorporate the whole family also seem crucial.	[Estevez, Natalia; Dey, Michelle; Mohler-Kuo, Meichun] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland; [Estevez, Natalia] Univ Zurich Hosp, Dept Neuroradiol, CH-8091 Zurich, Switzerland; [Eich-Hoechli, Dominique] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Gmel, Gerhard; Studer, Joseph] CHU Vaudois, Univ Lausanne Hosp, Alcohol Treatment Ctr, Lausanne, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Estevez, N (corresponding author), Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland.	natalia.estevez@ifspm.uzh.ch	Gachoud, Céline/K-1104-2018	Dey, Michelle/0000-0002-4300-1877; Mohler-Kuo, Meichun/0000-0002-8595-0923; Gmel, Gerhard/0000-0001-9403-9405; Studer, Joseph/0000-0002-1390-7707	Swiss National Science Foundation [33CS30_139467]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study has been supported by the Swiss National Science Foundation [grant number: 33CS30_139467; website:www.snf.ch]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Babinski DE, 2016, J ATTEN DISORD, V20, P458, DOI 10.1177/1087054712461688; Barkley RA, 2002, J ABNORM PSYCHOL, V111, P279, DOI 10.1037//0021-843X.111.2.279; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Bernardi S, 2012, PSYCHOL MED, V42, P875, DOI 10.1017/S003329171100153X; Biederman Joseph, 2006, MedGenMed, V8, P12; Biederman J, 2012, J CLIN PSYCHIAT, V73, P941, DOI 10.4088/JCP.11m07529; Bitter I, 2010, EUR ARCH PSY CLIN N, V260, P287, DOI 10.1007/s00406-009-0076-3; Brod M, 2012, QUAL LIFE RES, V21, P795, DOI 10.1007/s11136-011-9981-9; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Cuffe Steven P, 2005, J Atten Disord, V9, P392, DOI 10.1177/1087054705280413; Das D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031500; de Zwaan M, 2012, EUR ARCH PSY CLIN N, V262, P79, DOI 10.1007/s00406-011-0211-9; Dey M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1028; DuPaul GJ, 2001, J LEARN DISABIL-US, V34, P370, DOI 10.1177/002221940103400412; Ebejer JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047404; Ezpeleta L, 2014, SOC PSYCH PSYCH EPID, V49, P145, DOI 10.1007/s00127-013-0683-1; Faraone Stephen V, 2005, J Atten Disord, V9, P384, DOI 10.1177/1087054705281478; Faraone SV, 2000, BIOL PSYCHIAT, V48, P9, DOI 10.1016/S0006-3223(00)00889-1; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Gau SSF, 2010, J ABNORM CHILD PSYCH, V38, P521, DOI 10.1007/s10802-009-9381-6; Harpin V. A., 2005, ARCH DIS CHILD, V90, P2, DOI DOI 10.1136/ADC.2004.059006; Heiligenstein E, 1998, J AM COLL HEALTH, V46, P185, DOI 10.1080/07448489809595609; Hesselbrock M, 1999, ADDICTION, V94, P1361, DOI 10.1046/j.1360-0443.1999.94913618.x; Iacus SA, 2007, COMPUT STAT DATA AN, V52, P773, DOI 10.1016/j.csda.2006.12.036; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kessler RC, 2007, INT J METH PSYCH RES, V16, P52, DOI 10.1002/mpr.208; Knight JR, 2002, J STUD ALCOHOL, V63, P263, DOI 10.15288/jsa.2002.63.263; Kooij JJS, 2005, PSYCHOL MED, V35, P817, DOI 10.1017/S003329170400337X; Lecrubier Y., 1998, MINI MINIINTERNATION; MCLELLAN AT, 1985, J NERV MENT DIS, V173, P412, DOI 10.1097/00005053-198507000-00005; Medina-Mora ME, 2005, PSYCHOL MED, V35, P1773, DOI 10.1017/S0033291705005672; Minde K, 2003, J CHILD PSYCHOL PSYC, V44, P637, DOI 10.1111/1469-7610.00150; MONTES LGA, 2007, J ATTEN DISORD, V11, P150; Moss SB, 2007, PRIMARY CARE, V34, P445, DOI 10.1016/j.pop.2007.05.005; Olsen LR, 2003, PSYCHOL MED, V33, P351, DOI 10.1017/S0033291702006724; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Pelham WE, 1999, ALCOHOL RES HEALTH, V23, P292; Rosler M, 2010, WORLD J BIOL PSYCHIA, V11, P684, DOI 10.3109/15622975.2010.483249; Sibley MH, 2012, J CONSULT CLIN PSYCH, V80, P1052, DOI 10.1037/a0029098; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Skounti M, 2007, EUR J PEDIATR, V166, P117, DOI 10.1007/s00431-006-0299-5; Steinhausen HC, 1998, ACTA PSYCHIAT SCAND, V98, P262, DOI 10.1111/j.1600-0447.1998.tb10082.x; Waite R, 2010, J ATTEN DISORD, V13, P424, DOI 10.1177/1087054709332393; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8	46	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89298	10.1371/journal.pone.0089298	http://dx.doi.org/10.1371/journal.pone.0089298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586672	Green Accepted, Green Published, gold			2022-12-27	WOS:000331714700094
J	Horne, AW; Brown, JK; Nio-Kobayashi, J; Abidin, HBZ; Adin, ZEHA; Boswell, L; Burgess, S; Lee, KF; Duncan, WC				Horne, Andrew W.; Brown, Jeremy K.; Nio-Kobayashi, Junko; Abidin, Hazirah B. Z.; Adin, Zety E. H. A.; Boswell, Lyndsey; Burgess, Stewart; Lee, Kai-Fai; Duncan, W. Colin			The Association between Smoking and Ectopic Pregnancy: Why Nicotine Is BAD for Your Fallopian Tube	PLOS ONE			English	Article							SMOOTH-MUSCLE; CANCER CELLS; APOPTOSIS; PHOSPHORYLATION; SUPPRESSION; EXPRESSION; MANAGEMENT; DIAGNOSIS; EXPOSURE; COTININE	Epidemiological studies have shown that cigarette smoking is a major risk factor for tubal ectopic pregnancy but the reason for this remains unclear. Here, we set out to determine the effect of smoking on Fallopian tube gene expression. An oviductal epithelial cell line (OE-E6/ E7) and explants of human Fallopian tubes from non-pregnant women (n = 6) were exposed to physiologically relevant concentrations of cotinine, the principle metabolite of nicotine, and changes in gene expression analyzed using the Illumina Human HT-12 array. Cotinine sensitive genes identified through this process were then localized and quantified in Fallopian tube biopsies from non-pregnant smokers (n = 10) and non-smokers (n = 11) using immunohistochemistry and TaqMan RT-PCR. The principle cotinine induced change in gene expression detected by the array analysis in both explants and the cell line was significant down regulation (P, 0.05) of the pro-apoptotic gene BAD. We therefore assessed the effect of smoking on cell turnover in retrospectively collected human samples. Consistent with the array data, smoking was associated with decreased levels of BAD transcript (P<0.01) and increased levels of BCL2 transcript (P<0.05) in Fallopian tube biopsies. BAD and BCL2 specific immunolabelling was localized to Fallopian tube epithelium. Although no other significant differences in levels of apoptosis or cell cycle associated proteins were observed, smoking was associated with significant changes in the morphology of the Fallopian tube epithelium (P<0.05). These results suggest that smoking may alter tubal epithelial cell turnover and is associated with structural, as well as functional, changes that may contribute to the development of ectopic pregnancy.	[Horne, Andrew W.; Brown, Jeremy K.; Nio-Kobayashi, Junko; Abidin, Hazirah B. Z.; Adin, Zety E. H. A.; Boswell, Lyndsey; Duncan, W. Colin] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Nio-Kobayashi, Junko] Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Sapporo, Hokkaido, Japan; [Burgess, Stewart] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Lee, Kai-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Obstet & Gynaecol, Pokfulam, Hong Kong, Peoples R China	University of Edinburgh; Hokkaido University; Moredun Research Institute; University of Hong Kong	Horne, AW (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	andrew.horne@ed.ac.uk	; Lee, Calvin Kai Fai/C-4328-2009	Horne, Andrew/0000-0002-9656-493X; Lee, Calvin Kai Fai/0000-0001-5957-439X; burgess, stewart/0000-0002-9268-7641; NIO-KOBAYASHI, Junko/0000-0003-3019-2923	Chief Scientist Office [SCD/02]; Cunningham Trust; MRC [G0802808]; MRC [G1002033] Funding Source: UKRI; Medical Research Council [G1002033, G0802808] Funding Source: researchfish	Chief Scientist Office; Cunningham Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Array studies were funded by the Chief Scientist Office (SCD/02) and the laboratory work was supported by The Cunningham Trust and the MRC (G0802808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assis GF, 2005, J MOL HISTOL, V36, P483, DOI 10.1007/s10735-006-9023-z; Campling BG, 2003, MOL BIOTECHNOL, V24, P141, DOI 10.1385/MB:24:2:141; Chattopadhyay A, 2001, ONCOGENE, V20, P4507, DOI 10.1038/sj.onc.1204584; Dickinson RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027792; Duncan WC, 2010, MOL HUM REPROD, V16, P950, DOI 10.1093/molehr/gaq055; Duncan WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023595; ESKENAZI B, 1995, AM J EPIDEMIOL, V142, pS19, DOI 10.1093/aje/142.Supplement_9.S19; Farquhar CM, 2005, LANCET, V366, P583, DOI 10.1016/S0140-6736(05)67103-6; GALLO O, 1995, J NATL CANCER I, V87, P1024, DOI 10.1093/jnci/87.13.1024; Heusch WL, 1998, CARCINOGENESIS, V19, P551, DOI 10.1093/carcin/19.4.551; Horne AW, 2002, BIOCHEM BIOPH RES CO, V292, P102, DOI 10.1006/bbrc.2002.6624; Hu WH, 2009, DNA CELL BIOL, V28, P13, DOI 10.1089/dna.2008.0782; JANSEN RPS, 1984, ENDOCR REV, V5, P525, DOI 10.1210/edrv-5-4-525; Jiang M, 2003, GENE DEV, V17, P832, DOI 10.1101/gad.252603; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Jin ZH, 2004, J BIOL CHEM, V279, P23837, DOI 10.1074/jbc.M402566200; Jurkovic D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3397; LALA PK, 1990, CANCER METAST REV, V9, P369, DOI 10.1007/BF00049525; Lee YL, 2001, MOL REPROD DEV, V59, P400, DOI 10.1002/mrd.1046; LINDBLOM B, 1980, FERTIL STERIL, V33, P283; MAGERS T, 1995, REPROD TOXICOL, V9, P513, DOI 10.1016/0890-6238(95)02002-0; Mai HQ, 2003, J BIOL CHEM, V278, P1886, DOI 10.1074/jbc.M209044200; NERI A, 1969, FERTIL STERIL, V20, P818; Pier B, 2013, FERTIL STERIL, V99, P199, DOI 10.1016/j.fertnstert.2012.08.041; Shaw JLV, 2010, HUM REPROD UPDATE, V16, P432, DOI 10.1093/humupd/dmp057; Shaw JLV, 2010, AM J PATHOL, V177, P2509, DOI 10.2353/ajpath.2010.100243; Sivalingam VN, 2011, J FAM PLAN REPROD H, V37, P231, DOI 10.1136/jfprhc-2011-0073; STILLMAN RJ, 1986, FERTIL STERIL, V46, P545	28	20	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89400	10.1371/journal.pone.0089400	http://dx.doi.org/10.1371/journal.pone.0089400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586750	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700116
J	Li, S; Mo, CJ; Huang, S; Yang, S; Lu, Y; Peng, QL; Wang, J; Deng, Y; Qin, X; Liu, YK				Li, Shan; Mo, Cuiju; Huang, Shan; Yang, Shi; Lu, Yu; Peng, Qiliu; Wang, Jian; Deng, Yan; Qin, Xue; Liu, Yinkun			Over-Expressed Testis-Specific Protein Y-Encoded 1 as a Novel Biomarker for Male Hepatocellular Carcinoma	PLOS ONE			English	Article							GONADOBLASTOMA LOCUS; DNA METHYLATION; HEPATITIS-B; CANCER; GENE; TSPY; CELLS; SPERMATOGENESIS; IDENTIFICATION; PROGRESSION	Hepatocellular carcinoma (HCC) is a male-predominant cancer. Previous studies have focused on the sex-related disparity in HCC, but the underlying mechanism remains unclear. Here, we aimed to discover characteristic biomarkers for male HCC. Clinical samples were subjected to iTRAQ labeling followed by 2DLC-ESI-MS/MS analysis. Seventy-three differential proteins containing 16 up-regulated and 57 down-regulated proteins were screened out in the male HCC group compared to that in female HCC group. Testis-specific Protein Y-encoded 1(TSPY1) is characteristically present in male HCC and was chosen for further investigation. The data from the functional effects of TSPY1 indicated that over-expression of TSPY1 could potentiate HCC cell proliferation, increase soft agar colonization, induce higher cell invasive ability and correlate with the metastatic potential of the HCC cell lines. In addition, TSPY1 and androgen receptor (AR) were co-expressed simultaneously in HCC cell lines as well as in HCC tissue. TSPY1 up-or down-regulation could lead to a high or low level expression of AR. These results implied that TSPY1 may be included in the regulation of AR expression involved in male HCC and it may act as a novel biomarker for male HCC.	[Li, Shan; Mo, Cuiju; Huang, Shan; Yang, Shi; Lu, Yu; Peng, Qiliu; Wang, Jian; Deng, Yan; Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Liu, Yinkun] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai 200032, Peoples R China; [Liu, Yinkun] Fudan Univ, Canc Res Ctr, Inst Biomed Sci, Shanghai 200032, Peoples R China	Guangxi Medical University; Fudan University; Fudan University	Qin, X (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	qinxue919@126.com; liu.yinkun@zs-hospital.sh.cn		huang, shan/0000-0003-1340-9158	National Natural Science Foundation of China [81260302, 81060199]; National Natural Science Foundation of Guangxi [2012GXNSFAA053088]; National Research Program of China (973 Program) [2011CB910604, 2013CB910501]; National Research Program of China (863 program) [2011AA020204]; China National Key Projects for Infectious Diseases [2012ZX 10002-012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); National Research Program of China (973 Program)(National Basic Research Program of China); National Research Program of China (863 program)(National High Technology Research and Development Program of China); China National Key Projects for Infectious Diseases	This work was financially supported by National Natural Science Foundation of China (No. 81260302 and No. 81060199), National Natural Science Foundation of Guangxi (2012GXNSFAA053088); National Research Program of China (973 Program: 2011CB910604, 2013CB910501; 863 program: 2011AA020204), China National Key Projects for Infectious Diseases (2012ZX 10002-012). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bertran E, 2013, HEPATOLOGY; Chaerkady R, 2008, J PROTEOME RES, V7, P4289, DOI 10.1021/pr800197z; Chong PK, 2010, J PROTEOME RES, V9, P3671, DOI 10.1021/pr100192h; Donato F, 2002, AM J EPIDEMIOL, V155, P323, DOI 10.1093/aje/155.4.323; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gallagher WM, 2005, CARCINOGENESIS, V26, P1856, DOI 10.1093/carcin/bgi152; HALVORSON M, 1990, ARCH BIOCHEM BIOPHYS, V277, P166, DOI 10.1016/0003-9861(90)90566-H; Hertel JD, 2010, HUM PATHOL, V41, P1544, DOI 10.1016/j.humpath.2010.04.007; Kido T, 2005, GENESIS, V42, P263, DOI 10.1002/gene.20147; Kido T, 2008, INT J CANCER, V123, P1573, DOI 10.1002/ijc.23697; Kubicka S, 2008, GASTROENTEROLOGY, V135, P738, DOI 10.1053/j.gastro.2008.07.034; Lau YFC, 2011, SYST BIOL REPROD MED, V57, P27, DOI 10.3109/19396368.2010.499157; Lau YFC, 2009, BIRTH DEFECTS RES C, V87, P114, DOI 10.1002/bdrc.20144; Lee NP, 2009, J PROTEOME RES, V8, P1293, DOI 10.1021/pr800637z; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Niu DD, 2009, PROTEOMICS, V9, P3856, DOI 10.1002/pmic.200900071; Oram SW, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-154; PAGE DC, 1987, DEVELOPMENT, V101, P151; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; SALO P, 1995, GENE CHROMOSOME CANC, V14, P210, DOI 10.1002/gcc.2870140309; Schimanski CC, 2006, BRIT J CANCER, V95, P210, DOI 10.1038/sj.bjc.6603251; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Singh AP, 2008, CANCER LETT, V259, P28, DOI 10.1016/j.canlet.2007.09.018; Svacinova V, 2011, BIOMED PAP, V155, P287, DOI 10.5507/bp.2011.034; Taylor BC, 2009, HEPATOLOGY, V49, pS85, DOI 10.1002/hep.22929; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Wang C, 2011, CANCER LETT, V313, P154, DOI 10.1016/j.canlet.2011.08.031; Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Xiang Zuo-lin, 2010, Zhonghua Zhong Liu Za Zhi, V32, P344; Yin YH, 2005, BRIT J CANCER, V93, P458, DOI 10.1038/sj.bjc.6602716; Yu MW, 2001, J NATL CANCER I, V93, P1644, DOI 10.1093/jnci/93.21.1644; Zhao YC, 2009, EXPERT REV PROTEOMIC, V6, P115, DOI [10.1586/epr.09.8, 10.1586/EPR.09.8]	33	8	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89219	10.1371/journal.pone.0089219	http://dx.doi.org/10.1371/journal.pone.0089219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586606	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700074
J	Liu, JW; He, CY; Xu, Q; Xing, CZ; Yuan, Y				Liu, Jingwei; He, Caiyun; Xu, Qian; Xing, Chengzhong; Yuan, Yuan			NOD2 Polymorphisms Associated with Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							INNATE IMMUNITY GENES; NON-HODGKIN-LYMPHOMA; EARLY-ONSET BREAST; COLORECTAL-CANCER; INFLAMMATORY RESPONSE; 3020INSC MUTATION; GASTRIC-CANCER; SUSCEPTIBILITY; RECEPTORS; VARIANTS	Background: Emerging evidence indicated that common polymorphisms of NOD2 might impact individual susceptibility to cancer. However, the results from published studies were inconclusive. The aim of this meta-analysis was to elucidate whether NOD2 polymorphisms were associated with cancer risk. Methods: A systematically literature search was performed by using electronic databases including PubMed and Web of Science. ORs and their 95% CI were used to assess the strength of association between NOD2 gene polymorphisms and cancer risks. Results: Thirty case-control studies were included in this meta-analysis. The pooled analysis indicated that NOD2 rs2066842 C/T polymorphism was not significantly associated with cancer risk; for NOD2 rs2066844 C/T polymorphism, (TT+CT) genotype was associated with increased cancer risk compared with wild-type CC genotype (OR = 1.32, 95% CI = 1.01-1.72, P = 0.041); for NOD2 rs2066845 C/G polymorphism, individuals with (CC+CG) genotype were significantly associated with increased cancer risk compared with GG genotype (OR = 1.32, 95% CI = 1.01-1.72, P = 0.040); for NOD2 rs2066847 (3020insC) polymorphism, carriers of (insC/insC+insC/-) genotype were significantly associated with increased cancer risk compared with -/- carriers (OR = 1.23, 95% CI = 1.10-1.38, P < 0.001). In the subgroup analysis of cancer type, (insC/insC+insC/-) genotype was significantly associated with increased risk of colorectal cancer, gastric cancer and MALT lymphoma, breast cancer, lung cancer, laryngeal cancer but not with urogenital cancer, pancreatic cancer, melanoma or non-Hodgkin lymphoma. Conclusion: NOD2 rs2066844 C/T, rs2066845 C/G and rs2066847 (3020insC) polymorphisms might be associated with increased cancer risk. No significant association was observed between NOD2 rs2066842 C/T polymorphism and cancer risk. Further large-scale and well-designed studies are still needed to confirm the results of our meta-analysis.	[Liu, Jingwei; He, Caiyun; Xu, Qian; Xing, Chengzhong; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Inst Canc, Shenyang, Peoples R China; [Liu, Jingwei; He, Caiyun; Xu, Qian; Xing, Chengzhong; Yuan, Yuan] China Med Univ, Affiliated Hosp 1, Shenyang, Peoples R China; [Liu, Jingwei; He, Caiyun; Xu, Qian; Xing, Chengzhong; Yuan, Yuan] China Med Univ, Liaoning Prov Educ Dept, Key Lab Canc Etiol & Prevent, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Xing, CZ (corresponding author), China Med Univ, Affiliated Hosp 1, Tumor Etiol & Screening Dept, Inst Canc, Shenyang, Peoples R China.	xcz1966@126.com; yyuan@mail.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Basic Research Program of China (973 Program) [2010CB529304]; grants of the Science and Technology Project of Liaoning province [2011225002, 2012225016]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); grants of the Science and Technology Project of Liaoning province	This study is supported by grants from National Basic Research Program of China (973 Program Ref No.2010CB529304), the grants of the Science and Technology Project of Liaoning province (Ref No.2011225002) and the grants of the Science and Technology Project of Liaoning province (Ref No.2012225016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhopuro P, 2004, CANCER RES, V64, P7245, DOI 10.1158/0008-5472.CAN-04-2364; Angeletti S, 2009, HUM IMMUNOL, V70, P729, DOI 10.1016/j.humimm.2009.04.026; Ashton KA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-382; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Debniak T, 2005, EUR J CANCER PREV, V14, P143, DOI 10.1097/00008469-200504000-00010; Deng WY, 2012, CELL PHYSIOL BIOCHEM, V30, P953, DOI 10.1159/000341472; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ennas MG, 2008, HEMATOL ONCOL, V26, P98, DOI 10.1002/hon.843; Forrest MS, 2006, BRIT J HAEMATOL, V134, P180, DOI 10.1111/j.1365-2141.2006.06141.x; Freire P, 2010, INT J COLORECTAL DIS, V25, P1211, DOI 10.1007/s00384-010-1028-0; Frutuoso MS, 2010, MICROBES INFECT, V12, P819, DOI 10.1016/j.micinf.2010.05.006; Gazouli M, 2005, WORLD J GASTROENTERO, V11, P681, DOI 10.3748/wjg.v11.i5.681; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hnatyszyn A, 2010, EXP MOL PATHOL, V88, P388, DOI 10.1016/j.yexmp.2010.03.003; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Huzarski T, 2005, BREAST CANCER RES TR, V89, P91, DOI 10.1007/s10549-004-1250-y; Irmejs Arvids, 2006, Hered Cancer Clin Pract, V4, P48, DOI 10.1186/1897-4287-4-1-48; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Jaworowska E, 2006, BREAST CANCER RES TR, V97, P215, DOI 10.1007/s10549-005-9116-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003; Kurzawski G, 2004, CANCER RES, V64, P1604, DOI 10.1158/0008-5472.CAN-03-3791; Lakatos PL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-54; Lener MR, 2006, BREAST CANCER RES TR, V95, P141, DOI 10.1007/s10549-005-9057-z; Lubinski J, 2005, HERED CANCER CLIN PR, V3, P59, DOI 10.1186/1897-4287-3-2-59; Magnowski P, 2008, GINEKOL POL, V79, P544; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mockelmann N, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-79; Nej Katarzyna, 2004, Hered Cancer Clin Pract, V2, P149, DOI 10.1186/1897-4287-2-3-149; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Papaconstantinou L, 2005, INT J CANCER, V114, P433, DOI 10.1002/ijc.20747; Rigoli L, 2010, ANTICANCER RES, V30, P513; Roberts RL, 2006, CANCER RES, V66, P2532, DOI 10.1158/0008-5472.CAN-05-4165; Rosenstiel P, 2006, CELL MICROBIOL, V8, P1188, DOI 10.1111/j.1462-5822.2006.00701.x; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Skibola CF, 2010, AM J EPIDEMIOL, V171, P267, DOI 10.1093/aje/kwp383; Strober W, 2011, MUCOSAL IMMUNOL, V4, P484, DOI 10.1038/mi.2011.29; Suchy J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-112; Szeliga J, 2008, MED SCI MONITOR, V14, pCR480; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Ture-Ozdemir F, 2008, ANTICANCER RES, V28, P3697; Tuupanen S, 2007, INT J CANCER, V121, P76, DOI 10.1002/ijc.22651; Vogel U, 2007, MUTAT RES-FUND MOL M, V624, P88, DOI 10.1016/j.mrfmmm.2007.04.006; Wex T, 2008, ANTICANCER RES, V28, P757; Zaridze DG, 2008, BIOCHEMISTRY-MOSCOW+, V73, P532, DOI 10.1134/S0006297908050064; Zhong Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00333	48	32	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89340	10.1371/journal.pone.0089340	http://dx.doi.org/10.1371/journal.pone.0089340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586700	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700106
J	Tauler, P; Bennasar-Veny, M; Morales-Asencio, JM; Lopez-Gonzalez, AA; Vicente-Herrero, T; De Pedro-Gomez, J; Royo, V; Pericas-Beltran, J; Aguilo, A				Tauler, Pedro; Bennasar-Veny, Miquel; Morales-Asencio, Jose M.; Lopez-Gonzalez, Angel A.; Vicente-Herrero, Teofila; De Pedro-Gomez, Joan; Royo, Vanessa; Pericas-Beltran, Jordi; Aguilo, Antoni			Prevalence of Premorbid Metabolic Syndrome in Spanish Adult Workers Using IDF and ATPIII Diagnostic Criteria: Relationship with Cardiovascular Risk Factors	PLOS ONE			English	Article							CHOLESTEROL EDUCATION-PROGRAM; PHYSICAL-ACTIVITY; PROVISIONAL REPORT; DIABETES-MELLITUS; HEALTH-PROMOTION; WORKPLACE; DISEASE; INTERVENTIONS; DEFINITION; OBESITY	Background: Metabolic Syndrome (MetS) is a complex disorder defined as a cluster of interconnected risk factors such as hypertension, dyslipidemia, obesity and high blood glucose levels. Premorbid metabolic syndrome (PMetS) is defined by excluding patients with previously diagnosed cardiovascular disease or diabetes mellitus from those suffering MetS. We aimed to determine the prevalence of PMetS in a working population, and to analyse the relationship between the diagnostic criteria of the International Diabetes Federation (IDF) and of the National Cholesterol Education Program Adult Treatment Panel III (ATPIII). The relationship between the presence of PMetS and cardiovascular risk factors was also analysed. Research Methodology/Findings: A cross-sectional study was conducted in 24,529 male and 18,736 female Spanish (white western European) adult workers (20-65 years) randomly selected during their work health periodic examinations. Anthropometrics, blood pressure and serum parameters were measured. The presence of MetS and PMetS was ascertained using ATPIII and IDF criteria. Cardiovascular risk was determined using the Framingham-REGICOR equation. The results showed MetS had an adjusted global prevalence of 12.39% using ATPIII criteria and 16.46% using IDF criteria. The prevalence of PMetS was slightly lower (11.21% using ATPIII criteria and 14.72% using IDF criteria). Prevalence in males was always higher than in females. Participants with PMetS displayed higher values of BMI, waist circumference, blood pressure, glucose and triglycerides, and lower HDL-cholesterol levels. Logistic regression models reported lower PMetS risk for females, non-obese subjects, non-smokers and younger participants. Cardiovascular risk determined with Framingham-REGICOR was higher in participants with PMetS. Conclusions: PMetS could be a reliable tool for the early identification of apparently healthy individuals who have a significant risk for developing cardiovascular events and type 2 diabetes.	[Tauler, Pedro] Univ Illes Balears, Fundamental Biol & Hlth Sci Dept, Palma De Mallorca, Spain; [Bennasar-Veny, Miquel; Morales-Asencio, Jose M.; De Pedro-Gomez, Joan; Pericas-Beltran, Jordi; Aguilo, Antoni] Univ Illes Balears, Res Grp Evidence Lifestyles & Hlth, Palma De Mallorca, Spain; [Lopez-Gonzalez, Angel A.] Balearic Isl Hlth Serv, Prevent Occupat Risks Hlth Serv, Palma De Mallorca, Spain; [Vicente-Herrero, Teofila] Correos, Prevent Occupat Risks, Valencia, Spain; [Royo, Vanessa] Manacor Hosp, Gastroenterol Serv, Manacor, Spain	Universitat de les Illes Balears; Universitat de les Illes Balears; Hospital de Manacor	Bennasar-Veny, M (corresponding author), Univ Illes Balears, Res Grp Evidence Lifestyles & Hlth, Palma De Mallorca, Spain.	miquel.bennasar@uib.es	Bennasar-Veny, Miquel/C-5881-2008; Tauler, Pedro/M-4126-2018; MORALES-ASENCIO, JOSE MIGUEL/B-4996-2008; López, Ángel Arturo/AAN-2248-2021	Bennasar-Veny, Miquel/0000-0003-1668-2141; Tauler, Pedro/0000-0003-0841-1720; MORALES-ASENCIO, JOSE MIGUEL/0000-0001-7911-7487; López, Ángel Arturo/0000-0002-7439-8117				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alegria E, 2005, REV ESP CARDIOL, V58, P797, DOI 10.1157/13077231; Alkerwi A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-4; Anderson LM, 2009, AM J PREV MED, V37, P340, DOI 10.1016/j.amepre.2009.07.003; Balkau B, 1999, DIABETIC MED, V16, P442; Barham K, 2011, J PUBLIC HEALTH MAN, V17, P233, DOI 10.1097/PHH.0b013e3181fd4cf6; Bennasar-Veny M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063999; Bhanushali CJ, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/516475; Bruno G, 2004, DIABETES CARE, V27, P2689, DOI 10.2337/diacare.27.11.2689; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; Cheal KL, 2004, DIABETES, V53, P1195, DOI 10.2337/diabetes.53.5.1195; Choi SW, 2009, KOREAN J CHEM ENG, V26, P26, DOI 10.1007/s11814-009-0005-1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Davila EP, 2010, DIABETES CARE, V33, P2390, DOI 10.2337/dc10-0681; Domingo-Salvany A, 2000, ATEN PRIM, V25, P350, DOI [DOI 10.1016/S0212-6567(00)78518-0, 10.1016/50212-6567(00)78518-0, DOI 10.1016/50212-6567(00)78518-0]; Dunkley AJ, 2012, DIABETES OBES METAB, V14, P616, DOI 10.1111/j.1463-1326.2012.01571.x; Dunkley AJ, 2009, PRIM CARE DIABETES, V3, P49, DOI 10.1016/j.pcd.2009.02.002; Fernandez-Berges D, 2012, REV ESP CARDIOL, V65, P241, DOI [10.1016/j.rec.2011.10.017, 10.1016/j.recesp.2011.10.015]; Fernandez-Berges D, 2011, GAC SANIT, V25, P519, DOI 10.1016/j.gaceta.2011.05.009; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Grau M, 2011, REV ESP CARDIOL, V64, P295, DOI [10.1016/j.rec.2010.11.005, 10.1016/j.recesp.2010.11.005]; Groeneveld IF, 2010, SCAND J WORK ENV HEA, V36, P202, DOI 10.5271/sjweh.2891; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gundogan K, 2009, METAB SYNDR RELAT D, V7, P427, DOI 10.1089/met.2008.0068; Heinen L, 2009, MILBANK Q, V87, P101, DOI 10.1111/j.1468-0009.2009.00549.x; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; Huang Y, 2011, PREV CHRONIC DIS, V8; INE, 2012, ENC POBL ACT 2011; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Khunti K, 2010, PRIM CARE DIABETES, V4, P25, DOI 10.1016/j.pcd.2010.01.002; Kirkendoll K, 2010, J TRANSCULT NURS, V21, P104, DOI 10.1177/1043659609357636; Linnan L, 2008, AM J PUBLIC HEALTH, V98, P1503, DOI 10.2105/AJPH.2006.100313; Maes L, 2012, EUR J PUBLIC HEALTH, V22, P677, DOI 10.1093/eurpub/ckr098; Marrugat J, 2003, REV ESP CARDIOL, V56, P253, DOI 10.1157/13043951; Martinez MA, 2008, METABOLISM, V57, P1232, DOI 10.1016/j.metabol.2008.04.017; Martinez-Larrad MT, 2005, MED CLIN-BARCELONA, V125, P481; Maruyama C, 2010, PREV MED, V51, P11, DOI 10.1016/j.ypmed.2010.04.008; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Moe B, 2013, OCCUP ENVIRON MED, V70, P86, DOI 10.1136/oemed-2012-100734; Mohan V, 2006, DIABETIC MED, V23, P845, DOI 10.1111/j.1464-5491.2006.01898.x; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Ngo AD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-681; Punnett L, 2009, PUBLIC HEALTH REP, V124, P16, DOI 10.1177/00333549091244S103; Qiao Q, 2006, DIABETOLOGIA, V49, P2837, DOI 10.1007/s00125-006-0438-6; Reaven GM, 2005, CLIN CHEM, V51, P931, DOI 10.1373/clinchem.2005.048611; Sanchez-Chaparro MA, 2006, REV ESP CARDIOL, V59, P421, DOI 10.1157/13087894; Sanchez-Chaparro MA, 2008, DIABETES CARE, V31, P1884, DOI 10.2337/dc08-0431; Santos AC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-62; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Shil LE, 2012, J ADV NURS; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; Simons LA, 2011, HEART LUNG CIRC, V20, P214, DOI 10.1016/j.hlc.2010.12.005; Stewart A., 2011, INT STANDARDS ANTHRO, V137; Vakil KP, 2012, METAB SYNDR RELAT D, V10, P225, DOI 10.1089/met.2011.0099; Verweij LM, 2011, OBES REV, V12, P406, DOI 10.1111/j.1467-789X.2010.00765.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organisation, 2000, OB PREV MAN GLOB EP; Yamaoka K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-138	63	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89281	10.1371/journal.pone.0089281	http://dx.doi.org/10.1371/journal.pone.0089281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586656	gold, Green Submitted, Green Published			2022-12-27	WOS:000331714700085
J	Tong, XJ; Li, J; Yu, Q; Lin, ZH				Tong, Xiaojuan; Li, Jun; Yu, Qiang; Lin, Zhonghui			Biophysical Controls on Light Response of Net CO2 Exchange in a Winter Wheat Field in the North China Plain	PLOS ONE			English	Article							CARBON-DIOXIDE EXCHANGE; ENVIRONMENTAL CONTROLS; ECOSYSTEM EXCHANGE; DIFFUSE-RADIATION; MIXED FOREST; PHOTOSYNTHESIS; PRODUCTIVITY; RESPIRATION; CROPLAND; STOMATA	To investigate the impacts of biophysical factors on light response of net ecosystem exchange (NEE), CO2 flux was measured using the eddy covariance technique in a winter wheat field in the North China Plain from 2003 to 2006. A rectangular hyperbolic function was used to describe NEE light response. Maximum photosynthetic capacity (P-max) was 46.6 +/- 4.0 mu mol CO2 m(-2) s(-1) and initial light use efficiency (alpha) 0.059 +/- 0.006 mu mol mu mol(-1) in April-May, two or three times as high as those in March. Stepwise multiple linear regressions showed that Pmax increased with the increase in leaf area index (LAI), canopy conductance (g(c)) and air temperature (T-a) but declined with increasing vapor pressure deficit (VPD) (P<0.001). The factors influencing Pmax were sorted as LAI, g(c), T-a and VPD. alpha was proportional to ln(LAI), g(c), T-a and VPD (P<0.001). The effects of LAI, gc and Ta on a were larger than that of VPD. When Ta>25 degrees C or VPD>1.1-1.3 kPa, NEE residual increased with the increase in Ta and VPD (P<0.001), indicating that temperature and water stress occurred. When g(c) was more than 14 mm s(-1) in March and May and 26 mm s(-1) in April, the NEE residuals decline disappeared, or even turned into an increase in g(c) (P<0.01), implying shifts from stomatal limitation to non-stomatal limitation on NEE. Although the differences between sunny and cloudy sky conditions were unremarkable for light response parameters, simulated net CO2 uptake under the same radiation intensity averaged 18% higher in cloudy days than in sunny days during the year 2003-2006. It is necessary to include these effects in relevant carbon cycle models to improve our estimation of carbon balance at regional and global scales.	[Tong, Xiaojuan] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Li, Jun; Yu, Qiang; Lin, Zhonghui] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Water Cycle & Related Land Surface Proc, Beijing, Peoples R China; [Yu, Qiang] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia	Beijing Forestry University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; University of Technology Sydney	Tong, XJ (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	tongxjsxbs@sina.com; lijun@igsnrr.ac.cn	Yu, Qiang/D-3702-2009	Yu, Qiang/0000-0001-6950-1821	National Natural Science Foundation of China [31100322]; National Basic Research Program of China [2010CB428404, 2012CB955304]; Fundamental Research Funds for the Central Universities [YX2011-19]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is jointly supported by National Natural Science Foundation of China (Grant No. 31100322), National Basic Research Program of China ( Grant No. 2010CB428404 and Grant No. 2012CB955304) and the Fundamental Research Funds for the Central Universities (NO. YX2011- 19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthoni PM, 2004, GLOBAL CHANGE BIOL, V10, P2005, DOI 10.1111/j.1365-2486.2004.00863.x; Anthoni PM, 1999, AGR FOREST METEOROL, V95, P151, DOI 10.1016/S0168-1923(99)00029-5; APHALO PJ, 1993, J EXP BOT, V44, P791, DOI 10.1093/jxb/44.4.791; Aubinet M, 2001, AGR FOREST METEOROL, V108, P293, DOI 10.1016/S0168-1923(01)00244-1; Beziat P, 2009, AGR FOREST METEOROL, V149, P1628, DOI 10.1016/j.agrformet.2009.05.004; Carrara A, 2004, AGR FOREST METEOROL, V126, P15, DOI 10.1016/j.agrformet.2004.05.002; Dengel S, 2010, OECOLOGIA, V164, P797, DOI 10.1007/s00442-010-1687-0; Dufranne D, 2011, AGR ECOSYST ENVIRON, V141, P133, DOI 10.1016/j.agee.2011.02.023; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Flanagan LB, 2002, GLOBAL CHANGE BIOL, V8, P599, DOI 10.1046/j.1365-2486.2002.00491.x; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Giasson MA, 2006, AGR FOREST METEOROL, V140, P23, DOI 10.1016/j.agrformet.2006.08.001; Gilmanov TG, 2010, RANGELAND ECOL MANAG, V63, P16, DOI 10.2111/REM-D-09-00072.1; Gilmanov TG, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002023; Glenn AJ, 2010, AGR FOREST METEOROL, V150, P908, DOI 10.1016/j.agrformet.2010.02.010; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Gu LH, 2003, SCIENCE, V299, P2035, DOI 10.1126/science.1078366; HARLEY PC, 1992, PLANT CELL ENVIRON, V15, P271, DOI 10.1111/j.1365-3040.1992.tb00974.x; Hirasawa T, 1999, FIELD CROP RES, V62, P53, DOI 10.1016/S0378-4290(99)00005-2; Hirata R, 2007, AGR FOREST METEOROL, V147, P110, DOI 10.1016/j.agrformet.2007.07.005; Hollinger DY, 1998, AGR FOREST METEOROL, V90, P291, DOI 10.1016/S0168-1923(98)00057-4; HOLLINGER DY, 1994, ECOLOGY, V75, P134, DOI 10.2307/1939390; James G. B., 1976, VEGETATION ATMOSPHER, V2; KARLSSON PE, 1986, PHYSIOL PLANTARUM, V66, P207, DOI 10.1111/j.1399-3054.1986.tb02410.x; KUIPER PJC, 1964, PLANT PHYSIOL, V39, P952, DOI 10.1104/pp.39.6.952; Laurila T, 2001, THEOR APPL CLIMATOL, V70, P183, DOI 10.1007/s007040170014; LHOMME JP, 1991, AGR FOREST METEOROL, V54, P227, DOI 10.1016/0168-1923(91)90007-D; Li J, 2006, SCI CHINA SER D, V49, P226, DOI 10.1007/s11430-006-8226-1; Loescher HW, 2003, GLOBAL CHANGE BIOL, V9, P396, DOI 10.1046/j.1365-2486.2003.00599.x; MANSFIELD TA, 1966, J EXP BOT, V17, P510, DOI 10.1093/jxb/17.3.510; Matsuda R, 2004, PLANT CELL PHYSIOL, V45, P1870, DOI 10.1093/pcp/pch203; MCMILLEN RT, 1988, BOUND-LAY METEOROL, V43, P231, DOI 10.1007/BF00128405; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Migliavacca M, 2009, AGR FOREST METEOROL, V149, P1460, DOI 10.1016/j.agrformet.2009.04.003; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Monteith J.L., 1990, PRINCIPLES ENV PHYS, V2nd; MORISON JIL, 1983, PLANT CELL ENVIRON, V6, P95, DOI 10.1111/j.1365-3040.1983.tb01881.x; NBSC, 1998, CHIN STAT YB; Pejam MR, 2006, HYDROL PROCESS, V20, P3709, DOI 10.1002/hyp.6384; Powell TL, 2006, AGR FOREST METEOROL, V141, P19, DOI 10.1016/j.agrformet.2006.09.002; Rocha AV, 2004, FOREST SCI, V50, P793; Ruimy A., 1995, Advances in Ecological Research, V26, P1, DOI 10.1016/S0065-2504(08)60063-X; RUTTER AJ, 1972, AGR METEOROL, V9, P367; Suyker AE, 2004, AGR FOREST METEOROL, V124, P1, DOI 10.1016/j.agrformet.2004.01.011; Teklemariam T, 2009, AGR FOREST METEOROL, V149, P2040, DOI 10.1016/j.agrformet.2009.07.011; Tong XJ, 2007, NEW ZEAL J AGR RES, V50, P1347; Urban O, 2007, GLOBAL CHANGE BIOL, V13, P157, DOI 10.1111/j.1365-2486.2006.01265.x; Urban O, 2012, FUNCT ECOL, V26, P46, DOI 10.1111/j.1365-2435.2011.01934.x; Wang FH, 2009, FIELD CROP RES, V111, P181, DOI 10.1016/j.fcr.2008.12.004; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wild M., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127003; WILD M, 2009, J GEOPHYS RES-ATMOS, V114, DOI DOI 10.1029/2008JD011470; Zhang M, 2010, BIOGEOSCIENCES, V7, P711, DOI 10.5194/bg-7-711-2010; Zhang P, 2012, J PLANT ECOL, V5, P238, DOI 10.1093/jpe/rtr017	55	11	11	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89469	10.1371/journal.pone.0089469	http://dx.doi.org/10.1371/journal.pone.0089469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586800	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700121
J	Yanai, M; Rocha, MA; Matolek, AZ; Chintalacharuvu, A; Taira, Y; Chintalacharuvu, K; Beenhouwer, DO				Yanai, Machi; Rocha, Miguel A.; Matolek, Anthony Z.; Chintalacharuvu, Archana; Taira, Yasuhiko; Chintalacharuvu, Koteswara; Beenhouwer, David O.			Separately or Combined, LukG/LukH Is Functionally Unique Compared to Other Staphylococcal Bicomponent Leukotoxins	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; NF-KAPPA-B; INTERLEUKIN-8 GENE-EXPRESSION; HUMAN NEUTROPHILS; POLYMORPHONUCLEAR LEUKOCYTES; SUBSEQUENT ACTIVATION; GAMMA-HEMOLYSIN; IL-8 PRODUCTION; PORE FORMATION; 2 COMPONENTS	Staphylococcus aureus is a major human pathogen that elaborates several exotoxins. Among these are the bicomponent leukotoxins (BCLs), which include gamma-hemolysin, Panton-Valentine leukocidin (PVL), and LukDE. The toxin components are classified as either F or S proteins, which are secreted individually and assemble on cell surfaces to form hetero-oligomeric pores resulting in lysis of PMNs and/or erythrocytes. F and S proteins of gamma-hemolysin, PVL and LukDE have similar to 70% sequence homology within the same class and several heterologous combinations of F and S members from these three bicomponent toxin groups are functional. Recently, an additional BCL pair, LukGH (also called LukAB) that has only 30% homology to gamma-hemolysin, PVL and LukDE, has been characterized from S. aureus. Our results showed that LukGH was more cytotoxic to human PMNs than PVL. However, LukGH-induced calcium ion influx in PMNs was markedly attenuated and slower than that induced by PVL and other staphylococcal BCLs. In contrast to other heterologous BCL combinations, LukG in combination with heterologous S components, and LukH in combination with heterologous F components did not induce calcium ion entry or cell lysis in human PMNs or rabbit erythrocytes. Like PVL, LukGH induced IL-8 production by PMNs. While individual components LukG and LukH had no cytolytic or calcium influx activity, they each induced high levels of IL-8 transcription and secretion. IL-8 production induced by LukG or LukH was dependent on NF-kappa B. Therefore, our results indicate LukGH differs functionally from other staphylococcal BCLs.	[Yanai, Machi; Rocha, Miguel A.; Matolek, Anthony Z.; Chintalacharuvu, Archana; Chintalacharuvu, Koteswara; Beenhouwer, David O.] Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA 90073 USA; [Yanai, Machi; Taira, Yasuhiko] St Marianna Univ, Sch Med, Kawasaki, Kanagawa, Japan; [Beenhouwer, David O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90024 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Saint Marianna University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Beenhouwer, DO (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA 90073 USA.	dbeenhou@ucla.edu			NIH [AI071025]; Veterans Affairs (Merit Award); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071025] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs (Merit Award)(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from NIH (AI071025, DOB) and the Veterans Affairs (Merit Award, DOB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman MJ, 2010, J BIOMOL STRUCT DYN, V28, P1; Blidberg K, 2012, RESPIROLOGY, V17, P854, DOI 10.1111/j.1440-1843.2012.02181.x; Boyle-Vavra S, 2007, LAB INVEST, V87, P3, DOI 10.1038/labinvest.3700501; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; COLIN DA, 1994, INFECT IMMUN, V62, P3184, DOI 10.1128/IAI.62.8.3184-3188.1994; Cowburn AS, 2004, EUR J IMMUNOL, V34, P1733, DOI 10.1002/eji.200425091; DEFORGE LE, 1992, J IMMUNOL, V148, P2133; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Drewniak A, 2010, BLOOD, V115, P4588, DOI 10.1182/blood-2009-11-253245; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; FINCKBARBANCON V, 1993, BIOCHIM BIOPHYS ACTA, V1182, P275, DOI 10.1016/0925-4439(93)90069-D; FUJISHIMA S, 1993, J CELL PHYSIOL, V154, P478, DOI 10.1002/jcp.1041540305; Gauduchon V, 2004, J INFECT DIS, V189, P346, DOI 10.1086/380909; Godaly G, 1997, INFECT IMMUN, V65, P3451, DOI 10.1128/IAI.65.8.3451-3456.1997; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Iho S, 2003, J LEUKOCYTE BIOL, V74, P942, DOI 10.1189/jlb.1202626; Inden K, 2009, MICROBES INFECT, V11, P245, DOI 10.1016/j.micinf.2008.11.013; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Konig B, 1997, J MED MICROBIOL, V46, P479; KONIG B, 1994, INFECT IMMUN, V62, P4831; Langereis JD, 2010, J LEUKOCYTE BIOL, V88, P655, DOI 10.1189/jlb.0809544; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Ma XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034970; Malachowa N, 2012, J INFECT DIS, V206, P1185, DOI 10.1093/infdis/jis495; Marie C, 1997, INFECT IMMUN, V65, P865, DOI 10.1128/IAI.65.3.865-871.1997; Mellstrom B, 2008, PHYSIOL REV, V88, P421, DOI 10.1152/physrev.00041.2005; Menestrina G, 2003, FEBS LETT, V552, P54, DOI 10.1016/S0014-5793(03)00850-0; Miskolci V, 2007, MOL MED, V13, P134, DOI 10.2119/2006-00072.Miskolci; Moussa LB, 1999, FEBS LETT, V461, P280, DOI 10.1016/S0014-5793(99)01453-2; Pang G, 1997, AM J RESP CRIT CARE, V155, P726, DOI 10.1164/ajrccm.155.2.9032219; Perret M, 2012, CELL MICROBIOL; Prevost G, 2001, CURR TOP MICROBIOL, V257, P53; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Staali L, 1998, J MEMBRANE BIOL, V162, P209, DOI 10.1007/s002329900358; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Werner S, 2002, INFECT IMMUN, V70, P1310, DOI 10.1128/IAI.70.3.1310-1318.2002; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108; Zivkovic A, 2011, J IMMUNOL, V186, P1608, DOI 10.4049/jimmunol.1001665	43	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89308	10.1371/journal.pone.0089308	http://dx.doi.org/10.1371/journal.pone.0089308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586678	Green Submitted, Green Published, gold			2022-12-27	WOS:000331714700098
J	Domenis, R; Bergamin, N; Gianfranceschi, G; Vascotto, C; Romanello, M; Rigo, S; Vagnarelli, G; Faggiani, M; Parodi, P; Kelley, MR; Beltrami, CA; Cesselli, D; Tell, G; Beltrami, AP				Domenis, Rossana; Bergamin, Natascha; Gianfranceschi, Giuseppe; Vascotto, Carlo; Romanello, Milena; Rigo, Silvia; Vagnarelli, Giovanna; Faggiani, Massimo; Parodi, Piercamillo; Kelley, Mark R.; Beltrami, Carlo Alberto; Cesselli, Daniela; Tell, Gianluca; Beltrami, Antonio Paolo			The Redox Function of APE1 Is Involved in the Differentiation Process of Stem Cells toward a Neuronal Cell Fate	PLOS ONE			English	Article							DOPAMINERGIC-NEURONS; ENDONUCLEASE; APE1/REF-1; EXPRESSION; PROTEIN; OXYGEN; DAMAGE; GENE; REDUCTION; DOMAIN	Low-to-moderate levels of reactive oxygen species (ROS) govern different steps of neurogenesis via molecular pathways that have been decrypted only partially. Although it has been postulated that redox-sensitive molecules are involved in neuronal differentiation, the molecular bases for this process have not been elucidated yet. The aim of this work was therefore to study the role played by the redox-sensitive, multifunctional protein APE1/Ref-1 (APE1) in the differentiation process of human adipose tissue-derived multipotent adult stem cells (hAT-MASC) and embryonic carcinoma stem cells (EC) towards a neuronal phenotype. Methods and results: Applying a definite protocol, hAT-MASC can adopt a neural fate. During this maturation process, differentiating cells significantly increase their intracellular Reactive Oxygen Species (ROS) levels and increase the APE1 nuclear fraction bound to chromatin. This latter event is paralleled by the increase of nuclear NF-kappa B, a transcription factor regulated by APE1 in a redox-dependent fashion. Importantly, the addition of the antioxidant N-acetyl cysteine (NAC) to the differentiation medium partially prevents the nuclear accumulation of APE1, increasing the neuronal differentiation of hAT-MASC. To investigate the involvement of APE1 in the differentiation process, we employed E3330, a specific inhibitor of the APE1 redox function. The addition of E3330, either to the neurogenic embryonic carcinoma cell line NT2-D1or to hAT-MASC, increases the differentiation of stem cells towards a neural phenotype, biasing the differentiation towards specific subtypes, such as dopaminergic cells. In conclusion, during the differentiation process of stem cells towards a neuroectodermic phenotype, APE1 is recruited, in a ROS-dependent manner, to the chromatin. This event is associated with an inhibitory effect of APE1 on neurogenesis that may be reversed by E3330. Therefore, E3330 may be employed both to boost neural differentiation and to bias the differentiation potential of stem cells towards specific neuronal subtypes. These findings provide a molecular basis for the redox-mediated hypothesis of neuronal differentiation program.	[Domenis, Rossana; Bergamin, Natascha; Gianfranceschi, Giuseppe; Vascotto, Carlo; Romanello, Milena; Rigo, Silvia; Vagnarelli, Giovanna; Faggiani, Massimo; Beltrami, Carlo Alberto; Cesselli, Daniela; Tell, Gianluca; Beltrami, Antonio Paolo] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Parodi, Piercamillo] Univ Udine, Dept Expt & Clin Med Sci, I-33100 Udine, Italy; [Kelley, Mark R.] Indiana Univ Sch Med, Dept Pediat, Hematol Oncol Sect, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	University of Udine; University of Udine; Indiana University System; Indiana University Bloomington	Tell, G (corresponding author), Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy.	gianluca.tell@uniud.it; antonio.beltrami@uniud.it	Parodi, Pier camillo/AAG-8676-2019; CESSELLI, DANIELA/C-7052-2008; Beltrami, Antonio/C-5291-2008	Beltrami, Antonio/0000-0002-0679-2710; Cesselli, Daniela/0000-0002-0562-7852; Tell, Gianluca/0000-0001-8845-6448; vascotto, carlo/0000-0003-4431-029X; Kelley, Mark/0000-0002-6120-9532	European Union [Health-F2-2009-241762]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG10269]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [FIRB_RBRN07BMCT]; Regione Friulia Venezia Giulia; Italian Ministry of Health [G.R.-2007-683407]; Project ERC-7FP SP 2 IDEAS QUIDPROQUO G.A. [269051]; National Institutes of Health [NCICA121168, CA167291]; Riley Children's Foundation; NATIONAL CANCER INSTITUTE [R01CA121168, R01CA167291] Funding Source: NIH RePORTER	European Union(European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Regione Friulia Venezia Giulia; Italian Ministry of Health(Ministry of Health, Italy); Project ERC-7FP SP 2 IDEAS QUIDPROQUO G.A.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors declare that the research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement Health-F2-2009-241762, for the project FLIP and by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) (IG10269), Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (FIRB_RBRN07BMCT); the Regione Friulia Venezia Giulia for the Project 'MINA' under the program entitled: "Programma per la Cooperazione Transfrontaliera Italia-Slovenia 2007-2013'' to GT; Italian Ministry of Health, G.R.-2007-683407 (D.C.); and Project ERC-7FP SP 2 IDEAS QUIDPROQUO G.A. n. 269051 (D.C., A.P.B., G.G.). Financial support for this work was provided by the National Institutes of Health (NCICA121168, CA167291), and the Riley Children's Foundation to MRK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addae C, 2013, INT J ENV RES PUB HE, V10, P5244, DOI 10.3390/ijerph10105244; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bergamin N, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-34; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Cesaratto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070909; Chung U, 1996, J BIOL CHEM, V271, P8593, DOI 10.1074/jbc.271.15.8593; Coyle DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016174; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Gil-Perotin S, 2011, EUR J NEUROSCI, V34, P1040, DOI 10.1111/j.1460-9568.2011.07836.x; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Kennedy KAM, 2012, CELL MOL LIFE SCI, V69, P215, DOI 10.1007/s00018-011-0807-2; Kim MH, 2009, MOL CELL BIOL, V29, P2264, DOI 10.1128/MCB.01484-08; Kuninger DT, 2002, NUCLEIC ACIDS RES, V30, P823, DOI 10.1093/nar/30.3.823; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Liu HJ, 2013, STEM CELLS DEV, V22, P913, DOI 10.1089/scd.2012.0370; Liu S, 2009, BRAIN RES BULL, V80, P62, DOI 10.1016/j.brainresbull.2009.05.007; Ludwig DL, 1998, MUTAT RES-DNA REPAIR, V409, P17, DOI 10.1016/S0921-8777(98)00039-1; Marcon G, 2009, NEUROSCI LETT, V466, P124, DOI 10.1016/j.neulet.2009.09.039; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; ONO Y, 1995, J NEURO-ONCOL, V25, P183, DOI 10.1007/BF01053151; Pines A, 2005, NUCLEIC ACIDS RES, V33, P4379, DOI 10.1093/nar/gki751; Podrygajlo G, 2009, CELL TISSUE RES, V336, P439, DOI 10.1007/s00441-009-0783-0; Poletto M, 2013, BIOCHEM J, V452, P545, DOI 10.1042/BJ20121277; Rajan P, 1998, J NEUROSCI, V18, P3620; Sakurai M, 2003, J VASC SURG, V37, P446, DOI 10.1067/mva.2003.100; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; Su DA, 2011, BIOCHEMISTRY-US, V50, P82, DOI 10.1021/bi101248s; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Tell G, 2010, CELL MOL LIFE SCI, V67, P3589, DOI 10.1007/s00018-010-0486-4; Tell G, 2010, MOL CELL BIOL, V30, P366, DOI 10.1128/MCB.01174-09; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Vascotto C, 2011, MOL BIOL CELL, V22, P3887, DOI 10.1091/mbc.E11-05-0391; Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08; Walton M, 1997, MOL BRAIN RES, V44, P167, DOI 10.1016/S0169-328X(96)00291-4; Wilson TM, 1996, MUTAT RES-DNA REPAIR, V362, P237, DOI 10.1016/0921-8777(95)00053-4; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; Zeppieri M, 2013, CURR EYE RES, V38, P451, DOI 10.3109/02713683.2012.763100; Zhang J, 2013, BIOCHEMISTRY-US, V52, P2955, DOI 10.1021/bi400179m; Zou GM, 2008, MOL CANCER THER, V7, P2012, DOI 10.1158/1535-7163.MCT-08-0113; Zou GM, 2007, BLOOD, V109, P1917, DOI 10.1182/blood-2006-08-044172	43	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89232	10.1371/journal.pone.0089232	http://dx.doi.org/10.1371/journal.pone.0089232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586617	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900111
J	Shen, XY; Zhang, JH; Zhang, RD				Shen, Xiaoyun; Zhang, Jinhua; Zhang, Renduo			Phosphorus Metabolic Disorder of Guizhou Semi-Fine Wool Sheep	PLOS ONE			English	Article							ABSORPTION; EXCRETION; SECRETION; ROUGHAGE; DIETS	Guizhou semi-fine wool sheep are affected by a disease, characterized by emaciation, lameness, stiffness in the gait, enlargement of the costochondral junctions, and abnormal curvature in the long bones. The objective of this study was to determine possible relationships between the disease and mineral deficiencies. Samples of tissue and blood were collected from affected and unaffected sheep. Samples of soil and forage were collected from affected and unaffected areas. The samples were used for biochemical analyses and mineral nutrient measurements. Results showed that phosphorus (P) concentrations in forage samples from affected areas were significantly lower than those from unaffected areas (P<0.01) and the mean ratio of calcium (Ca) to P in the affected forage was 12:1. Meanwhile, P concentrations of blood, bone, tooth, and wool from the affected sheep were also significantly lower than those from the unaffected group (P<0.01). Serum P levels of the affected animals were much lower than those of the unaffected ones, whereas serum alkaline phosphatase levels from the affected were significantly higher than those from the unaffected (P<0.01). Inorganic P levels of the affected sheep were about half of those in the control group. Oral administration of disodium hydrogen phosphate prevented and cured the disease. The study clearly demonstrated that the disease of Guizhou semi-fine wool sheep was mainly caused by the P deficiency in forage, as a result of fenced pasture and animal habitat fragmentation.	[Shen, Xiaoyun] Chongqing Univ Sci & Technol, Chongqing, Peoples R China; [Zhang, Renduo] Sun Yat Sen Univ, Guangdong Prov Key Lab Environm Pollut Control &, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Jinhua] Guizhou Normal Univ, Guiyang, Peoples R China; [Shen, Xiaoyun] Off Poverty Alleviat Guizhou Prov, Guiyang, Peoples R China; [Zhang, Jinhua] Guizhou Inst Pratacultural, Guiyang, Peoples R China; [Shen, Xiaoyun] Bijie Univ, Pratacultural Ecol Inst, Bijie, Peoples R China	Chongqing University of Science & Technology; Sun Yat Sen University; Guizhou Normal University	Zhang, RD (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Environm Pollut Control &, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China.	zhangrd@mail.sysu.edu.cn			national science and technology support program [2011BAC09B01]; Natural Science Foundation of Guizhou Province of China [[2012]2184]; cooperation projects of Guizhou Province, Bijie City; Kunming Branch of Chinese Academy of Science [2010-04]; China Agriculture Research System [CARS-40-30]	national science and technology support program; Natural Science Foundation of Guizhou Province of China; cooperation projects of Guizhou Province, Bijie City; Kunming Branch of Chinese Academy of Science; China Agriculture Research System	This work was partly supported by the national science and technology support program (2011BAC09B01), the Natural Science Foundation of Guizhou Province of China ([2012]2184), the cooperation projects of Guizhou Province, Bijie City, and the Kunming Branch of Chinese Academy of Science (2010-04), and the China Agriculture Research System (CARS-40-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUID CAR US AGR AN R; Arthington JD, 2002, J ANIM SCI, V80, P2507; Blood DC, 1989, VET MED; BRAITHWAITE GD, 1985, J AGR SCI, V105, P67, DOI 10.1017/S0021859600055726; FIELD AC, 1985, J AGR SCI, V105, P237, DOI 10.1017/S0021859600056288; Heuer C, 1998, PREV VET MED, V33, P69, DOI 10.1016/S0167-5877(97)00064-0; Huang Y, 2001, TOXICOPATHY NUTR DIS, P194; Huang YD, 2002, VET RES COMMUN, V26, P39, DOI 10.1023/A:1013353604974; Huang YD, 2001, VET RES COMMUN, V25, P631, DOI 10.1023/A:1012739129271; Karn JF, 2001, ANIM FEED SCI TECH, V89, P133, DOI 10.1016/S0377-8401(00)00231-5; Liu ZP, 2005, VET J, V169, P444, DOI 10.1016/j.tvjl.2004.03.014; Maduell F, 2005, J NEPHROL, V18, P739; McDowell LR, 1992, MINERAL ANIMALS HUMA; SALMELA S, 1981, ANAL CHIM ACTA, V125, P131, DOI 10.1016/S0003-2670(01)85057-1; SCOTT D, 1984, Q J EXP PHYSIOL CMS, V69, P439, DOI 10.1113/expphysiol.1984.sp002830; SCOTT D, 1985, Q J EXP PHYSIOL CMS, V70, P365, DOI 10.1113/expphysiol.1985.sp002922; SCOTT D, 1987, Q J EXP PHYSIOL CMS, V72, P331, DOI 10.1113/expphysiol.1987.sp003078; SCOTT D, 1995, J AGR SCI-CAMBRIDGE, V124, P145, DOI 10.1017/S0021859600071355; Shen XY, 2006, CAN VET J, V47, P902; Shen XY, 2011, AGR SCI CHINA, V10, P1618, DOI 10.1016/S1671-2927(11)60159-4; Shen XY, 2012, J WILDLIFE DIS, V48, P542, DOI 10.7589/0090-3558-48.3.542; SHUPE JL, 1988, AM J VET RES, V49, P1629; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P306, DOI 10.1079/9781845934729.0306; Tiffany ME, 2002, J ANIM SCI, V80, P260; Wang J, 2004, VET CLIN DIAGNOSIS; Wang K, 1996, TRACE ELEMENT LIFE S; Wang Z, 1995, MINERAL ELEMENT META; Yuan-Rong, 2011, AFR J BIOTECHNOL, V10, P17043, DOI 10.5897/AJB11.2398; ZHANG D, 1989, J GANSU AGR U, V3, P324	29	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89472	10.1371/journal.pone.0089472	http://dx.doi.org/10.1371/journal.pone.0089472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586803	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900146
J	Usami, M; Iwadare, Y; Watanabe, K; Kodaira, M; Ushijima, H; Tanaka, T; Harada, M; Tanaka, H; Sasaki, Y; Saito, K				Usami, Masahide; Iwadare, Yoshitaka; Watanabe, Kyota; Kodaira, Masaki; Ushijima, Hirokage; Tanaka, Tetsuya; Harada, Maiko; Tanaka, Hiromi; Sasaki, Yoshinori; Saito, Kazuhiko			Analysis of Changes in Traumatic Symptoms and Daily Life Activity of Children Affected by the 2011 Japan Earthquake and Tsunami over Time	PLOS ONE			English	Article							NORWEGIAN CHILDREN; STRESS-DISORDER; DISASTER; IMPACT	Background: On March 11, 2011, Japan was struck by a massive earthquake and tsunami. The tsunami caused tremendous damage and traumatized a number of people, including children. This study aimed to compare traumatic symptoms and daily life activity among children 20 months after the 2011 Great East Japan Earthquake and Tsunami with those observed after 8 months. Methods: The study comprised two groups. The first comprised 12,524 kindergarten, elementary school, and junior high school children in Ishinomaki City, Miyagi Prefecture, Japan, who were evaluated 8 months after the disaster. The second comprised 10,597 children from the same place who were evaluated 20 months after the disaster. The Post Traumatic Stress Symptoms for Children 15 items (PTSSC-15), a self-completion questionnaire on traumatic symptoms, and a questionnaire on children's daily life were distributed to the children. An effective response was obtained from 11,639 (92.9%, 8 months after) and 10,597 (86.9%, 20 months after) children. Results: The PTSSC-15 score was significantly higher in junior high school girls than in boys. The PTSSC-15 score was significantly higher in 4th-6th grade girls than in boys after 8 months. Elementary and junior high school children evaluated after 20 months had a significantly lower PTSSC-15 score than those evaluated after 8 months. The number of children having breakfast was significantly higher after 8 months than that after 20 months. In both the groups, children of all grades who had breakfast had a significantly lower PTSSC-15 score than those who did not have breakfast. Conclusions: We conclude that traumatic symptoms and daily life activity of children who survived the earthquake and tsunami improved over time.	[Usami, Masahide; Iwadare, Yoshitaka; Watanabe, Kyota; Ushijima, Hirokage; Tanaka, Tetsuya; Harada, Maiko; Tanaka, Hiromi; Sasaki, Yoshinori] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Chiba, Japan; [Kodaira, Masaki; Saito, Kazuhiko] Aiiku Hosp, Imperial Gift Fdn, Dept Child Mental Hlth, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Saiseikai Imperial Gift Foundation, Inc.	Usami, M (corresponding author), Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Chiba, Japan.	usami.masahide@hospk.ncgm.go.jp	Usami, Masahide/G-1404-2015	Usami, Masahide/0000-0002-1145-9971	National Center for Global Health and Medicine [24-108]; Soroptimist International of the Americas Japan Shimomatsu Region; Ishinomaki Rotary Club; Yaohigashi Rotary Club; Tokuyama Rotary Club	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Soroptimist International of the Americas Japan Shimomatsu Region; Ishinomaki Rotary Club; Yaohigashi Rotary Club; Tokuyama Rotary Club	This work was supported by the grant of National Center for Global Health and Medicine (24-108), Soroptimist International of the Americas Japan Shimomatsu Region, Ishinomaki Rotary Club, Yaohigashi Rotary Club, and Tokuyama Rotary Club. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsari S, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1001820; Becker SM, 2007, J CHILD ADOL PS NURS, V20, P148, DOI 10.1111/j.1744-6171.2007.00105.x; Butler D, 2011, NATURE, V472, P13, DOI 10.1038/472400a; Carballo M, 2005, J ROY SOC MED, V98, P396, DOI 10.1258/jrsm.98.9.396; Chance for Children, 2011, CHANC CHILDR ANN REP; Chemtob CM, 2008, ARCH PEDIAT ADOL MED, V162, P126, DOI 10.1001/archpediatrics.2007.36; Dyb Grete, 2011, Clin Child Psychol Psychiatry, V16, P621, DOI 10.1177/1359104510391048; Fukuchi N, 2012, J CHILD ABUSE NEGLEC, V14, P14; Hafstad GS, 2011, PSYCHOL TRAUMA-US, V3, P130, DOI 10.1037/a0023236; Hayashi K, 2012, ASIA-PAC J PUBLIC HE, V24, P681, DOI 10.1177/1010539512453255; Jensen TK, 2009, ARCH PEDIAT ADOL MED, V163, P856, DOI 10.1001/archpediatrics.2009.151; Jia ZB, 2010, QUAL LIFE RES, V19, P1381, DOI 10.1007/s11136-010-9703-8; Kato H, 1996, ACTA PSYCHIAT SCAND, V93, P477, DOI 10.1111/j.1600-0447.1996.tb10680.x; Kim BN, 2009, J CLIN PSYCHIAT, V70, P1148, DOI 10.4088/JCP.08m04896; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Mike T, 2011, No To Hattatsu, V43, P342; Mullett-Hume E, 2008, AM J ORTHOPSYCHIAT, V78, P103, DOI 10.1037/0002-9432.78.1.103; Nakahara S, 2013, J EPIDEMIOL, V23, P70, DOI 10.2188/jea.JE20120114; Oncu EC, 2010, CHILD DEV, V81, P1161, DOI 10.1111/j.1467-8624.2010.01460.x; Piyasil V, 2008, ASEAN J PSYCHIATR, V9, P99; Piyasil Vinadda, 2011, J Med Assoc Thai, V94 Suppl 3, pS138; Piyasil Vinadda, 2007, Journal of the Medical Association of Thailand, V90, P2370; Procter NG, 2011, HOLIST NURS PRACT, V25, P162, DOI 10.1097/HNP.0b013e31821a6955; Tominaga Y, 2002, HATTATSU SHINRI RINS, V8, p29.36; Ularntinon Sirirat, 2008, J Med Assoc Thai, V91 Suppl 3, pS69; Usami M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065398; Usami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050721; WEISAETH L, 1989, ACTA PSYCHIAT SCAND, V80, P13, DOI 10.1111/j.1600-0447.1989.tb05250.x; Weisz J.R., 2001, EUROPEAN CHILD ADOLE, V10, P12, DOI DOI 10.1007/S007870170003; WHO, 2005, TSUN WREAKS MENT HLT; WHO, MENT HLTH ASS POP AF; Wiguna T, 2010, ASIA-PAC PSYCHIAT, V2, P151, DOI 10.1111/j.1758-5872.2010.00079.x; Yamamoto A, 2011, INT NURS REV, V58, P332, DOI 10.1111/j.1466-7657.2011.00924.x	33	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88885	10.1371/journal.pone.0088885	http://dx.doi.org/10.1371/journal.pone.0088885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586427	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900057
J	Vuillier, F; Gaud, G; Guillemot, D; Commere, PH; Pons, C; Favre, M				Vuillier, Francoise; Gaud, Guillaume; Guillemot, Delphine; Commere, Pierre-Henri; Pons, Christian; Favre, Michel			Loss of the HPV-Infection Resistance EVER2 Protein Impairs NF-kappa B Signaling Pathways in Keratinocytes	PLOS ONE			English	Article							EPIDERMODYSPLASIA-VERRUCIFORMIS; SERIAL CULTIVATION; KINASE ALPHA; IKK-ALPHA; TRAF2; ACTIVATION; MECHANISMS; INFLAMMATION; EXPRESSION; MOUSE	Homozygous mutations in EVER genes cause epidermodysplasia verruciformis (EV), characterized by an immune defect and the development of skin cancers associated with beta- human papillomavirus (HPV) infections. The effects of EVER protein loss on the keratinocyte immune response remain unknown. We show here that EVER2 plays a critical role in the interplay between the NF-kappa B and JNK/AP-1 signaling pathways. EVER2-deficient cells overproduce IL-6 following the upregulation of JNK activation. They respond poorly to phorbol ester and TNF via the NF-kappa B pathway. They have lower levels of IKK alpha subunit, potentially accounting for impairments of p100 processing and the alternative NF-kappa B pathway. The loss of EVER2 is associated with an unusual TRAF protein profile. We demonstrate that EVER2 deficiency sustains TRAF2 ubiquitination and decreases the pool of TRAF2 available in the detergent-soluble fraction of the cell. Finally, we demonstrate that EVER2 loss induces constitutive PKC alpha-dependent c-jun phosphorylation and facilitates activation of the HPV5 long control region through a JNK-dependent pathway. These findings indicate that defects of the EVER2 gene may create an environment conducive to HPV replication and the persistence of lesions with the potential to develop into skin cancer.	[Vuillier, Francoise; Gaud, Guillaume; Guillemot, Delphine; Pons, Christian; Favre, Michel] Inst Pasteur, Unite Genet Papillomavirus & Canc Humain, Paris, France; [Commere, Pierre-Henri] Inst Pasteur, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Vuillier, F (corresponding author), Inst Pasteur, Unite Genet Papillomavirus & Canc Humain, Paris, France.	francoise.vuillier@pasteur.fr	Vuillier, Françoise/T-4699-2019	Vuillier, Francoise/0000-0002-5551-9876; Gaud, Guillaume/0000-0001-6066-806X	ANR [02601]; ARC [A09/1/5031]; Ligue Nationale Contre le Cancer [RS07/75-75]	ANR(French National Research Agency (ANR)); ARC(Australian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from the ANR (contract no 02601), ARC (contract no A09/1/5031) and the Ligue Nationale Contre le Cancer (contract no RS07/75-75) and by a donation from ODYSSE RE Holdings Corp. G. Gaud was supported by an ANR fellowship (contract no 02601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arron JR, 2002, J EXP MED, V196, P923, DOI 10.1084/jem.20020774; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Carpentier I, 1999, FEBS LETT, V460, P246, DOI 10.1016/S0014-5793(99)01356-3; Cassonnet P, 2011, NAT METHODS, V8, P990, DOI 10.1038/nmeth.1773; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chung JY, 2002, J CELL SCI, V115, P679; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Gaud G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.27; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jablonska S, 1997, CLIN DERMATOL, V15, P309, DOI 10.1016/S0738-081X(96)00170-8; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Leo E, 2001, J BIOL CHEM, V276, P8087, DOI 10.1074/jbc.M009450200; Li JJ, 1998, ONCOGENE, V16, P2711, DOI 10.1038/sj.onc.1201798; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; LIMAT A, 1986, J INVEST DERMATOL, V87, P485, DOI 10.1111/1523-1747.ep12455548; Liu B, 2011, CELL DEATH DIFFER, V18, P1854, DOI 10.1038/cdd.2011.56; Liu BG, 2006, P NATL ACAD SCI USA, V103, P17202, DOI 10.1073/pnas.0604481103; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; Majewski S, 1997, CLIN DERMATOL, V15, P321, DOI 10.1016/S0738-081X(96)00169-1; MAJEWSKI S, 1992, AM J MED SCI, V304, P174, DOI 10.1097/00000441-199209000-00006; Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008; Page A, 2010, J INVEST DERMATOL, V130, P1598, DOI 10.1038/jid.2010.28; Park E, 2007, CANCER RES, V67, P9158, DOI 10.1158/0008-5472.CAN-07-0590; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; van Hogerlinden M, 2002, ONCOGENE, V21, P4969, DOI 10.1038/sj.onc.1205620; Wang C, 2012, J EXP MED, V209, P77, DOI 10.1084/jem.20110675; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wicovsky A, 2009, ONCOGENE, V28, P1769, DOI 10.1038/onc.2009.29; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	40	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89479	10.1371/journal.pone.0089479	http://dx.doi.org/10.1371/journal.pone.0089479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586810	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900148
J	Zhou, J; Leu, NA; Eckardt, S; McLaughlin, KJ; Wang, PJ				Zhou, Jian; Leu, N. Adrian; Eckardt, Sigrid; McLaughlin, K. John; Wang, P. Jeremy			STK31/TDRD8, a Germ Cell-Specific Factor, Is Dispensable for Reproduction in Mice	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; STRUCTURAL BASIS; GENE-EXPRESSION; TUDOR DOMAINS; PIWI PROTEINS; BIOGENESIS; NUAGE; RNA; SPERMATOGENESIS; SPERMIOGENESIS	Tudor domain containing (Tdrd) proteins that are expressed in germ cells are divided into two groups. One group, consisting of TDRD1, TDRKH, TDRD9 and TDRD12, function in piRNA biogenesis and retrotransposon silencing, while the other group including RNF17/TDRD4 and TDRD5-7 are required for spermiogenesis. These Tdrd proteins play distinct roles during male germ cell development. Here, we report the characterization of STK31/TDRD8 in mice. STK31 contains a tudor domain and a serine/threonine kinase domain. We find that STK31 is a cytoplasmic protein in germ cells. STK31 is expressed in embryonic gonocytes of both sexes and postnatal spermatocytes and round spermatids in males. Disruption of the tudor domain and kinase domain of STK31 respectively does not affect fertility in mice. Our data suggest that the function of STK31 may be redundant with other Tdrd proteins in germ cell development.	[Zhou, Jian; Leu, N. Adrian; Wang, P. Jeremy] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Eckardt, Sigrid; McLaughlin, K. John] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA	University of Pennsylvania; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Wang, PJ (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	pwang@vet.upenn.edu	McLaughlin, Kenneth/E-3648-2011	Zhou, Jian/0000-0002-7061-5815	National Institutes of Health/National Institute of General Medical Sciences [GM089893, GM076327]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076327, R01GM089893] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences (Grant number GM089893 and GM076327 to PJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2012, EMBO J, V31, P870, DOI 10.1038/emboj.2011.449; Bao J, 2013, MOL REPROD DEV; Bao JQ, 2012, HISTOCHEM CELL BIOL, V137, P377, DOI 10.1007/s00418-011-0897-9; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Callebaut I, 1997, BIOCHEM J, V321, P125, DOI 10.1042/bj3210125; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Fok KL, 2012, CARCINOGENESIS, V33, P2044, DOI 10.1093/carcin/bgs246; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu HP, 2010, GENE DEV, V24, P1876, DOI 10.1101/gad.1956010; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Olesen C, 2007, CELL TISSUE RES, V328, P207, DOI 10.1007/s00441-006-0205-5; Pan JY, 2005, DEVELOPMENT, V132, P4029, DOI 10.1242/dev.02003; Pandey RR, 2013, P NATL ACAD SCI USA, V110, P16492, DOI 10.1073/pnas.1316316110; Pek JW, 2012, DEVELOPMENT, V139, P2255, DOI 10.1242/dev.073304; Ponting CP, 1997, TRENDS BIOCHEM SCI, V22, P51, DOI 10.1016/S0968-0004(96)30049-2; REDDI PP, 1995, BIOL REPROD, V53, P873, DOI 10.1095/biolreprod53.4.873; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Sabeur K, 2008, MOL REPROD DEV, V75, P867, DOI 10.1002/mrd.20792; Saxe JP, 2013, EMBO J, V32, P1869, DOI 10.1038/emboj.2013.121; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Su YQ, 2012, P NATL ACAD SCI USA, V109, P18653, DOI 10.1073/pnas.1216904109; Su YQ, 2012, SCIENCE, V335, P1496, DOI 10.1126/science.1214680; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tanaka T, 2011, P NATL ACAD SCI USA, V108, P10579, DOI 10.1073/pnas.1015447108; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Vasileva A, 2009, CURR BIOL, V19, P630, DOI 10.1016/j.cub.2009.02.047; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Yabuta Y, 2011, J CELL BIOL, V192, P781, DOI 10.1083/jcb.201009043; Yokoe T, 2008, CANCER RES, V68, P1074, DOI 10.1158/0008-5472.CAN-07-0964; Yu JY, 2001, BIOL REPROD, V65, P1260, DOI 10.1095/biolreprod65.4.1260; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011; Zhou J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002516	41	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89471	10.1371/journal.pone.0089471	http://dx.doi.org/10.1371/journal.pone.0089471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586802	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900145
J	Wang, XY; Kang, WY; Yang, Q; Zhang, LY; Chen, SD; Liu, J				Wang, Xiao-Ying; Kang, Wen-Yan; Yang, Qiong; Zhang, Lin-Yuan; Chen, Sheng-Di; Liu, Jun			Using Gastrocnemius sEMG and Plasma alpha-Synuclein for the Prediction of Freezing of Gait in Parkinson's Disease Patients	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; MUSCLE ACTIVATION; DJ-1	Freezing of gait (FOG) is a complicated gait disturbance in Parkinson's disease (PD) and a relevant subclinical predictor algorithm is lacking. The main purpose of this study is to explore the potential value of surface electromyograph (sEMG) and plasma alpha-synuclein levels as predictors of the FOG seen in PD. 21 PD patients and 15 normal controls were recruited. Motor function was evaluated using the Unified Parkinson's Disease Rating Scale (UPDRS) and Freezing of gait questionnaire (FOG-Q). Simultaneously, gait analysis was also performed using VICON capture system in PD patients and sEMG data was recorded as well. Total plasma alpha-synuclein was quantitatively assessed by Luminex assay in all participants. Recruited PD patients were classified into two groups: PD patients with FOG (PD+FOG) and without FOG (PD-FOG), based on clinical manifestation, the results of the FOG-Q and VICON capture system. PD+FOG patients displayed higher FOG-Q scores, decreased walking speed, smaller step length, smaller stride length and prolonged double support time compared to the PD-FOG in the gait trial. sEMG data indicated that gastrocnemius activity in PD+FOG patients was significantly reduced compared to PD-FOG patients. In addition, plasma alpha-synuclein levels were significantly decreased in the PD+FOG group compared to control group; however, no significant difference was found between the PD+FOG and PD-FOG groups. Our study revealed that gastrocnemius sEMG could be used to evaluate freezing gait in PD patients, while plasma alpha-synuclein might discriminate freezing of gait in PD patients from normal control, though no difference was found between the PD+FOG and PD-FOG groups.	[Chen, Sheng-Di] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China; Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Inst Neurol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, SD (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China.	chen_sd@medmail.com.cn; jly0520@hotmail.com			National Program of Basic Research of China [2010CB945200, 2011CB504104]; National Natural Science Fund [81071024, 81171202, 30872729, 30870879, 81129018]; Shanghai Shuguang Program [11SG20]; Fifth National Undergraduate Student Innovating Program [2011015]	National Program of Basic Research of China(National Basic Research Program of China); National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Shanghai Shuguang Program; Fifth National Undergraduate Student Innovating Program	This work was supported by grants from the National Program of Basic Research (2010CB945200, 2011CB504104) of China, National Natural Science Fund (81071024, 81171202, 30872729, 30870879 and 81129018), Shanghai Shuguang Program (11SG20) and the Fifth National Undergraduate Student Innovating Program (2011015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani G, 2003, FUNCT NEUROL, V18, P165; Caliandro P, 2011, GAIT POSTURE, V33, P436, DOI 10.1016/j.gaitpost.2010.12.020; Chee R, 2009, BRAIN, V132, P2151, DOI 10.1093/brain/awp053; Cioni M, 1997, ITAL J NEUROL SCI, V18, P195, DOI 10.1007/BF02080464; Dietz V, 1995, ELECTROMYOGR MOTOR C, V97, P408, DOI 10.1016/0924-980X(95)00109-X; Dietz V, 1997, ELECTROEN CLIN NEURO, V103, P333, DOI 10.1016/S0013-4694(97)00047-7; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Giladi N, 2008, MOVEMENT DISORD, V23, pS482, DOI 10.1002/mds.21914; Giladi N, 2009, MOVEMENT DISORD, V24, P655, DOI 10.1002/mds.21745; Gruden MA, 2013, BEHAV BRAIN RES, V243, P205, DOI 10.1016/j.bbr.2013.01.011; Hallett M, 2008, MOVEMENT DISORD, V23, pS439, DOI 10.1002/mds.21836; Hass CJ, 2008, CLIN BIOMECH, V23, P743, DOI 10.1016/j.clinbiomech.2008.02.012; Mitoma H, 2000, J NEUROL SCI, V174, P22, DOI 10.1016/S0022-510X(99)00329-9; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Nieuwboer A, 2004, BRAIN, V127, P1650, DOI 10.1093/brain/awh189; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; de Souza LAPS, 2011, J ELECTROMYOGR KINES, V21, P376, DOI 10.1016/j.jelekin.2010.10.013; Pelkonen A, 2011, NEUROSCI LETT, V487, P350, DOI 10.1016/j.neulet.2010.10.054; Ritz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036199; Roiz RD, 2010, ARQ NEURO-PSIQUIAT, V68, P81, DOI 10.1590/S0004-282X2010000100018; Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009; Snijders AH, 2008, MOVEMENT DISORD, V23, pS468, DOI 10.1002/mds.22144; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Gamo JV, 2010, NEUROLOGIA, V25, P27; Waragai M, 2006, BIOCHEM BIOPH RES CO, V345, P967, DOI 10.1016/j.bbrc.2006.05.011	27	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89353	10.1371/journal.pone.0089353	http://dx.doi.org/10.1371/journal.pone.0089353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586710	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800019
J	Watanabe, S; Takamatsu, A				Watanabe, Shin; Takamatsu, Atsuko			Transportation Network with Fluctuating Input/Output Designed by the Bio-Inspired Physarum Algorithm	PLOS ONE			English	Article								In this paper, we propose designing transportation network topology and traffic distribution under fluctuating conditions using a bio-inspired algorithm. The algorithm is inspired by the adaptive behavior observed in an amoeba-like organism, plasmodial slime mold, more formally known as plasmodium of Physarum plycephalum. This organism forms a transportation network to distribute its protoplasm, the fluidic contents of its cell, throughout its large cell body. In this process, the diameter of the transportation tubes adapts to the flux of the protoplasm. The Physarum algorithm, which mimics this adaptive behavior, has been widely applied to complex problems, such as maze solving and designing the topology of railroad grids, under static conditions. However, in most situations, environmental conditions fluctuate; for example, in power grids, the consumption of electric power shows daily, weekly, and annual periodicity depending on the lifestyles or the business needs of the individual consumers. This paper studies the design of network topology and traffic distribution with oscillatory input and output traffic flows. The network topology proposed by the Physarum algorithm is controlled by a parameter of the adaptation process of the tubes. We observe various rich topologies such as complete mesh, partial mesh, Y-shaped, and V-shaped networks depending on this adaptation parameter and evaluate them on the basis of three performance functions: loss, cost, and vulnerability. Our results indicate that consideration of the oscillatory conditions and the phase-lags in the multiple outputs of the network is important: The building and/or maintenance cost of the network can be reduced by introducing the oscillating condition, and when the phase-lag among the outputs is large, the transportation loss can also be reduced. We use stability analysis to reveal how the system exhibits various topologies depending on the parameter.	[Watanabe, Shin; Takamatsu, Atsuko] Waseda Univ, Dept Elect Engn & Biosci, Shinjuku Ku, Tokyo, Japan	Waseda University	Takamatsu, A (corresponding author), Waseda Univ, Dept Elect Engn & Biosci, Shinjuku Ku, Tokyo, Japan.	atsuko_ta@waseda.jp	Takamatsu, Atsuko/V-4902-2018	Takamatsu, Atsuko/0000-0002-5974-9820	Strategic Research Foundation from MEXT [S1001027];  [24.4255]	Strategic Research Foundation from MEXT; 	This work is partly supported by a grant of Strategic Research Foundation Grant-aided Project for Private Universities from MEXT, No. S1001027 and Grant-in-Aid for JSPS Fellows, No. 24.4255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamatzky A., 2010, WORLD SCI, DOI [10.1142/7968, DOI 10.1142/7968]; BURTON JL, 1985, ECOL ENTOMOL, V10, P131, DOI 10.1111/j.1365-2311.1985.tb00542.x; Dobson I, 2007, CHAOS, V17, DOI 10.1063/1.2737822; Hino H, 2013, IEEE T SMART GRID, V4, P1048, DOI 10.1109/TSG.2013.2240319; Ito M, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.074801; Keener J., 1998, INTERD APPL, V8; Latty T, 2011, J R SOC INTERFACE, V8, P1298, DOI 10.1098/rsif.2010.0612; Li K, 2010, LECT NOTES COMPUT SC, V6234, P299, DOI 10.1007/978-3-642-15461-4_26; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Nakagaki T, 2004, P ROY SOC B-BIOL SCI, V271, P2305, DOI 10.1098/rspb.2004.2856; Nakagaki T, 2001, BIOPHYS CHEM, V92, P47, DOI 10.1016/S0301-4622(01)00179-X; Takamatsu A, 2009, J THEOR BIOL, V256, P29, DOI 10.1016/j.jtbi.2008.09.010; Tao T, 2004, J PHYS SOC JPN, V73, P2333, DOI 10.1143/JPSJ.73.2333; Tero A, 2007, J THEOR BIOL, V244, P553, DOI 10.1016/j.jtbi.2006.07.015; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; Watanabe S, 2011, BIOSYSTEMS, V105, P225, DOI 10.1016/j.biosystems.2011.05.001	17	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89231	10.1371/journal.pone.0089231	http://dx.doi.org/10.1371/journal.pone.0089231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586616	gold, Green Submitted, Green Published			2022-12-27	WOS:000332389000034
J	Aanes, H; Winata, C; Moen, LF; Ostrup, O; Mathavan, S; Collas, P; Rognes, T; Alestrom, P				Aanes, Havard; Winata, Cecilia; Moen, Lars F.; Ostrup, Olga; Mathavan, Sinnakaruppan; Collas, Philippe; Rognes, Torbjorn; Alestrom, Peter			Normalization of RNA-Sequencing Data from Samples with Varying mRNA Levels	PLOS ONE			English	Article							GENE-EXPRESSION; SEQ; ZEBRAFISH; TRANSCRIPTOME; QUANTIFICATION; TRANSITION; DYNAMICS; EMBRYOS; PCR	Methods for normalization of RNA-sequencing gene expression data commonly assume equal total expression between compared samples. In contrast, scenarios of global gene expression shifts are many and increasing. Here we compare the performance of three normalization methods when polyA(+) RNA content fluctuates significantly during zebrafish early developmental stages. As a benchmark we have used reverse transcription-quantitative PCR. The results show that reads per kilobase per million (RPKM) and trimmed mean of M-values (TMM) normalization systematically leads to biased gene expression estimates. Biological scaling normalization (BSN), designed to handle differences in total expression, showed improved accuracy compared to the two other methods in estimating transcript level dynamics. The results have implications for past and future studies using RNA-sequencing on samples with different levels of total or polyA(+) RNA.	[Aanes, Havard; Moen, Lars F.; Alestrom, Peter] Norwegian Sch Vet Sci, BasAM, Oslo, Norway; [Winata, Cecilia; Mathavan, Sinnakaruppan] Genome Inst Singapore, Singapore, Singapore; [Ostrup, Olga; Collas, Philippe] Univ Oslo, Stem Cell Epigenet Lab, Inst Basic Med Sci, Fac Med, Oslo, Norway; [Rognes, Torbjorn] Univ Oslo, Dept Informat, N-0316 Oslo, Norway	Norwegian University of Life Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Oslo; University of Oslo	Aanes, H (corresponding author), Norwegian Sch Vet Sci, BasAM, Oslo, Norway.	haavarda@nvh.no; petera@nvh.no	Østrup, Olga/P-2981-2015; Rognes, Torbjørn/A-9692-2008	Rognes, Torbjørn/0000-0002-9329-9974; , Olga/0000-0002-5564-2356; winata, cecilia/0000-0002-7718-5248	Research Council of Norway; Norwegian Center for Stem Cell Research; A*STAR, Singapore; Carlsberg foundation; Norwegian School of Veterinary Science	Research Council of Norway(Research Council of Norway); Norwegian Center for Stem Cell Research; A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); Carlsberg foundation(Carlsberg Foundation); Norwegian School of Veterinary Science	This work was supported by grants from the Research Council of Norway, the Norwegian Center for Stem Cell Research, A*STAR, Singapore and the Carlsberg foundation (OO). HA holds a PhD fellowship from the Norwegian School of Veterinary Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Evsikov AV, 2009, MOL REPROD DEV, V76, P805, DOI 10.1002/mrd.21038; Gilbert I, 2009, MOL REPROD DEV, V76, P762, DOI 10.1002/mrd.21030; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KONSTANTINOVA IM, 1977, MOL CELL BIOCHEM, V18, P29, DOI 10.1007/BF00215276; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Peaston AE, 2010, METHOD ENZYMOL, V477, P481, DOI 10.1016/S0076-6879(10)77024-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIKO L, 1982, DEV BIOL, V89, P362, DOI 10.1016/0012-1606(82)90325-6; Qing T, 2013, SCI CHINA LIFE SCI, V56, P134, DOI 10.1007/s11427-013-4437-9; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; SAGATA N, 1980, DEV BIOL, V77, P431, DOI 10.1016/0012-1606(80)90486-8; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30	24	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89158	10.1371/journal.pone.0089158	http://dx.doi.org/10.1371/journal.pone.0089158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586560	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900030
J	Yi, SY; Shirasu, K; Moon, JS; Lee, SG; Kwon, SY				Yi, So Young; Shirasu, Ken; Moon, Jae Sun; Lee, Seung-Goo; Kwon, Suk-Yoon			The Activated SA and JA Signaling Pathways Have an Influence on flg22-Triggered Oxidative Burst and Callose Deposition	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; ACID-DEPENDENT DEFENSES; INNATE IMMUNE-RESPONSE; SALICYLIC-ACID; PSEUDOMONAS-SYRINGAE; PLANT DEFENSE; ARABIDOPSIS-THALIANA; ISOCHORISMATE SYNTHASE; TRANSCRIPTION FACTOR; BACTERIAL FLAGELLIN	The first line of defense in plants against pathogens is induced by the recognition of microbe-associated molecular patterns (MAMP). Perception of bacterial flagellin (flg22) by the pattern recognition receptor flagellin-sensing 2 (FLS2) is the best characterized MAMP response, although the underlying molecular mechanisms are not fully understood. Here we studied the relationship between salicylic acid (SA) or jasmonic acid (JA) signaling and FLS2-mediated signaling by monitoring flg22-triggered responses in known SA or JA related mutants of Arabidopsis thaliana (L.) Heynh. The sid2 mutant, impaired in SA biosynthesis, had less basal FLS2 mRNA accumulation than the wild type, which correlated with suppression of early flg22 responses such as ROS production and induction of marker genes, WRKY29 and FRK1. The JA-signaling mutants, jar1 and coi1, exhibited an enhanced flg22-triggered oxidative burst and more callose accumulation than the wild type, and pretreatment with SA or coronatine (COR), a structural mimic of JA-isoleucine, altered these flg22-induced responses. Nonexpressor of pathogenesis-related genes 1 (NPR1) acted downstream of SID2 and required SA-dependent priming for the enhanced flg22-triggered oxidative burst and callose deposition. Activation of JA signaling by COR pretreatment suppressed the flg22-triggered oxidative burst and callose accumulation in a coronatine insensitive 1 (COI1) dependent manner. COR had a negative effect on flg22 responses but only the flg22-triggered oxidative burst depended on SA-JA/COR signaling antagonism. Thus the activated SA and JA signaling pathways have an influence on flg22-triggered oxidative burst and callose deposition. These results may explain how SA and JA signaling are cross talked for regulation of flg22-triggered responses.	[Yi, So Young; Moon, Jae Sun; Kwon, Suk-Yoon] KRIBB, Plant Syst Engn Res Ctr, Taejon, South Korea; [Shirasu, Ken] RIKEN Ctr Sustainable Resource Sci, Plant Immun Res Grp, Yokohama, Kanagawa, Japan; [Lee, Seung-Goo] KRIBB, Biochem & Synthet Biol Res Ctr, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); RIKEN; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Yi, SY (corresponding author), KRIBB, Plant Syst Engn Res Ctr, Taejon, South Korea.	yisy@kribb.re.kr; sykwon@kribb.re.kr	Shirasu, Ken/ABF-5306-2020; Lee, Seung-Goo/AAS-1613-2021; Shirasu, Ken/A-4455-2010; Lee, Seung-Goo/AAR-9823-2021	Shirasu, Ken/0000-0002-0349-3870; Shirasu, Ken/0000-0002-0349-3870; Lee, Seung-Goo/0000-0003-4539-9812; Kwon, Suk-Yoon/0000-0002-5787-4898; Yi, So Young/0000-0002-1749-8859	Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Next-Generation BioGreen 21 Program of the Rural Development Administration of Korean [PJ0082002011]; Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program	Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Next-Generation BioGreen 21 Program of the Rural Development Administration of Korean; Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program	This work was supported by grants from Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea, the Next-Generation BioGreen 21 Program (PJ0082002011) of the Rural Development Administration of Korean, and the Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Boutrot F, 2010, P NATL ACAD SCI USA, V107, P14502, DOI 10.1073/pnas.1003347107; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chen HM, 2009, PLANT CELL, V21, P2527, DOI 10.1105/tpc.108.065193; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; DOARES SH, 1995, P NATL ACAD SCI USA, V92, P4095, DOI 10.1073/pnas.92.10.4095; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Felton GW, 1999, CURR BIOL, V9, P317, DOI 10.1016/S0960-9822(99)80140-7; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; FUJIWARA T, 1992, PLANT PHYSIOL, V99, P263, DOI 10.1104/pp.99.1.263; Galletti R, 2008, PLANT PHYSIOL, V148, P1695, DOI 10.1104/pp.108.127845; Geng XQ, 2012, PLANT CELL, V24, P4763, DOI 10.1105/tpc.112.105312; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; KAUSS H, 1995, PLANT PHYSIOL, V108, P1171, DOI 10.1104/pp.108.3.1171; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kloek AP, 2001, PLANT J, V26, P509, DOI 10.1046/j.1365-313x.2001.01050.x; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Laurie-Berry N, 2006, MOL PLANT MICROBE IN, V19, P789, DOI 10.1094/MPMI-19-0789; LAWTON KA, 1994, PLANT CELL, V6, P581, DOI 10.1105/tpc.6.5.581; Leon-Reyes A, 2010, PLANTA, V232, P1423, DOI 10.1007/s00425-010-1265-z; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Maleck K, 2002, GENETICS, V160, P1661; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Mersmann S, 2010, PLANT PHYSIOL, V154, P391, DOI 10.1104/pp.110.154567; Millet YA, 2010, PLANT CELL, V22, P973, DOI 10.1105/tpc.109.069658; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Moreau M, 2012, CELL RES, V22, P1631, DOI 10.1038/cr.2012.100; Moscatiello R, 2006, J EXP BOT, V57, P2847, DOI 10.1093/jxb/erl043; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Rogers EE, 1997, PLANT CELL, V9, P305, DOI 10.1105/tpc.9.3.305; Simpson SD, 1998, GLYCOBIOLOGY, V8, P579, DOI 10.1093/glycob/8.6.579; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Strawn MA, 2007, J BIOL CHEM, V282, P5919, DOI 10.1074/jbc.M605193200; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zhou N, 1998, PLANT CELL, V10, P1021, DOI 10.1105/tpc.10.6.1021	74	89	93	7	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88951	10.1371/journal.pone.0088951	http://dx.doi.org/10.1371/journal.pone.0088951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586453	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900022
J	Ait-Said, ED; Maquestiaux, F; Didierjean, A				Ait-Said, Elise Defrasne; Maquestiaux, Francois; Didierjean, Andre			Verbal Overshadowing of Memories for Fencing Movements Is Mediated by Expertise	PLOS ONE			English	Article							TUTORIAL DIALOGUES; VERBALIZATION; EXAMPLES; ANALOGY	Does verbalizing a previously-seen complex visual stimulus influence its subsequent recollection? We investigated this question by examining the mediating role played by expertise level in fencing on the effects of verbalizing upon visual memory. Participants with three distinct levels of expertise in fencing (novices, intermediates, experts) performed seven trials. In each trial, they first watched four times a short video that displayed fencing movements. Then, half of them verbalized the previously-seen visual stimulus (i.e., the verbalization group), the other half carried out a hidden-word task (i.e., the non-verbalization group). Finally, all the participants were asked to recognize the previously-seen fencing movements amongst novel fencing movements. Overall, verbalizing improved recognition for novices, altered recognition for intermediates, and had no effect for experts. These findings replicated the classical verbal-overshadowing effect, while extending it to a more conceptual material. They also point out to some potential benefits and costs of verbalizing on visual memory, depending on the level of expertise.	[Ait-Said, Elise Defrasne] Univ Franche Comte, F-25030 Besancon, France; [Maquestiaux, Francois] Univ Paris 11, Orsay, France; [Didierjean, Andre] Univ Franche Comte, Inst Univ France, F-25030 Besancon, France; [Didierjean, Andre] Univ Franche Comte, Psychol Lab, F-25030 Besancon, France	Universite de Franche-Comte; UDICE-French Research Universities; Universite Paris Saclay; Institut Universitaire de France; Universite de Franche-Comte; Universite de Franche-Comte	Ait-Said, ED (corresponding author), Univ Franche Comte, F-25030 Besancon, France.	defrasne@gmail.com	Maquestiaux, François/ABF-2432-2020	Maquestiaux, Francois/0000-0001-5439-3354				BRANDIMONTE MA, 1992, MEM COGNITION, V20, P449, DOI 10.3758/BF03210929; Brown C, 2005, MEM COGNITION, V33, P1442, DOI 10.3758/BF03193377; Chauvel G, 2013, PSYCHON B REV, V20, P177, DOI 10.3758/s13423-012-0331-x; Chauvel G, 2012, Q J EXP PSYCHOL, V65, P25, DOI 10.1080/17470218.2011.588714; Chi M.T.H, 2013, EXPERTISE SKILL ACQU, P1; Chi MTH, 2008, COGNITIVE SCI, V32, P301, DOI 10.1080/03640210701863396; CHI MTH, 1989, COGNITIVE SCI, V13, P145, DOI 10.1207/s15516709cog1302_1; CHI MTH, 1994, COGNITIVE SCI, V18, P439, DOI 10.1016/0364-0213(94)90016-7; Didierjean A, 1998, EUR J PSYCHOL EDUC, V13, P385, DOI 10.1007/BF03172952; FALLSHORE M, 1995, J EXP PSYCHOL LEARN, V21, P1608, DOI 10.1037/0278-7393.21.6.1608; Fiore SM, 2002, APPL COGNITIVE PSYCH, V16, P897, DOI 10.1002/acp.921; Flegal KE, 2008, PSYCHON B REV, V15, P927, DOI 10.3758/PBR.15.5.927; Fonseca BA, 2011, EDUC PSYCHOL HANDB, P296; Lloyd-Jones TJ, 2006, PSYCHON B REV, V13, P269, DOI 10.3758/BF03193842; Magill R.A., 2007, MOTOR LEARNING CONTR; Masters RSW, 2012, SKILL ACQUISITION SP, P59; Maxwell JP, 2001, Q J EXP PSYCHOL-A, V54, P1049, DOI 10.1080/02724980143000073; Melcher JM, 1996, J MEM LANG, V35, P231, DOI 10.1006/jmla.1996.0013; Melcher JM, 2004, MEM COGNITION, V32, P618, DOI 10.3758/BF03195853; Nakabayashi K, 2012, J EXP PSYCHOL LEARN, V38, P376, DOI 10.1037/a0025782; Perfect TJ, 2002, APPL COGNITIVE PSYCH, V16, P973, DOI 10.1002/acp.920; PIROLLI P, 1994, COGNITION INSTRUCT, V12, P235, DOI 10.1207/s1532690xci1203_2; Renkl A, 1997, COGNITIVE SCI, V21, P1, DOI 10.1207/s15516709cog2101_1; Ryan RS, 1998, APPL COGNITIVE PSYCH, V12, pS105; Schooler JW, 2002, APPL COGNITIVE PSYCH, V16, P989, DOI 10.1002/acp.930; SCHOOLER JW, 1990, COGNITIVE PSYCHOL, V22, P36, DOI 10.1016/0010-0285(90)90003-M; Starkes J. L., 2003, EXPERT PERFORMANCE S; SWELLER J, 1988, COGNITIVE SCI, V12, P257, DOI 10.1207/s15516709cog1202_4; Vanags T, 2005, APPL COGNITIVE PSYCH, V19, P1127, DOI 10.1002/acp.1160; VanLehn K, 1998, COGNITIVE SCI, V22, P347, DOI 10.1207/s15516709cog2203_4; VanLehn K, 2007, COGNITIVE SCI, V31, P3, DOI 10.1080/03640210709336984	32	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89276	10.1371/journal.pone.0089276	http://dx.doi.org/10.1371/journal.pone.0089276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3VI	24586652	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900078
J	Nguyen, PH; Nguyen, H; Gonzalez-Casanova, I; Copeland, E; Strizich, G; Lowe, A; Pham, H; Truong, TV; Nguyen, S; Martorell, R; Ramakrishnan, U				Nguyen, Phuong H.; Hieu Nguyen; Gonzalez-Casanova, Ines; Copeland, Erika; Strizich, Garrett; Lowe, Alyssa; Pham, Hoa; Truong, Truong V.; Nguyen, Son; Martorell, Reynaldo; Ramakrishnan, Usha			Micronutrient Intakes among Women of Reproductive Age in Vietnam	PLOS ONE			English	Article							DIETARY ASSESSMENT METHODS; FOOD-CONSUMPTION PATTERNS; SUPPLEMENTATION; PREGNANCY; TRIAL; IRON; ZINC	Background: Micronutrient deficiencies are a public health concern worldwide negatively affecting maternal and child health outcomes. The primary underlying causes of micronutrient deficiencies are insufficient intake and poor bioavailability of micronutrients. However, reliable data on micronutrient intakes are sparse. The objectives of this study were to identify the key local food sources providing the majority of micronutrients and assess the adequacy and determinants of micronutrient intakes. Methods: The study used data from a survey of 4,983 rural women of reproductive age (WRA) participating in a preconception micronutrient supplementation trial in Vietnam. Micronutrient intakes were assessed using a validated 107-item semi-quantitative food-frequency questionnaire. Multivariate linear and logistic regression analyses were used to examine the association between socioeconomic status and micronutrient intakes. Results: Starchy staples were the main source of iron and zinc (37% and 54%, respectively) with only a small proportion from meat (10% and 18%, respectively). The primary source of folate and vitamin A were vegetables; vitamin B12 came from meat and eggs. The proportion of the population with intakes below the estimated average requirement was 25% for iron, 16% for zinc, 54% for folate, 64% for vitamin B12 and 27% for vitamin A. Socioeconomic status was the main determinant of micronutrient intakes. WRA in the highest quintile consumed 26% more iron, 19% more zinc, 36% more folate, 82% more vitamin B12 and 47% more vitamin A compared to those in the lowest quintile. Women in the upper quintiles of SES were more likely to obtain nutrients from more nutritious and higher bioavailable foods than those in the lowest quintile. Conclusions: Underprivileged women were at increased risk for insufficient micronutrient intakes due to poor diet quality. Targeted efforts to promote the consumption of local nutrient rich foods along with educational programs and social development are needed.	[Nguyen, Phuong H.; Hieu Nguyen; Pham, Hoa; Truong, Truong V.; Nguyen, Son] Thai Nguyen Univ Pharm & Med, Thai Nguyen, Vietnam; [Nguyen, Phuong H.] Int Food Policy Res Inst, Hanoi, Vietnam; [Gonzalez-Casanova, Ines; Copeland, Erika; Lowe, Alyssa; Martorell, Reynaldo; Ramakrishnan, Usha] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Strizich, Garrett] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Thai Nguyen University; CGIAR; International Food Policy Research Institute (IFPRI); Emory University; Rollins School Public Health; Columbia University	Nguyen, PH (corresponding author), Thai Nguyen Univ Pharm & Med, Thai Nguyen, Vietnam.	P.H.Nguyen@cgiar.org	Gonzalez-Casanova, Ines/S-7398-2019; Martorell, Reynaldo/I-2539-2012; Ramakrishnan, Usha/L-8921-2016	Gonzalez-Casanova, Ines/0000-0001-5747-8636; 	Mathile Institute for the Advancement of Human Nutrition; Micronutrient Initiative	Mathile Institute for the Advancement of Human Nutrition; Micronutrient Initiative	Funding for this research was provided by the Mathile Institute for the Advancement of Human Nutrition and the Micronutrient Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutta ZA, 2004, BMJ-BRIT MED J, V328, P816, DOI 10.1136/bmj.328.7443.816; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Dickey Vanessa C, 2002, Food Nutr Bull, V23, P78; Dien LN, 2004, ASIA PAC J CLIN NUTR, V13, P40; FAVRI, 2010, VEG MARK RES VIETN; Gwatkin D R, 2007, Niger J Clin Pract, V10, P272; Henriquez-Sanchez P, 2009, BRIT J NUTR, V102, pS10, DOI 10.1017/S0007114509993126; Hoang L.V., 2009, DEPOCEN WORKING PAPE; Hop LT, 2003, J NUTR, V133, p4006S, DOI 10.1093/jn/133.11.4006S; Huy ND, 2009, FOOD NUTR BULL, V30, pS506, DOI 10.1177/15648265090304S405; International Food Policy Research Institute (IFPRI), 2002, FRUITS VEG VIETN ADD; Laillou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050538; Laillou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034906; Hop LT, 2011, ASIA PAC J CLIN NUTR, V20, P495; Molini V, 2006, 200667 CTR WORLD FOO; Nguyen PH, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-126; Nguyen PH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-898; NIN MOH, 2007, VIETN FOOD COMP TABL; NIN MOH UNICEF, 2012, SUMM REP GEN NUTR SU; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; SAS, 2004, SAS POW KNOW; Semba RD, 2008, NUTR HEALTH SER, P1, DOI 10.1007/978-1-59745-464-3; Serra-Majem L, 2009, BRIT J NUTR, V102, pS38, DOI 10.1017/S0007114509993138; Seshadri S, 2001, BRIT J NUTR, V85, pS87, DOI 10.1079/BJN2000299; Swinkels R, 2004, PAC C 24 26 NOV 2004; Tran DT, 2009, THESIS U NEWCASTLE A; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2012, HLTH IND SUST CIT CO; WHO/FAO, 2004, VIT MIN REQ HUM NUTR, VSecond; Yen H, 2009, 555 VIETNAMESE DISHE	30	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89504	10.1371/journal.pone.0089504	http://dx.doi.org/10.1371/journal.pone.0089504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586831	Green Published, gold			2022-12-27	WOS:000331717900110
J	Arawaka, S; Fukushima, S; Sato, H; Sasaki, A; Koga, K; Koyama, S; Kato, T				Arawaka, Shigeki; Fukushima, Shingo; Sato, Hiroyasu; Sasaki, Asuka; Koga, Kaori; Koyama, Shingo; Kato, Takeo			Zonisamide Attenuates alpha-Synuclein Neurotoxicity by an Aggregation-Independent Mechanism in a Rat Model of Familial Parkinson's Disease	PLOS ONE			English	Article							COMPLEX-I; MPTP-TOXICITY; NEUROPROTECTION; INHIBITION; NEURODEGENERATION; PATHOGENESIS; EXPRESSION; DOPAMINE; NEURONS; VECTOR		[Arawaka, Shigeki; Fukushima, Shingo; Sato, Hiroyasu; Sasaki, Asuka; Koga, Kaori; Koyama, Shingo; Kato, Takeo] Yamagata Univ, Fac Med, Dept Neurol Hematol Metab Endocrinol & Diabetol, Yamagata 990, Japan	Yamagata University	Arawaka, S (corresponding author), Yamagata Univ, Fac Med, Dept Neurol Hematol Metab Endocrinol & Diabetol, Yamagata 990, Japan.	arawaka@med.id.yamagata-u.ac.jp		Arawaka, Shigeki/0000-0002-1505-3012				Asanuma M, 2010, ANN NEUROL, V67, P239, DOI 10.1002/ana.21885; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Choudhury ME, 2011, BRAIN RES, V1384, P170, DOI 10.1016/j.brainres.2011.02.017; Ciron C, 2009, HUM GENE THER, V20, P350, DOI 10.1089/hum.2008.155; Decressac M, 2011, BRAIN, V134, P2302, DOI 10.1093/brain/awr149; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Eriksen JL, 2003, NEURON, V40, P453, DOI 10.1016/S0896-6273(03)00684-6; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GLINKA YY, 1995, EUR J PHARM-ENVIRON, V292, P329, DOI 10.1016/0926-6917(95)90040-3; Kara E, 2013, NEUROSCI LETT, V546, P67, DOI 10.1016/j.neulet.2013.04.058; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; Machiya Y, 2010, J BIOL CHEM, V285, P40732, DOI 10.1074/jbc.M110.141952; Mori A, 1998, EPILEPSY RES, V30, P153, DOI 10.1016/S0920-1211(97)00097-1; Murata M, 2007, NEUROLOGY, V68, P45, DOI 10.1212/01.wnl.0000250236.75053.16; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okada M, 1995, EPILEPSY RES, V22, P193, DOI 10.1016/0920-1211(95)00078-X; Olanow CW, 2008, ANN NEUROL, V64, pS101, DOI 10.1002/ana.21461; Olanow CW, 2004, MOVEMENT DISORD, V19, P997, DOI 10.1002/mds.20243; Olanow CW, 2001, NEUROLOGY, V56, pS1, DOI 10.1212/WNL.56.suppl_5.S1; Olanow CW, 2005, MOVEMENT DISORD, V20, pS3, DOI 10.1002/mds.20457; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Rosler TW, 2010, EXP NEUROL, V224, P336, DOI 10.1016/j.expneurol.2010.04.017; Sato H, 2011, J NEUROSCI, V31, P16884, DOI 10.1523/JNEUROSCI.3967-11.2011; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Sonsalla PK, 2010, EXP NEUROL, V221, P329, DOI 10.1016/j.expneurol.2009.11.018; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yano R, 2009, J MOL NEUROSCI, V39, P211, DOI 10.1007/s12031-009-9181-z; Yu S, 2004, NEUROSCI LETT, V367, P34, DOI 10.1016/j.neulet.2004.05.118; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	34	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89076	10.1371/journal.pone.0089076	http://dx.doi.org/10.1371/journal.pone.0089076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586512	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700058
J	Hazama, K; Hayata-Takano, A; Uetsuki, K; Kasai, A; Encho, N; Shintani, N; Nagayasu, K; Hashimoto, R; Reglodi, D; Miyakawa, T; Nakazawa, T; Baba, A; Hashimoto, H				Hazama, Keisuke; Hayata-Takano, Atsuko; Uetsuki, Kazuki; Kasai, Atsushi; Encho, Naoki; Shintani, Norihito; Nagayasu, Kazuki; Hashimoto, Ryota; Reglodi, Dora; Miyakawa, Tsuyoshi; Nakazawa, Takanobu; Baba, Akemichi; Hashimoto, Hitoshi			Increased Behavioral and Neuronal Responses to a Hallucinogenic Drug in PACAP Heterozygous Mutant Mice	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; PREPULSE INHIBITION; DEFICIENT MICE; RECEPTOR; 5-HT2A; STRESS; SCHIZOPHRENIA; CORTEX; CORTICOSTERONE; EXPRESSION	Accumulating evidence from human genetic studies implicates the pituitary adenylate cyclase-activating polypeptide (PACAP) gene as a risk factor for psychiatric disorders, including schizophrenia and stress-related diseases. Mice with homozygous disruption of the PACAP gene display profound behavioral and neurological abnormalities that are ameliorated with the atypical antipsychotic and dopamine D-2 and serotonin (5-HT)(2) antagonist risperidone and the 5-HT2 receptor antagonist ritanserin; however, the underlying mechanisms remain unknown. Here, we investigated if PACAP heterozygous mutant (PACAP+/2) mice, which appear behaviorally normal, are vulnerable to aversive stimuli. PACAP+/2 mice were administered a 5-HT2 receptor agonist, (6)-2,5-dimethoxy-4-iodoamphetamine (DOI), a hallucinogenic drug, and their responses were compared with the littermate wild-type mice. After DOI injection, PACAP+/2 mice showed increased head-twitch responses, while their behavior was normal after saline. DOI induced deficits in sensorimotor gating, as determined by prepulse inhibition, specifically in PACAP+/2 mice. However, other 5-HT2 receptor-dependent responses, such as corticosterone release and hypothermia, were similarly observed in PACAP+/2 and wild-type mice. c-Fos expression analysis, performed in various brain regions, revealed that the DOI-induced increase in the number of c-Fos-positive cells was more pronounced in 5-HT(2)A receptor-negative cells in the somatosensory cortex in PACAP+/2 mice compared with wild-type mice. These results indicate that PACAP+/2 mice exhibit specific vulnerability to DOI-induced deficits in cortical sensory function, such as exaggerated head-twitch responses and sensorimotor gating deficits. Our findings provide insight into the neural mechanisms underlying impaired behavioral responses in which 5-HT2 receptors are implicated.	[Hazama, Keisuke; Uetsuki, Kazuki; Kasai, Atsushi; Encho, Naoki; Shintani, Norihito; Nagayasu, Kazuki; Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka, Japan; [Hayata-Takano, Atsuko; Hashimoto, Ryota; Hashimoto, Hitoshi] Chiba Univ, Hamamatsu Univ Sch Med, Kanazawa Univ,United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev,Osaka Univ, Suita, Osaka, Japan; [Hayata-Takano, Atsuko; Hashimoto, Ryota; Hashimoto, Hitoshi] Univ Fukui, Suita, Osaka, Japan; [Kasai, Atsushi] Osaka Univ, Inst Acad Initiat, Interdisciplinary Program Biomed Sci, Suita, Osaka, Japan; [Nagayasu, Kazuki; Nakazawa, Takanobu; Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, iPS Cell Based Res Project Brain Neuropharmacol &, Suita, Osaka, Japan; [Hashimoto, Ryota] Osaka Univ, Dept Psychiat, Grad Sch Med, Suita, Osaka, Japan; [Reglodi, Dora] Univ Pecs, Fac Med, Dept Anat, PTE MTA Lendulet PACAP Res Team, Pecs, Hungary; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi, Japan; [Baba, Akemichi] Hyogo Univ Hlth Sci, Sch Pharm, Kobe, Hyogo, Japan	Osaka University; Chiba University; Kanazawa University; Osaka University; University of Fukui; Osaka University; Osaka University; Osaka University; University of Pecs; Fujita Health University	Hashimoto, H (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka, Japan.	hasimoto@phs.osaka-u.ac.jp	Shintani, Norihito/D-5860-2014; Hashimoto, Ryota/AAE-3200-2019; Kasai, Atsushi/C-8073-2011; Shintani, Norihito/N-1600-2019; Hashimoto, Ryota/P-8572-2014; Miyakawa, Tsuyoshi/A-7741-2008; Hashimoto, Hitoshi/D-1209-2010	Shintani, Norihito/0000-0002-7850-9064; Hashimoto, Ryota/0000-0002-5941-4238; Kasai, Atsushi/0000-0002-1612-3078; Shintani, Norihito/0000-0002-7850-9064; Hashimoto, Ryota/0000-0002-5941-4238; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Hashimoto, Hitoshi/0000-0001-6548-4016; NAKAZAWA, Takanobu/0000-0003-4863-1277	Japan Society for the Promotion of Science (JSPS) [21390069, 23790295, 25460100, 11J03702]; Funding Program for Next Generation WorldLeading Researchers [S22LS0810]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Funding Program for Next Generation WorldLeading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (B), Grant numbers 21390069 (A. B.), 23790295, 25460100 (AH-T), Grant-in-Aid for JSPS Fellows, Grant number 11J03702 (KH), and the Funding Program for Next Generation WorldLeading Researchers, Grant number S22LS0810 (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago Y, 2013, BEHAV PHARMACOL, V24, P74, DOI 10.1097/FBP.0b013e32835cf3e5; Almli LM, 2013, AM J MED GENET B, V162B, P262, DOI 10.1002/ajmg.b.32145; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Darmani NA, 1996, PHYSIOL BEHAV, V60, P1495, DOI 10.1016/S0031-9384(96)00323-X; Fox MA, 2010, PSYCHOPHARMACOLOGY, V212, P13, DOI 10.1007/s00213-009-1694-1; Freson K, 2004, J CLIN INVEST, V113, P905, DOI 10.1172/JCI200419252; Gaszner B, 2012, NEUROSCIENCE, V202, P283, DOI 10.1016/j.neuroscience.2011.11.046; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Halberstadt AL, 2010, PSYCHOPHARMACOLOGY, V208, P179, DOI 10.1007/s00213-009-1718-x; Hashimoto H, 2000, J NEUROCHEM, V75, P1810, DOI 10.1046/j.1471-4159.2000.0751810.x; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hashimoto H, 2009, J NEUROCHEM, V110, P595, DOI 10.1111/j.1471-4159.2009.06168.x; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Hattori Satoko, 2012, Front Behav Neurosci, V6, P58, DOI 10.3389/fnbeh.2012.00058; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Matsuyama S, 2003, NEUROREPORT, V14, P2095, DOI 10.1097/00001756-200311140-00017; Meltzer HY, 2011, CURR OPIN PHARMACOL, V11, P59, DOI 10.1016/j.coph.2011.02.007; Meltzer HY, 2012, HANDB EXP PHARMACOL, V212, P87, DOI 10.1007/978-3-642-25761-2_4; Moreno JL, 2011, J NEUROSCI, V31, P1863, DOI 10.1523/JNEUROSCI.4230-10.2011; Mori T, 2012, J PHARMACOL SCI, V120, P70, DOI 10.1254/jphs.12R08CP; Nagai T, 2012, J PHARMACOL SCI, V120, P213, DOI 10.1254/jphs.12142FP; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Sakaue M, 2003, PSYCHOPHARMACOLOGY, V170, P73, DOI 10.1007/s00213-003-1515-x; Scruggs JL, 2000, J NEUROSCI, V20, P8846; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Tanaka K, 2006, J NEUROSCI, V26, P5091, DOI 10.1523/JNEUROSCI.4376-05.2006; Tsukiyama N, 2011, STRESS, V14, P368, DOI 10.3109/10253890.2010.544345; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Van de Kar LD, 2001, J NEUROSCI, V21, P3572, DOI 10.1523/JNEUROSCI.21-10-03572.2001; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Willins DL, 1997, J PHARMACOL EXP THER, V282, P699	36	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89153	10.1371/journal.pone.0089153	http://dx.doi.org/10.1371/journal.pone.0089153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586556	Green Published, gold			2022-12-27	WOS:000331714700067
J	Xu, F; Chen, G; Stevens, K; Zhou, HR; Qi, SX; Wang, ZY; Hong, X; Chen, XP; Yang, HF; Wang, CC; Ratcliffe, J				Xu, Fei; Chen, Gang; Stevens, Katherine; Zhou, HaiRong; Qi, ShengXiang; Wang, ZhiYong; Hong, Xin; Chen, XuPeng; Yang, HuaFeng; Wang, ChenChen; Ratcliffe, Julie			Measuring and Valuing Health-Related Quality of Life among Children and Adolescents in Mainland China - A Pilot Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; UTILITY 9D; ECONOMIC-EVALUATION; VALIDITY; VERSION; TIME; BEHAVIORS; MODULE; CARE	Background: The Child Health Utility 9D (CHU9D), a new generic preference-based health-related quality of life (HRQoL) instrument, has been validated for use in young people in both the UK and Australia. The main objectives of this study were to examine the feasibility of using a Chinese version of the CHU9D (CHU9D-CHN) to assess HRQoL and to investigate the association of physical activity, homework hours and sleep duration with HRQoL in children and adolescents in Mainland China. Methods: Data were collected using a multi-stage sampling method from grades 4-12 students in May 2013 in Nanjing, China. Consenting participants (N = 815) completed a self-administered questionnaire including the CHU9D-CHN instrument and information on physical activity, homework and sleep duration, self-reported health status, and socio-demographic characteristics. Descriptive and multivariate linear regression analyses were undertaken. CHU9D-CHN utility scores were generated by employing two scoring algorithms currently available for the instrument, the first derived from UK adults utilising the standard gamble (SG) valuation method and the second derived from Australian adolescents utilising the best-worst scaling (BWS) method. Results: It was found that CHU9D utility scores discriminated well in relation to self-reported health status and that better health status was significantly associated with higher utility scores regardless of which scoring algorithm was employed (both p < 0.001). The adjusted mean utilities were significantly higher for physically active than inactive students (0.023 by SG, 0.029 by BWS scoring methods, p < 0.05). An additional hour of doing homework and sleep duration were, separately, associated with mean utilities of -0.019 and 0.032 based on SG, and -0.021 and 0.040 according to BWS scoring algorithms (p < 0.01). Conclusion: The CHU9D-CHN shows promise for measuring and valuing the HRQoL of children and adolescents in China. Levels of self-reported physical activity, homework and sleep time were important influencers of utility scores.	[Xu, Fei; Zhou, HaiRong; Qi, ShengXiang; Wang, ZhiYong; Hong, Xin; Chen, XuPeng; Yang, HuaFeng; Wang, ChenChen] Nanjing Municipal Ctr Dis Control & Prevent, Dept Noncommunicable Dis Prevent, Nanjing, Jiangsu, Peoples R China; [Xu, Fei] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Chen, Gang; Ratcliffe, Julie] Flinders Univ S Australia, Flinders Hlth Econ Grp, Adelaide, SA 5001, Australia; [Stevens, Katherine] Univ Sheffield, Sheffield, S Yorkshire, England	Nanjing Medical University; Flinders University South Australia; University of Sheffield	Xu, F (corresponding author), Nanjing Municipal Ctr Dis Control & Prevent, Dept Noncommunicable Dis Prevent, Nanjing, Jiangsu, Peoples R China.	f.xufei@gmail.com	Ratcliffe, Julie/G-3169-2017; Stevens, Katherine/E-4679-2010	Ratcliffe, Julie/0000-0001-7365-1988; Stevens, Katherine/0000-0002-9018-6413; Chen, Gang/0000-0002-8385-5965	Nanjing Municipal Science and Technique Foundation [ZDX12019]; Young Medical Experts Project of Nanjing Medical Science and Technique Development Foundation, China [QRX11038]	Nanjing Municipal Science and Technique Foundation; Young Medical Experts Project of Nanjing Medical Science and Technique Development Foundation, China	The study was supported by the Nanjing Municipal Science and Technique Foundation (ZDX12019) and the Young Medical Experts Project of Nanjing Medical Science and Technique Development Foundation (QRX11038), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acock A.C., 2012, GENTLE INTRO STATA, V3rd; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Alberga AS, 2012, PEDIATR OBES, V7, P261, DOI 10.1111/j.2047-6310.2011.00046.x; [Anonymous], 2009, METH DEV NICE PUBL H; Chen G, 2014, PEDIATRICS, V133, pE868, DOI 10.1542/peds.2013-0622; Chiu HFK, 2013, BEHAV SLEEP MED, V11, P360, DOI 10.1080/15402002.2013.764524; Drummond M, 2001, ANN MED, V33, P344, DOI 10.3109/07853890109002088; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Frisen A, 2007, ACTA PAEDIATR, V96, P963, DOI 10.1111/j.1651-2227.2007.00333.x; Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092; Gopinath B, 2012, PEDIATRICS, V130, pE167, DOI 10.1542/peds.2011-3637; Griebsch I, 2005, PEDIATRICS, V115, pE600, DOI 10.1542/peds.2004-2127; HealthActCHQ, 2008, CHILD HLTH QUEST SCO; Hong X, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-148; Hu J, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-47; Lacy KE, 2012, QUAL LIFE RES, V21, P1085, DOI 10.1007/s11136-011-0014-5; Lau JTF, 2010, J PEDIATR PSYCHOL, V35, P99, DOI 10.1093/jpepsy/jsp035; Lehnert T, 2012, OBES REV, V13, P537, DOI 10.1111/j.1467-789X.2011.00980.x; Li JL, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-113; Lo CMH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-72; Mitchell RB, 2008, SLEEP QUALITY LIFE C, P139; Moodie M, 2010, VALUE HEALTH, V13, P1014, DOI 10.1111/j.1524-4733.2010.00780.x; Naughton MJ, 2003, QUAL LIFE RES, V12, P73, DOI 10.1023/A:1023585707046; Prosser LA, 2007, HEALTH QUAL LIFE OUT, V5, P42; Rabe-Hesketh S.S.A., 2005, MULTILEVEL LONGITUDI; Ratcliffe J, 2012, PHARMACOECONOMICS, V30, P713, DOI 10.2165/11597900-000000000-00000; Ratcliffe J, 2012, QUAL LIFE RES, V21, P717, DOI 10.1007/s11136-011-9971-y; Ratcliffe J, 2011, APPL HEALTH ECON HEA, V9, P15, DOI 10.2165/11536960-000000000-00000; Ravens-Sieberer U, 2006, KIDSCREEN QUESTIONNA; Ravens-Sieberer U, 2010, QUAL LIFE RES, V19, P1487, DOI 10.1007/s11136-010-9706-5; Stevens K, 2012, VALUE HEALTH, V15, P1092, DOI 10.1016/j.jval.2012.07.011; Stevens K, 2012, PHARMACOECONOMICS, V30, P729, DOI 10.2165/11599120-000000000-00000; Stevens K, 2011, APPL HEALTH ECON HEA, V9, P157, DOI 10.2165/11587350-000000000-00000; Stevens K, 2009, QUAL LIFE RES, V18, P1105, DOI 10.1007/s11136-009-9524-9; Stevens KJ, 2010, QUAL HEALTH RES, V20, P340, DOI 10.1177/1049732309358328; Varni James W, 2005, Health Qual Life Outcomes, V3, P34, DOI 10.1186/1477-7525-3-34; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Wille N, 2010, QUAL LIFE RES, V19, P875, DOI 10.1007/s11136-010-9648-y; World Health Organization, 1995, SOC SCI MED, V41, P1403, DOI [DOI 10.1016/0277-9536(95)00112-K, 10.1016/0277-9536(95)00112-k]	40	23	24	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89222	10.1371/journal.pone.0089222	http://dx.doi.org/10.1371/journal.pone.0089222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586607	Green Published, Green Accepted, gold			2022-12-27	WOS:000331714700075
J	de Vrieze, E; Moren, M; Metz, JR; Flik, G; Lie, KK				de Vrieze, Erik; Moren, Mari; Metz, Juriaan R.; Flik, Gert; Lie, Kai Kristoffer			Arachidonic Acid Enhances Turnover of the Dermal Skeleton: Studies on Zebrafish Scales	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; COD GADUS-MORHUA; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; PROSTAGLANDIN E-2; OSTEOCLASTIC ACTIVITY; CELL-PROLIFERATION; GOLDFISH SCALE; BONE-FORMATION; DIETARY RATIO	In fish nutrition, the ratio between omega-3 and omega-6 poly-unsaturated fatty acids influences skeletal development. Supplementation of fish oils with vegetable oils increases the content of omega-6 fatty acids, such as arachidonic acid in the diet. Arachidonic acid is metabolized by cyclooxygenases to prostaglandin E2, an eicosanoid with effects on bone formation and remodeling. To elucidate effects of poly-unsaturated fatty acids on developing and existing skeletal tissues, zebrafish (Danio rerio) were fed (micro-) diets low and high in arachidonic acid content. Elasmoid scales, dermal skeletal plates, are ideal to study skeletal metabolism in zebrafish and were exploited in the present study. The fatty acid profile resulting from a high arachidonic acid diet induced mild but significant increase in matrix resorption in ontogenetic scales of adult zebrafish. Arachidonic acid affected scale regeneration (following removal of ontogenetic scales): mineral deposition was altered and both gene expression and enzymatic matrix metalloproteinase activity changed towards enhanced osteoclastic activity. Arachidonic acid also clearly stimulates matrix metalloproteinase activity in vitro, which implies that resorptive effects of arachidonic acid are mediated by matrix metalloproteinases. The gene expression profile further suggests that arachidonic acid increases maturation rate of the regenerating scale; in other words, enhances turnover. The zebrafish scale is an excellent model to study how and which fatty acids affect skeletal formation.	[de Vrieze, Erik; Metz, Juriaan R.; Flik, Gert] Radboud Univ Nijmegen, Dept Organismal Anim Physiol, NL-6525 ED Nijmegen, Netherlands; [de Vrieze, Erik; Metz, Juriaan R.; Flik, Gert] Radboud Univ Nijmegen, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands; [Moren, Mari; Lie, Kai Kristoffer] NIFES Natl Inst Nutr & Seafood Res, Bergen, Norway	Radboud University Nijmegen; Radboud University Nijmegen	de Vrieze, E (corresponding author), Radboud Univ Nijmegen, Dept Organismal Anim Physiol, NL-6525 ED Nijmegen, Netherlands.	e.devrieze@science.ru.nl	de Vrieze, Erik/B-2541-2014; Metz, Juriaan R./A-3290-2012; Lie, Kai Kristoffer/AAM-8809-2020; Flik, Gert/C-8229-2011	de Vrieze, Erik/0000-0003-3448-3269; Metz, Juriaan R./0000-0002-1515-1958; Flik, Gert/0000-0001-9285-7957	Norwegian Research Council [NFR 185177/S40]; Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	Norwegian Research Council(Research Council of NorwayEuropean Commission); Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	This study was financed by the Norwegian Research Council (project number NFR 185177/S40) and the SmartMix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atalah E, 2011, AQUAC RES, V42, P1279, DOI 10.1111/j.1365-2109.2010.02716.x; Bessonart M, 1999, AQUACULTURE, V179, P265, DOI 10.1016/S0044-8486(99)00164-7; Boglino A, 2012, J APPL ICHTHYOL, V28, P411, DOI 10.1111/j.1439-0426.2012.01977.x; Brittijn SA, 2009, INT J DEV BIOL, V53, P835, DOI 10.1387/ijdb.082615sb; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Coetzee M, 2007, PROSTAG LEUKOTR ESS, V76, P35, DOI 10.1016/j.plefa.2006.10.001; Coetzee M, 2009, CELL BIOCHEM FUNCT, V27, P3, DOI 10.1002/cbf.1526; de Vrieze E, 2014, OSTEOPOROSIS INT, V25, P567, DOI 10.1007/s00198-013-2441-3; de Vrieze E, 2012, J APPL ICHTHYOL, V28, P388, DOI 10.1111/j.1439-0426.2012.01989.x; de Vrieze E, 2011, BONE, V48, P704, DOI 10.1016/j.bone.2010.12.017; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8; FLIK G, 1986, J EXP BIOL, V120, P249; Guerreiro PM, 2013, FISH PHYSIOL BIOCHEM, V39, P917, DOI 10.1007/s10695-012-9751-9; Halver JE, 2001, AQUAC RES, V32, P615, DOI 10.1046/j.1365-2109.2001.00597.x; Hofbauer L. C., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P268; Izquierdo MS, 1996, AQUACULT NUTR, V2, P183, DOI 10.1111/j.1365-2095.1996.tb00058.x; Jaya-Ram A, 2008, AQUACULTURE, V277, P275, DOI 10.1016/j.aquaculture.2008.02.027; Kaunitz JD, 2008, J CELL BIOCHEM, V105, P655, DOI 10.1002/jcb.21885; Kjorsvik E, 2009, AQUACULTURE, V294, P246, DOI 10.1016/j.aquaculture.2009.06.012; KleinNulend J, 1997, J BONE MINER RES, V12, P45, DOI 10.1359/jbmr.1997.12.1.45; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Kruger MC, 2010, PROG LIPID RES, V49, P438, DOI 10.1016/j.plipres.2010.06.002; Kruger MC, 2005, PROSTAG LEUKOTR ESS, V73, P327, DOI 10.1016/j.plefa.2005.08.001; Lall SP, 2007, AQUACULTURE, V267, P3, DOI 10.1016/j.aquaculture.2007.02.053; Lie KK, 2012, COMP BIOCHEM PHYS A, V161, P174, DOI 10.1016/j.cbpa.2011.10.023; LIE O, 1991, COMP BIOCHEM PHYS A, V98, P159, DOI 10.1016/0300-9629(91)90594-3; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lund I, 2007, AQUACULTURE, V273, P532, DOI 10.1016/j.aquaculture.2007.10.047; Martens LG, 2010, J FISH DIS, V33, P957, DOI 10.1111/j.1365-2761.2010.01201.x; Metz JR, 2012, J APPL ICHTHYOL, V28, P382, DOI 10.1111/j.1439-0426.2012.01990.x; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; NOLAN RD, 1983, CALCIFIED TISSUE INT, V35, P294, DOI 10.1007/BF02405049; Omori K, 2012, ZOOL SCI, V29, P499, DOI 10.2108/zsj.29.499; Poulsen RC, 2007, EXP BIOL MED, V232, P1275, DOI 10.3181/0704-MR-100; Poulsen RC, 2006, PROSTAG LEUKOTR ESS, V75, P419, DOI 10.1016/j.plefa.2006.08.003; Rivest S, 2010, PROG BRAIN RES, V181, P43, DOI 10.1016/S0079-6123(08)81004-7; Rotllant J, 2005, REGUL PEPTIDES, V132, P33, DOI 10.1016/j.regpep.2005.08.004; Searby ND, 2005, AM J PHYSIOL-CELL PH, V289, pC148, DOI 10.1152/ajpcell.00524.2003; Sire JY, 2003, BIOL REV, V78, P219, DOI 10.1017/S1464793102006073; SIRE JY, 1989, TISSUE CELL, V21, P447, DOI 10.1016/0040-8166(89)90058-X; SMITH WL, 1989, BIOCHEM J, V259, P315, DOI 10.1042/bj2590315; Solakivi T, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-11; Suzuki N, 2000, PEPTIDES, V21, P115, DOI 10.1016/S0196-9781(99)00181-3; Takahashi H, 2008, ZOOL SCI, V25, P739, DOI 10.2108/zsj.25.739; Thamamongood TA, 2012, BONE, V50, P1240, DOI 10.1016/j.bone.2012.03.021; To TT, 2012, DEVELOPMENT, V139, P141, DOI 10.1242/dev.071035; Tocher DR, 2001, FISH PHYSIOL BIOCHEM, V24, P309, DOI 10.1023/A:1015022406790; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viegas MN, 2012, J APPL ICHTHYOL, V28, P427, DOI 10.1111/j.1439-0426.2012.01994.x; Villalta M, 2005, AQUACULTURE, V245, P193, DOI 10.1016/j.aquaculture.2004.11.035; Watkins BA, 2000, J NUTR, V130, P2274, DOI 10.1093/jn/130.9.2274; Watkins BA, 2006, J NUTR BIOCHEM, V17, P282, DOI 10.1016/j.jnutbio.2005.05.012; Yoshikubo H, 2005, LIFE SCI, V76, P2699, DOI 10.1016/j.lfs.2004.10.063; Yuan JZ, 2010, PROSTAG OTH LIPID M, V92, P85, DOI 10.1016/j.prostaglandins.2010.04.001	56	23	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89347	10.1371/journal.pone.0089347	http://dx.doi.org/10.1371/journal.pone.0089347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586706	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900129
J	Kietzman, HW; Everson, JL; Sulik, KK; Lipinski, RJ				Kietzman, Henry W.; Everson, Joshua L.; Sulik, Kathleen K.; Lipinski, Robert J.			The Teratogenic Effects of Prenatal Ethanol Exposure Are Exacerbated by Sonic Hedgehog or Gli2 Haploinsufficiency in the Mouse	PLOS ONE			English	Article							FETAL ALCOHOL SYNDROME; HOLOPROSENCEPHALY-LIKE FEATURES; 4 BRAZILIAN PATIENTS; NEURAL CREST; RISK-FACTORS; FLOOR PLATE; MUTATIONS; MICE; SHH; GENE	Disruption of the Hedgehog signaling pathway has been implicated as an important molecular mechanism in the pathogenesis of fetal alcohol syndrome. In severe cases, the abnormalities of the face and brain that result from prenatal ethanol exposure fall within the spectrum of holoprosencephaly. Single allele mutations in the Hh pathway genes Sonic Hedgehog (SHH) and GLI2 cause holoprosencephaly with extremely variable phenotypic penetrance in humans. Here, we tested whether mutations in these genes alter the frequency or severity of ethanol-induced dysmorphology in a mouse model. Timed pregnancies were established by mating Shh(+/-) or Gli2(+/-) male mice backcrossed to C57BL/6J strain, with wildtype females. On gestational day 7, dams were treated with two ip doses of 2.9 g/kg ethanol (or vehicle alone), administered four hrs apart. Fetuses were then genotyped and imaged, and the severity of facial dysmorphology was assessed. Following ethanol exposure, mean dysmorphology scores were increased by 3.2- and 6.6-fold in Shh(+/-) and Gli2(+/-) groups, respectively, relative to their wildtype littermates. Importantly, a cohort of heterozygous fetuses exhibited phenotypes not typically produced in this model but associated with severe holoprosencephaly, including exencephaly, median cleft lip, otocephaly, and proboscis. As expected, a correlation between the severity of facial dysmorphology and medial forebrain deficiency was observed in affected animals. While Shh(+/-) and Gli2(+/-) mice have been described as phenotypically normal, these results illustrate a functional haploinsufficiency of both genes in combination with ethanol exposure. By demonstrating an interaction between specific genetic and environmental risk factors, this study provides important insights into the multifactorial etiology and complex pathogenesis of fetal alcohol syndrome and holoprosencephaly.	[Kietzman, Henry W.; Everson, Joshua L.; Sulik, Kathleen K.; Lipinski, Robert J.] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27515 USA; [Lipinski, Robert J.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison	Lipinski, RJ (corresponding author), Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27515 USA.	rjlipinski@wisc.edu		Lipinski, Robert/0000-0002-1994-4090; Everson, Josh/0000-0002-2887-8574; Kietzman, Henry/0000-0001-7435-0546	National Institute on Alcohol Abuse and Alcoholism/NIH [U01-AA017124, U01-AA0216521, P60-AA011605]; National Institute of Dental and Craniofacial Research/NIH [K99DE022101-A1, R00DE022101-02]; David Baltimore/Broad Foundation Endowment Research Fellowship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K99DE022101, R00DE022101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA017124, P60AA011605] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Dental and Craniofacial Research/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); David Baltimore/Broad Foundation Endowment Research Fellowship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by grant nos. U01-AA017124, U01-AA0216521 and P60-AA011605 grants to KKS from the National Institute on Alcohol Abuse and Alcoholism/NIH and K99DE022101-A1 and R00DE022101-02 grants to RJL from the National Institute of Dental and Craniofacial Research/NIH and a David Baltimore/Broad Foundation Endowment Research Fellowship to HWK. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren SC, 2002, P NATL ACAD SCI USA, V99, P10476, DOI 10.1073/pnas.162356199; Aoto K, 2008, BIRTH DEFECTS RES A, V82, P224, DOI 10.1002/bdra.20447; Bae GU, 2011, AM J HUM GENET, V89, P231, DOI 10.1016/j.ajhg.2011.07.001; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; DEMYER W, 1964, PEDIATRICS, V34, P256; Ding Q, 1998, DEVELOPMENT, V125, P2533; Downing C, 2009, ALCOHOL CLIN EXP RES, V33, P1238, DOI 10.1111/j.1530-0277.2009.00949.x; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Edison Robin, 2003, Congenital Anomalies, V43, P1, DOI 10.1111/j.1741-4520.2003.tb01022.x; Fuccillo M, 2004, DEVELOPMENT, V131, P5031, DOI 10.1242/dev.01349; Godin EA, 2011, NEUROTOXICOL TERATOL, V33, P231, DOI 10.1016/j.ntt.2010.11.001; Godin EA, 2010, ALCOHOL CLIN EXP RES, V34, P98, DOI 10.1111/j.1530-0277.2009.01071.x; Higashiyama D, 2007, BIRTH DEFECTS RES A, V79, P513, DOI 10.1002/bdra.20367; Hong MI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002999; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Klingensmith J, 2010, AM J MED GENET C, V154C, P43, DOI 10.1002/ajmg.c.30256; Leoncini E, 2008, BIRTH DEFECTS RES A, V82, P585, DOI 10.1002/bdra.20479; Li YX, 2007, LAB INVEST, V87, P231, DOI 10.1038/labinvest.3700516; Lipinski RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043067; Lipinski RJ, 2010, AM J MED GENET C, V154C, P29, DOI 10.1002/ajmg.c.30239; Loucks EJ, 2009, BIRTH DEFECTS RES A, V85, P556, DOI 10.1002/bdra.20564; Marchetta Claire M., 2012, Morbidity and Mortality Weekly Report, V61, P534; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Matise MP, 1998, DEVELOPMENT, V125, P2759; MATSUNAGA E, 1977, TERATOLOGY, V16, P261, DOI 10.1002/tera.1420160304; Mattson SN, 2010, ALCOHOL, V44, P635, DOI 10.1016/j.alcohol.2009.08.005; May PA, 2013, J DEV BEHAV PEDIATR, V34, P314, DOI 10.1097/DBP.0b013e3182905587; May PA, 2011, DRUG ALCOHOL DEPEN, V119, P18, DOI 10.1016/j.drugalcdep.2011.05.009; Mo R, 1997, DEVELOPMENT, V124, P113; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Orioli IM, 2010, AM J MED GENET C, V154C, P13, DOI 10.1002/ajmg.c.30233; Pineda-Alvarez DE, 2012, HUM GENET, V131, P301, DOI 10.1007/s00439-011-1078-6; Pineda-Alvarez DE, 2010, AM J MED GENET C, V154C, P93, DOI 10.1002/ajmg.c.30253; Ribeiro LA, 2006, AM J MED GENET A, V140A, P2584, DOI 10.1002/ajmg.a.31369; Ribeiro LA, 2010, AM J MED GENET A, V152A, P1688, DOI 10.1002/ajmg.a.33466; Roessler E, 2003, P NATL ACAD SCI USA, V100, P13424, DOI 10.1073/pnas.2235734100; Roessler E, 2009, MOL GENET METAB, V98, P225, DOI 10.1016/j.ymgme.2009.05.005; SIEBERT JR, 1991, TERATOLOGY, V44, P29, DOI 10.1002/tera.1420440106; Solomon BD, 2012, J MED GENET, V49, P473, DOI 10.1136/jmedgenet-2012-101008; Solomon BD, 2010, AM J MED GENET C, V154C, P3, DOI 10.1002/ajmg.c.30245; SULIK KK, 1981, SCIENCE, V214, P936, DOI 10.1126/science.6795717; SULIK KK, 1982, SCAN ELECTRON MICROS, P309; Viljoen DL, 2001, ALCOHOL CLIN EXP RES, V25, P1719; Yamada Y, 2005, J CRANIOFAC SURG, V16, P1055, DOI 10.1097/01.scs.0000183470.31202.c9; Zhang CJ, 2011, BIRTH DEFECTS RES A, V91, P129, DOI 10.1002/bdra.20766	46	78	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89448	10.1371/journal.pone.0089448	http://dx.doi.org/10.1371/journal.pone.0089448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586787	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900143
J	Luksenburg, JA				Luksenburg, Jolanda A.			Prevalence of External Injuries in Small Cetaceans in Aruban Waters, Southern Caribbean	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; DORSAL FIN DISFIGUREMENTS; TURSIOPS-TRUNCATUS; MARINE MAMMALS; POSSIBLE INDICATOR; FISHING GEAR; FISHERIES; ENTANGLEMENT; PORPOISES; IMPACTS	Aruba, located close to the coasts of Colombia and Venezuela, is one of the most densely populated islands in the Caribbean and supports a wide range of marine-related socio-economic activities. However, little is known about the impacts of human activities on the marine environment. Injuries in marine mammals can be used to examine interactions with human activities and identify potential threats to the survival of populations. The prevalence of external injuries and tooth rake marks were examined in Atlantic spotted dolphin (Stenella frontalis) (n = 179), bottlenose dolphin (Tursiops truncatus) (n = 76) and false killer whale (Pseudorca crassidens) (n = 71) in Aruban waters using photo identification techniques. Eleven injury categories were defined and linked to either human-related activities or natural causes. All injury categories were observed. In total, 18.7% of all individuals had at least one injury. Almost half (41.7%) of the injuries could be attributed to human interactions, of which fishing gear was the most common cause (53.3%) followed by propeller hits (13.3%). Major disfigurements were observed in all three species and could be attributed to interactions with fishing gear. The results of this study indicate that fishing gear and propeller hits may pose threats to small and medium-sized cetaceans in Aruban waters. Thus, long-term monitoring of population trends is warranted. Shark-inflicted bite wounds were observed in Atlantic spotted dolphin and bottlenose dolphin. Bite wounds of cookie cutter sharks (Isistius sp.) were recorded in all three species, and include the first documented record of a cookie cutter shark bite in Atlantic spotted dolphin. This is one of the few studies which investigates the prevalence of injuries in cetaceans in the Caribbean. Further study is necessary to determine to which extent the injuries observed in Aruba affect the health and survival of local populations.	George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA	George Mason University	Luksenburg, JA (corresponding author), George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA.	j.luksenburg@yahoo.com		Luksenburg, Jolanda/0000-0003-4424-4368	Prins Bernhard Cultuurfonds; George Mason University; Cetacean Society International; Society for Marine Mammalogy; Lerner-Gray fund of the American Museum of Natural History; Humane Society International; Aruban Department of Agriculture; Husbandry and Fisheries; K.M. Luksenburg-Bouwmeester	Prins Bernhard Cultuurfonds; George Mason University; Cetacean Society International; Society for Marine Mammalogy; Lerner-Gray fund of the American Museum of Natural History; Humane Society International; Aruban Department of Agriculture; Husbandry and Fisheries; K.M. Luksenburg-Bouwmeester	Fieldwork was supported by grants provided by Prins Bernhard Cultuurfonds, George Mason University, Cetacean Society International, Society for Marine Mammalogy, Lerner-Gray fund of the American Museum of Natural History, Humane Society International, Aruban Department of Agriculture, Husbandry and Fisheries, and K.M. Luksenburg-Bouwmeester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Peter J., 2004, Mammalian Species, P1, DOI 10.1644/747; Arocha Freddy, 2002, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V54, P1123; Azevedo Alexandre F., 2009, Marine Biodiversity Records, V2, pe22, DOI 10.1017/S1755267208000262; Baird RW, 2005, PAC SCI, V59, P593, DOI 10.1353/psc.2005.0042; Barnett J, 2009, VET REC, V165, P441, DOI 10.1136/vr.165.15.441; Bechdel Sarah E., 2009, Aquatic Mammals, V35, P367, DOI 10.1578/AM.35.3.2009.367; Bermudez-Villapol L.A., 2008, REV CIENTIFICA UDO A, V8, P154; Bloom Peter, 1994, Aquatic Mammals, V20, P59; Bolanos-Jimenez J, 2014, MAMM REV IN PRESS; Byard RW, 2013, FORENSIC SCI MED PAT, V9, P103, DOI 10.1007/s12024-012-9335-0; Campbell-Malone R, 2008, J ZOO WILDLIFE MED, V39, P37, DOI 10.1638/2006-0057.1; CORKERON P J, 1987, Aquatic Mammals, V13, P109; CORKERON P J, 1987, Aquatic Mammals, V13, P96; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; Davidson AD, 2012, P NATL ACAD SCI USA, V109, P3395, DOI 10.1073/pnas.1121469109; Debrot A. O., 1998, Caribbean Journal of Science, V34, P204; DEBROT AO, 1994, MAR MAMMAL SCI, V10, P359, DOI 10.1111/j.1748-7692.1994.tb00491.x; DEBROT AO, 1992, MAR MAMMAL SCI, V8, P172, DOI 10.1111/j.1748-7692.1992.tb00379.x; Donaldson R., 2010, Pacific Conservation Biology, V16, P157; Dwyer SL, 2011, AQUAT MAMM, V37, P111, DOI 10.1578/AM.37.2.2011.111; Elwen SH, 2010, AQUAT MAMM, V36, P382, DOI 10.1578/AM.36.4.2010.382; Fertl D, 2003, MAMMAL REV, V33, P253, DOI 10.1046/j.1365-2907.2003.00033.x; Garrison LP, 2007, FISH B-NOAA, V105, P408; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heithaus MR, 2001, J ZOOL, V253, P53, DOI 10.1017/S0952836901000061; Heithaus MR, 2001, MAR MAMMAL SCI, V17, P526, DOI 10.1111/j.1748-7692.2001.tb01002.x; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; Jefferson TA, 2000, WILDLIFE MONOGR, P1; Jefferson Thomas A., 1994, Caribbean Journal of Science, V30, P83; Kiszka Jeremy, 2008, Western Indian Ocean Journal of Marine Science, V7, P185; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Kot BW, 2009, MAR MAMMAL SCI, V25, P706, DOI 10.1111/j.1748-7692.2009.00285.x; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Luksenburg JA, 2014, J MAR BIOL ASSOC UK, V94, P1161, DOI 10.1017/S0025315413000337; Luksenburg Jolanda A., 2011, Marine Biodiversity Records, V4, DOI 10.1017/S1755267210001193; MacLeod CD, 1998, J ZOOL, V244, P71, DOI 10.1017/S0952836998001083; Matkin CO., 1999, KILLER WHALES SO ALA; McCann C, 1974, SCI REPORTS WHALES R, V26, P145; McClenachan L, 2008, P ROY SOC B-BIOL SCI, V275, P1351, DOI 10.1098/rspb.2007.1757; Miyazaki N., 1994, HDB MARINE MAMMALS, V5, P1; Molenaar E, 2003, INT J MAR COAST LAW, V18, P127; Nery MF, 2008, BRAZ J OCEANOGR, V56, P313, DOI 10.1590/S1679-87592008000400007; Ortiz M, 2004, FISH RES, V70, P275, DOI 10.1016/j.fishres.2004.08.028; Parsons ECM, 2000, J WILDLIFE DIS, V36, P342, DOI 10.7589/0090-3558-36.2.342; Perez-Zayas Jose J., 2002, Aquatic Mammals, V28, P308; PERRIN WF, 1981, J MAMMAL, V62, P583, DOI 10.2307/1380405; Read A. J., 2000, NOAA TECHNICAL MEMOR; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Reeves R.R., 2003, DOLPHINS WHALES PORP, DOI 10.2305/IUCN.CH.2003.SSC-AP.2.en; Reynolds J.E., 2005, MARINE MAMMAL RES CO; Ross HM, 1996, P ROY SOC B-BIOL SCI, V263, P283, DOI 10.1098/rspb.1996.0043; Sanhueza Ward RE, 1993, FISHING GEARS METHOD; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Scott EM, 2005, BEHAVIOUR, V142, P21, DOI 10.1163/1568539053627712; THOMPSON PM, 1992, AMBIO, V21, P135; Van Bressem MF, 2013, MAR MAMMAL SCI, V29, P525, DOI 10.1111/j.1748-7692.2012.00589.x; Van Bressem Marie-Francoise, 2007, Latin American Journal of Aquatic Mammals, V6, P7; Van Vliet E., 2006, WERELDWIJZER ARUBA; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; Vidal O., 1994, REP INT WHAL COMM, P221; Visser IN, 1999, NEW ZEAL J MAR FRESH, V33, P635, DOI 10.1080/00288330.1999.9516906; Visser Ingrid N., 1998, Aquatic Mammals, V24, P71; Visser Ingrid N., 2000, Aquatic Mammals, V26, P232; Ward N., 2001, 1 M CONTR PART COP P; WELLER DW, 2002, ENCY MARINE MAMMALS, P985; Wells RS, 2008, MAR MAMMAL SCI, V24, P774, DOI 10.1111/j.1748-7692.2008.00212.x; Wells RS, 1997, MAR MAMMAL SCI, V13, P475, DOI 10.1111/j.1748-7692.1997.tb00654.x; Wells RS, 1998, FISH B-NOAA, V96, P647; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43	71	39	40	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88988	10.1371/journal.pone.0088988	http://dx.doi.org/10.1371/journal.pone.0088988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586473	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900068
J	Sachsenroder, J; Twardziok, SO; Scheuch, M; Johne, R				Sachsenroeder, Jana; Twardziok, Sven O.; Scheuch, Matthias; Johne, Reimar			The General Composition of the Faecal Virome of Pigs Depends on Age, but Not on Feeding with a Probiotic Bacterium	PLOS ONE			English	Article							ENTERIC VIRAL-INFECTIONS; LACTOBACILLUS-RHAMNOSUS; PORCINE ENTEROVIRUS; VIRUSES; PREVENTION; DIVERSITY; KOBUVIRUS; ALIGNMENT; DIARRHEA; PHAGE	Background: The pig faecal virome, which comprises the community of viruses present in pig faeces, is complex and consists of pig viruses, bacteriophages, transiently passaged plant viruses and other minor virus species. Only little is known about factors influencing its general composition. Here, the effect of the probiotic bacterium Enterococcus faecium (E. faecium) NCIMB 10415 on the pig faecal virome composition was analysed in a pig feeding trial with sows and their piglets, which received either the probiotic bacterium or not. Results: From 8 pooled faecal samples derived from the feeding trial, DNA and RNA virus particles were prepared and subjected to process-controlled Next Generation Sequencing resulting in 390,650 sequence reads. In average, 14% of the reads showed significant sequence identities to known viruses. The percentage of detected mammalian virus sequences was highest (55-77%) in the samples of the youngest piglets and lowest (8-10%) in the samples of the sows. In contrast, the percentage of bacteriophage sequences increased from 22-44% in the youngest piglets to approximately 90% in the sows. The dominating mammalian viruses differed remarkably among 12 day-old piglets (kobuvirus), 54 day-old piglets (boca-, dependo-and pig stool-associated small circular DNA virus [PigSCV]) and the sows (PigSCV, circovirus and "circovirus-like'' viruses CB-A and RW-A). In addition, the Shannon index, which reflects the diversity of sequences present in a sample, was generally higher for the sows as compared to the piglets. No consistent differences in the virome composition could be identified between the viromes of the probiotic bacterium-treated group and the control group. Conclusion: The analysis indicates that the pig faecal virome shows a high variability and that its general composition is mainly dependent on the age of the pigs. Changes caused by feeding with the probiotic bacterium E. faecium could not be demonstrated using the applied metagenomics method.	[Sachsenroeder, Jana; Johne, Reimar] Fed Inst Risk Assessment, Berlin, Germany; [Twardziok, Sven O.] Charite, Inst Mol Biol & Bioinformat, Berlin, Germany; [Scheuch, Matthias] Friedrich Loeffler Inst, Greifswald, Germany	Federal Institute for Risk Assessment; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Loeffler Institute	Johne, R (corresponding author), Fed Inst Risk Assessment, Berlin, Germany.	Reimar.Johne@bfr.bund.de		Twardziok, Sven/0000-0002-0326-5704	Deutsche Forschungsgemeinschaft (DFG) [SFB852/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was funded by the Deutsche Forschungsgemeinschaft (DFG) through grant SFB852/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker KS, 2013, VIROLOGY, V441, P95, DOI 10.1016/j.virol.2013.03.014; Boros A, 2011, INFECT GENET EVOL, V11, P1096, DOI 10.1016/j.meegid.2011.04.003; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2008, ARCH VIROL, V158, P799, DOI [10.1007/s00705-012-1543-0., DOI 10.1007/S00705-012-1543-0]; Chai WD, 2013, ARCH VIROL, V158, P799, DOI 10.1007/s00705-012-1543-0; Cheung AK, 2013, ARCH VIROL, V158, P2157, DOI 10.1007/s00705-013-1701-z; Colbere-Garapin F, 2007, MICROBES INFECT, V9, P1623, DOI 10.1016/j.micinf.2007.09.016; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; Di Profio F, 2013, RES VET SCI, V95, P782, DOI 10.1016/j.rvsc.2013.06.020; Erdogan O, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/787240; Fang SB, 2009, J TROP PEDIATRICS, V55, P297, DOI 10.1093/tropej/fmp001; Garneau JE, 2008, VIROLOGY, V373, P298, DOI 10.1016/j.virol.2007.12.002; Guandalini S, 2011, J CLIN GASTROENTEROL, V45, pS149, DOI 10.1097/MCG.0b013e3182257e98; Kreuzer S, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-58; Lager KM, 2012, J VET DIAGN INVEST, V24, P1177, DOI 10.1177/1040638712463212; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Martin L, 2012, ANIM FEED SCI TECH, V175, P65, DOI 10.1016/j.anifeedsci.2012.04.002; Meng XJ, 2012, TRANSBOUND EMERG DIS, V59, P85, DOI 10.1111/j.1865-1682.2011.01291.x; Midgley SE, 2012, VET MICROBIOL, V156, P238, DOI 10.1016/j.vetmic.2011.10.027; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Modi SR, 2013, NATURE, V499, P219, DOI 10.1038/nature12212; Moon HJ, 2012, J VIROL, V86, P10250, DOI 10.1128/JVI.01548-12; Ogilvie LA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3420; Park JM, 2013, BIORESOURCE TECHNOL, V135, P1, DOI 10.1016/j.biortech.2013.03.132; Reuter G, 2008, EMERG INFECT DIS, V14, P1968, DOI 10.3201/eid1412.080797; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rosario K, 2012, J GEN VIROL, V93, P2668, DOI 10.1099/vir.0.045948-0; Rowland I, 2010, GUT MICROBES, V1, P436, DOI 10.4161/gmic.1.6.13610; Sachsenroder J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034631; Scharek L, 2005, VET IMMUNOL IMMUNOP, V105, P151, DOI 10.1016/j.vetimm.2004.12.022; Scharek L, 2007, ARCH ANIM NUTR, V61, P223, DOI 10.1080/17450390701431540; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Shannon CE, 1997, M D COMPUT, V14, P306; Siebert B, 2013, VETIMMD13742R3; Starke I, 2013, INDIVIDUAL IN PRESS; Steward GF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-287; Szajewska H, 2011, ALIMENT PHARM THER, V34, P1079, DOI 10.1111/j.1365-2036.2011.04837.x; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Vahjen W, 2007, Curr Issues Intest Microbiol, V8, P1; Verma H, 2013, VIRUS GENES, V46, P551, DOI 10.1007/s11262-013-0879-1; Zhang JH, 2011, CURR MICROBIOL, V62, P1623, DOI 10.1007/s00284-011-9906-4; Zhang Q, 2013, ARCH VIROL, V158, P1631, DOI 10.1007/s00705-013-1659-x; Zhang Tao, 2006, Journal of Fungal Research, V4, P1	48	30	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88888	10.1371/journal.pone.0088888	http://dx.doi.org/10.1371/journal.pone.0088888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586429	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900058
J	Zhao, Y; Watanabe, A; Zhao, SJ; Kobayashi, T; Fukao, K; Tanaka, Y; Nakano, T; Yoshida, T; Takemoto, H; Tamaki, N; Kuge, Y				Zhao, Yan; Watanabe, Ayahisa; Zhao, Songji; Kobayashi, Tatsuo; Fukao, Keita; Tanaka, Yoshikazu; Nakano, Toru; Yoshida, Tetsuya; Takemoto, Hiroshi; Tamaki, Nagara; Kuge, Yuji			Suppressive Effects of Irbesartan on Inflammation and Apoptosis in Atherosclerotic Plaques of apoE(-/-) Mice: Molecular Imaging with C-14-FDG and Tc-99m-Annexin A5	PLOS ONE			English	Article							II RECEPTOR BLOCKERS; MACROPHAGE ACCUMULATION; VASCULAR INFLAMMATION; ANGIOTENSIN; EXPRESSION; CELLS; ANTAGONIST	Objectives: To investigate the effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques by histochemical examination and molecular imaging using C-14-FDG and Tc-99m-annexin A5. Background: Irbesartan has a peroxisome proliferator-activated receptor gamma (PPAR gamma) activation property in addition to its ability to block the AT1 receptor. Accordingly, irbesartan may exert further anti-inflammatory and anti-apoptotic effects in atherosclerotic plaques. However, such effects of irbesartan have not been fully investigated. Molecular imaging using F-18-FDG and Tc-99m-annexin A5 is useful for evaluating inflammation and apoptosis in atherosclerotic plaques. Methods: Female apoE(-/-) mice were treated with irbesartan-mixed (50 mg/kg/day) or irbesartan-free (control) diet for 12 weeks (n = 11/group). One week after the treatment, the mice were co-injected with C-14-FDG and Tc-99m-annexin A5, and cryostat sections of the aortic root were prepared. Histochemical examination with Movat's pentachrome (plaque size), Oil Red O (lipid deposition), Mac-2 (macrophage infiltration), and TUNEL (apoptosis) stainings were performed. Dual-tracer autoradiography was carried out to evaluate the levels of C-14-FDG and Tc-99m-annexin A5 in plaques (% IDxkg). In vitro experiments were performed to investigate the mechanism underlying the effects. Results: Histological examination indicated that irbesartan treatment significantly reduced plaque size (to 56.4% +/- 11.1% of control), intra-plaque lipid deposition (53.6%+/- 20.2%) and macrophage infiltration (61.9% +/- 20.8%) levels, and the number of apoptotic cells (14.5%+/- 16.6%). C-14-FDG (43.0% +/- 18.6%) and Tc-99m-annexin A5 levels (45.9% +/- 16.8%) were also significantly reduced by irbesartan treatment. Irbesartan significantly suppressed MCP-1 mRNA expression in TNF-alpha stimulated THP-1 monocytes (64.8% +/- 8.4% of un-treated cells). PPAR gamma activation was observed in cells treated with irbesartan (134% +/- 36% at 3 mu M to 3329% +/- 218% at 81 mu M) by a PPAR gamma reporter assay system. Conclusions: Remissions of inflammation and apoptosis as potential therapeutic effects of irbesartan on atherosclerosis were observed. The usefulness of molecular imaging using F-18-FDG and Tc-99m-annexin A5 for evaluating the therapeutic effects of irbesartan on atherosclerosis was also suggested.	[Zhao, Yan; Tamaki, Nagara] Hokkaido Univ, Dept Nucl Med, Grad Sch Med, Sapporo, Hokkaido, Japan; [Watanabe, Ayahisa] Hokkaido Univ, Grad Sch Med, Dept Integrated Mol Imaging, Sapporo, Hokkaido, Japan; [Watanabe, Ayahisa; Kobayashi, Tatsuo; Fukao, Keita; Tanaka, Yoshikazu; Nakano, Toru; Yoshida, Tetsuya; Takemoto, Hiroshi] Shionogi & Co Ltd, Shionogi Innovat Ctr Drug Discovery, Sapporo, Hokkaido, Japan; [Zhao, Songji; Kuge, Yuji] Hokkaido Univ, Grad Sch Med, Dept Tracer Kinet & Bioanal, Sapporo, Hokkaido, Japan; [Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Shionogi & Company Limited; Hokkaido University; Hokkaido University	Kuge, Y (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Tracer Kinet & Bioanal, Sapporo, Hokkaido, Japan.	kuge@ric.hokudai.ac.jp		Takemoto, Hiroshi/0000-0001-9893-0609	Ministry of Education, Culture, Sports, Science and Technology; Japanese Government	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Government	This work was supported by Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology, the Japanese Government (Creation of Innovation Centers for Advanced Interdiciplinary Research Areas Program, URL: http://www. jst. go. jp/ shincho/en/program/sentan_ino.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; BROWN RS, 1995, J NUCL MED, V36, P1854; Brunner HR, 1997, AM J HYPERTENS, V10, p311S, DOI 10.1016/S0895-7061(97)00391-9; Chatterjee A, 2013, BIOMED REP, V1, P65, DOI 10.3892/br.2012.28; Dol F, 2001, J CARDIOVASC PHARM, V38, P395, DOI 10.1097/00005344-200109000-00008; Ermak N, 2008, ATHEROSCLEROSIS, V200, P247, DOI 10.1016/j.atherosclerosis.2007.12.052; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; Fujino M, 2010, HYPERTENS RES, V33, P1044, DOI 10.1038/hr.2010.135; Hadi NR, 2013, J AM COLL CARDIOL, V62, pC58, DOI 10.1016/j.jacc.2013.08.182; Koh KK, 2003, J AM COLL CARDIOL, V42, P905, DOI 10.1016/S0735-1097(03)00846-5; Kowala MC, 2000, ATHEROSCLEROSIS, V149, P323, DOI 10.1016/S0021-9150(99)00342-1; Mattos RT, 2012, INFLAMM RES, V61, P37, DOI 10.1007/s00011-011-0386-6; Meijer P, 2011, J CARDIOVASC PHARM, V57, P702, DOI 10.1097/FJC.0b013e318218ef21; Montecucco F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/752406; Mortsell D, 2007, J INTERN MED, V261, P472, DOI 10.1111/j.1365-2796.2007.01775.x; MOVAT HZ, 1955, ARCH PATHOL, V60, P289; Schupp M, 2005, DIABETES, V54, P3442, DOI 10.2337/diabetes.54.12.3442; Sigovan M, 2012, INVEST RADIOL, V47, P546, DOI 10.1097/RLI.0b013e3182631e68; Sinno MCN, 2010, CARDIOL RES PRACT, V2010, DOI 10.4061/2010/134564; Siragy HM, 2010, ADV THER, V27, P257, DOI 10.1007/s12325-010-0028-3; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Vucic E, 2011, JACC-CARDIOVASC IMAG, V4, P1100, DOI 10.1016/j.jcmg.2011.04.020; Warnholtz A, 1999, CIRCULATION, V99, P2027, DOI 10.1161/01.CIR.99.15.2027; Watanabe K, 2005, J AM COLL CARDIOL, V46, P2022, DOI 10.1016/j.jacc.2005.04.070; Yao R, 2010, INT J CARDIOL, V139, P113, DOI 10.1016/j.ijcard.2008.10.013; Zhao Y, 2007, EUR J NUCL MED MOL I, V34, P1747, DOI 10.1007/s00259-007-0433-2; Zhao Y, 2013, MOL IMAGING, V12, P300, DOI 10.2310/7290.2012.00045; Zhao Y, 2011, MOL IMAGING BIOL, V13, P712, DOI 10.1007/s11307-010-0389-7	29	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89338	10.1371/journal.pone.0089338	http://dx.doi.org/10.1371/journal.pone.0089338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586699	Green Published, gold			2022-12-27	WOS:000331711900127
J	Eloyan, A; Li, SS; Muschelli, J; Pekar, JJ; Mostofsky, SH; Caffo, BS				Eloyan, Ani; Li, Shanshan; Muschelli, John; Pekar, Jim J.; Mostofsky, Stewart H.; Caffo, Brian S.			Analytic Programming with fMRI Data: A Quick-Start Guide for Statisticians Using R	PLOS ONE			English	Article							RANDOM-FIELD; BRAIN; CONNECTIVITY; FRAMEWORK; INFERENCE; CONTRAST; SIGNAL; TESTS; IMAGE; MRI	Functional magnetic resonance imaging (fMRI) is a thriving field that plays an important role in medical imaging analysis, biological and neuroscience research and practice. This manuscript gives a didactic introduction to the statistical analysis of fMRI data using the R project, along with the relevant R code. The goal is to give statisticians who would like to pursue research in this area a quick tutorial for programming with fMRI data. References of relevant packages and papers are provided for those interested in more advanced analysis.	[Eloyan, Ani; Muschelli, John; Caffo, Brian S.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Li, Shanshan] Indiana Univ, Dept Biostat, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Pekar, Jim J.; Mostofsky, Stewart H.] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD USA; [Pekar, Jim J.] Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD USA; [Mostofsky, Stewart H.] Johns Hopkins Sch Med, Dept Neurol & Psychiat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Indiana University System; Indiana University-Purdue University Indianapolis; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Eloyan, A (corresponding author), Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	aeloyan@jhsph.edu		Pekar, James/0000-0002-9830-0655	National Institute of Biomedical Imaging and Bioengineering [P41EB015909, R01EB012547]; National Institute of Neurological Disorders and Stroke [R01NS060]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012547, P41EB015909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000247] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project was supported by grants P41EB015909 and R01EB012547 from the National Institute of Biomedical Imaging and Bioengineering, grant R01NS060, from the National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S., 2010, BRAINWAVER BASIC WAV; Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Avants B, 2009, INSIGHT J; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bordier C., 2009, USER 2009; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Caffo BS, 2010, NEUROIMAGE, V51, P1140, DOI 10.1016/j.neuroimage.2010.02.081; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; CALHOUN VD, 2003, P INT WORKSH IND COM, P281; Callaghan P., 1991, PRINCIPLES NUCL MAGN; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Clayden J, 2011, RNIFTYREG MED IMAGE; Clayden JD, 2011, J STAT SOFTW, V44, P1; da Silva AF, 2010, R J, V2, P48; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Granert O., 2010, RNIFTILIB R INTERFAC; Guo Y, 2008, NEUROIMAGE, V42, P1078, DOI 10.1016/j.neuroimage.2008.05.008; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Henson RNA, 2002, CEREB CORTEX, V12, P178, DOI 10.1093/cercor/12.2.178; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Lazar NA, 2001, INT STAT REV, V69, P105, DOI 10.1111/j.1751-5823.2001.tb00482.x; Lazar NA, 2008, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-78191-4_1; Lindquist MA, 2008, STAT SCI, V23, P439, DOI 10.1214/09-STS282; Liu TT, 2001, NEUROIMAGE, V13, P759, DOI 10.1006/nimg.2000.0728; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lu YL, 2006, NEUROIMAGE, V32, P238, DOI 10.1016/j.neuroimage.2005.11.040; Mennes M, 2013, NEUROIMAGE, V82, P683, DOI 10.1016/j.neuroimage.2012.10.064; MILLER MI, 1993, P NATL ACAD SCI USA, V90, P11944, DOI 10.1073/pnas.90.24.11944; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Polzehl J, 2007, R NEWS; Prince JL, 2006, MED IMAGING SIGNALS; R Development Core Team, 2011, R LANG ENV STAT COMP; SIEGMUND DO, 1995, ANN STAT, V23, P608, DOI 10.1214/aos/1176324539; Smith SM, 2004, BRIT J RADIOL, V77, pS167, DOI 10.1259/bjr/33553595; Tabelow K, 2011, NEUROIMAGE, V55, P1686, DOI 10.1016/j.neuroimage.2011.01.013; TABELOW K, 2011, J STAT SOFTW, V44, P1; Tabelow K, 2006, NEUROIMAGE, V33, P55, DOI 10.1016/j.neuroimage.2006.06.029; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; TURNER R, 1991, MAGNET RESON MED, V22, P159, DOI 10.1002/mrm.1910220117; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Weeda W, 2010, ARF3DS4 ACTIVATED RE; Whitcher B, 2010, ORO DICOM RIGOROUS D; WHITCHER B, 2007, WAVESLIM BASIC WAVEL; Whitcher B, 2011, ORO NIFTI RIGOROUS N; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 2006, NEUROIMAGE, V29, P649, DOI 10.1016/j.neuroimage.2005.07.032; WORSLEY KJ, 1995, ANN STAT, V23, P640, DOI 10.1214/aos/1176324540; Worsley KJ, 1997, HUM BRAIN MAPP, V5, P254, DOI 10.1002/(SICI)1097-0193(1997)5:4<254::AID-HBM9>3.0.CO;2-2; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Younes L, 2010, SHAPES DI EOMORPHISM; Zhou JY, 2001, J CEREBR BLOOD F MET, V21, P440, DOI 10.1097/00004647-200104000-00013	59	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89470	10.1371/journal.pone.0089470	http://dx.doi.org/10.1371/journal.pone.0089470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586801	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200053
J	Townley-Tilson, WHD; Wu, YX; Ferguson, JE; Patterson, C				Townley-Tilson, W. H. Davin; Wu, Yaxu; Ferguson, James E., III; Patterson, Cam			The Ubiquitin Ligase ASB4 Promotes Trophoblast Differentiation through the Degradation of ID2	PLOS ONE			English	Article							ENDOTHELIAL-CELL LINES; ANKYRIN REPEAT; CYTOTROPHOBLAST DIFFERENTIATION; PROTEIN-4 ASB-4; HUMAN PLACENTA; C-KIT; MOUSE; EXPRESSION; VASCULOGENESIS; HYPERTENSION	Vascularization of the placenta is a critical developmental process that ensures fetal viability. Although the vascular health of the placenta affects both maternal and fetal well being, relatively little is known about the early stages of placental vascular development. The ubiquitin ligase Ankyrin repeat, SOCS box-containing 4 (ASB4) promotes embryonic stem cell differentiation to vascular lineages and is highly expressed early in placental development. The transcriptional regulator Inhibitor of DNA binding 2 (ID2) negatively regulates vascular differentiation during development and is a target of many ubiquitin ligases. Due to their overlapping spatiotemporal expression pattern in the placenta and contrasting effects on vascular differentiation, we investigated whether ASB4 regulates ID2 through its ligase activity in the placenta and whether this activity mediates vascular differentiation. In mouse placentas, ASB4 expression is restricted to a subset of cells that express both stem cell and endothelial markers. Placentas that lack Asb4 display immature vascular patterning and retain expression of placental progenitor markers, including ID2 expression. Using JAR placental cells, we determined that ASB4 ubiquitinates and represses ID2 expression in a proteasome-dependent fashion. Expression of ASB4 in JAR cells and primary isolated trophoblast stem cells promotes the expression of differentiation markers. In functional endothelial co-culture assays, JAR cells ectopically expressing ASB4 increased endothelial cell turnover and stabilized endothelial tube formation, both of which are hallmarks of vascular differentiation within the placenta. Co-transfection of a degradation-resistant Id2 mutant with Asb4 inhibits both differentiation and functional responses. Lastly, deletion of Asb4 in mice induces a pathology that phenocopies human pre-eclampsia, including hypertension and proteinuria in late-stage pregnant females. These results indicate that ASB4 mediates vascular differentiation in the placenta via its degradation of ID2.	[Townley-Tilson, W. H. Davin; Wu, Yaxu; Ferguson, James E., III; Patterson, Cam] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27514 USA; [Townley-Tilson, W. H. Davin; Patterson, Cam] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Patterson, C (corresponding author), Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27514 USA.	cpatters@med.unc.edu	, Histology Research Core Facility/ABF-6317-2021		NIH [5R01HL061656]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768, R01HL061656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant 5R01HL061656 to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Aldo PB, 2007, AM J REPROD IMMUNOL, V58, P98, DOI 10.1111/j.1600-0897.2007.00493.x; Benezra R, 2001, ONCOGENE, V20, P8334, DOI 10.1038/sj.onc.1205160; Bode M, 2011, CELL BIOCHEM FUNCT, V29, P334, DOI 10.1002/cbf.1755; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Carmeliet P, 1999, NATURE, V401, P657, DOI 10.1038/44304; Chen Q, 2005, PLACENTA, V26, P617, DOI 10.1016/j.placenta.2004.09.014; Coma S, 2010, CANCER RES, V70, P3823, DOI 10.1158/0008-5472.CAN-09-3048; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; De Val S, 2011, ARTERIOSCL THROM VAS, V31, P1469, DOI 10.1161/ATVBAHA.110.221168; Dokras A, 2006, BIOL REPROD, V75, P899, DOI 10.1095/biolreprod.106.053603; Downs KM, 1998, CURR TOP DEV BIOL, V39, P1, DOI 10.1016/S0070-2153(08)60451-2; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Ferguson JE, 2005, ARTERIOSCL THROM VAS, V25, P2246, DOI 10.1161/01.ATV.0000183609.55154.44; Ferguson JE, 2007, INVESTIGATING ROLE A; Fisher S J, 1993, Semin Cell Biol, V4, P183, DOI 10.1006/scel.1993.1022; Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53; Himeno E, 2008, CURR PROTOC STEM CEL; Hohn HP, 1998, EXP CELL RES, V244, P249, DOI 10.1006/excr.1998.4184; HORIE K, 1992, BIOL REPROD, V47, P614, DOI 10.1095/biolreprod47.4.614; James JL, 2005, REPRODUCTION, V130, P95, DOI 10.1530/rep.1.00723; Janatpour MJ, 2000, DEVELOPMENT, V127, P549; Kam EPY, 1999, HUM REPROD, V14, P2131, DOI 10.1093/humrep/14.8.2131; Kile BT, 2000, GENE, V258, P31, DOI 10.1016/S0378-1119(00)00402-9; Kim SK, 2008, MOL CELLS, V25, P317; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Li JY, 2007, CELL SIGNAL, V19, P1185, DOI 10.1016/j.cellsig.2006.12.010; Li JY, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-95; Li JY, 2010, ENDOCRINOLOGY, V151, P134, DOI 10.1210/en.2009-0560; Liu YP, 2004, MOL CELL ENDOCRINOL, V222, P83, DOI 10.1016/j.mce.2004.04.016; Luttun A, 2003, CARDIOVASC RES, V58, P378, DOI 10.1016/S0008-6363(03)00258-X; Mayhew TM, 2001, HISTOL HISTOPATHOL, V16, P1213, DOI 10.14670/HH-16.1213; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Merviel P, 2001, FETAL DIAGN THER, V16, P364, DOI 10.1159/000053942; Mitsunari M, 1999, MOL HUM REPROD, V5, P874, DOI 10.1093/molehr/5.9.874; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Moser M, 2003, MOL CELL BIOL, V23, P5664, DOI 10.1128/MCB.23.16.5664-5679.2003; MUNTENER M, 1977, ACTA ANAT, V98, P241; Mutter WP, 2008, MICROVASC RES, V75, P1, DOI 10.1016/j.mvr.2007.04.009; Myatt L, 2009, J THROMB HAEMOST, V7, P375, DOI 10.1111/j.1538-7836.2008.03259.x; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Norton JD, 2000, J CELL SCI, V113, P3897; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Uy GD, 2002, DEVELOPMENT, V129, P3913; Vatansever HS, 2003, ACTA HISTOCHEM, V105, P253, DOI 10.1078/0065-1281-00708; Waldo KL, 1996, DEV DYNAM, V205, P281, DOI 10.1002/(SICI)1097-0177(199603)205:3<281::AID-AJA8>3.0.CO;2-E; Walter-Yohrling J, 2004, CLIN CANCER RES, V10, P2179, DOI 10.1158/1078-0432.CCR-03-1013; Wolfe MW, 2006, METH MOLEC MED, V121, P229; Wong MV, 2012, ACTA CRYSTALLOGR F, V68, P1354, DOI 10.1107/S174430911203895X; Zebedee Z, 2001, ONCOGENE, V20, P8317, DOI 10.1038/sj.onc.1205092; Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387	63	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89451	10.1371/journal.pone.0089451	http://dx.doi.org/10.1371/journal.pone.0089451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586788	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900098
J	Sharifai, N; Samarajeewa, H; Kamiyama, D; Deng, TC; Boulina, M; Chiba, A				Sharifai, Nima; Samarajeewa, Hasitha; Kamiyama, Daichi; Deng, Tzyy-Chyn; Boulina, Maria; Chiba, Akira			Imaging Dynamic Molecular Signaling by the Cdc42 GTPase within the Developing CNS	PLOS ONE			English	Article							FLUORESCENT PROTEINS; DROSOPHILA-MELANOGASTER; GREEN; CELLS; LIFETIMES; NETWORKS; RED	Protein interactions underlie the complexity of neuronal function. Potential interactions between specific proteins in the brain are predicted from assays based on genetic interaction and/or biochemistry. Genetic interaction reveals endogenous, but not necessarily direct, interactions between the proteins. Biochemistry-based assays, on the other hand, demonstrate direct interactions between proteins, but often outside their native environment or without a subcellular context. We aimed to achieve the best of both approaches by visualizing protein interaction directly within the brain of a live animal. Here, we show a proof-of-principle experiment in which the Cdc42 GTPase associates with its alleged partner WASp within neurons during the time and space that coincide with the newly developing CNS.	[Sharifai, Nima; Samarajeewa, Hasitha; Kamiyama, Daichi; Deng, Tzyy-Chyn; Boulina, Maria; Chiba, Akira] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Sharifai, Nima; Samarajeewa, Hasitha; Kamiyama, Daichi; Deng, Tzyy-Chyn; Boulina, Maria; Chiba, Akira] Miami Inst Mol Imaging & Computat, Coral Gables, FL USA; [Kamiyama, Daichi] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA	University of Miami; University of California System; University of California San Francisco	Chiba, A (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	akira.chiba@miami.edu	Chiba, Akira/AAF-5073-2020	Sharifai, Nima/0000-0002-4992-3629	National Institutes of Health (NIH) research award (DO/NINDS); National Institutes of Health (NIH) research award (NIMH); NIH/NIMH F30 fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH097427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS069488] Funding Source: NIH RePORTER	National Institutes of Health (NIH) research award (DO/NINDS); National Institutes of Health (NIH) research award (NIMH); NIH/NIMH F30 fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) research awards (DO/NINDS and NIMH) and American Recovery and Reinvestment Act to A.C. N.S. is a Lois Pope LIFE Fellow and was supported by an NIH/NIMH F30 fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Yaacov S, 2001, J CELL BIOL, V152, P1, DOI 10.1083/jcb.152.1.1; Bierhuizen MFA, 1997, BIOCHEM BIOPH RES CO, V234, P371, DOI 10.1006/bbrc.1997.6648; Boulina M, 2013, DEVELOPMENT, V140, P1605, DOI 10.1242/dev.088930; Buranachai C, 2008, J FLUORESC; Clegg RM, 2003, METHOD ENZYMOL, V360, P509; Clegg RM, 2005, MICROSC MICROANAL S2, V11, P272; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Fehon RG, 1997, GENETICS, V146, P245; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hall A, 1993, CURR OPIN CELL BIOL, V5, P265, DOI 10.1016/0955-0674(93)90114-6; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Kamiyama D, 2009, SCIENCE, V324, P1338, DOI 10.1126/science.1170615; Kim MD, 2003, DEV BIOL, V262, P282, DOI 10.1016/S0012-1606(03)00393-2; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Redford GI, 2005, J FLUORESC, V15, P805, DOI 10.1007/s10895-005-2990-8; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660	28	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88870	10.1371/journal.pone.0088870	http://dx.doi.org/10.1371/journal.pone.0088870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586421	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900053
J	Trecker, MA; Waldner, C; Jolly, A; Liao, MM; Gu, WM; Dillon, JAR				Trecker, Molly A.; Waldner, Cheryl; Jolly, Ann; Liao, Mingmin; Gu, Weiming; Dillon, Jo-Anne R.			Behavioral and Socioeconomic Risk Factors Associated with Probable Resistance to Ceftriaxone and Resistance to Penicillin and Tetracycline in Neisseria gonorrhoeae in Shanghai	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; REDUCED SUSCEPTIBILITY; PREVALENCE; SEX; CIPROFLOXACIN; DETERMINANTS; MUTATIONS; EMERGENCE; SYPHILIS; DISEASES	Globally, incidence of Neisseria gonorrhoeae infection is once again the highest of the bacterial sexually transmitted infections. The bacterium can produce serious complications in those infected, and emerging resistance to third generation cephalosporins could usher in an era of potentially untreatable gonorrhea. This research aimed to identify risk factors for antibiotic resistant gonorrhea infection among clients at a Shanghai sexually transmitted infection clinic over two time periods, 2004-2005 and 2008-2011. Demographic and risk factor behavior data, and biological samples for antimicrobial resistance analysis, were collected. Statistical models were built to identify risk factors associated with probable resistance to ceftriaxone and resistance to penicillin and tetracycline. High levels of ciprofloxacin resistance (98%) in our sample precluded examining its risk factors; all isolates were susceptible to spectinomycin. Overall (P<0.001), chromosomal (P<0.001), and plasmid-mediated (P = 0.01) penicillin resistance decreased from the first to second period of the study. For tetracycline, chromosomal resistance decreased (P = 0.01) and plasmid-mediated resistance increased (P<0.001) between the first and second periods of study. In multi-level multivariable regression models, male gender (P = 0.03) and older age (P = 0.01) were associated with increased minimum inhibitory concentrations to ceftriaxone. Male gender (P = 0.03) and alcohol use (P = 0.02) were associated with increased odds of overall tetracycline resistance. Male gender was associated with increased odds of chromosomally-mediated tetracycline resistance (P = 0.04), and alcohol use was associated with increased odds of plasmid-mediated tetracycline resistance (P = 0.02). Additionally, individuals in middle-salary categories were found to have lower odds of plasmid-mediated resistance to tetracycline compared with those in the lowest salary category (P <= 0.02). This study is one of the first to use multilevel analysis to consider the association between risk factors for gonorrhea infections and mechanisms of resistance to individual antibiotics. Such information is urgently needed to combat the growing threat of untreatable gonorrhea.	[Trecker, Molly A.; Dillon, Jo-Anne R.] Vaccine & Infect Dis Org, Int Vaccine Ctr, Saskatoon, SK, Canada; [Trecker, Molly A.; Waldner, Cheryl] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada; [Waldner, Cheryl] Univ Saskatchewan, Western Coll Vet Med, Saskatoon, SK S7N 0W0, Canada; [Jolly, Ann] Hlth Canada, Ctr Infect Dis Prevent & Control, Ottawa, ON K1A 0L2, Canada; [Jolly, Ann] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Liao, Mingmin; Dillon, Jo-Anne R.] Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK S7N 0W0, Canada; [Gu, Weiming] Shanghai Skin Dis & Sexually Transmitted Dis Hosp, Shanghai, Peoples R China	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; Health Canada; Public Health Agency of Canada; University of Saskatchewan	Dillon, JAR (corresponding author), Vaccine & Infect Dis Org, Int Vaccine Ctr, Saskatoon, SK, Canada.	j.dillon@usask.ca		Waldner, Cheryl/0000-0002-7152-4261	Canadian Institutes of Health Research (CIHR) [OPC-67017, MOP77748]; CIHR; University of Saskatchewan	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan	The authors gratefully acknowledge the support of the Canadian Institutes of Health Research (CIHR; grant nos OPC-67017 and MOP77748). Molly Trecker was supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship and funding to Jo-Anne Dillon from the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen VG, 2013, JAMA-J AM MED ASSOC, V309, P163, DOI 10.1001/jama.2012.176575; Allen VG, 2011, ANTIMICROB AGENTS CH, V55, P703, DOI 10.1128/AAC.00788-10; Bauer HM, 2005, CLIN INFECT DIS, V41, P795, DOI 10.1086/432801; Bjekic M, 2000, Med Pregl, V53, P600; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE; Cole MJ, 2013, SEX TRANSM INFECT, V89, pA30, DOI 10.1136/sextrans-2013-051184.0095; Cook RL, 2005, SEX TRANSM DIS, V32, P156, DOI 10.1097/01.olq.0000151418.03899.97; de Vries HJ, 2009, EUROSURVEILLANCE, V14; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS98, DOI 10.1097/QAI.0b013e3181c7df71; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Goldstein E, 2012, EMERG INFECT DIS, V18, P1290, DOI 10.3201/eid1808.111202; Hong Y, 2011, J WOMENS HEALTH, V20, P129, DOI 10.1089/jwh.2010.2139; HOOK EW, 1989, J INFECT DIS, V159, P900, DOI 10.1093/infdis/159.5.900; Hook III EW, 2007, SEXUALLY TRANSMITTED, P627; Hughes G, 2000, SEX TRANSM INFECT, V76, P262, DOI 10.1136/sti.76.4.262; Hvistendahl M, 2012, SCIENCE, V336, P795, DOI 10.1126/science.336.6083.795; Klausner JD, 1999, J INFECT DIS, V179, P729, DOI 10.1086/314625; Koedijk FDH, 2010, SEX TRANSM INFECT, V86, P41, DOI 10.1136/sti.2009.037135; Kretzschmar M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-108; Liao M, 2011, THESIS U SASKATCHEWA; Liao MM, 2008, J ANTIMICROB CHEMOTH, V61, P478, DOI 10.1093/jac/dkm544; Liao MM, 2011, J ANTIMICROB CHEMOTH, V66, P1016, DOI 10.1093/jac/dkr021; Liao MM, 2009, J CLIN MICROBIOL, V47, P489, DOI 10.1128/JCM.01612-08; Ota KV, 2009, CAN MED ASSOC J, V180, P287, DOI 10.1503/cmaj.080222; Pflieger JC, 2013, AM J PUBLIC HEALTH, V103, P903, DOI 10.2105/AJPH.2012.301005; Rabe-Hesketh S., 2004, UC BERKELEY DIVISION; Ratelle S., 2004, Morbidity and Mortality Weekly Report, V53, P335; Salerno J, 2013, J SCHOOL HEALTH, V83, P99, DOI 10.1111/josh.12004; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Seth P, 2011, WOMEN HEALTH ISS, V21, P130, DOI 10.1016/j.whi.2010.10.005; StataCorp, 2011, STAT STAT SOFTW REL; Stryhn H., 2012, METHODS EPIDEMIOLOGI; Tang HL, 2010, WORLD MED HEALTH POL, V2, P317, DOI 10.2202/1948-4682.1026; Thakur SD, 2014, J ANTIMICROB CHEMOTH, V69, P1510, DOI 10.1093/jac/dkt543; Thompson JC, 2005, PREV MED, V41, P247, DOI 10.1016/j.ypmed.2004.11.008; Unemo M, 2010, EUROSURVEILLANCE, V15, P9; Unemo M, 2011, EURO SURVEILL, V16; Unemo M, 2012, FUTURE MICROBIOL, V7, P1401, DOI [10.2217/FMB.12.117, 10.2217/fmb.12.117]; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Whiley DM, 2010, J ANTIMICROB CHEMOTH, V65, P1615, DOI 10.1093/jac/dkq187; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; Wong SPY, 2007, SEX TRANSM INFECT, V83, P351, DOI 10.1136/sti.2007.025015; World Health Organization, 2012, GLOB ACT PLAN CONTR; Yang Y, 2006, J ANTIMICROB CHEMOTH, V58, P868, DOI 10.1093/jac/dkl301; Zhou H, 2007, SEX TRANSM INFECT, V83, P476, DOI 10.1136/sti.2007.026187	46	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89458	10.1371/journal.pone.0089458	http://dx.doi.org/10.1371/journal.pone.0089458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586792	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900144
J	Yamasaki, T; Iwashima, Y; Jesmin, S; Ohta, Y; Kusunoki, H; Hayashi, S; Horio, T; Kawano, Y				Yamasaki, Tomohiro; Iwashima, Yoshio; Jesmin, Subrina; Ohta, Yuko; Kusunoki, Hiroshi; Hayashi, Shin-ichiro; Horio, Takeshi; Kawano, Yuhei			Comparison of Efficacy of Intensive versus Mild Pitavastatin Therapy on Lipid and Inflammation Biomarkers in Hypertensive Patients with Dyslipidemia	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; LOW-DENSITY-LIPOPROTEIN; CORONARY ATHEROSCLEROSIS; HYPERCHOLESTEROLEMIA; ATORVASTATIN; EVENTS; RISK; CHOLESTEROL; PREVENTION; INHIBITOR	Objective: Intensive as compared to mild statin therapy has been proven to be superior in improving cardiovascular outcome, whereas the effects of intensive statin therapy on inflammation and lipoprotein biomarkers are not well defined. Methods: This study assigned essential hypertensive patients with dyslipidemia to 6 months administration of mild (1 mg/day, n = 34) or intensive pitavastatin therapy (4 mg/day, n = 29), and various lipid and inflammation biomarkers were measured at baseline, and 3 and 6 months after the start of treatment. Results: Both pitavastatin doses were well tolerated, and there were no serious treatment-related adverse events. After 6 months, significant improvements in total cholesterol, triglycerides, low- density lipoprotein (LDL-) cholesterol, LDL/highdensity lipoprotein cholesterol (LDL/HDL), apolipoproteins B, C- II, and E, apolipoprotein-B/apolipoprotein-A-I (Apo B/Apo AI), and malondialdehyde (MDA-) LDL were observed in both groups. Compared with the mild pitavastatin group, the intensive pitavastatin therapy showed significantly greater decreases in C reactive protein (F = 3.76, p, 0.05), total cholesterol (F = 10.65), LDL-cholesterol (F = 23.37), LDL/HDL (F = 12.34), apolipoproteins B (F = 19.07) and E (F = 6.49), Apo B/Apo A-I (F = 13.26), and MDA-LDL (F = 5.76) (p<0.01, respectively). Conclusion: Intensive pitavastatin therapy may have a more favorable effect not only in decreasing LDL-cholesterol but also in pleiotropic benefits in terms of improvement of apolipoproteins, inflammation, or oxidation.	[Yamasaki, Tomohiro] Natl Cerebral & Cardiovasc Ctr, Div Cardiovasc Med, Suita, Osaka, Japan; [Iwashima, Yoshio; Ohta, Yuko; Kusunoki, Hiroshi; Hayashi, Shin-ichiro; Kawano, Yuhei] Natl Cerebral & Cardiovasc Ctr, Div Nephrol & Hypertens, Suita, Osaka, Japan; [Jesmin, Subrina] Univ Tsukuba, Fac Med, Tsukuba, Ibaragi, Japan; [Horio, Takeshi] Kawasaki Med Sch, Dept Gen Internal Med 3, Okayama, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; University of Tsukuba; Kawasaki Medical School	Iwashima, Y (corresponding author), Natl Cerebral & Cardiovasc Ctr, Div Nephrol & Hypertens, Suita, Osaka, Japan.	iwashima@hsp.ncvc.go.jp	Kawano, Yuhei/AAM-2251-2020		Grants-in-Aid for Scientific Research [23590874, 24406026] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; Aoki T, 1997, ARZNEIMITTELFORSCH, V47, P904; Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070; Chapman MJ, 2011, ATHEROSCLEROSIS SUPP, V12, P277, DOI 10.1016/S1567-5688(11)70887-X; Davignon J, 2012, BRIT J CLIN PHARMACO, V73, P518, DOI 10.1111/j.1365-2125.2011.04139.x; Duggan ST, 2012, DRUGS, V72, P565, DOI 10.2165/11207180-000000000-00000; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gumprecht J, 2011, DIABETES OBES METAB, V13, P1047, DOI 10.1111/j.1463-1326.2011.01477.x; Hayashi T, 2007, EXPERT OPIN PHARMACO, V8, P2315, DOI 10.1517/14656566.8.14.2315; Hiro T, 2009, J AM COLL CARDIOL, V54, P293, DOI 10.1016/j.jacc.2009.04.033; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Kannel WB, 2000, AM J HYPERTENS, V13, p3S, DOI 10.1016/S0895-7061(99)00252-6; KOTANI K, 1994, BBA-LIPID LIPID MET, V1215, P121, DOI 10.1016/0005-2760(94)90100-7; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Maejima T, 2004, BIOCHEM BIOPH RES CO, V324, P835, DOI 10.1016/j.bbrc.2004.09.122; Morikawa S, 2000, J Atheroscler Thromb, V7, P138; Ooyen C, 1999, ATHEROSCLEROSIS, V145, P87, DOI 10.1016/S0021-9150(99)00018-0; Ose L, 2010, ATHEROSCLEROSIS, V210, P202, DOI 10.1016/j.atherosclerosis.2009.12.009; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sacks FM, 2006, ATHEROSCLEROSIS SUPP, V7, P23, DOI 10.1016/j.atherosclerosissup.2006.05.004; Saito Y, 2011, ATHEROSCLEROSIS SUPP, V12, P271, DOI 10.1016/S1567-5688(11)70886-8; Selby JV, 2004, AM J MANAG CARE, V10, P163; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Sniderman AD, 2003, LANCET, V361, P777, DOI 10.1016/S0140-6736(03)12663-3; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Yokote K, 2011, EXPERT REV CARDIOVAS, V9, P555, DOI [10.1586/erc.11.47, 10.1586/ERC.11.47]; Yoshida H, 2013, ATHEROSCLEROSIS, V226, P161, DOI 10.1016/j.atherosclerosis.2012.10.069; ZANCHETTI A, 1994, AM J MED, V96, pS3, DOI 10.1016/0002-9343(94)90225-9	30	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89057	10.1371/journal.pone.0089057	http://dx.doi.org/10.1371/journal.pone.0089057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586502	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900079
J	Bhuyan, ZA; Asanoma, M; Iwata, A; Ishifune, C; Maekawa, Y; Shimada, M; Yasutomo, K				Bhuyan, Zaied Ahmed; Asanoma, Michihito; Iwata, Akiko; Ishifune, Chieko; Maekawa, Yoichi; Shimada, Mitsuo; Yasutomo, Koji			Abrogation of Rbpj Attenuates Experimental Autoimmune Uveoretinitis by Inhibiting IL-22-Producing CD4(+) T Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; NOTCH; UVEITIS; DELTA; GAMMA; ENCEPHALOMYELITIS; TRANSCRIPTION; INFLAMMATION; MECHANISM; RESPONSES	Experimental autoimmune uveoretinitis (EAU) is an organ-specific T cell-mediated disease induced by immunizing mice with interphotoreceptor retinoid binding protein (IRBP). Autoaggressive CD4(+) T cells are the major pathogenic population for EAU. We investigated the contribution of Notch signaling in T cells to EAU pathogenesis because Notch signaling regulates various aspects of CD4(+) T cell functions. Rbpj is required for Notch signaling, and Rbpj deficiency in T cells inhibited EAU disease severity. The amelioration of EAU in T cell-specific Rbpj-deficient mice correlated with low levels of IL-22 production from CD4(+) T cells, although IRBP-specific CD4(+) T cell proliferation and Th17 differentiation were unaffected. Administration of recombinant IL-22 during the late phase, but not the early phase, of EAU increased EAU clinical scores in T cell-specific Rbpj-deficient mice. Notch inhibition in mice immunized with IRBP with a c-secretase inhibitor (GSI) suppressed EAU progression, even when GSI was administered as late as 13 days after IRBP immunization. Our data demonstrate that Rbpj/Notch-mediated IL-22 production in T cells has a key pathological role in the late phase of EAU, and suggest that Notch blockade might be a useful therapeutic approach for treating EAU.	[Bhuyan, Zaied Ahmed; Asanoma, Michihito; Iwata, Akiko; Ishifune, Chieko; Maekawa, Yoichi; Yasutomo, Koji] Univ Tokushima, Grad Sch, Dept Immunol & Parasitol, Inst Hlth Biosci, Tokushima 770, Japan; [Asanoma, Michihito; Shimada, Mitsuo] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 770, Japan; [Iwata, Akiko] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 770, Japan	Tokushima University; Tokushima University; Tokushima University	Yasutomo, K (corresponding author), Univ Tokushima, Grad Sch, Dept Immunol & Parasitol, Inst Hlth Biosci, Tokushima 770, Japan.	yasutomo@tokushima-u.ac.jp		Maekawa, Yoichi/0000-0002-3879-5713	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Young Scientists (S) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2010, P NATL ACAD SCI USA, V107, P5943, DOI 10.1073/pnas.0911755107; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Andersen P, 2012, TRENDS CELL BIOL, V22, P257, DOI 10.1016/j.tcb.2012.02.003; Bailis W, 2013, IMMUNITY, V39, P148, DOI 10.1016/j.immuni.2013.07.006; Bassil R, 2011, J IMMUNOL, V187, P2322, DOI 10.4049/jimmunol.1100725; Boggs K, 2009, CELL BIOL INT, V33, P318, DOI 10.1016/j.cellbi.2008.12.005; CALDER VL, 1993, IMMUNOLOGY, V79, P255; Caspi R, 2008, IMMUNOL RES, V42, P41, DOI 10.1007/s12026-008-8031-3; Caspi RR, 1996, J IMMUNOL, V157, P2668; Caspi RR, 2003, IMMUNOL RES, V27, P149, DOI 10.1385/IR:27:2-3:149; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Ishida W, 2011, INVEST OPHTH VIS SCI, V52, P8224, DOI 10.1167/iovs.11-7756; Jin S, 2013, ONCOGENE, V32, P4892, DOI 10.1038/onc.2012.517; Ke Y, 2011, J IMMUNOL, V187, P2130, DOI 10.4049/jimmunol.1100482; Kitamura M, 2007, J IMMUNOL, V178, P6567, DOI 10.4049/jimmunol.178.10.6567; Kolls JK, 2008, NAT REV IMMUNOL, V8, P829, DOI 10.1038/nri2433; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Reynolds ND, 2011, J IMMUNOL, V187, P2803, DOI 10.4049/jimmunol.1100160; Shao H, 2006, EXP EYE RES, V82, P323, DOI 10.1016/j.exer.2005.07.008; Sonoda KH, 2003, J IMMUNOL, V171, P2652, DOI 10.4049/jimmunol.171.5.2652; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tarrant TK, 1999, J EXP MED, V189, P219, DOI 10.1084/jem.189.2.219; Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023	32	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89266	10.1371/journal.pone.0089266	http://dx.doi.org/10.1371/journal.pone.0089266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586644	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200042
J	Flegler, AJ; Cianci, GC; Hope, TJ				Flegler, Ayanna J.; Cianci, Gianguido C.; Hope, Thomas J.			CCR5 Conformations Are Dynamic and Modulated by Localization, Trafficking and G Protein Association	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR5; IMMUNODEFICIENCY-VIRUS TYPE-1; AGONIST-INDUCED ENDOCYTOSIS; COATED PIT FORMATION; COUPLED RECEPTORS; LIVING CELLS; MONOCLONAL-ANTIBODIES; DISEASE PROGRESSION; HIV-1 TRANSMISSION; BETA-ARRESTINS	CCR5 acts as the principal coreceptor during HIV-1 transmission and early stages of infection. Efficient HIV-1 entry requires a series of processes, many dependent on the conformational state of both viral envelope protein and cellular receptor. Monoclonal antibodies (MAbs) are able to identify different CCR5 conformations, allowing for their use as probes to distinguish CCR5 populations. Not all CCR5 MAbs are able to reduce HIV-1 infection, suggesting the use of select CCR5 populations for entry. In the U87.CD4.CCR5-GFP cell line, we used such HIV-1-restricting MAbs to probe the relation between localization, trafficking and G protein association for individual CCR5 conformations. We find that CCR5 conformations not only exhibit different localization and abundance patterns throughout the cell, but that they also display distinct sensitivities to endocytosis inhibition. Using chemokine analogs that vary in their HIV-1 inhibitory mechanisms, we also illustrate that responses to ligand engagement are conformation-specific. Additionally, we provide supporting evidence for the select sensitivity of conformations to G protein association. Characterizing the link between the function and dynamics of CCR5 populations has implications for understanding their selective targeting by HIV-1 and for the development of inhibitors that will block CCR5 utilization by the virus.	[Flegler, Ayanna J.; Cianci, Gianguido C.; Hope, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hope, TJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	thope@northwestern.edu			NIH [R01 AI052051]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052051] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the NIH R01 AI052051 (with associated diversity supplement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Bernstone L, 2012, HYBRIDOMA, V31, P7, DOI 10.1089/hyb.2010.0092; Berro R, 2013, J VIROL, V87, P6569, DOI 10.1128/JVI.00099-13; Berro R, 2011, J VIROL, V85, P8227, DOI 10.1128/JVI.00767-11; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Cardaba CM, 2008, CELL SIGNAL, V20, P1687, DOI 10.1016/j.cellsig.2008.05.014; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Colin P, 2013, P NATL ACAD SCI USA, V110, P9475, DOI 10.1073/pnas.1222205110; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Gaertner H, 2004, P NATL ACAD SCI USA, V101, P16460; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Gong WH, 1998, J BIOL CHEM, V273, P4289, DOI 10.1074/jbc.273.8.4289; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Johnston SH, 2009, J VIROL, V83, P11016, DOI 10.1128/JVI.01242-09; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Luangsay S, 2003, GASTROENTEROLOGY, V125, P491, DOI 10.1016/S0016-5085(03)00903-X; Luttrell LM, 2002, J CELL SCI, V115, P455; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Michael NL, 1997, NAT MED, V3, P338, DOI 10.1038/nm0397-338; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Moreira AP, 2008, J IMMUNOL, V180, P3049, DOI 10.4049/jimmunol.180.5.3049; Mueller A, 2002, BLOOD, V99, P785, DOI 10.1182/blood.V99.3.785; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Polo S, 2000, EUR J IMMUNOL, V30, P3190, DOI 10.1002/1521-4141(200011)30:11<3190::AID-IMMU3190>3.0.CO;2-E; Proudfoot AEI, 1999, J BIOL CHEM, V274, P32478, DOI 10.1074/jbc.274.45.32478; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Robertson AS, 2009, CELL MOL LIFE SCI, V66, P2049, DOI 10.1007/s00018-009-0001-y; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Steffens CM, 2004, J VIROL, V78, P9573, DOI 10.1128/JVI.78.17.9573-9578.2004; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Zhao J, 1998, J CELL BIOCHEM, V71, P36, DOI 10.1002/(SICI)1097-4644(19981001)71:1<36::AID-JCB4>3.0.CO;2-2	50	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89056	10.1371/journal.pone.0089056	http://dx.doi.org/10.1371/journal.pone.0089056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586501	Green Submitted, Green Published, gold			2022-12-27	WOS:000332396200033
J	Sharpe, KH; McMahon, AD; Raab, GM; Brewster, DH; Conway, DI				Sharpe, Katharine H.; McMahon, Alex D.; Raab, Gillian M.; Brewster, David H.; Conway, David I.			Association between Socioeconomic Factors and Cancer Risk: A Population Cohort Study in Scotland (1991-2006)	PLOS ONE			English	Article							LUNG-CANCER; SOCIAL-INEQUALITY; PROSTATE-CANCER; MARITAL-STATUS; HEALTH; SURVIVAL; DENMARK; POSITION; DISPARITIES; BIRTH	Background: Lung and upper aero-digestive tract (UADT) cancer risk are associated with low socioeconomic circumstances and routinely measured using area socioeconomic indices. We investigated effect of country of birth, marital status, one area deprivation measure and individual socioeconomic variables (economic activity, education, occupational social class, car ownership, household tenure) on risk associated with lung, UADT and all cancer combined (excluding non melanoma skin cancer). Methods: We linked Scottish Longitudinal Study and Scottish Cancer Registry to follow 203,658 cohort members aged 15+ years from 1991-2006. Relative risks (RR) were calculated using Poisson regression models by sex offset for person-years of follow-up. Results: 21,832 first primary tumours (including 3,505 lung, 1,206 UADT) were diagnosed. Regardless of cancer, economically inactivity (versus activity) was associated with increased risk (male: RR 1.14, 95% CI 1.10-1.18; female: RR 1.06, 95% CI 1.02-1.11). For lung cancer, area deprivation remained significant after full adjustment suggesting the area deprivation cannot be fully explained by individual variables. No or non degree qualification (versus degree) was associated with increased lung risk; likewise for UADT risk (females only). Occupational social class associations were most pronounced and elevated for UADT risk. No car access (versus ownership) was associated with increased risk (excluding all cancer risk, males). Renting (versus home ownership) was associated with increased lung cancer risk, UADT cancer risk (males only) and all cancer risk (females only). Regardless of cancer group, elevated risk was associated with no education and living in deprived areas. Conclusions: Different and independent socioeconomic variables are inversely associated with different cancer risks in both sexes; no one socioeconomic variable captures all aspects of socioeconomic circumstances or life course. Association of multiple socioeconomic variables is likely to reflect the complexity and multifaceted nature of deprivation as well as the various roles of these dimensions over the life course.	[Sharpe, Katharine H.; Brewster, David H.] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [Sharpe, Katharine H.; McMahon, Alex D.; Conway, David I.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Dent, Glasgow, Lanark, Scotland; [Raab, Gillian M.] Univ St Andrews, St Andrews, Fife, Scotland; [Brewster, David H.] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland	NHS National Services Scotland; University of Glasgow; University of St Andrews; University of Edinburgh	Sharpe, KH (corresponding author), NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland.	k.sharpe.1@research.gla.ac.uk	van Ham, Maarten/AAA-6263-2020	van Ham, Maarten/0000-0002-2106-0702; Brewster, David/0000-0002-5346-5608; Conway, David/0000-0001-7762-4063	Economic and Social Research Council [ES/K000454/1, ES/K000454/2] Funding Source: researchfish; ESRC [ES/K000454/2, ES/K000454/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Andersen ZJ, 2008, EUR J CANCER, V44, P1950, DOI 10.1016/j.ejca.2008.06.019; [Anonymous], 1997, IARC Sci Publ, P1; [Anonymous], 2013, NAT CANC INT NETW E; Baastrup R, 2008, EUR J CANCER, V44, P1962, DOI 10.1016/j.ejca.2008.06.013; Bailey J, 2009, AM FAM PHYSICIAN, V80, P1052; Beelen R, 2008, EPIDEMIOLOGY, V19, P702, DOI 10.1097/EDE.0b013e318181b3ca; Benzeval M, 2001, SOC SCI MED, V52, P1371, DOI 10.1016/S0277-9536(00)00244-6; Berkman L F, 1997, IARC Sci Publ, P51; Bilello KS, 2002, CLIN CHEST MED, V23, P1, DOI 10.1016/S0272-5231(03)00057-1; Bishop J, 2004, DEPRIVATION URBAN RU, P1; Black D., 1980, INEQUALITIES HLTH; Boyle PJ, 2009, INT J EPIDEMIOL, V38, P385, DOI 10.1093/ije/dyn087; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Brewster DH, 2002, EUR J CANCER, V38, P414, DOI 10.1016/S0959-8049(01)00385-9; Brown J, 1997, Popul Trends, P40; Cambois E, 2011, EUR J PUBLIC HEALTH, V21, P667, DOI 10.1093/eurpub/ckq119; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; Conway DI, 2010, EUR J CANCER, V46, P588, DOI 10.1016/j.ejca.2009.09.028; Conway DI, 2008, INT J CANCER, V122, P2811, DOI 10.1002/ijc.23430; Conway DI, 2010, BRIT J ORAL MAX SURG, V48, P11, DOI 10.1016/j.bjoms.2009.03.020; Craig P, 2005, J BIOSOC SCI, V37, P89, DOI 10.1017/S0021932003006424; Currin LG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-62; Dalton SO, 2008, EUR J CANCER, V44, P1938, DOI [10.1016/j.ejca.2008.06.010, 10.1016/j.ejca.2008.06.034]; Dalton SO, 2008, EUR J CANCER, V44, P1989, DOI 10.1016/j.ejca.2008.06.023; Dignam JJ, 2012, CLIN CANCER RES, V18, P2301, DOI 10.1158/1078-0432.CCR-11-2097; Ellaway A, 1998, HEALTH PLACE, V4, P141, DOI 10.1016/S1353-8292(98)00006-9; Frohlich KL, 2001, SOCIOL HEALTH ILL, V23, P776, DOI 10.1111/1467-9566.00275; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Harvei S, 1997, PREV MED, V26, P623, DOI 10.1006/pmed.1997.0153; Hemminki K, 2003, INT J CANCER, V105, P692, DOI 10.1002/ijc.11150; International Agency for Research on Cancer, 2008, GLOBOCAN 2008 FAST F; Jones AM, 2004, HEALTH ECON, V13, P1015, DOI 10.1002/hec.904; Kelly-Irving M, 2013, INT J PUBLIC HEALTH, V58, P1661; KKSR Pye S, 2006, AEATENV2170; Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186; Lancaster GA, 2006, J EPIDEMIOL COMMUN H, V60, P1093, DOI 10.1136/jech.2005.043356; Leyland AH, 2005, J EPIDEMIOL COMMUN H, V59, P799, DOI 10.1136/jech.2005.034017; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Macintyre S, 2003, SOCIAL EPIDEMIOLOGY, P332; Mackay J, 2012, PUBLIC HEALTH, V126, P199, DOI 10.1016/j.puhe.2012.01.027; Mackay J, 2003, RESPIROLOGY, V8, P123, DOI 10.1046/j.1440-1843.2003.00464.x; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marshall B, 1999, CANCER CAUSE CONTROL, V10, P495, DOI 10.1023/A:1008921720493; Mathieson A., 2013, REV SOC DET HLTH DIV, P1; McLaren GL, 2012, DEPRIVATION HTLH SCO, P1; McLoone P, 2000, CARSTAINS SCORES SCO, P1; Meijer M, 2013, J EPIDEMIOL COMMUN H, V67, P6, DOI 10.1136/jech-2011-200192; Melchior M, 2005, CANCER CAUSE CONTROL, V16, P515, DOI 10.1007/s10552-004-7116-0; Menvielle G, 2009, JNCI-J NATL CANCER I, V101, P321, DOI 10.1093/jnci/djn513; Pavanello S, 2011, INT J CANCER, V129, P983, DOI 10.1002/ijc.25999; Pevalin DJ, 2008, HOUSING STUD, V23, P679, DOI 10.1080/02673030802253848; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Pollack CE, 2007, AM J PREV MED, V33, P250, DOI 10.1016/j.amepre.2007.04.033; Prescott J, 2012, MUTAT RES-FUND MOL M, V730, P75, DOI 10.1016/j.mrfmmm.2011.06.009; Randi G, 2004, PREV MED, V38, P523, DOI 10.1016/j.ypmed.2003.12.004; Riva M, 2007, J EPIDEMIOL COMMUN H, V61, P853, DOI 10.1136/jech.2006.050740; Robertson T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041805; Rose D, 1995, SOCIAL RES UPDAT JUL, P1; ScotPHO, 2008, AD TOB US SCOTL EP B; Scottish Government, 2010, SUST PROC DEL PLAN, P1; Scottish Government, 2012, SCOTT LAW COMM ANN R, P1; Scottish Government, 2013, LONG TERM MON HLTH I, P1; Sharpe KH, 2012, CANCER EPIDEMIOL, V36, pE164, DOI 10.1016/j.canep.2012.01.007; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Shaw D, 2009, BIOETHICS, V23, P131, DOI 10.1111/j.1467-8519.2008.00715.x; Shiels PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022521; Smith JP, 2007, J HUM RESOUR, V42, P739; Spadea T, 2010, CANCER CAUSE CONTROL, V21, P1117, DOI 10.1007/s10552-010-9539-0; Weiderpass E, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-41; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; Wild SH, 2006, BRIT J CANCER, V95, P424, DOI 10.1038/sj.bjc.6603263; Wild SH, 2006, BRIT J CANCER, V94, P1079, DOI 10.1038/sj.bjc.6603031; Wilkinson R, 2003, SAF NUMB POINT GLOB, P1; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011	78	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89513	10.1371/journal.pone.0089513	http://dx.doi.org/10.1371/journal.pone.0089513			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC3BU	24586838	gold, Green Accepted, Green Published			2022-12-27	WOS:000332390800025
J	Wang, LF				Wang, Li-feng			Physiological and Molecular Responses to Variation of Light Intensity in Rubber Tree (Hevea brasiliensis Muell. Arg.)	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; NUCLEOTIDE-SEQUENCE; ELECTRON-TRANSPORT; LIPID-PEROXIDATION; PLANT-MITOCHONDRIA; LEAF SENESCENCE; PHOTOSYNTHESIS; CHLOROPLASTS	Light is one of most important factors to plants because it is necessary for photosynthesis. In this study, physiological and gene expression analyses under different light intensities were performed in the seedlings of rubber tree (Hevea brasiliensis) clone GT1. When light intensity increased from 20 to 1000 mu mol m(-2) s(-1), there was no effect on the maximal quantum yield of photosystem II (PSII) photochemistry (Fv/Fm), indicating that high light intensity did not damage the structure and function of PSII reaction center. However, the effective photochemical quantum yield of PSII (Y(II)), photochemical quenching coefficient (qP), electron transfer rate (ETR), and coefficient of photochemical fluorescence quenching assuming interconnected PSII antennae (qL) were increased significantly as the light intensity increased, reached a maximum at 200 mmol m(-2) s(-1), but decreased from 400 mu mol m(-2) s(-1). These results suggested that the PSII photochemistry showed an optimum performance at 200 mu mol m(-2) s(-1) light intensity. The chlorophyll content was increased along with the increase of light intensity when it was no more than 400 mu mol m(-2) s(-1). Since increasing light intensity caused significant increase in H2O2 content and decreases in the per unit activity of antioxidant enzymes SOD and POD, but the malondialdehyde (MDA) content was preserved at a low level even under high light intensity of 1000 mmol m(-2) s(-1), suggesting that high light irradiation did not induce membrane lipid peroxidation in rubber tree. Moreover, expressions of antioxidant-related genes were significantly up-regulated with the increase of light intensity. They reached the maximum expression at 400 mu mol m(-2) s(-1), but decreased at 1000 mu mol m(-2) s(-1). In conclusion, rubber tree could endure strong light irradiation via a specific mechanism. Adaptation to high light intensity is a complex process by regulating antioxidant enzymes activities, chloroplast formation, and related genes expressions in rubber tree.	Chinese Acad Trop Agr Sci, Rubber Res Inst, State Key Lab Incubat Base Cultivat & Physiol Tro, Key Lab Biol & Genet Resources Rubber Tree, Danzhou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences	Wang, LF (corresponding author), Chinese Acad Trop Agr Sci, Rubber Res Inst, State Key Lab Incubat Base Cultivat & Physiol Tro, Key Lab Biol & Genet Resources Rubber Tree, Danzhou, Hainan, Peoples R China.	lfngwang@yahoo.com	Wang, Li-feng/D-1508-2019	Wang, Li-feng/0000-0003-2803-3464	Natural Science Foundation of China [31270643]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	LF Wang is supported by Natural Science Foundation of China (31270643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; [蔡甫格 CAI Fuge], 2011, [热带作物学报, Chinese Journal of Tropical Crops], V32, P891; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; CHYE ML, 1992, PLANT MOL BIOL, V18, P611, DOI 10.1007/BF00040680; CHYE ML, 1991, PLANT MOL BIOL, V16, P1077, DOI 10.1007/BF00016079; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Deng LH, 2012, BIOSCIENCE BIOTECHNO; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Doyle SM, 2010, J EXP BOT, V61, P473, DOI 10.1093/jxb/erp320; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; Fankhauser C, 1997, ANNU REV CELL DEV BI, V13, P203, DOI 10.1146/annurev.cellbio.13.1.203; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; KITAJIMA M, 1975, BIOCHIM BIOPHYS ACTA, V376, P105, DOI 10.1016/0005-2728(75)90209-1; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Leclercq J, 2012, PLANT MOL BIOL, V80, P255, DOI 10.1007/s11103-012-9942-x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Link G, 2004, REDOX REGULATION PHO, P85; Lu CM, 2001, J EXP BOT, V52, P1805, DOI 10.1093/jexbot/52.362.1805; Mai J, 2009, TREES-STRUCT FUNCT, V23, P863, DOI 10.1007/s00468-009-0328-x; Marrero-Degro J, 2011, PLANT MOL BIOL REP, V29, P514, DOI 10.1007/s11105-010-0255-4; Maxwell K, 1999, PLANT PHYSIOL, V121, P89, DOI 10.1104/pp.121.1.89; MIAO ZH, 1993, PLANT MOL BIOL, V23, P267, DOI 10.1007/BF00029003; Miguel AA, 2007, CIENC AGROTEC, V31, P91, DOI 10.1590/S1413-70542007000100014; Molina-Rueda JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056421; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Nataraja KN, 1999, PHOTOSYNTHETICA, V36, P89, DOI 10.1023/A:1007070820925; PEEVER TL, 1989, PLANT PHYSIOL, V90, P867, DOI 10.1104/pp.90.3.867; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; Puskas JE, 2006, PROG POLYM SCI, V31, P533, DOI 10.1016/j.progpolymsci.2006.05.002; Rentsch D, 1995, J BIOL CHEM, V270, P30525, DOI 10.1074/jbc.270.51.30525; Rhoads DM, 2006, PLANT PHYSIOL, V141, P357, DOI 10.1104/pp.106.079129; SAMSUDDIN Z, 1979, BIOL PLANTARUM, V21, P154, DOI 10.1007/BF02909469; SAMSUDDIN Z, 1978, EXP AGR, V14, P337, DOI 10.1017/S0014479700008978; Takahashi Shunichi, 2002, BMC Plant Biology, V2, P1; Tang CR, 2007, J BIOCHEM BIOPH METH, V70, P749, DOI 10.1016/j.jbbm.2007.04.002; Webster C.C., 1989, RUBBER; Xiao XH, 2009, MOL BIOTECHNOL, V42, P91, DOI 10.1007/s12033-008-9139-3; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	42	13	16	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89514	10.1371/journal.pone.0089514	http://dx.doi.org/10.1371/journal.pone.0089514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586839	Green Published, Green Submitted, gold			2022-12-27	WOS:000332390800026
J	Benlloch, S; Botero, ML; Beltran-Alamillo, J; Mayo, C; Gimenez-Capitan, A; de Aguirre, I; Queralt, C; Ramirez, JL; Cajal, SRY; Klughammer, B; Schlegel, M; Bordogna, W; Chen, D; Zhang, GL; Kovach, B; Shieh, F; Palma, JF; Wu, L; Lawrence, HJ; Taron, M				Benlloch, Susana; Luisa Botero, Maria; Beltran-Alamillo, Jordi; Mayo, Clara; Gimenez-Capitan, Ana; de Aguirre, Itziar; Queralt, Cristina; Luis Ramirez, Jose; Ramon y Cajal, Santiago; Klughammer, Barbara; Schlegel, Mariette; Bordogna, Walter; Chen, David; Zhang, Guili; Kovach, Barbara; Shieh, Felice; Palma, John F.; Wu, Lin; Lawrence, H. Jeffrey; Taron, Miquel			Clinical Validation of a PCR Assay for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer: Retrospective Testing of Specimens from the EURTAC Trial	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; EMBEDDED TISSUE SPECIMENS; BRAF V600E MUTATION; ANALYTIC PERFORMANCE; 1ST-LINE TREATMENT; GENE-MUTATIONS; OPEN-LABEL; GEFITINIB; CHEMOTHERAPY; ERLOTINIB	The EURTAC trial demonstrated that the tyrosine kinase inhibitor (TKI) erlotinib was superior to chemotherapy as first-line therapy for advanced non-small cell lung cancers (NSCLC) that harbor EGFR activating mutations in a predominantly Caucasian population. Based on EURTAC and several Asian trials, anti-EGFR TKIs are standard of care for EGFR mutation-positive NSCLC. We sought to validate a rapid multiplex EGFR mutation assay as a companion diagnostic assay to select patients for this therapy. Samples from the EURTAC trial were prospectively screened for EGFR mutations using a combination of laboratory-developed tests (LDTs), and tested retrospectively with the cobas EGFR mutation test (EGFR PCR test). The EGFR PCR test results were compared to the original LDT results and to Sanger sequencing, using a subset of specimens from patients screened for the trial. Residual tissue was available from 487 (47%) of the 1044 patients screened for the trial. The EGFR PCR test showed high concordance with LDT results with a 96.3% overall agreement. The clinical outcome of patients who were EGFR-mutation detected by the EGFR PCR test was very similar to the entire EURTAC cohort. The concordance between the EGFR PCR test and Sanger sequencing was 90.6%. In 78.9% of the discordant samples, the EGFR PCR test result was confirmed by a sensitive deep sequencing assay. This retrospective study demonstrates the clinical utility of the EGFR PCR test in the accurate selection of patients for anti-EGFR TKI therapy. The EGFR PCR test demonstrated improved performance relative to Sanger sequencing.	[Benlloch, Susana; Luisa Botero, Maria; Beltran-Alamillo, Jordi; Mayo, Clara; Gimenez-Capitan, Ana; Ramon y Cajal, Santiago; Taron, Miquel] Pangaea Biotech SL, Barcelona, Spain; [de Aguirre, Itziar; Queralt, Cristina; Luis Ramirez, Jose; Taron, Miquel] Hosp Badalona Germans Trias & Pujol, Med Oncol Serv ICO, Badalona, Spain; [Klughammer, Barbara; Schlegel, Mariette; Bordogna, Walter] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland; [Chen, David] Genentech Inc, San Francisco, CA 94080 USA; [Zhang, Guili; Kovach, Barbara; Shieh, Felice; Palma, John F.; Wu, Lin; Lawrence, H. Jeffrey] Roche Mol Syst, Pleasanton, CA USA; [Ramon y Cajal, Santiago] Univ Autonoma Barcelona, Dept Pathol, Univ Hosp, E-08193 Barcelona, Spain	Hospital Germans Trias i Pujol; Roche Holding; Roche Holding; Genentech; Roche Holding; Autonomous University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Benlloch, S (corresponding author), Pangaea Biotech SL, Barcelona, Spain.	sbenlloch@pangaeabiotech.com	Ramon y Cajal, Santiago/H-4955-2016; Giménez-Capitán, Ana/AAX-1433-2021; Ramirez, Jose Luis/E-5161-2018	Ramon y Cajal, Santiago/0000-0002-3867-1390; Ramirez, Jose Luis/0000-0003-1447-2941; Queralt, Cristina/0000-0001-9875-0173	Roche	Roche(Roche Holding)	This study was funded by Roche. The funders contributed to the study design, data collection, analysis, decision to publish and preparation of the manuscript.	Administration USFaD, 2010, CLASS LAB CHANG ANT; Administration USFaD, 2013, FDA APPR 1 COMP DIAG; Anderson S, 2012, ARCH PATHOL LAB MED, V136, P1385, DOI 10.5858/arpa.2011-0505-OA; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; [Anonymous], 2011, COB EGFR MUT TEST CE; Beau-Faller M, 2011, J THORAC ONCOL, V6, P1006, DOI 10.1097/JTO.0b013e318211dcee; Bellon E, 2011, ONCOLOGIST, V16, P467, DOI 10.1634/theoncologist.2010-0429; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Conde E, 2006, CLIN CANCER RES, V12, P710, DOI 10.1158/1078-0432.CCR-05-1362; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Garrido P, 2012, CLIN TRANSL ONCOL, V14, P338, DOI 10.1007/s12094-012-0806-2; Harbison CT, 2013, ARCH PATHOL LAB MED, V137, P820, DOI 10.5858/arpa.2012-0367-OA; Hirsch FR, 2011, J CLIN ONCOL, V29, P3567, DOI 10.1200/JCO.2010.34.4929; Jane O'Donnell PF, 2012, REAL TIME PCR ASSAY; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kotoula V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007746; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; O'Bryant CL, 2013, ANN PHARMACOTHER, V47, P189, DOI 10.1345/aph.1R002; O'Donnell P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-210; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ou SHI, 2012, ONCOLOGIST, V17, P1351, DOI 10.1634/theoncologist.2012-0311; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Riely GJ, 2006, CLIN CANCER RES, V12, P7232, DOI 10.1158/1078-0432.CCR-06-0658; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Ruiz MIG, 2007, CELL ONCOL, V29, P257; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sun JM, 2012, J THORAC ONCOL, V7, pE36, DOI 10.1097/JTO.0b013e318274694e; Tan YH, 2008, PATHOLOGY, V40, P295, DOI 10.1080/00313020801911512; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	39	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89518	10.1371/journal.pone.0089518	http://dx.doi.org/10.1371/journal.pone.0089518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586842	Green Submitted, Green Published, gold			2022-12-27	WOS:000332385900050
J	Griva, K; Lai, AY; Lim, HA; Yu, ZL; Foo, MWY; Newman, SP				Griva, Konstadina; Lai, Alden Yuanhong; Lim, Haikel Asyraf; Yu, Zhenli; Foo, Marjorie Wai Yin; Newman, Stanton P.			Non-Adherence in Patients on Peritoneal Dialysis: A Systematic Review	PLOS ONE			English	Article							MEDICATION ADHERENCE; HEMODIALYSIS; PRESCRIPTION; CARE; NONCOMPLIANCE; CONSEQUENCES; EXCHANGES; CAPD; PREVALENCE; IMPACT	Background: It has been increasingly recognized that non-adherence is an important factor that determines the outcome of peritoneal dialysis (PD) therapy. There is therefore a need to establish the levels of non-adherence to different aspects of the PD regimen (dialysis procedures, medications, and dietary/fluid restrictions). Methods: A systematic review of peer-reviewed literature was performed in PubMed, PsycINFO and CINAHL databases using PRISMA guidelines in May 2013. Publications on non-adherence in PD were selected by two reviewers independently according to predefined inclusion and exclusion criteria. Relevant data on patient characteristics, measures, rates and factors associated with non-adherence were extracted. The quality of studies was also evaluated independently by two reviewers according to a revised version of the Effective Public Health Practice Project assessment tool. Results: The search retrieved 204 studies, of which a total of 25 studies met inclusion criteria. Reported rates of non-adherence varied across studies: 2.6-53% for dialysis exchanges, 3.9-85% for medication, and 14.4-67% for diet/fluid restrictions. Methodological differences in measurement and definition of non-adherence underlie the observed variation. Factors associated with non-adherence that showed a degree of consistency were mostly socio-demographical, such as age, employment status, ethnicity, sex, and time period on PD treatment. Conclusion: Non-adherence to different dimensions of the dialysis regimen appears to be prevalent in PD patients. There is a need for further, high-quality research to explore these factors in more detail, with the aim of informing intervention designs to facilitate adherence in this patient population.	[Griva, Konstadina; Lai, Alden Yuanhong; Lim, Haikel Asyraf] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Yu, Zhenli] Khoo Teck Puat Hosp, Dept Renal Med, Singapore, Singapore; [Foo, Marjorie Wai Yin] Singapore Gen Hosp, Peritoneal Dialysis Ctr, Dept Nephrol, Singapore, Singapore; [Griva, Konstadina; Newman, Stanton P.] UCL, Behav Med Unit, London, England; [Newman, Stanton P.] City Univ London, Hlth Serv Res Grp, London EC1V 0HB, England	National University of Singapore; Singapore General Hospital; University of London; University College London; City University London	Griva, K (corresponding author), Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore.	psygk@nus.edu.sg	Griva, Konstadina/A-6549-2018; Lim, Haikel A./C-7965-2014; Lai, Alden Yuanhong/ABA-5873-2020	Lim, Haikel A./0000-0002-9529-3517; /0000-0002-2416-2915; Newman, Stanton/0000-0001-6712-6079; GRIVA, KONSTADINA/0000-0001-8173-5663				Amici G, 1996, Perit Dial Int, V16 Suppl 1, pS176; Bane C, 2006, PATIENT EDUC COUNS, V60, P187, DOI 10.1016/j.pec.2005.01.003; Bender BG, 2004, CURR OPIN ALLERGY CL, V4, P191, DOI 10.1097/01.all.0000129449.73727.cf; Bender FH, 2006, KIDNEY INT, V70, pS44, DOI 10.1038/sj.ki.5001915; Bernardini J, 2000, AM J KIDNEY DIS, V35, P1104, DOI 10.1016/S0272-6386(00)70047-3; Bernardini J, 1997, PERITON DIALYSIS INT, V17, P338; Bernardini J, 1998, AM J KIDNEY DIS, V31, P101, DOI 10.1053/ajkd.1998.v31.pm9428459; Blake PG, 1999, PERITON DIALYSIS INT, V19, pS495; Blake PG, 2000, AM J KIDNEY DIS, V35, P506, DOI 10.1016/S0272-6386(00)70205-8; Bland RJ, 2008, DIALYSIS TRANSPLANT, V37, P174, DOI 10.1002/dat.20207; Chan MF, 2010, J CLIN NURS, V19, P649, DOI 10.1111/j.1365-2702.2009.03103.x; Chen W, 2006, J RENAL NUTR, V16, P132, DOI 10.1053/j.jrn.2006.01.009; Chua AN, 2011, PEDIATR NEPHROL, V26, P789, DOI 10.1007/s00467-011-1792-2; Denhaerynck K, 2005, TRANSPL INT, V18, P1121, DOI 10.1111/j.1432-2277.2005.00176.x; Denhaerynck K, 2009, TRANSPL INT, V22, P441, DOI 10.1111/j.1432-2277.2008.00820.x; Denhaerynd K, 2007, AM J CRIT CARE, V16, P222; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Effective Public Health Practice Project, 1998, QUAL ASS TOOL QUANT; Figueiredo Ana E, 2005, Adv Perit Dial, V21, P77; Fine A, 1997, PERITON DIALYSIS INT, V17, P343; Garcia-Llana H, 2013, PSICOTHEMA, V25, P79, DOI 10.7334/psicothema2012.96; Hailey B.J., 2000, PSYCHOL HEALTH MED, V5, P395, DOI [10.1080/713690222, DOI 10.1111/SDI.12123]; Hall Gayle, 2004, Nephrol Nurs J, V31, P149; Hirth RA, 2008, HEALTH AFFAIR, V27, P89, DOI 10.1377/hlthaff.27.1.89; Hollis JL, 2006, J RENAL CARE, V32, P202, DOI 10.1111/j.1755-6686.2006.tb00023.x; Hung KY, 2013, THER APHER DIAL, V17, P72, DOI 10.1111/j.1744-9987.2012.01098.x; Jain AK, 2012, J AM SOC NEPHROL, V23, P533, DOI 10.1681/ASN.2011060607; Juergensen Peter H, 2004, Adv Perit Dial, V20, P90; Kara B, 2007, J NURS SCHOLARSHIP, V39, P243, DOI 10.1111/j.1547-5069.2007.00175.x; Karamanidou C, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-2; Khalil Amani Anwar, 2010, Issues Ment Health Nurs, V31, P324, DOI 10.3109/01612840903384008; Kugler C, 2011, J NEPHROL, V24, P366, DOI 10.5301/JN.2010.5823; Kutner NG, 2002, NEPHROL DIAL TRANSPL, V17, P93, DOI 10.1093/ndt/17.1.93; Lam LW, 2010, J ADV NURS, V66, P763, DOI 10.1111/j.1365-2648.2009.05235.x; Lehane E, 2007, INT J NURS STUD, V44, P1468, DOI 10.1016/j.ijnurstu.2006.07.010; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin Chiu-Chu, 1997, Kaohsiung Journal of Medical Sciences, V13, P243; Lindberg M, 2007, SCAND J UROL NEPHROL, V41, P546, DOI 10.1080/00365590701421363; Lulowsky L, 2013, CLIN J AM SOC NEPHRO, V8; Mawar S, 2012, INT UROL NEPHROL, V44, P1243, DOI 10.1007/s11255-011-0079-7; MORRIS LS, 1992, J CLIN PHARM THER, V17, P283, DOI 10.1111/j.1365-2710.1992.tb01306.x; National Kidney Foundation, 2012, DIAL; Neri L, 2002, ADV PERIT DIAL, V18; Pruthi R, 2013, UK RENAL REGISTRY 16; Quan L, 2006, PERITON DIALYSIS INT, V26, P95; Ricka R, 2002, INT J NURS STUD, V39, P329, DOI 10.1016/S0020-7489(01)00024-4; Rivetti M, 2002, EDTNA ERCA J, V28, P40; Rivetti M, 2002, EDTNA ERCA J, V28, P55; Russo R, 2006, KIDNEY INT, V70, pS127, DOI 10.1038/sj.ki.5001929; SabatU E., 2003, ADHERENCE LONG TERM; Schmid H, 2009, EUR J MED RES, V14, P185, DOI 10.1186/2047-783X-14-5-185; Sevick MA, 1999, PERITON DIALYSIS INT, V19, P23; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Sunanda K, 2008, DIGEST DIS SCI, V53, P1020; Termorshuizen F, 2003, J AM SOC NEPHROL, V14, P2851, DOI 10.1097/01.ASN.0000091585.45723.9E; Vlaminck H, 2001, J CLIN NURS, V10, P707, DOI 10.1046/j.1365-2702.2001.00537.x; Vonesh E, 2004, KIDNEY INT, V66; WARREN PJ, 1994, J AM SOC NEPHROL, V4, P1627; Wazny LD, 2002, AM J KIDNEY DIS, V40, P623, DOI 10.1053/ajkd.2002.34925; Weed-Collins M, 1989, ANNA J, V16, P278; Wright M, 2004, NEPHROL DIAL TRANSPL, V19, P1581, DOI 10.1093/ndt/gfh227; Yu ZL, 2012, SINGAP MED J, V53, P474	62	55	60	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89001	10.1371/journal.pone.0089001	http://dx.doi.org/10.1371/journal.pone.0089001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2ZX	24586478	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000332385900025
J	Sindato, C; Karimuribo, ED; Pfeiffer, DU; Mboera, LEG; Kivaria, F; Dautu, G; Bernard, B; Paweska, JT				Sindato, Calvin; Karimuribo, Esron D.; Pfeiffer, Dirk U.; Mboera, Leonard E. G.; Kivaria, Fredrick; Dautu, George; Bernard, Bett; Paweska, Janusz T.			Spatial and Temporal Pattern of Rift Valley Fever Outbreaks in Tanzania; 1930 to 2007	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; MOLECULAR EPIDEMIOLOGY; ARBOVIRAL DISEASES; IGG-SANDWICH; VIRUS; ANTIBODY; KENYA; HUMANS; TRANSMISSION; CIRCULATION	Background: Rift Valley fever (RVF)-like disease was first reported in Tanzania more than eight decades ago and the last large outbreak of the disease occurred in 2006-07. This study investigates the spatial and temporal pattern of RVF outbreaks in Tanzania over the past 80 years in order to guide prevention and control strategies. Materials and Methods: A retrospective study was carried out based on disease reporting data from Tanzania at district or village level. The data were sourced from the Ministries responsible for livestock and human health, Tanzania Meteorological Agency and research institutions involved in RVF surveillance and diagnosis. The spatial distribution of outbreaks was mapped using ArcGIS 10. The space-time permutation model was applied to identify clusters of cases, and a multivariable logistic regression model was used to identify risk factors associated with the occurrence of outbreaks in the district. Principal Findings: RVF outbreaks were reported between December and June in 1930, 1947, 1957, 1960, 1963, 1968, 1977-79, 1989, 1997-98 and 2006-07 in 39.2% of the districts in Tanzania. There was statistically significant spatio-temporal clustering of outbreaks. RVF occurrence was associated with the eastern Rift Valley ecosystem (OR = 6.14, CI: 1.96, 19.28), total amount of rainfall of >405.4 mm (OR = 12.36, CI: 3.06, 49.88), soil texture (clay [OR = 8.76, CI: 2.52, 30.50], and loam [OR = 8.79, CI: 2.04, 37.82]). Conclusion/Significance: RVF outbreaks were found to be distributed heterogeneously and transmission dynamics appeared to vary between areas. The sequence of outbreak waves, continuously cover more parts of the country. Whenever infection has been introduced into an area, it is likely to be involved in future outbreaks. The cases were more likely to be reported from the eastern Rift Valley than from the western Rift Valley ecosystem and from areas with clay and loam rather than sandy soil texture.	[Sindato, Calvin] Natl Inst Med Res, Tabora, Tanzania; [Sindato, Calvin; Karimuribo, Esron D.] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania; [Sindato, Calvin; Karimuribo, Esron D.] Southern Africa Ctr Infect Dis Surveillance, Morogoro, Tanzania; [Pfeiffer, Dirk U.] Univ London Royal Vet Coll, London, England; [Mboera, Leonard E. G.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Kivaria, Fredrick] UN, Food & Agr Org, Dar Es Salaam, Tanzania; [Dautu, George] Univ Zambia, Dept Dis Control, Lusaka, Zambia; [Bernard, Bett] Int Livestock Res Inst, Nairobi, Kenya; [Paweska, Janusz T.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Emerging & Zoonot Dis, Johannesburg, South Africa; [Paweska, Janusz T.] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa	Sokoine University of Agriculture; University of London; University of London Royal Veterinary College; National Institute of Medical Research; Food & Agriculture Organization of the United Nations (FAO); University of Zambia; CGIAR; International Livestock Research Institute (ILRI); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Sindato, C (corresponding author), Natl Inst Med Res, Tabora, Tanzania.	kndato@yahoo.co.uk	Pfeiffer, Dirk U/C-5002-2009; Ibrahim, Essam Hassan/G-1960-2018	Pfeiffer, Dirk U/0000-0001-7000-0530; Ibrahim, Essam Hassan/0000-0003-0130-2257	Wellcome Trust [WT087546MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study received financial support from the Wellcome Trust Grant [WT087546MA] to the Southern African Centre for Infectious Disease Surveillance (www.sacids.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 1998, EPIDEMIOL INFECT, V121, P441, DOI 10.1017/S0950268898001289; Anyamba A, 2001, Cad Saude Publica, V17 Suppl, P133, DOI 10.1590/S0102-311X2001000700022; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Archer BN, 2013, EMERG INFECT DIS, V19, P1918, DOI 10.3201/eid1912.121527; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; Bird BH, 2008, J VIROL, V111, P52; Britch SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066626; Cetre-Sossah C, 2012, EMERG INFECT DIS, V18, P6, DOI [10.3201/eid186.111165, DOI 10.3201/EID186.111165]; Chevalier W, 2005, EMERG INFECT DIS, V11, P1693, DOI 10.3201/eid1111.050193; Dar O, 2013, EMERG INFECT DIS, V19, P189, DOI 10.3201/eid1902.120941; EFSA, 2005, EFSA J, V3, P1, DOI DOI 10.2903/J.EFSA.2005.238; Evans A, 2008, EPIDEMIOL INFECT, V136, P1261, DOI 10.1017/S0950268807009806; Fafetine J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002065; FAO-Unesco, 1988, SOIL MAP WORLD; Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263; Food and Agriculture Organization, LIV INF SECT AN POL; Grobbelaar AA, 2011, EMERG INFECT DIS, V17, P2270, DOI 10.3201/eid1712.111035; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Hartley DM, 2011, EMERG INFECT DIS, V17, DOI DOI 10.3201/EID1708.101088.ACCESSED; Heinrich N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001557; Hightower A, 2012, AM J TROP MED HYG, V86, P373, DOI 10.4269/ajtmh.2012.11-0450; Hosmer D., 2002, APPL LOGISTIC REGRES; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; LaBeaud AD, 2008, EMERG INFECT DIS, V14, P1240, DOI 10.3201/eid1408.080082; LaBeaud AD, 2007, AM J TROP MED HYG, V76, P795, DOI 10.4269/ajtmh.2007.76.795; LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1; Mboera L E, 2001, Afr J Health Sci, V8, P17; Ministry of Health and Social Welfare United Republic of Tanzania, 2011, NAT INT DIS SURV RES; Mlozi MRS, 2008, SOC IMP AN REC RIFT; Mohamed M, 2010, AM J TROP MED HYG, V83, P22, DOI 10.4269/ajtmh.2010.09-0318; MORLEY CK, 1999, ACTA VULCANOLOGICA, V11, P1; MORVAN J, 1992, RES VIROLOGY, V143, P407, DOI 10.1016/S0923-2516(06)80134-2; Munyua P, 2010, AM J TROP MED HYG, V83, P58, DOI 10.4269/ajtmh.2010.09-0292; Murithi RM, 2011, EPIDEMIOL INFECT, V139, P372, DOI 10.1017/S0950268810001020; Murphy FA, 1999, VET VIROLOGY, P469; NBS, 2002, UN REP TANZ POP HOUS; Nderitu L, 2011, J INFECT DIS, V203, P655, DOI 10.1093/infdis/jiq004; Nguku PM, 2010, AM J TROP MED HYG, V83, P5, DOI 10.4269/ajtmh.2010.09-0288; Paweska JT, 2007, J VIROL METHODS, V146, P119, DOI 10.1016/j.jviromet.2007.06.006; Paweska JT, 2014, ROLE OF ANIMALS IN EMERGING VIRAL DISEASES, P169, DOI 10.1016/B978-0-12-405191-1.00008-9; Paweska JT, 2005, J VIROL METHODS, V127, P10, DOI 10.1016/j.jviromet.2005.02.008; Paweska JT, 2005, J VIROL METHODS, V124, P173, DOI 10.1016/j.jviromet.2004.11.020; Paweska JT, 2003, J VIROL METHODS, V113, P103, DOI 10.1016/S0166-0934(03)00228-3; Paweska JT, 2003, ONDERSTEPOORT J VET, V70, P49; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Pfeffer M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-35; Pienaar NJ, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.384; Pourrut X, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000763; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195; Sindato C., 2013, Tanzania Veterinary Journal, V28, P21; Sindato Calvin, 2011, Tanzan J Health Res, V13, P305; Swanepoel R, 1994, INFECT DIS LIVESTOCK, P688; TURELL MJ, 1991, AM J TROP MED HYG, V44, P278, DOI 10.4269/ajtmh.1991.44.278; United republic of Tanzania, 2007, NAT SAMPL CENS AGR S, VIII; Versteirt V., 2013, SYSTEMATIC LIT REV G	57	47	49	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88897	10.1371/journal.pone.0088897	http://dx.doi.org/10.1371/journal.pone.0088897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586433	gold, Green Published			2022-12-27	WOS:000332385900016
J	Zhang, P; Li, MH; Gao, L; Fan, Y; Di, ZR				Zhang, Peng; Li, Menghui; Gao, Liang; Fan, Ying; Di, Zengru			Characterizing and Modeling the Dynamics of Activity and Popularity	PLOS ONE			English	Article							SOCIAL-INFLUENCE; EMERGENCE; BEHAVIOR; NETWORKS	Social media, regarded as two-layer networks consisting of users and items, turn out to be the most important channels for access to massive information in the era of Web 2.0. The dynamics of human activity and item popularity is a crucial issue in social media networks. In this paper, by analyzing the growth of user activity and item popularity in four empirical social media networks, i.e., Amazon, Flickr, Delicious and Wikipedia, it is found that cross links between users and items are more likely to be created by active users and to be acquired by popular items, where user activity and item popularity are measured by the number of cross links associated with users and items. This indicates that users generally trace popular items, overall. However, it is found that the inactive users more severely trace popular items than the active users. Inspired by empirical analysis, we propose an evolving model for such networks, in which the evolution is driven only by two-step random walk. Numerical experiments verified that the model can qualitatively reproduce the distributions of user activity and item popularity observed in empirical networks. These results might shed light on the understandings of micro dynamics of activity and popularity in social media networks.	[Zhang, Peng] Beijing Univ Posts & Telecommun, Sch Sci, Beijing 100088, Peoples R China; [Li, Menghui; Fan, Ying; Di, Zengru] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China; [Li, Menghui] Beijing Inst Sci & Technol Intelligence, Beijing, Peoples R China; [Gao, Liang] Beijing Jiaotong Univ, Inst Syst Sci, Beijing, Peoples R China; [Gao, Liang] Beijing Jiaotong Univ, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China	Beijing University of Posts & Telecommunications; Beijing Normal University; Beijing Jiaotong University; Beijing Jiaotong University	Li, MH (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	limenghui76@gmail.com	Li, Menghui/E-7613-2011	Li, Menghui/0000-0001-8151-5898	Fundamental Research Funds for the Central Universities [2012RC0707, 2012JBM067]; National Natural Science Foundation of China [61174150, 71101009, 61374175, NCET-09-0228]; Doctoral Fund of the Ministry of Education [20110003110027]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of the Ministry of Education(Ministry of Education, China)	This work is supported by the Fundamental Research Funds for the Central Universities under Grant Nos. 2012RC0707 and 2012JBM067, National Natural Science Foundation of China under Grant Nos. 61174150, 71101009 and 61374175, NCET-09-0228 and the Doctoral Fund of the Ministry of Education (20110003110027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cha M, P 18 INT C WORLD WID, P721, DOI DOI 10.1145/1526709.1526806; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Dezso Z, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066132; Eom YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024926; Jeong H, 2003, EUROPHYS LETT, V61, P567, DOI 10.1209/epl/i2003-00166-9; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Kietzmann JH, 2011, BUS HORIZONS, V54, P241, DOI 10.1016/j.bushor.2011.01.005; Li MH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02512; Li MH, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043029; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; McAuley J.J., 2013, WWW, P897, DOI DOI 10.1145/2488388.2488466; Muchnik L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01783; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Saramaki J, 2004, PHYSICA A, V341, P80, DOI 10.1016/j.physa.2004.04.110; SIMON HA, 1955, BIOMETRIKA, V42, P425; Szabo G, 2010, COMMUN ACM, V53, P80, DOI 10.1145/1787234.1787254; Wei T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02207; Weng L, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00335; Wetzker Robert, 2008, P ECAI 2008 MIN SOC, P26; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; Yan Q, 2012, DISCRETE DYN NAT SOC, V2012, DOI 10.1155/2012/872908; Yasseri T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030091, 10.1371/journal.pone.0038869]; Zhao ZD, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/48004; Zhou T, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28002	36	7	7	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89192	10.1371/journal.pone.0089192	http://dx.doi.org/10.1371/journal.pone.0089192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586586	gold, Green Submitted, Green Published			2022-12-27	WOS:000332385900034
J	Abiko, Y; Nagano, K; Yoshida, Y; Yoshimura, F				Abiko, Yuki; Nagano, Keiji; Yoshida, Yasuo; Yoshimura, Fuminobu			Major Membrane Protein TDE2508 Regulates Adhesive Potency in Treponema denticola	PLOS ONE			English	Article							OUTER SHEATH PROTEIN; PORPHYROMONAS-GINGIVALIS; BINDING-PROPERTIES; VIRULENCE FACTORS; ADHERENCE; MECHANISM; ANTIGENS; DOMAINS; COMPLEX; BARRIER	The cultivation and genetic manipulation of Treponema denticola, a Gram-negative oral spirochaeta associated with periodontal diseases, is still challenging. In this study, we formulated a simple medium based on a commercially available one, and established a transformation method with high efficiency. We then analyzed proteins in a membrane fraction in T. denticola and identified 16 major membrane-associated proteins, and characterized one of them, TDE2508, whose biological function was not yet known. Although this protein, which exhibited a complex conformation, was presumably localized in the outer membrane, we did not find conclusive evidence that it was exposed on the cell surface. Intriguingly, a TDE2508-deficient mutant exhibited significantly increased biofilm formation and adherent activity on human gingival epithelial cells. However, the protein deficiency did not alter autoaggregation, coaggregation with Porphyromonas gingivalis, hemagglutination, cell surface hydrophobicity, motility, or expression of Msp which was reported to be an adherent molecule in this bacteria. In conclusion, the major membrane protein TDE2508 regulates biofilm formation and the adhesive potency of T. denticola, although the underlying mechanism remains unclear.	[Abiko, Yuki; Nagano, Keiji; Yoshida, Yasuo; Yoshimura, Fuminobu] Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Chikusa Ku, Nagoya, Aichi 464, Japan	Aichi Gakuin University	Nagano, K (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Chikusa Ku, Kusumoto Cho, Nagoya, Aichi 464, Japan.	nagano@dpc.agu.ac.jp	Nagano, Keiji/AAS-4912-2020	Nagano, Keiji/0000-0003-3587-7606	JSPS [24791973, 25462880]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI Grant Numbers 24791973 (Y. A.), and 25462880 (K. N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, MOL ORAL MICROBIOL, V26, P374, DOI 10.1111/j.2041-1014.2011.00625.x; Anand A, 2013, J BACTERIOL, V195, P2060, DOI 10.1128/JB.00078-13; Bamford CV, 2010, MOL ORAL MICROBIOL, V25, P369, DOI 10.1111/j.2041-1014.2010.00584.x; Bamford CV, 2007, INFECT IMMUN, V75, P4364, DOI 10.1128/IAI.00258-07; Bian J, 2012, APPL ENVIRON MICROB, V78, P2059, DOI 10.1128/AEM.07461-11; Bian J, 2011, J BACTERIOL, V193, P3912, DOI 10.1128/JB.00386-11; Caimano MJ, 1999, INFECT IMMUN, V67, P4072, DOI 10.1128/IAI.67.8.4072-4083.1999; COCKAYNE A, 1989, J GEN MICROBIOL, V135, P3209; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; da Silva APB, 2004, CELL MICROBIOL, V6, P485, DOI 10.1111/j.1462-5822.2004.00377.x; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; De Ciccio A, 1999, ORAL MICROBIOL IMMUN, V14, P384, DOI 10.1034/j.1399-302X.1999.140610.x; Edwards AM, 2005, INFECT IMMUN, V73, P2891, DOI 10.1128/IAI.73.5.2891-2898.2005; EGLI C, 1993, INFECT IMMUN, V61, P1694, DOI 10.1128/IAI.61.5.1694-1699.1993; Fenno JC, 1996, J BACTERIOL, V178, P2489, DOI 10.1128/jb.178.9.2489-2497.1996; Fenno JC, 2012, J ORAL MICROBIOL, V4; Fenno JC., 2005, CURR PROTOC MICROBIO, VChapter 12, pUnit 12B.1, DOI [10.1002/9780471729259.mc12b01s00, DOI 10.1002/9780471729259.MC12B01S00]; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Goetting-Minesky MP, 2010, J MICROBIOL METH, V83, P66, DOI 10.1016/j.mimet.2010.07.020; HAAPASALO M, 1992, INFECT IMMUN, V60, P2058, DOI 10.1128/IAI.60.5.2058-2065.1992; Hashimoto M, 2003, FEMS MICROBIOL LETT, V226, P267, DOI 10.1016/S0378-1097(03)00615-3; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Ishihara K, 1999, FEMS MICROBIOL LETT, V181, P199; Ishihara K, 1998, J BACTERIOL, V180, P3837, DOI 10.1128/JB.180.15.3837-3844.1998; Ishihara K, 1996, INFECT IMMUN, V64, P5178, DOI 10.1128/IAI.64.12.5178-5186.1996; Ishihara K, 2010, PERIODONTOL 2000, V54, P117, DOI 10.1111/j.1600-0757.2009.00345.x; Ito R, 2010, FEMS IMMUNOL MED MIC, V60, P251, DOI 10.1111/j.1574-695X.2010.00737.x; Izard J, 2001, J BACTERIOL, V183, P1078, DOI 10.1128/JB.183.3.1078-1084.2001; Kuramitsu HK, 2005, CURR PROTOC MICROBIO, DOI DOI 10.1002/9780471729259.MC12B02S0018770552; MIKX FHM, 1992, INFECT IMMUN, V60, P1761, DOI 10.1128/IAI.60.5.1761-1766.1992; Murakami Y, 2002, EUR J ORAL SCI, V110, P157, DOI 10.1034/j.1600-0722.2002.11171.x; Nagano K, 2005, J BACTERIOL, V187, P902, DOI 10.1128/JB.187.3.902-911.2005; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NIKAIDO H, 1989, ANTIMICROB AGENTS CH, V33, P1831, DOI 10.1128/AAC.33.11.1831; Nobbs AH, 2011, J DENT RES, V90, P1271, DOI 10.1177/0022034511399096; Okuda K, 2001, J CLIN MICROBIOL, V39, P1114, DOI 10.1128/JCM.39.3.1114-1117.2001; QIU YS, 1994, ORAL MICROBIOL IMMUN, V9, P301, DOI 10.1111/j.1399-302X.1994.tb00075.x; ROSEN G, 1995, INFECT IMMUN, V63, P3973, DOI 10.1128/IAI.63.10.3973-3979.1995; ROSEY EL, 1995, J BACTERIOL, V177, P5959, DOI 10.1128/jb.177.20.5959-5970.1995; Ruby JD, 2008, ORAL MICROBIOL IMMUN, V23, P234, DOI 10.1111/j.1399-302X.2007.00417.x; Sakakibara J, 2007, MICROBIOL-SGM, V153, P866, DOI 10.1099/mic.0.29275-0; Schultz CP, 1998, J BIOL CHEM, V273, P15661, DOI 10.1074/jbc.273.25.15661; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; TALL BD, 1994, J MED MICROBIOL, V40, P62, DOI 10.1099/00222615-40-1-62; Umemoto T, 1997, MICROBIOL IMMUNOL, V41, P917, DOI 10.1111/j.1348-0421.1997.tb01950.x; UMEMOTO T, 1994, MICROBIOL IMMUNOL, V38, P655, DOI 10.1111/j.1348-0421.1994.tb01836.x; Veith PD, 2009, BBA-PROTEINS PROTEOM, V1794, P1421, DOI 10.1016/j.bbapap.2009.06.001; Visser MB, 2011, CLIN MICROBIOL INFEC, V17, P502, DOI 10.1111/j.1469-0691.2011.03460.x	50	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89051	10.1371/journal.pone.0089051	http://dx.doi.org/10.1371/journal.pone.0089051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586498	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900046
J	Borisyuk, R; al Azad, A; Conte, D; Roberts, A; Soffe, SR				Borisyuk, Roman; al Azad, Abul Kalam; Conte, Deborah; Roberts, Alan; Soffe, Stephen R.			A Developmental Approach to Predicting Neuronal Connectivity from Small Biological Datasets: A Gradient-Based Neuron Growth Model	PLOS ONE			English	Article							AXON GUIDANCE; SPINAL-CORD; MOLECULAR-MECHANISMS; FLOOR PLATE; CHEMOATTRACTANT; SPECIFICATION; INTERNEURONS; CHEMOTAXIS; MORPHOGENS; BEHAVIORS	Relating structure and function of neuronal circuits is a challenging problem. It requires demonstrating how dynamical patterns of spiking activity lead to functions like cognitive behaviour and identifying the neurons and connections that lead to appropriate activity of a circuit. We apply a "developmental approach" to define the connectome of a simple nervous system, where connections between neurons are not prescribed but appear as a result of neuron growth. A gradient based mathematical model of two-dimensional axon growth from rows of undifferentiated neurons is derived for the different types of neurons in the brainstem and spinal cord of young tadpoles of the frog Xenopus. Model parameters define a twodimensional CNS growth environment with three gradient cues and the specific responsiveness of the axons of each neuron type to these cues. The model is described by a nonlinear system of three difference equations; it includes a random variable, and takes specific neuron characteristics into account. Anatomical measurements are first used to position cell bodies in rows and define axon origins. Then a generalization procedure allows information on the axons of individual neurons from small anatomical datasets to be used to generate larger artificial datasets. To specify parameters in the axon growth model we use a stochastic optimization procedure, derive a cost function and find the optimal parameters for each type of neuron. Our biologically realistic model of axon growth starts from axon outgrowth from the cell body and generates multiple axons for each different neuron type with statistical properties matching those of real axons. We illustrate how the axon growth model works for neurons with axons which grow to the same and the opposite side of the CNS. We then show how, by adding a simple specification for dendrite morphology, our model "developmental approach" allows us to generate biologically-realistic connectomes.	[Borisyuk, Roman; al Azad, Abul Kalam] Univ Plymouth, Sch Comp & Math, Plymouth PL4 8AA, Devon, England; [Conte, Deborah; Roberts, Alan; Soffe, Stephen R.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Borisyuk, Roman] Russian Acad Sci, Inst Math Problems Biol, Pushchino 142292, Russia	University of Plymouth; University of Bristol; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences	Borisyuk, R (corresponding author), Univ Plymouth, Sch Comp & Math, Plymouth PL4 8AA, Devon, England.	rborisyuk@plymouth.ac.uk	Azad, Abul Kalam al/GQP-7911-2022	Azad, Abul Kalam al/0000-0003-3399-3195; Conte, Deborah/0000-0002-8648-7336	BBSRC [BB/G006652/1, BB/G006369/1]; Biotechnology and Biological Sciences Research Council [BB/L002353/1, BB/L000814/1, BB/G006652/1, BB/G006369/1] Funding Source: researchfish; BBSRC [BB/L002353/1, BB/L000814/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC grants BB/G006652/1 and BB/G006369/1 (www.bbsrc.ac.uk/?). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet C, 2003, SIAM J OPTIMIZ, V13, P889, DOI 10.1137/S1052623400378742; Borisyuk R, 2008, BIOSYSTEMS, V93, P101, DOI 10.1016/j.biosystems.2008.03.012; Borisyuk Roman, 2011, Front Neuroinform, V5, P20, DOI 10.3389/fninf.2011.00020; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Forbes EM, 2012, NEURON, V74, P490, DOI 10.1016/j.neuron.2012.02.035; Godfrey KB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000600; Goodhill GJ, 1998, TRENDS NEUROSCI, V21, P226, DOI 10.1016/S0166-2236(97)01203-4; Goodhill GJ, 1998, NEURAL COMPUT, V10, P521, DOI 10.1162/089976698300017638; Goodhill GJ, 1997, EUR J NEUROSCI, V9, P1414, DOI 10.1111/j.1460-9568.1997.tb01496.x; Goodhill GJ, 2003, NEURAL COMPUT, V15, P549, DOI 10.1162/089976603321192077; Gordon-Weeks PR, 2000, NEURONAL GROWTH CONE, Vxii; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Hentschel HGE, 1999, P ROY SOC B-BIOL SCI, V266, P2231, DOI 10.1098/rspb.1999.0913; Imondi R, 2001, DEVELOPMENT, V128, P4859; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jung H, 2011, CURR OPIN GENET DEV, V21, P458, DOI 10.1016/j.gde.2011.04.004; Krottje JK, 2007, B MATH BIOL, V69, P3, DOI 10.1007/s11538-006-9142-4; Lewis KE, 2006, PHILOS T R SOC B, V361, P45, DOI 10.1098/rstb.2005.1778; Li WC, 2006, J NEUROSCI, V26, P4026, DOI 10.1523/JNEUROSCI.4727-05.2006; Li WC, 2003, J NEUROSCI, V23, P9068; Li WC, 2002, J NEUROSCI, V22, P10924; Li WC, 2001, J COMP NEUROL, V441, P248, DOI 10.1002/cne.1410; Li WC, 2004, J NEUROSCI, V24, P5840, DOI 10.1523/JNEUROSCI.1633-04.2004; Li WC, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-17; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Marder E, 2011, NAT NEUROSCI, V14, P133, DOI 10.1038/nn.2735; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Moon MS, 2005, DEV BIOL, V288, P474, DOI 10.1016/j.ydbio.2005.09.049; Mortimer D, 2008, TRENDS NEUROSCI, V31, P90, DOI 10.1016/j.tins.2007.11.008; Mortimer D, 2011, NEURAL COMPUT, V23, P336, DOI 10.1162/NECO_a_00075; Mortimer D, 2010, PHYSICA D, V239, P477, DOI 10.1016/j.physd.2009.09.009; Mortimer D, 2010, P NATL ACAD SCI USA, V107, P5202, DOI 10.1073/pnas.0909254107; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Munno DW, 2003, J PHYSIOL-LONDON, V552, P1, DOI 10.1113/jphysiol.2003.045062; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Polleux F, 2007, NAT REV NEUROSCI, V8, P331, DOI 10.1038/nrn2118; Rehder V, 1996, SEMIN NEUROSCI, V8, P81, DOI 10.1006/smns.1996.0011; ROBERTS A, 1982, PHILOS T R SOC B, V296, P195, DOI 10.1098/rstb.1982.0002; Roberts A, 2010, FRONTIERS BEHAV NEUR, V4; Roberts A, 2014, J NEUROSCI, V34, P608, DOI 10.1523/JNEUROSCI.3248-13.2014; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; Schnorrer F, 2004, CURR BIOL, V14, pR19, DOI 10.1016/j.cub.2003.12.016; Sergi PN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070304; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; Shirasaki R, 2001, DEV BIOL, V236, P99, DOI 10.1006/dbio.2001.0321; Shirasaki R, 2006, NEURON, V50, P841, DOI 10.1016/j.neuron.2006.04.030; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Strogatz SH, 1994, NONLINEAR DYNAMICS C, Vxi; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; van Ooyen A, 2011, NAT REV NEUROSCI, V12, P311, DOI 10.1038/nrn3031; Yamamoto N, 2002, PROG NEUROBIOL, V68, P393, DOI 10.1016/S0301-0082(02)00129-6; Zou YM, 2007, CURR OPIN NEUROBIOL, V17, P22, DOI 10.1016/j.conb.2007.01.006; Zubler F, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.025.2009	57	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89461	10.1371/journal.pone.0089461	http://dx.doi.org/10.1371/journal.pone.0089461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586794	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900100
J	Gonsior, C; Biname, F; Fruhbeis, C; Bauer, NM; Hoch-Kraft, P; Luhmann, HJ; Trotter, J; White, R				Gonsior, Constantin; Biname, Fabien; Fruhbeis, Carsten; Bauer, Nina M.; Hoch-Kraft, Peter; Luhmann, Heiko J.; Trotter, Jacqueline; White, Robin			Oligodendroglial p130Cas Is a Target of Fyn Kinase Involved in Process Formation, Cell Migration and Survival	PLOS ONE			English	Article							CRK-ASSOCIATED SUBSTRATE; CENTRAL-NERVOUS-SYSTEM; SRC FAMILY KINASES; TYROSINE PHOSPHORYLATION; PRECURSOR CELLS; CNS MYELINATION; P130(CAS); ACTIVATION; DIFFERENTIATION; MOLECULE	Oligodendrocytes are the myelinating glial cells of the central nervous system. In the course of brain development, oligodendrocyte precursor cells migrate, scan the environment and differentiate into mature oligodendrocytes with multiple cellular processes which recognize and ensheath neuronal axons. During differentiation, oligodendrocytes undergo dramatic morphological changes requiring cytoskeletal rearrangements which need to be tightly regulated. The nonreceptor tyrosine kinase Fyn plays a central role in oligodendrocyte differentiation and myelination. In order to improve our understanding of the role of oligodendroglial Fyn kinase, we have identified Fyn targets in these cells. Purification and massspectrometric analysis of tyrosine-phosphorylated proteins in response to overexpressed active Fyn in the oligodendrocyte precursor cell line Oli-neu, yielded the adaptor molecule p130Cas. We analyzed the function of this Fyn target in oligodendroglial cells and observed that reduction of p130Cas levels by siRNA affects process outgrowth, the thickness of cellular processes and migration behavior of Oli-neu cells. Furthermore, long term p130Cas reduction results in decreased cell numbers as a result of increased apoptosis in cultured primary oligodendrocytes. Our data contribute to understanding the molecular events taking place during oligodendrocyte migration and morphological differentiation and have implications for myelin formation.	[Gonsior, Constantin; Biname, Fabien; Fruhbeis, Carsten; Hoch-Kraft, Peter; Trotter, Jacqueline] Johannes Gutenberg Univ Mainz, Dept Biol, D-55122 Mainz, Germany; [Bauer, Nina M.; Luhmann, Heiko J.; White, Robin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	White, R (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol, D-55122 Mainz, Germany.	white@uni-mainz.de	Luhmann, Heiko J./N-8797-2019; BINAME, Fabien/ABD-8279-2021	Luhmann, Heiko J./0000-0002-7934-8661; Biname, Fabien/0000-0002-9758-1512	University Medical Center Mainz (MAIFOR); Deutsche Forschungsgemeinschaft (DFG) [WH 168/1-1, TR 1008/1-1, TR 1008/2-1, CRC TR 128/1, GRK1044]	University Medical Center Mainz (MAIFOR); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	RW is grateful for funding by the University Medical Center Mainz (MAIFOR) and the Deutsche Forschungsgemeinschaft (DFG) (WH 168/1-1). JT thanks the DFG for funding (TR 1008/1-1, TR 1008/2-1, CRC TR 128/1 and the GRK1044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, DEV CELL, V21, P445, DOI 10.1016/j.devcel.2011.08.001; Barrett A, 2013, CELL SIGNAL, V25, P766, DOI 10.1016/j.cellsig.2012.12.019; Biname F, 2013, J NEUROSCI, V33, P10858, DOI 10.1523/JNEUROSCI.5010-12.2013; Buttery PC, 1999, MOL CELL NEUROSCI, V14, P199, DOI 10.1006/mcne.1999.0781; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Camara J, 2009, J CELL BIOL, V185, P699, DOI 10.1083/jcb.200807010; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Colognato H, 2011, DEV NEUROBIOL, V71, P924, DOI 10.1002/dneu.20966; Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Donato DM, 2010, J BIOL CHEM, V285, P20769, DOI 10.1074/jbc.M109.091207; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Gustavsson A, 2004, J BIOL CHEM, V279, P22893, DOI 10.1074/jbc.M309693200; Honda H, 1999, BIOCHEM BIOPH RES CO, V262, P25, DOI 10.1006/bbrc.1999.1162; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Huang J, 2006, MOL BIOL CELL, V17, P3187, DOI 10.1091/mbc.E05-12-1122; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kim W, 2004, J BIOL CHEM, V279, P8333, DOI 10.1074/jbc.M312026200; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Kramer EM, 1999, J BIOL CHEM, V274, P29042, DOI 10.1074/jbc.274.41.29042; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Liu XJ, 2012, J BIOL CHEM, V287, P17503, DOI 10.1074/jbc.M111.317610; Manie SN, 1997, J BIOL CHEM, V272, P15636, DOI 10.1074/jbc.272.25.15636; Meenderink LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013412; Milner R, 1997, GLIA, V19, P85, DOI 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Olsen IM, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-25; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Sakai R, 1997, ONCOGENE, V14, P1419, DOI 10.1038/sj.onc.1200954; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sharma A, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-50; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Simons M, 2013, CURR OPIN CELL BIOL, V25, P512, DOI 10.1016/j.ceb.2013.04.007; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; TROTTER J, 1989, J NEUROSCI RES, V22, P369, DOI 10.1002/jnr.490220402; Vuori K, 1996, MOL CELL BIOL, V16, P2606; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wei L, 2002, J CELL BIOCHEM, V87, P439, DOI 10.1002/jcb.10322; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; White R, 2012, J BIOL CHEM, V287, P1742, DOI 10.1074/jbc.M111.235010	49	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89423	10.1371/journal.pone.0089423	http://dx.doi.org/10.1371/journal.pone.0089423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586768	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900094
J	Iuso, A; Sibon, OCM; Gorza, M; Heim, K; Organisti, C; Meitinger, T; Prokisch, H				Iuso, Arcangela; Sibon, Ody C. M.; Gorza, Matteo; Heim, Katharina; Organisti, Cristina; Meitinger, Thomas; Prokisch, Holger			Impairment of Drosophila Orthologs of the Human Orphan Protein C19orf12 Induces Bang Sensitivity and Neurodegeneration	PLOS ONE			English	Article							BRAIN; GENE; DEGENERATION; MUTATIONS; FEATURES; SUBTYPE; MODEL	Mutations in the orphan gene C19orf12 were identified as a genetic cause in a subgroup of patients with NBIA, a neurodegenerative disorder characterized by deposits of iron in the basal ganglia. C19orf12 was shown to be localized in mitochondria, however, nothing is known about its activity and no functional link exists to the clinical phenotype of the patients. This situation led us to investigate the effects of C19orf12 down-regulation in the model organism Drosophila melanogaster. Two genes are present in D. melanogaster, which are orthologs of C19orf12, CG3740 and CG11671. Here we provide evidence that transgenic flies with impaired C19orf12 homologs reflect the neurodegenerative phenotype and represent a valid tool to further analyze the pathomechanism in C19orf12-associated NBIA.	[Iuso, Arcangela; Heim, Katharina; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Iuso, Arcangela; Gorza, Matteo; Heim, Katharina; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Sibon, Ody C. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Organisti, Cristina] Max Planck Inst Neurobiol, Sensory Neurogenet Res Grp, D-82152 Martinsried, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Groningen; Max Planck Society	Prokisch, H (corresponding author), Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany.	prokisch@helmholtz-muenchen.de	Meitinger, Thomas/O-1318-2015	Meitinger, Thomas/0000-0002-8838-8403; Prokisch, Holger/0000-0003-2379-6286; Sibon, Ody/0000-0002-6836-6063	Dutch organization of Scientific Research, NOW; European Commission [277984]	Dutch organization of Scientific Research, NOW; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the NBIA Disorders Association Grant 2011 (AI), by the VICI grant from the Dutch organization of Scientific Research, NOW (OS), and by the European Commission's Seventh Framework Program (FP7/2007-2013, HEALTH-F2-2011, grant agreement No. 277984, TIRCON) (OS, HP, TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bosveld F, 2008, HUM MOL GENET, V17, P2058, DOI 10.1093/hmg/ddn105; Cowan C. M., 2011, INT J ALZHEIMERS DIS, V2011; Deschauer M, 2012, J NEUROL, V259, P2434, DOI 10.1007/s00415-012-6521-7; Dezfouli MA, 2013, MOVEMENT DISORD, V28, P228, DOI 10.1002/mds.25271; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dogu O, 2013, CLIN GENET, V84, P350, DOI 10.1111/cge.12079; Goldman JG, 2013, MOVEMENT DISORD, V28, P1462, DOI 10.1002/mds.25410; Gregory A., 2013, GENE REV, P1993; Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007; Hogarth P, 2013, NEUROLOGY, V80, P268, DOI 10.1212/WNL.0b013e31827e07be; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jaiswal M, 2012, ANNU REV GENET, V46, P371, DOI 10.1146/annurev-genet-110711-155456; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Panteghini C, 2012, SEMIN PEDIATR NEUROL, V19, P75, DOI 10.1016/j.spen.2012.03.006; Rana A, 2010, P NATL ACAD SCI USA, V107, P6988, DOI 10.1073/pnas.0912105107; Schottmann G, 2013, CLIN GENET; Schulte EC, 2013, MOVEMENT DISORD, V28, P224, DOI 10.1002/mds.25256; Soldano A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001562; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Wu ZH, 2009, HUM MOL GENET, V18, P3659, DOI 10.1093/hmg/ddp314; Zhang HG, 2002, GENETICS, V162, P1283	25	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89439	10.1371/journal.pone.0089439	http://dx.doi.org/10.1371/journal.pone.0089439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586779	Green Published, gold			2022-12-27	WOS:000331717900097
J	Iwata, M; Ohno, Y; Otaki, JM				Iwata, Masaki; Ohno, Yoshikazu; Otaki, Joji M.			Real-Time In Vivo Imaging of Butterfly Wing Development: Revealing the Cellular Dynamics of the Pupal Wing Tissue	PLOS ONE			English	Article							COLOR-PATTERN MODIFICATIONS; PRECIS-COENIA LEPIDOPTERA; EYESPOT PATTERNS; DISTAL-LESS; EVOLUTION; ARRANGEMENT; TUNGSTATE; ELEMENTS; STRESS; SYSTEM	Butterfly wings are covered with regularly arranged single-colored scales that are formed at the pupal stage. Understanding pupal wing development is therefore crucial to understand wing color pattern formation. Here, we successfully employed real-time in vivo imaging techniques to observe pupal hindwing development over time in the blue pansy butterfly, Junonia orithya. A transparent sheet of epithelial cells that were not yet regularly arranged was observed immediately after pupation. Bright-field imaging and autofluorescent imaging revealed free-moving hemocytes and tracheal branches of a crinoid-like structure underneath the epithelium. The wing tissue gradually became gray-white, epithelial cells were arranged regularly, and hemocytes disappeared, except in the bordering lacuna, after which scales grew. The dynamics of the epithelial cells and scale growth were also confirmed by fluorescent imaging. Fluorescent in vivo staining further revealed that these cells harbored many mitochondria at the surface of the epithelium. Organizing centers for the border symmetry system were apparent immediately after pupation, exhibiting a relatively dark optical character following treatment with fluorescent dyes, as well as in autofluorescent images. The wing tissue exhibited slow and low-frequency contraction pulses with a cycle of approximately 10 to 20 minutes, mainly occurring at 2 to 3 days postpupation. The pulses gradually became slower and weaker and eventually stopped. The wing tissue area became larger after contraction, which also coincided with an increase in the autofluorescence intensity that might have been caused by scale growth. Examination of the pattern of color development revealed that the black pigment was first deposited in patches in the central areas of an eyespot black ring and a parafocal element. These results of live in vivo imaging that covered wide wing area for a long time can serve as a foundation for studying the cellular dynamics of living wing tissues in butterflies.	[Iwata, Masaki; Ohno, Yoshikazu; Otaki, Joji M.] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, BCPH Unit Mol Physiol, Nishihara, Okinawa 90301, Japan	University of the Ryukyus	Otaki, JM (corresponding author), Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, BCPH Unit Mol Physiol, Nishihara, Okinawa 90301, Japan.	otaki@sci.u-ryukyu.ac.jp	Ohno, Yoshikazu/AAU-9366-2021	Ohno, Yoshikazu/0000-0002-6179-0363	Research Foundation for Opto-Science and Technology, Hamamatsu, Japan; University of the Ryukyus, Okinawa, Japan	Research Foundation for Opto-Science and Technology, Hamamatsu, Japan; University of the Ryukyus, Okinawa, Japan	This work was supported by funds from the Research Foundation for Opto-Science and Technology, Hamamatsu, Japan, and from University of the Ryukyus, Okinawa, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Beldade P, 2002, NATURE, V415, P315, DOI 10.1038/415315a; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; BRAKEFIELD PM, 1995, DEV BIOL, V168, P98, DOI 10.1006/dbio.1995.1064; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Cho EH, 2013, ARTHROPOD STRUCT DEV, V42, P37, DOI 10.1016/j.asd.2012.09.003; Dhungel B, 2014, ENTOMOL SCI, V17, P207, DOI 10.1111/ens.12046; Dhungel B, 2013, J THERM BIOL, V38, P427, DOI 10.1016/j.jtherbio.2013.06.002; Dhungel B, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-27; Dhungel B, 2009, ZOOL SCI, V26, P758, DOI 10.2108/zsj.26.758; Dohrmann CE, 1990, J RES LEPIDOPTERA, V27, P151; FRENCH V, 1992, DEVELOPMENT, V116, P103; Galant R, 1998, CURR BIOL, V8, P807, DOI 10.1016/S0960-9822(98)70322-7; Ghiradella H, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P257; GREENSTEIN ME, 1972, J MORPHOL, V136, P23, DOI 10.1002/jmor.1051360103; HENKE K, 1952, Z NATURFORSCH B, V7, P65; Henke K., 1946, Biologisches Zentralblatt Leipzig, V65, P120; Hiyama Atsuki, 2012, Frontiers in Genetics, V3, P15, DOI 10.3389/fgene.2012.00015; Iwata M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02379; Koch PB, 2003, DEV GENES EVOL, V212, P571, DOI 10.1007/s00427-002-0277-5; KODAMA R, 1995, ROUX ARCH DEV BIOL, V204, P418, DOI 10.1007/BF00360849; Kristensen Niels P., 2003, Handbuch der Zoologie (Berlin), V4, P9; Kuhn A, 1954, VORLESUNGEN UNBER EN; KUNTZE HELMUT, 1935, ZOOL JAHRB ABT ALLG ZOOL U PHYSIOL, V30, P544, DOI 10.1007/BF00403137; Kusaba K, 2009, J INSECT PHYSIOL, V55, P174, DOI 10.1016/j.jinsphys.2008.11.006; Macdonald WP, 2010, EVOL DEV, V12, P296, DOI 10.1111/j.1525-142X.2010.00415.x; Mahdi SHA, 2010, J INSECT PHYSIOL, V56, P1022, DOI 10.1016/j.jinsphys.2010.02.013; Monteiro A, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-52; Monteiro A, 2013, J EXP ZOOL PART B, V320B, P321, DOI 10.1002/jez.b.22503; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; NIJHOUT HF, 1985, J EMBRYOL EXP MORPH, V86, P191; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; NIJHOUT HF, 1980, DEV BIOL, V80, P275, DOI 10.1016/0012-1606(80)90404-2; Nijhout HF, 2001, J EXP ZOOL, V291, P213, DOI 10.1002/jez.1099; Ohno Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00290; Otaki JM, 2005, ZOOL SCI, V22, P21, DOI 10.2108/zsj.22.21; Otaki JM, 2005, ZOOL SCI, V22, P635, DOI 10.2108/zsj.22.635; Otaki JM, 2004, DEV GROWTH DIFFER, V46, P1; Otaki JM, 2007, J INSECT PHYSIOL, V53, P526, DOI 10.1016/j.jinsphys.2007.02.005; Otaki JM, 2012, ZOOL SCI, V29, P568, DOI 10.2108/zsj.29.568; Otaki JM, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-17; Otaki JM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00111; Otaki JM, 2011, ZOOL SCI, V28, P817, DOI 10.2108/zsj.28.817; Otaki JM, 2011, ZOOL SCI, V28, P403, DOI 10.2108/zsj.28.403; Otaki JM, 2009, ENTOMOL SCI, V12, P74, DOI 10.1111/j.1479-8298.2009.00306.x; Reed RD, 2004, CURR BIOL, V14, P1159, DOI 10.1016/j.cub.2004.06.046; Reed RD, 2004, DEV GENES EVOL, V214, P43, DOI 10.1007/s00427-003-0366-0; Saenko SV, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-111; Shirai LT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-21; SUFFERT FRITZ, 1929, ZEITSCHR WISS BIOL ABT A ZEITSCHR F MORPH U OKOL TIERE, V14, P338, DOI 10.1007/BF00419303; YOSHIDA A, 1983, P JPN ACAD B-PHYS, V59, P236, DOI 10.2183/pjab.59.236; YOSHIDA A, 1989, DEV GROWTH DIFFER, V31, P601; Yoshida A, 1989, MORPH HISTOL FINE ST, V94, P467; Yoshida A, 1988, SPECIAL B LEPIDOPTER, V6, P447	54	34	34	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89500	10.1371/journal.pone.0089500	http://dx.doi.org/10.1371/journal.pone.0089500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586829	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900109
J	Zhang, ZH; Lin, WX; Deng, M; Zhao, ST; Zeng, HS; Chen, FP; Song, YZ				Zhang, Zhan-Hui; Lin, Wei-Xia; Deng, Mei; Zhao, Shu-Tao; Zeng, Han-Shi; Chen, Feng-Ping; Song, Yuan-Zong			Clinical, Molecular and Functional Investigation on an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency (NICCD)	PLOS ONE			English	Article							ASPARTATE-GLUTAMATE CARRIER; MESSENGER-RNA DECAY; II CITRULLINEMIA; SLC25A13 GENE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; SWISS-MODEL; PROTEIN; MUTATIONS; IDENTIFICATION	Background and Objective: SLC25A13 analysis has provided reliable evidences for the definitive diagnosis of citrin deficiency (CD) in the past decade. Meanwhile, these studies generated some issues yet to be resolved, including the pathogenicity of SLC25A13 missense mutations and the mRNA product from the mutation c.615+5G>A. This study aims to investigate the effect of a novel missense mutation on the aspartate/glutamate carrier (AGC) function of citrin protein, and to explore the aberrant transcript from c.615+5G>A in the same CD infant. Methods and Results: By means of screening for prevalent SLC25A13 mutations and exons sequencing, the patient proved a compound heterozygote of c.615+5G>A and a novel c.1064G>A (p.Arg355Gln) mutation. An aberrant transcript with retention of the entire intron 6, r.[615+1_615+1789ins; 615+5 g>a] (GenBank accession number KJ128074), which was resulted from c.615+5G>A, was detected by RT-PCR and cDNA sequencing. After bioinformatic analyses of the novel missense mutation c.1064G>A, the growth abilities of three agc1D yeast strains were tested, which had been transformed with recombinant or empty vectors, respectively. Besides the bioinformatically pathogenic evidences, the growth ability of the agc1 Delta strains transformed with mutant recombinant was the same as with empty vector, but significantly lower than that with normal control in functional analysis. Conclusions: A CD infant was definitely diagnosed in this paper by a genetic, transcriptional and functional analysis of SLC25A13 gene. This study provided direct laboratory evidences supporting the splice-site nature of the c.615+5G>A mutation, and the novel c.1064G>A variation, which proved a pathogenic mutation bioinformatically and functionally, enriched the SLC25A13 mutation spectrum.	[Zhang, Zhan-Hui; Lin, Wei-Xia; Deng, Mei; Zhao, Shu-Tao; Zeng, Han-Shi; Song, Yuan-Zong] Jinan Univ, Dept Pediat, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zhang, Zhan-Hui] Jinan Univ, Cent Lab, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Chen, Feng-Ping] Jinan Univ, Dept Lab Sci, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University	Song, YZ (corresponding author), Jinan Univ, Dept Pediat, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	songyuanzong@vip.tom.com			Innovation Fund of Jinan University [21612430]; National Natural Science Foundation of China [81070279, 81270957]	Innovation Fund of Jinan University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was financially supported by the Innovation Fund of Jinan University No. 21612430 (The Fundamental Research Funds for Central Universities) and the projects supported by the National Natural Science Foundation of China (Nos. 81070279 and 81270957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bach A, 1982, AM J CLIN NUTR, V35, P950; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bosch AM, 2006, J INHERIT METAB DIS, V29, P516, DOI 10.1007/s10545-006-0382-0; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Cavero S, 2003, MOL MICROBIOL, V50, P1257, DOI 10.1046/j.1365-2958.2003.03742.x; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen R, 2013, WORLD J GASTROENTERO, V19, P4545, DOI 10.3748/wjg.v19.i28.4545; Dimmock D, 2007, PEDIATRICS, V119, pE773, DOI 10.1542/peds.2006-1950; Fiermonte G, 2011, MOL GENET METAB, V104, P501, DOI 10.1016/j.ymgme.2011.08.022; Fu HY, 2011, J GASTROENTEROL, V46, P510, DOI 10.1007/s00535-010-0329-y; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Green RE, 2003, BIOINFORMATICS, V19, pi118, DOI 10.1093/bioinformatics/btg1015; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hayasaka K, 2012, JIMD REP, V2, P37, DOI 10.1007/8904_2011_42; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jiang Guang-yu, 2012, Chinese Journal of Pathology, V41, P452, DOI 10.3760/cma.j.issn.0529-5807.2012.07.005; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; Kobayashi K., 2012, GENEREVIEWS; KOBAYASHI K, 2003, MEMBRANE TRANSPORTER, P147; Lehner F, 2006, J LIPID RES, V47, P404, DOI 10.1194/jlr.M500423-JLR200; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lin WX, 2012, GENE, V505, P269, DOI 10.1016/j.gene.2012.06.012; Lu YB, 2005, J HUM GENET, V50, P338, DOI 10.1007/s10038-005-0262-8; Ning C, 2000, PEDIATR RES, V48, P211, DOI 10.1203/00006450-200008000-00015; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; Ohura T, 2007, J INHERIT METAB DIS, V30, P139, DOI 10.1007/s10545-007-0506-1; Okano Y, 2013, MOL GENET METAB, V109, P9, DOI 10.1016/j.ymgme.2013.01.020; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Roca X, 2013, GENE DEV, V27, P129, DOI 10.1101/gad.209759.112; Roman C, 2007, PEDIATR RES, V61, P83, DOI 10.1203/01.pdr.0000250199.24107.fb; Saheki T, 2006, HEPATIC ENCEPHALOPATHY AND NITROGEN METABOLISM, P320, DOI 10.1007/1-4020-4456-9_23; Saheki T, 2005, HEPATOL RES, V33, P181, DOI 10.1016/j.hepres.2005.09.031; Saheki T, 2004, MOL GENET METAB, V81, pS20, DOI 10.1016/j.ymgme.2004.01.006; Saheki T, 2002, J HUM GENET, V47, P333, DOI 10.1007/s100380200046; Saheki T, 2011, MOL GENET METAB, V104, P492, DOI 10.1016/j.ymgme.2011.08.015; Saheki T, 2005, RECENT RES DEV LIFE, P59; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Song YZ, 2009, DIGEST LIVER DIS, V41, P683, DOI 10.1016/j.dld.2008.11.014; Song Y. Z., 2010, JAPANESE J INHERITED, V26, P57; Song YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074544; Song YZ, 2011, INT J MOL MED, V28, P33, DOI 10.3892/ijmm.2011.653; Tabata A, 2008, J HUM GENET, V53, P534, DOI 10.1007/s10038-008-0282-2; Tokuhara D, 2007, MOL GENET METAB, V90, P30, DOI 10.1016/j.ymgme.2006.09.009; Vitoria I, 2013, MOL GENET METAB, V110, P181, DOI 10.1016/j.ymgme.2013.06.011; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wongkittichote P, 2013, J INHERIT METAB DIS, V36, P821, DOI 10.1007/s10545-012-9543-5; Yazaki M, 2013, CLIN NEUROL NEUROSUR, V115, P1542, DOI 10.1016/j.clineuro.2012.12.027; Zhang ZH, 2012, GENE, V511, P227, DOI 10.1016/j.gene.2012.09.049	53	16	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89267	10.1371/journal.pone.0089267	http://dx.doi.org/10.1371/journal.pone.0089267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586645	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900076
J	Chiang, KC; Tsui, KH; Chung, LC; Yeh, CN; Chang, PL; Chen, WT; Juang, HH				Chiang, Kun-Chun; Tsui, Ke-Hung; Chung, Li-Chuan; Yeh, Chun-Nan; Chang, Phei-Lang; Chen, Wen-Tsung; Juang, Horng-Heng			Topoisomerase Inhibitors Modulate Gene Expression of B-Cell Translocation Gene 2 and Prostate Specific Antigen in Prostate Carcinoma Cells	PLOS ONE			English	Article							CANCER-SPECIFIC SURVIVAL; MITOCHONDRIAL ACONITASE; ANDROGEN RECEPTOR; TUMOR PROGRESSION; DOWN-REGULATION; UP-REGULATION; DNA-DAMAGE; PROLIFERATION; GROWTH; P53	Camptothecin (CPT) and doxorubicin (DOX) have been demonstrated to have potent anti-tumor activity. The B-cell translocation gene 2 (BTG2) is involved in the regulation of cell cycle progression. We evaluated the molecular mechanisms of CPT and DOX on cell proliferation and the expressions of BTG2 and prostate specific antigen (PSA) in prostate carcinoma cells. Our results indicated that CPT or DOX treatments induced Go/G1 cell cycle arrest in LNCaP cells and apoptosis at higher dosage. Immunoblot and transient gene expression assay indicated that CPT or DOX treatments induced p53 and BTG2 gene expression, with the later effect dependent on the p53 response element within BTG2 promoter area since mutation of the p53 response element from GGGAAAGTCC to GGAGTCC or from GGCAGAGCCC to GGCACC by site-directed mutagenesis abolished the stimulation of CPT or DOX on the BTG2 promoter activity, which is also supported by our results that cotreatments of pifithrin-a, an inhibitor of p53 dependent transcriptional activation, blocked the induction of CPT or DOX on BTG2 gene expression. CPT or DOX also downregulated the protein expressions of androgen receptor (AR) and PSA. Transient gene expression assays suggested that CPT or DOX's attenuation of PSA promoter activity is dependent on both the androgen and p53 response elements within of the PSA promoter. Our results indicated that CPT and DOX attenuate cell proliferation via upregulation of BTG2 gene expression through the p53-dependent pathway. The CPT and DOX block the PSA gene expression by upregulation of p53 activity and downregulation of androgen receptor activity.	[Chiang, Kun-Chun] Chang Gung Mem Hosp, Dept Gen Surg, Keelung, Taiwan; [Tsui, Ke-Hung; Chang, Phei-Lang] Chang Gung Mem Hosp, Dept Urol, Tao Yuan, Taiwan; [Tsui, Ke-Hung; Chung, Li-Chuan; Chang, Phei-Lang; Juang, Horng-Heng] Chang Gung Univ, Dept Anat, Coll Med, Tao Yuan, Taiwan; [Yeh, Chun-Nan] Chang Gung Mem Hosp, Dept Gen Surg, Tao Yuan, Taiwan; [Chen, Wen-Tsung] Natl Kaohsiung Univ Hospitality & Tourism, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Kaohsiung University of Hospitality & Tourism	Juang, HH (corresponding author), Chang Gung Univ, Dept Anat, Coll Med, Tao Yuan, Taiwan.	hhj143@mail.cgu.edu.tw	Juang, Horng-Heng/G-2313-2012; Juang, Horng-Heng/AAG-7683-2020; Tsui, Ke hung/O-3551-2016	Juang, Horng-Heng/0000-0002-8524-8253; Tsui, Ke hung/0000-0001-9814-0914	Chang Gung Memorial Hospital [CMRP-D190543, CMRP-D190613, CMRP-D1D0201]; Taiwan National Science Council [101-2314-B-182A-099-MY3, NSC102-2320-B-182 -003 -MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This Research was supported by Chang Gung Memorial Hospital (CMRP-D190543, -D190613, -D1D0201) and Taiwan National Science Council (101-2314-B-182A-099-MY3 and NSC102-2320-B-182 -003 -MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya S, 2009, CELL SIGNAL, V21, P509, DOI 10.1016/j.cellsig.2008.12.003; Box VGS, 2007, J MOL GRAPH MODEL, V26, P14, DOI 10.1016/j.jmgm.2006.09.005; Chen CD, 2002, MOL CELL BIOL, V22, P2862, DOI 10.1128/MCB.22.8.2862-2870.2002; Chung LC, 2012, AM J PHYSIOL-CELL PH, V302, pC676, DOI 10.1152/ajpcell.00180.2011; Cortes U, 2000, MOL CARCINOGEN, V27, P57, DOI 10.1002/(SICI)1098-2744(200002)27:2<57::AID-MC1>3.3.CO;2-9; D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061; Duriez C, 2002, GENE, V282, P207, DOI 10.1016/S0378-1119(01)00825-3; Elmore LW, 2005, CLIN CANCER RES, V11, P2637, DOI 10.1158/1078-0432.CCR-04-1462; Fitzpatrick JM, 2009, BJU INT, V103, P578, DOI 10.1111/j.1464-410X.2009.08345.x; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; Hoffman KL, 2013, HORM CANCER-US, V4, P24, DOI 10.1007/s12672-012-0123-9; Juang HH, 2013, PROSTATE, V73, P1495, DOI 10.1002/pros.22697; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; Lim IK, 2006, J CANCER RES CLIN, V132, P417, DOI 10.1007/s00432-006-0080-1; Loeb S, 2012, EUR UROL, V61, P1, DOI 10.1016/j.eururo.2011.07.067; Mizutani K., 2006, Experimental Oncology, V28, P209; Niu YJ, 2008, CANCER RES, V68, P7110, DOI 10.1158/0008-5472.CAN-07-6507; Osman I, 1999, CLIN CANCER RES, V5, P2082; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Ryu MS, 2004, EXP CELL RES, V299, P159, DOI 10.1016/j.yexcr.2004.05.014; Sasajima H, 2002, EUR J BIOCHEM, V269, P3596, DOI 10.1046/j.1432-1033.2002.03052.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Tsui KH, 2008, ANTICANCER RES, V28, P1969; Tsui KH, 2008, PROSTATE, V68, P610, DOI 10.1002/pros.20725; Tsui KH, 2013, J MOL ENDOCRINOL, V51, P131, DOI 10.1530/JME-13-0090; Tsui KH, 2012, INT J CANCER, V130, P2812, DOI 10.1002/ijc.26284; Tsui KH, 2011, J ANDROL, V32, P383, DOI 10.2164/jandrol.109.009878; Tsui KH, 2011, PROSTATE, V71, P62, DOI 10.1002/pros.21222; Tsui KH, 2004, J UROLOGY, V172, P2029, DOI 10.1097/01.ju.0000141147.96640.76; Tsui KH, 2004, J UROLOGY, V172, P2035, DOI 10.1097/01.ju.0000138053.78518.b2; Vukmirovic-Popovic S, 2008, ONCOL REP, V20, P897, DOI 10.3892/or_00000089; Zaorsky NG, 2013, SEMIN ONCOL, V40, P308, DOI 10.1053/j.seminoncol.2013.04.006; Zhang L, 2010, MOL BIOL REP, V37, P2579, DOI 10.1007/s11033-009-9777-y	37	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89117	10.1371/journal.pone.0089117	http://dx.doi.org/10.1371/journal.pone.0089117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586533	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700061
J	Liu, ZY; Fang, J; Dearman, J; Zhang, LL; Zuo, J				Liu, Zhiyong; Fang, Jie; Dearman, Jennifer; Zhang, Lingli; Zuo, Jian			In Vivo Generation of Immature Inner Hair Cells in Neonatal Mouse Cochleae by Ectopic Atoh1 Expression	PLOS ONE			English	Article							VESICULAR GLUTAMATE TRANSPORTER-3; MAMMALIAN COCHLEA; RECEPTOR EXPRESSION; AFFERENT SYNAPSES; SUPPORTING CELLS; RIBBON SYNAPSE; HEARING-LOSS; RAT COCHLEA; STEM-CELLS; NULL MICE	Regeneration of auditory hair cells (HCs) is a promising approach to restore hearing. Recent studies have demonstrated that induced pluripotent stem cells/embryonic stem cells or supporting cells (SCs) adjacent to HCs can be converted to adopt the HC fate. However, little is known about whether new HCs are characteristic of outer or inner HCs. Here, we showed in vivo conversion of 2 subtypes of SCs, inner border cells (IBs) and inner phalangeal cells (IPhs), to the inner HC (IHC) fate. This was achieved by ectopically activating Atoh1, a transcription factor necessary for HC fate, in IBs/IPhs at birth. Atoh1+ IBs/IPhs first turned on Pou4f3, another HC transcription factor, before expressing 8 HC markers. The conversion rate gradually increased from similar to 2.4% at 1 week of age to similar to 17.8% in adult. Interestingly, new HCs exhibited IHC characteristics such as straight line-shaped stereociliary bundles, expression of Fgf8 and otoferlin, and presence of larger outward currents than those of outer HCs. However, new HCs lacked the terminal differentiation IHC marker vGlut3, exhibited reduced density of presynaptic Cbtp2 puncta that had little postsynaptic GluR2 specialization, and displayed immature IHC outward currents. Our results demonstrate that the conversion rate of IBs/IPhs in vivo by Atoh1 ectopic expression into the IHC fate was higher and faster and the conversion was more complete than that of the 2 other SC subtypes underneath the outer HCs; however, these new IHCs are arrested before terminal differentiation. Thus, IBs/IPhs are good candidates to regenerate IHCs in vivo.	[Liu, Zhiyong; Fang, Jie; Dearman, Jennifer; Zhang, Lingli; Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Liu, Zhiyong] Univ Tennessee, Ctr Hlth Sci, Integrated Program Biomed Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Zuo, J (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jian.zuo@stjude.org			National Institute of Health [DC006471, DC008800, CA21765]; Office of Naval Research [N000140911014, N000141210191, N000141210775]; National Organization for Hearing Research Foundation; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; Hartwell Individual Biomedical Research Award; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC008800, R01DC006471] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); National Organization for Hearing Research Foundation; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Hartwell Individual Biomedical Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding provided by National Institute of Health (DC006471 (JZ), DC008800 (JZ), CA21765 (St. Jude), and the Office of Naval Research (N000140911014 (JZ), N000141210191 (JZ), and N000141210775 (JZ)), the National Organization for Hearing Research Foundation (JF), the American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital. JZ is a recipient of The Hartwell Individual Biomedical Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2012, DEV CELL, V22, P377, DOI 10.1016/j.devcel.2011.12.006; Akil O, 2012, NEURON, V75, P283, DOI 10.1016/j.neuron.2012.05.019; Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Cafaro J, 2007, DEV DYNAM, V236, P156, DOI 10.1002/dvdy.21023; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; COREY DP, 1983, J NEUROSCI, V3, P962; Fekete DM, 1998, J NEUROSCI, V18, P7811; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Glowatzki E, 2006, J NEUROSCI, V26, P7659, DOI 10.1523/JNEUROSCI.1545-06.2006; Golub JS, 2012, J NEUROSCI, V32, P15093, DOI 10.1523/JNEUROSCI.1709-12.2012; Gomez-Casati ME, 2010, JARO-J ASSOC RES OTO, V11, P19, DOI 10.1007/s10162-009-0191-x; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Jacques BE, 2007, DEVELOPMENT, V134, P3021, DOI 10.1242/dev.02874; Jahan I, 2013, HEARING RES, V297, P30, DOI 10.1016/j.heares.2012.11.008; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Jin ZH, 2003, TOHOKU J EXP MED, V200, P137, DOI 10.1620/tjem.200.137; Kelley MW, 2007, INT J DEV BIOL, V51, P571, DOI 10.1387/ijdb.072388mk; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Lewis RM, 2012, HEARING RES, V289, P74, DOI 10.1016/j.heares.2012.04.008; Li SG, 2002, DEVELOPMENT, V129, P3523; Liberman LD, 2011, J NEUROSCI, V31, P801, DOI 10.1523/JNEUROSCI.3389-10.2011; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064903; Liu ZY, 2012, J NEUROSCI, V32, P10530, DOI 10.1523/JNEUROSCI.0686-12.2012; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Liu ZY, 2010, DEV DYNAM, V239, P1674, DOI 10.1002/dvdy.22302; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Macatee TL, 2003, DEVELOPMENT, V130, P6361, DOI 10.1242/dev.00850; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Masuda M, 2012, DEV BIOL, V372, P68, DOI 10.1016/j.ydbio.2012.09.002; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Meyers JR, 2003, J NEUROSCI, V23, P4054; Nagiel A, 2008, J NEUROSCI, V28, P8442, DOI 10.1523/JNEUROSCI.2425-08.2008; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Neves J, 2013, HEARING RES, V297, P20, DOI 10.1016/j.heares.2012.11.003; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Pan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030358; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Reim G, 2002, DEVELOPMENT, V129, P917; Roux I, 2011, J NEUROSCI, V31, P15092, DOI 10.1523/JNEUROSCI.2743-11.2011; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Shi FX, 2010, J BIOL CHEM, V285, P392, DOI 10.1074/jbc.M109.059055; Simonneau L, 2003, J COMP NEUROL, V459, P113, DOI 10.1002/cne.10604; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Sweet EM, 2011, DEV BIOL; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Uthaiah RC, 2010, J NEUROSCI, V30, P12387, DOI 10.1523/JNEUROSCI.1014-10.2010; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Walters BJ, 2013, HEARING RES, V297, P68, DOI 10.1016/j.heares.2012.11.009; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Yang H, 2010, GENESIS, V48, P407, DOI 10.1002/dvg.20633; Yang H, 2010, GENESIS, V48, P400, DOI 10.1002/dvg.20632; Yang JM, 2012, J NEUROSCI, V32, P3712, DOI 10.1523/JNEUROSCI.6093-11.2012; Yu YL, 2010, J NEUROSCI, V30, P5927, DOI 10.1523/JNEUROSCI.5989-09.2010; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8; Zuo J, 1999, P NATL ACAD SCI USA, V96, P14100, DOI 10.1073/pnas.96.24.14100	75	21	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89377	10.1371/journal.pone.0089377	http://dx.doi.org/10.1371/journal.pone.0089377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586731	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700113
J	Nafissi, N; Sum, CH; Wettig, S; Slavcev, RA				Nafissi, Nafiseh; Sum, Chi Hong; Wettig, Shawn; Slavcev, Roderick A.			Optimization of a One-Step Heat-Inducible In Vivo Mini DNA Vector Production System	PLOS ONE			English	Article							RECOMBINANT ESCHERICHIA-COLI; GENERAL STRESS-RESPONSE; HETEROLOGOUS PROTEINS; PLASMA-MEMBRANE; SHOCK PROTEINS; GROWTH-RATE; FTSH HFLB; EXPRESSION; TEMPERATURE; REPRESSOR	While safer than their viral counterparts, conventional circular covalently closed (CCC) plasmid DNA vectors offer a limited safety profile. They often result in the transfer of unwanted prokaryotic sequences, antibiotic resistance genes, and bacterial origins of replication that may lead to unwanted immunostimulatory responses. Furthermore, such vectors may impart the potential for chromosomal integration, thus potentiating oncogenesis. Linear covalently closed (LCC), bacterial sequence free DNA vectors have shown promising clinical improvements in vitro and in vivo. However, the generation of such minivectors has been limited by in vitro enzymatic reactions hindering their downstream application in clinical trials. We previously characterized an in vivo temperature-inducible expression system, governed by the phage lambda pL promoter and regulated by the thermolabile lambda CI[Ts] 857 repressor to produce recombinant protelomerase enzymes in E. coli. In this expression system, induction of recombinant protelomerase was achieved by increasing culture temperature above the 37 degrees C threshold temperature. Overexpression of protelomerase led to enzymatic reactions, acting on genetically engineered multi-target sites called "Super Sequences" that serve to convert conventional CCC plasmid DNA into LCC DNA minivectors. Temperature up-shift, however, can result in intracellular stress responses and may alter plasmid replication rates; both of which may be detrimental to LCC minivector production. We sought to optimize our one-step in vivo DNA minivector production system under various induction schedules in combination with genetic modifications influencing plasmid replication, processing rates, and cellular heat stress responses. We assessed different culture growth techniques, growth media compositions, heat induction scheduling and temperature, induction duration, post-induction temperature, and E. coli genetic background to improve the productivity and scalability of our system, achieving an overall LCC DNA minivector production efficiency of similar to 90%. We optimized a robust technology conferring rapid, scalable, one-step in vivo production of LCC DNA minivectors with potential application to gene transfer-mediated therapeutics.	[Nafissi, Nafiseh; Sum, Chi Hong; Wettig, Shawn; Slavcev, Roderick A.] Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Slavcev, RA (corresponding author), Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada.	slavcev@uwaterloo.ca	Wettig, Shawn/ABE-5382-2020	Wettig, Shawn/0000-0002-6490-264X	Natural Sciences and Engineering Research Council (NSERC)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Natural Sciences and Engineering Research Council (NSERC), funding to RAS and SW [http://www.nserc-crsng.gc.ca/index_eng.asp]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akiyama Y, 1999, BIOCHEMISTRY-US, V38, P11693, DOI 10.1021/bi991177c; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Berlec A, 2013, J IND MICROBIOL BIOT, V40, P257, DOI 10.1007/s10295-013-1235-0; Bissonnette SA, 2010, MOL MICROBIOL, V75, P1539, DOI 10.1111/j.1365-2958.2010.07070.x; Caspeta L, 2009, BIOTECHNOL BIOENG, V102, P468, DOI 10.1002/bit.22084; Chou CP, 2007, APPL MICROBIOL BIOT, V76, P521, DOI 10.1007/s00253-007-1039-0; CHUANG SE, 1993, J BACTERIOL, V175, P5242, DOI 10.1128/JB.175.16.5242-5252.1993; CURLESS C, 1990, BIOTECHNOL PROGR, V6, P149, DOI 10.1021/bp00002a009; Darling PJ, 2000, BIOCHEMISTRY-US, V39, P11500, DOI 10.1021/bi000935s; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; Dodd IB, 2001, GENE DEV, V15, P3013, DOI 10.1101/gad.937301; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Ferenci T, 2001, ENVIRON MICROBIOL, V3, P605, DOI 10.1046/j.1462-2920.2001.00238.x; FIGGE J, 1988, CELL, V52, P713, DOI 10.1016/0092-8674(88)90409-6; GEORGE HA, 1992, BIOTECHNOL BIOENG, V40, P437, DOI 10.1002/bit.260400314; Gill RT, 2000, METAB ENG, V2, P178, DOI 10.1006/mben.2000.0148; GROSSMAN AD, 1987, GENE DEV, V1, P179, DOI 10.1101/gad.1.2.179; GROSSMAN AD, 1984, CELL, V38, P383, DOI 10.1016/0092-8674(84)90493-8; Hannig G, 1998, TRENDS BIOTECHNOL, V16, P54, DOI 10.1016/S0167-7799(97)01155-4; Harcum SW, 2006, J IND MICROBIOL BIOT, V33, P801, DOI 10.1007/s10295-006-0122-3; Hengge-Aronis R, 2002, J MOL MICROB BIOTECH, V4, P341; Hoffmann F, 2000, BIOTECHNOL PROGR, V16, P1000, DOI 10.1021/bp0000959; Hoffmann F, 2004, ADV BIOCHEM ENG BIOT, V89, P73; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; Kihara A, 1996, EMBO J, V15, P6122, DOI 10.1002/j.1460-2075.1996.tb01000.x; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; Le Borgne S, 1998, GENE, V223, P213, DOI 10.1016/S0378-1119(98)00168-1; Lim HK, 1998, BIOTECHNOL PROGR, V14, P548, DOI 10.1021/bp980059y; Menart V, 2003, BIOTECHNOL BIOENG, V83, P181, DOI 10.1002/bit.10660; Meyer AS, 2011, CURR OPIN MICROBIOL, V14, P194, DOI 10.1016/j.mib.2011.02.001; Micevski Dimce, 2013, Subcell Biochem, V66, P105, DOI 10.1007/978-94-007-5940-4_5; Nafissi N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-154; Nicastro J., 2013, APPL MICROBIOL BIOT, P1; Palomares Laura A, 2004, Methods Mol Biol, V267, P15; PTASHNE M, 1980, CELL, V19, P1, DOI 10.1016/0092-8674(80)90383-9; Saikawa N, 2004, J STRUCT BIOL, V146, P123, DOI 10.1016/j.jsb.2003.09.020; Sambrook J., 2001, MOL CLONING LAB MANU; SAYADI S, 1987, J GEN MICROBIOL, V133, P1901; Schroedel Andrea, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-10; Schweder T, 2002, APPL MICROBIOL BIOT, V58, P330, DOI 10.1007/s00253-001-0904-5; Sevastsyanovich YR, 2010, BIOTECHNOL APPL BIOC, V55, P9, DOI 10.1042/BA20090174; SU TZ, 1990, GENE, V90, P129, DOI 10.1016/0378-1119(90)90448-Z; Tabandeh F, 2004, BIOTECHNOL LETT, V26, P245, DOI 10.1023/B:BILE.0000013714.88796.5f; Valdez-Cruz Norma A, 2011, Bioeng Bugs, V2, P105, DOI 10.4161/bbug.2.2.14316; Valdez-Cruz NA, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-18; YAMAMORI T, 1980, J BACTERIOL, V142, P843, DOI 10.1128/JB.142.3.843-851.1980; Yin JC, 2007, J BIOTECHNOL, V127, P335, DOI 10.1016/j.jbiotec.2006.07.012	50	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89345	10.1371/journal.pone.0089345	http://dx.doi.org/10.1371/journal.pone.0089345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586704	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700109
J	Sheng, WP; Yu, GR; Fang, HJ; Jiang, CM; Yan, JH; Zhou, M				Sheng, Wenping; Yu, Guirui; Fang, Huajun; Jiang, Chunming; Yan, Junhua; Zhou, Mei			Sinks for Inorganic Nitrogen Deposition in Forest Ecosystems with Low and High Nitrogen Deposition in China	PLOS ONE			English	Article							NATURAL-ABUNDANCE; FOLIAR RETENTION; N-15 ABUNDANCE; TEMPERATE; SATURATION; CANOPY; CARBON; INPUTS; ADDITIONS; DYNAMICS	We added the stable isotope N-15 in the form of ((NH4)-N-15)(2)SO4 and (KNO3)-N-15 to forest ecosystems in eastern China under two different N deposition levels to study the fate of the different forms of deposited N. Prior to the addition of the N-15 tracers, the natural N-15 abundance ranging from -3.4 parts per thousand to +10.9 parts per thousand in the forest under heavy N deposition at Dinghushan (DHS), and from -3.92 parts per thousand to +7.25 parts per thousand in the forest under light N deposition at Daxinganling (DXAL). Four months after the tracer application, the total N-15 recovery from the major ecosystem compartments ranged from 55.3% to 90.5%. The total N-15 recoveries were similar under the ((NH4)-N-15)(2)SO4 tracer treatment in both two forest ecosystems, whereas the total 15 N recovery was significantly lower in the subtropical forest ecosystem at DHS than in the boreal forest ecosystem at DXAL under the (KNO3)-N-15 tracer treatment. The N-15 assimilated into the tree biomass represented only 8.8% to 33.7% of the N-15 added to the forest ecosystems. In both of the tracer application treatments, more N-15 was recovered from the tree biomass in the subtropical forest ecosystem at DHS than the boreal forest ecosystem at DXAL. The amount of N-15 assimilated into tree biomass was greater under the (KNO3)-N-15 tracer treatment than that of the ((NH4)-N-15)(2)SO4 treatment in both forest ecosystems. This study suggests that, although less N was immobilized in the forest ecosystems under more intensive N deposition conditions, forest ecosystems in China strongly retain N deposition, even in areas under heavy N deposition intensity or in ecosystems undergoing spring freezing and thawing melts. Compared to ammonium deposition, deposited nitrate is released from the forest ecosystem more easily. However, nitrate deposition could be retained mostly in the plant N pool, which might lead to more C sequestration in these ecosystems.	[Sheng, Wenping; Yu, Guirui; Fang, Huajun] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Jiang, Chunming] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Yan, Junhua] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Zhou, Mei] Inner Mongolia Agr Univ, Coll Ecol & Environm Sci, Hohhot Inner Mongolia, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Inner Mongolia Agricultural University	Yu, GR (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	yugr@igsnrr.ac.cn	于, 贵瑞/C-1768-2014	于, 贵瑞/0000-0002-1859-8966	National Basic Research Program of China [2010CB833504]; CAS Strategic Priority Research Program Grant [XDA05050601]; Natural Science Foundation of China [31100356]; China Postdoctoral Science Foundation [2012M510042]	National Basic Research Program of China(National Basic Research Program of China); CAS Strategic Priority Research Program Grant; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Basic Research Program of China (2010CB833504) (http://www.973.gov.cn/Default_3.aspx), CAS Strategic Priority Research Program Grant (XDA05050601) (http://www.cas.cn/), Natural Science Foundation of China (31100356) (http://www.nsfc.gov.cn/Portal0/default152.htm), China Postdoctoral Science Foundation (2012M510042) (http://res.chinapostdoctor.org.cn/Program/Main.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Aber JD, 2004, FOREST ECOL MANAG, V196, P1, DOI 10.1016/j.foreco.2004.03.009; Aber JD, 2003, BIOSCIENCE, V53, P375, DOI 10.1641/0006-3568(2003)053[0375:INDATN]2.0.CO;2; Chen Y, 2006, SOIL BIOL BIOCHEM, V38, P2001, DOI 10.1016/j.soilbio.2005.11.026; Currie WS, 1999, ECOSYSTEMS, V2, P4, DOI 10.1007/s100219900054; Fan PP, 2010, J PLANT RES, V123, P433, DOI 10.1007/s10265-009-0303-z; Fang HJ, 2010, BIOGEOSCIENCES, V7, P395, DOI 10.5194/bg-7-395-2010; Fang YT, 2008, BIOGEOSCIENCES, V5, P339, DOI 10.5194/bg-5-339-2008; Fang YT, 2009, FOREST ECOL MANAG, V257, P332, DOI 10.1016/j.foreco.2008.09.004; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Garten CT, 1998, FOREST ECOL MANAG, V103, P211, DOI 10.1016/S0378-1127(97)00185-0; GARTEN CT, 1990, ENVIRON EXP BOT, V30, P333, DOI 10.1016/0098-8472(90)90045-6; GIFFORD RM, 1994, AUST J PLANT PHYSIOL, V21, P1, DOI 10.1071/PP9940001; Gundersen P, 2006, ENVIRON REV, V14, P1, DOI [10.1139/a05-015, 10.1139/A05-015]; Hobbie EA, 2008, ECOSYSTEMS, V11, P815, DOI 10.1007/s10021-008-9159-7; Hogberg P, 2006, GLOBAL CHANGE BIOL, V12, P489, DOI 10.1111/j.1365-2486.2006.01102.x; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Hogberg P, 1996, OECOLOGIA, V108, P207, DOI 10.1007/BF00334643; Klopatek JM, 2006, FOREST ECOL MANAG, V234, P344, DOI 10.1016/j.foreco.2006.07.019; Koba K, 2003, ECOSYSTEMS, V6, P457, DOI 10.1007/s10021-002-0132-6; Lamarque JF, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005825; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Lovett GM, 2002, BIOSCIENCE, V52, P335, DOI 10.1641/0006-3568(2002)052[0335:IDANCI]2.0.CO;2; Lue C., 2007, J GEOPHYS RES, V112, DOI [DOI 10.1029/2006JD007990, 10. 1029/2006JD007990]; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Magill AH, 2000, ECOSYSTEMS, V3, P238, DOI 10.1007/s100210000023; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Neff JC, 2003, FRONT ECOL ENVIRON, V1, P205, DOI 10.1890/1540-9295(2003)001[0205:BITCDO]2.0.CO;2; Peri PL, 2011, GLOBAL CHANGE BIOL, V28, P1365; PRESTON CM, 1990, CAN J FOREST RES, V20, P1583, DOI 10.1139/x90-210; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Sheng WP, 2013, ENVIRON MONIT ASSESS, V185, P833, DOI 10.1007/s10661-012-2594-0; Stachurski A, 2002, ENVIRON POLLUT, V118, P75, DOI 10.1016/S0269-7491(01)00238-X; Templer PH, 2012, ECOLOGY, V93, P1816, DOI 10.1890/11-1146.1; Tietema A, 1998, FOREST ECOL MANAG, V101, P29, DOI 10.1016/S0378-1127(97)00122-9; Turner MM, 2009, GLOBAL CHANGE BIOL, V15, P2885, DOI 10.1111/j.1365-2486.2009.01881.x; Venterea RT, 2004, FOREST ECOL MANAG, V196, P129, DOI 10.1016/j.foreco.2004.03.016; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Wright RF, 1998, FOREST ECOL MANAG, V101, P1, DOI 10.1016/S0378-1127(97)00120-5; Xu XL, 2011, J ECOL, V99, P563, DOI 10.1111/j.1365-2745.2010.01789.x; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066184	44	25	29	5	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89322	10.1371/journal.pone.0089322	http://dx.doi.org/10.1371/journal.pone.0089322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586688	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700102
J	Bhattacharyya, S; Ghosh, S; Sil, PC				Bhattacharyya, Sudip; Ghosh, Shatadal; Sil, Parames C.			Amelioration of Aspirin Induced Oxidative Impairment and Apoptotic Cell Death by a Novel Antioxidant Protein Molecule Isolated from the Herb Phyllanthus niruri	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; NF-KAPPA-B; INDUCED HEPATIC DISORDER; PROTECTIVE ROLE; COLORECTAL-CANCER; ARJUNOLIC ACID; IN-VITRO; ACTIVATION; STRESS; MITOCHONDRIA	Aspirin has been used for a long time as an analgesic and anti-pyretic drug. Limitations of its use, however, remain for the gastro-intestinal side effects and erosions. Although the role of aspirin on gastro-intestinal injury has been extensively studied, the molecular mechanisms underlying aspirin-induced liver and spleen pathophysiology are poorly defined. The present study has been conducted to investigate whether phyllanthus niruri protein (PNP) possesses any protective role against aspirin mediated liver and spleen tissue toxicity, and if so, what signaling pathways it utilizes to convey its protective action. Aspirin administration in mice enhanced serum marker (ALP) levels, reactive oxygen species (ROS) generation, reduced antioxidant power and altered oxidative stress related biochemical parameters in liver and spleen tissues. Moreover, we observed that aspirin intoxication activated both the extrinsic and intrinsic apoptotic pathways, as well as down regulated NF-kB activation and the phosphorylation of p38 and JNK MAPKs. Histological assessments and TUNEL assay also supported that aspirin induced tissue damages are apoptotic in nature. PNP treatment after aspirin exposure effectively neutralizes all these abnormalities via the activation of survival PI3k/Akt pathways. Combining all results suggest that PNP could be a potential protective agent to protect liver and spleen from the detrimental effects of aspirin.	[Bhattacharyya, Sudip; Ghosh, Shatadal; Sil, Parames C.] Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Sil, PC (corresponding author), Bose Inst, Div Mol Med, Kolkata, India.	parames@jcbose.ac.in	Sil, Parames C./AAJ-9795-2020; Ghosh, Shatadal/GOE-5737-2022	Ghosh, Shatadal/0000-0002-9557-2997	Council of Scientific and Industrial Research (CSIR) [37 (1457)/10/EMR-II]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	The work has been supported by the Council of Scientific and Industrial Research (CSIR) (Sanction No: 37 (1457)/10/EMR-II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2007, HISTOL HISTOPATHOL, V22, P437, DOI 10.14670/HH-22.437; Ahmed H, 2013, TURK J BIOL, V37, P39, DOI 10.3906/biy-1110-29; Angel GR., 2013, J PHYTOPHARM, V4, P96; ATHREYA BH, 1973, AM J DIS CHILD, V126, P638, DOI 10.1001/archpedi.1973.02110190510010; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Becker JC, 2004, BRIT J CLIN PHARMACO, V58, P587, DOI 10.1111/j.1365-2125.2004.02198.x; Bellosillo B, 1998, BLOOD, V92, P1406, DOI 10.1182/blood.V92.4.1406.416k17_1406_1414; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Bessone F, 2010, WORLD J GASTROENTERO, V16, P5651, DOI 10.3748/wjg.v16.i45.5651; Bhattacharjee Rajesh, 2006, Biomedical Research (Aligarh), V17, P75; Bhattacharjee R, 2007, FOOD CHEM TOXICOL, V45, P817, DOI 10.1016/j.fct.2006.10.029; Bhattacharjee R, 2006, PHYTOTHER RES, V20, P595, DOI 10.1002/ptr.1933; Bhattacharyya S, 2013, FOOD CHEM TOXICOL, V56, P119, DOI 10.1016/j.fct.2013.02.013; Bhattacharyya S, 2012, FREE RADICAL RES, V46, P1296, DOI 10.3109/10715762.2012.712690; Chatterjee Mary, 2006, Pathophysiology, V13, P95, DOI 10.1016/j.pathophys.2006.02.003; Chatterjee M, 2006, INDIAN J BIOCHEM BIO, V43, P299; Cheng JT, 1995, CAN J PHYSIOL PHARM, V73, P1425, DOI 10.1139/y95-198; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Das J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012602; Das J, 2010, FREE RADICAL RES, V44, P340, DOI 10.3109/10715760903513017; DAVENPORT HW, 1967, NEW ENGL J MED, V276, P1307, DOI 10.1056/NEJM196706082762308; De Berardis G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4531; Devi M, 1986, J RES ED IND MED, V5, P11; Dreser M. H., 1970, PFLUGERS ARCH, V76, P306, DOI [10.1007/bf01662127, DOI 10.1007/BF01662127]; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GARBER E, 1975, ANN INTERN MED, V82, P592, DOI 10.7326/0003-4819-82-4-592_2; Ghosh J, 2008, TOXICOL IN VITRO, V22, P1918, DOI 10.1016/j.tiv.2008.09.010; Ghosh J, 2011, BIOMATERIALS, V32, P4857, DOI 10.1016/j.biomaterials.2011.03.048; Ghosh J, 2010, TOXICOLOGY, V268, P8, DOI 10.1016/j.tox.2009.11.011; Ghosh J, 2010, FREE RADICAL BIO MED, V48, P535, DOI 10.1016/j.freeradbiomed.2009.11.023; Ghosh M, 2011, FREE RADICAL RES, V45, P620, DOI 10.3109/10715762.2011.564166; Giardina C, 1998, BBA-MOL CELL RES, V1401, P277, DOI 10.1016/S0167-4889(97)00140-7; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Gu Q, 2005, CARCINOGENESIS, V26, P541, DOI 10.1093/carcin/bgh345; Harish R, 2006, FOOD CHEM, V95, P180, DOI 10.1016/j.foodchem.2004.11.049; Hossain MA, 2012, INT J ONCOL, V40, P1636, DOI 10.3892/ijo.2012.1359; Jana NR, 2008, CELL MOL LIFE SCI, V65, P1295, DOI 10.1007/s00018-008-7511-x; Khatoon S, 2006, J ETHNOPHARMACOL, V104, P79, DOI 10.1016/j.jep.2005.08.048; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim KM, 2005, J BIOL CHEM, V280, P41047, DOI 10.1074/jbc.M503713200; KIND PRN, 1954, J CLIN PATHOL, V7, P322, DOI 10.1136/jcp.7.4.322; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Lanas A, 2013, ALIMENT PHARM THER, V37, P738, DOI 10.1111/apt.12240; Lee SJ, 2006, J PHARM PHARMACOL, V58, P143, DOI 10.1211/jpp.58.1.0018; Li WG, 2003, FREE RADICAL BIO MED, V34, P937, DOI 10.1016/S0891-5849(03)00032-7; LOPEZMORANTE AJ, 1993, J CLIN GASTROENTEROL, V16, P270, DOI 10.1097/00004836-199304000-00029; Manna P., 2011, EVID-BASED COMPL ALT, V2011, DOI DOI 10.1093/ECAM/NEQ065; Manna P, 2007, BASIC CLIN PHARMACOL, V101, P333, DOI 10.1111/j.1742-7843.2007.00132.x; Manna P, 2010, FREE RADICAL BIO MED, V48, P1465, DOI 10.1016/j.freeradbiomed.2010.02.025; Manna P, 2010, TOXICOL APPL PHARM, V244, P114, DOI 10.1016/j.taap.2009.12.024; Manov I, 2006, ACTA PHARMACOL SIN, V27, P259, DOI 10.1111/j.1745-7254.2006.00278.x; McCarty MF, 2006, INTEGR CANCER THER, V5, P252, DOI 10.1177/1534735406291499; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Mingatto FE, 1996, ARCH BIOCHEM BIOPHYS, V334, P303, DOI 10.1006/abbi.1996.0459; Nishiura J, 2004, UROL RES, V32, P362, DOI 10.1007/s00240-004-0432-8; Oh PS, 2006, J BIOMED SCI, V13, P549, DOI 10.1007/s11373-006-9083-9; Pal S, 2012, BIOCHIMIE, V94, P1356, DOI 10.1016/j.biochi.2012.03.003; Piazza GA, 1997, CANCER RES, V57, P2452; Ramadas D., 2011, ASIAN J PHARM CLIN R, V4, P119; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Raphael KR, 2003, J ETHNOPHARMACOL, V87, P193, DOI 10.1016/S0378-8741(03)00120-X; Rashid K, 2012, FREE RADICAL RES, V46, P240, DOI 10.3109/10715762.2011.650694; Sarkar K, 2006, TOXICOL IN VITRO, V20, P634, DOI 10.1016/j.tiv.2005.11.003; Sarkar MK, 2010, TOXICOL IN VITRO, V24, P1711, DOI 10.1016/j.tiv.2010.05.014; Sarkar Mrinal K, 2007, Pathophysiology, V14, P113, DOI 10.1016/j.pathophys.2007.08.001; Sarkar MK, 2009, FOOD CHEM, V114, P1405, DOI 10.1016/j.foodchem.2008.11.022; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Sivapriya M, 2007, FOOD CHEM, V104, P510, DOI 10.1016/j.foodchem.2006.11.060; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; Suzuki Y, 2010, PHARMACEUTICALS, V3, P1594, DOI 10.3390/ph3051594; THYAGARAJAN SP, 1988, LANCET, V2, P764; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; Wang J, 2005, TISSUE CELL, V37, P25, DOI 10.1016/j.tice.2004.09.002; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948	75	28	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89026	10.1371/journal.pone.0089026	http://dx.doi.org/10.1371/journal.pone.0089026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586486	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900072
J	Jardim, DL; Wheler, JJ; Hess, K; Tsimberidou, AM; Zinner, R; Janku, F; Subbiah, V; Naing, A; Piha-Paul, SA; Westin, SN; Roy-Chowdhuri, S; Meric-Bernstam, F; Hong, DS				Jardim, Denis L.; Wheler, Jennifer J.; Hess, Kenneth; Tsimberidou, Apostolia M.; Zinner, Ralph; Janku, Filip; Subbiah, Vivek; Naing, Aung; Piha-Paul, Sarina A.; Westin, Shannon N.; Roy-Chowdhuri, Sinchita; Meric-Bernstam, Funda; Hong, David S.			FBXW7 Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; TYROSINE KINASE; UBIQUITIN LIGASE; SOLID TUMORS; GENE; RESISTANCE; MELANOMA; LEUKEMIA; EFFICACY; TRIALS	Purpose: FBXW7 is a tumor suppressor gene responsible for the degradation of several proto-oncogenes. Preclinical data suggest that FBXW7 mutations sensitize cells to mTOR inhibitors. Clinicopathologic characteristics of cancer patients with FBXW7 mutations and their responses to mTOR inhibitors remain unknown. Methods: Using multiplex gene panels we evaluated how the FBXW7 mutation affected the cancer phenotype of patients referred to a phase I clinic starting January 2012. Whenever possible patients positive for FBXW7 mutation were treated with regimens containing an mTOR inhibitors and their outcomes were reviewed. Results: FBXW7 mutations were detected in 17 of 418 patients (4.0%). Among tumor types with more than 10 patients tested, FBXW7 mutations occurred in colorectal cancer (7/49; 14.3%), squamous cell cancer of head and neck (2/18; 11.1%), liver (1/13; 7.7%), and ovarian cancers (1/40; 2.5%). No one clinical, pathological or demographic feature was characteristic of the FBXW7-mutated patient population. The mutation occurred in isolation in only 2/17 (12%) patients, and KRAS was frequently found as a concomitant mutation, especially in patients with colorectal cancer (6/7; 86%). Ten patients were treated on a protocol containing an mTOR inhibitor, with a median time to treatment failure of 2.8 months (range, 1.3-6.8). One patient with liver cancer (fibrolamellar subtype) continues to have a prolonged stable disease for 6.8+ months. Conclusion: In patients with advanced cancers, somatic mutations in FBXW7 usually occur with other simultaneous molecular aberrations, which can contribute to limited therapeutic efficacy of mTOR inhibitors.	[Jardim, Denis L.; Wheler, Jennifer J.; Tsimberidou, Apostolia M.; Zinner, Ralph; Janku, Filip; Subbiah, Vivek; Naing, Aung; Piha-Paul, Sarina A.; Meric-Bernstam, Funda; Hong, David S.] Univ Texas MD Anderson Canc Ctr, Phase Clin Trials Program 1, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Hess, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Roy-Chowdhuri, Sinchita] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Westin, Shannon N.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Hong, DS (corresponding author), Univ Texas MD Anderson Canc Ctr, Phase Clin Trials Program 1, Dept Invest Canc Therapeut, Houston, TX 77030 USA.	dshong@mdanderson.org	Subbiah, Vivek/O-3347-2019; Janku, Filip/ABB-9136-2020; Hess, Kenneth/K-6546-2019	Subbiah, Vivek/0000-0002-6064-6837; Hess, Kenneth/0000-0003-1377-6070; Roy-Chowdhuri, Sinchita/0000-0002-9447-7701; Tsimberidou, Apostolia M./0000-0003-2713-233X; Piha-Paul, Sarina/0000-0001-9455-1660; Naing, Aung/0000-0002-4803-8513	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000371] Funding Source: Medline; NCI NIH HHS [P30 CA016672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Falchook GS, 2012, LANCET ONCOL, V13, P782, DOI 10.1016/S1470-2045(12)70269-3; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Hubalek MM, 2004, ONCOGENE, V23, P4187, DOI 10.1038/sj.onc.1207560; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Janku F, 2011, MOL CANCER THER, V10, P558, DOI 10.1158/1535-7163.MCT-10-0994; Koh MS, 2006, CANCER BIOL THER, V5, P78, DOI 10.4161/cbt.5.1.2290; Lee JW, 2006, EUR J CANCER, V42, P2369, DOI 10.1016/j.ejca.2005.10.034; Liu YY, 2013, AGING-US, V5, P111, DOI 10.18632/aging.100535; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tran B, 2012, J CLIN ONCOL, V30, P647, DOI 10.1200/JCO.2011.39.2316; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Wang Y, 2013, BIOCH BIOPHYS RES CO; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wellcome Trust Sanger Institute, COSMIC CAT SOM MUT C	30	46	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89388	10.1371/journal.pone.0089388	http://dx.doi.org/10.1371/journal.pone.0089388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586741	Green Submitted, Green Published, gold			2022-12-27	WOS:000331711900137
J	Padalino, B; Aube, L; Fatnassi, M; Monaco, D; Khorchani, T; Hammadi, M; Lacalandra, GM				Padalino, Barbara; Aube, Lydiane; Fatnassi, Meriem; Monaco, Davide; Khorchani, Touhami; Hammadi, Mohamed; Lacalandra, Giovanni Michele			Could Dromedary Camels Develop Stereotypy? The First Description of Stereotypical Behaviour in Housed Male Dromedary Camels and How It Is Affected by Different Management Systems	PLOS ONE			English	Article							PREVALENCE; WELFARE; ENVIRONMENT; MACAQUES; ANIMALS; STRESS; HORSES	Dromedary camel husbandry has recently been evolving towards a semi-intensive system, due to the changes in use of the animal and the settlement of nomadic populations. Captivity could restrict its social activities, limiting the expression of various behavioural needs and causing the manifestation of stereotypy. The aims of this trial were, firstly, to identify and describe some stereotypical behaviours in captive male dromedary camels used for artificial insemination and, secondly, to study the effects on them of the following husbandry management systems: i) housing in single boxes for 24 hours (H24), ii) housing in single boxes for 23 hours with one hour free in the paddock (H23), and iii) housing in single boxes for 22 hours 30 min with 1 h of paddock time and 30 min exposure to a female camel herd (ExF). Every day, the camels were filmed in their single box in the morning for 30 minutes to record their behavioural activities and a focal animal sampling ethogram was filled in. In this study, male camels showed both oral and locomotor stereotypy most frequently when the bulls were reared in H24. Overall, this preliminary study is a starting point in the identification of stereotypies in male camels, reporting the positive effects of spending one hour outdoor and of social interaction with females.	[Padalino, Barbara] Univ Bari, Dept Vet Med, Bari, Italy; [Aube, Lydiane] Univ Rennes, Lab Ethol Anim & Humaine EthoS, Rennes, France; [Fatnassi, Meriem; Khorchani, Touhami; Hammadi, Mohamed] Arid Lands Inst, Livestock & Wildlife Lab, Medenine, Tunisia; [Monaco, Davide; Lacalandra, Giovanni Michele] Univ Bari, DETO, Vet Clin, Bari, Italy; [Monaco, Davide; Lacalandra, Giovanni Michele] Univ Bari, Anim Prod Sect, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universite de Rennes; Institut des Regions Arides; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Padalino, B (corresponding author), Univ Bari, Dept Vet Med, Bari, Italy.	barbara.padalino@uniba.it	LACALANDRA, Giovanni Michele/P-4661-2014; Padalino, Barbara/AAJ-7498-2020	MONACO, DAVIDE/0000-0001-8938-9099; PADALINO, BARBARA/0000-0002-7630-8285; Aube, Lydiane/0000-0002-6174-3743	European Union [I.B/1.1/493]	European Union(European Commission)	This document has been produced with the financial assistance of the European Union through the "PROCAMED'' Project: Promotion des systemes camelins innovants et des filieres locales pour une gestion durable des territoires saharienne (reference number: I.B/1.1/493). The contents of this document are the sole responsibility of Livestock and Wildlife Laboratory, IRA Medenine, Tunisia and Veterinary Clinics and Animal Productions Unit D.E.T.O. Bari, Italy, and can under no circumstances be regarded as reflecting the position of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel Rahim S.E.A., 1992, P115; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bashaw MJ, 2001, APPL ANIM BEHAV SCI, V73, P235, DOI 10.1016/S0168-1591(01)00137-X; Bassett Lois, 2003, Journal of Applied Animal Welfare Science, V6, P221, DOI 10.1207/S15327604JAWS0603_07; Baxter E, 2001, ANIM WELFARE, V10, P281; Bolinger DJ, 1997, J DAIRY SCI, V80, P2411, DOI 10.3168/jds.S0022-0302(97)76193-9; BROOM DM, 1991, J ANIM SCI, V69, P4167, DOI 10.2527/1991.69104167x; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Cook WR, 2003, PFERDEHEILKUNDE, V19, P75, DOI 10.21836/PEM20030111; Cooper J, 2007, WELFARE HORSES, P99; Cooper JJ, 2000, APPL ANIM BEHAV SCI, V69, P67, DOI 10.1016/S0168-1591(00)00115-5; Crockett CM, 2007, PEPTIDES, V28, P1987, DOI 10.1016/j.peptides.2007.07.014; CRONIN GM, 1985, NEUROPEPTIDES, V6, P527, DOI 10.1016/0143-4179(85)90114-3; Crowell-Davis SL, 2008, COMPENDIUM EQUINE, P466; DALLAIRE A, 1993, ANN NY ACAD SCI, V697, P269, DOI 10.1111/j.1749-6632.1993.tb49940.x; ELWISHY AB, 1988, ANIM REPROD SCI, V17, P217, DOI 10.1016/0378-4320(88)90060-7; Faye B, 2001, EMIRATES J AGR SCI, V13, P01; Friend TH, 1999, APPL ANIM BEHAV SCI, V62, P73, DOI 10.1016/S0168-1591(98)00210-X; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gauthier-Pilters H., 1981, CAMEL ITS EVOLUTION; Haskell MJ, 2003, ANIM WELFARE, V12, P553; Hausberger M, 2009, PLOS ONE, V4, P1; HOLMGREN B, 1976, PHARMACOL BIOCHEM BE, V5, P23, DOI 10.1016/0091-3057(76)90283-5; Inglis IR, 2006, BEHAVIOUR, V143, P1563, DOI 10.1163/156853906779367044; Kim JW, 1996, BIOL PSYCHIAT, V40, P918, DOI 10.1016/0006-3223(95)00546-3; Laudadio V, 2009, TROP ANIM HEALTH PRO, V41, P1219, DOI 10.1007/s11250-008-9303-6; LAWRENCE AB, 1993, J ANIM SCI, V71, P2815, DOI 10.2527/1993.71102815x; Lay DC, 2011, POULTRY SCI, V90, P278, DOI 10.3382/ps.2010-00962; Lutz C, 2003, AM J PRIMATOL, V60, P1, DOI 10.1002/ajp.10075; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason GJ, 2004, ANIM WELFARE, V13, pS57; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; McDonnell SM, 2008, ANIM REPROD SCI, V107, P219, DOI 10.1016/j.anireprosci.2008.04.012; McGreevy P., 2004, EQUINE BEHAV GUIDE V, DOI 10.1016/B978-0-7020-2634-8.50006-X; McGreevy P D, 1998, Equine Vet J Suppl, P35; MCGREEVY PD, 1995, VET REC, V137, P36, DOI 10.1136/vr.137.2.36; Mills DS, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P212; Mills DS, 2002, APPL ANIM BEHAV SCI, V78, P115, DOI 10.1016/S0168-1591(02)00096-5; Monaco D, 2013, P 11 C IT SOC AN REP, P132; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Nicol C, 1999, Equine Vet J Suppl, P20; Normando S, 2011, APPL ANIM BEHAV SCI, V133, P186, DOI 10.1016/j.applanim.2011.06.012; Odberg F., 1978, P 1 WORLD C ETH APPL, P475; Pollard JC, 1996, APPL ANIM BEHAV SCI, V47, P247, DOI 10.1016/0168-1591(95)00621-4; REDBO I, 1990, APPL ANIM BEHAV SCI, V26, P57, DOI 10.1016/0168-1591(90)90087-T; Rushen J, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P1, DOI 10.1079/9780851990040.0001; Singer HS, 2009, SEMIN PEDIATR NEUROL, V16, P77, DOI 10.1016/j.spen.2009.03.008; Skidmore JA, 2013, ANIM REPROD SCI, V136, P178, DOI 10.1016/j.anireprosci.2012.10.008; Vickery S, 2004, ZOO BIOL, V23, P409, DOI 10.1002/zoo.20027	50	19	19	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89093	10.1371/journal.pone.0089093	http://dx.doi.org/10.1371/journal.pone.0089093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586522	gold, Green Submitted, Green Published			2022-12-27	WOS:000331711900088
J	Tavano, B; Boasso, A				Tavano, Barbara; Boasso, Adriano			Effect of Immunoglobin-Like Transcript 7 Cross-Linking on Plasmacytoid Dendritic Cells Differentiation into Antigen-Presenting Cells	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; CXCR3 LIGANDS; CUTTING EDGE; RECEPTORS; ILT7; ACTIVATION; CHEMOKINES; TOLERANCE; MIGRATION; RESPONSES	Plasmacytoid dendritic cells (pDC) are innate immunity effector cells which play a critical role in the transition from innate to adaptive immune response. Circulating blood pDC present an immature phenotype and can differentiate into either antigen-presenting cells (APC) or type I interferon (IFN-I)-producing cells (IPC). The immunoglobulin-like transcript (ILT)7 is a surface receptor expressed by immature pDC, and ILT7 cross-linking (XL-ILT7) inhibits IFN-I production by pDC in response to toll-like receptor (TLR)7 and 9 stimulation. We used peripheral blood mononuclear cells (PBMC) from healthy donors to test the effect of XL-ILT7 on 1) TLR7/9-mediated regulation of gut mucosal (alpha 4 beta 7 integrin) and lymph node (CCR7) migration markers; and 2) the maturation of pDC into APC. We found that XL-ILT7 mitigated the upregulation of CCR7 and enhanced that of beta 7 on TLR7/9-stimulated pDC. TLR7/9 stimulation induced upregulation of CD40, CD80 and CD86. CD40 expression was partially reduced by XL-ILT7, whereas CD86 was further enhanced. Plasmacytoid DC stimulated with TLR9 ligand in presence of XL-ILT7 retained the ability to induce T cell proliferation and activation in response to staphylococcal enterotoxin B (SEB) in pDC-T cell co-cultures. Our results suggest that XL-ILT7 favours the differentiation of immature pDC into APC rather than IPC.	[Tavano, Barbara; Boasso, Adriano] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Immunol Sect, London, England	Imperial College London	Boasso, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Immunol Sect, London, England.	a.boasso@imperial.ac.uk		Boasso, Adriano/0000-0001-9673-6319	Wellcome Trust [085164/Z/08/Z, 085164/Z/08/A]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (awards n. 085164/Z/08/Z and 085164/Z/08/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Boasso A, 2009, J INTERN MED, V265, P78, DOI 10.1111/j.1365-2796.2008.02043.x; Boasso A, 2008, CLIN IMMUNOL, V126, P235, DOI 10.1016/j.clim.2007.08.015; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2010, IMMUNOL REV, V234, P163, DOI 10.1111/j.0105-2896.2009.00867.x; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Colonna M, 2000, SEMIN IMMUNOL, V12, P121, DOI 10.1006/smim.2000.0214; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; de la Rosa G, 2003, J LEUKOCYTE BIOL, V73, P639, DOI 10.1189/jlb.1002516; Fallarino F, 2007, CURR DRUG METAB, V8, P209, DOI 10.2174/138920007780362581; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Gurtner GJ, 2003, GASTROENTEROLOGY, V125, P1762, DOI 10.1053/j.gastro.2003.08.031; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Jegalian AG, 2009, ADV ANAT PATHOL, V16, P392, DOI 10.1097/PAP.0b013e3181bb6bc2; Ju XS, 2004, GENE, V331, P159, DOI 10.1016/j.gene.2004.02.018; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Kohrgruber N, 2004, J IMMUNOL, V173, P6592, DOI 10.4049/jimmunol.173.11.6592; Krug A, 2002, J IMMUNOL, V169, P6079, DOI 10.4049/jimmunol.169.11.6079; Kubo-Murai M, 2008, J BIOCHEM, V143, P295, DOI 10.1093/jb/mvm234; Kudo Y, 2000, BBA-MOL BASIS DIS, V1500, P119, DOI 10.1016/S0925-4439(99)00096-4; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Munn DH, 2004, TRENDS MOL MED, V10, P15, DOI 10.1016/j.molmed.2003.11.003; O'Sullivan B, 2003, CRIT REV IMMUNOL, V23, P83, DOI 10.1615/CritRevImmunol.v23.i12.50; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Sakurai K, 2002, J NEUROIMMUNOL, V129, P186, DOI 10.1016/S0165-5728(02)00176-5; Schmid MA, 2011, BLOOD, V118, P4829, DOI 10.1182/blood-2011-03-344960; Seth S, 2011, J IMMUNOL, V186, P3364, DOI 10.4049/jimmunol.1002598; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Swanson KA, 2004, AM J RESP CELL MOL, V30, P311, DOI 10.1165/rcmb.2003-0268OC; Tavano B, 2013, J IMMUNOL, V190, P2622, DOI 10.4049/jimmunol.1202391; Vanbervliet B, 2003, J EXP MED, V198, P823, DOI 10.1084/jem.20020437	35	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89414	10.1371/journal.pone.0089414	http://dx.doi.org/10.1371/journal.pone.0089414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586760	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900140
J	Arai, T; Akao, N; Seki, T; Kumagai, T; Ishikawa, H; Ohta, N; Hirata, N; Nakaji, S; Yamauchi, K; Hirai, M; Shiratori, T; Kobayashi, M; Fujii, H; Ishii, E; Naito, M; Saitoh, S; Yamaguchi, T; Shibata, N; Shimo, M; Tokiwa, T				Arai, Toshio; Akao, Nobuaki; Seki, Takenori; Kumagai, Takashi; Ishikawa, Hirofumi; Ohta, Nobuo; Hirata, Nobuto; Nakaji, So; Yamauchi, Kenji; Hirai, Mitsuru; Shiratori, Toshiyasu; Kobayashi, Masayoshi; Fujii, Hiroyuki; Ishii, Eiji; Naito, Mikio; Saitoh, Shin-ichi; Yamaguchi, Toshikazu; Shibata, Nobumitsu; Shimo, Masamune; Tokiwa, Toshihiro			Molecular Genotyping of Anisakis Larvae in Middle Eastern Japan and Endoscopic Evidence for Preferential Penetration of Normal over Atrophic Mucosa	PLOS ONE			English	Article							PEGREFFII NEMATODA-ANISAKIDAE; SIMPLEX SENSU-STRICTO; IDENTIFICATION; GASTRITIS; RISK; FISH	Background: Anisakiasis is a parasitic disease caused primarily by Anisakis spp. larvae in Asia and in Western countries. The aim of this study was to investigate the genotype of Anisakis larvae endoscopically removed from Middle Eastern Japanese patients and to determine whether mucosal atrophy affects the risk of penetration in gastric anisakiasis. Methods: In this study, 57 larvae collected from 44 patients with anisakiasis (42 gastric and 2 colonic anisakiasis) were analyzed retrospectively. Genotyping was confirmed by restriction fragment length polymorphism (RFLP) analysis of ITS regions and by sequencing the mitochondrial small subunit (SSU) region. In the cases of gastric anisakiasis, correlation analyses were conducted between the frequency of larval penetration in normal/atrophic area and the manifestation of clinical symptoms. Results: Nearly all larvae were A. simplex seusu stricto (s.s.) (99%), and one larva displayed a hybrid genotype. The A. simplex larvae penetrated normal mucosa more frequently than atrophic area (p = 0.005). Finally, patients with normal mucosa infection were more likely to exhibit clinical symptoms than those with atrophic mucosa infection (odds ratio, 6.96; 95% confidence interval, 1.52-31.8). Conclusions: In Japan, A. simplex s.s. is the main etiological agent of human anisakiasis and tends to penetrate normal gastric mucosa. Careful endoscopic examination of normal gastric mucosa, particularly in the greater curvature of the stomach will improve the detection of Anisakis larvae.	[Arai, Toshio; Akao, Nobuaki; Seki, Takenori; Kumagai, Takashi; Ishikawa, Hirofumi; Ohta, Nobuo] Tokyo Med & Dent Univ, Dept Environm Parasitol, Grad Sch, Bunkyo Ku, Tokyo, Japan; [Hirata, Nobuto; Nakaji, So; Yamauchi, Kenji; Hirai, Mitsuru; Shiratori, Toshiyasu; Kobayashi, Masayoshi; Fujii, Hiroyuki; Ishii, Eiji] Kameda Med Ctr, Dept Gastroenterol, Chiba, Japan; [Naito, Mikio; Saitoh, Shin-ichi] Kameda Med Ctr, Dept Endoscopy, Chiba, Japan; [Arai, Toshio; Yamaguchi, Toshikazu] Toukatsu Hosp, Dept Gastroenterol, Nagareyama, Chiba, Japan; [Shibata, Nobumitsu; Shimo, Masamune] Toukatsu Hosp, Dept Pathol, Nagareyama, Chiba, Japan; [Tokiwa, Toshihiro] Azabu Univ, Lab Vet Pathol, Sagamihara, Kanagawa, Japan	Tokyo Medical & Dental University (TMDU); Azabu University	Akao, N (corresponding author), Tokyo Med & Dent Univ, Dept Environm Parasitol, Grad Sch, Bunkyo Ku, Tokyo, Japan.	ocha.vip@tmd.ac.jp	KUMAGAI, TAKASHI/GQP-1073-2022; Kumagai, Takashi/AGE-2182-2022; Tokiwaa, Toshihiro/B-4664-2015	Kumagai, Takashi/0000-0001-8371-513X; Tokiwaa, Toshihiro/0000-0003-1943-5146	Japan Society for Promotion of Science [25460513]; Ministry of Health, Labour and Welfare [2250502]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants 25460513 (Japan Society for Promotion of Science) and 2250502 (Ministry of Health, Labour and Welfare). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abollo E, 2003, INFECT GENET EVOL, V3, P175, DOI 10.1016/S1567-1348(03)00073-X; Arizono N, 2012, FOODBORNE PATHOG DIS, V9, P517, DOI 10.1089/fpd.2011.1076; Audicana MT, 2008, CLIN MICROBIOL REV, V21, P360, DOI 10.1128/CMR.00012-07; Cavallero S, 2011, PARASITOL RES, V108, P781, DOI 10.1007/s00436-010-2226-y; D'Amelio S, 2000, INT J PARASITOL, V30, P223, DOI 10.1016/S0020-7519(99)00178-2; Hochberg NS, 2010, CLIN INFECT DIS, V51, P806, DOI 10.1086/656238; Ito S, 1996, GUT, V39, P800, DOI 10.1136/gut.39.6.800; KAKIZOE S, 1995, AM J GASTROENTEROL, V90, P761; Kapral C, 2009, Z GASTROENTEROL, V47, P1059, DOI 10.1055/s-0028-1109468; Kojima F, 2012, CLIN PARASITOL, V23, P64; Lee Eun Jung, 2009, Korean J Gastroenterol, V53, P90; Caballero ML, 2013, INT ARCH ALLERGY IMM, V162, P39, DOI 10.1159/000351056; MAROTTA F, 1990, GUT, V31, P279, DOI 10.1136/gut.31.3.279; Martin-Sanchez J, 2005, MOL BIOCHEM PARASIT, V141, P155, DOI 10.1016/j.molbiopara.2005.02.005; Mattiucci S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-82; Mercado R, 1997, REV SAUDE PUBL, V31, P178, DOI 10.1590/S0034-89101997000200012; Murata R, 2011, PARASITOL INT, V60, P193, DOI 10.1016/j.parint.2011.02.008; Nawa Y, 2005, CLIN INFECT DIS, V41, P1297, DOI 10.1086/496920; Quiazon KMA, 2008, PARASITOL INT, V57, P483, DOI 10.1016/j.parint.2008.06.003; Quiazon KMA, 2011, PARASITOL INT, V60, P126, DOI 10.1016/j.parint.2010.11.007; Ramos L, 2005, CLIN GASTROENTEROL H, V3, P667, DOI 10.1016/S1542-3565(05)00363-0; Sohn Woon-Mok, 1994, Korean Journal of Parasitology, V32, P53, DOI 10.3347/kjp.1994.32.1.53; Suzuki J, 2010, INT J FOOD MICROBIOL, V137, P88, DOI 10.1016/j.ijfoodmicro.2009.10.001; Tachibana M, 1986, Nihon Shokakibyo Gakkai Zasshi, V83, P2132; Taranto Domenico, 2011, Dig Liver Dis, V43, pe5, DOI 10.1016/j.dld.2010.02.007; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ubeira FM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001214; Umehara A, 2007, PARASITOL INT, V56, P211, DOI 10.1016/j.parint.2007.02.005; Umehara A, 2006, PARASITOL INT, V55, P267, DOI 10.1016/j.parint.2006.07.001; Yagi K, 2005, J GASTROENTEROL, V40, P443, DOI 10.1007/s00535-005-1605-0	30	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89188	10.1371/journal.pone.0089188	http://dx.doi.org/10.1371/journal.pone.0089188			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586583	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200041
J	DuVal, MG; Gilbert, MJH; Watson, DE; Zerulla, TC; Tierney, KB; Allison, WT				DuVal, Michele G.; Gilbert, Matthew J. H.; Watson, D. Ezekiel; Zerulla, Tanja C.; Tierney, Keith B.; Allison, W. Ted			Growth Differentiation Factor 6 As a Putative Risk Factor in Neuromuscular Degeneration	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; REGULATES SYNAPTIC GROWTH; BMP HOMOLOG GBB; MOTOR-NEURON; TGF-BETA; NEUROPROTECTIVE EFFICACY; AMINOPROPYL CARBAZOLES; SWIMMING PERFORMANCE; GENE-EXPRESSION; MUTANT SOD1	Mutation of Glass bottom boat, the Drosophila homologue of the bone morphogenetic protein or growth/differentiation factor (BMP/GDF) family of genes in vertebrates, has been shown to disrupt development of neuromuscular junctions (NMJ). Here we tested whether this same conclusion can be broadened to vertebrate BMP/GDF genes. This analysis was also extended to consider whether such genes are required for NMJ maintenance in post-larval stages, as this would argue that BMP genes are viable candidates for analysis in progressive neuromuscular disease. Zebrafish mutants harboring homozygous null mutations in the BMP-family gene gdf6a were raised to adulthood and assessed for neuromuscular deficits. Fish lacking gdf6a exhibited decreased endurance (similar to 50%, p = 0.005) compared to wild type, and this deficit progressively worsened with age. These fish also presented with significantly disrupted NMJ morphology (p = 0.009), and a lower abundance of spinal motor neurons (similar to 50%, p<0.001) compared to wild type. Noting the similarity of these symptoms to those of Amyotrophic Lateral Sclerosis (ALS) model mice and fish, we asked if mutations in gdf6a would enhance the phenotypes observed in the latter, i.e. in zebrafish over-expressing mutant Superoxide Dismutase 1 (SOD1). Amongst younger adult fish only bigenic fish harboring both the SOD1 transgene and gdf6a mutations, but not siblings with other combinations of these gene modifications, displayed significantly reduced endurance (75%, p<0.05) and strength/power (75%, p<0.05), as well as disrupted NMJ morphology (p<0.001) compared to wild type siblings. Bigenic fish also had lower survival rates compared to other genotypes. Thus conclusions regarding a role for BMP ligands in effecting NMJ can be extended to vertebrates, supporting conservation of mechanisms relevant to neuromuscular degenerative diseases. These conclusions synergize with past findings to argue for further analysis of GDF6 and other BMP genes as modifier loci, potentially affecting susceptibility to ALS and perhaps a broader suite of neurodegenerative diseases.	[DuVal, Michele G.; Gilbert, Matthew J. H.; Watson, D. Ezekiel; Zerulla, Tanja C.; Tierney, Keith B.; Allison, W. Ted] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Watson, D. Ezekiel; Allison, W. Ted] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Allison, WT (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ted.allison@ualberta.ca	Allison, W. Ted/K-5228-2012; Zerulla, Tanja/AAO-2514-2021; Allison, W. Ted/A-2612-2014; Tierney, Keith/H-8338-2012	Allison, W. Ted/0000-0002-8461-4864; DuVal, Michele/0000-0001-6975-8117; Zerulla, Tanja/0000-0003-1341-4213; Tierney, Keith/0000-0002-8342-3783; Gilbert, Matthew/0000-0001-8000-7568	Natural Sciences and Engineering Research Council of Canada; Alberta Prion Research Institute; Canadian Institutes of Health Research; Canadian Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Prion Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	The work was supported by the Natural Sciences and Engineering Research Council of Canada [Operating funds to WTA and KBT], Alberta Prion Research Institute [Operating funds to WTA] and the Canadian Institutes of Health Research [studentship to MGD]. Infrastructure was funded in part by the Canadian Foundation for Innovation [to WTA and KBT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Allison WT, 2004, VISUAL NEUROSCI, V21, P945, DOI 10.1017/S0952523804216145; Asai-Coakwell M, 2007, AM J HUM GENET, V80, P306, DOI 10.1086/511280; Asai-Coakwell M, 2013, HUM MOL GENET, V22, P1432, DOI 10.1093/hmg/dds560; Asai-Coakwell M, 2009, HUM MOL GENET, V18, P1110, DOI 10.1093/hmg/ddp008; Baines RA, 2004, J NEUROSCI, V24, P6904, DOI 10.1523/JNEUROSCI.1978-04.2004; Banyai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010758; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Chang CB, 1999, DEVELOPMENT, V126, P3347; Chou HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058441; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; DEININGER M, 1995, ACTA NEUROPATHOL, V90, P76; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Farrell AP, 2008, J FISH BIOL, V72, P693, DOI 10.1111/j.1095-8649.2007.01759.x; Fassier C, 2010, NAT NEUROSCI, V13, P1380, DOI 10.1038/nn.2662; Feng Z, 2008, J NEUROSCI, V28, P9599, DOI 10.1523/JNEUROSCI.2589-08.2008; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Fraser B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055410; French CR, 2009, DEV BIOL, V333, P37, DOI 10.1016/j.ydbio.2009.06.018; Galbiati M, 2012, PHARMACOL RES, V65, P221, DOI 10.1016/j.phrs.2011.12.001; Gilbert MJH, 2014, EXP GERONTOL, V50, P106, DOI 10.1016/j.exger.2013.11.013; Gosse NJ, 2009, P NATL ACAD SCI USA, V106, P2236, DOI 10.1073/pnas.0803202106; Graff JM, 1997, CELL, V89, P171, DOI 10.1016/S0092-8674(00)80196-8; Hashimoto Y, 2005, MOL CELL BIOL, V25, P9304, DOI 10.1128/MCB.25.21.9304-9317.2005; Henriquez JP, 2011, INT J MOL SCI, V12, P8924, DOI 10.3390/ijms12128924; Hewamadduma CAA, 2013, HUM MOL GENET, V22, P2376, DOI 10.1093/hmg/ddt082; Hurley FM, 2004, EXP NEUROL, V185, P281, DOI 10.1016/j.expneurol.2003.10.003; James RE, 2011, DEVELOPMENT, V138, P3273, DOI 10.1242/dev.066142; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kahlem P, 2009, DEVELOPMENT, V136, P3729, DOI 10.1242/dev.030320; Kaiser DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051305; Katsuno M, 2011, Curr Mol Med, V11, P48, DOI 10.2174/156652411794474356; Krieglstein K, 2002, J PHYSIOLOGY-PARIS, V96, P25, DOI 10.1016/S0928-4257(01)00077-8; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Lemmens R, 2007, HUM MOL GENET, V16, P2359, DOI 10.1093/hmg/ddm193; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McClelland GB, 2006, J PHYSIOL-LONDON, V577, P739, DOI 10.1113/jphysiol.2006.119032; McGown A, 2013, ANN NEUROL, V73, P246, DOI 10.1002/ana.23780; Metz GAS, 2000, BRAIN RES, V883, P165, DOI 10.1016/S0006-8993(00)02778-5; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nakamura M, 2012, NEUROPATHOL APPL NEU; Nakamura M, 2008, ACTA NEUROPATHOL, V115, P327, DOI 10.1007/s00401-007-0337-z; Nakamura M, 2013, NEURODEGENER DIS, V11, P182, DOI 10.1159/000338151; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; PERIDES G, 1995, NEUROSCI LETT, V187, P21, DOI 10.1016/0304-3940(95)11327-S; Plaut I, 2000, J EXP BIOL, V203, P813; Pokrishevsky E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035050; Ramesh T, 2010, DIS MODEL MECH, V3, P652, DOI 10.1242/dmm.005538; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; RISSI M, 1995, MECH DEVELOP, V49, P223, DOI 10.1016/0925-4773(94)00320-M; Ruschke K, 2012, CELL TISSUE RES, V347, P521, DOI 10.1007/s00441-011-1283-6; Sasagawa S, 2002, GENESIS, V33, P86, DOI 10.1002/gene.10095; Schmid B, 2013, P NATL ACAD SCI USA, V110, P4986, DOI 10.1073/pnas.1218311110; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Strelau J, 2009, J NEUROSCI, V29, P13640, DOI 10.1523/JNEUROSCI.1133-09.2009; Tassabehji M, 2008, HUM MUTAT, V29, P1017, DOI 10.1002/humu.20741; TAYLOR W R, 1985, Cybium, V9, P107; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; Tierney KB, 2011, JOVE-J VIS EXP, DOI 10.3791/2572; Tierney KB, 2011, BBA-MOL BASIS DIS, V1812, P381, DOI 10.1016/j.bbadis.2010.10.011; Vaccaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042117; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Vawter MP, 1996, EXP NEUROL, V142, P313, DOI 10.1006/exnr.1996.0200; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wyss-Coray T, 2000, ANN NY ACAD SCI, V903, P317, DOI 10.1111/j.1749-6632.2000.tb06382.x; Xiao L, 2013, NAT NEUROSCI, V16, P856, DOI 10.1038/nn.3414; Ye M, 2010, HUM MOL GENET, V19, P287, DOI 10.1093/hmg/ddp496; Zhang L, 2012, J BIOL CHEM, V287, P1520, DOI 10.1074/jbc.M111.275990	73	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89183	10.1371/journal.pone.0089183	http://dx.doi.org/10.1371/journal.pone.0089183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586579	Green Published, gold, Green Submitted			2022-12-27	WOS:000332396200040
J	Husain, S; Abdul, Y; Webster, C; Chatterjee, S; Kesarwani, P; Mehrotra, S				Husain, Shahid; Abdul, Yasir; Webster, Christine; Chatterjee, Shilpak; Kesarwani, Pravin; Mehrotra, Shikhar			Interferon-Gamma (IFN-gamma)-Mediated Retinal Ganglion Cell Death in Human Tyrosinase T Cell Receptor Transgenic Mouse	PLOS ONE			English	Article							OPTIC-NERVE HEAD; HYPERTENSIVE-RAT MODEL; NECROSIS-FACTOR-ALPHA; OPEN-ANGLE GLAUCOMA; INFLAMMATORY CYTOKINES; NEOVASCULAR GLAUCOMA; AQUEOUS-HUMOR; DIABETIC-RATS; MECHANISMS; AUTOIMMUNITY	We have recently demonstrated the characterization of human tyrosinase TCR bearing h3T-A2 transgenic mouse model, which exhibits spontaneous autoimmune vitiligo and retinal dysfunction. The purpose of current study was to determine the role of T cells and IFN-gamma in retina dysfunction and retinal ganglion cell (RGC) death using this model. RGC function was measured by pattern electroretinograms (ERGs) in response to contrast reversal of patterned visual stimuli. RGCs were visualized by fluorogold retrograde-labeling. Expression of CD3, IFN-gamma, GFAP, and caspases was measured by immunohistochemistry and Western blotting. All functional and structural changes were measured in 12-month-old h3-TA2 mice and compared with age-matched HLA-A2 wild-type mice. Both pattern-ERGs (42%, p = 0.03) and RGC numbers (37%, p = 0.0001) were reduced in h3T-A2 mice when compared with wild-type mice. The level of CD3 expression was increased in h3T-A2 mice (h3T-A2: 174 +/- 27% vs. HLA-A2: 100%; p = 0.04). The levels of effector cytokine IFN-gamma were also increased significantly in h3T-A2 mice (h3T-A2: 189 +/- 11% vs. HLA-A2: 100%; p = 0.023). Both CD3 and IFN-gamma immunostaining were increased in nerve fiber (NF) and RGC layers of h3T-A2 mice. In addition, we have seen a robust increase in GFAP staining in h3T-A2 mice (mainly localized to NF layer), which was substantially reduced in IFN-gamma((-/-)) knockout h3T-A2 mice. We also have seen an up-regulation of caspase-3 and -9 in h3T-A2 mice. Based on our data we conclude that h3T-A2 transgenic mice exhibit visual defects that are mostly associated with the inner retinal layers and RGC function. This novel h3T-A2 transgenic mouse model provides opportunity to understand RGC pathology and test neuroprotective strategies to rescue RGCs.	[Husain, Shahid; Abdul, Yasir] Med Univ S Carolina, Dept Ophthalmol, Storm Eye Inst, Hewitt Lab,Ola B Williams Glaucoma Ctr, Charleston, SC 29425 USA; [Webster, Christine; Chatterjee, Shilpak; Kesarwani, Pravin; Mehrotra, Shikhar] Med Univ S Carolina, Dept Surg, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Husain, S (corresponding author), Med Univ S Carolina, Dept Ophthalmol, Storm Eye Inst, Hewitt Lab,Ola B Williams Glaucoma Ctr, 171 Ashley Ave, Charleston, SC 29425 USA.	Husain@musc.edu		Kesarwani, Pravin/0000-0002-9095-1568; Abdul, Yasir/0000-0002-4973-1918	National Institutes of Health/National Eye Institute (NIH/NEI) [EY019081, R21AR056524, R01AR057643, PO1CA154778]; Research to Prevent Blindness, New York, NY; NATIONAL CANCER INSTITUTE [P01CA154778] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056524, R01AR057643] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute (NIH/NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health/National Eye Institute (NIH/NEI) grant EY019081 (SH), R21AR056524, R01AR057643, and PO1CA154778 (SM) and an unrestricted grant to MUSC-SEI from Research to Prevent Blindness, New York, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 2008, INVEST OPHTH VIS SCI, V49, P5581, DOI 10.1167/iovs.07-1032; Abdul Y, 2013, INVEST OPHTH VIS SCI, V54, P1816, DOI 10.1167/iovs.12-10741; Aizu Y, 2002, NEUROPATHOLOGY, V22, P161, DOI 10.1046/j.1440-1789.2002.00439.x; Albert ML, 2000, ANN NEUROL, V47, P9; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; AYAKI M, 1994, BRIT J OPHTHALMOL, V78, P238, DOI 10.1136/bjo.78.3.238-a; Bajaire BJ, 2011, CASE REP OPHTHALM, V2, P23, DOI 10.1159/000323942; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Chatterjee S, 2013, J INVEST DE IN PRESS; Chua J, 2012, MOL VIS, V18, P431; COUSINS SW, 1991, INVEST OPHTH VIS SCI, V32, P2201; Egwuagu CE, 1999, CLIN IMMUNOL, V91, P196, DOI 10.1006/clim.1999.4701; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Gargiulo A, 2009, MOL THER, V17, P1347, DOI 10.1038/mt.2009.112; Gregg RK, 2010, J IMMUNOL, V184, P1909, DOI 10.4049/jimmunol.0902778; Grus FH, 2008, J GLAUCOMA, V17, P79, DOI 10.1097/IJG.0b013e318156a592; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Hernandez MR, 1997, ARCH OPHTHALMOL-CHIC, V115, P389, DOI 10.1001/archopht.1997.01100150391013; Holder GE, 2001, PROG RETIN EYE RES, V20, P531, DOI 10.1016/S1350-9462(00)00030-6; Huang Ping, 2009, J Ocul Biol Dis Infor, V2, P78; Husain S, 2012, INVEST OPHTH VIS SCI, V53, P4289, DOI 10.1167/iovs.12-9467; Husain S, 2011, INVEST OPHTH VIS SCI, V52, P2577, DOI 10.1167/iovs.10-5629; Husain S, 2009, INVEST OPHTH VIS SCI, V50, P3853, DOI 10.1167/iovs.08-2907; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; Jung KI, 2013, J PHARMACOL EXP THER, V345, P457, DOI 10.1124/jpet.113.203067; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Kwon YS, 2001, YONSEI MED J, V42, P134, DOI 10.3349/ymj.2001.42.1.134; Li Y, 1997, J IMMUNOL, V158, P1428; Malvitte L, 2007, BRIT J OPHTHALMOL, V91, P29, DOI 10.1136/bjo.2006.101485; Mashiah J, 2008, CLIN EXP DERMATOL, V33, P74, DOI 10.1111/j.1365-2230.2007.02520.x; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; Mehrotra S, 2012, J IMMUNOL, V189, P1627, DOI 10.4049/jimmunol.1103271; MORRISON JC, 1990, ARCH OPHTHALMOL-CHIC, V108, P1020, DOI 10.1001/archopht.1990.01070090122053; Nguyen SM, 2003, ANTIOXID REDOX SIGN, V5, P629, DOI 10.1089/152308603770310293; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Nishimura MI, 1999, CANCER RES, V59, P6230; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Qu J, 2010, EXP EYE RES, V91, P48, DOI 10.1016/j.exer.2010.04.002; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Rachitskaya AV, 2012, EUR J OPHTHALMOL, V22, P284, DOI 10.5301/ejo.5000037; SIMA AAF, 1992, DIABETOLOGIA, V35, P602, DOI 10.1007/BF00400249; Son JL, 2010, GLIA, V58, P780, DOI 10.1002/glia.20962; Tezel G, 2000, J NEUROSCI, V20, P8693; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tezel Gulgun, 2004, Curr Opin Ophthalmol, V15, P80, DOI 10.1097/00055735-200404000-00003; Tura A, 2009, INVEST OPHTH VIS SCI, V50, P452, DOI 10.1167/iovs.08-1973; van den Boorn JG, 2009, J INVEST DERMATOL, V129, P2220, DOI 10.1038/jid.2009.32; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Wax MB, 2011, EXP EYE RES, V93, P187, DOI 10.1016/j.exer.2010.08.016; Wax MB, 2009, EXP EYE RES, V88, P825, DOI 10.1016/j.exer.2009.02.005; Yang JJ, 2001, AM J OPHTHALMOL, V131, P421, DOI 10.1016/S0002-9394(00)00862-X; Yang XJ, 2011, INVEST OPHTH VIS SCI, V52, P8442, DOI 10.1167/iovs.11-8152; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V	59	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89392	10.1371/journal.pone.0089392	http://dx.doi.org/10.1371/journal.pone.0089392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586745	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200051
J	Okabe, S; Tauchi, T; Kimura, S; Maekawa, T; Kitahara, T; Tanaka, Y; Ohyashiki, K				Okabe, Seiichi; Tauchi, Tetsuzo; Kimura, Shinya; Maekawa, Taira; Kitahara, Toshihiko; Tanaka, Yoko; Ohyashiki, Kazuma			Combining the ABL1 Kinase Inhibitor Ponatinib and the Histone Deacetylase Inhibitor Vorinostat: A Potential Treatment for BCR-ABL-Positive Leukemia	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; DEPSIPEPTIDE; CELLS; FK228; HDAC	Resistance to imatinib (Gleevec(R)) in cancer cells is frequently because of acquired point mutations in the kinase domain of BCR-ABL. Ponatinib, also known as AP24534, is an oral multi-targeted tyrosine kinase inhibitor (TKI), and it has been investigated in a pivotal phase 2 clinical trial. The histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid) has been evaluated for its significant clinical activity in hematological malignancies. Thus, treatments combining ABL TKIs with additional drugs may be a promising strategy in the treatment of leukemia. In the current study, we analyzed the efficacy of ponatinib and vorinostat treatment by using BCR-ABL-positive cell lines. Treatment with ponatinib for 72 h inhibited cell growth and induced apoptosis in K562 cells in a dose-dependent manner. We found that ponatinib potently inhibited the growth of Ba/F3 cells ectopically expressing BCR-ABL T315I mutation. Upon BCR-ABL phosphorylation, Crk-L was decreased, and poly (ADP-ribose) polymerase (PARP) was activated in a dose-dependent manner. Combined treatment of Ba/F3 T315I mutant cells with vorinostat and ponatinib resulted in significantly increased cytotoxicity. Additionally, the intracellular signaling of ponatinib and vorinostat was examined. Caspase 3 and PARP activation increased after combination treatment with ponatinib and vorinostat. Moreover, an increase in the phosphorylation levels of cH2A. X was observed. Previously established ponatinib-resistant Ba/F3 cells were also resistant to imatinib, nilotinib, and dasatinib. We investigated the difference in the efficacy of ponatinib and vorinostat by using ponatinib-resistant Ba/F3 cells. Combined treatment of ponatinib-resistant cells with ponatinib and vorinostat caused a significant increase in cytotoxicity. Thus, combined administration of ponatinib and vorinostat may be a powerful strategy against BCR-ABL mutant cells and could enhance the cytotoxic effects of ponatinib in those BCR-ABL mutant cells.	[Okabe, Seiichi; Tauchi, Tetsuzo; Kitahara, Toshihiko; Tanaka, Yoko; Ohyashiki, Kazuma] Tokyo Med Univ, Dept Internal Med 1, Tokyo 1608402, Japan; [Kimura, Shinya] Saga Univ, Fac Med, Div Hematol Resp Med & Oncol, Dept Internal Med, Saga 840, Japan; [Maekawa, Taira] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan	Tokyo Medical University; Saga University; Kyoto University	Okabe, S (corresponding author), Tokyo Med Univ, Dept Internal Med 1, Tokyo 1608402, Japan.	okabe@tokyo-med.ac.jp			"High-Tech Research Center" Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); "University-Industry Joint Research Project" from the MEXT; MEXT; Grants-in-Aid for Scientific Research [25461425] Funding Source: KAKEN	"High-Tech Research Center" Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); "University-Industry Joint Research Project" from the MEXT; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a "High-Tech Research Center" Project for private universities-a matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-and by the "University-Industry Joint Research Project" for private universities-a matching fund subsidy from the MEXT. This work was also supported by Grants-in-Aid for Scientific Research from the MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Hoover RR, 2001, ONCOGENE, V20, P5826, DOI 10.1038/sj.onc.1204549; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Jabbour E, 2011, CANCER-AM CANCER SOC, V117, P1800, DOI 10.1002/cncr.25717; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian HM, 2006, ANN INTERN MED, V145, P913, DOI 10.7326/0003-4819-145-12-200612190-00008; Kimura S, 2005, BLOOD, V106, P3948, DOI 10.1182/blood-2005-06-2209; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Okabe S, 2007, STEM CELLS DEV, V16, P503, DOI 10.1089/scd.2007.9994; Okabe S, 2013, BLOOD, V122, P3086, DOI 10.1182/blood-2013-04-494773; Okabe S, 2013, BIOCHEM BIOPH RES CO, V435, P506, DOI 10.1016/j.bbrc.2013.05.022; Okabe S, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-32; Okabe S, 2010, ANN HEMATOL, V89, P1081, DOI 10.1007/s00277-010-0998-x; Pemmaraju N, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.2845.2845; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Santos FPS, 2011, CANCER J, V17, P465, DOI 10.1097/PPO.0b013e31823dec8d; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; Selvi B. Ruthrotha, 2009, Biotechnology Journal, V4, P375, DOI 10.1002/biot.200900032; Shah NP, 2013, BRIT J HAEMATOL, V162, P548, DOI 10.1111/bjh.12382; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; VanderMolen KM, 2011, J ANTIBIOT, V64, P525, DOI 10.1038/ja.2011.35; Wilson AJ, 2011, CANCER BIOL THER, V12, P484, DOI 10.4161/cbt.12.6.15956; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644	26	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89080	10.1371/journal.pone.0089080	http://dx.doi.org/10.1371/journal.pone.0089080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586514	gold, Green Submitted, Green Published			2022-12-27	WOS:000332396200034
J	Cozzoli, F; Eelkema, M; Bouma, TJ; Ysebaert, T; Escaravage, V; Herman, PMJ				Cozzoli, Francesco; Eelkema, Menno; Bouma, Tjeerd J.; Ysebaert, Tom; Escaravage, Vincent; Herman, Peter M. J.			A Mixed Modeling Approach to Predict the Effect of Environmental Modification on Species Distributions	PLOS ONE			English	Article							COCKLES CERASTODERMA-EDULE; QUANTILE REGRESSION; LANICE-CONCHILEGA; BODY-SIZE; SEDIMENT TRANSPORT; ABUNDANCE; OOSTERSCHELDE; CHALLENGES; ORGANISMS; RESPONSES	Human infrastructures can modify ecosystems, thereby affecting the occurrence and spatial distribution of organisms, as well as ecosystem functionality. Sustainable development requires the ability to predict responses of species to anthropogenic pressures. We investigated the large scale, long term effect of important human alterations of benthic habitats with an integrated approach combining engineering and ecological modelling. We focused our analysis on the Oosterschelde basin (The Netherlands), which was partially embanked by a storm surge barrier (Oosterscheldekering, 1986). We made use of 1) a prognostic (numerical) environmental (hydrodynamic) model and 2) a novel application of quantile regression to Species Distribution Modeling (SDM) to simulate both the realized and potential (habitat suitability) abundance of four macrozoobenthic species: Scoloplos armiger, Peringia ulvae, Cerastoderma edule and Lanice conchilega. The analysis shows that part of the fluctuations in macrozoobenthic biomass stocks during the last decades is related to the effect of the coastal defense infrastructures on the basin morphology and hydrodynamics. The methodological framework we propose is particularly suitable for the analysis of large abundance datasets combined with high-resolution environmental data. Our analysis provides useful information on future changes in ecosystem functionality induced by human activities.	[Cozzoli, Francesco; Bouma, Tjeerd J.; Ysebaert, Tom; Herman, Peter M. J.] Netherlands Inst Sea Res, Spatial Ecol Dept, Yerseke, Netherlands; [Eelkema, Menno] Delft Univ Technol, Dept Hydraul Engn, Delft, Netherlands; [Ysebaert, Tom] Wageningen Univ, Inst Marine Resources & Ecosyst Studies, Yerseke, Netherlands; [Escaravage, Vincent] Netherlands Inst Sea Res, Yerseke, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Delft University of Technology; Wageningen University & Research; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Cozzoli, F (corresponding author), Netherlands Inst Sea Res, Spatial Ecol Dept, Yerseke, Netherlands.	francesco.cozzoli@nioz.nl	Herman, Peter M.J./A-9018-2011; Cozzoli, Francesco/K-1273-2019; Bouma, Tjeerd J/A-9841-2011	Herman, Peter M.J./0000-0003-2188-6341; Cozzoli, Francesco/0000-0002-6413-0977; Bouma, Tjeerd/0000-0001-7824-7546	Ecoshape/Building with Nature project; Rijkswaterstaat (Dutch Ministry of Infrastructure and the Environment)	Ecoshape/Building with Nature project; Rijkswaterstaat (Dutch Ministry of Infrastructure and the Environment)	This work was mainly funded by the Ecoshape/Building with Nature project. The NIOZ Monitor Taskforce was, for a large part, responsible for the fieldwork and the taxonomic analysis of the macrofauna samples. Rijkswaterstaat (executive body of the Dutch Ministry of Infrastructure and the Environment) was responsible for the funding of these activities in the framework of different national monitoring projects such as MWTL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JR, 1985, J COASTAL RES, V1, P231; Anderson MJ, 2008, J EXP MAR BIOL ECOL, V366, P16, DOI 10.1016/j.jembe.2008.07.006; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bijker WE, 2002, TECHNOL CULT, V43, P569, DOI 10.1353/tech.2002.0104; BLACKBURN TM, 1992, OIKOS, V65, P107, DOI 10.2307/3544892; BLACKBURN TM, 1993, J ANIM ECOL, V62, P519, DOI 10.2307/5201; Borja A, 2011, MAR POLLUT BULL, V62, P499, DOI 10.1016/j.marpolbul.2010.12.009; Borsje BW, 2008, ESTUAR COAST SHELF S, V78, P468, DOI 10.1016/j.ecss.2008.01.009; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Cade BS, 2005, ECOLOGY, V86, P786, DOI 10.1890/04-0785; CAREY DA, 1987, SEDIMENTOLOGY, V34, P49, DOI 10.1111/j.1365-3091.1987.tb00559.x; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Ciutat A, 2007, J EXP MAR BIOL ECOL, V346, P114, DOI 10.1016/j.jembe.2007.03.005; COOSEN J, 1994, HYDROBIOLOGIA, V283, P381; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cozzoli F, 2013, MAR ECOL PROG SER, V475, P119, DOI 10.3354/meps10112; De Vriend HJ, 1989, HYDRAULIC ENV MODELL, V14, P145; Degraer S, 2008, CONT SHELF RES, V28, P369, DOI 10.1016/j.csr.2007.09.001; Degraer S., 2006, BELGIAN SCI POLICY; DEVRIEND HJ, 1993, COAST ENG, V21, P193, DOI 10.1016/0378-3839(93)90050-I; Downes BJ, 2010, FRESHWATER BIOL, V55, P60, DOI 10.1111/j.1365-2427.2009.02377.x; Eelkema M, 2012, J COASTAL RES, V28, P1591, DOI 10.2112/JCOASTRES-D-11-00003.1; FENCHEL T, 1975, MAR BIOL, V30, P119, DOI 10.1007/BF00391586; Franklin J, 2009, MAPPING SPECIES DIST; Gray J.S., 1974, Oceanography mar Biol, V12, P223; Haas H, 2008, EFFECTEN ZOUT VOLKER; He F, 2007, AM NAT, V170, P655, DOI 10.1086/521340; Hijmans RJ, 2013, RASTER GEOGRAPHIC DA; Holtmann S, 1996, ATLAS ZOOBEN THOS DU; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jongeling T, 2007, TECHNICAL REPORT; Kamino LHY, 2012, BIOL LETTERS, V8, P324, DOI 10.1098/rsbl.2011.0942; Kater BJ, 2006, MAR ECOL PROG SER, V318, P221, DOI 10.3354/meps318221; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; KOENKER R., 2013, QUANTREG QUANTILE RE; Lesser GR, 2004, COAST ENG, V51, P883, DOI 10.1016/j.coastaleng.2004.07.014; Louters T, 1998, J COASTAL RES, V14, P1134; MARQUET PA, 1995, J ANIM ECOL, V64, P325, DOI 10.2307/5894; Matthews JH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001159; Montserrat F, 2008, MAR ECOL PROG SER, V372, P43, DOI 10.3354/meps07769; Orvain F, 2006, J SEA RES, V55, P54, DOI 10.1016/j.seares.2005.10.002; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; R Development Core Team, 2011, R LANG ENV STAT COMP; Rabaut M, 2007, ESTUAR COAST SHELF S, V75, P525, DOI 10.1016/j.ecss.2007.05.041; Rabaut M, 2009, HELGOLAND MAR RES, V63, P37, DOI 10.1007/s10152-008-0137-4; Ricciardi A, 1998, MARINE ECOLOGY PROGR, V163, P246; Schmidt TS, 2012, FRESHW SCI, V31, P709, DOI 10.1899/11-133.1; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Suykerbuyk W, 2012, ECOL APPL, V22, P1224, DOI 10.1890/11-1625.1; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Thomson JD, 1996, ECOLOGY, V77, P1698, DOI 10.2307/2265776; Thrush SF, 2005, MAR ECOL PROG SER, V302, P13, DOI 10.3354/meps302013; Thrush SF, 2003, MAR ECOL PROG SER, V263, P101, DOI 10.3354/meps263101; Ubertini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044155; VANDENBERG JH, 1982, GEOL MIJNBOUW, V61, P253; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Wenger SJ, 2008, ECOLOGY, V89, P2953, DOI 10.1890/07-1127.1; Wolff WJ, 1983, ECOSYSTEMS WORLD EST, P121; Ysebaert T, 2012, J SHELLFISH RES, V31, P362; Zuhlke R, 2001, J SEA RES, V46, P261, DOI 10.1016/S1385-1101(01)00091-0	64	19	19	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89131	10.1371/journal.pone.0089131	http://dx.doi.org/10.1371/journal.pone.0089131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586545	Green Published, Green Submitted, gold			2022-12-27	WOS:000332389000028
J	Saw, KG; Tneh, SS; Yam, FK; Ng, SS; Hassan, Z				Saw, Kim Guan; Sau Siong Tneh; Fong Kwong Yam; Sha Shiong Ng; Hassan, Zainuriah			Determination of Acceptor Concentration, Depletion Width, Donor Level Movement and Sensitivity Factor of ZnO on Diamond Heterojunction under UV Illumination	PLOS ONE			English	Article							FILMS; FABRICATION; NITRIDE; OXIDE	The concentration of acceptor carriers, depletion width, magnitude of donor level movement as well as the sensitivity factor are determined from the UV response of a heterojunction consisting of ZnO on type IIb diamond. From the comparison of the I-V measurements in dark condition and under UV illumination we show that the acceptor concentration (similar to 10(17) cm(-3)) can be estimated from p-n junction properties. The depletion width of the heterojunction is calculated and is shown to extend farther into the ZnO region in dark condition. Under UV illumination, the depletion width shrinks but penetrates both materials equally. The ultraviolet illumination causes the donor level to move closer to the conduction band by about 50 meV suggesting that band bending is reduced to allow more electrons to flow from the intrinsically n-type ZnO. The sensitivity factor of the device calculated from the change of threshold voltages, the ratio of dark and photocurrents and identity factor is consistent with experimental data.	[Saw, Kim Guan; Sau Siong Tneh; Fong Kwong Yam; Sha Shiong Ng; Hassan, Zainuriah] Univ Sains Malaysia, Nanooptoelect Res Lab, Minden, Penang, Malaysia	Universiti Sains Malaysia	Saw, KG (corresponding author), Univ Sains Malaysia, Nanooptoelect Res Lab, Minden, Penang, Malaysia.	kgsaw@usm.my	Ng, Sha Shiong/G-6189-2010; Ng, Sha Shiong/L-6879-2019; Hassan, Zainuriah/F-9100-2010	Ng, Sha Shiong/0000-0003-2023-6419; Ng, Sha Shiong/0000-0003-2023-6419; Hassan, Zainuriah/0000-0003-0403-8391; Saw, Kim Guan/0000-0002-9427-8884	Fundamental Research Grant Scheme [203/PJJAUH/6711290]	Fundamental Research Grant Scheme	This study was supported by Fundamental Research Grant Scheme 2013 No. 203/PJJAUH/6711290. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGER JW, 1995, APPL PHYS LETT, V66, P616, DOI 10.1063/1.114031; Barnes TM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1884747; Endo H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2715100; Fedison JB, 1998, APPL PHYS LETT, V72, P2841, DOI 10.1063/1.121475; Hikavyy A, 2007, DIAM RELAT MATER, V16, P983, DOI 10.1016/j.diamond.2006.11.035; Huang J, 2012, APPL SURF SCI, V258, P2010, DOI 10.1016/j.apsusc.2011.05.027; Kim J, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/11/115205; Kohn E, 2007, THIN SOLID FILMS, V515, P4333, DOI 10.1016/j.tsf.2006.07.179; Li QH, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1883711; Liang S, 2001, J CRYST GROWTH, V225, P110, DOI 10.1016/S0022-0248(01)00830-2; Luo L, 2006, SENSOR ACTUAT A-PHYS, V127, P201, DOI 10.1016/j.sna.2005.06.023; Mandalapu LJ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2178470; Mega T, 1996, SURF INTERFACE ANAL, V24, P375, DOI 10.1002/(SICI)1096-9918(199606)24:6<375::AID-SIA127>3.0.CO;2-T; Nebel CE, 2005, NEW DIAM FRONT C TEC, V15, P247; Ngo TH, 2011, MATER CHEM PHYS, V126, P54, DOI 10.1016/j.matchemphys.2010.12.012; Ohta H, 2003, THIN SOLID FILMS, V445, P317, DOI 10.1016/S0040-6090(03)01178-7; Sang DD, 2012, J APPL PHYS, V112, DOI 10.1063/1.4745039; Saw KG, 2010, PHYSICA B, V405, P4123, DOI 10.1016/j.physb.2010.06.064; Soci C, 2007, NANO LETT, V7, P1003, DOI 10.1021/nl070111x; Thonke K, 2003, SEMICOND SCI TECH, V18, pS20, DOI 10.1088/0268-1242/18/3/303; Wan Q, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2338660; Wang CX, 2004, CARBON, V42, P317, DOI 10.1016/j.carbon.2003.10.038; Ye JD, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2201895	23	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89348	10.1371/journal.pone.0089348	http://dx.doi.org/10.1371/journal.pone.0089348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586707	gold, Green Published, Green Submitted			2022-12-27	WOS:000332389000040
J	Cozza, G; Zanin, S; Determann, R; Ruzzene, M; Kunick, C; Pinna, LA				Cozza, Giorgio; Zanin, Sofia; Determann, Renate; Ruzzene, Maria; Kunick, Conrad; Pinna, Lorenzo A.			Synthesis and Properties of a Selective Inhibitor of Homeodomain-Interacting Protein Kinase 2 (HIPK2)	PLOS ONE			English	Article							APOPTOTIC RESPONSE; CATALYTIC-ACTIVITY; ACTIVATION-LOOP; CANCER-CELLS; DNA-DAMAGE; CK2; P53; PHOSPHORYLATION; UPDATE; SITE	Homeodomain-interacting protein kinase 2 (HIPK2) is a Ser/Thr kinase controlling cell proliferation and survival, whose investigation has been hampered by the lack of specific inhibitors able to dissect its cellular functions. SB203580, a p38 MAP kinase inhibitor, has been used as a tool to inhibit HIPK2 in cells, but here we show that its efficacy as HIPK2 inhibitor is negligible (IC50>40 mu M). In contrast by altering the scaffold of the promiscuous CK2 inhibitor TBI a new class of HIPK2 inhibitors has been generated. One of these, TBID, displays toward HIPK2 unprecedented efficacy (IC50 = 0.33 mu M) and selectivity (Gini coefficient 0.592 out of a panel of 76 kinases). The two other members of the HIPK family, HIPK1 and HIPK3, are also inhibited by TBID albeit less efficiently than HIPK2. The mode of action of TBID is competitive with respect to ATP, consistent with modelling. We also provide evidence that TBID is cell permeable by showing that HIPK2 activity is reduced in cells treated with TBID, although with an IC50 two orders of magnitude higher (about 50 mu M) than in vitro.	[Cozza, Giorgio; Zanin, Sofia; Ruzzene, Maria; Pinna, Lorenzo A.] Univ Padua, Dept Biomed Sci, Padua, Italy; [Cozza, Giorgio; Zanin, Sofia; Ruzzene, Maria; Pinna, Lorenzo A.] CNR, Inst Neurosci, Padua, Italy; [Determann, Renate; Kunick, Conrad] Tech Univ Carolo Wilhelmina Braunschweig, Inst Med & Pharmazeut Chem, D-38106 Braunschweig, Germany; [Ruzzene, Maria; Pinna, Lorenzo A.] VIMM, Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); Braunschweig University of Technology; Veneto Institute Molecular Medicine	Pinna, LA (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	lorenzo.pinna@unipd.it	ZANIN, SOFIA/AAJ-5529-2020; Zanin, Sofia/ABA-3509-2021	Kunick, Conrad/0000-0001-7041-5322; Pinna, Lorenzo A./0000-0002-8856-4956; Ruzzene, Maria/0000-0001-8712-8151; COZZA, GIORGIO/0000-0002-5155-4682; Zanin, Sofia/0000-0002-9421-8793	European Commission [LSHB-CT-2004-503467]; AIRC (Associazione Italian per la Ricerca sul Cancro) [IG10312]; Italian Miur (PRIN LAP)	European Commission(European CommissionEuropean Commission Joint Research Centre); AIRC (Associazione Italian per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Italian Miur (PRIN LAP)(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the European Commission (ProkinaseResearch, Contract LSHB-CT-2004-503467, to L.A.P. and C.K.), AIRC (Associazione Italian per la Ricerca sul Cancro) Project IG10312, Italian Miur (PRIN 2008, LAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2011, MOL CELL BIOCHEM, V356, P1, DOI 10.1007/s11010-011-0940-0; Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Battistutta R, 2001, PROTEIN SCI, V10, P2200, DOI 10.1110/ps.19601; Battistutta R, 2007, CHEMBIOCHEM, V8, P1804, DOI 10.1002/cbic.200700307; Brandt W, 2010, EUR J MED CHEM, V45, P2919, DOI 10.1016/j.ejmech.2010.03.017; Cozza G, 2008, BIOORG MED CHEM LETT, V18, P5672, DOI 10.1016/j.bmcl.2008.08.072; Cozza G, 2013, BBA-PROTEINS PROTEOM, V1834, P1402, DOI 10.1016/j.bbapap.2013.01.018; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; D'Orazi G, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-63; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Egert-Schmidt AM, 2010, J MED CHEM, V53, P2433, DOI 10.1021/jm901388c; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Graczyk PP, 2007, J MED CHEM, V50, P5773, DOI 10.1021/jm070562u; Hofmann TG, 2003, CANCER RES, V63, P8271; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1981, J BIOL CHEM, V256, P1958; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Pratt DS, 1918, J AM CHEM SOC, V40, P1415, DOI 10.1021/ja02242a008; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Ruzzene M, 2011, MOL CELL BIOCHEM, V356, P5, DOI 10.1007/s11010-011-0959-2; Ruzzene M, 2010, METHOD ENZYMOL, V484, P495, DOI [10.1016/S0076-6879(10)84024-8, 10.1016/B978-0-12-381298-8.00024-1]; Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018; Salvi M, 2009, BBA-MOL CELL RES, V1793, P847, DOI 10.1016/j.bbamcr.2009.01.013; Sarno S, 2011, CURR TOP MED CHEM, V11, P1340, DOI 10.2174/156802611795589638; Sarno S, 2012, CELL MOL LIFE SCI, V69, P449, DOI 10.1007/s00018-011-0758-7; Saul VV, 2013, J MOL CELL BIOL, V5, P27, DOI 10.1093/jmcb/mjs053; Siepi F, 2013, BBA-MOL CELL RES, V1833, P1443, DOI 10.1016/j.bbamcr.2013.02.018; Sombroek D, 2009, CELL DEATH DIFFER, V16, P187, DOI 10.1038/cdd.2008.154; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Yamada D, 2009, ONCOGENE, V28, P2535, DOI 10.1038/onc.2009.109; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Zanin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049193; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X	42	17	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89176	10.1371/journal.pone.0089176	http://dx.doi.org/10.1371/journal.pone.0089176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586573	gold, Green Submitted, Green Published			2022-12-27	WOS:000331880700020
J	Okada, T; Nitta, T; Kaji, K; Takashima, A; Oda, H; Tamehiro, N; Goto, M; Okamura, T; Patrick, MS; Suzuki, H				Okada, Toshiyuki; Nitta, Takeshi; Kaji, Kentaro; Takashima, Akiko; Oda, Hiroyo; Tamehiro, Norimasa; Goto, Motohito; Okamura, Tadashi; Patrick, Michael S.; Suzuki, Harumi			Differential Function of Themis CABIT Domains during T Cell Development	PLOS ONE			English	Article							THYMOCYTE DEVELOPMENT; POSITIVE SELECTION; TYROSINE KINASES; PROTEIN; GRB2; RAS; FAMILY; MICE	Themis (also named Gasp) is a newly identified Grb2-binding protein that is essential for thymocyte positive selection. Despite the possible involvement of Themis in TCR-mediated signal transduction, its function remains unresolved and controversial. Themis contains two functionally uncharacterized regions called CABIT (cysteine-containing, all-beta in Themis) domains, a nuclear localization signal (NLS), and a proline-rich sequence (PRS). To elucidate the role of these motifs in Themis's function in vivo, we established a series of mutant Themis transgenic mice on a Themis(-/-) background. Deletion of the highly conserved Core motif of CABIT1 or CABIT2 (Core1 or Core2, respectively), the NLS, or the PRS abolished Grb2-association, as well as TCR-dependent tyrosine-phosphorylation and the ability to induce positive selection in the thymus. The NLS and Core1 motifs were required for the nuclear localization of Themis, whereas Core2 and PRS were not. Furthermore, expression of Delta Core1- but not Delta Core2-Themis conferred dominant negative-type inhibition on T cell development. Collectively, our current results indicate that PRS, NLS, CABIT1, and CABIT2 are all required for positive selection, and that each of the CABIT domains exerts distinct functions during positive selection.	[Okada, Toshiyuki; Nitta, Takeshi; Kaji, Kentaro; Takashima, Akiko; Oda, Hiroyo; Tamehiro, Norimasa; Patrick, Michael S.; Suzuki, Harumi] Natl Ctr Global Hlth & Med, Res Inst, Dept Pathol & Immunol, Chiba, Japan; [Goto, Motohito; Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Lab Anim Med, Shinjuku Ku, Tokyo, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Shinjuku Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Suzuki, H (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Pathol & Immunol, Chiba, Japan.	hsuzuki@ri.ncgm.go.jp	Suzuki, Harumi/L-1271-2013	Suzuki, Harumi/0000-0003-3616-9361; yuan ren, hou teng/0000-0001-6288-4583	JSPS [22390098];  [21-111];  [22-303]; Grants-in-Aid for Scientific Research [24790491] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS Grant-in-Aid for Scientific Research (B) 22390098, and grant for National Center for Global Health and Medicine (21-111, 22-303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Chabod M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002461; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Jang IK, 2010, P NATL ACAD SCI USA, V107, P10620, DOI 10.1073/pnas.0905039107; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Kortum RL, 2012, MOL CELL BIOL, V32, P2748, DOI 10.1128/MCB.00317-12; Lesourne R, 2012, J IMMUNOL, V189, P1154, DOI 10.4049/jimmunol.1200123; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	18	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89115	10.1371/journal.pone.0089115	http://dx.doi.org/10.1371/journal.pone.0089115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586531	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900053
J	Umemura, M; Baljinnyam, E; Feske, S; De Lorenzo, MS; Xie, LH; Feng, XF; Oda, K; Makino, A; Fujita, T; Yokoyama, U; Iwatsubo, M; Chen, SZ; Goydos, JS; Ishikawa, Y; Iwatsubo, K				Umemura, Masanari; Baljinnyam, Erdene; Feske, Stefan; De Lorenzo, Mariana S.; Xie, Lai-Hua; Feng, Xianfeng; Oda, Kayoko; Makino, Ayako; Fujita, Takayuki; Yokoyama, Utako; Iwatsubo, Mizuka; Chen, Suzie; Goydos, James S.; Ishikawa, Yoshihiro; Iwatsubo, Kousaku			Store-Operated Ca2+ Entry (SOCE) Regulates Melanoma Proliferation and Cell Migration	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CALCIUM-ENTRY; ENDOPLASMIC-RETICULUM; HEPARAN-SULFATE; TRPC CHANNELS; CRAC CHANNEL; ACTIVATION; PATHWAY; KINASE; GROWTH	Store-operated Ca2+ entry (SOCE) is a major mechanism of Ca2+ import from extracellular to intracellular space, involving detection of Ca2+ store depletion in endoplasmic reticulum (ER) by stromal interaction molecule (STIM) proteins, which then translocate to plasma membrane and activate Orai Ca2+ channels there. We found that STIM1 and Orai1 isoforms were abundantly expressed in human melanoma tissues and multiple melanoma/melanocyte cell lines. We confirmed that these cell lines exhibited SOCE, which was inhibited by knockdown of STIM1 or Orai1, or by a pharmacological SOCE inhibitor. Inhibition of SOCE suppressed melanoma cell proliferation and migration/metastasis. Induction of SOCE was associated with activation of extracellular-signal-regulated kinase (ERK), and was inhibited by inhibitors of calmodulin kinase II (CaMKII) or Raf-1, suggesting that SOCE-mediated cellular functions are controlled via the CaMKII/Raf-1/ERK signaling pathway. Our findings indicate that SOCE contributes to melanoma progression, and therefore may be a new potential target for treatment of melanoma, irrespective of whether or not Braf mutation is present.	[Umemura, Masanari; Feng, Xianfeng; Oda, Kayoko; Makino, Ayako; Fujita, Takayuki; Yokoyama, Utako; Ishikawa, Yoshihiro; Iwatsubo, Kousaku] Yokohama City Univ, Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 232, Japan; [Baljinnyam, Erdene; De Lorenzo, Mariana S.; Xie, Lai-Hua; Iwatsubo, Mizuka; Iwatsubo, Kousaku] Rutgers State Univ, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07102 USA; [Feske, Stefan] NYU, Sch Med, Dept Pathol, New York, NY USA; [Chen, Suzie] Rutgers State Univ, Dept Biol Chem, Susan Lehman Cullen Lab, Canc Res Ernest Mario Sch Pharm, Piscataway, NJ USA; [Goydos, James S.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Surg, Div Surg Oncol, Piscataway, NJ 08854 USA	Yokohama City University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; New York University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Umemura, M (corresponding author), Yokohama City Univ, Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 232, Japan.	umemurma@yokohama-cu.ac.jp; iwatuko@njms.rutgers.edu	Yokoyama, Utako/AAD-1404-2022; Umemura, Masanari/D-3607-2018; Feske, stefan/ABB-3554-2021; Goydos, James/AAR-8990-2020	Yokoyama, Utako/0000-0003-1803-0155; Umemura, Masanari/0000-0002-1812-5720; Feske, stefan/0000-0001-5431-8178; Goydos, James/0000-0001-9811-939X; De Lorenzo, Mariana/0000-0002-7753-8138	American Heart Association [SDG 0835596D]; Foundation of UMDNJ; Melanoma Research Foundation; Japan Heart Foundation; Kanagawa Nanbyo Foundation; Ministry of Health, Labor and Welfare; Japanese Ministry of Education, Culture, Sports, Science, and Technology;  [22136009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097302] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25293236] Funding Source: KAKEN	American Heart Association(American Heart Association); Foundation of UMDNJ; Melanoma Research Foundation; Japan Heart Foundation; Kanagawa Nanbyo Foundation(Kanagawa Nanbyo Foundation); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the American Heart Association (SDG 0835596D) and by the Foundation of UMDNJ and by the Melanoma Research Foundation (K. Iwatsubo). This study was also supported by the Japan Heart Foundation and by the Kanagawa Nanbyo Foundation (M. Umemura). This study was supported in part by the Ministry of Health, Labor and Welfare, a Grant-in-Aid for Scientific Research on Innovative Areas (22136009), and the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Y. Ishikawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Baba Y, 2009, IMMUNOL REV, V231, P174, DOI 10.1111/j.1600-065X.2009.00813.x; Baljinnyam E, 2011, PIGM CELL MELANOMA R, V24, P680, DOI 10.1111/j.1755-148X.2011.00863.x; Baljinnyam E, 2010, CANCER RES, V70, P5607, DOI 10.1158/0008-5472.CAN-10-0056; Baljinnyam E, 2009, AM J PHYSIOL-CELL PH, V297, pC802, DOI 10.1152/ajpcell.00129.2009; Batchelder EL, 2011, P NATL ACAD SCI USA, V108, P11429, DOI 10.1073/pnas.1010481108; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen HL, 2010, J BIOL CHEM, V285, P2368, DOI 10.1074/jbc.M109.049379; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; DAYTON WR, 1976, BIOCHEMISTRY-US, V15, P2150, DOI 10.1021/bi00655a019; Di Capite J, 2009, IMMUNOL REV, V231, P45, DOI 10.1111/j.1600-065X.2009.00808.x; Fedida-Metula S, 2012, CARCINOGENESIS, V33, P740, DOI 10.1093/carcin/bgs021; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Hordijk PL, 2006, FEBS J, V273, P4408, DOI 10.1111/j.1742-4658.2006.05440.x; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Illario M, 2003, J BIOL CHEM, V278, P45101, DOI 10.1074/jbc.M305355200; Ishikawa J, 2003, J IMMUNOL, V170, P4441, DOI 10.4049/jimmunol.170.9.4441; Ivanov VN, 2005, ONCOGENE, V24, P616, DOI 10.1038/sj.onc.1208125; Iwatsubo K, 2004, J BIOL CHEM, V279, P40938, DOI 10.1074/jbc.M314238200; Mattheij NJA, 2013, J BIOL CHEM, V288, P13325, DOI 10.1074/jbc.M112.428359; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ogawa A, 2012, AM J PHYSIOL-CELL PH, V302, pC405, DOI 10.1152/ajpcell.00337.2011; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Ohashi K, 2011, J BIOL CHEM, V286, P36340, DOI 10.1074/jbc.M111.259135; Pirraco A, 2010, J CELL BIOCHEM, V111, P433, DOI 10.1002/jcb.22725; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Potter DA, 2003, J BIOL CHEM, V278, P30403, DOI 10.1074/jbc.M304616200; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Salzano M, 2012, CELL CYCLE, V11, P2100, DOI 10.4161/cc.20543; Sullivan RJ, 2010, EXPERT OPIN INV DRUG, V19, P1205, DOI 10.1517/13543784.2010.504709; Suyama E, 2004, J BIOL CHEM, V279, P38083, DOI 10.1074/jbc.C400313200; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; Wang JY, 2012, CELL SIGNAL, V24, P162, DOI 10.1016/j.cellsig.2011.08.017; Yang N, 2013, CANC LETT; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yokoyama U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036724; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	51	116	122	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89292	10.1371/journal.pone.0089292	http://dx.doi.org/10.1371/journal.pone.0089292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586666	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900079
J	Wu, SH; Lee, KL; Weng, RH; Zheng, ZX; Chiou, A; Wei, PK				Wu, Shu-Han; Lee, Kuang-Li; Weng, Ruei-Hung; Zheng, Zhao-Xian; Chiou, Arthur; Wei, Pei-Kuen			Dynamic Monitoring of Mechano-Sensing of Cells by Gold Nanoslit Surface Plasmon Resonance Sensor	PLOS ONE			English	Article							SHEAR-STRESS; MECHANOTRANSDUCTION; ADHESION; STRETCH; TRANSDUCTION; FIBROBLASTS; HOMEOSTASIS; ACTIVATION; INTEGRINS; KINASE	We demonstrated a real-time monitoring of live cells upon laminar shear stress stimulation via surface plasmon resonance (SPR) in gold nanoslit array. A large-area gold nanostructure consisted of 500-nm-period nanoslits was fabricated on a plastic film using the thermal-annealed template-stripping method. The SPR in the gold nanoslit array provides high surface sensitivity to monitor cell adhesion changes near the sensor surface. The human non-small cell lung cancer (CL1-0), human lung fibroblast (MRC-5), and human dermal fibroblast (Hs68) were cultured on the gold nanoslits and their dynamic responses to laminar shear stress were measured under different stress magnitudes from 0 to 30 dyne/cm(2). Cell adhesion was increased in CL1-0 under shear flow stimulation. No adhesion recovery was observed after stopping the flow. On the other hand, MRC-5 and Hs68 decreased adhesion and recovered from the shear stress. The degree of recovery was around 70% for MRC-5. This device provides dynamic study and early detection of cell adhesion changes under shear flow conditions.	[Wu, Shu-Han; Zheng, Zhao-Xian; Chiou, Arthur; Wei, Pei-Kuen] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Lee, Kuang-Li; Wei, Pei-Kuen] Acad Sinica, Res Ctr Appl Sci, Taipei 115, Taiwan; [Weng, Ruei-Hung] Natl Taiwan Ocean Univ, Dept Mech & Mechatron Engn, Keelung, Taiwan; [Chiou, Arthur; Wei, Pei-Kuen] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan Ocean University; National Yang Ming Chiao Tung University	Wei, PK (corresponding author), Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan.	pkwei@sinica.edu.tw	Stefanadis, Christodoulos/ABH-2232-2020; wei, pei-kuen/C-9885-2012	Stefanadis, Christodoulos/0000-0001-5974-6454; wei, pei-kuen/0000-0002-3002-0526	National Science Council, Taipei, Taiwan [NSC-99-2120-M-007-009, NSC-97-3112-B-001-022]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Taipei, Taiwan, under contract No. NSC-99-2120-M-007-009 and NSC-97-3112-B-001-022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Barkhausen T, 2003, EXP TOXICOL PATHOL, V55, P153, DOI 10.1078/0940-2993-00302; Chiu JJ, 1997, ARTERIOSCL THROM VAS, V17, P3570, DOI 10.1161/01.ATV.17.12.3570; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Clark CB, 2002, BIOCHEM BIOPH RES CO, V299, P258, DOI 10.1016/S0006-291X(02)02628-1; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; DAVIES PF, 1993, CIRC RES, V72, P239, DOI 10.1161/01.RES.72.2.239; DAVIES PF, 1994, J CLIN INVEST, V93, P2031, DOI 10.1172/JCI117197; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Eckes B, 2004, CLIN EXP RHEUMATOL, V22, pS73; Edwards YS, 2001, COMP BIOCHEM PHYS A, V129, P245, DOI 10.1016/S1095-6433(01)00321-X; Elder SH, 2000, J ORTHOPAED RES, V18, P78, DOI 10.1002/jor.1100180112; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; Ferko MC, 2007, ANN BIOMED ENG, V35, P208, DOI 10.1007/s10439-006-9223-4; Galbraith CG, 1998, CELL MOTIL CYTOSKEL, V40, P317, DOI 10.1002/(SICI)1097-0169(1998)40:4<317::AID-CM1>3.0.CO;2-8; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Goldmann WH, 2013, CELL BIOL INT, V37, P397, DOI 10.1002/cbin.10064; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hecht E, 2012, ANALYST, V137, P5208, DOI 10.1039/c2an36001b; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; Ingber DE, 1998, BIOL BULL-US, V194, P323, DOI 10.2307/1543102; Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7; KARIN M, 1992, FASEB J, V6, P2581, DOI 10.1096/fasebj.6.8.1317309; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Ko KS, 2001, J BIOL CHEM, V276, P35967, DOI 10.1074/jbc.M104106200; Lammerding J, 2004, ANN NY ACAD SCI, V1015, P53, DOI 10.1196/annals.1302.005; Lee KL, 2008, BIOSENS BIOELECTRON, V24, P210, DOI 10.1016/j.bios.2008.03.044; Lee KL, 2012, ACS NANO, V6, P2931, DOI 10.1021/nn3001142; Lee KL, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3628641; Lee KL, 2010, SMALL, V6, P1900, DOI 10.1002/smll.201000598; Lee KL, 2009, OPT EXPRESS, V17, P23104, DOI 10.1364/OE.17.023104; LEVESQUE MJ, 1990, BIOMATERIALS, V11, P702, DOI 10.1016/0142-9612(90)90031-K; Lopez-Tejeira F, 2007, NAT PHYS, V3, P324, DOI 10.1038/nphys584; Lu H, 2004, ANAL CHEM, V76, P5257, DOI 10.1021/ac049837t; Miroshnichenko AE, 2010, REV MOD PHYS, V82, P2257, DOI 10.1103/RevModPhys.82.2257; Mott RE, 2007, AM J PHYSIOL-CELL PH, V293, pC1616, DOI 10.1152/ajpcell.00457.2006; ORDAL MA, 1983, APPL OPTICS, V22, P1099, DOI 10.1364/AO.22.001099; Papaioannou Theodoros G, 2005, Hellenic J Cardiol, V46, P9; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Said G, 2012, CHEMOTHER RES PRACT, P1; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001; Stewart ME, 2008, CHEM REV, V108, P494, DOI 10.1021/cr068126n; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Tymchenko N, 2007, BIOPHYS J, V93, P335, DOI 10.1529/biophysj.106.093302; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wang JX, 2002, J BIOL CHEM, V277, P22889, DOI 10.1074/jbc.M203130200	49	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89522	10.1371/journal.pone.0089522	http://dx.doi.org/10.1371/journal.pone.0089522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586846	Green Published, gold, Green Submitted			2022-12-27	WOS:000331717900115
J	Amin, MM; Asaad, GF; Salam, RMA; El-Abhar, HS; Arbid, MS				Amin, Mohamed M.; Asaad, Gihan F.; Salam, Rania M. Abdel; El-Abhar, Hanan S.; Arbid, Mahmoud S.			Novel CoQ10 Antidiabetic Mechanisms Underlie Its Positive Effect: Modulation of Insulin and Adiponectine Receptors, Tyrosine Kinase, PI3K, Glucose Transporters, sRAGE and Visfatin in Insulin Resistant/Diabetic Rats	PLOS ONE			English	Article							ENDOGENOUS SECRETORY RAGE; BETA-CELL FUNCTION; COENZYME Q(10); SKELETAL-MUSCLE; MESSENGER-RNA; METABOLIC SYNDROME; OXIDATIVE STRESS; GLYCEMIC CONTROL; SOLUBLE RAGE; VISCERAL FAT	As a nutritional supplement, coenzyme Q10 (CoQ10) was tested previously in several models of diabetes and/or insulin resistance (IR); however, its exact mechanisms have not been profoundly explicated. Hence, the objective of this work is to verify some of the possible mechanisms that underlie its therapeutic efficacy. Moreover, the study aimed to assess the potential modulatory effect of CoQ10 on the antidiabetic action of glimebiride. An insulin resistance/type 2 diabetic model was adopted, in which rats were fed high fat/high fructose diet (HFFD) for 6 weeks followed by a single sub-diabetogenic dose of streptozotocin (35 mg/kg, i. p.). At the end of the 7 th week animals were treated with CoQ10 (20 mg/kg, p. o) and/or glimebiride (0.5 mg/kg, p. o) for 2 weeks. CoQ10 alone opposed the HFFD effect and increased the hepatic/muscular content/activity of tyrosine kinase (TK), phosphatidylinositol kinase (PI3K), and adiponectin receptors. Conversely, it decreased the content/activity of insulin receptor isoforms, myeloperoxidase and glucose transporters (GLUT4; 2). Besides, it lowered significantly the serum levels of glucose, insulin, fructosamine and HOMA index, improved the serum lipid panel and elevated the levels of glutathione, sRAGE and adiponectin. On the other hand, CoQ10 lowered the serum levels of malondialdehyde, visfatin, ALT and AST. Surprisingly, CoQ10 effect surpassed that of glimepiride in almost all the assessed parameters, except for glucose, fructosamine, TK, PI3K, and GLUT4. Combining CoQ10 with glimepiride enhanced the effect of the latter on the aforementioned parameters. Conclusion: These results provided a new insight into the possible mechanisms by which CoQ10 improves insulin sensitivity and adjusts type 2 diabetic disorder. These mechanisms involve modulation of insulin and adiponectin receptors, as well as TK, PI3K, glucose transporters, besides improving lipid profile, redox system, sRAGE, and adipocytokines. The study also points to the potential positive effect of CoQ10 as an adds-on to conventional antidiabetic therapies.	[Salam, Rania M. Abdel; El-Abhar, Hanan S.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Amin, Mohamed M.; Asaad, Gihan F.; Arbid, Mahmoud S.] Natl Res Ctr, Div Med, Dept Pharmacol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	El-Abhar, HS (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	Hanabhar@yahoo.com	El-Abhar, Hanan/L-2289-2019; Amin, Mohamed M./O-2396-2018; Asaad, Gihan/AAB-8649-2022	El-Abhar, Hanan/0000-0001-8819-9891; Amin, Mohamed M./0000-0002-3602-5555; Asaad, Gihan/0000-0002-7679-5968; Arbid, Mahmoud/0000-0002-6773-3650; , Gihan/0000-0002-8017-6668; Abd El Salam, Rania/0000-0003-4623-8754	NOAA Ocean Acidification Program, NOAA Pacific Marine Environmental Laboratory; University of Washington including the PRISM program; Washington State Department of Ecology; Hood Canal Dissolved Oxygen Program via Naval Sea Systems Command [N00024-02-D-6602 Task 50]; National Research Fellowship award; National Oceanic and Atmospheric Administration's Northwest Fisheries Science Center, Pacific Marine Environmental Laboratory, Ocean Acidification Program, and Integrated Ocean Observing System Program; University of Washington, including Northwest Association of Networked Ocean Observing Systems (NANOOS), Puget Sound Regional Synthesis Model (PRISM), Applied Physics Laboratory, and School of Oceanography	NOAA Ocean Acidification Program, NOAA Pacific Marine Environmental Laboratory; University of Washington including the PRISM program; Washington State Department of Ecology; Hood Canal Dissolved Oxygen Program via Naval Sea Systems Command; National Research Fellowship award; National Oceanic and Atmospheric Administration's Northwest Fisheries Science Center, Pacific Marine Environmental Laboratory, Ocean Acidification Program, and Integrated Ocean Observing System Program; University of Washington, including Northwest Association of Networked Ocean Observing Systems (NANOOS), Puget Sound Regional Synthesis Model (PRISM), Applied Physics Laboratory, and School of Oceanography	This research was supported by the NOAA Ocean Acidification Program, NOAA Pacific Marine Environmental Laboratory, the University of Washington including the PRISM program, and the Washington State Department of Ecology. Work in Hood Canal was partially funded through the Hood Canal Dissolved Oxygen Program via Naval Sea Systems Command Contract # N00024-02-D-6602 Task 50. J. C. P. R was supported by a National Research Fellowship award. This work was co-sponsored by the National Oceanic and Atmospheric Administration's Northwest Fisheries Science Center, Pacific Marine Environmental Laboratory, Ocean Acidification Program, and Integrated Ocean Observing System Program; the University of Washington, including Northwest Association of Networked Ocean Observing Systems (NANOOS), Puget Sound Regional Synthesis Model (PRISM), Applied Physics Laboratory, and School of Oceanography; and the Washington State Department of Ecology. Work in Hood Canal was partially funded through the Hood Canal Dissolved Oxygen Program via Naval Sea Systems Command Contract # N00024-02-D-6602 Task 50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadvand H, 2012, J DIABETES COMPLICAT, V26, P476, DOI 10.1016/j.jdiacomp.2012.06.004; Andersen CB, 1997, MOL ASPECTS MED, V18, pS307; Anderson JW, 1999, J AM COLL NUTR, V18, P451, DOI 10.1080/07315724.1999.10718883; Avramoglu RK, 2006, CLIN CHIM ACTA, V368, P1, DOI 10.1016/j.cca.2005.12.026; Baron AD, 1995, J CLIN INVEST, V96, P2792, DOI 10.1172/JCI118349; Bauerova K, 2010, ACTA BIOCHIM POL, V57, P347; Bemat-Karpinska M, 2012, ENDOKRYNOL POL, V63, P212; Bernsmeier C, 2009, SWISS MED WKLY, V139, P678, DOI smw-12765; Bhagavan HN, 2007, MITOCHONDRION, V7, pS78, DOI 10.1016/j.mito.2007.03.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURCELIN R, 1992, BIOCHEM J, V288, P675, DOI 10.1042/bj2880675; Chew GT, 2004, QJM-INT J MED, V97, P537, DOI 10.1093/qjmed/hch089; Choi H, 2013, STEM CELLS DEV, V22, P2112, DOI 10.1089/scd.2012.0604; CORIN RE, 1982, J BIOL CHEM, V257, P104; Crane FL, 2001, J AM COLL NUTR, V20, P591, DOI 10.1080/07315724.2001.10719063; Crescenzo R, 2012, OBESITY, V20, P1763, DOI 10.1038/oby.2011.167; Devangelio E, 2007, FREE RADICAL BIO MED, V43, P511, DOI 10.1016/j.freeradbiomed.2007.03.015; Dzugkoev SG, 2012, B EXP BIOL MED+, V152, P364, DOI 10.1007/s10517-012-1529-7; El-Abhar HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037757; El-Ghoroury EA, 2009, BLOOD COAGUL FIBRIN, V20, P248, DOI 10.1097/MBC.0b013e3283254549; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; Esposito E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-66; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Haider DG, 2006, DIABETOLOGIA, V49, P1909, DOI 10.1007/s00125-006-0303-7; Ho YJ, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-99; Hodgson JM, 2002, EUR J CLIN NUTR, V56, P1137, DOI 10.1038/sj.ejcn.1601464; Julius U, 2003, EXP CLIN ENDOCR DIAB, V111, P246, DOI 10.1055/s-2003-41284; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Keller KB, 2003, AM J CRIT CARE, V12, P167, DOI 10.4037/ajcc2003.12.2.167; KELLERER M, 1993, DIABETOLOGIA, V36, P628, DOI 10.1007/BF00404072; Kim SR, 2008, BBA-MOL CELL RES, V1783, P886, DOI 10.1016/j.bbamcr.2008.01.004; Koyama H, 2005, ARTERIOSCL THROM VAS, V25, P2587, DOI 10.1161/01.ATV.0000190660.32863.cd; Koyama H, 2007, BIOMARK INSIGHTS, V2, P331; Krauss H, 2004, MED SCI MONITOR, V10, pBR11; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Kruszynska YT, 2002, J CLIN ENDOCR METAB, V87, P226, DOI 10.1210/jc.87.1.226; Kunitomo M, 2008, J PHARMACOL SCI, V107, P128, DOI 10.1254/jphs.FP0072365; Lamson Davis W, 2002, Altern Med Rev, V7, P94; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Lee WJ, 2009, INT J OBESITY, V33, P465, DOI 10.1038/ijo.2009.24; Leguisamo NM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-100; Lu JY, 2008, J BIOMED SCI, V15, P565, DOI 10.1007/s11373-008-9261-z; Lu L, 2011, J ZHEJIANG UNIV-SC B, V12, P652, DOI 10.1631/jzus.B1101004; Ma P, 2011, ARCH ORAL BIOL, V56, P307, DOI 10.1016/j.archoralbio.2010.10.009; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarty MF, 1999, MED HYPOTHESES, V52, P397, DOI 10.1054/mehy.1997.0681; McClain DA, 2002, J DIABETES COMPLICAT, V16, P72, DOI 10.1016/S1056-8727(01)00188-X; Mezawa M, 2012, BIOFACTORS, V38, P416, DOI 10.1002/biof.1038; Milan G, 2002, OBES RES, V10, P1095, DOI 10.1038/oby.2002.149; Miller JL, 2011, AM J MED GENET A, V155A, P569, DOI 10.1002/ajmg.a.33887; Molyneux SL, 2008, J AM COLL CARDIOL, V52, P1435, DOI 10.1016/j.jacc.2008.07.044; Moore MC, 2000, J CLIN ENDOCR METAB, V85, P4515, DOI 10.1210/jc.85.12.4515; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; MOSTHAF L, 1991, P NATL ACAD SCI USA, V88, P4728, DOI 10.1073/pnas.88.11.4728; OKA Y, 1990, DIABETES, V39, P441, DOI 10.2337/diabetes.39.4.441; POSTIC C, 1993, BIOCHEM J, V293, P119, DOI 10.1042/bj2930119; Sbraccia P, 1996, DIABETOLOGIA, V39, P220, DOI 10.1007/BF00403966; Schaalan M, 2009, J DIABETES COMPLICAT, V23, P199, DOI 10.1016/j.jdiacomp.2008.02.003; Sena CM, 2008, NUTR RES, V28, P113, DOI 10.1016/j.nutres.2007.12.005; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sohet FM, 2009, BIOCHEM PHARMACOL, V78, P1391, DOI 10.1016/j.bcp.2009.07.008; Song HY, 2002, BIOCHEM BIOPH RES CO, V299, P291, DOI 10.1016/S0006-291X(02)02551-2; Sourris KC, 2012, FREE RADICAL BIO MED, V52, P716, DOI 10.1016/j.freeradbiomed.2011.11.017; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Tan KCB, 2011, DIABETES-METAB RES, V27, P488, DOI 10.1002/dmrr.1188; TASKINEN MR, 1986, DIABETES, V35, P1268, DOI 10.2337/diabetes.35.11.1268; Tsai KL, 2011, MOL NUTR FOOD RES, V55, pS227, DOI 10.1002/mnfr.201100147; Ueno M, 2000, BRAZ J MED BIOL RES, V33, P1421, DOI 10.1590/S0100-879X2000001200004; van de Weijer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051648; Villalba JM, 2010, EXPERT OPIN INV DRUG, V19, P535, DOI 10.1517/13543781003727495; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557	74	58	59	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89169	10.1371/journal.pone.0089169	http://dx.doi.org/10.1371/journal.pone.0089169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586567	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700068
J	Kubicek, C; de Boisferon, AH; Dupierrix, E; Pascalis, O; Loevenbruck, H; Gervain, J; Schwarzer, G				Kubicek, Claudia; de Boisferon, Anne Hillairet; Dupierrix, Eve; Pascalis, Olivier; Loevenbruck, Helene; Gervain, Judit; Schwarzer, Gudrun			Cross-Modal Matching of Audio-Visual German and French Fluent Speech in Infancy	PLOS ONE			English	Article							SPECIES INTERSENSORY PERCEPTION; 1ST YEAR; INTERMODAL REPRESENTATION; PHONETIC INFORMATION; SELECTIVE ATTENTION; REDUNDANCY GUIDES; FACE; VOICE; LIPS; INTEGRATION	The present study examined when and how the ability to cross-modally match audio-visual fluent speech develops in 4.5-, 6- and 12-month-old German-learning infants. In Experiment 1, 4.5- and 6-month-old infants' audio-visual matching ability of native (German) and non-native (French) fluent speech was assessed by presenting auditory and visual speech information sequentially, that is, in the absence of temporal synchrony cues. The results showed that 4.5-month-old infants were capable of matching native as well as non-native audio and visual speech stimuli, whereas 6-month-olds perceived the audio-visual correspondence of native language stimuli only. This suggests that intersensory matching narrows for fluent speech between 4.5 and 6 months of age. In Experiment 2, auditory and visual speech information was presented simultaneously, therefore, providing temporal synchrony cues. Here, 6-month-olds were found to match native as well as non-native speech indicating facilitation of temporal synchrony cues on the intersensory perception of non-native fluent speech. Intriguingly, despite the fact that audio and visual stimuli cohered temporally, 12-month-olds matched the non-native language only. Results were discussed with regard to multisensory perceptual narrowing during the first year of life.	[Kubicek, Claudia; Schwarzer, Gudrun] Univ Giessen, Dept Dev Psychol, D-35390 Giessen, Germany; [de Boisferon, Anne Hillairet; Dupierrix, Eve; Pascalis, Olivier; Loevenbruck, Helene] Univ Pierre Mendes France, CNRS UMR 5105, Lab Psychol & Neurocognit, Grenoble, France; [Loevenbruck, Helene] Univ Grenoble, CNRS UMR 5216, Speech & Cognit Dept GIPSA Lab, Grenoble, France; [Gervain, Judit] Univ Paris 05, Lab Psychol Percept, Sorbonne Paris Cite, Paris, France; [Gervain, Judit] CNRS UMR 8158, Lab Psychol Percept, Paris, France	Justus Liebig University Giessen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Kubicek, C (corresponding author), Univ Giessen, Dept Dev Psychol, D-35390 Giessen, Germany.	claudia.kubicek@psychol.uni-giessen.de	Hillairet de Boisferon, Anne/H-4655-2019	Hillairet de Boisferon, Anne/0000-0002-7304-6291; Gervain, Judit/0000-0002-2125-6369; pascalis, olivier/0000-0003-4609-3233	German Research Foundation [SCHW 665/11-1, ANR-10-FRAL-017]	German Research Foundation(German Research Foundation (DFG))	This study was supported through a grant from the German Research Foundation (www.dfg.de) for GS (SCHW 665/11-1) and ANR-10-FRAL-017 (www.agence-nationale-recherche.fr) for OP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge MA, 1999, DEVELOPMENTAL SCI, V2, P42, DOI 10.1111/1467-7687.00052; Bahrick LE, 2000, DEV PSYCHOL, V36, P190, DOI 10.1037//0012-1649.36.2.190; Bahrick LE, 2004, CURR DIR PSYCHOL SCI, V13, P99, DOI 10.1111/j.0963-7214.2004.00283.x; Baier R, 2007, 2 MONTHS OLDS SENSIT; Burnham D, 2004, DEV PSYCHOBIOL, V45, P204, DOI 10.1002/dev.20032; Cashon CH, 2004, J COGN DEV, V5, P59, DOI 10.1207/s15327647jcd0501_4; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; DODD B, 1979, COGNITIVE PSYCHOL, V11, P478, DOI 10.1016/0010-0285(79)90021-5; DODD B, 1988, VOLTA REV, V90, P45; Gervain J, 2010, ANNU REV PSYCHOL, V61, P191, DOI 10.1146/annurev.psych.093008.100408; Gogate LJ, 2001, INFANCY, V2, P219, DOI 10.1207/S15327078IN0202_7; Gogate LJ, 2000, CHILD DEV, V71, P878, DOI 10.1111/1467-8624.00197; Gogate LJ, 1998, J EXP CHILD PSYCHOL, V69, P133, DOI 10.1006/jecp.1998.2438; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kubicek C, 2013, INT J BEHAV DEV, V37, P106, DOI 10.1177/0165025412473016; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; KUHL PK, 1984, INFANT BEHAV DEV, V7, P361, DOI 10.1016/S0163-6383(84)80050-8; Kushnerenko E, 2008, P NATL ACAD SCI USA, V105, P11442, DOI 10.1073/pnas.0804275105; Lewkowicz D. J., 2004, HDB MULTISENSORY PRO, P655; Lewkowicz DJ, 2013, INT J BEHAV DEV, V37, P90, DOI 10.1177/0165025412467582; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Lewkowicz DJ, 2010, INFANCY, V15, P46, DOI 10.1111/j.1532-7078.2009.00005.x; Lewkowicz DJ, 2010, DEV PSYCHOL, V46, P66, DOI 10.1037/a0015579; Lewkowicz DJ, 2008, BRAIN RES, V1242, P291, DOI 10.1016/j.brainres.2008.03.084; Lewkowicz DJ, 2006, P NATL ACAD SCI USA, V103, P6771, DOI 10.1073/pnas.0602027103; MACKAIN K, 1983, SCIENCE, V219, P1347, DOI 10.1126/science.6828865; Maurer D, 2013, PERCEPTUAL NARROWING; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Munhall KG, 2004, PSYCHOL SCI, V15, P133, DOI 10.1111/j.0963-7214.2004.01502010.x; Oller D.K, 2000, EMERGENCE SPEECH CAP, DOI [10.4324/9781410602565, DOI 10.4324/9781410602565]; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Patterson ML, 1999, INFANT BEHAV DEV, V22, P237, DOI 10.1016/S0163-6383(99)00003-X; PICKENS J, 1994, INFANT BEHAV DEV, V17, P447, DOI 10.1016/0163-6383(94)90036-1; POLKA L, 1994, J EXP PSYCHOL HUMAN, V20, P421, DOI 10.1037/0096-1523.20.2.421; Pons F, 2009, P NATL ACAD SCI USA, V106, P10598, DOI 10.1073/pnas.0904134106; Rosenblum LD, 1997, PERCEPT PSYCHOPHYS, V59, P347, DOI 10.3758/BF03211902; Sai FZ, 2005, INFANT CHILD DEV, V14, P29, DOI 10.1002/icd.376; Schneirla T. C., 1965, P1; Schneirla T. C., 1957, CONCEPT DEV, P78; Scott LS, 2007, CURR DIR PSYCHOL SCI, V16, P197, DOI 10.1111/j.1467-8721.2007.00503.x; SPELKE ES, 1979, DEV PSYCHOL, V15, P626; Streri A, 2013, INT J BEHAV DEV, V37, P79, DOI 10.1177/0165025412465361; TURKEWITZ G, 1982, DEV PSYCHOBIOL, V15, P357, DOI 10.1002/dev.420150408; WALKER AS, 1982, J EXP CHILD PSYCHOL, V33, P514, DOI 10.1016/0022-0965(82)90063-7; WALKER-ANDREWS A S, 1991, Ecological Psychology, V3, P55, DOI 10.1207/s15326969eco0302_1; WALTON GE, 1993, INFANT BEHAV DEV, V16, P233, DOI 10.1016/0163-6383(93)80019-5; Weikum WM, 2007, SCIENCE, V316, P1159, DOI 10.1126/science.1137686; Werker J.F., 1995, INVITATION COGNITIVE, P87; Werker JF, 2004, J COGN DEV, V5, P147; Werker JF, 2012, CURR DIR PSYCHOL SCI, V21, P221, DOI 10.1177/0963721412449459; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3; Werker JF, 1999, ANNU REV PSYCHOL, V50, P509, DOI 10.1146/annurev.psych.50.1.509; Yehia H, 1998, SPEECH COMMUN, V26, P23, DOI 10.1016/S0167-6393(98)00048-X; Yeung HH, 2013, PSYCHOL SCI, V24, P603, DOI 10.1177/0956797612458802	58	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89275	10.1371/journal.pone.0089275	http://dx.doi.org/10.1371/journal.pone.0089275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586651	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700084
J	Karimi, MA; Lee, E; Bachmann, MH; Salicioni, AM; Behrens, EM; Kambayashi, T; Baldwin, CL				Karimi, Mobin A.; Lee, Eric; Bachmann, Michael H.; Salicioni, Ana Maria; Behrens, Edward M.; Kambayashi, Taku; Baldwin, Cynthia L.			Measuring Cytotoxicity by Bioluminescence Imaging Outperforms the Standard Chromium-51 Release Assay	PLOS ONE			English	Article							KILLER-CELLS; T-CELLS; PLATFORM; NKG2D	The chromium-release assay developed in 1968 is still the most commonly used method to measure cytotoxicity by T cells and by natural killer cells. Target cells are loaded in vitro with radioactive chromium and lysis is determined by measuring chromium in the supernatant released by dying cells. Since then, alternative methods have been developed using different markers of target cell viability that do not involve radioactivity. Here, we compared and contrasted a bioluminescence (BLI)based cytotoxicity assay to the standard radioactive chromium-release assay using an identical set of effector cells and tumor target cells. For this, we stably transduced several human and murine tumor cell lines to express luciferase. When co-cultured with cytotoxic effector cells, highly reproducible decreases in BLI were seen in an effector to target cell dose-dependent manner. When compared to results obtained from the chromium release assay, the performance of the BLI-based assay was superior, because of its robustness, increased signal-to-noise ratio, and faster kinetics. The reduced/delayed detection of cytotoxicity by the chromium release method was attributable to the association of chromium with structural components of the cell, which are released quickly by detergent solubilization but not by hypotonic lysis. We conclude that the (BLI)-based measurement of cytotoxicity offers a superior non-radioactive alternative to the chromium-release assay that is more robust and quicker to perform.	[Karimi, Mobin A.; Lee, Eric; Salicioni, Ana Maria; Baldwin, Cynthia L.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Karimi, Mobin A.; Kambayashi, Taku] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Bachmann, Michael H.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Behrens, Edward M.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Pennsylvania; Pennsylvania Medicine; Stanford University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Karimi, MA (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	mkarimi@mail.med.upenn.edu	Karimi, Mobin/AAG-8286-2020; Salicioni, Ana Maria/ABD-8384-2021; Bachmann, Michael Hubertus/N-9339-2016	Karimi, Mobin/0000-0002-3240-4814; Salicioni, Ana Maria/0000-0002-8951-3587; Bachmann, Michael Hubertus/0000-0002-0204-3720	NIH [T32-HL-007775-20]; Honors College of the University of Massachusetts, Amherst; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107589, T32HL007775, R01HL111501] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Honors College of the University of Massachusetts, Amherst; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	M.K. was supported by funding from the NIH (T32-HL-007775-20) and Eric Lee was supported by the Honors College of the University of Massachusetts, Amherst. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BORELLA P, 1995, J IMMUNOL METHODS, V186, P101, DOI 10.1016/0022-1759(95)00140-6; Brown CE, 2005, J IMMUNOL METHODS, V297, P39, DOI 10.1016/j.jim.2004.11.021; Chan JK, 2006, CLIN CANCER RES, V12, P1859, DOI 10.1158/1078-0432.CCR-05-2019; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; Creusot RJ, 2008, CLIN IMMUNOL, V127, P176, DOI 10.1016/j.clim.2007.12.009; Das SK, 2009, J HAZARD MATER, V167, P685, DOI 10.1016/j.jhazmat.2009.01.037; de Haart SJ, 2013, CLIN CANCER RES, V19, P5591, DOI 10.1158/1078-0432.CCR-12-3676; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Ewen C, 2003, J IMMUNOL METHODS, V276, P89, DOI 10.1016/S0022-1759(03)00073-5; Fischer K, 2003, METHODS, V31, P135, DOI 10.1016/S1046-2023(03)00123-3; FLIEGER D, 1995, J IMMUNOL METHODS, V180, P1, DOI 10.1016/0022-1759(94)00293-6; Karimi M, 2005, J IMMUNOL, V175, P7819, DOI 10.4049/jimmunol.175.12.7819; LILIEN DL, 1970, J CLIN INVEST, V49, P1551, DOI 10.1172/JCI106372; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; McMillin DW, 2012, BLOOD, V119, pE131, DOI 10.1182/blood-2011-04-348490; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Nakagawa Y, 2011, BIOMED RES-TOKYO, V32, P159, DOI 10.2220/biomedres.32.159; Peyvandi Flora, 2004, Hum Mutat, V23, P98, DOI 10.1002/humu.9206; Poljsak B, 2010, J BASIC MICROB, V50, P21, DOI 10.1002/jobm.200900170; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Volland S, 2012, AQUAT TOXICOL, V109, P59, DOI 10.1016/j.aquatox.2011.11.013; Wonderlich J., 2006, CURR PROTOC IMMUNOL, DOI 10.1002/0471142735.im0311s72	23	62	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89357	10.1371/journal.pone.0089357	http://dx.doi.org/10.1371/journal.pone.0089357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586714	gold, Green Published, Green Submitted			2022-12-27	WOS:000331711900132
J	Li, LP; Han, WX; Thevs, N; Jia, XH; Ji, CJ; Jin, DM; He, P; Schmitt, AO; Cirella, GT; Zerbe, S				Li, Liping; Han, Wenxuan; Thevs, Niels; Jia, Xiuhong; Ji, Chengjun; Jin, Dongmei; He, Ping; Schmitt, Armin O.; Cirella, Giuseppe Tommaso; Zerbe, Stefan			A Comparison of the Functional Traits of Common Reed (Phragmites australis) in Northern China: Aquatic vs. Terrestrial Ecotypes	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; BIOMASS ALLOCATION; LEAF; GROWTH; ROOT; ECONOMICS; PATTERNS; NUTRIENT; NITROGEN; STEM	Common reed (Phragmites australis (Cav.) Trin. ex Steud.) is distributed widely throughout the world with various ecotypes. This research compares the functional traits and biomass allocation patterns of two contrasting reed ecotypes. Twelve pairs of aquatic and terrestrial reed samples were collected in northern China. Significant differences in functional traits between the two reed ecotypes were observed, while biomass allocation patterns of reed organs did not differ significantly except for at the root. The dry matter content (DMC) in the whole of the reed plant, leaf, root, and rhizome was higher; while the specific leaf area (SLA) and specific root length (SRL) were lower in terrestrial versus aquatic reed. The biomass allocation in organs of the two forms of reed was isometric, only root in the terrestrial habitat increased faster with an increase in the whole plant biomass. It can be affirmed that aquatic and terrestrial reed that adapt to different environments generally has distinct leaf and root functional traits but isometric biomass allocation patterns. This suggests different resource acquisition strategies: (1) aquatic reed grows faster with high SLA and SRL and is more responsive to the environment, while (2) terrestrial reed with high DMC grows slower and is less responsive to the adverse environment (e.g. dry soil conditions).	[Li, Liping] Chinese Acad Med Sci, Peking Union Med Coll, Key Lab Bioact Subst & Resources Utilizat Chinese, Minist Educ,Inst Med Plant Dev, Beijing 100730, Peoples R China; [Li, Liping; Schmitt, Armin O.; Cirella, Giuseppe Tommaso; Zerbe, Stefan] Free Univ Bozen Bolzano, Fac Sci & Technol, Bolzano, Italy; [Han, Wenxuan] China Agr Univ, Coll Resources & Environm Sci, Minist Educ, Key Lab Plant Soil Interact, Beijing 100094, Peoples R China; [Thevs, Niels] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany; [Jia, Xiuhong] Huazhong Agr Univ, Coll Hort & Forestry, Wuhan, Peoples R China; [Ji, Chengjun; Jin, Dongmei] Peking Univ, Key Lab Earth Surface Proc, Minist Educ, Dept Ecol,Coll Urban & Environm Sci, Beijing 100871, Peoples R China; [He, Ping] Chinese Res Inst Environm Sci, State Environm Protect Key Lab Reg Ecoproc & Func, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; Free University of Bozen-Bolzano; China Agricultural University; Ernst Moritz Arndt Universitat Greifswald; Huazhong Agricultural University; Peking University; Chinese Research Academy of Environmental Sciences	Zerbe, S (corresponding author), Free Univ Bozen Bolzano, Fac Sci & Technol, Bolzano, Italy.	Stefan.Zerbe@unibz.it	Li, Liping/C-2574-2011; Han, Wenxuan/B-8791-2016; Cirella, Giuseppe T./H-9082-2016	Li, Liping/0000-0002-5550-1932; Han, Wenxuan/0000-0001-8678-7147; Cirella, Giuseppe T./0000-0002-0810-0589; Schmitt, Armin/0000-0002-4910-9467	Kurt Eberhard Bode Foundation, Germany; National Natural Science Foundation of China [41173083]	Kurt Eberhard Bode Foundation, Germany; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the Kurt Eberhard Bode Foundation, Germany (within the Stifterverband fur die Deutsche Wissenschaft) and the National Natural Science Foundation of China (41173083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo JT, 2003, NEW PHYTOL, V158, P305, DOI 10.1046/j.1469-8137.2003.00745.x; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Baruch Z, 2011, ACTA OECOL, V37, P455, DOI 10.1016/j.actao.2011.05.014; Birouste M, 2012, ANN BOT-LONDON, V109, P463, DOI 10.1093/aob/mcr297; Cheng DL, 2007, J INTEGR PLANT BIOL, V49, P1573, DOI 10.1111/j.1774-7909.2007.00576.x; Ding HongWei, 2009, Arid Land Geography, V32, P1; Duan XiaoNan, 2004, Arid Land Geography, V27, P637; Eissenstat DM, 1997, ADV ECOL RES, V27, P1, DOI 10.1016/S0065-2504(08)60005-7; Engloner AI, 2004, FLORA, V199, P256, DOI 10.1078/0367-2530-00153; Engloner AI, 2009, FLORA, V204, P331, DOI 10.1016/j.flora.2008.05.001; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Fang J, 2006, FRONT ECOL ENVIRON, V4, P369, DOI 10.1890/1540-9295(2006)004[0369:BCITLO]2.0.CO;2; Fortunel C, 2012, FUNCT ECOL, V26, P1153, DOI 10.1111/j.1365-2435.2012.02020.x; Freschet GT, 2010, J ECOL, V98, P362, DOI 10.1111/j.1365-2745.2009.01615.x; Garnier E, 2001, NEW PHYTOL, V152, P69, DOI 10.1046/j.0028-646x.2001.00239.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; He JS, 2006, OECOLOGIA, V149, P115, DOI 10.1007/s00442-006-0425-0; Jiang XH, 2001, NW WATER RESOURCES W, V12, P24; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Li LP, 2014, AQUAT BOT, V112, P84, DOI 10.1016/j.aquabot.2013.08.002; McCarthy J.J., 2001, CLIMATE CHANGE 2001; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; Patuzzi F, 2013, GCB BIOENERGY, V5, P367, DOI 10.1111/gcbb.12000; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Thevs N, 2007, J APPL BOT FOOD QUAL, V81, P62; VANDEVIJVER CADM, 1993, OECOLOGIA, V96, P548, DOI 10.1007/BF00320512; Wang JW, 2008, AQUAT BOT, V89, P357, DOI 10.1016/j.aquabot.2008.04.001; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Willby NJ, 2000, FRESHWATER BIOL, V43, P43, DOI 10.1046/j.1365-2427.2000.00523.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Yang YH, 2011, J ECOL, V99, P431, DOI 10.1111/j.1365-2745.2010.01774.x; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Zerbe S, 2011, ECOLOGICAL RES MONOG; [赵红洋 Zhao Hongyang], 2010, [中国沙漠, Journal of Desert Research], V30, P1292; Zhou Peng, 2010, Chinese Journal of Plant Ecology, V34, P7, DOI 10.3773/j.issn.1005-264x.2010.01.003	44	11	16	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89063	10.1371/journal.pone.0089063	http://dx.doi.org/10.1371/journal.pone.0089063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586505	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900081
J	Purcell, J; Avril, A; Jaffuel, G; Bates, S; Chapuisat, M				Purcell, Jessica; Avril, Amaury; Jaffuel, Geoffrey; Bates, Sarah; Chapuisat, Michel			Ant Brood Function as Life Preservers during Floods	PLOS ONE			English	Article							SOLENOPSIS-INVICTA; QUEEN NUMBER; FIRE ANT; FORMICIDAE; HYMENOPTERA; COLONIES; AGGREGATION; POPULATION; SOCIETIES; HABITATS	Social organisms can surmount many ecological challenges by working collectively. An impressive example of such collective behavior occurs when ants physically link together into floating 'rafts' to escape from flooded habitat. However, raft formation may represent a social dilemma, with some positions posing greater individual risks than others. Here, we investigate the position and function of different colony members, and the costs and benefits of this functional geometry in rafts of the floodplain-dwelling ant Formica selysi. By causing groups of ants to raft in the laboratory, we observe that workers are distributed throughout the raft, queens are always in the center, and 100% of brood items are placed on the base. Through a series of experiments, we show that workers and brood are extremely resistant to submersion. Both workers and brood exhibit high survival rates after they have rafted, suggesting that occupying the base of the raft is not as costly as expected. The placement of all brood on the base of one cohesive raft confers several benefits: it preserves colony integrity, takes advantage of brood buoyancy, and increases the proportion of workers that immediately recover after rafting.	[Purcell, Jessica; Avril, Amaury; Jaffuel, Geoffrey; Bates, Sarah; Chapuisat, Michel] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Jaffuel, Geoffrey] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	University of Lausanne; University of Neuchatel	Purcell, J (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	Jessica.Purcell@unil.ch	Purcell, Jessica/A-2445-2013; Chapuisat, Michel/T-8686-2017	Purcell, Jessica/0000-0001-8568-4162; Chapuisat, Michel/0000-0001-7207-199X; Avril, Amaury/0000-0001-5388-4223	Swiss National Science Foundation [31003A_125306]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation grant 31003A_125306 (http://www.snf.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BJ, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.17101; Anderson C, 2002, INSECT SOC, V49, P99, DOI 10.1007/s00040-002-8286-y; BOURKE AFG, 1991, ANIM BEHAV, V42, P295, DOI 10.1016/S0003-3472(05)80561-5; Chapuisat M, 1997, P ROY SOC B-BIOL SCI, V264, P1255, DOI 10.1098/rspb.1997.0173; Chapuisat M, 2004, EVOLUTION, V58, P1064, DOI 10.1111/j.0014-3820.2004.tb00440.x; Cully SM, 2004, INSECT SOC, V51, P317, DOI 10.1007/s00040-004-0743-3; Depickere S, 2004, INSECT SOC, V51, P81, DOI 10.1007/s00040-003-0719-8; Detrain C, 2006, PHYS LIFE REV, V3, P162, DOI 10.1016/j.plrev.2006.07.001; Dornhaus A, 2012, ANNU REV ENTOMOL, V57, P123, DOI 10.1146/annurev-ento-120710-100604; Dussutour A, 2009, ANIM COGN, V12, P21, DOI 10.1007/s10071-008-0165-0; Gordon DM, 2007, NATURE, V446, P143, DOI 10.1038/446143a; Haight KL, 2006, INSECT SOC, V53, P32, DOI 10.1007/s00040-005-0832-y; Lude A, 1999, ENTOMOL GEN, V24, P75; MASUKO K, 1989, BEHAV ECOL SOCIOBIOL, V24, P127, DOI 10.1007/BF00299644; Mlot NJ, 2011, P NATL ACAD SCI USA, V108, P7669, DOI 10.1073/pnas.1016658108; Nielsen MG, 2011, MYRMECOL NEWS, V14, P113; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Powell S, 2004, INSECT SOC, V51, P342, DOI 10.1007/s00040-004-0752-2; Purcell J, 2013, EVOLUTION, V67, P1169, DOI 10.1111/evo.12010; Schneirla T. C., 1971, ARMY ANTS STUDY SOCI; Sempo G, 2006, INSECT SOC, V53, P241, DOI 10.1007/s00040-006-0864-y; WILSON EO, 1980, P NATL ACAD SCI-BIOL, V77, P2343, DOI 10.1073/pnas.77.4.2343	22	8	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89211	10.1371/journal.pone.0089211	http://dx.doi.org/10.1371/journal.pone.0089211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586600	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900107
J	Radley-Crabb, HG; Marini, JC; Sosa, HA; Castillo, LI; Grounds, MD; Fiorotto, ML				Radley-Crabb, Hannah G.; Marini, Juan C.; Sosa, Horacio A.; Castillo, Liliana I.; Grounds, Miranda D.; Fiorotto, Marta L.			Dystropathology Increases Energy Expenditure and Protein Turnover in the Mdx Mouse Model of Duchenne Muscular Dystrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; GENE-EXPRESSION; MYOGENIC CELLS; METABOLIC-RATE; BODY-COMPOSITION; IN-VIVO; GROWTH; MICE; DIAPHRAGM; COLLAGEN	The skeletal muscles in Duchenne muscular dystrophy and the mdx mouse model lack functional dystrophin and undergo repeated bouts of necrosis, regeneration, and growth. These processes have a high metabolic cost. However, the consequences for whole body energy and protein metabolism, and on the dietary requirements for these macronutrients at different stages of the disease, are not well-understood. This study used juvenile (4- to 5- wk-old) and adult (12- to 14- wk-old) male dystrophic C57BL/10ScSn-mdx/J and age-matched C57BL/10ScSn/J control male mice to measure total and resting energy expenditure, food intake, spontaneous activity, body composition, whole body protein turnover, and muscle protein synthesis rates. In juvenile mdx mice that have extensive muscle damage, energy expenditure, muscle protein synthesis, and whole body protein turnover rates were higher than in age-matched controls. Adaptations in food intake and decreased activity were insufficient to meet the increased energy and protein needs of juvenile mdx mice and resulted in stunted growth. In (non-growing) adult mdx mice with less severe dystropathology, energy expenditure, muscle protein synthesis, and whole body protein turnover rates were also higher than in age-matched controls. Food intake was sufficient to meet their protein and energy needs, but insufficient to result in fat deposition. These data show that dystropathology impacts the protein and energy needs of mdx mice and that tailored dietary interventions are necessary to redress this imbalance. If not met, the resultant imbalance blunts growth, and may limit the benefits of therapies designed to protect and repair dystrophic muscles.	[Radley-Crabb, Hannah G.] Curtin Univ, CHIRI Biosci Res Precinct, Sch Biomed Sci, Perth, WA 6845, Australia; [Radley-Crabb, Hannah G.; Grounds, Miranda D.] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Marini, Juan C.; Sosa, Horacio A.; Castillo, Liliana I.; Fiorotto, Marta L.] ARS, USDA, Childrens Nutr Res Ctr, Dept Pediat,Baylor Coll Med, Houston, TX 77041 USA; [Marini, Juan C.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Curtin University; University of Western Australia; Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine	Fiorotto, ML (corresponding author), ARS, USDA, Childrens Nutr Res Ctr, Dept Pediat,Baylor Coll Med, Houston, TX 77041 USA.	martaf@bcm.edu		Grounds, Miranda/0000-0002-4530-9402; Radley, Hannah/0000-0002-3803-7314	Australian Postgraduate Award; UWA; USDA/ARS	Australian Postgraduate Award(Australian Government); UWA; USDA/ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	H. Radley-Crabb was supported by an Australian Postgraduate Award and a Grant for Research Student Training provided by UWA. Support for isotope analyses was provided by USDA/ARS funds. Body composition, energy balance, and food intake measurements were performed in the Mouse Metabolic Research Unit at the USDA/ARS Children's Nutrition Research Center, which is supported by funds from the USDA/ARS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopal P, 2006, AM J PHYSIOL-ENDOC M, V290, pE530, DOI 10.1152/ajpendo.00412.2005; BEILHARZ MW, 1992, MOL CELL NEUROSCI, V3, P326, DOI 10.1016/1044-7431(92)90029-2; Belke DD, 1999, AM J PHYSIOL-REG I, V277, pR1210, DOI 10.1152/ajpregu.1999.277.4.R1210; Biolo G, 2002, J CLIN ENDOCR METAB, V87, P3378, DOI 10.1210/jc.87.7.3378; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BURBACH JA, 1987, AM J PHYSIOL, V253, pR275, DOI 10.1152/ajpregu.1987.253.2.R275; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Crabb H, 2011, PLOS CURR, V3; Davidson ZE, 2009, J HUM NUTR DIET, V22, P383, DOI 10.1111/j.1365-277X.2009.00979.x; Davis TA, 2009, CURR OPIN CLIN NUTR, V12, P78, DOI 10.1097/MCO.0b013e32831cef9f; DUPONTVERSTEEGDEN EE, 1994, J NEUROL SCI, V121, P203, DOI 10.1016/0022-510X(94)90353-0; DUPONTVERSTEEGDEN EE, 1992, MUSCLE NERVE, V15, P1105, DOI 10.1002/mus.880151008; Elliott SA, 2012, EUR J PAEDIATR NEURO, V16, P631, DOI 10.1016/j.ejpn.2012.02.011; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Evans NP, 2010, CLIN NUTR, V29, P391, DOI 10.1016/j.clnu.2009.10.001; Evans NP, 2009, AM J PHYS MED REHAB, V88, P502, DOI 10.1097/PHM.0b013e3181a5a24f; EVEN PC, 1994, BIOCHEM J, V304, P649, DOI 10.1042/bj3040649; Fiorotto ML, 2012, METHODS MOL BIOL, V798, P245, DOI 10.1007/978-1-61779-343-1_14; Fiorotto ML, 2000, AM J PHYSIOL-REG I, V278, pR845, DOI 10.1152/ajpregu.2000.278.4.R845; GOLDSPINK DF, 1987, EXP GERONTOL, V22, P67, DOI 10.1016/0531-5565(87)90016-7; GOLDSPINK G, 1994, NEUROMUSCULAR DISORD, V4, P183, DOI 10.1016/0960-8966(94)90019-1; Gonzalez-Bermejo J, 2005, EUR RESPIR J, V25, P682, DOI 10.1183/09031936.05.00031304; Graham KM, 2010, J NEUROL SCI, V294, P43, DOI 10.1016/j.jns.2010.04.007; Grounds MD, 2004, FASEB J, V18, P676, DOI 10.1096/fj.03-1024com; GROUNDS MD, 1991, PATHOL RES PRACT, V187, P1; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Grounds MD, 2011, BIOESSAYS, V33, P458, DOI 10.1002/bies.201000136; HALLIDAY D, 1988, CLIN SCI, V74, P237, DOI 10.1042/cs0740237; Hankard R, 1998, REPROD NUTR DEV, V38, P181, DOI 10.1051/rnd:19980205; Hankard R, 1996, PEDIATR RES, V40, P29, DOI 10.1203/00006450-199607000-00006; Helliwell TR, 1996, CLIN SCI, V90, P467, DOI 10.1042/cs0900467; JOHN AM, 1976, J NUTR, V106, P1361, DOI 10.1093/jn/106.9.1361; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Leighton S., 2003, Nutrition & Dietetics, V60, P11; LEWIS SEM, 1984, BIOCHEM J, V217, P517, DOI 10.1042/bj2170517; MACLENNAN PA, 1991, AM J PHYSIOL, V260, pE594, DOI 10.1152/ajpendo.1991.260.4.E594; MACLENNAN PA, 1990, BIOCHEM J, V268, P795, DOI 10.1042/bj2680795; MACLENNAN PA, 1991, BIOCHEM J, V275, P477, DOI 10.1042/bj2750477; Marini JC, 2006, LAB ANIM-UK, V40, P275, DOI 10.1258/002367706777611479; MARSHALL PA, 1989, MUSCLE NERVE, V12, P528, DOI 10.1002/mus.880120703; Martigne L, 2011, BRIT J NUTR, V105, P1486, DOI 10.1017/S0007114510005180; MCCRACKEN KJ, 1980, BRIT J NUTR, V43, P305, DOI 10.1079/BJN19800093; MCCRACKEN KJ, 1975, BRIT J NUTR, V33, P277, DOI 10.1079/BJN19750030; MCGEACHIE JK, 1993, J NEUROL SCI, V119, P169, DOI 10.1016/0022-510X(93)90130-Q; McGeachie JK, 1999, J ANAT, V194, P287, DOI 10.1046/j.1469-7580.1999.19420287.x; MEHTA JR, 1989, RES VET SCI, V47, P17, DOI 10.1016/S0034-5288(18)31225-6; Mokhtarian A, 1996, PFLUG ARCH EUR J PHY, V431, P527, DOI 10.1007/BF02191899; MUNRO HN, 1966, ANALYST, V91, P78, DOI 10.1039/an9669100078; OKADA K, 1992, J NUTR SCI VITAMINOL, V38, P141, DOI 10.3177/jnsv.38.141; Orengo JP, 2011, ANN NEUROL, V69, P681, DOI 10.1002/ana.22278; Partridge TA, 2013, FEBS J, V280, P4177, DOI 10.1111/febs.12267; PELLETT PL, 1972, J NUTR, V102, P61, DOI 10.1093/jn/102.1.61; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Reed P, 2005, NEUROMUSCULAR DISORD, V15, P552, DOI 10.1016/j.nmd.2005.03.007; RIFAI Z, 1995, AM J PHYSIOL-ENDOC M, V268, pE67, DOI 10.1152/ajpendo.1995.268.1.E67; ROBERTSON TA, 1990, J STRUCT BIOL, V105, P170, DOI 10.1016/1047-8477(90)90111-O; ROBERTSON TA, 1993, NEUROPATH APPL NEURO, V19, P350, DOI 10.1111/j.1365-2990.1993.tb00451.x; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Selman C, 2001, J EXP BIOL, V204, P777; Shavlakadze T, 2004, MOL THER, V10, P829, DOI 10.1016/j.ymthe.2004.07.026; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; Shimizu-Fujiwara M, 2012, BRAIN DEV-JPN, V34, P206, DOI 10.1016/j.braindev.2011.05.005; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Stupka N, 2004, ACTA NEUROPATHOL, V107, P299, DOI 10.1007/s00401-003-0807-x; Svanberg E, 1998, ENDOCRINOLOGY, V139, P4906, DOI 10.1210/en.139.12.4906; THOMPSON GN, 1989, AM J PHYSIOL, V256, pE631, DOI 10.1152/ajpendo.1989.256.5.E631; THONNEY ML, 1987, J NUTR, V117, P2135, DOI 10.1093/jn/117.12.2135; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Van Erp C, 2010, MUSCLE NERVE, V42, P504, DOI 10.1002/mus.21716; VERNADAKIS A, 1964, AM J PHYSIOL, V206, P1365, DOI 10.1152/ajplegacy.1964.206.6.1365; Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; West NA, 2013, J PEDIATR-US, V163, P1759, DOI 10.1016/j.jpeds.2013.08.004; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Willmann R, 2012, NEUROMUSCULAR DISORD, V22, P43, DOI 10.1016/j.nmd.2011.04.012; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015; Zanardi MC, 2003, EUR J CLIN NUTR, V57, P273, DOI 10.1038/sj.ejcn.1601524	81	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89277	10.1371/journal.pone.0089277	http://dx.doi.org/10.1371/journal.pone.0089277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586653	Green Published, gold			2022-12-27	WOS:000331711900121
J	Engels, T; Baglione, Q; Audibert, M; Viallefont, A; Mourji, F; Faris, ME				Engels, Thomas; Baglione, Quentin; Audibert, Martine; Viallefont, Anne; Mourji, Fouzi; Faris, Mustapha El Alaoui		GRAVCM Study Grp	Socioeconomic Status and Stroke Prevalence in Morocco: Results from the Rabat-Casablanca Study	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; CARDIOVASCULAR-DISEASES; GLOBAL BURDEN; RISK-FACTORS; MIDDLE-EAST; EPIDEMIOLOGY; TRANSITION; COUNTRIES; MORTALITY; POVERTY	Background: Stroke is a growing public health concern in low-and middle-income countries. Improved knowledge about the association between socioeconomic status and stroke in these countries would enable the development of effective stroke prevention and management strategies. This study presents the association between socioeconomic status and the prevalence of stroke in Morocco, a lower middle-income country. Methods: Data on the prevalence of stroke and stroke-related risk factors were collected during a large population-based survey. The diagnosis of stroke in surviving patients was confirmed by neurologists while health, demographic, and socioeconomic characteristics of households were collected using structured questionnaires. We used Multiple Correspondence Analysis to develop a wealth index based on characteristics of the household dwelling as well as ownership of selected assets. We used logistic regressions controlling for multiple variables to assess the statistical association between socioeconomic status and stroke. Findings: Our results showed a significant association between household socioeconomic status and the prevalence of stroke. This relationship was non-linear, with individuals from both the poorest (mainly rural) and richest (mainly urban) households having a lower prevalence of stroke as compared to individuals with medium wealth level. The latter belonged mainly to urban households with a lower socioeconomic status. When taking into account the urban population only, we observed that a third of poorest households experienced a significantly higher prevalence of stroke compared to the richest third (OR = 2.06; CI 95%: 1.09; 3.89). Conclusion: We conclude that individuals from the most deprived urban households bear a higher risk of stroke than the rest of the population in Morocco. This result can be explained to a certain extent by the higher presence of behavioral risk factors in this specific category of the population, which leads in turn to metabolic and physiological risk factors of stroke, such as obesity, diabetes, and hypertension.	[Engels, Thomas; Baglione, Quentin; Audibert, Martine; Viallefont, Anne] Univ Auvergne, CERDI CNRS, Clermont Ferrand, France; [Mourji, Fouzi] Hassan II Ain Chock Univ, Casablanca, Morocco; [Mourji, Fouzi] LASAARE, Casablanca, Morocco; [Faris, Mustapha El Alaoui] Hop Specialites, Dept Neurol & Neuropsychol, Rabat, Morocco; [Faris, Mustapha El Alaoui] Mohamed V Souissi Univ, Rabat, Morocco	Universite Clermont Auvergne (UCA); Hassan II University of Casablanca; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat	Engels, T (corresponding author), Univ Auvergne, CERDI CNRS, Clermont Ferrand, France.	engels_thomas@hotmail.com			Hassan II Academy of Science and Technology, Rabat, Morocco	Hassan II Academy of Science and Technology, Rabat, Morocco	The epidemiological study was supported by a grant from the Hassan II Academy of Science and Technology, Rabat, Morocco: http://www.academie.hassan2.sciences.ma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboussad A, 2010, SANTE VULNERABILITE; Addo J, 2012, STROKE, V43, P1186, DOI 10.1161/STROKEAHA.111.639732; Aidi S, 2011, 20 WORLD C NEUR 12 1; [Anonymous], 2005, PUBLIC HLTH OBSERVAT; Benjelloun S, 2002, PUBLIC HEALTH NUTR, V5, P135, DOI 10.1079/PHN2001285; Berraho M, 2012, PAN AFR MED J, V11; Boutayeb A, 2006, INT J EQUITY HLTH, V5; Boutayeb A, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-23; Cherkaoui M, 2007, 16 IUSSP POP C MARR; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; Dalal PM, 2006, INT J STROKE, V1, P164, DOI 10.1111/j.1747-4949.2006.00051.x; Essiarab F., 2011, EUR J SCI RES, V49, P581; Fahed AC, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/109037; Falkingham J, 2002, MEASURING HLTH POVER; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Ferri CP, 2011, J NEUROL NEUROSUR PS, V82, P1074, DOI 10.1136/jnnp.2010.234153; Garenne M, 2003, J HEALTH POPUL NUTR, V21, P235; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Khatib O, 2004, East Mediterr Health J, V10, P778; Lemogoum D, 2005, AM J PREV MED, V29, P95, DOI 10.1016/j.amepre.2005.07.025; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mensah GA, 2008, HEART, V94, P697, DOI 10.1136/hrt.2007.127753; Ministry of Health Morocco, 2008, PLAN ACT SANT 2008 2; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; Nicoletti A, 2000, STROKE, V31, P882, DOI 10.1161/01.STR.31.4.882; Organization WH, 2016, GLOBAL STATUS REPORT; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; Pandian JD, 2007, STROKE, V38, P3063, DOI 10.1161/STROKEAHA.107.496869; Paul SL, 2007, CURR DRUG TARGETS, V8, P786; Pollack CE, 2007, AM J PREV MED, V33, P250, DOI 10.1016/j.amepre.2007.04.033; Reddy KS, 2007, P NATL ACAD SCI USA, V104, P16263, DOI 10.1073/pnas.0700933104; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Reddy KS, 2002, PUBLIC HEALTH NUTR, V5, P231, DOI 10.1079/PHN2001298; Reid CM, 2005, CLIN EXP PHARMACOL P, V32, P374, DOI 10.1111/j.1440-1681.2005.04199.x; Ridcker PM, 1997, NEW ENGL J MED, V136, P973; Sahn DE, 2000, WORLD DEV, V28, P2123, DOI 10.1016/S0305-750X(00)00075-9; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Tazi MA, 2003, J HYPERTENS, V21, P897, DOI 10.1097/00004872-200305000-00013; Tran J, 2011, J NEUROL SCI, V308, P135, DOI 10.1016/j.jns.2011.05.016; Truelsen T, 2002, GLOBAL BURDEN CEREBR; World Health Organization, 2006, WHO STEPS STROK MAN; Xu F, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-170; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	45	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89271	10.1371/journal.pone.0089271	http://dx.doi.org/10.1371/journal.pone.0089271			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586649	Green Published, gold			2022-12-27	WOS:000332396200044
J	Lawson, B; De Pinna, E; Horton, RA; Macgregor, SK; John, SK; Chantrey, J; Duff, JP; Kirkwood, JK; Simpson, VR; Robinson, RA; Wain, J; Cunningham, AA				Lawson, Becki; De Pinna, Elizabeth; Horton, Robert A.; Macgregor, Shaheed K.; John, Shinto K.; Chantrey, Julian; Duff, J. Paul; Kirkwood, James K.; Simpson, Victor R.; Robinson, Robert A.; Wain, John; Cunningham, Andrew A.			Epidemiological Evidence That Garden Birds Are a Source of Human Salmonellosis in England and Wales	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; WILD BIRDS; SEROTYPE TYPHIMURIUM; RESISTANT SALMONELLA; NORTHERN ENGLAND; NEW-ZEALAND; CATS; INFECTION; TRANSMISSION; STRAINS	The importance of wild bird populations as a reservoir of zoonotic pathogens is well established. Salmonellosis is a frequently diagnosed infectious cause of mortality of garden birds in England and Wales, predominantly caused by Salmonella enterica subspecies enterica serovar Typhimurium definitive phage types 40, 56(v) and 160. In Britain, these phage types are considered highly host-adapted with a high degree of genetic similarity amongst isolates, and in some instances are clonal. Pulsed field gel electrophoresis, however, demonstrated minimal variation amongst matched DT40 and DT56(v) isolates derived from passerine and human incidents of salmonellosis across England in 2000-2007. Also, during the period 1993-2012, similar temporal and spatial trends of infection with these S. Typhimurium phage types occurred in both the British garden bird and human populations; 1.6% of all S. Typhimurium (0.2% of all Salmonella) isolates from humans in England and Wales over the period 2000-2010. These findings support the hypothesis that garden birds act as the primary reservoir of infection for these zoonotic bacteria. Most passerine salmonellosis outbreaks identified occurred at and around feeding stations, which are likely sites of public exposure to sick or dead garden birds and their faeces. We, therefore, advise the public to practise routine personal hygiene measures when feeding wild birds and especially when handling sick wild birds.	[Lawson, Becki; John, Shinto K.; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London, England; [De Pinna, Elizabeth] Publ Hlth England, Salmonella Reference Serv, London, England; [Horton, Robert A.] Anim Hlth & Vet Labs Agcy, Dept Bacteriol, Addlestone, Surrey, England; [Macgregor, Shaheed K.] Zool Soc London, Vet Dept, London, England; [Chantrey, Julian] Univ Liverpool, Sch Vet Sci, Neston, Cheshire, England; [Duff, J. Paul] Anim Hlth & Vet Labs Agcy, Penrith, Cumbria, England; [Kirkwood, James K.] Univ Federat Anim Welf, Wheathampstead, Herts, England; [Simpson, Victor R.] Wildlife Vet Invest Ctr, Truro, Cornwall, England; [Robinson, Robert A.] British Trust Ornithol, Norfolk, VA USA; [Wain, John] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England	Zoological Society of London; Public Health England; Veterinary Laboratories Agency; Zoological Society of London; University of Liverpool; University of East Anglia	Lawson, B (corresponding author), Zool Soc London, Inst Zool, London, England.	becki.lawson@ioz.ac.uk	Horton, Robert/C-6511-2011; Robinson, Robert/B-8237-2009; Cunningham, Andrew A/E-7536-2010; Wain, John Richard/B-3446-2013	Robinson, Robert/0000-0003-0504-9906; lawson, becki/0000-0003-1706-7140; Wain, John Richard/0000-0002-1257-1148	Universities Federation for Animal Welfare; RSPB; Defra; CJ Wildbird Foods; Gardman Ltd.; Cranswick Pet Products; Birdcare Standards Association; BVA Animal Welfare Foundation; UK Government, Department of Environment, Food and Rural Affairs [ED1600, FZ2000]; Norwich Medical School, University of East Anglia; Royal Society Wolfson Research Merit Award	Universities Federation for Animal Welfare; RSPB; Defra(Department for Environment, Food & Rural Affairs (DEFRA)); CJ Wildbird Foods; Gardman Ltd.; Cranswick Pet Products; Birdcare Standards Association; BVA Animal Welfare Foundation; UK Government, Department of Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Norwich Medical School, University of East Anglia; Royal Society Wolfson Research Merit Award(Royal Society of London)	The Garden Bird Health initiative received financial support from the Universities Federation for Animal Welfare (http://www.ufaw.org.uk), the RSPB (http://www.rspb.org.uk), Defra (http://www.defra.gov.uk), CJ Wildbird Foods (http://www.birdfood.co.uk), Gardman Ltd. (http://www.gardman.co.uk), Cranswick Pet Products (http://www.cranswickpetproducts.co.uk), the Birdcare Standards Association (http://www.birdcare.org.uk) and the BVA Animal Welfare Foundation (http://www.bva-awf.org.uk). The work at AHVLA (http://www.defra.gov.uk/ahvla-en/) was funded by the UK Government, Department of Environment, Food and Rural Affairs (project grants ED1600, AHVLA Diseases of Wildlife Scheme (AHVLA DoWS) and FZ2000). The work carried out by PHE was done as part of the routine Salmonella reference service of the Gastrointestinal Bacteria Reference Unit. JW is funded through the Norwich Medical School, University of East Anglia. AAC is supported by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulreesh Hussein H., 2007, Ringing & Migration, V23, P193; Alley MR, 2002, NEW ZEAL VET J, V50, P170; ANDERSON ES, 1977, J HYG-CAMBRIDGE, V78, P297, DOI 10.1017/S0022172400056187; Baird-Parker A. C., 1991, A lancet review: foodborne illness., P53; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Dhanoa A, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-15; EUDEN PR, 1990, BRIT VET J, V146, P228, DOI 10.1016/S0007-1935(11)80006-0; Friend M, 1999, FIELD MANUAL WILDLIF, P201; Frost J, 1994, METHODS PRACTICAL LA, P73; Gibbons DW, 1993, NEW ATLAS BREEDING B, P1; Grimont P. A. D., 2007, ANTIGENIC FORMULAS S; Hauser E, 2009, BERL MUNCH TIERARZTL, V122, P169, DOI 10.2376/0005-9366-122-169; Hernandez J, 2003, EMERG INFECT DIS, V9, P753; Holley RA, 2006, J ENVIRON QUAL, V35, P1170, DOI 10.2134/jeq2005.0449; Hopkins KL, 2004, J MED MICROBIOL, V53, P539, DOI 10.1099/jmm.0.05510-0; Horton RA, 2013, RES VET SCI, V95, P45, DOI 10.1016/j.rvsc.2013.02.008; HUDSON C. B., 1957, CORNELL VET, V47, P394; Hughes LA, 2010, LETT APPL MICROBIOL, V51, P477, DOI 10.1111/j.1472-765X.2010.02918.x; Hughes LA, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-4; Kapperud G, 1998, AM J EPIDEMIOL, V147, P774, DOI 10.1093/oxfordjournals.aje.a009522; Kariuki S, 2000, FEMS IMMUNOL MED MIC, V29, P9, DOI 10.1111/j.1574-695X.2000.tb01498.x; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Lawson B, 2010, ECOHEALTH, V7, P294, DOI 10.1007/s10393-010-0349-3; Lawson B, 2011, APPL ENVIRON MICROB, V77, P8139, DOI 10.1128/AEM.00131-11; LEMINOR L, 1987, INT J SYST BACTERIOL, V37, P465, DOI 10.1099/00207713-37-4-465; Macdonald J. W., 1969, British Birds, V62, P28; MACDONALD JW, 1980, VET REC, V107, P46, DOI 10.1136/vr.107.2.46; Nair S., 2008, ECOSAL ESCHERICHIA C; Office for National Statistics, 2001, 2001 CENS AGGR DAT E; Palmgren H, 1997, SCAND J INFECT DIS, V29, P565, DOI 10.3109/00365549709035895; PENFOLD JB, 1979, BRIT MED J, V2, P802; Pennycott TW, 2006, VET REC, V158, P817, DOI 10.1136/vr.158.24.817; Pennycott TW, 2010, VET REC, V166, P419, DOI 10.1136/vr.b4761; Philbey AW, 2008, VET REC, V162, P120, DOI 10.1136/vr.162.4.120; Public Health England, 2013, SALM RAT AG; R Core Team, 2012, R LANG ENV STAT COMP; Rabsch W, 2002, INFECT IMMUN, V70, P2249, DOI 10.1128/IAI.70.5.2249-2255.2002; Refsum T, 2003, J WILDLIFE DIS, V39, P64, DOI 10.7589/0090-3558-39.1.64; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Robinson RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012215; TAMASI G, 1981, ACTA VET ACAD SCI H, V29, P119; Tauni MA, 2000, J SMALL ANIM PRACT, V41, P339, DOI 10.1111/j.1748-5827.2000.tb03214.x; Taylor DJ, 2010, VET REC, V167, P26, DOI 10.1136/vr.c3156; Taylor J., 1968, S ZOOL SOC LON, V24, P51; Thornley CN, 2003, EMERG INFECT DIS, V9, P493, DOI 10.3201/eid0904.020439; Tizard I, 2004, SEMIN AVIAN EXOT PET, V13, P50, DOI 10.1053/j.saep.2004.01.008; Tsiodras S, 2008, J INFECTION, V56, P83, DOI 10.1016/j.jinf.2007.11.001; Van Immerseel F, 2004, EMERG INFECT DIS, V10, P2169, DOI 10.3201/eid1012.040904; WILSON JE, 1967, BRIT VET J, V123, P212, DOI 10.1016/S0007-1935(17)40005-4	49	43	45	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88968	10.1371/journal.pone.0088968	http://dx.doi.org/10.1371/journal.pone.0088968			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586464	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000332389000019
J	Taguchi, K; Watanabe, Y; Tsujimura, A; Tatebe, H; Miyata, S; Tokuda, T; Mizuno, T; Tanaka, M				Taguchi, Katsutoshi; Watanabe, Yoshihisa; Tsujimura, Atsushi; Tatebe, Harutsugu; Miyata, Seiji; Tokuda, Takahiko; Mizuno, Toshiki; Tanaka, Masaki			Differential Expression of Alpha-Synuclein in Hippocampal Neurons	PLOS ONE			English	Article							PARKINSONS-DISEASE; LEWY BODIES; POOL; SYNAPSES; DEMENTIA; MUTATION; LOCALIZATION; DYSFUNCTION; DISORDERS; GLUTAMATE	alpha-Synuclein is the major pathological component of synucleinopathies including Parkinson's disease and dementia with Lewy bodies. Recent studies have demonstrated that alpha-synuclein also plays important roles in the release of synaptic vesicles and synaptic membrane recycling in healthy neurons. However, the precise relationship between the pathogenicity and physiological functions of alpha-synuclein remains to be elucidated. To address this issue, we investigated the subcellular localization of alpha-synuclein in normal and pathological conditions using primary mouse hippocampal neuronal cultures. While some neurons expressed high levels of alpha-synuclein in presynaptic boutons and cell bodies, other neurons either did not or only very weakly expressed the protein. These alpha-synuclein-negative cells were identified as inhibitory neurons by immunostaining with specific antibodies against glutamic acid decarboxylase (GAD), parvalbumin, and somatostatin. In contrast, alpha-synuclein-positive synapses were colocalized with the excitatory synapse marker vesicular glutamate transporter-1. This expression profile of alpha-synuclein was conserved in the hippocampus in vivo. In addition, we found that while presynaptic alpha-synuclein colocalizes with synapsin, a marker of presynaptic vesicles, it is not essential for activity-dependent membrane recycling induced by high potassium treatment. Exogenous supply of preformed fibrils generated by recombinant alpha-synuclein was shown to promote the formation of Lewy body (LB) -like intracellular aggregates involving endogenous alpha-synuclein. GAD-positive neurons did not form LB-like aggregates following treatment with preformed fibrils, however, exogenous expression of human alpha-synuclein allowed intracellular aggregate formation in these cells. These results suggest the presence of a different mechanism for regulation of the expression of alpha-synuclein between excitatory and inhibitory neurons. Furthermore, alpha-synuclein expression levels may determine the efficiency of intracellular aggregate formation in different neuronal subtypes.	[Taguchi, Katsutoshi; Watanabe, Yoshihisa; Tsujimura, Atsushi; Tanaka, Masaki] Kyoto Prefectural Univ Med, Dept Basic Geriatr, Kamikyo Ku, Kyoto, Japan; [Tatebe, Harutsugu; Tokuda, Takahiko; Mizuno, Toshiki] Kyoto Prefectural Univ Med, Dept Neurol, Kamikyo Ku, Kyoto, Japan; [Miyata, Seiji] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 606, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Dept Mol Pathobiol Brain Dis, Kamikyo Ku, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Institute of Technology; Kyoto Prefectural University of Medicine	Tanaka, M (corresponding author), Kyoto Prefectural Univ Med, Dept Basic Geriatr, Kamikyo Ku, Kyoto, Japan.	mtanaka@koto.kpu-m.ac.jp	Mizuno, Toshiki/AAH-7155-2020		Japan Society for Promotion of Science; Adaptable and Seamless Technology transfer Program through target-driven R&D from Japan Science and Technology Agency (MT); Grants-in-Aid for Scientific Research [25640024] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Adaptable and Seamless Technology transfer Program through target-driven R&D from Japan Science and Technology Agency (MT); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by scientific research grants from the Japan Society for Promotion of Science (YW and MT) and a grant of Adaptable and Seamless Technology transfer Program through target-driven R&D from Japan Science and Technology Agency (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Dickson DW, 2001, CURR OPIN NEUROL, V14, P423, DOI 10.1097/00019052-200108000-00001; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Gomez-Tortosa E, 2001, ACTA NEUROPATHOL, V101, P36; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Gureviciene I, 2007, NEUROBIOL DIS, V28, P83, DOI 10.1016/j.nbd.2007.06.016; Hsu LJ, 1998, J NEUROCHEM, V71, P338; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Liu G, 2013, J NEURAL TRANSM; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Morita S, 2012, CELL BIOCH FUNCT; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Moulder KL, 2007, J NEUROSCI, V27, P9846, DOI 10.1523/JNEUROSCI.2803-07.2007; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakata Y, 2012, J NEUROSCI, V32, P17186, DOI 10.1523/JNEUROSCI.2220-12.2012; Petersen K, 1999, NEUROSCIENCE, V91, P651, DOI 10.1016/S0306-4522(98)00596-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Scott D, 2012, J NEUROSCI, V32, P10129, DOI 10.1523/JNEUROSCI.0535-12.2012; Shah MM, 2010, TRENDS NEUROSCI, V33, P307, DOI 10.1016/j.tins.2010.03.002; Sheng M., 2011, COLD SPRING HARB PER, V3; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Tatebe H, 2010, NEUROSCI RES, V67, P341, DOI 10.1016/j.neures.2010.04.008; Totterdell S, 2005, NEUROSCIENCE, V135, P907, DOI 10.1016/j.neuroscience.2005.06.047; Vivacqua G, 2011, J CHEM NEUROANAT, V41, P97, DOI 10.1016/j.jchemneu.2010.12.003; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Watanabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052868; Winner B, 2012, J NEUROSCI, V32, P16906, DOI 10.1523/JNEUROSCI.2723-12.2012; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	32	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89327	10.1371/journal.pone.0089327	http://dx.doi.org/10.1371/journal.pone.0089327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586691	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900038
J	Braach, N; Frommhold, D; Buschmann, K; Pflaum, J; Koch, L; Hudalla, H; Staudacher, K; Wang, HJ; Isermann, B; Nawroth, P; Poeschl, J				Braach, Natascha; Frommhold, David; Buschmann, Kirsten; Pflaum, Johanna; Koch, Lutz; Hudalla, Hannes; Staudacher, Kathrin; Wang, Hongjie; Isermann, Berend; Nawroth, Peter; Poeschl, Johannes			RAGE Controls Activation and Anti-Inflammatory Signalling of Protein C	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INFLAMMATORY CELL RECRUITMENT; ENDOTHELIAL-CELLS; IN-VIVO; LEUKOCYTE RECRUITMENT; P-SELECTIN; DIABETIC-NEPHROPATHY; IMPROVES SURVIVAL; ENDPRODUCTS RAGE; SEPTIC SHOCK	Aims: The receptor for advanced glycation endproducts, RAGE, is a multiligand receptor and NF-kappa B activator leading to perpetuation of inflammation. We investigated whether and how RAGE is involved in mediation of anti-inflammatory properties of protein C. Methods and Results: We analyzed the effect of protein C on leukocyte adhesion and transmigration in WT- and RAGE-deficient mice using intravital microscopy of cremaster muscle venules during trauma-and TNF alpha-induced inflammation. Both, protein C (PC, Ceprotin, 100 U/kg) and activated protein C (aPC, 24 mu g/kg/h) treatment significantly inhibited leukocyte adhesion in WT mice in these inflammation models. The impaired leukocyte adhesion after trauma-induced inflammation in RAGE knockout mice could not be further reduced by PC and aPC. After TNF alpha-stimulation, however, aPC but not PC treatment effectively blocked leukocyte adhesion in these mice. Consequently, we asked whether RAGE is involved in PC activation. Since RAGE-deficient mice and endothelial cells showed insufficient PC activation, and since thrombomodulin (TM) and endothelial protein C receptor (EPCR) are reduced on the mRNA and protein level in RAGE deficient endothelial cells, an involvement of RAGE in TM-EPCR-dependent PC activation is likely. Moreover, TNF alpha-induced activation of MAPK and upregulation of ICAM-1 and VCAM-1 are reduced both in response to aPC treatment and in the absence of RAGE. Thus, there seems to be interplay of the RAGE and the PC pathway in inflammation. Conclusion: RAGE controls anti-inflammatory properties and activation of PC, which might involve EPCR and TM.	[Braach, Natascha; Frommhold, David; Buschmann, Kirsten; Pflaum, Johanna; Koch, Lutz; Hudalla, Hannes; Staudacher, Kathrin; Poeschl, Johannes] Univ Childrens Hosp, Dept Neonatol, Heidelberg, Germany; [Wang, Hongjie; Isermann, Berend] Otto Von Guericke Univ, Dept Clin Chem & Biochem, Magdeburg, Germany; [Nawroth, Peter] Univ Hosp, Dept Med & Clin Chem 1, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Otto von Guericke University; Ruprecht Karls University Heidelberg	Braach, N (corresponding author), Univ Childrens Hosp, Dept Neonatol, Heidelberg, Germany.	natascha.braach@uni-heidelberg.de; David.Frommhold@med.uni-heidelberg.de		Koch, Lutz/0000-0003-3683-2274	Deutsche Forschungsgemeinschaft [SFB938, DFG BI 1281/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was in part supported by grants from the Deutsche Forschungsgemeinschaft to PN (SFB938 and DFG BI 1281/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104; Bae JS, 2011, BLOOD, V118, P3952, DOI 10.1182/blood-2011-06-360701; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Bock F, 2013, P NATL ACAD SCI USA, V110, P648, DOI 10.1073/pnas.1218667110; Buschmann K, 2012, MEDIATORS INFLAMMATI, V2012, P12; Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Elphick GF, 2009, BLOOD, V113, P4078, DOI 10.1182/blood-2008-09-180968; Esmon CT, 2004, J THROMB HAEMOST, V2, P209, DOI 10.1046/j.1538-7933.2003.00537.x; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; ESMON CT, 1993, METHOD ENZYMOL, V222, P359; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Fink K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053103; Forlow SB, 2001, AM J PHYSIOL-HEART C, V280, pH634, DOI 10.1152/ajpheart.2001.280.2.H634; Frommhold D, 2008, J EXP MED, V205, P1435, DOI 10.1084/jem.20070846; Frommhold D, 2011, AM J PATHOL, V179, P2637, DOI 10.1016/j.ajpath.2011.07.023; Frommhold D, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-56; Frommhold D, 2010, BLOOD, V116, P841, DOI 10.1182/blood-2009-09-244293; Guitton C, 2011, AM J PHYSIOL-CELL PH, V300, pC833, DOI 10.1152/ajpcell.00003.2010; Isermann B, 2001, J CLIN INVEST, V108, P537, DOI 10.1172/JCI13077; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Jackson CJ, 2008, INT J BIOCHEM CELL B, V40, P2692, DOI 10.1016/j.biocel.2007.12.013; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Jung U, 1997, MICROCIRCULATION-LON, V4, P311, DOI 10.3109/10739689709146794; Jung U, 1996, AM J PHYSIOL-HEART C, V271, pH2740, DOI 10.1152/ajpheart.1996.271.6.H2740; Kau JH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-98; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Lange-Sperandio B, 2007, CURR PEDIATR REV, V3, P1, DOI 10.2174/157339607779941598; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liaw PCY, 2003, J THROMB HAEMOST, V1, P662, DOI 10.1046/j.1538-7836.2003.00153.x; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Luo Y, 2013, BIOCH BIOPH IN PRESS; Madhusudhan T, 2012, BLOOD, V119, P874, DOI 10.1182/blood-2011-07-365973; Messaris E, 2010, CRIT CARE MED, V38, P209, DOI 10.1097/CCM.0b013e3181b4a972; Minhas N, 2010, FASEB J, V24, P873, DOI 10.1096/fj.09-134445; Moore CC, 2013, J SURG RES, V182, P116, DOI 10.1016/j.jss.2012.07.063; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; OWEN WG, 1981, J BIOL CHEM, V256, P5532; Pusterla T, 2013, HEPATOLOGY, V58, P363, DOI 10.1002/hep.26395; Ramsgaard L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020132; Rance JB, 2003, BLOOD, V101, P4393, DOI 10.1182/blood-2002-05-1570; Rezaie AR, 2010, CURR MED CHEM, V17, P2059, DOI 10.2174/092986710791233706; Rezaie AR, 2011, IUBMB LIFE, V63, P390, DOI 10.1002/iub.447; Riehl A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-537; Riewald M, 2003, J ENDOTOXIN RES, V9, P317, DOI 10.1179/096805103225002584; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; Sopel MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045663; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Sturn DH, 2003, BLOOD, V102, P1499, DOI 10.1182/blood-2002-12-3880; Taylor FB, 2001, BLOOD, V97, P1685, DOI 10.1182/blood.V97.6.1685; TAZAWA R, 1993, J BIOCHEM-TOKYO, V113, P600, DOI 10.1093/oxfordjournals.jbchem.a124089; Uchiba M, 2004, CIRC RES, V95, P34, DOI 10.1161/01.RES.0000133680.87668.FA; van Zoelen Marieke A D, 2011, Front Biosci (Schol Ed), V3, P1119; van Zoelen MAD, 2009, J INFECT DIS, V200, P765, DOI 10.1086/604730; van Zoelen MA, 2011, CRIT CARE, V15, DOI 10.1186/cc9990; Weiler H, 2001, ARTERIOSCL THROM VAS, V21, P1531, DOI 10.1161/hq0901.094496; Yamamoto Y, 2011, J IMMUNOL, V186, P3248, DOI 10.4049/jimmunol.1002253	61	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89422	10.1371/journal.pone.0089422	http://dx.doi.org/10.1371/journal.pone.0089422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586767	Green Published, gold, Green Submitted			2022-12-27	WOS:000331880700041
J	Nisar, N; Aamir, UB; Badar, N; Mehmood, MR; Alam, MM; Kazi, BM; Zaidi, SSZ				Nisar, Nadia; Aamir, Uzma Bashir; Badar, Nazish; Mehmood, Muhammad Rashid; Alam, Muhammad Masroor; Kazi, Birjees Mazher; Zaidi, Syed Sohail Zahoor			Prediction of Clinical Factors Associated with Pandemic Influenza A (H1N1) 2009 in Pakistan	PLOS ONE			English	Article							INFECTION; EPIDEMICS; CHILDREN; ILLNESS; AGE	Background: Influenza is a viral infection that can lead to serious complications and death(s) in vulnerable groups if not diagnosed and managed in a timely manner. This study was conducted to improve the accuracy of predicting influenza through various clinical and statistical models. Methodology: A retrospective cross sectional analysis was done on demographic and epidemiological data collected from March 2009 to March 2010. Patients were classified as ILI or SARI using WHO case definitions. Respiratory specimens were tested by RT-PCR. Clinical symptoms and co-morbid conditions were analyzed using binary logistic regression models. Results: In the first approach, analysis compared children (<= 12) and adults (>= 12). Of 1,243 cases, 262 (21%) tested positive for A(H1N1)pdm09 and the proportion of children (<= 12) and adults (>12) were 27% and 73% respectively. Four symptoms predicted influenza in children: fever (OR 2.849, 95% CI 1.931-8.722), cough (OR 1.99, 95% CI 1.512-3.643), diarrhea (OR 2.100, 95% CI 2.040-3.25) and respiratory disease (OR 3.269, 95% CI 2.128-12.624). In adults, the strongest clinical predictor was fever (OR 2.80, 95% CI 1.025-3.135) followed by cough (OR 1.431, 95% CI 1.032-2.815). In the second instance, patients were separated into two groups: SARI 326 (26%) and ILI 917 (74%) cases. Male to female ratio was 1.41:1.12 for SARI and 2:1.5 for ILI cases. Chi-square test showed that fever, cough and sore throat were significant factors for A(H1N1) pdm09 infections (p = 0.008). Conclusion: Studies in a primary care setting should be encouraged focused on patients with influenza-like illness to develop sensitive clinical case definition that will help to improve accuracy of detecting influenza infections. Formulation of a standard "one size fits all'' case definition that best correlates with influenza infections can help guide decisions for additional diagnostic testing and also discourage unjustified antibiotic prescription and usage in clinical practice.	[Nisar, Nadia; Aamir, Uzma Bashir; Badar, Nazish; Mehmood, Muhammad Rashid; Alam, Muhammad Masroor; Kazi, Birjees Mazher; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan		Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	zaidis@pak.emro.who.int	Zaidi, Syed Sohail Zahoor/F-7432-2015					Barakat A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024579; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; European Influenza Surveillance Scheme, 2005, ANN REPORT; Kao Hsiu-Tsun, 2000, Journal of Microbiology Immunology and Infection, V33, P105; Karageorgopoulos DE, 2011, PLOS ONE, V6; Kim CO, 2010, YONSEI MED J, V51, P895, DOI 10.3349/ymj.2010.51.6.895; Kuo CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028102; Lee VJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017468; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Louie JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018221; Michiels B, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-4; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Navarro-Mari JM, 2005, J CLIN EPIDEMIOL, V58, P275, DOI 10.1016/j.jclinepi.2004.08.014; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Rajatonirina S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037067; Socan M, 2010, CENT EUR J MED, V5, P41, DOI 10.2478/s11536-009-0089-3; Thompson DL, 2011, AM J PUBLIC HEALTH, V101, P1776, DOI 10.2105/AJPH.2011.300223; van Elden LJR, 2001, BRIT J GEN PRACT, V51, P630; World Health Organization, 2011, WHO GLOB TECHN CONS; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028786	22	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89178	10.1371/journal.pone.0089178	http://dx.doi.org/10.1371/journal.pone.0089178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586575	gold, Green Published, Green Submitted			2022-12-27	WOS:000331880700021
J	Tyrer, RA; Fazel, M				Tyrer, Rebecca A.; Fazel, Mina			School and Community-Based Interventions for Refugee and Asylum Seeking Children: A Systematic Review	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CREATIVE EXPRESSION WORKSHOPS; MENTAL-HEALTH INTERVENTION; EXPOSURE THERAPY; NORTHERN UGANDA; RISK-FACTORS; 2 DECADES; WAR; PROGRAM; IMMIGRANT	Background: Research for effective psychological interventions for refugee and asylum-seeking children has intensified. The need for interventions in environments more easily accessed by children and families is especially relevant for newly arrived populations. This paper reviews the literature on school and community-based interventions aimed at reducing psychological disorders in refugee and asylum-seeking children. Methods and Findings: Comprehensive searches were conducted in seven databases and further information was obtained through searching reference lists, grey literature, and contacting experts in the field. Studies were included if they reported on the efficacy of a school or community-based mental health intervention for refugee or asylum-seeking children. Two independent reviewers made the final study selection, extracted data, and reached consensus on study quality. Results were summarized descriptively. The marked heterogeneity of studies excluded conducting a meta-analysis but study effect-sizes were calculated where possible. Twenty one studies met inclusion criteria for the review reporting on interventions for approximately 1800 refugee children. Fourteen studies were carried out in high-income countries in either a school (n = 11) or community (n = 3) setting and seven studies were carried out in refugee camps. Interventions were either primarily focused on the verbal processing of past experiences (n = 9), or on an array of creative art techniques (n = 7) and others used a combination of these interventions (n = 5). While both intervention types reported significant changes in symptomatology, effect sizes ranged from 0.31 to 0.93 and could mainly be calculated for interventions focusing on the verbal processing of past experiences. Conclusions: Only a small number of studies fulfilled inclusion criteria and the majority of these were in the school setting. The findings suggest that interventions delivered within the school setting can be successful in helping children overcome difficulties associated with forced migration.	[Tyrer, Rebecca A.; Fazel, Mina] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England	University of Oxford	Fazel, M (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England.	mina.fazel@psych.ox.ac.uk		Fazel, Mina/0000-0001-9342-2365	NIHR Post-Doctoral Fellowship [PDF-2010-03-10]; National Institute for Health Research [PDF-2010-03-10] Funding Source: researchfish	NIHR Post-Doctoral Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by a NIHR Post-Doctoral Fellowship for MF (PDF-2010-03-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager A, 2011, J CHILD PSYCHOL PSYC, V52, P1124, DOI 10.1111/j.1469-7610.2011.02407.x; Andemicael A., 2011, POSITIVE ENERGY REV; Baker F, 2006, EMOT BEHAV DIFFIC, V11, P249, DOI 10.1080/13632750601022170; Barrett PM, 2000, BEHAV CHANGE, V17, P124, DOI 10.1375/bech.17.3.124; Barrett PM, 2003, CLIN CHILD PSYCHOL P, V8, P241, DOI DOI 10.1177/1359104503008002008; Basoglu M, 2006, BMJ-BRIT MED J, V333, P1230, DOI 10.1136/bmj.39036.739236.43; Becker LA, 1999, EFFECT SIZE CALCULAT; Beehler S, 2012, AM J COMMUN PSYCHOL, V50, P155, DOI 10.1007/s10464-011-9486-2; Betancourt TS, 2008, INTERVENTION, V6, P39, DOI 10.1097/WTF.0b013e3282f761ff; Betancourt TS, 2012, J ADOLESCENT HEALTH, V51, P544, DOI 10.1016/j.jadohealth.2012.02.010; Birman D., 2007, PREVENTION RES, V14, P14, DOI DOI 10.1037/E717692007-004; Birman D, 2008, AM J ORTHOPSYCHIAT, V78, P121, DOI 10.1037/0002-9432.78.1.121; Bogic M, 2012, BRIT J PSYCHIAT, V200, P216, DOI 10.1192/bjp.bp.110.084764; Bolton P, 2007, JAMA-J AM MED ASSOC, V298, P519, DOI 10.1001/jama.298.5.519; Catani C, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-22; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crisp J, 2000, AFR AFFAIRS, V99, P601, DOI 10.1093/afraf/99.397.601; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Dura-Vila G, 2013, CLIN CHILD PSYCHOL P, V18, P604, DOI 10.1177/1359104512462549; Ehntholt K.A., 2005, CLIN CHILD PSYCHOL P, V10, P235, DOI [10.1177/1359104505051214, DOI 10.1177/1359104505051214]; Ellis BH, 2013, J CONSULT CLIN PSYCH, V81, P129, DOI 10.1037/a0029844; Ertl V, 2011, JAMA-J AM MED ASSOC, V306, P503, DOI 10.1001/jama.2011.1060; Evans SW, 1999, CLIN PSYCHOL REV, V19, P165, DOI 10.1016/S0272-7358(98)00069-5; Fazel M, 2003, BMJ-BRIT MED J, V327, P297; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Fazel Mina, 2009, Clin Child Psychol Psychiatry, V14, P297, DOI 10.1177/1359104508100128; Folkes Crystal E, 2002, Int J Emerg Ment Health, V4, P99; Fox Patricia G, 2005, Int J Psychiatr Nurs Res, V11, P1227; Fremont WP, 2004, J AM ACAD CHILD PSY, V43, P381, DOI 10.1097/00004583-200404000-00004; Gupta L, 2008, BRIT J PSYCHIAT, V192, P212, DOI 10.1192/bjp.bp.107.038182; Henley J, 2011, CLIN PSYCHOL-UK, V15, P51, DOI 10.1111/j.1742-9552.2011.00024.x; Hoagwood K, 1997, J CHILD FAM STUD, V6, P135; Hodes M., 2000, CHILD PSYCHOL PSYCHI, V5, P57, DOI [DOI 10.1017/S136064170000215X, 10.1017/S136064170000215X]; Hodes M, 2008, J CHILD PSYCHOL PSYC, V49, P723, DOI 10.1111/j.1469-7610.2008.01912.x; Jordans MJD, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-15; Jordans MJD, 2009, CHILD ADOL MENT H-UK, V14, P2, DOI 10.1111/j.1475-3588.2008.00515.x; Kalantari M, 2012, OMEGA-J DEATH DYING, V65, P139, DOI 10.2190/OM.65.2.d; Kataoka SH, 2003, J AM ACAD CHILD PSY, V42, P311, DOI 10.1097/00004583-200303000-00011; Kia-Keating Maryam, 2007, Clin Child Psychol Psychiatry, V12, P29, DOI 10.1177/1359104507071052; Marshall GN, 2005, JAMA-J AM MED ASSOC, V294, P571, DOI 10.1001/jama.294.5.571; Masia-Warner C., 2006, EDUC TREAT CHILD, V29, P165; Mels C, 2010, J CHILD PSYCHOL PSYC, V51, P1096, DOI 10.1111/j.1469-7610.2010.02241.x; Miller KE, 2010, SOC SCI MED, V70, P7, DOI 10.1016/j.socscimed.2009.09.029; Mohlen H, 2005, AUST NZ J PSYCHIAT, V39, P81, DOI 10.1111/j.1440-1614.2005.01513.x; Nickerson A, 2011, CLIN PSYCHOL REV, V31, P399, DOI 10.1016/j.cpr.2010.10.004; O'Shea B., 2000, CLIN CHILD PSYCHOL P, V5, P189, DOI DOI 10.1177/1359104500005002004; Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147; Onyut LP, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-7; Paardekooper BP, 2002, THESIS VRIJE U AMSTE; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Reed RV, 2012, LANCET, V379, P250, DOI 10.1016/S0140-6736(11)60050-0; Rousseau C, 2005, J CHILD PSYCHOL PSYC, V46, P180, DOI 10.1111/j.1469-7610.2004.00344.x; Rousseau C, 2004, J AM ACAD CHILD PSY, V43, P235, DOI 10.1097/00004583-200402000-00021; Rousseau C, 2008, CHILD ADOL PSYCH CL, V17, P533, DOI 10.1016/j.chc.2008.02.002; Rousseau Cecile, 2007, Clin Child Psychol Psychiatry, V12, P451; Rousseau C, 2009, J CHILD PSYCHOL PSYC, V50, P743, DOI 10.1111/j.1469-7610.2008.02003.x; Schaefer C. E., 1993, THERAPEUTIC POWERS P; Schottelkorb A.A., 2012, INT J PLAY THERAPY, V21, P57, DOI [10.1037/a0027430, DOI 10.1037/A0027430]; Shergill NK, 2010, THESIS U BIRMINGHAM; Stein BD, 2002, J BEHAV HEALTH SER R, V29, P318, DOI 10.1007/BF02287371; Thabet AA, 2005, EUR CHILD ADOLES PSY, V14, P262, DOI 10.1007/s00787-005-0466-7; Thalheimer W., 2002, CALCULATE EFFECT SIZ, DOI DOI 10.1113/jphysiol.2004.078915; Tingvold L, 2012, INT J INTERCULT REL, V36, P563, DOI 10.1016/j.ijintrel.2012.03.004; Tol WA, 2013, J CHILD PSYCHOL PSYC, V54, P445, DOI 10.1111/jcpp.12053; Tol WA, 2012, WORLD PSYCHIATRY, V11, P114, DOI 10.1016/j.wpsyc.2012.05.008; Torbert M, 1990, FOLLOW ME HDB MOVEME; UNHCR, 2012, STAT YB 2011 TRENDS, P20; UNHCR, 1992, HDB PROC CRIT DET RE; UNHCR, 2013, GLOB TRENDS 2012; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Yates SL, 2005, PAIN, V117, P314, DOI 10.1016/j.pain.2005.06.018	72	154	156	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89359	10.1371/journal.pone.0089359	http://dx.doi.org/10.1371/journal.pone.0089359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB6EP	24586715	gold, Green Published			2022-12-27	WOS:000331880700030
J	Zhang, TX; Han, BX				Zhang, Tengxiao; Han, Buxin			Experience Reverses the Red Effect among Chinese Stockbrokers	PLOS ONE			English	Article							PERFORMANCE; COLOR; CONTESTS; WOMEN	Recent research has shown that the color red influences psychological functioning. Red is hypothesized to be linked to aggression and danger in evolution, and these links are enhanced by culture-specific uses of red. Thus, color meanings are thought to be grounded in biologically based proclivities and learned associations. However, to date, there has been no direct evidence for the influence of experience on the red effect. This study focused on whether experience could change the psychological effects of the color red. In the context of the Chinese stock market, contrary to the meaning generally associated with red as negative and green as positive, red represents a rise in stock price and green stands for a decrease. An experiment using a 262 between subjects factorial design demonstrated that red (compared with green) impaired Chinese college students' performance on an IQ test (in accordance with the red effect), but the opposite effect was found among stockbrokers. These results provide direct evidence of learned color meanings, in support of the general model of color effect.	[Zhang, Tengxiao; Han, Buxin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Han, BX (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	hanbx@psych.ac.cn	Zhang, Tengxiao/P-2629-2015	Zhang, Tengxiao/0000-0001-5239-9904	Standardization Administration of the People's Republic of China [Y0HX331Y01]	Standardization Administration of the People's Republic of China	This study was supported by the Standardization Administration of the People's Republic of China (Y0HX331Y01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton RA, 2005, NATURE, V437, pE10, DOI 10.1038/nature04307; Bergman TJ, 2009, INT J PRIMATOL, V30, P791, DOI 10.1007/s10764-009-9374-x; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Elliot AJ, 2007, CURR DIR PSYCHOL SCI, V16, P250, DOI 10.1111/j.1467-8721.2007.00514.x; Elliot AJ, 2007, J EXP PSYCHOL GEN, V136, P154, DOI 10.1037/0096-3445.136.1.154; Elliot AJ, 2012, ADV EXP SOC PSYCHOL, V45, P61, DOI 10.1016/B978-0-12-394286-9.00002-0; Elliot AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034607; Elliot AJ, 2011, PSYCHOPHYSIOLOGY, V48, P1340, DOI 10.1111/j.1469-8986.2011.01216.x; Elliot AJ, 2010, J EXP PSYCHOL GEN, V139, P399, DOI 10.1037/a0019689; Elliot AJ, 2009, PERS SOC PSYCHOL B, V35, P365, DOI 10.1177/0146167208328330; GUEGUEN N, 2012, INT J PSYCHOL STUD, V4, pP206; Gueguen N, 2012, INT J HOSP MANAG, V31, P1333, DOI 10.1016/j.ijhm.2012.03.012; Hill RA, 2005, NATURE, V435, P293, DOI 10.1038/435293a; Lichtenfeld S, 2009, J EXP SOC PSYCHOL, V45, P1273, DOI 10.1016/j.jesp.2009.06.003; Maier MA, 2008, PERS SOC PSYCHOL B, V34, P1530, DOI 10.1177/0146167208323104; Meier BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040333; Pryke SR, 2009, ANIM BEHAV, V78, P393, DOI 10.1016/j.anbehav.2009.05.013; Roberts SC, 2010, EVOL PSYCHOL-US, V8, P350, DOI 10.1177/147470491000800304; Setchell JM, 2005, ETHOLOGY, V111, P25, DOI 10.1111/j.1439-0310.2004.01054.x; ZHANG H, 1989, PSYCHOL SINICA, V21, P113	20	20	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89193	10.1371/journal.pone.0089193	http://dx.doi.org/10.1371/journal.pone.0089193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB6EP	24586587	gold, Green Submitted, Green Published			2022-12-27	WOS:000331880700023
J	Jiang, YS; Zhang, LY; Kong, FW; Zhang, MM; Lv, HC; Liu, GY; Liao, MZ; Feng, RN; Li, J; Zhang, RJ				Jiang, Yongshuai; Zhang, Lanying; Kong, Fanwu; Zhang, Mingming; Lv, Hongchao; Liu, Guiyou; Liao, Mingzhi; Feng, Rennan; Li, Jin; Zhang, Ruijie			MCPerm: A Monte Carlo Permutation Method for Accurately Correcting the Multiple Testing in a Meta-Analysis of Genetic Association Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SYSTEMATIC METAANALYSES; HETEROGENEITY; SCHIZOPHRENIA; VARIANCE; DATABASE; REVIEWS	Traditional permutation (TradPerm) tests are usually considered the gold standard for multiple testing corrections. However, they can be difficult to complete for the meta-analyses of genetic association studies based on multiple single nucleotide polymorphism loci as they depend on individual-level genotype and phenotype data to perform random shuffles, which are not easy to obtain. Most meta-analyses have therefore been performed using summary statistics from previously published studies. To carry out a permutation using only genotype counts without changing the size of the TradPerm P-value, we developed a Monte Carlo permutation (MCPerm) method. First, for each study included in the meta-analysis, we used a two-step hypergeometric distribution to generate a random number of genotypes in cases and controls. We then carried out a meta-analysis using these random genotype data. Finally, we obtained the corrected permutation P-value of the meta-analysis by repeating the entire process N times. We used five real datasets and five simulation datasets to evaluate the MCPerm method and our results showed the following: (1) MCPerm requires only the summary statistics of the genotype, without the need for individual-level data; (2) Genotype counts generated by our two-step hypergeometric distributions had the same distributions as genotype counts generated by shuffling; (3) MCPerm had almost exactly the same permutation P-values as TradPerm (r = 0.999; P < 2.2e-16); (4) The calculation speed of MCPerm is much faster than that of TradPerm. In summary, MCPerm appears to be a viable alternative to TradPerm, and we have developed it as a freely available R package at CRAN: http://cran.r-project.org/web/packages/MCPerm/index.html.	[Jiang, Yongshuai; Zhang, Lanying; Zhang, Mingming; Lv, Hongchao; Li, Jin; Zhang, Ruijie] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Kong, Fanwu] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Peoples R China; [Liu, Guiyou] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Genome Anal Lab, Tianjin, Peoples R China; [Liao, Mingzhi] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Feng, Rennan] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Northwest A&F University - China; Harbin Medical University	Jiang, YS (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	jiangyongshuai@gmail.com; zhangruijie2013@gmail.com		Jiang, Yongshuai/0000-0002-7163-6554; Liu, Guiyou/0000-0002-1126-2888	National Natural Science Foundation of China [81172842, 31200934]; Natural Science Foundation of Heilongjiang Province [C201206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 81172842, 31200934) and Natural Science Foundation of Heilongjiang Province (Grant No. C201206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Bass NJ, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-28; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Engberg S, 2008, J WOUND OSTOMY CONT, V35, P258, DOI 10.1097/01.WON.0000319122.76112.23; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Green S., 2005, SMJ Singapore Medical Journal, V46, P270; Green S., 2005, SINGAP MED J, V46; Haerian BS, 2013, PHARMACOGENOMICS, V14, P813, DOI [10.2217/PGS.13.57, 10.2217/pgs.13.57]; HAUCK WW, 1979, BIOMETRICS, V35, P817, DOI 10.2307/2530114; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; KACHITVICHYANUKUL V, 1985, J STAT COMPUT SIM, V22, P127, DOI 10.1080/00949658508810839; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Lill CM, 2011, AMYOTROPH LATERAL SC, V12, P238, DOI 10.3109/17482968.2011.584629; Liu G, 2013, NEUROSCI LETT; Pahl R, 2010, BIOINFORMATICS, V26, P2093, DOI 10.1093/bioinformatics/btq399; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wu Z, 2013, TUMOUR BIOL	25	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89212	10.1371/journal.pone.0089212	http://dx.doi.org/10.1371/journal.pone.0089212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586601	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900062
J	Marsan, M; Van den Eynden, G; Limame, R; Neven, P; Hauspy, J; Van Dam, PA; Vergote, I; Dirix, LY; Vermeulen, PB; Van Laere, SJ				Marsan, Melike; Van den Eynden, Gert; Limame, Ridha; Neven, Patrick; Hauspy, Jan; Van Dam, Peter A.; Vergote, Ignace; Dirix, Luc Y.; Vermeulen, Peter B.; Van Laere, Steven J.			A Core Invasiveness Gene Signature Reflects Epithelial-to-Mesenchymal Transition but Not Metastatic Potential in Breast Cancer Cell Lines and Tissue Samples	PLOS ONE			English	Article							NF-KAPPA-B; HISTOLOGIC GRADE; CLAUDIN-LOW; STEM-CELLS; EXPRESSION; MOTILITY; POPULATION; PREDICTOR; INVASION; THERAPY	Introduction: Metastases remain the primary cause of cancer-related death. The acquisition of invasive tumour cell behaviour is thought to be a cornerstone of the metastatic cascade. Therefore, gene signatures related to invasiveness could aid in stratifying patients according to their prognostic profile. In the present study we aimed at identifying an invasiveness gene signature and investigated its biological relevance in breast cancer. Methods & Results: We collected a set of published gene signatures related to cell motility and invasion. Using this collection, we identified 16 genes that were represented at a higher frequency than observed by coincidence, hereafter named the core invasiveness gene signature. Principal component analysis showed that these overrepresented genes were able to segregate invasive and non-invasive breast cancer cell lines, outperforming sets of 16 randomly selected genes (all P<0.001). When applied onto additional data sets, the expression of the core invasiveness gene signature was significantly elevated in cell lines forced to undergo epithelial-mesenchymal transition. The link between core invasiveness gene expression and epithelial-mesenchymal transition was also confirmed in a dataset consisting of 2420 human breast cancer samples. Univariate and multivariate Cox regression analysis demonstrated that CIG expression is not associated with a shorter distant metastasis free survival interval (HR = 0.956, 95% C. I. = 0.896-1.019, P = 0.186). Discussion: These data demonstrate that we have identified a set of core invasiveness genes, the expression of which is associated with epithelial-mesenchymal transition in breast cancer cell lines and in human tissue samples. Despite the connection between epithelial-mesenchymal transition and invasive tumour cell behaviour, we were unable to demonstrate a link between the core invasiveness gene signature and enhanced metastatic potential.	[Marsan, Melike; Van den Eynden, Gert; Hauspy, Jan; Dirix, Luc Y.; Vermeulen, Peter B.; Van Laere, Steven J.] GZA Hosp Sint Augustinus, Ctr Oncol, Translat Canc Res Unit, Antwerp, Belgium; [Limame, Ridha] Univ Antwerp, Lab Canc Res & Clin Oncol, B-2020 Antwerp, Belgium; [Marsan, Melike; Neven, Patrick; Vergote, Ignace; Van Laere, Steven J.] Katholieke Univ Leuven, Dept Oncol, Louvain, Belgium; [Van Dam, Peter A.] UZA, Antwerp, Belgium	University of Antwerp; KU Leuven	Marsan, M (corresponding author), GZA Hosp Sint Augustinus, Ctr Oncol, Translat Canc Res Unit, Antwerp, Belgium.	melike.marsan@GZA.be	Van Laere, Steven/GQA-8872-2022; Dirix, Luc/AAI-8880-2020	Van Laere, Steven/0000-0002-2640-0040; 				Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Alakel N, 2009, EXP HEMATOL, V37, P504, DOI 10.1016/j.exphem.2008.12.005; Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Andarawewa KL, 2007, CANCER RES, V67, P8662, DOI 10.1158/0008-5472.CAN-07-1294; Bilban M, 2009, ENDOCRINOLOGY, V150, P1000, DOI 10.1210/en.2008-0456; Binger T, 2009, EXP CELL RES, V315, P1468, DOI 10.1016/j.yexcr.2008.12.022; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Charafe-Jaufrret E, 2004, J PATHOL, V202, P265, DOI 10.1002/path.1515; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Cheng CF, 2008, J INVEST DERMATOL, V128, P1981, DOI 10.1038/jid.2008.34; Choi YL, 2010, CANCER RES, V70, P2296, DOI 10.1158/0008-5472.CAN-09-3141; Colpaert CG, 2003, BRIT J CANCER, V88, P718, DOI 10.1038/sj.bjc.6600807; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Dawood S, 2011, ANN ONCOL, V22, P515, DOI 10.1093/annonc/mdq345; Demuth T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-54; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dirix LY, 2006, CURR OPIN ONCOL, V18, P563, DOI 10.1097/01.cco.0000245307.29026.0a; Dong HM, 2007, J CANCER RES CLIN, V133, P83, DOI 10.1007/s00432-006-0140-6; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fabre-Guillevin E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2203; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Horak CE, 2007, CANCER RES, V67, P7238, DOI 10.1158/0008-5472.CAN-07-0962; Hu F, 2011, BBA-GENE REGUL MECH, V1809, P200, DOI 10.1016/j.bbagrm.2011.01.003; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Liu SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001770; Lopez D, 2009, ARCH BIOCHEM BIOPHYS, V482, P77, DOI 10.1016/j.abb.2008.11.016; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Nakamura T, 2007, CANCER RES, V67, P7597, DOI 10.1158/0008-5472.CAN-07-0874; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rodenhiser DI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2121; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shimamura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020804; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Trinh XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022469; Van Laere SJ, 2006, CLIN CANCER RES, V12, P3249, DOI 10.1158/1078-0432.CCR-05-2800; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Zabouo G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2215; Zhang Y, 2009, BREAST CANCER RES TR, V116, P303, DOI 10.1007/s10549-008-0183-2	70	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89262	10.1371/journal.pone.0089262	http://dx.doi.org/10.1371/journal.pone.0089262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586640	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900075
J	Wu, JM; Lin, R; Huang, JH; Guan, WH; Oetting, WS; Sriramarao, P; Blumenthal, MN				Wu, Jianming; Lin, Rui; Huang, Jinhai; Guan, Weihua; Oetting, William S.; Sriramarao, P.; Blumenthal, Malcolm N.			Functional Fcgamma Receptor Polymorphisms Are Associated with Human Allergy	PLOS ONE			English	Article							FC-GAMMA-RIIB; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; B-CELL RECEPTOR; TRANSMEMBRANE POLYMORPHISM; SUSCEPTIBILITY LOCI; HUMAN-NEUTROPHILS; LIPID RAFTS; MAST-CELLS; IGG	Objective: IgG Fc receptors (Fc gamma Rs) play important roles in immune responses. It is not clear whether Fc gamma R receptors play a role in human asthma and allergy. The aim of current study was to investigate whether functional single nucleotide polymorphisms (SNPs) of Fc gamma R genes (FCGR) are associated with human asthma and allergy. Methods: Functional SNPs of FCGR2A (FccRIIA-131His. Arg, rs1801274), FCGR2B (Fc gamma RIIB-187Ile. Thr, rs1050501), FCGR2C (Fc gamma RIIC-13Gln. Stop, rs10917661), FCGR3A (Fc gamma RIIIA-158Val. Phe, rs396991), and FCGR3B variants (Fc gamma RIIIB NA1 and NA2) were genotyped in an asthma family cohort including 370 atopy positive, 239 atopy negative, and 169 asthma positive subjects. The genotype and phenotype data (asthma, bronchial hyper-responsiveness, and atopy) of subjects were analyzed using family-based association tests (FBAT) and logistic regression adjusted for age and sex. Result: The Fc gamma RIIA-131His. Arg SNP is significantly associated with atopy in a family-based association test (P = 0.00287) and in a logistic regression analysis (P = 0.0269, OR 0.732, 95% CI: 0.555-0.965). The Fc gamma RIIA-131His (or rs1801274-A) allele capable of binding human IgG2 has a protective role against atopy. In addition, the rare Fc gamma RIIB-187Thr (or rs1050501-C) allele defective for the receptor-mediated inhibitory signals is a risk factor for atopy (P = 0.0031, OR 1.758, 95% CI: 1.2092.556) and IgE production (P, 0.001). However, variants of activating Fc gamma RIIIA (rs396991), and Fc gamma RIIIB (NA1 and NA2), and Fc gamma RIIC (rs10917661) are not associated with asthma, BHR, and atopy (P. 0.05). Conclusions: FccRIIA and FccRIIB functional polymorphisms may have a role in the pathogenesis of allergy.	[Wu, Jianming; Lin, Rui; Huang, Jinhai; Sriramarao, P.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Wu, Jianming; Sriramarao, P.; Blumenthal, Malcolm N.] Univ Minnesota, Dept Med, St Paul, MN 55108 USA; [Guan, Weihua] Univ Minnesota, Dept Biostat, St Paul, MN 55108 USA; [Oetting, William S.] Univ Minnesota, Dept Expt & Clin Pharmacol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wu, JM (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	jmwu@umn.edu	huang, jinhai/B-1334-2016	huang, jinhai/0000-0002-1073-533X; Rao, Srirama/0000-0001-9082-1029	National Institutes of Health [R21HL117652]; American College of Rheumatology -Research and Education Foundation Within Our Reach: Finding a Cure for Rheumatoid Arthritis program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL117652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Rheumatology -Research and Education Foundation Within Our Reach: Finding a Cure for Rheumatoid Arthritis program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research was partly supported by National Institutes of Health grant R21HL117652 and a grant from American College of Rheumatology -Research and Education Foundation Within Our Reach: Finding a Cure for Rheumatoid Arthritis program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; BREDIUS RGM, 1993, J IMMUNOL, V151, P1463; Brownlie RJ, 2008, J EXP MED, V205, P883, DOI 10.1084/jem.20072565; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Chai L, 2012, J PERIODONTAL RES, V47, P273, DOI 10.1111/j.1600-0765.2011.01437.x; Chen JY, 2008, GENES IMMUN, V9, P680, DOI 10.1038/gene.2008.56; Chen JY, 2006, ARTHRITIS RHEUM-US, V54, P3908, DOI 10.1002/art.22220; Chu SY, 2012, J ALLERGY CLIN IMMUN, V129, P1102, DOI 10.1016/j.jaci.2011.11.029; Clatworthy MR, 2007, P NATL ACAD SCI USA, V104, P7169, DOI 10.1073/pnas.0608889104; Cohen-Solal JLF, 2004, IMMUNOL LETT, V92, P199, DOI 10.1016/j.imlet.2004.01.012; Dharajiya N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009337; Diamantopoulos PT, 2013, LEUKEMIA LYMPHOMA, V54, P2030, DOI 10.3109/10428194.2012.762512; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Edberg JC, 2002, ARTHRITIS RHEUM, V46, P2132, DOI 10.1002/art.10438; Endeman H, 2009, CLIN VACCINE IMMUNOL, V16, P1087, DOI 10.1128/CVI.00037-09; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Jonsson F, 2012, BLOOD, V119, P2533, DOI 10.1182/blood-2011-07-367334; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kono H, 2005, HUM MOL GENET, V14, P2881, DOI 10.1093/hmg/ddi320; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Li XL, 2003, ARTHRITIS RHEUM, V48, P3242, DOI 10.1002/art.11313; Malbec O, 2002, MOL IMMUNOL, V38, P1295, DOI 10.1016/S0161-5890(02)00078-0; Morgan AW, 2000, ARTHRITIS RHEUM, V43, P2328, DOI 10.1002/1529-0131(200010)43:10<2328::AID-ANR21>3.0.CO;2-Z; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; NIEMINEN MM, 1991, CHEST, V100, P70, DOI 10.1378/chest.100.1.70; ORY PA, 1989, J CLIN INVEST, V83, P1676, DOI 10.1172/JCI114067; ORY PA, 1989, J CLIN INVEST, V84, P1688, DOI 10.1172/JCI114350; QIU WQ, 1990, SCIENCE, V248, P732, DOI 10.1126/science.2139735; Rascu A, 1997, ANN NY ACAD SCI, V815, P282, DOI 10.1111/j.1749-6632.1997.tb52070.x; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Reilly C, 2007, HUM HERED, V64, P136, DOI 10.1159/000101992; SALMON JE, 1992, J CLIN INVEST, V89, P1274, DOI 10.1172/JCI115712; Salmon JE, 1996, J CLIN INVEST, V97, P1348, DOI 10.1172/JCI118552; SANDERS LAM, 1995, INFECT IMMUN, V63, P73, DOI 10.1128/IAI.63.1.73-81.1995; SANDERS LAM, 1994, J INFECT DIS, V170, P854, DOI 10.1093/infdis/170.4.854; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; TAKIZAWA F, 1992, J EXP MED, V176, P469, DOI 10.1084/jem.176.2.469; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573; van der Pol WL, 2000, NEUROLOGY, V54, P1661, DOI 10.1212/WNL.54.8.1661; WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338; Watanabe T, 2004, AM J RESP CRIT CARE, V169, P105, DOI 10.1164/rccm.200302-239OC; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Willcocks LC, 2010, P NATL ACAD SCI USA, V107, P7881, DOI 10.1073/pnas.0915133107; Wu JM, 1997, J CLIN INVEST, V100, P1059, DOI 10.1172/JCI119616; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Yamamoto K, 2004, J PERIODONTOL, V75, P517, DOI 10.1902/jop.2004.75.4.517; Yee AMF, 2000, CLIN INFECT DIS, V30, P25, DOI 10.1086/313588; Yuan FF, 2005, TISSUE ANTIGENS, V66, P291, DOI 10.1111/j.1399-0039.2005.00476.x; 1997, NAT GENET, V15, P389	57	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89196	10.1371/journal.pone.0089196	http://dx.doi.org/10.1371/journal.pone.0089196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586589	Green Submitted, Green Published, gold			2022-12-27	WOS:000331717900060
J	Xiao, X; Yu, SR; Li, SC; Wu, JZ; Ma, R; Cao, HX; Zhu, YL; Feng, JF				Xiao, Xia; Yu, Shaorong; Li, Shuchun; Wu, Jianzhong; Ma, Rong; Cao, Haixia; Zhu, Yanliang; Feng, Jifeng			Exosomes: Decreased Sensitivity of Lung Cancer A549 Cells to Cisplatin	PLOS ONE			English	Article							TUMOR-DERIVED EXOSOMES; CELLULAR ACCUMULATION; MEDIATED TRANSFER; STROMAL CELLS; DNA-DAMAGE; EXPRESSION; GROWTH; MICROVESICLES; CHEMOTHERAPY	Exosomes are small extracellular membrane vesicles of endocytic origin released by many cells that could be found in most body fluids. The main functions of exosomes are cellular communication and cellular waste clean-up. This study was conducted to determine the involvement of exosomes in the regulation of sensitivity of the lung cancer cell line A549 to cisplatin (DDP). When DDP was added to A549 cells, exosomes secretion was strengthened. Addition of the secreted exosomes to other A549 cells increased the resistance of these A549 cells to DDP. Upon exposure of A549 to DDP, the expression levels of several miRNAs and mRNAs reportedly associated with DDP sensitivity changed significantly in exosomes; these changes may mediate the resistance of A549 cells to DDP. Exosomes released by A549 cells during DDP exposure decreased the sensitivity of other A549 cells to DDP, which may be mediated by miRNAs and mRNAs exchange by exosomes via cell-to-cell communication. Although the detailed mechanism of resistance remains unclear, we believed that inhibition of exosomes formation and release might present a novel strategy for lung cancer treatment in the future.	[Xiao, Xia; Yu, Shaorong; Wu, Jianzhong; Ma, Rong; Cao, Haixia; Feng, Jifeng] Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Canc Hosp, Res Ctr Clin Oncol, Nanjing, Jiangsu, Peoples R China; [Xiao, Xia; Yu, Shaorong; Wu, Jianzhong; Ma, Rong; Cao, Haixia; Feng, Jifeng] Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China; [Li, Shuchun] Nanjing Univ Technol, Nanjing, Jiangsu, Peoples R China; [Zhu, Yanliang] Southeast Univ, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Tech University; Southeast University - China	Feng, JF (corresponding author), Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Canc Hosp, Res Ctr Clin Oncol, Nanjing, Jiangsu, Peoples R China.	fjif@vip.sina.com	ma, rong/GVU-3096-2022; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; Li, Shuchun/0000-0003-4636-4005	National Natural Science Foundation of China [81372396]; Six Talent Peak of Human Affairs Hall in Jiangsu Province [40]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Six Talent Peak of Human Affairs Hall in Jiangsu Province	This work was supported by the National Natural Science Foundation of China (No. 81372396) and the Six Talent Peak of Human Affairs Hall in Jiangsu Province (No. 40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Corcoran C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050999; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Gao W, 2012, CANCER BIOL THER, V13, P330, DOI 10.4161/cbt.19073; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052589; GATELY DP, 1993, BRIT J CANCER, V67, P1171, DOI 10.1038/bjc.1993.221; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; Jiang JW, 2012, MOL BIOL REP, V39, P6933, DOI 10.1007/s11033-012-1520-4; Katakowski M, 2013, CANCER LETT, V335, P201, DOI 10.1016/j.canlet.2013.02.019; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; SHELLARD SA, 1993, ANTI-CANCER DRUG, V4, P491, DOI 10.1097/00001813-199308000-00011; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Whiteside TL, 2013, BIOCHEM SOC T, V41, P245, DOI 10.1042/BST20120265; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wu Y, 2011, MOL PHARMACEUT, V8, P1381, DOI 10.1021/mp2002076; Xiang Q, 2013, PHARMAZIE, V68, P274, DOI 10.1691/ph.2013.2759; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Zhang GL, 2012, MUTAT RES-GEN TOX EN, V746, P66, DOI 10.1016/j.mrgentox.2012.03.004; Zhang HJ, 2013, CELL PHYSIOL BIOCHEM, V31, P56, DOI 10.1159/000343349; Zhou C, 2009, J CLIN ONCOL, V27	28	143	153	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89534	10.1371/journal.pone.0089534	http://dx.doi.org/10.1371/journal.pone.0089534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586853	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900118
J	Fry, DL; Stephens, SL; Collins, BM; North, MP; Franco-Vizcaino, E; Gill, SJ				Fry, Danny L.; Stephens, Scott L.; Collins, Brandon M.; North, Malcolm P.; Franco-Vizcaino, Ernesto; Gill, Samantha J.			Contrasting Spatial Patterns in Active-Fire and Fire-Suppressed Mediterranean Climate Old-Growth Mixed Conifer Forests	PLOS ONE			English	Article							PONDEROSA PINE FOREST; LAKE TAHOE BASIN; SAN-PEDRO-MARTIR; SIERRA-NEVADA; JEFFREY PINE; RESTORATION TREATMENTS; STAND STRUCTURE; FUEL-REDUCTION; WOODY DEBRIS; LONG-TERM	In Mediterranean environments in western North America, historic fire regimes in frequent-fire conifer forests are highly variable both temporally and spatially. This complexity influenced forest structure and spatial patterns, but some of this diversity has been lost due to anthropogenic disruption of ecosystem processes, including fire. Information from reference forest sites can help management efforts to restore forests conditions that may be more resilient to future changes in disturbance regimes and climate. In this study, we characterize tree spatial patterns using four-ha stem maps from four old-growth, Jeffrey pine-mixed conifer forests, two with active-fire regimes in northwestern Mexico and two that experienced fire exclusion in the southern Sierra Nevada. Most of the trees were in patches, averaging six to 11 trees per patch at 0.007 to 0.014 ha(-1), and occupied 27-46% of the study areas. Average canopy gap sizes (0.04 ha) covering 11-20% of the area were not significantly different among sites. The putative main effects of fire exclusion were higher densities of single trees in smaller size classes, larger proportion of trees (>= 56%) in large patches (>= 10 trees), and decreases in spatial complexity. While a homogenization of forest structure has been a typical result from fire exclusion, some similarities in patch, single tree, and gap attributes were maintained at these sites. These within-stand descriptions provide spatially relevant benchmarks from which to manage for structural heterogeneity in frequent-fire forest types.	[Fry, Danny L.; Stephens, Scott L.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Collins, Brandon M.; North, Malcolm P.] US Forest Serv, USDA, Pacific Southwest Res Stn, Davis, CA USA; [Collins, Brandon M.] Univ Calif Berkeley, Ctr Fire Res & Outreach, Coll Nat Resources, Berkeley, CA 94720 USA; [Franco-Vizcaino, Ernesto] Ctr Invest Cient & Educ Super Ensenada, Dept Biol Conservac, Ensenada, Baja California, Mexico; [Gill, Samantha J.] Calif Polytech State Univ San Luis Obispo, Nat Resources Management & Bioresource Dept, San Luis Obispo, CA 93407 USA; [Gill, Samantha J.] Calif Polytech State Univ San Luis Obispo, Dept Agr Engn, San Luis Obispo, CA 93407 USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Berkeley; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo	Fry, DL (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	dfry@berkeley.edu	North, Malcolm/AAW-8897-2020	North, Malcolm/0000-0002-9090-784X	USDA Agricultural Experiment Station Funds from University of California, Berkeley	USDA Agricultural Experiment Station Funds from University of California, Berkeley	This project was supported by the USDA Agricultural Experiment Station Funds from University of California, Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella SR, 2009, CAN J FOREST RES, V39, P2391, DOI 10.1139/X09-146; Agee J.K., 1998, NW SCI, V72, P24; Ansley JAS, 1998, J TORREY BOT SOC, V125, P297, DOI 10.2307/2997243; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Barbour M, 2002, J VEG SCI, V13, P461, DOI 10.1111/j.1654-1103.2002.tb02073.x; BARRO SC, 1991, ENVIRON INT, V17, P135, DOI 10.1016/0160-4120(91)90096-9; Batllori E, 2013, GLOBAL ECOL BIOGEOGR, V22, P1118, DOI 10.1111/geb.12065; Bechtold WA, 2004, WEST J APPL FOR, V19, P245, DOI 10.1093/wjaf/19.4.245; Bigelow SW, 2011, CAN J FOREST RES, V41, P2051, DOI [10.1139/X11-120, 10.1139/x11-120]; Biswell HH, 1989, PRESCRIBED FIRE CALI; Boer MM, 2009, FOREST ECOL MANAG, V259, P132, DOI 10.1016/j.foreco.2009.10.005; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Boyden S, 2005, FOREST ECOL MANAG, V219, P43, DOI 10.1016/j.foreco.2005.08.041; Brown PM, 1999, LANDSCAPE ECOL, V14, P513, DOI 10.1023/A:1008137005355; Chen JQ, 2004, FOREST SCI, V50, P364; Churchill DJ, 2013, FOREST ECOL MANAG, V291, P442, DOI 10.1016/j.foreco.2012.11.007; Collins BM, 2007, LANDSCAPE ECOL, V22, P545, DOI 10.1007/s10980-006-9047-5; Collins BM, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00026.1; Covington W. W., 1994, Journal of Sustainable Forestry, V2, P13, DOI 10.1300/J091v02n01_02; Elliott-Fisk DL, 1996, 36 U CAL CTR WAT WIL; Evett RR, 2007, CAN J FOREST RES, V37, P318, DOI 10.1139/X06-280; Fernandes PM, 2013, LANDSCAPE URBAN PLAN, V110, P175, DOI 10.1016/j.landurbplan.2012.10.014; Fettig CJ, 2007, FOREST ECOL MANAG, V238, P24, DOI 10.1016/j.foreco.2006.10.011; Fiedler CE, 2007, ECOL SOC, V12; Franco-Vizcaino E, 2002, ARID LAND RES MANAG, V16, P133, DOI 10.1080/153249802317304431; Franklin JF, 2012, J FOREST, V110, P429, DOI 10.5849/jof.10-006; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Fry DL, 2010, CAN J FOREST RES, V40, P1803, DOI 10.1139/X10-122; Fule PZ, 2014, GLOBAL ECOL BIOGEOGR, V23, P825, DOI 10.1111/geb.12136; Ganey J. L., 2012, International Journal of Forestry Research, V2012, P529197; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Getzin S, 2008, J ECOL, V96, P807, DOI 10.1111/j.1365-2745.2008.01377.x; Girvetz EH, 2007, LANDSCAPE ECOL, V22, P1131, DOI 10.1007/s10980-007-9104-8; Goheen D.J., 1993, P175; Gray AN, 2005, FOREST SCI, V51, P198; Hagmann RK, 2013, FOREST ECOL MANAG, V304, P492, DOI 10.1016/j.foreco.2013.04.005; Hessburg PF, 2005, FOREST ECOL MANAG, V211, P117, DOI 10.1016/j.foreco.2005.02.016; Hirsch K, 2001, FOREST CHRON, V77, P1; Hood SM, 2010, RMRS238 USDA FOR SER; Innes JC, 2006, CAN J FOREST RES, V36, P3183, DOI 10.1139/X06-184; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Knapp E, 2012, MANAGING SIERRA NEVA; Larson AJ, 2012, FOREST ECOL MANAG, V267, P74, DOI 10.1016/j.foreco.2011.11.038; Larson AJ, 2008, CAN J FOREST RES, V38, P2814, DOI 10.1139/X08-123; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Lutz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036131; Lydersen J, 2012, ECOSYSTEMS, V15, P1134, DOI 10.1007/s10021-012-9573-8; Lydersen JM, 2013, FOREST ECOL MANAG, V304, P370, DOI 10.1016/j.foreco.2013.05.023; Mantgem P. J. van, 2009, Fire Ecology, V5, P116; McGarigal K., 2000, MULTIVARIATE STAT WI; Meador AJS, 2011, RESTOR ECOL, V19, P490, DOI 10.1111/j.1526-100X.2010.00652.x; Meador AJS, 2009, J VEG SCI, V20, P79, DOI 10.1111/j.1654-1103.2009.05464.x; Meyer MD, 2007, PLANT SOIL, V294, P113, DOI 10.1007/s11104-007-9235-3; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Miller JD, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00158.1; Minnich RA, 2000, J BIOGEOGR, V27, P105, DOI 10.1046/j.1365-2699.2000.00368.x; Minnich RA, 1998, U CALIFORNIA PUBLICA, V80; Moghaddas JJ, 2007, INT J WILDLAND FIRE, V16, P673, DOI 10.1071/WF06066; Moreira F, 2011, J ENVIRON MANAGE, V92, P2389, DOI 10.1016/j.jenvman.2011.06.028; Naficy C, 2010, ECOL APPL, V20, P1851, DOI 10.1890/09-0217.1; Nesmith JCB, 2011, FOREST ECOL MANAG, V261, P1275, DOI 10.1016/j.foreco.2011.01.006; North M, 2005, FOREST SCI, V51, P187; North M, 2004, FOREST SCI, V50, P299; North M, 2009, PSW237 USDA FOR SERV; North M., 2002, PSWGTR186 USFS; North M, 2012, PSW237 USDA FOR SERV; North M. P., 2009, Fire Ecology, V5, P20; North M, 2007, CAN J FOREST RES, V37, P331, DOI 10.1139/X06-236; North M, 2012, J FOREST, V110, P392, DOI 10.5849/jof.12-021; PARSONS DJ, 1979, FOREST ECOL MANAG, V2, P21, DOI 10.1016/0378-1127(79)90034-3; Pausas JC, 2008, INT J WILDLAND FIRE, V17, P713, DOI 10.1071/WF07151; Pearson GA, 1950, USDA FOREST SERVICE, V6; Plotkin JB, 2002, AM NAT, V160, P629, DOI 10.1086/342823; Potter DA, 1998, PSW169 USDA FOR SERV; R Core Team, 2020, R LANG ENV STAT COMP; Safford HD, 2009, FOREST ECOL MANAG, V258, P773, DOI 10.1016/j.foreco.2009.05.024; Schoennagel T, 2011, FRONT ECOL ENVIRON, V9, P271, DOI 10.1890/090199; Skinner CN, 2008, J BIOGEOGR, V35, P1436, DOI 10.1111/j.1365-2699.2008.01893.x; Stephens SL, 2013, SCIENCE, V342, P41, DOI 10.1126/science.1240294; Stephens SL, 2012, BIOSCIENCE, V62, P549, DOI 10.1525/bio.2012.62.6.6; Stephens SL, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024003; Stephens SL, 2008, ECOL SOC, V13; Stephens SL, 2005, J FOREST, V103, P357; Stephens SL, 2005, J VEG SCI, V16, P693, DOI 10.1111/j.1654-1103.2005.tb02412.x; Stephens SL, 2005, FOREST ECOL MANAG, V214, P53, DOI 10.1016/j.foreco.2005.03.055; Stephens SL, 2005, FOREST ECOL MANAG, V205, P15, DOI 10.1016/j.foreco.2004.10.003; Stephens SL, 2004, FOREST ECOL MANAG, V199, P103, DOI 10.1016/j.foreco.2004.04.017; Stephens SL, 2003, CAN J FOREST RES, V33, P1090, DOI [10.1139/x03-031, 10.1139/X03-031]; Stephens SL, 2005, ECOL APPL, V15, P532, DOI 10.1890/04-0545; Stephenson NL, 1999, ECOL APPL, V9, P1253, DOI 10.1890/1051-0761(1999)009[1253:RCFGSF]2.0.CO;2; Stoyan D., 1995, FRACTALS RANDOM SHAP; Taylor AH, 2004, ECOL APPL, V14, P1903, DOI 10.1890/02-5257; Taylor AH, 2010, J VEG SCI, V21, P561, DOI 10.1111/j.1654-1103.2009.01164.x; Vallejo R, 2006, RESTORATION ECOLOGY, P193; van Mantgem PJ, 2011, FOREST ECOL MANAG, V261, P989, DOI 10.1016/j.foreco.2010.12.013; Van Pelt R, 2000, CAN J FOREST RES, V30, P1231, DOI 10.1139/cjfr-30-8-1231; Wayman RB, 2007, FOREST ECOL MANAG, V239, P32, DOI 10.1016/j.foreco.2006.11.011; Weaver H., 1943, Journal of Forestry, V41, P7; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; York RA, 2004, CAN J FOREST RES, V34, P630, DOI 10.1139/X03-222; York RA, 2003, FOREST ECOL MANAG, V179, P107, DOI 10.1016/S0378-1127(02)00487-5; York RA, 2010, APPL VEG SCI, V13, P498, DOI 10.1111/j.1654-109X.2010.01089.x; Youngblood A, 2004, FOREST ECOL MANAG, V199, P191, DOI 10.1016/j.foreco.2004.05.056; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]; [No title captured]	108	43	45	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88985	10.1371/journal.pone.0088985	http://dx.doi.org/10.1371/journal.pone.0088985			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586472	Green Published, gold			2022-12-27	WOS:000331714700047
J	Jolley, D; Douglas, KM				Jolley, Daniel; Douglas, Karen M.			The Effects of Anti-Vaccine Conspiracy Theories on Vaccination Intentions	PLOS ONE			English	Article							CONTINUED INFLUENCE; AFRICAN-AMERICANS; BELIEFS; ATTITUDES; MISINFORMATION; HIV/AIDS; IMPACT; ONLINE	The current studies investigated the potential impact of anti-vaccine conspiracy beliefs, and exposure to anti-vaccine conspiracy theories, on vaccination intentions. In Study 1, British parents completed a questionnaire measuring beliefs in anti-vaccine conspiracy theories and the likelihood that they would have a fictitious child vaccinated. Results revealed a significant negative relationship between anti-vaccine conspiracy beliefs and vaccination intentions. This effect was mediated by the perceived dangers of vaccines, and feelings of powerlessness, disillusionment and mistrust in authorities. In Study 2, participants were exposed to information that either supported or refuted anti-vaccine conspiracy theories, or a control condition. Results revealed that participants who had been exposed to material supporting anti-vaccine conspiracy theories showed less intention to vaccinate than those in the anti-conspiracy condition or controls. This effect was mediated by the same variables as in Study 1. These findings point to the potentially detrimental consequences of anti-vaccine conspiracy theories, and highlight their potential role in shaping health-related behaviors.	[Jolley, Daniel; Douglas, Karen M.] Univ Kent, Sch Psychol, Canterbury, Kent, England	University of Kent	Jolley, D (corresponding author), Univ Kent, Sch Psychol, Canterbury, Kent, England.	dj93@kent.ac.uk; k.douglas@kent.ac.uk		Douglas, Karen/0000-0002-0381-6924; Jolley, Daniel/0000-0001-7232-8599				Abalakina-Paap M, 1999, POLIT PSYCHOL, V20, P637, DOI 10.1111/0162-895X.00160; Aitken C, 2011, GLOBAL ENVIRON CHANG, V21, P752, DOI 10.1016/j.gloenvcha.2011.01.002; [Anonymous], 2013, BBC NEWS, V1, P125; [Anonymous], 2011, WHAT IS AV READ SPEE; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Betsch C, 2013, MED DECIS MAKING, V33, P14, DOI 10.1177/0272989X12452342; Betsch C, 2013, HEALTH PSYCHOL, V32, P146, DOI 10.1037/a0027387; Bird ST, 2003, J HEALTH PSYCHOL, V8, P263, DOI 10.1177/1359105303008002669; Bogart LM, 2006, J NATL MED ASSOC, V98, P1144; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burgess DC, 2006, VACCINE, V24, P3921, DOI 10.1016/j.vaccine.2006.02.033; BUTLER LD, 1995, POLIT PSYCHOL, V16, P237, DOI 10.2307/3791831; Conroy K, 2009, J WOMENS HEALTH, V18, P1679, DOI 10.1089/jwh.2008.1329; Douglas KM, 2008, J SOC PSYCHOL, V148, P210, DOI 10.3200/SOCP.148.2.210-222; Douglas KM, 2011, BRIT J SOC PSYCHOL, V50, P544, DOI 10.1111/j.2044-8309.2010.02018.x; Downs JS, 2008, VACCINE, V26, P1595, DOI 10.1016/j.vaccine.2008.01.011; Ecker UKH, 2010, MEM COGNITION, V38, P1087, DOI 10.3758/MC.38.8.1087; GOERTZEL T, 1994, POLIT PSYCHOL, V15, P731, DOI 10.2307/3791630; Hayes AF, 2013, BR J MATH S IN PRESS; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Health Protection Agency, 2008, MEASL FIG SOAR; Health Protection Service, 2013, INF DIS MRR GEN INF; Hopfer S, 2012, PREV SCI, V13, P173, DOI 10.1007/s11121-011-0254-1; Hoyt MA, 2012, HEALTH PSYCHOL, V31, P269, DOI 10.1037/a0025953; Jolley D, 2014, BRIT J PSYCHOL, V105, P35, DOI 10.1111/bjop.12018; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022; LaPiere RT, 1934, SOC FORCES, V13, P230, DOI 10.2307/2570339; Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637; Lewandowsky S, 2013, PSYCHOL SCI, V24, P622, DOI 10.1177/0956797612457686; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; LINN LS, 1965, SOC FORCES, V43, P353, DOI 10.2307/2574765; MCCAULEY C, 1979, J PERS SOC PSYCHOL, V37, P637, DOI 10.1037/0022-3514.37.5.637; Mills E, 2005, J CLIN EPIDEMIOL, V58, P1081, DOI 10.1016/j.jclinepi.2005.09.002; Niehuis S., 2006, N AM J PSYCHOL, V8, P69; Offit P., 2010, DEADLY CHOICES ANTIV; Opel DJ, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Public Policy Polling, 2013, DEM REP DIFF CONSP T; Salmon Daniel A, 2009, WMJ, V108, P17; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [10.1080/14792772143000003, DOI 10.1080/14792772143000003]; Sporton RK, 2001, FAM PRACT, V18, P181, DOI 10.1093/fampra/18.2.181; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175; Sunstein CR, 2009, J POLIT PHILOS, V17, P202, DOI 10.1111/j.1467-9760.2008.00325.x; Swami V, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00280; Swami V, 2010, APPL COGNITIVE PSYCH, V24, P749, DOI 10.1002/acp.1583; Swami V, 2010, PSYCHOLOGIST, V23, P560; Wilson T, 2000, J Pediatr Health Care, V14, P117, DOI 10.1016/S0891-5245(00)70022-8; Wood MJ, 2012, SOC PSYCHOL PERS SCI, V3, P767, DOI 10.1177/1948550611434786	51	538	545	16	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89177	10.1371/journal.pone.0089177	http://dx.doi.org/10.1371/journal.pone.0089177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3UC	24586574	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000331714700070
J	Tatarinova, O; Tsvetkov, V; Basmanov, D; Barinov, N; Smirnov, I; Timofeev, E; Kaluzhny, D; Chuvilin, A; Klinov, D; Varizhuk, A; Pozmogova, G				Tatarinova, Olga; Tsvetkov, Vladimir; Basmanov, Dmitry; Barinov, Nikolay; Smirnov, Igor; Timofeev, Edward; Kaluzhny, Dmitry; Chuvilin, Andrey; Klinov, Dmitry; Varizhuk, Anna; Pozmogova, Galina			Comparison of the 'Chemical' and 'Structural' Approaches to the Optimization of the Thrombin-Binding Aptamer	PLOS ONE			English	Article							NUCLEIC-ACID; G-QUADRUPLEX; OPTICAL BIOSENSORS; HIGH-AFFINITY; DNA-APTAMER; STABILITY; DENSITY	Noncanonically structured DNA aptamers to thrombin were examined. Two different approaches were used to improve stability, binding affinity and biological activity of a known thrombin-binding aptamer. These approaches are chemical modification and the addition of a duplex module to the aptamer core structure. Several chemically modified aptamers and the duplex-bearing ones were all studied under the same conditions by a set of widely known and some relatively new methods. A number of the thrombin-binding aptamer analogs have demonstrated improved characteristics. Most importantly, the study allowed us to compare directly the two approaches to aptamer optimization and to analyze their relative advantages and disadvantages as well as their potential in drug design and fundamental studies.	[Tatarinova, Olga; Tsvetkov, Vladimir; Basmanov, Dmitry; Barinov, Nikolay; Smirnov, Igor; Klinov, Dmitry; Varizhuk, Anna; Pozmogova, Galina] Inst Phys Chem Med, Moscow, Russia; [Tsvetkov, Vladimir] Orekhovich Inst Biomed Chem, Moscow, Russia; [Tsvetkov, Vladimir] AV Topchiev Petrochem Synth Inst, Moscow 117912, Russia; [Timofeev, Edward; Kaluzhny, Dmitry; Chuvilin, Andrey; Varizhuk, Anna] VA Engelhardt Mol Biol Inst, Moscow 117984, Russia; [Klinov, Dmitry] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; Russian Academy of Sciences; Topchiev Institute of Petrochemical Synthesis RAS; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Varizhuk, A (corresponding author), Inst Phys Chem Med, Moscow, Russia.	annavarizhuk@gmail.com; pozmge@gmail.com	Timofeev, Edward/AAD-3002-2021; Klinov, Dmitry/ABF-3830-2020; Varizhuk, Anna/Y-7558-2019; Tsvetkov, Vladimir B/L-9399-2013; Kaluzhny, Dmitry N/G-7256-2014; Barinov, Nikolay/L-9357-2016; Galina, Pozmogova/S-6204-2017	Timofeev, Edward/0000-0002-9314-1499; Klinov, Dmitry/0000-0001-8288-2198; Varizhuk, Anna/0000-0001-9359-8651; Tsvetkov, Vladimir B/0000-0003-0494-3332; Barinov, Nikolay/0000-0002-0512-2547; Galina, Pozmogova/0000-0001-9458-4972; Basmanov, Dmitry/0000-0001-6620-7360; Kaluzhny, Dmitry/0000-0001-7090-3334	Russian Foundation for Basic Research [14-04-01244, 14-04-01035]; Presidium of the Russian Academy of Sciences on Molecular and Cell Biology	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences on Molecular and Cell Biology	This work was supported by Russian Foundation for Basic Research [14-04-01244; 14-04-01035] and the program of the Presidium of the Russian Academy of Sciences on Molecular and Cell Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2009, FEBS J, V276, P3628, DOI 10.1111/j.1742-4658.2009.07082.x; Avino A, 2012, CURR PHARM DESIGN, V18, P2036, DOI 10.2174/138161212799958387; Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; Bashford D, 2000, ANNU REV PHYS CHEM, V51, P129, DOI 10.1146/annurev.physchem.51.1.129; Batista ER, 2004, J CHEM PHYS, V121, P11104, DOI 10.1063/1.1811607; Bonifacio L, 2008, INT J MOL SCI, V9, P422, DOI 10.3390/ijms9030422; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Dhakal S, 2012, BIOPHYS J, V102, P2575, DOI 10.1016/j.bpj.2012.04.024; Dolinnaya NG, 2012, J BIOMOL STRUCT DYN, V30, P524, DOI 10.1080/07391102.2012.687518; Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022; Galanakis DK, 1995, PLASMA THROMBIN TIME; GRIFFIN LC, 1993, BLOOD, V81, P3271, DOI 10.1182/blood.V81.12.3271.3271; Jensen TB, 2011, BIOORGAN MED CHEM, V19, P4739, DOI 10.1016/j.bmc.2011.06.087; Klinov D, 2007, NANO LETT, V7, P3583, DOI 10.1021/nl072177y; Konopsky VN, 2007, ANAL CHEM, V79, P4729, DOI 10.1021/ac070275y; Konopsky VN, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/093006; Konopsky Valery N., 2009, V503, P49, DOI 10.1007/978-1-60327-567-5_4; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; MACAYA RF, 1993, P NATL ACAD SCI USA, V90, P3745, DOI 10.1073/pnas.90.8.3745; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Morvan F, 2010, CHEM BIODIVERS, V7, P494, DOI 10.1002/cbdv.200900220; MULLIKEN RS, 1955, J CHEM PHYS, V23, P1833, DOI 10.1063/1.1740588; Musumeci D, 2012, PHARMACOL THERAPEUT, V136, P202, DOI 10.1016/j.pharmthera.2012.07.011; Onufriev A, 2002, J COMPUT CHEM, V23, P1297, DOI 10.1002/jcc.10126; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Padmanabhan K, 1996, ACTA CRYSTALLOGR D, V52, P272, DOI 10.1107/S0907444995013977; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Pagano B, 2008, BIOPHYS J, V94, P562, DOI 10.1529/biophysj.107.117382; Parr R. G., 1989, DENSITY FUNCTIONAL T; Pozmogova GE, 2010, B EXP BIOL MED+, V150, P180, DOI 10.1007/s10517-010-1099-5; REED AE, 1983, J CHEM PHYS, V78, P4066, DOI 10.1063/1.445134; Russo Krauss I, 2012, NUCLEIC ACIDS RES, V40, P8119, DOI 10.1093/nar/gks512; Russo Krauss I, 2011, NUCLEIC ACIDS RES, V39, P7858, DOI 10.1093/nar/gkr522; Stein CA, 1996, CHEM BIOL, V3, P319, DOI 10.1016/S1074-5521(96)90113-1; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Szabo A., 1989, MODERN QUANTUM CHEM; Tan WH, 2011, TRENDS BIOTECHNOL, V29, P634, DOI 10.1016/j.tibtech.2011.06.009; Varizhuk AM, 2013, EUR J MED CHEM, V67, P90, DOI 10.1016/j.ejmech.2013.06.034; Varizhuk AM, 2013, J ORG CHEM, V78, P5964, DOI 10.1021/jo400651k; Wang RE, 2011, CURR MED CHEM, V18, P4126; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Xiao ZY, 2012, ACS NANO, V6, P3670, DOI 10.1021/nn301869z; Zaitseva M, 2010, BIOPHYS CHEM, V146, P1, DOI 10.1016/j.bpc.2009.09.011; Zhou J, 2008, CHEM BIOL, V15, P644, DOI 10.1016/j.chembiol.2008.07.004	44	25	27	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89383	10.1371/journal.pone.0089383	http://dx.doi.org/10.1371/journal.pone.0089383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586736	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700114
J	Vela, D; Fontdevila, A; Vieira, C; Guerreiro, MPG				Vela, Doris; Fontdevila, Antonio; Vieira, Cristina; Garcia Guerreiro, Maria Pilar			A Genome-Wide Survey of Genetic Instability by Transposition in Drosophila Hybrids	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; EVOLUTIONARY HISTORY; MALE RECOMBINATION; MOLECULAR-BASIS; RETROTRANSPOSON; DYSGENESIS; BUZZATII; RATES; OSVALDO; DNA	Hybridization between species is a genomic instability factor involved in increasing mutation rate and new chromosomal rearrangements. Evidence of a relationship between interspecific hybridization and transposable element mobilization has been reported in different organisms, but most studies are usually performed with particular TEs and do not discuss the real effect of hybridization on the whole genome. We have therefore studied whole genome instability of Drosophila interspecific hybrids, looking for the presence of new AFLP markers in hybrids. A high percentage (27-90%) of the instability markers detected corresponds to TEs belonging to classes I and II. Moreover, three transposable elements (Osvaldo, Helena and Galileo) representative of different families, showed an overall increase of transposition rate in hybrids compared to parental species. This research confirms the hypothesis that hybridization induces genomic instability by transposition bursts and suggests that genomic stress by transposition could contribute to a relaxation of mechanisms controlling TEs in the Drosophila genome.	[Vela, Doris; Fontdevila, Antonio; Garcia Guerreiro, Maria Pilar] Univ Autonoma Barcelona, Fac Biociencies, Dept Genet & Microbiol, Grp Biol Evolut, E-08193 Barcelona, Spain; [Vieira, Cristina] Univ Lyon 1, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Vieira, Cristina] Inst Univ France, Paris, France	Autonomous University of Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Institut Universitaire de France	Guerreiro, MPG (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Genet & Microbiol, Grp Biol Evolut, E-08193 Barcelona, Spain.	mariapilar.garcia.guerreiro@uab.es	Fontdevila, Antonio/A-4765-2009; Vela, Doris/HCI-9001-2022; Guerreiro, Maria Pilar Garcia/AAB-5507-2019; Vieira, Cristina/Q-3137-2017	Fontdevila, Antonio/0000-0003-2531-915X; Guerreiro, Maria Pilar Garcia/0000-0001-9951-1879; Vieira, Cristina/0000-0003-3414-3993	Ministerio de Educacion y Ciencia (Spain) [CGL2006-13423-C02-01/02]; Ministerio de Ciencia e Innovacion (Spain) [CGL2009-12912-C03-01, CGL2010-15395]; Generalitat de Catalunya [2005SGR 00995, 2009SGR 636]; Genemobile [ANR-09-BLAN-0103]; Institut Universitaire de France; CNRS GDRE Comparative Genomics	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Genemobile; Institut Universitaire de France; CNRS GDRE Comparative Genomics	This work was supported by research grants CGL2006-13423-C02-01/02 from the Ministerio de Educacion y Ciencia (Spain)(www.educacion.gob.es), grants CGL2009-12912-C03-01 and CGL2010-15395 from the Ministerio de Ciencia e Innovacion (Spain)(www.educacion.gob.es), and grants 2005SGR 00995 and 2009SGR 636 from Generalitat de Catalunya (www.gencat.cat) to the Grup de Biologia Evolutiva. ANR-09-BLAN-0103 (www.agence-nationale-recherche.fr) Genemobile and Institut Universitaire de France and the CNRS GDRE Comparative Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkouche A, 2013, EMBO REP, V14, P458, DOI 10.1038/embor.2013.38; Akkouche A, 2012, J VIROL, V86, P3675, DOI 10.1128/JVI.07146-11; Arnold M, 2006, NATURAL HYBRIDIZATIO; Arnold M.L., 1997, EVOLUTION GENETIC EX; BINGHAM PM, 1982, CELL, V29, P995, DOI 10.1016/0092-8674(82)90463-9; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Capy P, 1998, MOL B INT U, P1; COYNE JA, 1986, GENETICS, V114, P485; COYNE JA, 1989, HEREDITY, V63, P155, DOI 10.1038/hdy.1989.87; Desset S, 2003, GENETICS, V164, P501; Finnegan DJ, 1992, CURR OPIN GENET DEV, V2, P861, DOI 10.1016/S0959-437X(05)80108-X; Fontdevila A, 2004, INTROGRESSION HYBRID, P182; Guerreiro MPG, 2012, HEREDITY, V108, P461, DOI 10.1038/hdy.2011.89; GINZBURG LR, 1984, GENETICS, V107, P331; Guerreiro MPG, 2007, GENETICS, V175, P301, DOI 10.1534/genetics.106.064378; HEY J, 1989, GENETICA, V78, P97; Hoskins R a, 2002, GENOME BIOL, V3; ISHHOROWICZ D, 1982, NATURE, V299, P676, DOI 10.1038/299676a0; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kawakami T, 2010, HEREDITY, V104, P341, DOI 10.1038/hdy.2009.182; Kelleher ES, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001428; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Labrador M, 1999, MOL BIOL EVOL, V16, P931, DOI 10.1093/oxfordjournals.molbev.a026182; LABRADOR M, 1990, J HERED, V81, P83, DOI 10.1093/oxfordjournals.jhered.a110934; LABRADOR M, 1994, MOL GEN GENET, V245, P661, DOI 10.1007/BF00297273; Liu B, 2000, GENOME, V43, P874, DOI 10.1139/gen-43-5-874; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Malone JH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-82; Marzo M, 2008, P NATL ACAD SCI USA, V105, P2957, DOI 10.1073/pnas.0712110105; Metcalfe CJ, 2007, GENETICS, V177, P2507, DOI 10.1534/genetics.107.082313; Michalak P, 2010, HEREDITY, V104, P329, DOI 10.1038/hdy.2009.187; NAVEIRA H, 1985, CHROMOSOMA, V91, P87, DOI 10.1007/BF00294050; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; NUZHDIN SV, 1995, MOL BIOL EVOL, V12, P180, DOI 10.1093/oxfordjournals.molbev.a040188; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Pantazidis A, 1999, MOL BIOL EVOL, V16, P909, DOI 10.1093/oxfordjournals.molbev.a026180; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; PETROV DA, 1995, P NATL ACAD SCI USA, V92, P8050, DOI 10.1073/pnas.92.17.8050; PICARD G, 1976, GENETICS, V83, P107; PINOL J, 1988, NUCLEIC ACIDS RES, V16, P2736, DOI 10.1093/nar/16.6.2736; Pollock, 1988, MORPHOMETRIC ANAL PS; Rebollo R, 2010, GENE, V454, P1, DOI 10.1016/j.gene.2010.01.003; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Roy AM, 1999, GENETICA, V107, P149, DOI 10.1023/A:1003941704138; RUBIN GM, 1982, CELL, V29, P987, DOI 10.1016/0092-8674(82)90462-7; Salomon S, 1998, EMBO J, V17, P6086, DOI 10.1093/emboj/17.20.6086; Shan XH, 2005, MOL BIOL EVOL, V22, P976, DOI 10.1093/molbev/msi082; SHEEN FM, 1993, GENETICS, V133, P315; Shivaprasad PV, 2012, EMBO J, V31, P257, DOI 10.1038/emboj.2011.458; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Steinau AN, 2003, WEED SCI, V51, P696, DOI 10.1614/P2002-159; Stuart JR, 2002, GENETICS, V162, P1641; SUH DS, 1995, MOL BIOL EVOL, V12, P748; Ungerer MC, 2006, GENOME EXPANSION 3 H, P16, DOI DOI 10.1016/J.CUB.2006.09.020; Vela D, 2011, BIOTECHNIQUES, V50, P247, DOI 10.2144/000113655; Vieira C, 1996, J MOL EVOL, V42, P443; Vu W, 2011, HEREDITY, V106, P207, DOI 10.1038/hdy.2010.41; YANNOPOULOS G, 1987, CELL, V49, P487, DOI 10.1016/0092-8674(87)90451-X; Zampicinini G, 2004, GENOME, V47, P1154, DOI [10.1139/g04-066, 10.1139/G04-066]	61	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88992	10.1371/journal.pone.0088992	http://dx.doi.org/10.1371/journal.pone.0088992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586475	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700049
J	Yang, F; Xiong, J; Jia, XE; Gu, ZH; Shi, JY; Zhao, Y; Li, JM; Chen, SJ; Zhao, WL				Yang, Fan; Xiong, Jie; Jia, Xiao-E; Gu, Zhao-Hui; Shi, Jing-Yi; Zhao, Yan; Li, Jun-Min; Chen, Sai-Juan; Zhao, Wei-Li			GSTT1 Deletion Is Related to Polycyclic Aromatic Hydrocarbons-Induced DNA Damage and Lymphoma Progression	PLOS ONE			English	Article							B-CELL LYMPHOMA; GENETIC POLYMORPHISMS; METABOLIZING ENZYMES; CANCER; MYC; TRANSFERASES; ACTIVATION; PATHWAY; GSTM1; RISK	The interrelationship between genetic susceptibility and carcinogenic exposure is important in cancer development. Polymorphisms in detoxification enzymes of the glutathione-S-transferases (GST) family are associated with an increased incidence of lymphoma. Here we investigated the molecular connection of the genetic polymorphism of GSTT1 to the response of lymphocytes to polycyclic aromatic hydrocarbons (PAH). In neoplastic situation, GSTT1 deletions were more frequently observed in lymphoma patients (54.9%) than in normal controls (42.0%, P = 0.009), resulting in an increased risk for lymphoma in individuals with GSTT1-null genotype (Odds ratio = 1.698, 95% confidence interval = 1.145-2.518). GSTT1 gene and protein expression were accordingly decreased in GSTT1-deleting patients, consistent with activated profile of cell cycle regulation genes. Mimicking environmental exposure using long-term repeat culture with low-dose PAH metabolite Hydroquinone, malignant B-and T-lymphocytes presented increased DNA damage, pCHK1/MYC expression and cell proliferation, which were counteracted by ectopic expression of GSTT1. Moreover, GSTT1 expression retarded xenograft tumor formation of Hydroquinone-treated lymphoma cells in nude mice. In non-neoplastic situation, when zebrafish was exposed to PAH Benzo(a) pyrene, molecular silencing of gstt1 enhanced the proliferation of normal lymphocytes and upregulated myca expression. Collectively, these findings suggested that GSTT1 deletion is related to genetic predisposition to lymphoma, particularly interacting with environmental pollutants containing PAH.	[Yang, Fan; Xiong, Jie; Shi, Jing-Yi; Zhao, Yan; Li, Jun-Min; Chen, Sai-Juan; Zhao, Wei-Li] Shanghai Jiao Tong Univ, Sch Med, Shanghai Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, Shanghai 200030, Peoples R China; [Yang, Fan; Chen, Sai-Juan; Zhao, Wei-Li] Pole Rech Sinofrancais Sci Vivant & Genom, Lab Mol Pathol, Shanghai, Peoples R China; [Jia, Xiao-E] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Jia, Xiao-E] Chinese Acad Sci, Grad Univ, Shanghai, Peoples R China; [Jia, Xiao-E] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Gu, Zhao-Hui] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhao, WL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, Shanghai 200030, Peoples R China.	zhao.weili@yahoo.com	Gu, Zhaohui/L-8586-2015	Li, Junmin/0000-0003-1338-8764; Xiong, Jie/0000-0002-7547-5049	National Natural Science Foundation of China [81325003, 81172254, 81101793]; Shanghai Commission of Science and Technology [11JC1407300]; Program of Shanghai Subject Chief Scientists [13XD1402700]; Shanghai Municipal Education Commission and Shanghai Education Development Foundation; "Shu Guang" project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Program of Shanghai Subject Chief Scientists; Shanghai Municipal Education Commission and Shanghai Education Development Foundation(Shanghai Municipal Education Commission (SHMEC)); "Shu Guang" project(Chinese Academy of Sciences)	The work was supported, in part, by the National Natural Science Foundation of China (81325003, 81172254 and 81101793), the Shanghai Commission of Science and Technology (11JC1407300), the Program of Shanghai Subject Chief Scientists (13XD1402700), and the "Shu Guang" project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian J, 2009, J EXP MED, V206, P1473, DOI 10.1084/jem.20082842; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Billiard SM, 2006, TOXICOL SCI, V92, P526, DOI 10.1093/toxsci/kfl011; Bin Q, 2013, LEUKEMIA LYMPHOMA, V54, P14, DOI 10.3109/10428194.2012.706284; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Campaner S, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-6; Clapp Richard W., 2008, Reviews on Environmental Health, V23, P1; Cuccuini W, 2012, BLOOD, V119, P4619, DOI 10.1182/blood-2012-01-406033; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Duarte ECB, 2008, ANTICANCER RES, V28, P1101; Gupta M, 2012, BLOOD, V120, P4400, DOI 10.1182/blood-2012-05-428466; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; Hoglund A, 2011, CLIN CANCER RES, V17, P7067, DOI 10.1158/1078-0432.CCR-11-1198; Koh WP, 2011, CARCINOGENESIS, V32, P1507, DOI 10.1093/carcin/bgr175; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Nemajerova A, 2010, J CLIN INVEST, V120, P2070, DOI 10.1172/JCI40331; Paffett-Lugassy NN, 2004, METH MOLEC MED, V105, P171; Pang YQ, 2008, TOXICOL APPL PHARM, V232, P478, DOI 10.1016/j.taap.2008.08.009; Rahman HAA, 2012, J CANCER RES CLIN, V138, P1363, DOI 10.1007/s00432-012-1208-0; Rimando MG, 2008, BIOSCIENCE REP, V28, P117, DOI 10.1042/BSR20070010; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skibola CF, 2007, HAEMATOLOGICA, V92, P960, DOI 10.3324/haematol.11011; Wang SS, 2010, EXPERT REV ANTICANC, V10, P403, DOI [10.1586/era.09.194, 10.1586/ERA.09.194]; Wassenberg DM, 2004, ENVIRON HEALTH PERSP, V112, P1658, DOI 10.1289/ehp.7168; Westerfield O, 1995, Healthc Facil Manag Ser, P1; Xiong P, 2001, CANCER RES, V61, P8465; Yri OE, 2013, LEUKEMIA LYMPHOMA	29	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89302	10.1371/journal.pone.0089302	http://dx.doi.org/10.1371/journal.pone.0089302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586676	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700096
J	Holtappels, M; Tiano, L; Kalvelage, T; Lavik, G; Revsbech, NP; Kuypers, MMM				Holtappels, Moritz; Tiano, Laura; Kalvelage, Tim; Lavik, Gaute; Revsbech, Niels Peter; Kuypers, Marcel M. M.			Aquatic Respiration Rate Measurements at Low Oxygen Concentrations	PLOS ONE			English	Article							ORGANIC-MATTER EXPORT; MINIMUM ZONES; WATER; ANAMMOX; OPTODE; GROWTH; SEA	Despite its huge ecological importance, microbial oxygen respiration in pelagic waters is little studied, primarily due to methodological difficulties. Respiration measurements are challenging because of the required high resolution of oxygen concentration measurements. Recent improvements in oxygen sensing techniques bear great potential to overcome these limitations. Here we compare 3 different methods to measure oxygen consumption rates at low oxygen concentrations, utilizing amperometric Clark type sensors (STOX), optical sensors (optodes), and mass spectrometry in combination with O-18-18(2) labeling. Oxygen concentrations and consumption rates agreed well between the different methods when applied in the same experimental setting. Oxygen consumption rates between 30 and 400 nmol L-1 h(-1) were measured with high precision and relative standard errors of less than 3%. Rate detection limits in the range of 1 nmol L-1 h(-1) were suitable for rate determinations in open ocean water and were lowest at the lowest applied O-2 concentration.	[Holtappels, Moritz; Kalvelage, Tim; Lavik, Gaute; Kuypers, Marcel M. M.] Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany; [Tiano, Laura; Revsbech, Niels Peter] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Kalvelage, Tim] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada	Max Planck Society; Aarhus University; Dalhousie University	Holtappels, M (corresponding author), Max Planck Inst Marine Microbiol, Dept Biogeochem, Bremen, Germany.	mholtapp@mpi-bremen.de	Revsbech, Niels P/I-8040-2013; Holtappels, Moritz/ABC-7901-2020	Holtappels, Moritz/0000-0003-3682-1903; Revsbech, Niels Peter/0000-0002-2193-262X	Max-Planck-Gesellschaft; DFG-Research Center/Cluster of Excellence "The Ocean in the Earth System'' at the University of Bremen; DFG [Sonderforschungsbereich 754]; European Union; EC [226213]; European Research Council [267233]; Danish Council for Independent Research: Natural Sciences [10-083140]	Max-Planck-Gesellschaft(Max Planck Society); DFG-Research Center/Cluster of Excellence "The Ocean in the Earth System'' at the University of Bremen(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); European Union(European Commission); EC(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research: Natural Sciences(Det Frie Forskningsrad (DFF))	The study was funded by the Max-Planck-Gesellschaft (www.mpg.de), the DFG-Research Center/Cluster of Excellence "The Ocean in the Earth System'' at the University of Bremen (http://www.marum.de), the DFG-funded Sonderforschungsbereich 754 "Climate-Biogeochemistry Interactions in the Tropical Ocean" (www.sfb754.de), the European Union project "HYPOX - In situ monitoring of oxygen depletion in hypoxic ecosystems of coastal and open seas and land-locked water bodies'', EC grant 226213 (http://ec.europa.eu/research/fp7), the European Research Council, grant 267233 (www.erc.europa.eu), and the Danish Council for Independent Research: Natural Sciences, grant 10-083140 (http://en.fi.dk/councils-commissions/the-danishcouncil-for-independent-research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dalsgaard T, 2012, LIMNOL OCEANOGR, V57, P1331, DOI 10.4319/lo.2012.57.5.1331; De Brabandere L, 2012, J MICROBIOL METH, V88, P147, DOI 10.1016/j.mimet.2011.11.001; Deutsch C, 2011, SCIENCE, V333, P336, DOI 10.1126/science.1202422; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Gao H, 2010, ISME J, V4, P417, DOI 10.1038/ismej.2009.127; GARCIA HE, 1992, LIMNOL OCEANOGR, V37, P1307, DOI 10.4319/lo.1992.37.6.1307; Gustafsson BG, 2001, CONT SHELF RES, V21, P1485, DOI 10.1016/S0278-4343(01)00014-0; Holtappels M, 2011, METHOD ENZYMOL, V486, P223, DOI [10.1016/S0076-6879(11)86010-6, 10.1016/B978-0-12-381294-0.00010-9]; Iversen MH, 2010, DEEP-SEA RES PT I, V57, P771, DOI 10.1016/j.dsr.2010.03.007; Jensen MM, 2011, ISME J, V5, P1660, DOI 10.1038/ismej.2011.44; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; KLIMANT I, 1995, LIMNOL OCEANOGR, V40, P1159, DOI 10.4319/lo.1995.40.6.1159; Konovalov SK, 2006, DEEP-SEA RES PT II, V53, P1817, DOI 10.1016/j.dsr2.2006.03.013; Loebl M, 2007, J SEA RES, V58, P269, DOI 10.1016/j.seares.2007.06.003; Morrison JM, 1999, DEEP-SEA RES PT II, V46, P1903, DOI 10.1016/S0967-0645(99)00048-X; Nielsen K, 2003, AMBIO, V32, P287, DOI 10.1639/0044-7447(2003)032[0287:ARCATT]2.0.CO;2; OLSON DB, 1993, DEEP-SEA RES PT II, V40, P673, DOI 10.1016/0967-0645(93)90051-N; Ploug H, 1997, AQUAT MICROB ECOL, V13, P285, DOI 10.3354/ame013285; Revsbech NP, 2011, METHOD ENZYMOL, V486, P325, DOI [10.1016/S0076-6879(11)86014-3, 10.1016/B978-0-12-381294-0.00014-6]; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Stolper DA, 2010, P NATL ACAD SCI USA, V107, P18755, DOI 10.1073/pnas.1013435107; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Taylor GT, 1996, CAN J MICROBIOL, V42, P911, DOI 10.1139/m96-117; Tengberg A, 2006, LIMNOL OCEANOGR-METH, V4, P7, DOI 10.4319/lom.2006.4.7; Thamdrup B, 2012, DEEP-SEA RES PT I, V65, P36, DOI 10.1016/j.dsr.2012.03.001; Uchida H, 2008, J ATMOS OCEAN TECH, V25, P2271, DOI 10.1175/2008JTECHO549.1	29	21	21	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89369	10.1371/journal.pone.0089369	http://dx.doi.org/10.1371/journal.pone.0089369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586724	Green Published, Green Accepted, gold			2022-12-27	WOS:000331711900134
J	Lee, SA; Sinclair, E; Hatano, H; Hsue, PY; Epling, L; Hecht, FM; Bangsberg, DR; Martin, JN; McCune, JM; Deeks, SG; Hunt, PW				Lee, Sulggi A.; Sinclair, Elizabeth; Hatano, Hiroyu; Hsue, Priscilla Y.; Epling, Lorrie; Hecht, Frederick M.; Bangsberg, David R.; Martin, Jeffrey N.; McCune, Joseph M.; Deeks, Steven G.; Hunt, Peter W.			Impact of HIV on CD8+T Cell CD57 Expression Is Distinct from That of CMV and Aging	PLOS ONE			English	Article							CD8(+) T-CELLS; IMMUNE RISK PROFILE; SWEDISH NONA IMMUNE; CYTOMEGALOVIRUS-INFECTION; LYMPHOCYTE SUBPOPULATIONS; ANTIRETROVIRAL THERAPY; IMMUNOSENESCENCE; INDIVIDUALS; DISEASE; REPERTOIRE	Background: Chronic antigenic stimulation by cytomegalovirus (CMV) is thought to increase "immunosenesence'' of aging, characterized by accumulation of terminally differentiated CD28-CD8+ T cells and increased CD57, a marker of proliferative history. Whether chronic HIV infection causes similar effects is currently unclear. Methods: We compared markers of CD8+ T cell differentiation (e. g., CD28, CD27, CCR7, CD45RA) and CD57 expression on CD28-CD8+ T cells in healthy HIV-uninfected adults with and without CMV infection and in both untreated and antiretroviral therapy (ART)-suppressed HIV-infected adults with asymptomatic CMV infection. Results: Compared to HIV-uninfected adults without CMV (n = 12), those with asymptomatic CMV infection (n = 31) had a higher proportion of CD28-CD8+ T cells expressing CD57 (P = 0.005). Older age was also associated with greater proportions of CD28-CD8+ T cells expressing CD57 (rho: 0.47, P = 0.007). In contrast, untreated HIV-infected CMV+ participants (n = 55) had much lower proportions of CD28-CD8+ cells expressing CD57 than HIV-uninfected CMV+ participants (P<0.0001) and were enriched for less well-differentiated CD28-transitional memory (T-TR) CD8+ T cells (P<0.0001). Chronically HIV-infected adults maintaining ART-mediated viral suppression (n = 96) had higher proportions of CD28-CD8+ T cells expressing CD57 than untreated patients (P<0.0001), but continued to have significantly lower levels than HIV-uninfected controls (P = 0.001). Among 45 HIV-infected individuals initiating their first ART regimen, the proportion of CD28-CD8+ T cells expressing CD57 declined (P<0.0001), which correlated with a decline in percent of transitional memory CD8+ T cells, and appeared to be largely explained by a decline in CD28-CD57-CD8+ T cell counts rather than an expansion of CD28-CD57+ CD8+ T cell counts. Conclusions: Unlike CMV and aging, which are associated with terminal differentiation and proliferation of effector memory CD8+ T cells, HIV inhibits this process, expanding less well-differentiated CD28-CD8+ T cells and decreasing the proportion of CD28-CD8+ T cells that express CD57.	[Lee, Sulggi A.; Sinclair, Elizabeth; Hatano, Hiroyu; Hsue, Priscilla Y.; Epling, Lorrie; Hecht, Frederick M.; Martin, Jeffrey N.; McCune, Joseph M.; Deeks, Steven G.; Hunt, Peter W.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Dept Med, San Francisco, CA 94143 USA; [Bangsberg, David R.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Bangsberg, David R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Bangsberg, David R.] Mbarara Univ Sci & Technol, Dept Med, Mbarara, Uganda	University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Mbarara University of Science & Technology	Hunt, PW (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, Dept Med, San Francisco, CA 94143 USA.	phunt@php.ucsf.edu	Hunt, Peter W./P-2976-2017	Hunt, Peter W./0000-0002-4571-4870; Deeks, Steven/0000-0001-6371-747X; Hecht, Frederick/0000-0002-5782-1171	National Institute of Allergy and Infectious Diseases [R56AI100765, R21 AI087035, R21AI078774, RO1 AI087145, K24AI069994, P01AI076174]; National Institutes of Mental Health [R01 MH54907]; Doris Duke Charitable Foundation [2008047]; University of California San Francisco (UCSF)/Gladstone Institute of Virology & Immunology Centers for AIDS Research (CFAR) [P30 AI027763]; UCSF Clinical and Translational Research Institute Clinical Research Center [UL1 RR024131]; Center for AIDS Prevention Studies [P30 MH62246]; CFAR Network of Integrated Systems [R24 AI067039]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087145, R56AI100765, P01AI076174, T32AI060530, R21AI078774, K24AI069994, P30AI027763, R21AI087035, R24AI067039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907, P30MH062246] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); University of California San Francisco (UCSF)/Gladstone Institute of Virology & Immunology Centers for AIDS Research (CFAR); UCSF Clinical and Translational Research Institute Clinical Research Center; Center for AIDS Prevention Studies; CFAR Network of Integrated Systems; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the National Institute of Allergy and Infectious Diseases (R56AI100765, R21 AI087035, R21AI078774, RO1 AI087145, K24AI069994, P01AI076174), National Institutes of Mental Health (R01 MH54907), the Doris Duke Charitable Foundation (Clinical Scientist Development Award #2008047), the University of California San Francisco (UCSF)/Gladstone Institute of Virology & Immunology Centers for AIDS Research (CFAR) (grant number P30 AI027763), the UCSF Clinical and Translational Research Institute Clinical Research Center (UL1 RR024131), the Center for AIDS Prevention Studies (P30 MH62246), and the CFAR Network of Integrated Systems (R24 AI067039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almanzar G, 2005, J VIROL, V79, P3675, DOI 10.1128/JVI.79.6.3675-3683.2005; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2011, AIDS, V25, P1813, DOI 10.1097/QAD.0b013e32834640e6; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Combadiere B, 2003, AIDS, V17, P1279, DOI 10.1097/00002030-200306130-00002; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Dock JN, 2011, AGING DIS, V2, P382; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; FERGUSON FG, 1995, J GERONTOL A-BIOL, V50, pB378, DOI 10.1093/gerona/50A.6.B378; Hadrup SR, 2006, J IMMUNOL, V176, P2645, DOI 10.4049/jimmunol.176.4.2645; Hatano H, 2013, J INFECT DIS, V208, P50, DOI 10.1093/infdis/jis630; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Hunt P., 2012, 19 C RETR OPP INF SE; Jain V, 2013, J INFECT DI IN PRESS; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Ladell K, 2008, J IMMUNOL, V180, P7907, DOI 10.4049/jimmunol.180.12.7907; Lee SA, 2014, INFECT J IN IN PRESS; Lieberman J, 1999, AIDS, V13, P891, DOI 10.1097/00002030-199905280-00004; Merino J, 1998, CLIN EXP IMMUNOL, V112, P48; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Olsson J, 2000, MECH AGEING DEV, V121, P187; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Plana M, 2000, AIDS, V14, P1921, DOI 10.1097/00002030-200009080-00007; Qin OY, 2004, EXP GERONTOL, V39, P607, DOI 10.1016/j.exger.2003.11.016; Qin OY, 2003, J CLIN IMMUNOL, V23, P247, DOI 10.1023/A:1024580531705; Strindhall J, 2007, EXP GERONTOL, V42, P753, DOI 10.1016/j.exger.2007.05.001; Tenorio A, 2013, 20 C RETR OPP INF AT; Tortajada C, 2000, J ACQ IMMUN DEF SYND, V25, P296, DOI 10.1097/00126334-200012010-00002; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Vasto Sonya, 2007, Immun Ageing, V4, P2, DOI 10.1186/1742-4933-4-2; WANG ECY, 1995, J IMMUNOL, V155, P5046; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; Wikby A, 2008, BIOGERONTOLOGY, V9, P299, DOI 10.1007/s10522-008-9138-6	37	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2014	9	2							e89444	10.1371/journal.pone.0089444	http://dx.doi.org/10.1371/journal.pone.0089444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BU	24586783	gold, Green Published, Green Submitted			2022-12-27	WOS:000332390800023
J	Werner, J; Griebeler, EM				Werner, Jan; Griebeler, Eva Maria			Allometries of Maximum Growth Rate versus Body Mass at Maximum Growth Indicate That Non-Avian Dinosaurs Had Growth Rates Typical of Fast Growing Ectothermic Sauropsids	PLOS ONE			English	Article							ADAPTIVE SIGNIFICANCE; METABOLIC-RATE; PARENTAL CARE; SIZE; EVOLUTION; REPRODUCTION; PATTERNS; TEMPERATURE; ENDOTHERMY; REVEALS	We tested if growth rates of recent taxa are unequivocally separated between endotherms and ectotherms, and compared these to dinosaurian growth rates. We therefore performed linear regression analyses on the log-transformed maximum growth rate against log-transformed body mass at maximum growth for extant altricial birds, precocial birds, eutherians, marsupials, reptiles, fishes and dinosaurs. Regression models of precocial birds (and fishes) strongly differed from Case's study (1978), which is often used to compare dinosaurian growth rates to those of extant vertebrates. For all taxonomic groups, the slope of 0.75 expected from the Metabolic Theory of Ecology was statistically supported. To compare growth rates between taxonomic groups we therefore used regressions with this fixed slope and group-specific intercepts. On average, maximum growth rates of ectotherms were about 10 (reptiles) to 20 (fishes) times (in comparison to mammals) or even 45 (reptiles) to 100 (fishes) times (in comparison to birds) lower than in endotherms. While on average all taxa were clearly separated from each other, individual growth rates overlapped between several taxa and even between endotherms and ectotherms. Dinosaurs had growth rates intermediate between similar sized/scaled-up reptiles and mammals, but a much lower rate than scaled-up birds. All dinosaurian growth rates were within the range of extant reptiles and mammals, and were lower than those of birds. Under the assumption that growth rate and metabolic rate are indeed linked, our results suggest two alternative interpretations. Compared to other sauropsids, the growth rates of studied dinosaurs clearly indicate that they had an ectothermic rather than an endothermic metabolic rate. Compared to other vertebrate growth rates, the overall high variability in growth rates of extant groups and the high overlap between individual growth rates of endothermic and ectothermic extant species make it impossible to rule out either of the two thermoregulation strategies for studied dinosaurs.	[Werner, Jan; Griebeler, Eva Maria] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, Mainz, Germany	Johannes Gutenberg University of Mainz	Werner, J (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, Saarstr 21, Mainz, Germany.	wernerja@uni-mainz.de			421 German Research Foundation [GR 2625/2-2]	421 German Research Foundation	The project was financed by the 421 German Research Foundation (grant GR 2625/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RM, 1985, PHYSIOL ZOOL, V58, P214, DOI 10.1086/physzool.58.2.30158569; Apanius V., 1998, AVIAN GROWTH DEV EVO; AVERY RA, 1994, GERONTOLOGY, V40, P193, DOI 10.1159/000213587; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton T, 2011, P ROY SOC B; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Chiappe Luis M., 2009, Evolution Education and Outreach, V2, P248; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Damuth J, 2001, P NATL ACAD SCI USA, V98, P2113, DOI 10.1073/pnas.051011198; DUNHAM AE, 1978, ECOLOGY, V59, P770, DOI 10.2307/1938781; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Erickson GM, 2011, HIST BIOL, V23, P327, DOI 10.1080/08912963.2010.546856; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Farmer CG, 2000, AM NAT, V155, P326, DOI 10.1086/303323; Farmer CG, 2003, AM NAT, V162, P826, DOI 10.1086/380922; FITZHUGH HA, 1976, J ANIM SCI, V42, P1036, DOI 10.2527/jas1976.4241036x; FRAZER NB, 1985, COPEIA, P73; Gaillard JM, 1997, P ROY SOC B-BIOL SCI, V264, P859, DOI 10.1098/rspb.1997.0120; Griebeler EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074317; Griebeler Eva Maria, 2011, P263; Hemmingsen AM., 1960, REP STENO MEM HOSP N, V9, P1; Hendriks AJ, 2008, OECOLOGIA, V155, P705, DOI 10.1007/s00442-007-0952-3; Hendriks AJ, 2007, ECOL MODEL, V205, P196, DOI 10.1016/j.ecolmodel.2007.02.029; HEUSNER AA, 1991, J EXP BIOL, V160, P25; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Lee AH, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P217; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; LINDSTEDT SL, 1981, Q REV BIOL, V56, P1, DOI 10.1086/412080; Lloyd GT, 2008, P ROY SOC B-BIOL SCI, V275, P2483, DOI 10.1098/rspb.2008.0715; MAGNUSSON WE, 1995, COPEIA, P498; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Mcnab BK, 2009, COMP BIOCHEM PHYS A, V152, P22, DOI 10.1016/j.cbpa.2008.08.021; Montes L, 2007, BIOL J LINN SOC, V92, P63, DOI 10.1111/j.1095-8312.2007.00881.x; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; OWENS FN, 1993, J ANIM SCI, V71, P3138, DOI 10.2527/1993.71113138x; PAULY D, 1980, J CONSEIL, V39, P175; Pinheiro J., 2019, NLME LINEAR NONLINEA; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POND CM, 1977, EVOLUTION, V31, P177, DOI [10.2307/2407556, 10.1111/j.1558-5646.1977.tb00995.x]; PONTIER D, 1989, OECOLOGIA, V80, P390, DOI 10.1007/BF00379041; Pyron RA, 2014, ECOL LETT, V17, P13, DOI 10.1111/ele.12168; R Core Team, 2012, R LANG ENV STAT COMP; RAHN H, 1975, AUK, V92, P750, DOI 10.2307/4084786; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Ricklefs RE, 2003, FUNCT ECOL, V17, P384, DOI 10.1046/j.1365-2435.2003.00745.x; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Ricklefs RE, 2010, P NATL ACAD SCI USA, V107, P10314, DOI 10.1073/pnas.1005862107; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander P. Martin, 2011, P276; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; SHINE R, 1992, AM NAT, V139, P1257, DOI 10.1086/285385; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Sieg AE, 2009, AM NAT, V174, P720, DOI 10.1086/606023; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P247; Starck J. Matthias, 1998, Oxford Ornithology Series, V8, P381; Stearns S.C., 1992, pi; STEARNS SC, 1983, OIKOS, V41, P173, DOI 10.2307/3544261; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Weathers Wesley W., 1996, P461; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Zhang FC, 2006, GEOL J, V41, P395, DOI 10.1002/gj.1057; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844	76	28	28	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e88834	10.1371/journal.pone.0088834	http://dx.doi.org/10.1371/journal.pone.0088834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586409	Green Published, Green Submitted, gold			2022-12-27	WOS:000332385900014
J	Yao, MH; Zou, LL; Wu, R; Guo, LH; Xu, G; Xie, J; Li, P; Wang, S				Yao, Ming-Hua; Zou, Li-Ling; Wu, Rong; Guo, Le-Hang; Xu, Guang; Xie, Juan; Li, Pei; Wang, Shuai			Transperineal Ultrasound-Guided 12-Core Prostate Biopsy: An Extended Approach to Diagnose Transition Zone Prostate Tumors	PLOS ONE			English	Article							CANCER DETECTION RATE; SERVICES TASK-FORCE; GREATER-THAN-10 NG/ML; GLEASON SCORE; COMPARING 6; ANTIGEN; CORES; MEN; METAANALYSIS; PREDICTS	Objective: Transperineal ultrasound-guided (TPUS) 12-core prostate biopsy was evaluated as an initial strategy for the diagnosis of prostate cancer, The distribution of prostate cancer lesions was assessed with zone-specific biopsy. Methods: From January 2010 to December 2012, 287 patients underwent TPUS-guided 12-core prostate biopsy. Multiple cores were obtained from both the peripheral zone (PZ) and the transition zone (TZ) of the prostate. Participants' clinical data and the diagnostic yield of the cores were recorded and prospectively analyzed as a cross-sectional study. Results: The diagnostic yield of the 12-core prostate biopsy was significantly higher compared to the 6-core scheme (42.16 vs. 21.6%). The diagnostic yield of the 10-core prostate biopsy was significantly higher compared to the 6-core scheme (37.6 vs. 21.6%). The 12-core scheme improved the diagnostic yield in prostates >50 ml (12-core scheme: 28.1% vs. 10-core scheme: 20.4%; p = 0.034). Conclusions: The 12-core biopsy scheme is a safe and effective approach for the diagnosis of prostate cancer. TZ biopsies in patients with larger prostates should be included in the initial biopsy strategy.	[Yao, Ming-Hua; Wu, Rong; Guo, Le-Hang; Xu, Guang; Xie, Juan; Li, Pei; Wang, Shuai] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Ultrasound Med, Shanghai 200092, Peoples R China; [Zou, Li-Ling] Tongji Univ, Sch Med, Dept Hlth Stat, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Wu, R (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Ultrasound Med, Shanghai 200092, Peoples R China.	wurongmedsci@163.com						Abd TT, 2011, UROLOGY, V77, P541, DOI 10.1016/j.urology.2010.06.008; Angel Arrabal-Polo Miguel, 2010, Archivos Espanoles de Urologia, V63, P791; [Anonymous], 2013, NAT REV UROL; Bigliocchi M, 2007, Minerva Urol Nefrol, V59, P395; Brett AS, 2011, NEW ENGL J MED, V365, P1949, DOI 10.1056/NEJMp1112191; Chang D., 2013, NAT REV UROL; de la Rosette JJMCH, 2009, J UROLOGY, V182, P1329, DOI 10.1016/j.juro.2009.06.037; Demura T, 2005, CANCER-AM CANCER SOC, V103, P1826, DOI 10.1002/cncr.21020; Deshields TL, 2013, SUPPORT CARE CANC; Dogan B, 2012, INT UROL NEPHROL, V44, P1071, DOI 10.1007/s11255-012-0139-7; Elabbady AA, 2006, EUR UROL, V49, P49, DOI 10.1016/j.eururo.2005.08.013; Emiliozzi P, 2004, J UROLOGY, V171, P197, DOI 10.1097/01.ju.0000099824.73886.f3; Emiliozzi P, 2001, J UROLOGY, V166, P845, DOI 10.1016/S0022-5347(05)65849-1; Ficarra V, 2005, EUR UROL, V48, P932, DOI 10.1016/j.eururo.2005.08.008; Fine SW, 2012, HISTOPATHOLOGY, V60, P142, DOI 10.1111/j.1365-2559.2011.04004.x; Fujita K, 2012, PROSTATE CANCER P D, V15, P386, DOI 10.1038/pcan.2012.27; Gore JL, 2001, J UROLOGY, V165, P1554, DOI 10.1016/S0022-5347(05)66347-1; Hamstra DA, 2011, INT J RADIAT ONCOL, V81, P1293, DOI 10.1016/j.ijrobp.2010.07.2004; Hara R, 2008, UROLOGY, V71, P191, DOI 10.1016/j.urology.2007.09.029; Heidenreich A, 2011, EUR UROL, V59, P61, DOI 10.1016/j.eururo.2010.10.039; Humphrey Peter A, 2010, Mo Med, V107, P107; Hwang SI, 2009, J CLIN ULTRASOUND, V37, P281, DOI 10.1002/jcu.20565; Jeong H, 2008, WORLD J UROL, V26, P395, DOI 10.1007/s00345-008-0264-1; Kopke T, 2010, ANTICANCER RES, V30, P1823; Liu Xi-Gao, 2012, Zhonghua Nan Ke Xue, V18, P155; Luciani LG, 2006, UROLOGY, V67, P555, DOI 10.1016/j.urology.2005.09.036; Moussa AS, 2010, UROLOGY, V75, P1034, DOI 10.1016/j.urology.2009.11.008; Naughton CK, 2000, J UROLOGY, V164, P388, DOI 10.1016/S0022-5347(05)67367-3; Nesrallah L, 2008, INT BRAZ J UROL, V34, P563, DOI 10.1590/S1677-55382008000500004; Ng MK, 2009, BJU INT, V103, P872, DOI 10.1111/j.1464-410X.2008.08116.x; Novara G, 2010, BJU INT, V105, P1242, DOI 10.1111/j.1464-410X.2009.08954.x; O'Connell MJ, 2004, ABDOM IMAGING, V29, P132, DOI 10.1007/s00261-003-0089-8; Philip J, 2009, CANCER DETECT PREV, V32, P314, DOI 10.1016/j.cdp.2008.12.004; Ravizzini G, 2009, EUR J RADIOL, V70, P212, DOI 10.1016/j.ejrad.2008.09.019; Scattoni V, 2011, EUR UROL, V60, P834, DOI 10.1016/j.eururo.2011.07.036; Scattoni V, 2010, EUR UROL, V57, P1, DOI 10.1016/j.eururo.2009.08.011; Schroder FH, 2012, EUR UROL, V62, P745, DOI 10.1016/j.eururo.2012.05.068; Schroder FH, 2011, NEW ENGL J MED, V365, P1953, DOI 10.1056/NEJMp1112140; Shen PF, 2012, ASIAN J ANDROL, V14, P310, DOI 10.1038/aja.2011.130; Stamatiou KN, 2011, UROL J, V8, P83; Takenaka A, 2008, PROSTATE CANCER P D, V11, P134, DOI 10.1038/sj.pcan.4500985; Takenaka A, 2006, INT J UROL, V13, P10, DOI 10.1111/j.1442-2042.2006.01221.x; Talab SS, 2012, RADIOL CLIN N AM, V50, P1015, DOI 10.1016/j.rcl.2012.08.004; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Tobiume M, 2008, INT BRAZ J UROL, V34, P9, DOI 10.1590/S1677-55382008000100003; Van der Kwast T, 2013, VIRCHOWS ARCH; Yamamoto Shinya, 2005, Int J Clin Oncol, V10, P117; Yan WG, 2009, UROL ONCOL-SEMIN ORI, V27, P520, DOI 10.1016/j.urolonc.2008.05.002; Zhu YK, 2010, CLIN IMAG, V34, P43, DOI 10.1016/j.clinimag.2009.02.003; Zullig LL, 2012, MIL MED, V177, P693, DOI 10.7205/MILMED-D-11-00434	50	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89171	10.1371/journal.pone.0089171	http://dx.doi.org/10.1371/journal.pone.0089171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586569	Green Published, gold, Green Submitted			2022-12-27	WOS:000332385900032
J	Plow, EB; Varnerin, N; Cunningham, DA; Janini, D; Bonnett, C; Wyant, A; Hou, J; Siemionow, V; Wang, XF; Machado, AG; Yue, GH				Plow, Ela B.; Varnerin, Nicole; Cunningham, David A.; Janini, Daniel; Bonnett, Corin; Wyant, Alexandria; Hou, Juliet; Siemionow, Vlodek; Wang, Xiao-Feng; Machado, Andre G.; Yue, Guang H.			Age-Related Weakness of Proximal Muscle Studied with Motor Cortical Mapping: A TMS Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INPUT-OUTPUT PROPERTIES; INTRACORTICAL INHIBITION; CORTICOSPINAL PROJECTIONS; EVOKED-POTENTIALS; PRECISION GRIP; HAND MUSCLE; CORTEX; STRENGTH; REORGANIZATION	Aging-related weakness is due in part to degeneration within the central nervous system. However, it is unknown how changes to the representation of corticospinal output in the primary motor cortex (M1) relate to such weakness. Transcranial magnetic stimulation (TMS) is a noninvasive method of cortical stimulation that can map representation of corticospinal output devoted to a muscle. Using TMS, we examined age-related alterations in maps devoted to biceps brachii muscle to determine whether they predicted its age-induced weakness. Forty-seven right-handed subjects participated: 20 young (22.6 +/- 0.90 years) and 27 old (74.96 +/- 1.35 years). We measured strength as force of elbow flexion and electromyographic activation of biceps brachii during maximum voluntary contraction. Mapping variables included: 1) center of gravity or weighted mean location of corticospinal output, 2) size of map, 3) volume or excitation of corticospinal output, and 4) response density or corticospinal excitation per unit area. Center of gravity was more anterior in old than in young (p<0.001), though there was no significant difference in strength between the age groups. Map size, volume, and response density showed no significant difference between groups. Regardless of age, center of gravity significantly predicted strength (beta = 20.34, p = 0.005), while volume adjacent to the core of map predicted voluntary activation of biceps (beta = 0.32, p = 0.008). Overall, the anterior shift of the map in older adults may reflect an adaptive change that allowed for the maintenance of strength. Laterally located center of gravity and higher excitation in the region adjacent to the core in weaker individuals could reflect compensatory recruitment of synergistic muscles. Thus, our study substantiates the role of M1 in adapting to aging-related weakness and subtending strength and muscle activation across age groups. Mapping from M1 may offer foundation for an examination of mechanisms that preserve strength in elderly.	[Plow, Ela B.; Varnerin, Nicole; Cunningham, David A.; Janini, Daniel; Bonnett, Corin; Siemionow, Vlodek] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA; [Plow, Ela B.; Hou, Juliet] Cleveland Clin, Neurol Inst, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA; [Wang, Xiao-Feng] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Wyant, Alexandria; Machado, Andre G.] Cleveland Clin, Neurol Inst, Dept Neurosurg, Ctr Neurol Restorat, Cleveland, OH 44106 USA; [Yue, Guang H.] Kessler Fdn Res Ctr, Human Performance & Engn Lab, W Orange, NJ USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Kessler Institute for Rehabilitation	Plow, EB (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA.	plowe2@ccf.org			National Institutes of Health (NIH) [R01NS35130, K01HD069504, R01HD061363, OD00646]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061363, K01HD069504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035130] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH) grant R01NS35130 (to GHY). NIH grants supporting investigator roles included Career Development Award K01HD069504 (to EP), and R01HD061363 and New Innovator's Award OD00646 (to AGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER AT, 1985, LANCET, V1, P1106; Bastings EP, 2002, NEUROREHAB NEURAL RE, V16, P275, DOI 10.1177/154596802401105207; Beck S, 2007, BRAIN RES, V1179, P51, DOI 10.1016/j.brainres.2007.08.048; Bernard JA, 2012, NEUROBIOL AGING, V33, P1890, DOI 10.1016/j.neurobiolaging.2011.06.021; BRASILNETO JP, 1992, ELECTROEN CLIN NEURO, V85, P9, DOI 10.1016/0168-5597(92)90095-S; Brogardh C, 2010, J REHABIL MED, V42, P789, DOI 10.2340/16501977-0588; Brouwer B, 2001, EXP BRAIN RES, V138, P467, DOI 10.1007/s002210100730; Butler AJ, 2007, PHYS THER, V87, P719, DOI 10.2522/ptj.20060274; Butler Andrew J, 2005, J Neuroeng Rehabil, V2, P10, DOI 10.1186/1743-0003-2-10; Canning CG, 2000, J NEUROL SCI, V176, P45, DOI 10.1016/S0022-510X(00)00305-1; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Corneal SF, 2005, ARCH PHYS MED REHAB, V86, P1670, DOI 10.1016/j.apmr.2004.12.039; Cros D, 2007, BRAIN RES, V1185, P103, DOI 10.1016/j.brainres.2007.09.003; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Di Lazzaro V, 1998, J PHYSIOL-LONDON, V508, P625; Diekhoff S, 2011, HUM BRAIN MAPP, V32, P341, DOI 10.1002/hbm.21024; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; DUM RP, 1991, J NEUROSCI, V11, P667; Eisen A, 1996, NEUROLOGY, V46, P1396, DOI 10.1212/WNL.46.5.1396; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Freund P, 2011, EUR J NEUROSCI, V34, P1839, DOI 10.1111/j.1460-9568.2011.07895.x; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; Gagne M, 2011, HUM BRAIN MAPP, V32, P509, DOI 10.1002/hbm.21038; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Goodwill AM, 2012, MUSCLE NERVE, V46, P384, DOI 10.1002/mus.23316; Grabiner M D, 1995, Exerc Sport Sci Rev, V23, P65; Griffin L, 2007, J ELECTROMYOGR KINES, V17, P446, DOI 10.1016/j.jelekin.2006.05.001; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; HAUG H, 1991, NEUROBIOL AGING, V12, P336, DOI 10.1016/0197-4580(91)90013-A; HE SQ, 1993, J NEUROSCI, V13, P952; HENDERSON G, 1980, J NEUROL SCI, V46, P113, DOI 10.1016/0022-510X(80)90048-9; Hetu S, 2011, J CLIN NEUROSCI, V18, P728, DOI 10.1016/j.jocn.2010.09.011; HOPP JF, 1993, PHYS THER, V73, P361, DOI 10.1093/ptj/73.6.361; Hortobagyi T, 2006, EXP BRAIN RES, V171, P322, DOI 10.1007/s00221-005-0274-9; Hutchinson S, 2002, NEUROIMAGE, V17, P1720, DOI 10.1006/nimg.2002.1309; KANEHISA H, 1994, EUR J APPL PHYSIOL, V68, P148, DOI 10.1007/BF00244028; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Kido A, 2004, CAN J PHYSIOL PHARM, V82, P238, DOI 10.1139/Y04-017; Kossev AR, 2002, NEUROSCI LETT, V333, P83, DOI 10.1016/S0304-3940(02)00986-2; Kouchtir-Devanne N, 2012, J NEUROPHYSIOL, V107, P1522, DOI 10.1152/jn.00786.2011; La Corte G, 2013, J NEUROPHYSIOL; Lee M, 2009, MED SCI SPORT EXER, V41, P1452, DOI 10.1249/MSS.0b013e3181998837; Liang N, 2007, EXP BRAIN RES, V182, P459, DOI 10.1007/s00221-007-1004-2; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Liepert J, 2006, NEUROIMAGE, V32, P1216, DOI 10.1016/j.neuroimage.2006.05.028; Lindberg PG, 2010, J NEUROSCI, V30, P4102, DOI 10.1523/JNEUROSCI.5529-09.2010; Lindle RS, 1997, J APPL PHYSIOL, V83, P1581, DOI 10.1152/jappl.1997.83.5.1581; Lotze M, 2006, RESTOR NEUROL NEUROS, V24, P97; Malcolm MP, 2006, CLIN NEUROPHYSIOL, V117, P1037, DOI 10.1016/j.clinph.2006.02.005; Marconi B, 2011, NEUROREHAB NEURAL RE, V25, P48, DOI 10.1177/1545968310376757; Marneweck M, 2011, NEUROSCI RES, V70, P408, DOI 10.1016/j.neures.2011.04.004; McGinley M, 2010, EXP GERONTOL, V45, P671, DOI 10.1016/j.exger.2010.04.005; McGregor KM, 2012, EXP BRAIN RES, V219, P97, DOI 10.1007/s00221-012-3070-3; Morecraft RJ, 2002, BRAIN, V125, P176, DOI 10.1093/brain/awf011; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliviero A, 2006, NEUROSCI RES, V55, P74, DOI 10.1016/j.neures.2006.02.002; Peinemann A, 2001, NEUROSCI LETT, V313, P33, DOI 10.1016/S0304-3940(01)02239-X; Pitcher JB, 2003, J PHYSIOL-LONDON, V546, P605, DOI 10.1113/jphysiol.2002.029454; Plow EB, 2013, J NEUROPHYSIOL; Porter R, 1993, CORTICOSPINAL FUNCTI; Reilly KT, 2008, HUM BRAIN MAPP, V29, P594, DOI 10.1002/hbm.20421; Remple MS, 2001, BEHAV BRAIN RES, V123, P133, DOI 10.1016/S0166-4328(01)00199-1; Rijntjes M, 1997, ANN NEUROL, V41, P621, DOI 10.1002/ana.410410511; Roricht S, 2001, ANN NEUROL, V50, P240, DOI 10.1002/ana.1091; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROTHWELL JC, 1991, EXP PHYSIOL, V76, P159, DOI 10.1113/expphysiol.1991.sp003485; Sale MV, 2005, J APPL PHYSIOL, V99, P1483, DOI 10.1152/japplphysiol.00371.2005; Sawaki L, 2008, NEUROREHAB NEURAL RE, V22, P505, DOI 10.1177/1545968308317531; Semmler JG, 2006, EXP BRAIN RES, V172, P507, DOI 10.1007/s00221-006-0367-0; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Soer R, 2012, ARCH PHYS MED REHAB, V93, P2326, DOI 10.1016/j.apmr.2012.07.009; Streletz Leopold J., 1995, Brain Topography, V7, P245, DOI 10.1007/BF01202383; Suzuki M, 2012, BRAIN RES, V1473, P114, DOI 10.1016/j.brainres.2012.07.043; Svensson P, 2003, EXP BRAIN RES, V152, P42, DOI 10.1007/s00221-003-1517-2; Talelli P, 2008, NEUROIMAGE, V40, P1772, DOI 10.1016/j.neuroimage.2008.01.039; Talelli P, 2008, EXP BRAIN RES, V186, P59, DOI 10.1007/s00221-007-1205-8; Triggs WJ, 1999, BRAIN RES, V835, P324, DOI 10.1016/S0006-8993(99)01629-7; Tsao H, 2011, SPINE, V36, P1721, DOI 10.1097/BRS.0b013e31821c4267; Tyc F, 2005, EUR J NEUROSCI, V21, P259, DOI 10.1111/j.1460-9568.2004.03835.x; Tyc F, 2011, CLIN NEUROPHYSIOL, V122, P153, DOI 10.1016/j.clinph.2010.05.022; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; Weier AT, 2012, ACTA PHYSIOL, V206, P109, DOI 10.1111/j.1748-1716.2012.02454.x; Wolf SL, 2004, CLIN NEUROPHYSIOL, V115, P1740, DOI 10.1016/j.clinph.2004.02.027; YOUNG A, 1985, CLIN PHYSIOL, V5, P145; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006; Zoghi M, 2007, EXP BRAIN RES, V177, P266, DOI 10.1007/s00221-006-0669-2	88	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89371	10.1371/journal.pone.0089371	http://dx.doi.org/10.1371/journal.pone.0089371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586726	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900086
J	Ponrartana, S; Patil, S; Aggabao, PC; Pavlova, Z; Devaskar, SU; Gilsanz, V				Ponrartana, Skorn; Patil, Shilpa; Aggabao, Patricia C.; Pavlova, Zdena; Devaskar, Sherin U.; Gilsanz, Vicente			Brown Adipose Tissue in the Buccal Fat Pad during Infancy	PLOS ONE			English	Article							EXPRESSION	Background: The buccal fat pad (BFP) is an encapsulated mass of adipose tissue thought to enhance the sucking capabilities of the masticatory muscles during infancy. To date, no conclusive evidence has been provided as to the composition of the BFP in early postnatal life. Objective: The purpose of this study was to examine whether the BFP of neonates and infants is primarily composed of white adipose tissue (WAT) or brown adipose tissue (BAT). Materials and Methods: The percentage of fat in the BFP in 32 full-term infants (16 boys and 16 girls), aged one day to 10.6 months, was measured using magnetic resonance imaging (MRI) determinations of fat fraction. Results: BFP fat fraction increased with age (r = 0.67; P <.0001) and neonates had significantly lower values when compared to older infants; 72.6 +/- 9.6 vs. 91.8 +/- 2.4, P <.0001. Multiple regression analysis indicated that the age-dependent relationship persisted after accounting for gender, gestational age, and weight percentile (P = .001). Two subjects (aged one and six days) depicted a change in the MRI characteristics of the BFP from primarily BAT to WAT at follow-up examinations two to six weeks later, respectively. Histological post-mortem studies of a 3 day and 1.1 month old revealed predominantly BAT and WAT in the BFP, respectively. Conclusion: The BFP is primarily composed of BAT during the first weeks of life, but of WAT thereafter. Studies are needed to investigate the contributions of BAT in the BFP to infant feeding and how it is altered by postnatal nutrition.	[Ponrartana, Skorn; Aggabao, Patricia C.; Gilsanz, Vicente] Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA; [Patil, Shilpa; Gilsanz, Vicente] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Pavlova, Zdena] Childrens Hosp Los Angeles, Dept Pathol, Los Angeles, CA 90027 USA; [Devaskar, Sherin U.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ponrartana, S (corresponding author), Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA 90027 USA.	sponrartana@chla.usc.edu			National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R21DK090778]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK090778] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases supported this work (R21DK090778). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; BAGDADE JD, 1966, P SOC EXP BIOL MED, V122, P616; Branca RT, 2011, MAGN RESON MED, V65, P313, DOI 10.1002/mrm.22622; BURDI AR, 1985, INT J OBESITY, V9, P247; Chen YI, 2012, OBESITY, V20, P1519, DOI 10.1038/oby.2012.22; Clarke IJ, 2010, CLIN EXP PHARMACOL P, V37, P121, DOI 10.1111/j.1440-1681.2009.05259.x; Commins SP, 1999, ENDOCRINOLOGY, V140, P292, DOI 10.1210/en.140.1.292; Eggers H, 2011, MAGN RESON MED, V65, P96, DOI 10.1002/mrm.22578; Gilsanz V, 2012, J PEDIATR-US, V160, P604, DOI 10.1016/j.jpeds.2011.09.035; Hamilton G, 2011, J MAGN RESON IMAGING, V34, P468, DOI 10.1002/jmri.22623; Hu HCH, 2013, J MAGN RESON IMAGING, V38, P885, DOI 10.1002/jmri.24053; Hu HH, 2013, AM J ROENTGENOL, V200, P177, DOI 10.2214/AJR.12.8996; Hu HCH, 2012, J MAGN RESON IMAGING, V35, P938, DOI 10.1002/jmri.23531; Kahn JL, 2000, CLIN ANAT, V13, P373, DOI 10.1002/1098-2353(2000)13:5<373::AID-CA7>3.0.CO;2-W; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Lindqvist A, 2007, REGUL PEPTIDES, V142, P24, DOI 10.1016/j.regpep.2007.01.007; Okamatsu-Ogura Y, 2007, OBES RES CLIN PRACT, V1, P233, DOI 10.1016/j.orcp.2007.08.001; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Racz L, 1989, Morphol Embryol (Bucur), V35, P73; Ross MH, 2010, ADIPOSE TISSUE HISTO, P252; Saito K, 2006, BBA-MOL CELL BIOL L, V1761, P709, DOI 10.1016/j.bbalip.2006.04.016; Savino F, 2009, INT J PEDIATR ENDOCR, DOI 10.1155/2009/327505; Scammon RE, 1919, ANAT REC, V15, P267, DOI 10.1002/ar.1090150602; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Tostevin P M, 1995, Clin Anat, V8, P403, DOI 10.1002/ca.980080606; Zhang HM, 2002, PLAST RECONSTR SURG, V109, P2509, DOI 10.1097/00006534-200206000-00052	26	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89533	10.1371/journal.pone.0089533	http://dx.doi.org/10.1371/journal.pone.0089533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586852	Green Published, gold			2022-12-27	WOS:000331717900117
J	Rogers, MAM; Micic, D; Blumberg, N; Young, VB; Aronoff, DM				Rogers, Mary A. M.; Micic, Dejan; Blumberg, Neil; Young, Vincent B.; Aronoff, David M.			Storage Duration of Red Blood Cell Transfusion and Clostridium difficile Infection: A Within Person Comparison	PLOS ONE			English	Article							PROLONGED STORAGE; CARDIAC-SURGERY; CRITICALLY-ILL; IMMUNE; IMPACT; TRIAL; TIME	Objective: Randomized controlled trials demonstrated that red blood cell (RBC) transfusion elevates the risk of infection, and trials are underway to evaluate whether RBC storage affects outcomes. We previously reported that transfusion predicts Clostridium difficile infection (CDI) and, therefore, planned an investigation to examine this further using a more robust design. Design: Within-person case-crossover study. Hospitalizations in which CDI developed (n = 406) were compared to hospitalizations for the same individuals in which CDI did not occur (n = 949). Transfusion volume and storage duration were assessed prior to the onset of CDI. Setting: University of Michigan Health System. Patients: Participants were individuals with a diagnosis of CDI from July 2009 through June 2012. Measurements and Main Results: During the hospitalizations when CDI occurred, 34.7% of the patients received allogeneic RBC transfusions (mean volume, 688 ml) compared to 19.0% of patients in hospitalizations without CDI (mean volume, 180 ml). The odds of healthcare-associated CDI increased by 76% (95% CI 1.39-2.23) for every liter of RBCs transfused and was elevated in both nonsurgical (OR = 1.90) and surgical (OR = 1.86) hospitalizations. In patients who received RBC transfusions, the odds of developing CDI increased by 6% for every additional day of RBC stored and by 53% for every week of additional storage (P = 0.002). Conclusions: Hospitalizations in which a patient received a greater volume of RBC transfusions were more likely to be associated with the development of CDI. RBC units stored for a longer duration were associated with the development of healthcare-associated CDI after adjustment for RBC volume.	[Rogers, Mary A. M.; Micic, Dejan; Young, Vincent B.; Aronoff, David M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Blumberg, Neil] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Young, Vincent B.; Aronoff, David M.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Aronoff, David M.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	University of Michigan System; University of Michigan; University of Rochester; University of Michigan System; University of Michigan; Vanderbilt University	Rogers, MAM (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	maryroge@umich.edu	Young, Vincent B/B-3179-2009; Young, Vincent Bensan/M-9916-2019	Young, Vincent B/0000-0003-3687-2364; Young, Vincent Bensan/0000-0003-3687-2364; Rogers, Mary/0000-0001-5519-3223; Aronoff, David/0000-0003-4587-6121	National Institute of Allergy and Infectious Diseases [5U19AI090871-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090871] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by a grant from the National Institute of Allergy and Infectious Diseases (grant number 5U19AI090871-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar I, 2011, ARCH INTERN MED, V171, P1385, DOI 10.1001/archinternmed.2011.231; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Bernard A, 2010, J TRAUMA, V69, P320, DOI 10.1097/TA.0b013e3181e401f0; BLUMBERG N, 1989, ARCH PATHOL LAB MED, V113, P246; Butler M, 2011, COMP EFFECTIVENESS R; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub3; Crabtree T, 2007, ANN THORAC SURG, V83, P1396, DOI 10.1016/j.athoracsur.2006.10.067; Dubberke E, 2012, J HOSP MED, V7, pS1, DOI 10.1002/jhm.1916; Fergusson DA, 2012, JAMA-J AM MED ASSOC, V308, P1443, DOI 10.1001/2012.jama.11953; Glynn SA, 2013, TRANSFUSION, V53, P438, DOI 10.1111/j.1537-2995.2012.03742.x; Hebert PC, 2005, ANESTH ANALG, V100, P1433, DOI 10.1213/01.ANE.0000148690.48803.27; Hess JR, 2010, TRANSFUS APHER SCI, V43, P51, DOI 10.1016/j.transci.2010.05.009; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Horvath KA, 2013, ANN THORAC SURG, V95, P2194, DOI 10.1016/j.athoracsur.2012.11.078; Hoyert DL, 2012, NATL VITAL STAT REPO, V2012, P6; Koch C, 2013, RED CELL STORAGE DUR; Kor DJ, 2012, AM J RESP CRIT CARE, V185, P842, DOI 10.1164/rccm.201107-1332OC; La Gamma EF, 2012, SEMIN PERINATOL, V36, P294, DOI 10.1053/j.semperi.2012.04.011; Lacroix J, 2011, TRANSFUS MED REV, V25, P197, DOI 10.1016/j.tmrv.2011.03.001; Lannan KL, 2013, BLOOD CELL MOL DIS, V50, P61, DOI 10.1016/j.bcmd.2012.08.009; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Muszynski J, 2012, TRANSFUSION, V52, P794, DOI 10.1111/j.1537-2995.2011.03348.x; Mynster T, 2001, TRANSFUS APHER SCI, V25, P17, DOI 10.1016/S1473-0502(01)00081-7; Rogers MAM, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-37; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Spinella PC, 2011, TRANSFUSION, V51, P894, DOI 10.1111/j.1537-2995.2011.03103.x; Steiner ME, 2010, TRANSFUS APHER SCI, V43, P107, DOI 10.1016/j.transci.2010.05.014; US Department of Health and Human Services, 2009, NAT ACT PLAN PREV HE; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Walsh TS, 2004, CRIT CARE MED, V32, P364, DOI 10.1097/01.CCM.0000108878.23703.E0	31	7	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89332	10.1371/journal.pone.0089332	http://dx.doi.org/10.1371/journal.pone.0089332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586694	Green Published, Green Submitted, gold			2022-12-27	WOS:000331717900081
J	Workman, AM; Jacobs, AK; Vogel, AJ; Condon, S; Brown, DM				Workman, Aspen M.; Jacobs, Ashley K.; Vogel, Alexander J.; Condon, Shirley; Brown, Deborah M.			Inflammation Enhances IL-2 Driven Differentiation of Cytolytic CD4 T Cells	PLOS ONE			English	Article							INFLUENZA-VIRUS INFECTION; TRANS-PRESENTATION; MEDIATED CYTOTOXICITY; REQUIRE INTERACTIONS; LETHAL INFLUENZA; DENDRITIC CELLS; IN-VIVO; PERFORIN; EXPRESSION; PROTECTION	Cytolytic CD4 T cells (CD4 CTL) have been identified in vivo in response to viral infections; however, the factors necessary for driving the cytolytic phenotype have not been fully elucidated. Our previously published work suggests IL-2 may be the master regulator of perforin-mediated cytotoxicity in CD4 effectors. To further dissect the role of IL-2 in CD4 CTL generation, T cell receptor transgenic mice deficient in the ability to produce IL-2 or the high affinity IL-2 receptor (IL-2R alpha, CD25) were used. Increasing concentrations of IL-2 were necessary to drive perforin (Prf) expression and maximal cytotoxicity. Granzyme B (GrB) expression and killing correlated with STAT5 activation and CD25 expression in vitro, suggesting that signaling through the high affinity IL-2R is critical for full cytotoxicity. IL-2 signaling was also necessary in vivo for inducing the Th1 phenotype and IFN-gamma expression in CD4 T cells during influenza A (IAV) infection. In addition, GrB expression, as measured by mean fluorescent intensity, was decreased in CD25 deficient cells; however, the frequency of CD4 cells expressing GrB was unchanged. Similarly, analysis of cytolytic markers such as CD107a/b and Eomesodermin indicate high IL-2Ra expression is not necessary to drive the CD4 CTL phenotype during IAV infection. Thus, inflammatory signals induced by viral infection may overcome the need for strong IL-2 signals in driving cytotoxicity in CD4 cells.	[Workman, Aspen M.; Vogel, Alexander J.; Condon, Shirley; Brown, Deborah M.] Univ Nebraska Lincoln, Sch Biol Sci, Lincoln, NE 68583 USA; [Workman, Aspen M.; Jacobs, Ashley K.; Condon, Shirley; Brown, Deborah M.] Univ Nebraska Lincoln, Nebraska Ctr Virol, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Brown, DM (corresponding author), Univ Nebraska Lincoln, Sch Biol Sci, Lincoln, NE 68583 USA.	dbrown7@unl.edu		Workman, Aspen/0000-0003-2852-3519	Public Health Service grants from the National Center for Research Resources [P30RR031151-03]; National Institute of General Medical Sciences [P30GM103509-03]; National Institute of Immunology, Allergy and Infectious Disease [R21-AI090438, T32-AI060547]; University of Nebraska Research Council; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI100929, R21AI090438, T32AI060547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	Public Health Service grants from the National Center for Research Resources; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Immunology, Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Nebraska Research Council; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service grants from the National Center for Research Resources (P30RR031151-03), the National Institute of General Medical Sciences (P30GM103509-03), National Institute of Immunology, Allergy and Infectious Disease (R21-AI090438), National Institute of Immunology, Allergy and Infectious Disease (T32-AI060547 to AJV), and the University of Nebraska Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2004, CLIN EXP IMMUNOL, V138, P10, DOI 10.1111/j.1365-2249.2004.02605.x; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Banchereau J, 2012, BLOOD, V119, P5742, DOI 10.1182/blood-2011-08-371245; BILLINGS P, 1977, J EXP MED, V145, P1387, DOI 10.1084/jem.145.5.1387; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; Brown DM, 2010, CELL IMMUNOL, V262, P89, DOI 10.1016/j.cellimm.2010.02.008; Brown DM, 2009, CELL IMMUNOL, V257, P69, DOI 10.1016/j.cellimm.2009.03.002; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; Curran MA, 2013, J EXP MED, V210, P743, DOI 10.1084/jem.20121190; Cush SS, 2011, J IMMUNOL, V186, P4051, DOI 10.4049/jimmunol.1003122; de Berg PJV, 2008, CURR OPIN IMMUNOL, V20, P339, DOI 10.1016/j.coi.2008.03.007; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Fang M, 2012, P NATL ACAD SCI USA, V109, P9983, DOI 10.1073/pnas.1202143109; Haigh TA, 2008, J IMMUNOL, V180, P1643, DOI 10.4049/jimmunol.180.3.1643; HANABUCHI S, 1994, P NATL ACAD SCI USA, V91, P4930, DOI 10.1073/pnas.91.11.4930; Hidalgo LG, 2008, AM J TRANSPLANT, V8, P627, DOI 10.1111/j.1600-6143.2007.02128.x; Hildemann SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060420; Hirschhorn-Cymerman D, 2012, J EXP MED, V209, P2113, DOI 10.1084/jem.20120532; Hua LQ, 2013, J VIROL, V87, P11884, DOI 10.1128/JVI.01461-13; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; JACOBSON S, 1984, J IMMUNOL, V133, P754; Jelley-Gibbs DM, 2007, J IMMUNOL, V178, P7563, DOI 10.4049/jimmunol.178.12.7563; Jellison ER, 2005, J IMMUNOL, V174, P614, DOI 10.4049/jimmunol.174.2.614; JU ST, 1990, J IMMUNOL, V144, P23; Khanna R, 1997, J IMMUNOL, V158, P3619; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; LUKACHER AE, 1985, J EXP MED, V162, P171, DOI 10.1084/jem.162.1.171; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; MAHON BP, 1995, J EXP MED, V181, P1285, DOI 10.1084/jem.181.4.1285; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; McGill J, 2010, J EXP MED, V207, P521, DOI 10.1084/jem.20091711; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Qui HZ, 2011, J IMMUNOL, V187, P3555, DOI 10.4049/jimmunol.1101244; Sharma R, 2011, J AUTOIMMUN, V36, P91, DOI 10.1016/j.jaut.2011.01.001; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; STALDER T, 1994, J IMMUNOL, V152, P1127; Strutt TM, 2012, P NATL ACAD SCI USA, V109, pE2551, DOI 10.1073/pnas.1205894109; Stuller KA, 2010, J IMMUNOL, V184, P3850, DOI 10.4049/jimmunol.0902935; Stuller KA, 2009, J VIROL, V83, P4700, DOI 10.1128/JVI.02240-08; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106; White L, 2007, BLOOD, V109, P3873, DOI 10.1182/blood-2006-09-045278; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Zhang J, 1999, J EXP MED, V190, P1297, DOI 10.1084/jem.190.9.1297; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	54	31	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89010	10.1371/journal.pone.0089010	http://dx.doi.org/10.1371/journal.pone.0089010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586481	Green Published, gold			2022-12-27	WOS:000331714700051
J	Payet, LA; Kadri, L; Giraud, S; Norez, C; Berjeaud, JM; Jayle, C; Mirval, S; Becq, F; Vandebrouck, C; Ferreira, T				Payet, Laurie-Anne; Kadri, Linette; Giraud, Sebastien; Norez, Caroline; Berjeaud, Jean Marc; Jayle, Christophe; Mirval, Sandra; Becq, Frederic; Vandebrouck, Clarisse; Ferreira, Thierry			Cystic Fibrosis Bronchial Epithelial Cells Are Lipointoxicated by Membrane Palmitate Accumulation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNFOLDED PROTEIN RESPONSE; FATTY-ACID-COMPOSITION; PANCREATIC-BETA-CELLS; INDUCED ER STRESS; AIRWAY EPITHELIA; DELTA-F508 CFTR; F508DEL-CFTR; APOPTOSIS	The F508del-CFTR mutation, responsible for Cystic Fibrosis (CF), leads to the retention of the protein in the endoplasmic reticulum (ER). The mistrafficking of this mutant form can be corrected by pharmacological chaperones, but these molecules showed limitations in clinical trials. We therefore hypothesized that important factors in CF patients may have not been considered in the in vitro assays. CF has also been associated with an altered lipid homeostasis, i. e. a decrease in polyunsaturated fatty acid levels in plasma and tissues. However, the precise fatty acyl content of membrane phospholipids from human CF bronchial epithelial cells had not been studied to date. Since the saturation level of phospholipids can modulate crucial membrane properties, with potential impacts on membrane protein folding/trafficking, we analyzed this parameter for freshly isolated bronchial epithelial cells from CF patients. Interestingly, we could show that Palmitate, a saturated fatty acid, accumulates within Phosphatidylcholine (PC) in CF freshly isolated cells, in a process that could result from hypoxia. The observed PC pattern can be recapitulated in the CFBE41o(-) cell line by incubation with 100 mM Palmitate. At this concentration, Palmitate induces an ER stress, impacts calcium homeostasis and leads to a decrease in the activity of the corrected F508del-CFTR. Overall, these data suggest that bronchial epithelial cells are lipointoxicated by hypoxia-related Palmitate accumulation in CF patients. We propose that this phenomenon could be an important bottleneck for F508del- CFTR trafficking correction by pharmacological agents in clinical trials.	[Payet, Laurie-Anne; Norez, Caroline; Mirval, Sandra; Becq, Frederic; Vandebrouck, Clarisse; Ferreira, Thierry] Univ Poitiers, ERL CNRS 7368, Poitiers, France; [Kadri, Linette; Berjeaud, Jean Marc] Univ Poitiers, UMR CNRS 7267, Poitiers, France; [Giraud, Sebastien] CHU Poitiers, Serv Biochim, Poitiers, France; [Giraud, Sebastien] INSERM, U1082, Poitiers, France; [Giraud, Sebastien] Univ Poitiers, Fac Med & Pharm, Poitiers, France; [Jayle, Christophe] CHU Poitiers, Serv Chirurg Cardiothorac, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Ferreira, T (corresponding author), Univ Poitiers, ERL CNRS 7368, Poitiers, France.	thierry.ferreira@univ-poitiers.fr	vandebrouck, clarisse/P-9463-2016; Berjeaud, Jean-Marc/GOP-0237-2022; GIRAUD, Sebastien/AAB-9095-2021; Becq, Frederic/P-9233-2016; Norez, Caroline/P-9567-2016; Berjeaud, Jean-Marc/ABF-9966-2021	Becq, Frederic/0000-0003-3915-0973; Berjeaud, Jean-Marc/0000-0001-9013-8430; Vandebrouck, clarisse/0000-0002-9401-0546; giraud, sebastien/0000-0001-9015-8968	Ministere de l'Enseignement superieur et de la Recherche; Vaincre La Mucoviscidose; Centre National de la Recherche Scientifique	Ministere de l'Enseignement superieur et de la Recherche; Vaincre La Mucoviscidose; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	Funding provided by Ministere de l'Enseignement superieur et de la Recherche (http://www.enseignementsup-recherche.gouv.fr/); Vaincre La Mucoviscidose (http://www.vaincrelamuco.org/); Centre National de la Recherche Scientifique (http://www.cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULKARIM FW, 1986, ARCH PATHOL LAB MED, V110, P602; Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Andersson C, 2000, EUR RESPIR J, V15, P937, DOI 10.1034/j.1399-3003.2000.15e21.x; Andersson C, 2008, J LIPID RES, V49, P1692, DOI 10.1194/jlr.M700388-JLR200; Antigny F, 2008, CELL CALCIUM, V43, P175, DOI 10.1016/j.ceca.2007.05.002; Antigny F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-70; Blohmke CJ, 2012, J IMMUNOL, V189, P5467, DOI 10.4049/jimmunol.1103661; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; da Cruz FP, 2011, TETRAHEDRON LETT, V52, P219, DOI 10.1016/j.tetlet.2010.10.173; Deguil J, 2011, TRAFFIC, V12, P349, DOI 10.1111/j.1600-0854.2010.01150.x; Dhayal S, 2011, FEBS LETT, V585, P2243, DOI 10.1016/j.febslet.2011.05.045; Diakogiannaki E, 2008, J ENDOCRINOL, V197, P553, DOI 10.1677/JOE-08-0041; DUKE RC, 1986, LYMPHOKINE RES, V5, P289; Ferreira T, 2004, BIOCHEM J, V378, P899, DOI 10.1042/BJ20031064; FOLCH J, 1951, J BIOL CHEM, V191, P833; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Freedman Steven D, 2002, Methods Mol Med, V70, P517; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Guerrera IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007735; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; IANNUCCI A, 1984, HUM PATHOL, V15, P278, DOI 10.1016/S0046-8177(84)80191-4; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kelly A, 2013, J CYST FIBROS, V12, P318, DOI 10.1016/j.jcf.2013.02.008; KOPELMAN H, 1985, NEW ENGL J MED, V312, P329, DOI 10.1056/NEJM198502073120601; KOPELMAN H, 1988, GASTROENTEROLOGY, V95, P349, DOI 10.1016/0016-5085(88)90490-8; KUO PT, 1962, J PEDIATR-US, V60, P394, DOI 10.1016/S0022-3476(62)80065-1; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Leonard A, 2012, J CYST FIBROS, V11, P231, DOI 10.1016/j.jcf.2011.12.004; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; McCarty NA, 2002, PEDIATR PULM, V33, P90, DOI 10.1002/ppul.10041; Moran A, 2009, DIABETES CARE, V32, P1626, DOI 10.2337/dc09-0586; Nanua S, 2006, BIOCHEM BIOPH RES CO, V343, P135, DOI 10.1016/j.bbrc.2006.02.137; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; Norez C, 2006, FEBS LETT, V580, P2081, DOI 10.1016/j.febslet.2006.03.010; Payet LA, 2013, TRAFFIC; Pineau L, 2008, MOL BIOL CELL, V19, P807, DOI 10.1091/mbc.E07-06-0600; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Potiron VA, 2007, CANCER RES, V67, P8708, DOI 10.1158/0008-5472.CAN-06-3612; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; SOEJIMA K, 1986, Pediatric Pathology, V6, P25; Strandvik B, 2010, PROSTAG LEUKOTR ESS, V83, P121, DOI 10.1016/j.plefa.2010.07.002; UNDERWOOD BA, 1972, ANN NY ACAD SCI, V203, P237, DOI 10.1111/j.1749-6632.1972.tb27879.x; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180	55	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89044	10.1371/journal.pone.0089044	http://dx.doi.org/10.1371/journal.pone.0089044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586495	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900078
J	Wu, CY; Hu, HY; Huang, N; Fang, YT; Chou, YJ; Li, CP				Wu, Chen-Yi; Hu, Hsiao-Yun; Huang, Nicole; Fang, Yi-Ting; Chou, Yiing-Jeng; Li, Chung-Pin			Determinants of Long-Term Care Services among the Elderly: A Population-Based Study in Taiwan	PLOS ONE			English	Article							PHYSICAL-DISABILITY; RISK-FACTORS; HOME-CARE; PEOPLE; HEALTH; COMMUNITY; INSURANCE; TRENDS	Objectives: The aim of the study was to investigate determinants of long-term care use and to clarify the differing characteristics of home/community-based and institution-based services users. Design: Cross-sectional, population-based study. Setting: Utilizing data from the 2005 National Health Interview Survey conducted in Taiwan. Participants: A national sample of 2,608 people (1,312 men, 1,296 women) aged 65 and older. Measurements: The utilization of long-term care services (both home/community- and institution-based services) was measured. A chi(2) analysis tested differences in baseline characteristics between home/community-based and institution-based long-term care users. The multiple-logistic model was adopted with a hierarchical approach adding the Andersen model's predisposing, enabling, and need factors sequentially. Multiple logistic models further stratified data by gender and age. Results: Compared with users of home/community-based care, those using institution-based care had less education (p = 0.019), greater likelihood of being single (p = 0.001), fewer family members (p = 0.002), higher prevalence of stool incontinence (p = 0.011) and dementia (P =.025), and greater disability (p = 0.016). After adjustment, age (compared with 65-69 years; 75-79 years, odds ratio [OR] = 2.08, p = 0.044; age >= 80, OR = 3.30, p = 0.002), being single (OR = 2.16, p = 0.006), urban living (OR = 1.68, p = 0.037), stroke (OR = 2.08, p = 0.015), dementia (OR = 2.32, p = 0.007), 1-3 items of activities of daily living (ADL) disability (OR = 5.56, p<0.001), and 4-6 items of ADL disability (OR = 21.57, p<0.001) were significantly associated with long-term care use. Conclusion: Age, single marital status, stroke, dementia, and ADL disability are predictive factors for long-term care use. The utilization was directly proportional to the level of disability.	[Wu, Chen-Yi; Hu, Hsiao-Yun; Chou, Yiing-Jeng] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Wu, Chen-Yi] Taipei City Hosp, Dept Dermatol, Heping Fuyou Branch, Taipei, Taiwan; [Hu, Hsiao-Yun; Huang, Nicole] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Huang, Nicole] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Fang, Yi-Ting] Natl Yang Ming Univ, Inst Hlth & Welf Policy, Taipei 112, Taiwan; [Fang, Yi-Ting] Universal Eye Ctr, Taoyuan Branch, Tao Yuan, Taiwan; [Li, Chung-Pin] Taipei Vet Gen Hosp, Div Gastroenterol, Dept Med, Taipei, Taiwan; [Li, Chung-Pin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chou, YJ (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	yjchou@ym.edu.tw; cpli@vghtpe.gov.tw		Huang, Nicole/0000-0002-6629-1176	Taiwan Ministry of Education; Taiwan's National Science Council [98-2314-B-010-015-MY2]	Taiwan Ministry of Education(Ministry of Education, Taiwan); Taiwan's National Science Council	This study was supported by the Taiwan Ministry of Education through its "Aim for the Top University Plan,'' and by Taiwan's National Science Council through Grant 98-2314-B-010-015-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Bonsang E, 2009, J HEALTH ECON, V28, P143, DOI 10.1016/j.jhealeco.2008.09.002; Chang HT, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-274; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; de Meijer C, 2011, J HEALTH ECON, V30, P425, DOI 10.1016/j.jhealeco.2010.12.010; de Meijer CAM, 2009, MED CARE, V47, P1156, DOI 10.1097/MLR.0b013e3181b69fa8; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Honda A, 2013, GERIATR GERONTOL INT; Kashiwagi M, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-1; Kato Gohei, 2009, BMC Geriatr, V9, P58, DOI 10.1186/1471-2318-9-58; KATZ S, 1976, INT J HEALTH SERV, V6, P493, DOI 10.2190/UURL-2RYU-WRYD-EY3K; Katz SJ, 2000, JAMA-J AM MED ASSOC, V284, P3022, DOI 10.1001/jama.284.23.3022; Knol HR, 2003, DISABIL REHABIL, V25, P845, DOI 10.1080/0963828031000090542; Kosloski K, 1994, J Aging Health, V6, P17, DOI 10.1177/089826439400600102; Ku LJE, 2013, ARCH GERONTOL GERIAT, V56, P370, DOI 10.1016/j.archger.2012.11.005; Lafortune L, 2009, MED CARE, V47, P286, DOI 10.1097/MLR.0b013e3181894293; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Li IC, 2011, ARCH GERONTOL GERIAT, V53, P303, DOI 10.1016/j.archger.2010.11.009; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Manton KG, 2008, ANNU REV PUBL HEALTH, V29, P91, DOI 10.1146/annurev.publhealth.29.020907.090812; Murtagh KN, 2004, AM J PUBLIC HEALTH, V94, P1406, DOI 10.2105/AJPH.94.8.1406; Olivares-Tirado P, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-103; Oman D, 1999, AM J EPIDEMIOL, V150, P834; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Tang Z, 1999, ARCH GERONTOL GERIAT, V29, P115, DOI 10.1016/S0167-4943(99)00026-6; Tsai ACH, 2011, ARCH GERONTOL GERIAT, V53, P298, DOI 10.1016/j.archger.2010.12.003; van Campen C, 2005, HEALTH SOC CARE COMM, V13, P287, DOI 10.1111/j.1365-2524.2005.00546.x; Weaver F, 2009, HEALTH ECON, V18, P867, DOI 10.1002/hec.1409	30	37	40	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89213	10.1371/journal.pone.0089213	http://dx.doi.org/10.1371/journal.pone.0089213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586602	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900108
J	Wang, PK; Cheng, TL; Wu, S; Zhao, FF; Wang, GP; Yang, LM; Lu, MZ; Chen, JH; Shi, JS				Wang, Pengkai; Cheng, Tielong; Wu, Shuang; Zhao, Fangfang; Wang, Guangping; Yang, Liming; Lu, Mengzhu; Chen, Jinhui; Shi, Jisen			Phylogeny and Molecular Evolution Analysis of PIN-FORMED 1 in Angiosperm	PLOS ONE			English	Article							POLAR AUXIN TRANSPORT; SELECTION; LIKELIHOOD; PHOSPHORYLATION; SUBSTITUTION; PARSIMONY; DISTANCE; CARRIERS; MOTIFS; FAMILY	PIN-FORMED 1 (PIN1) is an important secondary transporter and determines the direction of intercellular auxin flow. As PIN1 performs the conserved function of auxin transport, it is expected that the sequence and structure of PIN1 is conserved. Therefore, we hypothesized that PIN1 evolve under pervasive purifying selection in the protein-coding sequences in angiosperm. To test this hypothesis, we performed detailed evolutionary analyses of 67 PIN1 sequences from 35 angiosperm species. We found that the PIN1 sequences are highly conserved within their transmembrane regions, part of their hydrophilic regions. We also found that there are two or more PIN1 copies in some of these angiosperm species. PIN1 sequences from Poaceae and Brassicaceae are representative of the modern clade. We identified 12 highly conserved motifs and a significant number of family-specific sites within these motifs. One family-specific site within Motif 11 shows a different residue between monocots and dicots, and is functionally critical for the polarity of PIN1. Likewise, the function of PIN1 appears to be different between monocots and dicots since the phenotype associated with PIN1 overexpression is opposite between Arabidopsis and rice. The evolution of angiosperm PIN1 protein-coding sequences appears to have been primarily driven by purifying selection, but traces of positive selection associated with sequences from certain families also seem to be present. We verified this observation by calculating the numbers of non-synonymous and synonymous changes on each branch of a phylogenetic tree. Our results indicate that the evolution of angiosperm PIN1 sequences involve strong purifying selection. In addition, our results suggest that the conserved sequences of PIN1 derive from a combination of the family-specific site variations and conserved motifs during their unique evolutionary processes, which is critical for the functional integrity and stability of these auxin transporters, especially in new species. Finally, functional difference of PIN1 is likely to be present in angiosperm because the positive selection is occurred in one branch of Poaceae.	[Wang, Pengkai; Wu, Shuang; Zhao, Fangfang; Wang, Guangping; Chen, Jinhui; Shi, Jisen] Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Cheng, Tielong] Chinese Acad Forestry, Div Res Management, Beijing, Peoples R China; [Yang, Liming] Huaiyin Normal Univ, Sch Life Sci, Huaian, Jiangsu, Peoples R China; [Lu, Mengzhu] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Res Inst Forestry, Beijing, Peoples R China	Nanjing Forestry University; Chinese Academy of Forestry; Huaiyin Normal University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Chen, JH (corresponding author), Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Biotechnol, Nanjing, Jiangsu, Peoples R China.	chenjh@njfu.edu.cn; jshi@njfu.edu.cn	Lu, Meng-Zhu/AAN-9710-2020		National High Technology Research and Development Program of China (863 Program) [2013AA102705]; National Science Foundation of China [31170619, 30930077, 31270707]; Program for New Century Excellent Talents by the Ministry of Education; priority Academic Program Development of Jiangsu Higher Education Institutions	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents by the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program, 2013AA102705), the National Science Foundation of China to Jinhui Chen (No. 31170619), to Jisen Shi (No. 30930077), To Tielong Cheng (No. 31270707), the Program for New Century Excellent Talents by the Ministry of Education and The priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benjamins R, 2008, ANNU REV PLANT BIOL, V59, P443, DOI 10.1146/annurev.arplant.58.032806.103805; Berleth T, 2009, ARABIDOPSIS BOOK, P1; Bremer B., 2009, BOT J LINNEAN SOC; Dhonukshe P, 2010, DEVELOPMENT, V137, P3245, DOI 10.1242/dev.052456; Forestan C, 2012, MOL PLANT, V5, P787, DOI 10.1093/mp/ssr103; Forestan C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00016; Friml J, 2010, EUR J CELL BIOL, V89, P231, DOI 10.1016/j.ejcb.2009.11.003; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grosse-Veldmann B, 2011, SIBBALDIA, V9, P143; Guenot B, 2012, PLANT PHYSIOL, V159, P1501, DOI 10.1104/pp.112.200402; Huang F, 2010, PLANT CELL, V22, P1129, DOI 10.1105/tpc.109.072678; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Krecek P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-249; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Muday GK, 2001, TRENDS PLANT SCI, V6, P535, DOI 10.1016/S1360-1385(01)02101-X; Peng J., 2013, POLAR AUXIN TRANSPOR, P239; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Rahman A, 2012, PHYSL PLANTARUM; Seo TK, 2004, MOL BIOL EVOL, V21, P1201, DOI 10.1093/molbev/msh088; Simon S, 2011, PLANT SCI, V180, P454, DOI 10.1016/j.plantsci.2010.12.007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Viaene T, 2013, TRENDS PLANT SCI, V18, P5, DOI 10.1016/j.tplants.2012.08.009; Wang BJ, 2012, PLANT SIGNAL BEHAV, V7, P1515, DOI 10.4161/psb.22093; Xu M, 2005, PLANT CELL PHYSIOL, V46, P1674, DOI 10.1093/pcp/pci183; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang J, 2011, DEV CELL, V20, P855, DOI 10.1016/j.devcel.2011.05.013; Zhang J, 2010, P NATL ACAD SCI USA, V107, P918, DOI 10.1073/pnas.0909460107; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	39	5	6	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2014	9	2							e89289	10.1371/journal.pone.0089289	http://dx.doi.org/10.1371/journal.pone.0089289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3DW	24586663	Green Published, Green Submitted, gold			2022-12-27	WOS:000332396200046
J	Caldas, J; Vinga, S				Caldas, Jose; Vinga, Susana			Global Meta-Analysis of Transcriptomics Studies	PLOS ONE			English	Article							STEM-CELLS; EXPRESSION; GENES; GENERATION; DATABASE; MAP	Transcriptomics meta-analysis aims at re-using existing data to derive novel biological hypotheses, and is motivated by the public availability of a large number of independent studies. Current methods are based on breaking down studies into multiple comparisons between phenotypes (e.g. disease vs. healthy), based on the studies' experimental designs, followed by computing the overlap between the resulting differential expression signatures. While useful, in this methodology each study yields multiple independent phenotype comparisons, and connections are established not between studies, but rather between subsets of the studies corresponding to phenotype comparisons. We propose a rank-based statistical meta-analysis framework that establishes global connections between transcriptomics studies without breaking down studies into sets of phenotype comparisons. By using a rank product method, our framework extracts global features from each study, corresponding to genes that are consistently among the most expressed or differentially expressed genes in that study. Those features are then statistically modelled via a term-frequency inverse-document frequency (TF-IDF) model, which is then used for connecting studies. Our framework is fast and parameter-free; when applied to large collections of Homo sapiens and Streptococcus pneumoniae transcriptomics studies, it performs better than similarity-based approaches in retrieving related studies, using a Medical Subject Headings gold standard. Finally, we highlight via case studies how the framework can be used to derive novel biological hypotheses regarding related studies and the genes that drive those connections. Our proposed statistical framework shows that it is possible to perform a meta-analysis of transcriptomics studies with arbitrary experimental designs by deriving global expression features rather than decomposing studies into multiple phenotype comparisons.	[Caldas, Jose] INESC ID, Lisbon, Portugal; [Vinga, Susana] Univ Lisbon, Inst Super Tecn, LAETA, IDMEC, P-1699 Lisbon, Portugal	INESC-ID; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico	Caldas, J (corresponding author), INESC ID, Lisbon, Portugal.	jose@kdbio.inesc-id.pt	Vinga, Susana/B-8450-2008; Peixoto Caldas, Jose Manuel/K-5410-2013	Vinga, Susana/0000-0002-1954-5487; Peixoto Caldas, Jose Manuel/0000-0003-0796-1595	national funds through Fundacao para a Cieancia e a Tecnologia (FCT, Portugal) [PestOE/EEI/LA0021/2011]; national funds through IDMEC under LAETA [PestOE/EME/LA0022]; project PneumoSyS [PTDC/SAUMII/100964/2008]; project InteleGen [PTDC/DTPFTO/1747/2012]; project BacHBerry [FP7KBBE20137, 613793]; FCT [IF/00653/2012]; European Social Fund (ESF) through the Operational Program Human Potential(POPH)	national funds through Fundacao para a Cieancia e a Tecnologia (FCT, Portugal); national funds through IDMEC under LAETA; project PneumoSyS; project InteleGen; project BacHBerry; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Social Fund (ESF) through the Operational Program Human Potential(POPH)	This work was supported by national funds through Fundacao para a Cieancia e a Tecnologia (FCT, Portugal) under contracts PestOE/EEI/LA0021/2011; through IDMEC, under LAETA (PestOE/EME/LA0022); and projects PneumoSyS (PTDC/SAUMII/100964/2008), InteleGen (PTDC/DTPFTO/1747/2012), and BacHBerry (FP7KBBE20137 singlestage, Grant Agreement no 613793). SV acknowledges support by Program Investigador FCT (IF/00653/2012) from FCT, co-funded by the European Social Fund (ESF) through the Operational Program Human Potential(POPH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Caldas J, 2012, BIOINFORMATICS, V28, P246, DOI 10.1093/bioinformatics/btr634; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Eisinga R, 2013, FEBS LETT, V587, P677, DOI 10.1016/j.febslet.2013.01.037; Fujibuchi W, 2007, BIOINFORMATICS, V23, P3103, DOI 10.1093/bioinformatics/btm462; Heo JS, 2006, AM J PHYSIOL-CELL PH, V290, pC123, DOI 10.1152/ajpcell.00142.2005; Hollander M, 2000, NONPARAMETRIC STAT M, Vthird; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Huang HY, 2010, P NATL ACAD SCI USA, V107, P6823, DOI 10.1073/pnas.0912043107; Huang HY, 2011, INT J ONCOL, V38, P1557, DOI 10.3892/ijo.2011.994; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Jiang L, 2013, APOPTOSIS, V18, P556, DOI 10.1007/s10495-013-0828-4; Koziol JA, 2010, FEBS LETT, V584, P941, DOI 10.1016/j.febslet.2010.01.031; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lipscomb CE, 2000, B MED LIBR ASSOC, V88, P265; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200; Malone J, 2010, BIOINFORMATICS, V26, P1112, DOI 10.1093/bioinformatics/btq099; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Nordmann AJ, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13518; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Potapova IA, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt35; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Reyes-Caballero H, 2010, J MOL BIOL, V403, P197, DOI 10.1016/j.jmb.2010.08.030; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shafeeq S, 2011, METALLOMICS, V3, P609, DOI 10.1039/c1mt00030f; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Squire JA, 2009, NAT GENET, V41, P509, DOI 10.1038/ng0509-509; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265	40	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e89318	10.1371/journal.pone.0089318	http://dx.doi.org/10.1371/journal.pone.0089318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586684	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000039
J	Ziyatdinov, A; Perera-Lluna, A				Ziyatdinov, Andrey; Perera-Lluna, Alexandre			Data Simulation in Machine Olfaction with the R Package Chemosensors	PLOS ONE			English	Article								In machine olfaction, the design of applications based on gas sensor arrays is highly dependent on the robustness of the signal and data processing algorithms. While the practice of testing the algorithms on public benchmarks is not common in the field, we propose software for performing data simulations in the machine olfaction field by generating parameterized sensor array data. The software is implemented as an R language package chemosensors which is open-access, platform-independent and self-contained. We introduce the concept of a virtual sensor array which can be used as a data generation tool. In this work, we describe the data simulation workflow which basically consists of scenario definition, virtual array parameterization and the generation of sensor array data. We also give examples of the processing of the simulated data as proof of concept for the parameterized sensor array data: the benchmarking of classification algorithms, the evaluation of linear-and non-linear regression algorithms, and the biologically inspired processing of sensor array data. All the results presented were obtained under version 0.7.6 of the chemosensors package whose home page is chemosensors. r-forge.r-project.org.	[Ziyatdinov, Andrey; Perera-Lluna, Alexandre] Univ Politecn Cataluna, Dept ESAII, Barcelona, Spain; Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Barcelona, Spain	Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Ziyatdinov, A (corresponding author), Univ Politecn Cataluna, Dept ESAII, Barcelona, Spain.	andrey.ziyatdinov@upc.edu	Lluna, Alexandre Perera/R-8546-2018; Perera Lluna, Alexandre/CAG-2156-2022	Lluna, Alexandre Perera/0000-0001-6427-851X; Perera Lluna, Alexandre/0000-0001-6427-851X	European Community [216916]; Ramon y Cajal program from the Spanish Ministerio de Educacion y Ciencia;  [TEC2010-20886-C02-02]	European Community(European Commission); Ramon y Cajal program from the Spanish Ministerio de Educacion y Ciencia(German Research Foundation (DFG)); 	This work was funded from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 216916: Biologically inspired computation for chemical sensing (NEUROChem), the Ramon y Cajal program from the Spanish Ministerio de Educacion y Ciencia and TEC2010-20886-C02-02. CIBER-BBN is an initiative of the Spanish ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfons A, 2010, OBJECT ORIENTED FRAM; Berna AZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006406; Di Natale C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003139; Eriksen MMA, 2012, FWSIM FISHER WRIGHT; Fonollosa J, 2011, PROCEDIA COMPUT SCI, V7, P226, DOI 10.1016/j.procs.2011.09.066; Gutierrez-Osuna R, 2002, IEEE SENS J, V2, P189, DOI 10.1109/JSEN.2002.800688; Kuhn M, 2008, CARET PACKAGE 28; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Marco S, 2012, IEEE SENS J, V12, P3189, DOI 10.1109/JSEN.2012.2192920; Montana G, 2012, HAPSIM HAPLOTYPE DAT; Pearce T. C., 2003, HDB MACHINE OLFACTIO; PERSAUD K, 1982, NATURE, V299, P352, DOI 10.1038/299352a0; R Core Team, 2021, R LANGUAGE ENV STAT; Raman B., 2004, 2004 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS) (IEEE Cat. No.04CH37566), P319; Raman B, 2005, THESIS TEXAS A M U; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Vergara A, 2012, SENSOR ACTUAT B-CHEM, P1; Vigeland MD, 2012, IBDSIM SIMULATION CH; Wehrens R, 2007, J STAT SOFTWARE, V21; Zeileis A, 1999, COLLABORATIVE SOFTWA, P9; Ziyatdinov A, 2013, SENSOR ACTUAT B-CHEM, V177, P596, DOI 10.1016/j.snb.2012.09.093; Ziyatdinov A, 2010, SENSOR ACTUAT B-CHEM, V146, P460, DOI 10.1016/j.snb.2009.11.034; Ziyatdinov A, 2012, HOME PAGE CHEMOSENSO	23	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2014	9	2							e88839	10.1371/journal.pone.0088839	http://dx.doi.org/10.1371/journal.pone.0088839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC3BC	24586410	Green Submitted, Green Published, gold			2022-12-27	WOS:000332389000018
J	Cui, L; Li, Y; Ma, G; Wang, Y; Cai, Y; Liu, S; Chen, Y; Li, J; Xie, Y; Liu, G; Zhao, B; Li, K				Cui, Lili; Li, You; Ma, Guoda; Wang, Yan; Cai, Yujie; Liu, Shengyuan; Chen, Yanyan; Li, Jia; Xie, Yuliu; Liu, Gen; Zhao, Bin; Li, Keshen			A Functional Polymorphism in the Promoter Region of MicroRNA-146a Is Associated with the Risk of Alzheimer Disease and the Rate of Cognitive Decline in Patients	PLOS ONE			English	Article							NF-KAPPA-B; THAN-C POLYMORPHISM; DIFFERENTIAL EXPRESSION; CANCER SUSCEPTIBILITY; TRANSCRIPTION FACTOR; PRE-MIR-146A GENE; MIR-146A; RS2910164; BRAIN; CELLS	miR146a is well known for its regulatory role in the immune response and inflammation. Recent studies have demonstrated the links between miR146a and Alzheimer disease (AD) and suggested that miR146a may be involved in neuroinflammation and the metabolism of amyloid-beta (Ab), which are critical events in AD pathology. Although genetic studies have focused on the association between the miR146a gene and susceptibility to several diseases, no association study of miR146a variability with AD has been conducted. In this report, we performed a case-control association study to analyze the genotype and allele distributions of the miR146a, rs2910464 and rs57095329 polymorphisms in a Chinese population consisting of 292 AD cases and 300 healthy controls. We found a significant difference in the genotypes and allele frequencies of rs57095329 between the AD cases and the controls (p = 0.0147 and p = 0.0184, respectively), where the AA genotype of rs57095329 was associated with an increased risk of AD as well the cognitive decline in AD patients. Additionally, the AA genotype of rs57095329 exhibited significantly higher miR146a expression than the GG+GA genotypes of rs2910164 in the peripheral blood cells (PBMCs) of healthy individuals and had a stronger effect on the production of IL-6 and IL-1 beta when the cells were stimulated with LPS. Our data provide preliminary evidence that the rs57095329 polymorphism in the miR146a promoter is involved in the genetic susceptibility to AD, and this risk AA genotype may increase the expression of miR146a and influence certain proinflammatory cytokines, thus playing a role in the pathogenesis of AD.	[Cui, Lili; Li, You; Ma, Guoda; Cai, Yujie; Chen, Yanyan; Liu, Gen; Zhao, Bin; Li, Keshen] Guangdong Med Coll, Affiliated Hosp, Guangdong Key Lab Age Related Cardiac & Cerebral, Zhanjiang, Peoples R China; [Wang, Yan] Guangdong Med Coll, Affiliated Hosp, Clin Res Ctr, Zhanjiang, Peoples R China; [Liu, Shengyuan] Shenzhen Nanshan Ctr Chron Dis Control, Dept Chron Dis, Shenzhen, Peoples R China; [Li, Jia; Xie, Yuliu] Guangdong Med Coll, Intens Care Unit, Affiliated Hosp, Zhanjiang, Peoples R China; [Liu, Gen; Zhao, Bin] Guangdong Med Coll, Affiliated Hosp, Inst Neurol, Zhanjiang, Peoples R China	Guangdong Medical University; Guangdong Medical University; Guangdong Medical University; Guangdong Medical University	Zhao, B (corresponding author), Guangdong Med Coll, Affiliated Hosp, Guangdong Key Lab Age Related Cardiac & Cerebral, Zhanjiang, Peoples R China.	binzhao0759@163.com; likeshen1971@126.com	, YoMo/AGX-5555-2022	, YoMo/0000-0003-0273-2531; Li, Jia/0000-0002-1353-7347	National Nature Science Foundation of China [31171219, 81271213, 81070878, 81271214, 81300929, 81261120404]; Natural Science Foundation of Guangdong Province [S2013040013740]; Medical Scientific Research Foundation of Guangdong Province [B2013306]; PhD Start-up Fund of Guangdong Medical College [B2012020]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Medical Scientific Research Foundation of Guangdong Province; PhD Start-up Fund of Guangdong Medical College	This work was supported by funding from the National Nature Science Foundation of China (31171219; 81271213; 81070878; 81271214; 81300929; 81261120404), the Natural Science Foundation of Guangdong Province (S2013040013740), Medical Scientific Research Foundation of Guangdong Province (B2013306) and The PhD Start-up Fund of Guangdong Medical College (B2012020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, GENE, V486, P104, DOI 10.1016/j.gene.2011.07.006; Barber Robert, 2011, Cleve Clin J Med, V78 Suppl 1, pS47, DOI 10.3949/ccjm.78.s1.08; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Chae YS, 2013, ANTICANCER RES, V33, P3233; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Doody RS, 2001, ARCH NEUROL-CHICAGO, V58, P449, DOI 10.1001/archneur.58.3.449; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Guo H, 2010, FAM CANCER, V9, P599, DOI 10.1007/s10689-010-9370-5; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Holmes C, 2011, NEUROLOGY, V77, P212, DOI 10.1212/WNL.0b013e318225ae07; Jantaratnotai N, 2013, J ALZHEIMERS DIS, V37, P367, DOI 10.3233/JAD-122191; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jiang W, 2013, BIOINFORMATICS, V29, P2596, DOI 10.1093/bioinformatics/btt423; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Li YY, 2011, NEUROSCI LETT, V487, P94, DOI 10.1016/j.neulet.2010.09.079; Li YY, 2011, NEUROSCI LETT, V499, P109, DOI 10.1016/j.neulet.2011.05.044; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Lukiw WJ, 2012, MOL NEUROBIOL, V46, P11, DOI 10.1007/s12035-012-8234-4; Luo XB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002128; Madathil SK, 2011, BIOESSAYS, V33, P21, DOI 10.1002/bies.201000069; Manna I, 2013, GENE, V516, P181, DOI 10.1016/j.gene.2012.09.137; Meraz-Rios MA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00059; Montgomery SL, 2013, AM J PATHOL, V182, P2285, DOI 10.1016/j.ajpath.2013.02.030; Muller M, 2014, NEUROBIOL AGING, V35, P152, DOI 10.1016/j.neurobiolaging.2013.07.005; Nelson O, 2010, J ALZHEIMERS DIS, V21, P781, DOI 10.3233/JAD-2010-100159; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; Okubo M, 2011, J CLIN IMMUNOL, V31, P69, DOI 10.1007/s10875-010-9461-y; Permuth-Wey J, 2011, J NEURO-ONCOL, V105, P639, DOI 10.1007/s11060-011-0634-1; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Song M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-92; Song MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061250; Srivastava K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050966; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wang AX, 2012, GENET MOL RES, V11, P3051, DOI 10.4238/2012.August.31.2; Wang W, 2009, DRUG TODAY, V45, P95; Wu D, 2013, ASIAN PAC J CANCER P, V14, P399, DOI 10.7314/APJCP.2013.14.1.399; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Xu YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065123; Yamashita J, 2013, MELANOMA RES, V23, P13, DOI 10.1097/CMR.0b013e32835c5b30; Yang B, 2011, MOL BIOL REP, V38, P4913, DOI 10.1007/s11033-010-0633-x; Yin ZH, 2013, MOL BIOL REP, V40, P3003, DOI 10.1007/s11033-012-2372-7; Zhou Q, 2012, ANN RHEUM DIS; Zhou QY, 2012, MOL VIS, V18, P426	49	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2014	9	2							e89019	10.1371/journal.pone.0089019	http://dx.doi.org/10.1371/journal.pone.0089019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2ZX	24586483	gold, Green Submitted, Green Published			2022-12-27	WOS:000332385900026
J	Banu, S; Hu, WB; Guo, YM; Naish, S; Tong, SL				Banu, Shahera; Hu, Wenbiao; Guo, Yuming; Naish, Suchithra; Tong, Shilu			Dynamic Spatiotemporal Trends of Dengue Transmission in the Asia-Pacific Region, 1955-2004	PLOS ONE			English	Article							CLIMATE-CHANGE; FEVER; DISEASE; IMPACT; EPIDEMIOLOGY; QUEENSLAND; CLUSTERS; PATTERNS	Background: Dengue fever (DF) is one of the most important emerging arboviral human diseases. Globally, DF incidence has increased by 30-fold over the last fifty years, and the geographic range of the virus and its vectors has expanded. The disease is now endemic in more than 120 countries in tropical and subtropical parts of the world. This study examines the spatiotemporal trends of DF transmission in the Asia-Pacific region over a 50-year period, and identified the disease's cluster areas. Methodology and Findings: The World Health Organization's DengueNet provided the annual number of DF cases in 16 countries in the Asia-Pacific region for the period 1955 to 2004. This fifty-year dataset was divided into five ten-year periods as the basis for the investigation of DF transmission trends. Space-time cluster analyses were conducted using scan statistics to detect the disease clusters. This study shows an increasing trend in the spatiotemporal distribution of DF in the Asia-Pacific region over the study period. Thailand, Vietnam, Laos, Singapore and Malaysia are identified as the most likely clusters (relative risk = 13.02) of DF transmission in this region in the period studied (1995 to 2004). The study also indicates that, for the most part, DF transmission has expanded southwards in the region. Conclusions: This information will lead to the improvement of DF prevention and control strategies in the Asia-Pacific region by prioritizing control efforts and directing them where they are most needed.	[Banu, Shahera; Hu, Wenbiao; Naish, Suchithra; Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [Guo, Yuming] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Queensland University of Technology (QUT); University of Queensland	Banu, S (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia.	s.banu@qut.edu.au	Guo, Yuming/I-8353-2018	Guo, Yuming/0000-0002-1766-6592; Hu, Wenbiao/0000-0001-6422-9240	QUT postgraduate scholarships; NMHRC postdoctoral training fellowship; NMHRC research fellowship	QUT postgraduate scholarships; NMHRC postdoctoral training fellowship; NMHRC research fellowship	The work was supported by QUT postgraduate scholarships (SB), NMHRC postdoctoral training fellowship (WH) and NMHRC research fellowship (ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams AM, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-6; [Anonymous], 2012, CIA WORLD FACTB; Arcari P, 2007, SINGAPORE J TROP GEO, V28, P251, DOI 10.1111/j.1467-9493.2007.00300.x; Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892; Banu S, 2011, TROP MED INT HEALTH, V16, P598, DOI 10.1111/j.1365-3156.2011.02734.x; Barbazan P, 2002, MICROBES INFECT, V4, P699, DOI 10.1016/S1286-4579(02)01589-7; Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521; Benitez MA, 2009, LANCET, V373, P1070, DOI 10.1016/S0140-6736(09)60634-6; Carbajo AE, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-26; Chen Jin, 2008, Int J Health Geogr, V7, P57, DOI 10.1186/1476-072X-7-57; Gubler DJ, 2004, NAT MED, V10, P129, DOI 10.1038/nm0204-129; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Cuong HQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001322; Hu W, 2011, EPIDEMIOL INFECT, V139, P391, DOI 10.1017/S0950268810000713; Hu WB, 2012, ENVIRON HEALTH PERSP, V120, P260, DOI 10.1289/ehp.1003270; Kulldorf M, 2010, SATSCAN USER GUIDE V; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Naish S, 2011, TROP MED INT HEALTH, V16, P884, DOI 10.1111/j.1365-3156.2011.02775.x; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Robertson C, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-16; Russell RC, 2009, AUST J ENTOMOL, V48, P1, DOI 10.1111/j.1440-6055.2008.00677.x; Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Thai KTD, 2010, EPIDEMIOL INFECT, V138, P585, DOI 10.1017/S095026880999046X; Tran A, 2004, EMERG INFECT DIS, V10, P615, DOI 10.3201/eid1004.030186; Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5; Wen TH, 2006, SCI TOTAL ENVIRON, V367, P631, DOI 10.1016/j.scitotenv.2006.02.009; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Wilder-Smith A, 2012, PAEDIATR INT CHILD H, V32, P28, DOI 10.1179/2046904712Z.00000000050; Woodruff RE, 2006, AUST NZ J PUBL HEAL, V30, P567, DOI 10.1111/j.1467-842X.2006.tb00788.x; World Health Organization, 2012, DENG SEV DENG; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034	43	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2014	9	2							e89440	10.1371/journal.pone.0089440	http://dx.doi.org/10.1371/journal.pone.0089440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB6EP	24586780	Green Submitted, gold, Green Published			2022-12-27	WOS:000331880700044
J	Eddyani, M; Lavender, C; de Rijk, WB; Bomans, P; Fyfe, J; de Jong, B; Portaels, F				Eddyani, Miriam; Lavender, Caroline; de Rijk, Willem Bram; Bomans, Pieter; Fyfe, Janet; de Jong, Bouke; Portaels, Francoise			Multicenter External Quality Assessment Program for PCR Detection of Mycobacterium ulcerans in Clinical and Environmental Specimens	PLOS ONE			English	Article							BURULI ULCER; LABORATORY DIAGNOSIS; DNA EXTRACTION; AMPLIFICATION; DISEASE; DECONTAMINATION; TUBERCULOSIS; ECOLOGY; SAMPLES	Background: Mycobacterium ulcerans is the causative agent of Buruli ulcer (BU), a necrotizing disease of the skin, soft tissue and bone. PCR is increasingly used in the diagnosis of BU and in research on the mode of transmission and environmental reservoir of M. ulcerans. Methodology/Principal Findings: The aim of this study was to evaluate the performance of laboratories in detecting M. ulcerans using molecular tests in clinical and environmental samples by implementing sequential multicenter external quality assessment (EQA) programs. The second round of the clinical EQA program revealed somewhat improved performance. Conclusions/Significance: Ongoing EQA programs remain essential and continued participation in future EQA programs by laboratories involved in the molecular testing of clinical and environmental samples for M. ulcerans for diagnostic and research purposes is strongly encouraged. Broad participation in such EQA programs also benefits the harmonization of quality in the BU research community and enhances the credibility of advances made in solving the transmission enigma of M. ulcerans.	[Eddyani, Miriam; de Rijk, Willem Bram; Bomans, Pieter; de Jong, Bouke; Portaels, Francoise] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Lavender, Caroline; Fyfe, Janet] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia	Institute of Tropical Medicine (ITM); Victorian Infectious Diseases Reference Laboratory	Eddyani, M (corresponding author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	meddyani@itg.be	de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675; Lavender, Caroline/0000-0002-2213-4005	Global Buruli Ulcer Initiative of the World Health Organization; Stop Buruli Initiative; UBS Optimus Foundation (Zurich, Switzerland); European Commission [HEALTH-F3-2010-241500-BuruliVac]; Victorian Government Department of Public Health Grant	Global Buruli Ulcer Initiative of the World Health Organization; Stop Buruli Initiative; UBS Optimus Foundation (Zurich, Switzerland); European Commission(European CommissionEuropean Commission Joint Research Centre); Victorian Government Department of Public Health Grant	This work was supported by the Global Buruli Ulcer Initiative of the World Health Organization, the Stop Buruli Initiative funded by the UBS Optimus Foundation (Zurich, Switzerland) and by the European Commission (project HEALTH-F3-2010-241500-BuruliVac). C.L. was supported by a Victorian Government Department of Public Health Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolabi D, 2009, THESIS U ANTWERP; Affolabi D, 2012, J CLIN MICROBIOL, V50, P1195, DOI 10.1128/JCM.05592-11; Beissner M, 2010, FUTURE MICROBIOL, V5, P363, DOI 10.2217/FMB.10.3; DEBEENHOUWER H, 1995, J CLIN MICROBIOL, V33, P2994, DOI 10.1128/JCM.33.11.2994-2998.1995; Durnez L, 2009, J MICROBIOL METH, V76, P152, DOI 10.1016/j.mimet.2008.10.002; Eddyani M, 2008, J CLIN MICROBIOL, V46, P69, DOI 10.1128/JCM.00301-07; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; Fyfe JAM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000791; Guimaraes-Peres A, 1999, J CLIN MICROBIOL, V37, P206, DOI 10.1128/JCM.37.1.206-208.1999; Herbinger KH, 2009, CLIN INFECT DIS, V48, P1055, DOI 10.1086/597398; Kibadi K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000736; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Noordhoek GT, 2004, CLIN MICROBIOL INFEC, V10, P295, DOI 10.1111/j.1198-743X.2004.00825.x; Noordhoek GT, 1996, J CLIN MICROBIOL, V34, P2522, DOI 10.1128/JCM.34.10.2522-2525.1996; Portaels F, 2001, REV SCI TECH OIE, V20, P252, DOI 10.20506/rst.20.1.1270; Portaels F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000178; Portaels F, 2009, CLIN DERMATOL, V27, P291, DOI 10.1016/j.clindermatol.2008.09.021; Ross BC, 1997, J CLIN MICROBIOL, V35, P1696, DOI 10.1128/JCM.35.7.1696-1700.1997; Ross BC, 1997, APPL ENVIRON MICROB, V63, P4135, DOI 10.1128/AEM.63.10.4135-4138.1997; Siegmund V, 2005, J CLIN MICROBIOL, V43, P271, DOI 10.1128/JCM.43.1.271-276.2005; Trouet C, 2004, CLIN TRIALS BELGIUM, P192; Valentine-Thon E, 2001, J CLIN MICROBIOL, V39, P4407, DOI 10.1128/JCM.39.12.4407-4412.2001; van der Werf TS, 2005, B WORLD HEALTH ORGAN, V83, P785; Walsh DS, 2011, DERMATOL CLIN, V29, P1, DOI 10.1016/j.det.2010.09.006; Williamson HR., 2008, PLOS NEGL TROP DIS, V2, P1; World Health Organization, 2001, WHOCDSGPEGBUI20014; Yeboah-Manu D, 2004, J CLIN MICROBIOL, V42, P5875, DOI 10.1128/JCM.42.12.5875-5876.2004; Yeboah-Manu D, 2011, AM J TROP MED HYG, V85, P900, DOI 10.4269/ajtmh.2011.11-0362; Yeboah-Manu D, 2011, J CLIN MICROBIOL, V49, P1997, DOI 10.1128/JCM.02279-10	29	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89407	10.1371/journal.pone.0089407	http://dx.doi.org/10.1371/journal.pone.0089407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586755	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900091
J	Vodicka, M; Ergang, P; Mikulecka, A; Rehakova, L; Klusonova, P; Makal, J; Sotak, M; Musilkova, J; Zach, P; Pacha, J				Vodicka, Martin; Ergang, Peter; Mikulecka, Anna; Rehakova, Lenka; Klusonova, Petra; Makal, Jakub; Sotak, Matus; Musilkova, Jana; Zach, Petr; Pacha, Jiri			Regulation of 11 beta-Hydroxysteroid Dehydrogenase Type 1 and 7 alpha-Hydroxylase CYP7B1 during Social Stress	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; NECROSIS-FACTOR-ALPHA; PROINFLAMMATORY CYTOKINES; GLUCOCORTICOID REGULATION; IMMUNE FUNCTION; MESSENGER-RNA; ANIMAL-MODELS; EXPRESSION; BRAIN; METABOLISM	11 beta-hydroxysteroid dehydrogenase type 1 (11HSD1) is an enzyme that amplifies intracellular glucocorticoid concentration by the conversion of inert glucocorticoids to active forms and is involved in the interconversion of 7-oxo- and 7-hydroxysteroids, which can interfere with the activation of glucocorticoids. The presence of 11HSD1 in the structures of the hypothalamic-pituitary-adrenal (HPA) axis suggests that this enzyme might play a role in the regulation of HPA output. Here we show that the exposure of Fisher 344 rats to mild social stress based on the resident-intruder paradigm increased the expression of 11HSD1 and CYP7B1, an enzyme that catalyzes 7-hydroxylation of steroids. We found that social behavioral profile of intruders was significantly decreased whereas their plasma levels of corticosterone were increased more than in residents. The stress did not modulate 11HSD1 in the HPA axis (paraventricular nucleus, pituitary, adrenal cortex) but selectively upregulated 11HSD1 in some regions of the hippocampus, amygdala and prelimbic cortex. In contrast, CYP7B1 was upregulated not only in the hippocampus and amygdala but also in paraventricular nucleus and pituitary. Furthermore, the stress downregulated 11HSD1 in the thymus and upregulated it in the spleen and mesenteric lymphatic nodes whereas CYP7B1 was upregulated in all of these lymphoid organs. The response of 11HSD1 to stress was more obvious in intruders than in residents and the response of CYP7B1 to stress predominated in residents. We conclude that social stress induces changes in enzymes of local metabolism of glucocorticoids in lymphoid organs and in brain structures associated with the regulation of the HPA axis. In addition, the presented data clearly suggest a role of 11HSD1 in modulation of glucocorticoid feedback of the HPA axis during stress.	[Vodicka, Martin; Ergang, Peter; Mikulecka, Anna; Rehakova, Lenka; Klusonova, Petra; Sotak, Matus; Musilkova, Jana; Pacha, Jiri] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Vodicka, Martin; Makal, Jakub; Pacha, Jiri] Charles Univ Prague, Fac Sci, Dept Physiol, Prague, Czech Republic; [Zach, Petr] Charles Univ Prague, Fac Med 3, Inst Anat, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; Charles University Prague	Pacha, J (corresponding author), Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic.	pacha@biomed.cas.cz	Mikulecka, Anna/C-3889-2012; Sotak, Matus/C-3407-2013; Ergang, Peter/H-2533-2014; Pacha, Jiri/C-7094-2012; Musilkova, Jana/D-1280-2012; Vodička, Martin/P-2117-2017; Zach, Petr/D-8955-2016; Klusonova, Petra/C-6665-2012	Mikulecka, Anna/0000-0002-8702-5029; Sotak, Matus/0000-0002-9984-9340; Ergang, Peter/0000-0002-7750-3541; Pacha, Jiri/0000-0003-2335-6715; Musilkova, Jana/0000-0001-9605-9821; Vodička, Martin/0000-0002-4508-9841; Zach, Petr/0000-0003-1941-2972; Klusonova, Petra/0000-0002-3164-295X	Czech Science Foundation [P303/10/0969]; Grant Agency of the Charles University [5366/2012, PRVOUK P34]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of the Charles University	This work was supported by grant P303/10/0969 from Czech Science Foundation and by Grant Agency of the Charles University (Grants No. 5366/2012 and PRVOUK P34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahasan MM, 2012, ARTHRITIS RHEUM-US, V64, P2404, DOI 10.1002/art.34414; Audet MC, 2011, BRAIN BEHAV IMMUN, V25, P1197, DOI 10.1016/j.bbi.2011.03.010; Bailey MT, 2009, PHYSIOL BEHAV, V98, P351, DOI 10.1016/j.physbeh.2009.06.013; Barnum CJ, 2008, BRAIN BEHAV IMMUN, V22, P517, DOI 10.1016/j.bbi.2007.10.004; Bisschop PH, 2013, J NEUROENDOCRINOL, V25, P425, DOI 10.1111/jne.12017; Blanchard RJ, 2001, PHYSIOL BEHAV, V73, P261, DOI 10.1016/S0031-9384(01)00449-8; Carter RN, 2009, J NEUROENDOCRINOL, V21, P879, DOI 10.1111/j.1365-2826.2009.01899.x; Cooper MS, 2001, J BONE MINER RES, V16, P1037, DOI 10.1359/jbmr.2001.16.6.1037; D'Elia M, 2009, AM J PHYSIOL-ENDOC M, V296, pE97, DOI 10.1152/ajpendo.90582.2008; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; DIORIO D, 1993, J NEUROSCI, V13, P3839; Dulos J, 2004, ARTHRITIS RHEUM-US, V50, P3346, DOI 10.1002/art.20509; Engler H, 2008, PSYCHONEUROENDOCRINO, V33, P108, DOI 10.1016/j.psyneuen.2007.10.007; Ergang P, 2011, J STEROID BIOCHEM, V126, P19, DOI 10.1016/j.jsbmb.2011.04.002; Escher G, 1997, J EXP MED, V186, P189, DOI 10.1084/jem.186.2.189; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Friedberg M, 2003, J CLIN ENDOCR METAB, V88, P385, DOI 10.1210/jc.2002-020510; Hanafusa J, 2002, AM J PHYSIOL-ENDOC M, V282, pE466, DOI 10.1152/ajpendo.00065.2001; Harris HJ, 2001, ENDOCRINOLOGY, V142, P114, DOI 10.1210/en.142.1.114; Herbert J, 2006, J NEUROENDOCRINOL, V18, P393, DOI 10.1111/j.1365-2826.2006.01429.x; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Ignatova ID, 2009, AM J PHYSIOL-ENDOC M, V296, pE367, DOI 10.1152/ajpendo.90531.2008; Iwasaki Y, 2008, MOL CELL ENDOCRINOL, V285, P10, DOI 10.1016/j.mce.2008.01.012; Jamieson, 1997, Stress, V2, P123; Jones KR, 2011, PHYSIOL BEHAV, V104, P266, DOI 10.1016/j.physbeh.2011.03.021; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Korbonits M, 2001, J CLIN ENDOCR METAB, V86, P2728, DOI 10.1210/jc.86.6.2728; Krugers Harmen J, 2010, Front Synaptic Neurosci, V2, P24, DOI 10.3389/fnsyn.2010.00024; LOW SC, 1994, J NEUROENDOCRINOL, V6, P285, DOI 10.1111/j.1365-2826.1994.tb00584.x; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 1997, BRAIN RES REV, V23, P79, DOI 10.1016/S0165-0173(96)00012-4; Mitchell PJ, 2005, CURR PHARM DESIGN, V11, P171, DOI 10.2174/1381612053382250; MOISAN MP, 1990, ENDOCRINOLOGY, V127, P1450, DOI 10.1210/endo-127-3-1450; MONDER C, 1994, ENDOCRINOLOGY, V134, P1193, DOI 10.1210/en.134.3.1193; Muller C, 2006, J STEROID BIOCHEM, V100, P95, DOI 10.1016/j.jsbmb.2006.03.001; Myers B, 2012, CELL MOL NEUROBIOL, V32, P683, DOI 10.1007/s10571-012-9801-y; Nashev LG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000561; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pelletier G, 2007, NEUROSCIENCE, V145, P110, DOI 10.1016/j.neuroscience.2006.11.038; Porterfield VM, 2011, NEUROSCIENCE, V188, P48, DOI 10.1016/j.neuroscience.2011.05.023; Rajan V, 1996, J NEUROSCI, V16, P65; Reber SO, 2011, BRAIN BEHAV IMMUN, V25, P1153, DOI 10.1016/j.bbi.2011.03.004; Sai S, 2008, MOL ENDOCRINOL, V22, P2049, DOI 10.1210/me.2007-0489; SAKAI RR, 1992, J NEUROENDOCRINOL, V4, P101, DOI 10.1111/j.1365-2826.1992.tb00351.x; Schmid J, 2011, P NATL ACAD SCI USA, V108, P13722, DOI 10.1073/pnas.1110965108; Shimojo M, 1996, ENDOCR RES, V22, P771, DOI 10.1080/07435809609043775; Sterzl I, 1999, J STEROID BIOCHEM, V71, P133, DOI 10.1016/S0960-0760(99)00134-X; Svec J, 2010, INT J EXP PATHOL, V91, P44, DOI 10.1111/j.1365-2613.2009.00698.x; Tsugita M, 2008, LIFE SCI, V83, P426, DOI 10.1016/j.lfs.2008.07.005; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Wyrwoll CS, 2011, FRONT NEUROENDOCRIN, V32, P265, DOI 10.1016/j.yfrne.2010.12.001; Yang Z, 2007, J ENDOCRINOL, V195, P241, DOI 10.1677/JOE-07-0303; Zuckerman-Levin N, 2001, J CLIN ENDOCR METAB, V86, P5920, DOI 10.1210/jc.86.12.5920	56	9	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89421	10.1371/journal.pone.0089421	http://dx.doi.org/10.1371/journal.pone.0089421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586766	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900093
J	Lolupiman, S; Siripurkpong, P; Yuvaniyama, J				Lolupiman, Sirisak; Siripurkpong, Pilaiwan; Yuvaniyama, Jirundon			Disulfide Linkages in Plasmodium falciparum Plasmepsin-I Are Essential Elements for Its Processing Activity and Multi- Milligram Recombinant Production Yield	PLOS ONE			English	Article							HISTO-ASPARTIC PROTEASE; ENZYMATIC CHARACTERIZATION; CRYSTAL-STRUCTURES; EXPRESSION; INHIBITION; TARGETS; FORMS	Plasmodium falciparum plasmepsin-I (PM-I) has been considered a potential drug target for the parasite that causes fatal malaria in human. Determination of PM-I structures for rational design of its inhibitors is hindered by the difficulty in obtaining large quantity of soluble enzyme. Nearly all attempts for its heterologous expression in Escherichia coli result in the production of insoluble proteins in both semi-pro-PM-I and its truncated form, and thus require protein refolding. Moreover, the yields of purified, soluble PM-I from all reported studies are very limited. Exclusion of truncated semi-pro-PM-I expression in E. coli C41(DE3) is herein reported. We also show that the low preparation yield of purified semi-pro-PM-I with autoprocessing ability is mainly a result of structural instability of the refolded enzyme in acidic conditions due to incomplete formation of disulfide linkages. Upon formation of at least one of the two natural disulfide bonds, nearly all of the refolded semi-pro-PM-I could be activated to its mature form. A significantly improved yield of 10 mg of semi-pro-PM-I per liter of culture, which resulted in 6-8 mg of the mature PM-I, was routinely obtained using this strategy.	[Lolupiman, Sirisak; Yuvaniyama, Jirundon] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Lolupiman, Sirisak; Yuvaniyama, Jirundon] Mahidol Univ, Fac Sci, Ctr Excellence Prot Struct & Funct, Bangkok 10400, Thailand; [Siripurkpong, Pilaiwan] Thammasat Univ, Fac Allied Hlth Sci, Dept Med Technol, Pathum Thani, Thailand	Mahidol University; Mahidol University; Thammasat University	Yuvaniyama, J (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand.	jirundon.yuv@mahidol.ac.th		Yuvaniyama, Jirundon/0000-0002-6800-8944	Mahidol University, Thailand [2556A11003230, 00-2-MAL/TARUN-02-010]	Mahidol University, Thailand	This work was supported in part by Mahidol University Research Grant 2556A11003230 and TARUN Grant 00-2-MAL/TARUN-02-010, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaumik P, 2011, J STRUCT BIOL, V175, P73, DOI 10.1016/j.jsb.2011.04.009; Bhaumik P, 2009, J MOL BIOL, V388, P520, DOI 10.1016/j.jmb.2009.03.011; COLLIER HB, 1973, ANAL BIOCHEM, V56, P310, DOI 10.1016/0003-2697(73)90196-6; Ersmark K, 2006, MED RES REV, V26, P626, DOI 10.1002/med.20082; Flotow H, 2002, J BIOMOL SCREEN, V7, P367, DOI 10.1177/108705710200700409; FRANCIS SE, 1994, EMBO J, V13, P306, DOI 10.1002/j.1460-2075.1994.tb06263.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Gulnik SV, 2002, PROTEIN EXPRES PURIF, V24, P412, DOI 10.1006/prep.2001.1590; HILL J, 1994, FEBS LETT, V352, P155, DOI 10.1016/0014-5793(94)00940-6; Li T, 2004, MOL BIOCHEM PARASIT, V135, P101, DOI 10.1016/j.molbiopara.2004.01.010; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Liu P, 2009, BIOCHEMISTRY-US, V48, P4086, DOI 10.1021/bi802059r; Luker KE, 1996, MOL BIOCHEM PARASIT, V79, P71, DOI 10.1016/0166-6851(96)02651-5; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moon RP, 1997, EUR J BIOCHEM, V244, P552, DOI 10.1111/j.1432-1033.1997.00552.x; Olliaro PL, 1999, PHARMACOL THERAPEUT, V81, P91, DOI 10.1016/S0163-7258(98)00036-9; Silva AM, 1996, P NATL ACAD SCI USA, V93, P10034, DOI 10.1073/pnas.93.19.10034; Siripurkpong P, 2002, J BIOL CHEM, V277, P41009, DOI 10.1074/jbc.M204852200; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tyas L, 1999, FEBS LETT, V454, P210, DOI 10.1016/S0014-5793(99)00805-4; Wei CJ, 1999, BIOCHEM J, V340, P345, DOI 10.1042/0264-6021:3400345; Xiao HG, 2007, PROTEIN ENG DES SEL, V20, P625, DOI 10.1093/protein/gzm066; Xiao HG, 2006, PROTEIN EXPRES PURIF, V49, P88, DOI 10.1016/j.pep.2006.02.022	26	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89424	10.1371/journal.pone.0089424	http://dx.doi.org/10.1371/journal.pone.0089424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586769	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700118
J	Nallamilli, BRR; Edelmann, MJ; Zhong, XX; Tan, F; Mujahid, H; Zhang, J; Nanduri, B; Peng, ZH				Nallamilli, Babi Ramesh Reddy; Edelmann, Mariola J.; Zhong, Xiaoxian; Tan, Feng; Mujahid, Hana; Zhang, Jian; Nanduri, Bindu; Peng, Zhaohua			Global Analysis of Lysine Acetylation Suggests the Involvement of Protein Acetylation in Diverse Biological Processes in Rice (Oryza sativa)	PLOS ONE			English	Article							TANDEM AFFINITY PURIFICATION; HISTONE DEACETYLASE GENES; COMPLEX; ACETYLTRANSFERASE; PHOSPHORYLATION; WIDESPREAD; RESISTANCE; EXPRESSION; RESOURCE; REMOVAL	Lysine acetylation is a reversible, dynamic protein modification regulated by lysine acetyltransferases and deacetylases. Recent advances in high-throughput proteomics have greatly contributed to the success of global analysis of lysine acetylation. A large number of proteins of diverse biological functions have been shown to be acetylated in several reports in human cells, E. coli, and dicot plants. However, the extent of lysine acetylation in non-histone proteins remains largely unknown in monocots, particularly in the cereal crops. Here we report the mass spectrometric examination of lysine acetylation in rice (Oryza sativa). We identified 60 lysine acetylated sites on 44 proteins of diverse biological functions. Immunoblot studies further validated the presence of a large number of acetylated non-histone proteins. Examination of the amino acid composition revealed substantial amino acid bias around the acetylation sites and the amino acid preference is conserved among different organisms. Gene ontology analysis demonstrates that lysine acetylation occurs in diverse cytoplasmic, chloroplast and mitochondrial proteins in addition to the histone modifications. Our results suggest that lysine acetylation might constitute a regulatory mechanism for many proteins, including both histones and non-histone proteins of diverse biological functions.	[Nallamilli, Babi Ramesh Reddy; Zhong, Xiaoxian; Tan, Feng; Mujahid, Hana; Zhang, Jian; Peng, Zhaohua] Mississippi State Univ, Dept Biochem & Mol Biol, Starkville, MS 39759 USA; [Edelmann, Mariola J.; Nanduri, Bindu] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi Agr & Forestry Expt Stn, Starkville, MS USA; [Nanduri, Bindu] Mississippi State Univ, Coll Vet Med, Starkville, MS USA	Mississippi State University; Mississippi State University; Mississippi State University	Peng, ZH (corresponding author), Mississippi State Univ, Dept Biochem & Mol Biol, Starkville, MS 39759 USA.	zp7@BCH.msstate.edu		Zhang, Jian/0000-0003-2804-0162; Edelmann, Mariola/0000-0003-0459-7716	USDA [2011-67013-30125]; Southern Crop Fund [322038-191400-027000-241080, 322431-191400-027000-329180]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	USDA(United States Department of Agriculture (USDA)); Southern Crop Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Peng's group is supported by USDA grant 2011-67013-30125. MJ Edelmann is supported by Southern Crop Fund 322038-191400-027000-241080 and 322431-191400-027000-329180 (USDA ARS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, PLANT CELL PHYSIOL, V49, P420, DOI 10.1093/pcp/pcn019; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Brown AP, 2006, J EXP BOT, V57, P1563, DOI 10.1093/jxb/erj150; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Cheema A, 2010, J CELL PHYSIOL, V225, P371, DOI 10.1002/jcp.22224; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Chitteti BR, 2008, PROTEOMICS, V8, P4303, DOI 10.1002/pmic.200701149; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Hollender C, 2008, J INTEGR PLANT BIOL, V50, P875, DOI 10.1111/j.1744-7909.2008.00704.x; Hu YF, 2009, BIOCHEM BIOPH RES CO, V388, P266, DOI 10.1016/j.bbrc.2009.07.162; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jeffers V, 2012, EUKARYOT CELL, V11, P735, DOI 10.1128/EC.00088-12; Kelly TJ, 2009, J BIOL CHEM, V284, P19945, DOI 10.1074/jbc.M109.015164; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Lee TJ, 2004, PLANT MOL BIOL REP, V22, P259, DOI 10.1007/BF02773136; Li GS, 2008, ELECTROPHORESIS, V29, P604, DOI 10.1002/elps.200700412; Liu ZX, 2011, NUCLEIC ACIDS RES, V39, pD1029, DOI 10.1093/nar/gkq939; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; McEwan DG, 2011, TRENDS CELL BIOL, V21, P195, DOI 10.1016/j.tcb.2010.12.006; Melo-Braga MN, 2012, MOL CELL PROTEOMICS, V11, P945, DOI 10.1074/mcp.M112.020214; Montgomerie S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-301; Mujahid H, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-26; Mutskov V, 1998, MOL CELL BIOL, V18, P6293, DOI 10.1128/MCB.18.11.6293; Nallamilli BRR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003322; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pan G, 2006, PLANT MOL BIOL, V61, P933, DOI 10.1007/s11103-006-0058-z; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Park HJ, 2011, MOL CELLS, V32, P305, DOI 10.1007/s10059-011-0122-7; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Puig OM, 1998, BBA-GENE STRUCT EXPR, V1397, P79, DOI 10.1016/S0167-4781(98)00008-6; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rivas S, 2002, PLANT CELL, V14, P689, DOI [10.1105/tpc.010357, 10.​1105/​tpc.​010357]; Rohila JS, 2006, PLANT J, V46, P1, DOI 10.1111/j.1365-313X.2006.02671.x; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Servet C, 2010, MOL PLANT, V3, P670, DOI 10.1093/mp/ssq018; Sobott F, 2009, J AM SOC MASS SPECTR, V20, P1652, DOI 10.1016/j.jasms.2009.04.023; Tan F, 2011, J PROTEOME RES, V10, P551, DOI 10.1021/pr100748e; Tsuji H, 2006, PLANT CELL PHYSIOL, V47, P995, DOI 10.1093/pcp/pcj072; Van Leene J, 2007, MOL CELL PROTEOMICS, V6, P1226, DOI 10.1074/mcp.M700078-MCP200; Ventura M, 2010, INT J BIOCHEM CELL B, V42, P1672, DOI 10.1016/j.biocel.2010.06.014; Wang DX, 2005, PROTEOMICS, V5, P2288, DOI 10.1002/pmic.200401167; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wu X, 2011, PLANT PHYSIOL, V155, P1769, DOI 10.1104/pp.110.165852; Yin BL, 2008, MOL PLANT, V1, P816, DOI 10.1093/mp/ssn037; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zhang J, 2010, PLANT J, V64, P604, DOI 10.1111/j.1365-313X.2010.04354.x; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou DX, 2010, RICE, V3, P103, DOI 10.1007/s12284-010-9045-8; Zybailov B, 2009, ANAL CHEM, V81, P8015, DOI 10.1021/ac9011792	62	77	82	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89283	10.1371/journal.pone.0089283	http://dx.doi.org/10.1371/journal.pone.0089283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586658	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700086
J	Nelson, ACG; Paul, KR; Petri, M; Flores, N; Rogge, RA; Cascarina, SM; Ross, ED				Nelson, Aaron C. Gonzalez; Paul, Kacy R.; Petri, Michelina; Flores, Noe; Rogge, Ryan A.; Cascarina, Sean M.; Ross, Eric D.			Increasing Prion Propensity by Hydrophobic Insertion	PLOS ONE			English	Article							GUANIDINE-HYDROCHLORIDE; SEQUENCE DETERMINANTS; OLIGOPEPTIDE REPEATS; PROTEIN AGGREGATION; PSI+ PRION; YEAST; PROPAGATION; DOMAINS; GENE; APPEARANCE	Prion formation involves the conversion of proteins from a soluble form into an infectious amyloid form. Most yeast prion proteins contain glutamine/asparagine-rich regions that are responsible for prion aggregation. Prion formation by these domains is driven primarily by amino acid composition, not primary sequence, yet there is a surprising disconnect between the amino acids thought to have the highest aggregation propensity and those that are actually found in yeast prion domains. Specifically, a recent mutagenic screen suggested that both aromatic and non-aromatic hydrophobic residues strongly promote prion formation. However, while aromatic residues are common in yeast prion domains, non-aromatic hydrophobic residues are strongly under-represented. Here, we directly test the effects of hydrophobic and aromatic residues on prion formation. Remarkably, we found that insertion of as few as two hydrophobic residues resulted in a multiple orders-of-magnitude increase in prion formation, and significant acceleration of in vitro amyloid formation. Thus, insertion or deletion of hydrophobic residues provides a simple tool to control the prion activity of a protein. These data, combined with bioinformatics analysis, suggest a limit on the number of strongly prion-promoting residues tolerated in glutamine/asparagine-rich domains. This limit may explain the under-representation of non-aromatic hydrophobic residues in yeast prion domains. Prion activity requires not only that a protein be able to form prion fibers, but also that these fibers be cleaved to generate new independently-segregating aggregates to offset dilution by cell division. Recent studies suggest that aromatic residues, but not non-aromatic hydrophobic residues, support the fiber cleavage step. Therefore, we propose that while both aromatic and non-aromatic hydrophobic residues promote prion formation, aromatic residues are favored in yeast prion domains because they serve a dual function, promoting both prion formation and chaperone-dependent prion propagation.	[Nelson, Aaron C. Gonzalez; Paul, Kacy R.; Petri, Michelina; Flores, Noe; Rogge, Ryan A.; Cascarina, Sean M.; Ross, Eric D.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University	Ross, ED (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	eric.ross@colostate.edu		Ross, Eric/0000-0002-6473-9977; Cascarina, Sean/0000-0002-3054-2332; Rogge, Ryan/0000-0002-8368-1184	National Science Foundation [MCB-1023771]; Direct For Biological Sciences [1023771] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a National Science Foundation grant (MCB-1023771) to EDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Alexandrov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046458; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bradley ME, 2004, MOL MICROBIOL, V51, P1649, DOI 10.1111/j.1365-2958.2003.03955.x; Chen BX, 2010, MOL MICROBIOL, V76, P1483, DOI 10.1111/j.1365-2958.2010.07177.x; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Couthouis J, 2012, HUM MOL GENET; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; COX BS, 1971, HEREDITY, V26, P211, DOI 10.1038/hdy.1971.28; Crow ET, 2011, MOL CELL BIOL, V31, P3436, DOI 10.1128/MCB.05338-11; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1997, GENETICS, V147, P507; Angarica VE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-316; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Geser F, 2009, J NEUROL, V256, P1205, DOI 10.1007/s00415-009-5069-7; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Klar J, 2013, HUM MUTAT, V34, P572, DOI 10.1002/humu.22282; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; MacLea KS, 2011, PRION, V5, P263, DOI [10.4161/pri.5.4.17918, 10.4161/pri.17918]; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Ross CD, 2009, GENETICS, V183, P929, DOI 10.1534/genetics.109.109322; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Ross ED, 2010, PRION, V4, DOI 10.4161/pri.4.2.12190; Ross Eric D, 2013, Methods Mol Biol, V1017, P219, DOI 10.1007/978-1-62703-438-8_16; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Pastor MT, 2007, PRION, V1, P9, DOI 10.4161/pri.1.1.4100; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Toombs JA, 2012, P NATL ACAD SCI USA, V109, P6519, DOI 10.1073/pnas.1119366109; Toombs JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021953; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Wadsworth JDF, 2007, BBA-MOL BASIS DIS, V1772, P598, DOI 10.1016/j.bbadis.2007.02.010; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	68	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89286	10.1371/journal.pone.0089286	http://dx.doi.org/10.1371/journal.pone.0089286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586661	gold, Green Published, Green Submitted			2022-12-27	WOS:000331714700089
J	Przybycien-Szymanska, MM; Rao, YS; Prins, SA; Pak, TR				Przybycien-Szymanska, Magdalena M.; Rao, Yathindar S.; Prins, Sarah A.; Pak, Toni R.			Parental Binge Alcohol Abuse Alters F1 Generation Hypothalamic Gene Expression in the Absence of Direct Fetal Alcohol Exposure	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BONE MORPHOGENETIC PROTEINS; MESSENGER-RIBONUCLEIC-ACID; PROLINE-RICH LIGANDS; FEMALE RAT MODEL; MENTAL-RETARDATION; APOLIPOPROTEIN-E; DELAYED PUBERTY; PLASMINOGEN-ACTIVATOR; SPINE MORPHOGENESIS	Adolescent binge alcohol exposure has long-lasting effects on the expression of hypothalamic genes that regulate the stress response, even in the absence of subsequent adult alcohol exposure. This suggests that alcohol can induce permanent gene expression changes, potentially through epigenetic modifications to specific genes. Epigenetic modifications can be transmitted to future generations therefore, and in these studies we investigated the effects of adolescent binge alcohol exposure on hypothalamic gene expression patterns in the F1 generation offspring. It has been well documented that maternal alcohol exposure during fetal development can have devastating neurological consequences. However, less is known about the consequences of maternal and/or paternal alcohol exposure outside of the gestational time frame. Here, we exposed adolescent male and female rats to a repeated binge EtOH exposure paradigm and then mated them in adulthood. Hypothalamic samples were taken from the offspring of these animals at postnatal day (PND) 7 and subjected to a genome-wide microarray analysis followed by qRT-PCR for selected genes. Importantly, the parents were not intoxicated at the time of mating and were not exposed to EtOH at any time during gestation therefore the offspring were never directly exposed to EtOH. Our results showed that the offspring of alcohol-exposed parents had significant differences compared to offspring from alcohol-naive parents. Specifically, major differences were observed in the expression of genes that mediate neurogenesis and synaptic plasticity during neurodevelopment, genes important for directing chromatin remodeling, posttranslational modifications or transcription regulation, as well as genes involved in regulation of obesity and reproductive function. These data demonstrate that repeated binge alcohol exposure during pubertal development can potentially have detrimental effects on future offspring even in the absence of direct fetal alcohol exposure.	[Przybycien-Szymanska, Magdalena M.; Rao, Yathindar S.; Prins, Sarah A.; Pak, Toni R.] Loyola Univ, Chicago Hlth Sci Div, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Pak, TR (corresponding author), Loyola Univ, Chicago Hlth Sci Div, Dept Cell & Mol Physiol, Maywood, IL 60153 USA.	tpak@lumc.edu			National Institutes of Health [NIH R01AA021517, NIH T32 AA013527]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013527, R01AA021517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding came from National Institutes of Health NIH R01AA021517 and NIH T32 AA013527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed EI, 2008, NAT NEUROSCI, V11, P995, DOI 10.1038/nn.2178; Allen CD, 2011, NEUROSCIENCE, V182, P162, DOI 10.1016/j.neuroscience.2011.03.003; Allen CD, NEUROSCIENCE; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Arrigo T, 1999, EUR J ENDOCRINOL, V141, P140, DOI 10.1530/eje.0.1410140; Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Bajpai Anurag, 2002, Indian Pediatr, V39, P633; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Boda B, 2006, MOL NEUROBIOL, V34, P67, DOI 10.1385/MN:34:1:67; Bond AM, 2012, DEV NEUROBIOL, V72, P1068, DOI 10.1002/dneu.22022; Borges VM, 2010, J NEUROSCI RES, V88, P2610, DOI 10.1002/jnr.22428; Brand SR, 2010, PSYCHONEUROENDOCRINO, V35, P686, DOI 10.1016/j.psyneuen.2009.10.009; BUCHANAN KL, 1991, NEUROENDOCRINOLOGY, V54, P96, DOI 10.1159/000125857; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; Crews D, 2011, HORM BEHAV, V59, P393, DOI 10.1016/j.yhbeh.2010.07.001; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; DiVall SA, 2010, J CLIN INVEST, V120, P2900, DOI 10.1172/JCI41069; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Donovan JE, 2009, PEDIATRICS, V123, pE975, DOI 10.1542/peds.2008-0027; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Dubos A, 2012, J NEUROSCI, V32, P519, DOI 10.1523/JNEUROSCI.3252-11.2012; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3; Fabbro S, 2009, J NEUROCHEM, V109, P303, DOI 10.1111/j.1471-4159.2009.05894.x; Fanous S, 2013, J NEUROCHEM, V124, P100, DOI 10.1111/jnc.12074; Feng J., 2013, CURR OPIN NEUROBIOL; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Gal J, 2012, NEUROCHEM INT, V61, P992, DOI 10.1016/j.neuint.2012.07.010; Gilpin NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031466; Govorko D, 2012, BIOL PSYCHIAT, V72, P378, DOI 10.1016/j.biopsych.2012.04.006; Grasemann C, 2004, EUR J ENDOCRINOL, V150, P691, DOI 10.1530/eje.0.1500691; Greene JM, 1998, EUR J NEUROSCI, V10, P1911, DOI 10.1046/j.1460-9568.1998.00211.x; Haramati S, 2011, J NEUROSCI, V31, P14191, DOI 10.1523/JNEUROSCI.1673-11.2011; Harris VM, 2012, J ENDOCRINOL, V212, P139, DOI 10.1530/JOE-11-0359; He F, 2006, NEUROTOXICOL TERATOL, V28, P198, DOI 10.1016/j.ntt.2005.12.003; Hellemans KGC, 2008, ANN NY ACAD SCI, V1144, P154, DOI 10.1196/annals.1418.016; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hill RM, 2002, ANN NY ACAD SCI, V971, P406, DOI 10.1111/j.1749-6632.2002.tb04503.x; Hill SY, 2011, J PSYCHIATR RES, V45, P285, DOI 10.1016/j.jpsychires.2010.08.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang XJ, 2009, J BIOL CHEM, V284, P25375, DOI 10.1074/jbc.M109.024828; HUHTANIEMI IT, 1986, BIOL REPROD, V35, P501, DOI 10.1095/biolreprod35.3.501; Jones EA, 2012, HUM MOL GENET, V21, P1581, DOI 10.1093/hmg/ddr595; KETELSLEGERS JM, 1978, ENDOCRINOLOGY, V103, P212, DOI 10.1210/endo-103-1-212; King SM, 2009, ADDICTION, V104, P578, DOI 10.1111/j.1360-0443.2008.02469.x; Knopik VS, 2009, TWIN RES HUM GENET, V12, P53, DOI 10.1375/twin.12.1.53; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krajnak K, 1998, ENDOCRINOLOGY, V139, P4189, DOI 10.1210/en.139.10.4189; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lauing K, 2008, ALCOHOL, V42, P649, DOI 10.1016/j.alcohol.2008.08.005; Liu HJ, 2013, STEM CELLS DEV, V22, P913, DOI 10.1089/scd.2012.0370; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Malone SM, 2010, J CHILD PSYCHOL PSYC, V51, P1067, DOI 10.1111/j.1469-7610.2010.02219.x; Mauras N, 1996, HORM RES, V45, P74, DOI 10.1159/000184763; MCGIVERN RF, 1992, ALCOHOL, V9, P335, DOI 10.1016/0741-8329(92)90077-N; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Molina BSG, 2010, ALCOHOL CLIN EXP RES, V34, P1972, DOI 10.1111/j.1530-0277.2010.01287.x; Morgan PT, 2010, ALCOHOL CLIN EXP RES, V34, P1759, DOI 10.1111/j.1530-0277.2010.01263.x; Pinilla L, 2009, ENDOCRINOLOGY, V150, P2889, DOI 10.1210/en.2008-1381; Przybycien-Szymanska MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032263; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018350; Przybycien-Szymanska MM, 2010, AM J PHYSIOL-ENDOC M, V298, pE320, DOI 10.1152/ajpendo.00615.2009; Przybycien-Szymanska MM, 2009, AM J PHYSL ENDOCRINO; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Rankin SL, 2003, BRAIN RES, V971, P189, DOI 10.1016/S0006-8993(03)02350-3; Raymond AD, 2006, BRAIN RES, V1102, P44, DOI 10.1016/j.brainres.2006.04.113; Read JP, 2008, ADDICT BEHAV, V33, P225, DOI 10.1016/j.addbeh.2007.09.001; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; RIVIER C, 1984, J PHARMACOL EXP THER, V229, P127; Roth C, 2000, PEDIATR RES, V48, P468, DOI 10.1203/00006450-200010000-00009; Roth C, 2001, J ENDOCRINOL, V169, P361, DOI 10.1677/joe.0.1690361; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Schmeisser MJ, 2012, J NEUROSCI, V32, P5688, DOI 10.1523/JNEUROSCI.0111-12.2012; Schubert V, 2011, GLIA, V59, P1472, DOI 10.1002/glia.21190; Shen L, 2008, DIABETES, V57, P2092, DOI 10.2337/db08-0291; Shen L, 2009, PHYSIOL BEHAV, V98, P223, DOI 10.1016/j.physbeh.2009.05.013; Sirivaidyapong S, 2012, REPROD DOMEST ANIM, V47, P400, DOI 10.1111/rda.12066; Sisk CL, 2001, ENDOCRINOLOGY, V142, P2929, DOI 10.1210/en.142.7.2929; Skinner MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003745; SODERSTEN P, 1975, HORM BEHAV, V6, P307, DOI 10.1016/0018-506X(75)90001-X; SODERSTEN P, 1977, HORM BEHAV, V8, P320, DOI 10.1016/0018-506X(77)90006-X; Sorensen HJ, 2011, ALCOHOL CLIN EXP RES, V35, P1315, DOI 10.1111/j.1530-0277.2011.01467.x; Soriano FX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021056; Teesalu T, 2004, THROMB HAEMOSTASIS, V92, P358; Thomson RE, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-4; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Vialou V, 2013, ANNU REV PHARMACOL, V53, P59, DOI 10.1146/annurev-pharmtox-010611-134540; Viau V, 2005, ENDOCRINOLOGY, V146, P137, DOI 10.1210/en.2004-0846; Whitlock KE, 2006, MOL CELL ENDOCRINOL, V254, P39, DOI 10.1016/j.mce.2006.04.038; Woo TU, 1997, NEUROSCIENCE, V80, P1149, DOI 10.1016/S0306-4522(97)00059-6; Wu QF, 2012, CELL, V149, P1549, DOI 10.1016/j.cell.2012.04.046; Yang W, 2013, CANCER SCI, V104, P70, DOI 10.1111/cas.12047; Yepes M, 2004, THROMB HAEMOSTASIS, V91, P457, DOI 10.1160/TH03-12-0766; You SH, 2010, MOL ENDOCRINOL, V24, P1359, DOI 10.1210/me.2009-0501; Zehr JL, 2006, J NEUROBIOL, V66, P578, DOI 10.1002/neu.20251; Zhao ST, 2004, DEVELOPMENT, V131, P5117, DOI 10.1242/dev.01387	105	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89320	10.1371/journal.pone.0089320	http://dx.doi.org/10.1371/journal.pone.0089320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586686	Green Submitted, gold, Green Published			2022-12-27	WOS:000331714700101
J	Wang, L; Ye, TJ; Deng, LF; Shao, J; Qi, J; Zhou, Q; Wei, L; Qiu, SJ				Wang, Lei; Ye, Tingjun; Deng, Lianfu; Shao, Jin; Qi, Jin; Zhou, Qi; Wei, Li; Qiu, Shijing			Repair of Microdamage in Osteonal Cortical Bone Adjacent to Bone Screw	PLOS ONE			English	Article							OSTEOCYTE; ASSOCIATION; STABILITY; MECHANISM; RANKL	Up to date, little is known about the repair mode of microdamage in osteonal cortical bone resulting from bone screw implantation. In this study, self-tapping titanium cortical bone screws were inserted into the tibial diaphyses of 24 adult male rabbits. The animals were sacrificed at 1 day, 2 weeks, 1 month and 2 months after surgery. Histomorphometric measurement and confocal microscopy were performed on basic fuchsin stained bone sections to examine the morphological characteristics of microdamage, bone resorption activity and spatial relationship between microdamage and bone resorption. Diffuse and linear cracks were coexisted in peri-screw bone. Intracortical bone resorption was significantly increased 2 weeks after screw installation and reach to the maximum at 1 month. There was no significant difference in bone resorption between 1-month and 2-months groups. Microdamage was significantly decreased within 1 month after surgery. Bone resorption was predisposed to occur in the region of <100 mu m from the bone-screw interface, where had extensive diffuse damage mixed with linear cracks. Different patterns of resorption cavities appeared in peri-screw bone. These data suggest that 1) the complex microdamage composed of diffuse damage and linear cracks is a strong stimulator for initiating targeted bone remodeling; 2) bone resorption activities taking place on the surfaces of differently oriented Haversian and Volkmann canals work in a team for the repair of extensive microdamage; 3) targeted bone remodeling is a short-term reaction to microdamage and thereby it may not be able to remove all microdamage resulting from bone screw insertion.	[Wang, Lei; Ye, Tingjun; Deng, Lianfu; Shao, Jin; Qi, Jin; Zhou, Qi; Wei, Li; Qiu, Shijing] Shanghai Jiao Tong Univ, Shanghai Inst Traumatol & Orthoped, Dept Orthoped, Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China; [Qiu, Shijing] Henry Ford Hosp, Bone & Mineral Res Lab, Detroit, MI 48202 USA	Shanghai Jiao Tong University; Henry Ford Health System; Henry Ford Hospital	Qiu, SJ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Traumatol & Orthoped, Dept Orthoped, Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China.	qiu@bjc.hfh.edu	Ye, Tingjun/AAL-5581-2020		Science and Technology Commission of Shanghai Municipality [11JC1141700]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the Science and Technology Commission of Shanghai Municipality (grant number 11JC1141700). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentolila V, 1998, BONE, V23, P275, DOI 10.1016/S8756-3282(98)00104-5; Boyde A, 2003, J ANAT, V203, P173, DOI 10.1046/j.1469-7580.2003.00213.x; Buchter A, 2005, CLIN ORAL IMPLAN RES, V16, P1, DOI 10.1111/j.1600-0501.2004.01081.x; Burr D, 2003, OSTEOPOROSIS INT, V14, pS67, DOI 10.1007/s00198-003-1476-2; Burr DB, 2011, J MUSCULOSKEL NEURON, V11, P270; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; BURR DB, 1995, BONE, V17, P431, DOI 10.1016/S8756-3282(95)00241-3; BURR DB, 1993, CALCIFIED TISSUE INT, V53, pS75, DOI 10.1007/BF01673407; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Errani C, 2010, CANCER TREAT REV, V36, P1, DOI 10.1016/j.ctrv.2009.09.002; Frost HM, 1960, H FORD HOSP B, V8, P25; Garetto L P, 1995, Implant Dent, V4, P235, DOI 10.1097/00008505-199500440-00002; Hazenberg JG, 2006, J BIOMECH, V39, P2096, DOI 10.1016/j.jbiomech.2005.06.006; Herman BC, 2010, BONE, V47, P766, DOI 10.1016/j.bone.2010.07.006; Hong C, 2011, ANGLE ORTHOD, V81, P1001, DOI 10.2319/031011-176.1; Hoshaw SJ, 1995, MICRODAMAGE BONE IMP, P188; Hoshaw SJ, 1994, EFFECTS THREAD DESIG, P537; Huja SS, 1999, BONE, V25, P217, DOI 10.1016/S8756-3282(99)00151-9; Jilka RL, 2013, BONE, V54, P264, DOI 10.1016/j.bone.2012.11.038; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Kogianni G, 2008, J BONE MINER RES, V23, P915, DOI 10.1359/JBMR.080207; MacFarlane M, 2009, XENOBIOTICA, V39, P616, DOI 10.1080/00498250903137990; Martin RB, 2007, BONE, V40, P1574, DOI 10.1016/j.bone.2007.02.023; MARTIN RB, 1987, J ORTHOPAED RES, V5, P445, DOI 10.1002/jor.1100050317; Moore TLA, 2001, J BIOMECH ENG-T ASME, V123, P613, DOI 10.1115/1.1407828; Mulcahy LE, 2011, BONE, V48, P182, DOI 10.1016/j.bone.2010.09.014; Oh TJ, 2002, J PERIODONTOL, V73, P322, DOI 10.1902/jop.2002.73.3.322; Parfitt AM, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P71; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Parfitt AM, 2000, BONE, V26, P319, DOI 10.1016/S8756-3282(00)80937-0; Qiu SJ, 2005, BONE, V37, P10, DOI 10.1016/j.bone.2005.01.023; SCHAFFLER MB, 1990, BONE, V11, P321, DOI 10.1016/8756-3282(90)90087-F; Schaffler MB, 2003, OSTEOPOROSIS INT, V14, pS73; Seeman E, 2013, J GERONTOL A; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Tami AE, 2002, J BONE MINER RES, V17, P2030, DOI 10.1359/jbmr.2002.17.11.2030; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; USUI Y, 1989, J ORTHOP RES, V7, P12, DOI 10.1002/jor.1100070103; Vashishth D, 2007, INT J FATIGUE, V29, P1024, DOI 10.1016/j.ijfatigue.2006.09.010; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Wang L, 2012, MICROSC MICROANAL, V18, P1106, DOI 10.1017/S1431927612001286; Warreth A, 2009, CLIN ORAL IMPLAN RES, V20, P1300, DOI 10.1111/j.1600-0501.2009.01808.x; Wawrzinek C, 2008, J OROFAC ORTHOP, V69, P121, DOI 10.1007/s00056-008-0742-5; Xiong J., 2011, NAT MED; Xiong JH, 2012, J BONE MINER RES, V27, P499, DOI 10.1002/jbmr.1547; Xu C, 2013, CLIN IMPLANT DENT RE; Yadav S, 2012, AM J ORTHOD DENTOFAC, V141, P538, DOI 10.1016/j.ajodo.2011.12.016; Yu Z., 2013, OSTEOPOROS INT	48	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89343	10.1371/journal.pone.0089343	http://dx.doi.org/10.1371/journal.pone.0089343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586702	Green Published, Green Submitted, gold			2022-12-27	WOS:000331714700108
J	Feng, ZQ; Nie, YQ; Zhang, YX; Li, QN; Xia, HM; Gong, ST; Huang, H				Feng, Zhiqiang; Nie, Yuqiang; Zhang, Youxiang; Li, Qingning; Xia, HuiMing; Gong, SiTang; Huang, Hai			The Clinical Features of Infantile Hypertrophic Pyloric Stenosis in Chinese Han Population: Analysis from 1998 to 2010	PLOS ONE			English	Article							EPIDEMIOLOGY; ULTRASOUND; DIAGNOSIS; ACCURATE; MUSCLE; AGE	Objective: To investigate clinical features of infantile hypertrophic pyloric stenosis (IHPS) in Chinese Han population. Methods: Three hundred and sixteen hospitalized patients with IHPS from January 1998 to February 2010 were retrospectively reviewed, and data including patient's sex, onset age, other coexisting congenital defects, pyloric circular muscle thickness evaluated by ultrasonograph, serum electrolytes concentration, and results of arterial blood gas analysis on admission were collected. The patients were divided into two groups: the duration between first onset and admission less than or equal to 10 days (early onset group), and more than 10 days (late onset group). The results of arterial blood gas and serum electrolyte concentration were compared between the two groups. Results: There were 271 males and 45 females in 316 patients; the onset age ranged between 1 and 351 (26.5 +/- 26.6) days. The birth weight ranged between 1.6 and 4.5 (3.23 +/- 0.44) kilograms; coexisting congenital defects were found in 65 cases (20.6%). Pyloric circular muscle thickness was 4-8 (5.4 +/- 1.0) millimetres (mm). For the early onset group, the rates of hypokalemia, hypochloraemia and hypercapnia were significantly lower than those in the late onset group (18.67% VS 50%, P < 0.0001; 46.03% VS 71.01%, P = 0.003; 56.58% VS 83.44%, P = 2.17x10(-5); respectively). Conclusions: The symptom duration in Chinese Han population was longer than that in other populations. And as the prolongation of symptom duration, the incidence of acid-base imbalance increased significantly. Infants with persistent vomiting at the age of 3 similar to 5 weeks after birth should be considered IHPS, and go to hospital as soon as possible in order to reduce the incidence of hypokalemia, hypochloraemia and hypercapnia, and avoid deterioration.	[Feng, Zhiqiang; Nie, Yuqiang; Li, Qingning] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Guangzhou Digest Dis Ctr, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Feng, Zhiqiang; Nie, Yuqiang; Li, Qingning] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Guangzhou Key Lab Digest Dis, Guangzhou, Guangdong, Peoples R China; [Zhang, Youxiang] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Pediat, Guangzhou, Guangdong, Peoples R China; [Xia, HuiMing] Guangzhou Women & Childrens Med Ctr, Dept Surg, Guangzhou, Guangdong, Peoples R China; [Gong, SiTang; Huang, Hai] Guangzhou Women & Childrens Med Ctr, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Nie, YQ (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Guangzhou Digest Dis Ctr, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China.	nieyq@medmail.com.cn	Huang, Huang/AAN-5671-2020		Guangdong Natural Science Foundation [S2012040007771]; Bureau of Health of Guangzhou Municipality [2007-Zdi-10, 20121A011005]; national key clinical specialty	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Bureau of Health of Guangzhou Municipality; national key clinical specialty	This work was sponsored by Guangdong Natural Science Foundation (S2012040007771), Bureau of Health of Guangzhou Municipality (2007-Zdi-10, 20121A011005), and project funding for the construction of national key clinical specialty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEGATE MS, 1995, ARCH PEDIAT ADOL MED, V149, P1123, DOI 10.1001/archpedi.1995.02170230077011; BEASLEY SW, 1986, AUST PAEDIATR J, V22, P193; BREAUX CW, 1989, J PEDIATR SURG, V24, P1250, DOI 10.1016/S0022-3468(89)80561-5; Gotley LM, 2009, EMERG MED AUSTRALAS, V21, P407, DOI 10.1111/j.1742-6723.2009.01218.x; HABBICK BF, 1989, CAN MED ASSOC J, V140, P395; Hernanz-Schulman M, 2003, RADIOLOGY, V227, P319, DOI 10.1148/radiol.2272011329; HERNANZSCHULMAN M, 1994, RADIOLOGY, V193, P771, DOI 10.1148/radiology.193.3.7972822; Huang IF, 2011, PEDIATR INT, V53, P18, DOI 10.1111/j.1442-200X.2010.03185.x; LAMMER EJ, 1987, J MED GENET, V24, P482, DOI 10.1136/jmg.24.8.482; Leong MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019404; MacMahon B, 2006, EPIDEMIOLOGY, V17, P195, DOI 10.1097/01.ede.0000192032.83843.c9; Mcvay MR, 2009, J PEDIATR SURG, V44, P169, DOI 10.1016/j.jpedsurg.2008.10.028; MITCHELL LE, 1993, AM J DIS CHILD, V147, P1203, DOI 10.1001/archpedi.1993.02160350077012; Oakley EA, 2000, J PAEDIATR CHILD H, V36, P587, DOI 10.1046/j.1440-1754.2000.00578.x; OKEEFFE FN, 1991, RADIOLOGY, V178, P827, DOI 10.1148/radiology.178.3.1994426; Ostlie DJ, 2004, SURGERY, V136, P827, DOI 10.1016/j.surg.2004.06.020; Papadakis K, 1999, AM J EMERG MED, V17, P67, DOI 10.1016/S0735-6757(99)90020-7; Pedersen RN, 2008, J MATERN-FETAL NEO M, V21, P599, DOI 10.1080/14767050802214824; Reed AA, 2010, J DIAGN MED SONOG, V26, P157, DOI 10.1177/8756479310363912; Rohrschneider WK, 1998, PEDIATR RADIOL, V28, P429, DOI 10.1007/s002470050377; ROLLINS MD, 1989, ARCH DIS CHILD, V64, P138, DOI 10.1136/adc.64.1.138; Saula PW, 2011, TROP DOCT, V41, P204, DOI 10.1258/td.2011.110145; Schechter R, 1997, PAEDIATR PERINAT EP, V11, P407, DOI 10.1046/j.1365-3016.1997.d01-32.x; Shaoul R, 2004, ISRAEL MED ASSOC J, V6, P134; To T, 2005, ARCH PEDIAT ADOL MED, V159, P520, DOI 10.1001/archpedi.159.6.520; Vasavada P, 2004, RADIOL CLIN N AM, V42, P445, DOI 10.1016/j.rcl.2004.01.003; Velaoras K, 2005, PEDIATR SURG INT, V21, P669, DOI 10.1007/s00383-005-1435-4; Walker K, 2010, J PEDIATR SURG, V45, P2369, DOI 10.1016/j.jpedsurg.2010.08.035; WALSWORTHBELL JP, 1983, J EPIDEMIOL COMMUN H, V37, P149, DOI 10.1136/jech.37.2.149; Wang J, 2008, BIRTH DEFECTS RES A, V82, P763, DOI 10.1002/bdra.20527; Yesildag E, 2005, J PEDIATR SURG, V40, P1802, DOI 10.1016/j.jpedsurg.2005.07.043	31	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e88925	10.1371/journal.pone.0088925	http://dx.doi.org/10.1371/journal.pone.0088925			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586444	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900062
J	Rogers, SM; Turner, CF; Miller, WC; Erbelding, E; Eggleston, E; Tan, S; Roman, A; Hobbs, M; Chromy, J; Muvva, R; Ganapathi, L				Rogers, Susan M.; Turner, Charles F.; Miller, William C.; Erbelding, Emily; Eggleston, Elizabeth; Tan, Sylvia; Roman, Anthony; Hobbs, Marcia; Chromy, James; Muvva, Ravikiran; Ganapathi, Laxminarayana			Gender-Based Screening for Chlamydial Infection and Divergent Infection Trends in Men and Women	PLOS ONE			English	Article							UNITED-STATES; DRUG-USE; PREVALENCE; TRANSMISSION; TRACHOMATIS; BIAS; STD	Objectives: To assess the potential impact of chlamydial screening policy that recommends routine screening of women but not men. Methods: Population surveys of probability samples of Baltimore adults aged 18 to 35 years in 1997-1998 and 2006-2009 collected biospecimens to estimate trends in undiagnosed chlamydial infection. Survey estimates are compared to surveillance data on diagnosed chlamydial infections reported to the Health Department. Results: Prevalence of undiagnosed chlamydial infection among men increased from 1.6% to 4.0%, but it declined from 4.3% to 3.1% among women (p = 0.028 for test of interaction). The annual (average) number of diagnosed infections was substantially higher among women than men in both time periods and increased among both men and women. Undiagnosed infection prevalence was substantially higher among black than non-black adults (4.0% vs 1.2%, p = 0.042 in 1997-98 and 5.5% vs 0.7%, p<0.001 in 2006-09). Conclusion: Divergent trends in undiagnosed chlamydial infection by gender parallel divergent screening recommendations that encourage chlamydial testing for women but not for men.	[Rogers, Susan M.; Eggleston, Elizabeth; Tan, Sylvia] Res Triangle Inst, Stat & Epidemiol Div, Washington, DC 20005 USA; [Turner, Charles F.] CUNY, Queens Coll, Flushing, NY USA; [Turner, Charles F.] CUNY, Grad Ctr, Flushing, NY USA; [Miller, William C.; Hobbs, Marcia] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Erbelding, Emily] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Roman, Anthony] Univ Massachusetts, Survey Res Ctr, Boston, MA 02125 USA; [Chromy, James] Res Triangle Inst, Stat & Epidemiol Div, Res Triangle Pk, NC 27709 USA; [Muvva, Ravikiran] Bur STI HIV Prevent, Baltimore City Dept Hlth, Baltimore, MD USA; [Ganapathi, Laxminarayana] Res Triangle Inst, Res Comp Div, Res Triangle Pk, NC 27709 USA	Research Triangle Institute; City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University; University of Massachusetts System; University of Massachusetts Boston; Research Triangle Institute; Research Triangle Institute	Rogers, SM (corresponding author), Res Triangle Inst, Stat & Epidemiol Div, Washington, DC 20005 USA.	smr@rti.org	Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827; Tan, Sylvia Margaret/0000-0002-2987-0072; Ganapathi, Laxminarayana/0000-0001-8751-3797	NIH [R01-HD47163, R01-HD31067]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047163, R01HD031067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Primary support for this research and the Monitoring STDs Survey Program was provided by NIH grant R01-HD47163. Primary support for the Baltimore STD and Behavior Survey was provided by NIH grant R01-HD31067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K., 2009, Morbidity and Mortality Weekly Report, V58, P362; Allsworth JE, 2009, SEX TRANSM DIS, V36, P738, DOI 10.1097/OLQ.0b013e3181b38a4b; Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; Centers for Disease Control and Prevention, 2010, MMWR RECOMM REP, V17, P44; Centers for Disease Control and Prevention (CDC), SEX TRANSM DIS SURV; Cooley PC, 1999, COMPUT HUMAN BEHAV, V14, P195; Curtin LR, 2012, VITAL HLTH STAT SERI, V155; Datta SD, 2012, SEX TRANSM DIS, V39, P92, DOI 10.1097/OLQ.0b013e31823e2ff7; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Eggleston E, 2011, SEX TRANSM DIS, V38, P743, DOI 10.1097/OLQ.0b013e318214c149; ENG TR, 1997, HIDDEN EPIDEMIC CONF; Fisman DN, 2008, SEX TRANSM DIS, V35, pS61, DOI 10.1097/OLQ.0b013e3181802822; Gindi RM, 2011, SEX TRANSM DIS, V38, P260, DOI 10.1097/OLQ.0b013e3181f7d7f4; Gribble JN, 2000, SUBST USE MISUSE, V35, P869, DOI 10.3109/10826080009148425; Heijne JCM, 2011, J INFECT DIS, V203, P372, DOI 10.1093/infdis/jiq050; Ku L, 2002, AM J PUBLIC HEALTH, V92, P1140, DOI 10.2105/AJPH.92.7.1140; Mayer KH, 2011, AM J REPROD IMMUNOL, V65, P308, DOI 10.1111/j.1600-0897.2010.00942.x; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Moncada J, 2004, SEX TRANSM DIS, V31, P273, DOI 10.1097/01.OLQ.0000124611.73009.D5; Rogers SM, 2007, SEX TRANSM INFECT, V84, P23, DOI 10.1136/sti.2007.027029; Satterwhite CL, 2010, SEX TRANSM DIS, V37, P63, DOI 10.1097/OLQ.0b013e3181bc097a; StataCorp, 2011, STAT STAT SOFTW REL, P173; StataCorp L, 2007, STAT DAT AN STAT SOF; State of Maryland Department of Health and Mental Hygeine, 2000, MAR HLTH IMPR PLAN 2; Turner CF, 2005, ADDICTION, V100, P1432, DOI 10.1111/j.1360-0443.2005.01196.x; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; USPSTF, 2007, ANN INTERN MED, P128; Villarroel MA, 2008, SEX TRANSM DIS, V35, P499, DOI 10.1097/OLQ.0b013e318165925a; Volker R, 2010, JAMA-J AM MED ASSOC, V303, P823; Zenilman JM, 1999, SEX TRANSM DIS, V26, P75, DOI 10.1097/00007435-199902000-00002; Zernilman J, 2003, SEX TRANSM INFECT, V79, P94	31	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89035	10.1371/journal.pone.0089035	http://dx.doi.org/10.1371/journal.pone.0089035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	24586491	Green Published, gold, Green Submitted			2022-12-27	WOS:000331711900075
J	Suksomboon, N; Poolsup, N; Nge, YL				Suksomboon, Naeti; Poolsup, Nalinee; Nge, Yuu Lay			Impact of Phone Call Intervention on Glycemic Control in Diabetes Patients: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials	PLOS ONE			English	Article							AFRICAN-AMERICAN WOMEN; IMPROVE SELF-CARE; NURSE FOLLOW-UP; DELIVERED INTERVENTION; AUTOMATED CALLS; GLUCOSE CONTROL; CASE-MANAGEMENT; OUTCOMES; ADHERENCE; SUPPORT	Background: Telephone-delivered intervention can provide many supports in diabetes self-management to improve glycemic control. Several trials showed that telephone intervention was positively associated with glycemic outcomes in diabetes. The objective of this meta-analysis was to assess the impact of telephone contact intervention (intervention group) on glycemic control compared with standard clinical care (control group). Methods: Randomized control studies of telephone intervention in diabetes were searched on Medline (Pubmed), the Cochrane Central Register of Controlled Trials, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science (ISI), and Scopus. Electronic search was done from inception to April 2013. The following MeSH terms were used: diabetes mellitus, randomized control trials and telemedicine, together with keywords including phone intervention, diabetes, and glycemic control. Historical search was also conducted on the references of relevant articles. The quality of the trials was assessed using Maastricht-Amsterdam scale. Treatment effect was estimated with mean difference in the change of hemoglobin A1c (HbA1c) from baseline between the intervention and control groups. Results: A total of 203 articles were examined. Five trials involving 953 patients met the inclusion criteria and contributed to the meta-analysis. Telephone contact intervention was no more effective than standard clinical care in improving glycemic control (pooled mean difference in HbA1c 20.38%, 95% CI - 0.91 to 0.16%). Conclusions: This meta-analysis showed that the phone contact intervention was no more effective than standard clinical care in improving glycemic control in diabetes. However, telephone intervention may still have potential benefits especially for low-and middle-income countries; thus further large sample size and well-controlled studies are needed to evaluate the impact of the intervention.	[Suksomboon, Naeti; Nge, Yuu Lay] Mahidol Univ, Dept Pharm, Fac Pharm, Bangkok 10700, Thailand; [Poolsup, Nalinee] Silpakorn Univ, Dept Pharm, Fac Pharm, Nakhon Pathom, Thailand	Mahidol University; Silpakorn University	Poolsup, N (corresponding author), Silpakorn Univ, Dept Pharm, Fac Pharm, Nakhon Pathom, Thailand.	npoolsup@hotmail.com						Adwan Mezyed A, 2013, Glob J Health Sci, V5, P213, DOI 10.5539/gjhs.v5n2p213; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; Bogner HR, 2012, ANN FAM MED, V10, P15, DOI 10.1370/afm.1344; Crowley MJ, 2013, AM HEART J, V166, P179, DOI 10.1016/j.ahj.2013.04.004; Dale J, 2009, PATIENT EDUC COUNS, V75, P91, DOI 10.1016/j.pec.2008.09.014; Eakin EG, 2013, ANN BEHAV MED, V46, P193, DOI 10.1007/s12160-013-9498-2; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Graziano Judith A, 2009, ANS Adv Nurs Sci, V32, pE42, DOI 10.1097/ANS.0b013e3181b117a9; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Holtz B, 2012, TELEMED E-HEALTH, V18, P175, DOI 10.1089/tmj.2011.0119; Howe Carol J, 2005, J Pediatr Nurs, V20, P83, DOI 10.1016/j.pedn.2004.12.010; Howells L, 2002, DIABETIC MED, V19, P643, DOI 10.1046/j.1464-5491.2002.00791.x; Institute of Medicine, 1996, TEL GUID ASS TEL HLT; International Diabetes Federation, 2013, IDF DIABETES ATLAS; International Telecommunication Union, 2013, STAT AGGR DAT; Jaana M, 2007, J EVAL CLIN PRACT, V13, P242, DOI 10.1111/j.1365-2753.2006.00686.x; Jarab AS, 2012, J MANAGE CARE PHARM, V18, P516, DOI 10.18553/jmcp.2012.18.7.516; Keogh KM, 2011, AM J MANAG CARE, V17, P105; Keyserling TC, 2002, DIABETES CARE, V25, P1576, DOI 10.2337/diacare.25.9.1576; Khattab M, 2010, J DIABETES COMPLICAT, V24, P84, DOI 10.1016/j.jdiacomp.2008.12.008; Kim HS, 2003, J ADV NURS, V44, P256, DOI 10.1046/j.1365-2648.2003.02800.x; Krein SL, 2004, AM J MED, V116, P732, DOI 10.1016/j.amjmed.2003.11.028; Krishna Santosh, 2008, J Diabetes Sci Technol, V2, P509; Liang X, 2011, DIABETIC MED, V28, P455, DOI 10.1111/j.1464-5491.2010.03180.x; Maljanian Rose, 2005, Dis Manag, V8, P15, DOI 10.1089/dis.2005.8.15; Minet L, 2010, PATIENT EDUC COUNS, V80, P29, DOI 10.1016/j.pec.2009.09.033; Moriyama M, 2009, JPN J NURS SCI, V6, P51, DOI 10.1111/j.1742-7924.2009.00120.x; Naik AD, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-37; Nesari M, 2010, JPN J NURS SCI, V7, P121, DOI 10.1111/j.1742-7924.2010.00146.x; Norris AC, 2002, ESSENTIALS TELEMEDIC; Nunn E, 2006, PEDIATR DIABETES, V7, P254, DOI 10.1111/j.1399-5448.2006.00200.x; Oh JA, 2003, YONSEI MED J, V44, P1, DOI 10.3349/ymj.2003.44.1.1; Piette JD, 2000, AM J MED, V108, P20, DOI 10.1016/S0002-9343(99)00298-3; Piette JD, 2001, DIABETES CARE, V24, P202, DOI 10.2337/diacare.24.2.202; Piette JD, 2011, MED CARE, V49, P641, DOI 10.1097/MLR.0b013e318215d0c9; Polisena J, 2009, DIABETES OBES METAB, V11, P913, DOI 10.1111/j.1463-1326.2009.01057.x; Samuel-Hodge Carmen D, 2006, Prev Chronic Dis, V3, pA93; Skelly AH, 2009, NURS RES, V58, P410, DOI 10.1097/NNR.0b013e3181bee597; Song MS, 2007, J CLIN NURS, V16, P1367, DOI 10.1111/j.1365-2702.2007.01800.x; Taylor CB, 2003, DIABETES CARE, V26, P1058, DOI 10.2337/diacare.26.4.1058; Thom DH, 2013, ANN FAM MED, V11, P137, DOI 10.1370/afm.1443; Thompson DM, 1999, CAN MED ASSOC J, V161, P959; Walker EA, 2011, DIABETES CARE, V34, P2, DOI 10.2337/dc10-1005; Whittemore R, 2004, DIABETES EDUCATOR, V30, P795, DOI 10.1177/014572170403000515; Williams ED, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-602; Young RJ, 2005, DIABETES CARE, V28, P278, DOI 10.2337/diacare.28.2.278	47	30	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89207	10.1371/journal.pone.0089207	http://dx.doi.org/10.1371/journal.pone.0089207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB3TA	24586596	Green Published, Green Submitted, gold			2022-12-27	WOS:000331711900104
J	Hung, TM; Ho, CM; Liu, YC; Lee, JL; Liao, YR; Wu, YM; Ho, MC; Chen, CH; Lai, HS; Lee, PH				Hung, Tzu-Min; Ho, Cheng-Maw; Liu, Yen-Chun; Lee, Jia-Ling; Liao, Yow-Rong; Wu, Yao-Ming; Ho, Ming-Chih; Chen, Chien-Hung; Lai, Hong-Shiee; Lee, Po-Huang			Up-Regulation of MicroRNA-190b Plays a Role for Decreased IGF-1 That Induces Insulin Resistance in Human Hepatocellular Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR-I; SERUM-INSULIN; BINDING-PROTEINS; CANCER-RISK; LIVER; EXPRESSION; DISEASE; CELLS; GENE; RNA	Background & Aims: Insulin-like growth factor, (IGF)-1, is produced mainly by the liver and plays important roles in promoting growth and regulating metabolism. Previous study reported that development of hepatocellular carcinoma (HCC) was accompanied by a significant reduction in serum IGF-1 levels. Here, we hypothesized that dysregulation of microRNAs (miRNA) in HCC can modulate IGF-1 expression post-transcriptionally. Methods: The miRNAs expression profiles in a dataset of 29 HCC patients were examined using illumina BeadArray. Specific miRNA (miR)-190b, which was significantly up-regulated in HCC tumor tissues when compared with paired non-tumor tissues, was among those predicted to interact with 3'-untranslated region (UTR) of IGF-1. In order to explore the regulatory effects of miR-190b on IGF-1 expression, luciferase reporter assay, quantitative real-time PCR, western blotting and immunofluorecence analysis were performed in HCC cells. Results: Overexpression of miR-190b in Huh7 cells attenuated the expression of IGF-1, whereas inhibition of miR-190b resulted in up-regulation of IGF-1. Restoration of IGF-1 expression reversed miR-190b-mediated impaired insulin signaling in Huh7 cells, supporting that IGF-1 was a direct and functional target of miR-190b. Additionally, low serum IGF-1 level was associated with insulin resistance and poor overall survival in HCC patients. Conclusions: Increased expression of miR-190 may cause decreased IGF-1 in HCC development. Insulin resistance appears to be a part of the physiopathologic significance of decreased IGF-1 levels in HCC progression. This study provides a novel miRNA-mediated regulatory mechanism for controlling IGF-1 expression in HCC and elucidates the biological relevance of this interaction in HCC.	[Hung, Tzu-Min; Ho, Cheng-Maw; Liu, Yen-Chun; Lee, Jia-Ling; Liao, Yow-Rong; Wu, Yao-Ming; Ho, Ming-Chih; Lai, Hong-Shiee; Lee, Po-Huang] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Hung, Tzu-Min; Ho, Cheng-Maw; Liu, Yen-Chun; Lee, Jia-Ling; Liao, Yow-Rong; Wu, Yao-Ming; Ho, Ming-Chih; Lai, Hong-Shiee; Lee, Po-Huang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hung, Tzu-Min; Liu, Yen-Chun] E DA Hosp, Dept Med Res, Kaohsiung, Taiwan; [Ho, Cheng-Maw] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chen, Chien-Hung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lee, Po-Huang] E DA Hosp, Dept Surg, Kaohsiung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; E-Da Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; E-Da Hospital	Lee, PH (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	pohuang1115@ntu.edu.tw	Ho, Ming-Chih/AAR-9783-2021; Ho, Cheng-Maw/H-5366-2019; Dawson, Angela/A-6872-2011; Hung, Tommy/E-7450-2014	Ho, Ming-Chih/0000-0003-3660-1062; Ho, Cheng-Maw/0000-0003-1874-7615; LEE, Regina Lai Tong/0000-0003-1884-8360; Dawson, Angela/0000-0003-0926-2202; LEE, PO-HUANG/0000-0001-5831-035X; Chiang, Vico/0000-0002-6973-7241; Hung, Tommy/0000-0002-4031-7606; WU, YAO-MING/0000-0002-1720-7863; Lai, Hong-Shiee/0000-0002-7958-2183	National Science Council [NSC-99-2314-B-002-068-MY2, NSC-101-2314-B -650-005, NSC-102-2314-B-650-007-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by research grants NSC-99-2314-B-002-068-MY2, NSC-101-2314-B -650-005 and NSC-102-2314-B-650-007-MY3 from the National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Afroze, 2008, Expert Rev Cardiovasc Ther, V6, P1135, DOI 10.1586/14779072.6.8.1135; Adeli K, 2011, AM J PHYSIOL-ENDOC M, V301, pE1051, DOI 10.1152/ajpendo.00399.2011; Bonefeld K, 2011, LIVER INT, V31, P911, DOI 10.1111/j.1478-3231.2010.02428.x; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Hung CH, 2010, WORLD J GASTROENTERO, V16, P2265, DOI 10.3748/wjg.v16.i18.2265; Hung TM, 2011, CARCINOGENESIS, V32, P1815, DOI 10.1093/carcin/bgr219; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Kaseb AO, 2011, J CLIN ONCOL, V29, P3892, DOI 10.1200/JCO.2011.36.0636; Kawaguchi T, 2011, WORLD J HEPATOL, V3, P99, DOI 10.4254/wjh.v3.i5.99; Kim SJ, 2011, J CONTROL RELEASE, V155, P427, DOI 10.1016/j.jconrel.2011.06.026; Kwiecinski M, 2012, LAB INVEST, V92, P978, DOI 10.1038/labinvest.2012.70; Lee EK, 2010, ENDOCRINOLOGY, V151, P1403, DOI 10.1210/en.2009-1123; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Loeper S, 2008, REV ENDOCR METAB DIS, V9, P41, DOI 10.1007/s11154-007-9063-z; Mazziotti G, 2002, CANCER, V95, P2539, DOI 10.1002/cncr.11002; Miuma S, 2009, ONCOL REP, V22, P1415, DOI 10.3892/or_00000583; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Raddatz D, 2007, Z GASTROENTEROL, V45, P51, DOI 10.1055/s-2006-927394; Rajpathak SN, 2009, DIABETES-METAB RES, V25, P3, DOI 10.1002/dmrr.919; Rehem RNAMA, 2011, HEPATO-GASTROENTEROL, V58, P949; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Sceusi EL, 2011, HPB, V13, P369, DOI 10.1111/j.1477-2574.2011.00303.x; Schober ME, 2012, J NEUROTRAUM, V29, P2075, DOI 10.1089/neu.2011.2276; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Shao YY, 2012, CLIN CANCER RES, V18, P3992, DOI 10.1158/1078-0432.CCR-11-2853; Stuver SO, 2000, INT J CANCER, V87, P118, DOI 10.1002/1097-0215(20000701)87:1<118::AID-IJC17>3.0.CO;2-W; SU TS, 1989, CANCER RES, V49, P1773; Su WW, 2010, J CLIN LAB ANAL, V24, P195, DOI 10.1002/jcla.20320; Sumie S, 2007, ONCOL REP, V18, P545; Svoboda M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-195; Thissen JP, 1997, ENDOCRINOLOGY, V138, P1078, DOI 10.1210/en.138.3.1078; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Tsugane S, 2010, CANCER SCI, V101, P1073, DOI 10.1111/j.1349-7006.2010.01521.x; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yu R, 2003, MOL CELL ENDOCRINOL, V204, P31, DOI 10.1016/S0303-7207(03)00145-X; Yu XY, 2008, BIOCHEM BIOPH RES CO, V376, P548, DOI 10.1016/j.bbrc.2008.09.025	45	66	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e89446	10.1371/journal.pone.0089446	http://dx.doi.org/10.1371/journal.pone.0089446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586785	gold, Green Submitted, Green Published			2022-12-27	WOS:000331714700120
J	Wang, H; Sun, W; Ma, JQ; Pan, YC; Wang, L; Zhang, WB				Wang, Hua; Sun, Wen; Ma, Junqing; Pan, Yongchu; Wang, Lin; Zhang, Weibing			Polycystin-1 Mediates Mechanical Strain-Induced Osteoblastic Mechanoresponses via Potentiation of Intracellular Calcium and Akt/beta-Catenin Pathway	PLOS ONE			English	Article							FOCAL ADHESION KINASE; KIDNEY-DISEASE; PROTEIN-KINASE; OSTEOGENIC DIFFERENTIATION; FLUID-FLOW; BONE-CELLS; PKD1 GENE; SKELETAL; ACTIVATION; MECHANOTRANSDUCTION	Mechanical regulation of bone formation involves a complex biophysical process, yet the underlying mechanisms remain poorly understood. Polycystin-1 (PC1) is postulated to function as a mechanosensory molecule mediating mechanical signal transduction in renal epithelial cells. To investigate the involvement of PC1 in mechanical strain-induced signaling cascades controlling osteogenesis, PKD1 gene was stably silenced in osteoblastic cell line MC3T3-E1 by using lentivirus-mediated shRNA technology. Here, our findings showed that mechanical tensile strain sufficiently enhanced osteogenic gene expressions and osteoblastic proliferation. However, PC1 deficiency resulted in the loss of the ability to sense external mechanical stimuli thereby promoting osteoblastic osteogenesis and proliferation. The signal pathways implicated in this process were intracellular calcium and Akt/beta-catenin pathway. The basal levels of intracellular calcium, phospho-Akt, phospho-GSK-3 beta and nuclear accumulation of active beta-catenin were significantly attenuated in PC1 deficient osteoblasts. In addition, PC1 deficiency impaired mechanical strain-induced potentiation of intracellular calcium, and activation of Akt-dependent and Wnt/beta-catenin pathways, which was able to be partially reversed by calcium ionophore A23187 treatment. Furthermore, applications of LiCl or A23187 in PC1 deficient osteoblasts could promote osteoblastic differentiation and proliferation under mechanical strain conditions. Therefore, our results demonstrated that osteoblasts require mechanosensory molecule PC1 to adapt to external mechanical tensile strain thereby inducing osteoblastic mechanoresponse, partially through the potentiation of intracellular calcium and downstream Akt/b-catenin signaling pathway.	[Wang, Hua; Ma, Junqing; Pan, Yongchu; Wang, Lin; Zhang, Weibing] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China; [Sun, Wen] Nanjing Med Univ, Res Ctr Bone & Stem Cells, Dept Anat Histol & Embryol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, L (corresponding author), Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China.	nydwlktz@gmail.com; weibingzhang.njmu@gmail.com		wang, wei/0000-0002-0440-0859	National Natural Science Foundation of China [30973361, 81170981]; Natural Science Foundation for Colleges and Universities in JiangSu Province [10kJB320004]; Jiangsu Province Innovation Project for Graduate Student of China [CXZZ12_0589]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Colleges and Universities in JiangSu Province; Jiangsu Province Innovation Project for Graduate Student of China	This study was supported in part by the National Natural Science Foundation of China (30973361, 81170981) and Natural Science Foundation for Colleges and Universities in JiangSu Province (10kJB320004) and by the Jiangsu Province Innovation Project for Graduate Student of China (CXZZ12_0589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Boletta Alessandra, 2009, Pathogenetics, V2, P6, DOI 10.1186/1755-8417-2-6; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Case N, 2010, J CELL BIOCHEM, V110, P545, DOI 10.1002/jcb.22574; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dalagiorgou G, 2013, CELL MOL LIFE SCI, V70, P167, DOI 10.1007/s00018-012-1164-5; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Faibish D, 2006, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000200241.14684.4e; Forman JR, 2005, J MOL BIOL, V349, P861, DOI 10.1016/j.jmb.2005.04.008; Gao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063084; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gay IC, 2007, ORTHOD CRANIOFAC RES, V10, P149, DOI 10.1111/j.1601-6343.2007.00399.x; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hoey DA, 2012, STEM CELLS, V30, P2561, DOI 10.1002/stem.1235; Hou B, 2009, BONE, V44, P1121, DOI 10.1016/j.bone.2009.02.018; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Khan KM, 2009, BRIT J SPORT MED, V43, P247, DOI 10.1136/bjsm.2008.054239; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Kolpakova-Hart E, 2008, DEV BIOL, V321, P407, DOI 10.1016/j.ydbio.2008.07.005; Kreja L, 2008, BIOCHEM BIOPH RES CO, V368, P582, DOI 10.1016/j.bbrc.2008.01.106; Lei G, 2011, BIOL CELL, V103, P185, DOI 10.1042/BC20100134; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223; Qiu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046038; Qiu N, 2012, J CELL BIOCHEM, V113, P967, DOI 10.1002/jcb.23426; Raisz LG, 1999, CLIN CHEM, V45, P1353; Rangaswami H, 2012, J BIOL CHEM, V287, P21509, DOI 10.1074/jbc.M112.347245; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Walker LM, 2000, J CELL BIOCHEM, V79, P648, DOI 10.1002/1097-4644(20001215)79:4<648::AID-JCB130>3.0.CO;2-Q; Weimbs T, 2007, AM J PHYSIOL-RENAL, V293, pF1423, DOI 10.1152/ajprenal.00275.2007; Weimbs T, 2006, CELL CYCLE, V5, P2425, DOI 10.4161/cc.5.21.3408; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xiao ZS, 2010, J BIOL CHEM, V285, P1177, DOI 10.1074/jbc.M109.050906; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Yu Y, 2012, HISTOCHEM CELL BIOL, V137, P513, DOI 10.1007/s00418-011-0908-x; Zhang WB, 2009, J CELL BIOCHEM, V108, P600, DOI 10.1002/jcb.22291	58	93	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91730	10.1371/journal.pone.0091730	http://dx.doi.org/10.1371/journal.pone.0091730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24586557	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400123
J	Zhang, ZX; Zhao, H; Tang, J; Li, Z; Li, Z; Chen, DM; Lin, WX				Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Li, Zhou; Chen, Dongmei; Lin, Wenxiong			A Proteomic Study on Molecular Mechanism of Poor Grain-Filling of Rice (Oryza sativa L.) Inferior Spikelets	PLOS ONE			English	Article							STARCH BIOSYNTHETIC-ENZYMES; JAPONICA/INDICA HYBRID RICE; 14-3-3 PROTEINS; POSTANTHESIS DEVELOPMENT; SUPERIOR SPIKELETS; PLANT-METABOLISM; DIFFERENTIAL EXPRESSION; SIGNAL-TRANSDUCTION; DIFFERENT POSITIONS; BARLEY GRAINS	Cultivars of rice (Oryza sativa L.), especially of the type with large spikelets, often fail to reach the yield potential as expected due to the poor grain-filling on the later flowering inferior spikelets (in contrast to the earlier-flowering superior spikelets). The present study showed that the size and grain weight of superior spikelets (SS) was greater than those of inferior spikelets (IS), and the carbohydrate supply should not be the major problem for the poor grain-filling because there was adequate amount of sucrose in IS at the initial grain-filling stage. High resolution two-dimensional gel electrophoresis (2-DE) in combination with Coomassie-brilliant blue (CBB) and Pro-Q Diamond phosphoprotein fluorescence stain revealed that 123 proteins in abundance and 43 phosphoproteins generated from phosphorylation were significantly different between SS and IS. These proteins and phosphoproteins were involved in different cellular and metabolic processes with a prominently functional skew toward metabolism and protein synthesis/destination. Expression analyses of the proteins and phosphoproteins associated with different functional categories/subcategories indicated that the starch synthesis, central carbon metabolism, N metabolism and cell growth/division were closely related to the poor grain-filling of IS. Functional and expression pattern studies also suggested that 14-3-3 proteins played important roles in IS poor grain-filling by regulating the activity of starch synthesis enzymes. The proteome and phosphoproteome obtained from this study provided a better understanding of the molecular mechanism of the IS poor grain-filling. They were also expected to be highly useful for improving the grain filling of rice.	[Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Lin, Wenxiong] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Zhang, Zhixing; Zhao, Hong; Tang, Jun; Li, Zhong; Li, Zhou; Chen, Dongmei; Lin, Wenxiong] Fujian Agr & Forestry Univ, Fujian Prov Key Lab Agroecol Proc & Safety Monito, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Lin, WX (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China.	wenxiong181@163.com		liu, chun ming/0000-0002-7271-362X; Hoi, Maggie Pui Man/0000-0003-2630-3707; Zhang, Zhao/0000-0002-7323-5500; Song, Yin/0000-0002-6037-777X	National Natural Science Foundation of China [31271670]; Provincial Natural Science Foundation of Fujian, China [2012J01075, 2013J01092]; Department of Education Science and Technology Project of Fujian, China [JK2011014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Fujian, China(Natural Science Foundation of Fujian Province); Department of Education Science and Technology Project of Fujian, China	This work was sponsored by the National Natural Science Foundation of China (No. 31271670), Provincial Natural Science Foundation of Fujian, China (No. 2012J01075, 2013J01092), and Department of Education Science and Technology Project of Fujian, China (No. JK2011014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Chitteti BR, 2007, PROTEOMICS, V7, P1473, DOI 10.1002/pmic.200600871; Chung HJ, 1999, TRENDS PLANT SCI, V4, P367, DOI 10.1016/S1360-1385(99)01462-4; COHEN P, 1985, EUR J BIOCHEM, V151, P439, DOI 10.1111/j.1432-1033.1985.tb09121.x; Colleoni C., 2003, Journal of Applied Glycoscience, V50, P207; Comparot S, 2003, J EXP BOT, V54, P595, DOI 10.1093/jxb/erg057; COOPER JA, 1984, J BIOL CHEM, V259, P7835; Dinges JR, 2003, PLANT CELL, V15, P666, DOI 10.1105/tpc.007575; El-Sharkawy I, 2010, J EXP BOT, V61, P1761, DOI 10.1093/jxb/erq043; Fageria NK, 2007, J PLANT NUTR, V30, P843, DOI 10.1080/15226510701374831; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Ferl RJ, 1996, ANNU REV PLANT PHYS, V47, P49, DOI 10.1146/annurev.arplant.47.1.49; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; GARRELS JI, 1983, METHOD ENZYMOL, V100, P411; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Gururaj A, 2004, ONCOGENE, V23, P8118, DOI 10.1038/sj.onc.1207969; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Ishimaru T, 2003, FUNCT PLANT BIOL, V30, P1139, DOI 10.1071/FP03122; Kato T, 2007, PLANT PROD SCI, V10, P442, DOI 10.1626/pps.10.442; Kikuchi H, 1999, PLANT MOL BIOL, V39, P149, DOI 10.1023/A:1006156214716; Kim YM, 2012, MOL CELLS, V33, P617, DOI 10.1007/s10059-012-0080-8; Lin XM, 2008, J PROTEOME RES, V7, P1235, DOI 10.1021/pr7005928; LUR HS, 1993, PLANT PHYSIOL, V103, P273, DOI 10.1104/pp.103.1.273; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mayer U, 2002, CURR OPIN PLANT BIOL, V5, P494, DOI 10.1016/S1369-5266(02)00302-3; Mechin V, 2007, PLANT PHYSIOL, V143, P1203, DOI 10.1104/pp.106.092148; Membre N, 1997, PLANT MOL BIOL, V35, P459, DOI 10.1023/A:1005833028582; Meyer LJ, 2012, PLANT PHYSIOL, V159, P517, DOI 10.1104/pp.111.191700; Mohapatra PK, 2009, PLANT SCI, V176, P256, DOI 10.1016/j.plantsci.2008.11.001; MOHAPATRA PK, 1993, AUST J PLANT PHYSIOL, V20, P231, DOI 10.1071/PP9930231; MURTY PSS, 1982, INDIAN J PLANT PHYSI, V25, P40; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; Peng T, 2011, J EXP BOT, V62, P4943, DOI 10.1093/jxb/err205; Ramasamy S, 1997, FIELD CROP RES, V51, P65, DOI 10.1016/S0378-4290(96)01039-8; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rolletschek H, 2004, J EXP BOT, V55, P1351, DOI 10.1093/jxb/erh130; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Sehnke PC, 1996, CURR BIOL, V6, P1403, DOI 10.1016/S0960-9822(96)00742-7; Sehnke PC, 2001, P NATL ACAD SCI USA, V98, P765, DOI 10.1073/pnas.021304198; Song JianMin, 2009, Acta Agronomica Sinica, V35, P1445, DOI 10.3724/SP.J.1006.2009.01445; Tadege M, 1999, TRENDS PLANT SCI, V4, P320, DOI 10.1016/S1360-1385(99)01450-8; Tang T, 2009, J EXP BOT, V60, P2641, DOI 10.1093/jxb/erp114; Tao LongXing, 2003, Chinese Journal of Rice Science, V17, P149; Teng B, 2012, MOL BREEDING, V30, P583, DOI 10.1007/s11032-011-9647-x; Teo CJ, 2011, ACTA PHYSIOL PLANT, V33, P2259, DOI 10.1007/s11738-011-0765-1; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Thitisaksakul M, 2012, J CEREAL SCI, V56, P67, DOI 10.1016/j.jcs.2012.04.002; van Dongen JT, 2004, PLANT PHYSIOL, V135, P1809, DOI 10.1104/pp.104.040980; Vassileva V. N., 2005, PLANT BIOTECHNOL, V22, P171; Wojtaszek P, 1997, J EXP BOT, V48, P2015, DOI 10.1093/jexbot/48.317.2015; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2003, PLANT GROWTH REGUL, V41, P185, DOI 10.1023/B:GROW.0000007503.95391.38; Yang JC, 2002, CROP SCI, V42, P766, DOI 10.2135/cropsci2002.0766; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; YOSHIDA S, 1972, ANN REV PLANT PHYSIO, V23, P437, DOI 10.1146/annurev.pp.23.060172.002253; Yoshida S, 1976, ANNU REV PLANT PHYS, P46; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang ZhiXing, 2012, Australian Journal of Crop Science, V6, P316; Zhang ZX, 2012, PLANT SCI, V185, P259, DOI 10.1016/j.plantsci.2011.11.012; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Zhu QS, 1988, ACTA AGRON SIN, V3, P182; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x	70	98	104	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89140	10.1371/journal.pone.0089140	http://dx.doi.org/10.1371/journal.pone.0089140			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24992590	gold, Green Published, Green Submitted			2022-12-27	WOS:000331717900056
J	Wang, H; Zhou, L; Guo, JM; Sun, L; Long, QL; Ma, Y; Zhang, L; Lin, ZM; Zhu, TY; Wang, GM				Wang, Hang; Zhou, Lin; Guo, Jianming; Sun, Li'an; Long, Qilai; Ma, Yong; Zhang, Li; Lin, Zongming; Zhu, Tongyu; Wang, Guomin			Mini-Flank Supra-12th Rib Incision for Open Partial Nephrectomy Compared with Laparoscopic Partial Nephrectomy and Traditional Open Partial Nephrectomy	PLOS ONE			English	Article							RADICAL NEPHRECTOMY; COMPLICATIONS; OUTCOMES; SURGERY; TUMORS	Purpose: The purpose of this study was to report our approach of partial nephrectomy (PN) using a supra-12th rib mini-flank incision. We compared mini-incision open partial nephrectomy (MI-OPN) with open partial nephrectomy (OPN) and laparoscopic partial nephrectomy (LPN) to verify whether MI-OPN can be an alternative to OPN and LPN. Methods: This was a retrospective single-center study including 194 patients who underwent partial nephrectomy (PN) between February 2005 and December 2010. Demographic, perioperative, and complication data were compared among the MI-OPN group, OPN group and LPN group. Results: No statistical differences were reported in either group for age, sex, BMI, tumour side (right or left kidney), RENAL nephrometry scores, PADUA score and preoperative eGFR. The operative time was longer in LPN group when compared with MI-OPN and OPN group (all P < 0.001). The warm ischemia time of LPN group was longer than MI-OPN group (P = 0.032) and OPN group (P = 0.005). The length of stay of LPN group was shorter than OPN group (P = 0.018), but was similar to MI-OPN group (P = 0.094). The incidence of renal artery clamping was lower in OPN group when compared with MI-OPN and LPN group (all P, 0.001). More estimated blood loss was found in OPN group when compared with MI-OPN group (p = 0.003) and LPN group (P = 0.014). The overall incidence of postoperative complications was similar. Conclusions: The approach of MI-OPN can couple the benefits of both minimally invasive and open partial nephrectomy techniques with less estimated blood loss, shorter operative time, shorter length of stay, less postoperative complications, and a smaller incision. MI-OPN may be an effective alternative to laparoscopic or traditional open approaches, which maybe more suitable for the tumors with high RENAL nephrometry score or PADUA score.	[Wang, Hang; Zhou, Lin; Guo, Jianming; Sun, Li'an; Long, Qilai; Ma, Yong; Zhang, Li; Lin, Zongming; Zhu, Tongyu; Wang, Guomin] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China	Fudan University	Wang, H (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	wang.hang@zs-hospital.sh.cn; guo.jianming@zs-hospital.sh.cn		wang, wei/0000-0002-0440-0859				Breda A, 2007, J UROLOGY, V178, P47, DOI 10.1016/j.juro.2007.03.045; Chatterjee S, 2004, UROL ONCOL-SEMIN ORI, V22, P36, DOI 10.1016/S1078-1439(03)00099-1; DiBlasio CJ, 2006, BJU INT, V97, P149, DOI 10.1111/j.1464-410X.2006.05882.x; Ficarra V, 2009, EUR UROL, V56, P786, DOI 10.1016/j.eururo.2009.07.040; Frank I, 2006, J UROLOGY, V175, P849, DOI 10.1016/S0022-5347(05)00346-0; Gill IS, 2000, J UROLOGY, V163, P1665, DOI 10.1016/S0022-5347(05)67516-7; GILL IS, 1995, J UROLOGY, V154, P479, DOI 10.1016/S0022-5347(01)67078-2; Huang WC, 2007, NAT CLIN PRACT UROL, V4, P444, DOI 10.1038/ncpuro0855; Jain S, 2013, J UROLOGY, V189, P1643, DOI 10.1016/j.juro.2012.11.170; Kenney Chad Wotkowicz, 2012, CAMPBELL WALSH UROLO, V2, P1567; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Marszalek M, 2009, EUR UROL, V55, P1171, DOI 10.1016/j.eururo.2009.01.042; Mitropoulos D, 2012, EUR UROL, V61, P341, DOI 10.1016/j.eururo.2011.10.033; Nadu A, 2009, J UROLOGY, V181, P42, DOI 10.1016/j.juro.2008.09.014; Permpongkosol S, 2007, J UROLOGY, V177, P580, DOI 10.1016/j.juro.2006.09.031; Peycelon M, 2009, J UROLOGY, V181, P35, DOI 10.1016/j.juro.2008.09.025; Ramani AP, 2005, J UROLOGY, V173, P42, DOI 10.1097/01.ju.0000147177.20458.73; Russo P, 2010, BJU INT, V105, P1494, DOI 10.1111/j.1464-410X.2010.09388.x; Ward J N, 1974, Urology, V3, P163, DOI 10.1016/S0090-4295(74)80006-3	20	93	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89155	10.1371/journal.pone.0089155	http://dx.doi.org/10.1371/journal.pone.0089155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586557	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900058
J	Wang, HB; Fang, G; Yu, WZ; Du, F; Fan, CX; Liu, QL; Hao, LX; Liu, Y; Zheng, JS; Qin, ZY; Xia, W; Zhang, SY; Yin, ZD; Jing, Q; Zhang, YX; Huang, RN; Yang, RP; Tong, WB; Qi, Q; Guan, XJ; Jing, YL; Ma, QL; Wang, J; Ma, XZ; Chen, N; Zheng, HR; Li, YQ; Ma, C; Su, QR; Reilly, KH; Luo, HM; Wu, XP; Wen, N; Yang, WZ				Wang, Hai-Bo; Fang, Gang; Yu, Wen-Zhou; Du, Fei; Fan, Chun-Xiang; Liu, Qing-Lian; Hao, Li-Xin; Liu, Yu; Zheng, Jing-Shan; Qin, Zhi-Ying; Xia, Wei; Zhang, Shi-Yue; Yin, Zun-Dong; Jing, Qiong; Zhang, Yan-Xia; Huang, Rong-Na; Yang, Ru-Pei; Tong, Wen-Bin; Qi, Qi; Guan, Xu-Jing; Jing, Yu-Lin; Ma, Qian-Li; Wang, Jin; Ma, Xiao-Zhen; Chen, Na; Zheng, Hong-Ru; Li, Yin-Qiao; Ma, Chao; Su, Qi-Ru; Reilly, Kathleen H.; Luo, Hui-Ming; Wu, Xian-Ping; Wen, Ning; Yang, Wei-Zhong			An Outbreak of Type Pi Vaccine- Derived Poliovirus in Sichuan Province, China: Emergence and Circulation in an Under-Immunized Population	PLOS ONE			English	Article							POLIOMYELITIS	Background: During August 2011-February 2012, an outbreak of type P circulating vaccine-derived poliovirus (cVDPVs) occurred in Sichuan Province, China. Methods: A field investigation of the outbreak was conducted to characterize outbreak isolates and to guide emergency response. Sequence analysis of poliovirus capsid protein VP1 was performed to determine the viral propagation, and a coverage survey was carried out for risk assessment. Results: One clinical compatible polio case and three VDPV cases were determined in Ngawa County, Ngawa Tibetan and Qiang Autonomous Prefecture, Sichuan Province. Case patients were unimmunized children, 0.8-1 years old. Genetic sequencing showed that the isolates diverged from the VP1 region of the type P Sabin strain by 5-12 nucleotides (nt) and shared the same 5 nt VP1 substitutions, which indicate single lineage of cVDPVs. Of the 7 acute flaccid paralysis cases (all. 6 months) reported in Ngawa Prefecture in 2011, 4 (57.1%) cases (including 2 polio cases) did not receive oral attenuated poliovirus vaccine. Supplementary immunization activities (SIAs) were conducted in February-May, 2012, and the strain has not been isolated since. Conclusion: High coverage of routine immunization should be maintained among children until WPV transmission is globally eradicated. Risk assessments should be conducted regularly to pinpoint high risk areas or subpopulations, with SIAs developed if necessary.	[Wang, Hai-Bo; Yu, Wen-Zhou; Fan, Chun-Xiang; Hao, Li-Xin; Zheng, Jing-Shan; Xia, Wei; Yin, Zun-Dong; Zhang, Yan-Xia; Ma, Chao; Su, Qi-Ru; Luo, Hui-Ming; Wen, Ning; Yang, Wei-Zhong] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China; [Wang, Hai-Bo] Peking Univ, Clin Res Inst, Beijing 100191, Peoples R China; [Fang, Gang; Du, Fei; Liu, Qing-Lian; Liu, Yu; Qin, Zhi-Ying; Tong, Wen-Bin; Qi, Qi; Guan, Xu-Jing; Jing, Yu-Lin; Ma, Qian-Li; Wang, Jin; Ma, Xiao-Zhen; Chen, Na; Zheng, Hong-Ru; Li, Yin-Qiao; Wu, Xian-Ping] Sichuan Prov Ctr Dis Control & Prevent, Chengdu 610041, Sichuan Provinc, Peoples R China; [Zhang, Shi-Yue; Jing, Qiong] Ngawa Tibetan & Qiang Autonomous Prefectural Ctr, Chengdu 624000, Sichuan Provinc, Peoples R China; [Huang, Rong-Na; Yang, Ru-Pei] Chengdu City Ctr Dis Control & Prevent, Chengdu 610041, Sichuan Provinc, Peoples R China; [Reilly, Kathleen H.] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China	Chinese Center for Disease Control & Prevention; Peking University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Luo, HM (corresponding author), Chinese Ctr Dis Control & Prevent, Nanwei Rd 27, Beijing 100050, Peoples R China.	Hmluo@vip.sina.com; wwwuxp@163.com; ning_wen@163.com; yangwz@chinacdc.cn		wang, wei/0000-0002-0440-0859				Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P545; [Anonymous], 1999, MMWR MORB MORTAL WKL, V48, P747; Bahta L., 2005, Morbidity and Mortality Weekly Report, V54, P1053; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1002; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P967; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P145; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P113; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P357; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P736; Estivariz CF, 2008, J INFECT DIS, V197, P347, DOI 10.1086/525049; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; Lowther SA, 2013, MMWR-MORBID MORTAL W, V62, P335; Luo HM, 2013, NEW ENGL J MED, V369, P1981, DOI 10.1056/NEJMoa1303368; Mundel T, 2013, NEW ENGL J MED, V369, P2045, DOI 10.1056/NEJMe1311591; *NAT COMM CERT POL, 2000, DOC CERT POL ER; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; Patriarca PA, 1997, J INFECT DIS, V175, pS165, DOI 10.1093/infdis/175.Supplement_1.S165; Rakoto-Andrianarivelo M, 2008, J INFECT DIS, V197, P1427, DOI 10.1086/587694; Tao WJ, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20343; Wassilak Steve, 2012, Morbidity and Mortality Weekly Report, V61, P353; Wassilak S, 2011, J INFECT DIS, V203, P898, DOI 10.1093/infdis/jiq140; World Health Organization Advisory Committee on Poliomyelitis Eradication, 2005, Wkly Epidemiol Rec, V80, P410; Yoshida H, 2002, J GEN VIROL, V83, P1107, DOI 10.1099/0022-1317-83-5-1107	26	93	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113880	10.1371/journal.pone.0113880	http://dx.doi.org/10.1371/journal.pone.0113880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	24586557	gold, Green Submitted, Green Published			2022-12-27	WOS:000347146700011
J	Xiao, JB; Ding, Y; Huang, J; Li, QS; Liu, Y; Ni, W; Zhang, YQ; Zhu, YF; Chen, LH; Chen, B				Xiao, Jianbiao; Ding, Yi; Huang, Jing; Li, Qisheng; Liu, Ying; Ni, Wen; Zhang, Yuqin; Zhu, Yanfei; Chen, Longhua; Chen, Bin			The Association of HMGB1 Gene with the Prognosis of HCC	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; RECURRENT HEPATOCELLULAR-CARCINOMA; HIGH-MOBILITY-GROUP-BOX-1 HMGB1; INCREASED EXPRESSION; CHROMATIN PROTEIN; POOR-PROGNOSIS; GASTRIC-CANCER; UNITED-STATES; CYTOKINE; CELLS	High-mobility group box 1 protein (HMGB1) is an evolutionarily ancient and critical regulator of cell death and survival. HMGB1 is a chromatin-associated nuclear protein molecule that triggers extracellular damage. The expression of HMGB1 has been reported in many types of cancers, but the role of HMGB1 in hepato cellular carcinoma (HCC) is unknown. The aim of this study was to analyze the roles of HMGB1 in HCC progression using HCC clinical samples. We also investigated the clinical outcomes of HCC samples with a special focus on HMBG1 expression. In an immunohistochemical study conducted on 208 cases of HCC, HMGB1 had high expression in 134 cases(64.4%). The HMGB1 expression level did not correlate with any clinicopathological parameters, except alpha fetoprotein (AFP) (p = 0.041) and CLIP stage (p = 0.007). However, survival analysis showed that the group with HMBG1 overexpression had a significantly shorter overall survival time than the group with a down-regulatedexpression of HMBG1 (HR = 0.568, CI (0.398, 0.811), p = 0.002). Multivariate analysis showed that HMGB1 expression was a significant and independent prognostic parameter (HR = 0.562, CI (0.388, 0.815), p = 0.002) for HCC patients. The ability of proliferation, migration and invasion of HCC cells was suppressed with the disruption of endogenous HMGB1 using small interfering RNAs. On the other hand, the ability of proliferation, migration and invasion of HCC cells was strengthened when the expression endogenous HMGB1 was enhanced using HMGB1 DNA. HMGB1 expression may be a novel and independent predictor for the prognosis of HCC patients. The overexpression of HMGB1 in HCC could be a novel, effective, and supplementary biomarker for HCC, since it plays a vital role in the progression of HCC.	[Xiao, Jianbiao; Ding, Yi; Huang, Jing; Li, Qisheng; Liu, Ying; Ni, Wen; Zhang, Yuqin; Zhu, Yanfei; Chen, Longhua] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Chen, Bin] Peoples Liberat Army, Guangzhou Mil Command, Gen Hosp, Dept Sci & Training, Guangzhou, Guangdong, Peoples R China; [Huang, Jing] Guangdong Med Coll, Affiliated Hosp, Dept Canc Ctr, Zhanjiang, Guangdong, Peoples R China	Southern Medical University - China; Southern Theater Command General Hospital; Guangdong Medical University	Chen, LH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China.	chenlhsmu@126.com; cbgzzyy@163.com	Ding, Yi/CAG-6304-2022; Ma, Jinxing/D-9981-2013; Lang, Eric J/A-1136-2017; Wang, Zhiwei/F-5666-2012; Wise, Andrew/B-5943-2014	Cerminara, Nadia/0000-0001-8207-5871; Ding, Yi/0000-0001-5035-9255; Kotsurovskyy, Yuriy/0000-0002-1288-518X; Ma, Jinxing/0000-0002-5087-3972; Yan, Xiaolong/0000-0003-2419-9707; Lang, Eric J/0000-0002-8524-9854; Wang, Zhiwei/0000-0001-6729-2237; Wise, Andrew/0000-0001-9715-8784; Apps, Richard/0000-0002-2064-3359	National Natural Science Foundation of China [81101822]; Guangzhou science and technology [11C26090521]; Guangdong Provincal Science Foundation [10451001002005047, S2013010014185]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou science and technology; Guangdong Provincal Science Foundation	Grant support: National Natural Science Foundation of China (No. 81101822), Guangzhou science and technology key projects (No. 11C26090521), Guangdong Provincal Science Foundation (No. 10451001002005047, No. S2013010014185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 2007, ANTICANCER RES, V27, P449; Bianchi ME, 2004, TRENDS CELL BIOL, V14, P287, DOI 10.1016/j.tcb.2004.04.004; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Brezniceanu ML, 2003, FASEB J, V17, P1295, DOI 10.1096/fj.02-0621fje; Capocaccia R, 2007, AM J GASTROENTEROL, V102, P1661, DOI 10.1111/j.1572-0241.2007.01337.x; Choi YR, 2003, CANCER RES, V63, P2188; Dong XD, 2007, J IMMUNOTHER, V30, P596, DOI 10.1097/CJI.0b013e31804efc76; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Kim DY, 2007, ONCOLOGY-BASEL, V72, P52, DOI 10.1159/000111707; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maeda S, 2007, BIOCHEM BIOPH RES CO, V360, P394, DOI 10.1016/j.bbrc.2007.06.065; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Naghavi MH, 2003, VIROLOGY, V314, P179, DOI 10.1016/S0042-6822(03)00453-7; Ng KK, 2008, ARCH SURG-CHICAGO, V143, P68, DOI 10.1001/archsurg.2007.15; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Poser I, 2003, MOL CELL BIOL, V23, P2991, DOI 10.1128/MCB.23.8.2991-2998.2003; Rudmik LR, 2005, J SURG ONCOL, V92, P347, DOI 10.1002/jso.20393; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Ulloa L, 2003, ARTHRITIS RHEUM, V48, P876, DOI 10.1002/art.10854; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Volp K, 2006, GUT, V55, P234, DOI 10.1136/gut.2004.062729; Wu D, 2008, J PATHOL, V216, P167, DOI 10.1002/path.2391; Xu YF, 2010, J HEPATOL, V53, P872, DOI 10.1016/j.jhep.2010.05.019; Zhang HK, 2008, CANCER LETT, V261, P183, DOI 10.1016/j.canlet.2007.11.019	34	83	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89097	10.1371/journal.pone.0089097	http://dx.doi.org/10.1371/journal.pone.0089097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	25121125	gold, Green Published			2022-12-27	WOS:000331711900089
J	Liu, J; Gaj, T; Patterson, JT; Sirk, SJ; Barbas, CF				Liu, Jia; Gaj, Thomas; Patterson, James T.; Sirk, Shannon J.; Barbas, Carlos F., III			Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; EMBRYO MICROINJECTION; VECTOR TOOLKIT; KNOCKOUT RATS; GENE-TRANSFER; BASIC DOMAIN; IN-VIVO; DNA; RECOGNITION; EFFECTORS	Transcription activator-like (TAL) effector nucleases (TALENs) have enabled the introduction of targeted genetic alterations into a broad range of cell lines and organisms. These customizable nucleases are comprised of programmable sequence-specific DNA-binding modules derived from TAL effector proteins fused to the non-specific FokI cleavage domain. Delivery of these nucleases into cells has proven challenging as the large size and highly repetitive nature of the TAL effector DNA-binding domain precludes their incorporation into many types of viral vectors. Furthermore, viral and non-viral gene delivery methods carry the risk of insertional mutagenesis and have been shown to increase the off-target activity of site-specific nucleases. We previously demonstrated that direct delivery of zinc-finger nuclease proteins enables highly efficient gene knockout in a variety of mammalian cell types with reduced off-target effects. Here we show that conjugation of cell-penetrating poly-Arg peptides to a surface-exposed Cys residue present on each TAL effector repeat imparted cell-penetrating activity to purified TALEN proteins. These modifications are reversible under reducing conditions and enabled TALEN-mediated gene knockout of the human CCR5 and BMPR1A genes at rates comparable to those achieved with transient transfection of TALEN expression vectors. These findings demonstrate that direct protein delivery, facilitated by conjugation of chemical functionalities onto the TALEN protein surface, is a promising alternative to current non-viral and viral-based methods for TALEN delivery into mammalian cells.	[Barbas, Carlos F., III] Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell & Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Barbas, CF (corresponding author), Scripps Res Inst, Dept Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	carlos@scripps.edu	Liu, Jia/E-5758-2014	Patterson, James/0000-0001-6006-7184; liu, juanjuan/0000-0001-6941-0372; Ma, Leina/0000-0003-3964-632X; Lin, Xiukun/0000-0002-0306-4953; Spincemaille, Pascal/0000-0002-8821-1341; Prince, Martin/0000-0002-9883-0584; Saloner, David/0000-0002-6989-8547	US National Institutes for Health [DP1CA174426]; NATIONAL CANCER INSTITUTE [DP1CA174426] Funding Source: NIH RePORTER	US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Institutes for Health (DP1CA174426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen Z, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt710; Choi JM, 2006, NAT MED, V12, P574, DOI 10.1038/nm1385; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jin LH, 2001, FREE RADICAL BIO MED, V31, P1509, DOI 10.1016/S0891-5849(01)00734-1; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Kim SS, 2011, METHODS MOL BIOL, V721, P339, DOI 10.1007/978-1-61779-037-9_21; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056633; Mitsui H, 2006, J INVEST DERMATOL, V126, P1804, DOI 10.1038/sj.jid.5700335; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Provasi E, 2012, NAT MED, V18, P807, DOI 10.1038/nm.2700; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ru Renli, 2013, Cell Regen, V2, P5, DOI 10.1186/2045-9769-2-5; Segal DJ, 2013, ANNU REV GENOM HUM G, V14, P135, DOI 10.1146/annurev-genom-091212-153435; Stella S, 2013, ACTA CRYSTALLOGR D, V69, P1707, DOI 10.1107/S0907444913016429; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Van Tendeloo VFI, 2000, GENE THER, V7, P1431, DOI 10.1038/sj.gt.3301252; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009	48	200	240	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85755	10.1371/journal.pone.0085755	http://dx.doi.org/10.1371/journal.pone.0085755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24626155	gold, Green Published			2022-12-27	WOS:000330240500068
